FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hassert, M
   Harris, MG
   Brien, JD
   Pinto, AK
AF Hassert, Mariah
   Harris, Madison G.
   Brien, James D.
   Pinto, Amelia K.
TI Identification of Protective CD8 T Cell Responses in a Mouse Model of
   Zika Virus Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika; dengue; CD8+T cells; epitope; correlates of protection; immunology
   and infectious diseases; immunodominance
ID WEST-NILE-VIRUS; DENGUE VIRUS; YELLOW-FEVER; ARBOVIRUS INFECTIONS;
   SEXUAL TRANSMISSION; PREGNANT-WOMEN; UNITED-STATES; ANTIBODIES; NIGERIA;
   ENCEPHALITIS
AB Many flaviviruses including dengue (DENV), and Zika (ZIKV) have attracted significant attention in the past few years. As many flaviviruses are spread by arthropods, most of the world's population is at risk of encountering a flavivirus, and infection with these viruses has created a significant disease burden worldwide. Vaccination against flaviviruses is thought to be one of the most promising avenues for reducing the disease burden associated with these viruses. The optimism surrounding a vaccine approach is supported by the highly successful vaccines for yellow fever and Japanese encephalitis. Central to the development of new successful vaccines is the understanding of the correlates of protection that will be necessary to engineer into new vaccines. To aid in this endeavor we have directed our efforts to identify correlates of protection that will reduce the disease burden associated with ZIKV and DENV. Within this study we have identified a novel murine ZIKV specific CD8(+) T cell epitope, and shown that the ZIKV epitope specific CD8(+) T cell response has a distinct immunodominance hierarchy present during acute infection and is detectible as part of the memory T cell responses. Our studies confirm that ZIKV-specific CD8(+) T cells are an important correlate of protection for ZIKV and demonstrate that both naive and ZIKV immune CD8(+) T cells are sufficient for protection against a lethal ZIKV infection. Overall this study adds to the body of literature demonstrating a role for CD8(+) T cells in controlling flavivirus infection.
C1 [Hassert, Mariah; Harris, Madison G.; Brien, James D.; Pinto, Amelia K.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
RP Pinto, AK (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
EM amelia.pinto@health.slu.edu
FU Saint Louis University; NIH K22 awardUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA
   [5K22AI104794-02]
FX This research was funded be the institutional startup funds provided to
   AP and JB by Saint Louis University. NIH K22 award (5K22AI104794-02) JB
   Principal Investigator.
CR Ahmed QA, 2017, TROP DOCT, V47, P92, DOI 10.1177/0049475517699726
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakiboneka R, 2019, VACCINE, V37, P113, DOI 10.1016/j.vaccine.2018.11.024
   Neves PCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081953
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Shrestha B, 2008, VACCINE, V26, P2020, DOI 10.1016/j.vaccine.2008.02.009
   Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVI.01136-07
   Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watson AM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040077
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 71
TC 2
Z9 2
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 17
PY 2019
VL 10
AR 1678
DI 10.3389/fimmu.2019.01678
PG 12
WC Immunology
SC Immunology
GA IJ3UA
UT WOS:000475828800001
PM 31379867
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roberts, CC
AF Roberts, Christine C.
TI Emerging infectious disease laboratory and diagnostic preparedness to
   accelerate vaccine development
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Review
DE Emerging infectious disease; vaccines; immune response; virus detection;
   zika virus; flaviviruses; clinical trials
ID REVERSE TRANSCRIPTION-PCR; ZIKA; IMMUNOASSAY; ASSAYS; CORONAVIRUS;
   VALIDATION
AB Rapid vaccine development in response to an outbreak of a new emerging infectious disease (EID) is a goal targeted by public health agencies worldwide. This goal becomes more complicated when there are no standardized sets of viral and immunological assays, no accepted and well-characterized samples, standards or reagents, and no approved diagnostic tests for the EID pathogen. The diagnosis of infections is of critical importance to public health, but also in vaccine development in order to track incident infections during clinical trials, to differentiate natural infection responses from those that are vaccine-related and, if called for by study design, to exclude subjects with prior exposure from vaccine efficacy trials. Here we review emerging infectious disease biological standards development, vaccine clinical assay development and trial execution with the recent experiences of MERS-CoV and Zika virus as examples. There is great need to establish, in advance, the standardized reagents, sample panels, controls, and assays to support the rapid advancement of vaccine development efforts in response to EID outbreaks.
C1 [Roberts, Christine C.] GeneOne Life Sci Inc, Clin Lab Dev, 1040 DeKalb Pike,Suite 200, Blue Bell, PA 19422 USA.
RP Roberts, CC (corresponding author), GeneOne Life Sci Inc, Clin Lab Dev, 1040 DeKalb Pike,Suite 200, Blue Bell, PA 19422 USA.
EM croberts@geneonels-us.com
CR Alhetheel A, 2017, VIRAL IMMUNOL, V30, P649, DOI 10.1089/vim.2017.0091
   [Anonymous], 2017, CDC U INTERPRETATION
   [Anonymous], 2017, FDA PROVIDES NEW TOO
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004655
   Barchi F, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0047-3
   Baylor NW, 2016, METHODS MOL BIOL, V1404, P773, DOI 10.1007/978-1-4939-3389-1_51
   Beskow LM, 2015, GENET MED, V17, P226, DOI 10.1038/gim.2014.102
   Bossert S, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0232-7
   Bryan JT, 2016, CURR OPIN CHEM BIOL, V32, P34, DOI 10.1016/j.cbpa.2016.03.001
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cunningham AL, 2016, VACCINE, V34, P6655, DOI 10.1016/j.vaccine.2016.10.016
   de Vries J, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-5
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA, 2019, CURR EM US AUTH
   FDA, ZIK EM US AUTH
   Ghodbane M, 2015, LAB CHIP, V15, P3211, DOI 10.1039/c5lc00398a
   Giavarina D, 2017, CLIN BIOCHEM, V50, P568, DOI 10.1016/j.clinbiochem.2017.02.021
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hashemzadeh MS, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.23874
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kinkorova J, 2018, EPMA J, V9, P345, DOI 10.1007/s13167-018-0153-7
   Kudchodkar SB, 2018, MICROBES INFECT, V20, P676, DOI 10.1016/j.micinf.2018.03.001
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Li HB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01268
   Lippi G, 2017, J MED BIOCHEM, V36, P293, DOI 10.1515/jomb-2017-0029
   Lippi G, 2017, CLIN CHEM LAB MED, V55, P489, DOI 10.1515/cclm-2017-0107
   Lippi G, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.04.10
   Madore DV, 2010, VACCINE, V28, P4539, DOI 10.1016/j.vaccine.2010.04.094
   Marko-Varga G, 2014, J PROTEOME RES, V13, P5319, DOI 10.1021/pr500475q
   Maslow JN, 2017, HUM VACC IMMUNOTHER, V13, P2918, DOI 10.1080/21645515.2017.1358325
   Mungwira RG, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0077-x
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Nyan DC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17925
   Ohst C, 2018, ADV EXP MED BIOL, V1062, P19, DOI 10.1007/978-981-10-8727-1_3
   Park SW, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.41.30042
   Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Plotkin SA, 2017, HUM VACC IMMUNOTHER, V13, P2755, DOI 10.1080/21645515.2017.1306615
   Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238
   Rampling T, 2019, EMERG INFECT DIS, V25, P205, DOI 10.3201/eid2502.180798
   Roberts C, 2014, HUM VACC IMMUNOTHER, V10, P2168, DOI 10.4161/hv.29205
   Ronnberg B, 2017, MED MICROBIOL IMMUN, V206, P383, DOI 10.1007/s00430-017-0517-y
   Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Smith JF, 2008, HUM VACCINES, V4, P134, DOI 10.4161/hv.4.2.5261
   Staunton C, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-35
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Subramaniam TSS, 2016, ASIAN PAC J TROP MED, V9, P199, DOI 10.1016/j.apjtm.2016.01.016
   Taylor CT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050253
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tindana P, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-76
   Uyeki Timothy M, 2016, Emerg Infect Dis, V22, DOI 10.3201/eid2207.160022
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, R D BLUEPR 2018 LIST
   WHO, 2016, COLL STUD EV CAND WH
   WHO, WHO EM US LIST PROC
   WHO. World Health, 2017, ORG MAN PREP SEC REF
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wong G, 2018, HUM VACC IMMUNOTHER, V14, P1760, DOI 10.1080/21645515.2017.1412024
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Yamaoka Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00509
NR 68
TC 1
Z9 1
U1 4
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD OCT 3
PY 2019
VL 15
IS 10
BP 2258
EP 2263
DI 10.1080/21645515.2019.1634992
EA JUL 2019
PG 6
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA JG2QG
UT WOS:000476129500001
PM 31268394
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kam, YW
   Leite, JA
   Amrun, SN
   Lum, FM
   Yee, WX
   Abu Bakar, F
   Eng, KE
   Lye, DC
   Leo, YS
   Chong, CY
   Freitas, ARR
   Milanez, GP
   Proenca-Modena, JL
   Renia, L
   Costa, FTM
   Ng, LFP
AF Kam, Yiu-Wing
   Leite, Juliana Almeida
   Amrun, Siti Naqiah
   Lum, Fok-Moon
   Yee, Wearn-Xin
   Abu Bakar, Farhana
   Eng, Kai Er
   Lye, David C.
   Leo, Yee-Sin
   Chong, Chia-Yin
   Ribas Freitas, Andre Ricardo
   Milanez, Guilherme Paier
   Proenca-Modena, Jose Luiz
   Renia, Laurent
   Costa, Fabio T. M.
   Ng, Lisa F. P.
CA Zika-Unicamp Network
TI ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus
   Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; pregnant women; antibody response; epitopes
ID NONSTRUCTURAL PROTEIN-1; MONOCLONAL-ANTIBODIES; STRUCTURAL BIOLOGY;
   CHIKUNGUNYA VIRUS; PREGNANCY; OUTBREAK; STRAINS; BRAZIL; FEVER; ASSAY
AB Background. Zika virus (ZIKV) infections have reemerged as a global health issue due to serious clinical complications. Development of specific serological assays to detect and differentiate ZIKV from other cocirculating flaviviruses for accurate diagnosis remains a challenge.
   Methods. We investigated antibody responses in 51 acute ZIKV-infected adult patients from Campinas, Brazil, including 7 pregnant women who later delivered during the study. Using enzyme-linked immunosorbent assays, levels of antibody response were measured and specific epitopes identified.
   Results. Several antibody-binding hot spots were identified in ZIKV immunogenic antigens, including membrane, envelope (E) and nonstructural protein 1 (NS1). Interestingly, specific epitopes (2 from E and 2 from NS1) strongly recognized by ZIKV-infected patients' antibodies were identified and were not cross-recognized by dengue virus (DENV)-infected patients' antibodies. Corresponding DENV peptides were not strongly recognized by ZIKV-infected patients' antibodies. Notably, ZIKV-infected pregnant women had specific epitope recognition for ZIKV NS1 (amino acid residues 17-34), which could be a potential serological marker for early ZIKV detection.
   Conclusions. This study identified 6 linear ZIKV-specific epitopes for early detection of ZIKV infections. We observed differential epitope recognition between ZIKV-infected and DENV-infected patients. This information will be useful for developing diagnostic methods that differentiate between closely related flaviviruses.
C1 [Kam, Yiu-Wing; Amrun, Siti Naqiah; Lum, Fok-Moon; Yee, Wearn-Xin; Abu Bakar, Farhana; Eng, Kai Er; Renia, Laurent; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.
   [Leite, Juliana Almeida; Milanez, Guilherme Paier; Proenca-Modena, Jose Luiz; Costa, Fabio T. M.] Univ Campinas Unicamp, Dept Genet Evolut Microbiol & Immunol, Inst Biol, Campinas, SP, Brazil.
   [Abu Bakar, Farhana] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Lye, David C.; Leo, Yee-Sin] Natl Ctr Infect Dis, Singapore, Singapore.
   [Lye, David C.; Leo, Yee-Sin] Tan Tock Seng Hosp, Singapore, Singapore.
   [Lye, David C.; Leo, Yee-Sin; Chong, Chia-Yin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Lye, David C.; Leo, Yee-Sin; Chong, Chia-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Chong, Chia-Yin] KK Womens & Childrens Hosp, Singapore, Singapore.
   [Ribas Freitas, Andre Ricardo] Campinas Dept Publ Hlth Surveillance, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Sao Leopoldo Mandic Med Sch, Campinas, SP, Brazil.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Ng, LFP (corresponding author), ASTAR, Lab Microbial Immun, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Modena, Jose Luiz Proenca/C-8231-2014; de Toledo Teixeira, Daniel
   Augusto/C-6940-2017; Freitas, Andre Ricardo Ribas/L-1969-2016
OI Modena, Jose Luiz Proenca/0000-0002-4996-3153; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771; Lye, David/0000-0003-0324-0205
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR) [15/1/82/27/001]; Agency for Science, Technology and
   Research, SingaporeAgency for Science Technology & Research (ASTAR);
   Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/00194-8, 2013/25807-4];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
FX This work is supported by the Biomedical Research Council (BMRC) core
   research grants to the Singapore Immunology Network and the Zika Virus
   Consortium Fund, led by BMRC A*Star (project number 15/1/82/27/001);
   Agency for Science, Technology and Research, Singapore; Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (grant numbers 2016/00194-8 and
   2013/25807-4 fellowship to J.A.L.); and the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (research fellowships to G. P.
   M. and F. T. M. C.).
CR [Anonymous], 2018, 2018 ANN REV DIS PRI
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chang HH, 2002, J INFECT DIS, V186, P743, DOI 10.1086/342600
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   Deshni J, 2018, BIORXIV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engels G, 2017, CELL HOST MICROBE, V21, P321, DOI 10.1016/j.chom.2017.02.020
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Fanshawe AE, 2013, J CARDIOL, V61, P99, DOI 10.1016/j.jjcc.2012.09.009
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Chaves TDS, 2018, TRAVEL MED INFECT DI, V23, P1, DOI 10.1016/j.tmaid.2018.05.001
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 41
TC 1
Z9 1
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2019
VL 220
IS 2
BP 203
EP 212
DI 10.1093/infdis/jiz092
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IS7VN
UT WOS:000482357500005
PM 30901054
DA 2020-07-08
ER

PT J
AU Luo, SX
   Zhang, PL
   Ma, XR
   Wang, Q
   Lu, JH
   Lit, BC
   Zhao, W
   Allain, JP
   Li, CY
   Li, TT
AF Luo, Shengxue
   Zhang, Panli
   Ma, Xiaorui
   Wang, Qi
   Lu, Jinhui
   Lit, Bochao
   Zhao, Wei
   Allain, Jean-Pierre
   Li, Chengyao
   Li, Tingting
TI A rapid strategy for constructing novel simian adenovirus vectors with
   high viral titer and expressing highly antigenic proteins applicable for
   vaccine development
SO VIRUS RESEARCH
LA English
DT Article
DE Simian adenovirus type 23; Novel adenoviral vector; Gibson assembly;
   High titer; Vaccine candidate
ID CHIMPANZEE ADENOVIRUS; NEUTRALIZING ANTIBODIES; NONHUMAN-PRIMATES; HIV-1
   VACCINE; EFFICIENT; GENERATION; CHALLENGE; CELLS; INFECTION; PROTECTS
AB Adenoviral vectors have been widely used for the development of infectious disease vaccines. However, the challenge of human adenoviral vector rooted from the predominant adenovirus serotype 5 strain limiting its usefulness by the widespread pre-existing neutralizing antibodies in recipients. To circumvent this obstacle, we generated an ad-hoc adenovirus vector in human or primates. Here, a chimeric simian adenoviral vector Sad23 was constructed consisting in deleting of El and E3 regions of the full-length simian adenovirus serotype 23 genome (SAdV23) by Gibson assembly. To improve Sad23 virus propagating efficiency, the E4 region open reading frame 6 (orf6) was replaced by the corresponding element of human adenovirus type 5 (Ad5), designated Sad23L. The procedure for cloning this novel vector took a single week, and recombinant adenovirus was packaged with high titer in HEK293 cells. To verify the ability of this novel adenoviral vector to deliver foreign genes, Zika virus (ZIKV) prM-E genes were used as target genes for antigen expression. Recombinant adeno-viruses Sad23L-prM-E, Sad23-prM-E and Ad5-prM-E were intramuscularly inoculated into Ad5-eGFP none pre exposed or pre-exposed mice, and the immune response to ZIKV prM-E was compared between vectors. Sad23L-prM-E induced a fairly robust immune response and maintained immunogenicity in Ad5 pre-exposed mice, which suggested that Ad5 pre-existing immunity did not affect Sad23L-prM-E immunization. These preliminary results suggest that the proposed rapid strategy was effective in constructing a new adenoviral vector platform (Sad23 L) usable for the development of human vaccines.
C1 [Luo, Shengxue; Zhang, Panli; Ma, Xiaorui; Wang, Qi; Lu, Jinhui; Lit, Bochao; Allain, Jean-Pierre; Li, Chengyao; Li, Tingting] Southern Med Univ, Sch Lab Med & Biotechnol, Dept Transfus Med, Guangzhou 510515, Guangdong, Peoples R China.
   [Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Lab Biosafety, Guangzhou, Guangdong, Peoples R China.
   [Allain, Jean-Pierre] Univ Cambridge, Cambridge, England.
RP Li, CY; Li, TT (corresponding author), Southern Med Univ, Sch Lab Med & Biotechnol, Dept Transfus Med, Guangzhou 510515, Guangdong, Peoples R China.
EM chengyaoli@hotmail.com; apple-ting-007@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31770185, 31500134, 81371801, 81871655]; National
   Key Research and Development Program [2017YFD0500300]; Innovative R&D
   Team Introduction Program of Guangdong [2014ZT05S123]; Guangzhou major
   project of industry-university-research cooperation and collaborative
   innovation [201704020083]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 31770185, 31500134, 81371801 and 81871655), the
   National Key Research and Development Program (No. 2017YFD0500300), the
   Innovative R&D Team Introduction Program of Guangdong (No. 2014ZT05S123)
   and the Guangzhou major project of industry-university-research
   cooperation and collaborative innovation (No. 201704020083).
CR Abbink P, 2018, J VIROL, V92
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Alonso-Padilla J, 2016, MOL THER, V24, P6, DOI 10.1038/mt.2015.194
   Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155
   BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112
   Cheng T, 2016, VACCINE, V34, P4875, DOI 10.1016/j.vaccine.2016.08.066
   Colloca S, 2012, SCI TRANSL MED, V4
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441
   Dakin RS, 2015, HUM GENE THER, V26, P312, DOI 10.1089/hum.2015.019
   Di BY, 2012, J BIOTECHNOL, V157, P373, DOI 10.1016/j.jbiotec.2011.12.022
   Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043
   Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Holkers M, 2014, METHODS, V69, P179, DOI 10.1016/j.ymeth.2014.02.017
   Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4
   Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042
   Lemckert AAC, 2006, J GEN VIROL, V87, P2891, DOI 10.1099/vir.0.82079-0
   Li TT, 2014, HEPATOLOGY, V59, P789, DOI 10.1002/hep.26750
   Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469
   Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   Ng P, 2000, HUM GENE THER, V11, P693
   Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185
   Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317
   von Delft A, 2018, VACCINE, V36, P313, DOI 10.1016/j.vaccine.2017.10.079
   Weigel S, 2000, J VIROL, V74, P764, DOI 10.1128/JVI.74.2.764-772.2000
   Xiang ZQ, 2014, VIROLOGY, V450, P243, DOI 10.1016/j.virol.2013.12.029
   Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zhang NH, 2016, ONCOL REP, V36, P715, DOI 10.3892/or.2016.4870
   Zhang SJ, 2013, J MED VIROL, V85, P1077, DOI 10.1002/jmv.23546
   Zhou DM, 2010, NAT PROTOC, V5, P1775, DOI 10.1038/nprot.2010.134
   Zhu SM, 2016, J VIROL, V90, P8198, DOI 10.1128/JVI.02653-15
NR 37
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUL 15
PY 2019
VL 268
BP 1
EP 10
DI 10.1016/j.virusres.2019.05.008
PG 10
WC Virology
SC Virology
GA IE9IL
UT WOS:000472688000001
PM 31108113
DA 2020-07-08
ER

PT J
AU Lawrence, JH
   Sherer, ML
   Tavlarides-Hontz, P
   Parcells, MS
   Schwarz, JM
AF Lawrence, Jennifer H.
   Sherer, Morgan L.
   Tavlarides-Hontz, Phaedra
   Parcells, Mark S.
   Schwarz, Jaclyn M.
TI An investigation into the immune response of cultured neural rat cells
   following Zika virus infection
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Zika virus; Microglia; Cytokines; Interferon; Rat; Brain
AB The most notable effect of prenatal Zika virus (ZIKV) infection is severe microcephaly. ZIKV has a selective tropism for neural progenitor cells; however, it is not clear what role the immune cells of the brain, microglia, may have in mitigating or exacerbating neuronal cell death following ZIKV infection. We cultured hippocampal and cortical neural cells from neonatal rat pups and infected them with ZIKV at various multiplicities of infection (MOI). We found that the neuroimmune response to ZIKV infection is composed of both pro-inflammatory and type I interferon responses and is largely dependent upon the viral dose.
C1 [Lawrence, Jennifer H.; Sherer, Morgan L.; Schwarz, Jaclyn M.] Univ Delaware, Dept Psychol & Brain Sci, 108 Wolf Hall, Newark, DE 19716 USA.
   [Tavlarides-Hontz, Phaedra; Parcells, Mark S.] Univ Delaware, Dept Anim & Food Sci, 052 Townsend Hall, Newark, DE 19716 USA.
RP Lawrence, JH (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 108 Wolf Hall, Newark, DE 19716 USA.
EM jenniferhlawrence@gmail.com; msherer@psych.udel.edu; phaedra@udel.edu;
   parcells@udel.edu; jschwarz@psych.udel.edu
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R21 HD096309];
   NIMH NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01 MH106553]
CR Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267
NR 9
TC 0
Z9 0
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JUL 15
PY 2019
VL 332
BP 73
EP 77
DI 10.1016/j.jneuroim.2019.04.002
PG 5
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA IC4MT
UT WOS:000470940600010
PM 30959341
DA 2020-07-08
ER

PT J
AU Ciccozzi, M
   Lai, A
   Zehender, G
   Borsetti, A
   Cella, E
   Ciotti, M
   Sagnelli, E
   Sagnelli, C
   Angeletti, S
AF Ciccozzi, Massimo
   Lai, Alessia
   Zehender, Gianguglielmo
   Borsetti, Alessandra
   Cella, Eleonora
   Ciotti, Marco
   Sagnelli, Evangelista
   Sagnelli, Caterina
   Angeletti, Silvia
TI The phylogenetic approach for viral infectious disease evolution and
   epidemiology: An updating review
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE epidemiology; evolution; research and analysis methods
ID HEPATITIS-C VIRUS; MERKEL CELL POLYOMAVIRUS; INJECTING DRUG-USERS;
   CHILD-CARE CENTER; HIV-1 SUBTYPE B; RIO-DE-JANEIRO; A-VIRUS; MOLECULAR
   EPIDEMIOLOGY; ZIKA VIRUS; GLOBAL EPIDEMIOLOGY
AB In the last decade, the phylogenetic approach is recurrent in molecular evolutionary analysis. On 12 May, 2019, about 2 296 213 papers are found, but typing "phylogeny" or "epidemiology AND phylogeny" only 199 804 and 20 133 are retrieved, respectively. Molecular epidemiology in infectious diseases is widely used to define the source of infection as so as the ancestral relationships of individuals sampled from a population. Coalescent theory and phylogeographic analysis have had scientific application in several, recent pandemic events, and nosocomial outbreaks. Hepatitis viruses and immunodeficiency virus (human immunodeficiency virus) have been largely studied. Phylogenetic analysis has been recently applied on Polyomaviruses so as in the more recent outbreaks due to different arboviruses type as Zika and chikungunya viruses discovering the source of infection and the geographic spread. Data on sequences isolated by the microorganism are essential to apply the phylogenetic tools and research in the field of infectious disease phylodinamics is growing up. There is the need to apply molecular phylogenetic and evolutionary methods in areas out of infectious diseases, as translational genomics and personalized medicine. Lastly, the application of these tools in vaccine strategy so as in antibiotic and antiviral researchers are encouraged.
C1 [Ciccozzi, Massimo; Cella, Eleonora] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Via Alvaro del Portillo 21, I-00128 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.
   [Borsetti, Alessandra] Ist Super Sanita, Natl HIV AIDS Res Ctr, Rome, Italy.
   [Ciotti, Marco] Polyclin Tor Vergata Fdn, Lab Mol Virol, Rome, Italy.
   [Sagnelli, Evangelista; Sagnelli, Caterina] Univ Campania Luigi Vanvitelli, Infect Dis Sect, Dept Mental Hlth & Publ Med, Naples, Italy.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
RP Ciccozzi, M (corresponding author), Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Via Alvaro del Portillo 21, I-00128 Rome, Italy.
EM m.ciccozzi@unicampus.it
RI Cella, Eleonora/J-9961-2016; ciccozzi, massimo/C-6484-2016; Sagnelli,
   Caterina/K-9338-2016
OI Cella, Eleonora/0000-0002-7870-9744; Ciotti, Marco/0000-0002-9943-9130;
   ciccozzi, massimo/0000-0003-3866-9239; Sagnelli,
   Caterina/0000-0002-6413-7810
CR *AASLD IDSA IAS US, REC TEST MAN TREAT H
   Abecasis AB, 2005, AIDS, V19, P1799, DOI 10.1097/01.aids.0000188422.95162.b7
   ABECASIS AB, 2013, RETROVIROLOGY, V10, DOI DOI 10.1186/1742-4690-10-7
   Abecasis AB, 2006, ANTIVIR THER, V11, P581
   Abecasis AB, 2018, AIDS, V32, P543, DOI 10.1097/QAD.0000000000001728
   Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09
   Agostini HT, 2000, J NEUROVIROL, V6, pS101
   Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07
   Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599
   Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571
   de Souza TMA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110623
   Amado LA, 2011, J MED VIROL, V83, P768, DOI 10.1002/jmv.22045
   AMENDOLA A, 2017, EUROSURVEILLANCE, V22, DOI DOI 10.1038/444836A
   Amon JJ, 2005, J INFECT DIS, V192, P1323, DOI 10.1086/462425
   Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618
   Angeletti S, 2018, MICROB PATHOGENESIS, V123, P233, DOI 10.1016/j.micpath.2018.07.020
   Angeletti S, 2016, PATHOG GLOB HEALTH, V110, P269, DOI 10.1080/20477724.2016.1235337
   Angeletti S, 2016, INFECT GENET EVOL, V46, P85, DOI 10.1016/j.meegid.2016.10.031
   Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x
   Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   ASHFAQ UA, 2011, VIROL J, V8, DOI DOI 10.1186/1743-422X-8-161
   Awerkiew S, 2007, J CLIN VIROL, V38, P83, DOI 10.1016/j.jcv.2006.10.006
   AZARIAN T, 2015, SCI REP-UK, V5, DOI DOI 10.1038/SREP10170
   Babakir-Mina M, 2009, NEW MICROBIOL, V32, P397
   Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682
   Bar-Gal GK, 2012, HEPATOLOGY, V56, P1671, DOI 10.1002/hep.25852
   Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003
   Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x
   Bialasiewicz S, 2010, J VIROL, V84, P6229, DOI 10.1128/JVI.02658-09
   Bialek SR, 2007, CLIN INFECT DIS, V44, P838, DOI 10.1086/511874
   Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902
   Bobkov AF, 1998, VOP VIRUSOL+, V43, P253
   Bon I, 2010, J CLIN VIROL, V48, P212, DOI 10.1016/j.jcv.2010.03.021
   Bondarenko T Iu, 2013, Mol Gen Mikrobiol Virusol, P12
   Bordi L, 2012, J CLIN VIROL, V54, P26, DOI 10.1016/j.jcv.2012.01.009
   Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001
   Brown JR, 2019, CLIN INFECT DIS, V68, P222, DOI 10.1093/cid/ciy438
   BUKH J, 1993, P NATL ACAD SCI USA, V90, P8234, DOI 10.1073/pnas.90.17.8234
   Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019
   Calvignac-Spencer S, 2016, ARCH VIROL, V161, P1739, DOI 10.1007/s00705-016-2794-y
   Camacho RJ, 2007, CURR OPIN HIV AIDS, V2, P123, DOI 10.1097/COH.0b013e328029824a
   Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003
   Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027
   Carvalho C, 2012, EUROSURVEILLANCE, V17, P14
   Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019
   *CDC, ARB CAT, DOI DOI 10.1371/JOURNAL.PCBI.1000520
   Cella E, 2018, PATHOG GLOB HEALTH, V112, P93, DOI 10.1080/20477724.2017.1406565
   Cella E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03581-4
   Chow VT, 2013, INFECT GENET EVOL, V18, P351, DOI 10.1016/j.meegid.2012.11.008
   Ciccozzi M, 2007, AVIAN DIS, V51, P455, DOI 10.1637/7620-042606R.1
   Ciccozzi M, 2014, J MED VIROL, V86, P454, DOI 10.1002/jmv.23787
   Ciccozzi M, 2012, J MED VIROL, V84, P1613, DOI 10.1002/jmv.23384
   Ciccozzi M, 2011, J MED VIROL, V83, P1565, DOI 10.1002/jmv.22154
   Ciccozzi Massimo, 2011, Open Virol J, V5, P22, DOI 10.2174/1874357901105010022
   Cohen Yehuda Z, 2013, Ther Adv Vaccines, V1, P99, DOI 10.1177/2051013613494535
   Cotter SM, 2003, J INFECT DIS, V187, P1235, DOI 10.1086/374057
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   D'Amelio R, 2005, EMERG INFECT DIS, V11, P1155
   de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a
   de Paula VS, 2003, J VIROL METHODS, V107, P223, DOI 10.1016/S0166-0934(02)00248-3
   de Paula VS, 2002, J MED VIROL, V66, P22, DOI 10.1002/jmv.2106
   De Rochars VMB, 2017, AM J TROP MED HYG, V96, P144, DOI [10.4269/ajtmh.16-0685, 10.4269/ajtmh.16-0585]
   De Sabato L, 2018, VIRUS GENES, V54, P812, DOI 10.1007/s11262-018-1597-5
   Doceul V, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100270
   Ebranati E, 2019, INFECT GENET EVOL, V73, P33, DOI 10.1016/j.meegid.2019.04.006
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
   FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279
   Forbi JC, 2012, J GEN VIROL, V93, P1410, DOI 10.1099/vir.0.042184-0
   Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615
   Franco E, 2003, VACCINE, V21, P2224, DOI 10.1016/S0264-410X(03)00137-3
   FRETZ C, 1995, J MED VIROL, V47, P435, DOI 10.1002/jmv.1890470423
   Gao J, 2019, MBIO, V10, DOI 10.1128/mBio.00307-19
   Garbuglia AR, 2013, EMERG INFECT DIS, V19, P110, DOI 10.3201/eid1901.120983
   GARDNER SD, 1971, LANCET, V1, P1253
   Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064
   Gededzha MP, 2012, J MED VIROL, V84, P601, DOI 10.1002/jmv.23215
   Geoghegan JL, 2018, GENETICS, V210, P1151, DOI 10.1534/genetics.118.301556
   Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Giovanetti M, 2015, J MED VIROL, V87, P893, DOI 10.1002/jmv.24133
   Godoy BA, 2013, ANTIVIR THER, V18, P505, DOI 10.3851/IMP2600
   Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027
   Gray RR, 2011, AIDS, V25, P143, DOI 10.1097/QAD.0b013e328340fdaf
   Greninger AL, 2017, J PEDIAT INF DIS SOC, V6, P168, DOI 10.1093/jpids/pix019
   Greninger AL, 2017, J CLIN MICROBIOL, V55, P177, DOI 10.1128/JCM.01881-16
   Grinde B, 1997, J MED VIROL, V53, P69, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt;69::AID-JMV12&gt;3.0.CO;2-S
   Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gwinn M, 2017, J CLIN MICROBIOL, V55, P703, DOI 10.1128/JCM.01967-16
   Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783
   Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866
   Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107
   Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0
   HARKESS J, 1989, AM J PUBLIC HEALTH, V79, P463, DOI 10.2105/AJPH.79.4.463
   Harries M, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.50.20992
   Hashida Y, 2018, J INFECT DIS, V217, P483, DOI 10.1093/infdis/jix516
   Ho JH, 2015, J INFECT DIS, V211, P1560, DOI 10.1093/infdis/jiu524
   Hofmeister MG, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033431
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012
   Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102
   Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07
   Ikegaya H, 2006, J GEN VIROL, V87, P3201, DOI 10.1099/vir.0.82266-0
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Jacka B, 2014, HEPATOLOGY, V60, P1571, DOI 10.1002/hep.27310
   Jansen van Vuren P, 2019, VIRUSES, V11, p[E71, 139]
   Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I
   Jensenius Mogens, 1997, Tidsskrift for den Norske Laegeforening, V117, P935
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   JIN L, 1993, J MED VIROL, V39, P50, DOI 10.1002/jmv.1890390110
   JIN L, 1995, CLIN DIAGN VIROL, V3, P285, DOI 10.1016/S0928-0197(94)00044-1
   Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108
   Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608
   KENNEDY PGE, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10110609
   Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021
   Kostaki EG, 2018, ELIFE, V7, DOI 10.7554/eLife.36709
   Kouri V, 2015, EBIOMEDICINE, V2, P244, DOI 10.1016/j.ebiom.2015.01.015
   Kouri V, 2014, J INT AIDS SOC, V17, P160, DOI 10.7448/IAS.17.4.19754
   Kramvis A, 2002, J GEN VIROL, V83, P835, DOI 10.1099/0022-1317-83-4-835
   Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657
   Kuhnert D, 2011, INFECT GENET EVOL, V11, P1825, DOI 10.1016/j.meegid.2011.08.005
   Lanini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185428
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lemey P, 2005, AIDS, V19, P1649, DOI 10.1097/01.aids.0000187904.02261.1a
   LEMEY P, 2009, PHYLOGENETIC HDB PRA, DOI DOI 10.1099/VIR.0.19240-0
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050
   Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231
   Lopalco PL, 2005, J VIRAL HEPATITIS, V12, P315, DOI 10.1111/j.1365-2893.2005.00593.x
   MAGIORKINIS G, 2009, PLOS MED, V6, DOI DOI 10.1371/JOURNAL.PMED.1000198
   Magiorkinis G, 2016, INFECT GENET EVOL, V46, P169, DOI 10.1016/j.meegid.2016.05.041
   Manara S, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0593-7
   Marascio N, 2014, INFECT GENET EVOL, V26, P352, DOI 10.1016/j.meegid.2014.06.006
   Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568
   Martel-Jantin C, 2012, VIROLOGY, V426, P134, DOI 10.1016/j.virol.2012.01.018
   McFarland N, 2011, EPIDEMIOL INFECT, V139, P336, DOI 10.1017/S0950268810001433
   MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493
   Menendez C, 1999, J MED VIROL, V58, P215, DOI 10.1002/(SICI)1096-9071(199907)58:3&lt;215::AID-JMV5&gt;3.0.CO;2-K
   Michitaka K, 2006, J MED VIROL, V78, P44, DOI 10.1002/jmv.20502
   MIN J, 2016, GLOBAL HLTH RES POLI, V1, P14, DOI DOI 10.1128/JVI.01022-09
   Mirazo S, 2016, INFECT GENET EVOL, V43, P267, DOI 10.1016/j.meegid.2016.06.003
   Mishra N, 2014, J INFECT DIS, V210, P1595, DOI 10.1093/infdis/jiu250
   Morais LM, 2006, MEM I OSWALDO CRUZ, V101, P401, DOI 10.1590/S0074-02762006000400010
   Moreno A, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0921-y
   MORTIMER PP, 1995, GENITOURIN MED, V71, P109
   Mugosa B, 2017, ARCH VIROL, V162, P1549, DOI 10.1007/s00705-017-3224-5
   Mugosa B, 2016, J MED VIROL, V88, P1905, DOI 10.1002/jmv.24552
   Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502
   Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14
   Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992
   Nakano T, 2016, LIVER INT, V36, P31, DOI 10.1111/liv.12880
   Nakano T, 2012, LIVER INT, V32, P675, DOI 10.1111/j.1478-3231.2011.02728.x
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0
   Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0
   Nishimoto Y, 2007, J MOL EVOL, V65, P103, DOI 10.1007/s00239-006-0269-6
   O'Donovan D, 2001, EPIDEMIOL INFECT, V127, P469, DOI 10.1017/S0950268801006185
   Ojosnegros Samuel, 2010, Immunome Res, V6 Suppl 2, pS5, DOI 10.1186/1745-7580-6-S2-S5
   Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112
   PADGETT BL, 1971, LANCET, V1, P1257
   Pantazis N, 2019, STAT METHODS MED RES, V28, P1979, DOI 10.1177/0962280217746437
   Paraskevis D, 2017, CLIN INFECT DIS, V65, P2078, DOI 10.1093/cid/cix717
   Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079
   Pelletier AR, 2010, PUBLIC HEALTH REP, V125, P642, DOI 10.1177/003335491012500505
   Perevoscikovs J, 2009, EUROSURVEILLANCE, V14, P7
   Perez-Sautu U, 2011, J CLIN VIROL, V52, P98, DOI 10.1016/j.jcv.2011.06.011
   Pol D, 2004, SYST BIOL, V53, P949, DOI 10.1080/10635150490888868
   Poovorawan Y, 2005, J CLIN VIROL, V32, P24, DOI 10.1016/j.jcv.2004.04.008
   Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376
   Pybus OG, 2000, GENETICS, V155, P1429
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Rantala M., 2008, Eurosurveillance, V13, P18880
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Rascovan N, 2016, CLIN INFECT DIS, V62, P1419, DOI 10.1093/cid/ciw135
   Read AF, 2007, EVOLUTION HLTH DIS, P139, DOI DOI 10.3201/EID2310.161855
   Rodrigues L, 2007, J MED VIROL, V79, P483, DOI 10.1002/jmv.20851
   Ruggieri A, 1996, J GEN VIROL, V77, P2073, DOI 10.1099/0022-1317-77-9-2073
   Sagnelli C, 2017, J MED VIROL, V89, P1015, DOI 10.1002/jmv.24724
   Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004
   SALEMI M, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0001390
   Sasmono RT, 2017, AM J TROP MED HYG, V97, P1393, DOI 10.4269/ajtmh.16-0935
   Schenkel K, 2006, EPIDEMIOL INFECT, V134, P1292, DOI 10.1017/S0950268806006212
   Schmid D, 2009, EUR J CLIN MICROBIOL, V28, P385, DOI 10.1007/s10096-008-0633-0
   Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Sengupta N, 2007, J INFECT DIS, V196, P1014, DOI 10.1086/521365
   Shieh YC, 2007, J FOOD PROTECT, V70, P145, DOI 10.4315/0362-028X-70.1.145
   Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12
   Soli R, 2019, MOL PHYLOGENET EVOL, V134, P253, DOI 10.1016/j.ympev.2019.01.019
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Stene-Johansen K, 2005, J GEN VIROL, V86, P2739, DOI 10.1099/vir.0.81155-0
   Stroffolini T, 2019, DIGEST LIVER DIS, V51, P434, DOI 10.1016/j.dld.2018.09.010
   STUYVER L, 1993, J GEN VIROL, V74, P1093, DOI 10.1099/0022-1317-74-6-1093
   Sugimoto C, 1997, P NATL ACAD SCI USA, V94, P9191, DOI 10.1073/pnas.94.17.9191
   Takahashi H, 2006, J GASTROENTEROL, V41, P981, DOI 10.1007/s00535-006-1888-9
   TANABE ELD, 2018, REV INST MED TROP SP, V60, DOI DOI 10.1590/S1678-9946201860019
   Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757
   Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010
   Urbanus AT, 2009, EUROSURVEILLANCE, V14, P19421, DOI DOI 10.2807/ESE.14.47.19421-EN
   van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006
   van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4
   van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024
   van Houdt R, 2010, J VIRAL HEPATITIS, V17, P108, DOI 10.1111/j.1365-2893.2009.01158.x
   van Steenbergen JE, 2004, J INFECT DIS, V189, P471, DOI 10.1086/381152
   Vaughan G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074546
   Villar LM, 2006, BRAZ J MED BIOL RES, V39, P873, DOI 10.1590/S0100-879X2006000700004
   Vrancken B, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex028
   Wansbrough-Jones MH, 1998, T ROY SOC TROP MED H, V92, P496, DOI 10.1016/S0035-9203(98)90887-2
   Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764
   Welzel TM, 2017, J HEPATOL, V67, P224, DOI 10.1016/j.jhep.2017.03.014
   Wenzel JJ, 2014, LANCET INFECT DIS, V14, P907, DOI 10.1016/S1473-3099(14)70897-7
   Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855
   *WHO, WHO REC COMP INFL VI, DOI DOI 10.1016/J.MICPATH.2018.07.020
   Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029
   Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747
   XU LZ, 1994, J GEN VIROL, V75, P2393, DOI 10.1099/0022-1317-75-9-2393
   Yegani S, 2019, TROP ANIM HEALTH PRO, V51, P605, DOI 10.1007/s11250-018-1731-3
   Yogo Y, 2004, REV MED VIROL, V14, P179, DOI 10.1002/rmv.428
   YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990
   Ypma RJF, 2013, GENETICS, V195, P1055, DOI 10.1534/genetics.113.154856
   Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009
   Zehender G, 2015, INFECT GENET EVOL, V32, P361, DOI 10.1016/j.meegid.2015.03.009
   Zehender G, 2014, INFECT GENET EVOL, V25, P138, DOI 10.1016/j.meegid.2014.04.016
   Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047517
   Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198
   Zehender G, 2012, INFECT GENET EVOL, V12, P291, DOI [10.101, 10.1016/j.meegid.2011.11.009]
   Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002
   Zhou S, 2017, J VIRAL HEPATITIS, V24, P551, DOI 10.1111/jvh.12677
   Zhu YJ, 2017, J CLIN MICROBIOL, V55, P2956, DOI [10.1128/JCM.00360-17, 10.1128/jcm.00360-17]
   Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453
   Zuckerkandl E, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477
NR 240
TC 2
Z9 2
U1 5
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2019
VL 91
IS 10
BP 1707
EP 1724
DI 10.1002/jmv.25526
EA JUL 2019
PG 18
WC Virology
SC Virology
GA IO0YH
UT WOS:000476154200001
PM 31243773
DA 2020-07-08
ER

PT J
AU Zhao, S
   Musa, SS
   Fu, H
   He, DH
   Qin, J
AF Zhao, Shi
   Musa, Salihu S.
   Fu, Hao
   He, Daihai
   Qin, Jing
TI Simple framework for real-time forecast in a data-limited situation: the
   Zika virus (ZIKV) outbreaks in Brazil from 2015 to 2016 as an example
SO PARASITES & VECTORS
LA English
DT Article
DE Zika virus; Brazil; Modeling analysis; Reproduction number; Epidemic
   size; Spatial heterogeneity
ID REPRODUCTION NUMBER; FRENCH-POLYNESIA; EPIDEMIC; TRANSMISSION;
   INFECTION; BORNE; COLOMBIA; DISEASE; SPREAD; BAHIA
AB BackgroundIn 2015-2016, Zika virus (ZIKV) caused serious epidemics in Brazil. The key epidemiological parameters and spatial heterogeneity of ZIKV epidemics in different states in Brazil remain unclear. Early prediction of the final epidemic (or outbreak) size for ZIKV outbreaks is crucial for public health decision-making and mitigation planning. We investigated the spatial heterogeneity in the epidemiological features of ZIKV across eight different Brazilian states by using simple non-linear growth models.ResultsWe fitted three different models to the weekly reported ZIKV cases in eight different states and obtained an R-2 larger than 0.995. The estimated average values of basic reproduction numbers from different states varied from 2.07 to 3.41, with a mean of 2.77. The estimated turning points of the epidemics also varied across different states. The estimation of turning points nevertheless is stable and real-time. The forecast of the final epidemic size (attack rate) is reasonably accurate, shortly after the turning point. The knowledge of the epidemic turning point is crucial for accurate real-time projection of the outbreak.ConclusionsOur simple models fitted the epidemic reasonably well and thus revealed the spatial heterogeneity in the epidemiological features across Brazilian states. The knowledge of the epidemic turning point is crucial for real-time projection of the outbreak size. Our real-time estimation framework is able to yield a reliable prediction of the final epidemic size.
C1 [Zhao, Shi; Qin, Jing] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   [Zhao, Shi; Musa, Salihu S.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
   [Fu, Hao] South China Agr Univ, Coll Agr, Dept Crop Sci & Technol, Guangzhou, Guangdong, Peoples R China.
RP Zhao, S (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.; Zhao, S; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
EM zhaoshi.cmsa@gmail.com; daihai.he@polyu.edu.hk
OI Qin, Jing/0000-0002-7059-0929; He, Daihai/0000-0003-3253-654X; Musa,
   Salihu Sabiu/0000-0001-6335-2335
FU Hong Kong Polytechnic UniversityHong Kong Polytechnic University
   [1-ZE8J]
FX The work described in this paper was partly supported by a grant from
   The Hong Kong Polytechnic University (Project no.: 1-ZE8J). The funding
   agencies had no role in the design and conduct of the study; collection,
   management, analysis, or interpretation of the data; preparation,
   review, or approval of the manuscript; or decision to submit the
   manuscript for publication.
CR Arino J, 2007, MATH BIOSCI ENG, V4, P159, DOI 10.3934/mbe.2007.4.159
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brauer F, 2012, MATH MODELS POPULATI
   Brazilian Institute of Geography and Statistics, 2019, RES POP FIG SENT BRA
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Earn DJ, 2008, MATH EPIDEMIOLOGY
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251
   Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Funk S, 2018, EPIDEMICS-NETH, V22, P56, DOI 10.1016/j.epidem.2016.11.003
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gompertz B., 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026
   Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Hollingsworth TD, 2015, EPIDEMICS-NETH, V10, P16, DOI 10.1016/j.epidem.2014.08.007
   Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396
   Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023
   Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Keeling M. J., 2011, MODELING INFECT DIS
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Liao JJZ, 2009, J CHEMOMETR, V23, P248, DOI 10.1002/cem.1218
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7
   Ma JL, 2014, B MATH BIOL, V76, P245, DOI 10.1007/s11538-013-9918-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK EP REP BRAZ
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Reuters, 2016, REUTERS
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Rozema E., 2007, COLL MATH J, V38, P246, DOI DOI 10.1080/07468342.2007.11922245
   Sebrango-Rodriguez CR, 2017, EPIDEMIOL INFECT, V145, P2313, DOI [10.1017/S0950268817001078, 10.1017/s0950268817001078]
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Verhulst P.-F., 1945, NOUVEAUX MEMOIRES AC, V18, P1
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   WHO, 2019, INT CAS DEF ZIK VIR
   WHO, 2019, LAB TEST ZIK VIR INF
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2019, ZIK VIR
   Yang W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004383
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhao S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006158
   Zhou GF, 2003, EMERG INFECT DIS, V9, P1608
NR 69
TC 8
Z9 8
U1 3
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 12
PY 2019
VL 12
AR 344
DI 10.1186/s13071-019-3602-9
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA II9YN
UT WOS:000475557400003
PM 31300061
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ulbert, S
AF Ulbert, Sebastian
TI West Nile virus vaccines - current situation and future directions
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE West Nile virus; vaccines; flavivirus; antibodies
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; CLINICAL DEVELOPMENT;
   COST-EFFECTIVENESS; CHIMERIC VACCINE; PROTECTS MICE; ZIKA; EUROPE;
   INFECTION; IMMUNITY
AB West Nile virus (WNV) is a widely spread human pathogenic arthropod-borne virus. It can lead to severe, sometimes fatal, neurological disease. Over the last two decades, several vaccine candidates for the protection of humans from WNV have been developed. Some technologies were transferred into clinical testing, but these approaches have not yet led to a licensed product. This review summarizes the current status of a human WNV vaccine and discusses reasons for the lack of clinically advanced product candidates. It also discusses the problem of immunological cross-reactivity between flaviviruses and how it can be addressed during vaccine development.
C1 [Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
RP Ulbert, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
EM Sebastian.ulbert@izi.fraunhofer.de
CR Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309
   Anticoli S, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700443
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett PN, 2017, EXPERT REV VACCINES, V16, P883, DOI 10.1080/14760584.2017.1357471
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457
   Cahill ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3186-6
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Coller B. A, 2012, United States patent application, Patent No. [US20120141520A1, 20120141520]
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dayan GH, 2013, VIRUSES-BASEL, V5, P3048, DOI 10.3390/v5123048
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Del Giudice G, 2017, NPJ AGING MECH DIS, V4, DOI 10.1038/s41514-017-0020-0
   Duehr J, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00011-18, 10.1128/mspheredirect.00011-18]
   Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gruber MF, 2017, J INFECT DIS, V216, pS964, DOI 10.1093/infdis/jix433
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/erv.11.180, 10.1586/ERV.11.180]
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   McMullen AR, 2013, J GEN VIROL, V94, P318, DOI 10.1099/vir.0.046888-0
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Ng T, 2003, Dev Biol (Basel), V114, P221
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pierce KK, 2017, J INFECT DIS, V215, P52, DOI 10.1093/infdis/jiw501
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Shankar MB, 2017, VACCINE, V35, P3143, DOI 10.1016/j.vaccine.2016.11.078
   Snoy PJ, 2010, VET PATHOL, V47, P774, DOI 10.1177/0300985810372506
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/FMB.14.67, 10.2217/fmb.14.67]
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Verstrepen BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112568
   Woods CW, 2019, VACCINE, VS0264-410X, P31699
   Ziegler U, 2019, ANTIVIR RES, V162, P39, DOI 10.1016/j.antiviral.2018.12.005
   Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 62
TC 4
Z9 4
U1 1
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD OCT 3
PY 2019
VL 15
IS 10
BP 2337
EP 2342
DI 10.1080/21645515.2019.1621149
EA JUL 2019
PG 6
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA JG2QG
UT WOS:000475057500001
PM 31116691
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Romero, HA
   Pavia, TAV
   Cervantes, MAV
   Pliego, AF
   Repetto, ACH
   Juarez, ML
AF Arevalo Romero, Haruki
   Vargas Pavia, Tania A.
   Velazquez Cervantes, Manuel A.
   Flores Pliego, Arturo
   Helguera Repetto, Addy C.
   Leon Juarez, Moises
TI The Dual Role of the Immune Response in Reproductive Organs During Zika
   Virus Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE Zika virus; sexual transmission; immune response; reproduction;
   interferon
ID SEXUAL TRANSMISSION; PROTECTS; CONTACT; TRACT; BRAIN
AB Zika virus is a mosquito-borne viral disease that emerged as a significant health problem in the Americas after an epidemic in 2015. Especially concerning are cases where Zika is linked to the development of brain abnormalities in newborns. Unlike other flaviviruses, Zika can be transmitted sexually, increasing the potential for intraspecies infection. Several reports show that the virus can persist for months in the testis of males after clearance of viremia, and that females are highly susceptible to infection via sexual transmission. The most common route of sexual transmission is male-to-female, which suggests that the mechanism driving persistence of Zika in the testis is essential for dissemination. The immune system plays an essential role in Zika infection. In females, a robust response inhibits the virus to control the infection. In males, however, the immunological response to Zika infection correlates with viral persistence. Thus, the immune system may have a dual role in sexually transmitted pathogenesis. The mechanism by which the immune system allows the virus to enter an immune-privileged site while continuing to disseminate is unclear. In this mini-review, we highlight advances in our knowledge of sexually transmitted Zika virus pathogenesis and the possible mechanisms mounted by the immune system that control or exacerbate the infection.
C1 [Arevalo Romero, Haruki] Univ Juarez Autonomous Tabasco, Multidisciplinary Acad Div Jalpa de Mendez, Dept Genom, Lab Immunol & Mol Microbiol, Jalpa De Mendez, Mexico.
   [Vargas Pavia, Tania A.; Velazquez Cervantes, Manuel A.; Flores Pliego, Arturo; Helguera Repetto, Addy C.; Leon Juarez, Moises] Natl Inst Perinatol Isidro Espinosa Reyes, Dept Immuno Biochem, Lab Perinatal Virol, Mexico City, DF, Mexico.
RP Juarez, ML (corresponding author), Natl Inst Perinatol Isidro Espinosa Reyes, Dept Immuno Biochem, Lab Perinatal Virol, Mexico City, DF, Mexico.
EM moisesleoninper@gmail.com
RI Juarez, Moises Leon/AAI-1958-2019
OI Flores Pliego, Arturo/0000-0001-7876-6098
FU Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
   [212250-3210-21007-03-16]
FX ML was supported by Instituto Nacional de Perinatologia Isidro Espinosa
   de los Reyes (212250-3210-21007-03-16). Additionally, HA, AH, and ML
   acknowledge their membership of the National System of Researchers
   (SNI).
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Aryee EAN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-61
   Ayehunie S, 2018, TOXICOL REP, V5, P134, DOI 10.1016/j.toxrep.2017.12.011
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   da Silva LRC, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020051
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   Craigo JK, 2006, CURR OPIN HIV AIDS, V1, P97, DOI 10.1097/01.COH.0000200507.27578.26
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P51, DOI 10.1111/aji.12027
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hafez E S, 1982, Obstet Gynecol Surv, V37, P507, DOI 10.1097/00006254-198208000-00002
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kinlock BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096760
   Leon-Juarez Moises, 2017, Pathog Dis, V75, DOI 10.1093/femspd/ftx093
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matsumura N, 2017, AM J PHYSIOL-HEART C, V312, pH561, DOI 10.1152/ajpheart.00604.2016
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nguyen PV, 2014, CELL MOL IMMUNOL, V11, P410, DOI 10.1038/cmi.2014.41
   Niedrig M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3611-x
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Patel MV, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13042
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puggioni G, 2018, J VIROL, V92, DOI 10.1128/JVI.01131-18
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   REINER NE, 1982, ANN INTERN MED, V96, P170, DOI 10.7326/0003-4819-96-2-170
   Reyes Y, 2019, EMERG INFECT DIS, V25, P808, DOI 10.3201/eid2504.180977
   Salam AP, 2018, LANCET INFECT DIS, V18, P144, DOI 10.1016/S1473-3099(18)30020-3
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Sutthent Ruengpung, 1997, Journal of the Medical Association of Thailand, V80, P348
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254
   Walczynska A, 2017, ECOL EVOL, V7, P7434, DOI 10.1002/ece3.3263
   Wejstal R, 1999, J HEPATOL, V31, P92, DOI 10.1016/S0168-8278(99)80382-1
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
NR 65
TC 2
Z9 2
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 11
PY 2019
VL 10
AR 1617
DI 10.3389/fimmu.2019.01617
PG 7
WC Immunology
SC Immunology
GA II8CE
UT WOS:000475417700001
PM 31354746
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yoon, JS
   Kim, G
   Jarhad, DB
   Kim, HR
   Shin, YS
   Qu, SH
   Sahu, PK
   Kim, HO
   Lee, HW
   Wan, SB
   Kong, YJ
   Chang, TS
   Ogando, NS
   Kovacikova, K
   Snijder, EJ
   Posthuma, CC
   van Hemert, MJ
   Jeong, LS
AF Yoon, Ji-seong
   Kim, Gyudong
   Jarhad, Dnyandev B.
   Kim, Hong-Rae
   Shin, Young-Sup
   Qu, Shuhao
   Sahu, Pramod K.
   Kim, Hea Ok
   Lee, Hyuk Woo
   Wan, Su Bin
   Kong, Yun Jeong
   Chang, Tong-Shin
   Ogando, Natacha S.
   Kovacikova, Kristina
   Snijder, Eric J.
   Posthuma, Clara C.
   van Hemert, Martijn J.
   Jeong, Lak Shin
TI Design, Synthesis, and Anti-RNA Virus Activity of 6
   '-Fluorinated-Aristeromycin Analogues
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID L-CYCLOPENTENONE DERIVATIVES; MECHANISM-BASED INHIBITORS; CHIKUNGUNYA
   VIRUS; CARBOCYCLIC NUCLEOSIDES; BIOLOGICAL EVALUATION; SEXUAL
   TRANSMISSION; PROTIDE TECHNOLOGY; NEPLANOCIN-A; ZIKA VIRUS; ADENOSINE
AB The 6'-fluorinated aristeromycins were designed as dual-target antiviral compounds aimed at inhibiting both the viral RNA-dependent RNA polymerase (RdRp) and the host cell S-adenosyl-L-homocysteine (SAH) hydrolase, which would indirectly target capping of viral RNA. The introduction of a fluorine at the 6'-position enhanced the inhibition of SAH hydrolase and the activity against RNA viruses. The adenosine and N-6-methyladenosine analogues 2a-e showed potent inhibition against SAH hydrolase, while only the adenosine derivatives 2a-c exhibited potent antiviral activity against all tested RNA viruses such as Middle East respiratory syndrome-coronavirus (MERS-CoV), severe acute respiratory syndrome-coronavirus, chikungunya virus, and/or Zika virus. 6',6'-Difluoroaristeromycin (2c) showed the strongest antiviral effect for MERS-CoV, with a similar to 2.5 log reduction in infectious progeny titer in viral load reduction assay. The phosphoramidate prodrug 3a also demonstrated potent broad-spectrum antiviral activity, possibly by inhibiting the viral RdRp. This study shows that 6'-fluorinated aristeromycins can serve as starting points for the development of broad-spectrum antiviral agents that target RNA viruses.
C1 [Yoon, Ji-seong; Kim, Gyudong; Jarhad, Dnyandev B.; Kim, Hong-Rae; Shin, Young-Sup; Qu, Shuhao; Jeong, Lak Shin] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea.
   [Kim, Gyudong] Chonnam Natl Univ, Coll Pharm, Gwangju 500757, South Korea.
   [Kim, Gyudong] Chonnam Natl Univ, Res Inst Drug Dev, Gwangju 500757, South Korea.
   [Sahu, Pramod K.; Kim, Hea Ok; Lee, Hyuk Woo] Future Med Co Ltd, Seoul 06665, South Korea.
   [Wan, Su Bin; Kong, Yun Jeong; Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea.
   [Ogando, Natacha S.; Kovacikova, Kristina; Snijder, Eric J.; Posthuma, Clara C.; van Hemert, Martijn J.] Leiden Univ, Dept Med Microbiol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.
   [Qu, Shuhao] Henan Univ Anim Husb & Econ, Coll Pharmaceut Engn, Zhengzhou 450046, Henan, Peoples R China.
RP Jeong, LS (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea.
EM lakjeong@snu.ac.kr
FU Mid-career Research Program of the National Research Foundation (NRF),
   Korea [2016R1A2B3010164]; Ministry of Science, ICT & Future Planning of
   the National Research Foundation (NRF), Korea [2017M3A9A8032086]; EU
   Marie Sklodowska-Curie ETN "ANTIVIRALS" [642434]
FX This research was supported by grants from Mid-career Research Program
   (2016R1A2B3010164) and the Ministry of Science, ICT & Future Planning
   (2017M3A9A8032086) of the National Research Foundation (NRF), Korea. The
   work in Leiden (N.S.O. and K.K.) was supported by the EU Marie
   Sklodowska-Curie ETN "ANTIVIRALS" (grant agreement no. 642434).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Agumadu VC, 2018, CUREUS, V10, DOI 10.7759/cureus.3025
   Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   ARITA M, 1983, J AM CHEM SOC, V105, P4049, DOI 10.1021/ja00350a050
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   BENNETT LL, 1986, MOL PHARMACOL, V29, P383
   BENNETT LL, 1986, BIOCHEM PHARMACOL, V35, P4106, DOI 10.1016/0006-2952(86)90036-5
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CANTONI GL, 1986, BIOL METHYLATION DRU, P227
   Case JB, 2016, J VIROL, V90, P7248, DOI 10.1128/JVI.00542-16
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chandra G, 2015, J MED CHEM, V58, P5108, DOI 10.1021/acs.jmedchem.5b00553
   Choi WJ, 2001, J ORG CHEM, V66, P6490, DOI 10.1021/jo015733w
   Cougot N, 2004, TRENDS BIOCHEM SCI, V29, P436, DOI 10.1016/j.tibs.2004.06.008
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DIVAKAR KJ, 1982, J CHEM SOC PERK T 1, P1171, DOI 10.1039/p19820001171
   Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007
   Forgie S, 2009, SEMIN RESP CRIT CARE, V30, P67, DOI 10.1055/s-0028-1119811
   GILMAN H, 1952, J ORG CHEM, V17, P1630, DOI 10.1021/jo50012a009
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Jeong LS, 2003, NUCLEOS NUCLEOT NUCL, V22, P589, DOI 10.1081/NCN-120021961
   Jeong LS, 2003, J MED CHEM, V46, P201, DOI 10.1021/jm025557z
   Jeong LS, 1998, J MED CHEM, V41, P2572, DOI 10.1021/jm980111x
   Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010
   Kim G, 2017, ORG LETT, V19, P5732, DOI 10.1021/acs.orglett.7b02470
   KUSAKA T, 1968, J ANTIBIOT, V21, P255, DOI 10.7164/antibiotics.21.255
   Lee KM, 2011, J MED CHEM, V54, P930, DOI 10.1021/jm1010836
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Lozada-Ramirez JD, 2006, J BIOCHEM BIOPH METH, V67, P131, DOI 10.1016/j.jbbm.2006.01.008
   MADHAVAN GVB, 1988, J MED CHEM, V31, P1798, DOI 10.1021/jm00117a021
   MADHAVAN GVB, 1986, J ORG CHEM, V51, P1287, DOI 10.1021/jo00358a023
   McGuigan C, 2005, J MED CHEM, V48, P3504, DOI 10.1021/jm0491400
   MCGUIGAN C, 1993, J MED CHEM, V36, P1048, DOI 10.1021/jm00060a013
   McGuigan C, 2006, J MED CHEM, V49, P7215, DOI 10.1021/jm060776w
   Mehellou Y, 2018, J MED CHEM, V61, P2211, DOI 10.1021/acs.jmedchem.7b00734
   Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289
   Modrow S., 2013, VIRUSES SINGLE STRAN, P185
   MONTGOMERY JA, 1957, J AM CHEM SOC, V79, P5238, DOI 10.1021/ja01576a046
   Moon HR, 2002, TETRAHEDRON-ASYMMETR, V13, P1189, DOI 10.1016/S0957-4166(02)00316-6
   Mulamoottil VA, 2014, ASIAN J ORG CHEM, V3, P748, DOI 10.1002/ajoc.201402032
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng LFP, 2017, ANNU REV VIROL, V4, P413, DOI 10.1146/annurev-virology-101416-041808
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Ross BS, 2011, J ORG CHEM, V76, P8311, DOI 10.1021/jo201492m
   RUBOTTOM GM, 1978, TETRAHEDRON LETT, P4603
   Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   SHAW G, 1958, J CHEM SOC, P157, DOI 10.1039/jr9580000157
   SHEALY YF, 1980, CHEM PHARM BULL, V28, P3114
   SHEALY YF, 1969, J AM CHEM SOC, V91, P3075, DOI 10.1021/ja01039a042
   SHEALY YF, 1966, J AM CHEM SOC, V88, P3885, DOI 10.1021/ja00968a055
   Siddiqui AQ, 1999, J MED CHEM, V42, P393, DOI 10.1021/jm9803931
   Slusarczyk M, 2014, J MED CHEM, V57, P1531, DOI 10.1021/jm401853a
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Song GY, 2001, J MED CHEM, V44, P3985, DOI 10.1021/jm010256v
   Thiel Volker, 2007, P109
   Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   van den Worm SHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032857
   Verheyden J. P., 1986, U.S. Patent, Patent No. [4,605,659, 4605659]
   WOLFE MS, 1992, J MED CHEM, V35, P1782, DOI 10.1021/jm00088a013
   WOLFE MS, 1991, J MED CHEM, V34, P1521, DOI 10.1021/jm00109a001
   Yin XQ, 2005, TETRAHEDRON LETT, V46, P7535, DOI 10.1016/j.tetlet.2005.08.163
   YOSHIKAWA M, 1990, TETRAHEDRON, V46, P7459, DOI 10.1016/S0040-4020(01)89060-8
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 71
TC 4
Z9 4
U1 13
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD JUL 11
PY 2019
VL 62
IS 13
BP 6346
EP 6362
DI 10.1021/acs.jmedchem.9b00781
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA II9TQ
UT WOS:000475543300025
PM 31244113
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wenham, C
   Farias, DBL
AF Wenham, Clare
   Farias, Deborah B. L.
TI Securitizing Zika: The case of Brazil
SO SECURITY DIALOGUE
LA English
DT Article
DE Civil Society; Copenhagen School; Gender; global health security;
   health; Human Security; Securitization; Zika
ID GLOBAL HEALTH SECURITY; VIRUS OUTBREAK; AEDES-AEGYPTI; HUMAN-RIGHTS;
   HIV/AIDS; POLITICS; HUMANITARIANISM; SECURITISATION; VULNERABILITY;
   CONSTRUCTION
AB Brazil's Zika virus crisis (2015-17), following hot on the heels of the Ebola outbreak (2014-15), dominated newsfeeds and high-level discussions amid governments, the UN system and beyond, with emerging fears relating to Congenital Zika Syndrome (CZS), embodied by microcephaly. However, beyond the ensuing panic in Latin America facing a generation of Zika babies, the outbreak demonstrates key developments in our understanding of the interaction between health and security, based on the Copenhagen School's securitization approach. It suggests that unlike previous diseases that were securitized, it was not the virus that was the cause of the security threat, nor how many people were affected, but a combined concern over where (in Brazil at a time of domestic political crisis), when (immediately post-Ebola), who (foetuses and babies), how (unknown disease characteristics) and what was the existential threat (the vectorized unknown). This article shows these developments for global health security through empirical analysis of the multiple securitization processes that occurred within Brazil for the Zika virus, at the subnational and federal levels.
C1 [Wenham, Clare] London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.
   [Farias, Deborah B. L.] Univ New South Wales, Sydney, NSW, Australia.
RP Wenham, C (corresponding author), London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.
EM c.wenham@lse.ac.uk
OI Wenham, Clare/0000-0001-5378-3203
CR [Anonymous], 2008, REUTERS
   [Anonymous], 2015, DECR EM GOIAS COMB A
   [Anonymous], 2016, INT HLTH REG
   Attaran Amrir, 2016, HARVARD PUBLIC HLTH, V10
   Balzacq T, 2005, EUR J INT RELAT, V11, P171, DOI 10.1177/1354066105052960
   Balzacq Thierry, 2010, SECURITIZATION THEOR
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   BBC, 2016, ZIK VIR WORST DAY MY
   BBC, 2017, BRAZ CORR SCAND ALL
   Bixio D, 2008, WATER PRACT TECHNOL, V3, DOI 10.2166/WPT.2008037
   Boseley S, 2016, GUARDIAN
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brocklehurst H, 2017, WHOS AFRAID CHILDREN
   BURMAN E, 1994, DISASTERS, V18, P238, DOI 10.1111/j.1467-7717.1994.tb00310.x
   Buzan B., 1998, SECURITY NEW FRAMEWO
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32
   CDC, 2016, ZIK TRAV INF
   CONASS, 2015, SAUD FOC 17 PROP CON
   CONASS   Conselho Nacional de Secretarios de Saude, 2015, AUM CAS MICR COL AL
   Cook AH, 2010, RISK HAZARDS CRISIS, V1, P11, DOI 10.2202/1944-4079.1019
   Crawford NC, 2000, INT SECURITY, V24, P116, DOI 10.1162/016228800560327
   Crick E, 2012, INT J DRUG POLICY, V23, P407, DOI 10.1016/j.drugpo.2012.03.004
   Davies S. E., 2015, DIS DIPLOMACY INT NO
   Davies SE, 2008, INT AFF, V84, P295, DOI 10.1111/j.1468-2346.2008.00704.x
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Wit JBF, 2008, HEALTH PSYCHOL, V27, P110, DOI 10.1037/0278-6133.27.1.110
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eba PM, 2014, LANCET, V384, P2091, DOI 10.1016/S0140-6736(14)61412-4
   Elbe S, 2006, INT STUD QUART, V50, P119, DOI 10.1111/j.1468-2478.2006.00395.x
   Elbe S., 2010, SECURITY GLOBAL HLTH
   Elbe S, 2018, PANDEMICS PILLS POLI
   Elbe S, 2012, INT POLIT SOCIOL, V6, P320, DOI 10.1111/j.1749-5687.2012.00166_3.x
   Enemark C, 2007, DIS SECURITY NATURAL
   Enemark Christian, 2017, J GLOBAL SECURITY ST, V2, P137
   FGV   FundacAo Getulio Vargas, 2016, IND CONF JUST BRAS I
   Fidler D. P., 2016, GOVERNING GLOBAL HLT, P57, DOI [10.4324/9781315585550, DOI 10.4324/9781315585550]
   Flahault A, 2016, B WORLD HEALTH ORGAN, V94, P863, DOI 10.2471/BLT.16.171488
   Fourie P, 2007, GLOB CHANG PEACE SEC, V19, P281, DOI 10.1080/14781150701599473
   Gates B, 2014, DEADLIEST ANIMAL WOR
   Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255
   Globo, 2015, MOSQ AED AEG FAZ MAN
   Globo, 2015, REC PE DECR EST EM D
   Globo, 2015, ZIK VIR FAZ GOV ES D
   Globo, 2015, GOV PB DECR EM AP AL
   Globo, 2015, GOV SERG DECR EM DEV
   Globo, 2015, GOV RN DECR EM AP AL
   Glynn RW, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0173-9
   Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P1451, DOI 10.1001/jama.2016.1964
   Gostin LO, 2017, J NATL SECURITY LAW, V9, P1
   Government of Brazil, 2016, MOSQ NAO MAIS FORT Q
   Government of Brazil, 2016, COMMUNICATION
   Government of Brazil, 2012, MIL PREST AP MED AR
   Government of Brazil, 2016, BRAS VAI VENC GUERR
   Government of Brazil, 2016, BRAS VIV HOJ DIA NAC
   Hansen L, 2011, EUR J INT RELAT, V17, P51, DOI 10.1177/1354066110388593
   Hansen L, 2009, INT STUD QUART, V53, P1155, DOI 10.1111/j.1468-2478.2009.00572.x
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hollande F, 2016, LANCET, V387, P2173, DOI 10.1016/S0140-6736(16)30393-2
   Howell A, 2014, REV INT STUD, V40, P961, DOI 10.1017/S0260210514000369
   Ingram A, 2009, GEOGR COMPASS, V3, P2084, DOI 10.1111/j.1749-8198.2009.00284.x
   Kale S, 2016, BRAZIL TAKES HIST 1
   Kamradt-Scott A., 2015, MANAGING GLOBAL HLTH
   Kamradt-Scott A, 2012, GLOB PUBLIC HEALTH, V7, pS95, DOI 10.1080/17441692.2012.725752
   Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3
   Lakoff A., 2017, UNPREPARED GLOBAL HL
   Levina M, 2015, PANDEMICS MEDIA GLOB
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202
   Macmillan L, 2015, CRITICAL STUDIES SEC, V3, P62
   Malkki LH, 1996, CULT ANTHROPOL, V11, P377, DOI 10.1525/can.1996.11.3.02a00050
   Mcdonald M, 2008, EUR J INT RELAT, V14, P563, DOI 10.1177/1354066108097553
   McInnes C, 2013, EUR J INT RELAT, V19, P115, DOI 10.1177/1354066111425258
   McInnes Colin, 2012, GLOBAL HLTH INT RELA
   Ministry of Defence   Brazil, 2017, MAR BRAS
   Ministry of Health   Brazil, 2015, MIN SAUD CONF REL EN
   Ministry of Health   Brazil, 2016, PREV COMB DENG CHIK
   Ministry of Health   Brazil, 2016, BRAS NAO SER DERR MO
   Ministry of Health   Brazil, 2016, B EPIDEMIOLOGICO
   Ministry of Health   Brazil, 2015, CONF ZIK VIR BRAS
   Ministry of Health   Brazil, 2015, B EPIDEMIOLOGICO
   Ministry of Health   Brazil, 2016, COMB AO AED 40 IM JA
   Mirzoeff N, 2002, VISUAL CULTURE READE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Palazzo Chiara, 2016, TELEGRAPH
   Patterson GM, 2016, INSECTS, V7, DOI 10.3390/insects7040056
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Rebelo A, 2016, DEFESA SAUDE
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Rousseff D. J., 2015, COMMUNICATION
   Rushton S., 2014, ROUTLEDGE HDB GLOBAL
   Rushton S, 2011, POLIT STUD-LONDON, V59, P779, DOI 10.1111/j.1467-9248.2011.00919.x
   Salter MB, 2008, J INT RELAT DEV, V11, P321, DOI 10.1057/jird.2008.20
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Seckinelgin H, 2010, SECUR DIALOGUE, V41, P515, DOI 10.1177/0967010610382110
   Secretary of Health   Bahia, 2015, MOSQ AED AEG PRINC A
   Senn M, 2017, J INT RELAT DEV, V20, P605, DOI 10.1057/jird.2016.7
   Stephenson N, 2014, SOC SCI MED, V102, P10, DOI 10.1016/j.socscimed.2013.11.031
   Stern J, 2002, INT SECURITY, V27, P89, DOI 10.1162/01622880260553642
   Tavernise S, 2016, NY TIMES
   Valle D, 2016, EPIDEMIOL SERV SAUDE, V25, P629, DOI 10.5123/S1679-49742016000300018
   Vuori JA, 2008, EUR J INT RELAT, V14, P65, DOI 10.1177/1354066107087767
   Vuori JA, 2010, SECUR DIALOGUE, V41, P255, DOI 10.1177/0967010610370225
   Wagnsson C, 2010, INT POLIT SOCIOL, V4, P1, DOI 10.1111/j.1749-5687.2009.00090.x
   Waldby Catherine, 1995, J SOCIOL, V31, P1
   Watson S, 2011, SECUR DIALOGUE, V42, P3, DOI 10.1177/0967010610393549
   Watson SD, 2009, ROUTL ADV INT RELAT, P1
   Williams MC, 2003, INT STUD QUART, V47, P511, DOI 10.1046/j.0020-8833.2003.00277.x
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organisation, 2016, ADV GLOB HLTH SEC CO
   World Health Organization, 2014, WHO GLOB HLTH DAY 20
   World Health Organization, 2018, MAL FACTF
   World Health Organization, 2017, VECT BORN DIS
   World Health Organization, 2016, ZIK FACTSH
   Wyness M, 2004, SOCIOLOGY, V38, P81, DOI 10.1177/0038038504039362
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   YOUDE J, 2016, GLOBAL SECURITY STUD, V1, P157, DOI DOI 10.1093/JOGSS/OGW001
NR 121
TC 4
Z9 4
U1 3
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0967-0106
EI 1460-3640
J9 SECUR DIALOGUE
JI Secur. Dialogue
PD OCT
PY 2019
VL 50
IS 5
BP 398
EP 415
AR UNSP 0967010619856458
DI 10.1177/0967010619856458
EA JUL 2019
PG 18
WC International Relations
SC International Relations
GA IY2WY
UT WOS:000474963400001
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Smith, MR
   Bugada, LF
   Wen, F
AF Smith, Mason R.
   Bugada, Luke F.
   Wen, Fei
TI Rapid microsphere-assisted peptide screening (MAPS) of promiscuous
   MHCII-binding peptides in Zika virus envelope protein
SO AICHE JOURNAL
LA English
DT Article
DE B cell epitopes; CD4(+) T cell epitopes; MHC class II; peptide binding
   prediction; promiscuous peptide; rotavirus; vaccine; Zika virus
ID EX-VIVO ANALYSIS; T-CELL EPITOPES; THERAPEUTIC VACCINES; ROTAVIRUS
   VACCINE; PREDICTION; CD4(+); ANTIBODIES; IMMUNITY; SPECIFICITY;
   MOLECULES
AB Despite promising developments in computational tools, peptide-class II MHC (MHCII) binding predictors continue to lag behind their peptide-class I MHC counterparts. Consequently, peptide-MHCII binding is often evaluated experimentally using competitive binding assays, which tend to sacrifice throughput for quantitative binding detail. Here, we developed a high-throughput semiquantitative peptide-MHCII screening strategy termed microsphere-assisted peptide screening (MAPS) that aims to balance the accuracy of competitive binding assays with the throughput of computational tools. Using MAPS, we screened a peptide library from Zika virus envelope (E) protein for binding to four common MHCII alleles (DR1, DR4, DR7, DR15). Interestingly, MAPS revealed a significant overlap between peptides that promiscuously bind multiple MHCII alleles and antibody neutralization sites. This overlap was also observed for rotavirus outer capsid glycoprotein VP7, suggesting a deeper relationship between B cell and CD4(+) T cell specificity which can facilitate the design of broadly protective vaccines to Zika and other viruses.
C1 [Smith, Mason R.; Bugada, Luke F.; Wen, Fei] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Bugada, Luke F.; Wen, Fei] Univ Michigan, Catalysis Sci & Technol Inst, Ann Arbor, MI 48109 USA.
RP Wen, F (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
EM feiwenum@umich.edu
FU Division of Chemical, Bioengineering, Environmental, and Transport
   SystemsNational Science Foundation (NSF)NSF - Directorate for
   Engineering (ENG) [1511720, 1645229, 1653611]; University of
   MichiganUniversity of Michigan System; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA046592, OD020053]; National Science
   FoundationNational Science Foundation (NSF)
FX Division of Chemical, Bioengineering, Environmental, and Transport
   Systems, Grant/Award Numbers: 1511720, 1645229, 1653611; University of
   Michigan; National Institutes of Health, Grant/Award Numbers: CA046592,
   OD020053; National Science Foundation
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y
   [Anonymous], PYMOL MOL GRAPHICS S
   Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481
   Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bernardeau K, 2011, J IMMUNOL METHODS, V371, P97, DOI 10.1016/j.jim.2011.06.018
   Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509
   Hattotuwagama Channa K., 2007, V409, P227, DOI 10.1007/978-1-60327-118-9_16
   Hill BD, 2018, CURR PROTEIN PEPT SC, V19, P112, DOI 10.2174/1389203718666161122113041
   Huang M, 2017, J COMPUT CHEM, V38, P2007, DOI 10.1002/jcc.24845
   Jang MH, 2003, J IMMUNOL, V171, P4175, DOI 10.4049/jimmunol.171.8.4175
   Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889
   Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3
   Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107
   Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656
   Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2
   Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156
   Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294
   Kumar N, 2007, NUCLEIC ACIDS RES, V35, pW549, DOI 10.1093/nar/gkm266
   LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0
   Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liao WWP, 2011, AUTOIMMUN REV, V10, P469, DOI 10.1016/j.autrev.2011.02.003
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22
   Luo H, 2015, BIOINFORM BIOL INSIG, V9, P21, DOI 10.4137/BBI.S29466
   Madhi SA, 2016, MALAWI MED J, V28, P108, DOI 10.1056/NEJMoa0904797
   Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005
   MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Narayan K, 2009, MOL IMMUNOL, V46, P3157, DOI 10.1016/j.molimm.2009.07.001
   Natarajan SK, 1999, J IMMUNOL, V162, P3463
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pimentel-Coelho PM, 2018, NAT COMMUN, V9, P1
   Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Reynolds C, 2015, J IMMUNOL, V194, P4814, DOI 10.4049/jimmunol.1402862
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161
   Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018
   Sidney J, 2001, CURR PROTOC IMMUNOL, V31
   Smith MR, 2018, ACS SYNTH BIOL, V7, P1629, DOI 10.1021/acssynbio.8b00119
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wen F, 2009, PROTEIN ENG DESIGN, P153
   Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008
   Wen F, 2013, METHODS MOL BIOL, V1061, P245, DOI 10.1007/978-1-62703-589-7_15
   Xu X, 2016, PLOS CURR, V8
   Yee CM, 2018, IND ENG CHEM RES, V57, P10061, DOI 10.1021/acs.iecr.8b00985
   Yin Liusong, 2014, Curr Protoc Immunol, V106, DOI 10.1002/0471142735.im0510s106
   Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
NR 70
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-1541
EI 1547-5905
J9 AICHE J
JI AICHE J.
PD MAR
PY 2020
VL 66
IS 3
AR UNSP e16697
DI 10.1002/aic.16697
EA JUL 2019
PG 12
WC Engineering, Chemical
SC Engineering
GA KM2LT
UT WOS:000479630500001
DA 2020-07-08
ER

PT J
AU von Hammerstein, F
   Lauth, LM
   Hammerschmidt, S
   Wagner, A
   Schirmeister, T
   Hellmich, UA
AF von Hammerstein, Franziska
   Lauth, Luca M.
   Hammerschmidt, Stefan
   Wagner, Annika
   Schirmeister, Tanja
   Hellmich, Ute A.
TI Cis autocatalytic cleavage of glycine-linked Zika virus NS2B-NS3
   protease constructs
SO FEBS LETTERS
LA English
DT Article
DE autocatalytic cleavage; flavivirus; NS2B-NS3 protease;
   proteolysisserine; Zika virus
ID YELLOW-FEVER VIRUS; CRYSTAL-STRUCTURE; DOMAIN; INFECTION; PROTEINS; NS3
AB The flaviviral heterodimeric serine protease NS2B-NS3, consisting of the NS3 protease domain and the NS2B co-factor, is essential for ZIKA virus maturation and replication in cells. For in vitro studies a 'linked' construct, where a polyglycine linker connects NS2B(CF) and NS3(pro), is often used. This construct undergoes autocatalytic cleavage. Here, we show that linked ZIKV NS2B(CF)-NS3(pro) is cleaved in cis in the NS2B(CF) exclusively at position R95 and not at the previously proposed alternate cleavage site at residue R29 in the NS3(pro). Cleavage neither affects protease stability nor activity, despite some observed differences in spectroscopic behavior. This minimally modified construct may thus be useful for future structural and functional studies of the flaviviral protease, for example when testing new inhibitors.
C1 [von Hammerstein, Franziska; Lauth, Luca M.; Hammerschmidt, Stefan; Wagner, Annika; Schirmeister, Tanja; Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becherweg 30, D-55128 Mainz, Germany.
   [Wagner, Annika; Hellmich, Ute A.] Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany.
RP Hellmich, UA (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becherweg 30, D-55128 Mainz, Germany.
EM u.hellmich@uni-mainz.de
FU Carl-Zeiss Foundation; Centre for Biomolecular Magnetic Resonance (BMRZ)
   - State of Hesse, Germany; Gutenberg Junior Academy Fellowship; Mainz
   Stufe I program
FX Research was supported by the Carl-Zeiss Foundation (to UAH) and the
   Centre for Biomolecular Magnetic Resonance (BMRZ) funded by the State of
   Hesse, Germany. FvH acknowledges a Gutenberg Junior Academy Fellowship
   and financial support by the Mainz Stufe I program. We acknowledge Nadja
   Hellmann as well as the entire Schneider group, biochemistry, JGU Mainz,
   Claudia Janssen and Sabine Maehrlein for fruitful discussions and
   technical support.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Braack L, 2018, PARASITE VECTOR, V11, P1552
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   TAL M, 1985, J BIOL CHEM, V260, P9976
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 25
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG
PY 2019
VL 593
IS 16
BP 2204
EP 2213
DI 10.1002/1873-3468.13507
EA JUL 2019
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA IV6LR
UT WOS:000477103200001
PM 31240714
DA 2020-07-08
ER

PT J
AU Piltch-Loeb, R
   Zikmund-Fisher, BJ
   Shaffer, VA
   Scherer, LD
   Knaus, M
   Fagerlin, A
   Abramson, DM
   Scherer, AM
AF Piltch-Loeb, Rachael
   Zikmund-Fisher, Brian J.
   Shaffer, Victoria A.
   Scherer, Laura D.
   Knaus, Megan
   Fagerlin, Angie
   Abramson, David M.
   Scherer, Aaron M.
TI Cross-Sectional Psychological and Demographic Associations of Zika
   Knowledge and Conspiracy Beliefs Before and After Local Zika
   Transmission
SO RISK ANALYSIS
LA English
DT Article
DE Conspiracy belief; knowledge; perceived risk; Zika
ID CHINESE COMMUNITIES; UNITED-KINGDOM; INFORMATION; INFLUENZA; SARS;
   COMMUNICATION; GOVERNMENT; BEHAVIORS; ATTITUDES; THREAT
AB Perceptions of infectious diseases are important predictors of whether people engage in disease-specific preventive behaviors. Having accurate beliefs about a given infectious disease has been found to be a necessary condition for engaging in appropriate preventive behaviors during an infectious disease outbreak, while endorsing conspiracy beliefs can inhibit preventive behaviors. Despite their seemingly opposing natures, knowledge and conspiracy beliefs may share some of the same psychological motivations, including a relationship with perceived risk and self-efficacy (i.e., control). The 2015-2016 Zika epidemic provided an opportunity to explore this. The current research provides some exploratory tests of this topic derived from two studies with similar measures, but different primary outcomes: one study that included knowledge of Zika as a key outcome and one that included conspiracy beliefs about Zika as a key outcome. Both studies involved cross-sectional data collections that occurred during the same two periods of the Zika outbreak: one data collection prior to the first cases of local Zika transmission in the United States (March-May 2016) and one just after the first cases of local transmission (July-August). Using ordinal logistic and linear regression analyses of data from two time points in both studies, the authors show an increase in relationship strength between greater perceived risk and self-efficacy with both increased knowledge and increased conspiracy beliefs after local Zika transmission in the United States. Although these results highlight that similar psychological motivations may lead to Zika knowledge and conspiracy beliefs, there was a divergence in demographic association.
C1 [Piltch-Loeb, Rachael; Abramson, David M.] NYU, Coll Global Publ Hlth, 715 Broadway,Room 1229, New York, NY 10003 USA.
   [Zikmund-Fisher, Brian J.; Knaus, Megan] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Shaffer, Victoria A.] Univ Missouri, Columbia, MO USA.
   [Scherer, Laura D.] Univ Denver, Denver, CO USA.
   [Fagerlin, Angie] Univ Utah Salt Lake City VA, Salt Lake City, UT USA.
   [Scherer, Aaron M.] Univ Iowa, Iowa City, IA USA.
RP Piltch-Loeb, R (corresponding author), NYU, Coll Global Publ Hlth, 715 Broadway,Room 1229, New York, NY 10003 USA.
EM rpl5@nyu.edu
OI Scherer, Aaron M/0000-0002-4134-9300; Zikmund-Fisher,
   Brian/0000-0002-1637-4176
FU National Science FoundationNational Science Foundation (NSF) [1638545]
FX Funding for this research was provided to Aaron M. Scherer, Victoria A.
   Shaffer, Angie Fagerlin, Laura D. Scherer, Megan Knaus, and Brian J.
   Zikmund-Fisher by a grant from the National Science Foundation (Grant
   #15-PAF03878). Funding was also provided to Rachael Piltch-Loeb and
   David M. Abramson by a grant from the National Science Foundation (RAPID
   Grant #1638545). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   article.
CR Abramowitz S, 2017, J HEALTH COMMUN, V22, P59, DOI 10.1080/10810730.2016.1209599
   Abramson D., 2016, 1 NYU COLL GLOB PUBL
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Cheng C, 2006, J APPL SOC PSYCHOL, V36, P222, DOI 10.1111/j.0021-9029.2006.00059.x
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Earnshaw VA, 2019, J HEALTH PSYCHOL, V24, P219, DOI 10.1177/1359105316650507
   Epstein S, 1996, IMPURE SCI AIDS ACTI, V7
   FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739
   Friedman AL, 2007, HEALTH EDUC BEHAV, V34, P471, DOI 10.1177/1090198106292022
   Galliford N, 2017, SCAND J PSYCHOL, V58, P422, DOI 10.1111/sjop.12382
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Hogg R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165087
   Jiang XY, 2009, INT J BEHAV MED, V16, P58, DOI 10.1007/s12529-008-9005-5
   Johnson BB, 2018, RISK ANAL, V38, P2561, DOI 10.1111/risa.13184
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   LOEWENSTEIN G, 1990, J RISK UNCERTAINTY, V3, P155, DOI 10.1007/BF00056370
   Lohiniva AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096244
   Manierre MJ, 2015, SOC SCI MED, V128, P151, DOI 10.1016/j.socscimed.2015.01.028
   Oliver JE, 2014, JAMA INTERN MED, V174, P817, DOI 10.1001/jamainternmed.2014.190
   Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Popova L, 2012, HEALTH EDUC BEHAV, V39, P455, DOI 10.1177/1090198111418108
   Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   SLOVIC P, 1979, ENVIRONMENT, V21, P14, DOI 10.1080/00139157.1979.9933091
   Taha SA, 2013, J HEALTH COMMUN, V18, P278, DOI 10.1080/10810730.2012.727960
   Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887
   Taylor M, 2009, RISK MANAG HEALTHC P, V2, P9, DOI 10.2147/RMHP.S4810
   US Government Accountability Office, 2017, ACT NEED ADDR CHALL
   van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575
   van Prooijen JW, 2017, MEM STUD, V10, P323, DOI 10.1177/1750698017701615
   Van Prooijen JW, 2013, EUR J SOC PSYCHOL, V43, P109, DOI 10.1002/ejsp.1922
   Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4
   Vraga E. K., 2017, INFORM COMMUNICATION, V21, P1
NR 40
TC 1
Z9 1
U1 4
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2019
VL 39
IS 12
BP 2683
EP 2693
DI 10.1111/risa.13369
EA JUL 2019
PG 11
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA JS4CM
UT WOS:000477463400001
PM 31290166
DA 2020-07-08
ER

PT J
AU Chesnut, M
   Munoz, LS
   Harris, G
   Freeman, D
   Gama, L
   Pardo, CA
   Pamies, D
AF Chesnut, Megan
   Munoz, Laura S.
   Harris, Georgina
   Freeman, Dana
   Gama, Lucio
   Pardo, Carlos A.
   Pamies, David
TI In vitro and in silico Models to Study Mosquito-Borne Flavivirus
   Neuropathogenesis, Prevention, and Treatment
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE mosquito-borne flavivirus; flaviviridae; Zika virus (ZIKV); West Nile
   virus (WNV); Dengue virus (DENV); neuropathogenesis; in vitro; in silico
ID WEST-NILE-VIRUS; TETRAVALENT DENGUE VACCINE; PLURIPOTENT STEM-CELLS;
   HUMAN BRAIN-DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; ZIKA-VIRUS; DENDRITIC
   CELLS; PHASE-II; HEALTHY-ADULTS; NEURAL PROGENITORS
AB Mosquito-borne flaviviruses can cause disease in the nervous system, resulting in a significant burden of morbidity and mortality. Disease models are necessary to understand neuropathogenesis and identify potential therapeutics and vaccines. Non-human primates have been used extensively but present major challenges. Advances have also been made toward the development of humanized mouse models, but these models still do not fully represent human pathophysiology. Recent developments in stem cell technology and cell culture techniques have allowed the development of more physiologically relevant human cell-based models. In silico modeling has also allowed researchers to identify and predict transmission patterns and discover potential vaccine and therapeutic candidates. This review summarizes the research on in vitro and in silico models used to study three mosquito-borne flaviviruses that cause neurological disease in humans: West Nile, Dengue, and Zika. We also propose a roadmap for 21st century research on mosquito-borne flavivirus neuropathogenesis, prevention, and treatment.
C1 [Chesnut, Megan; Harris, Georgina; Pamies, David] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.
   [Munoz, Laura S.; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuroimmunol, Baltimore, MD 21205 USA.
   [Munoz, Laura S.; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Neuroviruses Emerging Amer Study, Baltimore, MD USA.
   [Freeman, Dana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA.
   [Gama, Lucio] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA.
   [Gama, Lucio] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Pamies, David] Univ Lausanne, Dept Physiol, Lausanne, Switzerland.
RP Pamies, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.; Pamies, D (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.
EM david.pamies@unil.ch
OI Munoz Arcos, Laura Sofia/0000-0002-0229-9056; Pamies,
   David/0000-0002-1224-573X
FU HSI; Bart McLean Fund for Neuroimmunology Research
FX The review was funded by HSI, as a series of grants for writing a review
   on in vitro and in silico methods in different areas. LM and CP were
   supported by the Bart McLean Fund for Neuroimmunology Research.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abreu CM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02766
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alepee N, 2014, ALTEX-ALTERN ANIM EX, V31, P441, DOI 10.14573/altex.1406111
   Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   Allen DD, 2008, DRUG DEV IND PHARM, V34, P234, DOI 10.1080/03639040801957662
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309
   Amorim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044984
   An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Anusuya S, 2016, J BIOMOL STRUCT DYN, V34, P1512, DOI 10.1080/07391102.2015.1081620
   Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Bang S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07416-0
   Bonin CRB, 2017, HUM VACC IMMUNOTHER, V13, P484, DOI 10.1080/21645515.2017.1264774
   Bauer K, 2015, AM J TROP MED HYG, V93, P441, DOI 10.4269/ajtmh.14-0625
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Beauchamp P, 2015, TISSUE ENG PART C-ME, V21, P852, DOI [10.1089/ten.tec.2014.0376, 10.1089/ten.TEC.2014.0376]
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Ben-Shachar R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005194
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Booij TH, 2019, SLAS DISCOV, V24, P615, DOI 10.1177/2472555219830087
   Bouden M, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-35
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Brown JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4934713
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Canizares-Carmenate Y, 2017, J VECTOR DIS, V54, P164
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Caraballo H., 2014, EMERG MED PRACT, V16, P23
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chanprasopchai P, 2017, COMPUT MATH METHOD M, DOI 10.1155/2017/2541862
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Cho HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15222
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   Chowers MY, 2001, EMERG INFECT DIS, V7, P675
   Clark DC, 2012, ARCH VIROL, V157, P1423, DOI 10.1007/s00705-012-1337-4
   Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Costin JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000721
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva JBP, 2015, EUR J MED CHEM, V100, P162, DOI 10.1016/j.ejmech.2015.04.061
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   de Borba L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001624
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013
   Dhananjeyan KJ, 2009, J MOL MODEL, V15, P507, DOI 10.1007/s00894-008-0408-7
   Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961
   Dhole P, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0658-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954
   Dubey AP, 2016, HUM VACC IMMUNOTHER, V12, P512, DOI 10.1080/21645515.2015.1076598
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Duran A, 2016, LIFE SCI, V162, P33, DOI 10.1016/j.lfs.2016.08.023
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Durrant DM, 2014, J IMMUNOL, V193, P4095, DOI 10.4049/jimmunol.1401192
   Dwivedi VD, 2016, J VECTOR DIS, V53, P156
   Edelman R, 2003, AM J TROP MED HYG  S, V69, P48
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Fahimi H, 2016, CLIN EXP VACCINE RES, V5, P41, DOI 10.7774/cevr.2016.5.1.41
   Fan GH, 2010, MATH BIOSCI, V228, P119, DOI 10.1016/j.mbs.2010.08.010
   Fang Y, 2017, SLAS DISCOV, V22, P456, DOI 10.1177/1087057117696795
   Fazi R, 2015, J CHEM INF MODEL, V55, P2443, DOI 10.1021/acs.jcim.5b00419
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gandini M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002257
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179
   Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045
   Goh GKM, 2016, MOL BIOSYST, V12, P1881, DOI 10.1039/c6mb00228e
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grebenyuk S, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00039
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380
   Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165
   Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y
   Hu XL, 2009, MATH BIOSCI ENG, V6, P301, DOI 10.3934/mbe.2009.6.301
   Huang CN, 2002, EMERG INFECT DIS, V8, P1367, DOI 10.3201/eid0812.020532
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Huang YX, 2007, EVOLUTION, V61, P717, DOI 10.1111/j.1558-5646.2007.00075.x
   Jacobs M, 2002, J VIROL METHODS, V104, P173, DOI 10.1016/S0166-0934(02)00065-4
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Jones ML, 2017, MOLECULES, V22, DOI 10.3390/molecules22040607
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Knipl D, 2015, B MATH BIOL, V77, P2212, DOI 10.1007/s11538-015-0120-6
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Kuszpit K, 2018, MOL IMAGING BIOL, V20, P275, DOI 10.1007/s11307-017-1118-2
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Laperriere V, 2011, PREV VET MED, V98, P99, DOI 10.1016/j.prevetmed.2010.10.013
   Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001
   Lim DSL, 2014, J IMMUNOL, V193, P5065, DOI 10.4049/jimmunol.1302240
   Liu FK, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00334
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lucas M, 2003, IMMUNOL CELL BIOL, V81, P230, DOI 10.1046/j.1440-1711.2003.01166.x
   Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494
   Majolo F, 2019, J MED VIROL, V91, P525, DOI 10.1002/jmv.25345
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manore C. A., 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.f0b3978230599a56830ce30cb9ce0500, DOI 10.1371/CURRENTS.OUTBREAKS.FOB3978230599A56830CE30CB9CE0500]
   Manvar D, 2016, BIOCHEM BIOPH RES CO, V469, P743, DOI 10.1016/j.bbrc.2015.12.042
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004980
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Merkle FT, 2015, DEVELOPMENT, V142, P633, DOI 10.1242/dev.117978
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nantachit N, 2017, MICROBIOL IMMUNOL, V61, P305, DOI 10.1111/1348-0421.12497
   Nantachit N, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0598-z
   Ng T, 2003, Dev Biol (Basel), V114, P221
   Reis SRNI, 2007, MEM I OSWALDO CRUZ, V102, P983, DOI 10.1590/S0074-02762007000800014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Okamoto KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081860
   Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367
   Oliferenko PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064547
   Otero M, 2011, MATH BIOSCI, V232, P87, DOI 10.1016/j.mbs.2011.04.006
   Pambudi S, 2013, BIOCHEM BIOPH RES CO, V440, P393, DOI 10.1016/j.bbrc.2013.09.078
   Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P362, DOI 10.14573/altex.1609122
   Pamies D, 2017, CHEM RES TOXICOL, V30, P43, DOI 10.1021/acs.chemrestox.6b00269
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Parida P, 2013, CURR PHARM BIOTECHNO, V14, P995
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pawelek KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108452
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m
   Poo J, 2011, PEDIATR INFECT DIS J, V30, pE9, DOI 10.1097/INF.0b013e3181fe05af
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, CURR OPIN CELL BIOL, V49, P47, DOI 10.1016/j.ceb.2017.11.010
   Raekiansyah M, 2014, JPN J INFECT DIS, V67, P86, DOI 10.7883/yoken.67.86
   Rasgon JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005833
   Rattanamahaphoom J, 2017, ASIAN PAC J ALLERGY, V35, P171, DOI 10.12932/AP0810
   Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683
   Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahu R, 2014, NEUROLOGY, V83, P1601, DOI 10.1212/WNL.0000000000000935
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silva VB, 2017, J ARTHROPOD-BORNE DI, V11, P315
   Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Siraj AS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005797
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Somasetia DH, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0466-4
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stolp ZD, 2015, J BIOMOL SCREEN, V20, P616, DOI 10.1177/1087057115571247
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Su HL, 2001, VIROLOGY, V282, P141, DOI 10.1006/viro.2000.0820
   Sultana H, 2012, J IMMUNOL, V189, P3150, DOI 10.4049/jimmunol.1201140
   Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Thavara U, 2014, EPIDEMIOL INFECT, V142, P1245, DOI 10.1017/S0950268813001866
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   van der Helm MW, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1142493
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Correa ARV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143391
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Von Tobel JS, 2016, TOXICOL LETT, V258, pS140, DOI 10.1016/j.toxlet.2016.06.1548
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wang X, 2016, J THEOR BIOL, V411, P27, DOI 10.1016/j.jtbi.2016.09.015
   Watanaveeradej V, 2014, AM J TROP MED HYG, V91, P119, DOI 10.4269/ajtmh.13-0452
   Weeber F, 2017, CELL CHEM BIOL, V24, P1092, DOI 10.1016/j.chembiol.2017.06.012
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499
   Wichapong K, 2013, TROP BIOMED, V30, P388
   Wolff A, 2015, J PHARM SCI-US, V104, P2727, DOI 10.1002/jps.24329
   Wright PF, 2009, AM J TROP MED HYG, V81, P834, DOI 10.4269/ajtmh.2009.09-0131
   Wu WL, 2011, J CLIN IMMUNOL, V31, P1065, DOI 10.1007/s10875-011-9578-7
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xue L, 2017, J BIOL DYNAM, V11, P216, DOI 10.1080/17513758.2016.1229051
   Yang SH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005607
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang J, 2016, IMMUNOLOGY, V148, P363, DOI 10.1111/imm.12615
   Zhang XH, 2016, B MATH BIOL, V78, P1968, DOI 10.1007/s11538-016-0208-7
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 248
TC 1
Z9 1
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUL 9
PY 2019
VL 9
AR 223
DI 10.3389/fcimb.2019.00223
PG 19
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IH8SO
UT WOS:000474776600001
PM 31338335
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pinson, A
   Namba, T
   Huttner, WB
AF Pinson, Anneline
   Namba, Takashi
   Huttner, Wieland B.
TI Malformations of Human Neocortex in Development - Their Progenitor Cell
   Basis and Experimental Model Systems
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Review
DE neocortex; malformations; development; progenitors; model systems
ID OUTER SUBVENTRICULAR ZONE; RADIAL GLIAL-CELLS; HUMAN CEREBRAL ORGANOIDS;
   GROWTH-FACTOR RECEPTOR-3; ZIKA VIRUS-INFECTION; HUMAN-FETAL CEREBRUM;
   NEURAL PROGENITORS; BRAIN ORGANOIDS; PROLIFERATIVE CHARACTERISTICS;
   LISSENCEPHALIC PRIMATE
AB Malformations of the human neocortex in development constitute a heterogeneous group of complex disorders, resulting in pathologies such as intellectual disability and abnormal neurological/psychiatric conditions such as epilepsy or autism. Advances in genomic sequencing and genetic techniques have allowed major breakthroughs in the field, revealing the molecular basis of several of these malformations. Here, we focus on those malformations of the human neocortex, notably microcephaly, and macrocephaly, where an underlying basis has been established at the level of the neural stem/progenitor cells (NPCs) from which neurons are directly or indirectly derived. Particular emphasis is placed on NPC cell biology and NPC markers. A second focus of this review is on experimental model systems used to dissect the underlying mechanisms of malformations of the human neocortex in development at the cellular and molecular level. The most commonly used model system have been genetically modified mice. However, although basic features of neocortical development are conserved across the various mammalian species, some important differences between mouse and human exist. These pertain to the abundance of specific NPC types and/or their proliferative capacity, as exemplified in the case of basal radial glia. These differences limit the ability of mouse models to fully recapitulate the phenotypes of malformations of the human neocortex. For this reason, additional experimental model systems, notably the ferret, non-human primates and cerebral organoids, have recently emerged as alternatives and shown to be of increasing relevance. It is therefore important to consider the benefits and limitations of each of these model systems for studying malformations of the human neocortex in development.
C1 [Pinson, Anneline; Namba, Takashi; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
RP Namba, T; Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
EM namba@mpi-cbg.de; huttner@mpi-cbg.de
OI Namba, Takashi/0000-0003-4875-666X
FU DFGGerman Research Foundation (DFG) [SFB 655]; ERCEuropean Research
   Council (ERC) [250197]; ERA-NET NEURON; Yamada Science Foundation;
   Wallonie-Bruxelles International (WBI)
FX WBH was supported by grants from the DFG (SFB 655, A2), the ERC (250197)
   and ERA-NET NEURON (MicroKin). TN was supported by a long-term
   fellowship from the Yamada Science Foundation. AP was supported by
   Wallonie-Bruxelles International (WBI).
CR Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388
   Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357
   Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032
   BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5
   Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327
   Brochner CB, 2016, GLIA, V64, P90, DOI 10.1002/glia.22905
   Bryant KL, 2018, REPLACE NEANDERTHAL, P239, DOI 10.1007/978-4-431-56582-6_16
   Buchsbaum IY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.163766
   Capecchi MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9763
   Cardenas A, 2018, CELL, V174, P590, DOI 10.1016/j.cell.2018.06.007
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P408, DOI 10.1097/00005072-198607000-00003
   CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Gama AM, 2017, CELL REP, V21, P3754, DOI 10.1016/j.celrep.2017.11.106
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060
   Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312
   Ding WY, 2019, J NEUROSCI, V39, P1994, DOI 10.1523/JNEUROSCI.1849-18.2018
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7
   Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144
   Fujimori A, 2014, BRAIN DEV-JPN, V36, P661, DOI 10.1016/j.braindev.2013.10.006
   Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   Heide M, 2018, CURR OPIN CELL BIOL, V55, P8, DOI 10.1016/j.ceb.2018.06.006
   Heng X, 2017, ELIFE, V6, DOI 10.7554/eLife.23253
   Hevner R. F., 2019, J ANAT
   Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512
   Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009
   Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015
   Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035
   Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jayaraman D, 2018, ANNU REV GENOM HUM G, V19, P177, DOI 10.1146/annurev-genom-083117-021441
   Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056
   Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0
   Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980
   Juric-Sekhar G, 2019, ANNU REV PATHOL-MECH, V14, P293, DOI 10.1146/annurev-pathmechdis-012418-012927
   Kalebic N, 2019, CELL STEM CELL, V24, P535, DOI 10.1016/j.stem.2019.02.017
   Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kawasaki H, 2018, BIOL PHARM BULL, V41, P1324, DOI 10.1248/bpb.b18-00142
   Kawasaki H, 2013, BIOL OPEN, V2, P95, DOI 10.1242/bio.20123160
   Kawasaki H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-24
   Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301
   Klaus J, 2019, NAT MED, V25, P561, DOI 10.1038/s41591-019-0371-0
   Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   KURTZ A, 1994, DEVELOPMENT, V120, P2637
   LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lin T, 2003, HUM MOL GENET, V12, P2863, DOI 10.1093/hmg/ddg309
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676
   Masuda K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15370
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948
   MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181
   Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683
   Namba T, 2019, J COMP NEUROL, V527, P1621, DOI 10.1002/cne.24606
   Namba T, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.256
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okamoto M, 2013, NAT NEUROSCI, V16, P1556, DOI 10.1038/nn.3525
   Ostrem BEL, 2014, CELL REP, V8, P656, DOI 10.1016/j.celrep.2014.06.058
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447
   Passemard S, 2016, CORTEX, V74, P158, DOI 10.1016/j.cortex.2015.10.010
   Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010
   Pollen AA, 2019, CELL, V176, P743, DOI 10.1016/j.cell.2019.01.017
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244
   Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Reillo I, 2017, CEREB CORTEX, V27, P4586, DOI 10.1093/cercor/bhx171
   Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238
   Reiner O, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/393975
   Romero DM, 2018, SEMIN CELL DEV BIOL, V76, P33, DOI 10.1016/j.semcdb.2017.09.031
   ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0
   Roy A, 2015, ELIFE, V4, DOI 10.7554/eLife.12703
   Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090
   Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207
   Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106
   Shi L, 2019, NATL SCI REV, V6, P480, DOI 10.1093/nsr/nwz043
   SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6
   Shibata T, 1997, J NEUROSCI, V17, P9212
   Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011
   Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37
   SMART IHM, 1972, J ANAT, V113, P109
   SMART IHM, 1972, J ANAT, V111, P365
   Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0
   Taverna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep21206
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321
   Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/nmeth.3629, 10.1038/NMETH.3629]
   Vaid S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.169276
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307
   Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilsch-Brauninger M, 2016, CURR OPIN NEUROBIOL, V39, P122, DOI 10.1016/j.conb.2016.05.004
   Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294
   WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683
   Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017
NR 139
TC 2
Z9 2
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD JUL 9
PY 2019
VL 13
AR 305
DI 10.3389/fncel.2019.00305
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA IH9GX
UT WOS:000474815700004
PM 31338027
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dhiman, G
   Abraham, R
   Griffin, DE
AF Dhiman, Gaurav
   Abraham, Rachy
   Griffin, Diane E.
TI Human Schwann cells are susceptible to infection with Zika and yellow
   fever viruses, but not dengue virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; HEPATITIS-E VIRUS; DC-SIGN; PROTEIN;
   HETEROGENEITY; TRANSMISSION; EXPRESSION; ANTIBODIES; RECEPTORS;
   RESPONSES
AB Zika virus (ZIKV) is a re-emerged flavivirus transmitted by Aedes spp mosquitoes that has caused outbreaks of fever and rash on islands in the Pacific and in the Americas. These outbreaks have been associated with neurologic complications that include congenital abnormalities and Guillain-Barre syndrome (GBS). The pathogenesis of ZIKV-associated GBS, a potentially life-threatening peripheral nerve disease, remains unclear. Because Schwann cells (SCs) play a central role in peripheral nerve function and can be the target for damage in GBS, we characterized the interactions of ZIKV isolates from Africa, Asia and Brazil with human SCs in comparison with the related mosquito-transmitted flaviviruses yellow fever virus 17D (YFV) and dengue virus type 2 (DENV2). SCs supported sustained replication of ZIKV andYFV, but not DENV. ZIKV infection induced increased SC expression of IL-6, interferon (IFN)beta 1, IFN-lambda, IFIT-1,TNF alpha and IL-23A mRNAs as well as IFN-lambda receptors and negative regulators of IFN signaling. SCs expressed baseline mRNAs for multiple potential flavivirus receptors and levels did not change after ZIKV infection. SCs did not express detectable levels of cell surface Fc gamma receptors. This study demonstrates the susceptibility and biological responses of SCs to ZIKV infection of potential importance for the pathogenesis of ZIKV-associated GBS.
C1 [Dhiman, Gaurav; Abraham, Rachy; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 North Wolfe St, Baltimore, MD 21205 USA.
RP Griffin, DE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 North Wolfe St, Baltimore, MD 21205 USA.
EM dgriffi6@jhu.edu
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 NS87539]
FX These studies were supported by a supplement to research grant R01
   NS87539 (D.E.G.) from the U.S. National Institutes of Health. We thank
   Ahmet Hoke (Johns Hopkins School of Medicine) for the immortalized human
   Schwann cells and Anna Durbin and Andrew Pekosz (Johns Hopkins Bloomberg
   School of Public Health) for viruses and reagents used in this study.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Alanne MH, 2009, J HISTOCHEM CYTOCHEM, V57, P523, DOI 10.1369/jhc.2009.951681
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Armati PJ, 2013, J NEUROL SCI, V333, P68, DOI 10.1016/j.jns.2013.01.018
   Ayala-Nunez NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep28768
   Baetas-da-Cruz W, 2009, J PERIPHER NERV SYST, V14, P84, DOI 10.1111/j.1529-8027.2009.00217.x
   Bazerbachi F, 2016, GASTROENTEROL REP, V4, P1, DOI 10.1093/gastro/gov042
   Bowman LR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006876
   Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009
   da Silva SR, 2019, J MED VIROL, V91, P179, DOI 10.1002/jmv.25306
   Dalton HR, 2016, NAT REV NEUROL, V12, P77, DOI 10.1038/nrneurol.2015.234
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gao F, 2010, BIOCHEM BIOPH RES CO, V391, P952, DOI 10.1016/j.bbrc.2009.11.172
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelm NE, 2016, CRIT REV ONCOL HEMAT, V106, P91, DOI 10.1016/j.critrevonc.2016.08.002
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257
   Lee H, 2007, GLIA, V55, P712, DOI 10.1002/glia.20493
   Lehmann HC, 2016, BRAIN RES, V1638, P97, DOI 10.1016/j.brainres.2015.10.040
   Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513
   LIPRANDI F, 1983, ARCH VIROL, V76, P51, DOI 10.1007/BF01315703
   Lisak R P, 1997, J Peripher Nerv Syst, V2, P233
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mandl JN, 2011, J IMMUNOL, V186, P6406, DOI 10.4049/jimmunol.1001191
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mietto BS, 2013, EUR J NEUROSCI, V37, P1682, DOI 10.1111/ejn.12161
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliveira ACV, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/473170
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Spierings E, 2001, J IMMUNOL, V166, P5883, DOI 10.4049/jimmunol.166.10.5883
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tzekova N, 2014, J CLIN IMMUNOL, V34, pS86, DOI 10.1007/s10875-014-0015-6
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111
   VEDELER CA, 1990, ACTA NEUROPATHOL, V80, P35, DOI 10.1007/BF00294219
   VEDELER CA, 1991, ACTA NEUROL SCAND, V84, P177, DOI 10.1111/j.1600-0404.1991.tb04933.x
   Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhou X, 2017, J INFECT DIS, V215, P1197, DOI 10.1093/infdis/jix079
NR 90
TC 4
Z9 4
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 9
PY 2019
VL 9
AR UNSP 9951
DI 10.1038/s41598-019-46389-0
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IH5BJ
UT WOS:000474505900062
PM 31289325
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mordecai, EA
   Caldwell, JM
   Grossman, MK
   Lippi, CA
   Johnson, LR
   Neira, M
   Rohr, JR
   Ryan, SJ
   Savage, V
   Shocket, MS
   Sippy, R
   Ibarra, AMS
   Thomas, MB
   Villena, O
AF Mordecai, Erin A.
   Caldwell, Jamie M.
   Grossman, Marissa K.
   Lippi, Catherine A.
   Johnson, Leah R.
   Neira, Marco
   Rohr, Jason R.
   Ryan, Sadie J.
   Savage, Van
   Shocket, Marta S.
   Sippy, Rachel
   Ibarra, Anna M. Stewart
   Thomas, Matthew B.
   Villena, Oswaldo
TI Thermal biology of mosquito-borne disease
SO ECOLOGY LETTERS
LA English
DT Review
DE Arbovirus; climate change; dengue virus; malaria; mosquito; Ross River
   virus; temperature; thermal performance curve; West Nile virus; Zika
   virus
ID ROSS-RIVER-VIRUS; CLIMATE-CHANGE; TEMPERATURE-DEPENDENCE; MALARIA
   TRANSMISSION; PERFORMANCE CURVES; PLASMODIUM-FALCIPARUM; WARMER
   TEMPERATURES; DENGUE EPIDEMICS; METABOLIC THEORY; HOST
AB Mosquito-borne diseases cause a major burden of disease worldwide. The vital rates of these ectothermic vectors and parasites respond strongly and nonlinearly to temperature and therefore to climate change. Here, we review how trait-based approaches can synthesise and mechanistically predict the temperature dependence of transmission across vectors, pathogens, and environments. We present 11 pathogens transmitted by 15 different mosquito species - including globally important diseases like malaria, dengue, and Zika - synthesised from previously published studies. Transmission varied strongly and unimodally with temperature, peaking at 23-29oC and declining to zero below 9-23oC and above 32-38oC. Different traits restricted transmission at low versus high temperatures, and temperature effects on transmission varied by both mosquito and parasite species. Temperate pathogens exhibit broader thermal ranges and cooler thermal minima and optima than tropical pathogens. Among tropical pathogens, malaria and Ross River virus had lower thermal optima (25-26oC) while dengue and Zika viruses had the highest (29oC) thermal optima. We expect warming to increase transmission below thermal optima but decrease transmission above optima. Key directions for future work include linking mechanistic models to field transmission, combining temperature effects with control measures, incorporating trait variation and temperature variation, and investigating climate adaptation and migration.
C1 [Mordecai, Erin A.; Caldwell, Jamie M.; Shocket, Marta S.] Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
   [Grossman, Marissa K.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
   [Grossman, Marissa K.; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   [Lippi, Catherine A.; Ryan, Sadie J.; Sippy, Rachel] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Lippi, Catherine A.; Ryan, Sadie J.; Sippy, Rachel] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Johnson, Leah R.; Villena, Oswaldo] Virginia Polytech & State Univ, Dept Stat, 250 Drillfield Dr, Blacksburg, VA USA.
   [Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer CISeAL, Quito, Ecuador.
   [Rohr, Jason R.] Univ Notre Dame, Dept Biol Sci, Environm Change Initiat, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Savage, Van] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.
   [Savage, Van] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA.
   [Savage, Van] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.
   [Sippy, Rachel; Ibarra, Anna M. Stewart] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
RP Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
EM emordeca@stanford.edu
OI Sziklay, Jamie/0000-0002-6220-918X; Mordecai, Erin/0000-0002-4402-5547;
   Lippi, Catherine/0000-0002-7988-0324; Shocket,
   Marta/0000-0002-8995-4446; Johnson, Leah/0000-0002-9922-579X
FU National Science Foundation Ecology and Evolution of Infectious Diseases
   [DEB-1518681]; NIH NIAID Grant [R01AI110793]; Stanford Woods Institute
   for the Environment; Hellman Faculty Fellowship; Terman Fellowship
FX We are grateful to Iain Caldwell, Hannah Fung, Sindiso Nyathi and
   Johannah Farner for helpful feedback on the manuscript and to Nicole
   Nova for manuscript feedback and for making Fig. 1. EAM, LRJ, MN, JRR,
   SJR, VS, AMSI and MBT were funded by a National Science Foundation
   Ecology and Evolution of Infectious Diseases grant (DEB-1518681). MBT
   was also part supported by NIH NIAID Grant #R01AI110793. EAM and JMC
   were supported by the Stanford Woods Institute for the Environment
   (https://woods.stanford.edu/research/environmental-venture-projects).EAM
   was supported by the Hellman Faculty Fellowship and the Terman
   Fellowship.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   AKEY DH, 1978, ANN ENTOMOL SOC AM, V71, P411, DOI 10.1093/aesa/71.3.411
   Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020
   Alsan M, 2015, AM ECON REV, V105, P382, DOI 10.1257/aer.20130604
   Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677
   Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1
   [Anonymous], 2016, CHIK STAT DAT
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Bacaer N, 2012, J MATH BIOL, V65, P601, DOI 10.1007/s00285-011-0479-4
   Bayoh Mohamed N., 2001, STUDIES DEV SURVIVAL
   Bernhardt JR, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1076
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bi P, 2009, EPIDEMIOL INFECT, V137, P1486, DOI 10.1017/S0950268809002441
   Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22
   Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000
   Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987
   Carter KH, 2015, AM J TROP MED HYG, V92, P302, DOI 10.4269/ajtmh.14-0368
   Cator L., 2019, MORE FLYING SYRINGE
   Cheng A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060609
   Cohen JM, 2019, GLOBAL CHANGE BIOL, V25, P927, DOI 10.1111/gcb.14489
   Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113
   Cox FEG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-5
   Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4
   Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108
   Department of Defence, 2014, QUADR DEF REV 2014
   Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681
   Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39150
   Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Gatton ML, 2005, AM J TROP MED HYG, V72, P792, DOI 10.4269/ajtmh.2005.72.792
   Gehman ALM, 2018, P NATL ACAD SCI USA, V115, P744, DOI 10.1073/pnas.1705067115
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gilbert L, 2014, ECOL EVOL, V4, P1186, DOI 10.1002/ece3.1014
   Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3
   Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027
   Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1
   Hu WB, 2010, AM J TROP MED HYG, V83, P722, DOI 10.4269/ajtmh.2010.09-0551
   Huber JH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006451
   Huber JH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1537-6
   Huey RB, 2011, P NATL ACAD SCI USA, V108, P10377, DOI 10.1073/pnas.1107430108
   Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314
   Pena-Garcia VH, 2017, ANN GLOB HEALTH, V83, P509, DOI 10.1016/j.aogh.2017.10.011
   Jaramillo-Ochoa R, 2019, EMERG INFECT DIS, V25, P834, DOI 10.3201/eid2504.181355
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   JOHNSON FH, 1946, J CELL COMPAR PHYSL, V28, P47, DOI 10.1002/jcp.1030280104
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034
   Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kingsolver JG, 2016, AM NAT, V187, P283, DOI 10.1086/684786
   Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310
   Kirk D, 2019, AM NAT, V193, P661, DOI 10.1086/702846
   Kirk D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004608
   Koolhof IS, 2017, EPIDEMIOL INFECT, V145, P2949, DOI [10.1017/S095026881700190X, 10.1017/s095026881700190x]
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x
   Kushmaro A., 2015, J TROP DIS, pS1
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lefevre T, 2018, EVOL APPL, V11, P456, DOI 10.1111/eva.12571
   Li RY, 2019, P NATL ACAD SCI USA, V116, P3624, DOI 10.1073/pnas.1806094116
   Little E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005828
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649
   Lowe R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002613
   Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932
   Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502
   Mena N, 2011, REV PANAM SALUD PUBL, V29, P234, DOI 10.1590/S1020-49892011000400004
   Metcalf CJE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0901
   Mitchell C., 2016, PAHO WHO PAHO STATEM
   Molnar PK, 2017, J PARASITOL, V103, P423, DOI 10.1645/16-148
   Molnar PK, 2013, ECOL LETT, V16, P9, DOI 10.1111/ele.12022
   Moore S, 2012, J R SOC INTERFACE, V9, P817, DOI 10.1098/rsif.2011.0654
   Mordecai E.A., NAT CLIM CHANGE
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Murdock CC, 2014, J INSECT PHYSIOL, V67, P37, DOI 10.1016/j.jinsphys.2014.05.020
   O'Connor MI, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005628
   Ohm JR, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2761-4
   Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051
   Overgaard J, 2014, GLOBAL CHANGE BIOL, V20, P1738, DOI 10.1111/gcb.12521
   Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240
   Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075
   Paaijmans KP, 2011, NAT CLIM CHANGE, V1, P349
   Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183
   Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196
   Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103
   Pascual M, 2009, ECOLOGY, V90, P906, DOI 10.1890/08-0730.1
   Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078
   Pena-Garcia VH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070734
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961
   Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Ren ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20604
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6
   Rohr JR, 2018, ECOL LETT, V21, P1425, DOI 10.1111/ele.13107
   Rohr JR, 2011, TRENDS ECOL EVOL, V26, P270, DOI 10.1016/j.tree.2011.03.002
   Ruybal JE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1402-z
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Santos-Vega M., 2019, LOCAL CLIMATE SOCIAL, DOI [10.1101/583880, DOI 10.1101/583880]
   Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030
   Shah MM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3547-z
   Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489
   Shocket M.S., 2019, TRANSMISSION W NILE, DOI [10.1101/597898, DOI 10.1101/597898]
   Shocket MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37762
   Sinclair BJ, 2016, ECOL LETT, V19, P1372, DOI 10.1111/ele.12686
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Siraj AS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005797
   Sloyer KE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206648
   Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010
   Stewart-Ibarra AM, 2013, PLOS ONE, V8
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Taylor R.A., 2018, PREDICTING FUNDAMENT, DOI [10.1101/465898, DOI 10.1101/465898]
   Taylor RA, 2016, PEERJ, V4, DOI 10.7717/peerj.2642
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thomson MC, 2017, AM J TROP MED HYG, V97, P32, DOI 10.4269/ajtmh.16-0696
   Thomson MC, 2011, NATURE, V471, P440, DOI 10.1038/471440a
   Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65
   Vogels CBF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05185-4
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Waite JL, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0275
   Werner AK, 2012, EPIDEMIOL INFECT, V140, P359, DOI 10.1017/S0950268811000446
   Wesolowski A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02064-4
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037
   Yamana TK, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0410
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 158
TC 16
Z9 16
U1 7
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1461-023X
EI 1461-0248
J9 ECOL LETT
JI Ecol. Lett.
PD OCT
PY 2019
VL 22
IS 10
BP 1690
EP 1708
DI 10.1111/ele.13335
EA JUL 2019
PG 19
WC Ecology
SC Environmental Sciences & Ecology
GA IX9CW
UT WOS:000477442600001
PM 31286630
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Uraki, R
   Hastings, AK
   Brackney, DE
   Armstrong, PM
   Fikrig, E
AF Uraki, Ryuta
   Hastings, Andrew K.
   Brackney, Doug E.
   Armstrong, Philip M.
   Fikrig, Erol
TI AgBR1 antibodies delay lethal Aedes aegypti-borne West Nile virus
   infection in mice
SO NPJ VACCINES
LA English
DT Article
ID MOSQUITO; EPIDEMIOLOGY; TRANSMISSION; PROTEINS
AB West Nile virus (WNV) is transmitted by mosquitoes and can cause severe disease, including meningoencephalitis. AgBR1 is a mosquito salivary protein that enhances Aedes aegypti mosquito-borne Zika virus pathogenesis in mice. Here, we show that AgBR1 antibodies reduce the initial West Nile viral load and delay lethal infection after feeding by an infected Aedes aegypti mosquito. Targeting AgBR1 may therefore be incorporated into strategies to prevent mosquito-transmitted West Nile virus infection.
C1 [Uraki, Ryuta; Hastings, Andrew K.; Fikrig, Erol] Yale Univ, Anlyan Ctr Med Res & Educ, Dept Internal Med, Sch Med,Sect Infect Dis, 300 Cedar St, New Haven, CT 06520 USA.
   [Brackney, Doug E.; Armstrong, Philip M.] Connecticut Agr Expt Stn, Dept Environm Sci, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06511 USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Anlyan Ctr Med Res & Educ, Dept Internal Med, Sch Med,Sect Infect Dis, 300 Cedar St, New Haven, CT 06520 USA.; Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu
OI Uraki, Ryuta/0000-0003-0890-1922
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI145779, AI127865, AI08992]; Japan
   Society for the Promotion of Science Overseas Research
   FellowshipsMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science
FX This work was supported by NIH grants AI145779, AI127865, AI08992 and
   the Japan Society for the Promotion of Science Overseas Research
   Fellowships. E.F. is an Investigator with the Howard Hughes Medical
   Institute.
CR Andersen LK, 2017, INT J DERMATOL, V56, P252, DOI 10.1111/ijd.13438
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Coutinho-Abreu IV, 2015, CURR OPIN INSECT SCI, V10, P98, DOI 10.1016/j.cois.2015.04.014
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hastings AK, 2019, J VIROL, V93, DOI 10.1128/JVI.00395-19
   Hayashi H, 2012, THROMB RES, V129, P169, DOI 10.1016/j.thromres.2011.09.015
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   McGee CE, 2007, AM J TROP MED HYG, V76, P424, DOI 10.4269/ajtmh.2007.76.424
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Shi L, 2004, INSECT MOL BIOL, V13, P387, DOI 10.1111/j.0962-1075.2004.00496.x
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Uraki R, 2019, NAT MICROBIOL, V4, P948, DOI 10.1038/s41564-019-0385-x
   Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
NR 26
TC 2
Z9 2
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD JUL 8
PY 2019
VL 4
AR 23
DI 10.1038/s41541-019-0120-x
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IK5BR
UT WOS:000476601200001
PM 31312526
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferraris, P
   Cochet, M
   Hamel, R
   Gladwyn-Ng, I
   Alfan, C
   Diop, F
   Garcia, D
   Talignani, L
   Montero-Menei, CN
   Nougairede, A
   Yssel, H
   Nguyen, L
   Coulpier, M
   Misse, D
AF Ferraris, Pauline
   Cochet, Marielle
   Hamel, Rodolphe
   Gladwyn-Ng, Ivan
   Alfan, Christian
   Diop, Fode
   Garcia, Deborah
   Talignani, Loic
   Montero-Menei, Claudia N.
   Nougairede, Antoine
   Yssel, Hans
   Nguyen, Laurent
   Coulpier, Muriel
   Misse, Dorothee
TI Zika virus differentially infects human neural progenitor cells
   according to their state of differentiation and dysregulates
   neurogenesis through the Notch pathway
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika; arbovirus; human neural progenitor; Notch; neurogenesis;
   flavivirus
ID GUILLAIN-BARRE-SYNDROME; CEREBRAL ORGANOIDS; FRENCH-POLYNESIA; HUMAN
   BRAIN; AXL; ACTIVATION; RECEPTOR; AFRICAN; TROPISM
AB Zika virus (ZIKV) is a mosquito-borne Flavivirus that causes Zika disease with particular neurological complications, including Guillain-Barre Syndrome and congenital microcephaly. Although ZIKV has been shown to directly infect human neural progenitor cells (hNPCs), thereby decreasing their viability and growth, it is as yet unknown which of the cellular pathways involved in the disruption of neurogenesis are affected following ZIKV infection. By comparing the effect of two ZIKV strains in vitro on hNPCs, the differentiation process of the latter cells was found to lead to a decreased susceptibility to infection and cell death induced by each of the ZIKV strains, which was associated with an earlier and stronger antiviral innate immune response in infected, differentiated hNPCs, as compared to undifferentiated cells. Moreover, ZIKV modulated, both in hNPCs and in vivo in fetal brain in an experimental mouse model, the expression of the Notch pathway which is involved in cellular proliferation, apoptosis and differentiation during neurogenesis. These results show that the differentiation state of hNPCs is a significant factor contributing to the outcome of ZIKV infection and furthermore suggest that ZIKV infection might initiate early activation of the Notch pathway resulting in an abnormal differentiation process, implicated in ZIKV-induced brain injury.
C1 [Ferraris, Pauline; Hamel, Rodolphe; Diop, Fode; Garcia, Deborah; Talignani, Loic; Misse, Dorothee] Univ Montpellier, CNRS, MIVEGEC, IRD, Montpellier, France.
   [Cochet, Marielle; Coulpier, Muriel] Univ Paris Est, Ecole Natl Vet Alft, ANSES, INRA,UMR1161 Virol, Maisons Alfort, France.
   [Gladwyn-Ng, Ivan; Alfan, Christian; Nguyen, Laurent] Univ Liege, CHU Sart Tilman, Interdisciplinary Cluster Appl Genoprote GIGA R, GIGA Neurosci, Liege, Belgium.
   [Montero-Menei, Claudia N.] Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France.
   [Nougairede, Antoine] Aix Marseille Univ, Inserm 1207 IHU Mediterranee Infect, IRD 190, UVE, Marseille, France.
   [Yssel, Hans] UPMC, Hop Pitie Salpetriere, AP HP, Sorbonne Univ,Inserm U1135,Ctr Immunol & Malad In, Paris, France.
RP Misse, D (corresponding author), IRD MIVEGEC 911 Ave Agropolis, F-34394 Montpellier 5, France.
EM dorothee.misse@ird.fr
RI Hamel, Rodolphe/AAG-1714-2020; Ferraris, Pauline/F-9077-2017
OI Hamel, Rodolphe/0000-0001-8603-7039; Ferraris,
   Pauline/0000-0002-8796-3074
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-14-CE14-0029, ANR-15-CE15-00029]; European Union's Horizon 2020
   research and innovation programme under ZIKAlliance [734548]; French
   National Research Agency under the "Investissements d'avenir"
   programmeFrench National Research Agency (ANR) [ANR-16-IDEX-0006]
FX This work was supported by grants from the Agence Nationale de la
   Recherche grant numbers [ANR-14-CE14-0029 and ANR-15-CE15-00029]. We
   thank the European Union's Horizon 2020 research and innovation
   programme under ZIKAlliance grant agreement No. 734548. This work was
   also publicly funded through the French National Research Agency under
   the "Investissements d'avenir" programme with the reference
   ANR-16-IDEX-0006.
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11
   Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Fan Y, 2016, J NEUROSCI, V36, P11362, DOI 10.1523/JNEUROSCI.1208-16.2016
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu XJ, 2017, VIROL SIN, V32, P188, DOI 10.1007/s12250-017-3956-0
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naveca FG, 2018, MEM I O CRUZ, P113
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Souza BSF, 2016, SCI REP, P6
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang J, 2016, BRAIN RES, V1634, P34, DOI 10.1016/j.brainres.2015.11.029
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhang RR, 2018, CELL TISSUE RES, V371, P73, DOI 10.1007/s00441-017-2641-9
NR 60
TC 5
Z9 5
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 8
PY 2019
VL 8
IS 1
BP 1003
EP 1016
DI 10.1080/22221751.2019.1637283
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IH4MF
UT WOS:000474465800001
PM 31282298
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Branche, E
   Simon, AY
   Sheets, N
   Kim, K
   Barker, D
   Nguyen, AVT
   Sahota, H
   Young, MP
   Salgado, R
   Mamidi, A
   Viramontes, KM
   Carnelley, T
   Qiu, HY
   Ngono, AE
   Regla-Nava, JA
   Susantono, MX
   Cuevas, JMV
   Kennedy, K
   Kodihalli, S
   Shresta, S
AF Branche, Emilie
   Simon, Ayo Yila
   Sheets, Nicholas
   Kim, Kenneth
   Barker, Douglas
   Nguyen, Anh-Viet T.
   Sahota, Harpreet
   Young, Matthew Perry
   Salgado, Rebecca
   Mamidi, Anila
   Viramontes, Karla M.
   Carnelley, Trevor
   Qiu, Hongyu
   Ngono, Annie Elong
   Regla-Nava, Jose Angel
   Susantono, Mercylia Xevana
   Cuevas, Joan M. Valls
   Kennedy, Kieron
   Kodihalli, Shantha
   Shresta, Sujan
TI Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; VIRAL-INFECTIONS;
   MOUSE MODEL; DISEASE; NIGERIA; SERA; TRANSMISSION; PATHOGENESIS
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that represents a major threat to global health. ZIKV infections in adults are generally asymptomatic or present with mild symptoms. However, recent outbreaks of ZIKV have revealed that it can cause Congenital Zika Syndrome in neonates and Guillain-Barre syndrome in adults. Currently, no ZIKV-specific vaccines or antiviral treatments are available. In this study, we tested the efficacy of convalescent plasma IgG hyperimmune product (ZIKV-IG) isolated from individuals with high neutralizing anti-ZIKV titers as a therapeutic candidate against ZIKV infection using a model of ZIKV infection in Ifnar1(-/-) mice. ZIKV-IG successfully protected mice from lethal ZIKV challenge. In particular, ZIKV-IG treatment at 24 hours after lethal ZIKV infection improved survival by reducing weight loss and tissue viral burden and improving clinical score. Additionally, ZIKV-IG eliminated ZIKV-induced tissue damage and inflammation in the brain and liver. These results indicate that ZIKV-IG is efficacious against ZIKV, suggesting this human polyclonal antibody is a viable candidate for further development as a treatment against human ZIKV infection.
C1 [Branche, Emilie; Sheets, Nicholas; Kim, Kenneth; Nguyen, Anh-Viet T.; Young, Matthew Perry; Salgado, Rebecca; Mamidi, Anila; Viramontes, Karla M.; Ngono, Annie Elong; Regla-Nava, Jose Angel; Susantono, Mercylia Xevana; Cuevas, Joan M. Valls; Shresta, Sujan] La Jolla Inst Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.
   [Simon, Ayo Yila; Barker, Douglas; Carnelley, Trevor; Qiu, Hongyu; Kennedy, Kieron; Kodihalli, Shantha] Emergent BioSolut Canada Inc, Res & Dev, 155 Innovat Dr, Winnipeg, MB R3T 5Y3, Canada.
   [Sahota, Harpreet] Emergent BioSolut Canada Inc, Med Affairs, 155 Innovat Dr, Winnipeg, MB R3T 5Y3, Canada.
RP Shresta, S (corresponding author), La Jolla Inst Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.; Kodihalli, S (corresponding author), Emergent BioSolut Canada Inc, Res & Dev, 155 Innovat Dr, Winnipeg, MB R3T 5Y3, Canada.
EM skodihalli@ebsi.com; sujan@lji.org
OI Regla-Nava, Jose Angel/0000-0002-5438-1369
FU Emergent BioSolutions Canada Inc, Winnipeg, Canada
   [AP028-SS1-0615/AP00001029]
FX This research was supported by Emergent BioSolutions Canada Inc,
   Winnipeg, Canada. The animal studies described herein were conducted in
   accordance with the approval of the Institutional Animal Care and Use
   Committee of La Jolla Institute for Immunology (Protocol #
   AP028-SS1-0615/AP00001029).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   ALEXANDER HE, 1946, JAMA-J AM MED ASSOC, V132, P434, DOI 10.1001/jama.1946.02870430014005
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CASADEVALL A, 1994, ANTIMICROB AGENTS CH, V38, P1695, DOI 10.1128/AAC.38.8.1695
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham BS, 2015, CURR OPIN HIV AIDS, V10, P129, DOI 10.1097/COH.0000000000000154
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HAMMON WM, 1953, JAMA-J AM MED ASSOC, V151, P1272
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   JANEWAY CA, 1945, B NEW YORK ACAD MED, V21, P202
   Kammanadiminti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106393
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D., 2014, EURO SURVEILL, V19
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sauter P, 2009, MICROBES INFECT, V11, P443, DOI 10.1016/j.micinf.2009.01.005
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Sparrow E, 2017, B WORLD HEALTH ORGAN, V95, P235, DOI [10.2471/BLT.16.178061, 10.2471/blt.16.178061]
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581
   TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 93
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 8
PY 2019
VL 9
AR 9857
DI 10.1038/s41598-019-46291-9
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IH2PD
UT WOS:000474335800054
PM 31285451
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Polonsky, JA
   Baidjoe, A
   Kamvar, ZN
   Cori, A
   Durski, K
   Edmunds, WJ
   Eggo, RM
   Funk, S
   Kaiser, L
   Keating, P
   de Waroux, OL
   Marks, M
   Moraga, P
   Morgan, O
   Nouvellet, P
   Ratnayake, R
   Roberts, CH
   Whitworth, J
   Jombart, T
AF Polonsky, Jonathan A.
   Baidjoe, Amrish
   Kamvar, Zhian N.
   Cori, Anne
   Durski, Kara
   Edmunds, W. John
   Eggo, Rosalind M.
   Funk, Sebastian
   Kaiser, Laurent
   Keating, Patrick
   de Waroux, Olivier le Polain
   Marks, Michael
   Moraga, Paula
   Morgan, Oliver
   Nouvellet, Pierre
   Ratnayake, Ruwan
   Roberts, Chrissy H.
   Whitworth, Jimmy
   Jombart, Thibaut
TI Outbreak analytics: a developing data science for informing the response
   to emerging pathogens
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE epidemics; infectious; methods; tools; pipeline; software
ID EBOLA-VIRUS DISEASE; RESPIRATORY SYNDROME CORONAVIRUS; REAL-TIME;
   SYSTEMATIC ANALYSIS; TRANSMISSION TREES; BAYESIAN-INFERENCE; GLOBAL
   BURDEN; ZIKA VIRUS; EPIDEMIC; SURVEILLANCE
AB Despite continued efforts to improve health systems worldwide, emerging pathogen epidemics remain a major public health concern. Effective response to such outbreaks relies on timely intervention, ideally informed by all available sources of data. The collection, visualization and analysis of outbreak data are becomingincreasingly complex, owingtothediversityintypes ofdata, questions and available methods to address them. Recent advances have led to the rise of outbreak analytics, an emerging data science focused on the technological and methodological aspects of the outbreak data pipeline, fromcollection to analysis, modelling and reporting to inform outbreak response. In this article, we assess the current state of the field. After laying out the context of outbreak response, we critically review the most common analytics components, their interdependencies, data requirements and the type of information they can provide to informoperations in real time. We discuss some challenges and opportunities and conclude on the potential role of outbreak analytics for improving our understanding of, and response to outbreaks of emerging pathogens.
   This article is part of the theme issue 'Modelling infectious disease outbreaks in humans, animals and plants: epidemic forecasting and control`. This theme issue is linked with the earlier issue 'Modelling infectious disease outbreaks in humans, animals and plants: approaches and important themes'.
C1 [Polonsky, Jonathan A.; Morgan, Oliver] WHO, Dept Hlth Emergency Informat & Risk Assess, Ave Appia 20, CH-1211 Geneva, Switzerland.
   [Durski, Kara] WHO, Dept Infect Hazard Management, Ave Appia 20, CH-1211 Geneva, Switzerland.
   [Polonsky, Jonathan A.; Kaiser, Laurent] Univ Geneva, Fac Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.
   [Baidjoe, Amrish; Kamvar, Zhian N.; Cori, Anne; Nouvellet, Pierre; Jombart, Thibaut] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, Dept Infect Dis Epidemiol, Med Sch Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.
   [Edmunds, W. John; Eggo, Rosalind M.; Funk, Sebastian; Keating, Patrick; de Waroux, Olivier le Polain; Ratnayake, Ruwan; Whitworth, Jimmy; Jombart, Thibaut] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Edmunds, W. John; Eggo, Rosalind M.; Funk, Sebastian; Ratnayake, Ruwan] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Marks, Michael; Roberts, Chrissy H.] London Sch Hyg & Trop Med, Clin Res Dept, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Keating, Patrick; de Waroux, Olivier le Polain; Whitworth, Jimmy; Jombart, Thibaut] London Sch Hyg & Trop Med, UK Publ Hlth Rapid Support Team, Keppel St, London WC1E 7HT, England.
   [de Waroux, Olivier le Polain] Publ Hlth England, Wellington House,133-155 Waterloo Rd, London SE1 8UG, England.
   [Moraga, Paula] Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster LA1 4YW, England.
   [Nouvellet, Pierre] Univ Sussex, Sch Life Sci, Sussex House, Brighton BN1 9RH, E Sussex, England.
RP Jombart, T (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, Dept Infect Dis Epidemiol, Med Sch Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.; Jombart, T (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.; Jombart, T (corresponding author), London Sch Hyg & Trop Med, UK Publ Hlth Rapid Support Team, Keppel St, London WC1E 7HT, England.
EM thibautjombart@gmail.com
RI Ratnayake, Ruwan/AAH-2417-2020; Kamvar, Zhian/C-5236-2017
OI Ratnayake, Ruwan/0000-0003-4978-6668; Polonsky,
   Jonathan/0000-0002-8634-4255; Kamvar, Zhian/0000-0003-1458-7108;
   Roberts, Chrissy h./0000-0003-1064-5980; le Polain de Waroux,
   Olivier/0000-0003-3458-2945; Baidjoe, Amrish/0000-0001-5295-5085;
   /0000-0001-5266-0201; Funk, Sebastian/0000-0002-2842-3406; Marks,
   Michael/0000-0002-7585-4743; Cori, Anne/0000-0002-8443-9162
FU Global Challenges Research Fund (GCRF) [ES/P010873/1]; UK Public Health
   Rapid Support Team - United Kingdom Department of Health and Social
   Care; National Institute for Health Research-Health Protection Research
   Unit for Modelling Methodology; National Institute for Health
   ResearchNational Institute for Health Research (NIHR)
   [PR-OD-1017-20001]; HDR UK Innovation Fellowship [MR/S003975/1]; Medical
   Research CouncilMedical Research Council UK (MRC); Wellcome
   TrustWellcome Trust [210758/Z/18/Z]
FX This paper was supported with funding from the Global Challenges
   Research Fund (GCRF) for the project 'RECAP-research capacity building
   and knowledge generation to support preparedness and response to
   humanitarian crises and epidemics' managed through RCUK and ESRC
   (ES/P010873/1). P.K., O.L.P., J.W. and T.J. receive support from the UK
   Public Health Rapid Support Team, which is funded by the United Kingdom
   Department of Health and Social Care. We acknowledge the National
   Institute for Health Research-Health Protection Research Unit for
   Modelling Methodology (T.J.) for funding. M.M., C.H.R., receive funding
   through the National Institute for Health Research (PR-OD-1017-20001).
   R.M.E. acknowledges funding from an HDR UK Innovation Fellowship (grant
   no. MR/S003975/1). A.C. thanks the Medical Research Council for funding.
   S.F. was supported by the Wellcome Trust (210758/Z/18/Z). The authors
   alone are responsible for the views expressed in this article and they
   do not necessarily represent the views, decisions or policies of the
   institutions with which they are affiliated.
CR Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968
   Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   Agua-Agum J, 2016, NEW ENGL J MED, V374, P96, DOI 10.1056/NEJMc1510305
   Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318
   Ahmed R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193917
   Ahuka-Mundeke S, 2018, LANCET, V392, P213, DOI 10.1016/S0140-6736(18)31387-4
   ANDERSON R M, 1991
   Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490
   Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Backer JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005210
   Baidjoe AY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1362-y
   Bausch DG, 2018, AM J TROP MED HYG, V98, P1214, DOI 10.4269/ajtmh.18-0150
   Bausch DG, 2015, J INFECT DIS, V212, pS79, DOI 10.1093/infdis/jiv359
   Birrell PJ, 2018, STAT SCI, V33, P34, DOI 10.1214/17-STS631
   Bogoch II, 2017, AM J TROP MED HYG, V96, P1468, DOI 10.4269/ajtmh.16-0912
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993
   Brookmeyer R, 2006, BIOMETRICS, V62, P61, DOI 10.1111/j.1541-0420.2005.00421.x
   Brunette W, 2013, P 14 WORKSH MOB COMP
   Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482
   Buring JE, 1987, EPIDEMIOLOGY MED
   Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019
   Camacho A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009346
   Campbell F, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006885
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cauchemez S., 2013, Eurosurveillance, V18, P20503
   Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108
   Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y
   Cori A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0371
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Crawley M.J., 2012, R BOOK
   Dallman T, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000070
   De Maio N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005130
   Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Fahnrich C, 2015, EUROSURVEILLANCE, V20
   Famulare M, 2015, INT HEALTH, V7, P130, DOI 10.1093/inthealth/ihv012
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Felsenstein J, 2004, INFERRING PHYLOGENIE
   Finger F, 2018, BIORXIV, DOI [10.1101/388645, DOI 10.1101/388645]
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Funk S., 2018, BIORXIV, DOI [10.1101/177451, DOI 10.1101/177451]
   Funk S, 2018, EPIDEMICS-NETH, V22, P56, DOI 10.1016/j.epidem.2016.11.003
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gignoux E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194276
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038
   Grandesso F, 2014, EPIDEMIOL INFECT, V142, P1625, DOI 10.1017/S0950268813002562
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   GROSS M, 1976, PUBLIC HEALTH REP, V91, P168
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2
   Hartung C., 2010, P 4 ACM IEEE INT C I, P1, DOI DOI 10.1145/2369220.2369236
   Hatherell HA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000060
   Held L, 2017, STAT MED, V36, P3443, DOI 10.1002/sim.7363
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Hohle M, 2007, COMPUTATION STAT, V22, P571, DOI 10.1007/s00180-007-0074-8
   Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Inns T, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.16.21098
   Jenkins C, 2015, APPL ENVIRON MICROB, V81, P3946, DOI 10.1128/AEM.04188-14
   Jombart T, 2011, HEREDITY, V106, P383, DOI 10.1038/hdy.2010.78
   Jombart T, 2014, EPIDEMICS-NETH, V7, P28, DOI 10.1016/j.epidem.2014.04.003
   Jombart T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003457
   Karo B, 2018, EMERG INFECT DIS, V24, P2074, DOI 10.3201/eid2411.181237
   KEELING MJ, 2008, CLIN INFECT DIS, V47, P864, DOI DOI 10.1086/591197
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   King JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074570
   King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002
   Klinkenberg D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005495
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Kuhnemund M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13913
   Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103
   Lewnard JA, 2018, LANCET, V392, P189, DOI 10.1016/S0140-6736(18)31443-0
   Macharia P, 2015, 2015 INT C COMP COMM
   McKinley T, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1171
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Moraga Paula, 2018, F1000Res, V7, P1374, DOI 10.12688/f1000research.16032.2
   Nagraj V P, 2018, F1000Res, V7, P566, DOI 10.12688/f1000research.14492.1
   Nishiura H, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.27.21181
   Nishiura H, 2016, EMERG INFECT DIS, V22, P146, DOI 10.3201/eid2201.151383
   Njuguna HN, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0107-5
   Nouvellet P, 2018, EPIDEMICS-NETH, V22, P29, DOI 10.1016/j.epidem.2017.02.012
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147
   Page AL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003605
   Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003
   Park SW, 2018, BIORXIV, DOI [10.1101/312397, DOI 10.1101/312397]
   Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Polonsky J, 2019, WEEKLY EPIDEMIOLOGIC, V94, P23
   Polonsky JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114702
   Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184
   Poushter J., 2016, SMARTPHONE OWNERSHIP, V22, P1, DOI DOI 10.1017/CBO9781107415324.004
   Pruss-Ustun A, 2003, WHO ENV BURDEN DIS S
   Quesada-Gonzalez D, 2017, BIOSENS BIOELECTRON, V92, P549, DOI 10.1016/j.bios.2016.10.062
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   R Core Team, 2018, R LANG ENV STAT COMP
   Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440
   Saurabh S, 2017, AFR HEALTH SCI, V17, P225, DOI 10.4314/ahs.v17i1.28
   Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706
   Senga M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0300
   Shrivastava Saurabh RamBihariLal, 2014, Germs, V4, P97, DOI 10.11599/germs.2014.1063
   Siddle KJ, 2018, NEW ENGL J MED, V379, P1745, DOI 10.1056/NEJMoa1804498
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Snow J, 1855, MODE COMMUNICATION C
   Solomon AW, 2018, AM J TROP MED HYG, V99, P858, DOI 10.4269/ajtmh.18-0082
   Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015
   Springborn M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0691-0
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tom-Aba D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131000
   Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006
   Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19
   Viboud C, 2018, EPIDEMICS-NETH, V22, P13, DOI 10.1016/j.epidem.2017.08.002
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wertheim HFL, 2012, ATLAS HUMAN INFECT D
   WHO, 2017, EB OUTBR DEM REP CON
   WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Wickham H, 2014, J STAT SOFTW, V59, P1
   Xie Y., 2018, R MARKDOWN DEFINITIV
   Xie Y., 2016, BOOKDOWN AUTHORING B
   Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913
   Ypma RJF, 2013, GENETICS, V195, P1055, DOI 10.1534/genetics.113.154856
NR 146
TC 10
Z9 10
U1 6
U2 9
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD JUL 8
PY 2019
VL 374
IS 1776
AR 20180276
DI 10.1098/rstb.2018.0276
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IE2KQ
UT WOS:000472213400007
PM 31104603
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Zheng, B
   Liu, XP
   Tang, MX
   Xi, ZY
   Yu, JS
AF Zheng, Bo
   Liu, Xiaoping
   Tang, Moxun
   Xi, Zhiyong
   Yu, Jianshe
TI Use of age-stage structural models to seek optimal Wolbachia-infected
   male mosquito releases for mosquito-borne disease control
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Wolbachia; Release strategy; Population suppression; Suppression
   efficiency; Population replacement
ID AEDES-ALBOPICTUS DIPTERA; DRIVEN ABUNDANCE MODEL; DENGUE; VECTOR;
   TEMPERATURE; SURVIVAL; DIAPAUSE; TIME
AB Due to the lack of vaccines and effective clinical cures, current methods to control mosquito-borne viral diseases such as dengue and Zika are primarily targeting to eradicate the major mosquito vectors. However, traditional means, including larval source reduction and applications of insecticides etc, are not sufficient to keep vector population density below the epidemic risk threshold. An innovative and operational strategy is to release Wolbachia-infected male mosquitoes into wild areas to sterilize wild female mosquitoes by cytoplasmic incompatibility. To help design optimal release strategies before large scale and expensive operations, we started with an age-stage discrete model to track daily abundances of wild female mosquitoes, which fitted the field data collected by Guangzhou Center for Disease Control and Prevention from 2015 to 2017 with an average Pearson correlation coefficient 0.7283. Then, we modeled the Wolbachia interference by introducing the proportional releases of Wolbachia-infected males, and eight optimal release policies which guarantee more than 95% suppression efficiency were sought. Finally, we assessed the robustness of the optimality of the eight release policies by allowing the migration of females or the contamination of Wolbachia-infected females by two further extended mathematical models. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zheng, Bo; Liu, Xiaoping; Yu, Jianshe] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Zheng, Bo; Liu, Xiaoping; Yu, Jianshe] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
RP Yu, JS (corresponding author), Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
EM jsyu@gzhu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11826302, 11631005, 11871174]; Program for
   Changjiang Scholars and Innovative Research Team in UniversityProgram
   for Changjiang Scholars & Innovative Research Team in University
   (PCSIRT) [IRT_16R16]; Department of Education of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2017KTSCX148]
FX This work was supported by National Natural Science Foundation of China
   (11826302, 11631005, 11871174), Program for Changjiang Scholars and
   Innovative Research Team in University (IRT_16R16) and Department of
   Education of Guangdong Province (2017KTSCX148).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Cohen J., 1988, STAT POWER ANAL BEHA
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Estrada-Franco R., 1995, 42 PAN AM HLTH ORG
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Lee Shae-Jinn, 1994, Chinese Journal of Entomology, V14, P13
   Li J, 2013, J DIFFER EQU APPL, V19, P649, DOI 10.1080/10236198.2012.672566
   Li Y, 2018, RIC MAT, P1
   Liu Fusheng, 1992, Acta Scientiarum Naturalium Universitatis Sunyatseni, V31, P84
   Maciá Arnaldo, 2009, Rev. Soc. Entomol. Argent., V68, P107
   MORI A, 1981, Tropical Medicine, V23, P79
   PUMPUNI CB, 1992, J AM MOSQUITO CONTR, V8, P223
   Rozilawati H, 2007, TROP BIOMED, V24, P83
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tang B, 2016, J THEOR BIOL, V410, P65, DOI 10.1016/j.jtbi.2016.09.012
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008
   Vinogradova E., 2007, DIAPAUSE AQUATIC INV, V112, P218
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Wang R. l., 1966, Acta Entomologica Sinica, V15, P75
   Wang YG, 2017, J ECON ENTOMOL, V110, P239, DOI 10.1093/jee/tow254
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yan Zi-qiang, 2010, Redai Yixue Zazhi, V10, P606
   Yu JS, 2018, SIAM J APPL MATH, V78, P3168, DOI 10.1137/18M1204917
   Zhang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130156
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zheng B, 2018, ECOL MODEL, V387, P38, DOI 10.1016/j.ecolmodel.2018.09.004
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 45
TC 5
Z9 5
U1 5
U2 32
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD JUL 7
PY 2019
VL 472
BP 95
EP 109
DI 10.1016/j.jtbi.2019.04.010
PG 15
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA HY4VF
UT WOS:000468125300012
PM 30991073
DA 2020-07-08
ER

PT J
AU Liu, RF
   Wang, XZ
   Ma, Y
   Wu, JY
   Mao, C
   Yuan, LH
   Lu, JH
AF Liu, Rongfei
   Wang, Xuanzhuo
   Ma, Yu
   Wu, Jianyong
   Mao, Chen
   Yuan, Lihong
   Lu, Jiahai
TI Prevalence of Zika virus in blood donations: a systematic review and
   meta-analysis
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus (ZIKV); Blood donors; donations; Blood screening tests
ID INFECTIOUS-DISEASE AGENTS; WEST NILE VIRUS; PUERTO-RICO;
   TRANSFUSION-TRANSMISSION; POTENTIAL THREAT; DENGUE VIRUS; DONORS;
   OUTBREAK; SAFETY; STATES
AB BackgroundTransfusion-Transmitted Zika virus (TT-ZIKV) has become an emerging threat to world blood banks due to the fast spread of ZIKV epidemics and high rate of asymptomatic infections. For the risk assessment of ZIKV infection in blood products, relevant studies in blood donations or blood donors tested for ZIKV were collected and analyzed systematically. The overall prevalence of ZIKV infection were estimated through meta-analysis and potential risk factors were detected. The results will provide important clues for the protocol design of blood screening tests.MethodsRelevant articles about the rate of ZIKV detected in blood samples were identified from PubMed, Scopus and Web Of Science using key terms search strategy until October 7, 2017. Eligible articles were screened following inclusion and exclusion criteria. Meta-analysis and subgroup analyses were performed by software R3.4.1. Overall postdonation and posttransfusion follow-ups were analyzed.ResultsTen literatures (528,947 blood samples) were included for meta-analysis. The overall pooled prevalence of ZIKV (RNA and antibody) in blood donations was 1.02% (95%CI 0.36-1.99). The pooled prevalence of ZIKV RNA in blood donations was 0.85% (95%CI 0.21-1.88) less than the pooled prevalence of anti-ZIKV antibodies 1.61% (95%CI 0.03-5.21), however the difference was not statistically significant (p=0.52). The prevalence varied significantly in different geographical regions (p<0.001). Blood donations were more than two times likely to be infected by ZIKV in Zika epidemic period (1.37, 95%CI 0.91-1.91) than in non-epidemic period (0.61, 95%CI 0-2.55). The prevalence of anti-ZIKV antibodies (1.61, 95%CI 0.03-5.21) was almost twice as much as ZIKV nucleic acid detected in blood donations (0.85, 95%CI 0.21-1.88). However, statistically significant differences were not observed. A total of 122 ZIKV positive blood donors were followed, of which 48 (39%) reported symptoms postdonation, but none of the 13 followed recipients reported any clinical symptoms related to Zika infection posttransfusion.ConclusionThe pooled prevalence of Zika infection in blood donations was 1.02%. The prevalence varied greatly and reached to high-risk level in most of the situations. The results suggest that nucleic acid tests (NAT) for blood screening and pathogen reduction/inactivation technology (PRT) should be implemented in Zika-endemic areas and appropriate strategies should be designed according to different conditions. More studies are needed in the future to provide more evidence.
C1 [Liu, Rongfei; Wang, Xuanzhuo; Wu, Jianyong; Yuan, Lihong; Lu, Jiahai] Sun Yat Sen Univ, Sch Publ Hlth, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
   [Liu, Rongfei] Southern Med Univ, Foshan Women & Children Hosp, Foshan, Guangdong, Peoples R China.
   [Wang, Xuanzhuo; Wu, Jianyong; Yuan, Lihong; Lu, Jiahai] Sun Yat Sen Univ, One Hlth Ctr Excellence Res & Training, Guangzhou, Guangdong, Peoples R China.
   [Ma, Yu] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
   [Mao, Chen] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jiahai] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jiahai] State Key Lab Vector Borne Infect Dis Hainan, Haikou, Hainan, Peoples R China.
RP Yuan, LH; Lu, JH (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM yuanlh3@mail.sysu.edu.cn; lujiahai@mail.sysu.edu.cn
FU Guangdong Provincial Science and Technology Project [2018B020241002,
   2018B020207013]; National Science and Technology Major Project
   [2018ZX10101002-001-001]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31872499]
FX This study was supported by the Guangdong Provincial Science and
   Technology Project (2018B020241002, 2018B020207013) and the National
   Science and Technology Major Project (2018ZX10101002-001-001) and the
   National Natural Science Foundation of China (31872499), The funds have
   no role in the design of the study, data collection and analysis.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2009, MMWR-MORBID MORTAL W, V59, P34
   Aubry M, 2017, TRANSFUSION, V57, P2888, DOI 10.1111/trf.14318
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Borena W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178175
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ford AC, 2010, CLIN GASTROENTEROL H, V8, P401, DOI 10.1016/j.cgh.2009.07.020
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hu Y, 2017, ALIMENT PHARM THER, V46, P773, DOI 10.1111/apt.14319
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kiely P, 2017, TRANSFUS MED REV, V31, P154, DOI 10.1016/j.tmrv.2017.05.002
   Kiely P, 2017, MED J AUSTRALIA, V206, P455, DOI 10.5694/mja16.00833
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Laughhunn A, 2018, TRANSFUSION, V58, P748, DOI 10.1111/trf.14442
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rostom A, 2004, AHRQ PUBLICATION, V04-E029-2
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   US Food and Drug Administration, 2016, ALL US INV TEST SCRE
   US Food and Drug Administration, REC DON SCREEN DEF P
   Watson-Brown P, 2018, AUST NZ J PUBL HEAL, V42, P104, DOI 10.1111/1753-6405.12697
   WHO, 2016, MAINT SAF AD BLOOD S
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 53
TC 0
Z9 0
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 6
PY 2019
VL 19
AR 590
DI 10.1186/s12879-019-4226-6
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA IH5SW
UT WOS:000474554800001
PM 31277583
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Scarbrough, AW
   Hoffpauir, DR
   Hill, J
   Koppada, SP
AF Scarbrough, Amanda W.
   Hoffpauir, David R.
   Hill, Jack
   Koppada, Satya Priya
TI How mapping can reduce threats to public health
SO INTERNATIONAL JOURNAL OF HEALTH PROMOTION AND EDUCATION
LA English
DT Article
DE Geographic information systems; maps; Zika virus; communicable disease;
   prevention
ID ZIKA VIRUS; DISEASES; COUNTIES
AB Worldwide, the number of deaths attributable to communicable diseases is on a steady decline. Although there have been significant decreases in deaths due to communicable diseases, infectious diseases have not become a negligible cause of illness and death. Because of a recent emergence in the US, we sought to explore the spread of one communicable disease: Zika virus. Because of the threat to individual and public health posed by Zika, this study sought to examine the presence of the virus in Cameron County Texas from 1 January 2016 to 20 September 2018. Using geographical analysis, the goal of this study was to explore potential patterns in the spread of the infectious disease in order to forecast community risk. While the overall numbers of cases of Zika virus may decrease, this project's findings indicate a geographic spread of the virus through Cameron county Texas. This geographic spread of Zika virus is a public health issue for concern. GIS mapping can help address this public health concern by offering support to public health officials in assessing the outbreaks of infectious diseases. Moreover, the details provided through geographic exploration can support public health officials in anticipating communities at risk for the spread of communicable disease.
C1 [Scarbrough, Amanda W.; Koppada, Satya Priya] Sam Houston State Univ, Dept Populat Hlth, 1806 Ave J, Huntsville, TX 77340 USA.
   [Hoffpauir, David R.] Sam Houston State Univ, Appl Geospatial Res Lab AG SRL, TRIES, ORSP,TISI, Huntsville, TX 77340 USA.
   [Hill, Jack] Sam Houston State Univ, Off Res & Sponsored Programs, Huntsville, TX 77340 USA.
RP Scarbrough, AW (corresponding author), Sam Houston State Univ, Dept Populat Hlth, 1806 Ave J, Huntsville, TX 77340 USA.
EM aes060@shsu.edu
CR ArcGIS, 2019, COMM AN
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Baylor College of Medicine, 2018, INTR INF DIS
   Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Centers for Disease Control and Prevention, 2018, ZIK CAS US
   Centers for Disease Control and Prevention, 2018, SYMPT
   Centers for Disease Control and Prevention, 2018, TRANSM METH
   Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426
   El Bcheraoui C, 2018, JAMA-J AM MED ASSOC, V319, P1248, DOI 10.1001/jama.2018.2089
   EPSTEIN PR, 1995, AM J PUBLIC HEALTH, V85, P168, DOI 10.2105/AJPH.85.2.168
   Evans AS, 1989, VIRAL INFECT HUMANS
   Ferede G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3557-z
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Kaiser Family Foundation, 2017, CAS ZIK VIR DIS US
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Maguire D. J., 1991, GEOGR INF SYST PRINC, P9
   Morris D., 1995, EPIDEMIC MODELS THEI
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Texas Department of State Health Services, 2018, HIST DAT
   United States Census Bureau, 2018, FACT FIND
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2019, VECT BORN DIS
   WHO, 2018, ZIK VIR
   World Health Organization, 2018, MORT GLOB HLTH EST
   World Health Organization, 2018, 10 THREATS GLOB HLTH
NR 29
TC 0
Z9 0
U1 3
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1463-5240
EI 2164-9545
J9 INT J HEALTH PROMOT
JI Int. J. Health Promot. Educ.
PD NOV 2
PY 2019
VL 57
IS 6
BP 332
EP 342
DI 10.1080/14635240.2019.1637767
EA JUL 2019
PG 11
WC Education, Scientific Disciplines
SC Education & Educational Research
GA JG7WY
UT WOS:000475057900001
DA 2020-07-08
ER

PT J
AU Paaijmans, K
   Brustollin, M
   Aranda, C
   Eritja, R
   Talavera, S
   Pages, N
   Huijben, S
AF Paaijmans, Krijn
   Brustollin, Marco
   Aranda, Carles
   Eritja, Roger
   Talavera, Sandra
   Pages, Nonito
   Huijben, Silvie
TI Phenotypic insecticide resistance in arbovirus mosquito vectors in
   Catalonia and its capital Barcelona (Spain)
SO PLOS ONE
LA English
DT Article
ID WEST-NILE-VIRUS; AEDES-ALBOPICTUS; CULEX-PIPIENS; DIPTERA; INFECTION;
   CULICIDAE; FEVER; ANOPHELES; FRANCE
AB A range of mosquito species that belong to the Culicidae family are responsible for the worldwide transmission of infectious arboviral diseases such as dengue fever, Zika, West Nile fever and Chikungunya fever. Spain is at risk of arbovirus outbreaks, as various arboviral diseases are frequently introduced and it has established competent vector populations. Autochthonous human cases of West Nile virus have been reported infrequently since 2004, and since October 2018 three autochthonous human case of dengue fever have been confirmed. In response to an outbreak of any arboviral disease, space spraying or fogging will be implemented to control adult mosquito populations. To ensure adulticiding is cost-effective, the insecticide susceptibility status of vectors throughout Catalonia, an autonomous region in north-eastern Spain, was assessed through standardized WHO tube and CDC bottle bioassays. All Culex pipiens populations tested were resistant to at least one of the pyrethroids tested, whereas Aedes albopictus populations were susceptible to all pyrethroids tested. More detailed studies on the Cx. pipiens populations from the Barcelona area (the capital and largest city of Catalonia) revealed resistance to all four classes of public health insecticides available (pyrethroids, carbamates, organophosphates and organochlorides). All Ae. albopictus populations were susceptible to those classes, except for one of the tests performed with pirimiphos-methyl (an organophosphate). Pyrethroids are currently the first line chemical class to be used in space spray operations in response to an outbreak of an arboviral disease. While pyrethroids can be effective in reducing Ae. albopictus populations, this class may not be effective to control Cx. pipiens populations.
C1 [Paaijmans, Krijn; Huijben, Silvie] ISGlobal, Barcelona, Spain.
   [Paaijmans, Krijn; Huijben, Silvie] Arizona State Univ, Ctr Evolut & Med, Sch Life Sci, Tempe, AZ 85281 USA.
   [Paaijmans, Krijn] Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ USA.
   [Brustollin, Marco; Aranda, Carles; Talavera, Sandra; Pages, Nonito] Ctr Recerca Sanitat Anim CReSA IRTA, Barcelona, Spain.
   [Brustollin, Marco] Penn State Univ, Ctr Infect Dis Dynam, Millennium Sci Complex, University Pk, PA 16802 USA.
   [Brustollin, Marco] Penn State Univ, Huck Inst Life Sci, Millennium Sci Complex, University Pk, PA 16802 USA.
   [Aranda, Carles; Eritja, Roger] Consell Comarcal Baix Llobregat, Serv Control Mosquits, Barcelona, Spain.
   [Eritja, Roger] CREAF, Cerdanyola Del Valles, Spain.
   [Pages, Nonito] CIRAD, UMR ASTRE, Petit Bourg, Guadeloupe, France.
   [Pages, Nonito] Montpellier Univ, INRA, CIRAD, ASTRE, Montpellier, France.
RP Huijben, S (corresponding author), ISGlobal, Barcelona, Spain.; Huijben, S (corresponding author), Arizona State Univ, Ctr Evolut & Med, Sch Life Sci, Tempe, AZ 85281 USA.
EM silvie.huijben@asu.edu
OI Huijben, Silvie/0000-0002-3537-1915; Brustolin,
   Marco/0000-0002-3594-4488
FU Programa Recercaixa 2011; Branco Weiss Fellowship
FX This work was financially supported by Programa Recercaixa 2011. Silvie
   Huijben was supported by a Branco Weiss Fellowship. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alout H, 2014, J INFECT DIS, V210, P1464, DOI 10.1093/infdis/jiu276
   Angelini R., 2007, EUROSURVEILLANCE, V12, P3313
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Aranda C, 2018, EUROSURVEILLANCE, V23, P23, DOI 10.2807/1560-7917.ES.2018.23.47.1700837
   Bagnarelli P, 2011, EUROSURVEILLANCE, V16, P5
   Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251
   Bahuon C, 2016, REV SCI TECH OIE, V35, P811, DOI 10.20506/rst.35.3.2571
   Bengoa M, 2017, J AM MOSQUITO CONTR, V33, P246, DOI 10.2987/17-6636R.1
   Bofill D, 2006, EMERG INFECT DIS, V12, P1163, DOI 10.3201/eid1207.060164
   Brogdon WG, 2010, GUIDELINE EVALUATING
   Brustolin M, 2017, MED VET ENTOMOL, V31, P365, DOI 10.1111/mve.12254
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Brustolin M., 2016, THESIS
   Bueno-Mari R., 2012, European Mosquito Bulletin, P91
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Catalunya AdSPd, 2017, PROT VIG CONTR ARB T
   Centro de Coordinacion de Alertas y Emergencias Sanitarias, 2016, EV RIESG VIR NIL OCC
   Abramides GC, 2013, T ROY SOC TROP MED H, V107, P706, DOI 10.1093/trstmh/trt093
   Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Durand Jean-Paul, 2004, Rev Prat, V54, P703
   ECDC, 2013, COMM DIS THREATS REP
   Eritja R., 2000, European Mosquito Bulletin, V8, P10
   Eritja R., 1998, ANALISI INTEGRADA DU
   European Centre for Disease Prevention and Control, 2017, VECT CONTR FOC AED A
   European Centre for Disease Prevention and Control (ECDC), 2018, LOC TRANSM DENG FEV
   Ferraguti M, 2016, EPIDEMIOL INFECT, V144, P1907, DOI 10.1017/S0950268816000133
   Fotakis EA, 2017, ACTA TROP, V174, P29, DOI 10.1016/j.actatropica.2017.06.005
   Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Glunt KD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003602
   Gobierno de Canaries, 2017, SIST VIG ENT CAN DET
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Huijben S, 2018, EVOL APPL, V11, P415, DOI 10.1111/eva.12530
   Junta de Andalucia, 2017, FIEBR NIL OCC
   Kaptoul D, 2007, SCAND J INFECT DIS, V39, P70, DOI 10.1080/00365540600740553
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Alarcon-Elbal PM, 2014, MEM I OSWALDO CRUZ, V109, P782, DOI 10.1590/0074-0276140214
   Neumayr A, 2017, EUROSURVEILLANCE, V22, P39, DOI 10.2807/1560-7917.ES.2017.22.1.30433
   Observatori del Turisme a Barcelona: ciutat i regio, 2017, BARC TOUR ACT REP 20
   Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390
   Owusu HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03918-z
   Padros J., 1997, CULICIDS BAIX LLOBRE
   Pichler V, PEST MANAG SCI
   Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840
   R Development Core Team, 2018, R LANG ENV STAT COMP
   Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009
   Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.28.20853
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241
   Sanchez BS, 2017, ENFERM INFECC MICROB, V23
   Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5
   Thomas MB, 2016, P NATL ACAD SCI USA, V113, P8900, DOI 10.1073/pnas.1609889113
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113
   WHO, 2012, GLOB PLAN INS RES MA
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   WHO-World Health Organization, 1992, VECT RES PEST 15 REP
   World Health Organization, 2016, TEST PROC INREMO
   World Health Organizations (WHO), 2003, SPAC SPRAY APPL INS
NR 62
TC 2
Z9 2
U1 4
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 5
PY 2019
VL 14
IS 7
AR e0217860
DI 10.1371/journal.pone.0217860
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4FP
UT WOS:000484936300012
PM 31276554
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, CP
   Zeng, F
   Gao, XY
   Zhao, SJ
   Li, X
   Liu, S
   Li, N
   Deng, CL
   Zhang, B
   Gong, R
AF Yang, Chunpeng
   Zeng, Fang
   Gao, Xinyu
   Zhao, Shaojuan
   Li, Xuan
   Liu, Sheng
   Li, Na
   Deng, Chenglin
   Zhang, Bo
   Gong, Rui
TI Characterization of two engineered dimeric Zika virus envelope proteins
   as immunogens for neutralizing antibody selection and vaccine design
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE antibody; vaccine; flavivirus; dimerization; protein structure; dimer;
   envelope protein; Fc fragment; quaternary epitope; Zika virus;
   immunogen; neutralizing antibody; vaccine development; Flaviviridae;
   neurological disease
ID STRUCTURAL BIOLOGY; DENGUE; MATURATION; POTENT; BRAZIL
AB The envelope protein of Zika virus (ZIKV) exists as a dimer on the mature viral surface and is an attractive antiviral target because it mediates viral entry. However, recombinant soluble wild-type ZIKV envelope (wtZE) might preferentially exist as monomer (monZE). Recently, it has been shown that the A264C substitution could promote formation of dimeric ZIKV envelope protein (ZE(A264C)), requiring further characterization of purified ZE(A264C) for its potential applications in vaccine development. We also noted that ZE(A264C), connected by disulfide bond, might be different from the noncovalent native envelope dimer on the virion surface. Because the antibody Fc fragment exists as dimer and is widely used for fusion protein construction, here we fused wtZE to human immunoglobulin G1 (IgG1) Fc fragment (ZE-Fc) for noncovalent wtZE dimerization. Using a multistep purification procedure, we separated dimeric ZE(A264C) and ZE-Fc, revealing that they both exhibit typical beta-sheet-rich secondary structures and stabilities similar to those of monZE. The binding activities of monZE, ZE(A264C), and ZE-Fc to neutralizing antibodies targeting different epitopes indicated that ZE(A264C) and ZE-Fc could better mimic the native dimeric status, especially in terms of the formation of tertiary and quaternary epitopes. Both ZE(A264C) and ZE-Fc recognize a ZIKV-sensitive cell line as does monZE, indicating that the two constructs are still functional. Furthermore, a murine immunization assay disclose that ZE(A264C) and ZE-Fc elicit more neutralizing antibody responses than monZE does. These results suggest that the two immunogen candidates ZE(A264C) and ZE-Fc have potential utility for neutralizing antibody selection and vaccine design against ZIKV.
C1 [Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Xuan; Li, Na; Deng, Chenglin; Zhang, Bo; Gong, Rui] Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.
   [Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Liu, Sheng] Huazhong Univ Sci & Technol, Key Lab Biomed Photon MOE, Wuhan Natl Lab Optoelect Hubei Bioinformat, Coll Life Sci & Technol,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China.
   [Liu, Sheng] Huazhong Univ Sci & Technol, Mol Imaging Key Lab Syst, Coll Life Sci & Technol, Syst Biol Theme,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China.
RP Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.
EM gongr@wh.iov.cn
FU Core Facility and Technical Support, Wuhan Institute of Virology,
   Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key
   Laboratory on Emerging Infectious Diseases and Biosafety; Wuhan National
   Bio-Safety Level 4 Lab of the Chinese Academy of Sciences
FX We are thankful to the Core Facility and Technical Support, Wuhan
   Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of
   Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and
   Biosafety; as well as Wuhan National Bio-Safety Level 4 Lab of the
   Chinese Academy of Sciences for the support.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu LM, 2018, PROTEIN CELL, V9, P15, DOI 10.1007/s13238-017-0408-4
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5
   Yang CP, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01860
   Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742
   Zeng F, 2018, J BIOL CHEM, V293, P19127, DOI 10.1074/jbc.RA118.005367
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 43
TC 1
Z9 1
U1 1
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 5
PY 2019
VL 294
IS 27
BP 10638
EP 10648
DI 10.1074/jbc.RA119.007443
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IN5LL
UT WOS:000478717100022
PM 31138647
DA 2020-07-08
ER

PT J
AU Doolabh, K
   Caviola, L
   Savulescu, J
   Selgelid, MJ
   Wilkinson, D
AF Doolabh, Keyur
   Caviola, Lucius
   Savulescu, Julian
   Selgelid, Michael J.
   Wilkinson, Dominic
TI Is the non-identity problem relevant to public health and policy? An
   online survey
SO BMC MEDICAL ETHICS
LA English
DT Article
DE Zika; Non-identity problem; Ethics; Survey; Harm; Person-affecting;
   Impersonal
ID ZIKA; HARM
AB BackgroundThe non-identity problem arises when our actions in the present could change which people will exist in the future, for better or worse. Is it morally better to improve the lives of specific future people, as compared to changing which people exist for the better? Affecting the timing of fetuses being conceived is one case where present actions change the identity of future people. This is relevant to questions of public health policy, as exemplified in some responses to the Zika epidemic. There is philosophical disagreement about the relevance of non-identity: some hold that non-identity is not relevant, while others think that the only morally relevant actions are those that affect specific people. Given this disagreement, we investigated the intuitions about the moral relevance of non-identity within an educated sample of the public, because there was previously little empirical data on the public's views on the non-identity problem.MethodsWe performed an online survey with a sample of the educated general public. The survey assessed participants' preferences between person-affecting and impersonal interventions for Zika, and their views on other non-identity thought experiments, once the non-identity problem had been explained. It aimed to directly measure the importance of non-identity in participants' moral decision-making.ResultsWe collected 763 valid responses from the survey. Half of the participants (50%) had a graduate degree, 47% had studied philosophy at a university level, and 20% had read about the non-identity problem before. Most participants favoured person-affecting interventions for Zika over impersonal ones, but the majority claimed that non-identity did not influence their decision (66% of those preferring person-affecting interventions, 95% of those preferring impersonal ones). In one non-identity thought experiment participants were divided, but in another they primarily answered that impersonally reducing the quality of life of future people would be wrong, harmful and blameworthy, even though no specific individuals would be worse off.ConclusionsNon-identity appeared to play a minor role in participants' moral decision-making. Moreover, participants seem to either misunderstand the non-identity problem, or hold non-counterfactual views of harm that do not define harm as making someone worse off than they would have been otherwise.
C1 [Doolabh, Keyur] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.
   [Caviola, Lucius; Savulescu, Julian; Wilkinson, Dominic] Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford, England.
   [Caviola, Lucius] Univ Oxford, Dept Expt Psychol, Oxford, England.
   [Selgelid, Michael J.] Monash Univ, Monash Bioeth Ctr, Melbourne, Vic, Australia.
   [Wilkinson, Dominic] John Radcliffe Hosp, Oxford, England.
RP Doolabh, K (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.
EM Keyurd12@gmail.com
FU Wellcome trustWellcome Trust [WT106587/Z/14/Z, WT 104848/Z/14/Z]
FX Dominic Wilkinson and Julian Savulescu were supported for this work by
   grants from the Wellcome trust (WT106587/Z/14/Z and WT 104848/Z/14/Z).
   The Wellcome trust played no role in the design of the study, the
   collection, analysis and interpretation of data, or the writing of the
   manuscript. Keyur Doolabh, Lucius Caviola and Michael Selgelid have no
   funding to declare.
CR [Anonymous], 2018, ZIK SUSP CONF CAS RE
   Arrhenius G., 2005, ETHICAL PERSPECT, V10, P185, DOI DOI 10.2143/EP.10.3.503884
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Bennett R, 2009, BIOETHICS, V23, P265, DOI 10.1111/j.1467-8519.2008.00655.x
   Doolabh K, 2017, DEV WORLD BIOETH, V17, P173, DOI 10.1111/dewb.12176
   Feinberg J., 1984, HARM OTHERS MORAL LI
   Harman E, 2009, INT LIBR ETH LAW NEW, V35, P137, DOI 10.1007/978-1-4020-5697-0_7
   Kahane G, 2012, J APPL PHILOS, V29, P318, DOI 10.1111/j.1468-5930.2012.00574.x
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   McMahan J, 2013, J ETHICS, V17, P5, DOI DOI 10.1007/s10892-012-9139-1
   NARVESON J, 1973, MONIST, V57, P62, DOI 10.5840/monist197357134
   Parfit D., 1984, REASONS PERSONS
   Purshouse C, 2016, BIOETHICS, V30, P251, DOI 10.1111/bioe.12207
   Rawls J., 1971, THEORY JUSTICE
   Savulescu J, 2001, BIOETHICS, V15, P413, DOI 10.1111/1467-8519.00251
   Shiffrin Seana Valentine, 1999, LEGAL THEORY, V5, P117, DOI DOI 10.1017/S1352325299052015
   Wilkinson D, 2017, WHICH LIVES MATTER M
   Wilkinson D, 2015, THEOR MED BIOETH, V36, P121, DOI 10.1007/s11017-015-9324-x
   Williams NJ, 2014, THEOR MED BIOETH, V35, P337, DOI 10.1007/s11017-014-9303-7
NR 19
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6939
J9 BMC MED ETHICS
JI BMC Med. Ethics
PD JUL 5
PY 2019
VL 20
AR 46
DI 10.1186/s12910-019-0379-5
PG 17
WC Ethics; Medical Ethics; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Biomedical Social
   Sciences
GA IH5TS
UT WOS:000474557000001
PM 31277715
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nyaruaba, R
   Mwaliko, C
   Mwau, M
   Mousa, S
   Wei, HP
AF Nyaruaba, Raphael
   Mwaliko, Caroline
   Mwau, Matilu
   Mousa, Samar
   Wei, Hongping
TI Arboviruses in the East African Community partner states: a review of
   medically important mosquito-borne Arboviruses
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Review
DE East African Community; mosquito-borne arboviruses; mosquito vector;
   public health; Africa
ID RIFT-VALLEY FEVER; WEST-NILE-VIRUS; ONYONG-NYONG FEVER;
   SEMLIKI-FOREST-VIRUS; SOUTH-CENTRAL UGANDA; NATURAL VERTICAL
   TRANSMISSION; YELLOW-FEVER; CHIKUNGUNYA-VIRUS; ZIKA VIRUS;
   HEMORRHAGIC-FEVER
AB Mosquito-borne diseases, including arbovirus-related diseases, make up a large proportion of infectious disease cases worldwide, causing a serious global public health burden with over 700,000 deaths annually. Mosquito-borne arbovirus outbreaks can range from global to regional. In the East African Community (EAC) region, these viruses have caused a series of emerging and reemerging infectious disease outbreaks. Member states in the EAC share a lot in common including regional trade and transport, some of the factors highlighted to be the cause of mosquito-borne arbovirus disease outbreaks worldwide. In this review, characteristics of 24 mosquito-borne arboviruses indigenous to the EAC are reviewed, including lesser or poorly understood viruses, like Batai virus (BATV) and Ndumu virus (NDUV), which may escape their origins under perfect conditions to establish a foothold in new geographical locations. Factors that may influence the future spread of these viruses within the EAC are addressed. With the continued development observed in the EAC, strategies should be developed by the Community in improving mosquito and mosquito-borne arbovirus surveillance to prevent future outbreaks.
C1 [Nyaruaba, Raphael; Mwaliko, Caroline; Mousa, Samar; Wei, Hongping] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, 44 Bayi Rd, Wuhan 430071, Hubei, Peoples R China.
   [Nyaruaba, Raphael; Mwaliko, Caroline; Mousa, Samar] Univ Chinese Acad Sci, Int Coll, Beijing, Peoples R China.
   [Mwau, Matilu] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya.
RP Wei, HP (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, 44 Bayi Rd, Wuhan 430071, Hubei, Peoples R China.
EM hpwei@wh.iov.cn
OI Nyaruaba, Raphael/0000-0001-8467-8959
CR Adam AA, 2010, INT J INFECT DIS, V14, pE179, DOI 10.1016/j.ijid.2009.03.029
   Adam A, 2016, VECTOR-BORNE ZOONOT, V16, P290, DOI 10.1089/vbz.2015.1897
   Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Andrewes C, 1964, VIRUSES VERTEBRATES
   Antipa C, 1984, Virologie, V35, P5
   Atkins GJ, 1999, J GEN VIROL, V80, P2287, DOI 10.1099/0022-1317-80-9-2287
   Atoni E, 2018, AFR J HLTH SC, V31, P121
   Baba M, 2016, REV MED VIROL, V26, P183, DOI 10.1002/rmv.1877
   BARDOS V., 1962, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V6, P186
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Berry IM, 2018, RECENT OUTBREAKS CHI
   BLACK FL, 1955, J IMMUNOL, V74, P411
   BOORMAN J. P. T., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P383, DOI 10.1016/0035-9203(58)90053-1
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bosa HK, 2014, INT J INFECT DIS, V21, P3, DOI 10.1016/j.ijid.2014.03.412
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burrell CJ, 2017, BUNYAVIRUSES, P407, DOI [10.1016/B978-0-12-375156-0.00029-1, DOI 10.1016/B978-0-12-375156-0.00029-1]
   Burt FJ, 2014, FUTURE VIROL, V9, P993, DOI 10.2217/FVL.14.87
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169
   Chege SM, 2019, TECHNOL SOC, V56, P79, DOI 10.1016/j.techsoc.2018.09.007
   Chen RB, 2018, J GEN VIROL, V99, P761, DOI 10.1099/jgv.0.001072
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Christian KA, 2017, HEALTH SECUR, V15, P453, DOI 10.1089/hs.2017.0004
   Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029
   Crabtree M, 2009, J MED ENTOMOL, V46, P961, DOI 10.1603/033.046.0431
   Dar O, 2013, EMERG INFECT DIS, V19, P189, DOI 10.3201/eid1902.120941
   Daubney R, 1932, LANCET, V1, P611
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   Davies FG, 2010, AM J TROP MED HYG, V83, P73, DOI 10.4269/ajtmh.2010.83s2a02
   de St Maurice A, 2016, MMWR-MORBID MORTAL W, V65, P1200, DOI 10.15585/mmwr.mm6543a5
   Depoortere E, 2004, TROP MED INT HEALTH, V9, P730, DOI 10.1111/j.1365-3156.2004.01253.x
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DIGOUTTE J-P, 1972, Bulletin de la Societe de Pathologie Exotique, V65, P751
   Dilcher M, 2013, VIRUS GENES, V46, P162, DOI 10.1007/s11262-012-0825-7
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Draganescu N, 1978, Virologie, V29, P107
   Draganescu N, 1975, Virologie, V26, P103
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106
   Dutuze MF, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00069
   Edwards F.W., 1941, MOSQUITOES ETHIOPIAN
   Eiden M, 2014, EMERG INFECT DIS, V20, P2174, DOI 10.3201/eid2012.140787
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733
   Enkhtsetseg A, 2016, AM J TROP MED HYG, V95, P1469, DOI 10.4269/ajtmh.16-0174
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FENNER F, 1974, INTERVIROLOGY, V3, P193, DOI 10.1159/000149755
   FENNER F, 1976, J GEN VIROL, V31, P463, DOI 10.1099/0022-1317-31-3-463
   Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009
   Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343
   Firehiwot G, 2013, CORRUPTION EC GROWTH, V39, P3
   Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   FRANCY DB, 1989, AM J TROP MED HYG, V41, P355, DOI 10.4269/ajtmh.1989.41.355
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   GAIDAMOVICH SY, 1973, ACTA VIROL, V17, P444
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GERMAIN M, 1982, B I PASTEUR, V80, P315
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   Gichaga FJ, 2017, IATSS RES, V40, P72, DOI 10.1016/j.iatssr.2016.05.002
   Gonzalez J-P, 1988, ARBOVIRUSES EPIDEMIO, V2, P87
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gratz NG Knudsen AB Organization WH, 1996, RISE SPREAD DENGUE D
   Groseth A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003147
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   GUBLER DJ, 1998, PATHOLOGY EMERGING I, V2, P43
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   HADDOW A. J., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P517, DOI 10.1016/0035-9203(60)90025-0
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamad H, 2016, AFRICOLOGY J PAN AFR, V9, P69
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1972, ANN TROP MED PARASIT, V66, P343, DOI 10.1080/00034983.1972.11686834
   Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393
   Himeidan YE, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00169
   Hirsch August, 1883, HDB GEOGRAPHICAL HIS, VI
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   HUNT AR, 1979, AM J TROP MED HYG, V28, P740, DOI 10.4269/ajtmh.1979.28.740
   HYAMS KC, 1986, AM J TROP MED HYG, V35, P860, DOI 10.4269/ajtmh.1986.35.860
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JOHNSON BK, 1981, T ROY SOC TROP MED H, V75, P239, DOI 10.1016/0035-9203(81)90325-4
   JUPP PG, 1976, J MED ENTOMOL, V12, P647, DOI 10.1093/jmedent/12.6.647
   Kading Rebekah C., 2018, Infection Ecology & Epidemiology, V8, P1439215, DOI 10.1080/20008686.2018.1439215
   KALUNDA M, 1985, T ROY SOC TROP MED H, V79, P567, DOI 10.1016/0035-9203(85)90105-1
   KAPLAN B, 2019, INFECT ECOL EPIDEMIO, V8, DOI DOI 10.1080/20008686.2018.1537461
   Karabastos N, 1985, AM SOC TROP MED HYG, V3, P361
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Ketkar H, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020150
   Khan AS, 2016, LANCET GLOB HEALTH, V4, pE773, DOI 10.1016/S2214-109X(16)30240-6
   Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P71
   KOKERNOT RH, 1958, AM J TROP MED HYG, V7, P579, DOI 10.4269/ajtmh.1958.7.579
   KOKERNOT RH, 1961, AM J TROP MED HYG, V10, P383, DOI 10.4269/ajtmh.1961.10.383
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Konongoi SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205058
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   LEE VH, 1974, T ROY SOC TROP MED H, V68, P39, DOI 10.1016/0035-9203(74)90249-1
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   LeRiche M, 2013, S SUDAN REVOLUTION I
   Lopez G, 2008, VECTOR-BORNE ZOONOT, V8, P615, DOI 10.1089/vbz.2007.0200
   Lundstrom JO, 2010, VECTOR-BORNE ZOONOT, V10, P889, DOI 10.1089/vbz.2009.0069
   Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981
   Lutomiah J, 2014, J MED ENTOMOL, V51, P1091, DOI 10.1603/ME14064
   Lutomiah J, 2014, VECTOR-BORNE ZOONOT, V14, P656, DOI 10.1089/vbz.2013.1564
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158, DOI 10.4269/ajtmh.1999.61.158
   Lutwama Julius J, 2002, Afr Health Sci, V2, P24
   Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190
   LWOFF A, 1966, ANNU REV MICROBIOL, V20, P45, DOI 10.1146/annurev.mi.20.100166.000401
   MacLachlan NJ, 2017, FENNERS VET VIROLOGY, P411, DOI [10.1016/B978-0-12-800946-8.00022-2, DOI 10.1016/B978-0-12-800946-8.00022-2]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malik Amal, 2011, J Infect Public Health, V4, P1, DOI 10.1016/j.jiph.2010.08.001
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   MANSONBAHR PE, 1973, BMJ-BRIT MED J, V2, P151, DOI 10.1136/bmj.2.5859.151
   Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218
   MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   McAuliffe MC, 2012, E AFRICAN COMMUNITY
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P63, DOI 10.1016/0035-9203(61)90041-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   MCINTOSH BM, 1976, S AFR J SCI, V72, P295
   MCINTOSH BM, 1976, J MED ENTOMOL, V12, P645, DOI 10.1093/jmedent/12.6.645
   MCINTOSH BM, 1985, INT CATALOGUE ARBOVI, V3, P1059
   McIntyre MMA, 2005, TRADE INTEGRATION E
   METSELAAR D, 1974, T ROY SOC TROP MED H, V68, P114, DOI 10.1016/0035-9203(74)90184-9
   Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   MORVAN JM, 1994, T ROY SOC TROP MED H, V88, P205, DOI 10.1016/0035-9203(94)90297-6
   Mossel EC, 2017, J MED ENTOMOL, V54, P1403, DOI 10.1093/jme/tjx120
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   NASHED NW, 1993, AM J TROP MED HYG, V48, P676, DOI 10.4269/ajtmh.1993.48.676
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Nobuchi H, 1979, KANPO RINSHO, V26, P422
   Nyakarahuka L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006412
   Obonyo M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198556
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Odhiambo CO, 2014, INT J INFECT DIS, V21, P230, DOI 10.1016/j.ijid.2014.03.900
   Ogola F., 2015, AFRICA J MANAGEMENT, V1, P333
   Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773
   Onyango CO, 2004, EMERG INFECT DIS, V10, P1668, DOI 10.3201/eid1009.030727
   Onyango CO, 2004, EMERG INFECT DIS, V10, P1064, DOI 10.3201/eid1006.030738
   Organization WH, 1993, MON DENG
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pauli G, 2014, TRANSFUS MED HEMOTH, V41, P73, DOI 10.1159/000357106
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   PORTERFIELD JS, 1978, INTERVIROLOGY, V9, P129, DOI 10.1159/000148930
   Porterfield JS, 1998, ENCY IMMUNOL, P390, DOI [10.1006/RWEI.1999.0104, DOI 10.1006/RWEI.1999.0104]
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Reed W, 1900, Public Health Pap Rep, V26, P37
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2017, PATHOG GLOB HEALTH, V111, P271, DOI 10.1080/20477724.2017.1355431
   ROBINSON M C, 1956, Cent Afr J Med, V2, P394
   RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155
   RODHAIN F, 1975, TROP GEOGR MED, V27, P307
   Rolandsen OH, 2015, J EAST AFR STUD, V9, P163, DOI 10.1080/17531055.2014.993210
   Saluzzo JF, 2017, ANN INFECT DIS EPIDE, V2, P1022
   Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680
   Sanders EJ, 1999, J INFECT DIS, V180, P1436, DOI 10.1086/315073
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644, DOI 10.4269/ajtmh.1998.59.644
   Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   Schlumberger CE, 2014, OPPORTUNITIES CHALLE, DOI [10.1596/978-1-4648-0282-9_ch5, DOI 10.1596/978-1-4648-0282-9_CH5]
   Seidahmed O. M. E., 2012, Eastern Mediterranean Health Journal, V18, P1217
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Seruyange E, 2018, CHIKUNGUNYA W NILE V, V1, DOI [10.11604/pamj.cp.2017.4.43.248, DOI 10.11604/PAMJ.CP.2017.4.43.248]
   Sigei F, 2018, ARCH VIROL, V163, P2465, DOI 10.1007/s00705-018-3869-8
   Simpson DIH, 1964, ANN TROP MED PARASIT, V58, P367
   SINGH KRP, 1966, INDIAN J MED RES, V54, P220
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74, DOI 10.1080/00034983.1949.11685396
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   Smithburn KC, 1941, AM J TROP MED HYG, V21, P75
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Sule WF, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2998-y
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Tchouassi DP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1473-x
   TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125
   TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   TOMORI O, 1974, T ROY SOC TROP MED H, V68, P461, DOI 10.1016/0035-9203(74)90069-8
   Ulmann E, 1957, WORLD ATLAS EPIDEM 3
   UMUHOZA T, 2017, J S AFR VET ASSOC, V88, P1379
   Vairo F, 2012, INT J INFECT DIS, V16, pE44, DOI 10.1016/j.ijid.2011.09.018
   Van Kleef E, 2010, TROP NET
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wandera C, 2018, 3 DEKUT INT C STI E
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P125, DOI 10.1159/000149632
   WHITE G B, 1975, Mosquito Systematics, V7, P303
   WILLEMS WR, 1979, SCIENCE, V203, P1127, DOI 10.1126/science.424742
   WILLIAMS M. C., 1965, ARCH GESAMTE VIRUSFORSCH, V15, P422, DOI 10.1007/BF01241769
   Wissenbach U, 2017, AFRICAN POLITICS MEE
   Woodall J, 1962, E AFR VIRUS RES I RE, V12, P17
   WOODALL JP, 1964, ANN TROP MED PARASIT, V58, P383, DOI 10.1080/00034983.1964.11686260
   Woodall JP, 1969, HUMAN INFECT ARBOVIR
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
   Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023
   Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zeller HG, 1996, B SOC PATHOL EXOT, V89, P12
NR 249
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD JUL 4
PY 2019
VL 113
IS 5
BP 209
EP 228
DI 10.1080/20477724.2019.1678939
PG 20
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA JP7FR
UT WOS:000498427400002
PM 31664886
DA 2020-07-08
ER

PT J
AU Muniz, RL
   Godoi, IP
   Reis, EA
   Garcia, MM
   Guerra, AA
   Godman, B
   Ruas, CM
AF Muniz Junior, Roberto Lucio
   Godoi, Isabella Piassi
   Reis, Edna Afonso
   Garcia, Marina Morgado
   Guerra-Junior, Augusto Afonso
   Godman, Brian
   Ruas, Cristina Mariano
TI Consumer willingness to pay for a hypothetical Zika vaccine in Brazil
   and the implications
SO EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
LA English
DT Article
DE Arbovirosis; Brazil; contingent valuation; reimbursement; vaccine;
   willingness to pay; Zika
ID DENGUE VACCINE; VIRUS; ATTITUDES; DEMAND
AB Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.
C1 [Muniz Junior, Roberto Lucio] Univ Fed Minas Gerais, Coll Pharm, Av Presidente Antonio Carlos,6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Godoi, Isabella Piassi; Guerra-Junior, Augusto Afonso; Ruas, Cristina Mariano] Univ Fed Minas Gerais, Fac Farm, Programa Posgrad Medicamentos & Assistencia Farma, Sala 1023,Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Godoi, Isabella Piassi; Guerra-Junior, Augusto Afonso] Univ Fed Minas Gerais, Fac Farm, SUS Collaborating Ctr Technol Assessment & Excell, Sala 1042,Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Godoi, Isabella Piassi] Univ Fed Sud & Sudeste Para, Inst Hlth & Biol Studies, Ave Ipes S-N, Maraba, Para, Brazil.
   [Reis, Edna Afonso] Univ Fed Minas Gerais, Exact Sci Inst, Dept Stat, Av Presidente Antonio Carlos6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Garcia, Marina Morgado; Godman, Brian] Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland.
   [Garcia, Marina Morgado; Godman, Brian] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, SE-14186 Stockholm, Sweden.
   [Godman, Brian] Liverpool Univ Management Sch, Hlth Econ Ctr, Liverpool, Merseyside, England.
   [Godman, Brian] Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, Garankuwa, South Africa.
RP Godman, B (corresponding author), Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland.; Godman, B (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, SE-14186 Stockholm, Sweden.
EM brian.godman@strath.ac.uk
RI ; Godoi, Isabella/G-3544-2019
OI Guerra Junior, Augusto Afonso/0000-0001-5256-0577; Godman,
   Brian/0000-0001-6539-6972; Godoi, Isabella/0000-0002-0568-6625
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; Newton Advanced Fellowship by the Academy of Medical
   Sciences
FX Financial support was received by one author from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior). The project was also in
   part supported by a Newton Advanced Fellowship by the Academy of Medical
   Sciences.
CR Agencia Nacional de Saude Complementar (ANS), 2017, CAD INF SAUD SUPL BE
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   [Anonymous], 2018, RED PART OF VAC FEBR
   ANVISA (National Sanitary Surveillance Agency) [Internet], 2016, VAC DENG TEM PREC DE
   Atlas do Desenvolvimento Humano no Brasil, 2016, IND BRAS
   Baylor College of Medicine [internet], 2013, VACC NAT 10 MOST IMP
   Brasil, 2017, MON CAS DENG FEBR CH, V49
   Brasil, 2016, MON CAS DENG FEBR CH, V47
   Brasil, 2018, MON CAS DENG FEBR CH, V49
   Brasil, 2018, MON INT ALT CRESC DE, V49
   Cameron MP, 2013, VACCINE, V31, P3712, DOI 10.1016/j.vaccine.2013.05.089
   Cohen J, 2017, SCIENCE, V357, P241, DOI 10.1126/science.357.6348.241
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond Michael F, 2015, METHODS EC EVALUATIO
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FINEP [Internet], 2016, FIN VAI INV RS 230 M
   Godoi IP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00041
   Guo N, 2017, VACCINE, V35, P2848, DOI 10.1016/j.vaccine.2017.04.006
   Haab T. C., 2002, NEW HORIZONS ENV EC
   Harapan H, 2017, HUM VACC IMMUNOTHER, V13, P786, DOI 10.1080/21645515.2016.1259045
   Huo X, 2016, VACCINE, V34, P1767, DOI 10.1016/j.vaccine.2016.02.046
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2014, SINT IND SOC AN COND
   Irwin KL, 2017, VACCINE, V35, P6915, DOI 10.1016/j.vaccine.2017.06.026
   Johnston RJ, 2017, J ASSOC ENVIRON RESO, V4, P319, DOI 10.1086/691697
   Lee JG, 2015, AM J PUBLIC HLTH, V9, pe1
   Nguyen LH, 2018, PATIENT PREFER ADHER, V12, P1917, DOI 10.2147/PPA.S178444
   Ministerio da Saude, 2002, PROGR NAC CONTR DENG
   Ministerio da Saude [Internet], 2018, OR VAC
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Nunn A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21290
   OECD (Organisation for Economic Co operation and Development) [Internet], 2017, EXCH RAT
   Olson D, 2018, PEDIATR INFECT DIS J, V37, P1184, DOI 10.1097/INF.0000000000002169
   Painter JE, 2018, HUM VACC IMMUNOTHER, V14, P1665, DOI 10.1080/21645515.2018.1423928
   Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL ZIK VIR INF
   PrevencAo e combate: DengueChikungunya e Zika [Internet] : Ministerio da Saude, 2016, PREV COMB DENG CHIK
   Secretaria de Saude de Estado de Minas Gerais, 2018, B EP MON CAS DENG CH
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tian T, 2019, HUM VACC IMMUNOTHER, V15, P1005, DOI 10.1080/21645515.2018.1520591
   Ughasoro MD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003838
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Whittington D, 2002, VACCINE, V20, P2585, DOI 10.1016/S0264-410X(02)00152-4
   WHO (World Health Organization), 2008, FLAW FAIR BRAZ HLTH
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   World Health Organization (WHO) [internet], 2017, ICD 11 MORT MORB STA
NR 49
TC 1
Z9 1
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1473-7167
EI 1744-8379
J9 EXPERT REV PHARM OUT
JI Expert Rev. Pharmacoecon. Outcomes Res.
PD JUL 4
PY 2019
VL 19
IS 4
BP 473
EP 482
DI 10.1080/14737167.2019.1552136
PG 10
WC Health Care Sciences & Services; Health Policy & Services; Pharmacology
   & Pharmacy
SC Health Care Sciences & Services; Pharmacology & Pharmacy
GA IS6NN
UT WOS:000482268600011
PM 30468095
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Khaiboullina, SF
   Ribeiro, FM
   Uppal, U
   Martynova, EV
   Rizvanov, AA
   Verma, SC
AF Khaiboullina, Svetlana F.
   Ribeiro, Fabiola M.
   Uppal, Urnsy
   Martynova, Ekaterina, V
   Rizvanov, Albert A.
   Verma, Subhash C.
TI Zika Virus Transmission Through Blood Tissue Barriers
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE ZIKV; ZIKV transmission; blood tissue barriers; placenta; microcephaly
ID MALE SEXUAL TRANSMISSION; HUMAN ENDOTHELIAL-CELLS; NF-KAPPA-B; NS3
   PROTEIN; STRUCTURAL BIOLOGY; SERINE-PROTEASE; PLACENTAL CELLS;
   BIRTH-DEFECTS; MOUSE MODEL; INFECTION
AB The recent Zika virus (ZIKV) epidemic in the Americas and the Caribbean revealed a new deadly strain of the mosquito-borne virus, which has never been associated with previous outbreaks in Asia. For the first time, widespread ZIKV infection was shown to cause microcephaly and death of newborns, which was most likely due to the mutation acquired during the large outbreak recorded in French Polynesia in 2013-2014. Productive ZIKV replication and persistence has been demonstrated in placenta and fetal brains. Possible association between ZIKV and microcephaly and fetal death has been confirmed using immunocompetent mouse models in vitro and in vivo. Having crossed the placenta, ZIKV directly targets neural progenitor cells (NPCs) in developing human fetus and triggers apoptosis. The embryonic endothelial cells are exceptionally susceptible to ZIKV infection, which causes cell death and tissue necrosis. On the contrary, ZIKV infection does not affect the adult brain microvascular cell morphology and blood-brain barrier function. ZIKV is transmitted primarily by Aedes mosquito bite and is introduced into the placenta/blood through replication at the site of the entry. Also, virus can be transmitted through unprotected sex. Although, multiple possible routes of virus infection have been identified, the exact mechanism(s) utilized by ZIKV to cross the placenta still remain largely unknown. In this review, the current understanding of ZIKV infection and transmission through the placental and brain barriers is summarized.
C1 [Khaiboullina, Svetlana F.; Uppal, Urnsy; Verma, Subhash C.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
   [Khaiboullina, Svetlana F.; Martynova, Ekaterina, V; Rizvanov, Albert A.] Kazan Fed Univ, Sci & Educ Ctr Pharmaceut, Dept Exploratory Res, Kazan, Russia.
   [Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
RP Verma, SC (corresponding author), Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
EM scverma@medicine.nevada.edu
RI Rizvanov, Albert/H-4486-2013; Ribeiro, Fabiola/E-8831-2013;
   Khaiboullina, Svetlana/M-4793-2016
OI Rizvanov, Albert/0000-0002-9427-5739; Ribeiro,
   Fabiola/0000-0001-7042-9433; Khaiboullina, Svetlana/0000-0002-5064-570X
FU Program of Competitive Growth of Kazan Federal UniversityMinistry of
   Education and Science, Russian FederationProject 5-100, Ministry of
   Education and Science, Russian Federation; National Institute of General
   Medical Sciences from the National Institutes of Health [GM103440]
FX This work was supported by Institutional and Departmental Funds. SFK,
   EVM, and AAR were supported by the Program of Competitive Growth of
   Kazan Federal University. This work was partly supported by a grant from
   the National Institute of General Medical Sciences (GM103440) from the
   National Institutes of Health.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2018, 2017 CAS COUNTS US
   CDC, 2017, 1 10 US PREGN WOM CO
   CDC [Centers for Disease Control and Prevention], 2016, 2016 CAS COUNTS US
   Center for Biologics Evaluation and Research, 2018, REV REC RED RISK ZIK
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Dong SP, 2018, VIROL SIN, V33, P125, DOI 10.1007/s12250-018-0007-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guzman M G, 1987, Bull Pan Am Health Organ, V21, P270
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Khaiboullina SF, 2005, VIROLOGY, V342, P167, DOI 10.1016/j.virol.2005.07.035
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lin JC, 2014, J IMMUNOL, V193, P1258, DOI 10.4049/jimmunol.1302675
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Long XG, 2013, FASEB J, V27, P1062, DOI 10.1096/fj.12-213967
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   PAHO, 2016, ZIK CUM CAS
   PAHO, 2017, REG ZIK EP UPD AM AU
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5
   SCHLESINGER RW, 1989, J VIROL, V63, P1695, DOI 10.1128/JVI.63.4.1695-1703.1989
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Valbuena G, 2006, ANNU REV PATHOL-MECH, V1, P171, DOI 10.1146/annurev.pathol.1.110304.100031
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363
   Wan CK, 2016, J IMMUNOL, V196, P543, DOI 10.4049/jimmunol.1502080
   Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Woollard SM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030070
   World Health Organization, 2018, INF YOUNG CHILD FEED
   Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
NR 164
TC 4
Z9 4
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 4
PY 2019
VL 10
AR 1465
DI 10.3389/fmicb.2019.01465
PG 13
WC Microbiology
SC Microbiology
GA IH0WK
UT WOS:000474213100001
PM 31333605
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barrows, NJ
   Anglero-Rodriguez, Y
   Kim, B
   Jamison, SF
   Le Sommer, C
   McGee, CE
   Pearson, JL
   Dimopoulos, G
   Ascano, M
   Bradrick, SS
   Garcia-Blanco, MA
AF Barrows, Nicholas J.
   Anglero-Rodriguez, Yesseinia
   Kim, Byungil
   Jamison, Sharon F.
   Le Sommer, Caroline
   McGee, Charles E.
   Pearson, James L.
   Dimopoulos, George
   Ascano, Manuel
   Bradrick, Shelton S.
   Garcia-Blanco, Mariano A.
TI Dual roles for the ER membrane protein complex in flavivirus infection:
   viral entry and protein biogenesis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID YELLOW-FEVER VIRUS; DENGUE VIRUS; ZIKA VIRUS; HOST FACTORS;
   IDENTIFICATION; SCREEN; INHIBITOR; BIOLOGY
AB Hundreds of cellular host factors are required to support dengue virus infection, but their identity and roles are incompletely characterized. Here, we identify human host dependency factors required for efficient dengue virus-2 (DENV2) infection of human cells. We focused on two, TTC35 and TMEM111, which we previously demonstrated to be required for yellow fever virus (YFV) infection and others subsequently showed were also required by other flaviviruses. These proteins are components of the human endoplasmic reticulum membrane protein complex (EMC), which has roles in ER-associated protein biogenesis and lipid metabolism. We report that DENV, YFV and Zika virus (ZIKV) infections were strikingly inhibited, while West Nile virus infection was unchanged, in cells that lack EMC subunit 4. Furthermore, targeted depletion of EMC subunits in live mosquitoes significantly reduced DENV2 propagation in vivo. Using a novel uncoating assay, which measures interactions between host RNA-binding proteins and incoming viral RNA, we show that EMC is required at or prior to virus uncoating. Importantly, we uncovered a second and important role for the EMC. The complex is required for viral protein accumulation in a cell line harboring a ZIKV replicon, indicating that EMC participates in the complex process of viral protein biogenesis.
C1 [Barrows, Nicholas J.; Jamison, Sharon F.; Le Sommer, Caroline; Pearson, James L.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Duke Univ, Dept Microbiol & Mol Genet, Durham, NC 27708 USA.
   [Barrows, Nicholas J.; Jamison, Sharon F.; Le Sommer, Caroline; Pearson, James L.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Duke Univ, Ctr RNA Biol, Durham, NC 27708 USA.
   [Barrows, Nicholas J.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Anglero-Rodriguez, Yesseinia; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Kim, Byungil; Ascano, Manuel] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.
   [McGee, Charles E.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
RP Bradrick, SS; Garcia-Blanco, MA (corresponding author), Duke Univ, Dept Microbiol & Mol Genet, Durham, NC 27708 USA.; Bradrick, SS; Garcia-Blanco, MA (corresponding author), Duke Univ, Ctr RNA Biol, Durham, NC 27708 USA.; Bradrick, SS; Garcia-Blanco, MA (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Garcia-Blanco, MA (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
EM ssbradri@utmb.edu; maragarc@utmb.edu
OI Kim, Byungil/0000-0002-1743-2657
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-AI089526, R01-AI101431,
   1R35GM119569]; CTSA award from the National Center for Advancing
   Translational SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR000445]; University of
   Texas Medical Branch, a University of Texas System Texas STARs Award;
   National Institutes of Health, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [UC6-AI058607]
FX We thank our colleagues from the Bradrick and Garcia-Blanco laboratory,
   University of Texas Medical Branch and Duke University for their
   support. We thank Drs. Xuping Xie and Pei-Yong Shi for the ZIKV replicon
   cell line, DENV2-RLuc virus and very helpful scientific input. This work
   was supported by NIH grants R01-AI089526 and R01-AI101431 (MAG-B),
   1R35GM119569 (M.A.), CTSA award No. UL1TR000445 from the National Center
   for Advancing Translational Sciences (B.K. and M.A.), startup funds from
   the University of Texas Medical Branch, a University of Texas System
   Texas STARs Award (MAG-B). BSL3 experiments were performed in the Duke
   Regional Biocontainment Laboratory (RBL) which received partial support
   for construction from the National Institutes of Health, National
   Institute of Allergy and Infectious Diseases (UC6-AI058607). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. During review of our
   manuscript a paper from Tai and colleagues, which was published in Cell
   Reports (PMID 31067454), reached similar conclusions as we had.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barrows NJ, 2014, METHODS MOL BIOL, V1138, P285, DOI 10.1007/978-1-4939-0348-1_18
   Barrows NJ, 2010, J BIOMOL SCREEN, V15, P735, DOI 10.1177/1087057110374994
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bircham PW, 2011, MOL BIOSYST, V7, P2589, DOI 10.1039/c1mb05175j
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220
   DeRossi C, 2016, MOL BIOL CELL, V27, P1220, DOI 10.1091/mbc.E15-08-0557
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li C, 2013, J BIOL CHEM, V288, P17908, DOI 10.1074/jbc.M113.458836
   Lilay A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2435-4
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729
   O'Neal WK, 2015, AM J HUM GENET, V96, P318, DOI 10.1016/j.ajhg.2014.12.022
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.2
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 54
TC 2
Z9 2
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 4
PY 2019
VL 9
AR 9711
DI 10.1038/s41598-019-45910-9
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IH1AL
UT WOS:000474223600057
PM 31273220
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Demok, S
   Endersby-Harshman, N
   Vinit, R
   Timinao, L
   Robinson, LJ
   Susapu, M
   Makita, L
   Laman, M
   Hoffmann, A
   Karl, S
AF Demok, Samuel
   Endersby-Harshman, Nancy
   Vinit, Rebecca
   Timinao, Lincoln
   Robinson, Leanne J.
   Susapu, Melinda
   Makita, Leo
   Laman, Moses
   Hoffmann, Ary
   Karl, Stephan
TI Insecticide resistance status of Aedes aegypti and Aedes albopictus
   mosquitoes in Papua New Guinea
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Pyrethroid resistance; Deltamethrin;
   Papua New Guinea; Port Moresby; Madang; Bioassay; Insecticide
ID KNOCKDOWN RESISTANCE; DIPTERA-CULICIDAE; SUSCEPTIBILITY; ASSOCIATION;
   VECTOR; SITES; NETS; GENE
AB BackgroundAedes aegypti and Ae. albopictus are important vectors of infectious diseases, especially those caused by arboviruses such as dengue, chikungunya and Zika. Aedes aegypti is very well adapted to urban environments, whereas Ae. albopictus inhabits more rural settings. Pyrethroid resistance is widespread in these vectors, but limited data exist from the Southwest Pacific Region, especially from Melanesia. While Aedes vector ecology is well documented in Australia, where incursion of Ae. albopictus and pyrethroid resistance have so far been prevented, almost nothing is known about Aedes populations in neighbouring Papua New Guinea (PNG). With pyrethroid resistance documented in parts of Indonesia but not in Australia, it is important to determine the distribution of susceptible and resistant Aedes populations in this region.MethodsThe present study was aimed at assessing Aedes populations for insecticide resistance in Madang and Port Moresby, located on the north and south coasts of PNG, respectively. Mosquitoes were collected using ovitraps and reared in an insectary. Standard WHO bioassays using insecticide-treated filter papers were conducted on a total of 253 Ae. aegypti and 768 Ae. albopictus adult mosquitoes. Subsets of samples from both species (55 Ae. aegypti and 48 Ae. albopictus) were screened for knockdown resistance mutations in the voltage-sensitive sodium channel (Vssc) gene, the target site of pyrethroid insecticides.ResultsHigh levels of resistance against pyrethroids were identified in Ae. aegypti from Madang and Port Moresby. Aedes albopictus exhibited susceptibility to pyrethroids, but moderate levels of resistance to DDT. Mutations associated with pyrethroid resistance were detected in all Ae. aegypti samples screened. Some genotypes found in the present study had been observed previously in Indonesia. No Vssc mutations associated with pyrethroid resistance were found in the Ae. albopictus samples.ConclusionsTo our knowledge, this is the first report of pyrethroid resistance in Ae. aegypti mosquitoes in PNG. Interestingly, usage of insecticides in PNG is low, apart from long-lasting insecticidal nets distributed for malaria control. Further investigations on how these resistant Ae. aegypti mosquito populations arose in PNG and how they are being sustained are warranted.
C1 [Demok, Samuel; Vinit, Rebecca; Timinao, Lincoln; Robinson, Leanne J.; Laman, Moses; Karl, Stephan] PNG Inst Med Res, Vector Borne Dis Unit, POB 378, Madang 511, Madang Province, Papua N Guinea.
   [Endersby-Harshman, Nancy; Hoffmann, Ary] Univ Melbourne, Bio21 Inst, Sch BioSci, 30 Flemington Rd, Parkville, Vic 3010, Australia.
   [Timinao, Lincoln; Karl, Stephan] James Cook Univ, Australian Inst Trop Hlth & Med, 1-14-88 McGregor Rd, Smithfield, Qld 4870, Australia.
   [Robinson, Leanne J.] Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.
   [Susapu, Melinda; Makita, Leo] Natl Dept Hlth, Waigani Dr,POB 807, Port Moresby, Papua N Guinea.
RP Karl, S (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, 1-14-88 McGregor Rd, Smithfield, Qld 4870, Australia.
EM stephan.karl@jcu.edu.au
RI Hoffmann, Ary/R-2972-2019
OI Hoffmann, Ary/0000-0001-9497-7645
FU NHMRCNational Health and Medical Research Council of Australia
   [GNT1141441]; JCU PhD Scholarship; Strive PNG (Australian Department of
   Foreign Affairs and Trade)
FX This study received no dedicated funding except that molecular assays
   were supported by an NHMRC Program grant and AH was supported by an
   NHMRC Fellowship. SK was supported by an NHMRC Career Development
   Fellowship GNT1141441, LT was supported by a JCU PhD Scholarship and LJR
   is supported by an NHMRC Career Development Fellowship. SD was
   supported, in part, by Strive PNG (Australian Department of Foreign
   Affairs and Trade).
CR Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   Ahmad Intan, 2007, Pakistan Journal of Biological Sciences, V10, P3688, DOI 10.3923/pjbs.2007.3688.3692
   Amelia-Yap ZH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2899-0
   Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Endersby-Harshman NM, 2017, J MED ENTOMOL, V54, P1649, DOI 10.1093/jme/tjx145
   Fonzi E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003829
   Hamid PH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1735358
   Hetzel MW, 2017, B WORLD HEALTH ORGAN, V95, P695, DOI 10.2471/BLT.16.189902
   Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105
   Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130
   Jones P, 2012, A DEAKIN RES I WORKI, P33
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Koimbu G, 2018, AM J TROP MED HYG, V98, P162, DOI 10.4269/ajtmh.17-0454
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lounibos LP, 2018, BIOL INVASIONS, V20, P1913, DOI 10.1007/s10530-018-1674-7
   Lukwa N., 2012, Journal of Entomological and Acarological Research, V44, P107, DOI 10.4081/jear.2012.e19
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Moore PR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.103
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Reimer LJ, 2013, NEW ENGL J MED, V369, P745, DOI 10.1056/NEJMoa1207594
   Schmidt TL, 2019, EVOL APPL, V12, P1136, DOI 10.1111/eva.12787
   Senn N, 2011, AM J TROP MED HYG, V85, P132, DOI 10.4269/ajtmh.2011.10-0482
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Webb C, 2016, A GUIDE TO MOSQUITOE
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   WHO, 2013, TEST PROC INREMO
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
NR 35
TC 4
Z9 4
U1 2
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 3
PY 2019
VL 12
AR UNSP 333
DI 10.1186/s13071-019-3585-6
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IH3VR
UT WOS:000474421200001
PM 31269965
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Snyder-Keller, A
   Kramer, LD
   Zink, S
   Bolivar, VJ
AF Snyder-Keller, Abigail
   Kramer, Laura D.
   Zink, Steven
   Bolivar, Valerie J.
TI Mouse Strain and Sex-Dependent Differences in Long-term Behavioral
   Abnormalities and Neuropathologies after Developmental Zika Infection
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE behavioral deficits; calcifications; congenital Zika syndrome;
   developmental exposure; neuropathology; Zika virus
ID VIRUS-INFECTION; BRAIN; MODEL; ANXIETY
AB Exposure of the developing fetus to Zika virus (ZIKV) results in a set of brain abnormalities described as the congenital Zika syndrome. Although microcephaly is the most obvious outcome, neuropathologies, such as intracranial calcifications and polymicrogyria, can occur in the absence of microcephaly. Moreover, the full impact of exposure on motor, social, and cognitive skills during development remains uncharacterized. We examined the long-term neurobehavioral consequences of neonatal ZIKV exposure in four genetically divergent inbred mouse strains (C57BL/6J, 129S1/SvImJ, FVB/NJ, and DBA/2J). Male and female mice were infected on postnatal day 1, considered comparable with exposure late in the second trimester of humans. We demonstrate strain differences in early susceptibility to the virus and the time course of glial reaction in the brain. These changes were associated with strain-and sex-dependent differences in long-term behavioral abnormalities that include hyperactivity, impulsiveness, and motor incoordination. In addition, the adult brains of susceptible mice exhibited widespread calcifications that may underlie the behavioral deficits observed. Characterization of the neuropathological sequelae of developmental exposure to the Zika virus in different immunocompetent mouse strains provides a foundation for identifying genetic and immune factors that contribute to long-term neurobehavioral consequences in susceptible individuals.
C1 [Snyder-Keller, Abigail; Kramer, Laura D.; Zink, Steven; Bolivar, Valerie J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
   [Snyder-Keller, Abigail; Kramer, Laura D.; Bolivar, Valerie J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, New York, NY 12214 USA.
RP Snyder-Keller, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.; Snyder-Keller, A (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, New York, NY 12214 USA.
EM Abigail.snyder-keller@health.ny.gov
OI Bolivar, Valerie/0000-0002-2143-4591
FU Wadsworth Center Grant
FX This work was supported by a Wadsworth Center Grant to A.S.-K., L.D.K.,
   and V.J.B. We thank the Wadsworth Center's Veterinary Sciences staff for
   the excellent care they provided for the mice; Kevin Manley for
   assistance with genotyping; and Dr. Linda Toth for helpful comments on
   the manuscript.
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ellison G, 2002, EUR NEUROPSYCHOPHARM, V12, P287, DOI 10.1016/S0924-977X(02)00020-2
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   LUND RD, 1966, SCIENCE, V151, P1397, DOI 10.1126/science.151.3716.1397
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x
   Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314
   SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871
NR 34
TC 2
Z9 2
U1 0
U2 1
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 3
PY 2019
VL 39
IS 27
BP 5393
EP 5403
DI 10.1523/JNEUROSCI.2666-18.2019
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA IG3PD
UT WOS:000473716000014
PM 31085612
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lopez, V
   Pavela, R
   Gomez-Rincon, C
   Les, F
   Bartolucci, F
   Galiffa, V
   Petrelli, R
   Cappellacci, L
   Maggi, F
   Canale, A
   Otranto, D
   Sut, S
   Dall'Acqua, S
   Benelli, G
AF Lopez, Victor
   Pavela, Roman
   Gomez-Rincon, Carlota
   Les, Francisco
   Bartolucci, Fabrizio
   Galiffa, Veronica
   Petrelli, Riccardo
   Cappellacci, Loredana
   Maggi, Filippo
   Canale, Angelo
   Otranto, Domenico
   Sut, Stefania
   Dall'Acqua, Stefano
   Benelli, Giovanni
TI Efficacy of Origanum syriacum Essential Oil against the Mosquito Vector
   Culex quinquefasciatus and the Gastrointestinal Parasite Anisakis
   simplex, with Insights on Acetylcholinesterase Inhibition
SO MOLECULES
LA English
DT Article
DE anisakiasis; contact toxicity; enzyme inhibition; fumigation toxicity;
   larvicide; mosquito control; penetration assay
ID APIACEAE ESSENTIAL OILS; INSECTICIDAL PROPERTIES; BOTANICAL
   INSECTICIDES; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION;
   PIMPINELLA-ANISUM; L. LAMIACEAE; ZIKA VIRUS; TOXICITY; PLANTS
AB Developing effective and eco-friendly antiparasitic drugs and insecticides is an issue of high importance nowadays. In this study, we evaluated the anthelminthic and insecticidal potential of the leaf essential oil obtained from Origanum syriacum against the L3 larvae of the parasitic nematode Anisakis simplex and larvae and adults of the mosquito Culex quinquefasciatus. Tests on A. simplex were performed by standard larvicidal and penetration assays, while mosquito toxicity was assessed relying on larvicidal, tarsal contact, and fumigation tests. To shed light on the possible mode of action, we analyzed the oil impact as acetylcholinesterase (AChE) inhibitor. This oil was particularly active on L3 larvae of A. simplex, showing a LC50 of 0.087 and 0.067 mg mL(-1) after 24 and 48 h treatment, respectively. O. syriacum essential oil was highly effective on both larvae and adults of C. quinquefasciatus, showing LC50 values of 32.4 mg L-1 and 28.1 mu g cm(-2), respectively. Its main constituent, carvacrol, achieved larvicidal LC50(90) of 29.5 and 39.2 mg L-1, while contact toxicity assays on adults had an LC50(90) of 25.5 and 35.8 mu g cm(-2), respectively. In fumigation assays, the LC50 was 12.1 mu L L-1 after 1 h and decreased to 1.3 mu L L-1 in 24 h of exposure. Similarly, the fumigation LC50 of carvacrol was 8.2 mu L L-1 after 1 h of exposure, strongly decreasing to 0.8 mu L L-1 after 24 h of exposure. These results support the folk usage of Lebanese oregano as an antiparasitic agent, providing new insights about its utilization for developing new effective and eco-friendly nematocidal and insecticidal products.
C1 [Lopez, Victor; Gomez-Rincon, Carlota; Les, Francisco] Univ San Jorge, Dept Pharm, Fac Hlth Sci, Zaragoza 50830, Spain.
   [Lopez, Victor] Univ Zaragoza, IA2, CITA, E-50013 Zaragoza, Spain.
   [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 1100011999, Czech Republic.
   [Bartolucci, Fabrizio] Univ Camerino, Sch Biosci & Vet Med, Ctr Ric Florist Appennino, I-67021 San Colombo, Barisciano, Italy.
   [Galiffa, Veronica; Petrelli, Riccardo; Cappellacci, Loredana; Maggi, Filippo] Univ Camerino, Sch Pharm, Via St Agostino 1, I-62032 Camerino, Italy.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Otranto, Domenico] Univ Bari Aldo Moro, Dept Vet Med, I-70100 Bari, Italy.
   [Sut, Stefania] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, I-35020 Legnaro, Italy.
   [Dall'Acqua, Stefano] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35128 Padua, Italy.
RP Maggi, F (corresponding author), Univ Camerino, Sch Pharm, Via St Agostino 1, I-62032 Camerino, Italy.; Dall'Acqua, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35128 Padua, Italy.
EM filippo.maggi@unicam.it; stefano.dallacqua@unipd.it
RI Lopez, Victor/D-3830-2013; Bartolucci, Fabrizio/K-4841-2015; Pavela,
   Roman/Q-8647-2016; Les, Francisco/C-2272-2019; Lopez,
   Victor/W-8917-2019; Maggi, Filippo/AAI-1551-2020
OI Lopez, Victor/0000-0001-6969-1055; Bartolucci,
   Fabrizio/0000-0001-8199-6003; Les, Francisco/0000-0002-7972-7119; Lopez,
   Victor/0000-0001-6969-1055; Maggi, Filippo/0000-0003-1375-4744;
   Petrelli, Riccardo/0000-0002-4760-1204; CAPPELLACCI,
   Loredana/0000-0001-8155-7211
FU Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [RO0418]; University of Camerino (Fondo di Ateneo per la
   Ricerca, FAR) [FPI 000044]
FX This research was funded by the Ministry of Agriculture of the Czech
   Republic (Project No. RO0418) and the University of Camerino (Fondo di
   Ateneo per la Ricerca, FAR 2014/2015, FPI 000044).
CR Aazza S, 2011, MOLECULES, V16, P7672, DOI 10.3390/molecules16097672
   Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Al Hafi M, 2016, CHEM BIODIVERS, V13, P555, DOI 10.1002/cbdv.201500178
   AlShebly MM, 2017, ECOTOX ENVIRON SAFE, V137, P149, DOI 10.1016/j.ecoenv.2016.11.028
   Audicana MT, 2008, CLIN MICROBIOL REV, V21, P360, DOI 10.1128/CMR.00012-07
   Baser KHC, 2003, FLAVOUR FRAG J, V18, P98, DOI 10.1002/ffj.1169
   Benelli G, 2019, IND CROP PROD, V134, P26, DOI 10.1016/j.indcrop.2019.03.055
   Benelli G, 2018, IND CROP PROD, V124, P236, DOI 10.1016/j.indcrop.2018.07.048
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2019, J ETHNOPHARMACOL, V229, P272, DOI 10.1016/j.jep.2018.08.030
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Carlstrom A, 1984, WILLDENOWIA, V14, P15
   Romero MC, 2014, TROP MED INT HEALTH, V19, P1430, DOI 10.1111/tmi.12399
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005
   Danin A., 1990, Willdenowia, V19, P401
   Danin A., 1996, Willdenowia, V25, P601
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Darwish RM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-9
   Romero MD, 2012, PHYTOMEDICINE, V19, P520, DOI 10.1016/j.phymed.2012.02.005
   Dirmenci T, 2018, TURK J BOT, V42, P73, DOI 10.3906/bot-1704-35
   Dudai N, 1999, J CHEM ECOL, V25, P1079, DOI 10.1023/A:1020881825669
   Duman H., 1996, FLORA MEDITERANEA, V5, P221
   Duman Hayri, 1998, Turkish Journal of Botany, V22, P51
   El Gendy AN, 2015, IND CROP PROD, V67, P201, DOI 10.1016/j.indcrop.2015.01.038
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   George DR, 2009, VET PARASITOL, V162, P129, DOI 10.1016/j.vetpar.2009.02.009
   Giarratana F, 2014, EXP PARASITOL, V142, P7, DOI 10.1016/j.exppara.2014.03.028
   Giarratana F, 2017, ASIAN PAC J TROP MED, V10, P440, DOI 10.1016/j.apjtm.2017.05.005
   Perez MGM, 2017, PHARM BIOL, V55, P456, DOI 10.1080/13880209.2016.1247880
   Gomez-Rincon C, 2014, BIOMED RES INT, DOI 10.1155/2014/549510
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   GREUTER W, 1986, MED CHECKLIST, V3, P308
   Guardone L, 2018, PARASITE, V25, DOI 10.1051/parasite/2018034
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Herrador Z, 2019, CLIN INFECT DIS, V69, P69, DOI 10.1093/cid/ciy853
   Ietswaart J.H., 1980, TAXONOMIC REVISION G
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063
   KASSAI T, 1988, VET PARASITOL, V29, P299, DOI 10.1016/0304-4017(88)90148-3
   Khoury M, 2016, EVID-BASED COMPL ALT, DOI 10.1155/2016/2547169
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kordali S, 2013, EGYPT J BIOL PEST CO, V23, P241
   Lahlou M, 2002, ANN TROP MED PARASIT, V96, P587, DOI 10.1179/000349802125001447
   Lee KW, 2003, J APPL POULTRY RES, V12, P394, DOI 10.1093/japr/12.4.394
   Loizzo MR, 2009, FOOD CHEM, V117, P174, DOI 10.1016/j.foodchem.2009.03.095
   Lopez V, 2018, PARASITOL RES, V117, P861, DOI 10.1007/s00436-018-5764-3
   Lukas B, 2010, ISR J PLANT SCI, V58, P211, DOI 10.1560/IJPS.58.3-4.211
   Marc EB, 2008, J ETHNOPHARMACOL, V120, P315, DOI 10.1016/j.jep.2008.08.024
   Marchese A, 2016, FOOD CHEM, V210, P402, DOI 10.1016/j.foodchem.2016.04.111
   Mattila HR, 2000, AM BEE J, V140, P68
   Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002
   Mouterde P., 2019, NOUVELLE FLORE LIBAN, V3
   Oka Y, 2000, PHYTOPATHOLOGY, V90, P710, DOI 10.1094/PHYTO.2000.90.7.710
   Otranto D, 2016, HUMAN EMERGING AND RE-EMERGING INFECTIONS: VIRAL AND PARASITIC INFECTIONS, VOL 1, P505
   Paternoster G., 2017, P 8 INT C EM ZOON FO, P28
   Pavela R, 2019, J PEST SCI, V92, P909, DOI 10.1007/s10340-018-01076-3
   Pavela R, 2019, IND CROP PROD, V129, P631, DOI 10.1016/j.indcrop.2018.11.073
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, CURR ORG CHEM, V20, P2674, DOI 10.2174/1385272820666151026231851
   Pavela R, 2016, IND CROP PROD, V83, P275, DOI 10.1016/j.indcrop.2015.11.090
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Salah SM, 2005, J ETHNOPHARMACOL, V97, P145, DOI 10.1016/j.jep.2004.10.023
   Sener O, 2009, ASIAN J CHEM, V21, P3995
   Sharifi-Rad M, 2018, PHYTOTHER RES, V32, P1675, DOI 10.1002/ptr.6103
   Shimamura Y, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/5176502
   Stevenson PC, 2017, IND CROP PROD, V110, P2, DOI 10.1016/j.indcrop.2017.08.034
   Tabari MA, 2017, VET PARASITOL, V245, P86, DOI 10.1016/j.vetpar.2017.08.012
   Tong F, 2010, PESTIC BIOCHEM PHYS, V98, P317, DOI 10.1016/j.pestbp.2010.07.003
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Tunc I, 2000, J STORED PROD RES, V36, P161, DOI 10.1016/S0022-474X(99)00036-3
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Viuda-Martos M, 2010, J AGR FOOD CHEM, V58, P9063, DOI 10.1021/jf101620c
   Waltner-Toews D, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0171
   WHO, 1996, REPORT OF THE WHO IN
   WHO, 2014, LYMPH FIL FACT SHEET
   Wilke ABB, 2020, ENTOMOL GEN, V40, P15, DOI 10.1127/entomologia/2019/0776
   YANIV Z, 1987, J ETHNOPHARMACOL, V19, P145, DOI 10.1016/0378-8741(87)90038-9
   Zein S, 2011, J MED PLANTS RES, V5, P379
NR 90
TC 2
Z9 2
U1 3
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUL 2
PY 2019
VL 24
IS 14
AR 2563
DI 10.3390/molecules24142563
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IS7AS
UT WOS:000482303000046
PM 31311079
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abu-rish, EY
   Elayeh, ER
   Browning, MJ
AF Abu-rish, Eman Y.
   Elayeh, Eman R.
   Browning, Michael J.
TI Travelers to US: Zika Virus Knowledge, Attitudes, and Determinants of
   Practices in the Middle East-Insights for Future Awareness Campaigns
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes; arboviruses; Middle East; traveler health; Zika virus
ID DISEASE; PREVENTION
AB Travelers act as sentinels for the spread of Zika virus. Imported Zika cases and the presence of Zika virus-transmitting mosquitoes have been documented in the Middle East. However, data on travelers' knowledge, attitude and practices regarding Zika and its prevention measures within the Middle East are scarce. This study aimed to address this issue in a sample of Jordanian and non-Jordanian travelers to U. S. in Jordan. Apaper-based questionnaire was distributed to 301 travelers to U. S. in Queen Alia International airport, Amman, Jordan. Only 2.7% of the travelers knew that Zika is associated with birth defects. A total of 10.4% of the participants knew that the bite of infected mosquitoes is a route of Zika transmission. Only 12.6% of respondents correctly identified Zika prevention measures. The level of education and future plans for pregnancy were significantly associated with a high knowledge score ( R-2 = 0.140, p-value < 0.005). Although 76.2% of the travelers perceived Zika as a health threat, only 11.2% believed in the efficacy of the prevention measures. Formulation of educational campaigns within Middle Eastern countries and development of awareness strategies regarding Zika and its prevention within the airports are required. This is particularly essential with the upcoming 2022 FIFA World Cup in Qatar.
C1 [Abu-rish, Eman Y.; Elayeh, Eman R.] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman 11942, Jordan.
   [Browning, Michael J.] Leicester Royal Infirm, Dept Immunol, Leicester LE1 5WW, Leics, England.
   [Browning, Michael J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England.
RP Abu-rish, EY (corresponding author), Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman 11942, Jordan.
EM e.aburish@ju.edu.jo
RI Abu-rish, Eman Y./G-2006-2016
OI Abu-rish, Eman Y./0000-0003-4274-9354
FU Deanship of Scientific Research (DSR) at the University of Jordan
FX This research received no external funding. This research was funded by
   The Deanship of Scientific Research (DSR) at the University of Jordan.
CR Abu-rish EY, 2019, AM J TROP MED HYG, V100, P974, DOI 10.4269/ajtmh.18-0715
   Abu-rish EY, 2016, FAM PRACT, V33, P690, DOI 10.1093/fampra/cmw086
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Berenson AB, 2018, AM J TROP MED HYG, V98, P178, DOI 10.4269/ajtmh.17-0595
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Howells ME, 2018, ANN HUM BIOL, V45, P229, DOI 10.1080/03014460.2018.1465594
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Kanani K, 2017, J AM MOSQUITO CONTR, V33, P134, DOI 10.2987/17-6641.1
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Pyke A. T., 2016, PLOS CURR, V8
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Smith D, 2011, J COMMUN HEALTHC, V4, P200, DOI DOI 10.1179/1753807611Y.0000000010
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Sweileh WM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5690-4
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 22
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL 2
PY 2019
VL 16
IS 14
AR 2517
DI 10.3390/ijerph16142517
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IQ3NV
UT WOS:000480659300070
PM 31337150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nguyen, NM
   Duong, BT
   Azam, M
   Phuong, TT
   Park, H
   Thuy, PTB
   Yeo, SJ
AF Ngoc Minh Nguyen
   Bao Tuan Duong
   Azam, Mudsser
   Truong Thai Phuong
   Park, Hyun
   Phung Thi Bich Thuy
   Yeo, Seon-Ju
TI Diagnostic Performance of Dengue Virus Envelope Domain III in Acute
   Dengue Infection
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE dengue virus recombinant envelope protein domain III; detection of IgM
   of dengue patient; acute phase infection
ID CELL EPITOPE PREDICTION; POTENTIAL USE; NS1 ANTIGEN; ZIKA VIRUS; RAPID
   TEST; PROTEIN; SERODIAGNOSIS; VACCINE; BURDEN; IGM
AB Dengue, one of the most prevalent illnesses caused by dengue viruses that are members of the genus Flavivirus, is a significant global health problem. However, similar clinical symptoms and high antigenic homologies with other Flaviviruses in the endemic area pose difficulties for differential diagnosis of dengue from other arbovirus infections. Here, we investigated four types of recombinant envelope protein domain III (DV-rED III) derived from four dengue virus (DENV) serotypes for diagnostic potential in detecting IgM in acute phase (mainly 2-3 days after onset of fever). Each independent DV-1,-3, and-4-rED III-ELISA showed less than 60% sensitivity, but the combined results of DV-1,-3, and-4-rED III-ELISA led to sensitivity of 81.82% (18/22) (95% CI, 59.72 to 94.81) and 100% specificity (46/46) (95% CI, 92.29 to 100.00) as each antigen compensated the other antigen-derived negative result. In conclusion, the independent combination of data derived from each recombinant antigen (DV1-, DV3-, and DV4-rED III) showed comparable efficacy for the detection of IgM in patients with acute-phase dengue infection.
C1 [Ngoc Minh Nguyen; Bao Tuan Duong; Azam, Mudsser; Park, Hyun; Yeo, Seon-Ju] Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, Iksan 570749, South Korea.
   [Truong Thai Phuong] Bach Mai Hosp, Dept Microbiol, Hanoi 100000, Vietnam.
   [Phung Thi Bich Thuy] Natl Childrens Hosp, Dept Res Biomol Infect Dis, Hanoi 100000, Vietnam.
RP Yeo, SJ (corresponding author), Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, Iksan 570749, South Korea.; Thuy, PTB (corresponding author), Natl Childrens Hosp, Dept Res Biomol Infect Dis, Hanoi 100000, Vietnam.
EM thuyphung.nhp@gmail.com; yeosj@wku.ac.kr
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) - Ministry of Education
   [NRF-2015R1A6A1A03032236]
FX This research was supported by Priority Research Centers Program through
   the National Research Foundation of Korea (NRF), funded by the Ministry
   of Education (NRF-2015R1A6A1A03032236).
CR Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Babu JP, 2008, VACCINE, V26, P4655, DOI 10.1016/j.vaccine.2008.07.006
   Bagut ET, 2013, CLIN VACCINE IMMUNOL, V20, P1150, DOI 10.1128/CVI.00243-13
   Batra G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-64
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cardoso SA, 2013, PROTEIN EXPRES PURIF, V92, P9, DOI 10.1016/j.pep.2013.08.014
   CDC, 2019, TEST GUID
   Chatchen S, 2017, ASIAN PAC J TROP MED, V10, P11, DOI 10.1016/j.apjtm.2016.12.002
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Chen J, 2016, MOL MED REP, V14, P1799, DOI 10.3892/mmr.2016.5454
   Chen WH, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0856-8
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Kim DTH, 2018, THERANOSTICS, V8, P3629, DOI 10.7150/thno.25955
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hermann LL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003193
   Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009
   Jang WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213451
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Krawczyk K, 2014, BIOINFORMATICS, V30, P2288, DOI 10.1093/bioinformatics/btu190
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lopez-Gatell H, 2016, B WORLD HEALTH ORGAN, V94, P850, DOI 10.2471/BLT.15.168765
   Mat J. T., 2017, J TROP MED, V2017
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   McBurney SP, 2016, VACCINE, V34, P3500, DOI 10.1016/j.vaccine.2016.03.108
   Munoz-Jordan JL, 2009, J CLIN MICROBIOL, V47, P927, DOI 10.1128/JCM.01564-08
   Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7
   Niu GY, 2015, VIRUS RES, V201, P73, DOI 10.1016/j.virusres.2015.02.008
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Potocnakova L, 2016, J IMMUNOL RES, DOI 10.1155/2016/6760830
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Shukla MK, 2017, J MED VIROL, V89, P1146, DOI 10.1002/jmv.24764
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI 10.4269/ajtmh.2010.10-0138
   Tsai JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205248
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   WHO, 2018, DENG SEV DENG
   Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021
   Yeo SJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-266
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
NR 53
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 2
PY 2019
VL 20
IS 14
AR 3464
DI 10.3390/ijms20143464
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IQ0OB
UT WOS:000480449300088
PM 31311082
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Olson, SM
   Delaney, A
   Jones, AM
   Carr, CP
   Liberman, RF
   Forestieri, NE
   Tong, VT
   Gilboa, SM
   Honein, MA
   Moore, CA
   Cragan, JD
AF Olson, Samantha M.
   Delaney, Augustina
   Jones, Abbey M.
   Carr, Christopher P.
   Liberman, Rebecca F.
   Forestieri, Nina E.
   Tong, Van T.
   Gilboa, Suzanne M.
   Honein, Margaret A.
   Moore, Cynthia A.
   Cragan, Janet D.
TI Updated baseline prevalence of birth defects potentially related to Zika
   virus infection
SO BIRTH DEFECTS RESEARCH
LA English
DT Letter
ID SURVEILLANCE
C1 [Olson, Samantha M.; Delaney, Augustina; Jones, Abbey M.; Carr, Christopher P.; Tong, Van T.; Gilboa, Suzanne M.; Honein, Margaret A.; Moore, Cynthia A.; Cragan, Janet D.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Olson, Samantha M.] G2S Corp, San Antonio, TX USA.
   [Delaney, Augustina; Jones, Abbey M.] Eagle Med Serv, San Antonio, TX USA.
   [Carr, Christopher P.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Liberman, Rebecca F.] Massachusetts Dept Publ Hlth, Ctr Birth Defects Res & Prevent, Boston, MA USA.
   [Forestieri, Nina E.] North Carolina Dept Hlth & Human Serv, Birth Defects Monitoring Program, Raleigh, NC USA.
RP Olson, SM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM ylz8@cdc.gov
OI Forestieri, Nina/0000-0001-7894-0279; Tong, Van/0000-0002-3970-1440;
   Carr, Christopher/0000-0001-7385-5016; Olson,
   Samantha/0000-0003-0589-5766
CR Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
NR 6
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD AUG 1
PY 2019
VL 111
IS 13
BP 938
EP 940
DI 10.1002/bdr2.1546
EA JUL 2019
PG 3
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA IM5YX
UT WOS:000473958300001
PM 31264801
OA Bronze
DA 2020-07-08
ER

PT J
AU Mulkey, SB
AF Mulkey, Sarah B.
TI Importance of Neuroimaging in the Evaluation of Zika Virus-Exposed
   Infants
SO JAMA NETWORK OPEN
LA English
DT Editorial Material
C1 [Mulkey, Sarah B.] Childrens Natl Hlth Syst, Washington, DC USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mulkey SB, 2019, JAMA PEDIATR, V173, P52, DOI 10.1001/jamapediatrics.2018.4138
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
NR 7
TC 0
Z9 0
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL
PY 2019
VL 2
IS 7
AR e198137
DI 10.1001/jamanetworkopen.2019.8137
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0VM
UT WOS:000513150700010
PM 31365103
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Pool, KL
   Adachi, K
   Karnezis, S
   Salamon, N
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Boechat, M
   Aibe, M
   da Silva, TG
   Ribeiro, CTM
   Boechat, I
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Daltro, P
   Ribeiro, BG
   Fazecas, T
   da Cruz, LCH
   Nogueira, R
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Chen, WQ
   Foo, SS
   Jung, J
   Moreira, ME
   Pone, M
AF Pool, Kara-Lee
   Adachi, Kristina
   Karnezis, Stellios
   Salamon, Noriko
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Boechat, Marcia
   Aibe, Mitsue
   da Silva, Tallita Gomes
   Martins Ribeiro, Carla Trevisan
   Boechat, Ines
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Daltro, Pedro
   Ribeiro, Bianca Guedes
   Fazecas, Tatiana
   Celso Hygino da Cruz, L.
   Nogueira, Renata
   Vasconcelos, Zilton
   Pereira, Jose Paulo, Jr.
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Chen, Weiqiang
   Foo, Suan-Sin
   Jung, Jae
   Moreira, Maria Elisabeth
   Pone, Marcos
TI Association Between Neonatal Neuroimaging and Clinical Outcomes in
   Zika-Exposed Infants From Rio de Janeiro, Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES
AB IMPORTANCE Congenital Zika virus (ZIKV) infection may present with a spectrum of clinical and neuroradiographic findings.
   OBJECTIVE To determine whether neuroimaging findings for infants with a history of ZIKV exposure are associated with infant clinical outcomes and gestational age at antenatal ZIKV infection.
   DESIGN, SETTING, AND PARTICIPANTS This cohort study retrospectively reviewed neuroimaging results (computed tomography and/or magnetic resonance imaging scans) of 110 ZIKV-exposed infants from a maternity and children's hospital in Rio de Janeiro, Brazil, following the 2015 to 2016 ZIKV epidemic. Neuroimaging from March 1, 2016, to June 30, 2017, was evaluated to determine whether findings were associated with clinical outcomes and the timing of maternal ZIKV infection. Data were analyzed from July 1, 2017, to August 30, 2018.
   EXPOSURES Neuroimaging (computed tomography and/or magnetic resonance imaging) was performed on ZIKV-exposed infants after birth. Blood and/or urine specimens from mothers and infants were tested for ZIKV by polymerase chain reaction assay.
   MAIN OUTCOMES AND MEASURES Neuroimaging studies were evaluated for structural abnormalities and other forms of brain injury.
   RESULTS A total of 110 infants with a mean (SD) gestational age of 38.4 (2.1) weeks had neuroimaging and clinical outcome data reviewed. Of these, 71 (65%) had abnormal neuroimaging findings, with the majority (96%) classified as having severe ZIKV infection at birth. The most common neuroimaging abnormalities were structural abnormalities including brain calcifications, especially at the cortico-subcortical white matter junction, cortex malformations, ventriculomegaly, and reduced brain volumes, followed by brainstem hypoplasia, cerebellar hypoplasia, and corpus callosum abnormalities. Frequency of abnormal imaging was higher in infants with specific clinical findings as opposed to those without them; these findings included fetal brain disruption sequence (100% vs 35%), microcephaly (100% vs 30%), congenital contractures (100% vs 58%), ophthalmologic abnormalities (95% vs 44%), hearing abnormalities (100% vs 58%), and neurologic symptoms (94% vs 10%). Four of 39 infants (10%) without initial evidence of severe ZIKV infection and normal findings on neurologic evaluation at birth had abnormal neuroimaging findings. Neuroimaging abnormalities differed by trimester of maternal ZIKV infection, with 63% of infants born to mothers infected in the first trimester, 13% of infants born to mothers infected in the second trimester, and 1% of infants born to mothers infected in the third trimester exhibiting neuroimaging abnormalities. The odds of abnormal neuroimaging were 7.9 times greater for infants with first trimester ZIKV exposure compared with other trimesters combined (odds ratio, 7.9; 95% CI, 3.0-20.4; P < .001).
   CONCLUSIONS AND RELEVANCE Neuroimaging abnormalities of computed tomography and/or magnetic resonance imaging scans were common in ZIKV-exposed infants. While neuroimaging abnormalities were seen in 10% of infants without clinically severe ZIKV, most occurred almost exclusively among those with clinically severe ZIKV, especially among those with a history of ZIKV exposure in the first trimester.
C1 [Pool, Kara-Lee; Adachi, Kristina; Karnezis, Stellios; Salamon, Noriko; Romero, Tahmineh; Nielsen-Saines, Karin; Boechat, Marcia; Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Boechat, Marcia; Aibe, Mitsue; da Silva, Tallita Gomes; Martins Ribeiro, Carla Trevisan; Brasil, Patricia; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo, Jr.; Salles, Tania Saad; Barbosa, Claudia Neves; Moreira, Maria Elisabeth; Pone, Marcos] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Daltro, Pedro; Ribeiro, Bianca Guedes; Fazecas, Tatiana; Celso Hygino da Cruz, L.; Nogueira, Renata] Clin Diagnost Imagem CDPI, Rio De Janeiro, Brazil.
   [Chen, Weiqiang; Foo, Suan-Sin; Jung, Jae] Univ Southern Calif, Sch Med, Los Angeles, CA 90007 USA.
RP Adachi, K (corresponding author), David Geffen UCLA Sch Med, Dept Pediat, Div Infect Dis, MDCC 22-442,10833 Le Conte Ave, Los Angeles, CA 90049 USA.
EM kadachi@mednet.ucla.edu
OI Vasconcelos, Zilton/0000-0002-2193-2224; Martins Ribeiro, Carla
   Trevisan/0000-0002-2478-9144; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01,
   AI140718-01]; National Eye Institute of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [AI129847-01]; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute [UL1TR001881]; Thrasher Research Fund [20164370]; United
   Kingdom's Department for International Development; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [441098/2016-9]; Fundo de amparo a
   pesquisa estado do Rio de Janeiro [E_18/2015TXB]
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   CAPES/88887.116627/2016-01); the National Institute of Allergy and
   Infectious Diseases (grants AI28697, AI1259534-01, AI140718-01) and the
   National Eye Institute (grant AI129847-01) of the National Institutes of
   Health; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute (grant UL1TR001881); Thrasher Research Fund (grant 20164370);
   and the United Kingdom's Department for International Development. The
   work was also supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 441098/2016-9) and Fundo de amparo a
   pesquisa estado do Rio de Janeiro (grant E_18/2015TXB).
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chan SRLL, 1992, J OBSTET GYNAECOL, V12, P25, DOI [10.3109/01443619209029914, DOI 10.3109/01443619209029914]
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raymond A, 2018, PEDIATR INFECT DIS J, V37, pE112, DOI 10.1097/INF.0000000000001832
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Uggetti C, 2009, AM J NEURORADIOL, V30, P1971, DOI 10.3174/ajnr.A1694
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 27
TC 2
Z9 2
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL
PY 2019
VL 2
IS 7
AR e198124
DI 10.1001/jamanetworkopen.2019.8124
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0VM
UT WOS:000513150700009
PM 31365112
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schultz, V
   Barrie, J
   Cumberworth, S
   Donald, C
   Kohl, A
   Willison, H
   Edgar, J
AF Schultz, V.
   Barrie, J.
   Cumberworth, S.
   Donald, C.
   Kohl, A.
   Willison, H.
   Edgar, J.
TI Zika virus infection of glia leads to secondary injury to axons and
   dendrites, in vitro
SO GLIA
LA English
DT Meeting Abstract
CT 14th European Meeting on Glial Cells in Health and Disease (GLIA)
CY JUL 10-13, 2019
CL Porto, PORTUGAL
C1 [Schultz, V.; Barrie, J.; Cumberworth, S.; Donald, C.; Kohl, A.; Willison, H.; Edgar, J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-1491
EI 1098-1136
J9 GLIA
JI Glia
PD JUL
PY 2019
VL 67
SU S1
MA T14-145C
BP E622
EP E623
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA JW2DC
UT WOS:000502867403132
DA 2020-07-08
ER

PT J
AU Park, J
   Jang, J
   Ahn, I
AF Park, Jooyeon
   Jang, Jinhwa
   Ahn, Insung
TI Comparison of Genetic Variations in Zika Virus Isolated From Different
   Geographic Regions
SO INTERNATIONAL JOURNAL OF HEALTHCARE INFORMATION SYSTEMS AND INFORMATICS
LA English
DT Article
DE Substitution; Transition; Transversion; Variation; Zika Virus
ID SUBSTITUTIONS; GENOME
AB The Zika virus (ZIKV) belongs to the genus Flavivirus, together with Dengue virus, yellow fever virus, and West Nile virus. The virus, which was first found in Africa in 1947, has spread across the world owing to a lack of effective drugs or vaccines. The complete genome sequence of ZIKV is now available; it includes three structural and seven non-structure genes arranged in the order of capsid, pre-membrane, envelope, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5. Two geographically distinct lineages are known, i.e., Asian and African, but ZIKV exhibits differences in clinical progression among regions.
C1 [Park, Jooyeon] Univ Sci & Technol, Dept Big Data Sci, Daejeon, South Korea.
   [Jang, Jinhwa] Korea Inst Sci & Technol Informat, Biomed Predict Technol Lab, Daejeon, South Korea.
   [Ahn, Insung] Univ Sci & Technol, Daejeon, South Korea.
RP Park, J (corresponding author), Univ Sci & Technol, Dept Big Data Sci, Daejeon, South Korea.
FU Bio & Medical Technology Development Program of the NRF - Korean
   government, MSIP [2016M3A9B6915714]
FX This research was supported by the Bio & Medical Technology Development
   Program of the NRF funded by the Korean government, MSIP
   (2016M3A9B6915714).
CR Author Futuyma D. J., 1983, SCI TRIAL CASE EVOLU, P82
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Han Y., 2015, INT J BIOSCIENCE BIO, V7, P287, DOI [10.14257/ijbsbt.2015.7.6.29, DOI 10.14257/IJBSBT.2015.7.6.29]
   Jang J. H., 2015, INT J BIOSCIENCE BIO, V7, P25, DOI [10.14257/ijbsbt.2015.7.6.03, DOI 10.14257/IJBSBT.2015.7.6.03]
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Park J., 2016, 11 2016 INT INT WORK
   Rubin E.J., 2016, ZIKA VIRUS MICROCEPH
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stauft C. B., 2016, BIORXIV
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101
   WHO, 2016, STATEMENT       0201
   Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406
   World Health Organization, 2016, ZIK SIT REP
   Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 32
TC 0
Z9 0
U1 1
U2 1
PU IGI GLOBAL
PI HERSHEY
PA 701 E CHOCOLATE AVE, STE 200, HERSHEY, PA 17033-1240 USA
SN 1555-3396
EI 1555-340X
J9 INT J HEALTHC INF SY
JI Int. J. Healthc. Inf. Syst. Inf.
PD JUL-SEP
PY 2019
VL 14
IS 3
SI SI
BP 29
EP 39
DI 10.4018/IJHISI.2019070103
PG 11
WC Medical Informatics
SC Medical Informatics
GA JT4BW
UT WOS:000500937500004
DA 2020-07-08
ER

PT J
AU Cousien, A
   Abel, S
   Monthieux, A
   Andronico, A
   Calmont, I
   Cervantes, M
   Cesaire, R
   Gallian, P
   de Lamballerie, X
   Laouenan, C
   Najioullah, F
   Pierre-Francois, S
   Pircher, M
   Salje, H
   ten Bosch, QA
   Cabie, A
   Cauchemez, S
AF Cousien, Anthony
   Abel, Sylvie
   Monthieux, Alice
   Andronico, Alessio
   Calmont, Isabelle
   Cervantes, Minerva
   Cesaire, Raymond
   Gallian, Pierre
   de lamballerie, Xavier
   Laouenan, Cedric
   Najioullah, Fatiha
   Pierre-Francois, Sandrine
   Pircher, Mathilde
   Salje, Henrik
   ten Bosch, Quirine A.
   Cabie, Andre
   Cauchemez, Simon
TI Assessing Zika Virus Transmission Within Households During an Outbreak
   in Martinique, 2015-2016
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE asymptomatic infections; final size model; household transmission; Zika
   virus
ID INFECTION; INFLUENZA; COMMUNITY; PARAMETERS; BRAZIL
AB Since 2015, Zika virus (ZIKV) has caused large epidemics in the Americas. Households are natural targets for control interventions, but quantification of the contribution of household transmission to overall spread is needed to guide policy. We developed a modeling framework to evaluate this contribution and key epidemic features of the ZIKV epidemic in Martinique in 2015-2016 from the joint analysis of a household transmission study (n = 68 households), a study among symptomatic pregnant women (n = 281), and seroprevalence surveys of blood donors (n = 457). We estimated that the probability of mosquito-mediated within-household transmission (from an infected member to a susceptible one) was 21% (95% credible interval (CrI): 5, 51), and the overall probability of infection from outside the household (i.e., in the community) was 39% (95% CrI: 27, 50). Overall, 50% (95% CrI: 43, 58) of the population was infected, with 22% (95% CrI: 5, 46) of infections acquired in households and 40% (95% CrI: 23, 56) being asymptomatic. The probability of presenting with Zika-like symptoms due to another cause was 16% (95% CrI: 10, 23). This study characterized the contribution of household transmission in ZIKV epidemics, demonstrating the benefits of integrating multiple data sets to gain more insight into epidemic dynamics.
C1 [Cousien, Anthony; Andronico, Alessio; Salje, Henrik; ten Bosch, Quirine A.; Cauchemez, Simon] CNRS, Inst Pasteur, Math Modelling Infect Dis Unit, UMR 2000, Paris, France.
   [Abel, Sylvie; Pierre-Francois, Sandrine; Pircher, Mathilde; Cabie, Andre] CHU Martinique, Serv Malad Infect & Trop, Fort De France, Martinique, France.
   [Monthieux, Alice] CHU Martinique, Serv Gynecol Obstet, Fort De France, Martinique, France.
   [Calmont, Isabelle; Cabie, Andre] INSERM, Ctr Invest Clin 1424, Fort De France, Martinique, France.
   [Cervantes, Minerva; Laouenan, Cedric] Univ Paris Diderot, INSERM, UMR 1137, Infect Antimicrobials Modelling Evolut, Paris, France.
   [Cervantes, Minerva; Laouenan, Cedric] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, Paris, France.
   [Cesaire, Raymond; Najioullah, Fatiha] CHU Martinique, Lab Virol, Fort De France, Martinique, France.
   [Gallian, Pierre; de lamballerie, Xavier] Aix Marseille Univ, Unite Mixte Rech Emergence Pathol Virales, INSERM 1207,Inst Hosp Univ Mediterranee Infect, Ecole Hautes Etud Sante Publ,Inst Rech Dev 190, Marseille, France.
   [Gallian, Pierre] Etab Francais Sang Provence Alpes Cote Azur & Cor, Marseille, France.
   [Cabie, Andre] Univ Antilles, Equipe Accueil 4537, Fort De France, Martinique, France.
RP Cauchemez, S (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Docteur Roux, F-75015 Paris, France.
EM simon.cauchemez@pasteur.fr
OI Cabie, Andre/0000-0003-0117-3061; ABEL, Sylvie/0000-0002-3351-0547
FU European Union's Horizon 2020 Programme through ZIKAlliance [734548];
   Investissements d'Avenir programFrench National Research Agency (ANR);
   Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious Disease
   Agent Study of the National Institute of GeneralMedical SciencesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; AXA Research Fund; INCEPTION project
   [PIA/ANR-16-CONV-0005]; FrenchMinistry of Health (Soutien Exceptionnel a
   la Recherche et a l'Innovation)
FX This work was supported by the European Union's Horizon 2020 Programme
   through ZIKAlliance (grant 734548), the Investissements d'Avenir
   program, the Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases program(grant ANR-10-LABX-62-IBEID), the Models of
   Infectious Disease Agent Study of the National Institute of
   GeneralMedical Sciences, the AXA Research Fund, and the INCEPTION
   project (grant PIA/ANR-16-CONV-0005). The Cohort of Patients Infected by
   an Arbovirus (CARBO) was fund by the FrenchMinistry of Health (Soutien
   Exceptionnel a la Recherche et a l'Innovation), and the protocol was
   prepared with the help of the Institut National de la Sante et de la
   RechercheMedicale Research and Action Targeting Emerging Infectious
   Disease (REACTing) network.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burnham KP, 2013, MODEL SELECTION INFE, P373
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cauchemez S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004310
   Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flamand C, 2016, EURO SURVEILL, V22
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fraser C, 2011, AM J EPIDEMIOL, V174, P505, DOI 10.1093/aje/kwr122
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gastanaduy PA, 2016, NEW ENGL J MED, V375, P1343, DOI 10.1056/NEJMoa1602295
   Gilks WR, 1995, MARKOV CHAIN MONTE C, P522
   Glynn JR, 2018, J INFECT DIS, V217, P232, DOI 10.1093/infdis/jix579
   Haut Conseil de la Sante Publique, 2016, PERS ATT VIR ZIK ACT
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Institut National de la Statistique et des Etudes Economiques, 2013, MEN1 MEN TAILL MEN C
   Institut National de Veille Sanitaire, 2016, SIT EP VIR ZIK ANT P
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Lau MSY, 2015, P NATL ACAD SCI USA, V112, P9094, DOI 10.1073/pnas.1423339112
   LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356
   LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   LUDWIG D, 1975, Mathematical Biosciences, V23, P33, DOI 10.1016/0025-5564(75)90119-4
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   World Health Organization, ZIK VIR FACT SHEET
NR 39
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD JUL
PY 2019
VL 188
IS 7
BP 1389
EP 1396
DI 10.1093/aje/kwz091
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JH8CH
UT WOS:000492995600029
PM 30995296
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Barrera, R
   Harris, A
   Hemme, RR
   Felix, G
   Nazario, N
   Munoz-Jordan, JL
   Rodriguez, D
   Miranda, J
   Soto, E
   Martinez, S
   Ryff, K
   Perez, C
   Acevedo, V
   Amador, M
   Waterman, SH
AF Barrera, Roberto
   Harris, Angela
   Hemme, Ryan R.
   Felix, Gilberto
   Nazario, Nicole
   Munoz-Jordan, Jorge L.
   Rodriguez, Damaris
   Miranda, Julieanne
   Soto, Eunice
   Martinez, Stephanie
   Ryff, Kyle
   Perez, Carmen
   Acevedo, Veronica
   Amador, Manuel
   Waterman, Stephen H.
TI Citywide Control of Aedes aegypti (Diptera: Culicidae) during the 2016
   Zika Epidemic by Integrating Community Awareness, Education, Source
   Reduction, Larvicides, and Mass Mosquito Trapping
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito control; Aedes aegypti; Zika virus; vector-borne pathogen; AGO
   traps
ID VECTOR CONTROL; DENGUE; CHIKUNGUNYA; INFECTION
AB This investigation was initiated to control Aedes aegypti and Zika virus transmission in Caguas City, Puerto Rico, during the 2016 epidemic using Integrated Vector Management (IVM), which included community awareness and education, source reduction, larviciding, and mass-trapping with autocidal gravid ovitraps (AGO). The epidemic peaked in August to October 2016 and waned after April 2017. There was a preintervention period in October/November 2016 and IVM lasted until August 2017. The area under treatment (23.1 km(2)) had 61,511 inhabitants and 25,363 buildings. The city was divided into eight even clusters and treated following a cluster randomized stepped-wedge design. We analyzed pools of female Ae. aegypti adults for RNA detection of dengue (DENV), chikungunya (CHIKV), and Zika (ZIKV) viruses using 360 surveillance AGO traps every week. Rainfall, temperature, and relative humidity were monitored in each cluster. Mosquito density significantly changed (generalized linear mixed model; F-8,F- 14,F-588 = 296; P < 0.001) from 8.0 +/- 0.1 females per trap per week before the intervention to 2.1 +/- 0.04 after the percentage of buildings treated with traps was 60% and to 1.4 +/- 0.04 when coverage was above 80%. Out of a total 12,081 mosquito pools, there were 1 DENV-, 7 CHIKV-, and 49 ZIKV-positive pools from October 2016 to March 2017. Afterward, we found only one positive pool of DENV in July 2017. This investigation demonstrated that it was possible to scale up effective Ae. aegypti control to a medium-size city through IVM that included mass trapping of gravid Ae. aegypti females.
C1 [Barrera, Roberto; Harris, Angela; Hemme, Ryan R.; Felix, Gilberto; Nazario, Nicole; Rodriguez, Damaris; Miranda, Julieanne; Soto, Eunice; Martinez, Stephanie; Ryff, Kyle; Perez, Carmen; Acevedo, Veronica; Amador, Manuel; Waterman, Stephen H.] Ctr Dis Control & Prevent, Dengue Branch, Entomol & Ecol Act, San Juan, PR 00920 USA.
   [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Dengue Branch, Mol Diagnost Lab, San Juan, PR USA.
RP Barrera, R (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, Entomol & Ecol Act, San Juan, PR 00920 USA.
EM rbarrera@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Amarakoon D, 2008, MITIG ADAPT STRAT GL, V13, P341, DOI 10.1007/s11027-007-9114-5
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2019, MED VET ENTOMOL, V33, P68, DOI 10.1111/mve.12338
   Barrera R., 2010, BIOMEDICA, V21, P179
   Barrera R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2596-4
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P103
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff B, 2016, POOLEDINRATE VERSION
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   (CDC). Centers for Disease Control and Prevention, 2018, DENG EP
   CHADEE DD, 1988, MED VET ENTOMOL, V2, P193, DOI 10.1111/j.1365-2915.1988.tb00072.x
   CHAN K L, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P56
   Chen L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02926-3
   Felix GE, 2018, J AM MOSQUITO CONTR, V34, P233, DOI 10.2987/18-6741.1
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628
   GUBLER DJ, 1988, ARBOVIRUSES EPIDEMIO, V2, P223
   Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391
   Johnson BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34161-9
   Johnson BJ, 2017, INSECTS, V8, DOI 10.3390/insects8010005
   Jones RC, 2011, J AM MOSQUITO CONTR, V27, P315, DOI 10.2987/10-6098.1
   Lega J, 2017, J MED ENTOMOL, V54, P1375, DOI 10.1093/jme/tjx077
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lounibos LP, 2003, WAG UR FRON, V2, P33
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Malmgren BA, 1998, J CLIMATE, V11, P2713, DOI 10.1175/1520-0442(1998)011<2713:ENOSOA>2.0.CO;2
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   (PAHO) Pan American Health Organization, 2018, ZIK CUM CAS
   Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462
   (PRDH) Puerto Rico Department of Health, 2018, WEEKL REP ARB DIS
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   (WHO). World Health Organization, 2009, DENG GUID DIAGN TREA, P147
   (WHO). World Health Organization, 2012, GLOB STRAT DENG PREV, P35
   (WHO). World Health Organization, 2018, EFF TEST TRAPS CONTR, P40
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 45
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2019
VL 56
IS 4
BP 1033
EP 1046
DI 10.1093/jme/tjz009
PG 14
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4IU
UT WOS:000492038700019
PM 30753539
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Njoroge, TM
   Berenbaum, MR
AF Njoroge, Teresia M.
   Berenbaum, May R.
TI Laboratory Evaluation of Larvicidal and Oviposition Deterrent Properties
   of Edible Plant Oils for Potential Management of Aedes aegypti (Diptera:
   Culicidae) in Drinking Water Containers
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; edible plant oil; larvicidal; oviposition deterrence;
   linoleic acid
ID FATTY-ACID-COMPOSITION; CULEX-QUINQUEFASCIATUS; MOSQUITO LARVICIDES;
   VEGETABLE-OILS; PUERTO-RICO; DENGUE; L.; IDENTIFICATION; SEED;
   REPELLENCY
AB The yellow fever mosquito, Aedes aegypti (Diptera: Culicidae) transmits several devastating arboviruses, including dengue, chikungunya, and Zika virus, making development of inexpensive and eco-friendly strategies for its control an urgent priority. We evaluated the lethality of 13 commonly used plant-derived edible oils against late-third instar Ae. aegypti and then tested the three most lethal oils for stage-specific differences in lethality. We also examined the effects of the most lethal (hempseed), moderately lethal (sunflower and peanut), and least lethal (olive) oils on survival to adulthood and oviposition behavior of gravid females. We hypothesized that the insecticidal activity of edible oils is a function of the content of their linoleic acid, a key fatty acid component with film-forming properties. Among the 13 oils tested, hempseed oil was the most lethal, with an LC50 of 348.25 ppm, followed by sesame (670.44 ppm) and pumpkinseed (826.91 ppm) oils. Oils with higher linoleic acid content were more lethal to larvae than those with low linoleic acid content. Furthermore, pure concentrated linoleic acid was more lethal to larvae compared to any edible oil. In comparison to early instars, late instars were more susceptible to hempseed, sunflower, peanut, and olive oils; these oils also acted as oviposition deterrents, with effective repellency >= 63%. The proportion of larvae surviving to adulthood was significantly reduced in hempseed, sunflower, peanut, and olive oil treatments relative to controls. Our results suggest that some edible plant oils have potential as effective, eco-friendly larvicides, and oviposition deterrents for controlling container-dwelling mosquitoes, especially in resource-limited settings.
C1 [Njoroge, Teresia M.; Berenbaum, May R.] Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.
RP Njoroge, TM (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.
EM tnjorog2@illinois.edu
CR Ali A, 2012, J MED ENTOMOL, V49, P1370, DOI 10.1603/ME12026
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Audouze K, 2018, TOXICOL APPL PHARM, V354, P56, DOI 10.1016/j.taap.2018.02.014
   Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   Silva VDC, 2015, REV SOC BRAS MED TRO, V48, P610, DOI 10.1590/0037-8682-0049-2015
   Bury NR, 1998, J EXP BIOL, V201, P81
   Cantrell CL, 2011, J MED ENTOMOL, V48, P836, DOI 10.1603/ME10244
   Cashman A, 2010, J ENVIRON DEV, V19, P42, DOI 10.1177/1070496509347088
   Chauhan KR, 2005, J MED ENTOMOL, V42, P643, DOI 10.1603/0022-2585(2005)042[0643:FDEOCO]2.0.CO;2
   Corbet SA, 2000, ENTOMOL EXP APPL, V94, P295, DOI 10.1023/A:1003920817649
   de Melo AR, 2018, ECOTOX ENVIRON SAFE, V154, P1, DOI 10.1016/j.ecoenv.2018.02.009
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Edward G Perkins, 1995, PRACTICAL HDB SOYBEA, P9, DOI DOI 10.1016/B978-0-935315-63-9.50006-1
   Erdemoglu N, 2003, CHEM NAT COMPD+, V39, P595, DOI 10.1023/B:CONC.0000018118.52743.a8
   Finney D, 1971, PROBIT ANAL, P50
   Gbolade A. A., 2000, Journal of Tropical Medicinal Plants, V1, P146
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hodgson E, 1996, ENVIRON HEALTH PERSP, V104, P97, DOI 10.2307/3432700
   HWANG YS, 1982, ENVIRON ENTOMOL, V11, P223, DOI 10.1093/ee/11.1.223
   HWANG YS, 1984, J CHEM ECOL, V10, P145, DOI 10.1007/BF00987651
   Jones AMP, 2012, J AGR FOOD CHEM, V60, P3867, DOI 10.1021/jf300101w
   KAMEL BS, 1985, J AM OIL CHEM SOC, V62, P881, DOI 10.1007/BF02541750
   Korul'kina LM, 2004, CHEM NAT COMPD+, V40, P417, DOI 10.1007/s10600-005-0002-5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lazos E. S, 1986, J ENVIRON DEV, V19, P42
   Lee DS, 1998, ANAL CHIM ACTA, V358, P163, DOI 10.1016/S0003-2670(97)00574-6
   Mann RS, 2012, MINI-REV ORG CHEM, V9, P185
   Mdoe FP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-426
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   MOROHASHI M, 1991, J COMP PHYSIOL B, V161, P69, DOI 10.1007/BF00258748
   NATHAN MB, 1991, J AM MOSQUITO CONTR, V7, P400
   Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x
   ONeil M. J, 2013, MERCK INDEX ENCY CHE, P1024
   Oomah BD, 2002, FOOD CHEM, V76, P33, DOI 10.1016/S0308-8146(01)00245-X
   Parens R, 2017, PLOS CURR, V9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Perumalsamy H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0848-8
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Rahuman AA, 2008, PARASITOL RES, V103, P1383, DOI 10.1007/s00436-008-1146-6
   Rajkumar S, 2011, ASIAN PAC J TROP MED, V4, P948, DOI 10.1016/S1995-7645(11)60224-1
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   Ribeiro-Neto JA, 2017, ECOTOX ENVIRON SAFE, V143, P57, DOI 10.1016/j.ecoenv.2017.05.004
   RICHARDS A. GLENN, 1941, TRANS ARNER ENT SOC, V67, P161
   Rico R, 2016, FOOD SCI NUTR, V4, P329, DOI 10.1002/fsn3.294
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Sabudak T, 2007, CHEM NAT COMPD+, V43, P465, DOI 10.1007/s10600-007-0163-5
   Scott B. A., 1989, ACS SYM SER, P25
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Tawatsin Apiwat, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P915
   Traboulsi AF, 2005, PEST MANAG SCI, V61, P597, DOI 10.1002/ps.1017
   Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023
   Uzun B, 2007, FOOD CHEM, V102, P45, DOI 10.1016/j.foodchem.2006.03.059
   Warikoo R, 2011, PARASITOL RES, V109, P1125, DOI 10.1007/s00436-011-2355-y
   WATSON G. I., 1941, BULL ENT RES, V31, P319, DOI 10.1017/S0007485300005095
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Wilder-Smith A, 2018, CLIN MICROBIOL INFEC, V24, P680, DOI 10.1016/j.cmi.2018.03.024
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
NR 70
TC 0
Z9 0
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2019
VL 56
IS 4
BP 1055
EP 1063
DI 10.1093/jme/tjz021
PG 9
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4IU
UT WOS:000492038700021
PM 30855084
DA 2020-07-08
ER

PT J
AU Staunton, KM
   Yeeles, P
   Townsend, M
   Nowrouzi, S
   Paton, CJ
   Trewin, B
   Pagendam, D
   Bondarenco, A
   Devine, GJ
   Snoad, N
   Beebe, NW
   Ritchie, SA
AF Staunton, Kyran M.
   Yeeles, Peter
   Townsend, Michael
   Nowrouzi, Somayeh
   Paton, Christopher J.
   Trewin, Brendan
   Pagendam, Daniel
   Bondarenco, Artiom
   Devine, Gregor J.
   Snoad, Nigel
   Beebe, Nigel W.
   Ritchie, Scott A.
TI Trap Location and Premises Condition Influences on Aedes aegypti
   (Diptera: Culicidae) Catches Using Biogents Sentinel Traps During a
   'Rear and Release' Program: Implications for Designing Surveillance
   Programs
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Biogents Sentinel trap; sterile insect release;
   Wolbachia; dengue; Zika
ID EXPERIMENTAL HUTS; DENGUE VECTOR; MOSQUITO; QUEENSLAND; CAIRNS;
   POPULATION; RECAPTURE; AUSTRALIA; WOLBACHIA; EFFICACY
AB As the incidence of arboviral diseases such as dengue, Zika, chikungunya, and yellow fever increases globally, controlling their primary vector, Aedes aegypti (L.) (Diptera: Culicidae), is of greater importance than ever before. Mosquito control programs rely heavily on effective adult surveillance to ensure methodological efficacy. The Biogents Sentinel (BGS) trap is the gold standard for surveilling adult Aedes mosquitoes and is commonly deployed worldwide, including during modern 'rear and release' programs. Despite its extensive use, few studies have directly assessed environmental characteristics that affect BGS trap catches, let alone how these influences change during 'rear and release' programs. We assessed male and female Ae. aegypti spatial stability, as well as premises condition and trap location influences on BGS trap catches, as part of Debug Innisfail 'rear and release' program in northern Australia. We found similar trends in spatial stability of male and female mosquitoes at both weekly and monthly resolutions. From surveillance in locations where no males were released, reduced catches were found at premises that contained somewhat damaged houses and unscreened properties. In addition, when traps were located in areas that were unsheltered, more than 10 m from commonly used sitting areas or more visually complex catches were also negatively affected. In locations where males were released, we found that traps in treatment sites, relative to control sites, displayed increased catches in heavily shaded premises and were inconsistently influenced by differences in house sets and building materials. Such findings have valuable implications for a range of Ae. aegypti surveillance programs.
C1 [Staunton, Kyran M.; Townsend, Michael; Paton, Christopher J.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.
   [Staunton, Kyran M.; Townsend, Michael; Paton, Christopher J.; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
   [Yeeles, Peter; Nowrouzi, Somayeh] James Cook Univ, Coll Sci & Engn, Smithfield, Qld 4878, Australia.
   [Trewin, Brendan; Beebe, Nigel W.] CSIRO, Hlth & Biosecur, Brisbane, Qld, Australia.
   [Pagendam, Daniel] CSIRO, Data 61, Brisbane, Qld, Australia.
   [Bondarenco, Artiom] CSIRO, Land & Water, Brisbane, Qld, Australia.
   [Devine, Gregor J.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, 300 Herston Rd, Herston, Qld 4006, Australia.
   [Snoad, Nigel] Verily Life Sci, 259 East Grand Ave, San Francisco, CA 94080 USA.
   [Beebe, Nigel W.] Univ Queensland, Fac Sci, Sch Biol Sci, Brisbane, Qld, Australia.
RP Staunton, KM (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.; Staunton, KM (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
EM kyran.staunton@jcu.edu.au
RI Devine, Gregor J/H-1141-2014; Staunton, Kyran/W-2263-2019; Beebe,
   Nigel/C-5610-2008
OI Devine, Gregor J/0000-0001-6312-0390; Staunton,
   Kyran/0000-0001-6812-3320; Beebe, Nigel/0000-0003-2877-0691; Trewin,
   Brendan/0000-0002-7244-4044
CR Ball TS, 2010, J MED ENTOMOL, V47, P657, DOI 10.1603/ME09242
   Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   BIDLINGMAYER WL, 1985, J MED ENTOMOL, V22, P295, DOI 10.1093/jmedent/22.3.295
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brelsfoard C.L., 2009, ASIA PAC J MOL BIOL, V17, P55
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1
   Chansang C, 2007, AM J TROP MED HYG, V77, P897, DOI 10.4269/ajtmh.2007.77.897
   Clements A. N., 1999, BIOL MOSQUITOES SENS, V90
   Clements A. N, 1999, BIOL MOSQUITOES VOLU, V2
   Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   Harrell Jr F. E., 2017, HMISC HARRELL MISCEL
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847
   Hegyi G, 2015, ANN ZOOL FENN, V52, P257, DOI 10.5735/086.052.0502
   Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P1647, DOI 10.1007/s00265-011-1175-5
   Hoffmann AA, 2014, MED VET ENTOMOL, V28, P90, DOI 10.1111/mve.12077
   Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Marris E, 2017, NATURE, V548, P17, DOI 10.1038/548017a
   Mukaka MM, 2012, MALAWI MED J, V24, P69
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   R Core Team, 2017, R LANG ENV STAT COMP
   Ritchie S, 2014, AUSTRAL ENTOMOL, V53, P363, DOI 10.1111/aen.12127
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Rodriguez-Tovar ML, 2000, SOUTHWEST ENTOMOL, V25, P55
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Salazar FV, 2018, J AM MOSQUITO CONTR, V34, P201, DOI 10.2987/17-6713.1
   Stachelek J., 2009, AED PACKAGE ACCOMPAN
   Suwonkerd W, 2006, J VECTOR ECOL, V31, P311, DOI 10.3376/1081-1710(2006)31[311:TEOHTO]2.0.CO;2
   TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591
   Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P635, DOI 10.2987/8756-971X(2006)22[635:OOUFAA]2.0.CO;2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
NR 46
TC 1
Z9 1
U1 2
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2019
VL 56
IS 4
BP 1102
EP 1111
DI 10.1093/jme/tjz018
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4IU
UT WOS:000492038700027
PM 30817823
DA 2020-07-08
ER

PT J
AU Thabet, HS
   Fawaz, EY
   Badziklou, K
   Eldin, RAT
   Kaldas, RM
   Fahmy, NT
   Tamekloe, TA
   Kere-Banla, A
   Diclaro, JW
AF Thabet, Hala S.
   Fawaz, Emadeldin Y.
   Badziklou, Kossi
   Eldin, Reham A. Tag
   Kaldas, Rania M.
   Fahmy, Nermeen T.
   Tamekloe, Tsidi Agbeko
   Kere-Banla, Abiba
   Diclaro, Joseph W., II
TI Preliminary Screening of Mosquito Spatial Distribution in Togo: With
   Special Focus on the Aedes (Diptera: Culicidae) Species
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; yellow fever; Togo
ID ANOPHELES-GAMBIAE COMPLEX; VALLEY FEVER VIRUS; CHIKUNGUNYA VIRUS;
   YELLOW-FEVER; IDENTIFICATION; VECTORS; SENEGAL; AEGYPTI; DENGUE
AB The Togolese Republic has a tropical and humid climate which constitutes an ideal environment for mosquitoes to breed and transmit diseases. The Aedes mosquito is known to transmit yellow fever (YF), dengue, chikungunya, and Zika viruses in West Africa. Togo has been suffering from YF virus transmission, despite vaccination efforts. Unfortunately, there is scarcity in the data that reflect mosquito spatial distribution in Togo, specifically possible YF vectors. In the current study, mosquito surveillance efforts targeted areas with confirmed YF cases between July and August 2012. Indoor mosquitoes were collected using knockdown insecticide spraying, whereas Biogents (BG) traps were used to collect outdoor mosquito adults. Mosquito larval surveillance was conducted as well. In total, 17 species were identified. This investigation revealed the presence of medically important vectors in Togo, especially the Aedes aegypti (Linnaeus) (Diptera: Culicidae) which was collected in the four regions. Screening of all pools of female Aedes mosquitoes for YF, by real-time PCR, showed negative results. This is the first record for Coquillettidia flavocincta (Edwards) (Diptera: Culicidae) species in West Africa. This preliminary work serves as a baseline for further mosquito distribution studies in Togo.
C1 [Thabet, Hala S.; Fawaz, Emadeldin Y.; Eldin, Reham A. Tag; Kaldas, Rania M.; Fahmy, Nermeen T.; Diclaro, Joseph W., II] US Agcy Int Dev, US Naval Med Res Unit NAMRU 3, Cairo, Egypt.
   [Thabet, Hala S.] Ain Shams Univ, Fac Med, Cairo, Egypt.
   [Badziklou, Kossi; Kere-Banla, Abiba] Inst Natl Hyg, BP 1396, Lome, Togo.
   [Tamekloe, Tsidi Agbeko] Minist Sante Togo, Div Epidemiol, Lome, Togo.
RP Thabet, HS (corresponding author), US Agcy Int Dev, US Naval Med Res Unit NAMRU 3, Cairo, Egypt.; Thabet, HS (corresponding author), Ain Shams Univ, Fac Med, Cairo, Egypt.
EM halasobhy@gmail.com
OI Thabet, Hala/0000-0002-4223-8952
FU Armed Forces Health Surveillance Center (AFHSC)/Division of Global
   Emerging Infections System Operations (GEIS Ops) Work Unit [10333_12_N3]
FX This work was funded by the Armed Forces Health Surveillance Center
   (AFHSC)/Division of Global Emerging Infections System Operations (GEIS
   Ops) Work Unit # 10333_12_N3. Last coauthor is a military service member
   of the U.S. Government. Title 17 U.S.C. S105 provides that 'Copyright
   protection under this title is not available for any work of the United
   States Government'. Title 17 U.S.C. S101 defines a U.S. Government work
   as a work prepared by a military service member or employee of the U.S.
   Government as part of that person's official duties. The views expressed
   in this article are those of the authors and do not necessarily reflect
   the official policy or position of the Department of the Navy,
   Department of Defense, or the U.S. Government.
CR Agi P. I., 2009, Journal of Applied Sciences and Environmental Management, V13, P15
   AHADJIDABLA KM, 2015, J ENTOMOL ZOOL STU B, V3, P71
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P401
   Appawu MA, 2001, TROP MED INT HEALTH, V6, P511, DOI 10.1046/j.1365-3156.2001.00737.x
   Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415
   David MR, 2012, REV SAUDE PUBL, V46, P858, DOI 10.1590/S0034-89102012000500013
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Edwards F.W., 1941, MOSQUITOES ETHIOPIAN
   Fahmy N. T., 2015, J MED ENTOMOL, P1
   Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   JUPP PG, 1986, T ROY SOC TROP MED H, V80, P226, DOI 10.1016/0035-9203(86)90019-2
   Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Njabo KY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-193
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520
   Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Ughasi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-89
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
NR 26
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2019
VL 56
IS 4
BP 1154
EP 1158
DI 10.1093/jme/tjz029
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4IU
UT WOS:000492038700035
PM 30927005
DA 2020-07-08
ER

PT J
AU Fitzpatrick, DM
   Hattaway, LM
   Hsueh, AN
   Ramos-Nino, ME
   Cheetham, SM
AF Fitzpatrick, Daniel M.
   Hattaway, Lindsey M.
   Hsueh, Andy N.
   Ramos-Nino, Maria E.
   Cheetham, Sonia M.
TI PCR-Based Bloodmeal Analysis of Aedes aegypti and Culex quinquefasciatus
   (Diptera: Culicidae) in St. George Parish, Grenada
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Culex; Grenada; bloodmeal analysis
ID WEST-NILE-VIRUS; FEEDING PATTERNS; ZIKA VIRUS; MOSQUITOS; TRANSMISSION;
   ALBOPICTUS; WORLDWIDE; SPREAD; DENGUE; ISLAND
AB Blood-feeding patterns of mosquitoes affect the transmission and maintenance of arboviral diseases. In the Caribbean, Aedes aegypti (L.) and Culex quinquefasciatus Say mosquitoes are the dominant mosquito species in developed areas. However, no information is available on the bloodmeal hosts of these invasive vectors in Grenada, where arboviral pathogens such as dengue, chikungunya, and Zika viruses cause significant human suffering. To this end, Ae. aegypti and Cx. quinquefasciatus mosquitoes were investigated from five semirural locations near houses in St. George's Parish, from 2017 to 2018. Polymerase chain reaction was conducted on DNA extracted from individual blood-fed mosquitoes using vertebrate-specific cytochrome b primers. The 32 Ae. aegypti bloodmeals included humans (70%), mongooses (18%), domestic dogs (6%), a domestic cat (3%), and an unidentified bird (3%). Thirty-seven Cx. quinquefasciatus mosquitoes took bloodmeals from seven species of birds (51%), humans (27%), domestic cats (8%), iguanas (5%), a domestic dog (3%), a rat (3%), and a common opossum (3%). The high percentage of human bloodmeal hosts in our study, especially by the normally anthropophilic Ae. aegypti, is expected. The bloodmeal sources and the percentage of nonhuman bloodmeals (30%) taken by Ae. aegypti are comparable to other studies. The large range of hosts may be explained in part by the semirural nature of most local housing. Accordingly, this may contribute to an exchange of pathogens between domestic, peridomestic, and sylvatic transmission cycles.
C1 [Fitzpatrick, Daniel M.; Hattaway, Lindsey M.; Hsueh, Andy N.; Cheetham, Sonia M.] St Georges Univ, Sch Vet Med, Dept Pathobiol, True Blue, Grenada.
   [Ramos-Nino, Maria E.] St Georges Univ, Sch Med, Dept Microbiol, True Blue, Grenada.
RP Cheetham, SM (corresponding author), St Georges Univ, Sch Vet Med, Dept Pathobiol, True Blue, Grenada.
EM scheetha@sgu.edu
RI Cheetham, Sonia/AAS-5409-2020
OI Cheetham, Sonia/0000-0002-0878-1222
FU Windward Islands Research and Education Foundation's One Health Research
   Initiative Grant [07-16-3]
FX We thank Mr. Andrew Kushnir and Ms. Jaelene Haynes for their assistance
   with mosquito identification and field work. This research was funded by
   The Windward Islands Research and Education Foundation's One Health
   Research Initiative Grant 07-16-3.
CR Aldridge RL, 2016, J AM MOSQUITO CONTR, V32, P282, DOI 10.2987/16-6609.1
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049
   Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x
   Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383
   Brenciaglia M, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/4635647
   Brito AC, 1999, MEM I OSWALDO CRUZ, V94, P575, DOI 10.1590/S0074-02761999000400026
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Calderon-Arguedas O, 2009, REV BIOL TROP, V57, P1223
   Centers for Disease Control and Prevention, 2019, SPEC DEAD BIRDS WHIC
   Chadee DD, 1998, J AM MOSQUITO CONTR, V14, P5
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Dupuis AP, 2005, AM J TROP MED HYG, V73, P474, DOI 10.4269/ajtmh.2005.73.474
   Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106
   EDMAN JD, 1968, SCIENCE, V161, P67, DOI 10.1126/science.161.3836.67
   EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Gibson K. E., 2016, CAB Reviews, V11, P1, DOI 10.1079/PAVSNNR201611022
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008
   Janssen N, 2015, TROP MED INT HEALTH, V20, P1488, DOI 10.1111/tmi.12587
   Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122
   Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082
   Kweka EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0968-1
   Lane J, 1953, NEOTROPICAL CULICIDA, VI
   Lane J, 1953, NEOTROPICAL CULICIDA, V2
   LEPAGE D, 2014, PETERS CHECK LIST BI
   Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Nellis D.W., 1983, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P1
   Panagos A, 2005, REV PANAM SALUD PUBL, V17, P225
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919
   Schioler KL, 2009, AM J TROP MED HYG, V81, P280, DOI 10.4269/ajtmh.2009.81.280
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Soares L, 2017, CONSERV BIOL, V31, P1477, DOI 10.1111/cobi.12995
   Stenn T, 2019, J MED ENTOMOL, V56, P10, DOI 10.1093/jme/tjy148
   TEMPELIS CH, 1970, AM J TROP MED HYG, V19, P335, DOI 10.4269/ajtmh.1970.19.335
   Thiemann TC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001452
   Tiawsirisup Sonthaya, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P110
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Walter Reed Biosystematics Unit, 2019, SYSTEMATIC CATALOG C
NR 50
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2019
VL 56
IS 4
BP 1170
EP 1175
DI 10.1093/jme/tjz037
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4IU
UT WOS:000492038700038
PM 31245825
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Rasmussen, CA
   Eaton, S
   Diers, N
   Cueno, P
   Mohr, EL
   O'Connor, DH
   Katz, AW
   Schotzko, M
   Murphy, CJ
   Huang, YJ
   Nork, TM
AF Rasmussen, Carol A.
   Eaton, Seth
   Diers, Nathan
   Cueno, Peter
   Mohr, Emma L.
   O'Connor, David H.
   Katz, Alexander W.
   Schotzko, Michelle
   Murphy, Christopher J.
   Huang, Yijun
   Nork, T. Michael
TI OCT in Neonate Monkeys With and Without Maternal Zika Virus Exposure
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 28-MAY 02, 2019
CL Vancouver, CANADA
SP Assoc Res Vis & Ophthalmol
C1 [Rasmussen, Carol A.; Katz, Alexander W.; Nork, T. Michael] Univ Wisconsin Madison, Ophthalmol & Visual Sci, Madison, WI USA.
   [Rasmussen, Carol A.; Eaton, Seth; Nork, T. Michael] OSOD LLC, Madison, WI USA.
   [Eaton, Seth; Diers, Nathan; Cueno, Peter; Huang, Yijun] EyeKor Inc, Madison, WI USA.
   [Mohr, Emma L.] Univ Wisconsin Madison, Dept Pediat, Madison, WI USA.
   [O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [O'Connor, David H.; Schotzko, Michelle] Univ Wisconsin Madison, Wisconsin Natl Primate Res Cente, Madison, WI USA.
   [Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Surg & Radiol Sci, Davis, CA USA.
   [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Ophthalmol & Vis Sci, Sacramento, CA USA.
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI116382-01A1S1,
   UL1 TR002373-02, TL1002375-02]; Pediatric Infectious Diseases Society;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P30 EY016665]; Research to Prevent
   Blindness (RPB) Unrestricted Departmental AwardResearch to Prevent
   Blindness (RPB); Office Of The Director, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011106]; Research Facilities
   Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459-01, RR020141-01]
FX Support This study was supported in part by: the National Institutes of
   Health (R01 AI116382-01A1S1 (DHO), UL1 TR002373-02 (ELM), TL1002375-02
   (ELM)) and the Pediatric Infectious Diseases Society (ELM), a Core Grant
   for Vision Research from the NIH to the University of Wisconsin-Madison
   (P30 EY016665), a Research to Prevent Blindness (RPB) Unrestricted
   Departmental Award (TMN), the Office Of The Director, National
   Institutes of Health under Award Number P51OD011106 to the Wisconsin
   National Primate Research Center, University of Wisconsin-Madison, at a
   facility constructed with support from Research Facilities Improvement
   Program grant numbers RR15459-01 and RR020141-01. The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2019
VL 60
IS 9
MA 201
PG 4
WC Ophthalmology
SC Ophthalmology
GA JB5TF
UT WOS:000488628100196
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Beaver, J
   Skountzou, I
AF Beaver, Jacob
   Skountzou, Ioanna
TI Zika virus microneedle vaccination confers long-term protection to
   immune-privileged compartments
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 28-MAY 02, 2019
CL Vancouver, CANADA
SP Assoc Res Vis & Ophthalmol
C1 [Beaver, Jacob; Skountzou, Ioanna] Emory Univ, Microbiol & Immunol, Atlanta, GA 30322 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2019
VL 60
IS 9
MA 6415
PG 2
WC Ophthalmology
SC Ophthalmology
GA JB8EY
UT WOS:000488800707141
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Li, Y
   Shan, C
   Ha, YJ
   Xia, F
   Liu, H
   Shi, PY
   Zhang, WB
AF Li, Yi
   Shan, Chao
   Ha, Yonju
   Xia, Fan
   Liu, Hua
   Shi, Peiyong
   Zhang, Wenbo
TI Zika virus infection induces retinal neuronal and vascular defects
   during development
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 28-MAY 02, 2019
CL Vancouver, CANADA
SP Assoc Res Vis & Ophthalmol
C1 [Li, Yi; Ha, Yonju; Xia, Fan; Liu, Hua; Zhang, Wenbo] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA.
   [Li, Yi] Tianjin Med Univ, Hosp Eye, Tianjin, Peoples R China.
   [Shan, Chao; Shi, Peiyong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Xia, Fan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan, Hubei, Peoples R China.
   [Zhang, Wenbo] Dept Neurosci, Galveston, TX USA.
   [Zhang, Wenbo] Dept Cell Biol & Anat, Galveston, TX USA.
FU NH Grant [EY022694, EY026629]; Retina Research Foundation; American
   Heart AssociationAmerican Heart Association [17SDG33630151]
FX NH Grant EY022694, EY026629; Retina Research Foundation (to W.Z.); and
   American Heart Association 17SDG33630151 (to H.L.)
NR 0
TC 0
Z9 0
U1 5
U2 6
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2019
VL 60
IS 9
MA 6008
PG 3
WC Ophthalmology
SC Ophthalmology
GA JB8EY
UT WOS:000488800706143
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yogurtcu, ON
   Yang, H
   Chancey, C
   Forshee, RA
   Eder, AF
AF Yogurtcu, Osman N.
   Yang, Hong
   Chancey, Caren
   Forshee, Richard A.
   Eder, Anne F.
TI Predictive model for Zika virus RNA minipool nucleic acid testing in
   outbreak scenarios
SO TRANSFUSION
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; BLOOD-DONATIONS; PUERTO-RICO; STATES
AB BACKGROUND: Zika virus (ZIKV), a mosquito-borne flavivirus, causes asymptomatic infections in blood donors and can be transmitted by transfusion. During the 2016 US outbreak, universal individual-donation nucleic acid testing (ID-NAT) was used to screen the blood supply for ZIKV. Testing pooled samples from multiple donations with minipool (MP)-NAT is less sensitive than ID-NAT, which raised questions about its utility in ZIKV outbreaks.
   STUDY DESIGN AND METHODS: A mathematical model and computer simulation determined the risk of missing ID-NAT-reactive and immunoglobulin (Ig) M-negative donations in a ZIKV outbreak if MP-NAT is used initially instead of ID-NAT. The model calculated the time required for ZIKV RNA to replicate to a concentration detectable by testing donations individually or in pools of 6 (MP6) or 16 (MP16). A computer simulation then randomly selected infection times to determine the probability of detection by the candidate tests.
   RESULTS: The probability of detecting the first ID-NAT-reactive unit in an outbreak is 92% (2.5th-97.5th percentile, 79%-99%) by MP6 and 85% (2.5th-97.5th percentile, 67%-99%) by MP16. When one donation is detected by MP-NAT, the model predicts that the chance of having missed one or more ID-NAT-reactive donations is 8% to 15%. The probability of missing a unit by MP-NAT is constant over the course of the outbreak (8% by MP6, 15% by MP16).
   CONCLUSION: The model predicts that the probability that a candidate MP-NAT will detect the first ID-NAT-reactive unit in a ZIKV outbreak is 85% to 92% and remains constant over time.
C1 [Yogurtcu, Osman N.; Yang, Hong; Forshee, Richard A.] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Chancey, Caren; Eder, Anne F.] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Eder, AF (corresponding author), US FDA, Off Blood Res & Review, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM anne.eder@fda.hhs.gov
CR [Anonymous], 2017, COB ZIK NUCL AC TEST
   [Anonymous], 2018, PROCL ZIK VIR ASS PA
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Busch MP, 2005, TRANSFUSION, V45, P254, DOI 10.1111/j.1537-2995.2004.04215.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   FDA, 2018, REV REC RED RISK ZIK
   FDA, 2016, REV REC RED RISK ZIK
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pan American Health Organization/World Health Organization Regional Office for the Americas, 2017, REG ZIK EP UPD AM
   Pate LL, 2017, TRANSFUSION, V57, p26A
   Pate LL, 2017, VOX SANG S1, V112, P185
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U.S. FDA CBER, 2017, 116 M BLOOD PROD ADV
   Williamson P, 2016, 35 INT C ISBT 2018
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
NR 27
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2019
VL 59
IS 7
BP 2211
EP 2217
DI 10.1111/trf.15296
PG 7
WC Hematology
SC Hematology
GA JD0XT
UT WOS:000489700500011
PM 30938839
DA 2020-07-08
ER

PT J
AU Kaid, C
   Semedo-Kuriki, P
   Goulart, E
   Caires, L
   Astray, R
   Okamoto, OK
   Zatz, M
AF Kaid, Carolini
   Semedo-Kuriki, Patricia
   Goulart, Ernesto
   Caires-Junior, Luiz
   Astray, Renato
   Okamoto, Oswaldo Keith
   Zatz, Mayana
TI Zika virus is a potent oncolytic agent against aggressive human
   ependymoma
SO CANCER RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-for-Cancer-Research (AACR)
CY MAR 29-APR 03, 2019
CL Atlanta, GA
SP Amer Assoc Canc Res
C1 [Kaid, Carolini; Semedo-Kuriki, Patricia; Goulart, Ernesto; Caires-Junior, Luiz; Okamoto, Oswaldo Keith; Zatz, Mayana] Univ Sao Paulo, Inst Biosci, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil.
   [Astray, Renato] Butantan Inst, Sao Paulo, Brazil.
RI Goulart, Ernesto/AAC-3713-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUL
PY 2019
VL 79
IS 13
SU S
MA 2869
DI 10.1158/1538-7445.AM2019-2869
PG 2
WC Oncology
SC Oncology
GA JB0WR
UT WOS:000488279401316
OA Other Gold
DA 2020-07-08
ER

PT J
AU Huang, CX
   Wang, XJ
   Huang, SY
   Ou, LL
   Dai, JF
   Wang, KZ
AF Huang, Chenxiao
   Wang, Xiujuan
   Huang, Shuyi
   Ou, Linlin
   Dai, Jianfeng
   Wang, Kezhen
TI Evasion strategies of Zika virus antagonizing host innate immunity
SO FUTURE VIROLOGY
LA English
DT Article
DE antiviral activity; evasion; flavivirus; innate immunity; interferon;
   Wnt signaling; Zika virus
ID WEST-NILE-VIRUS; INTERFERON-STIMULATED GENES; STRUCTURAL BIOLOGY;
   DENGUE; PROTEIN; ACTIVATION; NS5; RNA; INHIBITION; RECEPTOR
AB Zika virus is a small enveloped positive-strand RNA virus, which belongs to the Flaviviridae family. The RNA genome of all flaviviruses encodes three structural and seven nonstructural genes, together with 5'- and 3'-untranslated region genes flanking. Accompanying the explosive nature of the Zika outbreak in 2014, there was a devastating congenital neurodevelopmental disease in fetuses. Apart from viral RNA replication, polyprotein cleavage, Zika virus nonstructural proteins also play vital roles in the host's innate immune evasion. In this brief report, we summarize the evasion mechanisms of the viral nonstructural proteins antagonizing host antiviral innate immunity.
C1 [Huang, Chenxiao; Wang, Xiujuan; Huang, Shuyi; Ou, Linlin; Dai, Jianfeng; Wang, Kezhen] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
RP Dai, JF; Wang, KZ (corresponding author), Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
EM daijianfeng@suda.edu.cn; kzwang@suda.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31500700]; Jiangsu Natural Science
   FoundationNatural Science Foundation of Jiangsu Province [BK20140322];
   Shandong Natural Science FoundationNatural Science Foundation of
   Shandong Province [ZR2014CQ057]
FX This work was supported by National Natural Science Foundation of China
   (31500700), Jiangsu Natural Science Foundation (BK20140322) and Shandong
   Natural Science Foundation (ZR2014CQ057). The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   CLEARY CM, 1994, J BIOL CHEM, V269, P18747
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lin JJ, 2017, TAIWAN J OBSTET GYNE, V56, P585, DOI 10.1016/j.tjog.2017.08.003
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   Morazzani EM, 2019, ANTIVIR RES, V164, P106, DOI 10.1016/j.antiviral.2019.02.001
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3
   Whitehead SS, 2019, NATURE, V567, P467, DOI 10.1038/d41586-019-00868-6
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 61
TC 0
Z9 0
U1 0
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUL
PY 2019
VL 14
IS 7
BP 465
EP 471
DI 10.2217/fvl-2019-0037
PG 7
WC Virology
SC Virology
GA JB5JM
UT WOS:000488598000006
DA 2020-07-08
ER

PT J
AU Abu-rish, EY
   Elayeh, ER
   Browning, MJ
AF Abu-rish, Eman Y.
   Elayeh, Eman R.
   Browning, Michael J.
TI Physicians' knowledge, attitudes and practices towards Zika virus
   infection in Jordan
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Aedes; arboviruses; health personnel; Jordan; Middle East; Zika virus
ID DISEASE
AB Introduction: Zika virus (ZIKAV) disease is a public health problem of international concern. Recent evidence has documented imported ZIKAV cases into the Middle East and the existence of ZIKAV-transmitting mosquitoes in Jordan. However, limited data exist on the role of physicians in public awareness in this regard. This study aimed to assess ZIKAV knowledge, attitudes and counseling practices (KAP) of general physicians and gynecologists in Amman, Jordan.
   Methodology: In this cross-sectional study, a structured paper-based questionnaire was completed by 119 participants during 2016-2017.
   Results: Only 4.2% of the physicians correctly addressed ZIKAV-complication questions. A misconception of considering direct contact between individuals and breastfeeding as modes of ZIKAV transmission was observed. Only one participant correctly recognized that isolation of infected or exposed persons is not recommended. Having at least five years of experience in medical practice was the only factor that was significantly associated with a high knowledge score (P-value = 0.011). Although prevention measures are the sole method to control ZIKAV spread, only 50% of participants believed in the efficacy of such measures. Despite a quarter of participants perceiving ZIKAV as a threat to their patients, none of them have counseled a patient in this regard before. The presence of an evidence of ZIKAV in Jordan and health authorities' recommendations were the most important predictors for adoption of counseling practice.
   Conclusions: General physicians and gynecologists in Jordan had several gaps in knowledge of key aspects of ZIKAV disease, and there is a need for specific training programs of physicians and gynecologists.
C1 [Abu-rish, Eman Y.; Elayeh, Eman R.] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, POB 11942, Amman, Jordan.
   [Browning, Michael J.] Leicester Royal Infirm, Dept Immunol, Leicester LE1 5WW, Leics, England.
   [Browning, Michael J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England.
RP Abu-rish, EY (corresponding author), Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, POB 11942, Amman, Jordan.
EM e.aburish@ju.edu.jo
RI Abu-rish, Eman Y./G-2006-2016
OI Abu-rish, Eman Y./0000-0003-4274-9354
FU Deanship of Scientific Research (DSR) at the University of Jordan
FX We would like to thank The Deanship of Scientific Research (DSR) at the
   University of Jordan for the financial support of this work.
CR Abu-rish EY, 2019, AM J TROP MED HYG, V100, P974, DOI 10.4269/ajtmh.18-0715
   Abu-rish EY, 2016, FAM PRACT, V33, P690, DOI 10.1093/fampra/cmw086
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Asokan GV, 2018, DISASTER MED PUBLIC, V12, P7, DOI 10.1017/dmp.2017.26
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Berenson AB, 2018, AM J TROP MED HYG, V98, P178, DOI 10.4269/ajtmh.17-0595
   Brissett DI, 2018, AM J TROP MED HYG, V99, P211, DOI 10.4269/ajtmh.18-0014
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2017, ZIK VIR CLIN EV DIS
   Centers for disease control and prevention (CDC), 2018, ZIK VIR TYP ZIK VIR
   Centers for disease control and prevention (CDC), 2018, ZIK VIR HLTH EFF RIS
   Centers for disease control and prevention (CDC), 2019, WORLD MAP AR ZIK RIS
   Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Ibrahim NK, 2018, J INFECT PUBLIC HEAL, V11, P18, DOI 10.1016/j.jiph.2017.02.015
   Kanani K, 2017, J AM MOSQUITO CONTR, V33, P134, DOI 10.2987/17-6641.1
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Tridane A, 2016, TRAVEL MED INFECT DI, V14, P277, DOI 10.1016/j.tmaid.2016.03.003
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 23
TC 0
Z9 0
U1 0
U2 0
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUL
PY 2019
VL 13
IS 7
BP 584
EP 590
DI 10.3855/jidc.11356
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA JA1OD
UT WOS:000487585400001
PM 32065815
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Almeida, IMLM
   Ramos, CV
   Rodrigues, DC
   de Sousa, AC
   do Nascimento, MDCAPC
   da Silva, MVB
   Batista, FMA
   dos Santos, JP
   de Oliveira, RS
   Soares, FAD
   Xavier, SCD
   Carvalho-Costa, FA
AF Lopes Moreira de Almeida, Isabel Marlucia
   Ramos, Carmen Viana
   Rodrigues, Danielle Carvalho
   de Sousa, Amanda Carvalho
   Paz Carvalho do Nascimento, Maria de Lourdes Cristina Alcantara
   Bittencourt da Silva, Marcos Vilhena
   Araujo Batista, Francisca Miriane
   dos Santos, Jessica Pereira
   de Oliveira, Roselane Sampaio
   de Freitas Soares, Filipe Augusto
   das Chagas Xavier, Samanta Cristina
   Carvalho-Costa, Filipe Anibal
TI Clinical and epidemiological aspects of microcephaly in the state of
   Piaui, northeastern Brazil, 2015-2016
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Microcephaly; Infants; Zika; Stage of Piaui
ID ZIKA VIRUS-INFECTION; INFANTS
AB Objectives: To describe aspects of the microcephaly epidemic in the state of Piaui.
   Methods: All cases of congenital microcephaly confirmed in the state between 2015 and 2016 were included (n=100). Investigation forms of the Regional Reference Center for Microcephaly were reviewed. Discarded cases (n=63) were used as a comparison group.
   Results: In October, November, and December 2015 incidence rates reached 4.46, 6.33 and 3.86/1000 live births, respectively; 44 cases were reported in the state capital. Among the mothers of confirmed and discarded cases, the frequency of skin rash during pregnancy was 50/97 (51.5%) and 8/51 (15.7%), respectively (p< 0.001); 33 confirmed cases (35.9%) had a head circumference z-score between -2 and -3, 23 (25%) between -3 and -4, and 8 (8.7%) had a z-score of less than -4. Head computer tomography scans revealed calcifications in 78/95 (82.1%) cases. Lissencephaly, hydrocephalus and agenesis of the corpus callosum were also frequently observed. Ophthalmic findings included retinal pigment epithelium rarefaction and atrophy. Absence of otoacoustic emissions was observed in 21/70 cases. One newborn also presented lower limb muscle atrophy. There were no significant differences in vaccination rates for influenza, diphtheria-tetanus-acellular pertussis, and hepatitis B in either group.
   Conclusions: The state of Piaui, like others in the northeastern region, faced an epidemic of congenital microcephaly between 2015 and 2016, presumably related to congenital Zika virus infection, more intense in the capital. Current challenges include the improvement of vector control, basic research, scaling-up of diagnostic tools for pre-natal screening of Zika virus, vaccines, and health care for affected children. (C) 2018 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
C1 [Lopes Moreira de Almeida, Isabel Marlucia; Ramos, Carmen Viana; de Sousa, Amanda Carvalho; Paz Carvalho do Nascimento, Maria de Lourdes Cristina Alcantara; Bittencourt da Silva, Marcos Vilhena; Araujo Batista, Francisca Miriane] Ctr Reg Referencia Reg Microcefalia Governo Estad, Teresina, PI, Brazil.
   [Rodrigues, Danielle Carvalho; dos Santos, Jessica Pereira; de Freitas Soares, Filipe Augusto; das Chagas Xavier, Samanta Cristina; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
   [de Oliveira, Roselane Sampaio] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Ramos, Carmen Viana/AAK-9415-2020; Ramos, Carmem/AAG-3666-2020
OI araujo, miriane/0000-0002-0351-8994; Viana Ramos,
   Carmen/0000-0003-3378-0149; de Freitas Soares, Filipe
   Augusto/0000-0003-0510-3968; SANTOS, JESSICA/0000-0002-1639-517X
FU Fundacao Oswaldo Cruz (Fiocruz)
FX This research was supported by funds from the Fundacao Oswaldo Cruz
   (Fiocruz).
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention (CDC), 2017, ZIKA AND PREGNANCY C
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Mazzu-Nascimento T, 2017, GENET MOL BIOL, V40, P387, DOI [10.1590/1678-4685-GMB-2016-0179, 10.1590/1678-4685-gmb-2016-0179]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moura AA, 2016, VACCINE, V34, P445, DOI 10.1016/j.vaccine.2015.12.019
   Serafim AS, 2014, REV SOC BRAS MED TRO, V47, P170, DOI 10.1590/0037-8682-0045-2014
   Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146
   WHO, 2016, SCREEN ASS MAN NEON
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 24
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JUL-AUG
PY 2019
VL 95
IS 4
BP 466
EP 474
DI 10.1016/j.jped.2018.04.013
PG 9
WC Pediatrics
SC Pediatrics
GA IX6KR
UT WOS:000485792700012
PM 29963988
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Beys-da-Silva, WO
   Rosa, RL
   Santi, L
   Berger, M
   Park, SK
   Campos, AR
   Terraciano, P
   Varela, APM
   Teixeira, TF
   Roehe, PM
   Quincozes-Santos, A
   Yates, JR
   Souza, DO
   Cirne-Lima, EO
   Guimaraes, JA
AF Beys-da-Silva, Walter O.
   Rosa, Rafael L.
   Santi, Lucelia
   Berger, Markus
   Park, Sung Kyu
   Campos, Alexandre R.
   Terraciano, Paula
   Varela, Ana Paula M.
   Teixeira, Thais F.
   Roehe, Paulo M.
   Quincozes-Santos, Andre
   Yates, John R., III
   Souza, Diogo O.
   Cirne-Lima, Elizabeth O.
   Guimaraes, Jorge A.
TI Zika Virus Infection of Human Mesenchymal Stem Cells Promotes
   Differential Expression of Proteins Linked to Several Neurological
   Diseases
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Zika virus; Brain diseases; Human mesenchymal stem cells; Proteome;
   Microcephaly
ID NF-KAPPA-B; TANDEM MASS-SPECTRA; ASSOCIATION; ENVIRONMENT; ANNOTATION;
   ACTIVATION; INSIGHTS; REVEALS; GROWTH; BRAZIL
AB The recent microcephaly outbreak in Brazil has been associated with Zika virus (ZIKV) infection. The current understanding of damage caused by ZIKV infection is still unclear, since it has been implicated in other neurodegenerative and developmental complications. Here, the differential proteome analysis of human mesenchymal stem cells (hMSC) infected with a Brazilian strain of ZIKV was identified by shotgun proteomics (MudPIT). Our results indicate that ZIKV induces a potential reprogramming of the metabolic machinery in nucleotide metabolism, changes in the energy production via glycolysis and other metabolic pathways, and potentially inhibits autophagy, neurogenesis, and immune response by downregulation of signaling pathways. In addition, proteins previously described in several brain pathologies, such as Alzheimer's disease, autism spectrum disorder, amyotrophic lateral sclerosis, and Parkinson's disease, were found with altered expression due to ZIKV infection in hMSC. This potential link between ZIKV and several neuropathologies beyond microcephaly is being described here for the first time and can be used to guide specific follow-up studies concerning these specific diseases and ZIKV infection.
C1 [Beys-da-Silva, Walter O.; Santi, Lucelia] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.
   [Beys-da-Silva, Walter O.; Rosa, Rafael L.; Santi, Lucelia; Berger, Markus; Terraciano, Paula; Cirne-Lima, Elizabeth O.; Guimaraes, Jorge A.] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
   [Park, Sung Kyu; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA.
   [Campos, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, Prote Core, La Jolla, CA USA.
   [Varela, Ana Paula M.; Teixeira, Thais F.] Fundacao Univ Cardiol, Inst Cardiol, Ctr Cardiol Expt, Porto Alegre, RS, Brazil.
   [Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Dept Microbiol, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.
   [Cirne-Lima, Elizabeth O.] Univ Fed Rio Grande do Sul, Programa Posgrad Ginecol & Obstet, Porto Alegre, RS, Brazil.
   [Cirne-Lima, Elizabeth O.] Univ Fed Rio Grande do Sul, Fac Vet, Dept Patol Clin Vet, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.; Beys-da-Silva, WO; Guimaraes, JA (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.; Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br; guimar@cbiot.ufrgs.br
RI Berger, Markus/U-7682-2019; Santi, Lucelia/AAB-8349-2020; Cirne-Lima,
   Elizabeth Obino/N-9796-2018; Beys-da-Silva, Walter O/M-3760-2018;
   Terraciano, Paula B/H-1653-2015; Quincozes-Santos, Andre/AAO-2714-2020;
   Santi, Lucelia/AAK-9527-2020; Guimaraes, Jorge Almeida/V-2196-2019;
   Souza, Diogo/J-8894-2014
OI Berger, Markus/0000-0001-7670-2584; Santi, Lucelia/0000-0002-5698-7006;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Souza,
   Diogo/0000-0002-4322-0404; Campos, Alexandre/0000-0003-3988-7764;
   Quincozes-Santos, Andre/0000-0001-8611-4890
FU Brazilian funding agency Coordenacao de Aperfeicoamento Pessoal de Nivel
   Superior (CAPES)CAPES; Brazilian funding agency FAPERGSFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Brazilian funding
   agency Edital MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [14/2016,
   440763/2016-9]; NIH grantsUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH/NIHGM P41
   GM103533-22, NIH/NIMH 5 R01 MH067880-14]
FX This work was supported by the Brazilian funding agencies Coordenacao de
   Aperfeicoamento Pessoal de Nivel Superior (CAPES), FAPERGS, Edital
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No 14/2016, project 440763/2016-9.
   The study was also supported by NIH grants NIH/NIHGM P41 GM103533-22 and
   NIH/NIMH 5 R01 MH067880-14 (to JRY).
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Berger M, 2015, ARCH TOXICOL, V89, P459, DOI 10.1007/s00204-014-1264-0
   Beys-da-Silva WO, 2014, J PROTEOME RES, V13, P2282, DOI 10.1021/pr401204y
   Brahma R, 2018, VIRAL IMMUNOL, V31, P321, DOI 10.1089/vim.2017.0116
   D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Enav H, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-9
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042
   Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721
   Janssens Sylvie, 2018, mSystems, V3, DOI [10.1128/msystems.00219-17, 10.1128/mSystems.00219-17]
   Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543
   Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5
   Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036
   McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397
   McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/FMC.11.12, 10.4155/fmc.11.12]
   Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/nmeth.1195, 10.1038/NMETH.1195]
   Qimron U, 2010, MICROBE, V5, P117
   Rappaport N, 2017, NUCLEIC ACIDS RES, V45, pD877, DOI 10.1093/nar/gkw1012
   Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Santi L, 2014, J PROTEOME RES, V13, P1545, DOI 10.1021/pr401075f
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Scardoni Giovanni, 2014, F1000Res, V3, P139, DOI 10.12688/f1000research.4477.1
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q
   Terraciano P, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/720753
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Wang LZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01357-4
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Zelenaia O, 2000, MOL PHARMACOL, V57, P667
   Zomer HD, 2015, STEM CELLS CLONING, V8, P125, DOI 10.2147/SCCAA.S88036
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 50
TC 6
Z9 6
U1 3
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUL
PY 2019
VL 56
IS 7
BP 4708
EP 4717
DI 10.1007/s12035-018-1417-x
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA IT8VJ
UT WOS:000483159700007
PM 30377986
DA 2020-07-08
ER

PT J
AU Shaily, S
   Upadhya, A
AF Shaily, Sangya
   Upadhya, Archana
TI Zika virus: Molecular responses and tissue tropism in the mammalian host
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE pathophysiology; research models; tissue tropism; Zika virus
ID ORIGINAL ANTIGENIC SIN; NEURAL STEM-CELLS; STRUCTURAL BIOLOGY; NS2B-NS3
   PROTEASE; MOUSE MODEL; IN-VITRO; INFECTION; BRAIN; FETAL; TRANSMISSION
AB Zika virus (ZIKV) outbreaks have raised alarm because of reports of congenital Zika virus syndrome in infants. The virus is also known to cause the debilitating Guillain-Barre syndrome in adults. As a result, extensive research has been carried out on the virus over the past few years. To study the molecular responses of viral infectivity in mammals, in vitro two-dimensional and three-dimensional cellular models have been employed. The in vivo models of mouse, pig, chicken, and nonhuman primates are primarily used to investigate the teratogenicity of the virus, to study effects of the virus on specific tissues, and to study the systemic effects of a proposed antiviral agent. The virus exhibits wide tissue tropism in the mammalian host. The major host tissues of viral persistence and propagation are neural tissue, ocular tissue, testicular tissue and placental tissue. An understanding of the function of viral components, viral replication cycle, and the molecular responses elicited in the host tissues is imperative for designing antiviral treatment strategies and for development of vaccines. This review provides an update on ZIKV research models and mammalian host responses with respect to ZIKV tissue infection.
C1 [Shaily, Sangya; Upadhya, Archana] SVKMS NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Vile Parle W, Mumbai 400056, Maharashtra, India.
RP Upadhya, A (corresponding author), SVKMS NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Vile Parle W, Mumbai 400056, Maharashtra, India.
EM arch271@gmail.com
RI UPADHYA, ARCHANA/Q-5835-2019; UPADHYA, ARCHANA/A-4518-2016
OI UPADHYA, ARCHANA/0000-0002-6331-5179; UPADHYA,
   ARCHANA/0000-0002-6331-5179
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agrelli A, 2019, INFECT GENET EVOL, V69, P22, DOI 10.1016/j.meegid.2019.01.018
   Alfonso-Parra C, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020049
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Alves MP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110593
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Butler H, 1987, ATLAS STAGING MAMMAL, DOI [10.1201/9781351069939, DOI 10.1201/9781351069939]
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heide M, 2018, CURR OPIN CELL BIOL, V55, P8, DOI 10.1016/j.ceb.2018.06.006
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Ho BX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040936
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kalkeri Raj, 2017, F1000Res, V6, P1850, DOI 10.12688/f1000research.12695.1
   Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398
   Klein RS, 2017, CELL HOST MICROBE, V22, P9, DOI 10.1016/j.chom.2017.06.015
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kuo YP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006417
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Ma JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01350
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mruk DD, 2015, ENDOCR REV, V36, P564, DOI [10.1210/er.2014-1101, 10.1210/er.2015-1127]
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pena LJ, 2018, J GEN VIROL, V99, P1529, DOI 10.1099/jgv.0.001153
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reh TA, 2002, NAT NEUROSCI, V5, P392, DOI 10.1038/nn0502-392
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Romine J, 2015, NEUROBIOL AGING, V36, P1716, DOI 10.1016/j.neurobiolaging.2015.01.003
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Strange DP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0080-7
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   Thawani A, 2018, CELL REP, V23, P692, DOI 10.1016/j.celrep.2018.03.080
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Trus I, 2018, VIRULENCE, V9, P1338, DOI 10.1080/21505594.2018.1504558
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1890568
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang Y, 2010, VASCULAR BIOL PLACEN, V2, DOI 10.4199/C00016ED1V01Y201008ISP009
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   Xavier Analúcia R., 2017, J. Bras. Patol. Med. Lab., V53, P252, DOI 10.5935/1676-2444.20170039
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 132
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD JUL
PY 2019
VL 29
IS 4
AR e2050
DI 10.1002/rmv.2050
PG 16
WC Virology
SC Virology
GA IV4TG
UT WOS:000484264800010
PM 31095819
DA 2020-07-08
ER

PT J
AU Santiago, GA
   Sharp, TM
   Rosenberg, E
   Cardona, IIS
   Alvarado, L
   Paz-Bailey, G
   Munoz-Jordan, JL
AF Santiago, Gilberto A.
   Sharp, Tyler M.
   Rosenberg, Eli
   Sosa Cardona, Iris I.
   Alvarado, Luisa
   Paz-Bailey, Gabriela
   Munoz-Jordan, Jorge L.
TI Prior Dengue Virus Infection Is Associated With Increased Viral Load in
   Patients Infected With Dengue but Not Zika Virus
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE antibody-dependent enhancement; Puerto Rico; viral load; Zika virus
ID ENHANCEMENT
AB To evaluate potential enhancement of Zika virus (ZIKV) infection among patients with prior dengue virus (DENV) infection, we compared loads of viral RNA among patients infected with ZIKV (n = 1070), DENV-2 (n = 312), or DENV-3 (n = 260). Compared to patients without prior DENV infection, patients with prior DENV infection had significantly higher mean loads of viral RNA if infected with DENV-2 (10.6 vs 11.6 log(10) GCE/mL, respectively; t test, P < .0001) or DENV-3 (10.3 vs 10.9 log(10) GCE/mL; P < .0001), but not ZIKV (4.7 vs 4.7 log(10) GCE/mL; P = .959). These findings provide evidence against in vivo enhancement of ZIKV by anti-DENV antibodies.
C1 [Santiago, Gilberto A.; Sharp, Tyler M.; Sosa Cardona, Iris I.; Paz-Bailey, Gabriela; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR USA.
   [Sharp, Tyler M.] US PHS, Silver Spring, MD USA.
   [Rosenberg, Eli] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA.
   [Sosa Cardona, Iris I.] Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA.
   [Alvarado, Luisa] Ponce Hlth Sci Univ, San Juan, PR USA.
   [Alvarado, Luisa] San Lucas Episcopal Hosp, Ponce, PR USA.
RP Sharp, TM (corresponding author), 1324 Calle Canada, San Juan, PR 00920 USA.
EM fbz3@cdc.gov
FU US Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX This study was supported by the US Centers for Disease Control and
   Prevention.
CR Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Ramos MM, 2008, AM J TROP MED HYG, V79, P123, DOI 10.4269/ajtmh.2008.79.123
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 16
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JUL
PY 2019
VL 6
IS 7
AR UNSP ofz320
DI 10.1093/ofid/ofz320
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IR5UB
UT WOS:000481501400009
PM 31363765
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fischer, C
   de Lamballerie, X
   Drexler, JF
AF Fischer, Carlo
   de Lamballerie, Xavier
   Drexler, Jan Felix
TI Enhanced Molecular Surveillance of Chikungunya Virus
SO MSPHERE
LA English
DT Article
DE adaptive mutations; alphavirus; molecular epidemiology; vector-borne
   diseases
ID MUTATIONS; LINEAGES; SPREAD; INDIA; ZIKA; ASIA
AB Outbreaks of the emerging arbovirus chikungunya virus (CHIKV) affect millions of individuals in Asia, Africa, and Latin America. Vector competence can be changed dramatically by single amino acid exchanges located predominantly within the CHIKV E1 and E2 envelope proteins, which are associated with enhanced transmissibility by anthropophilic Aedes mosquitoes. Commonly used reference assays for molecular surveillance cover only a few adaptive mutations within the envelope domains and have not been validated for all CHIKV genotypes. The recognized landscape of CHIKV adaptive mutations is thus likely incomplete. We designed two nested reverse transcription-PCR (RT-PCR) assays that cover hot spots of viral adaptation to vectors within the E1 and E2 genomic domains. Primers were designed in conserved genomic regions to allow broad usability across CHIKV genotypes. The sensitivity of both assays was at least equivalent to E1- and E2-based reference assays and robust among CHIKV genotypes at 51.4 IU/reaction (E1, 95% confidence interval [CI], 39.8 to 78.9) and 4.0 IU/reaction (E2, 95% CI, 2.0 to 7.4). Upon analysis of the complete known CHIKV genomic diversity, up to 11 nucleotide mismatches with CHIKV variants occurred under oligonucleotide binding sites of reference assays, potentially limiting assay sensitivity, whereas no critical mismatches occurred in the new assays. Specificity testing with nine alphaviruses representing all serocomplexes showed amplification of Mayaro virus and O'nyong-nyong virus by the E1-based assay, but not by the E2-based assay. The high sensitivity and specificity of the new E2-based assay may allow its diagnostic usage in resource-limited settings. The combined new assays allow improved molecular epidemiological surveillance of CHIKV globally.
   IMPORTANCE The life cycle of arboviruses relies on efficient infection of and transmission by arthropod vectors. Adaptation to new vectors can thus dramatically increase the geographic range of an arbovirus. Several adaptive mutations enhance chikungunya virus (CHIKV) transmissibility by different mosquito species. The appearance of those adaptive mutations has led to large-scale CHIKV outbreaks in Asia, Africa, and Europe. Molecular surveillance of circulating CHIKV strains for adaptive mutations contributes to precise risk assessments and efficient vector control and provides new insight into the evolution of vector adaptation. Existing assays for molecular CHIKV surveillance are limited by poor coverage of known adaptive mutations, low sensitivity, and cost-intensive deep sequencing approaches, preventing universal application. We developed two highly sensitive nested RT-PCR assays that cover hot spots of vector adaptation in CHIKV envelope domains. The new assays allow unprecedented molecular surveillance across all CHIKV genotypes and diagnostic use in resource-limited settings globally.
C1 [Fischer, Carlo; Drexler, Jan Felix] Charite Univ Med Berlin, Inst Virol, Berlin Inst Hlth, Berlin, Germany.
   [Fischer, Carlo; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Fischer, Carlo; Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [de Lamballerie, Xavier] Aix Marseille Univ, Inserm 1207, IRD 190, IHU Mediterranee Infect,Unite Virus Emergents, Marseille, France.
   [Drexler, Jan Felix] German Ctr Infect Res, Braunschweig, Germany.
   [Drexler, Jan Felix] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
RP Drexler, JF (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin Inst Hlth, Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Humboldt Univ, Berlin, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res, Braunschweig, Germany.; Drexler, JF (corresponding author), Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
EM felix.drexler@charite.de
OI Fischer, Carlo/0000-0001-9163-2406
FU German Centre for Infection Research (DZIF) through the ZIKApath
   project; European Union's Horizon 2020 Research and Innovation Program
   through the ZIKAlliance project [734548]; German Research Foundation
   (DFG)German Research Foundation (DFG); Open Access Publication Fund of
   Charite-Universitatsmedizin Berlin
FX This work was supported by the German Centre for Infection Research
   (DZIF) through the ZIKApath project and the European Union's Horizon
   2020 Research and Innovation Program through the ZIKAlliance project
   (grant agreement no. 734548). We acknowledge support from the German
   Research Foundation (DFG) and the Open Access Publication Fund of
   Charite-Universitatsmedizin Berlin.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Collao X, 2010, AM J TROP MED HYG, V82, P505, DOI 10.4269/ajtmh.2010.09-0435
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Kreb JA, 2017, COLLABORATIVE STUDY
   Maljkovic Berry I, 2018, BIORXIV, DOI [10.1101/373316, DOI 10.1101/373316]
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Sahu A, 2013, INFECT GENET EVOL, V18, P113, DOI 10.1016/j.meegid.2013.04.037
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Vignuzzi M, 2017, ANNU REV VIROL, V4, P181, DOI 10.1146/annurev-virology-101416-041757
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 25
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JUL-AUG
PY 2019
VL 4
IS 4
AR e00295-19
DI 10.1128/mSphere.00295-19
PG 7
WC Microbiology
SC Microbiology
GA IU1ES
UT WOS:000483320200017
PM 31270168
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU De Jesus, JG
   Giovanetti, M
   Faria, NR
   Alcantara, LC
AF De Jesus, Jaqueline Goes
   Giovanetti, Marta
   Faria, Nuno Rodrigues
   Alcantara, Luiz Carlos Junior
TI Acute Vector-Borne Viral Infection:Zika and MinION Surveillance
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID ZIKA VIRUS-INFECTIONS; YELLOW-FEVER; ARBOVIRUS INFECTIONS;
   NUCLEOTIDE-SEQUENCE; EPIDEMIC; OUTBREAK; TRANSMISSION; CHIKUNGUNYA;
   ANTIBODIES; MOSQUITOS
AB The MinION sequencer was launched by the Oxford Nanopore Technologies start-up as a disruptive technology for genome sequencing based on single-molecule synthesis. Its characteristics as a portable device, low cost, and simple library preparation have made it a good candidate for field researchers. MinION has been used to sequence a number of microorganisms, such as bacteria, viruses, and fungi. Based on the experience that characterized the Ebola virus genetic diversity in Guinea during the 2014-2015 outbreak, the ZiBRA (Zika in Brazil Real-time Analysis) project aimed to sequence a large number of Zika virus genomes during a mobile laboratory trip in northeast Brazil to provide important epidemiological information about the spread of this disease in this country. In response to the positive and rapid results obtained by the ZiBRA project, the Brazilian Ministry of Health and many leading institutions, such as the Pan American Health Organization and WHO, have shown interest in expanding the strategy used in this project to other countries dealing with arbovirus infection.
C1 [De Jesus, Jaqueline Goes] Fundacao Oswaldo Cruz, Lab Expt Pathol, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com
RI Giovanetti, Marta/AAK-7408-2020
OI Alcantara, Luiz/0000-0002-6769-9931
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Ambardar S, 2016, INDIAN J MICROBIOL, V56, P394, DOI 10.1007/s12088-016-0606-4
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298
   Balasubramanian S, 2011, CHEM COMMUN, V47, P7281, DOI 10.1039/c1cc11078k
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V21, P27
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V6, P47
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003
   HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   Meinel DM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.010
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324
   Min Jou W, 1972, Nature, V237, P82
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nilakanta Haema, 2014, BMC Res Notes, V7, P830, DOI 10.1186/1756-0500-7-830
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003
   Plesivkova D, 2019, WIRES FORENSIC SCI, V1, pe1323, DOI [10.1002/wfs2.1323, DOI 10.1002/WFS2.1323]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   SANGER F., 1965, J MOL BIOL, V13, P373
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P376
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   WU R, 1968, J MOL BIOL, V35, P523, DOI 10.1016/S0022-2836(68)80012-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUL
PY 2019
VL 7
IS 4
AR UNSP AME-0008-2019
DI 10.1128/microbiolspec.AME-0008-2019
PG 11
WC Microbiology
SC Microbiology
GA IT2VO
UT WOS:000482711900003
PM 31400093
OA Bronze
DA 2020-07-08
ER

PT J
AU Moreira, MWL
   Rodrigues, JJPC
   Carvalho, FHC
   Al-Muhtadi, J
   Kozlov, S
   Rabelo, RAL
AF Moreira, Mario W. L.
   Rodrigues, Joel J. P. C.
   Carvalho, Francisco H. C.
   Al-Muhtadi, Jalal
   Kozlov, Sergey
   Rabelo, Ricardo A. L.
TI Classification of risk areas using a bootstrap-aggregated ensemble
   approach for reducing Zika virus infection in pregnant women
SO PATTERN RECOGNITION LETTERS
LA English
DT Article
DE Artificial intelligence; Epidemic risk areas recognition;
   Cross-validation; Ensemble learning
ID AEDES-AEGYPTI; DENGUE; EPIDEMIC; SPREAD; CARE
AB The Zika (ZIKV) virus has been a potential cause for the birth of children with microcephaly. This situation is unprecedented all over the world, presenting a small number of records in the medical literature. The latest ZIKV epidemic confirms the potential risk of international propagation of mosquito-borne diseases, especially the Aedes albopictus and aegypti species. Therefore, a strategy that aims to define priority areas for intervention is critical to contributing to the prevention and control of these diseases. Hence, this paper proposes the use of an ensemble learning technique, named bootstrap-aggregated ensemble of fine decision trees, to identify epidemic risk areas, reducing its impact on the population, principally in pregnant women. The study analyzed reported cases of ZIKV (n = 112) in Recife, Brazil, during 2015 and 2016. The identification of mosquito activity areas can guarantee a healthy formation for the fetus during and after the gestation through implementation strategies of public policies and further study to control the mosquito vector responsible for these diseases. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Moreira, Mario W. L.; Rodrigues, Joel J. P. C.] Univ Beira Interior, Inst Telecomunicacoes, Covilha, Portugal.
   [Moreira, Mario W. L.] Fed Inst Educ Sci & Technol Ceara IFCE, Aracati, CE, Brazil.
   [Rodrigues, Joel J. P. C.] Natl Inst Telecommun Inatel, Av Joao de Camargo,510 Ctr, BR-37540000 Santa Rita Do Sapucai, MG, Brazil.
   [Rodrigues, Joel J. P. C.; Rabelo, Ricardo A. L.] Univ Fed Piaui, Teresina, PI, Brazil.
   [Rodrigues, Joel J. P. C.; Al-Muhtadi, Jalal] King Saud Univ, Coll Comp & Informat Sci, Riyadh 12372, Saudi Arabia.
   [Rodrigues, Joel J. P. C.; Kozlov, Sergey] ITMO Univ, St Petersburg, Russia.
   [Carvalho, Francisco H. C.] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
RP Rodrigues, JJPC (corresponding author), Natl Inst Telecommun Inatel, Av Joao de Camargo,510 Ctr, BR-37540000 Santa Rita Do Sapucai, MG, Brazil.
EM joeljr@ieee.org
RI Rodrigues, Joel J. P. C./A-8103-2013; Moreira, Mario W. L./J-8961-2019;
   de Andrade Lira Rabelo, Ricardo/AAN-3551-2020
OI Rodrigues, Joel J. P. C./0000-0001-8657-3800; Moreira, Mario W.
   L./0000-0002-3463-8112; de Andrade Lira Rabelo,
   Ricardo/0000-0003-1482-6404
FU FCT - Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for
   Science and Technology [UID/EEA/50008/2019]; Government of Russian
   Federation [08-08]; RNP, under the Centro de Referencia em
   Radiocomunicacoes - CRR project of the Instituto Nacional de
   Telecomunicacoes (Inatel), Brazil [01250.075413/2018-04]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)CAPES
   [001]; Brazilian National Council for Research and Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [309335/2017-5]; Ciencia sem Fronteiras of CNPq, Brazil
   [207706/2014-0]; International Scientific Partnership Program ISPP at
   King Saud University through ISPP [0129]
FX This work was supported by national funding from the FCT - Fundacao para
   a Ciencia e a Tecnologia through the UID/EEA/50008/2019 Project; by the
   Government of Russian Federation, Grant 08-08; by RNP, with resources
   from MCTIC, grant no. 01250.075413/2018-04, under the Centro de
   Referencia em Radiocomunicacoes - CRR project of the Instituto Nacional
   de Telecomunicacoes (Inatel), Brazil; by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -Finance
   Code 001; by Brazilian National Council for Research and Development
   (CNPq) via grant no. 309335/2017-5; by Ciencia sem Fronteiras of CNPq,
   Brazil, through the process number 207706/2014-0; and by the
   International Scientific Partnership Program ISPP at King Saud
   University through ISPP #0129.
CR Abelha A, 2015, INT J E-HEALTH MED C, V6, P10, DOI 10.4018/IJEHMC.2015040102
   Alkhatib R., 2015, J COMPUTER COMMUNICA, V3, P13
   Bisanzio D., 2018, PLOS NEGLECT TROP D, V12, P1
   Carter JV, 2016, SURGERY, V159, P1638, DOI 10.1016/j.surg.2015.12.029
   Cavalcanti LP, 2017, REV MED UFC, V57, P30
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Deng BC, 2015, ANAL CHIM ACTA, V880, P32, DOI 10.1016/j.aca.2015.04.045
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Hafeez S, 2017, SPAT SPATIO-TEMPORAL, V21, P77, DOI 10.1016/j.sste.2017.04.001
   Hu F, 2016, STATISTICS-ABINGDON, V50, P733, DOI 10.1080/02331888.2016.1143473
   Jiang D, 2018, ACTA TROP, V185, P391, DOI 10.1016/j.actatropica.2018.06.021
   Latifi F, 2016, INT J E-HEALTH MED C, V7, P52, DOI 10.4018/IJEHMC.2016070104
   Lin CH, 2016, STOCH ENV RES RISK A, V30, P2057, DOI 10.1007/s00477-014-0940-1
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   MAGALHAES T, 2017, PLOS NEGLECT TROP D, V26, P1
   Mathan K, 2018, DES AUTOM EMBED SYST, V22, P225, DOI 10.1007/s10617-018-9205-4
   Mordelet F, 2014, PATTERN RECOGN LETT, V37, P201, DOI 10.1016/j.patrec.2013.06.010
   Moreira M.W., 2019, IEEE SYST J
   Morgan AJ, 2015, INT J E-HEALTH MED C, V6, P58, DOI 10.4018/IJEHMC.2015010105
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   O'Reilly K, 2018, INT J INFECT DIS, V73, P49, DOI 10.1016/j.ijid.2018.04.3535
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Rossi G, 2018, SPAT SPATIO-TEMPORAL, V26, P113, DOI 10.1016/j.sste.2018.06.002
   Sendra S, 2018, INFORM FUSION, V40, P76, DOI 10.1016/j.inffus.2017.06.002
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Song Yan-Yan, 2015, Shanghai Arch Psychiatry, V27, P130, DOI 10.11919/j.issn.1002-0829.215044
   Streimelweger B, 2016, INT J E-HEALTH MED C, V7, P16, DOI 10.4018/IJEHMC.2016070102
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 31
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-8655
EI 1872-7344
J9 PATTERN RECOGN LETT
JI Pattern Recognit. Lett.
PD JUL 1
PY 2019
VL 125
BP 289
EP 294
DI 10.1016/j.patrec.2019.04.020
PG 6
WC Computer Science, Artificial Intelligence
SC Computer Science
GA IS8CA
UT WOS:000482374500040
DA 2020-07-08
ER

PT J
AU Zhao, LM
   Alto, BW
   Jiang, YX
   Yu, FH
   Zhang, YP
AF Zhao, Liming
   Alto, Barry W.
   Jiang, Yongxing
   Yu, Fahong
   Zhang, Yanping
TI Transcriptomic Analysis of Aedes aegypti Innate Immune System in
   Response to Ingestion of Chikungunya Virus
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Aedes aegypti; transcriptome; immune responses; chikungunya virus;
   anti-microbial peptide; gene expression
ID MOSQUITO ANOPHELES-GAMBIAE; DIPTERA-CULICIDAE; INFECTION; GENE;
   TRANSMISSION; EXPRESSION; PROTEIN; VECTOR; IDENTIFICATION; DEFENSIN
AB Aedes aegypti (L.) is the primary vector of emergent mosquito-borne viruses, including chikungunya, dengue, yellow fever, and Zika viruses. To understand how these viruses interact with their mosquito vectors, an analysis of the innate immune system response was conducted. The innate immune system is a conserved evolutionary defense strategy and is the dominant immune system response found in invertebrates and vertebrates, as well as plants. RNA-sequencing analysis was performed to compare target transcriptomes of two Florida Ae. aegypti strains in response to chikungunya virus infection. We analyzed a strain collected from a field population in Key West, Florida, and a laboratory strain originating from Orlando. A total of 1835 transcripts were significantly expressed at different levels between the two Florida strains of Ae. aegypti. Gene Ontology analysis placed these genes into 12 categories of biological processes, including 856 transcripts (up/down regulated) with more than 1.8-fold (p-adj (p-adjust value) <= 0.01). Transcriptomic analysis and q-PCR data indicated that the members of the AaeCECH genes are important for chikungunya infection response in Ae. aegypti. These immune-related enzymes that the chikungunya virus infection induces may inform molecular-based strategies for interruption of arbovirus transmission by mosquitoes.
C1 [Zhao, Liming; Alto, Barry W.] Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
   [Jiang, Yongxing] Mosquito Control Serv, 405 NW 39th Ave Gainesville, Gainesville, FL 32609 USA.
   [Yu, Fahong; Zhang, Yanping] Univ Florida, Interdisciplinary Ctr Biotechnol Res, 2033 Mowry Rd, Gainesville, FL 32611 USA.
RP Zhao, LM (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
EM lmzhao@ufl.edu
FU Florida Department of Agriculture and Consumer Services [024246, 023557,
   020190, 021090, 020180, 021803, 022399]
FX This research was funded by the Florida Department of Agriculture and
   Consumer Services: Contract Numbers 024246, 023557, 020190, and 021090
   to Jorge Rey and Contract Number 020180 to Walter Tabachnick, Contract
   Numbers 021803 and 022399 to Liming Zhao and Barry W. Alto.
CR Aloor JJ, 2019, J BIOL CHEM, V294, P1997, DOI 10.1074/jbc.RA118.004300
   Amdekar S, 2017, VIRAL IMMUNOL, V30, P691, DOI 10.1089/vim.2017.0052
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253
   Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x
   Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004
   Bartholomay LC, 2018, ANNU REV ENTOMOL, V63, P145, DOI 10.1146/annurev-ento-010715-023530
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Ciocchetta S, 2018, PATHOG GLOB HEALTH, V112, P107, DOI 10.1080/20477724.2018.1464780
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115
   Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619
   Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Flajnik MF, 2018, NAT REV IMMUNOL, V18, P438, DOI 10.1038/s41577-018-0003-9
   Gaburro J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31608-x
   Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   HOUK EJ, 1981, ACTA TROP, V38, P163
   Hua C, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0694-0
   Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275
   Kim CH, 2013, J INSECT PHYSIOL, V59, P604, DOI 10.1016/j.jinsphys.2013.03.010
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Kumar A, 2018, INSECTS, V9, DOI 10.3390/insects9030095
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x
   Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009
   Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824
   Portereiko MF, 2006, PLANT PHYSIOL, V141, P957, DOI 10.1104/pp.106.079319
   Powers AM, 2016, J INFECT DIS, V214, pS449, DOI 10.1093/infdis/jiw382
   Ruiz VMR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214753
   Shin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-513
   Shrinet J, 2017, BIOCHEM BIOPH RES CO, V492, P617, DOI 10.1016/j.bbrc.2017.01.162
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Soares TS, 2018, BIOCHIMIE, V144, P160, DOI 10.1016/j.biochi.2017.11.005
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Sudeep AB, 2017, J VECTOR DIS, V54, P295, DOI 10.4103/0972-9062.225833
   Tchetgna HS, 2018, INTERVIROLOGY, V61, P174, DOI 10.1159/000495136
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Wang HD, 2017, INSECT BIOCHEM MOLEC, V91, P10, DOI 10.1016/j.ibmb.2017.10.002
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yan Y, 2019, INSECT BIOCHEM MOLEC, V107, P1, DOI 10.1016/j.ibmb.2019.01.007
   Yao JQ, 2011, BIOINFORMATION, V7, P44
   Zhao LM, 2008, J MED ENTOMOL, V45, P401, DOI 10.1603/0022-2585(2008)45[401:CCGAPE]2.0.CO;2
   Zhao LM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030615
   Zhao LM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090470
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
   Zhao LM, 2017, J MED ENTOMOL, V54, P878, DOI 10.1093/jme/tjw244
NR 59
TC 0
Z9 0
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 1
PY 2019
VL 20
IS 13
AR 3133
DI 10.3390/ijms20133133
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IL1EG
UT WOS:000477041100021
PM 31252518
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hasan, S
   Saeed, S
   Panigrahi, R
   Choudhary, P
AF Hasan, Shamimul
   Saeed, Shazina
   Panigrahi, Rajat
   Choudhary, Priyadarshini
TI Zika Virus: A Global Public Health Menace: A Comprehensive Update
SO JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY
LA English
DT Review
DE Guillain-Barre syndrome; microcephaly; pregnancy; public health menace;
   zika virus
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; YELLOW-FEVER;
   OUTBREAK; INFECTION; PREGNANCY; IMPACT; DENGUE; IMMUNOGENICITY
AB Zika virus (ZIKV) is a RNA virus and belongs to genus Flavivirus and family Flaviviridae. The virus was first discovered from a febrile primate from the Zika forests of Uganda in 1947 and the first human case was documented in 1954. The nonspecific clinical manifestations of ZIKV pose diagnostic dilemmas and delays early and effective treatment. Dental professionals should have a thorough knowledge about the virus and should follow standard infection control measures as the virus has been demonstrated in various body secretions (including salivary secretions). The disease is managed by symptomatic and supportive care and no vaccine exist till date. Recent ZIKV outbreaks and increase association of microcephaly with congenital ZIKV and neurological complications (Guillain-Barre syndrome) has drawn global public health attention. The World Health Organization declared it a public health emergency of international concern in 2016. This review article provides a detailed overview on ZIKV; it is clinical and oral manifestations, diagnostic aids, differential diagnosis, preventive aspects, and management protocol.
C1 [Hasan, Shamimul] Jamia Millia Islamia, Dept Oral Med & Radiol, Fac Dent, New Delhi, India.
   [Saeed, Shazina] Amity Univ, Amity Inst Publ Hlth, Noida, Uttar Pradesh, India.
   [Panigrahi, Rajat] SOA Univ, Inst Dent Sci, Dept Oral Med & Radiol, Bhubaneswar, Odisha, India.
   [Choudhary, Priyadarshini] KIIT Univ, Kalinga Inst Dent Sci, Dept Oral Med & Radiol, Bhubaneswar, Odisha, India.
RP Hasan, S (corresponding author), C-4 Duplex Quarters, Aligarh, Uttar Pradesh, India.
EM shamim0571@gmail.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   Cadu R, 2015, HEALTH, V386, P243
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, CDC HLTH ADV REC MAN
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2018, J TRAVEL MED, V25, P1, DOI DOI 10.1093/JTM/TAX097
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Dibo MR, 2011, REV SOC BRAS MED TRO, V44, P496, DOI 10.1590/S0037-86822011000400019
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jamieson DJ, 2011, AM J OBSTET GYNECOL, V204, pS1, DOI 10.1016/j.ajog.2011.04.010
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li R, 2017, RADIOL INFECT DIS, V4, P88, DOI [10.1016/j.jrid.2017.01.002, DOI 10.1016/J.JRID.2017.01.002]
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, B INFORM SANITAIRES, V20-21, P367
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Marques GR, 1998, OVERVIEW ARBOVIROLOG, P248
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Matthews A, 2016, PHARMACOEPIDEM DR S, V25, P40
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meghani Z, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006501
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399
   Ministry of Health. Secretariat of Health Surveillance. Department of Surveillance of Communicable Diseases, 2015, SURV PROT RESP OCC M, P55
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paniz-Mondolfi AE, 2019, CLIN EXP DERMATOL, V44, P13, DOI 10.1111/ced.13793
   Perry H, 2017, BRIT MED BULL, V124, P157, DOI 10.1093/bmb/ldx038v1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Report S, 2017, ZIK VIR MICR GUILL B
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sato H., 2010, RAPID COMMUNICATIONS, V15, P19455
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Shakib K, 2016, BRIT J ORAL MAX SURG, V54, P355, DOI 10.1016/j.bjoms.2016.02.001
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Siqueira WL, 2016, ORAL HLTH, P1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thompson SJ, 2017, ECOHEALTH, V14, P821, DOI 10.1007/s10393-017-1277-2
   Tomba GS, 2008, MATH BIOSCI, V214, P70, DOI 10.1016/j.mbs.2008.02.009
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 94
TC 1
Z9 1
U1 2
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2231-0762
EI 2250-1002
J9 J INT SOC PREV COMMU
JI J. Int. Soc. Prev. Community Dent.
PD JUL-AUG
PY 2019
VL 9
IS 4
BP 316
EP 327
DI 10.4103/jispcd.JISPCD_433_18
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA IT0FT
UT WOS:000482522800002
PM 31516865
OA Green Published
DA 2020-07-08
ER

PT J
AU Safadi, MAP
   Almeida, FJ
AF Palazzi Safadi, Marco Aurelio
   Almeida, Flavia J.
TI The Zika Virus Epidemic Four Years After: Where are We?
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Editorial Material
ID UPDATE
C1 [Palazzi Safadi, Marco Aurelio; Almeida, Flavia J.] Santa Casa Sao Paulo Sch Med Sci, Dept Pediat, Alameda Indigenas 228, BR-04059060 Sao Paulo, Brazil.
RP Safadi, MAP (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Dept Pediat, Alameda Indigenas 228, BR-04059060 Sao Paulo, Brazil.
EM masafadi@uol.com.br
RI safadi, marco aurelio palazzi/B-7157-2015
OI safadi, marco aurelio palazzi/0000-0002-4401-9446
CR [Anonymous], ZIK VIR
   BRASIL. Ministerio da SaUde. Secretaria de em SaUde, 2019, B EPIDEMIOLOGICO
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Kimberlin D W, 2018, RED BOOK 2018 2021 R, P894
   Ministerio da Saude, B EP
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Safadi MAP, 2017, PEDIATR INFECT DIS J, V36, P333, DOI 10.1097/INF.0000000000001449
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
NR 14
TC 0
Z9 0
U1 0
U2 1
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD JUL
PY 2019
VL 36
SU 2
BP S4
EP S8
DI 10.1055/s-0039-1691769
PG 5
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA IS7DT
UT WOS:000482311200002
PM 31238350
OA Bronze
DA 2020-07-08
ER

PT J
AU Langerak, T
   Brinkman, T
   Mumtaz, N
   Arron, G
   Hermelijn, S
   Baldewsingh, G
   Wongsokarijo, M
   Resida, L
   Rockx, B
   Koopmans, MPG
   van Gorp, ECM
   Vreden, S
AF Langerak, Thomas
   Brinkman, Tom
   Mumtaz, Noreen
   Arron, Georgina
   Hermelijn, Sandra
   Baldewsingh, Gaitree
   Wongsokarijo, Merril
   Resida, Lesley
   Rockx, Barry
   Koopmans, Marion P. G.
   van Gorp, Eric C. M.
   Vreden, Stephen
TI Zika Virus Seroprevalence in Urban and Rural Areas of Suriname, 2017
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; seroprevalence; Suriname; flaviviruses
AB In 2015-2016, a Zika virus (ZIKV) outbreak occurred in the Americas. In 2017, we conducted a ZIKV serosurvey in Suriname in which 770 participants were recruited from 1 urban area and 2 rural villages in the tropical rainforest. All collected samples were tested for presence of ZIKV antibodies using a ZIKV immunoglobulin G enzyme-linked immunosorbent assay and a virus neutralization assay. We found that 35.1% of the participants had neutralizing antibodies against ZIKV. In 1 remote village in the rainforest, 24.5% of the participants had neutralizing antibodies against ZIKV, suggesting that ZIKV was widely spread across Suriname.
C1 [Langerak, Thomas; Brinkman, Tom; Mumtaz, Noreen; Arron, Georgina; Rockx, Barry; Koopmans, Marion P. G.; van Gorp, Eric C. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Hermelijn, Sandra] Acad Hosp Paramaribo, Dept Microbiol, Paramaribo, Suriname.
   [Baldewsingh, Gaitree] Med Zending Primary Hlth Care Suriname, Paramaribo, Suriname.
   [Wongsokarijo, Merril; Resida, Lesley] Bur Publ Hlth, Paramaribo, Suriname.
   [Vreden, Stephen] Acad Hosp Paramaribo, Dept Internal Med, Paramaribo, Suriname.
RP Vreden, S (corresponding author), Acamed Hosp Paramaribo, Flustr, Paramaribo, Suriname.
EM stephenvreden@yahoo.com
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312; Langerak,
   Thomas/0000-0003-4340-1560
FU European Union's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance grant) [734548]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme (under ZIKAlliance grant agreement
   number 734548).
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Pan American Health Organization/ World Health Organization, 2017, ZIK EP REP SUR
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
NR 14
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 1
PY 2019
VL 220
IS 1
BP 28
EP 31
DI 10.1093/infdis/jiz063
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IS7UF
UT WOS:000482354100006
PM 30753538
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yoshikawa, FSY
   Pietrobon, AJ
   Branco, ACCC
   Pereira, NZ
   Oliveira, LMD
   Machado, CM
   Duarte, AJD
   Sato, MN
AF Yamada Yoshikawa, Fabio Seiti
   Pietrobon, Anna Julia
   Calvielli Castelo Branco, Anna Claudia
   Pereira, Natalli Zanete
   da Silva Oliveira, Luanda Mara
   Machado, Clarisse Martins
   da Silva Duarte, Alberto Jose
   Sato, Maria Notomi
TI Zika Virus Infects Newborn Monocytes Without Triggering a Substantial
   Cytokine Response
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; flavivirus; viral entry receptors; newborn; monocytes
ID PATTERN-RECOGNITION RECEPTORS; CLEC5A; CELLS; ACTIVATION; EXPRESSION;
   TARGET
AB Zika virus (ZIKV) is a clinically important flavivirus that can cause neurological disturbances in newborns. Here, we investigated comparatively the outcome of in vitro infection of newborn monocytes by ZIKV. We observed that neonatal cells show defective production of interleukin 1 beta, interleukin 10, and monocyte chemoattractant protein 1 in response to ZIKV, although they were as efficient as adult cells in supporting viral infection. Although CLEC5A is a classical flavivirus immune receptor, it is not essential to the cytokine response, but it regulates the viral load only in adult cells. Greater expression of viral entry receptors may create a favorable environment for viral invasion in neonatal monocytes. We are the first to suggest a role for CLEC5A in human monocyte infectivity and to show that newborn monocytes are interesting targets in ZIKV pathogenesis, owing to their ability to carry the virus with only a partial triggering of the immune response, creating a potentially favorable environment for virus-related pathologies in young individuals.
C1 [Yamada Yoshikawa, Fabio Seiti; Pietrobon, Anna Julia; Calvielli Castelo Branco, Anna Claudia; Pereira, Natalli Zanete; da Silva Oliveira, Luanda Mara; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Fac Med, Inst Med Trop, Lab Invest Dermatol & Imunodeficiencias, Sao Paulo, Brazil.
   [Pietrobon, Anna Julia; Calvielli Castelo Branco, Anna Claudia; Pereira, Natalli Zanete; Sato, Maria Notomi] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil.
   [Machado, Clarisse Martins] Univ Sao Paulo, Inst Med Trop, Lab Virol, Sao Paulo, Brazil.
RP Sato, MN (corresponding author), Univ Sao Paulo, Sch Med, Inst Trop Med, Lab Dermatol & Immunodeficiencies, LIM-56,Ave Dr Eneas de Carvalho Aguiar 500,3rd Fl, BR-05403000 Sao Paulo, Brazil.
EM marisato@usp.br
RI Yoshikawa, Fabio Seiti Yamada/F-3049-2014; Sato, Maria N/C-2853-2012;
   Sato, Maria N/C-1196-2012; Pereira, Natalli Zanete/U-7291-2019
OI Yoshikawa, Fabio Seiti Yamada/0000-0002-6112-7107; Sato, Maria
   N/0000-0002-7911-1824; Pereira, Natalli Zanete/0000-0002-8875-9470
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2016/16840-6, 2016/09764-1]
FX This work was supported by the Sao Paulo Research Foundation (grants
   2016/16840-6 and 2016/09764-1).
CR Aarreberg LD, 2018, MBIO, V9, DOI 10.1128/mBio.00342-18
   Castillo JA, 2019, ARCH IMMUNOL THER EX, V67, P27, DOI 10.1007/s00005-018-0525-7
   Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bordi L, 2017, ADV EXP MED BIOL, V972, P61, DOI 10.1007/5584_2016_187
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00356-3
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682
   Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646
   Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009
   Lo YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166474
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McGrath-Morrow SA, 2018, J BIOL CHEM, V293, P11772, DOI 10.1074/jbc.RA118.003589
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661
   Nikitina E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092821
   Normann E, 2010, AM J REPROD IMMUNOL, V63, P66, DOI 10.1111/j.1600-0897.2009.00767.x
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355
   Perry H, 2017, BRIT MED BULL, V124, P157, DOI 10.1093/bmb/ldx038v1
   Plato A, 2015, SEMIN IMMUNOPATHOL, V37, P97, DOI 10.1007/s00281-014-0462-4
   ROTH P, 1992, J PEDIATR-US, V121, P285, DOI 10.1016/S0022-3476(05)81205-3
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Slavica L, 2013, J LEUKOCYTE BIOL, V94, P1003, DOI 10.1189/jlb.1212617
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Teng OIE, 2017, J VIROL, V91, DOI 10.1128/JVI.01813-16
   Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005
   Valero N, 2014, VIRAL IMMUNOL, V27, P151, DOI 10.1089/vim.2013.0123
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Walter LT, 2018, MOL NEUROBIOL, V55, P1620, DOI 10.1007/s12035-017-0442-5
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591
NR 50
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 1
PY 2019
VL 220
IS 1
BP 32
EP 40
DI 10.1093/infdis/jiz075
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IS7UF
UT WOS:000482354100007
PM 30785182
DA 2020-07-08
ER

PT J
AU Singh, PK
   Singh, S
   Farr, D
   Kumar, A
AF Singh, Pawan Kumar
   Singh, Sneha
   Farr, Dustin
   Kumar, Ashok
TI Interferon-stimulated gene 15 (ISG15) restricts Zika virus replication
   in primary human corneal epithelial cells
SO OCULAR SURFACE
LA English
DT Article
DE Antiviral; Cornea; Dengue virus; Innate immune response; ISG15; Zika
   virus
ID MOUSE MODEL; INFECTION; TRANSMISSION; DENGUE; RISK; PROTEIN
AB Purpose: Zika virus (ZIKV) has emerged as an important human pathogen causing ocular complications. There have been reports of the shedding of ZIKV in human as well as animal tears. In this study, we investigated the infectivity of ZIKV in corneal epithelial cells and their antiviral immune response.
   Methods: Primary human corneal epithelial cells (Pr. HCECs) and an immortalized cell line (HUCL) were infected with two different strains of ZIKV (PRVABC59 & BeH823339) or dengue virus (DENY, serotypes 1-4). Viral infectivity was assessed by immunostaining of viral antigen and plaque assay. qRT-PCR and immunoblot analyses were used to assess the expression of innate inflammatory and antiviral genes. Supplementation of recombinant ISG15 (rISG15) and gene silencing approaches were used to elucidate the role of ISG15 in corneal antiviral defense.
   Results: Pr. HCECs, but not the HUCL cells, were permissive to both ZIKV strains and specifically to DENV3 infection. ZIKV induced the expression of viral recognition receptors (TLR3, RIG-I, & MDA5), and genes involved in inflammatory (CXCL10 & CCL5) and antiviral (IFNs, MX1, OAS2, ISG15) responses in Pr. HCECs. Furthermore, ZIKV infection caused Pr. HCECs cell death, as evidenced by TUNEL staining. Silencing of ISG15 increased ZIKV infectivity while supplementation with rISG15 reduced ZIKV infection by direct inactivation of ZIKV and inhibiting its entry.
   Conclusions: Our study demonstrates for the first time, that ZIKV can readily infect and replicate in Pr. HCECs. Therefore, ZIKV may persist in the cornea and pose the potential risk of transmission via corneal transplantation.
C1 [Singh, Pawan Kumar; Singh, Sneha; Kumar, Ashok] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48201 USA.
   [Farr, Dustin; Kumar, Ashok] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA.
RP Kumar, A (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, 4717 St Antoine, Detroit, MI 48201 USA.
EM akuma@med.wayne.edu
OI Singh, Pawan Kumar/0000-0001-5517-1120
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI135583, R01EY026964, R01EY02738,
   P30EY004068]; Research to Prevent Blindness Inc.Research to Prevent
   Blindness (RPB)
FX This study was supported by NIH grants R21AI135583, R01EY026964, &
   R01EY02738 (to A.K.). Our research is also supported in part by an
   unrestricted grant to the Kresge Eye Institute from Research to Prevent
   Blindness Inc. The immunology resource core is supported by an NIH
   center grant P30EY004068. The authors would like to thank other members
   of the lab for their helpful discussion and editing the final
   manuscript.
CR Bandyopadhyay D, 2018, EUR J INTERN MED, V47, pE18, DOI 10.1016/j.ejim.2017.06.016
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blitvich BJ, 2016, AM J TROP MED HYG, V95, P1185, DOI 10.4269/ajtmh.16-0256
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chugh PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104770
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   De Moraes CG, 2018, JMM CASE REP, V5, pe005145
   Dong C, 2017, INVEST OPHTH VIS SCI, V58, P2948, DOI 10.1167/iovs.17-21476
   Eslani M, 2014, INVEST OPHTH VIS SCI, V55, P6108, DOI 10.1167/iovs.14-14736
   Franca T.L.B., 2018, INT J ENV RES PUBLIC, V15
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776
   Grazel R, 2018, ADV NEONAT CARE, V18, P350, DOI 10.1097/ANC.0000000000000557
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hassan SS, 2008, ARCH OPHTHALMOL-CHIC, V126, P235, DOI 10.1001/archophthalmol.2007.45
   He M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00722
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Janani MK, 2018, CORNEA, V37, P1586, DOI 10.1097/ICO.0000000000001706
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Joob Beuy, 2018, Innov Clin Neurosci, V15, P12
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x
   Kumar A, 2004, INVEST OPHTH VIS SCI, V45, P3513, DOI 10.1167/iovs.04-0467
   Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572
   Lenschow DJ, 2010, VIRUSES-BASEL, V2, P2154, DOI 10.3390/v2102154
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mittal R, 2017, JAMA OTOLARYNGOL HEA, V144
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Moshfeghi DM, 2016, JAMA OPHTHALMOLOGY, V134
   Nagaraj Kalpana Badami, 2014, Middle East Afr J Ophthalmol, V21, P347, DOI 10.4103/0974-9233.142276
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Parthasarathy D, 2018, INFLAMM RES, V67, P555, DOI 10.1007/s00011-018-1148-5
   Peloggia A, 2018, INT J GYNAECOL OBSTE, V143
   Peters R, 2018, CLIN MICROBIOL INFEC, P25
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Remeijer L, 2001, LANCET, V357, P442, DOI 10.1016/S0140-6736(00)04011-3
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robert PYR, 2005, CLIN LAB, V51, P419
   Sabouri AH, 2014, BRAIN RES, V1574, P84, DOI 10.1016/j.brainres.2014.05.049
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Sejvar James J, 2018, Continuum (Minneap Minn), V24, P1512, DOI 10.1212/CON.0000000000000652
   Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010
   Singh PK, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.34
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119541
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Taylor JL, 1996, J INTERF CYTOK RES, V16, P937, DOI 10.1089/jir.1996.16.937
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu S, 2017, ANTIVIR RES, V145, P70, DOI 10.1016/j.antiviral.2017.07.012
NR 69
TC 5
Z9 6
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1542-0124
EI 1937-5913
J9 OCUL SURF
JI Ocul. Surf.
PD JUL
PY 2019
VL 17
IS 3
BP 551
EP 559
DI 10.1016/j.jtos.2019.03.006
PG 9
WC Ophthalmology
SC Ophthalmology
GA IS4IB
UT WOS:000482115800024
PM 30905842
DA 2020-07-08
ER

PT J
AU Malik, HAM
   Abid, F
   Mahmood, N
   Wahiddin, MR
   Malik, A
AF Malik, Hafiz Abid Mahmood
   Abid, Faiza
   Mahmood, Nadeem
   Wahiddin, Mohamed Ridza
   Malik, Asif
TI Nature of Complex Network of Dengue Epidemic as a Scale-Free Network
SO HEALTHCARE INFORMATICS RESEARCH
LA English
DT Article
DE Dengue Virus; Arboviruse; Epidemics; Big Data; Network Meta-Analysis
ID BEHAVIOR
AB Objectives: Dengue epidemic is a dynamic and complex phenomenon that has gained considerable attention due to its injurious effects. The focus of this study is to statically analyze the nature of the dengue epidemic network in terms of whether it follows the features of a scale-free network or a random network. Methods: A multifarious network of Aedes aegypti is addressed keeping the viewpoint of a complex system and modelled as a network. The dengue network has been transformed into a one-mode network from a two-mode network by utilizing projection methods. Furthermore, three network features have been analyzed, the power-law, clustering coefficient, and network visualization. In addition, five methods have been applied to calculate the global clustering coefficient. Results: It has been observed that dengue epidemic follows a power-law, with the value of its exponent gamma = -2.1. The value of the clustering coefficient is high for dengue cases, as weight of links. The minimum method showed the highest value among the methods used to calculate the coefficient. Network visualization showed the main areas. Moreover, the dengue situation did not remain the same throughout the observed period. Conclusions: The results showed that the network topology exhibits the features of a scale-free network instead of a random network. Focal hubs are highlighted and the critical period is found. Outcomes are important for the researchers, health officials, and policy makers who deal with arbovirus epidemic diseases. Zika virus and Chikungunya virus can also be modelled and analyzed in this manner.
C1 [Malik, Hafiz Abid Mahmood] AMA Int Univ, Dept Comp Sci, Salmabad, Bahrain.
   [Abid, Faiza] King Khalid Univ, Dept Comp Sci, Abha, Saudi Arabia.
   [Mahmood, Nadeem] Univ Karachi, Fac Comp Sci, Dept Comp Sci, Sindh, Pakistan.
   [Wahiddin, Mohamed Ridza] Int Islamic Univ, Fac Informat & Commun Technol, Selangor, Malaysia.
   [Malik, Asif] Govt Coll Univ, Dept Sci, Lahore, Pakistan.
RP Malik, HAM (corresponding author), AMA Int Univ, Dept Comp Sci, Salmabad, Bahrain.
EM hamalik@amaiu.edu.bh
RI Malik, Hafiz Abid M./AAL-7421-2020; Malik, Hafiz/AAE-6141-2020; Mahmood,
   Nadeem/AAK-2587-2020; Malik, Dr. Hafiz Abid Mahmood/B-6864-2019
OI Mahmood, Nadeem/0000-0001-6365-7649; Malik, Dr. Hafiz Abid
   Mahmood/0000-0002-1866-1494
CR [Anonymous], 2017, P SAE WORLD C EXP WC
   [Anonymous], 2019, P 2019 2 INT C COMP, P1
   Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60
   Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/NPHYS2741, 10.1038/nphys2741]
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Davis Allison, 1941, DEEP S SOCIAL ANTHR
   Kim PS, 2013, MATH METHODS MODELS, P33
   Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140
   Malik H., 2014, P IEEE IND C INDICON, P1, DOI DOI 10.1109/INDICON.2014.7030427
   Malik H. A. M., 2016, Sindh University Research Journal -Science Series, V48, P845
   Malik HAM, 2019, INT J ADV COMPUT SC, V10, P404
   Malik HAM, 2017, COMPLEXITY, DOI 10.1155/2017/2515928
   Malik HAM, 2017, APPL MATH MODEL, V43, P207, DOI 10.1016/j.apm.2016.10.060
   Massad E, 2008, APPL MATH COMPUT, V195, P376, DOI 10.1016/j.amc.2007.04.102
   Ministry of Health, 2016, MAL HLTH SYST RES, V1
   Ministry of Health Malaysia, 2019, SIT DEM DENGG MAL BA
   Moheeput K, 2013, INT J MED HLTH BIOME, V7, P373
   National Environment Agency, 2014, UNITEDENGUE CROSS BO
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Opsahl T, 2013, SOC NETWORKS, V35, P159, DOI 10.1016/j.socnet.2011.07.001
   Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701
   Pessanha J. E. M., 2012, Dengue Bulletin, V36, P73
   Side S., 2013, WORLD J MODEL SIMUL, V9, P96
   SOEWONO E, 2001, B MALAYS MATH SCI SO, V24, P49
   Uddin S, 2011, PHYSICA A, V390, P2845, DOI 10.1016/j.physa.2011.03.028
   World Health Organization, 2014, DENG SIT UPD NUMB 44
   World Health Organization, 2019, DENG SEV DENG
   Ximenes R, 2013, MODELLING RISK DENGU
NR 28
TC 0
Z9 0
U1 4
U2 6
PU KOREAN SOC MEDICAL INFORMATICS
PI SEOUL
PA 1618 KYUNGHEEGUNG ACHIM BLDG 3, 72 NAESOO-DONG CHONGRO-KU, SEOUL,
   110-872, SOUTH KOREA
SN 2093-3681
EI 2093-369X
J9 HEALTHC INFORM RES
JI Healthc. Inform. Res.
PD JUL
PY 2019
VL 25
IS 3
BP 182
EP 192
DI 10.4258/hir.2019.25.3.182
PG 11
WC Medical Informatics
SC Medical Informatics
GA IQ0FB
UT WOS:000480425100006
PM 31406610
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Hackett, BA
   Dittmar, M
   Segrist, E
   Pittenger, N
   To, J
   Griesman, T
   Gordesky-Gold, B
   Schultz, DC
   Cherry, S
AF Hackett, Brent A.
   Dittmar, Mark
   Segrist, Elisha
   Pittenger, Nathan
   To, Julie
   Griesman, Trevor
   Gordesky-Gold, Beth
   Schultz, David C.
   Cherry, Sara
TI Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses
SO MBIO
LA English
DT Article
DE alphavirus; arbovirus; bunyavirus; flavivirus; sirtinol; sirtuin
ID VIRUS; REPLICATION; ACTIVATION; SIRTINOL; PROTEIN; EMERGENCE; DISCOVERY;
   REVEALS
AB Arthropod-borne viruses are diverse pathogens and are often associated with human disease. These viruses span multiple genera, including flaviviruses, alphaviruses, and bunyaviruses. In a high-throughput drug screen, we found that tenovin-1 was antiviral against the flaviviruses Zika virus and dengue virus. Tenovin-1 is a sirtuin inhibitor, and here we found that inhibition of sirtuins, but not inhibition of the related histone deacetylases, is potently antiviral against diverse arboviruses. Sirtuin inhibitors block infection of arboviruses in multiple human cell types. We found that sirtuin inhibitors arrest infection downstream of entry but that they do so at an early step, preventing the accumulation of viral RNA and protein. However, sirtuin inhibitors had no impact on the replication of flaviviral replicons, suggesting a defect in the establishment of replication. Consistent with this, we found that sirtuin inhibitors impacted double-stranded RNA (dsRNA) accumulation during flaviviral infection. Since these viruses infect vector insects, we also tested whether sirtuin inhibitors impacted infection of adult flies and found that these inhibitors blocked infection; therefore, they target highly conserved facets of replication. Taken together, these results suggest that sirtuin inhibitors represent a new class of potent host-targeting antivirals.
   IMPORTANCE Arthropod-borne viruses are diverse pathogens and are associated with human disease. Through high-throughput drug screening, we found that sirtuin inhibitors are potently antiviral against diverse arboviruses, including flaviviruses such as West Nile virus, bunyaviruses such as Rift Valley fever virus, and alphaviruses such as chikungunya virus. Sirtuin inhibitors block infection of these viruses in multiple human cell types. Moreover, we found that sirtuin inhibitors arrest infection downstream of entry but that they do so at an early step, preventing the accumulation of viral RNA and protein. Since these viruses infect vector insects, we also tested whether sirtuin inhibitors impacted infection of adult flies and found that these inhibitors blocked infection; therefore, they target highly conserved facets of replication. Taken together, these results suggest that sirtuin inhibitors represent a new class of potent host-targeting antivirals.
C1 [Hackett, Brent A.; Dittmar, Mark; Segrist, Elisha; Pittenger, Nathan; To, Julie; Griesman, Trevor; Gordesky-Gold, Beth; Schultz, David C.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Schultz, David C.; Cherry, Sara] Univ Penn, High Throughput Screening Core, Philadelphia, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.; Cherry, S (corresponding author), Univ Penn, High Throughput Screening Core, Philadelphia, PA 19104 USA.
EM cherrys@pennmedicine.upenn.edu
OI Griesman, Trevor/0000-0001-5333-0837
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI074951, RO1AI122749,
   1R01AI140539]; Linda Montague Investigator Award; ITMAT Pilot; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund
FX This work was supported by NIH grants R01AI074951, RO1AI122749, and
   1R01AI140539 to S.C. Support was provided by the Linda Montague
   Investigator Award, ITMAT Pilot, and the Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease Award to S.C.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Budayeva HG, 2016, J VIROL, V90, P5, DOI 10.1128/JVI.03220-14
   Deng JJ, 2017, BBA-GENE REGUL MECH, V1860, P491, DOI 10.1016/j.bbagrm.2017.02.007
   Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483
   Frankel S, 2011, EXP GERONTOL, V46, P391, DOI 10.1016/j.exger.2010.08.007
   Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113
   Huang YJS, 2019, CURR OPIN VIROL, V34, P104, DOI 10.1016/j.coviro.2019.01.001
   Kanda T, 2015, BIOCHEM BIOPH RES CO, V466, P567, DOI 10.1016/j.bbrc.2015.09.083
   Kayashima Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43679
   Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14
   Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004
   Li QH, 2014, J VIROL, V88, P6355, DOI 10.1128/JVI.00219-14
   Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l
   Mao GX, 2016, MECH AGEING DEV, V158, P62, DOI 10.1016/j.mad.2015.12.005
   Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v
   Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041
   Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Piracha ZZ, 2018, J VIROL, V92, DOI 10.1128/JVI.00955-18
   Prince H, 2009, ABSTR HEMATOL M REP
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ren JH, 2014, J VIROL, V88, P2442, DOI 10.1128/JVI.02861-13
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Tabachnick WJ, 2016, ANNU REV VIROL, V3, P125, DOI 10.1146/annurev-virology-110615-035630
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Yang T, 2015, REV MED VIROL, V25, P431, DOI 10.1002/rmv.1858
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Yu HB, 2018, INT J MED SCI, V15, P1356, DOI 10.7150/ijms.26125
NR 32
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2019
VL 10
IS 4
AR e01446-19
DI 10.1128/mBio.01446-19
PG 12
WC Microbiology
SC Microbiology
GA IR7JO
UT WOS:000481617000070
PM 31289184
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shim, BS
   Kwon, YC
   Ricciardi, MJ
   Stone, M
   Otsuka, Y
   Berri, F
   Kwal, JM
   Magnani, DM
   Jackson, CB
   Richard, AS
   Norris, P
   Busch, M
   Curry, CL
   Farzan, M
   Watkins, D
   Choe, H
AF Shim, Byoung-Shik
   Kwon, Young-Chan
   Ricciardi, Michael J.
   Stone, Mars
   Otsuka, Yuka
   Berri, Fatma
   Kwal, Jaclyn M.
   Magnani, Diogo M.
   Jackson, Cody B.
   Richard, Audrey S.
   Norris, Philip
   Busch, Michael
   Curry, Christine L.
   Farzan, Michael
   Watkins, David
   Choe, Hyeryun
TI Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals
   Enhance Zika Pathogenesis in Adult and Pregnant Mice
SO MBIO
LA English
DT Article
DE Zika virus; antibody-dependent enhancement; congenital disease;
   homotypic; microcephaly; pregnancy; vaccine; viral pathogenesis
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; REACTIVE ANTIBODIES;
   MATERNAL ANTIBODY; CROSS-REACTIVITY; INFECTION; RHESUS; CELLS;
   REPLICATION; RECEPTORS
AB Preexisting immunity against dengue virus or West Nile virus was previously reported to mediate antibody-dependent enhancement (ADE) of Zika virus (ZIKV) infection in a mouse model. We show here that ZIKV-immune plasma samples from both symptomatic and asymptomatic individuals mediated ZIKV ADE of infection in vitro and in mice. In a lethal infection model with a viral inoculum 10 times higher, both ADE and protection were observed, depending on the amount of infused immune plasma. In a vertical-transmission model, ZIKV-immune plasma infused to timed pregnant mice increased fetal demise and decreased the body weight of surviving fetuses. Depletion of IgG from an immune plasma abolished ADE of infection, and the presence of purified IgG alone mediated ADE of infection. Higher viral loads and proinflammatory cytokines were detected in mice treated with ZIKV-immune plasma samples compared to those receiving control plasma. Together, these data show that passive immunization with homotypic ZIKV antibodies, depending on the concentration, could either worsen or limit a subsequent ZIKV infection.
   IMPORTANCE Antibody-dependent enhancement (ADE) of virus infection is common to many viruses and is problematic when plasma antibody levels decline to subneutralizing concentrations. ADE of infection is especially important among flaviviruses, many of which are the cause of global health problems. Recently, human plasma samples immune to heterologous flaviviruses were shown to promote Zika virus (ZIKV) infection. Here we showed in immunocompromised mouse models that homologous immune plasma samples protect mice from subsequent infection at high antibody concentrations but that they mediate ADE of infection and increase ZIKV pathogenesis in adult mice and fetal demise during pregnancy at low concentrations.
C1 [Shim, Byoung-Shik; Kwon, Young-Chan; Otsuka, Yuka; Berri, Fatma; Jackson, Cody B.; Richard, Audrey S.; Farzan, Michael; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.
   [Ricciardi, Michael J.; Magnani, Diogo M.; Watkins, David] Univ Miami, Leonard M Miller Sch Med, Dept Pathol, Miami, FL USA.
   [Stone, Mars; Norris, Philip; Busch, Michael] Blood Syst Res Inst, Viral Reference Lab, San Francisco, CA USA.
   [Stone, Mars; Norris, Philip; Busch, Michael] Blood Syst Res Inst, Repository Core, San Francisco, CA USA.
   [Kwal, Jaclyn M.; Curry, Christine L.] Univ Miami, Leonard M Miller Sch Med, Dept Obstet & Gynecol, Miami, FL USA.
   [Norris, Philip; Busch, Michael] Univ Calif San Francisco, Lab Med & Med, San Francisco, CA 94143 USA.
   [Shim, Byoung-Shik] G Flas Life Sci, Div Biopharmaceut, Seoul, South Korea.
   [Kwon, Young-Chan] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Yuseong, Daejeon, South Korea.
RP Choe, H (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.
EM hchoe@scripps.edu
OI Magnani, Diogo/0000-0002-1773-2406; Stone, Mars/0000-0001-5619-2767;
   Jackson, Cody/0000-0002-0686-9423; Farzan, Michael/0000-0002-2990-5319
FU Scripps Research Institute; NIAIDUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01 AI110692]; Zika
   Research Grant Initiative from the Florida Department of Health;
   NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HHSN268201100001I]
FX This work was supported by startup funds from The Scripps Research
   Institute and NIAID grant R01 AI110692 to H.C., the Zika Research Grant
   Initiative from the Florida Department of Health to D.W., and grant
   NHLBI HHSN268201100001I to the BSRI Recipient Epidemiology and Donor
   Evaluation (REDS-III) ZIKV Study Group.
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chen J, 2016, MOL MED REP, V14, P1799, DOI 10.3892/mmr.2016.5454
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   George JA, 2017, ONCOTARGET, V8, P106050, DOI 10.18632/oncotarget.22525
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Ito M, 2010, ARCH VIROL, V155, P1617, DOI 10.1007/s00705-010-0741-x
   Kalkeri Raj, 2017, F1000Res, V6, P1850, DOI 10.12688/f1000research.12695.1
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kowal C, 2015, IMMUNOL RES, V63, P18, DOI 10.1007/s12026-015-8714-5
   Kuczera D, 2018, J INTERF CYTOK RES, V38, P69, DOI 10.1089/jir.2017.0037
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   MILLER SC, 1983, AM J ANAT, V168, P1, DOI 10.1002/aja.1001680102
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stamou M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1050-z
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Tsai WY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01372
   Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005
   Voorham JMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029957
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   WOLFF H, 1992, J ACQ IMMUN DEF SYND, V5, P65
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 68
TC 6
Z9 6
U1 2
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2019
VL 10
IS 4
AR e00758-19
DI 10.1128/mBio.00758-19
PG 18
WC Microbiology
SC Microbiology
GA IR7JO
UT WOS:000481617000010
PM 31266863
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Strange, DP
   Jiyarom, B
   Zarandi, NP
   Xie, XP
   Baker, C
   Sadri-Ardekani, H
   Shi, PY
   Verma, S
AF Strange, Daniel P.
   Jiyarom, Boonyanudh
   Zarandi, Nima Pourhabibi
   Xie, Xuping
   Baker, Coleman
   Sadri-Ardekani, Hooman
   Shi, Pei-Yong
   Verma, Saguna
TI Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human
   Sertoli Cells
SO MBIO
LA English
DT Article
DE Axl receptor tyrosine kinase; Sertoli cells; Zika virus; interferon
   signaling; testes; testicular organoids; virus entry
ID INNATE IMMUNE-RESPONSES; ENDOTHELIAL-CELLS; MOUSE SERTOLI; INFECTION;
   ACTIVATION; RECEPTORS; MOLECULE; SURVIVAL; KINASE; GENES
AB Zika virus (ZIKV) is unique among mosquito-borne flaviviruses in its ability to be sexually transmitted. Persistent ZIKV infection in the testes, which are immune privileged organs, long after peripheral clearance suggests involvement of immunosuppressive pathways; however, the underlying mechanisms remain undetermined. We recently demonstrated that ZIKV infects human Sertoli cells (SC), the major cell type of the seminiferous epithelium responsible for maintaining the immune privileged compartment of seminiferous tubules. Recent reports have identified the TAM (Tyro3, Axl, Mer) receptor tyrosine kinase Axl as an entry receptor and/or immune modulator for ZIKV in a cell type-specific manner. Interestingly, the seminiferous epithelium exhibits high basal expression of the Axl receptor where it is involved in clearance of apoptotic germ cells and immunosuppression. Here, we show that Axl was highly expressed in SC compared to Leydig cells (LC) that correlated with robust ZIKV infection of SC, but not LC. Further, neutralization of Axl receptor and its ligand Gas6 strongly attenuated virus entry in SC. However, inhibition of Axl kinase did not affect ZIKV entry but instead led to decreased protein levels of suppressor of cytokine signaling 1 (SOCS1) and SOCS3, increased expression of interferon-stimulated genes (ISGs), and reduced ZIKV replication. Similarly, treatment of multicellular human testicular organoids with an Axl kinase inhibitor attenuated ZIKV replication and increased ISG expression. Together, our data demonstrate that Axl promotes ZIKV entry and negatively regulates the antiviral state of SC to augment ZIKV infection of the testes and provides new insights into testis antiviral immunity and ZIKV persistence.
   IMPORTANCE Recent Zika virus (ZIKV) outbreaks have identified sexual transmission as a new route of disease spread not reported for other flaviviruses. ZIKV crosses the blood-testis barrier and establishes infection in seminiferous tubules, the site for spermatozoa development. Currently, there are no therapies to treat ZIKV infection, and the immune mechanisms underlying testicular persistence are unclear. We found that multiple human testicular cell types, except Leydig cells, support ZIKV infection. Axl receptor, which plays a pivotal role in maintaining the immunosuppressive milieu of the testis, is highly expressed in Sertoli cells and augments ZIKV infection by promoting virus entry and negatively regulating the antiviral state. By using testicular organoids, we further describe the antiviral role of Axl inhibition. The significance of our research lies in defining cross talk between Axl and type I interferon signaling as an essential mechanism of immune control that can inform therapeutic efforts to clear ZIKV from the testis.
C1 [Strange, Daniel P.; Jiyarom, Boonyanudh; Verma, Saguna] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Zarandi, Nima Pourhabibi; Sadri-Ardekani, Hooman] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Sadri-Ardekani, Hooman] Wake Forest Sch Med, Dept Urol, Winston Salem, NC USA.
   [Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Baker, Coleman] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Verma, S (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM saguna@hawaii.edu
RI Xie, Xuping/AAD-7406-2019
FU Hawaii Community Foundation; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U42-RR006042,
   AI142759, AI127744, AI136126]; Kleberg Foundation; John S. Dunn
   Foundation; Amon G. Carter Foundation; Gilson Longenbaugh Foundation;
   Summerfield Robert Foundation;  [R21AI129465];  [R21AI140248]
FX This work was partially supported by grants R21AI129465 and R21AI140248
   and Hawaii Community Foundation. We acknowledge use of testicular
   tissues procured by the NDRI with support from NIH grant U42-RR006042.
   P.-Y.S. was supported by NIH grants AI142759, AI127744, and AI136126 and
   awards from the Kleberg Foundation, John S. Dunn Foundation, Amon G.
   Carter Foundation, Gilson Longenbaugh Foundation, and Summerfield Robert
   Foundation.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101
   Cheng XY, 2009, TRANSPLANTATION, V87, P1778, DOI 10.1097/TP.0b013e3181a75633
   D'Alessio A, 2001, P NATL ACAD SCI USA, V98, P3316, DOI 10.1073/pnas.051566098
   Diamond MS, 2014, CYTOKINE GROWTH F R, V25, P543, DOI 10.1016/j.cytogfr.2014.05.002
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   John SP, 2018, CELL REP, V25, P95, DOI 10.1016/j.celrep.2018.09.002
   Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pendergraft SS, 2017, BIOL REPROD, V96, P720, DOI 10.1095/biolreprod.116.143446
   Riccioli A, 2006, J IMMUNOL, V177, P7122, DOI 10.4049/jimmunol.177.10.7122
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Strange DP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0080-7
   Sun B, 2010, ENDOCRINOLOGY, V151, P2886, DOI 10.1210/en.2009-1498
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287
NR 51
TC 6
Z9 6
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2019
VL 10
IS 4
AR e01372-19
DI 10.1128/mBio.01372-19
PG 16
WC Microbiology
SC Microbiology
GA IR7JO
UT WOS:000481617000061
PM 31311882
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wong, CP
   Xu, ZK
   Hou, SM
   Limonta, D
   Kumar, A
   Power, C
   Hobman, TC
AF Wong, Cheung Pang
   Xu, Zaikun
   Hou, Shangmei
   Limonta, Daniel
   Kumar, Anil
   Power, Christopher
   Hobman, Tom C.
TI Interplay between Zika Virus and Peroxisomes during Infection
SO CELLS
LA English
DT Article
DE Zika virus; peroxisomes; innate immune response; interferon; astrocytes;
   fetal brain
ID INTERFERON-PRODUCTION; III INTERFERON; EXPRESSION; VIPERIN; PROTEIN;
   ABSENCE; BRAIN
AB Zika virus (ZIKV) has emerged as an important human pathogen that can cause congenital defects in the fetus and neurological conditions in adults. The interferon (IFN) system has proven crucial in restricting ZIKV replication and pathogenesis. The canonical IFN response is triggered by the detection of viral RNA through RIG-I like receptors followed by activation of the adaptor protein MAVS on mitochondrial membranes. Recent studies have shown that a second organelle, peroxisomes, also function as a signaling platforms for the IFN response. Here, we investigated how ZIKV infection affects peroxisome biogenesis and antiviral signaling. We show that ZIKV infection depletes peroxisomes in human fetal astrocytes, a brain cell type that can support persistent infection. The peroxisome biogenesis factor PEX11B was shown to inhibit ZIKV replication, likely by increasing peroxisome numbers and enhancing downstream IFN-dependent antiviral signaling. Given that peroxisomes play critical roles in brain development and nerve function, our studies provide important insights into the roles of peroxisomes in regulating ZIKV infection and potentially neuropathogenesis.
C1 [Wong, Cheung Pang; Power, Christopher; Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.
   [Xu, Zaikun; Hou, Shangmei; Limonta, Daniel; Kumar, Anil; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.
   [Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB T6G 2E1, Canada.
   [Power, Christopher; Hobman, Tom C.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB T6G 1C9, Canada.
   [Power, Christopher; Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.; Hobman, TC (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB T6G 1C9, Canada.; Hobman, TC (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada.
EM tom.hobman@ualberta.ca
OI Kumar, Anil/0000-0002-6179-4516
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [PJT-148699, ZV1-149782]; Alberta Innovates-Technology
   Futures; Alberta Advanced Education
FX This research was funded by Canadian Institutes of Health Research
   (PJT-148699 and ZV1-149782). C.P.W. is supported by a graduate
   studentship award from Alberta Innovates-Technology Futures, and Alberta
   Advanced Education.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Beltran PMJ, 2018, CELL HOST MICROBE, V24, P526, DOI 10.1016/j.chom.2018.09.002
   Bender S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005264
   Bottelbergs A, 2010, GLIA, V58, P1532, DOI 10.1002/glia.21027
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Deori NM, 2018, BIOGERONTOLOGY, V19, P303, DOI 10.1007/s10522-018-9761-9
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Ferreira AR, 2016, J CELL MOL MED, V20, P750, DOI 10.1111/jcmm.12801
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542
   Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Hughes R, 2012, REV MED VIROL, V22, P257, DOI 10.1002/rmv.1708
   Islinger M., 2018, CELL BIOL, V150, P1
   Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Limonta D., 2019, J INFECT DIS
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299
   Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Said EA, 2018, J IMMUNOL RES, DOI 10.1155/2018/9480497
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wong CP, 2018, DNA CELL BIOL, V37, P417, DOI 10.1089/dna.2018.4153
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu ZK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006360
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   ZHANG QZ, 2018, J VIROL, V92, DOI DOI 10.1128/JVI.01677-17
NR 53
TC 1
Z9 1
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUL
PY 2019
VL 8
IS 7
AR 725
DI 10.3390/cells8070725
PG 16
WC Cell Biology
SC Cell Biology
GA IN8AC
UT WOS:000478902000112
PM 31311201
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yamane, D
   Feng, H
   Rivera-Serrano, EE
   Selitsky, SR
   Hirai-Yuki, A
   Das, A
   McKnight, KL
   Misumi, I
   Hensley, L
   Lovell, W
   Gonzalez-Lopez, O
   Suzuki, R
   Matsuda, M
   Nakanishi, H
   Ohto-Nakanishi, T
   Hishiki, T
   Wauthier, E
   Oikawa, T
   Morita, K
   Reid, LM
   Sethupathy, P
   Kohara, M
   Whitmire, JK
   Lemon, SM
AF Yamane, Daisuke
   Feng, Hui
   Rivera-Serrano, Efrain E.
   Selitsky, Sara R.
   Hirai-Yuki, Asuka
   Das, Anshuman
   McKnight, Kevin L.
   Misumi, Ichiro
   Hensley, Lucinda
   Lovell, William
   Gonzalez-Lopez, Olga
   Suzuki, Ryosuke
   Matsuda, Mami
   Nakanishi, Hiroki
   Ohto-Nakanishi, Takayo
   Hishiki, Takayuki
   Wauthier, Eliane
   Oikawa, Tsunekazu
   Morita, Kouichi
   Reid, Lola M.
   Sethupathy, Praveen
   Kohara, Michinori
   Whitmire, Jason K.
   Lemon, Stanley M.
TI Basal expression of interferon regulatory factor 1 drives intrinsic
   hepatocyte resistance to multiple RNA viruses
SO NATURE MICROBIOLOGY
LA English
DT Article
ID TRANSCRIPTION FACTOR; HEPATITIS; GENES; IRF-1; REPLICATION; INDUCTION;
   SEQUENCES; RESPONSES; REVEALS; TARGET
AB Current models of cell-intrinsic immunity to RNA viruses centre on virus-triggered inducible antiviral responses initiated by RIG-I-like receptors or Toll-like receptors that sense pathogen-associated molecular patterns, and signal downstream through interferon regulatory factors (IRFs), transcription factors that induce synthesis of type I and type III interferons(1). RNA viruses have evolved sophisticated strategies to disrupt these signalling pathways and evade elimination by cells, attesting to their importance(2). Less attention has been paid to how IRFs maintain basal levels of protection against viruses. Here, we depleted antiviral factors linked to RIG-I-like receptor and Toll-like receptor signalling to map critical host pathways restricting positive-strand RNA virus replication in immortalized hepatocytes and identified an unexpected role for IRF1. We show that constitutively expressed IRF1 acts independently of mitochondria! antiviral signalling (MAVS) protein, IRF3 and signal transducer and activator of transcription 1 (STAT1)-dependent signalling to provide intrinsic antiviral protection in actinomycin D-treated cells. IRF1 localizes to the nucleus, where it maintains the basal transcription of a suite of antiviral genes that protect against multiple pathogenic RNA viruses, including hepatitis A and C viruses, dengue virus and Zika virus. Our findings reveal an unappreciated layer of hepatocyte-intrinsic immunity to these positive-strand RNA viruses and identify previously unrecognized antiviral effector genes.
C1 [Yamane, Daisuke; Feng, Hui; Rivera-Serrano, Efrain E.; Selitsky, Sara R.; Hirai-Yuki, Asuka; Das, Anshuman; McKnight, Kevin L.; Hensley, Lucinda; Lovell, William; Gonzalez-Lopez, Olga; Wauthier, Eliane; Oikawa, Tsunekazu; Reid, Lola M.; Sethupathy, Praveen; Whitmire, Jason K.; Lemon, Stanley M.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA.
   [Yamane, Daisuke; Feng, Hui; Rivera-Serrano, Efrain E.; Hirai-Yuki, Asuka; Das, Anshuman; McKnight, Kevin L.; Hensley, Lucinda; Lovell, William; Gonzalez-Lopez, Olga; Lemon, Stanley M.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Yamane, Daisuke; Feng, Hui; Rivera-Serrano, Efrain E.; Hirai-Yuki, Asuka; Das, Anshuman; McKnight, Kevin L.; Hensley, Lucinda; Lovell, William; Gonzalez-Lopez, Olga; Lemon, Stanley M.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA.
   [Yamane, Daisuke; Hishiki, Takayuki; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo, Japan.
   [Hirai-Yuki, Asuka] Natl Inst Infect Dis, Div Expt Anim Res, Tokyo, Japan.
   [Misumi, Ichiro; Whitmire, Jason K.] Univ North Carolina Chapel Hill, Dept Microbiol, Chapel Hill, NC USA.
   [Misumi, Ichiro; Whitmire, Jason K.] Univ North Carolina Chapel Hill, Dept Immunol & Genet, Chapel Hill, NC USA.
   [Suzuki, Ryosuke; Matsuda, Mami] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo, Japan.
   [Nakanishi, Hiroki] Akita Univ, Res Ctr Biosignaling, Akita, Japan.
   [Ohto-Nakanishi, Takayo] Lipidome Lab Co Ltd, Akita, Japan.
   [Wauthier, Eliane; Oikawa, Tsunekazu; Reid, Lola M.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Program Mol Biol & Biotechnol, Chapel Hill, NC 27515 USA.
   [Oikawa, Tsunekazu] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Minato Ku, Tokyo, Japan.
   [Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.
   [Sethupathy, Praveen] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.
RP Yamane, D; Lemon, SM (corresponding author), UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA.; Yamane, D; Lemon, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Yamane, D; Lemon, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA.; Yamane, D (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo, Japan.
EM yamane-ds@igakuken.or.jp; smlemon@med.unc.edu
OI Rivera-Serrano, Efrain E./0000-0002-1039-7182; Whitmire,
   Jason/0000-0003-2578-6073
FU Japan Society for the Promotion of Science (JSPS KAKENHI)Ministry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [JP16H07462, JP17H05070, JP18K05987, JP17K08870,
   JP15K19109]; Japan Agency for Medical Research and DevelopmentJapan
   Agency for Medical Research and Development (AMED) [JP18jk0210014,
   JP18fk0108035, JP16fk0210108]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01-AI103083, U19-AI109965, R01-AI131685]
FX The authors thank C.M. Rice, S. Inoue and N. Kato for the reagents, M.
   Soloway for the bioinformatics support, M. Chua for technical assistance
   and H. Dansako, B.B. Queliconi and W.J. Zuercher for helpful
   discussions. This work was supported in part by the Japan Society for
   the Promotion of Science (JSPS KAKENHI) (grant nos. JP16H07462 and
   JP17H05070 to D.Y., grant no. JP18K05987 to A.H-Y., grant no. JP17K08870
   and JP15K19109 to T.H.), Japan Agency for Medical Research and
   Development (grant no. JP18jk0210014 to A.H.-Y., grant no. JP18fk0108035
   to T.H. and grant no. JP16fk0210108 to M.K.) and National Institutes of
   Health grant no. R01-AI103083 and U19-AI109965 to S.M.L. and grant no.
   R01-AI131685 to S.M.L. and J.K.W.
CR Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921
   Beard MR, 2001, J VIROL, V75, P1414, DOI 10.1128/JVI.75.3.1414-1426.2001
   BINN LN, 1984, J CLIN MICROBIOL, V20, P28, DOI 10.1128/JCM.20.1.28-33.1984
   Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45
   Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200
   Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Feng H, 2017, NAT IMMUNOL, V18, P1299, DOI 10.1038/ni.3853
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Figueiredo VC, 2017, CELL MOL LIFE SCI, V74, P2537, DOI 10.1007/s00018-017-2481-5
   FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0
   Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Hsu TH, 2015, CELL DEATH DIFFER, V22, P801, DOI 10.1038/cdd.2014.175
   Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655
   Kielkowska Anna, 2014, Advances in Biological Regulation, V54, P131, DOI 10.1016/j.jbior.2013.09.001
   Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764
   LEBLANC JF, 1990, MOL CELL BIOL, V10, P3987, DOI 10.1128/MCB.10.8.3987
   Lemon SM, 2018, J HEPATOL, V68, P167, DOI 10.1016/j.jhep.2017.08.034
   Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021
   MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4
   Nair S, 2017, J VIROL, V91, DOI 10.1128/JVI.01419-17
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070
   Ou CC, 2008, CARCINOGENESIS, V29, P299, DOI 10.1093/carcin/bgm263
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4
   TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531
   Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001
   Verweij MC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004743
   Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740
   White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9
   Woodson SE, 2011, J GEN VIROL, V92, P2262, DOI 10.1099/vir.0.031617-0
   Yamane D, 2017, NUCLEIC ACIDS RES, V45, P4743, DOI 10.1093/nar/gkw1332
   Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610
   Yi M, 2002, J VIROL, V76, P1171, DOI 10.1128/JVI.76.3.1171-1180.2002
   Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012
NR 45
TC 7
Z9 7
U1 2
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JUL
PY 2019
VL 4
IS 7
BP 1096
EP 1104
DI 10.1038/s41564-019-0425-6
PG 9
WC Microbiology
SC Microbiology
GA IP9DF
UT WOS:000480348200005
PM 30988429
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Duarte-Neto, AN
   Monteiro, RAD
   Johnsson, J
   Cunha, MD
   Pour, SZ
   Saraiva, AC
   Ho, YL
   da Silva, LFF
   Mauad, T
   Zanotto, PMD
   Saldiva, PHN
   de Oliveira, IRS
   Dolhnikoff, M
AF Duarte-Neto, Amaro Nunes
   de Almeida Monteiro, Renata Aparecida
   Johnsson, Janaina
   Cunha, Marielton dos Passos
   Pour, Shahab Zaki
   Saraiva, Amanda Cartagenes
   Ho, Yeh-Li
   Ferraz da Silva, Luiz Fernando
   Mauad, Thais
   de Andrade Zanotto, Paolo Marinho
   Nascimento Saldiva, Paulo Hilario
   Souza de Oliveira, Ilka Regina
   Dolhnikoff, Marisa
TI Ultrasound-guided minimally invasive autopsy as a tool for rapid
   post-mortem diagnosis in the 2018 Sao Paulo yellow fever epidemic:
   Correlation with conventional autopsy
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DEATH; AFRICA; ZIKA
AB Background New strategies for collecting post-mortem tissue are necessary, particularly in areas with emerging infections. Minimally invasive autopsy (MIA) has been proposed as an alternative to conventional autopsy (CA), with promising results. Previous studies using MIA addressed the cause of death in adults and children in developing countries. However, none of these studies was conducted in areas with an undergoing infectious disease epidemic. We have recently experienced an epidemic of yellow fever (YF) in Brazil. Aiming to provide new information on low-cost post-mortem techniques that could be applied in regions at risk for infectious outbreaks, we tested the efficacy of ultrasound-guided MIA (MIA-US) in the diagnosis of patients who died during the epidemic.
   Methodology/principal findings In this observational study, we performed MIA-US in 20 patients with suspected or confirmed YF and compared the results with those obtained in subsequent CAs. Ultrasound-guided biopsies were used for tissue sampling of liver, kidneys, lungs, spleen, and heart. Liver samples from MIA-US and CA were submitted for RT-PCR and immunohistochemistry for detection of YF virus antigen. Of the 20 patients, 17 had YF diagnosis confirmed after autopsy by histopathological and molecular analysis. There was 100% agreement between MIA-US and CA in determining the cause of death (panlobular hepatitis with hepatic failure) and main disease (yellow fever). Further, MIA-US obtained samples with good quality for molecular studies and for the assessment of the systemic involvement of the disease. Main extrahepatic findings were pulmonary hemorrhage, pneumonia, acute tubular necrosis, and glomerulonephritis. One patient was a 24-year-old, 27-week pregnant woman; MIA-US assessed the placenta and provided adequate placental tissue for analysis.
   Conclusions MIA-US is a reliable tool for rapid post-mortem diagnosis of yellow fever and can be used as an alternative to conventional autopsy in regions at risk for hemorrhagic fever outbreaks with limited resources to perform complete diagnostic autopsy.
   Author summary Reliable mortality information is of paramount importance to establish sound public health policies. Autopsy is an important tool not only for determining the cause of death, but also for the detection of novel diseases. In the last decades, we have been globally identifying an unprecedented number of emerging infections. Therefore, there is great interest in the development of less invasive and low-cost tools for the accurate post-mortem diagnosis in fatal cases. Minimally invasive autopsy (MIA), conceived as targeting diagnostic biopsies of key organs by needle puncture, has been proposed as an alternative to conventional autopsy (CA) for the determination of cause of death in developing countries. In this research, we tested the efficacy of MIA in the post-mortem diagnosis of 20 patients with suspected or confirmed yellow fever who died during the recent epidemic of yellow fever that occurred in Brazil. There was a perfect agreement between MIA and CA in determining the cause of death (hepatic failure) and main disease (yellow fever) in all patients with confirmed yellow fever. This finding indicates that MIA can be used as an alternative to CA in regions at risk for infectious disease outbreaks with limited resources to perform conventional autopsies.
C1 [Duarte-Neto, Amaro Nunes; de Almeida Monteiro, Renata Aparecida; Saraiva, Amanda Cartagenes; Ferraz da Silva, Luiz Fernando; Mauad, Thais; Nascimento Saldiva, Paulo Hilario; Dolhnikoff, Marisa] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, Brazil.
   [Johnsson, Janaina] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
   [Cunha, Marielton dos Passos; Pour, Shahab Zaki; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, LEMB, Sao Paulo, Brazil.
   [Ho, Yeh-Li] Univ Sao Paulo, Fac Med, Hosp Clin, Div Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Souza de Oliveira, Ilka Regina] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil.
RP Dolhnikoff, M (corresponding author), Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, Brazil.
EM maridol@usp.br
RI de A. Zanotto, Paolo M./B-9286-2019; Dolhnikoff, Marisa/B-9019-2013;
   POUR, SHAHAB ZAKI/H-3846-2016; Silva, Luiz/D-2760-2012; Monteiro,
   Renata/AAR-3144-2020
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; POUR, SHAHAB
   ZAKI/0000-0002-7708-1406; Silva, Luiz/0000-0002-0181-6357; Monteiro,
   Renata/0000-0002-6709-5943
FU Bill & Melinda Gates FoundationGates Foundation; Fundacao de Amparo a
   Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [2016/08204-2]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [441105/2016-5]
FX This work was funded by the Bill & Melinda Gates Foundation
   (https://www.gatesfoundation.org/), Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (http://www.fapesp.br/).PMdAZ was funded by Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br/), process #441105/2016-5. MdPC received a
   scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo,
   process #2016/08204-2. MD, PHNS, and TM receive individual grants from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Avelino-Silva VI, 2013, BONE MARROW TRANSPL, V48, P1008, DOI 10.1038/bmt.2012.277
   Bassat Q, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002317
   Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8
   Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017
   Blokker BM, 2016, EUR RADIOL, V26, P1159, DOI 10.1007/s00330-015-3908-8
   Bolliger SA, 2010, AM J ROENTGENOL, V195, P1051, DOI 10.2214/AJR.10.4600
   Castillo P, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002431
   Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171
   Castillo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132057
   Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290
   Cox JA, 2010, AIDS REV, V12, P183
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Farina J, 2002, VIRCHOWS ARCH, V440, P635, DOI 10.1007/s00428-002-0607-z
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Gates B, BILL M GATES AUTOPSI
   Hanzlick RL, 2000, ARCH PATHOL LAB MED, V124, P594
   Karat AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174097
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinez MJ, 2016, DIAGN MICR INFEC DIS, V84, P80, DOI 10.1016/j.diagmicrobio.2015.10.002
   Mascheretti M, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004341
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5
   Tsegaye MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5726-9
   Vargas PA, 2000, HISTOPATHOLOGY, V37, P141, DOI 10.1046/j.1365-2559.2000.00951.x
NR 28
TC 5
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2019
VL 13
IS 7
AR e0007625
DI 10.1371/journal.pntd.0007625
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IN4RG
UT WOS:000478662500076
PM 31329590
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jia, PF
   Liang, L
   Tan, XY
   Chen, J
   Chen, X
AF Jia, Pengfei
   Liang, Lu
   Tan, Xiaoyue
   Chen, Jin
   Chen, Xiang
TI Potential effects of heat waves on the population dynamics of the dengue
   mosquito Aedes albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DRIVEN ABUNDANCE MODEL; METEOROLOGICAL FACTORS; EXTREME TEMPERATURE;
   GLOBAL DISTRIBUTION; DIPTERA-CULICIDAE; CLIMATE-CHANGE; IMPACT;
   MORTALITY; AEGYPTI; FEVER
AB Extreme weather events affect the development and survival of disease pathogens and vectors. Our aim was to investigate the potential effects of heat waves on the population dynamics of Asian tiger mosquito (Aedes albopictus), which is a major vector of dengue and Zika viruses. We modeled the population abundance of blood-fed mosquito adults based on a mechanistic population model of Ae. albopictus with the consideration of diapause. Using simulated heat wave events derived from a 35-year historical dataset, we assessed how the mosquito population responded to different heat wave characteristics, including the onset day, duration, and the average temperature. Two important observations are made: (1) a heat wave event facilitates the population growth in the early development phase but tends to have an overall inhibitive effect; and (2) two primary factors affecting the development are the unusual onset time of a heat wave and a relatively high temperature over an extended period. We also performed a sensitivity analysis using different heat wave definitions, justifying the robustness of the findings. The study suggests that particular attention should be paid to future heat wave events with an abnormal onset time or a lasting high temperature in order to develop effective strategies to prevent and control Ae. albopictus-borne diseases.
   Author summary Understanding the population dynamics of Asian Tiger mosquito (Ae. albopictus)-the most prevalent vector of global epidemics including West Nile virus, dengue fever, Zika-could shed lights on improving the understanding of vector transmission as well as developing effective disease control strategies. It is widely acknowledged that the life cycle of Ae. albopictus is firmly regulated by meteorological factors in a non-linear way and is sensitive to climate change. Our study extends the understanding about how extreme heat events manipulate the mosquito population abundance. We adopted an existing mechanistic population model of Ae. albopictus, combined with a rich set of simulated heat wave events derived from a 35-year historical dataset, to quantify the mosquito's responses to different heat wave characteristics. We found that an abnormal onset time and a lasting high temperature play the most important role in affecting the mosquito population dynamics. We also performed a sensitive analysis by changing the definition of the heat wave, justifying the rigor of the conclusion. This research provides implications for developing public health intervention strategies: to control dengue fever, Zika, as well as other far-reaching mosquito-borne epidemics, priority should be given to heat wave events with an abnormal onset time or a lasting high temperature.
C1 [Jia, Pengfei; Tan, Xiaoyue; Chen, Jin] Beijing Normal Univ, State Key Lab Earth Surface Proce & Resource Ecol, Beijing, Peoples R China.
   [Jia, Pengfei] China Acad Urban Planning & Design, Beijing, Peoples R China.
   [Liang, Lu] Univ North Texas, Dept Geog & Environm, Union Circle, TX USA.
   [Chen, Xiang] Univ Connecticut, Dept Geog, Storrs, CT 06269 USA.
RP Chen, J (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proce & Resource Ecol, Beijing, Peoples R China.; Chen, X (corresponding author), Univ Connecticut, Dept Geog, Storrs, CT 06269 USA.
EM chenjin@bnu.edu.cn; xiang.chen@uconn.edu
RI Chen, Jin/A-6417-2011; Chen, Xiang/F-8556-2015
OI Chen, Jin/0000-0002-6497-4141; Chen, Xiang/0000-0002-5045-9253; TAN,
   Xiaoyue/0000-0001-9989-0573
FU National Key Basic Research and Development Plan of the Ministry of
   Science and Technology of China [2012CB955501]
FX This work was supported by the National Key Basic Research and
   Development Plan of the Ministry of Science and Technology of China
   [grant number 2012CB955501]. JC received the award. The funder' website
   is as follows: http://www.most.gov.cn/eng/.The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x
   Barker T, 2007, CONTRIBUTION WORKING
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   Chapman RF, 1998, INSECTS STRUCTURE FU
   Chaves LF, 2014, ACTA TROP, V129, P15, DOI 10.1016/j.actatropica.2013.02.025
   Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021
   Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Dupuis DJ, 2012, J AM STAT ASSOC, V107, P24, DOI 10.1080/01621459.2011.643732
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Eskola H, 2009, THESIS
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Gao JH, 2015, SCI TOTAL ENVIRON, V505, P535, DOI 10.1016/j.scitotenv.2014.10.028
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Intergovernmental Panel on Climate Change, 5 ASS REP
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Liang L, 2017, ENVIRON INT, V103, P99, DOI 10.1016/j.envint.2017.03.011
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877
   Ma WJ, 2011, SCI TOTAL ENVIRON, V409, P3634, DOI 10.1016/j.scitotenv.2011.06.042
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   National Oceanic And Atmospheric Administration, SOL CALC DET
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0246
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Shen JC, 2015, BIOMED ENVIRON SCI, V28, P321, DOI 10.3967/bes2015.046
   Sivan A, 2017, ACTA TROP, V167, P121, DOI 10.1016/j.actatropica.2016.12.017
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089
   Tauber M.J., 1986, SEASONAL ADAPTATIONS
   Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   TRPIS M, 1973, CAN ENTOMOL, V105, P43, DOI 10.4039/Ent10543-1
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   WHO, MOSQ VECT CONTR EM R
   Wu PC, 2017, ACTA TROP, V103, P50
   Xu ZW, 2016, ENVIRON INT, V89-90, P193, DOI 10.1016/j.envint.2016.02.007
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yang J, 2013, BIOMED ENVIRON SCI, V26, P647, DOI 10.3967/0895-3988.2013.08.003
   Yu X., 2013, THESIS
   Zeng WL, 2014, SCI TOTAL ENVIRON, V482, P214, DOI 10.1016/j.scitotenv.2014.02.049
   Zhang R, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8020037
NR 56
TC 0
Z9 0
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2019
VL 13
IS 7
AR e0007528
DI 10.1371/journal.pntd.0007528
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IN4RG
UT WOS:000478662500030
PM 31276467
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sharp, TM
   Lorenzi, O
   Torres-Velasquez, B
   Acevedo, V
   Perez-Padilla, J
   Rivera, A
   Munoz-Jordan, J
   Margolis, HS
   Waterman, SH
   Biggerstaff, BJ
   Paz-Bailey, G
   Barrera, R
AF Sharp, Tyler M.
   Lorenzi, Olga
   Torres-Velasquez, Brenda
   Acevedo, Veronica
   Perez-Padilla, Janice
   Rivera, Aidsa
   Munoz-Jordan, Jorge
   Margolis, Harold S.
   Waterman, Stephen H.
   Biggerstaff, Brad J.
   Paz-Bailey, Gabriela
   Barrera, Roberto
TI Autocidal gravid ovitraps protect humans from chikungunya virus
   infection by reducing Aedes aegypti mosquito populations
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VECTOR CONTROL; HUMAN MOVEMENT; PUERTO-RICO; DENGUE; SURVEILLANCE;
   EPIDEMIC; MANIFESTATIONS; TRANSMISSION; MORTALITY; OUTBREAK
AB Background Public health responses to outbreaks of dengue, chikungunya, and Zika virus have been stymied by the inability to control the primary vector, Aedes aegypti mosquitos. Consequently, the need for novel approaches to Aedes vector control is urgent. Placement of three autocidal gravid ovitraps (AGO traps) in similar to 85% of homes in a community was previously shown to sustainably reduce the density of female Ae. aegypti by >80%. Following the introduction of chikungunya virus (CHIKV) to Puerto Rico, we conducted a seroprevalence survey to estimate the prevalence of CHIKV infection in communities with and without AGO traps and evaluate their effect on reducing CHIKV transmission.
   Methods and findings Multivariate models that calculated adjusted prevalence ratios (aPR) showed that among 175 and 152 residents of communities with and without AGO traps, respectively, an estimated 26.1% and 43.8% had been infected with CHIKV (aPR = 0.50, 95% CI: 0.37-0.91). After stratification by time spent in their community, protection from CHIKV infection was strongest among residents who reported spending many or all weekly daytime hours in their community:10.3% seropositive in communities with AGO traps vs. 48.7% in communities without (PR = 0.21, 95% CI: 0.11-0.41). The age-adjusted rate of fever with arthralgia attributable to CHIKV infection was 58% (95% CI: 46-66%). The monthly number of CHIKV-infected mosquitos and symptomatic residents were diminished in communities with AGO traps compared to those without.
   Conclusions These findings indicate that AGO traps are an effective tool that protects humans from infection with a virus transmitted by Ae. aegypti mosquitos. Future studies should evaluate their protective effectiveness in large, urban communities.
   Author summary Aedes species mosquitos transmit pathogens of public health importance, including dengue, Zika, and chikungunya viruses. No tools exist to control these mosquitos that sustainably and effectively prevent human infections. Autocidal gravid ovitraps (AGO traps) have been shown to sustainably reduce Aedes populations by >80%. After chikungunya virus was introduced into Puerto Rico, we conducted serosurveys in communities with and without AGO traps. We observed a two-fold lower prevalence of chikungunya virus infection among residents of communities with AGO traps compared to communities without. Among infected residents of communities with traps, a significant proportion likely had been infected while outside their community. These findings indicate that AGO traps are an effective tool that protects humans from infection with pathogens transmitted by Aedes mosquitos.
C1 [Sharp, Tyler M.; Lorenzi, Olga; Torres-Velasquez, Brenda; Acevedo, Veronica; Perez-Padilla, Janice; Rivera, Aidsa; Munoz-Jordan, Jorge; Margolis, Harold S.; Waterman, Stephen H.; Paz-Bailey, Gabriela; Barrera, Roberto] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR USA.
   [Sharp, Tyler M.; Waterman, Stephen H.] US PHS, Silver Spring, MD USA.
   [Biggerstaff, Brad J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Sharp, TM (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR USA.; Sharp, TM (corresponding author), US PHS, Silver Spring, MD USA.
EM tsharp@cdc.gov
OI Rivera, Aidsa/0000-0002-4548-5844
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Barrera R, 2019, MED VET ENTOMOL, V33, P68, DOI 10.1111/mve.12338
   Barrera R, 2019, J MED ENTOMOL, V56, P1033, DOI 10.1093/jme/tjz009
   Barrera R, 2019, AM J TROP MED HYG, V100, P1413, DOI 10.4269/ajtmh.19-0015
   Barrera R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2596-4
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P293, DOI 10.2987/13-6345R.1
   Barrozo R, DAILY RHYTHMS DIS VE
   Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   Cassadou S, 2013, EUROSURVEILLANCE, V19, P13
   Centers for Disease Control and Prevention and Panamerican Health Organization, 2011, PREP RESP CHIK VIR I
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Cockcroft A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4287-7
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Feldstein LR, 2017, EMERG INFECT DIS, V23, P673, DOI 10.3201/eid2304.161562
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hennessey MJ, 2018, AM J TROP MED HYG, V99, P1321, DOI 10.4269/ajtmh.18-0437
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Korn EL, 2011, ANAL HLTH SURVEYS
   Krishnamoorthy K, 2002, AM STAT, V56, P215, DOI 10.1198/000313002164
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Sarndal CE, 2005, WILEY SER SURV METH, P1
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Torres JR, 2015, IDCases, V2, P6, DOI 10.1016/j.idcr.2014.12.002
   United States Census Bureau, AM FACTFINDER 2011
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weaver SC, 2015, NEW ENGL J MED, V373, P94, DOI 10.1056/NEJMc1505501
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zou GY, 2008, STAT MED, V27, P1693, DOI 10.1002/sim.3095
NR 62
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2019
VL 13
IS 7
AR e0007538
DI 10.1371/journal.pntd.0007538
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IN4RG
UT WOS:000478662500033
PM 31344040
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stone, CM
   Schwab, SR
   Fonseca, DM
   Fefferman, NH
AF Stone, Chris M.
   Schwab, Samantha R.
   Fonseca, Dina M.
   Fefferman, Nina H.
TI Contrasting the value of targeted versus area-wide mosquito control
   scenarios to limit arbovirus transmission with human mobility patterns
   based on different tropical urban population centers
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HUMAN MOVEMENT; AEDES-AEGYPTI; BORNE DISEASE; DENGUE; DYNAMICS; IMPACT;
   DISPERSAL; NETWORK
AB Vector control is still our primary intervention for both prevention and mitigation of epidemics of many vector-borne diseases. Efficiently targeting control measures is important since control can involve substantial economic costs. Targeting is not always straightforward, as transmission of vector-borne diseases is affected by various types of host movement. Here we assess how taking daily commuting patterns into consideration can help improve vector control efforts. We examine three tropical urban centers (San Juan, Recife, and Jakarta) that have recently been exposed to Zika and/or dengue infections and consider whether the distribution of human populations and resulting commuting flows affects the optimal scale at which control interventions should be implemented. We developed a stochastic, spatial model and investigated four control scenarios. The scenarios differed in the spatial extent of their implementation and were: 1) a response at the level of an individual neighborhood; 2) a response targeted at a neighborhood in which infected humans were detected and the one with which it was most strongly connected by human movement; 3) a limited area-wide response where all neighborhoods within a certain radius of the focal area were included; and 4) a collective response where all participating neighborhoods implemented control. The relative effectiveness of the scenarios varied only slightly between different settings, with the number of infections averted over time increasing with the scale of implementation. This difference depended on the efficacy of control at the neighborhood level. At low levels of efficacy, the scenarios mirrored each other in infections averted. At high levels of efficacy, impact increased with the scale of the intervention. As a result, the choice between scenarios will not only be a function of the amount of effort decision-makers are willing to invest, but largely epend on the overall effectiveness of vector control approaches.
   Author summary Control and prevention of Aedes-transmitted viruses, such as dengue, chikungunya, or Zika relies heavily on vector control approaches. Given the effort and cost involved in implementation of vector control, targeting of control measures is highly desirable. However, it is unclear to what extent the effectiveness of highly focal and reactive control measures depends on the commuting and movement patterns of humans. To investigate this question, we developed a model and four control scenarios that ranged from highly focal to area-wide larval control. The distribution of humans and their commuting patterns were modelled after three major tropical urban centers, San Juan, Recife, and Jakarta. We show that as implementation is applied across a wider area, a greater number of infections is averted. Critically, this only occurs if the efficacy of control at the neighborhood level is sufficiently high. A consistent outcome across the three settings was that the focal strategy was most likely to provide the best outcome at lower levels of effort, and when the efficacy of control was low. These outcomes suggest that optimal control strategies will likely have to be tailored to individual settings by decision makers and would benefit from localized cost-effectiveness modelling studies.
C1 [Stone, Chris M.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.
   [Stone, Chris M.; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
   [Schwab, Samantha R.; Fonseca, Dina M.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
RP Stone, CM (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.; Stone, CM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
EM cstone@illinois.edu
RI Fonseca, Dina/B-9951-2011
OI Fonseca, Dina/0000-0003-4726-7100
FU National Science Foundation (NSF) RAPID [1640951]; State of Illinois
   Used Tire Management and Emergency Public Healths Funds
FX This work was supported by National Science Foundation (NSF) RAPID grant
   no. 1640951 to NHF. CMS was additionally supported through the State of
   Illinois Used Tire Management and Emergency Public Healths Funds. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Acevedo MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127552
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barrios E, 2018, J THEOR BIOL, V453, P14, DOI 10.1016/j.jtbi.2018.05.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Briggs A, 2006, DECISION MODELLING H
   Dalziel BD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0763
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   Erlander S., 1990, GRAVITY MODEL TRANSP
   Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Kim JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173673
   Kiss IZ, 2008, J R SOC INTERFACE, V5, P791, DOI 10.1098/rsif.2007.1272
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Marshall JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26023-1
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Nations U, 2014, WORLD URB PROSP 2014
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Perchoux C, 2013, HEALTH PLACE, V21, P86, DOI 10.1016/j.healthplace.2013.01.005
   Perkins TA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0390
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Prosper O, 2012, J THEOR BIOL, V303, P1, DOI 10.1016/j.jtbi.2012.02.010
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108
   Schwab S, 2019, ECOLOGICAL APPL
   Schwab SR, 2018, EPIDEMICS-NETH, V23, P55, DOI 10.1016/j.epidem.2017.12.004
   Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Stone CM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0336
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Turner HC, 2016, LANCET INFECT DIS, V16, P838, DOI 10.1016/S1473-3099(15)00268-6
   Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization, 2009, DENG GUID DIAGN TREA
   [World Health Organization Special Programme for Research TiTD], 2009, SPEC PROGR RES TITD
NR 47
TC 0
Z9 0
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2019
VL 13
IS 7
AR e0007479
DI 10.1371/journal.pntd.0007479
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IN4RG
UT WOS:000478662500017
PM 31269020
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cagno, V
   Tseligka, ED
   Jones, ST
   Tapparel, C
AF Cagno, Valeria
   Tseligka, Eirini D.
   Jones, Samuel T.
   Tapparel, Caroline
TI Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or
   Adaptation Bias?
SO VIRUSES-BASEL
LA English
DT Review
DE viral attachment receptor; heparan sulfate proteoglycans; HSPG;
   syndecans; glypicans; viral adaptation; intra-host adaptation; tropism;
   broad-spectrum antivirals; viral binding
ID RESPIRATORY-SYNCYTIAL-VIRUS; HERPES-SIMPLEX-VIRUS; COLI POLYSACCHARIDE
   DERIVATIVES; GLYCOSAMINOGLYCAN-BINDING VARIANTS; HUMAN
   CYTOMEGALOVIRUS-INFECTION; JAPANESE ENCEPHALITIS-VIRUS; ENTEROVIRUS 71
   INFECTION; CAPSID PROTEIN VP1; DENGUE-VIRUS; ZIKA VIRUS
AB Heparan sulfate proteoglycans (HSPG) are composed of unbranched, negatively charged heparan sulfate (HS) polysaccharides attached to a variety of cell surface or extracellular matrix proteins. Widely expressed, they mediate many biological activities, including angiogenesis, blood coagulation, developmental processes, and cell homeostasis. HSPG are highly sulfated and broadly used by a range of pathogens, especially viruses, to attach to the cell surface. In this review, we summarize the current knowledge on HSPG-virus interactions and distinguish viruses with established HS binding, viruses that bind HS only after intra-host or cell culture adaptation, and finally, viruses whose dependence on HS for infection is debated. We also provide an overview of the antiviral compounds designed to interfere with HS binding. Many questions remain about the true importance of these receptors in vivo, knowledge that is critical for the design of future antiviral therapies.
C1 [Cagno, Valeria; Tseligka, Eirini D.; Tapparel, Caroline] Univ Geneva, Med Sch, Dept Microbiol & Mol Med, CH-1205 Geneva, Switzerland.
   [Jones, Samuel T.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
RP Cagno, V (corresponding author), Univ Geneva, Med Sch, Dept Microbiol & Mol Med, CH-1205 Geneva, Switzerland.
EM valeria.cagno@unige.ch
RI Cagno, Valeria/AAE-7612-2020
OI Cagno, Valeria/0000-0002-5597-334X; Jones, Samuel/0000-0002-3907-0810
FU Leenaards Foundation [ME10409]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [310030_184777]; Sinergia grant
   [ME11323]
FX C.T. was supported by Leenaards Foundation grant n ME10409 and Swiss
   National Science Foundation grant n. 310030_184777 and Sinergia grant
   ME11323.
CR Acosta EG, 2014, VIRUS RES, V184, P39, DOI 10.1016/j.virusres.2014.02.011
   Agelidis AM, 2015, FUTURE VIROL, V10, P1145, DOI 10.2217/fvl.15.85
   Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x
   Anderson RA, 2002, J ANDROL, V23, P426
   [Anonymous], 2011, PEREIRA J CURRENT ON, V18, pe38
   Artpradit C, 2013, VIRUS RES, V176, P69, DOI 10.1016/j.virusres.2013.04.017
   Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140
   BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742
   Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R
   Becker M, 2018, J VIROL, V92, DOI 10.1128/JVI.02106-17
   Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093
   Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524
   Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004
   Bochkov YA, 2016, VIROLOGY, V499, P350, DOI 10.1016/j.virol.2016.09.025
   Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112
   Bon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076482
   Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484
   Brady MT, 2014, PEDIATRICS, V134, P415, DOI 10.1542/peds.2014-1665
   Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069
   Buck CB, 2013, VIROLOGY, V445, P169, DOI 10.1016/j.virol.2013.05.038
   Busse-Wicher M, 2014, MATRIX BIOL, V35, P25, DOI 10.1016/j.matbio.2013.10.001
   Cagno V, 2018, NAT MATER, V17, P195, DOI [10.1038/NMAT5053, 10.1038/nmat5053]
   Cagno V, 2015, ANTIMICROB AGENTS CH, V59, P5250, DOI 10.1128/AAC.00443-15
   Cagno V, 2014, ANTIMICROB AGENTS CH, V58, P4782, DOI 10.1128/AAC.02594-14
   Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032
   Chang A, 2012, J VIROL, V86, P3230, DOI 10.1128/JVI.06706-11
   Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004
   Chirkova T, 2015, J GEN VIROL, V96, P2543, DOI 10.1099/vir.0.000218
   Chiu YH, 2012, ANTIVIR RES, V95, P128, DOI 10.1016/j.antiviral.2012.05.009
   Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001
   Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998
   COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192
   Connell BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00385
   Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826
   Crim RL, 2007, J VIROL, V81, P261, DOI 10.1128/JVI.01226-06
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12
   de Haan CAM, 2008, J VIROL, V82, P6078, DOI 10.1128/JVI.00074-08
   DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992
   Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171
   Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001
   Delputte PL, 2005, J GEN VIROL, V86, P1441, DOI 10.1099/vir.0.80675-0
   Donalisio M, 2016, BIOMATERIALS, V85, P40, DOI 10.1016/j.biomaterials.2016.01.055
   Donalisio M, 2014, ANTIMICROB AGENTS CH, V58, P6315, DOI 10.1128/AAC.03420-14
   Donalisio M, 2012, ANTIMICROB AGENTS CH, V56, P5278, DOI 10.1128/AAC.00771-12
   Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10
   Du N, 2014, J VIROL, V88, P5816, DOI 10.1128/JVI.03826-13
   Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801
   Escribano-Romero E, 2004, J GEN VIROL, V85, P653, DOI 10.1099/vir.0.19603-0
   Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000
   Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fujii K, 2018, J VIROL, V92, DOI 10.1128/JVI.00682-18
   Gao HX, 2019, VIROLOGY, V529, P91, DOI 10.1016/j.virol.2019.01.019
   Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719
   Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108
   Geoghegan EM, 2017, CELL REP, V21, P1169, DOI 10.1016/j.celrep.2017.10.027
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035
   Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001
   Goodfellow IG, 2001, J VIROL, V75, P4918, DOI 10.1128/JVI.75.10.4918-4921.2001
   Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198
   Griggs TF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0567-0
   Gwaltney JM, 2002, AM J MED, V112, p13S
   Hadigal SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7985
   Haeger SM, 2018, AM J RESP CELL MOL, V59, P363, DOI 10.1165/rcmb.2017-0428OC
   Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000
   Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784
   Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600
   Hendricks GL, 2015, ANTIVIR RES, V116, P34, DOI 10.1016/j.antiviral.2015.01.008
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839
   Hopkins J, 2018, J VIROL, V92, DOI 10.1128/JVI.01179-18
   Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11
   Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004
   Israelsson S, 2010, VIRUS RES, V151, P170, DOI 10.1016/j.virusres.2010.05.001
   Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08
   Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115
   Johnson SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005318
   Jones KS, 2006, J VIROL, V80, P8291, DOI 10.1128/JVI.00389-06
   Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC
   Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09
   Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533
   Khan AG, 2007, J VIROL, V81, P4625, DOI 10.1128/JVI.02160-06
   Khan AG, 2011, VIROLOGY, V412, P55, DOI 10.1016/j.virol.2010.12.042
   Kherad O, 2010, CHEST, V138, P896, DOI 10.1378/chest.09-2225
   Kim SY, 2019, BIOCHEMISTRY-US, V58, P1155, DOI 10.1021/acs.biochem.8b01267
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Klimyte EM, 2016, J VIROL, V90, P9237, DOI 10.1128/JVI.01362-16
   Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x
   Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07
   Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Liu W, 2016, CURR OPIN VIROL, V20, P20, DOI 10.1016/j.coviro.2016.07.011
   Longarela OL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058340
   Luganini A, 2010, ANTIVIR RES, V85, P532, DOI 10.1016/j.antiviral.2010.01.003
   Maginnis MS, 2010, J VIROL, V84, P9677, DOI 10.1128/JVI.00978-10
   Magnan S, 2019, CLIN MICROBIOL INFEC, V25, P210, DOI 10.1016/j.cmi.2018.04.012
   Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Marais D, 2011, ANTIVIR THER, V16, P1219, DOI 10.3851/IMP1890
   Mathieu C, 2015, MBIO, V6, DOI 10.1128/mBio.02427-14
   McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1016/S0168-6445(02)00070-0
   Mercorelli B, 2010, ANTIMICROB AGENTS CH, V54, P4561, DOI 10.1128/AAC.00721-10
   Merilahti P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147168
   Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14
   Misinzo G, 2006, J VIROL, V80, P3487, DOI 10.1128/JVI.80.7.3487-3494.2006
   Murakami S, 2017, J VIROL, V91, DOI 10.1128/JVI.00503-17
   Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004
   Nishimura Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003511
   Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961
   O'Hearn A, 2015, J VIROL, V89, P5441, DOI 10.1128/JVI.03689-14
   Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X
   Pacciarini F, 2004, MICROBIOLOGICA, V27, P5
   PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pinna D, 2008, ANTIMICROB AGENTS CH, V52, P3078, DOI 10.1128/AAC.00359-08
   Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176
   Pomin VH, 2017, CURR PHARM DESIGN, V23, P3405, DOI 10.2174/1381612823666170127113958
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Price CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024095
   Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2
   Raff AB, 2013, J VIROL, V87, P6062, DOI 10.1128/JVI.00330-13
   Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312
   Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15
   Richards KF, 2013, J VIROL, V87, P11426, DOI 10.1128/JVI.01721-13
   Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103
   Rodriguez A, 2014, ANTIVIR RES, V108, P88, DOI 10.1016/j.antiviral.2014.05.018
   Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001
   Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06
   SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997
   Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12
   Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952
   Sasaki M, 2018, J INFECT DIS, V217, P1740, DOI 10.1093/infdis/jiy081
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidtke M, 2003, VIROLOGY, V311, P134, DOI 10.1016/S0042-6822(03)00166-1
   Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161
   Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x
   Seitz S, 2016, CELL HOST MICROBE, V20, P25, DOI 10.1016/j.chom.2016.05.013
   Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07
   Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/S0140-6736(17)30938-8, 10.1016/s0140-6736(17)30938-8]
   Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5
   Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002
   Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x
   Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13
   Su PY, 2015, J VIROL, V89, P4527, DOI 10.1128/JVI.03498-14
   Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998
   Surviladze Z, 2015, J GEN VIROL, V96, P2232, DOI 10.1099/vir.0.000147
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tamura M, 2004, J VIROL, V78, P3817, DOI 10.1128/JVI.78.8.3817-3826.2004
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12
   Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163
   Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444
   Thammawat S, 2008, J VIROL, V82, P11767, DOI 10.1128/JVI.01208-08
   Tiwari V, 2007, J GEN VIROL, V88, P1075, DOI 10.1099/vir.0.82476-0
   Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06
   Tiwari V, 2015, MOLECULES, V20, P2707, DOI 10.3390/molecules20022707
   Trybala E, 1998, J BIOL CHEM, V273, P5047, DOI 10.1074/jbc.273.9.5047
   Tseligka ED, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007190
   UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V
   Upfold N, 2018, VIRUS RES, V244, P153, DOI 10.1016/j.virusres.2017.11.017
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Vervaeke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074035
   Vlasak M, 2005, J VIROL, V79, P5963, DOI 10.1128/JVI.79.10.5963-5970.2005
   Wang Y, 2016, MBIO, V7, DOI 10.1128/mBio.00119-16
   Whitley R, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P589
   Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314
   Xu Y, 2015, J VIROL, V89, P3846, DOI 10.1128/JVI.03647-14
   Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992
   Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141
   Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11
   Yi EJ, 2017, CLIN EXP VACCINE RES, V6, P4, DOI [10.7774/cevr.2017.6.1.4, 10.7774/cevr.2017.6.1.4.]
   Zaiss AK, 2016, J VIROL, V90, P412, DOI 10.1128/JVI.01939-15
   Zautner AE, 2003, J VIROL, V77, P10071, DOI 10.1128/JVI.77.18.10071-10077.2003
   Zhang B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-243
   Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005
NR 197
TC 9
Z9 9
U1 4
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2019
VL 11
IS 7
AR 596
DI 10.3390/v11070596
PG 24
WC Virology
SC Virology
GA IN4TA
UT WOS:000478667800039
PM 31266258
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Conzelmann, C
   Zou, M
   Gross, R
   Harms, M
   Rocker, A
   Riedel, CU
   Munch, J
   Muller, JA
AF Conzelmann, Carina
   Zou, Min
   Gross, Ruediger
   Harms, Mirja
   Roecker, Annika
   Riedel, Christian U.
   Muench, Jan
   Mueller, Janis A.
TI Storage-Dependent Generation of Potent Anti-ZIKV Activity in Human
   Breast Milk
SO VIRUSES-BASEL
LA English
DT Article
DE zika virus; breast milk; transmission; breastfeeding
ID FATTY-ACIDS; VIRUS; INACTIVATION; TRANSMISSION; LACTATION; PROTEINS;
   LIPASE; TIME
AB Zika virus (ZIKV) causes congenital neurologic birth defects, notably microcephaly, and has been associated with other serious complications in adults. The virus has been detected in human breast milk and possible transmissions via breastfeeding have been reported. Breast milk is rich in nutrients and bio-active substances that might directly affect viral infectivity. Thus, here, we analyzed the effect of human breast milk on ZIKV infection. We observed that fresh human breast milk had no effect on ZIKV, but found that upon storage, milk effectively suppressed infection. The antiviral activity is present in the fat-containing cream fraction of milk and results in the destruction of the structural integrity of viral particles, thereby abrogating infectivity. The release of the factor is time dependent but varies with donors and incubation temperatures. The viral titer of milk that was spiked with ZIKV decreased considerably upon storage at 37 degrees C for 8 h, was lost entirely after 2 days of 4 degrees C storage, but was not affected at -20 degrees C. This suggests that cold storage of milk inactivates ZIKV and that the antiviral factor in milk may also be generated upon breastfeeding and limit this transmission route of ZIKV.
C1 [Conzelmann, Carina; Zou, Min; Gross, Ruediger; Harms, Mirja; Roecker, Annika; Muench, Jan; Mueller, Janis A.] Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.
   [Zou, Min] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Guangzhou 510515, Guangdong, Peoples R China.
   [Riedel, Christian U.] Ulm Univ, Inst Microbiol & Biotechnol, D-89081 Ulm, Germany.
   [Muench, Jan] Ulm Univ, Core Facil Funct Peptid, Med Ctr, D-89081 Ulm, Germany.
RP Munch, J; Muller, JA (corresponding author), Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.; Munch, J (corresponding author), Ulm Univ, Core Facil Funct Peptid, Med Ctr, D-89081 Ulm, Germany.
EM jan.muench@uni-ulm.de; janis.mueller@uni-ulm.de
OI Riedel, Christian/0000-0001-7134-7085; Jan, Munch/0000-0001-7316-7141
FU Collaborative Research Centre grant of the German Research Foundation
   [316249678 - SFB 1279]; Baden-Wurttemberg Stiftung; International
   Graduate School of Molecular Medicine Ulm
FX This research was funded by a Collaborative Research Centre grant of the
   German Research Foundation (316249678 - SFB 1279) to J.M. J.A.M. is
   indebted to the Baden-Wurttemberg Stiftung for the financial support of
   this research project by the Eliteprogramme for Postdocs. C.C. is a part
   of and R.G. is funded by a scholarship from the International Graduate
   School of Molecular Medicine Ulm.
CR AHRNE L, 1985, J DAIRY RES, V52, P55, DOI 10.1017/S002202990002389X
   Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013
   Atkinson S.A., 1989, PROTEINS NONPROTEIN
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blans K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1294340
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blohm GM, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00231-17, 10.1128/genomea.00231-17]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Chirico G, 2008, J NUTR, V138, p1801S
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickow JA, 2011, J DAIRY SCI, V94, P646, DOI 10.3168/jds.2010-3549
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fox P. F., 2003, Dairy processing: improving quality, P5
   Fox P.F., 2003, ADV DAIRY CHEM, P467
   FREDRIKZON B, 1978, PEDIATR RES, V12, P1048, DOI 10.1203/00006450-197811000-00004
   FREED LM, 1989, J AM COLL NUTR, V8, P143
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HIBBERD CM, 1982, ARCH DIS CHILD, V57, P658, DOI 10.1136/adc.57.9.658
   ISAACS CE, 1986, J INFECT DIS, V154, P966, DOI 10.1093/infdis/154.6.966
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Khan S, 2013, J HUM LACT, V29, P81, DOI 10.1177/0890334412448841
   KOHN A, 1980, ARCH VIROL, V66, P301, DOI 10.1007/BF01320626
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lawrence RM, 2004, CLIN PERINATOL, V31, P501, DOI 10.1016/j.clp.2004.03.019
   Liao Y, 2011, J PROTEOME RES, V10, P5409, DOI 10.1021/pr200660t
   Mandal SM, 2014, PEPTIDES, V56, P84, DOI 10.1016/j.peptides.2014.03.017
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Martin CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050279
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   MEHTA NR, 1982, J PEDIATR GASTR NUTR, V1, P317, DOI 10.1097/00005176-198201030-00007
   Mohanty D, 2016, INT J FOOD PROP, V19, P837, DOI 10.1080/10942912.2015.1048356
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morozov V, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700679
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Pfaender S, 2013, J INFECT DIS, V208, P1943, DOI 10.1093/infdis/jit519
   Garcia-Lara NR, 2012, BREASTFEED MED, V7, P295, DOI 10.1089/bfm.2011.0079
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regla-Nava JA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007080
   Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732
   World Health Organization, 2016, INF FEED AR ZIK VIR
NR 59
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2019
VL 11
IS 7
AR 591
DI 10.3390/v11070591
PG 15
WC Virology
SC Virology
GA IN4TA
UT WOS:000478667800040
PM 31261806
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Poonsiri, T
   Wright, GSA
   Solomon, T
   Antonyuk, SV
AF Poonsiri, Thanalai
   Wright, Gareth S. A.
   Solomon, Tom
   Antonyuk, Svetlana, V
TI Crystal Structure of the Japanese Encephalitis Virus Capsid Protein
SO VIRUSES-BASEL
LA English
DT Article
DE flavivirus; core protein; x-ray crystallography; homodimer
ID N-TERMINAL REGION; DENGUE-VIRUS; CORE PROTEIN; NUCLEAR-LOCALIZATION;
   FLAVIVIRUS; REPLICATION; INHIBITOR; TARGETS
AB Japanese encephalitis (JE) is inflammation and swelling of the brain caused by the JE virus (JEV), a mosquito-borne member of the Flavivirus family. There are around 68,000 JE cases worldwide each year, many of which result in permanent brain damage and death. There is no specific treatment for JE. Here we present the crystal structure of the JEV capsid protein, a potential drug target, at 1.98 angstrom, and compare it to other flavivirus capsid proteins. The JEV capsid has a helical secondary structure (alpha helixes 1-4) and a similar protein fold to the dengue virus (DENV), the West Nile virus (WNV), and the Zika virus (ZIKV) capsid proteins. It forms a homodimer by antiparallel pairing with another subunit (') through alpha-helix 1-1', 2-2', and 4-4' interactions. This dimeric form is believed to be the building block of the nucleocapsid. The flexibility of the N-terminal alpha helix-1 allows the formation of closed and open conformations with possible functional importance. The basic C-terminal pairing of alpha 4-4' forms a coiled-coil-like structure, indicating possible nucleic acid binding functionality. However, a comparison with other nucleic acid interacting domains indicates that homodimerization would preclude binding. This is the first JEV capsid protein to be described and is an addition to the structural biology of the Flavivirus.
C1 [Poonsiri, Thanalai; Wright, Gareth S. A.; Antonyuk, Svetlana, V] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England.
   [Poonsiri, Thanalai; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England.
   [Poonsiri, Thanalai] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.
RP Antonyuk, SV (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England.
EM s.antonyuk@liverpool.ac.uk
RI Antonyuk, Svetlana/W-5159-2019
OI Antonyuk, Svetlana/0000-0002-2779-9946; Wright,
   Gareth/0000-0002-3756-9634; Solomon, Tom/0000-0001-7266-6547
FU Mahidol-Liverpool Stang Mongkolsuk PhD scholarship; National Institute
   for Health Research (NIHR) Health Protection Research Unit in Emerging
   and Zoonotic Infections; NIHR Program [RP-PG-0108-10,048, 17/63/110];
   European Union's Horizon 2020 research and innovation program ZikaPLAN
   (Preparedness Latin America Network) [734584]
FX This work was supported by the Mahidol-Liverpool Stang Mongkolsuk PhD
   scholarship. T.S. is supported by the National Institute for Health
   Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic
   Infections and two NIHR Program Grants (RP-PG-0108-10,048 and
   17/63/110)"and the European Union's Horizon 2020 research and innovation
   program ZikaPLAN (Preparedness Latin America Network), grant agreement
   No. 734584.
CR Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Hakoshima T., 2005, ENCY LIFE SCI, DOI [10.1038/npg.els.0005049, DOI 10.1038/NPG.ELS.0005049]
   Hayakawa M, 2015, BIOCHEM BIOPH RES CO, V463, P1165, DOI 10.1016/j.bbrc.2015.06.077
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Ishikawa T, 2015, EXPERT OPIN THER TAR, V19, P1379, DOI 10.1517/14728222.2015.1065817
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Liu XY, 2019, PROTEIN CELL, V10, P149, DOI 10.1007/s13238-018-0551-6
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Makarov VA, 2015, CHEMMEDCHEM, V10, P1629, DOI 10.1002/cmdc.201500304
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Poonsiri T, 2018, J VIROL, V92, DOI [10.1128/JVI.01868-17, 10.1128/jvi.01868-17]
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 48
TC 4
Z9 4
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2019
VL 11
IS 7
AR 623
DI 10.3390/v11070623
PG 11
WC Virology
SC Virology
GA IN4TA
UT WOS:000478667800003
PM 31284608
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sexton, NR
   Ebel, GD
AF Sexton, Nicole R.
   Ebel, Gregory D.
TI Effects of Arbovirus Multi-Host Life Cycles on Dinucleotide and Codon
   Usage Patterns
SO VIRUSES-BASEL
LA English
DT Review
DE dinucleotide; codon; robustness; mosquito; arthropod-borne viruses;
   arbovirus; purifying selection; diversification
ID TRANSFER-RNA GENES; HEPATITIS-C-VIRUS; MUTATIONAL ROBUSTNESS; POPULATION
   DIVERSITY; EVOLUTION; BIAS; FITNESS; GENOME; ADAPTATION; SELECTION
AB Arthropod-borne viruses (arboviruses) of vertebrates including dengue, zika, chikungunya, Rift Valley fever, and blue tongue viruses cause extensive morbidity and mortality in humans, agricultural animals, and wildlife across the globe. As obligate intercellular pathogens, arboviruses must be well adapted to the cellular and molecular environment of both their arthropod (invertebrate) and vertebrate hosts, which are vastly different due to hundreds of millions of years of separate evolution. Here we discuss the comparative pressures on arbovirus RNA genomes as a result of a dual host life cycle, focusing on pressures that do not alter amino acids. We summarize what is currently known about arboviral genetic composition, such as dinucleotide and codon usage, and how cyclical infection of vertebrate and invertebrate hosts results in different genetic profiles compared with single-host viruses. To serve as a comparison, we compile what is known about arthropod tRNA, dinucleotide, and codon usages and compare this with vertebrates. Additionally, we discuss the potential roles of genetic robustness in arboviral evolution and how it may vary from other viruses. Overall, both arthropod and vertebrate hosts influence the resulting genetic composition of arboviruses, but a great deal remains to be investigated.
C1 [Sexton, Nicole R.; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM gregory.ebel@colostate.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1-AI067380, R21-AI125996,
   R21-AI129593]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX This work was supported by NIH grants RO1-AI067380 (G.D.E.),
   R21-AI125996 (G.D.E.), and R21-AI129593 (G.D.E.) from the National
   Institute of Allergy and Infectious Diseases.
CR Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127
   Martinez MA, 2016, TRENDS MICROBIOL, V24, P134, DOI 10.1016/j.tim.2015.11.002
   Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075
   Behura SK, 2011, INSECT MOL BIOL, V20, P177, DOI 10.1111/j.1365-2583.2010.01055.x
   Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x
   Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642
   Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Braun T, 2019, BIOINFORMATICS, V35, P1907, DOI 10.1093/bioinformatics/bty891
   Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Burow DA, 2018, CELL REP, V24, P1704, DOI 10.1016/j.celrep.2018.07.039
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Chan ST, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080224
   Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100
   Chiari Y, 2010, J MOL EVOL, V70, P339, DOI 10.1007/s00239-010-9329-z
   Ciota AT, 2007, J GEN VIROL, V88, P2398, DOI 10.1099/vir.0.83061-0
   Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Cuevas JM, 2009, J EVOLUTION BIOL, V22, P2041, DOI 10.1111/j.1420-9101.2009.01817.x
   Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522
   de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738
   de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R
   Di Giallonardo F, 2017, J VIROL, V91, DOI 10.1128/JVI.02381-16
   Dolan PT, 2018, CELL HOST MICROBE, V23, P435, DOI 10.1016/j.chom.2018.03.012
   Drolet BS, 2015, VECTOR-BORNE ZOONOT, V15, P339, DOI 10.1089/vbz.2014.1701
   Elena SF, 2012, CURR OPIN VIROL, V2, P525, DOI 10.1016/j.coviro.2012.06.008
   Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469
   Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050
   Fares MA, 2015, TRENDS GENET, V31, P373, DOI 10.1016/j.tig.2015.04.008
   Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249
   Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005
   Grubaugh ND, 2016, CURR OPIN VIROL, V21, P132, DOI 10.1016/j.coviro.2016.09.007
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Gumpper RH, 2019, J VIROL, V93, DOI 10.1128/JVI.01775-18
   Halbach R, 2017, CURR OPIN INSECT SCI, V22, P16, DOI 10.1016/j.cois.2017.05.004
   Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91
   Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442
   Jacobson GN, 2016, CURR OPIN STRUC BIOL, V38, P102, DOI 10.1016/j.sbi.2016.06.002
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837
   Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227
   Keller BC, 2007, CYTOKINE GROWTH F R, V18, P535, DOI 10.1016/j.cytogfr.2007.06.006
   Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010
   Krizek M, 2012, J THEOR BIOL, V304, P183, DOI 10.1016/j.jtbi.2012.03.026
   Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lachowiec J, 2016, ANN BOT-LONDON, V117, P795, DOI 10.1093/aob/mcv151
   Laksono BM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080210
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008
   Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Liu T, 2018, DEV COMP IMMUNOL, V83, P34, DOI 10.1016/j.dci.2017.12.025
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Luo XL, 2015, J BASIC MICROB, V55, P1374, DOI 10.1002/jobm.201500233
   Maclachlan NJ, 2019, CURR OPIN VIROL, V34, P56, DOI 10.1016/j.coviro.2018.12.005
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004
   Moratorio G, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.88
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Moutailler S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001156
   Nelson CW, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey013
   Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   NOVELLA IS, 1995, J VIROL, V69, P6805, DOI 10.1128/JVI.69.11.6805-6809.1995
   Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635
   Novella IS, 2011, J MOL MICROB BIOTECH, V21, P71, DOI 10.1159/000332752
   Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050
   Ochsenreiter R, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030298
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Parisien M, 2013, RNA BIOL, V10, P1853, DOI 10.4161/rna.27361
   PEDEN JF, 1999, THESIS U NOTTINGHAM, P1
   Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101
   Pinheiro M, 2006, METHOD INFORM MED, V45, P163
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Prostova MA, 2015, RNA BIOL, V12, P1338, DOI 10.1080/15476286.2015.1100794
   Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102
   Rihn SJ, 2015, J VIROL, V89, P552, DOI 10.1128/JVI.02451-14
   Rodrigo G, 2017, J PROTEOMICS, V156, P1, DOI 10.1016/j.jprot.2016.12.007
   Rodriguez O, 2012, INFECT GENET EVOL, V12, P1535, DOI 10.1016/j.meegid.2012.06.005
   Sanjuan R, 2010, PHILOS T R SOC B, V365, P1975, DOI 10.1098/rstb.2010.0063
   Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77
   Schweizer M, 2014, ANNU REV ANIM BIOSCI, V2, P141, DOI 10.1146/annurev-animal-022513-114209
   Sharma G, 2018, IUBMB LIFE, V70, P41, DOI 10.1002/iub.1702
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Simmonds P, 2015, P NATL ACAD SCI USA, V112, pE3633, DOI 10.1073/pnas.1507339112
   Simon D, 2017, BIOCHEM BIOPH RES CO, V492, P572, DOI 10.1016/j.bbrc.2017.06.088
   Singh NK, 2017, ARCH VIROL, V162, P1963, DOI 10.1007/s00705-017-3324-2
   Smith BL, 2018, MBIO, V9, DOI 10.1128/mBio.01222-18
   Smyth RP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02097
   Song YT, 2017, P NATL ACAD SCI USA, V114, pE8731, DOI 10.1073/pnas.1714385114
   Stauft CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198303
   Stern A, 2014, CELL REP, V8, P1026, DOI 10.1016/j.celrep.2014.07.011
   Supek F, 2016, J MOL EVOL, V82, P65, DOI 10.1007/s00239-015-9714-8
   Takata M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006824
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Tuorto F, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160287
   Vabret N, 2017, TRENDS IMMUNOL, V38, P53, DOI 10.1016/j.it.2016.10.006
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Velazquez-Salinas L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159943
   Velazquez-Salinas L, 2016, VIROLOGY, V494, P178, DOI 10.1016/j.virol.2016.04.007
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Visher E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005856
   Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Warmbrod KL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007610
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whittle CA, 2015, G3-GENES GENOM GENET, V5, P2307, DOI 10.1534/g3.115.021402
   Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Xu X, 2017, MICROB PATHOGENESIS, V107, P368, DOI 10.1016/j.micpath.2017.04.019
   Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015
NR 124
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2019
VL 11
IS 7
AR 643
DI 10.3390/v11070643
PG 20
WC Virology
SC Virology
GA IN4TA
UT WOS:000478667800084
PM 31336898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, F
   Bier, J
   Christensen, J
   Engelmann, L
   Helgesson, CF
   Williams, R
AF Lee, Francis
   Bier, Jess
   Christensen, Jeffrey
   Engelmann, Lukas
   Helgesson, Claes-Fredrik
   Williams, Robin
TI Algorithms as folding: Reframing the analytical focus
SO BIG DATA & SOCIETY
LA English
DT Article
DE Actor-network theory; algorithms; folding; normativities; social theory;
   theory
AB This article proposes an analytical approach to algorithms that stresses operations of folding. The aim of this approach is to broaden the common analytical focus on algorithms as biased and opaque black boxes, and to instead highlight the many relations that algorithms are interwoven with. Our proposed approach thus highlights how algorithms fold heterogeneous things: data, methods and objects with multiple ethical and political effects. We exemplify the utility of our approach by proposing three specific operations of folding-proximation, universalisation and normalisation. The article develops these three operations through four empirical vignettes, drawn from different settings that deal with algorithms in relation to AIDS, Zika and stock markets. In proposing this analytical approach, we wish to highlight the many different attachments and relations that algorithms enfold. The approach thus aims to produce accounts that highlight how algorithms dynamically combine and reconfigure different social and material heterogeneities as well as the ethical, normative and political consequences of these reconfigurations.
C1 [Lee, Francis; Helgesson, Claes-Fredrik] Uppsala Univ, Uppsala, Sweden.
   [Bier, Jess] Erasmus Univ, Rotterdam, Netherlands.
   [Christensen, Jeffrey] Linkopings Univ, Linkoping, Sweden.
   [Engelmann, Lukas; Williams, Robin] Univ Edinburgh, Edinburgh, Midlothian, Scotland.
RP Lee, F (corresponding author), Uppsala Univ, Uppsala, Sweden.
EM francis@francislee.org
OI Lee, Francis/0000-0002-7206-2046; Engelmann, Lukas/0000-0002-2175-0156
FU Riksbankens jubileumsfond
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: We would
   like to thank Riksbankens jubileumsfond for their generous funding of
   the workshops and PhD summer school that made this article possible.
CR Ames MG, 2018, BIG DATA SOC, V5, DOI 10.1177/2053951718779194
   Amoore L., 2013, POLITICS POSSIBILITY
   Angwin Julia, 2016, PROPUBLICA
   Bauer S, 2016, EASST 4S C BARC 31 A
   Benbouzid B, 2017, RESEAUX, V206, P95
   Bloor David, 1976, KNOWLEDGE SOCIAL IMA, P1
   Burrell J, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951715622512
   CALLON M, 1995, S ATL Q, V94, P481
   Christin A, 2017, BIG DATA SOC, V4, DOI 10.1177/2053951717718855
   COLLINS HM, 1975, SOCIOLOGY, V9, P205, DOI 10.1177/003803857500900202
   Daston L., 2019, AGAINST NATURE
   Deleuze Gilles, 1993, FOLD LEIBNIZ BAROQUE
   Diakopoulos N, 2016, COMMUN ACM, V59, P56, DOI 10.1145/2844110
   Dourish P, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716665128
   ENGELMANN L, 2018, MAPPING AIDS VISUAL
   Eubanks V, 2018, AUTOMATING INEQUALIT
   GOULD P, 1991, INTERFACES, V21, P80, DOI 10.1287/inte.21.3.80
   HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066
   Introna L., 2004, SURVEILLANCE SOC, V2, P177, DOI [DOI 10.1057/9780230594180, DOI 10.24908/ss.v2i2/3.3373]
   Kassam Ashifa, 2016, GUARDIAN
   Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07
   Kirkpatrick K, 1959, COMMUN ACM, V59, P16
   Koch Tom, 2005, CARTOGRAPHIES DIS MA
   Latour B, 2002, THEOR CULT SOC, V19, P247, DOI 10.1177/026327602761899246
   Latour B, 1999, ACTOR NETWORK THEORY AND AFTER, P15
   Latour B., 2010, SOCIAL GABRIEL TARDE, P145
   Latour B, 2012, BRIT J SOCIOL, V63, P590, DOI 10.1111/j.1468-4446.2012.01428.x
   Lowrie I, 2017, BIG DATA SOC, V4, DOI 10.1177/2053951717700925
   MacKenzie Donald A., 2006, ENGINE NOT CAMERA FI
   Mandelbrot B., 1997, FRACTALS SCALING FIN
   Mandelbrot BB, 2004, MIS EHAV MARKETS FRA
   McQuillan D, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716671340
   MOL A, 1994, SOC STUD SCI, V24, P641, DOI 10.1177/030631279402400402
   Murphy G, 2017, EPIDEMIOL INFECT, V145, P925, DOI 10.1017/S0950268816002910
   Noble S., 2018, ALGORITHMS OPPRESSIO
   Pasquale F., 2015, BLACK BOX SOC SECRET
   Ribes D, 2018, SCI TECHNOL, P514
   Ruppert E, 2018, COMPUTATIONAL CULTUR, V3, P1
   Ruppert E., 2013, DIALOGUES HUMAN GEOG, V3, P268, DOI [10.1177/2043820613514321, DOI 10.1177/2043820613514321]
   Sandvig C, 2016, INT J COMMUN-US, V10, P4972
   Seaver N, 2012, LIMN, V12
   Seaver N, 2018, CULT ANTHROPOL, V33, P375, DOI 10.14506/ca33.3.04
   Serres Michel, 1995, CONVERSATIONS SCI CU
   Steiner C., 2012, AUTOMATE THIS ALGORI
   Weait M, 2011, 3 M TECHN ADV GROUP
   Zarsky T, 2016, SCI TECHNOL HUM VAL, V41, P118, DOI 10.1177/0162243915605575
   Ziewitz M, 2016, SCI TECHNOL HUM VAL, V41, P3, DOI 10.1177/0162243915608948
NR 47
TC 1
Z9 1
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2053-9517
J9 BIG DATA SOC
JI Big Data Soc.
PD JUL
PY 2019
VL 6
IS 2
AR 2053951719863819
DI 10.1177/2053951719863819
PG 12
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA IN3SI
UT WOS:000478596200001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Souza, INDO
   Frost, P
   Franca, J
   Nascimento-Viana, J
   Neris, R
   Nogueira, C
   Neves, G
   Chimelli, L
   De-Felice, F
   Ferreira, S
   Assuncao-Miranda, I
   Figueiredo, C
   Poian, AD
   Clarke, J
AF Souza, I. N. D. O.
   Frost, P.
   Franca, J.
   Nascimento-Viana, J.
   Neris, R.
   Nogueira, C.
   Neves, G.
   Chimelli, L.
   De-Felice, F.
   Ferreira, S.
   Assuncao-Miranda, I.
   Figueiredo, C.
   Poian, A. D.
   Clarke, J.
TI Acute and chronic neurological consequences of neonatal zika virus
   infection in mice
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Souza, I. N. D. O.; Frost, P.; Nascimento-Viana, J.; Nogueira, C.; Figueiredo, C.; Clarke, J.] Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, Brazil.
   [Frost, P.; Franca, J.; Neves, G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Neris, R.; Assuncao-Miranda, I.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Chimelli, L.] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [De-Felice, F.; Ferreira, S.; Poian, A. D.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [De-Felice, F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA MTU05-06
BP 105
EP 105
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800238
DA 2020-07-08
ER

PT J
AU Wang, CL
   Puerta-Guardo, H
   Biering, SB
   Glasner, DR
   Tran, EB
   Patana, M
   Gomberg, TA
   Malvar, C
   Lo, NTN
   Espinosa, DA
   Harris, E
AF Wang, Chunling
   Puerta-Guardo, Henry
   Biering, Scott B.
   Glasner, Dustin R.
   Tran, Edwina B.
   Patana, Mark
   Gomberg, Trent A.
   Malvar, Carmel
   Lo, Nicholas T. N.
   Espinosa, Diego A.
   Harris, Eva
TI Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial
   hyperpermeability and is abolished by a single N-glycosylation site
   mutation
SO PLOS PATHOGENS
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; DENGUE VIRUS; SECRETED NS1; RECEPTOR; CELLS;
   SURFACE; ASSOCIATIONS; PATHOGENESIS; ANTIBODIES; INFECTION
AB Arthropod-borne flaviviruses cause life-threatening diseases associated with endothelial hyperpermeability and vascular leak. We recently found that vascular leak can be triggered by dengue virus (DENV) non-structural protein 1 (NS1) via the disruption of the endothelial glycocalyx-like layer (EGL). However, the molecular determinants of NS1 required to trigger EGL disruption and the cellular pathway(s) involved remain unknown. Here we report that mutation of a single glycosylated residue of NS1 (N207Q) abolishes the ability of NS1 to trigger EGL disruption and induce endothelial hyperpermeability. Intriguingly, while this mutant bound to the surface of endothelial cells comparably to wild-type NS1, it was no longer internalized, suggesting that NS1 binding and internalization are distinct steps. Using endocytic pathway inhibitors and gene-specific siRNAs, we determined that NS1 was endocytosed into endothelial cells in a dynamin- and clathrin-dependent manner, which was required to trigger endothelial dysfunction in vitro and vascular leak in vivo. Finally, we found that the N207 glycosylation site is highly conserved among flaviviruses and is also essential for West Nile and Zika virus NS1 to trigger endothelial hyperpermeability via clathrin-mediated endocytosis. These data provide critical mechanistic insight into flavivirus NS1-induced pathogenesis, presenting novel therapeutic and vaccine targets for flaviviral diseases.
C1 [Wang, Chunling; Puerta-Guardo, Henry; Biering, Scott B.; Glasner, Dustin R.; Tran, Edwina B.; Patana, Mark; Gomberg, Trent A.; Malvar, Carmel; Lo, Nicholas T. N.; Espinosa, Diego A.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
OI Espinosa, Diego A./0000-0002-4364-5031; Lo,
   Nicholas/0000-0002-4289-1222; Glasner, Dustin/0000-0001-9821-6683; Tran,
   Edwina/0000-0002-7225-2261; Biering, Scott/0000-0003-1991-629X
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI24493]
FX This work was supported by NIAID/NIH grant R01 AI24493 (E.H.). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Blouin CM, 2016, CELL, V166, P920, DOI 10.1016/j.cell.2016.07.003
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chao CH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007625
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dombu CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355102
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329
   Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   Igl W, 2011, MOL BIOSYST, V7, P1852, DOI 10.1039/c0mb00095g
   Ishidoh K, 1995, BIOCHEM BIOPH RES CO, V217, P624, DOI 10.1006/bbrc.1995.2820
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99
   Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009
   Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311
   Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Mustafa YM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00525
   Ng DHL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005369
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Torreno-Pina JA, 2014, P NATL ACAD SCI USA, V111, P11037, DOI 10.1073/pnas.1402041111
   von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025
NR 59
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2019
VL 15
IS 7
AR e1007938
DI 10.1371/journal.ppat.1007938
PG 33
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA IN4RQ
UT WOS:000478663700025
PM 31356638
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shewale, JB
   Cazaban, CMG
   Waller, DK
   Mitchell, LE
   Langlois, PH
   Agopian, AJ
AF Shewale, Jitesh B.
   Cazaban, Cecilia M. Ganduglia
   Waller, D. Kim
   Mitchell, Laura E.
   Langlois, Peter H.
   Agopian, A. J.
TI Microcephaly inpatient hospitalization and potential Zika outbreak in
   Texas: A cost and predicted economic burden analysis
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Microcephaly; Zika virus; Hospital cost
ID RISK-FACTORS; VIRUS; BRAZIL; PREVALENCE
AB Objective: Estimate inpatient hospitalization costs for patients with microcephaly, and predict cost increases due to a potential Zika virus outbreak.
   Methods: We identified Texas-wide inpatient hospitalization discharge records (2008-2015), for newborns and non-newborns with microcephaly. We estimated the cost of each hospitalization by applying cost-to-charge ratios on the actual hospitalization charge. For comparison, newborn visits for patients without microcephaly were also identified, and hospital costs were compared between patients with and without microcephaly. We estimated costs for microcephaly during the first year of life following a Zika outbreak (possible 1-50% increase in birth prevalence) in Texas.
   Results: There were 8005 microcephaly hospitalizations ($203,899,042; total cost). The median admission cost for newborns with microcephaly (N = 1393) was higher compared to those without microcephaly ($6751 vs $725, p < 0.001). Microcephaly hospitalizations of newborns had a lower median cost compared to non-newborns ($6751 vs $9754, p < 0.001). Based on these observed hospitalization costs, we estimated that a potential Zika virus outbreak in Texas could result in an additional $1-6 million per year for hospitalizations.
   Conclusion: Hospitalizations of patients with microcephaly are associated with high costs. An increase in microcephaly prevalence due to a Zika outbreak in Texas could have a considerable impact on health care costs.
C1 [Shewale, Jitesh B.; Waller, D. Kim; Mitchell, Laura E.; Agopian, A. J.] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, 1200 Pressler St, Houston, TX 77030 USA.
   [Cazaban, Cecilia M. Ganduglia] UTHlth Sch Publ Hlth, Dept Management Policy & Community Hlth, Houston, TX USA.
   [Langlois, Peter H.] Texas Dept State Hlth Serv, Birth Defects Epidemiol & Surveillance Branch, Austin, TX USA.
RP Agopian, AJ (corresponding author), UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, 1200 Pressler St, Houston, TX 77030 USA.
EM A.J.Agopian@uth.tmc.edu
RI Shewale, Jitesh/J-7721-2019
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
   [NU50DD000036]; Texas Department of State Health Services (DSHS)
   [NU50DD000036]
FX This publication was supported in part through a grant (NU50DD000036)
   between the Centers for Disease Control and Prevention (CDC) and the
   Texas Department of State Health Services (DSHS). Its contents are
   solely the responsibility of the authors and do not necessarily
   represent the official views of the CDC or DSHS.
CR Agency for Healthcare Research and Quality, 2008, HCUP COST TO CHARG R
   [Anonymous], 2017, THINKING DIAGNOSIS P
   [Anonymous], TEX HOSP INP DISCH P
   Arth AC, 2017, MMWR-MORBID MORTAL W, V2013, P66
   Auger N, 2018, ARCH DIS CHILD-FETAL, V103, pF167, DOI 10.1136/archdischild-2016-311199
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102
   Fitzpatrick MC, 2017, LANCET, V390, P2410, DOI 10.1016/S0140-6736(17)31440-X
   Hoyt AT, 2018, BIRTH DEFECTS RES, V110, P395, DOI 10.1002/bdr2.1164
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Landry MD, 2017, PHYS THER, V97, P275, DOI 10.2522/ptj.20160476
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Martin Joyce A, 2017, Natl Vital Stat Rep, V66, P1
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moffitt KB, 2016, BIRTH DEFECTS RES A, V106, P155, DOI 10.1002/bdra.23470
   Monaghan Ai., 2016, PLOS CURR, V8
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Smitherman S, 2017, HEALTH SECUR, V15, P238, DOI 10.1089/hs.2016.0075
   Texas Department of State Health Services, 2018, ZIK TEX
   U. S. Census Bureau, 2016, AM COMM SURV TABL 1
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2019
VL 30
BP 67
EP 72
DI 10.1016/j.tmaid.2019.01.001
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IN6OF
UT WOS:000478799000011
PM 30639780
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Failoc-Rojas, VE
   Diaz-Velez, C
AF Rodriguez-Morales, Alfonso J.
   Failoc-Rojas, Virgilio E.
   Diaz-Velez, Cristian
TI Gastrointestinal, respiratory and/or arboviral infections? What is the
   cause of the Guillain-Barre syndrome epidemics in Peru? Current
   status-2019
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Guillain-Barre syndrome; Zika; Enterovirus D68; Rhinovirus; Respiratory
   syncytial virus; Peru; Latin America
ID COLOMBIA
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Panamer Assoc Infect Dis API, Committe Travel Med, Asuncion, Paraguay.
   [Failoc-Rojas, Virgilio E.] Univ San Ignacio Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Lima, Peru.
   [Diaz-Velez, Cristian] Hosp Nacl Almanzor Aguinaga Asenjo EsSalud, Chiclayo, Peru.
   [Diaz-Velez, Cristian] Univ San Martin Porres, Ctr Invest Epidemiol Clin & Med Basada Evidencias, Chiclayo, Peru.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Panamer Assoc Infect Dis API, Committe Travel Med, Asuncion, Paraguay.
EM arodriguezm@utp.edu.co
RI Failoc-Rojas, Virgilio E/AAD-8668-2019; Diaz-Velez, Cristian/A-7675-2016
OI Diaz-Velez, Cristian/0000-0003-4593-2509; Failoc-Rojas, Virgilio
   Efrain/0000-0003-2992-9342
CR Diaz-Soto S, 2019, eNeurologicalSci, V14, P89, DOI 10.1016/j.ensci.2019.02.001
   Gallego V, 2019, TRAVEL MED INFECT DI
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Munayco César V, 2019, Rev. perú. med. exp. salud publica, V36, P10, DOI 10.17843/rpmesp.2019.361.3729
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Zambrano LI, 2019, INT J INFECT DIS, V84, P136, DOI 10.1016/j.ijid.2019.05.008
NR 6
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2019
VL 30
BP 114
EP 116
DI 10.1016/j.tmaid.2019.06.015
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IN6OF
UT WOS:000478799000014
PM 31265907
DA 2020-07-08
ER

PT J
AU Almuedo-Riera, A
   Rodriguez-Valero, N
   Camprubi, D
   Galvan, IL
   Zamora-Martinez, C
   Pousibet-Puerto, J
   Subira, C
   Martinez, MJ
   Pinazo, MJ
   Munoz, J
AF Almuedo-Riera, A.
   Rodriguez-Valero, N.
   Camprubi, D.
   Losada Galvan, I.
   Zamora-Martinez, C.
   Pousibet-Puerto, J.
   Subira, C.
   Martinez, M. J.
   Pinazo, M. J.
   Munoz, J.
TI Mirroring the Zika epidemics in Cuba: The view from a European imported
   diseases clinic
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Arboviruses; Travel; Cuba
C1 [Almuedo-Riera, A.; Rodriguez-Valero, N.; Camprubi, D.; Losada Galvan, I.; Subira, C.; Martinez, M. J.; Pinazo, M. J.; Munoz, J.] Univ Barcelona, ISGlobal, Hosp Clin, C Rossello 132 2 2a 4th Floor, E-08036 Barcelona, Spain.
   [Almuedo-Riera, A.] Hosp Gen Granollers, Dept Internal Med, Barcelona, Spain.
   [Zamora-Martinez, C.] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain.
   [Pousibet-Puerto, J.] Hosp De Poniente, Trop Med Unit, El Ejido, Almeria, Spain.
   [Martinez, M. J.] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain.
RP Almuedo-Riera, A (corresponding author), Univ Barcelona, ISGlobal, Hosp Clin, C Rossello 132 2 2a 4th Floor, E-08036 Barcelona, Spain.
EM almuedo@clinic.cat
RI Gutierrez, Jose Munoz/AAH-6954-2020; Rodriguez-Valero,
   Natalia/AAD-7083-2020; Pinazo, Maria Jesus M/X-6093-2018; Losada,
   Irene/AAM-6222-2020
OI Gutierrez, Jose Munoz/0000-0002-0945-1735; Pinazo, Maria Jesus
   M/0000-0002-4237-1075; Losada, Irene/0000-0002-5122-2039; Subira,
   Carme/0000-0002-6246-8501; Fernandez, Ivette/0000-0001-5179-0477;
   Martinez, Miguel Julian/0000-0002-0682-1075; Almuedo Riera,
   Alex/0000-0003-4643-4456
CR Acosta D, 2016, CARACTERIZACION ENFE
   [Anonymous], 2017, ZIK EP REP
   [Anonymous], 2018, EXECUTIVE SUMMARY NE
   Castro M, 2017, AM J TROP MED HYG, V97, P311, DOI 10.4269/ajtmh.16-0906
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
NR 6
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2019
VL 30
BP 125
EP 127
DI 10.1016/j.tmaid.2019.06.001
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IN6OF
UT WOS:000478799000018
PM 31207313
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lancaster, MA
   Huch, M
AF Lancaster, Madeline A.
   Huch, Meritxell
TI Disease modelling in human organoids
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Stem cells; Embryonic development; Regenerative medicine; In vitro
ID PLURIPOTENT STEM-CELLS; LONG-TERM EXPANSION; IN-VITRO EXPANSION; HUMAN
   BRAIN-DEVELOPMENT; ZIKA VIRUS-INFECTION; DIRECTED DIFFERENTIATION;
   CEREBRAL ORGANOIDS; SELF-ORGANIZATION; PROGENITOR CELLS; HUMAN
   ENDOMETRIUM
AB The past decade has seen an explosion in the field of in vitro disease modelling, in particular the development of organoids. These self-organizing tissues derived from stem cells provide a unique system to examine mechanisms ranging from organ development to homeostasis and disease. Because organoids develop according to intrinsic developmental programmes, the resultant tissue morphology recapitulates organ architecture with remarkable fidelity. Furthermore, the fact that these tissues can be derived from human progenitors allows for the study of uniquely human processes and disorders. This article and accompanying poster highlight the currently available methods, particularly those aimed at modelling human biology, and provide an overview of their capabilities and limitations. We also speculate on possible future technological advances that have the potential for great strides in both disease modelling and future regenerative strategies.
C1 [Lancaster, Madeline A.] MRC Lab Mol Biol, Cambridge Biomed Campus,Francis Crick Ave, Cambridge CB2 0QH, England.
   [Huch, Meritxell] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.
   [Huch, Meritxell] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EL, England.
   [Huch, Meritxell] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.
RP Lancaster, MA (corresponding author), MRC Lab Mol Biol, Cambridge Biomed Campus,Francis Crick Ave, Cambridge CB2 0QH, England.; Huch, M (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.; Huch, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EL, England.; Huch, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.
EM mlancast@mrc-lmb.cam.ac.uk; m.huch@rgurdon.cam.ac.uk
OI Lancaster, Madeline/0000-0003-2324-8853
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UP_1201/9]; European Research Council (ERC)European Research Council
   (ERC) [STG757710]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [104151/Z/14/Z]; H2020 European Research Council
   LSMF4LIFE grant [ECH2020-668350]; NC3Rs project grant [NC/R001162/1]
FX Work in the Lancaster laboratory is supported by the Medical Research
   Council MC_UP_1201/9, and the European Research Council (ERC STG757710).
   M.H. is a Wellcome Trust Sir Henry Dale Fellow and is jointly funded by
   the Wellcome Trust and the Royal Society (104151/Z/14/Z). In addition,
   the work in the Huch lab is also funded by an H2020 European Research
   Council LSMF4LIFE grant (ECH2020-668350) and an NC3Rs project grant
   (NC/R001162/1).
CR Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064
   Adli M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04252-2
   ALLEY MC, 1988, CANCER RES, V48, P589
   Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525
   Artegiani B, 2019, CELL STEM CELL, V24, P927, DOI 10.1016/j.stem.2019.04.017
   Asaad M, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031724
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782
   Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013
   Bartfeld S, 2016, DEV BIOL, V420, P262, DOI 10.1016/j.ydbio.2016.09.014
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Ben-David U, 2018, NATURE, V560, P325, DOI 10.1038/s41586-018-0409-3
   Berkers G, 2019, CELL REP, V26, P1701, DOI 10.1016/j.celrep.2019.01.068
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bertaux-Skeirik N, 2016, METHODS MOL BIOL, V1422, P23, DOI 10.1007/978-1-4939-3603-8_3
   Bian S, 2018, NAT METHODS, V15, P631, DOI 10.1038/s41592-018-0070-7
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X
   Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Boretto M, 2017, DEVELOPMENT, V144, P1775, DOI 10.1242/dev.148478
   Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438
   Cao WL, 2019, CARCINOGENESIS, V40, P145, DOI 10.1093/carcin/bgy129
   Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163
   de Paula F, 2017, ANAT REC, V300, P1180, DOI 10.1002/ar.23569
   Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201
   Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803
   Driehuis E, 2017, AM J PHYSIOL-GASTR L, V312, pG257, DOI 10.1152/ajpgi.00410.2016
   Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130
   Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Dye BR, 2016, ELIFE, V5, DOI 10.7554/eLife.19732
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005
   Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628
   Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8
   Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001
   Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y
   Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Hynds RE, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.037366
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989
   Kimura H, 2018, DRUG METAB PHARMACOK, V33, P43, DOI 10.1016/j.dmpk.2017.11.003
   Knight GT, 2018, ELIFE, V7, DOI 10.7554/eLife.37549
   Koehler KR, 2017, NAT BIOTECHNOL, V35, P583, DOI 10.1038/nbt.3840
   Kruitwagen HS, 2017, STEM CELL REP, V8, P822, DOI 10.1016/j.stemcr.2017.02.015
   Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044
   Kuijk EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22154
   Kurmann AA, 2015, CELL STEM CELL, V17, P527, DOI 10.1016/j.stem.2015.09.004
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanik WE, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030124
   Lechner AJ, 2017, CELL STEM CELL, V21, P120, DOI 10.1016/j.stem.2017.03.024
   Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039
   Lee SH, 2018, CELL, V173, P515, DOI 10.1016/j.cell.2018.03.017
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136
   Li XD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05190-9
   Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585
   Linnemann JR, 2015, DEVELOPMENT, V142, P3239, DOI 10.1242/dev.123554
   Little MH, 2016, NAT REV NEPHROL, V12, P624, DOI 10.1038/nrneph.2016.126
   Loomans CJM, 2018, STEM CELL REP, V10, P712, DOI 10.1016/j.stemcr.2018.02.005
   Maimets M, 2016, STEM CELL REP, V6, P150, DOI 10.1016/j.stemcr.2015.11.009
   MALLETTE JM, 1966, EXP CELL RES, V41, P642, DOI 10.1016/S0014-4827(66)80115-5
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   McCracken KW, 2017, NATURE, V541, P182, DOI 10.1038/nature21021
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9
   Mou HM, 2016, CELL STEM CELL, V19, P217, DOI 10.1016/j.stem.2016.05.012
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Mullenders J, 2019, P NATL ACAD SCI USA, V116, P4567, DOI 10.1073/pnas.1803595116
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nantasanti S, 2015, STEM CELL REP, V5, P895, DOI 10.1016/j.stemcr.2015.09.002
   Nikolic MZ, 2017, ELIFE, V6, DOI [10.7554/eLife.26575.001, 10.7554/eLife.26575]
   Noguchi TK, 2015, NAT CELL BIOL, V17, P984, DOI 10.1038/ncb3200
   Nuciforo S, 2018, CELL REP, V24, P1363, DOI 10.1016/j.celrep.2018.07.001
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951
   Ozone C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10351
   Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001
   Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154
   Peng WC, 2018, CELL, V175, P1607, DOI 10.1016/j.cell.2018.11.012
   Pringle S, 2016, STEM CELLS, V34, P640, DOI 10.1002/stem.2278
   Prior N, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174557
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106
   Rothova M, 2012, DEV DYNAM, V241, P1183, DOI 10.1002/dvdy.23804
   Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300
   Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saito Y, 2018, BIOCHEM BIOPH RES CO, V497, P783, DOI 10.1016/j.bbrc.2018.02.154
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sampaziotis F, 2017, NAT MED, V23, P954, DOI 10.1038/nm.4360
   Sampaziotis F, 2017, NAT PROTOC, V12, P814, DOI 10.1038/nprot.2017.011
   Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schlieve CR, 2017, STEM CELL REP, V9, P883, DOI 10.1016/j.stemcr.2017.07.017
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Seidlitz T, 2019, GUT, V68, P207, DOI 10.1136/gutjnl-2017-314549
   Seino T, 2018, CELL STEM CELL, V22, P454, DOI 10.1016/j.stem.2017.12.009
   SMITH E, 1946, CAN MED ASSOC J, V55, P151
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008
   Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637
   Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010
   Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894
   Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695
   Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112
   Takebe T, 2017, CELL REP, V21, P2661, DOI 10.1016/j.celrep.2017.11.005
   Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tiriac H, 2018, GASTROINTEST ENDOSC, V87, P1474, DOI 10.1016/j.gie.2017.12.032
   Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3
   Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774
   Wahlin KJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00774-9
   Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weeber F, 2017, CELL CHEM BIOL, V24, P1092, DOI 10.1016/j.chembiol.2017.06.012
   Wills ES, 2016, EUR J HUM GENET, V24, P1707, DOI 10.1038/ejhg.2016.97
   Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328
   Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233
   Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HHN, 2018, CELL STEM CELL, V23, P882, DOI 10.1016/j.stem.2018.09.016
   Zernicka-Goetz M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0535
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344
NR 168
TC 21
Z9 20
U1 3
U2 8
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD JUL
PY 2019
VL 12
IS 7
AR UNSP dmm039347
DI 10.1242/dmm.039347
PG 14
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA IN6AX
UT WOS:000478759400003
PM 31383635
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lavin, RP
   Veenema, TG
   Langan, JC
   Charney, RL
   Zimmerman, RS
   Bender, A
AF Lavin, Roberta P.
   Veenema, Tener G.
   Langan, Joanne C.
   Charney, Rachel L.
   Zimmerman, Rick S.
   Bender, Annah
TI Zika and Flint Water Public Health Emergencies Disaster Training Tool
   Kits Relevant to Pregnant Women and Children
SO JOURNAL OF PERINATAL & NEONATAL NURSING
LA English
DT Article
DE education; nurses; public health emergencies; readiness; tool kits
ID CORE COMPETENCES; PREPAREDNESS; NURSES; MEDICINE
AB Pregnant women and children and individuals suffering from chronic illness are disproportionally impacted by public health emergencies. To meet the healthcare needs of these populations, the nursing workforce must be capable of responding in a timely and appropriate manner. The goal of this project was to create interactive and engaging evidence-based educational tool kits to advance healthcare provider readiness in the management of population health in response to the Zika and Flint Water crises. A multipronged, mixed-methods approach was used to identify essential education needs and required core competencies. Data were synthesized from discussion with key informants, review of relevant documents, and surveys of schools of nursing, public health, and medicine. The ADDIE model was used to integrate results into the development of the online learning tool kits using the ThingLink software program. An innovative online educational program to prepare healthcare providers to rapidly identify, mitigate, and manage the impact of the Zika and Flint Water crises upon pregnant women and children was implemented by the Society for the Advancement of Disaster Nursing. Innovative online learning tool kits can advance healthcare provider readiness by increasing knowledge and understanding of key components of specific public health emergencies.
C1 [Lavin, Roberta P.] Univ Tennessee, Coll Nursing, 1200 Volunteer Blvd,319B, Knoxville, TN 37996 USA.
   [Veenema, Tener G.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA.
   [Langan, Joanne C.] St Louis Univ, Sch Nursing, St Louis, MO 63103 USA.
   [Charney, Rachel L.] St Louis Univ, Sch Med, St Louis, MO USA.
   [Zimmerman, Rick S.] LSU Hlth, Sch Nursing, New Orleans, LA USA.
   [Bender, Annah] Univ Missouri, Coll Nursing, St Louis, MO 63121 USA.
RP Lavin, RP (corresponding author), Univ Tennessee, Coll Nursing, 1200 Volunteer Blvd,319B, Knoxville, TN 37996 USA.
EM rlavin@utk.edu
OI Veenema, Tener/0000-0001-8977-9900
FU  [2016-N-03]
FX This work was partially funded through a Centers for Disease Control and
   Prevention/American Association of Colleges of Nursing Workforce
   Improvement Projects cooperative agreement no. 2016-N-03.
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Burkle FM, 2012, DISASTER MED PUBLIC, V6, P10, DOI 10.1001/dmp.2012.3
   Cederna-Meko C, 2016, J AM ACAD CHILD ADOL, V55, pS311
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2016, COMM ASS PUBL HLTH E
   Couig Mary Pat, 2017, Nurs Adm Q, V41, P112, DOI 10.1097/NAQ.0000000000000226
   Daily E, 2010, PREHOSP DISASTER MED, V25, P387, DOI 10.1017/S1049023X00008438
   Garbutt SJ, 2008, MIL MED, V173, P1073, DOI 10.7205/MILMED.173.11.1073
   Gebbie K, 2002, AM J NURS, V102, P46, DOI 10.1097/00000446-200201000-00023
   Grossman D.S., 2017, W VIRGINIA U COLL BU, P17
   Hsu Edbert B, 2006, BMC Med Educ, V6, P19, DOI 10.1186/1472-6920-6-19
   Jakeway CC, 2008, PUBLIC HEALTH NURS, V25, P353, DOI 10.1111/j.1525-1446.2008.00716.x
   Kurt S., 2017, ADDIE MODEL INSTRUCT
   Langan Joanne C, 2017, Nurs Adm Q, V41, P118, DOI 10.1097/NAQ.0000000000000225
   Lavin RP, 2017, DISASTER MED PUBLIC, V11, P641, DOI 10.1017/dmp.2017.10
   Littleton-Kearney Marguerite T, 2008, Crit Care Nurs Clin North Am, V20, P103, DOI 10.1016/j.ccell.2007.10.008
   Michigan Civil Rights Commission, 2017, FLINT WAT CRIS SYST
   Murata K, 2009, J OCCUP HEALTH, V51, P1, DOI 10.1539/joh.K8003
   Porse CC, 2018, EMERG INFECT DIS, V24, P1626, DOI 10.3201/eid2409.180203
   Qureshi KA, 2002, J URBAN HEALTH, V79, P413, DOI 10.1093/jurban/79.3.413
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schultz CH, 2012, ANN EMERG MED, V59, P196, DOI 10.1016/j.annemergmed.2011.09.003
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Slepski Lynn A, 2007, Disaster Manag Response, V5, P99, DOI 10.1016/j.dmr.2007.08.001
   Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af
   Veenema TG, 2006, NURS EDUC PERSPECT, V27, P93
   Veenema TG, 2016, J NURS SCHOLARSHIP, V48, P187, DOI 10.1111/jnu.12198
   Veenema TG, 2018, DISASTER NURSING EME
   Walsh L, 2014, DISASTER MED PUBLIC, V8, P70, DOI 10.1017/dmp.2014.7
   Walsh L, 2012, DISASTER MED PUBLIC, V6, P44, DOI 10.1001/dmp.2012.4
   Wilson Anne, 2017, Online J Issues Nurs, V22, P4, DOI 10.3912/OJIN.Vol22No01Man04
   WISE D, 2017, J EXT, V55
NR 35
TC 0
Z9 0
U1 4
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0893-2190
EI 1550-5073
J9 J PERINAT NEONAT NUR
JI J. Perinat. Neonatal Nurs.
PD JUL-SEP
PY 2019
VL 33
IS 3
SI SI
BP 229
EP 237
DI 10.1097/JPN.0000000000000418
PG 9
WC Nursing; Obstetrics & Gynecology; Pediatrics
SC Nursing; Obstetrics & Gynecology; Pediatrics
GA IM3JQ
UT WOS:000477889900009
PM 31335850
DA 2020-07-08
ER

PT J
AU Cirne-Santos, CC
   Barros, CD
   Gomes, MWL
   Gomes, R
   Cavalcanti, DN
   Obando, JMC
   Ramos, CJB
   Villaca, RC
   Teixeira, VL
   Paixao, ICND
AF Cirne-Santos, Claudio C.
   Barros, Caroline de S.
   Gomes, Max W. L.
   Gomes, Rafaela
   Cavalcanti, Diana N.
   Obando, Johana M. C.
   Ramos, Carlos J. B.
   Villaca, Roberto C.
   Teixeira, Valeria L.
   Paixao, Izabel C. N. de P.
TI In Vitro Antiviral Activity Against Zika Virus From a Natural Product of
   the Brazilian Brown Seaweed Dictyota menstrualis
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Anti-ZIKV; marine diterpenoids; Dictyota menstrualis; dictyotales;
   phaeophyceae
ID DITERPENES; HIV-1; PFAFFII
AB Natural products isolated from seaweeds have shown great antiviral potential against numerous viruses such as human type 1 herpes, human immunodeficiency virus, and dengue. Diterpenes produced by the brown seaweeds Dictyota and Canistrocarpus, in particular, have shown antiviral or virucidal activity. Recently, the Zika virus (ZIKV) has become a major public health concern due to its widespread dissemination throughout the Americas. Since no vaccines are available, and no drugs have effectively treated recent cases of infection, our group evaluated products from Dictyota menstrualis for their antiviral potential, alone and in combination with Ribavirin. We first evaluated the compounds' cytotoxicity at high concentrations, and then evaluated the inhibition of ZIKV replication by crude extracts and acetylated crude extracts and their fractions at 20 mu g/mL. The F-6 and FAc-2 fractions, rich in cyclic diterpenes with aldehyde groupings, inhibited ZIKV replication by >74%, with inhibition behaving in a dose-dependent manner and the 50% effective concentration (EC50) values of 2.80 (F-6) and 0.81 (FAc-2) mu g/mL. Regarding the mechanism of action, FAc-2 had strong virucidal potential, and F-6 inhibited viral adsorption. Associating FAc-2 with Ribavirin at suboptimal dosages produced a strong synergistic effect that completely inhibited viral replication. Our results indicate that these natural products have excellent inhibitory potential against ZIKV replication and may be promising for developing affective therapies.
C1 [Cirne-Santos, Claudio C.; Barros, Caroline de S.; Gomes, Max W. L.; Gomes, Rafaela; Ramos, Carlos J. B.; Teixeira, Valeria L.; Paixao, Izabel C. N. de P.] Univ Fed Fluminense, Inst Biol, Programa Posgrad Ciencias & Biotecnol, BR-24020141 Niteroi, RJ, Brazil.
   [Cirne-Santos, Claudio C.; Barros, Caroline de S.; Gomes, Max W. L.; Gomes, Rafaela; Paixao, Izabel C. N. de P.] Univ Fed Fluminense, Inst Biol, Lab Virol Mol & Biotecnol, Dept Biol Celular & Mol, Niteroi, RJ, Brazil.
   [Cavalcanti, Diana N.; Obando, Johana M. C.; Villaca, Roberto C.] Univ Fed Fluminense, Inst Biol, Programa Posgrad Biol Marinha & Ecossistemas Cost, Niteroi, RJ, Brazil.
   [Cavalcanti, Diana N.; Obando, Johana M. C.; Ramos, Carlos J. B.; Teixeira, Valeria L.] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Prod Nat Algas Marinhas ALGAMAR, BR-24020141 Niteroi, RJ, Brazil.
   [Cavalcanti, Diana N.; Obando, Johana M. C.; Ramos, Carlos J. B.; Teixeira, Valeria L.] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Ecol Bentica ECOBENTOS, BR-24020141 Niteroi, RJ, Brazil.
   [Villaca, Roberto C.] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Niteroi, RJ, Brazil.
   [Teixeira, Valeria L.] Inst Biociencias, Lab Biol & Taxon Algas, Programa Posgrad Biodiversidade Neotrop, Rio De Janeiro, Brazil.
RP Paixao, ICND (corresponding author), Univ Fed Fluminense, Inst Biol, Programa Posgrad Ciencias & Biotecnol, BR-24020141 Niteroi, RJ, Brazil.
EM izabeluff@gmail.com
RI Teixeira, Valeria L/E-8241-2018; Villaca, Roberto C./J-6432-2012;
   Paixao, Izabel/AAM-1668-2020; Barros, Caroline/S-7840-2019
OI Villaca, Roberto C./0000-0002-7329-3516; Barros,
   Caroline/0000-0002-4678-3093
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7, 04070/2014-9, 443911/2004,
   44021/2018]; FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.442/2014, E18/2015]; CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES;
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.344/2016]; CAPESCAPES
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowships to V.L.T. (443930/2014-7 and 04070/2014-9) and I.C.N.P.P.
   (443911/2004 and 44021/2018). V.L.T. (E-26/201.442/2014) and I.C.N.P.P.
   (E18/2015) also thank FAPERJ (Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro). I.C.C.C.S. thanks CAPES (Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior) for a Postdoc fellowship, and C.S.B.
   thanks FAPERJ for a Postdoc fellowship (E-26/201.344/2016). M.W.L.G.,
   R.G., C.O.M., C.J.B.R., and M.M. thank CAPES scholarships obtained
   during graduate school.
CR Abrantes JL, 2010, PLANTA MED, V76, P339, DOI 10.1055/s-0029-1186144
   Ahmad SAA, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0895-1
   Ahmadi A, 2016, RSC ADV, V6, P69421, DOI 10.1039/c6ra16640g
   Barbosa JP, 2004, PLANTA MED, V70, P856, DOI 10.1055/s-2004-827235
   Barros CD, 2017, J APPL PHYCOL, V29, P769, DOI 10.1007/s10811-016-0865-9
   Barros CD, 2016, J APPL PHYCOL, V28, P2523, DOI 10.1007/s10811-015-0776-1
   Barros CD, 2015, J APPL PHYCOL, V27, P1623, DOI 10.1007/s10811-014-0447-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti DN, 2006, NAT PROD COMMUN, V1, P609
   Cavalcanti DN, 2011, J APPL PHYCOL, V23, P873, DOI 10.1007/s10811-010-9601-z
   Cirne-Santos CC, 2006, PLANTA MED, V72, P295, DOI 10.1055/s-2005-916209
   Cirne-Santos CC, 2008, ANTIVIR RES, V77, P64, DOI 10.1016/j.antiviral.2007.08.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eom SH, 2012, FOOD CHEM TOXICOL, V50, P3251, DOI 10.1016/j.fct.2012.06.028
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garrido V, 2011, REV BRAS FARMACOGN, V21, P209, DOI 10.1590/S0102-695X2011005000053
   Kang HK, 2015, MAR DRUGS, V13, P618, DOI 10.3390/md13010618
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Miceli LA, 2013, MAR DRUGS, V11, P4127, DOI 10.3390/md11114127
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Ortiz-Ramirez FA, 2008, NAT PROD COMMUN, V3, P1879
   Pardo-Vargas A, 2014, MAR DRUGS, V12, P4247, DOI 10.3390/md12074247
   Pereira HDS, 2005, PLANTA MED, V71, P1019, DOI 10.1055/s-2005-873113
   Pereira HS, 2004, ANTIVIR RES, V64, P69, DOI 10.1016/j.antiviral.2004.06.006
   Soares AR, 2007, PLANTA MED, V73, P1221, DOI 10.1055/s-2007-981589
   Stephens PRS, 2017, J APPL PHYCOL, V29, P775, DOI 10.1007/s10811-016-0925-1
   Teixeira VL, 2001, BIOCHEM SYST ECOL, V29, P313, DOI 10.1016/S0305-1978(00)00055-7
   Thoka B, 2018, VIRUS GENES, V54, P48, DOI 10.1007/s11262-017-1524-1
   Vallim MA, 2010, J MED PLANTS RES, V4, P2379
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
   Yang XX, 2017, NANOSCALE, V9, P16086, DOI 10.1039/c7nr06520e
NR 34
TC 1
Z9 1
U1 6
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD JUL
PY 2019
VL 14
IS 7
DI 10.1177/1934578X19859128
PG 7
WC Chemistry, Medicinal; Food Science & Technology
SC Pharmacology & Pharmacy; Food Science & Technology
GA IM5OZ
UT WOS:000478044500008
OA Other Gold
DA 2020-07-08
ER

PT J
AU Goetzl, L
   Darbinian, N
   Merabova, N
AF Goetzl, Laura
   Darbinian, Nune
   Merabova, Nana
TI Noninvasive assessment of fetal central nervous system insult: Potential
   application to prenatal diagnosis
SO PRENATAL DIAGNOSIS
LA English
DT Article
ID BLOOD EXOSOMES; ZIKA VIRUS; ETHANOL; INFECTION; PROTEINS; DISEASE;
   CHILD; REST
AB ObjectiveWe have developed novel methods for isolating fetal central nervous system (CNS)-derived extracellular vesicles (FCEs) from maternal plasma as a non-invasive platform for testing aspects of fetal neurodevelopment in early pregnancy. We investigate the hypothesis that levels of defined sets of functional proteins in FCEs can be used to detect abnormalities in fetal neuronal and glial proliferation, differentiation, and survival.
   MethodMaternal plasma was obtained between 10 and 19weeks from women with current heavy EtOH exposure and matched controls. FCE levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were quantified normalized to the exosome marker CD81. Quantitative RT-PCR was performed with specific primers for miR-9.
   ResultsFCE cargo protein levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were all significantly reduced in pregnancies exposed to current heavy EtOH use (P<.001 for all). Both synaptophysin and neurogranin appeared to be particularly discriminatory with no overlap between exposed and control subjects. Up to tenfold inhibition (90%) in MicroRNA-9 was observed in FCEs from EtOH exposed fetuses compared with controls.
   ConclusionOur results suggest that FCEs purified from maternal plasma may be a powerful tool to assess abnormal proliferation and differentiation of CNS stem cells as early as the late first trimester.
C1 [Goetzl, Laura] Univ Texas Houston Hlth Sci, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Darbinian, Nune; Merabova, Nana] Temple Univ, Shriners Pediat Res Ctr, Ctr Neural Repair & Rehabil, Philadelphia, PA 19122 USA.
RP Goetzl, L (corresponding author), Univ Texas Houston Hlth Sci, Dept Obstet & Gynecol, Houston, TX 77030 USA.
EM laura.goetzl@uth.tmc.edu
OI Goetzl, Laura/0000-0003-4130-2809
FU Bill and Melinda Gates FoundationGates Foundation
FX Bill and Melinda Gates Foundation
CR Brasil P, 2016, N ENGL J MED
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Calvet G., 2016, LANCET INFECT DIS
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1097/00000374-200110000-00017
   Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702
   Goetzl EJ, 2015, ANN CLIN TRANSLATION
   Goetzl L, 2019, REPROD SCI, V26, p237A
   Goetzl L, 2018, ANN CLIN TRANSL NEUR, V5, P4, DOI 10.1002/acn3.499
   Goetzl L, 2016, ANN CLIN TRANSL NEUR, V3, P381, DOI 10.1002/acn3.296
   Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604
   Liesi P, 1997, J NEUROSCI RES, V48, P439, DOI 10.1002/(SICI)1097-4547(19970601)48:5<439::AID-JNR5>3.0.CO;2-F
   Masuda T, 2017, CELL ADHES MIGR, V11, P524, DOI 10.1080/19336918.2016.1269998
   Matsumoto J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0470-4
   May PA, 2018, JAMA-J AM MED ASSOC, V319, P474, DOI 10.1001/jama.2017.21896
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER MW, 1988, ALCOHOL CLIN EXP RES, V12, P440, DOI 10.1111/j.1530-0277.1988.tb00223.x
   Miranda Rajesh C., 2012, Frontiers in Genetics, V3, P77, DOI 10.3389/fgene.2012.00077
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008
   Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032
   Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheller-Miller S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00432
   Shi M, 2019, PROG NEUROBIOL, V175, P96, DOI 10.1016/j.pneurobio.2019.01.005
   Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 31
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD JUL
PY 2019
VL 39
IS 8
BP 609
EP 615
DI 10.1002/pd.5474
PG 7
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA IN3KM
UT WOS:000478575800005
PM 31069822
DA 2020-07-08
ER

PT J
AU Parker, C
   Garcia, F
   Menocal, O
   Jeer, D
   Alto, B
AF Parker, Casey
   Garcia, Felicita
   Menocal, Oscar
   Jeer, Dunia
   Alto, Barry
TI A Mosquito Workshop and Community Intervention: A Pilot Education
   Campaign to Identify Risk Factors Associated with Container Mosquitoes
   in San Pedro Sula, Honduras
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; community education; container
   mosquitoes; dengue; mosquito control; vector control
ID AEDES-AEGYPTI DIPTERA; DENGUE VECTOR CONTROL; CONTROL PROGRAM; ZIKA
   VIRUS; CULICIDAE; CHIKUNGUNYA; URBAN; MULTICOUNTRY; DISPERSAL; AMERICA
AB Dengue poses a significant public health threat and results in similar to 96 million clinical cases every year. Central America is a region burdened by neglected tropical diseases, including dengue. The primary vectors of dengue, Aedes aegypti and Aedes albopictus, are widely distributed in Honduras. Additionally, sustained and consistent mosquito control is lacking in the country. Successful control of container mosquitoes relies heavily on participation from community leaders, stakeholders, and the community itself. We conducted a pilot study in San Pedro Sula, Honduras where community leaders and stakeholders were trained on mosquito biology and control and were able to apply that knowledge to an underserved community in San Pedro Sula. Surveys to assess the number and type of containers in the community and the number of containers on the residence identified associations with select socioeconomic factors and other variables based on survey questions. The average number of containers on the premises was 15 (+/- 2.3) and the most prevalent containers (>50%) were flowerpots, garbage, and toys, which could be targeted in mosquito control programs. This pilot study offers a framework for training community leaders and stakeholders to create a sustainable community-based vector control program for container mosquitoes.
C1 [Parker, Casey; Alto, Barry] Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
   [Garcia, Felicita; Menocal, Oscar] Univ Nacl Autonoma Honduras Valle Sula, Dept Nursing, San Pedro Sula 21102, Honduras.
   [Jeer, Dunia] Univ Nacl Autonoma Honduras Valle Sula, Dept Biol, San Pedro Sula 21102, Honduras.
RP Parker, C (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
EM caseyparker@ufl.edu
OI Menocal Duron, Oscar/0000-0001-5431-4812; Parker,
   Casey/0000-0002-4173-0881
FU University of Florida, Florida Medical Entomology Laboratory; UNAH
FX For providing travel funding for this study, we thank the University of
   Florida, Florida Medical Entomology Laboratory and UNAH; for the
   equipment used in hands-on training activities, we thank Eva Buckner;
   for use of facilities in Honduras, we thank UNAH and Sistema Educativo
   de la Iglesia; for participation in community outreach and assistance
   with data collection, we thank the workshop attendees; for the internal
   review of this manuscript, we thank Cindy Prins.
CR [Anonymous], AYUD CONTR MOSQ QUE
   [Anonymous], MSF RESP NEW EP DENG
   Arredondo-Jimenez JI, 2006, ANN TROP MED PARASIT, V100, pS17, DOI 10.1179/136485906X105480
   Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bohra Alpana, 2001, Dengue Bulletin, V25, P92
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013
   Claro L. B. L., 2006, Dengue Bulletin, V30, P214
   Colton YM, 2003, MED VET ENTOMOL, V17, P195, DOI 10.1046/j.1365-2915.2003.00424.x
   Davis TJ, 2015, J AM MOSQUITO CONTR, V31, P321, DOI 10.2987/moco-31-04-321-328.1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferdousi Farhana, 2015, Tropical Medicine and Health, V43, P253, DOI 10.2149/tmh.2015-16
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Gautam I, 2012, J NAT HIST MUS, V26, P181, DOI DOI 10.3126/jnhm.v26i0.14142
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Hotez PJ, 2014, INT J PARASITOL, V44, P597, DOI 10.1016/j.ijpara.2014.04.001
   Institute of Medicine (US) Forum on Microbial Threats, 2011, CAUSES IMPACTS NEGLE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Ledogar RJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4298-4
   LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F
   Lockaby G, 2016, J VECTOR ECOL, V41, P232, DOI 10.1111/jvec.12218
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   McNaughton Darlene, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3020067
   McNaughton D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001785
   McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012
   Mosquito Control Collaborative, 2019, PUBL HLTH CONFR MOSQ
   Mukhtar MU, 2018, J MED ENTOMOL, V55, P1011, DOI 10.1093/jme/tjy010
   Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Roseghini WFF, 2011, REV BRASILEIRA CLIMA, V9, P94
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Trewin BJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005848
   Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   WHO, MOSQ BORN DIS
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   World Bank Group, POV HEADC RAT 1 90 D
   World Bank Group, POV HEADC RAT 190 DA
   Yaren O, 2018, JOVE-J VIS EXP, DOI 10.3791/57051
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
   Zettel C., YELLOW FEVER MOSQUIT
NR 55
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL 1
PY 2019
VL 16
IS 13
AR 2399
DI 10.3390/ijerph16132399
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IL1DA
UT WOS:000477037900143
PM 31284544
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Borges, ED
   Vireque, AA
   Berteli, TS
   Ferreira, CR
   Silva, AS
   Navarro, PA
AF Borges, E. D.
   Vireque, A. A.
   Berteli, T. S.
   Ferreira, C. R.
   Silva, A. S.
   Navarro, P. A.
TI An update on the aspects of Zika virus infection on male reproductive
   system
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Zika virus; Male reproductive tract; Assisted reproduction; Semen;
   Metabolomics
ID MALE SEXUAL TRANSMISSION; GUILLAIN-BARRE-SYNDROME; WHOLE-BLOOD;
   EXPOSURE; RESPONSES; MODEL; SEMEN; LEADS
AB Zika virus (ZIKV) is mainly transmitted through Aedes mosquito bites, but sexual and post-transfusion transmissions have been reported. During acute infection, ZIKV is detectable in most organs and body fluids including human semen. Although it is not currently epidemic, there is a concern that the virus can still reemerge since the male genital tract might harbor persistent reservoirs that could facilitate viral transmission over extended periods, raising concerns among public health and assisted reproductive technologies(ART) experts and professionals. So far, the consensus is that ZIKV infection in the testes or epididymis might affect sperm development and, consequently, male fertility. Still, diagnostic tests have not yet been adapted to resource-restricted countries. This manuscript provides an updated overview of the cellular and molecular mechanisms of ZIKV infection and reviews data on ZIKV persistence in semen and associated risks to the male reproductive system described in human and animal models studies. We provide an updated summary of the impact of the recent ZIKV outbreak on human-ART, weighing on current recommendations and diagnostic approaches, both available and prospective, with special emphasis on mass spectrometry-based biomarker discovery. In the light of the identified gaps in our accumulated knowledge on the subject, we highlight the importance for couples seeking ART to follow the constantly revised guidelines and the need of specific ZIKV diagnosis tools for semen screening to contain ZIKV virus spread and make ART safer.
C1 [Borges, E. D.; Berteli, T. S.; Navarro, P. A.] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Borges, E. D.; Vireque, A. A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
   [Ferreira, C. R.] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA.
   [Silva, A. S.] Univ Sao Paulo, Dept Social Med, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Navarro, P. A.] CNPq, Natl Inst Hormones & Womans Hlth, Brasilia, DF, Brazil.
RP Borges, ED (corresponding author), Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.; Borges, ED (corresponding author), Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
EM eduardoborgesd@gmail.com
RI Borges, Eduardo/Y-5712-2019; Silva, Anderson Soares/H-6934-2012;
   Ferreira, Christina R/F-4744-2012
OI Borges, Eduardo/0000-0002-0131-1121; Silva, Anderson
   Soares/0000-0002-0824-2616; Ferreira, Christina R/0000-0003-3988-6454;
   Navarro, Paula Andrea/0000-0003-2368-4188
FU Purdue University Women's Global Health Institute (WGHI); Indiana
   Clinical and Translational Sciences Institute (CTSI) through Mildred
   Elizabeth Edmundson Research (MEER) award [PDT 728 2017]
FX Financial support from the Purdue University Women's Global Health
   Institute (WGHI) and Indiana Clinical and Translational Sciences
   Institute (CTSI) through Mildred Elizabeth Edmundson Research (MEER)
   award PDT 728 2017 is acknowledged.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Araujo Filho E, 2017, JBRA ASSIST REPROD, V21, P276
   Ball D, 2016, GUIDELINES AM SOC RE
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   BFS. British Fertility Society, 2016, ZIK VIR FERT TREATM
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bujan L, 2016, BMJ-BRIT MED J, V352, pi1062
   da Silva LRC, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020051
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cassuto NG, 2018, J GYNECOL OBSTET HUM, V47, P211, DOI 10.1016/j.jogoh.2018.02.004
   CDC, 2016, ZIK TRAV INF
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Clancy CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33528-2
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Cordeiro CN, 2017, CURR OPIN OBSTET GYN, V29, P175, DOI 10.1097/GCO.0000000000000366
   Cordeiro Fernanda B, 2017, Rapid Commun Mass Spectrom, V31, P1462, DOI 10.1002/rcm.7927
   Crutchfield CA, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-015-9102-9
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Ferreira CR, 2016, ANALYST, V141, P5252, DOI 10.1039/c6an01618a
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kielian M, 2002, FUSION BIOL MEMBRANE, P409
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mariani BD, 2017, patent, Patent No. [US20180142310A1, 20180142310]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pando-Robles V, 2017, VECTOR-BORNE ZOONOT, V17, P361, DOI 10.1089/vbz.2016.2040
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Sikka V, J GLOBAL INFECT DIS, P3
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   WHO, 2016, PREV SEX TRANSM ZIK
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yarrington Christina D, 2019, Fertil Res Pract, V5, P1, DOI 10.1186/s40738-018-0053-5
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 90
TC 3
Z9 3
U1 1
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD JUL
PY 2019
VL 36
IS 7
BP 1339
EP 1349
DI 10.1007/s10815-019-01493-y
PG 11
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA IK4EU
UT WOS:000476540700005
PM 31147867
DA 2020-07-08
ER

PT J
AU Kalmin, MM
   Gower, EW
   Stringer, EM
   Bowman, NM
   McQuade, ETR
   Westreich, D
AF Kalmin, Mariah M.
   Gower, Emily W.
   Stringer, Elizabeth M.
   Bowman, Natalie M.
   McQuade, Elizabeth T. Rogawski
   Westreich, Daniel
TI Misclassification in defining and diagnosing microcephaly
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
DE epidemiology; microcephaly; misclassification; Zika virus
ID ZIKA VIRUS; SURVEILLANCE; STATES
AB Background Several health agencies define microcephaly for surveillance purposes using a single criterion, a percentile or Z-score cut-off for newborn head circumference. This definition, however, conflicts with the reported prevalence of microcephaly even in populations with endemic Zika virus. Objective We explored possible reasons for this conflict, hypothesising that the definition of microcephaly used in some studies may be incompletely described, lacking the additional clinical criteria that clinicians use to make a formal diagnosis. We also explored the potential for misclassification that can result from differences in these definitions, especially when applying a percentile cut-off definition in the presence of the much lower observed prevalence estimates that we believe to be valid. Methods We conducted simulations under a theoretical bimodal distribution of head circumference. For different definitions of microcephaly, we calculated the sensitivity and specificity using varying cut-offs of head circumference. We then calculated and plotted the positive predictive value for each of these definitions by prevalence of microcephaly. Results Simple simulations suggest that if the true prevalence of microcephaly is approximately what is reported in peer-reviewed literature, then relying on cut-off-based definitions may lead to very poor positive predictive value under realistic conditions. Conclusions While a simple head circumference criterion may be used in practice as a screening or surveillance tool, the definition lacks clarification as to what constitutes true pathological microcephaly and may lead to confusion about the true prevalence of microcephaly in Zika-endemic areas, as well as bias in aetiologic studies.
C1 [Kalmin, Mariah M.; Gower, Emily W.; Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA.
   [Stringer, Elizabeth M.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA.
   [Bowman, Natalie M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA.
   [McQuade, Elizabeth T. Rogawski] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA.
RP Kalmin, MM (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA.
EM mkalmin@email.unc.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); Office of the
   Director of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [DP2-HD084070]
FX This research was supported by the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development and the Office of the
   Director of the National Institutes of Health (awards DP2-HD084070).
CR [Anonymous], 2016, FACTS MICR
   BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198
   Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363
   Brandenburg KM, 2018, ECOL LETT, V21, P1561, DOI 10.1111/ele.13138
   Brandenburg KM, 2017, HARMFUL ALGAE, V63, P146, DOI 10.1016/j.hal.2017.02.004
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Tellechea AL, 2018, BIRTH DEFECTS RES, V110, P1016, DOI 10.1002/bdr2.1347
   McInerny TK, 2017, AM ACAD PEDIAT TXB P
   National Institute of Neurological Disorders and Stroke, 2017, MICR INF PAG
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Ribeiro IG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000100002
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   World Health Organization, 2016, MICR FACT SHEET
NR 16
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD JUL
PY 2019
VL 33
IS 4
BP 286
EP 290
DI 10.1111/ppe.12561
PG 5
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA IM0BP
UT WOS:000477650000007
PM 31347726
DA 2020-07-08
ER

PT J
AU Collins, MH
   Waggoner, JJ
AF Collins, Matthew H.
   Waggoner, Jesse J.
TI Detecting Vertical Zika Transmission: Emerging Diagnostic Approaches for
   an Emerged Flavivirus
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; vertical transmission; congenital infection; molecular
   diagnostics; serodiagnostics; flavivirus; maternal child health; TORCHZ
ID LINKED IMMUNOSORBENT ASSAYS; REVERSE TRANSCRIPTION-PCR; UPDATE INTERIM
   GUIDANCE; B-CELL RESPONSES; VIRUS-INFECTION; UNITED-STATES; REAL-TIME;
   CONGENITAL TOXOPLASMOSIS; MOLECULAR-DETECTION; PROLONGED DETECTION
AB Zika virus (Zika) was recently responsible for a massive epidemic that spread throughout Latin America and beyond. Though Zika is typically asymptomatic or self-limiting, the sheer numbers of Zika infections led to the identification of unexpected phenotypes including sexual transmission, Guillain-Barre syndrome, and teratogenicity. Thousands of infants in South, Central, and North America have now been born with microcephaly or one of a number of fetal anomalies constituting the congenital Zika syndrome (CZS). Diagnosing CZS is based on a combination of clinical risk assessment and laboratory testing (which includes determining whether the mother has experienced a possible Zika infection during her pregnancy). A newborn suspected of having congenital Zika infection (due to maternal Zika infection or a birth defect described in association with congenital Zika infection) is then specifically tested for presence of Zika virus in neonatal tissue or anti-Zika IgM in the blood or cerebrospinal fluid. Though the guidelines are clear, there is room for considerable practice variation to emerge from individualized patient-provider encounters, largely due to limitations in diagnostic testing for Zika. The natural history of Zika further obscures our ability to know who, when, and how to test. Molecular diagnostics are highly specific but may not serve well those with asymptomatic infection. Serologic assays expand the diagnostic window but are complicated by cross-reactivity among related flaviviruses and passive immunity transferred from mother to baby. Furthermore, existing and emerging diagnostic tools may not be widely available due to limitations in resources and infrastructure of health systems in affected areas. Improvements in assay parameters as well as advances in platforms and deployability hold promise for optimizing diagnostic approaches for congenital Zika infection. The diagnostic tools and technologies under development must be integrated with forthcoming clinical knowledge of congenital Zika infection to fully realize the value that laboratory testing holds for diagnosing in utero mother to child transmission but also for understanding, predicting, and managing the health outcomes due to congenital Zika infection.
C1 [Collins, Matthew H.; Waggoner, Jesse J.] Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA.
   [Waggoner, Jesse J.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.
RP Collins, MH (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA.
EM matthew.collins@emory.edu
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Anderson KB, 2018, J INFECT DIS, V218, P516, DOI 10.1093/infdis/jiy166
   Andrade P, 2018, METHODS MOL BIOL, V1808, P151, DOI 10.1007/978-1-4939-8567-8_13
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Azevedo RSS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120496
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Calvert AE, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00234-18, 10.1128/jcm.00234-18]
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   CDC, 2018, ZIK MAC ELISA INSTR
   CDC, 2018, EV TEST ZIK VIR ZIK
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chandru K, 2016, SCI REP, V6, P1
   Chao DY, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01506-18
   Chapey E, 2010, J CLIN MICROBIOL, V48, P41, DOI 10.1128/JCM.01903-09
   Chard AN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006418
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871
   Collins M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.82
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FDA, 2018, REV REC RED RISK ZIK
   Ford-Jones E L, 1999, Paediatr Child Health, V4, P109
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldfarb IT, 2017, JAMA-J AM MED ASSOC, V318, P2075, DOI 10.1001/jama.2017.15680
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Graciaa DS, 2018, ANN INTERN MED, V169, P337, DOI 10.7326/M18-1112
   Grifoni A., 2017, J VIROL, V91
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hermann E, 2002, BLOOD, V100, P2153, DOI 10.1182/blood.V100.6.2153.h81802002153_2153_2158
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Kurosaki Y., 2017, SCI REP, V7, P1
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lamb L. E., 2018, SCI REP, V8, P1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lau L, 2015, J CLIN VIROL, V69, P63, DOI 10.1016/j.jcv.2015.06.003
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lee S, 2016, ANAL CHEM, V88, P8359, DOI 10.1021/acs.analchem.6b01828
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liesnard C, 2000, OBSTET GYNECOL, V95, P881, DOI 10.1016/S0029-7844(99)00657-2
   Maistriau M, 2017, VIRUS RES, V237, P1, DOI 10.1016/j.virusres.2017.05.004
   Mansuy JM, 2018, DIAGN MICR INFEC DIS, V92, P284, DOI 10.1016/j.diagmicrobio.2018.06.019
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nduati EW, 2016, CLIN VACCINE IMMUNOL, V23, P576, DOI 10.1128/CVI.00149-16
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Odorizzi PM, 2016, TRENDS MOL MED, V22, P877, DOI 10.1016/j.molmed.2016.08.005
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Olschlager S, 2017, AM J TROP MED HYG, V97, P1070, DOI 10.4269/ajtmh.17-0268
   Oom AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05980-z
   Ould MAE, 2004, PEDIATR RES, V55, P280, DOI 10.1203/01.PDR.0000104150.85437.FE
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pacheco O, 2016, NEW ENGL J MED
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   PECKHAM CS, 1988, LANCET, V2, P1039
   Pedron B, 2007, J INFECT DIS, V196, P1033, DOI 10.1086/521196
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teo D, 2009, TRANSFUSION MED, V19, P66, DOI 10.1111/j.1365-3148.2009.00916.x
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Thiebaut R, 2007, LANCET, V369, P115
   Tien WP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2373-4
   Tokarz R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21349-2
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   United States Food and Drug Administration, 2018, TABL 2 MOL ZIK VIR Z
   United States Food and Drug Administration, 2018, TABL 1 MOL ZIK VIR Z
   Valle J, 2019, SOUTH MED J, V112, P45, DOI 10.14423/SMJ.0000000000000917
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wand NIV, 2018, J GEN VIROL, V99, P1012, DOI 10.1099/jgv.0.001083
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler C. W., 2017, SCI REP, V7, P1
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Wood AM, 2018, CLIN PERINATOL, V45, P307, DOI 10.1016/j.clp.2018.01.005
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu WH, 2018, J MED VIROL, V90, P1681, DOI 10.1002/jmv.25253
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 172
TC 1
Z9 1
U1 4
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JUL
PY 2019
VL 5
IS 7
BP 1055
EP 1069
DI 10.1021/acsinfecdis.9b00003
PG 29
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA IJ3SW
UT WOS:000475825800003
PM 30951637
DA 2020-07-08
ER

PT J
AU Hu, YX
   Sun, L
AF Hu, Yuxia
   Sun, Lei
TI Systematic Analysis of Structure Similarity between Zika Virus and Other
   Flaviviruses
SO ACS INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; flavivirus; structure comparison; inhibitor; antiviral drug
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; BROAD-SPECTRUM; MEMBRANE
   ASSOCIATION; ENDOTHELIAL-CELLS; ENVELOPE PROTEIN; CAPSID PROTEIN;
   DENGUE; INFECTION; AXL
AB Zika virus (ZIKV) infection has caused global concern because of its association with fetal microcephaly and serious neurological complications in adults since 2016. Currently, no specific anti-ZIKV therapy is available to control ZIKV infection. During the last couple of years, the intensive investigation of ZIKV structure has provided significant information for structure-based vaccine and drug design. In this review, we summarized the research progress on the structures of ZIKV and its component proteins. We analyzed the structure identity and the differences between ZIKV and other flaviviruses. This information is crucial to guiding structure-based anti-ZIKV inhibitors and vaccine discovery.
C1 [Sun, Lei] Fudan Univ, Peoples Hosp Shanghai 5, 131 Dongan Rd, Shanghai 20032, Peoples R China.
   Fudan Univ, Inst Biomed Sci, 131 Dongan Rd, Shanghai 20032, Peoples R China.
RP Sun, L (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, 131 Dongan Rd, Shanghai 20032, Peoples R China.
EM LLSun@fudan.edu.cn
OI Sun, Lei/0000-0001-8741-0202
FU Fudan University [JIH1340112]
FX This work is supported by a Fudan University grant awarded to L.S.
   (Grant No. JIH1340112).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chatrin C, 2018, ONCOTARGET, V9, P3160, DOI 10.18632/oncotarget.23223
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De La Guardia C, 2014, BIOMED RES INT, DOI 10.1155/2014/825039
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elfiky AA, 2018, SAR QSAR ENVIRON RES, V29, P409, DOI 10.1080/1062936X.2018.1454981
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li L, 2018, ACTA CRYSTALLOGR F, V74, P205, DOI 10.1107/S2053230X18003813
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shannon AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep37539
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yang XY, 2018, FASEB J, V32, P5250, DOI 10.1096/fj.201701140R
   Yarrington Christina D, 2019, Fertil Res Pract, V5, P1, DOI 10.1186/s40738-018-0053-5
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
NR 96
TC 1
Z9 1
U1 4
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JUL
PY 2019
VL 5
IS 7
BP 1070
EP 1080
DI 10.1021/acsinfecdis.9b00047
PG 21
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA IJ3SW
UT WOS:000475825800004
PM 31038920
DA 2020-07-08
ER

PT J
AU Oduyebo, T
   Zapata, LB
   Boutot, ME
   Tepper, NK
   Curtis, KM
   D'Angelo, DV
   Marchbanks, PA
   Whiteman, MK
AF Oduyebo, Titilope
   Zapata, Lauren B.
   Boutot, Maegan E.
   Tepper, Naomi K.
   Curtis, Kathryn M.
   D'Angelo, Denise V.
   Marchbanks, Polly A.
   Whiteman, Maura K.
TI Factors associated with postpartum use of long-acting reversible
   contraception
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE LARC; long-acting reversible contraception; postpartum; PRAMS; short
   interpregnancy interval; unintended pregnancy
ID SHORT INTERPREGNANCY INTERVALS; MEDICAL ELIGIBILITY CRITERIA;
   UNITED-STATES; UNINTENDED PREGNANCY; ZIKA PREPAREDNESS; WOMEN; RISK;
   IMPLEMENTATION; PROMOTION; CONTEXT
AB BACKGROUND: Contraception use among postpartum women is important to prevent unintended pregnancies and optimize birth spacing. Long-acting reversible contraception, including intrauterine devices and implants, is highly effective, yet compared to less effective methods utilization rates are low.
   OBJECTIVES: We sought to estimate prevalence of long-acting reversible contraception use among postpartum women and examine factors associated with long-acting reversible contraception use among those using any reversible contraception.
   STUDY DESIGN: We analyzed 2012-2015 data from the Pregnancy Risk Assessment Monitoring System, a population-based survey among women with recent live births. We included data from 37 sites that achieved the minimum overall response rate threshold for data release. We estimated the prevalence of long-acting reversible contraception use in our sample (n = 143,335). We examined maternal factors associated with long-acting reversible contraception use among women using reversible contraception (n = 97,013) using multivariable logistic regression (longacting reversible contraception vs other type of reversible contraception) and multinomial regression (long-acting reversible contraception vs other hormonal contraception and long-acting reversible contraception vs other nonhormonal contraception).
   RESULTS: The prevalence of long-acting reversible contraception use overall was 15.3%. Among postpartum women using reversible contraception, 22.5% reported long-acting reversible contraception use, which varied by site, ranging from 11.2% in New Jersey to 37.6% in Alaska. Factors associated with postpartum long-acting reversible contraception use vs use of another reversible contraceptive method included age <= 24 years (adjusted odds ratio = 1.43; 95% confidence interval = 1.33-1.54) and >= 35 years (adjusted odds ratio = 0.87; 95% confidence interval = 0.80-0.96) vs 25-34 years; public insurance (adjusted odds ratio = 1.15; 95% confidence interval = 1.08-1.24) and no insurance (adjusted odds ratio = 0.73; 95% confidence interval = 0.55-0.96) vs private insurance at delivery; having a recent unintended pregnancy (adjusted odds ratio = 1.44; 95% confidence interval = 1.34-1.54) or being unsure about the recent pregnancy (adjusted odds ratio = 1.29; 95% confidence interval = 1.18-1.40) vs recent pregnancy intended; having > 1 previous live birth (adjusted odds ratio = 1.40; 95% confidence interval = 1.31-1.48); and having a postpartum check-up after recent live birth (adjusted odds ratio = 2.70; 95% confidence interval = 2.35-3.11). Hispanic and non-Hispanic black postpartum women had a higher rate of long-acting reversible contraception use (26.6% and 23.4%, respectively) compared to non-Hispanic white women (21.5%), and there was significant race/ ethnicity interaction with educational level.
   CONCLUSION: Nearly 1 in 6 (15.3%) postpartum women with a recent live birth and nearly 1 in 4 (22.5%) postpartum women using reversible contraception reported long-acting reversible contraception use. Our analysis suggests that factors such as age, race/ ethnicity, education, insurance, parity, intendedness of recent pregnancy, and postpartum visit attendance may be associated with postpartum longacting reversible contraception use. Ensuring all postpartum women have access to the full range of contraceptive methods, including longacting reversible contraception, is important to prevent unintended pregnancy and optimize birth spacing. Contraceptive access may be improved by public health efforts and programs that address barriers in the postpartum period, including increasing awareness of the availability, effectiveness, and safety of long-acting reversible contraception (and other methods), as well as providing full reimbursement for contraceptive services and removal of administrative and logistical barriers.
C1 [Oduyebo, Titilope; Zapata, Lauren B.; Boutot, Maegan E.; Tepper, Naomi K.; Curtis, Kathryn M.; D'Angelo, Denise V.; Marchbanks, Polly A.; Whiteman, Maura K.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30333 USA.
RP Oduyebo, T (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30333 USA.
EM ydk7@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Ahrens KA, 2018, CONTRACEPTION, V98, P52, DOI 10.1016/j.contraception.2018.02.013
   American College of Obstetricians and Gynecologists, 2011, Obstet Gynecol, V118, P184, DOI 10.1097/AOG.0b013e318227f05e
   American College of Obstetricians and Gynecologists, MED REIMB POSTP LARC
   Boardman LA, 2004, WOMEN HEALTH ISS, V14, P51, DOI 10.1016/j.whi.2004.03.002
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Branum Amy M, 2015, NCHS Data Brief, P1
   Briggs PE, 2013, J FAM PLAN REPROD H, V39, P190, DOI 10.1136/jfprhc-2012-100376
   Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P983
   Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809
   COPEN CE, 2015, NATL VITAL STAT REP, V64, P1
   Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1
   Dahlke JD, 2012, J WOMENS HEALTH, V21, P388, DOI 10.1089/jwh.2011.2845
   Daniels Kimberly, 2015, Natl Health Stat Report, P1
   Dee DL, 2017, MMWR-MORBID MORTAL W, V66, P422, DOI 10.15585/mmwr.mm6616a3
   Dehlendorf C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.009
   DePineres T, 2005, CONTRACEPTION, V72, P422, DOI 10.1016/j.contraception.2005.05.022
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013
   Gemmill A, 2013, OBSTET GYNECOL, V122, P64, DOI 10.1097/AOG.0b013e3182955e58
   Godfrey EM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.006
   Godfrey EM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-5
   Gomez AM, 2014, PERSPECT SEX REPRO H, V46, P171, DOI 10.1363/46e1614
   Guttmacher Institute, 2016, STAT POL BRIEF MED F
   Hall JA, 2017, MATERN CHILD HLTH J, V21, P670, DOI 10.1007/s10995-016-2237-0
   Han L, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.015
   Heinemann K, 2015, CONTRACEPTION, V91, P274, DOI 10.1016/j.contraception.2015.01.007
   Higgins JA, 2016, AM J PUBLIC HEALTH, V106, P1932, DOI 10.2105/AJPH.2016.303393
   Kavanaugh ML, 2015, OBSTET GYNECOL, V126, P917, DOI 10.1097/AOG.0000000000001094
   KETTING E, 1988, MATURITAS, P23
   Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9
   Kramer RD, 2018, CONTRACEPTION, V97, P399, DOI 10.1016/j.contraception.2018.01.006
   Kroelinger CD, 2019, J WOMENS HEALTH, V28, P346, DOI 10.1089/jwh.2018.7083
   Kroelinger CD, 2017, MMWR-MORBID MORTAL W, V66, P1230, DOI 10.15585/mmwr.mm6644a6
   Kusunoki Y, 2016, DEMOGRAPHY, V53, P1399, DOI 10.1007/s13524-016-0507-5
   Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1
   Okoroh EM, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.03.007
   ORR ST, PAEDIAT PERINAT EPID, V14, P309
   Ott MA, 2014, PEDIATRICS, V134, pE1257, DOI 10.1542/peds.2014-2300
   Robbins CL, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.033
   Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017
   Shulman HB, 2006, PUBLIC HEALTH REP, V121, P74, DOI 10.1177/003335490612100114
   Skouby SO, 2010, EUR J CONTRACEP REPR, V15, pS42, DOI 10.3109/13625187.2010.533002
   Smedley BD, 2013, UNEQUAL TREATMENT CO
   Sonfield A, 2015, PUBLIC COSTS UNINTEN
   Stuebe A, 2018, OBSTET GYNECOL, V131, pE140, DOI 10.1097/AOG.0000000000002633
   Tang JH, 2013, CONTRACEPTION, V88, P52, DOI 10.1016/j.contraception.2012.10.014
   Trussell J, 2008, CONTRACEPTION, V77, P1, DOI 10.1016/j.contraception.2007.09.001
   Vela VX, 2018, WOMEN HEALTH ISS, V28, P137, DOI 10.1016/j.whi.2017.10.013
   Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1
   White K, 2015, OBSTET GYNECOL, V125, P1471, DOI 10.1097/AOG.0000000000000841
   White K, 2014, CONTRACEPTION, V89, P57, DOI 10.1016/j.contraception.2013.10.005
   Whiteman M., 2009, Morbidity and Mortality Weekly Report, V58, P821
   Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855
   Zapata LB, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.059
NR 54
TC 2
Z9 2
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUL
PY 2019
VL 221
IS 1
AR 43.e1-e11
DI 10.1016/j.ajog.2019.03.005
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IE6IY
UT WOS:000472481100005
PM 30885772
DA 2020-07-08
ER

PT J
AU de Oliveira, DR
   Ventura, CV
   Esporcatte, BLB
   Gracitelli, CPB
   Dias, NDC
   Ventura, LO
   Belfort, R
   Rolim-de-Moura, C
AF de Oliveira, Daniela R.
   Ventura, Camila V.
   Esporcatte, Bruno L. B.
   Gracitelli, Carolina P. B.
   Dias, Natalia D. C.
   Ventura, Liana O.
   Belfort, Rubens, Jr.
   Rolim-de-Moura, Christiane
TI Glaucoma Workup in Congenital Zika Syndrome
SO JOURNAL OF GLAUCOMA
LA English
DT Letter
ID OPHTHALMIC MANIFESTATIONS; INFANTS
C1 [de Oliveira, Daniela R.; Esporcatte, Bruno L. B.; Gracitelli, Carolina P. B.; Belfort, Rubens, Jr.; Rolim-de-Moura, Christiane] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Ventura, Camila V.; Dias, Natalia D. C.; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP de Oliveira, DR (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
OI de Oliveira, Daniela/0000-0002-9951-644X
CR Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rossi AD, 2019, J INTERN MED, V285, P215, DOI 10.1111/joim.12829
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 7
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD JUL
PY 2019
VL 28
IS 7
BP E131
EP E131
DI 10.1097/IJG.0000000000001253
PG 1
WC Ophthalmology
SC Ophthalmology
GA IJ5IM
UT WOS:000475936400026
PM 30921276
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Glaucoma in Congenital Zika Syndrome
SO JOURNAL OF GLAUCOMA
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
CR de Oliveira DR, 2018, GLAUCOMA, V28, P313
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 3
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD JUL
PY 2019
VL 28
IS 7
BP E131
EP E131
DI 10.1097/IJG.0000000000001252
PG 1
WC Ophthalmology
SC Ophthalmology
GA IJ5IM
UT WOS:000475936400025
PM 30921275
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Congenital Zika syndrome and cerebellar cortical problem
SO JOURNAL OF NEURORADIOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Ribeiro Bruno Niemeyer de Freitas, 2020, J Neuroradiol, V47, P182, DOI 10.1016/j.neurad.2018.10.009
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0150-9861
EI 1773-0406
J9 J NEURORADIOLOGY
JI J. Neuroradiol.
PD JUL
PY 2019
VL 46
IS 4
BP 277
EP 278
DI 10.1016/j.neurad.2019.02.008
PG 2
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA IJ2IE
UT WOS:000475720700010
PM 30853543
DA 2020-07-08
ER

PT J
AU Hancock, PA
   Ritchie, SA
   Koenraadt, CJM
   Scott, TW
   Hoffmann, AA
   Godfray, HCJ
AF Hancock, Penelope A.
   Ritchie, Scott A.
   Koenraadt, Constantianus J. M.
   Scott, Thomas W.
   Hoffmann, Ary A.
   Godfray, H. Charles J.
TI Predicting the spatial dynamics of Wolbachia infections in Aedes aegypti
   arbovirus vector populations in heterogeneous landscapes
SO JOURNAL OF APPLIED ECOLOGY
LA English
DT Article
DE arbovirus; dengue; gene drive; spatial spread; wAlbB; wMel; wMelPop;
   Zika
ID BLOOD-FEEDING SUCCESS; DENGUE VECTOR; PUERTO-RICO; CULICIDAE; DIPTERA;
   SPREAD; SIZE; SURVIVAL; IQUITOS; ESTABLISHMENT
AB A promising strategy for reducing the transmission of dengue and other arboviral human diseases by Aedes aegypti mosquito vector populations involves field introductions of the endosymbiotic bacteria Wolbachia. Wolbachia infections inhibit viral transmission by the mosquito, and can spread between mosquito hosts to reach high frequencies in the vector population. Wolbachia spreads by maternal transmission, and spread dynamics can be variable and highly dependent on natural mosquito population dynamics, population structure and fitness components. We develop a mathematical model of an A. aegypti metapopulation that incorporates empirically validated relationships describing density-dependent mosquito fitness components. We assume that density dependent relationships differ across subpopulations, and construct heterogeneous landscapes for which model-predicted patterns of variation in mosquito abundance and demography approximate those observed in field populations. We then simulate Wolbachia release strategies similar to that used in field trials. We show that our model can produce rates of spatial spread of Wolbachia similar to those observed following field releases. We then investigate how different types of spatio-temporal variation in mosquito habitat, as well as different fitness costs incurred by Wolbachia on the mosquito host, influence predicted spread rates. We find that fitness costs reduce spread rates more strongly when the habitat landscape varies temporally due to stochastic and seasonal processes. Synthesis and applications: Our empirically based modelling approach represents effects of environmental heterogeneity on the spatial spread of Wolbachia. The models can assist in interpreting observed spread patterns following field releases and in designing suitable release strategies for targeting spatially heterogeneous vector populations.
C1 [Hancock, Penelope A.; Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford, England.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia.
   [Koenraadt, Constantianus J. M.] Wageningen Univ, Lab Entomol, Wageningen, Netherlands.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Hoffmann, Ary A.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Parkville, Vic, Australia.
RP Hancock, PA (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM hancock.penelope@gmail.com
RI Hoffmann, Ary/R-2972-2019
OI Hoffmann, Ary/0000-0001-9497-7645; Hancock, Penelope/0000-0001-5531-1082
FU 7th European Community Framework ProgrammeEuropean Union (EU)
   [326551-WOLBACHIA-MOD]
FX 7th European Community Framework Programme, Grant/Award Number: Grant
   no. 326551-WOLBACHIA-MOD
CR Aldstadt J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000940
   Arrivillaga J, 2004, J VECTOR ECOL, V29, P11
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   FOCKS DA, 2006, MULTICOUNTRY STUDY A
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Hancock P. A., 2019, PAHANC WOLBACHIA INV, DOI [10.5284/zenodo.2784071, DOI 10.5284/ZENODO.2784071]
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Hancock PA, 2016, J APPL ECOL, V53, P785, DOI 10.1111/1365-2664.12620
   Hancock PA, 2012, J R SOC INTERFACE, V9, P3045, DOI 10.1098/rsif.2012.0253
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, AUSTRAL ENTOMOL, V53, P125, DOI 10.1111/aen.12068
   Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552
   Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Legros M, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1515
   Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634
   Schofield P, 2002, J THEOR BIOL, V215, P121, DOI 10.1006/jtbi.2001.2493
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
NR 50
TC 2
Z9 2
U1 3
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8901
EI 1365-2664
J9 J APPL ECOL
JI J. Appl. Ecol.
PD JUL
PY 2019
VL 56
IS 7
BP 1674
EP 1686
DI 10.1111/1365-2664.13423
PG 13
WC Biodiversity Conservation; Ecology
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA IH1RY
UT WOS:000474270200015
DA 2020-07-08
ER

PT J
AU Zhang, BX
   Cai, YL
   Wang, BX
   Wang, WM
AF Zhang, Baoxiang
   Cai, Yongli
   Wang, Bingxian
   Wang, Weiming
TI Pattern formation in a reaction-diffusion parasite-host model
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE parasite-host model; Stability; Steady-state; Turing pattern
ID PREDATOR-PREY MODEL; EPIDEMIC MODEL; TRANSMISSION DYNAMICS; TURING
   PATTERNS; SPATIOTEMPORAL DYNAMICS; SPATIAL-PATTERNS; TRAVELING-WAVES;
   STEADY-STATE; ZIKA VIRUS; DISEASE
AB In this paper, we investigate the Turing pattern formation of a reaction-diffusion parasite-host model analytically and numerically. We give the stability of the constant positive steady-state which shows that the model exhibits stationary Turing pattern as a result of diffusion. Via numerical simulations, we present the pattern formation and find that the model dynamics exhibits a diffusion-controlled formation growth of "spots -> spots-stripes -> stripes -> holes-stripes -> holes" pattern replication. The results show that we must do our best to regulate the parameters in the special range to avoid disease outbreak. (C) 2019 Published by Elsevier B.V.
C1 [Zhang, Baoxiang; Cai, Yongli; Wang, Bingxian; Wang, Weiming] Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
RP Wang, WM (corresponding author), Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
EM habao@hytc.edu.cn; caiyongli@hytc.edu.cn; bxwang@hytc.edu.cn;
   wangwm_math@hytc.edu.cn
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [11601179, 61672013, 61772017]; Huaian Key Laboratory for
   Infectious Diseases Control and Prevention, PR China [HAP201704]
FX This research was supported by the National Science Foundation of China
   (Grant No. 11601179, 61672013 and 61772017) and Huaian Key Laboratory
   for Infectious Diseases Control and Prevention, PR China (HAP201704).
CR Allen L, 2009, J MATH BIOL, V58, P339, DOI 10.1007/s00285-008-0194-y
   Berezovsky F, 2005, MATH BIOSCI ENG, V2, P133
   Brauer F., 2012, AM MATH MONTH, V40, P267
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cai YL, 2018, INT J BIFURCAT CHAOS, V28, DOI 10.1142/S0218127418501407
   Cai YL, 2018, NONLINEAR ANAL-REAL, V40, P444, DOI 10.1016/j.nonrwa.2017.10.001
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Cai YL, 2015, J DIFFER EQUATIONS, V259, P7463, DOI 10.1016/j.jde.2015.08.024
   Cai YL, 2015, DISCRETE CONT DYN-B, V20, P989, DOI 10.3934/dcdsb.2015.20.989
   Cao BQ, 2017, PHYSICA A, V486, P127, DOI 10.1016/j.physa.2017.05.083
   Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404
   Garvie MR, 2007, B MATH BIOL, V69, P931, DOI 10.1007/s11538-006-9062-3
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378
   Hwang TW, 2005, MATH BIOSCI ENG, V2, P743
   Hwang TW, 2003, J MATH BIOL, V46, P17, DOI 10.1007/s00285-002-0165-7
   Jaeduck Jang, 2004, Journal of Dynamics and Differential Equations, V16, P297
   Kang Y, 2014, DISCRETE CONT DYN-B, V19, P89, DOI 10.3934/dcdsb.2014.19.89
   Magal P, 2018, NONLINEARITY, V31, P5589, DOI 10.1088/1361-6544/aae1e0
   Neuhauser C., 2001, NOT AM MATH SOC, V48, P1304
   Ni WM, 2005, T AM MATH SOC, V357, P3953, DOI 10.1090/S0002-9947-05-04010-9
   OKUBO A, 2002, DIFFUSION ECOLOGICAL
   Peng R, 2013, PHYSICA D, V259, P8, DOI 10.1016/j.physd.2013.05.006
   Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043
   RASS L, 2003, SPATIAL DETERMINISTI
   Shi JP, 1999, J FUNCT ANAL, V169, P494, DOI 10.1006/jfan.1999.3483
   Song YL, 2017, SIAM J APPL DYN SYST, V16, P2030, DOI 10.1137/16M1097560
   Song YL, 2017, STUD APPL MATH, V139, P371, DOI 10.1111/sapm.12165
   Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002
   Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6
   VENTURINO E, 1994, ROCKY MT J MATH, V24, P381
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang WM, 2018, PHYSICA A, V509, P921, DOI 10.1016/j.physa.2018.06.099
   Wang WM, 2011, J BIOL SYST, V19, P19, DOI 10.1142/S0218339011003555
   Wang ZC, 2012, P AM MATH SOC, V140, P3931
   Wu SH, 2019, NONLINEAR ANAL-REAL, V48, P12, DOI 10.1016/j.nonrwa.2019.01.004
   Xiao YN, 2002, APPL MATH COMPUT, V131, P397, DOI 10.1016/S0096-3003(01)00156-4
   Xiao YN, 2001, MATH BIOSCI, V171, P59, DOI 10.1016/S0025-5564(01)00049-9
   Yang B, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1925-z
   Yang FY, 2015, NONLINEAR ANAL-REAL, V23, P129, DOI 10.1016/j.nonrwa.2014.12.001
   Yi FQ, 2009, J DIFFER EQUATIONS, V246, P1944, DOI 10.1016/j.jde.2008.10.024
   Zhang HS, 2019, APPL MATH COMPUT, V356, P328, DOI 10.1016/j.amc.2019.03.034
NR 44
TC 3
Z9 3
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4371
EI 1873-2119
J9 PHYSICA A
JI Physica A
PD JUL 1
PY 2019
VL 525
BP 732
EP 740
DI 10.1016/j.physa.2019.03.088
PG 9
WC Physics, Multidisciplinary
SC Physics
GA IH5AQ
UT WOS:000474503900066
DA 2020-07-08
ER

PT J
AU Rinkenberger, N
   Schoggins, JW
AF Rinkenberger, Nicholas
   Schoggins, John W.
TI Comparative analysis of viral entry for Asian and African lineages of
   Zika virus
SO VIROLOGY
LA English
DT Article
DE Zika; Flavivirus; Entry; Internalization; Endosome
ID BORNE ENCEPHALITIS-VIRUS; FUSION; CELLS; INFECTION; ENDOSOME; PROTEINS;
   PH; ENDOCYTOSIS; EFFECTORS; STRAINS
AB Zika virus (ZIKV) is an emerging pathogen with global health and economic impacts. ZIKV circulates as two major lineages, Asian or African. The Asian lineage has recently been associated with significant disease in humans. Numerous studies have revealed differences between African and Asian ZIKV strains with respect to cellular infectivity, pathogenesis, and immune activation. Less is known about the mechanism of ZIKV entry and whether viral entry differs between strains. Here, we characterized ZIKV entry with two Asian and two African strains. All viruses exhibited a requirement for clathrin-mediated endocytosis and Rab5a function. Additionally, all ZIKV strains tested were sensitive to pH in the range of 6.5-6.1 and were reliant on endosomal acidification for infection. Finally, we provide direct evidence that ZIKV primarily fuses with late endosomes. These findings contribute new insight into the ZIKV entry process and suggest that divergent ZIKV strains enter cells in a highly conserved manner.
C1 [Rinkenberger, Nicholas; Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
RP Schoggins, JW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
EM john.schoggins@utsouthwestern.edu
FU NCI Cancer Center Support GrantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [CA142543]; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [AI117922]; UT
   Southwestern Endowed Scholars program; NIH T32 Training GrantUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [AI007520]
FX We thank Jennifer Eitson and Didi Chen for technical assistance, and
   Katrina Mar for critical manuscript feedback. We acknowledge the
   assistance of the UT Southwestern Live Cell Imaging Facility, a shared
   resource of the Harold C. Simmons Cancer Center, supported in part by an
   NCI Cancer Center Support Grant, CA142543. This work was supported in
   part by NIH grants AI117922 and by the UT Southwestern Endowed Scholars
   program (J.W.S.). Additional support for N.R. was obtained from NIH T32
   Training Grant AI007520.
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404
   Helenius A, 2018, J MOL BIOL, V430, P1853, DOI 10.1016/j.jmb.2018.03.034
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hu YB, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0041-1
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Korte T, 1999, J VIROL, V73, P4567, DOI 10.1128/JVI.73.6.4567-4574.1999
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LOYTER A, 1988, METHOD BIOCHEM ANAL, V33, P129
   Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Rawle RJ, 2018, ACS CENTRAL SCI, V4, P1503, DOI 10.1021/acscentsci.8b00494
   Rinkenberger N, 2018, MBIO, V9, DOI 10.1128/mBio.02314-17
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14
   STEGMANN T, 1993, BIOCHEMISTRY-US, V32, P11330, DOI 10.1021/bi00093a009
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
   Yang SB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-258
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 53
TC 1
Z9 1
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUL
PY 2019
VL 533
BP 59
EP 67
DI 10.1016/j.virol.2019.04.008
PG 9
WC Virology
SC Virology
GA II1CA
UT WOS:000474941300007
PM 31112915
DA 2020-07-08
ER

PT J
AU Voermans, JJC
   Pas, SD
   van der Linden, A
   GeurtsvanKessel, C
   Koopmans, M
   van der Eijk, A
   Reusken, CBEM
AF Voermans, Jolanda J. C.
   Pas, Suzan D.
   van der Linden, Anne
   GeurtsvanKessel, Corine
   Koopmans, Marion
   van der Eijk, Annemiek
   Reusken, Chantal B. E. M.
TI Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in
   Routine Diagnostic Setting
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RNA DETECTION
AB We evaluated the benefit of whole blood versus plasma to detect acute Zika virus infections. Comparison of Zika virus quantitative reverse transcription PCR results in single timepoint whole blood-plasma pairs from 227 patients with suspected Zika virus infection resulted in confirmation of 8 additional patients with Zika virus infection.
C1 [Voermans, Jolanda J. C.; Pas, Suzan D.; van der Linden, Anne; GeurtsvanKessel, Corine; Koopmans, Marion; van der Eijk, Annemiek; Reusken, Chantal B. E. M.] Erasmus MC, Rotterdam, Netherlands.
   [Pas, Suzan D.] Microvida, Roosendaal, Netherlands.
   [Reusken, Chantal B. E. M.] Natl Inst Publ Hlth & Environm, Netherlands Ctr Infect Dis Control, Bilthoven, Netherlands.
RP Reusken, CBEM (corresponding author), Erasmus MC, Virosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
FU European Union's Horizon 2020 research and innovation program under
   project ZIKALLIANCE [734548]
FX The work described here was funded by the European Union's Horizon 2020
   research and innovation program under project ZIKALLIANCE (grant
   agreement no. 734548).
CR Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton N, 2014, TRAVEL MED INFECT DI, V12, P159, DOI 10.1016/j.tmaid.2013.10.015
   El Sahly HM, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy352
   Huang GKL, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx203
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   World Health Organization, 2016, ZIK VIR DIS INT CAS
NR 14
TC 2
Z9 2
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2019
VL 25
IS 7
BP 1394
EP 1396
DI 10.3201/eid2507.182000
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IG4LP
UT WOS:000473775400020
PM 31008703
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prudhomme, J
   Fontaine, A
   Lacour, G
   Gantier, JC
   Diancourt, L
   Velo, E
   Bino, S
   Reiter, P
   Mercier, A
AF Prudhomme, Jorian
   Fontaine, Albin
   Lacour, Guillaume
   Gantier, Jean-Charles
   Diancourt, Laure
   Velo, Enkelejda
   Bino, Silva
   Reiter, Paul
   Mercier, Aurelien
TI The native European Aedes geniculatus mosquito species can transmit
   chikungunya virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Aedes geniculatus; Aedes albopictus; chikungunya; Europe; vector
   competence; autochtonous species; arbovirus; globalization
ID INVASIVE MOSQUITOS; ALBOPICTUS; INFECTION; DIPTERA; ZIKA; EPIDEMIC;
   AEGYPTI; COMPETENT; CULICIDAE; OUTBREAK
AB Europe is the world's leading tourism destination and is receiving every year travellers from areas with active arbovirus transmission. There is thus a threat of mosquito-borne virus emergence in Europe due to the presence of the invasive mosquito vector Aedes albopictus. Little attention has been paid about the possible role of indigenous mosquito species as vectors of emerging arboviruses. Here, we assessed the vector competence dynamic of Aedes geniculatus, a European anthropophilic mosquito species, for chikungunya virus (CHIKV) in comparison with an European population of Ae. albopictus. We revealed that Ae. geniculatus is highly susceptible to CHIKV infection and could transmit the virus. By specifically exploring the vector competence dynamic in both mosquito species, we revealed that the cumulative distribution of CHIKV incubation period in Ae. geniculatus was delayed by several days as compared to Ae. albopictus. Our results strengthen the importance of considering indigenous species as potential vectors for emerging arboviruses. They also revealed the importance of considering variation in arbovirus dissemination or transmission dynamics in mosquitoes when performing vector competence assays. We will discuss the implications of our results on a CHIKV outbreak dynamic in a theoretical framework.
C1 [Prudhomme, Jorian] Univ Montpellier, UMR MIVEGEC, IRD 224, CNRS 5290, Montpellier, France.
   [Fontaine, Albin] IRBA, Unite Parasitol & Entomol, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
   [Fontaine, Albin] Aix Marseille Univ, IHU Mediterranee Infect, UMR Vecteurs Infect Trop & Mediterraneennes VITRO, IRD,AP HM,SSA, 19-21 Bd Jean Moulin, F-13385 Marseille, France.
   [Lacour, Guillaume] Inst Pasteur Guyane, Unite Controle & Adaptat Vecteurs, Cayenne, France.
   [Gantier, Jean-Charles] Lab Identificat Fong & Entomoparasitol, Mennecy, France.
   [Diancourt, Laure] Inst Pasteur, Genotyping Pathogens & Publ Hlth, Paris, France.
   [Velo, Enkelejda; Bino, Silva] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
   [Reiter, Paul; Mercier, Aurelien] Inst Pasteur, Unite Insectes & Malad Infect, Paris, France.
   [Mercier, Aurelien] INSERM, U1094, Neuroepidemiol Trop, Limoges, France.
RP Fontaine, A (corresponding author), IRBA, Unite Parasitol & Entomol, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.; Fontaine, A (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, UMR Vecteurs Infect Trop & Mediterraneennes VITRO, IRD,AP HM,SSA, 19-21 Bd Jean Moulin, F-13385 Marseille, France.
EM albinfont@gmail.com
RI Fontaine, Albin/K-4345-2019; Mercier, Aurelien/Q-4683-2016
OI Fontaine, Albin/0000-0001-6869-6516; Velo,
   Enkelejda/0000-0001-7283-2541; Mercier, Aurelien/0000-0003-4332-5879
FU EUEuropean Union (EU) [FP7-261504]; Direction Generale de l'Armement
   [PDH-2-NRBC-2-B-2113]
FX This study was funded by EU grant EDENext [FP7-261504]
   (http://www.edenext.eu) and the Direction Generale de l'Armement [grant
   number PDH-2-NRBC-2-B-2113].
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   BRADSHAW WE, 1986, NATL GEOGR RES, V2, P167
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Eckerle I, 2018, CLIN MICROBIOL INFEC, V24, P240, DOI 10.1016/j.cmi.2018.01.007
   European Centre for Disease Prevention and Control, 2018, MOSQ MAPS
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Fontaine A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007187
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Fortuna C, 2018, EUROSURVEILLANCE, V23, P6, DOI 10.2807/1560-7917.ES.2018.23.22.1800246
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Gossner CM, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.24.1800268
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Hothorn T, 2008, J STAT SOFTW, V28, P1
   Knight KL, 1977, ENTOMOLOGICAL SOC AM, P611
   Krueger Andreas, 2014, Journal of the European Mosquito Control Association, V32, P22
   Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0
   Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260
   Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Luhken R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-268
   MACDONALD G, 1961, PUBLIC HEALTH REP, V76, P753, DOI 10.2307/4591271
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Penot P, 2017, REV MED INTERNE, V38, P547, DOI 10.1016/j.revmed.2016.12.011
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002
   Rambaut A, 2009, FIGTREE VERSION 1 4
   Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x
   Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x
   Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x
   Rodhain F, 2017, Bull Soc Pathol Exot, V110, P147, DOI 10.1007/s13149-017-0557-y
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Severini F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006435
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsiodras S, 2016, PATHOG GLOB HEALTH, V110, P68, DOI 10.1080/20477724.2016.1176311
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   World Tourism Organization, 2018, UNWTO TOUR HIGHL 201, DOI [10.18111/9789284419876, DOI 10.18111/9789284419876]
   YATES MG, 1979, B ENTOMOL RES, V69, P611, DOI 10.1017/S0007485300020162
NR 69
TC 4
Z9 4
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 1
PY 2019
VL 8
IS 1
BP 962
EP 972
DI 10.1080/22221751.2019.1634489
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IG0PJ
UT WOS:000473492300001
PM 31259662
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lima, JCB
   Neves, DV
   De Oliveira, GM
   Gois, JF
   Garay, AV
   Barbosa, JARG
AF Cunha Barbosa Lima, J.
   Vieira Neves, D.
   Mendes De Oliveira, G.
   Faro Gois, J.
   Valle Garay, A.
   Ribeiro Goncalves Barbosa, J. A.
TI STRUCTURAL ANALYSIS OF PROTEASES NS3 OF FLAVIVIRUS ZIKA AND DENGUE, AND
   NSP2 OF ALPHAVIRUS CHIKUNGUNYA AND MAYARO BY IN SILICO AND IN VITRO
   TOOLS
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT Joint 12th EBSA European Biophysics Congress / 10th IUPAP International
   Conference on Biological Physics (ICBP)
CY JUL 20-24, 2019
CL Madrid, SPAIN
SP European Biophys Soc Assoc, Int Union Pure & Appl Phys, Biol Phys Commiss, Spanish Soc Biophys, IOP Publishing, Larodan, Avanti Polar Lipids Inc, Mad Citylab, Elsevier, Int Union Pure & Appl Biophys
C1 [Cunha Barbosa Lima, J.; Vieira Neves, D.; Mendes De Oliveira, G.; Faro Gois, J.; Valle Garay, A.; Ribeiro Goncalves Barbosa, J. A.] Univ Brasilia, Brasilia, DF, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2019
VL 48
SU 1
MA P-270
BP S146
EP S146
PG 1
WC Biophysics
SC Biophysics
GA IF9NS
UT WOS:000473420400458
DA 2020-07-08
ER

PT J
AU Bailey, MJ
   Broecker, F
   Freyn, AW
   Choi, A
   Brown, JA
   Fedorova, N
   Simon, V
   Lim, JK
   Evans, MJ
   Garca-Sastre, A
   Palese, P
   Tan, GS
AF Bailey, Mark J.
   Broecker, Felix
   Freyn, Alec W.
   Choi, Angela
   Brown, Julia A.
   Fedorova, Nadia
   Simon, Viviana
   Lim, Jean K.
   Evans, Matthew J.
   Garca-Sastre, Adolfo
   Palese, Peter
   Tan, Gene S.
TI Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select
   for Escape Mutations on the Lateral Ridge of the Envelope Protein
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; antibody-dependent cellular cytotoxicity; monoclonal
   antibodies; neutralizing antibodies; prM-E; whole-genome sequencing
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; BIOINFORMATICS DATABASE; ANALYSIS
   RESOURCE; CROSS-REACTIVITY; INFECTION; IMMUNOGENICITY; PHASE-1; SAFETY;
   VIPR
AB The mosquito-borne Zika virus (ZIKV) has been causing epidemic outbreaks on a global scale. Virus infection can result in severe disease in humans, including microcephaly in newborns and Guillain-Barre syndrome in adults. Here, we characterized monoclonal antibodies isolated from a patient with an active Zika virus infection that potently neutralized virus infection in Vero cells at the nanogram-per-milliliter range. In addition, these antibodies enhanced internalization of virions into human leukemia K562 cells in vitro, indicating their possible ability to cause antibody-dependent enhancement of disease. Escape variants of the ZIKV MR766 strain to a potently neutralizing antibody, AC10, exhibited an amino acid substitution at residue S368 in the lateral ridge region of the envelope protein. Analysis of publicly availably ZIKV sequences revealed the S368 site to be conserved among the vast majority (97.6%) of circulating strains. We validated the importance of this residue by engineering a recombinant virus with an S368R point mutation that was unable to be fully neutralized by AC10. Four out of the 12 monoclonal antibodies tested were also unable to neutralize the virus with the S368R mutation, suggesting this region to be an important immunogenic epitope during human infection. Last, a time-of-addition infection assay further validated the escape variant and showed that all monoclonal antibodies inhibited virus binding to the cell surface. Thus, the present study demonstrates that the lateral ridge region of the envelope protein is likely an immunodominant, neutralizing epitope.
   IMPORTANCE Zika virus (ZIKV) is a global health threat causing severe disease in humans, including microcephaly in newborns and Guillain-Barre syndrome in adults. Here, we analyzed the human monoclonal antibody response to acute ZIKV infection and found that neutralizing antibodies could not elicit Fc-mediated immune effector functions but could potentiate antibody-dependent enhancement of disease. We further identified critical epitopes involved with neutralization by generating and characterizing escape variants by whole-genome sequencing. We demonstrate that the lateral ridge region, particularly the S368 amino acid site, is critical for neutralization by domain III-specific antibodies.
C1 [Bailey, Mark J.; Broecker, Felix; Freyn, Alec W.; Choi, Angela; Brown, Julia A.; Simon, Viviana; Lim, Jean K.; Evans, Matthew J.; Garca-Sastre, Adolfo; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Bailey, Mark J.; Freyn, Alec W.; Choi, Angela; Brown, Julia A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Garca-Sastre, Adolfo; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
   [Fedorova, Nadia; Tan, Gene S.] J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.
   [Tan, Gene S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Choi, Angela; Simon, Viviana; Garca-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
RP Tan, GS (corresponding author), J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.; Tan, GS (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM gtan@jcvi.org
RI Broecker, Felix/AAC-5609-2019; Freyn, Alec/AAD-3481-2019
OI Bailey, Mark/0000-0003-3874-5334
FU J. Craig Venter Institute; National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, Department of Health and Human
   ServicesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI110819]; MSTP Training Grant [NIH T32
   GM007280]; German Academy of Sciences Leopoldina; Burroughs Wellcome
   FundBurroughs Wellcome Fund;  [R01AI120998];  [R21AI130299]; 
   [R21AI133649]
FX This work was supported by grants R01AI120998 (V.S), R21AI130299
   (J.K.L.), and R21AI133649 (M.J.E.). M.J.E. holds an Investigators in
   Pathogenesis of Infectious Disease Award from the Burroughs Wellcome
   Fund. G.S.T. is supported by a J. Craig Venter Institute start-up fund
   and U19AI110819. This project has been funded in part with federal funds
   from the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   award number U19AI110819. M.J.B. was supported by the MSTP Training
   Grant NIH T32 GM007280. F.B. thanks the German Academy of Sciences
   Leopoldina for financial support through a postdoctoral stipend.
CR ARMANDOLA EA, 1993, MOL IMMUNOL, V30, P287, DOI 10.1016/0161-5890(93)90057-I
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Burlingham WJ, 1998, J IMMUNOL, V161, P6705
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chambers MT, 2018, J VIROL, V92, DOI [10.1128/JVI.00505-18, 10.1128/jvi.00505-18]
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kuzmina NA, 2018, CELL REP, V24, P1802, DOI 10.1016/j.celrep.2018.07.035
   Leon PE, 2016, P NATL ACAD SCI USA, V113, pE5944, DOI 10.1073/pnas.1613225113
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shrivastava S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34147-7
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 46
TC 1
Z9 1
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 14
AR e00405-19
DI 10.1128/JVI.00405-19
PG 17
WC Virology
SC Virology
GA IF7OM
UT WOS:000473273500011
PM 31043537
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Mastrodomenico, V
   Esin, JJ
   Graham, ML
   Tate, PM
   Hawkins, GM
   Sandler, ZJ
   Rademacher, DJ
   Kicmal, TM
   Dial, CN
   Mounce, BC
AF Mastrodomenico, Vincent
   Esin, Jeremy J.
   Graham, Marion L.
   Tate, Patrick M.
   Hawkins, Grant M.
   Sandler, Zachary J.
   Rademacher, David J.
   Kicmal, Thomas M.
   Dial, Courtney N.
   Mounce, Bryan C.
TI Polyamine Depletion Inhibits Bunyavirus Infection via Generation of
   Noninfectious Interfering Virions
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE bunyaviruses; noninfectious particles; polyamines
ID RIFT-VALLEY FEVER; PROTEIN NSS COUNTERACTS; ANTIVIRAL IMMUNITY; LYTIC
   INFECTION; PHASE-II; VIRUS; RNA; SPERMIDINE; DIFLUOROMETHYLORNITHINE;
   REPLICATION
AB Several host and viral processes contribute to forming infectious virions. Polyamines are small host molecules that play diverse roles in viral replication. We previously demonstrated that polyamines are crucial for RNA viruses; however, the mechanisms by which polyamines function remain unknown. Here, we investigated the role of polyamines in the replication of the bunyaviruses Rift Valley fever virus (vaccine strain MP-12) and La Crosse virus (LACV). We found that polyamine depletion did not impact viral RNA or protein accumulation, despite significant decreases in titer. Viral particles demonstrated no change in morphology, size, or density. Thus, polyamine depletion promotes the formation of noninfectious particles. These particles interfere with virus replication and stimulate innate immune responses. We extended this phenotype to Zika virus; however, coxsackievirus did not similarly produce noninfectious particles. In sum, polyamine depletion results in the accumulation of noninfectious particles that interfere with replication and stimulate immune signaling, with important implications for targeting polyamines therapeutically, as well as for vaccine strategies.
   IMPORTANCE Bunyaviruses are emerging viral pathogens that cause encephalitis, hemorrhagic fevers, and meningitis. We have uncovered that diverse bunyaviruses require polyamines for productive infection. Polyamines are small, positively charged host-derived molecules that play diverse roles in human cells and in infection. In polyamine-depleted cells, bunyaviruses produce an overabundance of noninfectious particles that are indistinguishable from infectious particles. However, these particles interfere with productive infection and stimulate antiviral signaling pathways. We further find that additional enveloped viruses are similarly sensitive to polyamine depletion but that a nonenveloped enterovirus is not. We posit that polyamines are required to maintain bunyavirus infectivity and that polyamine depletion results in the accumulation of interfering noninfectious particles that limit infectivity. These results highlight a novel means by which bunyaviruses use polyamines for replication and suggest promising means to target host polyamines to reduce virus replication.
C1 [Mastrodomenico, Vincent; Esin, Jeremy J.; Graham, Marion L.; Tate, Patrick M.; Hawkins, Grant M.; Sandler, Zachary J.; Rademacher, David J.; Kicmal, Thomas M.; Dial, Courtney N.; Mounce, Bryan C.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.
   [Esin, Jeremy J.; Sandler, Zachary J.; Kicmal, Thomas M.; Dial, Courtney N.; Mounce, Bryan C.] Loyola Univ Chicago, Stritch Sch Med, Infect Dis & Immunol Res Inst, Maywood, IL 60153 USA.
   [Rademacher, David J.] Loyola Univ Chicago, Core Imaging Facil, Maywood, IL USA.
RP Mounce, BC (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.; Mounce, BC (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Infect Dis & Immunol Res Inst, Maywood, IL 60153 USA.
EM bmounce@luc.edu
OI Dial, Courtney/0000-0003-0004-7418
CR Alfson KJ, 2015, J VIROL, V89, P6773, DOI 10.1128/JVI.00649-15
   Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001
   Bouteille B, 2012, RES REP TROP MED, V3, P35, DOI 10.2147/RRTM.S24751
   Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5
   ELLIS DS, 1988, J MED VIROL, V24, P161, DOI 10.1002/jmv.1890240205
   Fabian CJ, 2002, CLIN CANCER RES, V8, P3105
   FOUT GS, 1984, J BIOL CHEM, V259, P3639
   FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818
   Goyal L, 2013, CANCER CHEMOTH PHARM, V72, P1305, DOI 10.1007/s00280-013-2293-8
   Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006
   Ivanov IP, 2018, MOL CELL, V70, P254, DOI 10.1016/j.molcel.2018.03.015
   Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004
   Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003
   LANZER W, 1975, J VIROL, V16, P1254, DOI 10.1128/JVI.16.5.1254-1264.1975
   Lednicky JA, 2019, CLIN INFECT DIS, V68, P143, DOI 10.1093/cid/ciy485
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Lowen AC, 2005, J VIROL, V79, P6940, DOI 10.1128/JVI.79.11.6940-6946.2005
   Madhubala R, 1998, Methods Mol Biol, V79, P131
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   Manzoni TB, 2018, FUTURE VIROL, V13, P493, DOI 10.2217/fvl-2018-0021
   McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4
   Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795
   Mounce BC, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00029-17
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Mounce BC, 2011, VIROLOGY, V421, P167, DOI 10.1016/j.virol.2011.09.024
   Moutailler S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001156
   Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07
   Olsen ME, 2018, J VIROL, V92, DOI [10.1128/JVI.01260-18, 10.1128/jvi.01260-18]
   Olsen ME, 2016, MBIO, V7, DOI 10.1128/mBio.00882-16
   Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   RAINA A, 1981, MED BIOL, V59, P428
   Ramot Y, 2010, EXP DERMATOL, V19, P784, DOI 10.1111/j.1600-0625.2010.01111.x
   Rezelj VV, 2018, CURR OPIN VIROL, V33, P74, DOI 10.1016/j.coviro.2018.07.014
   Romero Jose R, 2003, Semin Pediatr Infect Dis, V14, P72, DOI 10.1053/spid.2003.127223
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   SHEPPARD SL, 1980, J VIROL, V34, P266, DOI 10.1128/JVI.34.1.266-267.1980
   Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658
   Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wolff JC, 2003, CLIN CANCER RES, V9, P5922
   Xiao YH, 2016, CELL HOST MICROBE, V19, P493, DOI 10.1016/j.chom.2016.03.009
   Xu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00909-6
NR 46
TC 2
Z9 2
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 14
AR e00530-19
DI 10.1128/JVI.00530-19
PG 19
WC Virology
SC Virology
GA IF7OM
UT WOS:000473273500019
PM 31043534
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Miorin, L
   Laurent-Rolle, M
   Pisanelli, G
   Co, PH
   Albrecht, RA
   Garcia-Sastre, A
   Morrison, J
AF Miorin, Lisa
   Laurent-Rolle, Maudry
   Pisanelli, Giuseppe
   Co, Pierre Hendrick
   Albrecht, Randy A.
   Garcia-Sastre, Adolfo
   Morrison, Juliet
TI Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE NS5; STAT2; flavivirus; host tropism; interferon; interferon antagonism;
   yellow fever virus
ID ALPHA-INTERFERON; MOUSE MODEL; STAT2; MICE; RECEPTOR; PROTEIN
AB The recent yellow fever virus (YFV) epidemic in Brazil in 2017 and Zika virus (ZIKV) epidemic in 2015 serve to remind us of the importance of flaviviruses as emerging human pathogens. With the current global flavivirus threat, there is an urgent need for antivirals and vaccines to curb the spread of these viruses. However, the lack of suitable animal models limits the research questions that can be answered. A common trait of all flaviviruses studied thus far is their ability to antagonize interferon (IFN) signaling so as to enhance viral replication and dissemination. Previously, we reported that YFV NS5 requires the presence of type I IFN (IFN-alpha/beta) for its engagement with human signal transducer and activator of transcription 2 (hSTAT2). In this manuscript, we report that like the NS5 proteins of ZIKV and dengue virus (DENV), YFV NS5 protein is able to bind hSTAT2 but not murine STAT2 (mSTAT2). Contrary to what has been demonstrated with ZIKV NS5 and DENV NS5, replacing mSTAT2 with hSTAT2 cannot rescue the YFV NS5-STAT2 interaction, as YFV NS5 is also unable to interact with hSTAT2 in murine cells. We show that the IFN-alpha/beta-dependent ubiquitination of YFV NS5 that is required for STAT2 binding in human cells is absent in murine cells. In addition, we demonstrate that mSTAT2 restricts YFV replication in vivo. These data serve as further impetus for the development of an immunocompetent mouse model that can serve as a disease model for multiple flaviviruses.
   IMPORTANCE Flaviviruses such as yellow fever virus (YFV), Zika virus (ZIKV), and dengue virus (DENV) are important human pathogens. A common flavivirus trait is the antagonism of interferon (IFN) signaling to enhance viral replication and spread. We report that like ZIKV NS5 and DENV NS5, YFV NS5 binds human STAT2 (hSTAT2) but not mouse STAT2 (mSTAT2), a type I IFN (IFN-alpha/beta) pathway component. Additionally, we show that contrary to what has been demonstrated with ZIKV NS5 and DENV NS5, YFV NS5 is unable to interact with hSTAT2 in murine cells. We demonstrate that mSTAT2 restricts YFV replication in mice and that this correlates with a lack of IFN-alpha/beta-induced YFV NS5 ubiquitination in murine cells. The lack of suitable animal models limits flavivirus pathogenesis, vaccine, and drug research. These data serve as further impetus for the development of an immunocompetent mouse model that can serve as a disease model for multiple flaviviruses.
C1 [Miorin, Lisa; Pisanelli, Giuseppe; Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Miorin, Lisa; Pisanelli, Giuseppe; Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Laurent-Rolle, Maudry] Yale Univ, Sect Infect Dis, New Haven, CT USA.
   [Pisanelli, Giuseppe] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.
   [Co, Pierre Hendrick] CUNY, Dept Biol, Queens Coll, New York, NY 10021 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
   [Morrison, Juliet] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
RP Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.; Morrison, J (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
EM adolfo.garcia-sastre@mssm.edu; juliet.morrison@ucr.edu
RI Albrecht, Randy A./H-5119-2019
OI Albrecht, Randy A./0000-0003-4008-503X
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI118610, R21AI129486]
FX These studies were partly funded by NIAID grants U19AI118610 and
   R21AI129486 to A.G.-S.
CR Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427
   Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168
   Erickson AK, 2013, J VIROL, V87, P12392, DOI 10.1128/JVI.02149-13
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   LEUNG S, 1995, MOL CELL BIOL, V15, P1312
   Martins RD, 2015, HUM VACC IMMUNOTHER, V11, P2183, DOI 10.1080/21645515.2015.1022700
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E
   Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002
   Seligman SJ, 2016, EXPERT REV VACCINES, V15, P681, DOI 10.1080/14760584.2016.1180250
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   WHO, 2016, SIT REP YELL FEV
   World Health Organization, 2018, YELL FEV FACT SHEET
   World Health Organization-WHO, 2018, YELL FEV BRAZ
NR 25
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 14
AR e00151-19
DI 10.1128/JVI.00151-19
PG 10
WC Virology
SC Virology
GA IF7OM
UT WOS:000473273500005
PM 31043530
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Parry, R
   Asgari, S
AF Parry, Rhys
   Asgari, Sassan
TI Discovery of Novel Crustacean and Cephalopod Flaviviruses: Insights into
   the Evolution and Circulation of Flaviviruses between Marine
   Invertebrate and Vertebrate Hosts
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE RNA interference; cephalopod; Crustacea; evolutionary biology;
   flavivirus
ID YELLOW-FEVER VIRUS; TRANSCRIPTOMIC ANALYSIS; ENCEPHALITIS-VIRUS; GENUS
   FLAVIVIRUS; SEQUENCE; GENOME; GLYCOSYLATION; PHYLOGENY; MICRORNAS;
   PROTEINS
AB Most described flaviviruses (family Flaviviridae) are disease-causing pathogens of vertebrates maintained in zoonotic cycles between mosquitoes or ticks and vertebrate hosts. Poor sampling of flaviviruses outside vector-borne flaviviruses such as Zika virus and dengue virus has presented a narrow understanding of flavivirus diversity and evolution. In this study, we discovered three crustacean flaviviruses (Gammarus chevreuxi flavivirus, Gammarus pulex flavivirus, and Crangon crangon flavivirus) and two cephalopod flaviviruses (Southern Pygmy squid flavivirus and Firefly squid flavivirus). Bayesian and maximum likelihood phylogenetic methods demonstrate that crustacean flaviviruses form a well-supported clade and share a more closely related ancestor with terrestrial vector-borne flaviviruses than with classical insect-specific flaviviruses. In addition, we identify variants of Wenzhou shark flavivirus in multiple gazami crab (Portunus trituberculatus) populations, with active replication supported by evidence of an active RNA interference response. This suggests that Wenzhou shark flavivirus moves horizontally between sharks and gazami crabs in ocean ecosystems. Analyses of the mono-and dinucleotide composition of marine flaviviruses compared to that of flaviviruses with known host status suggest that some marine flaviviruses share a nucleotide bias similar to that of vector-borne flaviviruses. Furthermore, we identify crustacean flavivirus endogenous viral elements that are closely related to elements of terrestrial vector-borne flaviviruses. Taken together, these data provide evidence of flaviviruses circulating between marine vertebrates and invertebrates, expand our understanding of flavivirus host range, and offer potential insights into the evolution and emergence of terrestrial vector-borne flaviviruses.
   IMPORTANCE Some flaviviruses are known to cause disease in vertebrates and are typically transmitted by blood-feeding arthropods such as ticks and mosquitoes. While an ever-increasing number of insect-specific flaviviruses have been described, we have a narrow understanding of flavivirus incidence and evolution. To expand this understanding, we discovered a number of novel flaviviruses that infect a range of crustaceans and cephalopod hosts. Phylogenetic analyses of these novel marine flaviviruses suggest that crustacean flaviviruses share a close ancestor to all terrestrial vector-borne flaviviruses, and squid flaviviruses are the most divergent of all known flaviviruses to date. Additionally, our results indicate horizontal transmission of a marine flavivirus between crabs and sharks. Taken together, these data suggest that flaviviruses move horizontally between invertebrates and vertebrates in ocean ecosystems. This study demonstrates that flavivirus invertebrate-vertebrate host associations have arisen in flaviviruses at least twice and may potentially provide insights into the emergence or origin of terrestrial vector-borne flaviviruses.
C1 [Parry, Rhys; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.
EM s.asgari@uq.edu.au
RI Parry, Rhys/L-5804-2019; Asgari, Sassan/G-2678-2011
OI Parry, Rhys/0000-0001-9238-1952; Asgari, Sassan/0000-0001-7885-6544
FU Australian Research CouncilAustralian Research Council [DP150101782];
   University of Queensland scholarship
FX This project was funded by an Australian Research Council grant
   (DP150101782) to S.A. and by a University of Queensland scholarship to
   R.P.
CR Asgari S, 2018, ADV INSECT PHYSIOL, V55, P19, DOI 10.1016/bs.aiip.2018.07.004
   Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530
   Barnard AC, 2012, GENES-BASEL, V3, P702, DOI 10.3390/genes3040702
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Carpenter K.E., 1998, LIVING MARINE RESOUR, V1
   Caruana NJ, 2016, J PROTEOMICS, V148, P170, DOI 10.1016/j.jprot.2016.07.026
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109
   Collins M, 2017, MAR GENOM, V33, P17, DOI 10.1016/j.margen.2017.01.006
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Conway MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146037
   de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443
   Di Giallonardo F, 2017, J VIROL, V91, DOI 10.1128/JVI.02381-16
   Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1
   Duchene S, 2016, MOL BIOL EVOL, V33, P255, DOI 10.1093/molbev/msv207
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FAO, 2010, FISHSTAT PLUS UN SOF
   Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0
   Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Francois S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30880
   Gaibani P, 2017, MICROBES INFECT, V19, P382, DOI 10.1016/j.micinf.2017.05.003
   Geoghegan JL, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey031
   Gimenez G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27638
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990
   Huang BX, 2016, EMERG INFECT DIS, V22, P833, DOI 10.3201/eid2205.151566
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Jayachandran B, 2012, J VIROL, V86, P13729, DOI 10.1128/JVI.02041-12
   Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lawrie CH, 2004, MED VET ENTOMOL, V18, P268, DOI 10.1111/j.0269-283X.2004.00505.x
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001
   Liu CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28678
   Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009
   Liu L, 2018, GENE, V658, P113, DOI 10.1016/j.gene.2018.03.015
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Longdon B, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev014
   Lv JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175315
   Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155
   Martinez-Alarcon D, 2019, MAR GENOM, V43, P1, DOI 10.1016/j.margen.2018.09.006
   May FJ, 2013, J GEN VIROL, V94, P1462, DOI 10.1099/vir.0.049940-0
   Mejia-Ruiz CH, 2011, J INVERTEBR PATHOL, V107, P65, DOI 10.1016/j.jip.2011.02.002
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Meng XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128659
   Meng XL, 2018, GENE, V640, P6, DOI 10.1016/j.gene.2017.10.026
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller MA, 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101
   Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Savojardo C, 2019, MOL ECOL RESOUR, V19, P235, DOI 10.1111/1755-0998.12952
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Skoge RH, 2018, ARCH VIROL, V163, P679, DOI 10.1007/s00705-017-3643-3
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Trapp J, 2014, MOL CELL PROTEOMICS, V13, P3612, DOI 10.1074/mcp.M114.038851
   Truebano M, 2016, MAR GENOM, V28, P5, DOI 10.1016/j.margen.2016.02.002
   VARELASWESLEY I, 1982, AM J TROP MED HYG, V31, P1273, DOI 10.4269/ajtmh.1982.31.1273
   Vollmer J, 2006, INT REV IMMUNOL, V25, P125, DOI 10.1080/08830180600743115
   Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007
   Yang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138862
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
NR 97
TC 0
Z9 0
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 14
AR e00432-19
DI 10.1128/JVI.00432-19
PG 20
WC Virology
SC Virology
GA IF7OM
UT WOS:000473273500012
PM 31068424
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kallas, EG
   Zanella, LGFABD
   Moreira, CHV
   Buccheri, R
   Diniz, GBF
   Castineiras, ACP
   Costa, PR
   Dias, JZC
   Marmorato, MP
   Song, ATW
   Maestri, A
   Borges, IC
   Joelsons, D
   Cerqueira, NB
   Souza, NCSE
   Claro, IM
   Sabino, EC
   Levi, JE
   Avelino-Silva, VI
   Ho, YL
AF Kallas, Esper G.
   D'Elia Zanella, Luiz Gonzaga F. A. B.
   Moreira, Carlos Henrique, V
   Buccheri, Renata
   Diniz, Gabriela B. F.
   Castineiras, Anna Carla P.
   Costa, Priscilla R.
   Dias, Juliana Z. C.
   Marmorato, Mariana P.
   Song, Alice T. W.
   Maestri, Alvino
   Borges, Igor C.
   Joelsons, Daniel
   Cerqueira, Natalia B.
   Santiago e Souza, Nathalia C.
   Claro, Ingra Morales
   Sabino, Ester C.
   Levi, Jose Eduardo
   Avelino-Silva, Vivian, I
   Ho, Yeh-Li
TI Predictors of mortality in patients with yellow fever: an observational
   cohort study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS OUTBREAK; ZIKA VIRUS; PCR; RESURGENCE; SPREAD; ANGOLA
AB Background Yellow fever virus infection results in death in around 30% of symptomatic individuals. The aim of this study was to identify predictors of death measured at hospital admission in a cohort of patients admitted to hospital during the 2018 outbreak of yellow fever in the outskirts of Sao Paulo city, Brazil.
   Methods In this observational cohort study, we enrolled patients with yellow fever virus from two hospitals in Sao Paolo-the Hospital das Clinicas, University of Sao Paulo and the Infectious Diseases Institute "Emilio Ribas". Patients older than 18 years admitted to hospital with fever or myalgia, headache, arthralgia, oedema, rash, or conjunctivitis were consecutively screened for inclusion in the present study. Consenting patients were included if they had travelled to geographical areas in which yellow fever virus cases had been previously confirmed. Yellow fever infection was confirmed by real-time PCR in blood collected at admission or tissues at autopsy. We sequenced the complete genomes of yellow fever virus from infected individuals and evaluated demographic, clinical, and laboratory findings at admission and investigated whether any of these measurements correlated with patient outcome (death).
   Findings Between Jan 11, 2018, and May 10, 2018, 118 patients with suspected yellow fever were admitted to Hospital das Clinicas, and 113 patients with suspected yellow fever were admitted to Infectious Diseases Institute "Emilio Ribas". 95 patients with suspected yellow fever were included in the study, and 136 patients were excluded. Three (3%) of 95 patients with suspected yellow fever who were included in the study were excluded because they received a different diagnosis, and 16 patients with undetectable yellow fever virus RNA were excluded. Therefore, 76 patients with confirmed yellow fever virus infection, based on detectable yellow fever virus RNA in blood (74 patients) or yellow fever virus confirmed only at the autopsy report (two patients), were included in our analysis. 27 (36%) of 76 patients died during the 60 day period after hospital admission. We generated 14 complete yellow fever virus genomes from the first 15 viral load-detectable samples. The genomes belonged to a single monophyletic clade of the South America I genotype, sub-genotype E. Older age, male sex, higher leukocyte and neutrophil counts, higher alanine aminotransferase, aspartate transaminase (AST), bilirubin, and creatinine, prolonged prothrombin time, and higher yellow fever virus RNA plasma viral load were associated with higher mortality. In a multivariate regression model, older age, elevated neutrophil count, increased AST, and higher viral load remained independently associated with death. All 11 (100%) patients with neutrophil counts of 4000 cells per mL or greater and viral loads of 5.1 log(10) copies/mL or greater died (95% CI 72-100), compared with only three (11%) of 27 (95% CI 2-29) among patients with neutrophil counts of less than 4000 cells per mL and viral loads of less than 5.1 log(10) copies/mL.
   Interpretation We identified clinical and laboratory predictors of mortality at hospital admission that could aid in the care of patients with yellow fever virus. Identification of these prognostic markers in patients could help clinicians prioritise admission to the intensive care unit, as patients often deteriorate rapidly. Moreover, resource allocation could be improved to prioritise key laboratory examinations that might be more useful in determining whether a patient could have a better outcome. Our findings support the important role of the virus in disease pathogenesis, suggesting that an effective antiviral could alter the clinical course for patients with the most severe forms of yellow fever.
C1 [Kallas, Esper G.; D'Elia Zanella, Luiz Gonzaga F. A. B.; Moreira, Carlos Henrique, V; Costa, Priscilla R.; Dias, Juliana Z. C.; Marmorato, Mariana P.; Song, Alice T. W.; Maestri, Alvino; Borges, Igor C.; Joelsons, Daniel; Cerqueira, Natalia B.; Claro, Ingra Morales; Sabino, Ester C.; Avelino-Silva, Vivian, I; Ho, Yeh-Li] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, BR-01246903 Sao Paulo, Brazil.
   [D'Elia Zanella, Luiz Gonzaga F. A. B.; Moreira, Carlos Henrique, V; Buccheri, Renata; Diniz, Gabriela B. F.; Castineiras, Anna Carla P.] Infect Dis Inst Emilio Ribas, Sao Paulo, Brazil.
   [Santiago e Souza, Nathalia C.; Levi, Jose Eduardo] Univ Sao Paulo, Trop Med Inst, Sao Paulo, Brazil.
RP Kallas, EG (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, BR-01246903 Sao Paulo, Brazil.
EM esper.kallas@usp.br
RI Castineiras, Anna/AAB-6754-2019; Avelino-Silva, Vivian I/L-2640-2013;
   Sabino, Ester Cerdeira/F-7750-2010; Borges, Igor Carmo/AAG-8531-2019;
   Marmorato, Mariana/V-5375-2018
OI Castineiras, Anna/0000-0003-2503-9414; Avelino-Silva, Vivian
   I/0000-0002-6660-3088; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Marmorato, Mariana/0000-0002-0644-0862; Kallas,
   Esper/0000-0003-2026-6925; Barros D'Elia Zanella, Luiz Gonzaga Francisco
   de Assis/0000-0002-3166-5633; Carmo Borges, Igor/0000-0003-2749-0313
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)
FX Sao Paulo Research Foundation (FAPESP).
CR Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P442
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   BEEUWKES Henry, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V30, P61, DOI 10.1016/S0035-9203(36)90014-7
   Blake LE, 2014, MBIO, V5, DOI 10.1128/mBio.01253-14
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandes-Monteiro AG, 2015, HUM VACC IMMUNOTHER, V11, P1865, DOI 10.4161/21645515.2014.990854
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hughes HR, 2018, EMERG INFECT DIS, V24, P1598, DOI 10.3201/eid2408.180588
   Julander JG, 2014, ANTIVIR RES, V103, P32, DOI 10.1016/j.antiviral.2013.12.011
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lindsey NP, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay108
   Massad E, 2018, EPIDEMIOL INFECT, V146, P1219, DOI [10.1017/S0950268818001334, 10.1017/s0950268818001334]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Nunes PCG, 2018, VIRUSES, V10, pE236
   Plotkin SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay130
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777
   Secretary of Health State of Sao Paulo, 2018, B EP FEBR AM
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Song ATW, 2019, HEPATOLOGY, V69, P1349, DOI 10.1002/hep.30273
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wilder-Smith A, 2017, J TRAVEL MED, V24, P1
NR 35
TC 12
Z9 12
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2019
VL 19
IS 7
BP 750
EP 758
DI 10.1016/S1473-3099(19)30125-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA IF1DQ
UT WOS:000472818900035
PM 31104909
DA 2020-07-08
ER

PT J
AU Groisman, B
   Liascovich, R
   Bidondo, MP
   Barbero, P
   Duarte, S
   Tellechea, AL
   Holguin, J
   Rodriguez, C
   Hurtado-Villa, P
   Caicedo, N
   Botta, G
   Zarante, I
AF Groisman, Boris
   Liascovich, Rosa
   Bidondo, Maria Paz
   Barbero, Pablo
   Duarte, Santiago
   Laura Tellechea, Ana
   Holguin, Jorge
   Rodriguez, Catherine
   Hurtado-Villa, Paula
   Caicedo, Natalia
   Botta, Gabriela
   Zarante, Ignacio
TI Birth defects surveillance: experiences in Argentina and Colombia
SO JOURNAL OF COMMUNITY GENETICS
LA English
DT Article
DE Birth defects; Argentina; Colombia; Registries; Surveillance
ID NEURAL-TUBE DEFECTS; CONGENITAL-ANOMALIES; NATIONAL REGISTRY;
   PREVALENCE; MALFORMATIONS; BOGOTA; NETWORK; ECLAMC; CITIES; CALI
AB Birth defects (BDs) are structural or functional anomalies, sporadic or hereditary, of prenatal origin. Public health surveillance is defined as the ongoing systematic collection, analysis, and interpretation of outcome-specific data for use in the planning, implementation, and evaluation of public health practice. BD surveillance systems may have different characteristics according to design, coverage, type of surveillance, case ascertainment, case definition, BD description, maximum age of diagnosis, pregnancy outcomes, coding systems, and the location of the coding process (central or local). The aim of this article is to describe and compare methodology, applications, and results of birth defect surveillance systems in two South-American countries: Colombia and Argentina. In both countries, the surveillance systems developed activities in relation to the Zika virus emergency. For most BDs, a statistically significant higher prevalence is observed in Argentina-RENAC than in Colombian registries. This may be due to methodological reasons or real differences in prevalence. The strengths, weaknesses, and the future perspectives of the Argentine and Colombian systems are presented. When developing a surveillance system, the objectives, the available resources, and previous experiences in similar contexts must be taken into account. In that sense, the experience of Argentina and Colombia can be useful for others when developing a birth defect surveillance system.
C1 [Groisman, Boris; Liascovich, Rosa; Bidondo, Maria Paz; Barbero, Pablo; Duarte, Santiago; Laura Tellechea, Ana] Natl Minist Hlth, Natl Adm Labs & Hlth Inst, Natl Ctr Med Genet, Natl Network Congenital Anomalies Argentina RENAC, Ave Heras 2670,3rd Floor, RA-1425 Buenos Aires, DF, Argentina.
   [Holguin, Jorge] Pontificia Univ Javeriana Cali, Secretaria Salud Publ Municipal Cali, Cali, Colombia.
   [Rodriguez, Catherine] Secretaria Salud Bogota, Congenital Malformat Surveillance Programme Bogot, Bogota, Colombia.
   [Hurtado-Villa, Paula; Caicedo, Natalia] Pontificia Univ Javeriana Cali, Congenital Birth Defects Surveillance Programme C, Cali, Colombia.
   [Botta, Gabriela; Zarante, Ignacio] Pontificia Univ Javeriana Bogota, Cali, Colombia.
RP Groisman, B (corresponding author), Natl Minist Hlth, Natl Adm Labs & Hlth Inst, Natl Ctr Med Genet, Natl Network Congenital Anomalies Argentina RENAC, Ave Heras 2670,3rd Floor, RA-1425 Buenos Aires, DF, Argentina.
EM bgroisman@gmail.com
RI Zarante, Ignacio/L-6467-2017; Hurtado-Villa, Paula/O-2543-2014
OI Zarante, Ignacio/0000-0002-0729-6866; Hurtado-Villa,
   Paula/0000-0003-3822-7780; Groisman, Boris/0000-0001-6263-2562
FU UNICEF Argentina; National Ministry of Health; National Agency for
   Science and Technology; National Ministry of Science and Technology;
   Health Secretariat of Bogota; Pontificia Universidad Javeriana Bogota;
   Municipal Public Health Secretariat of Cali; Pontificia Universidad
   Javeriana Cali
FX RENAC was supported in-part by UNICEF Argentina; the National Ministry
   of Health; the National Agency for Science and Technology; and the
   National Ministry of Science and Technology.; The Bogota program is
   funded by the Health Secretariat of Bogota and the Pontificia
   Universidad Javeriana Bogota. The Cali program is funded by the
   Municipal Public Health Secretariat of Cali and the Pontificia
   Universidad Javeriana Cali.
CR Baltaxe Erik, 2006, Arch. Cardiol. Méx., V76, P263
   Bidondo MP, 2015, ARCH ARGENT PEDIATR, V113, P498, DOI [10.5546/aap.2015.eng.498, 10.5546/aap.2015.498]
   Bidondo MP, 2015, ARCH ARGENT PEDIATR, V113, P295, DOI [10.5546/aap.2015.295, 10.5546/aap.2015.eng.295]
   Bidondo MP, 2014, REV ARGENT SALUD PUB, V5, P38
   Botto LD, 2006, AM J PUBLIC HEALTH, V96, P774, DOI 10.2105/AJPH.2004.057760
   Calderon JS, 2006, ARCH ESP UROL, V59, P7
   Cassinelli A, 2018, ARCH ARGENT PEDIATR, V116, pE26, DOI [10.5546/aap.2018.e26, 10.5546/aap.2018.eng.e26]
   Castilla E E, 1992, Birth Defects Orig Artic Ser, V28, P27
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Christianson A, 2004, ANNU REV GENOM HUM G, V5, P219, DOI 10.1146/annurev.genom.5.061903.175935
   Christianson A, 2006, MARCH DIMES GLOBAL R
   Correa C, 2014, J PEDIATR SURG, V49, P1099, DOI 10.1016/j.jpedsurg.2014.03.001
   DEIS Direccion de Estadisticas e Informacion en Salud, 2017, DEATHS CHILDR 5 YEAR
   Fernandez N, 2017, INT BRAZ J UROL, V43, P325, DOI [10.1590/S1677-5538.IBJU.2016.0002, 10.1590/s1677-5538.ibju.2016.0002]
   Fernandez N, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2016.03.015
   Fernandez N, 2012, J PEDIATR UROL, V8, P121, DOI 10.1016/j.jpurol.2011.07.005
   Garcia MA, 2014, BIOMEDICA, V34, P379, DOI [10.7705/biomedica.v34i3.2259, 10.1590/S0120-41572014000300008]
   Groisman B, 2016, REV ARGENT SALUD PUB, V7, P39
   Groisman B, 2017, J COMMUN GENET, V8, P1, DOI 10.1007/s12687-016-0276-2
   Groisman B, 2016, ARCH ARGENT PEDIATR, V114, P295, DOI [10.5546/aap.2016.295, 10.5546/aap.2016.eng.295]
   Groisman B, 2016, BIRTH DEFECTS RES A, V106, P604, DOI 10.1002/bdra.23501
   Groisman B, 2013, ARCH ARGENT PEDIATR, V111, P484, DOI [10.1590/S0325-00752013000600006, 10.5546/aap.2013.484]
   Groisman Boris, 2013, J Registry Manag, V40, P29
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Tellechea AL, 2018, BIRTH DEFECTS RES, V110, P1016, DOI 10.1002/bdr2.1347
   Lopez B, 2015, MED INFORM, VXXII, P76
   Luquetti DV, 2011, CIENC SAUDE COLETIVA, V16, P777, DOI 10.1590/S1413-81232011000700008
   Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461
   Martin MC, 2014, REPROD TOXICOL, V50, P117, DOI 10.1016/j.reprotox.2014.10.015
   Bidondo MP, 2016, BIRTH DEFECTS RES A, V106, P993, DOI 10.1002/bdra.23549
   Bidondo MP, 2015, J COMMUN GENET, V6, P147, DOI 10.1007/s12687-014-0209-x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sargiotto C, 2015, BIRTH DEFECTS RES A, V103, P509, DOI 10.1002/bdra.23372
   SEVER L, 1993, TERATOLOGY, V48, P547, DOI 10.1002/tera.1420480603
   SGSS. Sistema General de Seguridad Social en Salud Colombia, 2013, GUIA PRACT CLIN DET
   Tassinari S, 2018, BIOMEDICA, V38, P141, DOI 10.7705/biomedica.v38i0.3381
   THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021
   WHO/CDC/ICBDSR, 2014, BIRTH DEF SURV MAN P
   Zarante Ignacio, 2016, J Registry Manag, V41, P116
   Zarante I, 2010, BIOMEDICA, V30, P65, DOI 10.7705/biomedica.v30i1.154
   Zarante I, 2009, INT J PEDIATR OTORHI, V73, P1434, DOI 10.1016/j.ijporl.2009.07.012
NR 41
TC 0
Z9 0
U1 1
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1868-310X
EI 1868-6001
J9 J COMMUN GENET
JI J. Commun. Genet.
PD JUL
PY 2019
VL 10
IS 3
BP 385
EP 393
DI 10.1007/s12687-018-00403-6
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA IF2LI
UT WOS:000472908300007
PM 30607893
OA Green Published
DA 2020-07-08
ER

PT J
AU Calle-Giraldo, JP
   Rojas, CA
   Hurtado, IC
   Barco, C
   Libreros, D
   Sanchez, PJ
   Lopez, P
   Arias, A
   Davalos, DM
   Lesmes, MC
   Pinzon, E
   Ortiz, VA
   Lopez-Medina, E
AF Calle-Giraldo, Juan P.
   Rojas, Christian A.
   Hurtado, Isabel C.
   Barco, Carolina
   Libreros, Diana
   Sanchez, Pablo J.
   Lopez, Pio
   Arias, Alejandra
   Davalos, Diana M.
   Lesmes, Maria C.
   Pinzon, Elisa
   Ortiz, Viviana A.
   Lopez-Medina, Eduardo
TI Outcomes of Congenital Zika Virus Infection During an Outbreak in Valle
   del Cauca, Colombia
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE Zika; pregnancy; congenital; microcephaly; neurologic
ID PREGNANCY OUTCOMES; BRAZIL; RISK; TERRITORIES; INFANTS; BIRTH
AB Background: Despite increasing information in the literature regarding congenital Zika infection, gaps remain in our knowledge of its clinical manifestations. Methods: We did a prospective observational study of exposed fetuses and infants whose mothers developed symptomatic and confirmed Zika infection during pregnancy in Valle del Cauca, Colombia. We performed neurological, ophthalmologic and audiologic evaluations, and classified outcomes as possibly or uncertainly related to Zika. Frequencies of outcomes were compared according to the trimester of pregnancy when infection occurred. Results: We evaluated 171 products of gestation including 17 pregnancy losses and 154 patients evaluated postnatally. Ninety (52.6%) pregnancies presented an adverse outcome, 36% possibly related with Zika and the remaining 64% of uncertain relation. Infection in the first trimester had the highest frequencies of adverse outcomes possibly related with Zika compared with the second and third trimesters (39% vs. 12.5% vs. 12%) with risk ratios of adverse outcomes possibly related to Zika in pregnancies infected in the first versus second or third trimester of 3.1 (95% CI: 2.4-4.1) and 3.3 (95% CI: 2.5-4.2), respectively. The frequencies of pregnancy loss and microcephaly were 9.4% and 4.5%, respectively. Auditory and ophthalmic abnormalities possibly related with Zika were present in 3% and 6% of the patients evaluated, respectively. Conclusions: We observed a high frequency of gestational and neonatal complications in pregnant women who acquired Zika infection, especially in early pregnancy, resulting in a broad spectrum of clinical manifestations. Preventive measures are urgently needed to reduce the clinical burden during future Zika outbreaks.
C1 [Calle-Giraldo, Juan P.] Univ Quindio, Dept Pediat, Armenia, Colombia.
   [Rojas, Christian A.; Hurtado, Isabel C.; Barco, Carolina; Lopez, Pio; Lopez-Medina, Eduardo] Univ Valle, Dept Pediat, Cali, Colombia.
   [Hurtado, Isabel C.] Hosp Univ Valle, Cali, Colombia.
   [Libreros, Diana] Univ Valle, Dept Ophthalmol, Cali, Colombia.
   [Libreros, Diana; Arias, Alejandra; Lopez-Medina, Eduardo] Ctr Med Imbanaco, Cali, Colombia.
   [Sanchez, Pablo J.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43210 USA.
   [Lopez, Pio; Lopez-Medina, Eduardo] Ctr Estudios Infectol Pediat, Calle 5 B 5 37 BIS-28, Cali, Colombia.
   [Davalos, Diana M.] Univ Icesi, Dept Publ Hlth, Cali, Colombia.
   [Hurtado, Isabel C.; Lesmes, Maria C.; Pinzon, Elisa; Ortiz, Viviana A.] Dept Hlth, Cali, Colombia.
RP Lopez-Medina, E (corresponding author), Ctr Estudios Infectol Pediat, Calle 5 B 5 37 BIS-28, Cali, Colombia.
EM eduardo.lopez@ceiponline.org
FU Thrasher Research Fund Award [13713]
FX This study was supported by the Thrasher Research Fund Award #13713. The
   Thrasher Fund was not involved in the study design, data collection or
   interpretation, or the design or writing of this manuscript.
CR Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito CAA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3313-4
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DANE, 2016, EST INF ESTR NAC DEF
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gobernacion del Valle, 2017, MAP POBL VALL CAUC
   Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Maitre NL, 2016, PEDIATR NEUROL, V65, P31, DOI 10.1016/j.pediatrneurol.2016.09.010
   Mittal R, 2017, JAMA OTOLARYNGOL NEC, V33136, P2013
   Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SIVIGILA, 2016, B EP SEM, V52, P113
   Suhag A, 2013, CURR OBSTET GYNECOL, V2, P102, DOI 10.1007/s13669-013-0041-z
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   WHO Organization, 2011, WHO CHILD GROWTH STA
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 33
TC 3
Z9 3
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JUL
PY 2019
VL 38
IS 7
BP 735
EP 740
DI 10.1097/INF.0000000000002307
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA IE2GT
UT WOS:000472203300028
PM 30985517
DA 2020-07-08
ER

PT J
AU Benelli, G
AF Benelli, Giovanni
TI Managing mosquitoes and ticks in a rapidly changing world - Facts and
   trends
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Review
DE Acaricides; Dengue; Integrated Vector Management; Lyme disease; Malaria;
   Nanoparticles; Repellents; Zika virus
ID RHIPICEPHALUS BOOPHILUS MICROPLUS; VECTOR-BORNE DISEASES; ESSENTIAL
   OILS; AEDES-ALBOPICTUS; CATTLE TICKS; INSECTICIDE RESISTANCE;
   IXODES-RICINUS; INTEGRATED CONTROL; DIPTERA-CULICIDAE; CURRENT KNOWLEDGE
AB Vector-borne diseases transmitted by mosquitoes and ticks are on the rise. The effective and sustainable control of these arthropod vectors is a puzzling challenge for public health worldwide. In the present review, I attempted to provide a concise and updated overview of the current mosquito and tick research scenario. The wide array of control tools recently developed has been considered, with special reference to those approved by the World Health Organization Vector Control Advisory Group (WHO VCAG), as well as novel ones with an extremely promising potential to be exploited in vector control programs. Concerning mosquitoes, a major focus has been given on genetically modified vectors, eave tubes, attractive toxic sugar baits (ATSB) and biocontrol agents. Regarding ticks, the recent development of highly effective repellents and acaricides (including nanoformulated ones) as well as behavior-based control tools, has been highlighted. In the second part of the review, key research questions about biology and control of mosquitoes and ticks have been critically formulated. A timely research agenda outlining hot issues to be addressed in mosquito and tick research is provided. Overall, it is expected that the present review will contribute to boost research and applications on successful mosquito and tick control strategies, along with an improved knowledge of their biology and ecology. (C) 2018 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
CR Abbas RZ, 2014, VET PARASITOL, V203, P6, DOI 10.1016/j.vetpar.2014.03.006
   Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Adenubi OT, 2016, S AFR J BOT, V105, P178, DOI 10.1016/j.sajb.2016.03.010
   Adenubi OT, 2018, VET PARASITOL, V254, P160, DOI 10.1016/j.vetpar.2018.03.008
   Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092
   Alkenani NA, 2017, SAUDI J BIOL SCI, V24, P1181, DOI 10.1016/j.sjbs.2017.02.006
   Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Bartholomay LC, 2018, ANNU REV ENTOMOL, V63, P145, DOI 10.1146/annurev-ento-010715-023530
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P656, DOI 10.1016/S2222-1808(16)61105-2
   Benelli G, 2018, TRENDS PARASITOL, V34, P351, DOI 10.1016/j.pt.2018.01.002
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2018, ACTA TROP, V178, P176, DOI 10.1016/j.actatropica.2017.11.024
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bergquist R, 2017, ACTA TROP, V175, P1, DOI 10.1016/j.actatropica.2017.07.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boka OM, 2017, EXP APPL ACAROL, V71, P355, DOI 10.1007/s10493-017-0129-7
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Brites-Neto J, 2017, VET PARASITOL, V238, P1, DOI 10.1016/j.vetpar.2017.03.002
   Buckingham SC, 2015, J INFECTION, V71, pS88, DOI 10.1016/j.jinf.2015.04.009
   CDC, 2015, ANOPHELES MOSQUITOES
   CDC, 2017, LYM DIS
   Chanda E, 2016, EMERG INFECT DIS, V22, P773, DOI 10.3201/eid2205.150984
   Chang KS, 2017, J PEST SCI, V90, P759, DOI 10.1007/s10340-016-0820-1
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   Dantas-Torres F, 2016, TRENDS PARASITOL, V32, P43, DOI 10.1016/j.pt.2015.09.004
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793
   de Fuentes-Vicente JA, 2018, ACTA TROP, V183, P23, DOI 10.1016/j.actatropica.2018.04.008
   de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23
   de la Fuente J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00114
   de la Fuente J, 2015, EXPERT REV VACCINES, V14, P1367, DOI 10.1586/14760584.2015.1076339
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Diuk-Wasser MA, 2016, TRENDS PARASITOL, V32, P30, DOI 10.1016/j.pt.2015.09.008
   Drexler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112368
   Eisen L, 2016, J MED ENTOMOL, V53, P1063, DOI 10.1093/jme/tjw103
   Ellse L, 2014, MED VET ENTOMOL, V28, P233, DOI 10.1111/mve.12033
   Estrada-Pena A, 2017, TICKS TICK-BORNE DIS, V8, P540, DOI 10.1016/j.ttbdis.2017.03.001
   Estrada-Pena A, 2013, AGRICULTURE-BASEL, V3, P221, DOI 10.3390/agriculture3020221
   Fernandes JN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0496
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x
   George DR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-28
   Ghosh S, 2006, EXP APPL ACAROL, V40, P49, DOI 10.1007/s10493-006-9022-5
   Ghosh S, 2014, J VECTOR DIS, V51, P259
   Ghosh S, 2015, EXP APPL ACAROL, V66, P159, DOI 10.1007/s10493-015-9890-7
   Gindin G, 2002, EXP APPL ACAROL, V28, P283, DOI 10.1023/A:1025379307255
   Gosling R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001994
   Guglielmone A. A., 2014, HARD TICKS ACARI IXO
   Hamainza B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1143-7
   Heng MY, 2013, TRAC-TREND ANAL CHEM, V50, P1, DOI 10.1016/j.trac.2013.03.012
   Inci A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005021
   Isman MB, 2017, IND CROP PROD, V110, P10, DOI 10.1016/j.indcrop.2017.07.012
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Jambulingam P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1768-y
   Johansson O, 2017, PARASITOL RES, V116, P1, DOI 10.1007/s00436-016-5272-2
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Junnila A, 2015, ACTA TROP, V152, P195, DOI 10.1016/j.actatropica.2015.09.006
   Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006
   Keirans JE, 2001, J MED ENTOMOL, V38, P850, DOI 10.1603/0022-2585-38.6.850
   Kelehear C, 2017, TICKS TICK-BORNE DIS, V8, P330, DOI 10.1016/j.ttbdis.2016.12.010
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Knols BGJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1452-x
   Koch LK, 2016, PARASITOL RES, V115, P957, DOI 10.1007/s00436-015-4822-3
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009
   Lani R, 2014, TICKS TICK-BORNE DIS, V5, P457, DOI 10.1016/j.ttbdis.2014.04.001
   Lednicky JA, 2019, CLIN INFECT DIS, V68, P143, DOI 10.1093/cid/ciy485
   Lehrer S, 2010, MED HYPOTHESES, V74, P167, DOI 10.1016/j.mehy.2009.07.005
   Lew-Tabor AE, 2016, TICKS TICK-BORNE DIS, V7, P573, DOI 10.1016/j.ttbdis.2015.12.012
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Lv J, 2014, PARASITOL VECTORS, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0096833
   Lv JZ, 2014, MITOCHONDR DNA, V25, P142, DOI 10.3109/19401736.2013.792052
   Manzano-Roman R., 2012, PARASITOLOGY
   Mapholi NO, 2014, TICKS TICK-BORNE DIS, V5, P475, DOI 10.1016/j.ttbdis.2014.04.006
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Mishra P, 2018, ENVIRON SCI POLLUT R, V25, P10151, DOI 10.1007/s11356-017-9640-y
   Molyneux DH, 2017, LANCET, V389, P312, DOI 10.1016/S0140-6736(16)30171-4
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210
   Murdock CC, 2014, J INSECT PHYSIOL, V67, P37, DOI 10.1016/j.jinsphys.2014.05.020
   Murugan K, 2016, PARASITOL RES, V115, P107, DOI 10.1007/s00436-015-4726-2
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051
   Pantchev N, 2015, PARASITOL RES, V114, pS19, DOI 10.1007/s00436-015-4513-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pfaffle M, 2013, INT J PARASITOL, V43, P1059, DOI 10.1016/j.ijpara.2013.06.009
   Pfister K, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1719-7
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Polar P, 2008, EXP APPL ACAROL, V46, P119, DOI 10.1007/s10493-008-9170-x
   Priya SP, 2017, ACTA TROP, V176, P206, DOI 10.1016/j.actatropica.2017.08.007
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Romano D, 2018, ACTA TROP, V183, P43, DOI 10.1016/j.actatropica.2018.04.009
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Saifi MA, 2016, SAUDI J BIOL SCI, V23, P649, DOI 10.1016/j.sjbs.2015.01.005
   Samish M, 1999, ANNU REV ENTOMOL, V44, P159, DOI 10.1146/annurev.ento.44.1.159
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Semmler M, 2011, PARASITOL RES, V108, P899, DOI 10.1007/s00436-010-2131-4
   Shyma K P, 2015, J Parasit Dis, V39, P1, DOI 10.1007/s12639-013-0294-5
   Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1596-0
   Sonenshine Daniel E., 2002, P517, DOI 10.1016/B978-012510451-7/50026-8
   Sonenshine DE, 2006, ANNU REV ENTOMOL, V51, P557, DOI 10.1146/annurev.ento.51.110104.151150
   Soonwera M, 2015, ACTA TROP, V142, P127, DOI 10.1016/j.actatropica.2014.11.010
   Sternberg ED, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1499-8
   Stone CM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2644-8
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   Tabari MA, 2017, VET PARASITOL, V245, P86, DOI 10.1016/j.vetpar.2017.08.012
   Tan KR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1154-4
   Tiono AB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0606-4
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   van Wieren SE, 2016, ECOLOGY AND PREVENTION OF LYME BORRELIOSIS: ECOLOGY AND CONTROL OF VECTOR-BORNE DISEASES, VOL 4, P75, DOI 10.3920/978-90-8686-838-4_6
   Vanickova L, 2017, PARASITOL INT, V66, P190, DOI 10.1016/j.parint.2016.09.010
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vudriko P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1278-3
   Ward M, 2018, PATHOG GLOB HEALTH, V112, P96, DOI 10.1080/20477724.2017.1397876
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Webster A, 2015, VET PARASITOL, V207, P302, DOI 10.1016/j.vetpar.2014.11.021
   West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Willadsen P, 2006, VET PARASITOL, V138, P161, DOI 10.1016/j.vetpar.2006.01.050
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yavuz O, 2017, LARGE ANIM REV, V23, P97
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang RL, 2014, TICKS TICK-BORNE DIS, V5, P352, DOI 10.1016/j.ttbdis.2014.01.001
NR 151
TC 13
Z9 13
U1 11
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD JUL
PY 2019
VL 26
IS 5
BP 921
EP 929
DI 10.1016/j.sjbs.2018.06.007
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IE8AZ
UT WOS:000472597600007
PM 31303820
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cannalire, R
   Tarantino, D
   Piorkowski, G
   Carletti, T
   Massari, S
   Felicetti, T
   Barreca, ML
   Sabatini, S
   Tabarrini, O
   Marcello, A
   Milani, M
   Cecchetti, V
   Mastrangelo, E
   Manfroni, G
   Querat, G
AF Cannalire, Rolando
   Tarantino, Delia
   Piorkowski, Geraldine
   Carletti, Tea
   Massari, Serena
   Felicetti, Tommaso
   Barreca, Maria Letizia
   Sabatini, Stefano
   Tabarrini, Oriana
   Marcello, Alessandro
   Milani, Mario
   Cecchetti, Violetta
   Mastrangelo, Eloise
   Manfroni, Giuseppe
   Querat, Gilles
TI Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less
   infective virions
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus inhibitors; Antiviral small molecules; Flavivirus
   replication; Antivirals; Dengue inhibitors; Zika virus
ID FAVIPIRAVIR T-705; RNA-POLYMERASE; DENGUE; VIRUS
AB We report the design, synthesis, and biological evaluation of a class of 1H-pyrido[2,1-b] [1,3]benzothiazol-1-ones originated from compound 1, previously identified as anti-flavivirus agent. Some of the new compounds showed activity in low mu M range with reasonable selectivity against Dengue 2, Yellow fever (Bolivia strain), and West Nile viruses. One of the most interesting molecules, compound 16, showed broad antiviral activity against additional flaviviruses such as Dengue 1, 3 and 4, Zika, Japanese encephalitis, several strains of Yellow fever, and tick-borne encephalitis viruses. Compound 16 did not exert any effect on alphaviruses and phleboviruses and its activity was maintained in YFV infected cells from different species. The activity of 16 appears specific for flavivirus with respect to other virus families, suggesting, but not proving, that it might be targeting a viral factor. We demonstrated that the antiviral effect of 16 is not related to reduced viral RNA synthesis or virion release. On the contrary, viral particles grown in the presence of 16 showed reduced infectivity, being unable to perform a second round of infection. The chemical class herein presented thus emerges as suitable to provide pan-flavivirus inhibitors.
C1 [Cannalire, Rolando; Massari, Serena; Felicetti, Tommaso; Barreca, Maria Letizia; Sabatini, Stefano; Tabarrini, Oriana; Cecchetti, Violetta; Manfroni, Giuseppe] Univ Perugia, Dipartimento Sci Farmaceut, Via Liceo 1, I-06123 Perugia, Italy.
   [Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.
   [Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise] CNR, IBF, Ist Biofis, Via Celoria 26, I-20133 Milan, Italy.
   [Piorkowski, Geraldine; Querat, Gilles] Aix Marseille Univ, UMR Emergence Pathol Virales, Fdn IHU Mediterranee Infect,IRD 190, Publ Hosp Marseille,AP HM,Fac Med,EHESP,Inserm 12, 27 Bd Jean Moulin, F-13005 Marseille, France.
   [Carletti, Tea; Marcello, Alessandro] ICGEB, Lab Mol Virol, AREA Sci Pk,Padriciano 99, I-34149 Trieste, Italy.
RP Manfroni, G (corresponding author), Univ Perugia, Dipartimento Sci Farmaceut, Via Liceo 1, I-06123 Perugia, Italy.; Mastrangelo, E (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.; Mastrangelo, E (corresponding author), CNR, IBF, Ist Biofis, Via Celoria 26, I-20133 Milan, Italy.; Querat, G (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, Fdn IHU Mediterranee Infect,IRD 190, Publ Hosp Marseille,AP HM,Fac Med,EHESP,Inserm 12, 27 Bd Jean Moulin, F-13005 Marseille, France.
EM eloise.mastrangelo@unimi.it; giuseppe.manfroni@unipg.it;
   gilles.querat@univ-amu.fr
RI Felicetti, Tommaso/O-2521-2019; Cannalire, Rolando/AAD-8206-2020
OI Felicetti, Tommaso/0000-0001-9369-8564; Mastrangelo,
   Eloise/0000-0002-5968-8386; Sabatini, Stefano/0000-0003-0971-3536;
   Barreca, Maria Letizia/0000-0003-3530-5042; Massari,
   Serena/0000-0002-9992-6318
FU SILVER project of the European Commission within the 7th Framework
   Program Cooperation Project [2606444]; Scientific Independence of young
   Researchers (SIR) project from Italian Ministry of Education, University
   and Research [RBSI14C78S]
FX This work has been realized thanks to the SILVER project of the European
   Commission within the 7th Framework Program Cooperation Project; grant
   agreement number: 2606444 and by Scientific Independence of young
   Researchers (SIR) project from Italian Ministry of Education, University
   and Research; grant number: RBSI14C78S.
CR Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Manfroni G, 2012, BIOORGAN MED CHEM, V20, P866, DOI 10.1016/j.bmc.2011.11.061
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Morrill LC, 2014, ORG BIOMOL CHEM, V12, P624, DOI 10.1039/c3ob41869c
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Tolou H, 2000, BIOCHEM BIOPH RES CO, V277, P89, DOI 10.1006/bbrc.2000.3640
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Ueda S, 2012, J ORG CHEM, V77, P2543, DOI 10.1021/jo202537e
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 19
TC 5
Z9 5
U1 5
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2019
VL 167
BP 6
EP 12
DI 10.1016/j.antiviral.2019.03.004
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IE2WB
UT WOS:000472244200002
PM 30849420
DA 2020-07-08
ER

PT J
AU Lee, JL
   Loe, MWC
   Lee, RCH
   Chu, JJH
AF Lee, Jia Le
   Loe, Marcus Wing Choy
   Lee, Regina Ching Hua
   Chu, Justin Jang Hann
TI Antiviral activity of pinocembrin against Zika virus replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika; Antiviral; Flavonoids; Natural compounds; Screening
ID DENGUE VIRUS; IN-VITRO; PROTECTS
AB Zika virus (ZIKV) is a mosquito-borne virus that has garnered a lot of attention in recent years, due to the explosive epidemic from 2014 to 2016. Since its introduction in the Americas in late 2014, ZIKV has spread at an unprecedented rate and scale throughout the world and infected millions of people. Its infection has also been associated with severe neurological disorders like Guillain-Barre syndrome and microcephaly in fetuses. Despite these, there is currently no approved antiviral against ZIKV. In this study, an immunofluorescence-based high throughput screen was conducted on a library of 483 flavonoid derivatives to identify potential anti-ZIKV compounds. Flavonoids, which are natural polyphenolic compounds found in plants, represent an attractive source of antivirals due to their abundance in food and expected low toxicity. From the primary screen, three hits were selected for validation by cell viability and viral plaque reduction assays. Pinocembrin, a flavanone found in honey, tea and red wine, was chosen for downstream studies as it exhibited the strongest inhibition of ZIKV infection in human placental JEG-3 cells (IC50 = 17.4 mu M). Time-course studies revealed that pinocembrin acts on post-entry process(es) of the ZIKV replication cycle. Furthermore, pinocembrin inhibits viral RNA production and envelope protein synthesis based on quantitative reverse transcription-PCR (qRT-PCR) and Western blot analyses. This study has demonstrated for the first time the in vitro anti-ZIKV activity of pinocembrin.
C1 [Lee, Jia Le; Loe, Marcus Wing Choy; Lee, Regina Ching Hua; Chu, Justin Jang Hann] Natl Univ Singapore, Lab Mol RNA Virol & Antiviral Strategies, Dept Microbiol, Yong Loo Lin Sch Med,Natl Univ Hlth Syst, Singapore, Singapore.
   [Chu, Justin Jang Hann] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.
RP Chu, JJH (corresponding author), Natl Univ Singapore, Lab Mol RNA Virol & Antiviral Strategies, Dept Microbiol, Yong Loo Lin Sch Med,Natl Univ Hlth Syst, Singapore, Singapore.
EM miccjh@nus.edu.sg
OI Lee, Jia Le/0000-0002-1600-6437
FU NRF-NSFC Joint Research Grant [NRF2016NRF-NSFC002-012]
FX This work was supported by the NRF-NSFC Joint Research Grant
   NRF2016NRF-NSFC002-012.
CR Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Cao GY, 2015, J ETHNOPHARMACOL, V168, P31, DOI 10.1016/j.jep.2015.03.041
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC C for D. C, 2018, AR RISK ZIK
   Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   KAUL TN, 1985, J MED VIROL, V15, P71, DOI 10.1002/jmv.1890150110
   Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lan X, 2016, MOL NEUROBIOL, V53, P1794, DOI 10.1007/s12035-015-9125-2
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Liu R, 2014, NEUROBIOL AGING, V35, P1275, DOI 10.1016/j.neurobiolaging.2013.12.031
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Ma YZ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8943210
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Rasul A, 2013, BIOMED RES INT, DOI 10.1155/2013/379850
   Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Saiz J. C, 2016, FRONT MICROBIOL, V7, P1
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wang YM, 2014, J MOL NEUROSCI, V53, P537, DOI 10.1007/s12031-013-0219-x
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 39
TC 7
Z9 7
U1 4
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2019
VL 167
BP 13
EP 24
DI 10.1016/j.antiviral.2019.04.003
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IE2WB
UT WOS:000472244200003
PM 30959074
DA 2020-07-08
ER

PT J
AU Watanabe, S
   Tan, NWW
   Chan, KWK
   Vasudevan, SG
AF Watanabe, Satoru
   Tan, Nicole Wei Wen
   Chan, Kitti Wing Ki
   Vasudevan, Subhash G.
TI Assessing the utility of antivirals for preventing maternal-fetal
   transmission of zika virus in pregnant mice
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Antivirals; Pregnant mouse model; Vertical transmission;
   NITD008
ID BIRTH-DEFECTS; DOUBLE-BLIND; INFECTION; CELGOSIVIR; INHIBITOR; DISEASE
AB Zika virus (ZIKV) infection during pregnancy has been associated with adverse outcomes and birth defects such as microcephaly in newborn children. Congenital malformations associated with ZIKV are believed to occur via direct infection of the fetus. Unfortunately, there are no licensed therapeutic or preventative tools to block maternal-fetal transmission of ZIKV. In this study, we developed a mouse model of ZIKV infection that specifically establishes vertical maternal-fetal transmission of ZIKV in 40-60% of fetuses when the dams acquire ZIKV infection during pregnancy. This mouse model somewhat mirrors the experience in humans at the peak of the epidemic in the Americas. Using this model, we demonstrate that a well-documented directly acting antiviral (DAA) compound that targets flaviviral RNA synthesis can completely prevent fetal infection when the treatment is started at the time of infection. Notably, we show that the treatment commenced at the time of peak viremia is still able to reduce the risk of fetal infection concomitant with significant reduction in placental viral load. Our results show for the first time the potential for clinical development of antiviral drugs for preventing vertical maternal-fetal transmission of ZIKV.
C1 [Watanabe, Satoru; Tan, Nicole Wei Wen; Chan, Kitti Wing Ki; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
RP Watanabe, S; Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
EM satoru.watanabe@duke-nus.edu.sg; subhash.vasudevan@duke-nus.edu.sg
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [0003/2016, 0103/2016]; National Research Foundation
   [NRF2016NRF-CRP001-063]
FX We thank Audrey Khoo for technical support for the neurological analysis
   of mouse fetuses/infants. ZIKV H/PF/2013 (French Polynesian: ZIKV-FP)
   strain was obtained from the European Virus Archive (EVAg). ZIKV Paraiba
   01/2015 (Brazilian: ZIKV-B) was a gift from Evandro Chagas Institute.
   NITD008 was a generous gift from Novartis Institute for Tropical
   Diseases, Singapore. This study was funded by National Medical Research
   Council/Open Fund Young Individual Research Grant/0003/2016 (to SW), and
   in part by the National Medical Research Council/Cooperative Basic
   Individual Research Grant/0103/2016 (to SGV) and National Research
   Foundation grant NRF2016NRF-CRP001-063 as co-PI to SGV.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Caine E. A, 2018, VIRUSES, P10
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chacko AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93474
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Coelho A. V. C, 2017, INT J MOL SCI, V18
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 34
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2019
VL 167
BP 104
EP 109
DI 10.1016/j.antiviral.2019.04.013
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IE2WB
UT WOS:000472244200012
PM 31051186
DA 2020-07-08
ER

PT J
AU Han, YS
   Pham, HT
   Xu, HT
   Quan, YD
   Mesplede, T
AF Han, Yingshan
   Pham, Hanh T.
   Xu, Hongtao
   Quan, Yudong
   Mesplede, Thibault
TI Antimalarial drugs and their metabolites are potent Zika virus
   inhibitors
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE antimalarial; antiviral drug; phenotypic screening; repurposing; Zika
ID DENGUE VIRUS; INFECTION; CHLOROQUINE; AMODIAQUINE; ANALOGS;
   IMMUNOGENICITY; ENDOCYTOSIS; CANDIDATES; PHASE-1; SCREEN
AB Studies aimed at repurposing existing drugs revealed that some antimalarial compounds possess anti-Zika virus (anti-ZIKV) activity. Here, we further tested 14 additional antimalarial drugs and their metabolites or analogs for anti-ZIKV activity using a phenotypic screening approach. We identified four compounds with varying anti-ZIKV activity, including a metabolite of amodiaquine termed desethylamodiaquine (DAQ) and N-desethylchloroquine (DECQ), a metabolite of chloroquine, which both exhibited low micromolar effective concentrations against three different ZIKV strains. Two other compounds termed dihydroartemisinin (DHA) and quinidine (QD) exhibited only partial inhibition of ZIKV replication. Characterization of the inhibitory mechanisms of DAQ and DECQ showed that both drugs target the entry step as well as postentry events of the viral replication cycle. These hits represent attractive starting points for future optimization of new anti-ZIKV drug candidates derived from antimalarial drugs and their analogs.
C1 [Han, Yingshan; Pham, Hanh T.; Xu, Hongtao; Quan, Yudong; Mesplede, Thibault] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Jewish Gen Hosp, F344,3755 Ch Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.
   [Pham, Hanh T.; Mesplede, Thibault] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ, Canada.
   [Mesplede, Thibault] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ, Canada.
   [Mesplede, Thibault] McGill Univ, Fac Med, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ, Canada.
RP Mesplede, T (corresponding author), McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Jewish Gen Hosp, F344,3755 Ch Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.
EM thibault.mesplede@mcgill.ca
RI Mesplede, Thibault/E-8550-2014
OI Mesplede, Thibault/0000-0003-0515-9128
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR)
FX Canadian Institutes of Health Research
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182
   Andjelic CD, 2008, MAR DRUGS, V6, P528, DOI 10.3390/md20080027
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   da Silva S, 2018, VIRUSES, V10, P10
   de la Guardia C, 2018, MOLECULES, V23, DOI 10.3390/molecules23030672
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han YS, 2018, EXPERT OPIN INV DRUG, V27, P951, DOI 10.1080/13543784.2018.1548609
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Jin GX, 2014, DRUG DISCOV TODAY, V19, P637, DOI 10.1016/j.drudis.2013.11.005
   Kizhatil K, 1997, J VIROL, V71, P7145, DOI 10.1128/JVI.71.10.7145-7156.1997
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Lee YH, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1637-5
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Mushtaque M, 2015, EUR J MED CHEM, V90, P280, DOI 10.1016/j.ejmech.2014.11.022
   Pai MY, 2015, METHODS MOL BIOL, V1263, P287, DOI 10.1007/978-1-4939-2269-7_22
   Parhizgar AR, 2017, IRAN J MED SCI, V42, P115
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 38
TC 3
Z9 4
U1 3
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 2019
VL 91
IS 7
BP 1182
EP 1190
DI 10.1002/jmv.25440
PG 9
WC Virology
SC Virology
GA ID5ZD
UT WOS:000471755300002
PM 30801742
DA 2020-07-08
ER

PT J
AU Ribas, MD
   Tejero, Y
   Cordero, Y
   Perez, D
   Sausy, A
   Muller, CP
   Hubschen, JM
AF de los Angeles Ribas, Maria
   Tejero, Yahisel
   Cordero, Yanislet
   Perez, Daileny
   Sausy, Aurelie
   Muller, Claude P.
   Hubschen, Judith M.
TI Identification of human parvovirus B19 among measles and rubella
   suspected patients from Cuba
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Cuba; human parvovirus B19; rash-fever
ID RASH; VIRUS
AB Between September 2014 and December 2015, 298 sera from rash and fever patients from all over Cuba were investigated for specific IgM antibodies against measles, rubella, dengue, human parvovirus B19 (B19V) and human herpesvirus 6 (HHV6) using a commercial enzyme-linked immunosorbent assay kits. B19V IgM positive and equivocal samples were investigated by a polymerase chain reaction and genotyping. No measles, rubella or dengue cases were detected. HHV6-IgM antibodies were confirmed in 5.7% and B19V-IgM antibodies in 10.7% of the patients. A total of 31.3% of the B19V cases were between 5 and 9 years old and 34.4% were 20 years and older. The only B19V sequence obtained belonged to genotype 1a. Diagnosis was established for only 16% of the rash and fever patients, suggesting that other diseases such as Zika or Chikungunya may play a role.
C1 [de los Angeles Ribas, Maria; Tejero, Yahisel; Cordero, Yanislet; Perez, Daileny] Pedro Kouri Inst Trop Med, Natl Reference Lab Measles Mumps Rubella, Virol Dept, Autopista Novia Mediodia Km 61-2,Lisa Marianao 13, Havana 601, Cuba.
   [Sausy, Aurelie; Muller, Claude P.; Hubschen, Judith M.] Luxembourg Inst Hlth, Infect Dis Res Unit, Dept Infect & Immun, Esch Sur Alzette, Luxembourg.
   [Muller, Claude P.] Lab Natl Sante, Inst Immunol, Dudelange, Luxembourg.
RP Ribas, MD (corresponding author), Pedro Kouri Inst Trop Med, Natl Reference Lab Measles Mumps Rubella, Virol Dept, Autopista Novia Mediodia Km 61-2,Lisa Marianao 13, Havana 601, Cuba.
EM maribas@ipk.sld.cu
RI Hubschen, Judith/AAF-5113-2020
CR [Anonymous], 2012, GLOB MEASL RUB STRAT
   de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490
   Freitas RB, 2008, J CLIN VIROL, V43, P60, DOI 10.1016/j.jcv.2008.03.033
   Freitas Ronaldo B., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P305, DOI 10.1590/S0036-46652000000600002
   Galindo M. A., 1998, PAN AM J PUBLIC HLTH, V4, P171
   Guzman M, 1995, REV CUBA MED TROP, V49, P1
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Hubschen JM, 2009, J CLIN MICROBIOL, V47, P3735, DOI 10.1128/JCM.01201-09
   Ivanova SK, 2016, EUROSURVEILLANCE, V21, P18, DOI 10.2807/1560-7917.ES.2016.21.4.30116
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Mendonca MCL, 2005, MEM I OSWALDO CRUZ, V100, P847, DOI 10.1590/S0074-02762005000800005
   Garcia RDNC, 2017, BRAZ J INFECT DIS, V21, P102, DOI 10.1016/j.bjid.2016.11.002
   Oliveira MI, 2002, REV SAUDE PUBL, V36, P155, DOI [10.1590/S0034-89102002000200006, 10.1590/s0034-89102002000200006]
   Pan American Health Organization (PAHO/ WHO), IMM NEWSL
   Pan American Health Organization (PAHO/ WHO), COUNTR REP PAHO EP W, V52
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Ribas M., 2011, THESIS
   Sanabani S, 2006, J CLIN MICROBIOL, V44, P604, DOI 10.1128/JCM.44.2.604-606.2006
   Thomas HIJ, 1999, J CLIN VIROL, V14, P107, DOI 10.1016/S1386-6532(99)00051-7
   Toshev A, 2014, BIOTECHNOL BIOTEC EQ, V28, P1103, DOI 10.1080/13102818.2014.967746
   Yermalovich MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111541
NR 21
TC 2
Z9 2
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 2019
VL 91
IS 7
BP 1351
EP 1354
DI 10.1002/jmv.25444
PG 4
WC Virology
SC Virology
GA ID5ZD
UT WOS:000471755300023
PM 30817853
DA 2020-07-08
ER

PT J
AU Bowen, LR
   Li, DJ
   Nola, DT
   Anderson, MO
   Heying, M
   Groves, AT
   Eagon, S
AF Bowen, Lucy R.
   Li, Dennis J.
   Nola, Derek T.
   Anderson, Marc O.
   Heying, Michael
   Groves, Adam T.
   Eagon, Scott
TI Identification of potential Zika virus NS2B-NS3 protease inhibitors via
   docking, molecular dynamics and consensus scoring-based virtual
   screening
SO JOURNAL OF MOLECULAR MODELING
LA English
DT Article
DE Docking; Zika; Molecular dynamics; Consensus scoring; Virtual screen
ID BINDING; DISCOVERY; ACCURACY; STABILIZATION; INFECTION; AMBER
AB The Zika virus has recently become a subject of acute interest after the discovery of the link between viral infection and microcephaly in infants. Though a number of treatments are under active investigation, there are currently no approved treatments for the disease. To address this critical need, we screened more than 7million compounds targeting the NS2B-NS3 protease in an attempt to identify promising inhibitor candidates. Starting with commercially and freely available compounds, we identified six hits utilizing an exhaustive consensus screening protocol, followed by molecular dynamics simulation and binding energy estimation using MM/GBSA and MM/PBSA methods. These compounds feature a variety of cores and functionalities, and all are predicted to have good pharmacokinetic profiles, making them promising candidates for screening assays.
C1 [Bowen, Lucy R.; Li, Dennis J.; Nola, Derek T.; Heying, Michael; Groves, Adam T.; Eagon, Scott] Calif Polytech State Univ San Luis Obispo, 1 Grand Ave, San Luis Obispo, CA 93407 USA.
   [Anderson, Marc O.] San Francisco State Univ, 1600 Holloway Ave, San Francisco, CA 94132 USA.
RP Eagon, S (corresponding author), Calif Polytech State Univ San Luis Obispo, 1 Grand Ave, San Luis Obispo, CA 93407 USA.
EM seagon@calpoly.edu
OI Eagon, Scott/0000-0001-9714-4139
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a
   Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381
   Case D.A., 2016, AMBER
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Ericksen SS, 2017, J CHEM INF MODEL, V57, P1579, DOI 10.1021/acs.jcim.7b00153
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936
   Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550
   Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kukol A, 2011, EUR J MED CHEM, V46, P4661, DOI 10.1016/j.ejmech.2011.05.026
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HJ, 2015, MOL INFORM, V34, P115, DOI 10.1002/minf.201400132
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 48
TC 1
Z9 1
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1610-2940
EI 0948-5023
J9 J MOL MODEL
JI J. Mol. Model.
PD JUL
PY 2019
VL 25
IS 7
AR 194
DI 10.1007/s00894-019-4076-6
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Chemistry,
   Multidisciplinary; Computer Science, Interdisciplinary Applications
SC Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer
   Science
GA ID8VA
UT WOS:000471963700002
PM 31209577
DA 2020-07-08
ER

PT J
AU Esser-Nobis, K
   Aarreberg, LD
   Roby, JA
   Fairgrieve, MR
   Green, R
   Gale, M
AF Esser-Nobis, Katharina
   Aarreberg, Lauren D.
   Roby, Justin A.
   Fairgrieve, Marian R.
   Green, Richard
   Gale, Michael, Jr.
TI Comparative Analysis of African and Asian Lineage-Derived Zika Virus
   Strains Reveals Differences in Activation of and Sensitivity to
   Antiviral Innate Immunity
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE RIG-I-like receptors; Zika virus; flavivirus; innate immunity
ID INTERFERON REGULATORY FACTOR-3; RIG-I; REPLICATION; INFECTION;
   RECEPTORS; EMERGENCE; PLATFORM; PROTEIN; DENGUE; BRAZIL
AB In recent years, Asian lineage Zika virus (ZIKV) strains emerged to cause pandemic outbreaks associated with a high rate of congenital ZIKV syndrome (CZVS). The reasons for the enhanced spread and severe disease caused by newly emerging strains are not fully understood. Here we compared viral sequences, viral replication, and innate immune signaling induction of three different ZIKV strains derived from African and Asian lineages and West Nile virus, another flavivirus. We found pronounced differences in activation of innate immune signaling and inhibition of viral replication across ZIKV strains. The newly emerged Asian ZIKV strain Brazil Fortaleza 2015, which is associated with a higher rate of neurodevelopmental disorders like microcephaly, induced much weaker and delayed innate immune signaling in infected cells. However, superinfection studies to assess control of innate immune signaling induced by Sendai virus argue against an active block of IRF3 activation by the Brazilian strain of ZIKV and rather suggest an evasion of detection by host cell pattern recognition receptors. Compared to the Asian strain FSS13025 isolated in Cambodia, both ZIKV Uganda MR766 and ZIKV Brazil Fortaleza appear less sensitive to the interferon-induced antiviral response. ZIKV infection studies of cells lacking the different RIG-I-like receptors identified RIG-I as the major cytosolic pattern recognition receptor for detection of ZIKV.
   IMPORTANCE Zika Virus (ZIKV), discovered in 1947, is divided into African and Asian lineages. Pandemic outbreaks caused by currently emerging Asian lineage strains are accompanied by high rates of neurological disorders and exemplify the global health burden associated with this virus. Here we compared virological and innate immunological aspects of two ZIKV strains from the Asian lineage, an emerging Brazilian strain and a less-pathogenic Cambodian strain, and the prototypic African lineage ZIKV strain from Uganda. Compared to the replication of other ZIKV strains, the replication of ZIKV Brazil was less sensitive to the antiviral actions of interferon (IFN), while infection with this strain induced weaker and delayed innate immune responses in vitro. Our data suggest that ZIKV Brazil directs a passive strategy of innate immune evasion that is reminiscent of a stealth virus. Such strain-specific properties likely contribute to differential pathogenesis and should be taken into consideration when choosing virus strains for future molecular studies.
C1 [Esser-Nobis, Katharina; Aarreberg, Lauren D.; Roby, Justin A.; Fairgrieve, Marian R.; Green, Richard; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Sch Med, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
RP Gale, M (corresponding author), Univ Washington, Dept Immunol, Sch Med, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
EM mgale@uw.edu
OI Roby, Justin/0000-0003-2434-4273; Hatfield, Lauren D/0000-0003-0095-9863
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI143265, AI145296, AI104002,
   AI083019, AI100625]
FX This work was supported by NIH grants AI143265, AI145296, AI104002,
   AI083019, and AI100625.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015
   Grunvogel O, 2015, J VIROL, V89, P10548, DOI 10.1128/JVI.01297-15
   Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hiet MS, 2015, J HEPATOL, V63, P829, DOI 10.1016/j.jhep.2015.04.015
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Neufeldt CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005428
   PAHO/ WHO, 2017, ZIK EP UPD
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rustagi A, 2013, METHODS, V59, P225, DOI 10.1016/j.ymeth.2012.05.011
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Sprokholt JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006738
   Sprokholt JK, 2017, J IMMUNOL, V198, P4764, DOI 10.4049/jimmunol.1602121
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 45
TC 10
Z9 10
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 13
AR e00640-19
DI 10.1128/JVI.00640-19
PG 18
WC Virology
SC Virology
GA ID6AW
UT WOS:000471760000032
PM 31019057
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hastings, AK
   Uraki, R
   Gaitsch, H
   Dhaliwal, K
   Stanley, S
   Sproch, H
   Williamson, E
   MacNeil, T
   Marin-Lopez, A
   Hwang, J
   Wang, YC
   Grover, JR
   Fikrig, E
AF Hastings, Andrew K.
   Uraki, Ryuta
   Gaitsch, Hallie
   Dhaliwal, Khushwant
   Stanley, Sydney
   Sproch, Hannah
   Williamson, Eric
   MacNeil, Tyler
   Marin-Lopez, Alejandro
   Hwang, Jesse
   Wang, Yuchen
   Grover, Jonathan R.
   Fikrig, Erol
TI Aedes aegypti NeSt1 Protein Enhances Zika Virus Pathogenesis by
   Activating Neutrophils
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE mosquito; mosquito-borne; salivary gland; Zika virus; arthropod-borne
   virus; flavivirus; immunity; neutrophils; vaccine; viral pathogenesis
ID WEST NILE VIRUS; DENGUE VIRUS; NONVASCULAR DELIVERY; ANTIBODY-RESPONSE;
   MOSQUITO; INFECTION; SALIVA; TRANSMISSION; ASSOCIATION; DISEASE
AB Saliva from the mosquito vector of flaviviruses is capable of changing the local immune environment, leading to an increase in flavivirus-susceptible cells at the infected bite site. In addition, an antibody response to specific salivary gland (SG) components changes the pathogenesis of flaviviruses in human populations. To investigate whether antigenic SG proteins are capable of enhancing infection with Zika virus (ZIKV), a reemerging flavivirus primarily transmitted by the Aedes aegypti mosquito, we screened for antigenic SG proteins using a yeast display library and demonstrate that a previously undescribed SG protein we term neutrophil stimulating factor 1 (NeSt1) activates primary mouse neutrophils ex vivo. Passive immunization against NeSt1 decreases pro-interleukin-1 beta and CXCL2 expression, prevents macrophages from infiltrating the bite site, protects susceptible IFNAR(-/-) IFNGR(-/-) (AG129) mice from early ZIKV replication, and ameliorates virus-induced pathogenesis. These findings indicate that NeSt1 stimulates neutrophils at the mosquito bite site to change the immune microenvironment, allowing a higher level of early viral replication and enhancing ZIKV pathogenesis.
   IMPORTANCE When a Zika virus-infected mosquito bites a person, mosquito saliva is injected into the skin along with the virus. Molecules in this saliva can make virus infection more severe by changing the immune system to make the skin a better place for the virus to replicate. We identified a molecule that activates immune cells, called neutrophils, to recruit other immune cells, called macrophages, that the virus can infect. We named this molecule neutrophil-stimulating factor 1 (NeSt1). When we used antibodies to block NeSt1 in mice and then allowed Zika virus-infected mosquitoes to feed on these mice, they survived much better than mice that do not have antibodies against NeSt1. These findings give us more information about how mosquito saliva enhances virus infection, and it is possible that a vaccine against NeSt1 might protect people against severe Zika virus infection.
C1 [Hastings, Andrew K.; Uraki, Ryuta; Gaitsch, Hallie; Dhaliwal, Khushwant; Stanley, Sydney; Sproch, Hannah; Williamson, Eric; MacNeil, Tyler; Marin-Lopez, Alejandro; Hwang, Jesse; Wang, Yuchen; Grover, Jonathan R.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.; Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu
OI Gaitsch, Hallie/0000-0002-6656-607X
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; NCATS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001863]
CR Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chagas AC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003923
   Choumet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050464
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Diaz-Nieto LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001963
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018
   Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hayashi H, 2012, THROMB RES, V129, P169, DOI 10.1016/j.thromres.2011.09.015
   He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106
   Horka H, 2009, INT J MED MICROBIOL, V299, P373, DOI 10.1016/j.ijmm.2008.10.009
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x
   Kieny MP, 2004, AM J PUBLIC HEALTH, V94, P1931, DOI 10.2105/AJPH.94.11.1931
   Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   Machain-Williams C, 2013, VIRAL IMMUNOL, V26, P84, DOI 10.1089/vim.2012.0051
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Narasimhan S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004278
   National Research Council, 2011, GUIDE CARE USE LAB A
   Oehler E, 2014, ZIKA VIRUS INFECT CO
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012
   Osorio JE, 1996, AM J TROP MED HYG, V54, P338, DOI 10.4269/ajtmh.1996.54.338
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110
   To KKW, 2012, CLIN VACCINE IMMUNOL, V19, P1012, DOI 10.1128/CVI.00081-12
   TURELL MJ, 1995, J MED ENTOMOL, V32, P563, DOI 10.1093/jmedent/32.4.563
   TURELL MJ, 1992, AM J TROP MED HYG, V47, P190, DOI 10.4269/ajtmh.1992.47.190
   Uraki R, 2019, NAT MICROBIOL, V4, P948, DOI 10.1038/s41564-019-0385-x
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
NR 67
TC 4
Z9 5
U1 1
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 13
AR e00395-19
DI 10.1128/JVI.00395-19
PG 16
WC Virology
SC Virology
GA ID6AW
UT WOS:000471760000019
PM 30971475
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Pardy, RD
   Valbon, SF
   Richer, MJ
AF Pardy, Ryan D.
   Valbon, Stefanie F.
   Richer, Martin J.
TI Running interference: Interplay between Zika virus and the host
   interferon response
SO CYTOKINE
LA English
DT Article; Proceedings Paper
CT 7th Annual symposium on Cytokines in Inflammation, Ageing, CanCer and
   Obesity (CIACCO)
CY MAY 25, 2018
CL Quebec, CANADA
DE Zika virus; Interferons; Host defense; Viral pathogenesis
ID CD8 T-CELLS; I INTERFERONS; STIMULATED GENES; III INTERFERONS; MOUSE
   MODEL; RIG-I; INFECTION; PROTECTION; INDUCTION; MONOCYTES
AB The interferon (IFN) family of cytokines is a crucial part of the host's ability to mount an effective immune response against viral infections. In addition to establishing an antiviral state within cells, IFNs also support the optimal activation of other key immune cell types. The ability of members of the Flaviviridae family to suppress type I IFN responses has been well-described. Of these viruses, Zika virus (ZIKV) has recently attracted international attention due to a series of major outbreaks that featured the novel association of neurological symptoms with infection. Researchers have begun to investigate the strategies ZIKV uses to evade type I IFNs, and the impact this has on the host. However, a unique feature of ZIKV infection compared to other flaviviruses is its capacity to be transmitted sexually, as well as its ability to infect and persist within reproductive tissues. As such, this raises the question of a potential role for type III IFN during ZIKV infection. In this review, we will discuss the interplay between these two classes of IFN with ZIKV, models that have been used to interrogate these interactions, and the effect this interplay has on infection and infection outcomes. We will also consider the intriguing possibility of whether ZIKV has evolved improved evasion mechanisms to suppress the IFN response in recent outbreaks.
C1 [Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, McIntyre Med Bldg,Room 712A, Montreal, PQ H3G 1Y6, Canada.
   McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada.
RP Richer, MJ (corresponding author), McGill Univ, Dept Microbiol & Immunol, McIntyre Med Bldg,Room 712A, Montreal, PQ H3G 1Y6, Canada.
EM martin.j.richer@mcgill.ca
OI Pardy, Ryan/0000-0002-0024-8888
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [PJT-152903]; Natural Sciences and Engineering Research
   CouncilNatural Sciences and Engineering Research Council of Canada
   [RGPIN-2016-04713]; Fonds de Recherche du Quebec - SanteFonds de la
   Recherche en Sante du Quebec [32807]; Canada Foundation for
   InnovationCanada Foundation for Innovation; Fonds de Recherche du Quebec
   SanteFonds de la Recherche en Sante du Quebec
FX We would like to thank Dr. Stephanie A. Condotta and Marilena Gentile
   for critical review of the manuscript. Funding for the Richer Lab is
   provided by the Canadian Institutes of Health Research (grant number
   PJT-152903), the Natural Sciences and Engineering Research Council
   (grant number RGPIN-2016-04713), Fonds de Recherche du Quebec - Sante
   (grant number 32807), and the Canada Foundation for Innovation. R.D.P is
   supported by a doctoral scholarship from Fonds de Recherche du Quebec
   Sante.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Barnard TR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120728
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Isaacs A., 1957, P ROY SOC LOND B BIO, V147, P258
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004
   Kelly A, 2016, J INTERF CYTOK RES, V36, P671, DOI 10.1089/jir.2015.0169
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kochs G, 2016, J VIROL, V90, P9330, DOI 10.1128/JVI.00744-16
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Ma F, 2015, J IMMUNOL, V194, P1545, DOI 10.4049/jimmunol.1402066
   Majoros A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00029
   Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E, 2014, EURO SURVEILL, V19
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Swati G., 2018, WASHINGTON POST
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   World Health Organization, 2017, HIST ZIK VIR
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 85
TC 2
Z9 2
U1 0
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUL
PY 2019
VL 119
BP 7
EP 15
DI 10.1016/j.cyto.2019.02.009
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA ID0EH
UT WOS:000471356000002
PM 30856603
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Fuentes-Barahona, IC
   Soto-Fernandez, RJ
   Zuniga, C
   da Silva, JC
   Rodriguez-Morales, AJ
AF Zambrano, Lysien I.
   Carolina Fuentes-Barahona, Itzel
   Jeremias Soto-Fernandez, Ramon
   Zuniga, Concepcion
   da Silva, Jose Claudio
   Rodriguez-Morales, Alfonso J.
TI Guillain-Barre syndrome associated with Zika virus infection in
   Honduras, 2016-2017
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Dept Morphol Sci, Sch Med, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo, EPM, Cardiovasc Div, UNIFESP,Dept Physiol, Sao Paulo, Brazil.
   [Zambrano, Lysien I.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Carolina Fuentes-Barahona, Itzel] Univ Nacl Autonoma Honduras, Sch Med Sci, Tegucigalpa, Honduras.
   [Carolina Fuentes-Barahona, Itzel] Hosp Escuela Tegucigalpa, Dept Gynecol & Obstet, Tegucigalpa, Honduras.
   [Jeremias Soto-Fernandez, Ramon; Zuniga, Concepcion] Hosp Escuela Univ, Dept Epidemiol, Tegucigalpa, Honduras.
   [da Silva, Jose Claudio] Ctr Univ CESMAC, Maceio, Alagoas, Brazil.
   [da Silva, Jose Claudio] State Univ Hlth Sci Alagoas, UNCISAL, Alagoas, Brazil.
   [Rodriguez-Morales, Alfonso J.] UTP, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Asociac Panamer Infectol, Comm Travel Med, Panama City, Panama.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Med Sch, Fac Hlth Sci, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), UTP, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI da Silva, Jose Claudio/D-8731-2016; Zambrano, Lysien/R-5628-2019
OI da Silva, Jose Claudio/0000-0003-3749-2822; Zambrano,
   Lysien/0000-0001-9002-5807; Rodriguez-Morales, Alfonso
   J./0000-0001-9773-2192; Fuentes Barahona, Itzel
   Carolina/0000-0002-9995-2276
FU Direccion de Investigacion Cientifica (DICU), Universidad Nacional
   Autonoma de Honduras
FX Direccion de Investigacion Cientifica (DICU), Universidad Nacional
   Autonoma de Honduras.
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Rodriguez-Morales AJ, 2019, INT J INFECT DIS
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Zambrano LI, 2019, TRAVEL MED INFECT DI
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 11
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2019
VL 84
BP 136
EP 137
DI 10.1016/j.ijid.2019.05.008
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA IC8NK
UT WOS:000471238000025
PM 31096053
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Maitra, A
   Cunha-Machado, AS
   Leandro, AD
   da Costa, FM
   Scarpassa, VM
AF Maitra, Ahana
   Cunha-Machado, Antonio Saulo
   Leandro, Andre de Souza
   da Costa, Fabio Medeiros
   Scarpassa, Vera Margarete
TI Exploring deeper genetic structures: Aedes aegypti in Brazil
SO ACTA TROPICA
LA English
DT Article
DE Arboviruses vector; Population genetics; Genetic diversity; Demographic
   dynamic; Microsatellites; Brazil
ID MAJOR DENGUE VECTOR; POPULATION-GENETICS; CULICIDAE; DIPTERA;
   VARIABILITY; SOFTWARE; DISPERSAL; PROGRAM; DIFFERENTIATION; COMPETENCE
AB Aedes aegypti, being the principal vector of dengue (DENV1 to 4), chikungunya and Zika viruses, is considered as one of the most important mosquito vectors. In Brazil, despite regular vector control programs, Ae. aegypti still persists with high urban density in all the states. This study aimed to estimate the intra and inter population genetic diversity and genetic structure among 15 Brazilian populations of Ae. aegypti based on 12 microsatellite loci. A total of 510 specimens were analyzed comprising eight locations from northern (Itacoatiara, Manaus, Novo Airao, Boa Vista, Rio Branco, Porto Velho, Guajara-Mirim and Macapa), three from southeastern (Aracatuba, Sao Jose de Rio Preto and Taubate), one from southern (Foz do Iguacu), one from central west (Cuiaba) and two from northeastern (Campina Grande and Teresina) regions of Brazil. Genetic distances (pairwise values of F-ST and Nm) and the analysis of molecular variance (AMOVA) were statistically significant, independent of geographic distances among the sites analyzed, indicating that them are under a complex dynamic process that influence the levels of gene flow within and among regions of the country. Bayesian analysis in STRUCTURE revealed the existence of two major genetic clusters, as well as there was genetic substructure within them; these results were confirmed by AMOVA, BAPS and DAPC analyses. This differentiation is the cumulative result of several factors combined as events of multiple introduction, passive dispersal, environmental and climatic conditions, use of insecticides, cycles of extinction and re-colonization followed by microevolutionary processes throughout the country. Isolation by distance also contributed to this differentiation, especially among geographically closer localities. These genetic differences may affect its vector competence to transmit dengue, chikungunya, Zika and the response to vector control programs.
C1 [Maitra, Ahana; Cunha-Machado, Antonio Saulo; Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Genet Conservacao & Biol Evolut, BR-69067375 Manaus, Amazonas, Brazil.
   [Leandro, Andre de Souza] Prefeitura Municipal Foz do Iguacu, Ctr Zoonoses, Secretaria Municipal Saude & Saneamento, Foz Do Iguacu, Parana, Brazil.
   [da Costa, Fabio Medeiros] Dept Meio Ambiente, Oikos Consultoria & Projetos, Estr Santo Antonio,3903 Apto 103 Triangulo, BR-76805696 Porto Velho, Rondonia, Brazil.
   [Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Lab Genet Populacoes & Evolucao Vetores Malaria &, BR-69067375 Manaus, Amazonas, Brazil.
RP Scarpassa, VM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Genet Populacoes & Evolucao Vetores Malaria &, Coordenacao Biodiversidade, BR-69067375 Manaus, Amazonas, Brazil.
EM vera@inpa.gov.br
OI Cunha-Machado, Antonio Saulo/0000-0002-3254-8260
FU MCTIC/INPA [PRJ 12.311]; Amazonas Research Foundation -FAPEAM
   [3111/2012]; PRO-EQUIPAMENTO-CAPES; CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This study was funded by MCTIC/INPA (grant number: PRJ 12.311) and by
   grants from Amazonas Research Foundation -FAPEAM (grant number:
   3111/2012) and from PRO-EQUIPAMENTO-CAPES to Vera Margarete Scarpassa.
   Ahana Maitra was scholarship student from CAPES and Antonio Saulo Cunha
   Machado is scholarship student from CNPq. We thank Renata da Silva
   Leandro, Marllon Rinaldo de Lima Andrade, Steffany Larissa da Silva
   Galdino for the field collections from Campina Grande; Dr. Raimundo
   Nonato Picanco Souto and Dr. Fred Julio Costa Monteiro for the field
   collections from Macapa; and MSc. Gersonval L.S. Monte for the field
   collections from Teresina. We also thank MSc. Jose F. Saraiva, MSc.
   Sandra M. H. Rangel and Dr. Ronildo B. Alencar, for helping with the
   analyses, figures and maps.
CR Mendonca BAA, 2014, ACTA TROP, V134, P80, DOI 10.1016/j.actatropica.2014.02.014
   Ayres CFJ, 2003, J MED ENTOMOL, V40, P430, DOI 10.1603/0022-2585-40.4.430
   Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bernhardt SA, 2009, INSECT MOL BIOL, V18, P557, DOI 10.1111/j.1365-2583.2009.00895.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392
   Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015
   Chaves BA, 2018, THESIS
   Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x
   Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015
   Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   DinardoMiranda LL, 1996, J MED ENTOMOL, V33, P726, DOI 10.1093/jmedent/33.5.726
   Paduan KD, 2006, GENET MOL BIOL, V29, P391, DOI 10.1590/S1415-47572006000200030
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Figueiredo L. T. M., 2003, Dengue Bulletin, V27, P25
   Forattini Oswaldo Paulo, 2002, CULICIDOLOGIA MED ID
   Fraga ED, 2003, GENET MOL BIOL, V26, P181, DOI 10.1590/S1415-47572003000200011
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   HOLM S, 1979, SCAND J STAT, V6, P65
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Lima RS, 2009, GENET MOL BIOL, V32, P414, DOI 10.1590/S1415-47572009005000036
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   MANTEL N, 1967, CANCER RES, V27, P209
   Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108
   Monteiro F. A., 2014, PLOS NEGLECT TROP D, V8, P1
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   PEEL D, 2004, NEESTIMATOR SOFTWARE
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Pritchard JK, 2000, GENETICS, V155, P945
   R Core Team, 2017, R LANG ENV STAT COMP
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Saarman NP, 2017, EVOL APPL, V10, P1031, DOI 10.1111/eva.12508
   Sambrook J., 2001, MOL CLONING LAB MANU
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Scarpassa VM, 2007, MEM I OSWALDO CRUZ, V102, P319, DOI 10.1590/S0074-02762007005000045
   Scarpassa VM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1217-6
   Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708
   SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Templeton A. R., 2011, SOC BRASILEIRA GENET
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Venables W. N., 2002, MODERN APPL STAT S
   Woodring Jennifer L., 1996, P51
NR 72
TC 0
Z9 0
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUL
PY 2019
VL 195
BP 68
EP 77
DI 10.1016/j.actatropica.2019.04.027
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IC6MS
UT WOS:000471086800011
PM 31034798
DA 2020-07-08
ER

PT J
AU Huang, HT
   Lin, CC
   Kuo, TC
   Chen, SJ
   Huang, RN
AF Huang, Hsiang-Ting
   Lin, Chien-Chung
   Kuo, Tai-Chih
   Chen, Shiang-Jiuun
   Huang, Rong-Nan
TI Phytochemical composition and larvicidal activity of essential oils from
   herbal plants
SO PLANTA
LA English
DT Article
DE Vector control; Essential oils; Larvicide; beta-Caryophyllene
ID VITEX-ROTUNDIFOLIA; PLECTRANTHUS-AMBOINICUS; CHEMICAL-COMPOSITION;
   CROSSOSTEPHIUM-CHINENSE; AEDES-AEGYPTI; ANTIBACTERIAL ACTIVITY; IN-VIVO;
   CONSTITUENTS; LEAVES; FRUITS
AB Main conclusionThe essential oils (EOs) of Plectranthus amboinicus showed the highest larvicidal activity among four herbal plants studied and -caryophyllene might be the major component responsible for its differential toxicity to the larvae of Culex quinquefasciatus and Aedes Aegypti.Mosquitoes act as vectors for many life-threatening diseases, including malaria, dengue fever, and Zika virus infection. Management of mosquitoes mainly relies on synthetic insecticides, which usually result in the rapid development of resistance; therefore, alternative mosquito control strategies are urgently needed. This study characterized the major component of essential oils (EOs) derived from the vegetative parts of four herbal plants and their larvicidal activity toward important mosquito vectors. The EOs were extracted by hydro-distillation and subjected to gas chromatography-mass spectrometry (GC-MS) analysis and a larvicidal activity assay toward Aedes aegypti, Ae. albopictus and Culex quinquefasciatus. In total, 14, 11, 11 and 9 compounds were identified from the EOs of Plectranthus amboinicus, Mentha requienii, Vitex rotundifolia and Crossostephium chinense, respectively. The EOs derived from four herbal plants exhibited remarkable larvicidal activity against the three mosquito species. In particular, the EOs of P. amboinicus showed the highest larvicidal activity, and the larvae of Cx. quinquefasciatus were more sensitive to the P. amboinicus EOs than that of Ae. Aegypti. Although carvacrol (61.53%) was the predominant constituent of the P. amboinicus EOs, its precursors, -terpinene (8.51%) and p-cymene (9.42%), exhibited the most larvicidal activity toward Ae. aegypti and Cx. quinquefasciatus. However, -caryophyllene (12.79%) might be the major component responsible for the differential toxicity of the P. amboinicus EOs, as indicated by the significant differences in its LC50 values toward both mosquitoes. Information from these studies will benefit the incorporation of EOs into integrated vector management.
C1 [Huang, Hsiang-Ting; Huang, Rong-Nan] Natl Taiwan Univ, Coll Bioresources & Agr, Dept Entomol, Taipei 10617, Taiwan.
   [Huang, Hsiang-Ting; Huang, Rong-Nan] Natl Taiwan Univ, Coll Bioresources & Agr, Res Ctr Plant Med, Taipei 10617, Taiwan.
   [Lin, Chien-Chung] Taipei City Hosp, Dept Orthoped Surg, Taipei 100, Taiwan.
   [Kuo, Tai-Chih] Taipei Med Univ, Dept Biochem, 250 Wu Hsing St, Taipei 110, Taiwan.
   [Chen, Shiang-Jiuun] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 106, Taiwan.
RP Huang, RN (corresponding author), Natl Taiwan Univ, Coll Bioresources & Agr, Dept Entomol, Taipei 10617, Taiwan.; Huang, RN (corresponding author), Natl Taiwan Univ, Coll Bioresources & Agr, Res Ctr Plant Med, Taipei 10617, Taiwan.
EM rongent@ntu.edu.tw
FU Ministry of Science and Technology, The Executive Yuan, Taiwan, R.O.C.
   [MOST 106-2321-B-002-037]
FX We would like to thanks American Journal Experts for helping on the
   grammar editing of this manuscript. Funding for this research was
   provided by the Ministry of Science and Technology (MOST
   106-2321-B-002-037), The Executive Yuan, Taiwan, R.O.C. are kindly
   acknowledged.
CR Adams R.P., 2017, IDENTIFICATION ESSEN
   Aguiar JJS, 2015, EUR J INTEGR MED, V7, P151, DOI 10.1016/j.eujim.2014.10.005
   Arumugam G, 2016, MOLECULES, V21, DOI 10.3390/molecules21040369
   Bae H, 2013, INT IMMUNOL, V25, P197, DOI 10.1093/intimm/dxs102
   Benelli G, 2017, PARASITOL RES, V116, P1175, DOI 10.1007/s00436-017-5395-0
   Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u
   Chen YS, 2014, BIOORGAN MED CHEM, V22, P1766, DOI 10.1016/j.bmc.2014.01.009
   Chessa M, 2013, NAT PROD RES, V27, P93, DOI 10.1080/14786419.2012.658798
   da Costa JGM, 2010, J ESSENT OIL RES, V22, P183, DOI 10.1080/10412905.2010.9700298
   Gurgel APAD, 2009, J ETHNOPHARMACOL, V125, P361, DOI 10.1016/j.jep.2009.07.006
   Gerberg EJ, 1979, BULLETIN, V5, P7
   Golden G, 2018, PEST MANAG SCI, V74, P820, DOI 10.1002/ps.4787
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hu Y, 2008, J INTEGR PLANT BIOL, V50, P1118, DOI 10.1111/j.1744-7909.2008.00635.x
   Hu Y, 2007, J PHARM PHARMACOL, V59, P1307, DOI 10.1211/jpp.59.9.0016
   Hu Y, 2007, BIOMED CHROMATOGR, V21, P967, DOI 10.1002/bmc.841
   Jayaraman M, 2015, PARASITOL RES, V114, P1511, DOI 10.1007/s00436-015-4335-0
   Kim YA, 2013, NAT PROD COMMUN, V8, P1405
   Kumar P, 2013, PARASITOL RES, V112, P69, DOI 10.1007/s00436-012-3105-5
   Kumaran A, 2006, FOOD CHEM, V97, P109, DOI 10.1016/j.foodchem.2005.03.032
   Lee C, 2013, BIOORG MED CHEM LETT, V23, P6010, DOI 10.1016/j.bmcl.2013.08.004
   Lee SM, 2012, INFLAMMATION, V35, P584, DOI 10.1007/s10753-011-9349-x
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu K, 2007, PHYTOCHEMISTRY, V68, P1698, DOI 10.1016/j.phytochem.2007.04.027
   Luo YP, 2014, J VECTOR ECOL, V39, P271, DOI 10.1111/jvec.12101
   Murthy PS, 2009, FOOD CHEM, V114, P1014, DOI 10.1016/j.foodchem.2008.10.064
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Patel Kanika, 2017, J Tradit Complement Med, V7, P360, DOI 10.1016/j.jtcme.2016.11.003
   Pavela R, 2018, IND CROP PROD, V112, P762, DOI 10.1016/j.indcrop.2018.01.012
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pinheiro PF, 2015, J AGR FOOD CHEM, V63, P8981, DOI 10.1021/acs.jafc.5b03049
   Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554
   Riccobono L, 2017, NAT PROD RES, V31, P2759, DOI 10.1080/14786419.2017.1297444
   SASAKI SI, 1965, CHEM PHARM BULL, V13, P87
   Senthilkumar A, 2010, PARASITOL RES, V107, P1275, DOI 10.1007/s00436-010-1996-6
   Senthilkumar N, 2009, PARASITOL RES, V104, P237, DOI 10.1007/s00436-008-1180-4
   Sohn SH, 2009, ANN ALLERG ASTHMA IM, V103, P152, DOI 10.1016/S1081-1206(10)60169-X
   Tabari MA, 2017, RES VET SCI, V114, P36, DOI 10.1016/j.rvsc.2017.03.001
   Tawaha K, 2010, PHARM BIOL, V48, P1108, DOI 10.3109/13880200903505641
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Uehara A, 2014, NAT PROD COMMUN, V9, P163
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   Wang Y, 2011, BIOPHARM DRUG DISPOS, V32, P16, DOI 10.1002/bdd.735
   WATANABE K, 1995, BIOSCI BIOTECH BIOCH, V59, P1979, DOI 10.1271/bbb.59.1979
   Wu Qi, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2206
   Wu Q, 2009, J ASIAN NAT PROD RES, V11, P85, DOI 10.1080/10286020802435703
   Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537
   Ye Q, 2010, ACTA PHARMACOL SIN, V31, P1564, DOI 10.1038/aps.2010.178
   You KM, 1998, PLANTA MED, V64, P546, DOI 10.1055/s-2006-957511
   Zhang B, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/278405
   Zhang ZL, 2017, ENVIRON SCI POLLUT R, V24, P24708, DOI 10.1007/s11356-017-0219-4
   Zhao YY, 2017, NAT PROD RES, V31, P2491, DOI 10.1080/14786419.2017.1314284
   Zou Lei, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1401
NR 55
TC 0
Z9 0
U1 5
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0032-0935
EI 1432-2048
J9 PLANTA
JI Planta
PD JUL
PY 2019
VL 250
IS 1
BP 59
EP 68
DI 10.1007/s00425-019-03147-w
PG 10
WC Plant Sciences
SC Plant Sciences
GA IC6CX
UT WOS:000471058300004
PM 30904944
DA 2020-07-08
ER

PT J
AU Lin, SC
   Chen, MC
   Liu, SF
   Callahan, VM
   Bracci, NR
   Lehman, CW
   Dahal, B
   de la Fuente, CL
   Lin, CC
   Wang, TT
   Kehn-Hall, K
AF Lin, Shih-Chao
   Chen, Mei-Chun
   Liu, Shufeng
   Callahan, Victoria M.
   Bracci, Nicole R.
   Lehman, Caitlin W.
   Dahal, Bibha
   de la Fuente, Cynthia L.
   Lin, Chi-Chen
   Wang, Tony T.
   Kehn-Hall, Kylene
TI Phloretin inhibits Zika virus infection by interfering with cellular
   glucose utilisation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Zika virus; Apoptosis; Phloretin; Antiviral effect; Flavonoid
ID PHLORHIZIN; KINASE
AB Zika virus (ZIKV) is a re-emerging Flavivirus that has been linked to microcephaly and other neurological pathologies. In this study, phloretin, a glucose transporter inhibitor naturally derived from plants, was used to investigate the glucose dependence of ZIKV replication in host cells. The results showed that phloretin significantly decreased infectious titres of two ZIKV strains, namely MR766 (African genotype) and PRVABC59 (Puerto Rico genotype). The 50% effective concentration (EC50) of phloretin against MR766 and PRVABC59 was 22.85 mu M and 9.31 mu M, respectively. Further analyses demonstrated that decreased viral production was due to host-targeted inhibition, including decreased apoptotic caspase-3 and -7 activities and reduced phosphorylation of Akt/mTOR pathways. In addition, upon disruption of cellular glucose availability within host cells using 2-deoxy-D-glucose, ZIKV propagation was inhibited. Collectively, we demonstrate phloretin inhibition of ZIKV propagation and provide evidence of glucose utilization pathways as being important for ZIKV propagation. The activity of phloretin and its role in inhibiting glucose uptake could provide a useful foundation for the development of ZIKV antivirals. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [Lin, Shih-Chao; Callahan, Victoria M.; Bracci, Nicole R.; Lehman, Caitlin W.; Dahal, Bibha; de la Fuente, Cynthia L.; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, 10650 Pyramid Pl, Manassas, VA 20110 USA.
   [Chen, Mei-Chun; Liu, Shufeng] SRI Int, Ctr Infect Dis, 140 Res Dr, Harrisonburg, VA 22802 USA.
   [Lin, Chi-Chen] Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan.
   [Wang, Tony T.] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Lab Vector Borne Viral Dis, Silver Spring, MD 20903 USA.
RP Kehn-Hall, K (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, 10650 Pyramid Pl, Manassas, VA 20110 USA.; Wang, TT (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Lab Vector Borne Viral Dis, Silver Spring, MD 20903 USA.
EM Tony.Wang@fda.hhs.gov; kkehnhal@gmu.edu
RI Kehn-Hall, Kylene/I-5752-2013; Lin, Shih-Chao/AAG-9173-2020
OI Lin, Shih-Chao/0000-0003-2942-5937; Bracci, Nicole/0000-0002-7298-4796
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [NIHR01DK088787]
FX This work was funded by a National Institutes of Health (NIH) grant
   [NIHR01DK088787 to TTW].
CR Bell TM, 2017, ANTIVIR RES, V143, P162, DOI 10.1016/j.antiviral.2017.04.011
   BETZ AL, 1975, BIOCHIM BIOPHYS ACTA, V406, P505
   Blonz ER, 2016, LANCET INFECT DIS, V16, P642, DOI 10.1016/S1473-3099(16)30062-7
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Gromova LV, 2006, J EVOL BIOCHEM PHYS+, V42, P454, DOI 10.1134/S0022093006040119
   Hung YP, 2017, ELIFE, V6, DOI 10.7554/eLife.27293
   Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee IK, 2007, PANCREAS, V35, P381, DOI 10.1097/01.mpa.0000297828.05678.7a
   Martin HJ, 2003, CHEM-BIOL INTERACT, V146, P225, DOI 10.1016/j.cbi.2003.06.001
   Mazzon M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006835
   Rieg T, 2018, DIABETOLOGIA, V61, P2079, DOI 10.1007/s00125-018-4654-7
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
NR 16
TC 3
Z9 3
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2019
VL 54
IS 1
BP 80
EP 84
DI 10.1016/j.ijantimicag.2019.03.017
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA IC4WZ
UT WOS:000470969800012
PM 30930299
DA 2020-07-08
ER

PT J
AU Bentes, AA
   Kroon, EG
   Romanelli, RMD
AF Bentes, Aline Almeida
   Kroon, Erna Geessien
   de Castro Romanelli, Roberta Maia
TI Neurological manifestations of pediatric arboviral infections in the
   Americas
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Review
DE Neurological manifestations; Dengue virus; Zika virus; Chikungunya
   virus; Yellow fever virus
ID DENGUE VIRUS; CLINICAL-FEATURES; ENCEPHALITIS SYNDROME; CHIKUNGUNYA
   VIRUS; CHILDREN; FEVER; ENCEPHALOPATHY; COMPLICATIONS; MENINGITIS;
   EPIDEMIC
AB Dengue, Zika, Chikungunya and yellow fever viruses are arboviruses transmitted by the mosquito Aedes aegypti. These viruses exhibit marked neurotropism but have rarely been studied. Here, we conduct an integrative review of the neurological manifestations caused by these arboviruses in the pediatric population. Data on patients under 18 years of age were extracted from literature databases. The most frequently reported neurological manifestations were encephalitis, meningitis, seizures, hypotonia, paresis, and behavioral changes. This review highlights the importance of accurately diagnosing these arboviral infections in children and adolescents with neurological manifestations.
C1 [Bentes, Aline Almeida; de Castro Romanelli, Roberta Maia] Univ Fed Minas Gerais, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Bentes, Aline Almeida] FHEMIG, Hosp Infantil Joao Paulo II, Belo Horizonte, MG, Brazil.
   [Bentes, Aline Almeida; de Castro Romanelli, Roberta Maia] Univ Fed Minas Gerais, Dept Pediat, Fac Med, Ave Prof Alfredo Balena,190 Santa Efigenia, BR-30130100 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM alinebentes2000@gmail.com; kroone@icb.ufmg.br; rmcromanelli@gmail.com
RI Kroon, Erna/V-5444-2019; Romanelli, Roberta M/H-4124-2018; Kroon,
   Erna/B-3631-2015
OI Romanelli, Roberta M/0000-0002-1660-0751; Kroon,
   Erna/0000-0003-2721-3826
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Ai JH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2572-9
   Alhakimi HA, 2015, AIMS PUBLIC HEALTH, V2, P132, DOI 10.3934/publichealth.2015.1.132
   Ali S, 2017, PROC EUR CONF ENTREP, P12
   Araujo F., 2012, EMERGING INFECT DIS, V18
   Baldacara L., 2013, J NEUROPSYCHIATRY CL, V25, P1
   Bermudez JE, 2011, KASMERA, V39, P49
   Bhatt GC, 2012, TROP DOCT, V42, P106, DOI 10.1258/td.2011.110391
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Biswas NM, 2014, INDIAN J MED RES, V140, P793
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Britt C, 2018, CRIT POLIT THEOR, P1, DOI 10.1007/978-3-319-70784-6
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Feitoza HAC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00178915, 10.1590/0102-311x00178915]
   Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026
   Chokephaibulkit K, 2001, PEDIATR INFECT DIS J, V20, P216, DOI 10.1097/00006454-200102000-00020
   Chowdhury R. N., 2011, Journal of Medicine, V12, P185
   de Oliveira DB, 2017, J NEUROL SCI, V375, P390, DOI 10.1016/j.jns.2017.02.025
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   de Souza Luiz Jose, 2016, DENG ZIK CHIK DIAGN
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Ernould S, 2008, ARCH PEDIATRIE, V15, P253, DOI 10.1016/j.arcped.2007.10.019
   Fong C. Y., 2016, J CLIN NEUROSCI, P1
   Fong CY, 2014, PEDIATR INFECT DIS J, V33, P1092, DOI 10.1097/INF.0000000000000382
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Garg RK, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0855-9
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, P7
   Gerardin P., 2016, NEUROLOGY, V86
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Goswami RP, 2012, J INFECT DEV COUNTR, V6, P208, DOI 10.3855/jidc.2241
   Gupta D., 2015, INDIAN J PEDIAT
   Horwood PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.15
   Jain P, 2014, JPN J INFECT DIS, V67, P197, DOI 10.7883/yoken.67.197
   JONES EMM, 1972, B WORLD HEALTH ORGAN, V46, P653
   Kalita J, 2005, Electromyogr Clin Neurophysiol, V45, P357
   Kalita J, 2006, CLIN NEUROPHYSIOL, V117, P2252, DOI 10.1016/j.clinph.2006.07.132
   Kamath Shrishu R., 2006, Indian Journal of Pediatrics, V73, P889, DOI 10.1007/BF02859281
   Kankirawatana P., 2000, JOUNAL CHILD NEUROLO, V15
   Kumar R, 2008, J NEUROL SCI, V269, P41, DOI 10.1016/j.jns.2007.12.018
   Landais A., 2017, J NEUROL SCI
   Le Bomin A, 2008, Med Trop (Mars), V68, P491
   Lee YS, 2010, PEDIATR INFECT DIS J, V29, P275, DOI 10.1097/INF.0b013e3181bce34d
   Lewthwait P., 2009, EMERGING INFECT DIS, V15
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Nunez RM, 2017, REV CHIL PEDIATR-CHI, V88, P765, DOI 10.4067/S0370-41062017000600765
   Maurya Pradeep K, 2016, J Clin Neuromuscul Dis, V18, P72
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Muzaffar J., 2006, SMJ Singapore Medical Journal, V47, P975
   NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398
   Diniz LMO, 2019, PEDIATR INFECT DIS J, V38, P300, DOI [10.1097/INF.0000000000002051, 10.1097/inf.0000000000002051]
   Palma-da Cunha-Matta A, 2004, REV NEUROLOGIA, V39, P233
   Pan American Health Organization, 2018, NUMB REP CAS CHIK FE
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Patterson J., 2016, W J EMERG MED, VXVII
   Paules C. I., 2017, N ENGL J MED
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]
   Salazar M. I., 2013, TRANSFUS APHER SCI
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Sanguansermsri T, 1976, ACUTE ENCEPHALOPATHY, P10
   Shaikh T, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.28_suppl.57
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sharma S., 2015, INFECT DIS OBSTET GY, V16
   Shishu R., 2006, INDIAN J PEDIAT, V73
   Sil A., 2016, TROP DOCT, P1
   Marinho PES, 2017, EMERG INFECT DIS, V23, P115, DOI 10.3201/eid2301.160817
   Singh A., 2017, INDIAN PEDIAT, V54
   Sinhabahu Vindika Prasad, 2014, BMC Res Notes, V7, P795, DOI 10.1186/1756-0500-7-795
   Sistayanarain Anchalee, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P221
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200
   Staples J. E., 2015, MMWR-MORBID MORTAL W, V64, P19
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Villar L., 2015, NEW ENGL J MED, V372, P2
   Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066
   Witayathawornwong P., 2005, SE ASIAN J TROP MED, V36
   Zucker J., 2017, EMERGING INFECT DIS, V23
NR 91
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2019
VL 116
BP 49
EP 57
DI 10.1016/j.jcv.2019.04.006
PG 9
WC Virology
SC Virology
GA IB4LQ
UT WOS:000470243900011
PM 31103802
DA 2020-07-08
ER

PT J
AU Jiao, XY
   Zhou, HQ
   Zhang, H
   Wu, D
   Ke, CW
AF Jiao, Xiaoyang
   Zhou, Huiqiong
   Zhang, Huan
   Wu, De
   Ke, Changwen
TI Community based serosurvey of naive population indicate no local
   circulation of Zika virus in an hyper endemic area of China 2016
SO JOURNAL OF INFECTION
LA English
DT Letter
ID DENGUE VIRUS; GUANGDONG; OUTBREAK
C1 [Jiao, Xiaoyang] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China.
   [Zhou, Huiqiong; Zhang, Huan; Wu, De; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510300, Guangdong, Peoples R China.
   [Zhou, Huiqiong; Zhang, Huan; Wu, De; Ke, Changwen] WHO Collaborating Ctr Surveillance Res & Training, Guangzhou, Guangdong, Peoples R China.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510300, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
RI Zhou, Huiqiong/S-1276-2016
OI Zhou, Huiqiong/0000-0003-2124-6563
FU Guangdong Provincial Science and Technology Program [2015A020213004];
   National Key Development Program [2016YFC1200201]; Popula-tion Based
   Surveillance of Zika, Dengue fever and Chikungunya in Guangdong Province
   Where is the Hometown of Oversea Chinese (China-US CDC union) [NU2GGH0 0
   0961-05-0]
FX We thank the laboratory and administrative personnel at Guangdong
   Provincial Center for Disease Control and Prevention and the Jiangmen
   City Center for Disease Control and Preven-tion for their contribution
   to the follow-up investigation. This project was supported by grants
   from the Guangdong Provincial Science and Technology Program
   (2015A020213004), the National Key Development Program (2016YFC1200201)
   and Popula-tion Based Surveillance of Zika, Dengue fever and Chikungunya
   in Guangdong Province Where is the Hometown of Oversea Chinese (China-US
   CDC union project: NU2GGH0 0 0961-05-0
CR Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Fang LQ, 2018, LANCET PUBLIC HEALTH, V3, pE385, DOI 10.1016/S2468-2667(18)30127-0
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Sun J., 2018, J INFECTION, V75, P356
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Sun JF, 2016, J INFECTION, V72, P80, DOI 10.1016/j.jinf.2015.10.007
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
NR 10
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUL
PY 2019
VL 79
IS 1
BP 64
EP 67
DI 10.1016/j.jinf.2019.03.013
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA IA8WC
UT WOS:000469838300012
PM 30946866
DA 2020-07-08
ER

PT J
AU Huang, FAS
   Danziger-Isakov, L
AF Huang, Felicia A. Scaggs
   Danziger-Isakov, Lara
TI Infectious disease risks in pediatric renal transplantation
SO PEDIATRIC NEPHROLOGY
LA English
DT Review
DE Pediatric infections; Renal transplant; Post-transplant infections;
   Infection in immunocompromised child
ID URINARY-TRACT-INFECTIONS; SOLID-ORGAN TRANSPLANTATION; POSTTRANSPLANT
   LYMPHOPROLIFERATIVE DISORDER; RESISTANT ENTEROCOCCI COLONIZATION;
   CLOSTRIDIUM-DIFFICILE INFECTION; CYTOMEGALOVIRUS-INFECTION;
   KLEBSIELLA-PNEUMONIAE; ZIKA VIRUS; KIDNEY-TRANSPLANTATION; PNEUMOCOCCAL
   VACCINE
AB Renal transplantation is a vital treatment option in children with ESRD with more than 10,000 pediatric kidney transplants and survival rates of greater than 80% at 10 years post-transplant in the USA alone. Despite these advances, infection remains a significant cause of morbidity in pediatric recipients. Screening potential organ donors and recipients is imperative to identify and mitigate infectious risks in the transplant patient. Despite the unique risks of each patient, the timing of many infections post-transplant is predictable. In early post-transplant infections (within 30 days), bacterial and fungal pathogens predominate with donor-derived events and nosocomial infections. In the intermediate period (31-180 days after transplant), latent infections from donor organs, such as EBV and CMV, develop. Late infections occurring > 180 days after the transplant can be due to latent pathogens or community-acquired organisms. Approaching an infectious evaluation in a pediatric kidney recipient requires finesse to diagnose and treat this vulnerable population in a timely manner. The following article highlights the most relevant and common infections including clinical manifestations, risk factors, diagnostic techniques, and treatment options.
C1 [Huang, Felicia A. Scaggs] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Dept Pediat, 333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA.
   [Danziger-Isakov, Lara] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Dept Pediat, Cincinnati, OH 45229 USA.
RP Huang, FAS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Dept Pediat, 333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA.
EM Felicia.ScaggsHuang@cchmc.org
CR Adams J, 2004, TRANSPLANT INT, V17, P596, DOI 10.1007/s00147-004-0784-6
   Al-Hasan MN, 2009, AM J TRANSPLANT, V9, P835, DOI 10.1111/j.1600-6143.2009.02559.x
   Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x
   AlDabbagh MA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14020
   Allen UD, 2005, ADV EXP MED BIOL, V568, P25
   Anthony KB, 2008, CLIN INFECT DIS, V46, P567, DOI 10.1086/526775
   Antonsson A, 2010, J GEN VIROL, V91, P1849, DOI 10.1099/vir.0.020115-0
   Arasaratnam RJ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.12
   Araya CE, 2010, PEDIATR TRANSPLANT, V14, P145, DOI 10.1111/j.1399-3046.2009.01183.x
   Asberg A, 2007, AM J TRANSPLANT, V7, P2106, DOI 10.1111/j.1600-6143.2007.01910.x
   Azami M, 2010, BRAZ J INFECT DIS, V14, P15, DOI 10.1590/S1413-86702010000100004
   Bandin F, 2009, PEDIATR NEPHROL, V24, P2245, DOI 10.1007/s00467-009-1274-y
   Beam E, 2012, CURR INFECT DIS REP, V14, P633, DOI 10.1007/s11908-012-0292-2
   Bergen PJ, 2011, ANTIMICROB AGENTS CH, V55, P5685, DOI 10.1128/AAC.05298-11
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Boutros M, 2012, TRANSPLANTATION, V93, P1051, DOI 10.1097/TP.0b013e31824d34de
   Bunnapradist S, 2008, AM J KIDNEY DIS, V51, P478, DOI 10.1053/j.ajkd.2007.11.013
   Burroughs M, 2000, CLIN INFECT DIS, V30, P857, DOI 10.1086/313823
   Cameron BM, 2017, PEDIATR TRANSPLANT, V21, DOI 10.1111/petr.12816
   Ciricillo J, 2016, TRANSPL INFECT DIS, V18, P706, DOI 10.1111/tid.12584
   da Cunha S, 1993, Acta Med Port, V6, P157
   Dharnidharka VR, 2011, AM J TRANSPLANT, V11, P751, DOI 10.1111/j.1600-6143.2011.03470.x
   Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5
   Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x
   Erdbrugger U, 2015, AM J PHYSIOL-RENAL, V309, pF925, DOI 10.1152/ajprenal.00317.2015
   Fernandes A, 2014, OJNEPH, P117, DOI [10.4236/oj-neph.2014.43017, DOI 10.4236/OJNEPH.2014.43017, 10.4236/ojneph.2014.43017]
   Fischer SA, 2009, AM J TRANSPLANT, V9, pS7, DOI 10.1111/j.1600-6143.2009.02888.x
   Fisher JF, 2011, CLIN INFECT DIS, V52, pS457, DOI 10.1093/cid/cir112
   Flokas ME, 2017, INT J ANTIMICROB AG, V49, P565, DOI 10.1016/j.ijantimicag.2017.01.008
   Freitas MCS, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-133
   GABRIEL R, 1976, NEPHRON, V16, P282, DOI 10.1159/000180612
   Ginevri F, 2003, TRANSPLANTATION, V75, P1266, DOI 10.1097/01.TP.0000061767.32870.72
   Green H, 2011, TRANSPL INFECT DIS, V13, P441, DOI 10.1111/j.1399-3062.2011.00644.x
   Green M, 2006, AM J TRANSPLANT, V6, P1906, DOI 10.1111/j.1600-6143.2006.01394.x
   Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008
   Hebert D, 1998, PEDIATR TRANSPLANT, V11, P59
   Hirsch HH, 2002, NEW ENGL J MED, V347, P488, DOI 10.1056/NEJMoa020439
   Hocker B, 2016, AM J TRANSPLANT, V16, P921, DOI 10.1111/ajt.13649
   Hocker B, 2016, TRANSPLANTATION, V100, P862, DOI 10.1097/TP.0000000000000888
   Humar A, 1999, TRANSPLANTATION, V68, P1305, DOI 10.1097/00007890-199911150-00015
   Ison MG, 2009, AM J TRANSPLANT, V9, P1929, DOI 10.1111/j.1600-6143.2009.02700.x
   Kable K, 2017, TRANSPLANT DIRECT, V3, DOI 10.1097/TXD.0000000000000641
   Kahwaji J, 2011, TRANSPLANTATION, V91, P225, DOI 10.1097/TP.0b013e3181ff8754
   Kasiske BL, 2001, AM J TRANSPLANT, V1, P7
   Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133
   Khoury JA, 2006, AM J TRANSPLANT, V6, P2134, DOI 10.1111/j.1600-6143.2006.01413.x
   Kimberlin DW, 2015, 2015 REPORT COMMITTE, V2015
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   KRISTJANSSON M, 1991, REV INFECT DIS, V13, P906
   Kumar D, 2011, AST HDB TRANSPLANT I
   Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028177
   Linares L, 2007, TRANSPL P, V39, P2222, DOI 10.1016/j.transproceed.2007.06.061
   LINNEMANN CC, 1981, ARCH INTERN MED, V141, P1637, DOI 10.1001/archinte.141.12.1637
   Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329
   Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10
   Maertens J, 2016, OPEN FORUM INFECT DI, DOI [10.1093/ofid/ofw172.1834, DOI 10.1093/0FID/0FW172.183]
   Maes B, 2006, AM J TRANSPLANT, V6, P1466, DOI 10.1111/j.1600-6143.2006.01320.x
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Marty FM, 2017, NEW ENGL J MED, V377, P2433, DOI 10.1056/NEJMoa1706640
   Mitra Subhashis, 2011, Curr Infect Dis Rep, V13, P579, DOI 10.1007/s11908-011-0210-z
   Moore C, 2014, TRANSPL INT, V27, P926, DOI 10.1111/tri.12357
   Mueller T, 2003, WIEN KLIN WOCHENSCHR, V115, P385, DOI 10.1007/BF03040357
   Nailescu C, 2011, PEDIATR NEPHROL, V26, P459, DOI 10.1007/s00467-010-1729-1
   Neu A. M, 2008, COMPREHENSIVE PEDIAT, P967
   NIKOSKELAINEN J, 1985, KIDNEY INT, V28, P672, DOI 10.1038/ki.1985.182
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nourse JP, 2011, AM J TRANSPLANT, V11, P888, DOI 10.1111/j.1600-6143.2011.03499.x
   Opelz G, 2007, LANCET ONCOL, V8, P212, DOI 10.1016/S1470-2045(07)70040-2
   Parasuraman R, 2013, AM J TRANSPLANT, V13, P327, DOI 10.1111/ajt.12124
   Parker A, 2010, BRIT J HAEMATOL, V149, P675, DOI 10.1111/j.1365-2141.2010.08161.x
   Pouch SM, 2015, TRANSPL INFECT DIS, V17, P800, DOI 10.1111/tid.12450
   Puliyanda DP, 2008, PEDIATR TRANSPLANT, V12, P180, DOI 10.1111/j.1399-3046.2007.00784.x
   Rafat C, 2011, TRANSPL INFECT DIS, V13, P344, DOI 10.1111/j.1399-3062.2011.00602.x
   Riddle DJ, 2008, CURR OPIN ORGAN TRAN, V13, P592, DOI 10.1097/MOT.0b013e3283186b51
   Roos-Weil D, 2011, TRANSPLANTATION, V92, P61, DOI 10.1097/TP.0b013e31821c9392
   Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365-2362.2008.02014.x
   Safdar N, 2005, CLIN INFECT DIS, V40, P1413, DOI 10.1086/429620
   Sagedal S, 2000, TRANSPLANTATION, V70, P1166, DOI 10.1097/00007890-200010270-00007
   Satlin MJ, 2011, ANTIMICROB AGENTS CH, V55, P5893, DOI 10.1128/AAC.00387-11
   Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x
   Schober T, 2013, TRANSPLANTATION, V95, P240, DOI 10.1097/TP.0b013e318277e344
   Sharifian M, 1998, NEPHROL DIAL TRANSPL, V13, P432, DOI 10.1093/oxfordjournals.ndt.a027842
   Simkins J, 2018, AM J TRANSPLANT, V18, P731, DOI 10.1111/ajt.14582
   Smith JM, 2007, CLIN J AM SOC NEPHRO, V2, P1037, DOI 10.2215/CJN.04051206
   Smith JM, 2013, PEDIATR TRANSPLANT, V17, P149, DOI 10.1111/petr.12034
   Suwantarat N, 2016, INFECT CONT HOSP EP, V37, P535, DOI 10.1017/ice.2016.16
   THALL TV, 1994, TRANSPLANT P, V26, P191
   Tokars JI, 2001, KIDNEY INT, V60, P1511, DOI 10.1046/j.1523-1755.2001.00955.x
   Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588
   Valera B, 2006, TRANSPLANT P, V38, P2414, DOI 10.1016/j.transproceed.2006.08.018
   von Baum H, 1999, CLIN INFECT DIS, V29, P912, DOI 10.1086/520455
   Yazdani MR, 2016, INT J TRANSPLANT MED, V7, P206
   ZAMORA I, 1994, PEDIATR NEPHROL, V8, P190, DOI 10.1007/BF00865476
NR 93
TC 3
Z9 3
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD JUL
PY 2019
VL 34
IS 7
BP 1155
EP 1166
DI 10.1007/s00467-018-3951-1
PG 12
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA HZ4VW
UT WOS:000468850500002
PM 29626241
DA 2020-07-08
ER

PT J
AU Hutchinson, EB
   Chatterjee, M
   Reyes, L
   Djankpa, FT
   Valiant, WG
   Dardzinski, B
   Mattapallil, JJ
   Pierpaoli, C
   Juliano, SL
AF Hutchinson, Elizabeth B.
   Chatterjee, Mitali
   Reyes, Laura
   Djankpa, Francis T.
   Valiant, William G.
   Dardzinski, Bernard
   Mattapallil, Joseph J.
   Pierpaoli, Carlo
   Juliano, Sharon L.
TI The effect of Zika virus infection in the ferret
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article
DE CT; diffusion tensor MRI; microcephaly; neural development; neural
   progenitor; vasculature
ID DIFFEOMORPHIC REGISTRATION; PATHOGENESIS; BRAIN; MODELS
AB Although initial observations of infections with the Zika virus describe a mild illness, more recent reports show that infections by Zika result in neurotropism. In 2015, substantial congenital malformations were observed, with numerous infants born with microcephaly in Brazil. To study the underlying mechanism and effects of the disease, it is critical to find suitable animal models. Rodents lack an immune system parallel to humans and also have lissencephalic brains, which are likely to react differently to infections. As the smallest gyrencephalic mammal, ferrets may provide an important animal model to study the Zika virus, as their brains share many characteristics with humans. To evaluate the prospect of using ferrets to study Zika virus infection, we injected seven pregnant jills with the PR strain subcutaneously on gestational day 21, corresponding to the initiation of corticogenesis. These injections resulted in mixed effects. Two animals died of apparent infection, and all kits were resorbed in another animal that did not die. The other four animals remained pregnant until gestational day 40, when the kits were delivered by caesarian section. We evaluated the animals using CT, MRI, diffusion tensor imaging, and immunohistochemistry. The kits displayed a number of features compatible with an infection that impacted both the brain and skull. The outcomes, however, were variable and differed within and across litters, which ranged from the absence of observable abnormalities to prominent changes, suggesting differential vulnerability of kits to infection by the Zika virus or to subsequent mechanisms of neurodevelopmental disruption.
C1 [Djankpa, Francis T.; Juliano, Sharon L.] USUHS, Program Neurosci, Bethesda, MD 20814 USA.
   [Chatterjee, Mitali; Juliano, Sharon L.] Dept Anat Physiol & Genet, Bethesda, MD USA.
   [Mattapallil, Joseph J.] Dept Microbiol & Immunol, Bethesda, MD USA.
   [Valiant, William G.; Mattapallil, Joseph J.] Program Emerging & Infect Dis, Bethesda, MD USA.
   [Dardzinski, Bernard] Dept Radiol, Bethesda, MD USA.
   [Hutchinson, Elizabeth B.; Reyes, Laura; Pierpaoli, Carlo] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, Bethesda, MD USA.
RP Juliano, SL (corresponding author), USUHS, Program Neurosci, Bethesda, MD 20814 USA.
EM sharon.juliano@usuhs.edu
RI Juliano, Sharon/AAO-1030-2020
OI Dardzinski, Bernard/0000-0001-7098-9131; Reyes,
   Laura/0000-0002-0404-1817; Hutchinson, Elizabeth/0000-0002-3374-5469;
   Juliano, Sharon/0000-0002-9346-7974
FU USUHS project [MIC-73-4107]
FX The authors wish to thank the USUHS Laboratory of Animal Medicine for
   substantial assistance with animal husbandry. All ex vivo MRI was
   performed with imaging resources in the Section for Quantitative Imaging
   and Tissue Sciences in the National Institute of Child Health and
   Development. We also thank Michael Ray for assistance with data
   analysis. This work was funded by USUHS project MIC-73-4107.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Albrecht RA, 2018, MBIO, V9, DOI 10.1128/mBio.01113-18
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961
   Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004
   Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014
   Belser JA, 2016, MICROBIOL MOL BIOL R, V80, P733, DOI 10.1128/MMBR.00022-16
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davatzikos C, 1996, J COMPUT ASSIST TOMO, V20, P88, DOI 10.1097/00004728-199601000-00017
   Empie K, 2015, INT J DEV NEUROSCI, V45, P2, DOI 10.1016/j.ijdevneu.2015.06.005
   Enkirch T, 2015, VIROLOGY, V479, P259, DOI 10.1016/j.virol.2015.03.017
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Green R, 2016, GENOM DATA, V10, P114, DOI 10.1016/j.gdata.2016.10.006
   Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009
   Irfanoglu M. O., 2017, 25 ANN M INT SOC FRO
   Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066
   Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042
   Juliano SL, 1996, J COMP NEUROL, V374, P259, DOI 10.1002/(SICI)1096-9861(19961014)374:2<259::AID-CNE8>3.0.CO;2-1
   Kiseleva I, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9695628
   Knutsen AK, 2013, CEREB CORTEX, V23, P488, DOI 10.1093/cercor/bhs042
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Kroenke CD, 2009, CEREB CORTEX, V19, P2916, DOI 10.1093/cercor/bhp061
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2017, CELL STEM CELL, V20, P749, DOI 10.1016/j.stem.2017.05.010
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Noctor SC, 1997, J COMP NEUROL, V387, P179
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J
   Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209
   Pierpaoli C, 2010, ISMRM P, V18, P1597, DOI DOI 10.1016/J.NEUROIMAGE.2011.01.038
   Poluch S, 2015, CEREB CORTEX, V25, P346, DOI 10.1093/cercor/bht232
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sadeghi N, 2018, HUM BRAIN MAPP, V39, P4643, DOI 10.1002/hbm.24278
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Smith Orla M, 2017, Science, V356, P497, DOI 10.1126/science.356.6337.497-g
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1
   Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042
NR 45
TC 2
Z9 2
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD JUL 1
PY 2019
VL 527
IS 10
SI SI
BP 1706
EP 1719
DI 10.1002/cne.24640
PG 14
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA HY3FF
UT WOS:000468008000012
PM 30680733
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gaviraghi, A
   Oliveira, MF
AF Gaviraghi, Alessandro
   Oliveira, Marcus F.
TI A method for assessing mitochondrial physiology using mechanically
   permeabilized flight muscle of Aedes aegypti mosquitoes
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE Metabolism; Mitochondria; Zika; Dengue; Bioenergetics; Respiration;
   Muscle; Permeabilization
ID SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; ACID CYCLE; FIBERS; PROLINE;
   BIOENERGETICS; SENSITIVITY; MECHANISMS; CELLS; HEART
AB Aedes aegypti is the most important and widespread vector of arboviruses, including dengue and zika. Insect dispersal through the flight activity is a key parameter that determines vector competence, and is energetically driven by oxidative phosphorylation in flight muscle mitochondria. Analysis of mitochondrial function is central for a better understanding of cellular metabolism, and is mostly studied using isolated organelles. However, this approach has several challenges and methods for assessment of mitochondrial function in chemically-permeabilized tissues were designed. Here, we described a reliable protocol to assess mitochondrial physiology using mechanically permeabilized flight muscle of single A. aegypti mosquitoes in combination with high-resolution respirometry. By avoiding the use of detergents, high respiratory rates were obtained indicating that substrate access to mitochondria was not limited. This was confirmed by using selective inhibitors for specific mitochondrial substrates. Additionally, mitochondria revealed highly coupled, as ATP synthase or adenine nucleotide translocator inhibition strongly impacted respiration. Finally, we determined that pyruvate and proline induced the highest respiratory rates compared to other substrates tested. This method allows the assessment of mitochondrial physiology in mosquito flight muscle at individual level, and can be used for the identification of novel targets aiming rational insect vector control.
C1 [Gaviraghi, Alessandro; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Ao Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Gaviraghi, Alessandro; Oliveira, Marcus F.] INCT, Rio De Janeiro, RJ, Brazil.
RP Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Lab Bioquim Resposta Ao Estresse, Inst Bioquim Med Leopoldo de Meis, Ctr Ciencias Saude, Sala D-4 Sub Solo, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM maroli@bioqmed.ufrj.br
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [404153/2016-0 MFO, 483334/2013-8 AG]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/102.333/2013, E-26/203.043/2016, E-26/111.169/2011]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [402409/2012-4]; PAPD-FAPERJ [E-44/208702/2014]
FX We would like to thank Mrs. Jaciara Miranda Freire for the excellent
   technical assistance on maintenance of A. aegypti colony. This work was
   supported by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico [grant number: 404153/2016-0 MFO, and 483334/2013-8 AG], and
   the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio
   de Janeiro [grant numbers E-26/102.333/2013, E-26/203.043/2016, and
   E-26/111.169/2011]. AG is a fellow from CNPq [fellowship number
   402409/2012-4] and from PAPD-FAPERJ [fellowship number
   E-44/208702/2014]. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALTSCHULD RA, 1985, J BIOL CHEM, V260, P4325
   BALBONI E, 1977, BIOCHIM BIOPHYS ACTA, V462, P171, DOI 10.1016/0005-2728(77)90199-2
   BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X
   Benador IY, 2018, CELL METAB, V27, P869, DOI 10.1016/j.cmet.2018.03.003
   Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672
   Conley KE, 2002, J EXP BIOL, V205, P2175
   Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600
   DJAFARZADEH S, 2017, JOVE J VIS EXP FEB, DOI DOI 10.3791/54985
   ELTHON TE, 1984, PLANT PHYSIOL, V74, P213, DOI 10.1104/pp.74.2.213
   FAST PG, 1966, LIPIDS, V1, P209, DOI 10.1007/BF02531874
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854
   HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085
   Hansford R G, 1974, Biochem J, V142, P509
   Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530
   Iwamoto Hiroyuki, 2011, Biophysics (Nagoya-shi), V7, P21, DOI 10.2142/biophysics.7.21
   JOHNSON RN, 1975, BIOCHEM J, V146, P527, DOI 10.1042/bj1460527
   KORN ED, 1969, ANNU REV BIOCHEM, V38, P263, DOI 10.1146/annurev.bi.38.070169.001403
   KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4
   Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141
   Lima-Camara TN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-304
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lombardi A, 2000, FEBS LETT, V475, P84, DOI 10.1016/S0014-5793(00)01633-1
   LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8
   Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534
   Masson SWC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13454-5
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Mollica MP, 2006, CELL MOL LIFE SCI, V63, P358, DOI 10.1007/s00018-005-5443-2
   Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014
   Nicholls DG, 2013, BIOENERGETICS 4, P1
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petric D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-187
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317
   Pichaud N, 2013, MITOCHONDRION, V13, P817, DOI 10.1016/j.mito.2013.05.008
   Pichaud N, 2011, AM J PHYSIOL-REG I, V301, pR48, DOI 10.1152/ajpregu.00542.2010
   PIPER HM, 1985, J MOL CELL CARDIOL, V17, P885, DOI 10.1016/S0022-2828(85)80102-4
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Rendon DA, 2016, CURR DIABETES REV, V12, P66, DOI 10.2174/1573399811666150427163840
   ROWAN AN, 1979, BIOCHEM J, V178, P209, DOI 10.1042/bj1780209
   Sacktor B, 1976, Biochem Soc Symp, P111
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011
   Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3
   Simard CJ, 2018, JOVE-J VIS EXP, DOI 10.3791/57376
   Teulier L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0333
   Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x
   VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5
   VIGNAIS PV, 1973, BIOCHEMISTRY-US, V12, P1508, DOI 10.1021/bi00732a007
   Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890
   Wegener G, 1996, EXPERIENTIA, V52, P404, DOI 10.1007/BF01919307
   WILLIAMS GR, 1965, CAN J BIOCHEM CELL B, V43, P603, DOI 10.1139/o65-070
   Yang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099120
NR 58
TC 1
Z9 1
U1 1
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD JUL 1
PY 2019
VL 576
BP 33
EP 41
DI 10.1016/j.ab.2019.04.005
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA HW6WP
UT WOS:000466831800006
PM 30974092
DA 2020-07-08
ER

PT J
AU Jabrane-Ferrat, N
AF Jabrane-Ferrat, Nabila
TI Features of Human Decidual NK Cells in Healthy Pregnancy and During
   Viral Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE pregnancy; decidual natural killer; congenital infection; receptor;
   cytokines
ID NATURAL-KILLER-CELLS; REGULATORY T-CELLS; ZIKA VIRUS; HLA-G; TGF-BETA;
   1ST TRIMESTER; CYTOMEGALOVIRUS-INFECTION; EXTRAVILLOUS TROPHOBLASTS;
   CD94/NKG2 RECEPTORS; DENDRITIC CELLS
AB The hallmark of human early pregnancy is the accumulation of a unique population of Natural Killer (dNK) cells at the main maternal-fetal interface, the decidua basalis. dNK cells play a crucial role in successful placentation probably by orchestrating the invasion of trophoblast cells deep into the decidua basalis and remodeling of the maternal spiral arteries. Recent advances in the field emphasize the importance of the local microenvironment in shaping both the phenotype and the effector functions of these innate lymphoid cells. Despite slow progress in the field, ex vivo studies revealed that dNK cells sense and destroy infected cells in order to protect the fetus from invading pathogens. In this review, we will discuss key features of dNK cells during healthy pregnancy as well as their functional adaptations in limiting pathogen dissemination to the growing conceptus. The challenge is to better understand the plasticity of dNK cells in the maternal-fetal interface. Such insights would enable greater understanding of the pathogenesis in congenital infections and pregnancy disorders.
C1 [Jabrane-Ferrat, Nabila] CNRS UMR 5282, Ctr Pathophysiol Toulouse Purpan, Toulouse, France.
   [Jabrane-Ferrat, Nabila] Purpan Univ Hosp, INSERM UMR1043, Toulouse, France.
   [Jabrane-Ferrat, Nabila] Toulouse III Univ, Toulouse, France.
RP Jabrane-Ferrat, N (corresponding author), CNRS UMR 5282, Ctr Pathophysiol Toulouse Purpan, Toulouse, France.; Jabrane-Ferrat, N (corresponding author), Purpan Univ Hosp, INSERM UMR1043, Toulouse, France.; Jabrane-Ferrat, N (corresponding author), Toulouse III Univ, Toulouse, France.
EM nabila.jabrane-ferrat@inserm.fr
FU INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm); CNRSCentre National de la Recherche Scientifique (CNRS);
   ANRSANRSFrench National Research Agency (ANR)
FX The work was supported by the INSERM, CNRS, and ANRS.
CR Allan DSJ, 2010, EUR J IMMUNOL, V40, P2289, DOI 10.1002/eji.200939910
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0
   Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34
   Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762
   Boyd J D, 1967, J Obstet Gynaecol Br Commonw, V74, P161
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Brosens I, 1966, J Obstet Gynaecol Br Commonw, V73, P357
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   BULMER JN, 1991, ANN NY ACAD SCI, V622, P57, DOI 10.1111/j.1749-6632.1991.tb37850.x
   Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954
   Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570
   Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582
   Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9
   CHUMBLEY G, 1994, CELL IMMUNOL, V155, P312, DOI 10.1006/cimm.1994.1125
   Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689
   Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0
   Dunn CL, 2002, J CLIN ENDOCR METAB, V87, P1898, DOI 10.1210/jc.87.4.1898
   El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Enders A C, 1976, Res Reprod, V8, P1
   ENDERS AC, 1991, AM J ANAT, V192, P329, DOI 10.1002/aja.1001920403
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Gamliel M, 2018, IMMUNITY, V48, P951, DOI 10.1016/j.immuni.2018.03.030
   Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574
   Gibbs A, 2017, MUCOSAL IMMUNOL, V10, P35, DOI 10.1038/mi.2016.30
   Gouilly J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07200-2
   Halwachs-Baumann G, 1998, J VIROL, V72, P7598, DOI 10.1128/JVI.72.9.7598-7602.1998
   HAMILTON WJ, 1960, J ANAT, V94, P297
   Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x
   Hempstock Joanne, 2004, Reprod Biol Endocrinol, V2, P58, DOI 10.1186/1477-7827-2-58
   Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998
   Honig A, 2004, J REPROD IMMUNOL, V61, P79, DOI 10.1016/j.jri.2003.11.002
   HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162, DOI 10.1016/S0002-9378(87)80371-X
   Ivarsson MA, 2013, J CLIN INVEST, V123, P3889, DOI 10.1172/JCI68989
   Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218
   Jauniaux E, 1999, HUM REPROD, V14, P842, DOI 10.1093/humrep/14.3.842
   Jokhi PP, 1997, CYTOKINE, V9, P126, DOI 10.1006/cyto.1996.0146
   Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076
   Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104
   King A, 1997, AM J REPROD IMMUNOL, V37, P459
   King A, 2000, PLACENTA, V21, P376, DOI 10.1053/plac.1999.0496
   King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M
   KING A, 1991, IMMUNOL TODAY, V12, P432, DOI 10.1016/0167-5699(91)90014-K
   Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305
   Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018
   Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8
   Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W
   Lockwood CJ, 2014, AM J PATHOL, V184, P2549, DOI 10.1016/j.ajpath.2014.05.025
   Lockwood CJ, 2013, AM J PATHOL, V183, P841, DOI 10.1016/j.ajpath.2013.05.029
   Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108
   Male V, 2011, EUR J IMMUNOL, V41, P3017, DOI 10.1002/eji.201141445
   Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637
   Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620
   McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795
   Moffett A, 2015, HUM REPROD, V30, P1519, DOI 10.1093/humrep/dev098
   Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107
   Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Montaldo E, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00646
   Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080
   Otun HA, 2011, J REPROD IMMUNOL, V88, P1, DOI 10.1016/j.jri.2010.10.003
   Parham P, 2010, J CLIN INVEST, V120, P3801, DOI 10.1172/JCI44559
   Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006
   PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5
   Prefumo F, 2006, FERTIL STERIL, V85, P1032, DOI 10.1016/j.fertnstert.2005.09.055
   Prossler J, 2014, CYTOKINE, V68, P9, DOI 10.1016/j.cyto.2014.03.001
   Ratsep MT, 2015, REPRODUCTION, V149, pR91, DOI 10.1530/REP-14-0271
   Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989
   Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306
   Robertson W B, 1975, Eur J Obstet Gynecol Reprod Biol, V5, P47, DOI 10.1016/0028-2243(75)90130-6
   Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002
   Santoni A, 2008, AM J REPROD IMMUNOL, V59, P417, DOI 10.1111/j.1600-0897.2008.00598.x
   Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229
   Siewiera J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10183
   Siewiera J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003257
   SOOTHILL P W, 1986, Fetal Therapy, V1, P168
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P13312, DOI 10.1073/pnas.1517724112
   Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P7219, DOI 10.1073/pnas.1507977112
   Vacca P, 2015, MUCOSAL IMMUNOL, V8, P254, DOI 10.1038/mi.2014.63
   Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343
   Vacca P, 2011, TRENDS IMMUNOL, V32, P517, DOI 10.1016/j.it.2011.06.013
   Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108
   Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Vujaklija DV, 2013, J REPROD IMMUNOL, V97, P186, DOI 10.1016/j.jri.2012.11.003
   Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624
   Wallace AE, 2015, J LEUKOCYTE BIOL, V97, P79, DOI 10.1189/jlb.2A0614-282R
   Wang F, 2017, GYNECOL ENDOCRINOL, V33, P265, DOI 10.1080/09513590.2016.1212829
   Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Yeang HXA, 2017, J IMMUNOL, V198, P1417, DOI 10.4049/jimmunol.1601818
   Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00727
NR 107
TC 5
Z9 5
U1 3
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 28
PY 2019
VL 10
AR 1397
DI 10.3389/fimmu.2019.01397
PG 10
WC Immunology
SC Immunology
GA IF7KV
UT WOS:000473263900001
PM 31379803
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nunes, J
AF Nunes, Joao
TI The everyday political economy of health: community health workers and
   the response to the 2015 Zika outbreak in Brazil
SO REVIEW OF INTERNATIONAL POLITICAL ECONOMY
LA English
DT Article
DE Everyday political economy; global health; community health workers;
   Zika; Brazil; neoliberalism
ID AGENTS; NEOLIBERALISM; WORKING; LIFE; POPULATION; INEQUALITY; DISTRESS;
   GENDER; VIRUS
AB How is neoliberalism implicated in concrete health vulnerabilities? How do macro-level political economy, policy and institutions translate into everyday experiences? Drawing on Marxist, feminist and International Political Economy critiques of everyday life, the article advances an everyday political economy of health focused on four key components: power, agency, intersectionality and the mutual implication of the global and the local. These components enable a nuanced investigation of concrete experiences of health and disease, and of the local implementation of health policies in the context of neoliberalism. The framework is applied to the case of the 2015 public health response to Zika in Brazil, and specifically to the role of community health workers, close-to-community healthcare providers tasked with bridging the health system and vulnerable groups. The everyday practice of these workers, and their working conditions overwhelmingly characterized by precarity and low pay, reveal the presence of global neoliberal dynamics pertaining to the reconfiguration of the Brazilian state as healthcare provider in a context of encroaching austerity, privatization and narrowly-defined cost-efficiency. These dynamics impacted detrimentally upon the effectiveness of the Zika response.
C1 [Nunes, Joao] Univ York, Dept Polit, Int Relat, York, N Yorkshire, England.
RP Nunes, J (corresponding author), Univ York, Dept Polit, York YO10 5DD, N Yorkshire, England.
EM joao.nunes@york.ac.uk
OI Nunes, Joao/0000-0002-0118-0993
FU Wellcome TrustWellcome Trust [110362/Z/15/Z]
FX Financial support from the Wellcome Trust (Award Number 110362/Z/15/Z)
   is gratefully acknowledged.
CR ABRASCO   AssociacAo Brasileira de Saude Coletiva, 2016, CID SUST SAUD MICR P
   Anderson Emma-Louise, 2017, DEPENDENT AGENCY GLO
   Bahia L, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00067218, 10.1590/0102-311X00067218]
   Bahia L, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00184516
   Baralhas Marilisa, 2011, Physis, V21, P31, DOI 10.1590/S0103-73312011000100003
   Biehl Joao, 2007, WILL LIVE AIDS THERA
   Bornstein Vera Joana, 2008, Trab. educ. saúde, V6, P457, DOI 10.1590/S1981-77462008000300004
   Bornstein VJ, 2008, CIENC SAUDE COLETIVA, V13, P259, DOI 10.1590/S1413-81232008000100029
   Brand C. I., 2010, COGITARE ENFERMAGEM, V15
   BRASIL Ministerio da Saude, 2012, POL NAC AT BAS
   Brownstein JN, 2011, J AMBUL CARE MANAG, V34, P210, DOI 10.1097/JAC.0b013e31821c645d
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Coburn D, 2004, SOC SCI MED, V58, P41, DOI 10.1016/S0277-9536(03)00159-X
   Cordoba E., 2013, SISTEMA UNICO SAUDE
   Cross J, 2010, CRIT ANTHROPOL, V30, P355, DOI 10.1177/0308275X10372467
   Costa Marta Cocco da, 2012, Rev. Gaúcha Enferm., V33, P134, DOI 10.1590/S1983-14472012000300018
   da Silva ZP, 2011, CIENC SAUDE COLETIVA, V16, P3807, DOI 10.1590/S1413-81232011001000016
   Davies M, 2006, INT POLIT ECON SER, P219
   De Vogli R, 2011, SOC THEOR HEALTH, V9, P311, DOI 10.1057/sth.2011.16
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Alonso CMD, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000395, 10.11606/s1518-8787.2018052000395]
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Elias J, 2016, GLOBALIZATIONS, V13, P787, DOI 10.1080/14747731.2016.1155797
   Elias J, 2013, INT FEM J POLIT, V15, P391, DOI 10.1080/14616742.2012.755835
   Engels Friedrich, 2010, CONDITION WORKING CL
   Farmer P, 2003, PATHOLOGIES POWER HL
   Fassin Didier, 2012, MED ANTHR INTERSECTI, P95
   Favoreto César Augusto Orazem, 2002, Physis, V12, P59, DOI 10.1590/S0103-73312002000100005
   Fernandes LCL, 2009, REV SAUDE PUBL, V43, P595, DOI 10.1590/s0034-89102009005000040
   Fonseca Angélica Ferreira, 2016, Trab. educ. saúde, V14, P327, DOI 10.1590/1981-7746-sip00120
   Foucault M, 2008, MICHEL FOUCAULT-LECT, P1, DOI 10.1057/9780230594180
   Foucault M., 1990, WILL KNOWLEDGE HIST, VI
   Gardiner Michael, 2000, CRITIQUES EVERYDAY L
   Goncalves AE, 2018, REV PESQUISA FISIOTE, V8, P155, DOI [10.17267/2238-2704rpf.v8i2.1865, DOI 10.17267/2238-2704RPF.V8I2.1865]
   Harding S., 1991, WHOSE SCI WHOSE KNOW
   Harman S., 2011, GLOBAL HLTH GOVERNAN
   Hearn J., 2008, J POWER, V1, P37, DOI DOI 10.1080/17540290801943406
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hobson J. M., 2008, EVERYDAY POLITICS WO
   Hobson JM, 2007, EVERYDAY POLITICS OF THE WORLD ECONOMY, P1
   Instituto Brasileiro de Geografia e Estatistica, 2017, EST POP RES BRAS UN
   Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174
   Jardim TD, 2009, INTERFACE-BOTUCATU, V13, P123, DOI 10.1590/S1414-32832009000100011
   Kalleberg AL, 2009, AM SOCIOL REV, V74, P1, DOI 10.1177/000312240907400101
   Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343
   Keshavjee S., 2014, BLIND SPOT NEOLIBERA
   Konings M, 2009, REV INT STUD, V35, P69, DOI 10.1017/S026021050900833X
   Labonte R, 2016, J EPIDEMIOL COMMUN H, V70, P312, DOI 10.1136/jech-2015-206295
   Langley P., 2008, EVERYDAY LIFE GLOBAL
   LEFEBVRE H, 1991, CRITIQUE EVERYDAY LI, V1
   Lefebvre H., 2002, CRITIQUE EVERYDAY LI, V2
   Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI [DOI 10.1080/10714839.2016.1201268, DOI 10.1080/10714839.2016.120168]
   Lima Jacob Carlos, 2008, Trab. educ. saúde, V6, P481, DOI 10.1590/S1981-77462008000300005
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Lino MM, 2012, COGITARE ENFERM, V17, P57
   LOTTA G. S., 2015, BUROCRACIA IMPLEMENT
   Maia Leandro Dias de Godoy, 2011, Rev. bras. saúde ocup., V36, P93, DOI 10.1590/S0303-76572011000100009
   Malta DC, 2017, CIENC SAUDE COLETIVA, V22, P179, DOI 10.1590/1413-81232017221.16782015
   Marx Karl, 2000, EC PHILOS MANUSCRIPT
   Mascarenhas CHM, 2013, CIENC SAUDE COLETIVA, V18, P1375, DOI 10.1590/S1413-81232013000500023
   Mengue P, 2017, MINISTRO SAUDE VOLTA
   Ministerio da Saude, 2018, MIN SAUD FORM 250 MI
   Ministerio da Saude, 2016, PAP AG COM SAUD
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Morosini M., 2007, PROCESSO HIST TRABAL, P189
   Morosini M.V., 2010, EDUCACAO TRABALHO DI
   Moss NE, 2002, SOC SCI MED, V54, P649, DOI 10.1016/S0277-9536(01)00115-0
   Musse JDO, 2015, CIENC SAUDE COLETIVA, V20, P525, DOI 10.1590/1413-81232015202.01212014
   Navarro V, 2007, INT J HEALTH SERV, V37, P47, DOI 10.2190/AP65-X154-4513-R520
   Nogueira R. P., 2000, VINCULACAO I TRABALH
   Moreira MCN, 2018, INTERFACE-BOTUCATU, V22, P697, DOI 10.1590/1807-57622017.0930
   Ocke-Reis C. O, 2012, SUS DESAFIO SER UNIC
   Peres E. M, 2007, AQUICHAN, V7
   Simas PRP, 2017, CIENC SAUDE COLETIVA, V22, P1865, DOI 10.1590/1413-81232017226.01532017
   Lopes DMQ, 2012, REV ESC ENFERM USP, V46, P633, DOI 10.1590/S0080-62342012000300015
   Rosa AJ, 2012, SAUDE SOC-SAO PAULO, V21, P141, DOI 10.1590/S0104-12902012000100014
   Rose N., 1996, FOUCAULT POLITICAL R, P37
   Rowden R., 2013, DEADLY IDEAS NEOLIBE
   Scheffer M, 2015, CAD SAUDE PUBLICA, V31, P663, DOI 10.1590/0102-311XPE010415
   Schneider H, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0163-2
   Schrecker T., 2015, POLITICS MAKES US SI
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2016, B EPIDEMIOLOGICO, V47
   Silva Joana Azevedo da, 2002, Interface (Botucatu), V6, P75, DOI 10.1590/S1414-32832002000100007
   Barbosa RHS, 2012, INTERFACE-BOTUCATU, V16, P751, DOI 10.1590/S1414-32832012000300013
   Sinclair T. J, 1999, APPROACHES GLOBAL GO, P157
   Smith DE, 1987, EVERYDAY WORLD PROBL
   Spedo Sandra Maria, 2010, Physis, V20, P953, DOI 10.1590/S0103-73312010000300014
   Telles SH, 2009, SAUDE SOC-SAO PAULO, V18, P467
   Martines WRV, 2007, REV ESC ENFERM USP, V41, P426, DOI 10.1590/S0080-62342007000300012
   Venkatapuram S., 2011, HLTH JUSTICE
   Vieira FS, 2016, REV ESTUDOS PESQUISA, V10, P28, DOI DOI 10.21057/repam.v10i3.21860
   Wacquant L, 2012, SOC ANTHROPOL, V20, P66, DOI 10.1111/j.1469-8676.2011.00189.x
   Wei MFP, 2009, REV ENFERM UERJ, V17, P563
   Wilkinson R., 2010, SPIRIT LEVEL WHY EQU
   Young IM, 2011, JUSTICE AND THE POLITICS OF DIFFERENCE, P1
NR 95
TC 0
Z9 0
U1 0
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0969-2290
EI 1466-4526
J9 REV INT POLIT ECON
JI Rev. Int. Polit. Econ.
PD JAN 2
PY 2020
VL 27
IS 1
SI SI
BP 146
EP 166
DI 10.1080/09692290.2019.1625800
EA JUN 2019
PG 21
WC Economics; International Relations; Political Science
SC Business & Economics; International Relations; Government & Law
GA KB3WM
UT WOS:000476097500001
PM 32256198
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stoops, CA
   Qualls, WA
   Nguyen, TVT
   Richards, SL
AF Stoops, Craig A.
   Qualls, Whitney A.
   Nguyen, Thuy-Vi T.
   Richards, Stephanie L.
TI A Review of Studies Evaluating Insecticide Barrier Treatments for
   Mosquito Control From 1944 to 2018
SO ENVIRONMENTAL HEALTH INSIGHTS
LA English
DT Review
DE mosquito; barrier application; pyrethroid; permethrin; bifenthrin; DDT;
   Aedes; Culex; Anopheles
ID CULEX-QUINQUEFASCIATUS; RESIDUAL EFFECTIVENESS; AEDES-ALBOPICTUS;
   FIELD-EVALUATION; VEGETATION; BIFENTHRIN; EFFICACY; FOLIAGE; SPRAYS;
   PERMETHRIN
AB BACKGROUND AND PURPOSE : Barrier insecticide treatments have a long history in mosquito control programs but have been used more frequently in the United States in recent years for control of invasive "backyard" species (eg, Aedes albopictus) and increases in incidence of vector-borne diseases (eg, Zika).
   METHODS: We reviewed the published literature for studies investigating barrier treatments for mosquito control during the last 74 years (1944-2018). We searched databases such as PubMed, Web of Science, and Google Scholar to retrieve worldwide literature on barrier treatments.
   RESULTS : Forty-four studies that evaluated 20 active ingredients (AIs) and 21 formulated products against multiple mosquito species are included. Insecticides investigated for efficacy included organochlorines (dichlorodiphenyltrichloroethane [DDT], beta-hexachlorocyclohexane [BHC]), organophosphates (malathion), and pyrethroids (bifenthrin, deltamethrin, permethrin, lambda-cyhalothrin) as AIs. Study design varied with multiple methods used to evaluate effectiveness of barrier treatments. Barrier treatments were effective at lowering mosquito populations although there was variation between studies and for different mosquito species. Factors other than AI, such as exposure to rainfall and application equipment used, also influenced control efficacy.
   CONCLUSIONS: Many of the basic questions on the effectiveness of barrier insecticide applications have been answered, but several important details still must be investigated to improve precision and impact on vector-borne pathogen transmission. Recommendations are made to assist future evaluations of barrier treatments for mosquito control and to limit the potential development of insecticide resistance.
C1 [Stoops, Craig A.] Mosquito Author Labs, 4048 J Louis St, Green Cove Springs, FL 32054 USA.
   [Qualls, Whitney A.] Texas Dept State Hlth Serv, Zoonosis Control Branch, Austin, TX USA.
   [Nguyen, Thuy-Vi T.] Georgia Dept Publ Hlth, Vector Borne & Zoonot Dis Team, Atlanta, GA USA.
   [Richards, Stephanie L.] East Carolina Univ, Dept Hlth Educ & Promot, Greenville, NC 27858 USA.
RP Stoops, CA (corresponding author), Mosquito Author Labs, 4048 J Louis St, Green Cove Springs, FL 32054 USA.
EM craig.stoops@bugsbite.com
CR Allan SA, 2009, J AM MOSQUITO CONTR, V25, P338, DOI 10.2987/09-5854.1
   American Mosquito Control Association (AMCA), 2017, BEST PRACT INT MOSQ
   Amoo AOJ, 2008, J AM MOSQUITO CONTR, V24, P543, DOI 10.2987/08-5783.1
   ANDERSON AL, 1991, J AM MOSQUITO CONTR, V7, P116
   Bengoa M, 2013, J AM MOSQUITO CONTR, V29, P284, DOI 10.2987/13-6331R.1
   Bibbs C, 2016, TECHNICAL B FLORIDA, P76
   BIDLINGMAYER W. L., 1956, MOSQUITO NEWS, V16, P17
   Britch SC, 2009, J AM MOSQUITO CONTR, V25, P184, DOI 10.2987/08-5830.1
   BUETTNER WILLIAM O., 1953, MOSQUITO NEWS, V13, P72
   Cilek JE, 2008, J AM MOSQUITO CONTR, V24, P172, DOI 10.2987/8756-971X(2008)24[172:AOITVA]2.0.CO;2
   Cilek JE, 2006, J AM MOSQUITO CONTR, V22, P725, DOI 10.2987/8756-971X(2006)22[725:REOPFA]2.0.CO;2
   Cooperband MF, 2009, J MED ENTOMOL, V46, P292, DOI 10.1603/033.046.0214
   Doyle MA, 2009, J AM MOSQUITO CONTR, V25, P179, DOI 10.2987/08-5804.1
   ELLIOTT M, 1976, ENVIRON HEALTH PERSP, V14, P3, DOI 10.2307/3428357
   Farooq M, 2010, J AM MOSQUITO CONTR, V26, P422, DOI 10.2987/09-5891.1
   Fulcher A, 2015, J AM MOSQUITO CONTR, V31, P85, DOI 10.2987/14-6424R.1
   Geib AF., 1957, MOSQ NEWS, V17, P166
   Gibson J, 2016, TECHNICAL B FLORIDA, P96
   GINSBURG JOSEPH M., 1956, MOSQUITO NEWS, V16, P137
   Ginsburg Joseph M., 1944, JOUR NEW YORK ENT SOC, V52, P247
   HELSON BV, 1983, MOSQ NEWS, V43, P164
   HOFFMAN ROBERT A., 1952, MOSQUITO NEWS, V12, P87
   Hoffmann WC, 2009, J AM MOSQUITO CONTR, V25, P323, DOI 10.2987/08-5780.1
   Hurst TP, 2012, J MED ENTOMOL, V49, P1021, DOI 10.1603/ME11278
   KNIPLING EF, 1945, J ECON ENTOMOL, V38, P205, DOI 10.1093/jee/38.2.205
   Li CX, 2010, J AM MOSQUITO CONTR, V26, P346, DOI 10.2987/10-6007.1
   LUDVIK GF, 1950, J ECON ENTOMOL, V43, P516, DOI 10.1093/jee/43.4.516
   MADDEN A. H., 1945, Mosquito News, V5, P100
   Madden A. H., 1946, MOSQUITO NEWS, V6, P7
   MADDEN AH, 1947, J ECON ENTOMOL, V40, P119, DOI 10.1093/jee/40.1.119
   Marini L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134831
   McMillan BE, 2018, J AM MOSQUITO CONTR, V34, P281, DOI 10.2987/18-6759.1
   Muzari OM, 2014, J MED ENTOMOL, V51, P444, DOI 10.1603/ME13141
   PERICH MJ, 1993, MED VET ENTOMOL, V7, P363, DOI 10.1111/j.1365-2915.1993.tb00706.x
   Qualls WA, 2013, TECHNICAL B FLORIDA, P33
   Qualls WA, 2013, TECHNICAL B FLORIDA, P29
   Qualls WA, 2012, J AM MOSQUITO CONTR, V28, P219, DOI 10.2987/12-6255R.1
   QUARTERMAN KD, 1955, J ECON ENTOMOL, V48, P107, DOI 10.1093/jee/48.1.107
   QUARTERMAN KENNETH D., 1957, MOSPUITO NEWS, V17, P254
   Richards SL, 2017, J MED ENTOMOL, V54, P1659, DOI 10.1093/jme/tjx152
   SANDERS HJ, 1954, IND ENG CHEM, V46, P414, DOI 10.1021/ie50531a018
   Standfast H., 2003, Bulletin of the Mosquito Control Association of Australia, V15, P19
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
   Trout RT, 2007, J MED ENTOMOL, V44, P470, DOI 10.1603/0022-2585(2007)44[470:EOTPIA]2.0.CO;2
   Trout RT, 2009, FLA ENTOMOL, V92, P91, DOI 10.1653/024.092.0115
   Unlu I, 2018, J MED ENTOMOL, V55, P472, DOI 10.1093/jme/tjx216
   VanDusen AE, 2016, PEST MANAG SCI, V72, P1004, DOI 10.1002/ps.4081
   WHO, SPAC SPRAY APPL INS
NR 48
TC 1
Z9 1
U1 2
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1178-6302
J9 ENVIRON HEALTH INSIG
JI Environ. Health Insights
PD JUN 26
PY 2019
VL 13
AR UNSP 1178630219859004
DI 10.1177/1178630219859004
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IG5EL
UT WOS:000473826200001
PM 31263373
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moraes, EV
   Toledo, OR
   David, FL
   Godoi, BN
   Monteiro, KA
   Deluqui, TC
   Teixeira, TW
   Carvalho, AL
   Avelino, MM
AF Moraes, Eleomar Vilela
   Toledo, Olegario Rosa
   David, Flavia Lucia
   Godoi, Bruna Nascimento
   Monteiro, Keila Araujo
   Deluqui, Thaisa Cimardi
   Teixeira, Thais Werica
   Carvalho, Andiara Luiza
   Avelino, Mariza Martins
TI Implications of the clinical gestational diagnosis of ZIKV infection in
   the manifestation of symptoms of postpartum depression: a case-control
   study
SO BMC PSYCHIATRY
LA English
DT Article
DE Pregnancy; Puerperium; Women; Divorce; EPDS
ID STRESSFUL LIFE EVENTS; MATERNAL DEPRESSION; POSTNATAL DEPRESSION;
   ANTENATAL DEPRESSION; VIRUS-INFECTION; MENTAL-HEALTH; PREGNANCY;
   ANXIETY; WOMEN; ASSOCIATION
AB BackgroundTraumatic events can trigger postpartum depression. Pregnant women in Brazil today are facing an extremely stressful experience. Thus, the objective here was to analyze the prevalence of symptoms of depression in the immediate postpartum period (IPPD) and associate these symptoms with previous stressful, social, psychological, behavioral, obstetrical, clinical, violent and infectious events, particularly exposure to Zika virus (ZIKV) infection during pregnancy.MethodsThis was a case-control study. The sample comprised 213 puerperal women treated in the maternity ward of a public reference hospital in the Araguaia River Valley of Mato Grosso and Goias, Brazil. Severe IPPD symptoms were confirmed based on the Edinburgh Postnatal Depression Scale (EPDS). A descriptive statistical analysis was carried out using the Epi Info version 7.1.5 suite of software tools and the Statistical Package for Social Sciences (SPSS) version 21.0.ResultsA bivariate analysis revealed a significant association between severe symptoms of IPPD and the following variables: clinical diagnosis of ZIKV during pregnancy (OR=13.36; 95% CI=5.34-33.39); was separated or divorced in the last year (OR=3.58; 95% CI=1.42-8.99); suffered an accident in the last year (OR=3.32, 95% CI=1.12-9.82); suffered emotional violence during pregnancy (OR=3.80; 95% CI=1.81-7.99); suffered physical violence during pregnancy (OR=11.86; 95% CI=2.07-67.82); fear of her partner (OR=17.90; 95% CI=3.44-92.99); dengue fever during pregnancy (OR=7.85; 95% CI: 1.66-37.05), and has a family member diagnosed with mental illness (OR=2.54; 95% CI=1.09-5.93). The multivariate analysis confirmed the association of severe PPD symptoms only with the variables of clinical diagnosis of ZIKV during pregnancy (OR=19.82; 95% CI: 5.35-73.39) and was separated or divorced in the last year (OR=3.92; 95% IC=1.12-13.63).ConclusionsClinically diagnosed ZIKV during pregnancy may be one of the main events associated with severe IPPD symptoms, showing an almost 20-fold higher chance of occurrence than other factors.
C1 [Moraes, Eleomar Vilela] Fed Univ Goias UFG, Sch Med, Av Primeira Ave S-N, BR-74605020 Goiania, Go, Brazil.
   [Toledo, Olegario Rosa; David, Flavia Lucia] Univ Fed Mato Grosso, UFMT, Inst Biol Sci & Hlth, BR 070,Km 05, BR-78600000 Barra Do Garcas, MT, Brazil.
   [Godoi, Bruna Nascimento; Monteiro, Keila Araujo; Deluqui, Thaisa Cimardi; Teixeira, Thais Werica; Carvalho, Andiara Luiza] Univ Fed Mato Grosso, UFMT, Pharm Course, Inst Biol Sci & Hlth, BR 070,Km 05, BR-78600000 Barra Do Garcas, MT, Brazil.
   [Avelino, Mariza Martins] Univ Fed Goias, UFG, Sch Med, Dept Pediat & Child Care, Av Primeira Ave S-N, BR-74605020 Goiania, Go, Brazil.
   [Moraes, Eleomar Vilela] Ave Getulio Vargas 663, BR-76240000 Aragarcas, Go, Brazil.
RP Moraes, EV (corresponding author), Fed Univ Goias UFG, Sch Med, Av Primeira Ave S-N, BR-74605020 Goiania, Go, Brazil.; Moraes, EV (corresponding author), Ave Getulio Vargas 663, BR-76240000 Aragarcas, Go, Brazil.
EM veleomar@gmail.com
FU Brazilian research funding agency CAPES (Federal Agency for the Support
   and Improvement of Higher Education)
FX This research was financially supported by the Brazilian research
   funding agency CAPES (Federal Agency for the Support and Improvement of
   Higher Education). The agency played no role in the design of this
   study, in the collection, analysis and interpretation of data, or in the
   writing of this manuscript.
CR Abdollahi F, 2014, ASIA-PAC PSYCHIAT, V6, P425, DOI 10.1111/appy.12152
   ABEP AssociacAo Brasileira de Empresas de Pesquisa, CRIT CLASS
   Alfayumi-Zeadna S, 2015, DEPRESS ANXIETY, V32, P120, DOI 10.1002/da.22290
   [Anonymous], 2008, MAT MENT HLTH CHILD
   [Anonymous], 2002, NAT CLIN GUID
   Ashford MT, 2016, J AFFECT DISORDERS, V197, P134, DOI 10.1016/j.jad.2016.02.057
   Ashley JM, 2016, ARCH WOMEN MENT HLTH, V19, P395, DOI 10.1007/s00737-015-0593-1
   Bernstein IH, 2008, DEPRESS ANXIETY, V25, P20, DOI 10.1002/da.20276
   Biaggi A, 2016, J AFFECT DISORDERS, V191, P62, DOI 10.1016/j.jad.2015.11.014
   Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924
   Browner WS, 2012, PUBLISHING PRESENTIN
   Byrne EM, 2014, ARCH WOMEN MENT HLTH, V17, P519, DOI 10.1007/s00737-014-0428-5
   Couto TCE, 2016, J AFFECT DISORDERS, V192, P70, DOI 10.1016/j.jad.2015.12.017
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias (COES), 2016, MON CAS MICR BRAS IN
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias (COES), 2015, MON CAS MICR BRAS IN
   Cheng Hsuesh-Yu, 2016, Hu Li Za Zhi, V63, P52, DOI 10.6224/JN.63.6.52
   COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Moraes EV, 2016, REV BRAS GINECOL OBS, V38, P293, DOI 10.1055/s-0036-1585072
   Dean A.G., 2013, OPEN EPI OPEN SOURCE
   Demirchyan A, 2014, ARCH WOMEN MENT HLTH, V17, P229, DOI 10.1007/s00737-013-0404-5
   Duncan LG, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1319-3
   ECLAMC, 2015, V3 ECLAMC
   Fleiss J. L., 1981, STAT METHODS RATES P
   Flynn HA, 2004, GEN HOSP PSYCHIAT, V26, P316, DOI 10.1016/j.genhosppsych.2004.03.009
   Giesbrecht GF, 2012, ARCH WOMEN MENT HLTH, V15, P481, DOI 10.1007/s00737-012-0300-4
   Glover Vivette, 2015, Adv Neurobiol, V10, P269, DOI 10.1007/978-1-4939-1372-5_13
   Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017
   GOMES L. A., 2010, REV RENE, V11, P117
   Gujarati DN, 2011, ECONOMETRIA BASICA 5
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kessler RC, 2015, EPIDEMIOL PSYCH SCI, V24, P210, DOI 10.1017/S2045796015000189
   Koushede V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176819
   Krueger PM, 2011, SOC SCI MED, V73, P1312, DOI 10.1016/j.socscimed.2011.08.007
   Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1
   McCabe ERB, 2016, ZIKA VIRUS INFECT EV
   McFarlane J, 1996, NURS RES, V45, P37, DOI 10.1097/00006199-199601000-00007
   MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miloca SA, 2013, MULTICOLINEARIDADE M
   Moraes EV, 2017, INDIAN J APPL RES, V7, P598
   MS Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   NORTON LB, 1995, OBSTET GYNECOL, V85, P321, DOI 10.1016/0029-7844(94)00429-H
   Nunnally Jum C, 1967, PSYCHOMETRIC THEORY
   O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002
   O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612
   Paul IM, 2013, PEDIATRICS, V131, pE1218, DOI 10.1542/peds.2012-2147
   Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605
   Pawluski JL, 2017, TRENDS NEUROSCI, V40, P106, DOI 10.1016/j.tins.2016.11.009
   Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883
   Redshaw M, 2013, J WOMENS HEALTH, V22, P518, DOI 10.1089/jwh.2012.4152
   Reichenheim ME, 2000, REV SAUDE PUBL, V34, P610, DOI 10.1590/S0034-89102000000600008
   Rodriguez MA, 2010, VIOLENCE AGAINST WOM, V16, P543, DOI 10.1177/1077801210366959
   Rogers CE, 2013, J PERINATOL, V33, P171, DOI 10.1038/jp.2012.75
   Roomruangwong C, 2018, PROG NEURO-PSYCHOPH, V81, P262, DOI 10.1016/j.pnpbp.2017.09.015
   Santos IS, 2007, CAD SAUDE PUBLICA, V23, P2577, DOI 10.1590/S0102-311X2007001100005
   Seib C, 2014, WOMEN HEALTH ISS, V24, pE43, DOI 10.1016/j.whi.2013.11.004
   Slopen N, 2011, SOC SCI MED, V73, P615, DOI 10.1016/j.socscimed.2011.06.022
   Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0
   Stone SL, 2015, J WOMENS HEALTH, V24, P384, DOI 10.1089/jwh.2014.4857
   Filha MMT, 2016, J AFFECT DISORDERS, V194, P159, DOI 10.1016/j.jad.2016.01.020
   Truijens SEM, 2017, ARCH WOMEN MENT HLTH, V20, P539, DOI 10.1007/s00737-017-0738-5
   Urbina S, 2007, FUNDAMENTOS TESTAGEM, P121
   Ward TS, 2017, ARCH WOMEN MENT HLTH, V20, P161, DOI 10.1007/s00737-016-0689-2
   WHO, 2012, DEPR GLOB CRIS WORLD
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, MAT MENT HLTH
NR 69
TC 1
Z9 1
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD JUN 26
PY 2019
VL 19
AR 199
DI 10.1186/s12888-019-2157-9
PG 10
WC Psychiatry
SC Psychiatry
GA IF3ZP
UT WOS:000473021900002
PM 31242891
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calderon-Pelaez, MA
   Velandia-Romero, ML
   Bastidas-Legarda, LY
   Beltran, EO
   Camacho-Ortega, SJ
   Castellanos, JE
AF Calderon-Pelaez, Maria-Angelica
   Velandia-Romero, Myriam L.
   Bastidas-Legarda, Leidy Y.
   Beltran, Edgar O.
   Camacho-Ortega, Sigrid J.
   Castellanos, Jaime E.
TI Dengue Virus Infection of Blood-Brain Barrier Cells: Consequences of
   Severe Disease
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE blood-brain barrier cells; breakdown; severe dengue; neurological
   manifestations; pathogenesis
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; HUMAN ENDOTHELIAL-CELLS;
   EXTENSIVE TRANSVERSE MYELITIS; ZIKA VIRUS; VASCULAR LEAKAGE;
   NERVOUS-SYSTEM; NEUROINVASIVE DISEASE; GLIAL ACTIVATION;
   IMMUNE-RESPONSES
AB More than 500 million people worldwide are infected each year by any of the four-dengue virus (DENV) serotypes. The clinical spectrum caused during these infections is wide and some patients may develop neurological alterations during or after the infection, which could be explained by the cryptic neurotropic and neurovirulent features of flaviviruses like DENV. Using in vivo and in vitro models, researchers have demonstrated that DENV can affect the cells from the blood-brain barrier (BBB) in several ways, which could result in brain tissue damage, neuronal loss, glial activation, tissue inflammation and hemorrhages. The latter suggests that BBB may be compromised during infection; however, it is not clear whether the damage is due to the infection per se or to the local and/or systemic inflammatory response established or activated by the BBB cells. Similarly, the kinetics and cascade of events that trigger tissue damage, and the cells that initiate it, are unknown. This review presents evidence of the BBB cell infection with DENV and the response established toward it by these cells; it also describes the consequences of this response on the nervous tissue, compares these evidence with the one reported with neurotropic viruses of the Flaviviridae family, and shows the complexity and unpredictability of dengue and the neurological alterations induced by it. Clinical evidence and in vitro and in vivo models suggest that this virus uses the bloodstream to enter nerve tissue where it infects the different cells of the neurovascular unit. Each of the cell populations respond individually and collectively and control infection and inflammation, in other cases this response exacerbates the damage leaving irreversible sequelae or causing death. This information will allow us to understand more about the complex disease known as dengue, and its impact on a specialized and delicate tissue like is the nervous tissue.
C1 [Calderon-Pelaez, Maria-Angelica; Velandia-Romero, Myriam L.; Bastidas-Legarda, Leidy Y.; Beltran, Edgar O.; Camacho-Ortega, Sigrid J.; Castellanos, Jaime E.] Univ El Bosque, Lab Virol, Vicerrectorta Invest, Bogota, Colombia.
   [Velandia-Romero, Myriam L.] Univ El Bosque, Grp Virol, Bogota, Colombia.
RP Velandia-Romero, ML (corresponding author), Univ El Bosque, Lab Virol, Vicerrectorta Invest, Bogota, Colombia.; Velandia-Romero, ML (corresponding author), Univ El Bosque, Grp Virol, Bogota, Colombia.
EM mlvelandiaro@gmail.com
OI Velandia-Romero, Myriam Lucia/0000-0002-3340-7304
FU Colombian Department for Science, Technology and Innovation
   (Colciencias) [1308-489-25267]; Vicerrectoria de Investigaciones
   Universidad El Bosque [PCI 2011-219, PCI 2015-3632]; Banco de la
   Republica Foundation [3632-2015]; Colciencias Young Researcher
   Fellowship
FX This review was supported by the Colombian Department for Science,
   Technology and Innovation (Colciencias), Project 1308-489-25267, the
   Vicerrectoria de Investigaciones Universidad El Bosque (PCI 2011-219 and
   PCI 2015-3632), and the Banco de la Republica Foundation (Project
   3632-2015). Colciencias Young Researcher Fellowship was granted to LB-L,
   M-AC-P, and SC-O.
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   ABOUNADER R, 1995, BRIT J PHARMACOL, V116, P2245, DOI 10.1111/j.1476-5381.1995.tb15060.x
   Abraham S, 2008, VIRUS RES, V133, P239, DOI 10.1016/j.virusres.2007.12.023
   Abraham SA, 2006, VIRUS RES, V119, P216, DOI 10.1016/j.virusres.2006.03.006
   Al-Fifi YSY, 2018, CASE REP INFECT DIS, DOI 10.1155/2018/4361706
   An J, 2003, VIRCHOWS ARCH, V442, P472, DOI 10.1007/s00428-003-0785-3
   ANDREWS BS, 1978, INFECT IMMUN, V20, P776, DOI 10.1128/IAI.20.3.776-781.1978
   Angibaud G, 2001, J CLIN NEUROSCI, V8, P63, DOI 10.1054/jocn.2000.0735
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Azmin S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-179
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Baymakova M, 2016, EMERG INFECT DIS, V22, P2203, DOI 10.3201/eid2212.151968
   Bhatt RS, 2015, IMMUNOBIOLOGY, V220, P1170, DOI 10.1016/j.imbio.2015.06.002
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Bopeththa B V K M, 2017, BMC Res Notes, V10, P655, DOI 10.1186/s13104-017-2954-5
   Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014
   Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002
   Calvert JK, 2015, J INTERF CYTOK RES, V35, P654, DOI 10.1089/jir.2014.0195
   Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135
   Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003
   Yam-Puc JC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00218
   Castellanos JE, 2016, TROP BIOMED, V33, P375
   Castellanos JE, 2016, BIOMEDICA, V36, P156, DOI 10.7705/biomedica.v36i0.2984
   Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004
   Chang CY, 2017, BRAIN BEHAV IMMUN, V66, P230, DOI 10.1016/j.bbi.2017.07.003
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Chanthick C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31855
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Chen CJ, 2011, NEUROCHEM INT, V58, P924, DOI 10.1016/j.neuint.2011.02.022
   Chen CJ, 2011, NEUROCHEM INT, V58, P234, DOI 10.1016/j.neuint.2010.12.009
   Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0
   Chen CJ, 2000, NEUROREPORT, V11, P1933, DOI 10.1097/00001756-200006260-00025
   Chen CJ, 2004, J VIROL, V78, P12107, DOI 10.1128/JVI.78.22.12107-12119.2004
   Chen L., 2011, Morbidity and Mortality Weekly Report, V60, P276
   Cheng VCC, 2018, EMERG INFECT DIS, V24, P49, DOI 10.3201/eid2401.171297
   Chotmongkol Verajit, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P160
   Chretien J.P., 2015, PLOS CURR, DOI [10.1371/currents.outbreaks.95fbc4a8fb4695e049baabfc2fc8289f, DOI 10.1371/CURRENTS.OUTBREAKS.95FBC4A8FB4695E049BAABFC2FC8289F]
   Chung CC, 2007, INFECTION, V35, P30, DOI 10.1007/s15010-007-6038-7
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cushing MM, 2004, AM J CLIN PATHOL, V121, P26, DOI 10.1309/G23CP54DAR1BCY8L
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006
   Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020
   Mota MTDO, 2017, AM J TROP MED HYG, V96, P380, DOI 10.4269/ajtmh.16-0284
   Delcambre GH, 2017, EQUINE VET J, V49, P815, DOI 10.1111/evj.12697
   DeSalvo D, 2004, TRANSPLANTATION, V77, P466, DOI 10.1097/01.TP.0000101434.98873.CB
   Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493
   Despres P, 1996, J VIROL, V70, P4090
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Doi Maegan Lm, 2017, Hawaii J Med Public Health, V76, P275
   Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107
   Doron SI, 2003, CLIN INFECT DIS, V37, pE74, DOI 10.1086/377177
   Doti P, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.35.20573
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fong CY, 2017, J CLIN NEUROSCI, V36, P73, DOI 10.1016/j.jocn.2016.10.050
   Fong CY, 2016, EUR J PAEDIATR NEURO, V20, P449, DOI 10.1016/j.ejpn.2016.01.012
   Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y
   Garcia-Ponce A, 2015, THROMB HAEMOSTASIS, V113, P20, DOI 10.1160/TH14-04-0298
   GEORGE S, 1984, B WORLD HEALTH ORGAN, V62, P879
   German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008
   Giladi M, 2001, EMERG INFECT DIS, V7, P659
   Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537
   Goswami RP, 2012, J INFECT DEV COUNTR, V6, P208, DOI 10.3855/jidc.2241
   Gotoh J, 2001, AM J PHYSIOL-HEART C, V280, pH821
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Hapuarachchi HC, 2013, J CLIN VIROL, V57, P91, DOI 10.1016/j.jcv.2012.12.021
   Hapuarachchi HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121696
   Hawkes MA, 2018, NEUROLOGIST, V23, P152, DOI 10.1097/NRL.0000000000000189
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   HOTTA H, 1981, MICROBIOL IMMUNOL, V25, P89, DOI 10.1111/j.1348-0421.1981.tb00012.x
   Hou JH, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1142492
   Hunsperger EA, 2009, J NEUROVIROL, V15, P211, DOI 10.1080/13550280902913255
   Hussmann KL, 2014, J GEN VIROL, V95, P862, DOI 10.1099/vir.0.060558-0
   Hwang J, 2015, J KOREAN MED SCI, V30, P343, DOI 10.3346/jkms.2015.30.3.343
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   IMBERT JL, 1994, J MED VIROL, V42, P228, DOI 10.1002/jmv.1890420304
   Salazar MI, 2013, SCI WORLD J, DOI 10.1155/2013/904067
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959
   Jhan MK, 2018, J LEUKOCYTE BIOL, V104, P961, DOI 10.1002/JLB.MA1217-484R
   Jhan MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00182-z
   Jia N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-344
   Kelley TW, 2003, AM J CLIN PATHOL, V119, P749, DOI 10.1309/PU4R76JJMG1F81RP
   Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001
   Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Kuwar RB, 2015, J NEUROL SCI, V358, P243, DOI 10.1016/j.jns.2015.09.003
   Landrith TA, 2015, SEMIN IMMUNOPATHOL, V37, P261, DOI 10.1007/s00281-015-0487-3
   Langevin S, 2012, J TRAVEL MED, V19, P127, DOI 10.1111/j.1708-8305.2011.00582.x
   Lannes N, 2017, ONCOTARGET, V8, P114393, DOI 10.18632/oncotarget.23106
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Lee KM, 2016, J NEUROVIROL, V22, P831, DOI 10.1007/s13365-016-0461-4
   Lehtinen VA, 2008, J CLIN VIROL, V43, P93, DOI 10.1016/j.jcv.2008.05.001
   Lei S, 2013, CELL BIOCHEM BIOPHYS, V67, P1333, DOI 10.1007/s12013-013-9665-x
   Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449
   Lima RS, 2013, NAT PROD COMMUN, V8, P1547
   Limonta D, 2012, INFECTION, V40, P689, DOI 10.1007/s15010-012-0260-7
   Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Liu Y, 1988, Ann N Y Acad Sci, V540, P483, DOI 10.1111/j.1749-6632.1988.tb27143.x
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Velandia ML, 2012, VIRAL GENOMES - MOLECULAR STRUCTURE, DIVERSITY, GENE EXPRESSION MECHANISMS AND HOST-VIRUS INTERACTIONS, P219
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]
   Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814
   Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mathew RP, 2014, J MED IMAG RADIAT ON, V58, P679, DOI 10.1111/1754-9485.12182
   McConnell HL, 2017, J BIOL CHEM, V292, P762, DOI 10.1074/jbc.R116.760215
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Méndez Ángela, 2006, Biomédica, V26, P61
   Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005
   Miljkovic D, 2007, J NEUROSCI RES, V85, P3598, DOI 10.1002/jnr.21453
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Mishra MK, 2007, NEUROCHEM INT, V50, P764, DOI 10.1016/j.neuint.2007.01.014
   Mittal Madhukar, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.12.2010.3672
   Mohta S, 2017, J VECTOR DIS, V54, P291, DOI 10.4103/0972-9062.217623
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nadarajah Jeyaseelan, 2015, Indian J Radiol Imaging, V25, P52, DOI 10.4103/0971-3026.150145
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   Narayanan S, 2017, INT J GEN MED, V10, P125, DOI 10.2147/IJGM.S129829
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Ng DHL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005369
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Patabendige A, 2018, MOL CELL NEUROSCI, V89, P60, DOI 10.1016/j.mcn.2018.04.002
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001
   Peyrefitte CN, 2006, J MED VIROL, V78, P229, DOI 10.1002/jmv.20532
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Plummer EM, 2014, J IMMUNOL METHODS, V410, P34, DOI 10.1016/j.jim.2014.01.001
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Puccioni-Sohler M, 2015, ARQ NEURO-PSIQUIAT, V73, P698, DOI 10.1590/0004-282X20150074
   Puccioni-Sohler M, 2012, NEUROL INT, V4, P65, DOI 10.4081/ni.2012.e15
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14
   Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Ramos-Castaneda J, 1997, J NEUROVIROL, V3, P435
   Rao Sachin, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-008229
   Reddy P, 2004, BONE MARROW TRANSPL, V33, P109, DOI 10.1038/sj.bmt.1704293
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5
   Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395
   Salomao NG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28137-y
   Sampson BA, 2001, ANN NY ACAD SCI, V951, P172
   Sandrone S, 2019, NAT MED, V25, P538, DOI 10.1038/s41591-019-0417-3
   Sanguansermsri T., 1976, BANGKOK SEAMEO TROPM, P10
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Scremin O U, 1973, Stroke, V4, P233
   Shah S, 2016, J CLIN VIROL, V75, P1, DOI 10.1016/j.jcv.2015.11.034
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sharma Shweta, 2014, International Journal of Current Microbiology and Applied Sciences, V3, P404
   Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Soe HJ, 2017, J GEN VIROL, V98, P2993, DOI 10.1099/jgv.0.000981
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Sountharalingam S., 2017, J MED CASE REP, V11, P1, DOI [10.1186/s13256-017-1454-1455, DOI 10.1186/S13256-017-1454-1455]
   Srikiatkhachorn A, 2014, ANTIVIR RES, V109, P160, DOI 10.1016/j.antiviral.2014.07.005
   SRIURAIRATNA S, 1973, INFECT IMMUN, V8, P1017, DOI 10.1128/IAI.8.6.1017-1028.1973
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Su HL, 2001, VIROLOGY, V282, P141, DOI 10.1006/viro.2000.0820
   Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4
   Suman V, 2016, J CLIN DIAGN RES, V10, pOD18, DOI 10.7860/JCDR/2016/16917.7274
   Suwanprinya L, 2017, JPN J INFECT DIS, V70, P383, DOI 10.7883/yoken.JJID.2016.236
   Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Tan IL, 2012, LANCET NEUROL, V11, P605, DOI 10.1016/S1474-4422(12)70098-4
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013
   Tohidpour A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00276
   Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313
   Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705
   Verma S, 2011, J GEN VIROL, V92, P507, DOI 10.1099/vir.0.026716-0
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Wan SW, 2012, J CELL BIOCHEM, V113, P1681, DOI 10.1002/jcb.24037
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wei HY, 2003, J GEN VIROL, V84, P3095, DOI 10.1099/vir.0.19308-0
   White RE, 2008, RESTOR NEUROL NEUROS, V26, P197
   (WHO). World Health Organization, 2009, DENG GUID DIAGN TREA, P147
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058
   Winkelmann Evandro R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7404.1
   Withana Milinda, 2014, BMC Res Notes, V7, P125, DOI 10.1186/1756-0500-7-125
   Wu-Hsieh BA, 2009, ANN NY ACAD SCI, V1171, pE42, DOI 10.1111/j.1749-6632.2009.05053.x
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Yamazaki T, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00078
   Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12
   Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107
   Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010
   Yeo P. S. D., 2005, SMJ Singapore Medical Journal, V46, P647
   Zaltzman R, 2017, J NEUROL SCI, V376, P38, DOI 10.1016/j.jns.2017.02.057
   Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051
   Zhang YL, 2015, EUR REV MED PHARMACO, V19, P4927
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
   Zorec R, 2019, NEUROSCI LETT, V689, P56, DOI 10.1016/j.neulet.2018.08.003
NR 250
TC 4
Z9 4
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 26
PY 2019
VL 10
AR 1435
DI 10.3389/fmicb.2019.01435
PG 15
WC Microbiology
SC Microbiology
GA IF4UP
UT WOS:000473077300002
PM 31293558
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nitsche, C
   Onagi, H
   Quek, JP
   Otting, G
   Luo, DH
   Huber, T
AF Nitsche, Christoph
   Onagi, Hideki
   Quek, Jun-Ping
   Otting, Gottfried
   Luo, Dahai
   Huber, Thomas
TI Biocompatible Macrocyclization between Cysteine and 2-Cyanopyridine
   Generates Stable Peptide Inhibitors
SO ORGANIC LETTERS
LA English
DT Article
ID ZIKA VIRUS; CONDENSATION REACTION; NS2B-NS3 PROTEASE; CLICK REACTION;
   SMALL-MOLECULE; STRATEGIES; DISCOVERY
AB Peptides featuring an N-terminal cysteine residue and the unnatural amino acid 3-(2-cyano-4-pyridyl)-alanine (Cpa) cyclize spontaneously in aqueous solution at neutral pH. Cpa is readily available and easily introduced into peptides using standard solid-phase peptide synthesis. The reaction is orthogonal to all proteinogenic amino acids, including cysteine residues that are not at the N-terminus. A substrate peptide of the Zika virus NS2B-NS3 protease cyclized in this way produced an inhibitor of high affinity and proteolytic stability.
C1 [Nitsche, Christoph; Onagi, Hideki; Otting, Gottfried; Huber, Thomas] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
   [Quek, Jun-Ping; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.
RP Nitsche, C; Huber, T (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
EM christoph.nitsche@anu.edu.au; t.huber@anu.edu.au
RI Onagi, Hideki/O-6978-2019; Otting, Gottfried/H-8413-2014
OI Onagi, Hideki/0000-0003-0085-7349; Otting,
   Gottfried/0000-0002-0563-0146; Quek, Jun Ping/0000-0002-3827-8580
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation;
   Australian Research CouncilAustralian Research Council [DE190100015];
   Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; Singapore National Research
   FoundationSingapore National Research Foundation [NRF2016NRF-CRP001-063]
FX C.N. thanks the Alexander von Humboldt Foundation for a Feodor Lynen
   Fellowship and the Australian Research Council for a Discovery Early
   Career Research Award (DE190100015). D.L. acknowledges the support from
   a start-up grant from Lee Kong Chian School of Medicine, Nanyang
   Technological University, and Singapore National Research Foundation
   grant NRF2016NRF-CRP001-063. We thank scientists from Australian Light
   Source MX beamlines for their help on diffraction data collection.
CR Berteotti A, 2014, ACS MED CHEM LETT, V5, P501, DOI 10.1021/ml400489b
   Bhat A, 2015, EUR J MED CHEM, V94, P471, DOI 10.1016/j.ejmech.2014.07.083
   Cheng YF, 2013, CHEM-EUR J, V19, P4036, DOI 10.1002/chem.201201677
   Deng Y, 2011, ORG BIOMOL CHEM, V9, P6917, DOI 10.1039/c1ob06132a
   FIFE WK, 1983, J ORG CHEM, V48, P1375, DOI 10.1021/jo00156a053
   Gruba N, 2018, ACS MED CHEM LETT, V9, P1025, DOI 10.1021/acsmedchemlett.8b00316
   Inoue M., 2018, Patent No. [WO 2018174078, 2018174078]
   Liang GL, 2010, NAT CHEM, V2, P54, DOI [10.1038/nchem.480, 10.1038/NCHEM.480]
   Maltsev OV, 2013, SYNTHESIS-STUTTGART, V45, P2763, DOI 10.1055/s-0033-1339492
   Morrison C, 2018, NAT REV DRUG DISCOV, V17, P531, DOI 10.1038/nrd.2018.125
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Ren HJ, 2009, ANGEW CHEM INT EDIT, V48, P9658, DOI 10.1002/anie.200903627
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sinha S, 2014, CHEM RES TOXICOL, V27, P2052, DOI 10.1021/tx500256j
   Toyama T, 2017, CHEM LETT, V46, P753, DOI 10.1246/cl.170094
   Wang YQ, 2019, ANGEW CHEM INT EDIT, V58, P4886, DOI 10.1002/anie.201813748
   White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062
   Ye DJ, 2014, BIOCONJUGATE CHEM, V25, P1526, DOI 10.1021/bc500254g
   Ye DJ, 2014, NAT CHEM, V6, P519, DOI [10.1038/NCHEM.1920, 10.1038/nchem.1920]
   Ye DJ, 2011, ANGEW CHEM INT EDIT, V50, P2275, DOI 10.1002/anie.201006140
   Yuan Y, 2014, ORG BIOMOL CHEM, V12, P865, DOI 10.1039/c3ob41241e
   Yuan Y, 2013, ANAL CHEM, V85, P1280, DOI 10.1021/ac303183v
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 29
TC 2
Z9 2
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1523-7060
EI 1523-7052
J9 ORG LETT
JI Org. Lett.
PD JUN 21
PY 2019
VL 21
IS 12
BP 4709
EP 4712
DI 10.1021/acs.orglett.9b01545
PG 4
WC Chemistry, Organic
SC Chemistry
GA IF5JB
UT WOS:000473116000066
PM 31188009
DA 2020-07-08
ER

PT J
AU Chukwurah, E
   Osmundsen, A
   Davis, SW
   Lizarraga, SB
AF Chukwurah, Evelyn
   Osmundsen, Allison
   Davis, Shannon W.
   Lizarraga, Sofia B.
TI All Together Now: Modeling the Interaction of Neural With Non-neura
   Systems Using Organoid Models
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Review
DE pluripotent; organoids; Alzheimer's; microglia; neuroimmune;
   neuroendocrine; gut; Zika
ID PLURIPOTENT STEM-CELLS; PRADER-WILLI-SYNDROME; BLOOD-BRAIN-BARRIER;
   MAMMALIAN CORTICAL NEUROGENESIS; MATERNAL IMMUNE ACTIVATION; AUTISM
   SPECTRUM DISORDER; GROWTH-HORMONE TREATMENT; ALZHEIMERS-DISEASE;
   CEREBRAL ORGANOIDS; APOLIPOPROTEIN-E
AB The complex development of the human nervous system has been traditionally studied using a combination of animal models, human post-mortem brain tissue, and human genetics studies. However, there has been a lack of experimental human cellular models that would allow for a more precise elucidation of the intricate dynamics of early human brain development. The development of stem cell technologies, both embryonic and induced pluripotent stem cells (iPSCs), has given neuroscientists access to the previously inaccessible early stages of human brain development. In particular, the recent development of three-dimensional culturing methodologies provides a platform to study the differentiation of stem cells in both normal development and disease states in a more in vivo like context. Three-dimensional neural models or cerebral organoids possess an innate advantage over two-dimensional neural cultures as they can recapitulate tissue organization and cell type diversity that resemble the developing brain. Brain organoids also provide the exciting opportunity to model the integration of different brain regions in vitro. Furthermore, recent advances in the differentiation of non-neuronal tissue from stem cells provides the opportunity to study the interaction between the developing nervous system and other non-neuronal systems that impact neuronal function. In this review, we discuss the potential and limitations of the organoid system to study in vitro neurological diseases that arise in the neuroendocrine and the enteric nervous system or from interactions with the immune system.
C1 [Chukwurah, Evelyn; Osmundsen, Allison; Davis, Shannon W.; Lizarraga, Sofia B.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.
   [Chukwurah, Evelyn; Osmundsen, Allison; Davis, Shannon W.; Lizarraga, Sofia B.] Univ South Carolina, Ctr Childhood Neurotherapeut, Columbia, SC 29208 USA.
RP Lizarraga, SB (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.; Lizarraga, SB (corresponding author), Univ South Carolina, Ctr Childhood Neurotherapeut, Columbia, SC 29208 USA.
EM lizarras@mailbox.sc.edu
OI Chukwurah, Evelyn/0000-0002-9706-7003
FU Center of Biomedical Excellence Dietary Supplements and
   Inflammation-NIGMS [P20GM103641]; SC INBRE NIGMS [P20GM103499]; SC
   EPSCoR/IDeA Program [18-SR04]
FX Center of Biomedical Excellence Dietary Supplements and
   Inflammation-NIGMS P20GM103641 and SC INBRE NIGMS P20GM103499 Pilot
   Award supported SBL. Research reported in this publication was supported
   in part by the SC EPSCoR/IDeA Program under award number 18-SR04 to SBL.
   The views, perspective, and content do not necessarily represent the
   official views of the SC EPSCoR/IDeA Program.
CR Abreu CM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02766
   Ahn S, 2016, METHODS, V101, P103, DOI 10.1016/j.ymeth.2015.09.009
   Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473
   Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3
   Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007
   Nicolas-Avila JA, 2018, J LEUKOCYTE BIOL, V104, P743, DOI 10.1002/JLB.6MR0118-041R
   Angulo MA, 2015, J ENDOCRINOL INVEST, V38, P1249, DOI 10.1007/s40618-015-0312-9
   Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517
   Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132
   Aycan Z, 2014, J CLIN RES PEDIATR E, V6, P62, DOI [10.4274/Jcrpe.1228, 10.4274/jcrpe.1228]
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4
   Bakker B, 2007, HORM RES, V67, P203, DOI 10.1159/000097928
   Bakker NE, 2017, J CLIN ENDOCR METAB, V102, P1702, DOI 10.1210/jc.2016-2962
   Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007
   Banks WA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-231
   Bergmann S, 2018, NAT PROTOC, V13, P2827, DOI 10.1038/s41596-018-0066-x
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648
   Brosens E, 2016, DEV BIOL, V417, P198, DOI 10.1016/j.ydbio.2016.07.008
   Brown J, 2018, CURR TOP DEV BIOL, V129, P99, DOI 10.1016/bs.ctdb.2018.03.002
   Bruce-Keller AJ, 2018, BIOL PSYCHIAT, V83, P214, DOI 10.1016/j.biopsych.2017.08.014
   Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014
   Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020
   Castillo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17999-3
   Chen HI, 2019, DEV DYNAM, V248, P53, DOI 10.1002/dvdy.24662
   Cho CF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15623
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Cvetkovic C, 2018, JOVE-J VIS EXP, DOI 10.3791/58034
   Dalton N, 2014, AUTISM RES, V7, P305, DOI 10.1002/aur.1350
   Darville H, 2016, EBIOMEDICINE, V9, P293, DOI 10.1016/j.ebiom.2016.05.032
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   Davis SW, 2013, CURR TOP DEV BIOL, V106, P1, DOI 10.1016/B978-0-12-416021-7.00001-8
   Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675
   DeFelipe J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00104
   del Pino I, 2018, CURR OPIN NEUROBIOL, V48, P174, DOI 10.1016/j.conb.2017.12.013
   Di Marco B, 2016, CNS NEUROL DISORD-DR, V15, P448, DOI 10.2174/1871527315666160321105039
   Doe CQ, 2017, ANNU REV CELL DEV BI, V33, P219, DOI 10.1146/annurev-cellbio-111315-125210
   Driscoll DJ, 1993, GENEREVIEWS
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951
   FELTEN DL, 1993, PSYCHOTHER PSYCHOSOM, V60, P46, DOI 10.1159/000288679
   FELTEN DL, 1993, NEUROPSYCHOBIOLOGY, V28, P110, DOI 10.1159/000119011
   Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Giordano M, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0220-z
   Goldstone AP, 2008, J CLIN ENDOCR METAB, V93, P4183, DOI 10.1210/jc.2008-0649
   Gonzalez C, 2018, MOL PSYCHIATR, V23, P2363, DOI 10.1038/s41380-018-0229-8
   Grugni G, 2011, J PEDIATR ENDOCR MET, V24, P477, DOI 10.1515/JPEM.2011.269
   GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0
   GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505
   Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012
   Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463
   Heide M, 2018, CURR OPIN CELL BIOL, V55, P8, DOI 10.1016/j.ceb.2018.06.006
   Hoffman GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02330-5
   HOLM VA, 1993, PEDIATRICS, V91, P398
   Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y
   Hook V, 2014, STEM CELL REP, V3, P531, DOI 10.1016/j.stemcr.2014.08.001
   Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447
   Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Jabaudon D, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.172049
   Jhou JF, 2017, NEUROL THER, V6, pS57, DOI 10.1007/s40120-017-0070-z
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236
   Kajantie E, 2004, AM J MED GENET A, V126A, P313, DOI 10.1002/ajmg.a.20604
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   Kiba T, 2006, DIGESTION, V74, P215, DOI 10.1159/000100512
   Kikuti M, 2018, EUROSURVEILLANCE, V23, P44, DOI 10.2807/1560-7917.ES.2018.23.45.1700757
   Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704
   Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065
   Krencik R, 2017, STEM CELL REP, V9, P1745, DOI 10.1016/j.stemcr.2017.10.026
   Kretzschmar H, 2009, NAT REV NEUROSCI, V10, P70, DOI 10.1038/nrn2535
   Labouesse MA, 2015, AM J PHYSIOL-REG I, V309, pR1, DOI 10.1152/ajpregu.00087.2015
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lauschke K, 2017, STEM CELLS DEV, V26, P857, DOI 10.1089/scd.2017.0003
   Le Tissier PR, 2012, FRONT NEUROENDOCRIN, V33, P252, DOI 10.1016/j.yfrne.2012.08.002
   Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lin DSY, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/aae7de
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160
   Lippmann ES, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-2
   Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1
   Lopez MF, 2014, EXPERT REV PROTEOMIC, V11, P371, DOI 10.1586/14789450.2014.901892
   Lu J, 2011, JOVE-J VIS EXP, V51, P2681, DOI DOI 10.3791/2681
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410
   McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore S, 2015, CELL REP, V11, P689, DOI 10.1016/j.celrep.2015.03.068
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muffat J, 2016, CURR OPIN CELL BIOL, V43, P96, DOI 10.1016/j.ceb.2016.10.001
   Muratore CR, 2017, STEM CELL REP, V9, P1868, DOI 10.1016/j.stemcr.2017.10.015
   Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064
   NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F
   Nardone S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3339/fnins.2016.00329, 10.3389/fnins.2016.00329]
   Nowakowski TJ, 2018, NAT NEUROSCI, V21, P1784, DOI 10.1038/s41593-018-0265-3
   Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809
   Nzou G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25603-5
   Ochiai H, 2015, STEM CELL RES, V15, P290, DOI 10.1016/j.scr.2015.06.011
   Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2
   Osmundsen AM, 2017, ENDOCRINOLOGY, V158, P3339, DOI 10.1210/en.2017-00581
   Ozone C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10351
   Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P362, DOI 10.14573/altex.1609122
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Paredes I, 2018, DEV CELL, V45, P10, DOI 10.1016/j.devcel.2018.01.023
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca Sergiu P, 2018, Nat Neurosci, DOI 10.1038/s41593-018-0107-3
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Pearson CA, 2013, CURR TOP DEV BIOL, V106, P49, DOI 10.1016/B978-0-12-416021-7.00002-X
   Pescosolido MF, 2014, ANN NEUROL, V76, P581, DOI 10.1002/ana.24225
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, CURR OPIN CELL BIOL, V49, P47, DOI 10.1016/j.ceb.2017.11.010
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Rana P, 2017, TOXICOL IN VITRO, V45, P111, DOI 10.1016/j.tiv.2017.08.014
   Rao M, 2018, NAT REV NEUROSCI, V19, P552, DOI 10.1038/s41583-018-0041-0
   REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207
   Regen F, 2017, CURR ALZHEIMER RES, V14, P1140, DOI 10.2174/1567205014666170203141717
   Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700
   Rizzoti K, 2016, RES PERSPECT END INT, P135, DOI 10.1007/978-3-319-41603-8_11
   Rothhammer V, 2015, SEMIN IMMUNOPATHOL, V37, P575, DOI 10.1007/s00281-015-0521-5
   Salick MR, 2017, JOVE-J VIS EXP, V127, P56404
   Sanchez-Mejias E, 2016, ACTA NEUROPATHOL, V132, P897, DOI 10.1007/s00401-016-1630-5
   Santos R, 2017, STEM CELL REP, V8, P1757, DOI 10.1016/j.stemcr.2017.05.011
   Sasai Y, 2012, DEVELOPMENT, V139, P4111, DOI 10.1242/dev.079590
   Saurat NG, 2016, METHODS MOL BIOL, V1303, P267, DOI 10.1007/978-1-4939-2627-5_16
   Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026
   Schlieve CR, 2017, STEM CELL REP, V9, P883, DOI 10.1016/j.stemcr.2017.07.017
   Seo J, 2017, J NEUROSCI, V37, P9917, DOI 10.1523/JNEUROSCI.0621-17.2017
   Setia H., 2019, SEMIN CELL DEV BIO
   Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334
   Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843
   Shi Y, 2012, NAT NEUROSCI, V15, pS1, DOI DOI 10.1038/NN.3041.
   Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771
   Shirai Y, 1921, JPN MED WORLD, V1, P14, DOI DOI 10.1038/NM.4041
   Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011
   Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Song LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42439-9
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Su A, 2017, PARKINSONISM RELAT D, V39, P17, DOI 10.1016/j.parkreldis.2017.02.029
   Suga H, 2016, RES PERSPECT END INT, P35, DOI 10.1007/978-3-319-41603-8_4
   Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527
   Uppal S, 2017, HORM-INT J ENDOCRINO, V16, P92, DOI 10.14310/horm.2002.1723
   Van Vliet G, 2004, J PEDIATR-US, V144, P129, DOI 10.1016/j.jpeds.2003.09.049
   Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8
   Wang C, 2017, STEM CELL REP, V9, P1221, DOI 10.1016/j.stemcr.2017.08.019
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105
   Weed LH, 1917, CONTRIB EMBRYOL, V5, P7
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Whittington J, 2004, J INTELL DISABIL RES, V48, P188, DOI 10.1111/j.1365-2788.2004.00473.x
   Wislocki G. B., 1891, CONTRIB EMBRYOL CARN, VVI, P45
   Wittkowski W, 1998, MICROSC RES TECHNIQ, V41, P29, DOI 10.1002/(SICI)1097-0029(19980401)41:1<29::AID-JEMT4>3.0.CO;2-P
   Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233
   Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008
   Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009
   Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007
   Zhu GD, 2007, PROSTATE, V67, P674, DOI 10.1002/pros.20563
   Zila I, 2017, PHYSIOL RES, V66, pS139, DOI 10.33549/physiolres.933671
   Zimmer B, 2016, STEM CELL REP, V6, P858, DOI 10.1016/j.stemcr.2016.05.005
   Zyga O, 2015, J AUTISM DEV DISORD, V45, P975, DOI 10.1007/s10803-014-2252-1
NR 197
TC 3
Z9 3
U1 2
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD JUN 21
PY 2019
VL 13
AR 582
DI 10.3389/fnins.2019.00582
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA IE6EP
UT WOS:000472469500001
PM 31293366
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Regier, MC
   Olszewski, E
   Carter, CC
   Aitchison, JD
   Kaushansky, A
   Davis, J
   Berthier, E
   Beebe, DJ
   Stevens, KR
AF Regier, Mary C.
   Olszewski, Emily
   Carter, Christoph C.
   Aitchison, John D.
   Kaushansky, Alexis
   Davis, Jennifer
   Berthier, Erwin
   Beebe, David J.
   Stevens, Kelly R.
TI Spatial presentation of biological molecules to cells by localized
   diffusive transfer
SO LAB ON A CHIP
LA English
DT Article
ID AGAROSE GELS; HINDERED DIFFUSION; GRADIENTS; MACROMOLECULES;
   GLUTATHIONE; MICROFLUIDICS; CANCER; RECOMBINATION; COEFFICIENTS;
   ACTIVATION
AB Cellular decisions in human development, homeostasis, regeneration, and disease are coordinated in large part by signals that are spatially localized in tissues. These signals are often soluble, such that biomolecules produced by one cell diffuse to receiving cells. To recapitulate soluble factor patterning in vitro, several microscale strategies have been developed. However, these techniques often introduce new variables into cell culture experiments (e.g., fluid flow) or are limited in their ability to pattern diverse solutes in a userdefined manner. To address these challenges, we developed an adaptable method that facilitates spatial presentation of biomolecules across cells in traditional open cultures in vitro. This technique employs device inserts that are placed in standard culture wells, which support localized diffusive pattern transmission through microscale spaces between device features and adherent cells. Devices can be removed and cultures can be returned to standard media following patterning. We use this method to spatially control cell labeling with pattern features ranging in scale from several hundred microns to millimeters and with sequential application of multiple patterns. To better understand the method we investigate relationships between pattern fidelity, device geometry, and consumption and diffusion kinetics using finite element modeling. We then apply the method to spatially defining reporter cell heterogeneity by patterning a small molecule modulator of genetic recombination with the requisite sustained exposure. Finally, we demonstrate use of this method for patterning larger and more slowly diffusing particles by creating focal sites of gene delivery and infection with adenoviral, lentiviral, and Zika virus particles. Thus, our method leverages devices that interface with standard culture vessels to pattern diverse diffusible factors, geometries, exposure dynamics, and recipient cell types, making it well poised for adoption by researchers across various fields of biological research.
C1 [Regier, Mary C.; Olszewski, Emily; Davis, Jennifer; Stevens, Kelly R.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Regier, Mary C.; Olszewski, Emily; Davis, Jennifer; Stevens, Kelly R.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.
   [Regier, Mary C.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Regier, Mary C.; Beebe, David J.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53792 USA.
   [Carter, Christoph C.; Aitchison, John D.; Kaushansky, Alexis] Seattle Childrens Res Inst, Seattle, WA 98109 USA.
   [Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA.
   [Kaushansky, Alexis] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.
   [Davis, Jennifer; Stevens, Kelly R.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Berthier, Erwin] Univ Washington, Dept Chem, Seattle, WA 98195 USA.
RP Stevens, KR (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Stevens, KR (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.; Stevens, KR (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
EM ksteve@uw.edu
OI Aitchison, John/0000-0002-9153-6497; Stevens, Kelly/0000-0002-4024-2990;
   Berthier, Erwin/0000-0002-4421-9034; Kaushansky,
   Alexis/0000-0001-5721-258X; Olszewski, Emily/0000-0001-5922-0452
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32GM008349, DP2HL137188, R01GM101183,
   R21 AI124266, P41 GM109824, P30CA014520]; WRF postdoctoral fellowship;
   NIH/NIBIBUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Biomedical
   Imaging & Bioengineering (NIBIB) [T32EB001650]
FX We would like to thank Dr. Dale Hailey and the Garvey Cell Imaging Lab
   for assistance with fluorescence microscopy and Dr. Ashleigh Theberge
   for providing access to equipment for micromilling. This research was
   funded by NIH grants DP2HL137188 (K. R. S.), R01GM101183 (A. K.), R21
   AI124266 (J. D. A.), P41 GM109824 (J. D. A.), and P30CA014520 (D. J.
   B.). M. C. R. was supported by NIH Grant T32GM008349 and a WRF
   postdoctoral fellowship. E. O. was supported by NIH/NIBIB T32EB001650.
CR Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h
   Acharya A, 2011, GENESIS, V49, P870, DOI 10.1002/dvg.20750
   Akpinar F, 2016, J VIROL, V90, P7552, DOI 10.1128/JVI.00807-16
   Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746
   Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163
   Atencia J, 2009, LAB CHIP, V9, P2707, DOI 10.1039/b902113b
   Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059
   Berry SB, 2017, LAB CHIP, V17, P4253, DOI 10.1039/c7lc00878c
   Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Bier E, 2015, SCIENCE, V348, DOI 10.1126/science.aaa5838
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Chen D, 2008, P NATL ACAD SCI USA, V105, P16843, DOI 10.1073/pnas.0807916105
   Chung BG, 2006, LAB CHIP, V6, P764, DOI 10.1039/b512667c
   Clague DS, 1996, PHYS FLUIDS, V8, P1720, DOI 10.1063/1.868884
   Cosson S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04462
   Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832
   Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017
   de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49
   DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Enache TA, 2015, BIOELECTROCHEMISTRY, V101, P46, DOI 10.1016/j.bioelechem.2014.07.002
   Etoc F, 2016, DEV CELL, V39, P302, DOI 10.1016/j.devcel.2016.09.016
   Fatin-Rouge N, 2004, BIOPHYS J, V86, P2710, DOI 10.1016/S0006-3495(04)74325-8
   Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720
   GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guckenberger DJ, 2015, LAB CHIP, V15, P2364, DOI 10.1039/c5lc00234f
   Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x
   Hawe A, 2011, PHARM RES-DORDR, V28, P2302, DOI 10.1007/s11095-011-0460-3
   Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597
   Hem LH, 2003, BIOTECHNOL PROGR, V19, P544, DOI 10.1021/bp0256059
   Hulme SE, 2009, LAB CHIP, V9, P79, DOI 10.1039/b809673b
   Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h
   Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   Johnson EM, 1996, BIOPHYS J, V70, P1017, DOI 10.1016/S0006-3495(96)79645-5
   Juncker D, 2005, NAT MATER, V4, P622, DOI 10.1038/nmat1435
   Kaigala GV, 2011, LANGMUIR, V27, P5686, DOI 10.1021/la2003639
   Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260
   Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423
   Keenan TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345914
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Kshitiz, 2011, TRENDS BIOTECHNOL, V29, P399, DOI 10.1016/j.tibtech.2011.03.006
   Lander AD, 2013, SCIENCE, V339, P923, DOI 10.1126/science.1224186
   LAURENT TC, 1976, EUR J BIOCHEM, V68, P95, DOI 10.1111/j.1432-1033.1976.tb10767.x
   Leong SP, 2018, CLIN EXP METASTAS, V35, P361, DOI 10.1007/s10585-018-9921-y
   Liegibel UM, 2004, EXP CLIN ENDOCR DIAB, V112, P356, DOI 10.1055/s-2004-821014
   Lindsay SM, 2016, AICHE J, V62, P2227, DOI 10.1002/aic.15194
   Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011
   Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7
   Merino MM, 2016, TRENDS CELL BIOL, V26, P776, DOI 10.1016/j.tcb.2016.05.009
   Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217
   Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Oppegard SC, 2010, LAB CHIP, V10, P2366, DOI 10.1039/c004856a
   Pandey S, 2018, CURR BIOL, V28, P1052, DOI 10.1016/j.cub.2018.02.040
   Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9
   Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111
   Perrault CM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3497302
   Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0
   Qasaimeh MA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1471
   Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148
   Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118
   SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shah AM, 2012, ANAL CHEM, V84, P3682, DOI 10.1021/ac300190j
   Sip CG, 2014, LAB CHIP, V14, P302, DOI 10.1039/c3lc51052b
   Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977
   Stevens KR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2853
   Tabata Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44711
   Tavana H, 2009, NAT MATER, V8, P736, DOI [10.1038/nmat2515, 10.1038/NMAT2515]
   Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145
   Tewary M, 2017, DEVELOPMENT, V144, P4298, DOI 10.1242/dev.149658
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k
   Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yu WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089966
NR 86
TC 0
Z9 0
U1 3
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PD JUN 21
PY 2019
VL 19
IS 12
BP 2114
EP 2126
DI 10.1039/c9lc00122k
PG 13
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics; Instruments & Instrumentation
GA IC5XX
UT WOS:000471043900004
PM 31111131
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Sherer, ML
   Khanal, P
   Talham, G
   Brannick, EM
   Parcells, MS
   Schwarz, JM
AF Sherer, Morgan L.
   Khanal, Pragyan
   Talham, Gwen
   Brannick, Erin M.
   Parcells, Mark S.
   Schwarz, Jaclyn M.
TI Zika virus infection of pregnant rats and associated neurological
   consequences in the offspring
SO PLOS ONE
LA English
DT Article
ID MATERNAL IMMUNE ACTIVATION; MICROGLIA; BRAIN; PATHOGENESIS; CHEMOKINES;
   OUTBREAK; AUTISM; STATES; MODEL
AB Zika virus (ZIKV) is a mosquito-borne flavivirus associated with microcephaly and other neurological disorders in infants born to infected mothers. Despite being declared an international emergency by the World Health Organization, very little is known about the mechanisms of ZIKV pathogenesis or the long-term consequences of maternal ZIKV infection in the affected offspring, largely due to the lack of appropriate rodent models. To address this issue, our lab has developed a working model of prenatal ZIKV infection in rats. In this study, we infected immune competent pregnant female rats with 10(5)-10(7) PFU of ZIKV (PRVABC59, Puerto Rico/Human/Dec 2015) in order to examine its pathogenesis in the dams and pups. We examined the febrile response and sickness behavior in the dams, in addition to neonatal mortality, microglia morphology, cortical organization, apoptosis, and brain region-specific volumes in the offspring. Here, we demonstrate that pregnant and non-pregnant female rats have a distinct febrile response to ZIKV infection. Moreover, prenatal ZIKV infection increased cell death and reduced tissue volume in the hippocampus and cortex in the neonatal offspring. For the first time, we demonstrate the efficacy and validity of an immunocompetent rat model for maternal ZIKV infection that results in significant brain malformations in the neonatal offspring.
C1 [Sherer, Morgan L.; Khanal, Pragyan; Schwarz, Jaclyn M.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.
   [Talham, Gwen] Univ Delaware, Off Lab Anim Med, Newark, DE USA.
   [Brannick, Erin M.; Parcells, Mark S.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA.
RP Sherer, ML (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.
EM msherer@psych.udel.edu
OI Brannick, Erin/0000-0002-7045-3430
FU NIH-NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P20 GM103446]; NSFNational Science Foundation
   (NSF) [IIA-1301765]; State of Delaware;  [S10 RR027273]
FX Microscopy access was supported by grants from the NIH-NIGMS (P20
   GM103446), the NSF (IIA-1301765) and the State of Delaware. LSM780
   confocal microscope (Wolf Hall): Microscopy equipment was acquired with
   a shared instrumentation grant (S10 RR027273) and access was supported
   by the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of
   Delaware. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; The
   authors declare no competing financial interests. The authors would like
   to recognize Julie Gomez for collecting data presented in this
   manuscript and Joanne Cooper of the University of Delaware Comparative
   Pathology Laboratory for performing the Hematoxylin and Eosin stain.
   Microscopy access was supported by grants from the NIH-NIGMS (P20
   GM103446), the NSF (IIA-1301765) and the State of Delaware. LSM780
   confocal microscope (Wolf Hall): Microscopy equipment was acquired with
   a shared instrumentation grant (S10 RR027273) and access was supported
   by the NIH-NIGMS (P20 GM103446), the NSF (IIA-1301765) and the State of
   Delaware.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bilbo SD, 2018, EXP NEUROL, V299, P241, DOI 10.1016/j.expneurol.2017.07.002
   Bilbo SD, 2010, PSYCHONEUROENDOCRINO, V35, P369, DOI 10.1016/j.psyneuen.2009.07.014
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dantzer R, 2001, ANN NY ACAD SCI
   de Noronha L, ZIKA VIRUS DAMAGES H
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Gladwyn-Ng I, 2017, NAT NEUROSCI
   Glaser J, 2007, STEREOLOGY BIOL RES
   Gomez-Gonzalez B, 2010, ACTA NEUROPATHOL, V119, P303, DOI 10.1007/s00401-009-0590-4
   Perez-Alvarez MJ, 2016, CURR PHARM DESIGN, V22, P1334, DOI 10.2174/138161282210160304112834
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lledo P, 2012, J NEUROCHEM, P948, DOI [10.1111/j.1471-4159.2011.07630.x, DOI 10.1111/J.1471-4159.2011.07630.X]
   Manangeeswaran M, 2016, ZIKA PRVABC59 INFECT, P1
   Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196
   Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MOUTON PR, 2002, PRINCIPLES PRACTICES
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nem I, 2018, ACUTE CHRONIC NEUROL, P1
   Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherer ML, 2017, BRAIN BEHAV IMMUN, V66, P201, DOI 10.1016/j.bbi.2017.06.016
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013
   WU CH, 1992, J ANAT, V181, P423
   Zhang Z, 2015, BRAIN BEHAV IMMUN, V45, P60, DOI 10.1016/j.bbi.2014.10.010
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 20
PY 2019
VL 14
IS 6
AR e0218539
DI 10.1371/journal.pone.0218539
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW3PH
UT WOS:000484893500061
PM 31220154
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Vasquez, C
   Medina, J
   Carvajal, A
   Petrie, W
   Beier, JC
AF Wilke, Andre B. B.
   Vasquez, Chalmers
   Medina, Johana
   Carvajal, Augusto
   Petrie, William
   Beier, John C.
TI Community Composition and Year-round Abundance of Vector Species of
   Mosquitoes make Miami-Dade County, Florida a Receptive Gateway for
   Arbovirus entry to the United States
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AUTOCHTHONOUS DENGUE-FEVER; WEST-NILE-VIRUS; ZIKA VIRUS;
   CULEX-CORONATOR; DIPTERA-CULICIDAE; CLIMATE-CHANGE; YELLOW-FEVER; ROCIO
   VIRUS; 1ST RECORD; TRANSMISSION
AB Vector-borne diseases are a heavy burden to human-kind. Global warming and urbanization have a significant impact on vector-borne disease transmission, resulting in more severe outbreaks, and outbreaks in formerly non-endemic areas. Miami-Dade County, Florida was the most affected area in the continental United States during the 2016 Zika virus outbreak. Miami is an important gateway and has suitable conditions for mosquitoes year-round. Therefore, it was critical to establish and validate a surveillance system to guide and improve mosquito control operations. Here we assess two years of mosquito surveillance in Miami established after the 2016 Zika virus outbreak. Our results show that the most abundant mosquito species are either well adapted to urban environments or are adapting to it. The five most abundant species comprised 85% of all specimens collected, with four of them being primary vectors of arboviruses. Aedes aegypti and Culex quinquefasciatus were found year-round throughout Miami regardless of urbanization level, vegetation, or socioeconomic variations. This study serves as a foundation for future efforts to improve mosquito surveillance and control operations.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Medina, Johana; Carvajal, Augusto; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [1U01CK000510-03]
FX We would like to thank the staff of Miami-Dade County Mosquito Control
   Division for their help with field collections. We would also like to
   thank the residents of Miami-Dade County that graciously allowed us to
   enter their properties. This research was supported by CDC
   (https://www.cdc.gov/) grant 1U01CK000510-03: Southeastern Regional
   Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC
   had no role in the design of the study and collection, analysis, and
   interpretation of data and in writing the manuscript.
CR Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501
   Amarilla AA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199071
   Amraoui F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32198-4
   Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackmore CGM, 2003, AM J TROP MED HYG, V69, P141, DOI 10.4269/ajtmh.2003.69.141
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CDC, 2017, MOSQ SPEC W NIL VIR
   Coffey LL, 2005, AM J TROP MED HYG, V73, P11, DOI 10.4269/ajtmh.2005.73.1.0730011
   Connelly CR, 2016, J VECTOR ECOL, V41, P195, DOI 10.1111/jvec.12213
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Darsie RF Jr, 2000, TECH B FLORIDA MOSQ, V1
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Debboun M, 2005, J AM MOSQUITO CONTR, V21, P455, DOI 10.2987/8756-971X(2006)21[455:FROCCC]2.0.CO;2
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fé Nelson Ferreira, 2003, Rev. Soc. Bras. Med. Trop., V36, P343, DOI 10.1590/S0037-86822003000300005
   Gething P. W, 2012, PLOS NEGL TROP DIS, V6
   Gill J, 2000, EMERG INFECT DIS, V6, P30
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Honorio N. A., 2018, PLOS NEGLECT TROP D, V12, P1
   Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0
   International Air Transport Association, 2017, WORLDW ANN AIR PASS
   Jensen T, 1998, AM J TROP MED HYG, V59, P591, DOI 10.4269/ajtmh.1998.59.591
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kitchen S. F., 1936, American Journal of Tropical Medicine, V16, P579
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   LEDUC JW, 1975, AM J TROP MED HYG, V24, P118, DOI 10.4269/ajtmh.1975.24.118
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001
   LOPES OD, 1981, AM J EPIDEMIOL, V113, P122
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Multini LC, 2019, ACTA TROP, V190, P30, DOI 10.1016/j.actatropica.2018.10.009
   Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   PAHO/WHO, ZIK CAS CONG SYNDR A
   PAHO/WHO, 2017, EP UPD YELL FEV, P1
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   POND WL, 1966, AM J TROP MED HYG, V15, P205, DOI 10.4269/ajtmh.1966.15.205
   Raoult D, 2018, CLIN MICROBIOL INFEC, P8
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   ROBERTS DR, 1975, J MED ENTOMOL, V12, P537, DOI 10.1093/jmedent/12.5.537
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Sakkas H., 2018, VIRUSES, V10, P1
   Semenza JC, 2018, FEMS MICROBIOL LETT, V365, P1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SHROYER DA, 1991, J AM MOSQUITO CONTR, V7, P63
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Trimm A, 2017, J AM MOSQUITO CONTR, V33, P345, DOI 10.2987/17-6702.1
   Vasconcelos PFC, 1999, WHO DENGUE B NEW DEL, V23, P55
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Wilke ABB, 2018, INFECT GENET EVOL, V65, P333, DOI 10.1016/j.meegid.2018.08.017
   World Health Organization-WHO, 2018, YELL FEV BRAZ
NR 83
TC 4
Z9 4
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 19
PY 2019
VL 9
AR 8732
DI 10.1038/s41598-019-45337-2
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ID9TD
UT WOS:000472029100011
PM 31217547
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dang, JW
   Tiwari, SK
   Qin, Y
   Rana, TM
AF Dang, Jason W.
   Tiwari, Shashi Kant
   Qin, Yue
   Rana, Tariq M.
TI Genome-wide Integrative Analysis of Zika-Virus-Infected Neuronal Stem
   Cells Reveals Roles for MicroRNAs in Cell Cycle and Stemness
SO CELL REPORTS
LA English
DT Article
ID HEPATITIS-C VIRUS; NEURAL PROGENITORS; HUMAN CYTOMEGALOVIRUS;
   MESSENGER-RNA; PROTEIN; REPLICATION; IDENTIFICATION; NEUROGENESIS;
   RECOGNITION; EXPRESSION
AB Zika virus (ZIKV) infection is implicated in severe fetal developmental disorders, including microcephaly. MicroRNAs (miRNAs) post-transcriptionally regulate numerous processes associated with viral infection and neurodegeneration, but their contribution to ZIKV pathogenesis is unclear. We analyzed the mRNA and miRNA transcriptomes of human neuronal stem cells (hNSCs) during infection with ZIKV MR766 and Paraiba strains. Integration of the miRNA and mRNA expression data into regulatory interaction networks showed that ZIKV infection resulted in miRNA-mediated repression of genes regulating the cell cycle, stem cell maintenance, and neurogenesis. Bioinformatics analysis of Argonaute-bound RNAs in ZIKV-infected hNSCs identified a number of miRNAs with predicted involvement in microcephaly, including miR-124-3p, which dysregulates NSC maintenance through repression of the transferrin receptor (TFRC). Consistent with this, ZIKV infection upregulated miR-124-3p and downregulated TFRC mRNA in ZIKV-infected hNSCs and mouse brain tissue. These data provide insights into the roles of miRNAs in ZIKV pathogenesis, particularly the microcephaly phenotype.
C1 [Dang, Jason W.; Tiwari, Shashi Kant; Qin, Yue; Rana, Tariq M.] Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.
   [Dang, Jason W.; Tiwari, Shashi Kant; Qin, Yue; Rana, Tariq M.] Univ Calif San Diego, Div Genet, 9500 Gilman Dr,MC 0762, San Diego, CA 92093 USA.
   [Dang, Jason W.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412, San Diego, CA 92093 USA.
   [Qin, Yue] Univ Calif San Diego, Bioinformat & Syst Biol, 9500 Gilman Dr,MC 0419, La Jolla, CA 92093 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Program Immunol, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Inst Genom Med, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.
RP Rana, TM (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Div Genet, 9500 Gilman Dr,MC 0762, San Diego, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Program Immunol, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Inst Genom Med, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr,MC 0762, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
RI Tiwari, Shashi Kant/R-8533-2018
OI Tiwari, Shashi Kant/0000-0002-6121-6249
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA177322, DP1DA039562, AI125103,
   DA046171]
FX We thank Gene Yeo and Amy Pasquinelli for their advice on AGO-iCLIP
   experiments. We also thank Steve Head and the staff of the Next
   Generation Sequencing core facility at The Scripps Research Institute
   for help with the HT-seq and data analysis and members of the Rana lab
   for helpful discussions and advice. This work was supported in part by
   NIH grants to T.M.R. (CA177322, DP1DA039562, AI125103, and DA046171).
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258
   Cloney R, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.148
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838
   Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895
   Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726
   Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200
   Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044
   Fu M, 2014, GENE, V536, P272, DOI 10.1016/j.gene.2013.12.012
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gerardin P, 2018, LANCET INFECT DIS, V18, P15, DOI 10.1016/S1473-3099(17)30710-7
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Grozhik AV, 2017, METHODS MOL BIOL, V1562, P55, DOI 10.1007/978-1-4939-6807-7_5
   Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011
   Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Konig Julian, 2011, J Vis Exp, DOI 10.3791/2638
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160
   Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178
   Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162
   Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100
   Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shin J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.439
   Shlapobersky M, 2006, J VIROL, V80, P9951, DOI 10.1128/JVI.01300-06
   Silvestroff L, 2013, ASN NEURO, V5, P43, DOI 10.1042/AN20120075
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528
   Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8
   Wu YE, 2016, NAT NEUROSCI, V19, P1463, DOI 10.1038/nn.4373
   Yu KR, 2015, CELL REP, V10, P441, DOI 10.1016/j.celrep.2014.12.038
   Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237
NR 72
TC 3
Z9 3
U1 2
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 18
PY 2019
VL 27
IS 12
BP 3618
EP +
DI 10.1016/j.celrep.2019.05.059
PG 16
WC Cell Biology
SC Cell Biology
GA ID7MO
UT WOS:000471867200017
PM 31216479
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Jung, E
   Nam, S
   Oh, H
   Jun, S
   Ro, HJ
   Kim, B
   Kim, M
   Go, YY
AF Jung, Eunhye
   Nam, Sangwoo
   Oh, Hyeryeon
   Jun, Sangmi
   Ro, Hyun-Joo
   Kim, Baek
   Kim, Meehyein
   Go, Yun Young
TI Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits
   Multiple Steps of the Dengue Virus Life Cycle In Vitro
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; ZIKA VIRUS; CELL ENTRY; FLAVIVIRUS; INFECTION;
   MATURATION; PRM; REPLICATION; ASSOCIATION; CLEAVAGE
AB Dengue fever is one of the most important mosquito-borne viral infections in large parts of tropical and subtropical countries and is a significant public health concern and socioeconomic burden. There is an urgent need to develop antivirals that can effectively reduce dengue virus (DENV) replication and decrease viral load. Niclosamide, an antiparasitic drug approved for human use, has been recently identified as an effective antiviral agent against a number of pH-dependent viruses, including flaviviruses. Here, we reveal that neutralization of low-pH intracellular compartments by niclosamide affects multiple steps of the DENV infectious cycle. Specifically, niclosamide-induced endosomal neutralization not only prevents viral RNA replication but also affects the maturation of DENV particles, rendering them non-infectious. We found that niclosamide-induced endosomal neutralization prevented E glycoprotein conformational changes on the virion surface of flaviviruses, resulting in the release of non-infectious immature virus particles with uncleaved pr peptide from host cells. Collectively, our findings support the potential application of niclosamide as an antiviral agent against flavivirus infection and highlight a previously uncharacterized mechanism of action of the drug.
C1 [Jung, Eunhye; Nam, Sangwoo; Oh, Hyeryeon; Kim, Meehyein; Go, Yun Young] Korea Res Inst Chem Technol, Virus Res Grp, Daejeon, South Korea.
   [Jun, Sangmi; Ro, Hyun-Joo] Korea Res Inst Chem Technol, Convergent Res Ctr Emerging Virus Infect, Daejeon, South Korea.
   [Jun, Sangmi; Ro, Hyun-Joo] Korea Basic Sci Inst, Drug & Dis Target Grp, Cheongju, South Korea.
   [Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA.
   [Kim, Baek] Kyung Hee Univ, Dept Pharm, Coll Pharm, Seoul, South Korea.
   [Nam, Sangwoo; Kim, Meehyein; Go, Yun Young] Univ Sci & Technol, Dept Med Chem & Pharmacol, Daejeon, South Korea.
   [Jun, Sangmi; Ro, Hyun-Joo] Univ Sci & Technol, Bioanalyt Sci, Daejeon, South Korea.
RP Go, YY (corresponding author), Korea Res Inst Chem Technol, Virus Res Grp, Daejeon, South Korea.; Go, YY (corresponding author), Univ Sci & Technol, Dept Med Chem & Pharmacol, Daejeon, South Korea.
EM yygo@krict.re.kr
FU Korea Research Institute of Chemical Technology [KK-1803]; National
   Research Council of Science and Technology (NST), Daejeon, Republic of
   Korea [CRC-16-01-KRICT]
FX The authors are grateful to Dr. Rolf Hilgenfeld (University of Lubeck,
   Lubeck, Germany) for kindly providing DENV-2 NS2B-NS3 protease
   expression plasmid used in this study. We would also like to acknowledge
   Dr. Udeni B. R. Balasuriya (Louisiana State University, Baton Rouge, LA,
   USA) for critical reading of the manuscript. This study was supported by
   intramural funding (KK-1803) from the Korea Research Institute of
   Chemical Technology. The National Research Council of Science and
   Technology (NST), Daejeon, Republic of Korea, provided funding to S. Jun
   and H. J. Ro under grant number CRC-16-01-KRICT.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Burke DS, 2001, FIELDS VIROLOGY, VI, P1043
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   DITZEL J, 1967, ACTA MED SCAND, V182, P663
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Frayha GJ, 1997, GEN PHARMACOL, V28, P273, DOI 10.1016/S0306-3623(96)00149-8
   Go Y. Y., 2015, GENOME ANNOUNC, V3
   Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16
   GOLLINS SW, 1984, J GEN VIROL, V65, P1261, DOI 10.1099/0022-1317-65-8-1261
   Gubler D.J., 2006, NOVART FDN SYMP, V277, P16, DOI DOI 10.1002/0470058005.CH2
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484
   Heinz FX, 2004, ARCH VIROL, P133
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   ISHAK R, 1988, J GEN VIROL, V69, P325, DOI 10.1099/0022-1317-69-2-325
   Jeong Young Eui, 2011, Osong Public Health Res Perspect, V2, P34, DOI 10.1016/j.phrp.2011.04.002
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002
   Nuckols JT, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0215-y
   PAMPORI NA, 1984, MOL BIOCHEM PARASIT, V11, P205, DOI 10.1016/0166-6851(84)90066-5
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   Rothan HA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251482
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sheth U K, 1975, Prog Drug Res, V19, P147
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vanderlinden E, 2012, J VIROL, V86, P9416, DOI 10.1128/JVI.07032-11
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 56
TC 2
Z9 2
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 18
PY 2019
VL 9
AR 8682
DI 10.1038/s41598-019-45095-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ID7MZ
UT WOS:000471868300004
PM 31213630
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sissoko, F
   Junnila, A
   Traore, MM
   Traore, SF
   Doumbia, S
   Dembele, SM
   Schlein, Y
   Traore, AS
   Gergely, P
   Xue, RD
   Arheart, KL
   Revay, EE
   Kravchenko, VD
   Beier, JC
   Muller, GC
AF Sissoko, Fatoumata
   Junnila, Amy
   Traore, Mohamad M.
   Traore, Sekou F.
   Doumbia, Seydou
   Dembele, Seydou Mamadou
   Schlein, Yosef
   Traore, Amadou Sekou
   Gergely, Petranyi
   Xue, Rui-De
   Arheart, Kristopher L.
   Revay, Edita E.
   Kravchenko, Vasiliy D.
   Beier, John C.
   Muller, Gunter C.
TI Frequent sugar feeding behavior by Aedes aegypti in Bamako, Mali makes
   them ideal candidates for control with attractive toxic sugar baits
   (ATSB)
SO PLOS ONE
LA English
DT Article
ID NONTARGET ORGANISMS; CULEX-PIPIENS; BLOOD MEAL; DIPTERA; MOSQUITOS;
   CULICIDAE; ALBOPICTUS; SEEKING; FECUNDITY; EFFICACY
AB Background
   Current tools and strategies are not sufficient to reliably address threats and outbreaks of arboviruses including Zika, dengue, chikungunya, and yellow fever. Hence there is a growing public health challenge to identify the best new control tools to use against the vector Aedes aegypti. In this study, we investigated Ae. aegypti sugar feeding strategies in Bamako, Mali, to determine if this species can be controlled effectively using attractive toxic sugar baits (ATSB).
   Methodology
   We determined the relative attraction of Ae. aegypti males and females to a variety of sugar sources including flowers, fruits, seedpods, and honeydew in the laboratory and using plant-baited traps in the field. Next, we observed the rhythm of blood feeding versus sugar feeding activity of Ae. aegypti in vegetation and in open areas. Finally, we studied the effectiveness of spraying vegetation with ATSB on Ae. aegypti in sugar rich (lush vegetation) and in sugar poor (sparse vegetation) urban environments.
   Principal findings
   Male and female laboratory sugar feeding rates within 24 h, on 8 of 16 plants offered were over 80%. The survival rates of mosquitoes on several plant sources were nearly as long as that of controls maintained on sucrose solution. In the field, females were highly attracted to 11 of 20 sugar sources, and 8 of these were attractive to males. Peak periods of host attraction for blood-feeding and sugar feeding in open areas were nearly identical and occurred shortly after sunrise and around sunset. In shaded areas, the first sugar-seeking peak occurred between 11: 30 and 12: 30 while the second was from 16: 30 to 17: 30. In a 50-day field trial, ATSB significantly reduced mean numbers of landing / biting female Ae. aegypti in the two types of vegetation. At sugar poor sites, the mean pre-treatment catch of 20.51 females on day 14 was reduced 70-fold to 0.29 on day 50. At sugar rich sites, the mean pretreatment catch of 32.46 females on day 14 was reduced 10-fold to a mean of 3.20 females on day 50.
   Conclusions
   This is the first study to show how the vector Ae. aegypti depends on environmental resources of sugar for feeding and survival. The demonstration that Ae. aegypti populations rapidly collapsed after ATSB treatment, in both sugar rich and sugar poor environments, is strong evidence that Ae. aegypti is sugar-feeding frequently. Indeed, this study clearly demonstrates that Ae. aegypti mosquitoes depend on natural sugar resources, and a promising new method for vector control, ATSB, can be highly effective in the fight against Aedestransmitted diseases.
C1 [Sissoko, Fatoumata; Traore, Mohamad M.; Traore, Sekou F.; Doumbia, Seydou; Dembele, Seydou Mamadou; Traore, Amadou Sekou; Muller, Gunter C.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali.
   [Junnila, Amy; Schlein, Yosef; Muller, Gunter C.] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Kuvin Ctr Study Infect & Trop Dis,Fac Med, Jerusalem, Israel.
   [Gergely, Petranyi] Zool Staatssammlung Munchen, Munich, Germany.
   [Xue, Rui-De] Anastasia Mosquito Control Dist, St Augustine, FL USA.
   [Arheart, Kristopher L.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Revay, Edita E.] Technion, Bruce Rappaport Fac Med, Dept Anat & Cell Biol, Haifa, Israel.
   [Kravchenko, Vasiliy D.] Tel Aviv Univ, Dept Zool, Tel Aviv, Israel.
RP Muller, GC (corresponding author), Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali.; Muller, GC (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Kuvin Ctr Study Infect & Trop Dis,Fac Med, Jerusalem, Israel.
EM guntercmuller@hotmail.com
FU NIH NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI129387]; National Institute of
   Allergy and Infectious Diseases of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI100968]
FX NIH NIAID grant number U19 AI129387 was awarded to JB and the funders
   had no role in the study design, data collection and analysis, the
   decision to publish, or preparation of the manuscript. See the funders
   website at https://www.nih.gov.; We dedicate this work to Fatoumata
   Sissoko who passed away suddenly after the completion of this work. We
   also wish to thank the participating communities of Bamako in Mali and
   M. Makan Keita for his GPS work. This work, titled "ICEMR-Mali:
   Multidisciplinary research for malaria control and prevention in West;
   Africa", was supported by NIH NIAID grant number U19 AI129387 awarded to
   SD. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. This
   study was also supported by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health grant number
   R01AI100968 awarded to JB. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health. The authors declare that no competing
   interests exist in relation to this project.
CR ANDERSSON IH, 1987, MED VET ENTOMOL, V1, P59, DOI 10.1111/j.1365-2915.1987.tb00323.x
   [Anonymous], 1990, Wkly Epidemiol Rec, V65, P213
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   BRIEGEL H, 1986, J INSECT PHYSIOL, V32, P455, DOI 10.1016/0022-1910(86)90006-5
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   FRANCE KR, 1979, J INSECT PHYSIOL, V25, P841, DOI 10.1016/0022-1910(79)90144-6
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   HANCOCK RG, 1993, J MED ENTOMOL, V30, P353, DOI 10.1093/jmedent/30.2.353
   HEALY TP, 1988, B ENTOMOL RES, V78, P651, DOI 10.1017/S0007485300015509
   Holstein M., 1954, BIOLOGY OF ANOPHELES
   Junnila A, 2015, ACTA TROP, V152, P195, DOI 10.1016/j.actatropica.2015.09.006
   Khallaayoune K, 2013, ENVIRON ENTOMOL, V42, P1040, DOI 10.1603/EN13119
   KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P583, DOI 10.1016/0022-1910(79)90073-8
   Laarman JJ, 1968, ACTA LEIDENSIA, V36
   Martinez-Ibarra JA, 1997, J MED ENTOMOL, V34, P589, DOI 10.1093/jmedent/34.6.589
   Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108
   Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008
   Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-262
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210
   Muirhead-Thomson R. C, 1951, MOSQUITO BEHAV RELAT
   Muller GC, 2008, T ROY SOC TROP MED H, V102, P480, DOI 10.1016/j.trstmh.2008.01.008
   Muller GC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1878-9
   Muller GC, 2010, ACTA TROP, V116, P235, DOI 10.1016/j.actatropica.2010.08.014
   Nayar J. K., 1981, Journal of the Florida Anti-Mosquito Association, V52, P24
   NAYAR JK, 1975, J MED ENTOMOL, V12, P99, DOI 10.1093/jmedent/12.1.99
   Qualls WA, 2016, J VECTOR ECOL, V41, P224, DOI 10.1111/jvec.12217
   Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   REISEN WK, 1986, J MED ENTOMOL, V23, P366, DOI 10.1093/jmedent/23.4.366
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20
   Scott JM, 2017, J MED ENTOMOL, V54, P236, DOI 10.1093/jme/tjw133
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Straif SC, 1996, J MED ENTOMOL, V33, P608, DOI 10.1093/jmedent/33.4.608
   Tsuzuki A, 2009, AM J TROP MED HYG, V80, P752, DOI 10.4269/ajtmh.2009.80.752
   United States Environmental Protection Agency (EPA), 2010, 712C1000 US EPA
   VANHANDEL E, 1994, J AM MOSQUITO CONTR, V10, P149
   VARGO AM, 1982, J MED ENTOMOL, V19, P710, DOI 10.1093/jmedent/19.6.710
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   WHO, 2016, DRAFT GLOB VECT CONT
   WHO, 1986, DENG HAEM FEV DIAGN, P7
   WHO, 2017, MOSQ VECT CONTR EM R, V11
   YEE WL, 1992, J MED ENTOMOL, V29, P784, DOI 10.1093/jmedent/29.5.784
   Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150
NR 55
TC 6
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 17
PY 2019
VL 14
IS 6
AR e0214170
DI 10.1371/journal.pone.0214170
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW3OC
UT WOS:000484890300007
PM 31206547
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ryu, H
AF Ryu, Hanbyul
TI The effect of the Zika virus outbreak on fertility and female labour
   market outcomes
SO APPLIED ECONOMICS LETTERS
LA English
DT Article; Early Access
DE Women; fertility; Zika virus; labor market outcomes
ID EPIDEMIC
AB Since the outbreak of the Zika virus in Brazil, the number of microcephaly cases significantly increased among newborn children. Detrimental effects on the health outcomes of newborn children provided incentives to delay pregnancy, thereby potentially affecting women's labour market outcomes. Using the variation of suspected microcephaly cases across states, we found that for every suspected microcephaly case per 10,000 residents, the probability of having a newborn child decreased by approximately 8%. This trend was more pronounced among younger and more educated women. Despite fertility decline, our findings provide little evidence that female labour market outcomes were altered by the outbreak of Zika virus.
C1 [Ryu, Hanbyul] Univ Calif Riverside, Dept Econ, Riverside, CA 92521 USA.
RP Ryu, H (corresponding author), Univ Calif Riverside, Dept Econ, Riverside, CA 92521 USA.
EM econtj17@gmail.edu
CR Aguero JM, 2011, J HUM RESOUR, V46, P800
   Diaz-Quijano FA, 2018, AM J PUBLIC HEALTH, V108, P514, DOI [10.2105/AJPH.2017.304260, 10.2105/ajph.2017.304260]
   Lowe R., 2018, INT J ENV RES PUB HE, V15, P1, DOI [10.3390/ijerph15061188, DOI 10.3390/IJERPH15061188]
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   PAHO, 2016, ZIK EP REP BRAZ
   Quintana-Domeque C, 2018, ECON HUM BIOL, V30, P14, DOI 10.1016/j.ehb.2018.04.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 7
TC 0
Z9 0
U1 1
U2 1
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1350-4851
EI 1466-4291
J9 APPL ECON LETT
JI Appl. Econ. Lett.
DI 10.1080/13504851.2019.1624913
EA JUN 2019
PG 4
WC Economics
SC Business & Economics
GA II3LA
UT WOS:000475099900001
DA 2020-07-08
ER

PT J
AU Masri, S
   Jia, JF
   Li, C
   Zhou, GF
   Lee, MC
   Yan, GY
   Wu, J
AF Masri, Shahir
   Jia, Jianfeng
   Li, Chen
   Zhou, Guofa
   Lee, Ming-Chieh
   Yan, Guiyun
   Wu, Jun
TI Use of Twitter data to improve Zika virus surveillance in the United
   States during the 2016 epidemic
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika; ZIKV; Zika virus; Disease surveillance; Disease forecasting;
   Predictive modeling; Autoregressive model
ID SOCIAL MEDIA DATA; QUERY DATA; INFLUENZA; FLU
AB BackgroundZika virus (ZIKV) is an emerging mosquito-borne arbovirus that can produce serious public health consequences. In 2016, ZIKV caused an epidemic in many countries around the world, including the United States. ZIKV surveillance and vector control is essential to combating future epidemics. However, challenges relating to the timely publication of case reports significantly limit the effectiveness of current surveillance methods. In many countries with poor infrastructure, established systems for case reporting often do not exist. Previous studies investigating the H1N1 pandemic, general influenza and the recent Ebola outbreak have demonstrated that time- and geo-tagged Twitter data, which is immediately available, can be utilized to overcome these limitations.MethodsIn this study, we employed a recently developed system called Cloudberry to filter a random sample of Twitter data to investigate the feasibility of using such data for ZIKV epidemic tracking on a national and state (Florida) level. Two auto-regressive models were calibrated using weekly ZIKV case counts and zika tweets in order to estimate weekly ZIKV cases 1 week in advance.ResultsWhile models tended to over-predict at low case counts and under-predict at extreme high counts, a comparison of predicted versus observed weekly ZIKV case counts following model calibration demonstrated overall reasonable predictive accuracy, with an R-2 of 0.74 for the Florida model and 0.70 for the U.S. model. Time-series analysis of predicted and observed ZIKV cases following internal cross-validation exhibited very similar patterns, demonstrating reasonable model performance. Spatially, the distribution of cumulative ZIKV case counts (local- & travel-related) and zika tweets across all 50U.S. states showed a high correlation (r=0.73) after adjusting for population.ConclusionsThis study demonstrates the value of utilizing Twitter data for the purposes of disease surveillance. This is of high value to epidemiologist and public health officials charged with protecting the public during future outbreaks.
C1 [Masri, Shahir; Zhou, Guofa; Lee, Ming-Chieh; Yan, Guiyun; Wu, Jun] Uniers Calif, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92697 USA.
   [Jia, Jianfeng; Li, Chen] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA.
RP Wu, J (corresponding author), Uniers Calif, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92697 USA.
EM junwu@uci.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1U01HG00848801];
   National Science Foundation's Computer and Network Systems grant
   [1305430]; Army Research LaboratoryUnited States Department of DefenseUS
   Army Research Laboratory (ARL) [W911NF-16-2-0110]
FX This research was funded by the National Institutes of Health grant
   [1U01HG00848801], the National Science Foundation's Computer and Network
   Systems grant [1305430], as well as the Army Research Laboratory under
   Cooperative Agreement Number W911NF-16-2-0110. The funders had no role
   in study design, data collection or analysis.
CR Alsubaiee S, 2012, PROC VLDB ENDOW, V5, P1898, DOI 10.14778/2367502.2367532
   Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   [Anonymous], 2018, COMMUNICATION
   Ashlynn Daughton DP, 2017, P 2018 C HUM INF INT
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Broniatowski David Andre, 2015, JMIR Public Health Surveill, V1, pe5
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   CDC, 2016, WHAT HAPP I AM TEST
   CDC, 2018, NAT NOT DIS SURV SYS
   CDC, 2016, CAS COUNTS US 2016
   CDC, 2016, TRANSM RISKS US CTR
   CDC, 2016, ZIK VIR INF CLIN
   CDC, 2017, ZIK VIR WHAT IS CDC
   CDC, 2018, PUBL HLTH SURV PREP
   CDC, ALL COUNTR TERR ACT
   CDC, 2017, CDC TAK HLTH PULS AM
   Centers for Disease Control, 2016, MORBIDITY MORTALITY
   Dalton C, 2009, COMMUN DIS INTELL, V33, P316
   Deiner MS, 2016, JAMA OPHTHALMOL, V134, P1024, DOI 10.1001/jamaophthalmol.2016.2267
   Duke CH, 2016, AM J INFECT CONTROL
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Florida Health, 2016, FLOR DEP HLTH ZIK DA
   Florida Health, 2016, FLOR HLTH S MIAM BEA
   Fu K-W, 2016, AM J INFECT CONTROL
   Giles J, 2010, NEW SCI, V206, P2
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Majumder Maimuna S, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.e6659013c1d7f11bdab6a20705d1e865
   Mandal S, 2018, CHIIR'18: PROCEEDINGS OF THE 2018 CONFERENCE ON HUMAN INFORMATION INTERACTION & RETRIEVAL, P269, DOI 10.1145/3176349.3176874
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Morstatter F., 2013, P 7 INT AAAI C WEBL, P400, DOI DOI 10.1007/978-3-319-05579-4_10
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416
   Nation Pot, 2010, US MOOD DAY INF TWIT
   Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060
   Nsoesie EO, 2015, SCI REP-UK, V5, DOI 10.1038/srep09112
   Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sakaki T, 2010, EARTHQUAKE SHAKES TW
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732
   Santillana M, 2014, CLIN INFECT DIS, V59, P1446, DOI 10.1093/cid/ciu647
   Schootman M, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0050-z
   Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Smolinski MS, 2015, AM J PUBLIC HEALTH, V105, P2124, DOI 10.2105/AJPH.2015.302696
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Twitter. com, 2010, STREAM API DOC 2010
   U. S. C. B, 2016, POP HOUS UN EST DAT
   Wang YZ, 2015, ACM T WEB, V9, DOI 10.1145/2746366
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Woo H, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4955
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323
NR 66
TC 2
Z9 2
U1 5
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 14
PY 2019
VL 19
AR 761
DI 10.1186/s12889-019-7103-8
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID4PW
UT WOS:000471659800006
PM 31200692
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sharp, TM
   Fischer, M
   Munoz-Jordan, JL
   Paz-Bailey, G
   Staples, JE
   Gregory, CJ
   Waterman, SH
AF Sharp, Tyler M.
   Fischer, Marc
   Munoz-Jordan, Jorge L.
   Paz-Bailey, Gabriela
   Staples, J. Erin
   Gregory, Christopher J.
   Waterman, Stephen H.
TI Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically
   Compatible Illness and Risk for Infection with Both Viruses
SO MMWR RECOMMENDATIONS AND REPORTS
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; PREGNANT-WOMEN; PROLONGED
   DETECTION; ANTIBODY; RNA; PERSISTENCE; GUIDELINES; EPIDEMIC; OUTBREAK
AB Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients with suspected dengue or Zika virus disease, nucleic acid amplification tests (NAATs) are the preferred method of diagnosis. Immunoglobulin M (IgM) antibody testing can identify additional infections and remains an important tool for the diagnosis of these diseases, but interpreting the results is complicated by cross-reactivity, and determining the specific timing of infection can be difficult. These limitations are a particular challenge for pregnant women in determining whether Zika virus infection occurred during or before the pregnancy.
   This report summarizes existing and new guidance on dengue and Zika virus diagnostic testing for patients with a clinically compatible illness who live in or recently traveled to an area where there is risk for infection with both viruses. CDC recommendations for screening of asymptomatic pregnant women with possible Zika virus exposure are unchanged. For symptomatic nonpregnant persons, dengue and Zika virus NAATs should be performed on serum collected <= 7 days after symptom onset. Dengue and Zika virus IgM antibody testing should be performed on NAAT-negative serum specimens or serum collected >7 days after onset of symptoms. For symptomatic pregnant women, serum and urine specimens should be collected as soon as possible within 12 weeks of symptom onset for concurrent dengue and Zika virus NAATs and and IgM antibody testing. Positive IgM antibody test results with negative NAAT results should be confirmed by neutralizing antibody tests when clinically or epidemiologically indicated, including for all pregnant women. Data on the epidemiology of viruses known to be circulating at the location of exposure and clinical findings should be considered when deciding which tests to perform and for interpreting results.
   Patients with clinically suspected dengue should receive appropriate management to monitor and treat shock and hemorrhage. Women with laboratory evidence of possible Zika virus infection during pregnancy and their infants should be evaluated and managed for possible adverse outcomes. Dengue and Zika virus disease are nationally notifiable conditions, and cases should be reported to public health authorities.
C1 [Sharp, Tyler M.; Fischer, Marc; Munoz-Jordan, Jorge L.; Paz-Bailey, Gabriela; Staples, J. Erin; Gregory, Christopher J.; Waterman, Stephen H.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Sharp, TM (corresponding author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM tsharp@cdc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2019, ZIK VIR DIS ZIK VIR
   CDC, 2017, DENG VIR INF 2015 CA
   CDC, 2018, TEST GUID
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chien YW, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3058-0
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Sahly HM, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy352
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Machain-Williams C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9643083
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Paixao ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28387-w
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   US Food and Drug Administration, 2019, EM US AUTH
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 71
TC 12
Z9 12
U1 2
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1057-5987
EI 1545-8601
J9 MMWR RECOMM REP
JI MMWR Recomm. Rep.
PD JUN 14
PY 2019
VL 68
IS 1
BP 1
EP 10
DI 10.15585/mmwr.rr6801a1
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IC9AC
UT WOS:000471272500001
PM 31194720
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shreve, M
   Jarrett, A
   Scott, AL
   McNeill, C
AF Shreve, Marilou
   Jarrett, Anna
   Scott, Allison L.
   McNeill, Charleen
TI Zika: An Unfolding Story
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE congenital anomalies; Guillain-Barre syndrome; infectious disease;
   microcephaly; Zika virus
ID GUILLAIN-BARRE-SYNDROME; VIRUS
AB In our previous article on Zika, we established that it is a member of the Flaviviridae virus family. In this article, we discuss updated information regarding transmission and complications of Zika. In addition to contracting Zika virus from an infected mosquito, it has been transmitted between mother and fetus/infant and between sexual partners. Zika has been associated with Guillain-Barre syndrome, although the causal link has yet to be established. Microcephaly is a primary concern for fetuses of pregnant women infected with Zika virus. The most effective prevention strategy is to avoid mosquito bites in high-risk Zika areas. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Shreve, Marilou; Jarrett, Anna; Scott, Allison L.] Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
   [McNeill, Charleen] East Carolina Univ, Coll Nursing, Greenville, NC 27858 USA.
RP Shreve, M (corresponding author), Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
EM mdshreve@uark.edu
RI McNeill, Charleen/AAE-9324-2019
OI McNeill, Charleen/0000-0002-6787-4787; Jarrett, Anna/0000-0001-6370-2542
CR Capra D, 2017, J HEAR SCI, V7, P42
   Centers for Disease Control and Prevention, 2018, ZIK PREGN
   Centers for Disease Control and Prevention, 2017, FACTS MICR
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Heald-Sargent T, 2017, PEDIATR ANN, V46, pE428, DOI 10.3928/19382359-20171025-01
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Lange D, 2018, UPTODATE        0822
   Lissauer D, 2016, BJOG, V123, P1264
   Mandary D., 2018, MEDSCAPE
   McNeill C, 2016, JNP-J NURSE PRACT, V12, P359, DOI 10.1016/j.nurpra.2016.04.009
   Mehand MS, 2018, EMERG INFECT DIS, V24
   Mungan S, 2014, DICLE MED J, V41, P667, DOI [10.5798/diclemedj.0921.2014.04.0496, DOI 10.5798/DICLEMEDJ.0921.2014.04.0496]
   Nguyen KK, 2017, CLIN PEDIATR, V56, P213, DOI 10.1177/0009922816677039
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Silva S, 2018, VIRUSES, V10, P255
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   van der Linden V, 2019, JAMA NEUROL, V76, P203, DOI 10.1001/jamaneurol.2018.3553
   Vriesendorp FJ, 2018, GUILLIAN BARRE SYNDR
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 29
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD JUN 13
PY 2019
VL 15
IS 6
SI SI
BP 410
EP +
DI 10.1016/j.nurpra.2018.11.010
PG 7
WC Nursing
SC Nursing
GA IC8GD
UT WOS:000471214000017
DA 2020-07-08
ER

PT J
AU Liu-Helmersson, J
   Brannstrom, A
   Sewe, MO
   Semenza, JC
   Rocklov, J
AF Liu-Helmersson, Jing
   Brannstrom, Ake
   Sewe, Maquins Odhiambo
   Semenza, Jan C.
   Rocklov, Joacim
TI Estimating Past, Present, and Future Trends in the Global Distribution
   and Abundance of the Arbovirus Vector Aedes aegypti Under Climate Change
   Scenarios
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Aedes aegypti; mathematical model; vector abundance; temperature;
   precipitation; climate change; socioeconomic factors; global vector
   abundance
ID SPATIAL-DISTRIBUTION; YELLOW-FEVER; TEMPERATURE; ALBOPICTUS; DENGUE;
   TRANSMISSION; DRIVERS; IMPACT; VIRUS; TRADE
AB Background: Aedes aegypti is the principal vector for several important arbovirus diseases, including dengue, chikungunya, yellow fever, and Zika. While recent empirical research has attempted to identify the current global distribution of the vector, the seasonal, and longer-term dynamics of the mosquito in response to trends in climate, population, and economic development over the twentieth and the twenty-first century remains to be elucidated.
   Methods: In this study, we use a process-based mathematical model to estimate global vector distribution and abundance. The model is based on the lifecycle of the vector and its dependence on climate, and the model sensitivity to socio-economic development is tested. Model parameters were generally empirically based, and the model was calibrated to global databases and time series of occurrence and abundance records. Climate data on temperature and rainfall were taken from CRU TS3.25 (1901-2015) and five global circulation models (CMIP5; 2006-2099) forced by a high-end (RCP8.5) and a low-end (RCP2.6) emission scenario. Socio-economic data on global GDP and human population density were from ISIMIP (1950-2099).
   Findings: The change in the potential of global abundance in A. aegypti over the last century up to today is estimated to be an increase of 9.5% globally and a further increase of 20 or 30% by the end of this century under a low compared to a high carbon emission future, respectively. The largest increase has occurred in the last two decades, indicating a tipping point in climate-driven global abundance which will be stabilized at the earliest in the mid-twenty-first century. The realized abundance is estimated to be sensitive to socioeconomic development.
   Interpretation: Our data indicate that climate change mitigation, i.e., following the Paris Agreement, could considerably help in suppressing risks of increased abundance and emergence of A. aegypti globally in the second half of the twenty-first century.
C1 [Liu-Helmersson, Jing] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
   [Brannstrom, Ake] Umea Univ, Dept Math & Math Stat, Umea, Sweden.
   [Brannstrom, Ake] Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria.
   [Sewe, Maquins Odhiambo; Rocklov, Joacim] Umea Univ, Sect Sustainable Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [Semenza, Jan C.] European Ctr Dis Prevent & Control, Stockholm, Sweden.
RP Liu-Helmersson, J (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
EM jing.helmersson@umu.se
OI Rocklov, Joacim/0000-0003-4030-0449; sewe, maquins/0000-0003-1267-649X;
   Helmersson, Jing/0000-0001-9647-1015
FU European Union Seventh Framework Programme FP7/2007-2013 [282589];
   European Union's Horizon 2020 research and innovation programme under
   ZikaPLAN grant [734584]; ISIpedia project [2017-01742]; Swedish Research
   CouncilSwedish Research Council [2015-03917]; Swedish research funding
   agency Formas [2017-01300]
FX This work was supported by the European Union Seventh Framework
   Programme FP7/2007-2013 [282589], the European Union's Horizon 2020
   research and innovation programme under ZikaPLAN grant [734584], the
   ISIpedia project [2017-01742], the Swedish Research Council [2015-03917]
   and the Swedish research funding agency Formas [2017-01300].
CR [Anonymous], 2013, INTERSECTORAL IMPACT
   Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liu-Helmersson J, 2019, ENVIRON RES, V172, P693, DOI 10.1016/j.envres.2019.02.026
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Murakami D, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11072106
   Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43
   Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yang HM, 2014, APPL MATH IRVINE, V5, P2696, DOI [10.4236/am.2014.517257, DOI 10.4236/AM.2014.517257]
   Yang HM, 2014, ECOLOGICAL MODELLING, P39
   Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186
   Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9
NR 43
TC 5
Z9 5
U1 3
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUN 12
PY 2019
VL 7
AR 148
DI 10.3389/fpubh.2019.00148
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IE9BC
UT WOS:000472667800001
PM 31249824
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Khaiboullina, S
   Uppal, T
   Kletenkov, K
   St Jeor, SC
   Garanina, E
   Rizvanov, A
   Verma, SC
AF Khaiboullina, Svetlana
   Uppal, Timsy
   Kletenkov, Konstatin
   St Jeor, Stephen Charles
   Garanina, Ekaterina
   Rizvanov, Albert
   Verma, Subhash C.
TI Transcriptome Profiling Reveals Pro-Inflammatory Cytokines and Matrix
   Metalloproteinase Activation in Zika Virus Infected Human Umbilical Vein
   Endothelial Cells
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE Zika virus; inflammation; cytokines; cell permeability; matrix
   metalloproteinase
ID NF-KAPPA-B; NATURAL-KILLER; APOPTOSIS; CADHERIN; PROTEIN; DEATH;
   INTERLEUKIN-15; PERMEABILITY; REPLICATION; INTEGRITY
AB The deformities in the newborns infected with Zika virus (ZIKV) present a new potential public health threat to the worldwide community. Although ZIKV infection is mainly asymptomatic in healthy adults, infection during pregnancy can cause microcephaly and other severe brain defects and potentially death of the fetus. The detailed mechanism of ZIKV-associated damage is still largely unknown; however, it is apparent that the virus crosses the placental barrier to reach the fetus. Endothelial cells are the key structural component of the placental barrier. Endothelium integrity as semi-permeable barrier is essential to control the molecules and leukocytes trafficking across the placenta. Damaged endothelium or disruption of adherens junctions could compromise endothelial barrier integrity causing leakage and inflammation. Endothelial cells are often targeted by viruses, including the members of the Flaviviridae family such as dengue virus (DENV) and West Nile virus (WNV); however, little is known about the effects of ZIKV infection of endothelial cell functions. Our transcriptomic data have demonstrated that the large number of cytokines is affected in ZIKV-infected endothelial cells, where significant changes in 13 and 11 cytokines were identified in cells infected with PRVABC59 and IBH30656 ZIKV strains, respectively. Importantly, these cytokines include chemokines attracting mononuclear leukocytes (monocytes and lymphocytes) as well as neutrophils. Additionally, changes in matrix metalloproteinase (MMPs) were detected in ZIKV-infected cells. Furthermore, we for the first time showed that ZIKV infection of human umbilical vein endothelial cells (HUVECs) increases endothelial permeability. We reason that increased endothelial permeability was due to apoptosis of endothelial cells caused by caspase-8 activation in ZIKV-infected cells.
C1 [Khaiboullina, Svetlana; Uppal, Timsy; St Jeor, Stephen Charles; Verma, Subhash C.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA.
   [Kletenkov, Konstatin; Garanina, Ekaterina; Rizvanov, Albert] Kazan Fed Univ, Dept Exploratory Res, Sci & Educ Ctr Pharmaceut, Kazan, Russia.
   [St Jeor, Stephen Charles] Genequest LLC, Reno, NV USA.
RP Verma, SC (corresponding author), Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA.
EM scverma@med.unr.edu
RI Rizvanov, Albert/H-4486-2013; Khaiboullina, Svetlana/M-4793-2016
OI Rizvanov, Albert/0000-0002-9427-5739; Khaiboullina,
   Svetlana/0000-0002-5064-570X
FU Program of Competitive Growth of Kazan Federal UniversityMinistry of
   Education and Science, Russian FederationProject 5-100, Ministry of
   Education and Science, Russian Federation; Ministry of Science and
   Higher EducationMinistry of Science and Higher Education, Poland
   [20.5175.2017/6.7]; National Institute of General Medical Sciences from
   the National Institutes of Health [GM103440]
FX RAA was supported by Program of Competitive Growth of Kazan Federal
   University and state assignment 20.5175.2017/6.7 of the Ministry of
   Science and Higher Education. This publication was made possible by a
   grant from the National Institute of General Medical Sciences (GM103440)
   from the National Institutes of Health. This work was supported by the
   institutional and departmental funds.
CR Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003
   Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189
   Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chanthick C, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020069
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772
   Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060
   Ferreri AJM, 2010, NAT REV CLIN ONCOL, V7, DOI 10.1038/nrclinonc.2010.9-c1
   Foong YY, 2009, VIROLOGY, V393, P228, DOI 10.1016/j.virol.2009.07.030
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330
   Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012
   Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240
   Griffiths SK, 2015, BJA EDUC, V15, P84, DOI 10.1093/bjaceaccp/mku013
   Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71
   Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035
   Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367
   Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Khaiboullina SF, 2005, VIROLOGY, V342, P167, DOI 10.1016/j.virol.2005.07.035
   Kiran MS, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-6
   KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x
   Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032
   Lander HM, 2014, AM J TROP MED HYG, V90, P993, DOI 10.4269/ajtmh.13-0382
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Llorens A, 1998, LAB INVEST, V78, P1131
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   Marianneau P, 1997, J VIROL, V71, P3244, DOI 10.1128/JVI.71.4.3244-3249.1997
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306
   Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Pang V, 2017, CLIN SCI, V131, P2763, DOI 10.1042/CS20171252
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07
   Ribeiro MR, 2018, ARCH VIROL, V163, P2687, DOI 10.1007/s00705-018-3911-x
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964
   Singh A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4423
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596
   Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818
   Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681
NR 64
TC 2
Z9 2
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 12
PY 2019
VL 10
AR 642
DI 10.3389/fphar.2019.00642
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IC7QC
UT WOS:000471169800001
PM 31249527
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xavier, J
   Giovanetti, M
   Fonseca, V
   Theze, J
   Graf, T
   Fabri, A
   de Jesus, JG
   de Mendonca, MCL
   Rodrigues, CDD
   Mares-Guia, MA
   dos Santos, CC
   Tosta, SFD
   Candido, D
   Nogueira, RMR
   de Abreu, AL
   Oliveira, WK
   de Albuquerque, CFC
   Chieppe, A
   de Oliveira, T
   Brasil, P
   Calvet, G
   Sequeira, PC
   Faria, NR
   de Filippis, AMB
   Alcantara, LCJ
AF Xavier, Joilson
   Giovanetti, Marta
   Fonseca, Vagner
   Theze, Julien
   Graf, Tiago
   Fabri, Allison
   de Jesus, Jaqueline Goes
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Mares-Guia, Maria Angelica
   dos Santos, Carolina Cardoso
   de Oliveira Tosta, Stephane Fraga
   Candido, Darlan
   Ribeiro Nogueira, Rita Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Campelo de Albuquerque, Carlos F.
   Chieppe, Alexandre
   de Oliveira, Tulio
   Brasil, Patricia
   Calvet, Guilherme
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Bispo de Filippis, Ana Maria
   Junior Alcantara, Luiz Carlos
TI Circulation of chikungunya virus East/Central/South African lineage in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; POPULATION; MODEL; ZIKA
AB The emergence of chikungunya virus (CHIKV) has raised serious concerns due to the virus' rapid dissemination into new geographic areas and the clinical features associated with infection. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. Our phylogenetic reconstructions indicated the circulation of the East-Central-South-African (ECSA) lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with CHIKV notified case numbers revealed the ECSA lineage was introduced in Rio de Janeiro around June 2015 (95% Bayesian credible interval: May to July 2015) indicating the virus was circulating unnoticed for 5 months before the first reports of CHIKV autochthonous transmissions in Rio de Janeiro, in November 2015. These findings reinforce that continued genomic surveillance strategies are needed to assist in the monitoring and understanding of arbovirus epidemics, which might help to attenuate public health impact of infectious diseases.
C1 [Xavier, Joilson; de Jesus, Jaqueline Goes] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Xavier, Joilson; Giovanetti, Marta; Fabri, Allison; Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Mares-Guia, Maria Angelica; dos Santos, Carolina Cardoso; Ribeiro Nogueira, Rita Maria; Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; de Oliveira Tosta, Stephane Fraga; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Theze, Julien; Candido, Darlan; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Graf, Tiago; Fabri, Allison] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz; Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Calvet, Guilherme] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP de Filippis, AMB; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM abispo@ioc.fiocruz.br; luiz.alcantara@ioc.fiocruz.br
RI Oliveira, Wanderson/AAF-5182-2019; Graf, Tiago/S-8535-2019; Giovanetti,
   Marta/AAK-7408-2020; Fonseca, Vagner/R-5813-2019; Faria, Nuno
   Rodrigues/I-2975-2012; Calvet, Guilherme/G-6959-2013
OI Oliveira, Wanderson/0000-0002-9662-1930; Graf,
   Tiago/0000-0003-4921-7975; Fonseca, Vagner/0000-0001-5521-6448; Xavier,
   Joilson/0000-0003-3916-2018; Faria, Nuno Rodrigues/0000-0001-8839-2798;
   Calvet, Guilherme/0000-0002-3545-5238; De Jesus,
   Jaqueline/0000-0002-5404-272X; Alcantara, Luiz/0000-0002-6769-9931
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro /FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.930/2016]; Coordenacao de Vigilancia em Saude e Laboratorios
   de Referencia da Fundacao Oswaldo Cruz
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /Faperj over the grant number E-26/202.930/2016
   and by the Coordenacao de Vigilancia em Saude e Laboratorios de
   Referencia da Fundacao Oswaldo Cruz.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Brasil, 2018, B EP MON CAS DENG FE
   Brasil, 2016, B EP ARB CEN EP DENG
   Brasil, 2019, B EP MON CAS DENG FE
   Brasil, 2015, B EP MON CAS DED FEB
   Brasil. Boletim Epidemiologico, 2017, B EP MON CAS DENG FE
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Collado D, 2018, J VIROL
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2017, BRIEF BIOINFORM
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   PAHO/WHO, 2017, NUM CAS REP CHIK PAI
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 46
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR e0217871
DI 10.1371/journal.pone.0217871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000023
PM 31185030
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiramel, AI
   Meyerson, NR
   McNally, KL
   Broeckel, RM
   Montoya, VR
   Mendez-Solis, O
   Robertson, SJ
   Sturdevant, GL
   Lubick, KJ
   Nair, V
   Youseff, BH
   Ireland, RM
   Bosio, CM
   Kim, K
   Luban, J
   Hirsch, VM
   Taylor, RT
   Bouamr, F
   Sawyer, SL
   Best, SM
AF Chiramel, Abhilash, I
   Meyerson, Nicholas R.
   McNally, Kristin L.
   Broeckel, Rebecca M.
   Montoya, Vanessa R.
   Mendez-Solis, Omayra
   Robertson, Shelly J.
   Sturdevant, Gail L.
   Lubick, Kirk J.
   Nair, Vinod
   Youseff, Brian H.
   Ireland, Robin M.
   Bosio, Catharine M.
   Kim, Kyusik
   Luban, Jeremy
   Hirsch, Vanessa M.
   Taylor, R. Travis
   Bouamr, Fadila
   Sawyer, Sara L.
   Best, Sonja M.
TI TRIM5 alpha( )Restricts Flavivirus Replication by Targeting the Viral
   Protease for Proteasomal Degradation
SO CELL REPORTS
LA English
DT Article
ID PROTEINS REGULATE AUTOPHAGY; CYCLOPHILIN-A; KUNJIN VIRUS; RESTRICTION;
   HIV-1; TRIM5; RNA; NS5; RESISTANCE; INHIBITION
AB Tripartite motif-containing protein 5 alpha (TRIM5 alpha) is a cellular antiviral restriction factor that prevents early events in retrovirus replication. The activity of TRIM5 alpha is thought to be limited to retroviruses as a result of highly specific interactions with capsid lattices. In contrast to this current understanding, we show that both human and rhesus macaque TRIM5 alpha suppress replication of specific flaviviruses. Multiple viruses in the tick-borne encephalitis complex are sensitive to TRIM5 alpha-dependent restriction, but mosquito-borne flaviviruses, including yellow fever, dengue, and Zika viruses, are resistant. TRIM5 alpha suppresses replication by binding to the viral protease NS2B/3 to promote its K48-linked ubiquitination and proteasomal degradation. Importantly, TRIM5 alpha contributes to the antiviral function of IFN-I against sensitive flaviviruses in human cells. Thus, TRIM5 alpha possesses remarkable plasticity in the recognition of diverse virus families, with the potential to influence human susceptibility to emerging flaviviruses of global concern.
C1 [Chiramel, Abhilash, I; McNally, Kristin L.; Broeckel, Rebecca M.; Montoya, Vanessa R.; Mendez-Solis, Omayra; Robertson, Shelly J.; Sturdevant, Gail L.; Lubick, Kirk J.; Best, Sonja M.] NIAID, Innate Immun & Pathogenesis Sect, Lab Virol, RML,NIH, Hamilton, MT 59840 USA.
   [Meyerson, Nicholas R.; Sawyer, Sara L.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.
   [Nair, Vinod] NIAID, Res Technol Branch, RML, NIH, Hamilton, MT 59840 USA.
   [Youseff, Brian H.; Taylor, R. Travis] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, Hlth Sci Campus, Toledo, OH 43606 USA.
   [Ireland, Robin M.; Bosio, Catharine M.] NIAID, Immun Pulm Pathogens Sect, Lab Bacteriol, RML,NIH, Hamilton, MT 59840 USA.
   [Kim, Kyusik; Luban, Jeremy] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01655 USA.
   [Hirsch, Vanessa M.; Bouamr, Fadila] NIAID, Lab Mol Microbiol, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Best, SM (corresponding author), NIAID, Innate Immun & Pathogenesis Sect, Lab Virol, RML,NIH, Hamilton, MT 59840 USA.
EM sbest@niaid.nih.gov
OI Kim, Kyusik/0000-0001-9217-673X; SAWYER, SARA/0000-0002-6965-1085
FU Division of Intramural Research of the National Institute of Allergy and
   Infectious Diseases (NIAID), NIH; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01AI111809,
   DP1DA034990, RO1AI137011, DP1DA046108]; Burroughs Wellcome FundBurroughs
   Wellcome Fund
FX This work was supported by the Division of Intramural Research of the
   National Institute of Allergy and Infectious Diseases (NIAID), NIH, by
   NIH grants R01AI111809 and DP1DA034990 to J.L. and RO1AI137011 and
   DP1DA046108 to S.L.S. S.L.S. is a Burroughs Wellcome Investigator in the
   Pathogenesis of Infectious Disease. N.R.M. was supported by the PDEP
   award from the Burroughs Wellcome Fund.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Campbell EM, 2016, J VIROL, V90, P1849, DOI 10.1128/JVI.01948-15
   Chiramel AI, 2016, J INFECT DIS, V214, pS355, DOI 10.1093/infdis/jiw241
   CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5
   Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040
   Fletcher AJ, 2018, CELL HOST MICROBE, V24, P761, DOI 10.1016/j.chom.2018.10.007
   Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1
   Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108
   Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16
   Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388
   Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994
   Ireland R, 2018, J INNATE IMMUN, V10, P291, DOI 10.1159/000489504
   Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579
   Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546
   Kazimirova M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00339
   Kim K., 2019, BIORXIV, DOI [10.1101/587907, DOI 10.1101/587907]
   Kutluay SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003214
   Lascano J, 2016, J VIROL, V90, P308, DOI 10.1128/JVI.02496-15
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6
   Luban J, 2012, MOL BIOL INT, V2012, P1
   Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mandell MA, 2014, AUTOPHAGY, V10, P2387, DOI 10.4161/15548627.2014.984278
   Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013
   McCarthy KR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005085
   Merindol N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007398
   Merindol N, 2015, CURR HIV RES, V13, P448, DOI 10.2174/1570162X13666150608104412
   O'Connor C, 2010, J VIROL, V84, P5997, DOI 10.1128/JVI.02412-09
   Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005
   Ribeiro CMS, 2016, NATURE, V540, P448, DOI 10.1038/nature20567
   Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102
   Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777
   Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1
   Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2
   Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]
   Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Stremlau M, 2007, SCIENCE, V318, P1565, DOI 10.1126/science.1152905
   Tareen SU, 2009, VIROLOGY, V385, P473, DOI 10.1016/j.virol.2008.12.018
   Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004
   TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Vidotto A, 2017, J PROTEOME RES, V16, P1542, DOI 10.1021/acs.jproteome.6b00933
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wu F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003577
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 60
TC 3
Z9 3
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 11
PY 2019
VL 27
IS 11
BP 3269
EP +
DI 10.1016/j.celrep.2019.05.040
PG 21
WC Cell Biology
SC Cell Biology
GA IC5FO
UT WOS:000470993200014
PM 31189110
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Shresta, S
AF Ngono, Annie Elong
   Shresta, Sujan
TI Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights
   Into Vaccine Development
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE cross-reactive T cell response; Dengue; Zika; Epitope Mapping; vaccine
   development
ID MOUSE MODEL; PROTECTIVE ROLE; RESPONSES; INFECTION; LYMPHOCYTES;
   SEROTYPE; DISEASE; CD4(+); NAIVE; NS3
AB Dengue virus (DENV) is a member of the Flavivirus family that includes Zika virus (ZIKV), West Nile virus, Japanese encephalitis virus, and yellow fever virus. As the most prevalent of the flaviviruses, DENV is responsible for tens of millions of infections each year. The clinical manifestations of infection with one of the four DENV serotypes (DENV1-4) range from no symptoms to hemorrhagic fever and shock ("severe dengue"), which is fatal in similar to 25,000 patients annually. Many factors contribute to the development of severe dengue, including the DENV serotype and host expression of certain HLA alleles; however, it now seems clear that pre-existing immunity to DENV-and possibly other flaviviruses-is a major precipitating factor. While primary infection with one DENV serotype elicits strong cellular and humoral immune responses that likely confer long-lived protection against the same serotype, subsequent infection with a different serotype carries an increased risk of developing severe dengue. Thus, primary DENV infection elicits cross-reactive immunity that may be protective or pathogenic, depending on the context of the subsequent infection. Many flaviviruses share high sequence homology, raising the possibility that cross-reactive immunity to one virus may contribute to protection against or pathogenesis of a second virus in a similar manner. In addition, several flaviviruses are now endemic in overlapping geographic regions, underscoring the need to gain more knowledge about the mechanisms underlying cross-reactive immunity to different DENV serotypes and flaviviruses. Here, we review our current understanding of T cell immunity to DENV, focusing on cross-reactivity with other serotypes and flaviviruses such as ZIKV, and the role of DENV-elicited CD4(+) and CD8(+) T cells in protection. Recent work in this area supports a beneficial role for cross-reactive T cells and provides new insights into the design of safe and efficient flavivirus/pan-flavivirus vaccines.
C1 [Ngono, Annie Elong; Shresta, Sujan] La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
RP Ngono, AE; Shresta, S (corresponding author), La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
EM aelong@lji.org; sujan@lji.org
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI116813, AI140063]
FX AEN and SS are supported by grants from the National Institutes of
   Health (AI116813 and AI140063).
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   Coudeville L, 2016, VACCINE, V34, P6417, DOI 10.1016/j.vaccine.2015.11.023
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   GREEN S, 1993, J VIROL, V67, P5962, DOI 10.1128/JVI.67.10.5962-5967.1993
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Haltaufderhyde K, 2018, J INFECT DIS, V218, P1675, DOI 10.1093/infdis/jiy360
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   LIVINGSTON PG, 1995, J IMMUNOL, V154, P1287
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Talarico LB, 2017, EBIOMEDICINE, V20, P202, DOI 10.1016/j.ebiom.2017.04.033
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wijeratne DT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006540
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 72
TC 4
Z9 4
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 11
PY 2019
VL 10
AR 1316
DI 10.3389/fimmu.2019.01316
PG 9
WC Immunology
SC Immunology
GA IC5HV
UT WOS:000470999400004
PM 31244855
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zigart, N
   Casar, Z
AF Zigart, Nina
   Casar, Zdenko
TI A literature review of the patent publications on venetoclax - a
   selective Bcl-2 inhibitor: discovering the therapeutic potential of a
   novel chemotherapeutic agent
SO EXPERT OPINION ON THERAPEUTIC PATENTS
LA English
DT Review
DE Apoptosis; bcl-2; bcl-2 inhibitor; cancer therapy; combinational
   therapy; venetoclax
ID CELL-DEATH; FAMILY; CANCER; APOPTOSIS; PROTEINS; ABT-199; MALIGNANCIES
AB Introduction: Studies presented in patents show that a novel chemotherapeutic agent, venetoclax, might be useful in additional therapeutic indications. Venetoclax is approved in America for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Venetoclax selectively inhibits the B-cell lymphoma-2 (Bcl-2) protein, an anti-apoptotic protein that can be overexpressed in most B-cell lymphoid malignancies. Areas covered: This is a review of all the patents granted until November 2018, with venetoclax in the examples or claim section of the patent document. The patents include the synthesis, polymorphism, formulations, in vitro and in vivo efficacy as well as the therapeutic application of venetoclax. Expert opinion: The approved indications for treatment with venetoclax are limited but expanding rapidly. Studies suggest that venetoclax might be useful in several other therapeutic indications, mostly other hematological malignancies. Numerous studies use venetoclax in combinations with other therapeutic agents. Such combinational treatment shows promising results in additional indications as well as drug-resistant cancers. Venetoclax is an interesting new therapeutic involved in a variety of clinical research. Patent applications in recent years even include venetoclax in somewhat exotic fields such as type 1 diabetes, asthma, and Zika virus treatment.
C1 [Zigart, Nina; Casar, Zdenko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.
   [Zigart, Nina; Casar, Zdenko] Lek Pharmaceut Dd, Analyt Dept, Sandoz Dev Ctr Slovenia, Verovskova Ulica 57, Ljubljana 1526, Slovenia.
RP Casar, Z (corresponding author), Lek Pharmaceut Dd, Analyt Dept, Sandoz Dev Ctr Slovenia, Verovskova Ulica 57, Ljubljana 1526, Slovenia.
EM zdenko.casar@sandoz.com
RI Casar, Zdenko/AAJ-1528-2020
OI Zigart, Nina/0000-0001-9388-8616
FU Lek/Sandoz
FX This paper was funded by Lek/Sandoz.
CR Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161
   Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253
   Barkalow J, 2014, Patent No. [WO 2014/165044 A1, 2014165044]
   Beauparlant P, 2004, CELL ENGN SER, P223
   Bernstein BE, 2013, Patent No. [WO 2013/192274 A9, 2013192274]
   Bernstein BE, 2017, Patent No. [US 9,763,956 B2, 9763956]
   Bhushan A., 2018, Patent No. [WO 2018/204830 A2, 2018204830]
   Bialucha CU, 2016, Patent No. [WO 2016/024195 A1, 2016024195]
   Birkinshaw RW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10363-1
   Birtalan E, 2012, Patent No. [WO 2012/121758 A1, 2012121758]
   Bruncko M, 2011, Patent No. [WO 2011/149492 A1, 2011149492]
   Bruncko M, 2015, Patent No. [EP 2 576 546 B1, 2576546]
   Bruncko M, 2015, Patent No. [US 9,174,982 B2, 9174982]
   Bruncko M, 2015, Patent No. [EP 2 435 432 B1, 2435432]
   Bruncko M, 2010, Patent No. [WO 2010/138588 A2, 2010138588, WO2010138588]
   Catron N. D., 2012, Patent No. [WO 2012071336, 2012071336]
   Catron ND, 2012, Patent No. [WO 2012/058392 A1, 2012058392, WO 2012058392 Al]
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Crawford J, 2014, Patent No. [WO 2015/082583 A1, 2015082583]
   Davids MS, 2013, CANCER CELL, V23, P139, DOI 10.1016/j.ccr.2013.01.018
   Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50
   Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17
   Drugscom, 2019, VENCL APPR HIST
   Du C, 2015, Patent No. [WO 2015/153513 A1, 2015153513]
   Eastman AR, 2015, Patent No. [WO 2015/149105 A1, 2015149105]
   Elmore S, 2012, Patent No. [WO 2012/071374 A1, 2012071374]
   European Medicines Agency, 2018, VENCL VEN EPAR OV VE
   Ge M, 2016, Patent No. [CN 104370905 B, 104370905]
   He W, 2017, Pharmaceutical Compositions, Optionally Containing Fluorinated Pyrazolopyrimidine Bruton's Tyrosine Kinase Inhibitors, for Treatment of Cancer and Autoimmune Diseases, Patent No. [WO 2017218844 A2, 2017218844]
   Hill O, 2015, Patent No. [WO 2015/164588 A1, 2015164588]
   Hughes DL, 2016, ORG PROCESS RES DEV, V20, P2028, DOI 10.1021/acs.oprd.6b00374
   Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186
   Kalkavan H, 2018, CELL DEATH DIFFER, V25, P46, DOI 10.1038/cdd.2017.179
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   King AC, 2017, ANN PHARMACOTHER, V51, P410, DOI 10.1177/1060028016685803
   Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149
   Laberge R.M., 2015, Patent No. [WO2015116740, 2015116740]
   Li F, 2017, Patent No. [CN 106822916 A, 106822916]
   Lichtman MA, 2008, ONCOLOGIST, V13, P126, DOI 10.1634/theoncologist.2007-0228
   Link AJ, 2016, Patent No. [US 9,464,125 B2, 9464125]
   Liu XH, 2018, BIOORGAN MED CHEM, V26, P443, DOI 10.1016/j.bmc.2017.12.001
   Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208
   Madhok R, 2015, BMJ CLIN EVID, V12, P1123
   Manion MK, 2006, CURR OPIN INVEST DR, V7, P1077
   Marchini A, 2017, Patent No. [AU 2014295442 B2, 2014295442]
   Marchini A, 2017, Patent No. [EP 3 024 491 B1, 3024491]
   Marchini A, 2015, Patent No. [WO 2015/010782 A1, 2015010782]
   Marchini A, 2017, Patent No. [JP 6195988 B2, 6195988]
   Marchini A, 2018, Patent No. [US 9,889,169 B2, 9889169, 9,889,169]
   Mavragani C. P., 2014, CMAJ, V186, P579
   Mihalyova J, 2018, EXP HEMATOL, V61, P10, DOI 10.1016/j.exphem.2018.02.002
   MIYASHITA T, 1992, CANCER RES, V52, P5407
   Montero J, 2018, CELL DEATH DIFFER, V25, P56, DOI 10.1038/cdd.2017.183
   Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012
   Mullard A, 2016, NAT REV DRUG DISCOV, V15, P147, DOI 10.1038/nrd.2016.23
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Opferman JT, 2018, CELL DEATH DIFFER, V25, P37, DOI 10.1038/cdd.2017.170
   Petch A, 2004, CELL ENGN SER, P25
   Reed JC, 2018, CELL DEATH DIFFER, V25, P3, DOI 10.1038/cdd.2017.188
   Reilly EB, 2015, Patent No. [WO 2015/143382 A1, 2015143382]
   Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Starczynowski D, 2017, Patent No. [EP 2 999 470 B1, 2999470]
   Starczynowski D, 2016, Patent No. [US 9,504,706 B2, 9504706]
   Starczynowski D, 2018, Patent No. [US 9,855,273 B2, 9855273]
   Starczynowski D, 2014, Patent No. [WO 2014/190163 A2, 2014190163]
   Starczynowski D, 2015, Patent No. [US 9,168,257 B2, 9168257]
   Stern HM, 2014, Patent No. [WO 2014/071109 A1, 2014071109]
   Strack P, 2018, Patent No. [US 9,925,192 B2, 9925192]
   Strack P, 2015, Patent No. [WO 2015/130585 A1, 2015130585]
   Sun LL, 2016, Patent No. [WO 2016/090210 A1, 2016090210]
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263
   U.S. Food and Drug Administration (FDA), SEARCH ORPH DRUG DES
   Vogler M, 2013, BRIT J HAEMATOL, V163, P139, DOI 10.1111/bjh.12457
   Walensky LD., 2017, Patent No. [AU 2013235425 B2, 2013235425]
   Walensky LD., 2018, Patent No. [US 9,926,306 B2, 9926306]
   Walensky LD, 2013, Patent No. [WO 2013/142281 A1, 2013142281]
   Walsh K, 2015, Patent No. [WO 2015/153514 A1, 2015153514]
   Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8
   Yap JL, 2017, J MED CHEM, V60, P821, DOI 10.1021/acs.jmedchem.5b01888
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yuan S, 2018, Patent No. [WO 2018/192083 A1, 2018192083]
   Zhu HY, 2017, DRUG DES DEV THER, V11, P685, DOI 10.2147/DDDT.S109325
NR 84
TC 1
Z9 1
U1 3
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-3776
EI 1744-7674
J9 EXPERT OPIN THER PAT
JI Expert Opin. Ther. Patents
PD JUL 3
PY 2019
VL 29
IS 7
BP 487
EP 496
DI 10.1080/13543776.2019.1627327
EA JUN 2019
PG 10
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IM4PM
UT WOS:000473870400001
PM 31154862
DA 2020-07-08
ER

PT J
AU Hu, YW
   Dong, XH
   He, ZJ
   Wu, Y
   Zhang, SH
   Lin, JJ
   Yang, Y
   Chen, JH
   An, S
   Yin, YX
   Shen, ZY
   Zeng, GC
   Tian, H
   Cai, JC
   Yang, Y
   Guan, HY
   Wu, JH
   Li, MF
   Zhu, X
AF Hu, Yiwen
   Dong, Xinhuai
   He, Zhenjian
   Wu, Yun
   Zhang, Shihao
   Lin, Jiajie
   Yang, Yi
   Chen, Jiahui
   An, Shu
   Yin, Yingxian
   Shen, Zhiyong
   Zeng, Gucheng
   Tian, Han
   Cai, Junchao
   Yang, Yi
   Guan, Hongyu
   Wu, Jueheng
   Li, Mengfeng
   Zhu, Xun
TI Zika virus antagonizes interferon response in patients and disrupts
   RIG-I-MAVS interaction through its CARD-TM domains
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Zika virus; Nonstructural protein 4A; Interferon; RIG-I; MAVS
ID INFECTION; PROTEIN; MUTATION
AB BackgroundThe emerging threat to global health associated with the Zika virus (ZIKV) epidemics and its link to severe complications highlights a growing need to better understand the pathogenic mechanisms of ZIKV. Accumulating evidence for a critical role of type I interferon (IFN-I) in protecting hosts from ZIKV infection lies in the findings that ZIKV has evolved various strategies to subvert the host defense line by counteracting the early IFN induction or subsequent IFN signaling. Yet, mechanisms underlying the counter-IFN capability of ZIKV and its proteins, which might contribute to the well-recognized broad cellular tropisms and persistence of ZIKV, remain incompletely understood.ResultsUsing RNA sequencing-based transcriptional profiling of whole blood cells isolated from patients acutely infected by ZIKV, we found that transcriptional signature programs of antiviral interferon-stimulated genes and innate immune sensors in ZIKV-infected patients remained inactive as compared to those of healthy donors, suggesting that ZIKV was able to suppress the induction of IFN-I during the natural infection process in humans. Furthermore, by analyzing the molecular interaction in a ZIKV NS4A-overexpression system, or in the context of actual ZIKV infection, we identified that ZIKV NS4A directly bound MAVS and thereby interrupted the RIG-I/MAVS interaction through the CARD-TM domains, leading to attenuated production of IFN-I.ConclusionsOur findings collectively revealed that ZIKV NS4A targeted MAVS and contributed to ZIKV immune evasion through abrogating MAVS-mediated IFN production. These findings obtained from patient studies have added new knowledge and molecular details to our understanding regarding how ZIKV mediates suppression of the IFN-I system and may provide anew basis for the future development of anti-ZIKV strategies.
C1 [Hu, Yiwen; Dong, Xinhuai; Wu, Yun; Chen, Jiahui; An, Shu; Shen, Zhiyong; Zeng, Gucheng; Tian, Han; Cai, Junchao; Yang, Yi; Wu, Jueheng; Li, Mengfeng; Zhu, Xun] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.
   [Hu, Yiwen] Changsha Customs Dist PR China, Changsha 410000, Hunan, Peoples R China.
   [Dong, Xinhuai; Wu, Yun; Chen, Jiahui; An, Shu; Zeng, Gucheng; Wu, Jueheng; Li, Mengfeng; Zhu, Xun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China.
   [He, Zhenjian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhang, Shihao; Yang, Yi] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Basic Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Lin, Jiajie] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Clin Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Yin, Yingxian] Guangzhou Med Univ, Guangzhou Inst Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Yang, Yi] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China.
   [Guan, Hongyu] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhu, Xun] Guangdong Prov Key Lab Orthoped & Traumatol, Guangzhou 510080, Guangdong, Peoples R China.
RP Li, MF; Zhu, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China.
EM limf@mail.sysu.edu.cn; zhuxun8@mail.sysu.edu.cn
FU National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103011]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81870960, 81571992, 81501744, 81330058];
   Guangdong Natural Science Funds for Distinguished Young Scholars
   [2014A030306023]; "Guangdong TeZhi program" youth science and technology
   talent of project [2015TQ01R281]; Guangdong Special Fund for Marine
   Economic Development [GDME-2018C004]
FX This work was supported by the National Mega Project on Major Infectious
   Disease Prevention (2017ZX10103011); the Natural Science Foundation of
   China (81870960, 81571992, 81501744, 81330058); Guangdong Natural
   Science Funds for Distinguished Young Scholars (2014A030306023);
   "Guangdong TeZhi program" youth science and technology talent of project
   (2015TQ01R281); and the Guangdong Special Fund for Marine Economic
   Development (GDME-2018C004). The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01350
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 30
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD JUN 7
PY 2019
VL 9
AR 46
DI 10.1186/s13578-019-0308-9
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IC1SI
UT WOS:000470739000001
PM 31183075
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Clancy, CS
   Van Wettere, AJ
   Morrey, JD
   Julander, JG
AF Clancy, Chad S.
   Van Wettere, Arnaud J.
   Morrey, John D.
   Julander, Justin G.
TI Zika Virus Associated Pathology and Antigen Presence in the Testicle in
   the Absence of Sexual Transmission During Subacute to Chronic Infection
   in a Mouse Model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACELLULAR ORGANELLES PROSTASOMES; VECTOR-BORNE TRANSMISSION; HUMAN
   SEMINAL PLASMA; COMPONENTS; SEMEN
AB Zika virus (ZIKV) is an arboviral infection that has been shown to be sexually transmitted. The study outlined herein aims to determine if accessory sex glands and epididymal epithelial cells are sources of viral persistence in subacute and chronic ZIKV infection, and if infection of these organs is important in sexual transmission during long-term (chronic) infection. Male interferon type I receptor knockout (Ifnar(-/-)) mice were challenged with ZIKV and reproductive tissues were harvested 14 and 35 days post infection (DPI) for inoculation studies and 14, 35 and 70 DPI for histopathology. Artificial insemination fluid derived from epididymal flush and seminal plasma from the prostate and seminal vesicle was obtained from ZIKV inoculated and sham-infected males. Naive interferon type I and II receptor knockout (AG129) female mice were pre-treated with progesterone and inoculated intravaginally with artificial insemination fluid from ZIKV-infected males. ZIKV RNA was detected in the artificial insemination fluid generated from epididymal flush or seminal plasma from ZIKV infected males at 14 and 35 DPI. ZIKV antigens were only detected in seminiferous tubules at 14 DPI. Epididymal epithelial cells did not show ZIKV antigen immunoreactivity at 14, 35 or 70 DPI. Severe fibrosing orchitis (end stage orchitis) was observed at 35 and 70 DPI. Mild inflammation and peri-tubular fibrosis were observed in the epididymis following clearance of virus. Viral RNA was not detected by PCR in whole blood samples of females from any intravaginal experimental group and only detected in 20% of subcutaneously inoculated animals (derived from 1 experimentally infected male) at 35 DPI. While ZIKV RNA and antigens can be detected in the male reproductive tract at 14 DPI and RNA can also be detected at 35 DPI, intravaginal inoculation of artificial insemination fluid from these time-points failed to result in viremia in naive females inoculated intravaginally. These studies support the hypothesis that epididymal epithelial cells are critical to sexual transmission in immunocompromised mice. Additionally, acute but not chronic male reproductive tract infection with ZIKV results in infectious virus capable of being sexually transmitted in mice.
C1 [Clancy, Chad S.; Van Wettere, Arnaud J.] Utah State Univ, Dept Anim Dairy & Vet Sci, Sch Vet Med, Utah Vet Diagnost Lab, Logan, UT 84341 USA.
   [Clancy, Chad S.; Morrey, John D.; Julander, Justin G.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.
RP Julander, JG (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.
EM Justin.julander@usu.edu
OI Clancy, Chad/0000-0002-5354-9270
FU Public Health Service (PHS) from the Virology Branch, National Institute
   of Allergy and Infectious Diseases (NIAID), National Institutes of
   Health [5R33AI101483, HHSN272201000039I/HHSN27200004]
FX The work was supported by Public Health Service (PHS) grant 5R33AI101483
   and contract HHSN272201000039I/HHSN27200004 to J.D.M. from the Virology
   Branch, National Institute of Allergy and Infectious Diseases (NIAID),
   National Institutes of Health.
CR ANDERSON DJ, 1982, J IMMUNOL, V128, P535
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bancroft J.D., 2008, THEORY PRACTICE HIST
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   CDC/EUA, 2015, ZIK VIR WEB, P2, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Clancy CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33528-2
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P3
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Habu A, 1977, Uirusu, V27, P21
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   KELLY RW, 1991, CLIN EXP IMMUNOL, V86, P550
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   National Research Council, 2011, THE NATIONAL, V66
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147
   SKIBINSKI G, 1992, AM J REPROD IMMUNOL, V28, P97, DOI 10.1111/j.1600-0897.1992.tb00767.x
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 36
TC 1
Z9 1
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 6
PY 2019
VL 9
AR 8325
DI 10.1038/s41598-019-44582-9
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IB4LP
UT WOS:000470243800006
PM 31171800
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, HB
   Liao, HM
   Li, BJ
   Tsai, S
   Hung, GC
   Lo, SC
AF Liu, Hebing
   Liao, Hsiao-Mei
   Li, Bingjie
   Tsai, Shien
   Hung, Guo-Chiuan
   Lo, Shyh-Ching
TI Comparative Genomics, Infectivity and Cytopathogenicity of American
   Isolates of Zika Virus that Developed Persistent Infections in Human
   Embryonic Kidney (HEK293) Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; viral persistence; HEK293; FLR strain; PRV strain
AB Zika virus (ZIKV) transmission can cause serious fetal neurological abnormalities. ZIKV persistence in various human cells and tissues can serve as infectious reservoirs and post serious threats to public health. The human embryonic kidney (HEK293) cell line with known neuronal developmental properties was readily infected by ZIKV in a strain-dependent fashion. Significant cytopathic effect in HEK293 cells infected by the prototype MR 766 strain of ZIKV resulted in complete loss of cells, while small numbers of HEK293 cells infected by contemporary ZIKV isolates (PRV or FLR strain) continued to survive and regrow to confluency in the culture around two months after initial infection. Most, if not all, of the cells in the two resulting persistently ZIKV-infected HEK293 cell lines tested positive for ZIKV antigen. Compared to HEK293 control cells, the persistently ZIKV-infected HEK293 cells had slower growth rates with some cells undergoing apoptosis in culture. The persistent ZIKVs produced constitutively by both PRV and FLR strains ZIKV-infected HEK293 cells had significantly attenuated cell infectivity and/or cytopathogenicity. Comparative genome sequence analyses between the persistent ZIKVs and the original inoculum ZIKVs showed no clonal selection with specific gene mutations in the prolonged process of establishing persistently PRV strain ZIKV-infected HEK293 cells; while selection of ZIKV subclones with mutations in the envelope, protein pr and multiple NS genes was evident in developing persistently FLR strain ZIKV-infected HEK293 cell line. Our study provides molecular insights into the complex interplays of ZIKV and human host cells in establishing ZIKV persistence.
C1 [Liu, Hebing; Liao, Hsiao-Mei; Li, Bingjie; Tsai, Shien; Hung, Guo-Chiuan; Lo, Shyh-Ching] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA.
RP Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA.
EM hebing.liu@fda.hhs.gov; hsiao-mei.liao@fda.hhs.gov;
   bingjie.li@fda.hhs.gov; shien.tsai@gmail.com;
   guo-chiuan.hung@fda.hhs.gov; shyhching.lo@fda.hhs.gov
FU Office of Tissue and Advanced Therapies/Center for Biologics Evaluation
   and Research, U.S. Food and Drug Administration (FDA)
FX This research was funded in part by an appointment to the Research
   Fellowship Program at the Office of Tissue and Advanced Therapies/Center
   for Biologics Evaluation and Research, U.S. Food and Drug Administration
   (FDA), administered by the Oak Ridge Institute for Science and Education
   through and interagency agreement between the U.S. Department of Energy
   and FDA.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998
   Li BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203331
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mlera L, 2015, MBIO, V6, DOI 10.1128/mBio.00614-15
   RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 20
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN 2
PY 2019
VL 20
IS 12
AR 3035
DI 10.3390/ijms20123035
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IG4ED
UT WOS:000473756000185
PM 31234341
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, K
   Arroyo, J
   Saxton, E
   Rawal, D
   Patibandla, S
AF Singh, K.
   Arroyo, J.
   Saxton, E.
   Rawal, D.
   Patibandla, S.
TI Performance evaluation of the ADVIA Centaur Zika Test
SO CLINICA CHIMICA ACTA
LA English
DT Meeting Abstract
CT 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory
   Medicine (EuroMedLab)
CY MAY 19-23, 2019
CL Barcelona, SPAIN
SP Int Federat Clin Chem & Lab Med, European Federat Clin Chem & Lab Med
C1 [Singh, K.; Arroyo, J.; Saxton, E.; Rawal, D.; Patibandla, S.] Siemens Healthcare Diagnost Inc, Tarrytown, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD JUN
PY 2019
VL 493
SU 1
MA W217
BP S540
EP S540
DI 10.1016/j.cca.2019.03.1135
PG 1
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA LI5NI
UT WOS:000529532101415
OA Bronze
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Female-to-male sexual transmssion of Zika virus infection
SO FAMILY MEDICINE AND COMMUNITY HEALTH
LA English
DT Letter
ID TRANSMISSION
C1 [Joob, Beuy] Med Acad Ctr, Sanitat 1, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Vidyapeeth Univ, Dept Community Med, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Med Acad Ctr, Sanitat 1, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Joob B, 2016, INT MARIT HEALTH, V67, P260, DOI 10.5603/IMH.2016.0046
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Sherley M, 2018, SEX HEALTH, V15, P183, DOI 10.1071/SH17046
   Sookaromdee P, 2018, INDIAN J SEX TRANSM, V39, P61, DOI 10.4103/ijstd.IJSTD_65_16
   Rodriguez JSV, 2018, FAM MED COMMUNITY HE, V6, P208, DOI 10.15212/FMCH.2018.0117
   Wiwanitkit S., 2016, Asian Pacific Journal of Tropical Disease, V6, P757, DOI 10.1016/S2222-1808(16)61124-6
NR 7
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2305-6983
EI 2009-8774
J9 FAM MED COMMUNITY HE
JI Fam. Med. Community Health
PD JUN
PY 2019
VL 7
IS 3
AR UNSP e000183
DI 10.1136/fmch-2019-000183
PG 1
WC Primary Health Care
SC General & Internal Medicine
GA KK7EN
UT WOS:000512901200010
PM 32148719
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yoon, J
   Hagen, L
   Andrews, J
   Scharf, R
   Keller, T
   Chung, E
AF Yoon, JungWon
   Hagen, Loni
   Andrews, James
   Scharf, Ryan
   Keller, Thomas
   Chung, EunKyung
TI On the use of multimedia in Twitter health communication: analysis of
   tweets regarding the Zika virus
SO INFORMATION RESEARCH-AN INTERNATIONAL ELECTRONIC JOURNAL
LA English
DT Article
ID INFORMATION
AB Introduction: This study investigated influences of multimedia tweets on retweetablity during public health crises, in order to provide evidence for facilitating effective use of Twitter for health communication.
   Method: Using the Twitter stream API, a total of 359,043 Zika-related tweets were collected for analysis.
   Analysis: The sampled tweets were quantitatively analysed using descriptive statistics and chisquared tests. For content analysis, subsets of the dataset were manually coded.
   Results: 1) text tweets were sent out more frequently than multimedia tweets, but multimedia tweets had higher retweetability, 2) tweets by government, mainstream news media, and online news media were frequently retweeted, 3) images were often used for educational and informational (not news) tweets, and videos were used for educational and political purposes, 4) however, considering retweetability, highly retweeted images were for disseminating brief news, and highly retweeted video tweets were for disseminating informational or educational messages, and 5) ratios of non-U.S. agents were higher in multimedia retweets than text retweets.
   Conclusion: The findings can help government and business practitioners to build their social media communication strategies in order to effectively select proper content and multimedia formats to enhance the impact of information sharing and communications during emergent health situations.
C1 [Yoon, JungWon; Hagen, Loni; Andrews, James] Univ S Florida, Sch Informat, Tampa, FL 33620 USA.
   [Scharf, Ryan] Amer Integr Insurance Co, Tampa, FL 33609 USA.
   [Keller, Thomas] Univ S Florida, Kami Kim Lab & Res Comp, Tampa, FL 33620 USA.
   [Chung, EunKyung] Ewha Womans Univ, Dept Lib & Informat Sci, Seoul 03760, South Korea.
RP Yoon, J (corresponding author), Univ S Florida, Sch Informat, Tampa, FL 33620 USA.
EM jyoon@usf.edu; lonihagen@usf.edu; jimandrews@usf.edu;
   ryan.scharf@gmail.com; tekeller@usf.edu; echung@ewha.ac.kr
FU National Research Foundation of Korea Grant - Korean Government
   [NRF-2017S1A3A2066084]
FX The authors would like to thank research assistants, Mary Kate Downing
   and Carrie Cullen, for help in data analysis. Loni Hagen was partially
   supported by the National Research Foundation of Korea Grant funded by
   the Korean Government (NRF-2017S1A3A2066084).
CR [Anonymous], 2016, REUTERS BJDEVTE 0225
   Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620
   Ulloa LC, 2015, INFORM RES, V20
   Chen T., 2013, P 21 ACM INT C MULT, P781, DOI DOI 10.1145/2502081.2502203
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chung EunKyung, 2013, [Journal of the Korean Biblia Society for Library and Information Science, 한국비블리아학회지], V24, P75, DOI 10.14699/kbiblia.2013.24.4.075
   Garcia-Retamero R, 2013, CURR DIR PSYCHOL SCI, V22, P392, DOI 10.1177/0963721413491570
   Garimella VRK, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P5543, DOI 10.1145/2858036.2858234
   Golbeck J, 2010, J AM SOC INF SCI TEC, V61, P1612, DOI 10.1002/asi.21344
   Hagen L., 2017, SOCIAL SCI COMPUTER
   Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273
   Holsti O. R., 1969, CONTENT ANAL SOCIAL
   Honeycutt Courtenay, 2009, P 42 HAW INT C SYST, P1, DOI DOI 10.1109/HICSS.2009.89
   Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004
   Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564
   Java A., 2007, P 9 WEBKDD 1 SNA KDD, V2007, P56, DOI DOI 10.1145/1348549.1348556
   Joffe H, 2008, DIOGENES, V55, P84, DOI 10.1177/0392192107087919
   Mayer R.E., 2005, CAMBRIDGE HDB MULTIM
   MedlinePlus, ZIK
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Morgan EM, 2010, COMPUT HUM BEHAV, V26, P1405, DOI 10.1016/j.chb.2010.04.017
   Naaman M, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P189
   Naik PA, 2003, J MARKETING RES, V40, P375, DOI 10.1509/jmkr.40.4.375.19385
   Rantasila A, 2018, INT J COMMUN-US, V12, P928
   Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199
   Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Sile A. W, 2016, CNBC
   Snyder J, 2014, J ASSOC INF SCI TECH, V65, P2233, DOI 10.1002/asi.23103
   Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237
   Tavernise S, 2016, NY TIMES
   Thelwall M, 2016, J ASSOC INF SCI TECH, V67, P2575, DOI 10.1002/asi.23620
   Toriumi F, 2014, P INT C INF SYST BUI, P10
   Vis F., 2013, TWITTER AND SOC, P385
   Westman S., 2010, P 3 S INF INT CONT, P323, DOI DOI 10.1145/1840784.1840833
   Westman Stina, 2006, P 1 INT C INF INT CO, V1, P102, DOI DOI 10.1145/1164820.1164843
   Xie Q, 2013, MODELING AND COMPUTATION IN ENGINEERING II, P55
   Yoon J, 2016, INFORM RES, V21
NR 38
TC 0
Z9 0
U1 5
U2 5
PU UNIV SHEFFIELD DEPT INFORMATION STUDIES
PI SHEFFIELD
PA UNIV SHEFFIELD, WESTERN BANK, SHEFFIELD S10 2TN, S YORKS, ENGLAND
SN 1368-1613
J9 INFORM RES
JI Inf. Res.
PD JUN
PY 2019
VL 24
IS 2
AR 823
PG 32
WC Information Science & Library Science
SC Information Science & Library Science
GA KG3UW
UT WOS:000509868600012
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wang, B
   Fish, EN
AF Wang, Ben X.
   Fish, Eleanor N.
TI Global virus outbreaks: Interferons as 1st responders
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Interferons-alpha/beta; Antiviral; Immune response
ID ACUTE RESPIRATORY SYNDROME; CHRONIC HEPATITIS-C; DOUBLE-STRANDED-RNA;
   INFLUENZA-A VIRUS; WEST-NILE-VIRUS; CD8 T-CELLS; NF-KAPPA-B; RIBAVIRIN
   COMBINATION THERAPY; HEMATOPOIETIC STEM-CELLS; CORONAVIRUS M PROTEIN
AB Outbreaks of severe virus infections with the potential to cause global pandemics are increasing. In many instances these outbreaks have been newly emerging (SARS coronavirus), re-emerging (Ebola virus, Zika virus) or zoonotic (avian influenza H5N1) virus infections. In the absence of a targeted vaccine or a pathogen-specific antiviral, broad-spectrum antivirals would function to limit virus spread. Given the direct antiviral effects of type I interferons (IFNs) in inhibiting the replication of both DNA and RNA viruses at different stages of their replicative cycles, and the effects of type I IFNs on activating immune cell populations to clear virus infections, IFNs-alpha/beta present as ideal candidate broad-spectrum antivirals.
C1 [Wang, Ben X.] Univ Hlth Network, Tumor Immunotherapy Program, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.
   [Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, 67 Coll St, Toronto, ON M5G 2M1, Canada.
   [Fish, Eleanor N.] Univ Toronto, Dept Immunol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
RP Fish, EN (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, 67 Coll St, Toronto, ON M5G 2M1, Canada.
EM en.fish@utoronto.ca
CR Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592
   Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525
   Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000
   Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256
   Antonelli A, 2010, CYTOKINE, V50, P260, DOI 10.1016/j.cyto.2010.01.009
   Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210
   Baek YH, 2015, J VIROL, V89, P287, DOI 10.1128/JVI.02485-14
   Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08
   Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06
   Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08
   Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297
   Bentz GL, 2010, VIROLOGY, V402, P121, DOI 10.1016/j.virol.2010.03.014
   Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000
   Blatt LM, 1996, J INTERF CYTOK RES, V16, P489, DOI 10.1089/jir.1996.16.489
   Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411
   Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200
   Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760
   Brzozka K, 2005, J VIROL, V79, P7673, DOI 10.1128/JVI.79.12.7673-7681.2005
   Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006
   Burke JD, 2014, J VIROL, V88, P3485, DOI 10.1128/JVI.02649-13
   Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583
   Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05
   CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652
   Caruntu FA, 2009, J GASTROINTEST LIVER, V18, P425
   Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000
   Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101
   Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064
   Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9
   Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273
   Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102
   Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200
   Conrady CD, 2013, MUCOSAL IMMUNOL, V6, P45, DOI 10.1038/mi.2012.46
   Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465
   Dagley A, 2014, ANTIVIR RES, V108, P1, DOI 10.1016/j.antiviral.2014.05.004
   Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975
   Dauber B, 2006, J VIROL, V80, P11667, DOI 10.1128/JVI.01142-06
   Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069
   Dauer M, 2006, J LEUKOCYTE BIOL, V80, P278, DOI 10.1189/jlb.1005592
   DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993
   Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200
   Dhillon S, 2010, DIGEST DIS SCI, V55, P1785, DOI 10.1007/s10620-010-1220-7
   Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373
   Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200
   Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815
   EVANS SS, 1993, J CELL BIOL, V123, P1889, DOI 10.1083/jcb.123.6.1889
   Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000
   Federico A, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(6)2015.18640
   Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13
   Fish EN, 2014, MOL CANCER RES, V12, P1691, DOI 10.1158/1541-7786.MCR-14-0450
   Formann E, 2003, J VIRAL HEPATITIS, V10, P271, DOI 10.1046/j.1365-2893.2003.00446.x
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555
   Fujita H, 2005, J INVEST DERMATOL, V125, P126, DOI 10.1111/j.0022-202X.2005.23803.x
   Furutani Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216139
   Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006
   Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208
   Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276
   Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964
   Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623
   Gowen BB, 2014, VIRUSES-BASEL, V6, P1410, DOI 10.3390/v6031410
   Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010
   Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005
   Hamilton JA, 2017, J IMMUNOL, V199, P2618, DOI 10.4049/jimmunol.1700888
   Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108
   Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963
   He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843
   Hijikata M, 2000, INTERVIROLOGY, V43, P124, DOI 10.1159/000025035
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   HOVANESSIAN AG, 1988, J BIOL CHEM, V263, P4945
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x
   Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469
   Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08
   Hunter CA, 1997, IMMUNOL LETT, V59, P1, DOI 10.1016/S0165-2478(97)00091-6
   Inoue Y, 2010, J VIRAL HEPATITIS, V17, P336, DOI 10.1111/j.1365-2893.2009.01182.x
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255
   Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310
   Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8
   Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001
   Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644
   Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837
   Kamar N, 2010, NEPHROL DIAL TRANSPL, V25, P2792, DOI 10.1093/ndt/gfq282
   Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103
   Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Keating GM, 2009, DRUGS, V69, P2633, DOI 10.2165/11203660-000000000-00000
   Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021
   Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x
   Kim SR, 2009, DIGESTION, V79, P36, DOI 10.1159/000203639
   Kim YJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005850
   Kirou KA, 2000, CLIN IMMUNOL, V95, P218, DOI 10.1006/clim.2000.4866
   Klein SB, 1996, J INTERF CYTOK RES, V16, P1, DOI 10.1089/jir.1996.16.1
   Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3
   Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Konde MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169255
   Konishi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00259
   Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022
   Kubota T, 2005, J VIROL, V79, P4451, DOI 10.1128/JVI.79.7.4451-4459.2005
   Kumaki Y, 2008, BIOCHEM BIOPH RES CO, V371, P110, DOI 10.1016/j.bbrc.2008.04.006
   Kumaki Yohichi, 2010, Antiviral Chemistry & Chemotherapy, V20, P169, DOI 10.3851/IMP1477
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12
   Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117
   Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074
   Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571
   Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328
   Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583
   Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102
   LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327
   Lieu KG, 2013, J VIROL, V87, P8261, DOI 10.1128/JVI.00989-13
   Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Luft T, 1998, J IMMUNOL, V161, P1947
   Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303
   Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709
   Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Marshall EE, 2009, J VIROL, V83, P4112, DOI 10.1128/JVI.02489-08
   Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592
   Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07
   MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193
   Matsuyama N, 2003, HEPATOL RES, V25, P221, DOI 10.1016/S1386-6346(02)00269-3
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McCarthy SDS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004364
   Melian EB, 2001, DRUGS, V61, P1661, DOI 10.2165/00003495-200161110-00009
   Menten P, 1999, EUR J IMMUNOL, V29, P678, DOI 10.1002/(SICI)1521-4141(199902)29:02<678::AID-IMMU678>3.0.CO;2-J
   Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06
   Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038
   Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103
   Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10
   Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263
   Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022
   Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039
   Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07
   Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001
   Negro F, 2010, BEST PRACT RES CL GA, V24, P183, DOI 10.1016/j.bpg.2009.10.012
   Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553
   Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279
   Niemeyer D, 2013, J VIROL, V87, P12489, DOI 10.1128/JVI.01845-13
   Nigg PE, 2015, J BIOL CHEM, V290, P29893, DOI 10.1074/jbc.M115.681494
   Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047
   Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428
   Pang PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006579
   Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019
   Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358
   Paulus C, 2006, P NATL ACAD SCI USA, V103, P3840, DOI 10.1073/pnas.0600007103
   Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039
   Persico M, 2008, GUT, V57, P507, DOI 10.1136/gut.2007.129478
   PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992
   Pogue SL, 2004, J INTERF CYTOK RES, V24, P131, DOI 10.1089/107999004322813372
   Poordad F, 2008, CLIN INFECT DIS, V46, P78, DOI 10.1086/523585
   Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605
   QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829
   Ramanan P, 2012, P NATL ACAD SCI USA, V109, P20661, DOI 10.1073/pnas.1213559109
   Rarnachandran A, 2008, J VIROL, V82, P8330, DOI 10.1128/JVI.00831-08
   Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05
   Richardson JS, 2011, J BIOTERROR BIODEF, V1, P007
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061
   Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626
   Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690
   Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06
   Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2
   Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973
   Schaap-Nutt A, 2010, VIROLOGY, V397, P285, DOI 10.1016/j.virol.2009.11.018
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304
   Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004
   Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09
   Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403
   Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606
   Simmons DP, 2012, J IMMUNOL, V188, P3116, DOI 10.4049/jimmunol.1101313
   Siu KL, 2014, CELL MOL IMMUNOL, V11, P141, DOI 10.1038/cmi.2013.61
   Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227
   Slonchak A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5835-6
   Smith LM, 2013, J INFECT DIS, V208, P310, DOI 10.1093/infdis/jis921
   Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005
   Stock AT, 2014, J EXP MED, V211, P751, DOI 10.1084/jem.20132183
   Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8
   Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103
   Sun JL, 2016, ANTIVIR RES, V134, P207, DOI 10.1016/j.antiviral.2016.09.003
   Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540
   Takayama I, 2012, VIROLOGY, V424, P45, DOI 10.1016/j.virol.2011.12.011
   Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107
   Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005
   Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200
   Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746
   Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006
   Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127
   Valmas C, 2011, J VIROL, V85, P4309, DOI 10.1128/JVI.02575-10
   van de Garde MDB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07434-y
   Varghese R, 2009, HEPATO-GASTROENTEROL, V56, P218
   Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12
   Wang BX, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050107
   Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07
   Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08
   Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002
   Xin LJ, 2010, J IMMUNOL, V184, P7047, DOI 10.4049/jimmunol.0903273
   Yamazaki M, 2010, INTERNAL MED, V49, P403, DOI 10.2169/internalmedicine.49.2656
   Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x
   Yang TC, 2013, PROTEOMICS, V13, P3442, DOI 10.1002/pmic.201300001
   Yang YA, 2013, PROTEIN CELL, V4, P331, DOI 10.1007/s13238-013-2093-2
   Yanguez E., 2016, PLOS PATHOG, V12
   Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558
   Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758
   Zhang APP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002550
   Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107
   Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10
   Zhou Z, 2011, VIROLOGY, V409, P175, DOI 10.1016/j.virol.2010.10.008
   Zhu JZ, 2014, IMMUNITY, V40, P936, DOI 10.1016/j.immuni.2014.05.007
   Zucchetto A, 2010, BRIT J HAEMATOL, V150, P111, DOI 10.1111/j.1365-2141.2010.08152.x
NR 244
TC 6
Z9 10
U1 7
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD JUN
PY 2019
VL 43
SI SI
AR UNSP 101300
DI 10.1016/j.smim.2019.101300
PG 12
WC Immunology
SC Immunology
GA JY8OB
UT WOS:000504666700002
PM 31771760
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Boonserm, R
   Jantorn, R
   Phumeet, A
   Sor-suwan, S
   Jariyapan, N
   Tiawsirisup, S
   Siriyasatien, P
AF Boonserm, Rungfar
   Jantorn, Ratchadaporn
   Phumeet, Atchara
   Sor-suwan, Sriwatapron
   Jariyapan, Narissara
   Tiawsirisup, Sonthaya
   Siriyasatien, Padet
TI Identification of blood meal from field collected filarial vector
   mosquitoes, Armigeres subalbatus by multiplex PCR
SO THAI JOURNAL OF VETERINARY MEDICINE
LA English
DT Article
DE Armigeres subalbatus; Mosquito; blood meal; Multiplex PCR
ID POLYMERASE-CHAIN-REACTION; HOST-FEEDING PATTERNS; FLORIDA MOSQUITOS;
   FLIES DIPTERA; ELISA; AEDES; ANOPHELES; VIRUS
AB Mosquitoes act as vectors of many diseases affecting humans and animal health, including Zika, malaria, dengue, chikungunya, viral encephalitis, and filariasis. One of the best strategies to control these vector-borne diseases is to control the mosquito vectors. Female mosquitoes require a blood source for egg development. As female mosquitoes take blood meals pathogens are released into the vertebrate host. Identification of the types of vertebrate blood sucked by the mosquito is essential information required to develop an effective strategy to control the mosquito populations and the related mosquito borne diseases. Objective of this study was to identify types of mammal blood in Armigeres subalbatus mosquito, the principal vector of filarial parasites especially Dirofilaria spp.. A total of 210 female Ar. subalbatus mosquitoes were collected from different place of Sai Kaew beaches, Samed Island, Rayong province, eastern Thailand. The blood meals of Ar. subalbatus were identified using multiplex PCR specific primers on mitochondrial cytochrome b gene. The result showed that 74 samples of Ar. subalbatus blood meals was positive for human (17.14%), pig (5.24%), cow (2.38%), dog (0.48%), and other mammals blood (10%). The 136 samples of negative detection by multiplex PCR were also positive 2 (0.95%) samples of avian blood, but 134 (63.81%) samples were not detected for vertebrate blood meal DNA. The benefits of this study are to understand the natural feeding behavior of Ar. subalbatus mosquitoes. Information obtained from the study would be applied to develop the effective control strategies for Ar. subalbatus and may provide indirect data suggesting what reservoirs are significant in the mosquito-borne diseases.
C1 [Boonserm, Rungfar; Phumeet, Atchara; Sor-suwan, Sriwatapron; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand.
   [Jantorn, Ratchadaporn] Ratchaphiphat Hosp, Cent Lab, Bangkok, Thailand.
   [Phumeet, Atchara] Chulalongkorn Hosp, Thai Red Cross Emerging Infect Dis Hlth Sci Ctr, WHO, Collaborating Ctr Res & Training Viral Zoonoses, Bangkok, Thailand.
   [Jariyapan, Narissara] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai, Thailand.
   [Tiawsirisup, Sonthaya] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Pathol, Vet Parasitol Unit, Bangkok, Thailand.
RP Siriyasatien, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand.
EM padet.s@chula.ac.th
FU National Research Council of. Thailand (NRCT)National Research Council
   of Thailand (NRCT); Faculty of Medicine, Chulalongkorn
   UniversityChulalongkorn University [GRB_APS_ 11_59_30_10]; National
   Science and Technology Development Agency (Thailand); Health Systems
   Research Institute [61-003]; World Health Organization Thailand
   (WHO-Thailand); United States Agency for International Development
   (USAID)United States Agency for International Development (USAID)
FX This study was supported by the National Research Council of. Thailand
   (NRCT) and Faculty of Medicine, Chulalongkorn University (grant No:
   GRB_APS_ 11_59_30_10), National Science and Technology Development
   Agency (Thailand) and Health Systems Research Institute (Grant No.
   61-003), and the World Health Organization Thailand (WHO-Thailand) and
   the United States Agency for International Development (USAID) grant..
CR Barraud PJ, 1934, FAUNA BRIT INDIA INC, V5
   BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9
   BOORMAN J, 1977, B ENTOMOL RES, V67, P305, DOI 10.1017/S0007485300011123
   CHEONG W H, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P611
   Christophers SR, 1933, FAUNA BRIT INDIA INC
   Cicero C, 2001, MOL PHYLOGENET EVOL, V20, P27, DOI 10.1006/mpev.2001.0944
   Sales KGD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0840-3
   DARSIE R F JR, 1990, Mosquito Systematics, V22, P69
   DAS P, 1983, INDIAN J MED RES, V78, P794
   EDMAN JD, 1968, SCIENCE, V161, P67, DOI 10.1126/science.161.3836.67
   EDMAN JD, 1972, J MED ENTOMOL, V9, P429, DOI 10.1093/jmedent/9.5.429
   EDMAN JD, 1971, J MED ENTOMOL, V8, P687, DOI 10.1093/jmedent/8.6.687
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020
   HUNTER FF, 1991, J MED ENTOMOL, V28, P527, DOI 10.1093/jmedent/28.4.527
   Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x
   Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336
   Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122
   Kirstein F, 1996, APPL ENVIRON MICROB, V62, P4060, DOI 10.1128/AEM.62.11.4060-4065.1996
   Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599
   Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016
   Muslim A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-219
   Niare S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1152-6
   Pitzer JB, 2011, J MED ENTOMOL, V48, P53, DOI 10.1603/ME10123
   Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017
   Sant'Anna MRV, 2008, ACTA TROP, V107, P230, DOI 10.1016/j.actatropica.2008.06.003
   Santos CS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212517
   Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43
   Srinivas S. D., 1994, Indian Journal of Experimental Biology, V32, P348
   Sukudom P., 2018, ACAD J SCI RES, V6, P114, DOI [10.15413/ajsr.2017.0179, DOI 10.15413/AJSR.2017.0179]
   Tandina F, 2018, PARASITE, V25, DOI 10.1051/parasite/2018041
   Tawatsin A, 2018, THAI J VET MED, V48, P551
   Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507
   WASHINO RK, 1983, ANNU REV ENTOMOL, V28, P179, DOI 10.1146/annurev.en.28.010183.001143
   Wilson J. John, 2015, Academic Journal of Entomology, V8, P80
NR 35
TC 0
Z9 0
U1 0
U2 0
PU CHULALONGKORN UNIV
PI BANGKOK
PA FAC VETERINARY SCI, HENRI DUNANT RD, BANGKOK, 10330, THAILAND
SN 0125-6491
J9 THAI J VET MED
JI Thai J. Vet. Med.
PD JUN
PY 2019
VL 49
IS 2
BP 155
EP 160
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA JU2FZ
UT WOS:000501492800007
DA 2020-07-08
ER

PT J
AU Araujo, SD
   Cordeiro, TME
   Belisario, AR
   Araujo, RFD
   Marinho, PES
   Kroon, EG
   de Oliveira, DB
   Teixeira, MM
   Silva, ACSE
AF Araujo, Stanley de Almeida
   Macedo e Cordeiro, Thiago
   Belisario, Andre Rolim
   de Almeida Araujo, Roberto Ferreira
   Silva Marinho, Paula Eillanny
   Kroon, Erna Geessien
   de Oliveira, Danilo Bretas
   Teixeira, Mauro Martins
   Simoes e Silva, Ana Cristina
TI First report of collapsing variant of focal segmental glomerulosclerosis
   triggered by arbovirus: dengue and Zika virus infection
SO CLINICAL KIDNEY JOURNAL
LA English
DT Article
DE arbovirus; chronic kidney disease; dengue infection; focal segmental
   glomerulosclerosis; renal histopahology
ID HEPATITIS-C; NEPHROPATHY; ENTRY; CELLS; FSGS
AB Background. The collapsing variant of focal segmental glomerulosclerosis (FSGS) is the most aggressive form of FSGS and is characterized by at least one glomerulus with segmental or global collapse and overlying podocyte hypertrophy and hyperplasia. Viruses can act as aetiological agents of secondary FSGS. This study aims to establish an aetiological link between dengue virus (DENV) infection and the collapsing variant of FSGS and to analyse possible influences of the apolipoprotein 1 (APOL1) gene risk alleles on the disease.
   Methods. Biopsies and medical records were gathered from 700 patients of the Instituto de Nefropatologia, Belo Horizonte, Brazil. Screening for the collapsing variant of FSGS was performed and serological, immunohistochemical, tissue polymerase chain reaction (PCR) and genetic analysis were conducted.
   Results. Eight patients were identified with positive DENV serology and negative serological and/or tissue markers for hepatitis B virus, hepatitis C virus, Epstein-Barr virus, human immunodeficiency virus, cytomegalovirus and parvovirus B19. In PCR analysis, six patients had positive markers for DENV strain genetic material, one patient had positive markers for co-infection of Zika virus (ZIKV) and DENV and one patient had positive markers only for ZIKV infection. Six of the eight patients did not show risk alleles of the APOL1 gene. One patient had only one risk allele (G1) and the sample from another did not contain enough DNA for genetic analysis to be performed.
   Conclusions. This study provided strong evidence that DENV can infect renal tissue and possibly functions as a second hit to the development of the collapsing variant of FSGS. Nonetheless, this study also highlights the possible implication of ZIKV infection in FSGS and supports the argument that risk alleles of the APOL1 gene may not be implicated in the susceptibility to FSGS in these patients.
C1 [Araujo, Stanley de Almeida; de Almeida Araujo, Roberto Ferreira] Inst Nefro Patol, Belo Horizonte, MG, Brazil.
   [Araujo, Stanley de Almeida; Macedo e Cordeiro, Thiago; Belisario, Andre Rolim; de Almeida Araujo, Roberto Ferreira; Teixeira, Mauro Martins; Simoes e Silva, Ana Cristina] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil.
   [Silva Marinho, Paula Eillanny; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, Diamantina, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Biol Sci, Lab Immunopharmacol, Natl Inst Sci & Technol Dengue, Belo Horizonte, MG, Brazil.
RP Silva, ACSE (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil.
EM acssilva@hotmail.com
RI Araujo, Stanley A/H-5895-2017; Simoes e Silva, Ana Cristina/A-4409-2013
OI Simoes e Silva, Ana Cristina/0000-0001-9222-3882
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado de Minas GeraisMinas Gerais State Research Foundation (FAPEMIG);
   National Institute of Science and Technology in Dengue
FX This study was partially supported by grants from the Brazilian National
   Research Council, Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais and the National Institute of Science and Technology in Dengue.
   M.M.T. and A.C.S.e.S. are recipients of productivity research
   fellowships from the Brazilian National Research Council. The results
   presented in this article have not been published previously in whole or
   part, except in abstract form.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Angioi A, 2016, J NEPHROL, V29, P517, DOI 10.1007/s40620-016-0333-2
   Bariety J, 1998, KIDNEY INT, V53, P918, DOI 10.1046/j.1523-1755.1998.00845.x
   Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205
   Besse W, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0330-7
   BOONPUCKNAVIG V, 1976, ARCH PATHOL LAB MED, V100, P206
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CARBONE L, 1989, AM J MED, V87, P389, DOI 10.1016/S0002-9343(89)80819-8
   Chandra P, 2013, CLIN KIDNEY J, V6, P1, DOI 10.1093/ckj/sft002
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Cheung KT, 2018, IMMUNOBIOLOGY, V223, P356, DOI 10.1016/j.imbio.2017.10.044
   Colares VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087716
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024
   Dettmar AK, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7351964
   Duchateau PN, 2001, J LIPID RES, V42, P620
   Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562
   Fowell AJ, 2008, LIVER INT, V28, P889, DOI 10.1111/j.1478-3231.2008.01672.x
   FUTRAKUL P, 1973, Journal of the Medical Association of Thailand, V56, P33
   Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032
   Joshi A, 2012, CLIN KIDNEY J, V5, P320, DOI 10.1093/ckj/sfs059
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Khaira A, 2009, CLIN EXP NEPHROL, V13, P373, DOI 10.1007/s10157-008-0124-8
   Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242
   Kruzel-Davila E, 2017, SEMIN NEPHROL, V37, P490, DOI 10.1016/j.semnephrol.2017.07.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Limou S, 2015, KIDNEY INT, V88, P28, DOI 10.1038/ki.2015.109
   Lum Lcs, 2014, Malays Fam Physician, V9, P2
   Mikulak J, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0296-3
   Mikulak J, 2010, NEPHRON EXP NEPHROL, V115, pE15, DOI 10.1159/000312882
   Perdomo-Celis F, 2017, ACTA TROP, V167, P1, DOI 10.1016/j.actatropica.2016.12.011
   Prevencaoe combate Dengue Chikungunya e Zika, 2016, B EPIDEMIOLOGICO, V47, P38
   Sperati CJ, 2013, CLIN NEPHROL, V80, P231, DOI 10.5414/CN107337
   Thomas DB, 2006, KIDNEY INT, V69, P920, DOI 10.1038/sj.ki.5000160
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wyatt CM, 2012, ANNU REV MED, V63, P147, DOI 10.1146/annurev-med-041610-134224
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 37
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-8505
EI 2048-8513
J9 CLIN KIDNEY J
JI Clin. Kidney J.
PD JUN
PY 2019
VL 12
IS 3
BP 355
EP 361
DI 10.1093/ckj/sfy104
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA JI4PP
UT WOS:000493450200007
PM 31198534
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gonzalez, PV
   Costa, AA
   Harburguer, LV
   Masuh, HM
AF Gonzalez, P., V
   Alvarez Costa, A.
   Harburguer, L., V
   Masuh, H. M.
TI Quantitative Evaluation of the Behavioral Response to Attractant and
   Repellent Compounds in Anopheles pseudopunctipennis and Aedes aegypti
   (Diptera: Culicidae) Larvae
SO JOURNAL OF ECONOMIC ENTOMOLOGY
LA English
DT Article
DE DEET; IR3535; yeast; proline; mosquito
ID COMPARATIVE EFFICACY; DEET; ALBOPICTUS; GAMBIAE; IR3535; RATS; FOOD
AB The mosquito Anopheles pseudopunctipennis (Theobald) is the principal vector for malaria in Latin-America. Aedes aegypti (L.) (Diptera: Culicidae) is the key vector of four important arboviral diseases: dengue, yellow fever, Zika, and chikungunya. Controlling larval stages to reduce the production of new adult mosquitoes is part of the integrated vector management strategies. However, there are few studies about the olfactory behavior on immature stages of mosquitoes, especially in An. pseudopunctipennis. In this work, we have evaluated the behavior of An. pseudopunctipennis and Ae. aegypti larvae in response to attractant or repellent stimuli through a video-tracking analysis. We used the software EthoVision to obtain behavioral variables related to the swimming activity, such as distance, speed, and mobility status. The response to the repellents stimulus results in an increase of the swimming activity and the absolute angular velocity in both species. Otherwise, the responses to the possible attractants stimulus results in a decrease of the activity of the larvae only for Ae. aegypti. The effects of these compounds were weaker in Anopheles; probably as a consequence of their adaptations to different aquatic ecosystems. The study of the larval olfactory response could contribute to the development of new control tools based on 'push-pull' strategies by 'pushing' mosquitoes away from certain places using repellents, and 'pulling' them towards other places like traps baited with attractive cues.
C1 [Gonzalez, P., V; Alvarez Costa, A.; Harburguer, L., V; Masuh, H. M.] Ctr Invest Plagas & Insecticidas CONICET CITEDEF, Juan Bautista de La Salle 4397,B1603ALO, Villa Martelli, Buenos Aires, Argentina.
RP Masuh, HM (corresponding author), Ctr Invest Plagas & Insecticidas CONICET CITEDEF, Juan Bautista de La Salle 4397,B1603ALO, Villa Martelli, Buenos Aires, Argentina.
EM hmasuh@gmail.com
FU Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of
   ArgentinaANPCyT [PICT 2012-1857]
FX This study received financial support from Agencia Nacional de Promocion
   Cientifica y Tecnologica (ANPCyT) of Argentina (PICT 2012-1857). The
   authors are grateful to Merck Argentina for donating IR3535. P.V.G.,
   A.A.C., L.V.H., and H.M.M. are members of CONICET. We are grateful to C.
   Laci, E. Laci, and Carrizo of the National Coordination of Vector
   Control, Argentinean Ministry of Health, for their assistance with
   fieldwork. We also would like to thank three anonymous reviewers for
   their valuable comments and suggestions, which helped improve the
   quality of this paper. Finally, we thank T. Comber for the English
   writing corrections.
CR Abdel-Rahman A, 2001, EXP NEUROL, V172, P153, DOI 10.1006/exnr.2001.7807
   Abdi H., 2010, ENCY RES DESIGN, P1, DOI DOI 10.4135/9781412961288
   Alvarez Costa A., 2018, J MED ENTOMOL, V54, P670
   ALY C, 1985, J AM MOSQUITO CONTR, V1, P506
   [Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1
   Armistead JS, 2008, J MED ENTOMOL, V45, P629, DOI 10.1603/0022-2585(2008)45[629:ILCBAA]2.0.CO;2
   Armsworth CG, 2005, ANIM BEHAV, V69, P805, DOI 10.1016/j.anbehav.2004.07.009
   Awasthi AK, 2015, HYDROBIOLOGIA, V749, P113, DOI 10.1007/s10750-014-2154-4
   Baglan H, 2017, J INSECT PHYSIOL, V98, P160, DOI 10.1016/j.jinsphys.2017.01.001
   BARBER JT, 1983, J MED ENTOMOL, V20, P641, DOI 10.1093/jmedent/20.6.641
   Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726
   Barnard DR, 2002, J MED ENTOMOL, V39, P895, DOI 10.1603/0022-2585-39.6.895
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476, DOI 10.1037/0735-7044.100.4.476
   Chavasse D. C., 1997, CHEM METHODS CONTROL
   Cilek JE, 2004, J AM MOSQUITO CONTR, V20, P299
   DARSIE R F JR, 1985, Mosquito Systematics, V17, P153
   Forattini O. P., 2002, CULICIDOLOGIA MED, V2, P864
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Gonzalez PV, 2017, J MED ENTOMOL, V54, P793, DOI 10.1093/jme/tjw229
   Gonzalez PV, 2016, PARASITOL RES, V115, P2185, DOI 10.1007/s00436-016-4960-2
   Gonzalez PV, 2015, J MED ENTOMOL, V52, P1315, DOI 10.1093/jme/tjv136
   Grieco F., 2010, ETHOVISION XT REFERE
   Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8
   Lardeux F, 2007, CR BIOL, V330, P571, DOI 10.1016/j.crvi.2007.04.002
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   Manguin S., 1996, CHARACTERIZATION ANO
   Marriel NB, 2016, ACTA TROP, V158, P88, DOI 10.1016/j.actatropica.2016.02.021
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   N'Guessan R, 2006, T ROY SOC TROP MED H, V100, P1091, DOI 10.1016/j.trstmh.2006.04.005
   Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394
   Osimitz TG, 1997, J TOXICOL-CLIN TOXIC, V35, P435, DOI 10.3109/15563659709001224
   PAHO (Pan American Health Organization), 1991, STAT MAL PROGR AM
   Pinheiro J., 2006, NLME LINEAR NONLINEA, V3, P1
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Reynoso MMN, 2017, PEERJ, V5, DOI 10.7717/peerj.3292
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Sfara V, 2008, ARCH INSECT BIOCHEM, V67, P1, DOI 10.1002/arch.20210
   Spruijt B. M., 1998, P MEAS BEH 98 2 INT, P264
   Thomas MB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001262
   Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195
   Torres-Estrada JL, 2007, J AM MOSQUITO CONTR, V23, P18, DOI 10.2987/8756-971X(2007)23[18:AOGAPF]2.0.CO;2
   Valenca MA, 2013, NEOTROP ENTOMOL, V42, P311, DOI 10.1007/s13744-013-0118-4
   White GB, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P3
   WHO, 2018, CHEM CONTR PROGR DEN
   Wigglesworth V. B., 1974, INSECT PHYSL, P163
   Xia Y., 2008, THESIS
   Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750
NR 52
TC 0
Z9 0
U1 3
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-0493
EI 1938-291X
J9 J ECON ENTOMOL
JI J. Econ. Entomol.
PD JUN
PY 2019
VL 112
IS 3
BP 1388
EP 1395
DI 10.1093/jee/toz004
PG 8
WC Entomology
SC Entomology
GA JE1XQ
UT WOS:000490489600047
PM 30753516
DA 2020-07-08
ER

PT J
AU Kong, WL
   Hayashi, T
   Fiches, G
   Xu, QK
   Li, MMZ
   Que, JW
   Liu, S
   Zhang, W
   Qi, J
   Santoso, N
   Elledge, SJ
   Zhu, J
AF Kong, Weili
   Hayashi, Tsuyoshi
   Fiches, Guillaume
   Xu, Qikai
   Li, Mamie Z.
   Que, Jianwen
   Liu, Shuai
   Zhang, Wei
   Qi, Jun
   Santoso, Netty
   Elledge, Stephen J.
   Zhu, Jian
TI Diversified Application of Barcoded PLATO (PLATO-BC) Platform for
   Identification of Protein Interactions
SO GENOMICS PROTEOMICS & BIOINFORMATICS
LA English
DT Article
DE Barcoded PLATO; Protein interaction; Ubiquitin-binding protein;
   Bromodomain inhibitor JQ1; Zika virus
ID ZIKA VIRUS-INFECTION; EWING SARCOMA; AUTOANTIBODIES; INHIBITION;
   EPITOPE; STAT3; AXL
AB Proteins usually associate with other molecules physically to execute their functions. Identifying these interactions is important for the functional analysis of proteins. Previously, we reported the parallel analysis of translated ORFs (PLATO) to couple ribosome display of full-length ORFs with affinity enrichment of mRNA/protein/ribosome complexes for the "bait" molecules, followed by the deep sequencing analysis of mRNA. However, the sample processing, from extraction of precipitated mRNA to generation of DNA libraries, includes numerous steps, which is tedious and may cause the loss of materials. Barcoded PLATO (PLATO-BC), an improved platform was further developed to test its application for protein interaction discovery. In this report, we tested the antisera-antigen interaction using serum samples from patients with inclusion body myositis (IBM). Tripartite motif containing 21 (TRIM21) was identified as a potentially new IBM autoantigen. We also expanded the application of PLATO-BC to identify protein interactions for JQ1, single ubiquitin peptide, and NS5 protein of Zika virus. From PLATO-BC analyses, we identified new protein interactions for these "bait" molecules. We demonstrate that Ewing sarcoma breakpoint region 1 (EWSR1) binds to JQ1 and their interactions may interrupt the EWSR1 association with acetylated histone H4. RIO kinase 3 (RIOK3), a newly identified ubiquitin-binding protein, is preferentially associated with K63-ubiquitin chain. We also find that Zika NS5 protein interacts with two previously unreported host proteins, par-3 family cell polarity regulator (PARD3) and chromosome 19 open reading frame 53 (C19orf53), whose attenuated expression benefits the replication of Zika virus. These results further demonstrate that PLATO-BC is capable of identifying novel protein interactions for various types of "bait" molecules.
C1 [Kong, Weili; Hayashi, Tsuyoshi; Fiches, Guillaume; Santoso, Netty] Univ Rochester, Dept Microbiol & Immunol, Dept Biochem & Biophys, Med Ctr, Rochester, NY 14642 USA.
   [Xu, Qikai; Li, Mamie Z.; Elledge, Stephen J.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Div Genet,Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Que, Jianwen] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA.
   [Liu, Shuai; Zhang, Wei] Univ Massachusetts, Dept Chem, Coll Sci & Math, Boston, MA 02125 USA.
   [Qi, Jun] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Zhu, Jian] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA.
RP Zhu, J (corresponding author), Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA.
EM Jian.Zhu@osumc.edu
RI kong, weili/H-8487-2019
OI Li, Mamie/0000-0002-7188-1330; Fiches, Guillaume/0000-0003-3515-8417
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R33AI116180,
   R01DE025447, R01GM117838]
FX This work is supported by grants from National Institute of Health
   (Grant Nos. R33AI116180, R01DE025447, and R01GM117838) to JZ. We thank
   Dr. Stephen Dewhurst (URMC) for providing the ZIKV PRVABC59 strain.
CR Al-Majdoub M, 2013, J MASS SPECTROM, V48, P651, DOI 10.1002/jms.3208
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Bonastre E, 2015, CANCER RES, V75, P1287, DOI 10.1158/0008-5472.CAN-14-2444
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14
   Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504
   Fraser JE, 2014, METHODS MOL BIOL, V1138, P301, DOI 10.1007/978-1-4939-0348-1_19
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guyer RA, 2015, J BIOL CHEM, V290, P8457, DOI 10.1074/jbc.M114.621011
   Hayes S, 2016, BIOCHEM SOC T, V44, P994, DOI 10.1042/BST20160092
   Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005
   Hensel T, 2016, ONCOTARGET, V7, P1451, DOI 10.18632/oncotarget.6385
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Jacques C, 2016, ONCOTARGET, V7, P24125, DOI 10.18632/oncotarget.8214
   Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043
   Jha HC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005801
   Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160
   Kim SK, 2016, HUM PATHOL, V55, P91, DOI 10.1016/j.humpath.2016.05.008
   Kong WL, 2018, MICROB PATHOGENESIS, V114, P476, DOI 10.1016/j.micpath.2017.12.031
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Larman HB, 2014, NAT PROTOC, V9, P90, DOI 10.1038/nprot.2013.167
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Lee AYS, 2017, RHEUMATOL INT, V37, P1323, DOI 10.1007/s00296-017-3718-1
   London Nir, 2012, Methods Mol Biol, V857, P375, DOI 10.1007/978-1-61779-588-6_17
   Lum KK, 2016, EXPERT REV PROTEOMIC, V13, P325, DOI 10.1586/14789450.2016.1147353
   Mahler M, 2014, J RHEUMATOL, V41, P1334, DOI 10.3899/jrheum.131450
   McFedries A, 2013, CHEM BIOL, V20, P667, DOI 10.1016/j.chembiol.2013.04.008
   Mizutani Y, 2013, J IMMUNOL METHODS, V387, P57, DOI 10.1016/j.jim.2012.09.011
   Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405
   Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014
   Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004
   Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086
   Sardiu ME, 2011, J BIOL CHEM, V286, P23645, DOI 10.1074/jbc.R110.174052
   Shan JX, 2009, MOL CELL BIOCHEM, V332, P113, DOI 10.1007/s11010-009-0180-8
   Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39
   Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Ullman CG, 2011, BRIEF FUNCT GENOMICS, V10, P125, DOI 10.1093/bfgp/elr010
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Xu GJ, 2016, P NATL ACAD SCI USA, V113, pE7526, DOI 10.1073/pnas.1615990113
   Yoshimi R, 2012, INT J RHEUMATOL, DOI 10.1155/2012/718237
   Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492
   Zhu J, 2013, NAT BIOTECHNOL, V31, P331, DOI 10.1038/nbt.2539
NR 47
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1672-0229
EI 2210-3244
J9 GENOM PROTEOM BIOINF
JI Genom. Proteomics Bioinformatics
PD JUN
PY 2019
VL 17
IS 3
BP 319
EP 331
DI 10.1016/j.gpb.2018.12.010
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA JE2UN
UT WOS:000490550300011
PM 31494268
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sharma, M
   Zunt, JR
AF Sharma, Malveeka
   Zunt, Joseph R.
TI Neurologic Infections in Travelers
SO SEMINARS IN NEUROLOGY
LA English
DT Article
DE neurological disease; infectious diseases; travel
ID ZIKA VIRUS-INFECTION; GUILLAIN-BARRE-SYNDROME; CLINICAL-FEATURES;
   EBOLA-VIRUS; DIAGNOSIS; MANIFESTATIONS; EFFICACY; NEUROBRUCELLOSIS;
   DISEASE; NEUROLEPTOSPIROSIS
AB This review will provide an outline of the neurological complications of specific parasitic, bacterial, and viral infectious diseases that can affect the international traveler. We will discuss the epidemiology, life cycle, ecology, clinical manifestation, diagnosis, treatment, and prevention.
C1 [Sharma, Malveeka; Zunt, Joseph R.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA.
   [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA.
   [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Med Infect Dis, Seattle, WA USA.
   [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA.
RP Sharma, M (corresponding author), Harborview Med Ctr, Dept Neurol, Box 359775,325 Ninth Ave South, Seattle, WA 98104 USA.
EM malveeka@uw.edu
CR Abreu-Mota T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06741-w
   Al Dahouk Sascha, 2003, Clin Lab, V49, P577
   Alexander J P, 2018, CDC YELLOW BOOK 2018
   Ambrosio A, 2011, HUM VACCINES, V7, P694, DOI 10.4161/hv.7.6.15198
   [Anonymous], 2018, WHO FACT SHEETS MENI
   [Anonymous], 2015, WHO FACT SHEETS JAPA
   [Anonymous], 2018, WHO FACT SHEETS RIFT
   [Anonymous], 2018, WHO FACT SHEETS TRYP
   [Anonymous], WHAT WE MAL STRAT OV
   [Anonymous], 2018, PAR AM TRYP ALS KNOW
   [Anonymous], 2018, WHO FACT SHEETS W NI
   Berkowitz AL, 2015, J NEUROL SCI, V349, P20, DOI 10.1016/j.jns.2015.01.001
   Boushab BM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw200
   Brett-Major DM, 2012, COCHRANE DB SYST REV, V2
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carod-Artal FJ, 2008, T ROY SOC TROP MED H, V102, P107, DOI 10.1016/j.trstmh.2007.08.004
   Centers for Disease Control and Prevention, 2017, BRUC REF GUID EXP TE
   Centers for Disease Control and Prevention, 2018, W NIL VIR INF HEALTH
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen T H, 2018, CDC YELLOW BOOK 2018
   Chiappe-Gonzalez A, 2017, INFECT DIS CLIN PRAC, V25, P329, DOI 10.1097/IPC.0000000000000529
   Corbel M., 2006, BRUCELLOSIS HUMANS A
   Cordova E, 2010, NEUROL RES, V32, P238, DOI 10.1179/016164110X12644252260637
   Cougo-Pinto PT, 2013, NEUROLOGY, V81, P1773, DOI 10.1212/01.wnl.0000435566.30728.be
   de Vries SG, 2018, AM J TROP MED HYG, V99, P127, DOI 10.4269/ajtmh.18-0020
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   El Sayed I, 2018, COCHRANE DB SYST REV, V9
   Erdem H, 2012, ANTIMICROB AGENTS CH, V56, P1523, DOI 10.1128/AAC.05974-11
   Faburay B, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030029
   Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5
   Ferrari TCA, 2011, LANCET NEUROL, V10, P853, DOI 10.1016/S1474-4422(11)70170-3
   Gancheva GI, 2009, J BIOMED CLIN RES, V2, P109
   Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8
   Gul HC, 2009, INT J INFECT DIS, V13, pE339, DOI 10.1016/j.ijid.2009.02.015
   Guven T, 2013, CLIN INFECT DIS, V56, P1407, DOI 10.1093/cid/cit072
   Han MH, 2005, NEUROLOGIST, V11, P30, DOI 10.1097/01.nrl.0000149972.87731.0f
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hills S L, 2018, CDC YELLOW BOOK 2018
   Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X
   Knust B, 2018, CDC YELLOW BOOK 2018
   Kotilainen P, 1998, J CLIN MICROBIOL, V36, P2205, DOI 10.1128/JCM.36.8.2205-2209.1998
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Mahajan SK, 2017, J NEUROSCI RURAL PRA, V8, P421, DOI 10.4103/jnrp.jnrp_44_17
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23
   Nadel S, 2016, J ADOLESCENT HEALTH, V59, pS21, DOI 10.1016/j.jadohealth.2016.04.013
   Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433
   Okokhere P O, 2017, EMJ NEUROL, V5, P73
   Pai HJ, 1997, CLIN INFECT DIS, V24, P436, DOI 10.1093/clinids/24.3.436
   Panicker JN, 2001, POSTGRAD MED J, V77, P589, DOI 10.1136/pmj.77.911.589
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pelton SI, 2016, J ADOLESCENT HEALTH, V59, pS3, DOI 10.1016/j.jadohealth.2016.04.012
   Petersen B W, 2018, CDC YELLOW BOOK 2018
   Poppas G, 2007, EXPERT REV ANTI-INFE, V5, P983, DOI 10.1586/14787210.5.6.983
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rapsang AG, 2013, INDIAN J ANAESTH, V57, P127, DOI 10.4103/0019-5049.111835
   Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281
   Serra LC, 2018, INFECT DIS THER, V7, P219, DOI 10.1007/s40121-018-0196-z
   Shikani HJ, 2012, AM J PATHOL, V181, P1484, DOI 10.1016/j.ajpath.2012.08.010
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   Smythe LD, 2009, AM J TROP MED HYG, V81, P695, DOI 10.4269/ajtmh.2009.09-0252
   Stein-Zamir C, 2014, PEDIATR INFECT DIS J, V33, P777, DOI 10.1097/INF.0000000000000282
   TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805
   Thakur K, 2015, NEUROINFECT DIS, V21, P1639
   Walker MD, 2005, SEMIN NEUROL, V25, P262, DOI 10.1055/s-2005-917663
   Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657
   WHO, 2018, ZOONOSES
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   World Health Organization, 2018, WORLD HLTH ORG FACT
   World Health Organization (WHO), 2018, WHO FACT SHEETS SCHI
   Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006062
   Zhao SG, 2016, MED SCI MONITOR, V22, P1005, DOI 10.12659/MSM.897947
NR 74
TC 0
Z9 0
U1 1
U2 1
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD JUN
PY 2019
VL 39
IS 3
BP 399
EP 413
DI 10.1055/s-0039-1688914
PG 15
WC Clinical Neurology
SC Neurosciences & Neurology
GA IV3KD
UT WOS:000484172800012
PM 31378875
DA 2020-07-08
ER

PT J
AU Yildiz, BU
   Yanik, K
   Yakupoglu, O
AF Yildiz, Bera Ubeyd
   Yanik, Keramettin
   Yakupoglu, Oguzhan
TI Zika virus: A current review of literature
SO UNIVERSITY OF TORONTO MEDICAL JOURNAL
LA English
DT Review
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION; TRANSMISSION; OUTBREAK;
   BRAZIL
AB Zika virus is a mosquito-transmitted flavivirus belonging to the family Flaviviridae. Its spread has been an ongoing pandemic and the focus of a public health emergency since 2007. Though Zika virus was first detected in 1947, its rapid spread, newfound modes of transmission, and the absence of adequate treatments have recently brought this virus into the public eye. After an outbreak of Zika virus in Brazil in 2007, many complications were suspected to be linked with to its infection. These complications include Guillain-Barre syndrome, several congenital malformations, microcephaly, and some neurological complications. There is no effective treatment nor vaccine for Zika virus. Ongoing research focusses largely on preventing infection in regions where transmission is most common, especially in populations of pregnant women. It is advisable for clinicians working in non-endemic areas to maintain a full awareness of Zika virus in order to properly manage this infection when it spreads into their catchment areas. This review aims to summarize what is currently known about the epidemiology, transmission, pathogenesis, clinical presentation, diagnosis, treatment, and prevention methods of the Zika virus.
C1 [Yildiz, Bera Ubeyd; Yanik, Keramettin; Yakupoglu, Oguzhan] Private Hosp, Istanbul, Turkey.
RP Yildiz, BU (corresponding author), Private Hosp, Istanbul, Turkey.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   [Anonymous], 2016, ZIK VIR TRANSM
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dar W, 2016, J GEN PRACT, V4, P237
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dolma K., 2016, J RES DEV, V4, P148
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, INT GUID HEALTHC ZIK
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2015, B INFORM SANITAIRES
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health Emergency of International Concern (PHEIC), 2016, DECL ZIK CLUST MICR
   Rabe Ingrid, 2016, ZIKA VIRUS WHAT CLIN
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Silva DME, 2016, J NEONATAL BIOL, V5, P219
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2016, ZIK VIR
NR 46
TC 0
Z9 0
U1 2
U2 4
PU UNIV TORONTO, MEDICAL SOC
PI TORONTO
PA STUDENT RUN, MEDICAL SCIENCES BLDG, RM 2171A, 1 KINGS COLLEGE CIRCLE,
   TORONTO, ON M5S 1A8, CANADA
SN 0833-2207
EI 1913-5440
J9 UNIV TOR MED J
JI Univ. Tor. Med. J.
PD JUN
PY 2019
VL 96
IS 3
BP 53
EP 56
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA IV3BJ
UT WOS:000484150000009
DA 2020-07-08
ER

PT J
AU Otu, A
   Ebenso, B
   Etokidem, A
   Chukwuekezie, O
AF Otu, Akaninyene
   Ebenso, Bassey
   Etokidem, Aniekan
   Chukwuekezie, Okechukwu
TI Dengue fever - an update review and implications for Nigeria, and
   similar countries
SO AFRICAN HEALTH SCIENCES
LA English
DT Review
DE Dengue fever update; Nigeria; review
ID VIRUS-INFECTION; RISK; ANTIBODIES; DIAGNOSIS; MALARIA; AFRICA; ELISA;
   IGM
AB Background: In the last five decades, dengue has emerged as one of the most important infectious diseases, following a 30-fold increase in global incidence throughout tropical and sub-tropical regions of the world. The actual numbers of dengue cases are under-reported and many cases are misclassified.
   Objectives: This article describes the epidemiology, pathophysiology, clinical features and management of dengue. It also explores the implications of infection with this flavivirus for Nigeria, and similar countries.
   Methods: The literature search for publications on dengue in West Africa was performed using PubMed, African Journals Online (AJOL), Google Scholar, Web of Science, databases and grey literature to identify all published papers regarding the topic. A snowballing strategy was adopted to identify additional publications.
   Results: Recent reports suggest that dengue is a growing public health problem in Nigeria, the magnitude of which needs to be more clearly defined. Nigeria, the most populous country in Africa has an abundance of the Aedes aegypti mosquito which is known to transmit dengue, Zika, as well as chikungunya (CHIKV) and West Nile viruses.
   Conclusion: This article provides practical suggestions for strengthening the dengue virus control programme in Nigeria. The Nigerian health system shares similarities with health systems in many other sub-Saharan countries. Therefore, the practical suggestions provided at the end of this review are likely to be applicable to many other African countries.
C1 [Otu, Akaninyene] Univ Calabar, Coll Med Sci, Dept Internal Med, Calabar, Nigeria.
   [Ebenso, Bassey] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.
   [Etokidem, Aniekan] Univ Calabar, Dept Community Med, Coll Med Sci, Calabar, Nigeria.
   [Chukwuekezie, Okechukwu] Natl Arbovirus & Vectors Res Ctr, 33 Pk Ave GRA, Enugu, Nigeria.
RP Otu, A (corresponding author), Univ Calabar, Coll Med Sci, Dept Internal Med, Calabar, Nigeria.
EM akanotu@yahoo.com; B.E.Ebenso@leeds.ac.uk; etokidem@etokidem.com;
   chukwuekezieo@yahoo.com
RI ; Ebenso, Bassey/H-5536-2017
OI Etokidem, Aniekan/0000-0003-4242-0604; Ebenso,
   Bassey/0000-0003-4147-0968
CR Adedayo F, 2013, AM J INFECT DIS, V9, P7, DOI 10.3844/ajidsp.2013.7.10
   Adeleke MA, 2010, J VECTOR DIS, V47, P33
   Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI [10.1016/S1473-3099(17)30752-1, 10.1016/S1473-3099(18)30023-9]
   Ayukekbong JA, 2014, BR J VIROL, V1, P106
   Baba M.M., 2011, N Y SCI J, V4, P28
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Back AT, 2013, INFECT ECOLOGY EPIDE, V3
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Carey DE, 1964, LANCET, V297, P105
   Carvalho DO, PLOS NEGL TROP DIS, V9
   Eisenhut Michael, 2013, J Travel Med, V20, P63, DOI 10.1111/j.1708-8305.2012.00664_1.x
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   GUBLER DJ, 1988, ARBOVIRUSES EPIDEMIO, V2, P223
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gulland A., 2016, BMJ, V352
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Idris A.N., 2013, INT J MED MED SCI, V5, P560, DOI DOI 10.5897/IJMMS2013.0994
   Irikannu KC, 2015, MALARIA MAN BITING M
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Johnson BK, LANCET, V320, P208
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004390
   Maron DF, 2015, 1 DENGUE FEVER VACCI
   McCall PJ, 2008, LANCET INFECT DIS, V8, P7, DOI 10.1016/S1473-3099(07)70298-0
   Nkoghe D, 2012, INFECT DIS REP, V4, P11, DOI 10.4081/idr.2012.e5
   Okogun GRA, 2003, ANN AGR ENV MED, V10, P217
   Oladipo EK, 2014, AM J INFECT DIS, V10, P64, DOI 10.3844/ajidsp.2014.64.67
   Onyido AE, 2008, INTERNET J PARASITIC, V4, P3
   Otu A, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0100-4
   Oyero OG, 2014, VIRUS RES, V191, P59, DOI 10.1016/j.virusres.2014.07.023
   Qsim M, 2017, CRIT REV EUKAR GENE, V27, P331, DOI 10.1615/CritRevEukaryotGeneExpr.2017019937
   Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613
   Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Schwartz E, 2000, J CLIN VIROL, V19, P169, DOI 10.1016/S1386-6532(00)00114-1
   Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003
   Stoler J, 2014, ACTA TROP, V134, P58, DOI 10.1016/j.actatropica.2014.02.017
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD URB PROSP 2010
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
   WHO, 2016, VACCINE SATETY BASIC
   WHO, 2012, GLOB STSRAT DENG PRE
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 50
TC 2
Z9 2
U1 0
U2 2
PU MAKERERE UNIV, FAC MED
PI KAMPALA
PA PO BOX 7072, KAMPALA, 00000, UGANDA
SN 1680-6905
EI 1729-0503
J9 AFR HEALTH SCI
JI Afr. Health Sci.
PD JUN
PY 2019
VL 19
IS 2
BP 2000
EP 2007
DI 10.4314/ahs.v19i2.23
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA IS5KQ
UT WOS:000482191800023
PM 31656483
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kotzky, K
   Allen, JE
   Robinson, LR
   Satterfield-Nash, A
   Bertolli, J
   Smith, C
   Pereira, IO
   Santelli, ACFES
   Peacock, G
AF Kotzky, Kim
   Allen, Jacob E.
   Robinson, Lara R.
   Satterfield-Nash, Ashley
   Bertolli, Jeanne
   Smith, Camille
   Pereira, Isabela Ornelas
   Faria e Silva Santelli, Ana Carolina
   Peacock, Georgina
TI Depressive Symptoms and Care Demands Among Primary Caregivers of Young
   Children with Evidence of Congenital Zika Virus Infection in Brazil
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
DE depression; caregiver; developmental delay; Zika virus; Brazil
ID HEALTH; FAMILIES; MOTHERS; PARENTS; SUPPORT; PROFILE; IMPACT; PHQ-9
AB Objective: Evidence suggests that caring for a child with special health care needs can affect many domains of family life, including caregiver mental health. However, few studies have examined these outcomes among families impacted by the Zika virus (ZIKV). This study examines depressive symptom severity and care demands among primary caregivers of children, aged 15 to 26 months, with evidence of congenital Zika virus infection (ZVI). Methods: A sample of primary caregivers of children with evidence of congenital ZVI in northeastern Brazil (n = 150) reported on depressive symptoms, care demands, and their children's development. Children were categorized into groups according to their developmental delay status. Bivariate analyses were run to test for differences between groups. A path analysis model was used to examine the indirect effects of developmental delay on depressive symptoms through economic challenges and time spent providing health care at home and whether these associations varied by child care support. Results: Compared to primary caregivers of children without developmental delay, primary caregivers of children with developmental delay had higher depression scores (p = 0.002), reported more economic (p < 0.001) and child care (p < 0.001) challenges, and spent more time providing health care at home (p < 0.001). Among primary caregivers who did not have child care support, developmental delay had a significant indirect effect on depressive symptoms through economic challenges but not through time spent providing health care at home. Conclusion: For families impacted by the ZIKV outbreak in Brazil, economic and child care challenges may be associated with primary caregiver mental health.
C1 [Kotzky, Kim; Satterfield-Nash, Ashley] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Allen, Jacob E.] Eagle Global Sci, San Antonio, TX USA.
   [Robinson, Lara R.; Bertolli, Jeanne; Smith, Camille; Peacock, Georgina] Ctr Dis Control & Prevent CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Pereira, Isabela Ornelas] Minist Hlth Brazil, Transmissible Dis Dept DEVIT, Brasilia, DF, Brazil.
   [Faria e Silva Santelli, Ana Carolina] Country Off Brasilia, CDC, Ctr Global Hlth, Brasilia, DF, Brazil.
RP Kotzky, K (corresponding author), Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS E-88, Atlanta, GA 30341 USA.
EM nnp7@cdc.gov
RI Nash, Ashley/Y-2026-2019
OI Kotzky, Kim/0000-0002-5114-4552
FU Office of Infectious Diseases, Bureau of Global Health, US Agency for
   International Development; CDCUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX This research was made possible through support provided by the Office
   of Infectious Diseases, Bureau of Global Health, US Agency for
   International Development, under the terms of an Interagency Agreement
   with the CDC and Cooperative Agreement number NU2G GH001152. This
   research was supported in part by an appointment to the Research
   Participation Program at the CDC administered by the Oak Ridge Institute
   for Science and Education through an interagency agreement between the
   US Department of Energy and CDC (for K. Kotzky and A. Satterfield-Nash).
CR Amendola F, 2011, REV ESC ENFERM USP, V45, P880
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Bitsko Rebecca H, 2016, MMWR Morb Mortal Wkly Rep, V65, P221, DOI 10.15585/mmwr.mm6509a1
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Caicedo C, 2015, J DEV BEHAV PEDIATR, V36, P352, DOI 10.1097/DBP.0000000000000167
   Cantwell J, 2015, J INTELL DISABIL RES, V59, P948, DOI 10.1111/jir.12205
   Chalmers RP, 2012, J STAT SOFTW, V48, P1
   Cheshire A, 2010, DISABIL REHABIL, V32, P1673, DOI 10.3109/09638281003649920
   de Souza LEC, 2018, J CHILD FAM STUD, V27, P1207, DOI 10.1007/s10826-017-0969-0
   Edelstein H, 2017, CHILD CARE HLTH DEV, V43, P323, DOI 10.1111/cch.12430
   Ferro MA, 2009, EPILEPSIA, V50, P2344, DOI 10.1111/j.1528-1167.2009.02276.x
   Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Health Resources & Services Administration, NSCH 2017
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuhlthau K, 2005, MATERN CHILD HLTH J, V9, P207, DOI 10.1007/s10995-005-4870-x
   Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   National Academies of Sciences Engineering and Medicine, 2016, PAR MATT SUPP PAR CH
   Nucleo De Tratamento E Estimulacao Precoce (NUTEP), 2017, AT CRIANC COM SINDR
   Pan American Health Organization/ World Health Organization, 2015, ZIK SUSP CONF CAS RE
   Pereira EL, 2017, CIENC SAUDE COLETIVA, V22, P3557, DOI 10.1590/1413-812320172211.22182017
   Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2
   Squires VR, 2009, RANGELAND DEGRADATION AND RECOVERY IN CHINA'S PASTORAL LANDS, P3, DOI 10.1079/9781845934965.0003
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x
   Whiting Mark, 2014, Nurs Child Young People, V26, P26, DOI 10.7748/ncyp.26.5.26.e390
   Woodgate RL, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0514-5
   World Health Organization, 2017, CHILD GROWTH STAND H
NR 35
TC 4
Z9 4
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD JUN
PY 2019
VL 40
IS 5
BP 344
EP 353
DI 10.1097/DBP.0000000000000666
PG 10
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA IQ4WA
UT WOS:000480750800004
PM 30921104
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Gordon-Lipkin, E
   Peacock, G
AF Gordon-Lipkin, Eliza
   Peacock, Georgina
TI The Spectrum of Developmental Disability with Zika Exposure: What Is
   Known, What Is Unknown, and Implications for Clinicians
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
DE Zika; microcephaly; development; disability
ID VIRUS-INFECTION; NEUROIMAGING FINDINGS; INFANTS; BRAZIL; CHILDREN;
   ABNORMALITIES; NEWBORNS; BIRTH; BORN
AB Clinicians who treat children with neurodevelopmental disabilities may encounter infants with congenital Zika syndrome or those exposed to Zika virus (ZIKV), either in utero or postnatally, in their practice and may have questions about diagnosis, management, and prognosis. In this special report, we reviewed the current literature to provide a comprehensive understanding of the findings and needs of children exposed to ZIKV in utero and postnatally. The current literature is sparse, and thus, this review is preliminary. We found that infants and children exposed to ZIKV in utero have a variety of health and developmental outcomes that suggest a wide range of lifelong physical and developmental needs. Postnatal exposure does not seem to have significant long-lasting health or developmental effects. We provide a comprehensive examination of the current knowledge on health and developmental care needs in children exposed to Zika in utero and postnatally. This can serve as a guide for health care professionals on the management and public health implications of this newly recognized population.
C1 [Gordon-Lipkin, Eliza] Kennedy Krieger Inst, Dept Neurol & Dev Med, Baltimore, MD USA.
   [Peacock, Georgina] Ctr Dis Control & Prevent, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy MS-E88, Atlanta, GA 30329 USA.
RP Peacock, G (corresponding author), Ctr Dis Control & Prevent, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy MS-E88, Atlanta, GA 30329 USA.
EM ghn3@cdc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cook CT, 2017, J PUBLIC HEALTH MAN, V24, P533
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Juca E, 2018, CHILD NERV SYST, V34, P101, DOI 10.1007/s00381-017-3636-2
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Lombardi G, 2010, J MATERN-FETAL NEO M, V23, P45, DOI 10.3109/14767058.2010.506753
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pereira EL, 2017, CIENC SAUDE COLETIVA, V22, P3557, DOI 10.1590/1413-812320172211.22182017
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Wahnich A, 2018, EMERG INFECT DIS, V24, P827, DOI 10.3201/eid2405.170764
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 57
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD JUN
PY 2019
VL 40
IS 5
BP 387
EP 395
DI 10.1097/DBP.0000000000000665
PG 9
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA IQ4WA
UT WOS:000480750800010
PM 30921103
DA 2020-07-08
ER

PT J
AU Lang, FC
   Singh, RK
   Pei, YG
   Zhang, SW
   Sun, KF
   Robertson, ES
AF Lang, Fengchao
   Singh, Rajnish Kumar
   Pei, Yonggang
   Zhang, Shengwei
   Sun, Kunfeng
   Robertson, Erle S.
TI EBV epitranscriptome reprogramming by METTL14 is critical for
   viral-associated tumorigenesis
SO PLOS PATHOGENS
LA English
DT Article
ID EPSTEIN-BARR-VIRUS; NUCLEAR ANTIGEN 3C; MESSENGER-RNA METHYLATION;
   C-MYC; M(6)A; N-6-METHYLADENOSINE; TRANSLATION; DEGRADATION; STABILITY;
   PROTEIN
AB Epstein-Barr virus (EBV) is a ubiquitous oncogenic virus that induces many cancers. N6-Methyladenosine (m6A) modification regulates many cellular processes. We explored the role of m6A in EBV gene regulation and associated cancers. We have comprehensively defined m6A modification of EBV latent and lytic transcripts. Furthermore, m6A modification demonstrated a functional role in regulation of the stability of viral transcripts. The methyltransferase METTL14 was induced at the transcript and protein levels, and knock-down of METTL14 led to decreased expression of latent EBV transcripts. METTL14 was also significantly induced in EBV-positive tumors, promoted growth of EBV-transformed cells and tumors in Xenograft animal models. Mechanistically, the viral-encoded latent oncoprotein EBNA3C activated transcription of METTL14, and directly interacted with METTL14 to promote its stability. This demonstrated that EBV hijacks METTL14 to drive EBV-mediated tumorigenesis. METTL14 is now a new target for development of therapeutics for treatment of EBV-associated cancers.
   Author summary Epstein-Barr virus (EBV) is a ubiquitous oncogenic virus that contributes to approximately 2% of all cancers by modulating a myriad of host cell activities. M6A is the most abundant RNA modification which is important for infection with HIV-1, HCV, Zika virus, KSHV and SV40 virus. The role of m6A modification and the associated enzymes in EBV infection and related oncogenic activities has not been explored. We investigated the role of m6A modification on EBV-infection and examined its effects on the proliferative activities of the virus which contributes to cancer. We showed that the m6A methyltransferase METTL14 is an important factor in EBV-induced oncogenesis. METTL14 was dramatically increased in EBV latently infected cells. Knock-down of METTL14 led to decreased latent viral gene expression. The essential EBV latent antigen EBNA3C was up-regulated by METTL14-mediated m6A modification, and its expression led to a feedback loop in up-regulation of METTL14 transcription, and the stability of its protein. We now provide a more comprehensive understanding of EBV and the host cell RNA processing machinery critical for regulation of EBV activities to maintain latent infection and its oncogenic properties.
C1 [Robertson, Erle S.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Tumor Virol Program, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Microbiol, Tumor Virol Program, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Robertson, ES (corresponding author), Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Tumor Virol Program, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA.
EM erle@pennmedicine.upenn.edu
RI Pei, Yonggang/I-6158-2019; Sun, Kunfeng/C-9828-2011; Lang,
   Fengchao/AAO-3282-2020
OI Pei, Yonggang/0000-0001-7296-8772; Lang, Fengchao/0000-0002-4617-938X;
   /0000-0002-3874-8909; Robertson, Erle/0000-0002-6088-2979
FU National Cancer Institute at the National Institutes of Health public
   health service [P30-CA016520, P30-DK050306, R01-CA171979, P01-CA174439,
   R01-CA177423]
FX This work was supported by National Cancer Institute at the National
   Institutes of Health public health service Grants P30-CA016520,
   P30-DK050306, R01-CA171979, P01-CA174439 and R01-CA177423 to ESR. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bajaj BG, 2008, J VIROL, V82, P4082, DOI 10.1128/JVI.02500-07
   BURKITT DP, 1969, JNCI-J NATL CANCER I, V42, P19
   Cotter MA, 2000, MOL CELL BIOL, V20, P5722, DOI 10.1128/MCB.20.15.5722-5735.2000
   Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059
   Cui XD, 2016, BIOINFORMATICS, V32, P378, DOI 10.1093/bioinformatics/btw281
   Dai DJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0129-x
   Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7
   Fish K, 2014, BLOOD, V123, P530, DOI 10.1182/blood-2013-07-517649
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995
   Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z
   Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276
   Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100
   Jha HC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01602
   Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102
   Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005
   Knight JS, 2003, J VIROL, V77, P4261, DOI 10.1128/JVI.77.7.4261-4272.2003
   Lang FC, 2017, P NATL ACAD SCI USA, V114, P10912, DOI 10.1073/pnas.1704076114
   Li LH, 2016, J VIROL, V90, P790, DOI 10.1128/JVI.02258-15
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Pei YG, 2018, J VIROL, V92, DOI 10.1128/JVI.00663-18
   Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15
   Skalska L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003187
   Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8
   Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016
   Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17
   Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452
   Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115
NR 42
TC 9
Z9 9
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2019
VL 15
IS 6
AR e1007796
DI 10.1371/journal.ppat.1007796
PG 25
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA IO1PP
UT WOS:000479154700017
PM 31226160
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thuilliez, J
   Dumont, Y
AF Thuilliez, Josselin
   Dumont, Yves
TI Public Mosquito Abatement: A Cluster Randomized Experiment
SO WORLD BANK ECONOMIC REVIEW
LA English
DT Article
DE Mosquito abatement; Public control; Private behaviors
ID AEDES-ALBOPICTUS; FIELD EXPERIMENT; SAMPLE-SIZE; CHIKUNGUNYA; PROGRAMS;
   TRIALS; VECTOR; DENGUE; SANITATION; BEHAVIOR
AB Mosquito abatement is a public good. A simultaneous model of mosquito abundance and abatement response is developed. We then use data from a cluster randomized controlled experiment conducted over the period 2012-2014 in urban areas of Reunion in France to study the impact of WHO-recommended mechanical elimination techniques, which involve removing sources of stagnant water around the house, on a number of outcomes, including objective entomological indices and self-declared protective behaviors. Empirical results document that households reduce their protective behavior in response to public control. This study holds implications for arboviral disease control, including Zika control.
C1 [Thuilliez, Josselin] CNRS, Ctr Econ Sorbonne, 106-112 Blvd Hop, F-75013 Paris, France.
   [Dumont, Yves] CIRAD UMR AMAP, F-34398 Montpellier 5, France.
RP Thuilliez, J (corresponding author), CNRS, Ctr Econ Sorbonne, 106-112 Blvd Hop, F-75013 Paris, France.
EM josselin.thuilliez@univ-paris1.fr; yves.dumont@cirad.fr
RI THUILLIEZ, Josselin/X-3786-2019; Dumont, Yves/O-3801-2017
OI THUILLIEZ, Josselin/0000-0001-5392-0917; Dumont,
   Yves/0000-0003-4817-685X
FU French Ministry of Health; Les Fonds Europeens; Le Conseil Regional de
   la Reunion (FEDER)
FX Josselin Thuilliez (corresponding author) is a researcher at CNRS-Centre
   d'economie de la Sorbonne. 106-112, Boulevard de l'Hopital, 75013 Paris;
   his email address isjosselin.thuilliez@univ-paris1.fr.Yves Dumont is a
   researcher at CIRAD UMR AMAP, 34398 Montpellier cedex 5; his email
   address isyves.dumont@cirad.fr.We are very grateful to the editor, three
   anonymous referees, Achyuta Adhvaryu, Emmanuelle Augeraud-Veron,
   Jean-Claude Berthelemy, Didier Fontenille, Pierre-Yves Geoffard, Mark
   Gersovitz, Maria Kuecken, Alessandro Tarozzi, and numerous seminar
   participants for their valuable comments and suggestions. Special thanks
   also go to ARS-OI and their team of coordinators, technicians, and
   agents. In particular, we would like to extend our gratitude to
   Jean-Sebastien Dehecq, Helene Thebault, and Olivier Reilhes, the
   coordinators Thomas Margueron and Manuel Rodicq, as well as the many
   technicians who helped in the implementation and organization of the
   fieldwork. Research assistance from Claire Bellia, Marie Hamsany, and
   Sera Onalan was greatly appreciated. Finally, the study could not have
   been achieved without the dedication and patience shown by all the
   agents who conducted the interviews. This program was funded by the
   French Ministry of Health and Les Fonds Europeens and Le Conseil
   Regional de la Reunion (FEDER). It was undertaken jointly by ARS (Agence
   Regionale de Sante), IRD (Institut de Recherche Developpement), CNRS
   (Centre National de la Recherche Scientifique) in collaboration with
   CRVOI (Centre de Recherche et de Veille sur les maladies emergentes dans
   l'Ocean Indien). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The content is solely the responsibility of the authors. A
   supplementary online appendix to this article is available at
   https://academic.oup.com/wber.
CR Angelini P., 2008, Parassitologia (Rome), V50, P97
   Arrow K.J., 1963, AM ECON REV, V53, P141
   Atienza AA, 2002, EPIDEMIOL REV, V24, P72, DOI 10.1093/epirev/24.1.72
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bennett D, 2012, J HUM RESOUR, V47, P146, DOI 10.1353/jhr.2012.0008
   Boyer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091170
   CARLSON GA, 1976, J ENVIRON ECON MANAG, V3, P142, DOI 10.1016/0095-0696(76)90028-0
   Dammert AC, 2014, J HEALTH ECON, V35, P147, DOI 10.1016/j.jhealeco.2014.02.002
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1
   Duret P, 2013, SOCIOLOGIE, V3
   FELDMAN HA, 1994, STAT MED, V13, P61, DOI 10.1002/sim.4780130108
   Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040
   Frondel M, 2005, ECOL ECON, V55, P515, DOI 10.1016/j.ecolecon.2004.12.013
   Gersovitz M, 2005, J PUBLIC ECON, V89, P647, DOI 10.1016/j.jpubeco.2004.02.007
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620
   Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x
   KOEPSELL TD, 1991, J CLIN EPIDEMIOL, V44, P701, DOI 10.1016/0895-4356(91)90030-D
   Murray DM, 2001, STAT MED, V20, P1373, DOI 10.1002/sim.675
   Nixon RM, 2003, STAT MED, V22, P2673, DOI 10.1002/sim.1483
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Setbon M, 2012, EMERGING HLTH THREAT, V2, P7083, DOI [10.3402/ehtj.v2i0.7083, DOI 10.3402/EHTJ.V2I0.7083]
   Tarozzi A, 2015, AM ECON J-APPL ECON, V7, P54, DOI 10.1257/app.20130475
   Thuilliez J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002609
   Ukoumunne OC, 2001, STAT MED, V20, P417, DOI 10.1002/1097-0258(20010215)20:3<417::AID-SIM802>3.0.CO;2-G
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 30
TC 1
Z9 1
U1 1
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0258-6770
EI 1564-698X
J9 WORLD BANK ECON REV
JI World Bank Econ. Rev.
PD JUN
PY 2019
VL 33
IS 2
BP 479
EP 497
DI 10.1093/wber/lhw066
PG 19
WC Business, Finance; Development Studies; Economics
SC Business & Economics; Development Studies
GA IO3NR
UT WOS:000479287800010
DA 2020-07-08
ER

PT J
AU Yee, SH
   Yee, DA
   Crespo, RD
   Oczkowski, A
   Bai, FW
   Friedman, S
AF Yee, Susan Harrell
   Yee, Donald A.
   Crespo, Rebeca de Jesus
   Oczkowski, Autumn
   Bai, Fengwei
   Friedman, Stephanie
TI Linking Water Quality to Aedes aegypti and Zika in Flood-Prone
   Neighborhoods
SO ECOHEALTH
LA English
DT Article
DE Aedes aegypti; Nitrogen; Carbon; Stable isotopes; Zika
ID LARVAL COMPETITION; ALTERS SUSCEPTIBILITY; VECTORIAL CAPACITY; HEALTH
   IMPACTS; DETRITUS TYPES; SEPTIC TANKS; SAN-JUAN; MOSQUITOS; VIRUS;
   DIPTERA
AB The ability of ecosystems to regulate water quality and flood events has been linked to health outcomes, including mosquito-borne illnesses. In the San Juan Bay Estuary watershed of Puerto Rico, habitat alterations and land-use development have disrupted watershed hydrology, exacerbating wastewater discharges and subjecting some neighborhoods to frequent flooding events. In 2016, the mosquito-borne illness Zika became a new cause for concern. We hypothesized that nutrient-enriched flood water could provide pulses of supplemental nutrients to local mosquito populations. We conducted a field study in six neighborhoods adjacent to the estuary to assess whether environmental variability of nutrient inputs could be linked to breeding habitat containers, Aedes aegypti larvae and adults, and the acquisition of Zika virus by adult mosquitoes. The most frequently flooded neighborhood had consistently higher levels of nitrogen in estuary water, leaf detritus, containers, and adult mosquitoes compared to other neighborhoods. Adult body nitrogen was significantly related to both nitrogen content of containers and leaf detritus from the local trapping area. Disseminated Zika concentration in adult Ae. aegypti tended to decrease as body carbon and nitrogen increased. Our study provides preliminary evidence that environmental variability in nutrient inputs can influence viral acquisition by mosquito vectors. This suggests that management actions to reduce flooding and improve water quality should go hand-in-hand with more traditional vector control methods, such as aerial spraying, to help control spread of vector-borne diseases.
C1 [Yee, Susan Harrell; Crespo, Rebeca de Jesus; Friedman, Stephanie] US EPA, Gulf Ecol Div, Natl Hlth & Environm Effects Res Lab, 1 Sabine Isl Dr, Gulf Breeze, FL 32561 USA.
   [Yee, Donald A.; Bai, Fengwei] Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
   [Oczkowski, Autumn] US EPA, Atlantic Ecol Div, Natl Hlth & Environm Effects Res Lab, Narragansett, RI 02882 USA.
RP Yee, SH (corresponding author), US EPA, Gulf Ecol Div, Natl Hlth & Environm Effects Res Lab, 1 Sabine Isl Dr, Gulf Breeze, FL 32561 USA.
EM yee.susan@epa.gov
OI de Jesus Crespo, Rebeca/0000-0003-1686-3575; Yee,
   Susan/0000-0002-5628-3033; Oczkowski, Autumn/0000-0002-2421-0956
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P20 GM103476]
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004
   Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886
   Azar D, 2007, GEOJOURNAL, V69, P23, DOI 10.1007/s10708-007-9106-8
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Brandeis TJ, 2014, SRS190 US FOR SERV
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   Canyon DV, 1999, J MED ENTOMOL, V36, P301, DOI 10.1093/jmedent/36.3.301
   CARPENTER SR, 1983, ECOLOGY, V64, P219, DOI 10.2307/1937068
   Carver S, 2015, HLTH WETLANDS HLTH P, P95
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Crespo RD, 2018, INT J PUBLIC HEALTH, V63, P81, DOI 10.1007/s00038-017-1020-3
   De Jesus Crespo R, 2018, LINKING WETLAND ECOS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051
   Gonzalez-Salazar C, 2017, ECOHEALTH, V14, P171, DOI 10.1007/s10393-017-1206-4
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hashizume M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-98
   Hinga KR, 2005, WASTE PROCESSING DET, V1, P417
   Ivers LC, 2006, CURR OPIN INFECT DIS, V19, P408, DOI 10.1097/01.qco.0000244044.85393.9e
   Klempner MS, 2007, NEW ENGL J MED, V356, P2567, DOI 10.1056/NEJMp078081
   Kling LJ, 2007, J VECTOR ECOL, V32, P207, DOI 10.3376/1081-1710(2007)32[207:LMCIDV]2.0.CO;2
   Korfmacher KS, 2015, INT J ENV RES PUB HE, V12, P300, DOI 10.3390/ijerph120100300
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   Lima F, 2017, LINEAR MIXED EFFECTS
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mbanzulu KM, 2017, INT J INFECT DIS, V57, P32, DOI 10.1016/j.ijid.2017.01.016
   Mendez-Lazaro P, 2014, INT J ENV RES PUB HE, V11, P9409, DOI 10.3390/ijerph110909409
   Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mutero CM, 2004, ACTA TROP, V89, P187, DOI 10.1016/j.actatropica.2003.08.006
   Muturi EJ, 2012, ENVIRON ENTOMOL, V41, P1062, DOI 10.1603/EN11301
   Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110
   NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123
   NOAA, 2018, COAST FLOOD EXP MAPP
   Oczkowski AJ, 2011, ECOL APPL, V21, P1708, DOI 10.1890/10-0446.1
   Oczkowski AJ, 2009, P NATL ACAD SCI USA, V106, P1364, DOI 10.1073/pnas.0812568106
   Oosterbroek B, 2016, ECOSYST SERV, V17, P237, DOI 10.1016/j.ecoser.2015.12.008
   Paul D, 2007, RAPID COMMUN MASS SP, V21, P3006, DOI 10.1002/rcm.3185
   Pires DA, 2010, J VECTOR ECOL, V35, P401, DOI 10.1111/j.1948-7134.2010.00099.x
   Puerto Rico Department of Health, 2016, INF SEM ENF ARB ARBO, P23
   Puerto Rico Department of Health, 2017, INF SEM ENF ARB ARBO
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Rhodus J., 2013, EPA600R13354
   San Juan Bay Estuary Program SJBEP, 2000, PROGR EST BAH SAN JU
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
   Sheffield P. E., 2014, HLTH IMPACT ASSESSME
   Shono H, 2008, FISH RES, V93, P154, DOI 10.1016/j.fishres.2008.03.006
   Thompson SJ, 2017, ECOHEALTH, V14, P821, DOI 10.1007/s10393-017-1277-2
   WHO, 2016, ZIK VIR INF US AM PU
   World Health Organization WHO, 2016, REP ZIK SIT NEUR SYN
   Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x
   Yee DA, 2007, OECOLOGIA, V153, P153, DOI 10.1007/s00442-007-0707-1
   Yee DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133734
   Yee DA, 2015, J MED ENTOMOL, V52, P394, DOI 10.1093/jme/tjv028
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zuur Alain F., 2009, P1
NR 64
TC 0
Z9 0
U1 3
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2019
VL 16
IS 2
BP 191
EP 209
DI 10.1007/s10393-019-01406-6
PG 19
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA IN7TN
UT WOS:000478884800002
PM 30945160
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Whiteman, A
   Gomez, C
   Rovira, J
   Chen, G
   McMillan, WO
   Loaiza, J
AF Whiteman, Ari
   Gomez, Carmelo
   Rovira, Jose
   Chen, Gang
   McMillan, W. Owen
   Loaiza, Jose
TI Aedes Mosquito Infestation in Socioeconomically Contrasting
   Neighborhoods of Panama City
SO ECOHEALTH
LA English
DT Article
DE Mosquito; Vector-borne disease; Social determinants of health;
   Entomology
ID OVIPOSITION HABITAT SELECTION; WEST-NILE-VIRUS; CULISETA-LONGIAREOLATA;
   CULEX-QUINQUEFASCIATUS; ALBOPICTUS DIPTERA; AEGYPTI; DISPERSAL;
   CULICIDAE; FOUNDATIONS; LANDSCAPE
AB The global expansion and proliferation of Aedes aegypti and Aedes albopictus represents a growing public health threat due to their capacity to transmit a variety of arboviruses to humans, including dengue, chikungunya, and Zika. Particularly important in urban regions, where these species have evolved to breed in man-made containers and feed nearly exclusively on human hosts, the threat of vector-borne disease has risen in recent decades due to the growth of cities, progression of climate change, and increase in globalization. While the dynamics of Aedes populations in urban settings have been well studied in relation to ecological features of the landscape, relatively less is known about the relationship between neighborhood socioeconomic status and Aedes infestation. Here, we compare infestation levels of both A. aegypti and A. albopictus in four socioeconomically contrasting neighborhoods of urban Panama City, Panama. Our results indicate that infestation levels for both Aedes species vary between neighborhoods of contrasting socioeconomic status, being higher in neighborhoods having lower percentage of residents with bachelor degrees and lower monthly household income. Additionally, we find that proximity between socioeconomically contrasting neighborhoods can predict infestation levels by species, with A. aegypti increasing and A. albopictus decreasing with proximity between neighborhoods. These findings hold key implications for the control and prevention of dengue, chikungunya, and Zika in Panama, a region with ongoing arbovirus outbreaks and high economic inequity.
C1 [Whiteman, Ari; Chen, Gang] Univ North Carolina Charlotte, Dept Geog & Earth Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
   [Whiteman, Ari; Rovira, Jose; McMillan, W. Owen; Loaiza, Jose] Smithsonian Trop Res Inst, POB 0843-03092, Balboa Ancon 03092, Panama.
   [Loaiza, Jose] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, POB 0843-01103, Panama City, Panama.
   [Gomez, Carmelo; Loaiza, Jose] Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.
RP Whiteman, A (corresponding author), Univ North Carolina Charlotte, Dept Geog & Earth Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA.; Whiteman, A (corresponding author), Smithsonian Trop Res Inst, POB 0843-03092, Balboa Ancon 03092, Panama.
EM Ari.whiteman@gmail.com
RI Chen, Gang/AAG-9414-2020
OI Chen, Gang/0000-0002-7469-3650
FU Smithsonian Tropical Research InstituteSmithsonian
   InstitutionSmithsonian Tropical Research Institute
FX This work was funded through a Short-Term Fellowship with the
   Smithsonian Tropical Research Institute.
CR Afify A, 2015, J MED ENTOMOLOGY
   Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360
   Barcena A, 2016, CEPAL
   Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x
   BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Calhoun LM, 2007, AM J TROP MED HYG, V77, P478, DOI 10.4269/ajtmh.2007.77.478
   Chansang C, 2007, AM J TROP MED HYG, V77, P897, DOI 10.4269/ajtmh.2007.77.897
   Chaves LF, 2009, J MED ENTOMOL, V46, P220, DOI 10.1603/033.046.0206
   Daniels Benjamin, 2012, STAT SOFTWARE COMPON
   Dhar-Chowdhury P, 2016, AM J TROPICAL MED HY
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Eskildsen GA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194874
   Estep LK, 2010, J MED ENTOMOL, V47, P977, DOI 10.1603/ME10056
   Farajollahi A, 2009, J MED ENTOMOL, V1, P1
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Ferreira AC, 2007, REV SAUDE PUBLICA
   Goni E, 2011, WORLD DEV, V39, P1558, DOI 10.1016/j.worlddev.2011.04.025
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147
   Guthman J, 2008, PROF GEOGR, V60, P197
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Joshi V, 2006, J MED ENTOMOLOGY
   Kiflawi M, 2003, ECOL ENTOMOL, V28, P168, DOI 10.1046/j.1365-2311.2003.00505.x
   Krishnan V., 2010, CONSTRUCTING AREA BA
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   LaDeau SL, 2013, INT J ENV RES PUBLIC
   Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21
   Li Y, 2014, PLOS NEGLECTED TROPI
   Little E, 2017, J MED ENTOMOLOGY
   McGarigal K, 2012, COMPUTER SOFTWARE PR, DOI [10.1002/ejoc.201200111, DOI 10.1002/EJOC.201200111]
   Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6
   Nylin S, 2001, AUSTRAL ECOL, V26, P507, DOI 10.1046/j.1442-9993.2001.01134.x
   PADMANABHA H, 2010, ECOHEALTH
   Paul KK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199457
   Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022
   Quintero J, 2009, CADERNOS SAUDE PUBLI
   Reisen WK, 2008, EMERGING INFECT DIS
   Reiskind MH, 2009, ECOLOGICAL ENTOMOLOG
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Ritchie SA, 2014, J MED ENTOMOLOGY
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ruiz MO, 2007, INT J HLTH GEOGRAPHI
   Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4
   Schafrick NH, 2013, AM J TROPICAL MED HY
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Spiegel JM, 2007, TROPICAL MED INT HLT
   Tedesco C, 2010, HEALTH PLACE, V16, P1188, DOI 10.1016/j.healthplace.2010.08.003
   The World Bank, 2015, GINI IND WORLD BANK, P1
   Torrisi GJ, 2013, NORTHEAST NAT, V20, P363, DOI 10.1656/045.020.0211
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Vanwambeke SO, 2011, TROP MED INT HEALTH, V1, P1
   Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4
   Whiteman A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102179
NR 62
TC 0
Z9 0
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2019
VL 16
IS 2
BP 210
EP 221
DI 10.1007/s10393-019-01417-3
PG 12
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA IN7TN
UT WOS:000478884800003
PM 31114946
DA 2020-07-08
ER

PT J
AU Saylan, Y
   Erdem, O
   Unal, S
   Denizli, A
AF Saylan, Yeseren
   Erdem, Ozgecan
   Unal, Serhat
   Denizli, Adil
TI An Alternative Medical Diagnosis Method: Biosensors for Virus Detection
SO BIOSENSORS-BASEL
LA English
DT Review
DE biosensor; medical applications; virus detection
ID SURFACE-PLASMON-RESONANCE; MOLECULARLY IMPRINTED POLYMER; LABEL-FREE
   DETECTION; REAL-TIME DETECTION; EBOLA-VIRUS; ZIKA VIRUS; ELECTROCHEMICAL
   BIOSENSOR; RAPID DETECTION; PIEZOELECTRIC BIOSENSOR; SENSITIVE DETECTION
AB Infectious diseases still pose an omnipresent threat to global and public health, especially in many countries and rural areas of cities. Underlying reasons of such serious maladies can be summarized as the paucity of appropriate analysis methods and subsequent treatment strategies due to the limited access of centralized and equipped health care facilities for diagnosis. Biosensors hold great impact to turn our current analytical methods into diagnostic strategies by restructuring their sensing module for the detection of biomolecules, especially nano-sized objects such as protein biomarkers and viruses. Unquestionably, current sensing platforms require continuous updates to address growing challenges in the diagnosis of viruses as viruses change quickly and spread largely from person-to-person, indicating the urgency of early diagnosis. Some of the challenges can be classified in biological barriers (specificity, low number of targets, and biological matrices) and technological limitations (detection limit, linear dynamic range, stability, and reliability), as well as economical aspects that limit their implementation into resource-scarce settings. In this review, the principle and types of biosensors and their applications in the diagnosis of distinct infectious diseases were comprehensively explained. The deployment of current biosensors into resource-scarce settings is further discussed for virus detection by elaborating the pros and cons of existing methods as a conclusion and future perspective.
C1 [Saylan, Yeseren; Denizli, Adil] Hacettepe Univ, Dept Chem, TR-06800 Ankara, Turkey.
   [Erdem, Ozgecan] Hacettepe Univ, Dept Biol, TR-06800 Ankara, Turkey.
   [Unal, Serhat] Hacettepe Univ, Dept Infect Dis & Clin Microbiol, TR-06230 Ankara, Turkey.
RP Denizli, A (corresponding author), Hacettepe Univ, Dept Chem, TR-06800 Ankara, Turkey.
EM yeseren@hacettepe.edu.tr; ozgecanerdem@hacettepe.edu.tr;
   sunal@hacettepe.edu.tr; denizli@hacettepe.edu.tr
RI UNAL, SERHAT/I-9034-2013
OI UNAL, SERHAT/0000-0003-1184-4711; Erdem, Ozgecan/0000-0002-1284-6113;
   SAYLAN, YESEREN/0000-0001-5173-1522
CR Abolhasan R, 2019, BIOSENS BIOELECTRON, V129, P164, DOI 10.1016/j.bios.2019.01.008
   Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Afzal A, 2017, CHEMOSENSORS, V5, DOI 10.3390/chemosensors5010007
   Altintas Z, 2015, BIOCHIMIE, V115, P144, DOI 10.1016/j.biochi.2015.05.010
   Alvarez MM, 2017, ACS NANO, V11, P5195, DOI 10.1021/acsnano.7b01493
   Anik U, 2016, ANAL CHEM, V88, P6151, DOI 10.1021/acs.analchem.6b01720
   Ashiba H, 2017, BIOSENS BIOELECTRON, V93, P260, DOI 10.1016/j.bios.2016.08.099
   Atay S, 2016, ANAL METHODS-UK, V8, P153, DOI 10.1039/c5ay02898a
   Babamiri B, 2018, BIOSENS BIOELECTRON, V117, P332, DOI 10.1016/j.bios.2018.06.003
   Baca JT, 2015, SENSORS-BASEL, V15, P8605, DOI 10.3390/s150408605
   Backer M, 2017, SENSOR ACTUAT B-CHEM, V238, P716, DOI 10.1016/j.snb.2016.07.096
   Bai H, 2012, SENSORS-BASEL, V12, P12506, DOI 10.3390/s120912506
   Bai W, 2014, ANGEW CHEM INT EDIT, V53, P2095, DOI 10.1002/anie.201309462
   Bartold K, 2018, ACS APPL MATER INTER, V10, P27562, DOI 10.1021/acsami.8b09296
   Battal D, 2018, BIOSENS BIOELECTRON, V111, P10, DOI 10.1016/j.bios.2018.03.055
   Bharadwaj R, 2016, PLASMONICS, V11, P753, DOI 10.1007/s11468-015-0106-0
   Bierhoff M, 2018, CLIN INFECT DIS, V67, P430, DOI 10.1093/cid/ciy091
   Birnbaumer GM, 2009, LAB CHIP, V9, P3549, DOI 10.1039/b914738a
   Bunroddith K, 2018, ANAL CHIM ACTA, V1001, P106, DOI 10.1016/j.aca.2017.10.037
   Cai H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14494
   Casadio S, 2017, CHEM ENG J, V315, P459, DOI 10.1016/j.cej.2017.01.050
   Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45
   Chang JE, 2018, SENSOR ACTUAT B-CHEM, V255, P800, DOI 10.1016/j.snb.2017.08.057
   Cheeveewattanagul N, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702741
   Cheng D, 2016, ANAL CHEM, V88, P820, DOI 10.1021/acs.analchem.5b03320
   Cheng SS, 2015, SENSOR ACTUAT B-CHEM, V212, P329, DOI 10.1016/j.snb.2015.02.038
   Cho KH, 2018, ACS APPL MATER INTER, V10, P28412, DOI 10.1021/acsami.8b09918
   Choi Dong-Hoon, 2018, J Cyst Fibros, V17, pe35, DOI 10.1016/j.jcf.2018.03.005
   Cunha I, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18072367
   Deng JJ, 2013, SENSORS-BASEL, V13, P7774, DOI 10.3390/s130607774
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Dibekkaya H, 2016, J MACROMOL SCI A, V53, P585, DOI 10.1080/10601325.2016.1201756
   do Nascimento NM, 2017, BIOSENS BIOELECTRON, V90, P166, DOI 10.1016/j.bios.2016.11.004
   Dudak FC, 2014, FOOD ANAL METHOD, V7, P506, DOI 10.1007/s12161-013-9739-9
   Dukar N, 2019, MATER CHEM PHYS, V228, P357, DOI 10.1016/j.matchemphys.2019.02.043
   Eissa S, 2015, BIOSENS BIOELECTRON, V69, P148, DOI 10.1016/j.bios.2015.01.055
   Erdem O, 2018, BIOMIMETICS, V3, DOI 10.3390/biomimetics3040038
   Erdem O, 2019, BIOSENS BIOELECTRON, V126, P608, DOI 10.1016/j.bios.2018.11.030
   Feng WB, 2018, NEW J CHEM, V42, P3503, DOI 10.1039/c7nj04791f
   Giamblanco N, 2015, RSC ADV, V5, P38152, DOI 10.1039/c5ra03467a
   Goode JA, 2015, LANGMUIR, V31, P6267, DOI 10.1021/la503533g
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hassen WM, 2008, SENSOR ACTUAT B-CHEM, V134, P755, DOI 10.1016/j.snb.2008.06.020
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hotez PJ, 2015, MICROBES INFECT, V17, P539, DOI 10.1016/j.micinf.2015.05.004
   Hu TX, 2016, BIOSENS BIOELECTRON, V77, P451, DOI 10.1016/j.bios.2015.09.068
   Hwang HJ, 2017, BIOSENS BIOELECTRON, V87, P164, DOI 10.1016/j.bios.2016.08.031
   Ilkhani H, 2018, ANAL BIOCHEM, V557, P151, DOI 10.1016/j.ab.2018.06.010
   Inan H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02672-6
   Inci F, 2015, P NATL ACAD SCI USA, V112, pE4354, DOI 10.1073/pnas.1510824112
   Inci F, 2013, ACS NANO, V7, P4733, DOI 10.1021/nn3036232
   Jahanshahi P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03851
   Jenik M, 2009, ANAL CHEM, V81, P5320, DOI 10.1021/ac8019569
   Jin CE, 2018, SENSOR ACTUAT B-CHEM, V255, P2399, DOI 10.1016/j.snb.2017.08.197
   Justino CIL, 2015, TRAC-TREND ANAL CHEM, V68, P2, DOI 10.1016/j.trac.2015.03.006
   Justino CIL, 2013, TRAC-TREND ANAL CHEM, V47, P27, DOI 10.1016/j.trac.2013.02.004
   Kabessa Y, 2016, BIOSENS BIOELECTRON, V79, P784, DOI 10.1016/j.bios.2016.01.011
   Kaushik A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28035-3
   Khan MS, 2018, BIOSENS BIOELECTRON, V110, P132, DOI 10.1016/j.bios.2018.03.044
   Khater M, 2017, BIOSENS BIOELECTRON, V93, P72, DOI 10.1016/j.bios.2016.09.091
   Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529
   Kreil TR, 2015, EMERG INFECT DIS, V21, P521, DOI 10.3201/eid2103.141838
   Krishna VD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00400
   Kuralay F, 2018, ELECTROANAL, V30, P1556, DOI 10.1002/elan.201800153
   La Spada L, 2018, MATERIALS, V11, DOI 10.3390/ma11040603
   Lavanchy D., 2016, HEPATITIS B VIRUS HU, P187, DOI DOI 10.1007/978-3-319-22330-8_9
   Lee J, 2018, BIOSENS BIOELECTRON, V102, P425, DOI 10.1016/j.bios.2017.11.052
   Li X, 2015, ANAL CHEM, V87, P9009, DOI 10.1021/acs.analchem.5b02210
   Lim JM, 2018, ANAL CHIM ACTA, V1026, P109, DOI 10.1016/j.aca.2018.04.005
   Liu XN, 2018, ANAL CHEM, V90, P3430, DOI 10.1021/acs.analchem.7b05113
   Liu Y, 2017, SENSOR ACTUAT B-CHEM, V253, P1188, DOI 10.1016/j.snb.2017.07.166
   Loyez M, 2019, BIOSENS BIOELECTRON, V131, P104, DOI 10.1016/j.bios.2019.01.062
   Lu CH, 2012, BIOSENS BIOELECTRON, V31, P439, DOI 10.1016/j.bios.2011.11.008
   Lv M, 2018, BIOSENS BIOELECTRON, V106, P122, DOI 10.1016/j.bios.2018.01.049
   Malik AA, 2017, MAT SCI ENG C-MATER, V77, P1341, DOI 10.1016/j.msec.2017.03.209
   Mao CB, 2009, ANGEW CHEM INT EDIT, V48, P6790, DOI 10.1002/anie.200900231
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Moulick A, 2017, ANAL CHIM ACTA, V983, P42, DOI 10.1016/j.aca.2017.06.045
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Navakul K, 2017, NANOMED-NANOTECHNOL, V13, P549, DOI 10.1016/j.nano.2016.08.009
   Osman B, 2013, MAT SCI ENG C-MATER, V33, P3609, DOI 10.1016/j.msec.2013.04.041
   Ozgur E, 2013, ENVIRON PROG SUSTAIN, V32, P1164, DOI 10.1002/ep.11718
   Pang Y, 2018, BIOSENS BIOELECTRON, V116, P123, DOI 10.1016/j.bios.2018.05.038
   Pang YF, 2015, BIOSENS BIOELECTRON, V66, P527, DOI 10.1016/j.bios.2014.10.052
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004
   Pohanka M, 2018, TALANTA, V178, P970, DOI 10.1016/j.talanta.2017.10.031
   Prabowo BA, 2017, BIOSENS BIOELECTRON, V92, P186, DOI 10.1016/j.bios.2017.01.043
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Rauf S, 2018, ANAL BIOCHEM, V545, P13, DOI 10.1016/j.ab.2018.01.007
   Riedel T, 2014, BIOSENS BIOELECTRON, V55, P278, DOI 10.1016/j.bios.2013.12.011
   Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14
   Russo L, 2018, ACS OMEGA, V3, P18849, DOI 10.1021/acsomega.8b02458
   Saini A, 2016, SENSOR ACTUAT B-CHEM, V228, P221, DOI 10.1016/j.snb.2016.01.026
   Sayhi M, 2018, BIOSENS BIOELECTRON, V107, P170, DOI 10.1016/j.bios.2018.02.018
   Saylan Y., 2018, SURFACE PLASMON RESO, P425
   Saylan Y, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19061279
   Saylan Y, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18093016
   Saylan Y, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2631
   Saylan Y, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040898
   Saylan Y, 2017, SENSOR ACTUAT B-CHEM, V241, P446, DOI 10.1016/j.snb.2016.10.017
   Schirhagl R, 2010, ADV MATER, V22, P2078, DOI 10.1002/adma.200903517
   Sciacca B, 2013, SENSOR ACTUAT B-CHEM, V183, P454, DOI 10.1016/j.snb.2013.03.131
   Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031
   Shafiee H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04116
   Shin SR, 2016, ANAL CHEM, V88, P10019, DOI 10.1021/acs.analchem.6b02028
   Shoaie N, 2018, IEEE SENS J, V18, P1835, DOI 10.1109/JSEN.2017.2787024
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   stek M.M., 2019, HACET J BIOL CHEM, V46, P495
   Suri CR, 2003, ADV BIOSENS, V5, P161
   Tam PD, 2009, J IMMUNOL METHODS, V350, P118, DOI 10.1016/j.jim.2009.08.002
   Tam YJ, 2017, BIOTECHNOL APPL BIOC, V64, P735, DOI 10.1002/bab.1528
   Tardivo M, 2015, BIOSENS BIOELECTRON, V72, P393, DOI 10.1016/j.bios.2015.05.026
   Theint HT, 2019, SPECTROCHIM ACTA A, V218, P348, DOI 10.1016/j.saa.2019.04.008
   Thevenot DR, 2001, ANAL LETT, V34, P635, DOI 10.1081/AL-100103209
   Tsang MK, 2016, ACS NANO, V10, P598, DOI 10.1021/acsnano.5b05622
   Uzun L, 2009, BIOSENS BIOELECTRON, V24, P2878, DOI 10.1016/j.bios.2009.02.021
   van Grinsven B, 2016, ACS SENSORS, V1, P1140, DOI 10.1021/acssensors.6b00435
   Verma N, 2015, APPL BIOCHEM BIOTECH, V175, P3093, DOI 10.1007/s12010-015-1489-2
   Viswanathan R., 2019, DIAGN MICROBIOL INFE
   Vollmer F, 2008, P NATL ACAD SCI USA, V105, P20701, DOI 10.1073/pnas.0808988106
   Wang HB, 2015, BIOSENS BIOELECTRON, V74, P581, DOI 10.1016/j.bios.2015.07.021
   Wang XD, 2016, ANAL CHEM, V88, P203, DOI 10.1021/acs.analchem.5b04298
   Wang ZQ, 2019, PROCESS BIOCHEM, V79, P57, DOI 10.1016/j.procbio.2018.12.007
   Weerathunge P, 2019, ANAL CHEM, V91, P3270, DOI 10.1021/acs.analchem.8b03300
   Wong CL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102363
   Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u
   Yu XF, 2018, J BIOTECHNOL, V266, P39, DOI 10.1016/j.jbiotec.2017.12.011
   Zengin A, 2017, J RAMAN SPECTROSC, V48, P668, DOI 10.1002/jrs.5109
   Zhang GJ, 2010, SENSOR ACTUAT B-CHEM, V146, P138, DOI 10.1016/j.snb.2010.02.021
   Zhang Q, 2015, BIOSENS BIOELECTRON, V68, P494, DOI 10.1016/j.bios.2015.01.040
   Zhang W, 2016, ANAL METHODS-UK, V8, P7847, DOI 10.1039/c6ay02158a
   Zhang Z, 2016, ELECTROANAL, V28, P620, DOI 10.1002/elan.201500412
   Zhu J, 2018, ANAL CHEM, V90, P5503, DOI 10.1021/acs.analchem.8b01217
NR 135
TC 9
Z9 10
U1 16
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-6374
J9 BIOSENSORS-BASEL
JI Biosensors-Basel
PD JUN
PY 2019
VL 9
IS 2
AR 65
DI 10.3390/bios9020065
PG 22
WC Chemistry, Analytical
SC Chemistry
GA IL0RR
UT WOS:000477008100019
PM 31117262
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bertolli, J
   Holbrook, J
   Dutton, ND
   Jones, B
   Dowling, NF
   Peacock, G
AF Bertolli, Jeanne
   Holbrook, Joseph
   Dutton, Nina D.
   Jones, Bryant
   Dowling, Nicole F.
   Peacock, Georgina
TI Readiness for an Increase in Congenital Zika Virus Infections in the
   United States: Geographic Distance to Pediatric Subspecialist Care
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE disease outbreaks; health care facilities; workforce; services; surge
   capacity
ID CLINICAL-MANIFESTATIONS; CHILDREN; INFANTS; RUBELLA; UPDATE
AB Objective The study's purpose was to investigate readiness for an increase in the congenital Zika infection (CZI) by describing the distribution of pediatric subspecialists needed for the care of children with CZI. Methods We applied county-level subspecialist counts to US maps, overlaying the geocoded locations of children's hospitals to assess the correlation of hospital and subspecialist locations. We calculated travel distance from census tract centroids to the nearest in-state children's hospital by state (with/without > 100 reported adult Zika virus cases) and by regions corresponding to the likely local Zika virus transmission area and to the full range of the mosquito vector. Travel distance percentiles reflect the population of children < 5 years old. Results Overall, 95% of pediatric subspecialists across the United States are located in the same county or neighboring county as a children's hospital. In the states where Zika virus transmission is likely, 25% of children must travel more than 50 miles for subspecialty care; in one state, 50% of children must travel > 100 miles. Conclusion The travel distance to pediatric subspecialty care varies widely by state and is likely to be an access barrier in some areas, particularly states bordering the Gulf of Mexico, which may have increasing numbers of CZI cases. (Disaster Med Public Health Preparedness. 2019;13:476-486)
C1 [Bertolli, Jeanne; Holbrook, Joseph; Dowling, Nicole F.; Peacock, Georgina] Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Dutton, Nina D.; Jones, Bryant] Oak Ridge Inst Sci & Educ, Res Participat Program, Oak Ridge, TN USA.
   [Dutton, Nina D.; Jones, Bryant] Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Geospatial Res Anal & Serv Program, Atlanta, GA USA.
RP Bertolli, J (corresponding author), 1600 Clifton Rd,MS E-88, Atlanta, GA 30329 USA.
EM JBertolli@cdc.gov
FU Intramural CDC HHS [CC999999]
CR American Telemedicine Association, 2017, 50 STAT TEL GAPS AN
   Basco WT, 2013, PEDIATRICS, V132, P390, DOI 10.1542/peds.2013-1517
   Bitsko Rebecca H, 2009, Pediatrics, V124 Suppl 4, pS343, DOI 10.1542/peds.2009-1255D
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   Centers for Disease Control and Prevention, 2016, MOSQ CONTR EST RANG
   Centers for Disease Control and Prevention, 2016, RUB US
   Centers for Disease Control and Prevention, 2018, ADV PEOPL LIV TRAV B
   Centers of Disease Control and Prevention, 2017, ZIK PREGN
   CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4
   Children's Hospital Association Children's hospital directory, CHILDR HOSP DIR
   COOPER LZ, 1969, AM J DIS CHILD, V118, P18, DOI 10.1001/archpedi.1969.02100040020004
   Cooper LZ, 1975, INFECT FETUS NEWBORN
   FORREST JM, 1971, LANCET, V2, P332
   Health Resources and Services Administration, HRSA NHSC ZIK LOAN R
   Houtrow AJ, 2014, PEDIATRICS, V134, P530, DOI 10.1542/peds.2014-0594
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuo DZ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-3021
   Kuo DZ, 2014, HEALTH AFFAIR, V33, P2190, DOI 10.1377/hlthaff.2014.0273
   Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mayer ML, 2008, MATERN CHILD HLTH J, V12, P624, DOI 10.1007/s10995-007-0275-3
   Mayer ML, 2009, ARCH PEDIAT ADOL MED, V163, P1087, DOI 10.1001/archpediatrics.2009.220
   Mayer ML, 2004, PEDIATRICS, V113, P109, DOI 10.1542/peds.113.2.e109
   Members of the Baylor Rubella Study Group, 1967, HOSP PRACT, V2, P27
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murphy Nancy, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P146, DOI 10.1016/S1538-5442(03)00002-6
   Neff JM, 2006, J AMBUL CARE MANAG, V29, P283, DOI 10.1097/00004479-200610000-00004
   Olson CA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2334
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ray KN, 2014, PEDIATRICS, V133, P1061, DOI 10.1542/peds.2013-3466
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rittenhouse DR, 2004, HEALTH SERV RES, V39, P1571, DOI 10.1111/j.1475-6773.2004.00304.x
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194
   SONDHEIMER JM, 1979, J PEDIATR-US, V94, P710, DOI 10.1016/S0022-3476(79)80135-3
   Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249
   The American Board of Pediatrics, 2016, WORKF DAT 2015 2016
   Zika cases in the US. Centers for Disease Control and Prevention, 2017, LAB CONF SYMPT ZIK V
   ZIRING PR, 1977, J PEDIATR-US, V90, P419, DOI 10.1016/S0022-3476(77)80705-1
   Ziring PR, 1977, J PEDIAT, V87, P1002
NR 44
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2019
VL 13
IS 3
BP 476
EP 486
DI 10.1017/dmp.2018.77
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IK6BI
UT WOS:000476670100016
PM 30139407
OA Green Accepted
DA 2020-07-08
ER

PT J
AU da Costa, GV
   Ferreira, EFB
   Ramos, RD
   da Silva, LB
   de Sa, EMF
   da Silva, AKP
   Lobato, CM
   Souto, RNP
   da Silva, CHTD
   Federico, LB
   Rosa, JMC
   dos Santos, CBR
AF da Costa, Glauber, V
   Ferreira, Elenilze F. B.
   Ramos, Ryan da S.
   da Silva, Luciane B.
   de Sa, Ester M. F.
   da Silva, Alicia K. P.
   Lobato, Cassio M.
   Souto, Raimundo N. P.
   da Silva, Carlos Henrique T. de P.
   Federico, Leonardo B.
   Rosa, Joaquin M. C.
   dos Santos, Cleydson B. R.
TI Hierarchical Virtual Screening of Potential Insectides Inhibitors of
   Acetylcholinesterase and Juvenile Hormone from Temephos
SO PHARMACEUTICALS
LA English
DT Article
DE acetylcholinesterase; juvenile hormone; temephos; molecular docking
ID ACUTE TOXICITY; MOLECULAR DOCKING; DESIGN; DERIVATIVES; DISCOVERY;
   PYMETROZINE; VALIDATION; ABATE(R); ANALOGS; FAMILY
AB Aedes aegypti (Linnaeus, 1762; Diptera: Culicidae) is the main vector transmitting viral diseases such as dengue fever, dengue haemorrhagic fever, urban yellow fever, zika and chikungunya. Worldwide, especially in the Americas and Brazil, many cases of dengue have been reported in recent years, which have shown significant growth. The main control strategy is the elimination of the vector, carried out through various education programs, to change human habits, but the most usual is biological control, together with environmental management and chemical control. The most commonly insecticide used is temephos (an organophosphorus compound), but Aedes aegypti populations have shown resistance and the product is highly toxic, so we chose it as a template molecule to perform a ligand-based virtual screening in the ChemBrigde (DIVERSet-CL subcollection) database, searching for derivatives with similarity in shape (ROCS) and electrostatic potential (EON). Thus, fourty-five molecules were filtered based on their pharmacokinetic and toxicological properties and 11 molecules were selected by a molecular docking study, including binding affinity and mode of interaction. The L46, L66 and L68 molecules show potential inhibitory activity for both the insect (-9.28, -10.08 and -6.78 Kcal/mol, respectively) and human (-6.05, 6.25 and 7.2 Kcal/mol respectively) enzymes, as well as the juvenile hormone protein (-9.2; -10.96 and -8.16 kcal/mol, respectively), showing a significant difference in comparison to the template molecule temephos. Molecules L46, L66 and L68 interacted with important amino acids at each catalytic site of the enzyme reported in the literature. Thus, the molecules here investigated are potential inhibitors for both the acetylcholinesterase enzymes and juvenile hormone protein-from insect and humans, characterizing them as a potential insecticide against the Aedes aegypti mosquito.
C1 [da Costa, Glauber, V; Ferreira, Elenilze F. B.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Postgrad Program Network Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.
   [da Costa, Glauber, V; Ferreira, Elenilze F. B.; Ramos, Ryan da S.; da Silva, Luciane B.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.
   [da Costa, Glauber, V; de Sa, Ester M. F.; da Silva, Alicia K. P.; Lobato, Cassio M.] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Biotechnol Nat Prod, BR-68902280 Macapa, AP, Brazil.
   [Souto, Raimundo N. P.] Univ Fed Amapa, Lab Arthropoda, BR-68902280 Macapa, AP, Brazil.
   [da Silva, Carlos Henrique T. de P.; Federico, Leonardo B.; dos Santos, Cleydson B. R.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Rosa, Joaquin M. C.] Univ Granada, Dept Pharmaceut & Organ Chem, Fac Pharm, Inst Biosanit Res Ibs GRANADA, Granada 18071, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Postgrad Program Network Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
EM vilhenac@hotmail.com; elenilze.batista@ueap.edu.br;
   ryanquimico@hotmail.com; luciaanebarros@hotmail.com;
   estersa07@gmail.com; aliciakarine1@gmail.com; cassio153bio@gmail.com;
   nonatoiepa@hotmail.com; tomich@fcfrp.usp.br; lbfederico@usp.br;
   jmcampos@ugr.es; breno@unifap.br
RI Federico, Leonardo Bruno/S-5368-2019; Ramos, Ryan/X-5824-2019; Campos,
   Joaquin/L-8436-2014
OI Federico, Leonardo Bruno/0000-0002-2943-8802; Ramos,
   Ryan/0000-0003-1802-1320; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X; Campos, Joaquin/0000-0002-9035-8123; Souto,
   Raimundo/0000-0002-8795-1217
CR Aiub Claudia Alessandra Fortes, 2002, Genetics and Molecular Research, V1, P159
   Anadu DI, 1996, J ENVIRON SCI HEAL B, V31, P1363, DOI 10.1080/03601239609373072
   Areiza M., 2018, THESIS
   Atanasova M, 2015, BIOORGAN MED CHEM, V23, P5382, DOI 10.1016/j.bmc.2015.07.058
   Ausborn J, 2005, J EXP BIOL, V208, P4451, DOI 10.1242/jeb.01917
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borges NM, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-017-3548-9
   Brown SM, 2012, J PHARMACOL EXP THER, V343, P53, DOI 10.1124/jpet.112.193433
   Burt B.P.E., 1970, PESTIC SCI, V1, P88, DOI [10.1002/ps.2780010303, DOI 10.1002/PS.2780010303]
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Cannalire R, 2018, EUR J MED CHEM, V143, P1667, DOI 10.1016/j.ejmech.2017.10.064
   Chauhan N, 2012, CHEM BIOL DRUG DES, V80, P54, DOI 10.1111/j.1747-0285.2012.01329.x
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Dulin F, 2012, ECOTOX ENVIRON SAFE, V79, P13, DOI 10.1016/j.ecoenv.2012.01.007
   Duvall L.B., 2018, NOVEL SMALL MOL AGON, DOI [10.1101/393793, DOI 10.1101/393793]
   Duvall LB, 2019, CELL, V176, P687, DOI 10.1016/j.cell.2018.12.004
   Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545
   Emerson C.L., 1995, J COMPUT CHEM, V16, P1170
   FITZPATRICK GE, 1981, ENVIRON ENTOMOL, V10, P728, DOI 10.1093/ee/10.5.728
   GEROLT P., 1970, Pesticide Science, V1, P209, DOI 10.1002/ps.2780010511
   Gholivand K, 2014, J AGR FOOD CHEM, V62, P5761, DOI 10.1021/jf5011726
   Ghose AK, 2012, ACS CHEM NEUROSCI, V3, P50, DOI 10.1021/cn200100h
   Guo JX, 2006, CHEM RES TOXICOL, V19, P209, DOI 10.1021/tx050090r
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hochreiter S, 2018, J CHEM INF MODEL, V58, P1723, DOI 10.1021/acs.jcim.8b00478
   Horowitz AR, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P1
   Hu J, 2018, BIOINFORMATICS, V34, P2209, DOI 10.1093/bioinformatics/bty081
   Hurst H, 1943, T FARADAY SOC, V39, P0390, DOI 10.1039/tf9433900390
   Junges CM, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3324-6
   Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]
   Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012
   Kobayashi H., 2011, ANTICHOLINESTERASE P, V3, P3
   Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008
   Kua J, 2002, J AM CHEM SOC, V124, P8260, DOI 10.1021/ja020429l
   Lauger P, 1944, HELV CHIM ACTA, V27, P892, DOI 10.1002/hlca.194402701115
   LEE BM, 1989, B ENVIRON CONTAM TOX, V43, P827, DOI 10.1007/BF01702051
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Loza-Mejia MA, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040121
   Maienfisch P, 2019, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 3RD EDITION, P1501
   MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   Milan D., 2013, U.S. Patent, P1, DOI 10.1016/j.(73), Patent No. 2009005354
   Mofidifar S, 2018, BIOGERONTOLOGY, V19, P133, DOI 10.1007/s10522-018-9744-x
   MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405
   Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013
   Onguene Pascal Amoa, 2014, Org Med Chem Lett, V4, P6, DOI 10.1186/s13588-014-0006-x
   Ozturk H, 2018, BIOINFORMATICS, V34, P821, DOI 10.1093/bioinformatics/bty593
   Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896
   Poli G, 2019, J ENZYM INHIB MED CH, V34, P589, DOI 10.1080/14756366.2019.1571271
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Print I., 2015, WORLD J PHARM SCI, V3, P2273
   Printes LB, 2004, ENVIRON TOXICOL CHEM, V23, P1241, DOI 10.1897/03-202
   Ramos RD, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010020
   Sechser B, 2002, ANZ SCHADL-J PEST SC, V75, P72, DOI 10.1034/j.1399-5448.2002.02021.x
   Sikka S., 2006, TOXICOLOGY ORGANOPHO, P447
   Silva RC, 2019, J SERB CHEM SOC, V84, P153, DOI 10.2298/JSC180129047S
   Sparling DW, 1997, B ENVIRON CONTAM TOX, V58, P475, DOI 10.1007/s001289900359
   Srivastava P, 2019, EUR J MED CHEM, V163, P116, DOI 10.1016/j.ejmech.2018.11.049
   Trosset JY, 1998, P NATL ACAD SCI USA, V95, P8011, DOI 10.1073/pnas.95.14.8011
   ul-Haq Z, 2003, J MED CHEM, V46, P5087, DOI 10.1021/jm0309194
   Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9
   Voutchkova AM, 2010, TETRAHEDRON, V66, P1031, DOI 10.1016/j.tet.2009.11.002
   Wan YF, 2020, J BIOMOL STRUCT DYN, V38, P410, DOI 10.1080/07391102.2019.1576543
   WEBB JE, 1945, J EXP BIOL, V22, P8
   WHO, 2009, TEM DRINK WAT US VEC
   Wiggers P., 2011, P 12 INT C COMP SYST, P411
   WINTERINGHAM FPW, 1955, PHYSIOL REV, V35, P701
   Yusuf D, 2008, J CHEM INF MODEL, V48, P1411, DOI 10.1021/ci800084x
   Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4
NR 72
TC 5
Z9 5
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2019
VL 12
IS 2
AR UNSP 61
DI 10.3390/ph12020061
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IL0ZM
UT WOS:000477028700016
PM 31003398
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martin-Acebes, MA
   de Oya, NJ
   Saiz, JC
AF Martin-Acebes, Miguel A.
   Jimenez de Oya, Nereida
   Saiz, Juan-Carlos
TI Lipid Metabolism as a Source of Druggable Targets for Antiviral
   Discovery against Zika and Other Flaviviruses
SO PHARMACEUTICALS
LA English
DT Review
DE Zika virus; West Nile virus; dengue virus; flavivirus; antiviral; lipids
ID WEST NILE; VIRUS-INFECTION; NORDIHYDROGUAIARETIC ACID; SPHINGOLIPID
   METABOLISM; MEMBRANE ASSOCIATION; DENGUE; REPLICATION; PROTEIN; BIOLOGY;
   DRUGS
AB The Zika virus (ZIKV) is a mosquito-borne flavivirus that can lead to birth defects (microcephaly), ocular lesions and neurological disorders (Guillain-Barre syndrome). There is no licensed vaccine or antiviral treatment against ZIKV infection. The effort to understand the complex interactions of ZIKV with cellular networks contributes to the identification of novel host-directed antiviral (HDA) candidates. Among the cellular pathways involved in infection, lipid metabolism gains attention. In ZIKV-infected cells lipid metabolism attributed to intracellular membrane remodeling, virion morphogenesis, autophagy modulation, innate immunity and inflammation. The key roles played by the cellular structures associated with lipid metabolism, such as peroxisomes and lipid droplets, are starting to be deciphered. Consequently, there is a wide variety of lipid-related antiviral strategies that are currently under consideration, which include an inhibition of sterol regulatory element-binding proteins (SREBP), the activation of adenosine-monophosphate activated kinase (AMPK), an inhibition of acetyl-Coenzyme A carboxylase (ACC), interference with sphingolipid metabolism, blockage of intracellular cholesterol trafficking, or a treatment with cholesterol derivatives. Remarkably, most of the HDAs identified in these studies are also effective against flaviviruses other than ZIKV (West Nile virus and dengue virus), supporting their broad-spectrum effect. Considering that lipid metabolism is one of the main cellular pathways suitable for pharmacological intervention, the idea of repositioning drugs targeting lipid metabolism as antiviral candidates is gaining force.
C1 [Martin-Acebes, Miguel A.; Jimenez de Oya, Nereida; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
RP Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
EM martin.mangel@inia.es; jdeoya@inia.es; jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; de Oya, Nereida
   Jimenez/T-6449-2019
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; de Oya, Nereida
   Jimenez/0000-0003-3129-813X; Saiz, Juan-Carlos/0000-0001-8269-5544
FU Spanish Ministry of Economy and Competitiveness [AGL2014-56518-JIN]
FX This research was funded by The Spanish Ministry of Economy and
   Competitiveness, grant number AGL2014-56518-JIN (to M.A.M-A.)
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beltran PMJ, 2018, CELL HOST MICROBE, V24, P526, DOI 10.1016/j.chom.2018.09.002
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byers NM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030225
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Cheng X, 2018, CURR TOP MED CHEM, V18, P484, DOI 10.2174/1568026618666180523104541
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Osuna-Ramos JF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00388
   Frentiu FD, 2017, TRENDS PARASITOL, V33, P916, DOI 10.1016/j.pt.2017.10.007
   Gault CR, 2010, ADV EXP MED BIOL, V688, P1
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   HA J, 1994, J BIOL CHEM, V269, P22162
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107
   Hardie DG, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0774
   Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   ICTV, VIR TAX 2018 REL
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   de Oya NJ, 2019, EMERG MICROBES INFEC, V8, P624, DOI 10.1080/22221751.2019.1604084
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Ke PY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123940
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liebscher S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007029
   Lima WG, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2056
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Majerova T, 2019, BIOCHIMIE, V166, P132, DOI 10.1016/j.biochi.2019.05.004
   Martin-Acebes MA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030369
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Newman CB, 2019, ARTERIOSCL THROM VAS, V39, pE38, DOI 10.1161/ATV.0000000000000073
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Queiroz A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00753
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Shanbhogue P., 2018, HDB EXPT PHARM
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Soyal SM, 2015, TRENDS PHARMACOL SCI, V36, P406, DOI 10.1016/j.tips.2015.04.010
   Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619
   Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Tricarico PM, 2019, INFLAMMOPHARMACOLOGY, V27, P621, DOI 10.1007/s10787-018-0517-6
   Uchida L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020046
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Willard KA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010020
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
NR 81
TC 4
Z9 4
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2019
VL 12
IS 2
AR UNSP 97
DI 10.3390/ph12020097
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IL0ZM
UT WOS:000477028700051
PM 31234348
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Souza, INO
   Barros-Aragao, FGQ
   Frost, PS
   Figueiredo, CP
   Clarke, JR
AF Souza, Isis N. O.
   Barros-Aragao, Fernanda G. Q.
   Frost, Paula S.
   Figueiredo, Claudia P.
   Clarke, Julia R.
TI Late Neurological Consequences of Zika Virus Infection: Risk Factors and
   Pharmaceutical Approaches
SO PHARMACEUTICALS
LA English
DT Review
DE microcephaly; arbovirus; flavivirus; drug development; neurodevelopment;
   therapy; drug screening; pregnancy; Food and Drug Administration (FDA);
   encephalitis
ID GUILLAIN-BARRE-SYNDROME; FDA-APPROVED DRUG; ANTIVIRAL ACTIVITY;
   IN-VITRO; NEURAL PROGENITORS; VIRAL DYNAMICS; STEM-CELLS; BRAIN;
   NICLOSAMIDE; REPLICATION
AB Zika virus (ZIKV) infection was historically considered a disease with mild symptoms and no major consequences to human health. However, several long-term, late onset, and chronic neurological complications, both in congenitally-exposed babies and in adult patients, have been reported after ZIKV infection, especially after the 2015 epidemics in the American continent. The development or severity of these conditions cannot be fully predicted, but it is possible that genetic, epigenetic, and environmental factors may contribute to determine ZIKV infection outcomes. This reinforces the importance that individuals exposed to ZIKV are submitted to long-term clinical surveillance and highlights the urgent need for the development of therapeutic approaches to reduce or eliminate the neurological burden of infection. Here, we review the epidemiology of ZIKV-associated neurological complications and the role of factors that may influence disease outcome. Moreover, we discuss experimental and clinical evidence of drugs that have shown promising results in vitro or in vitro against viral replication and and/or ZIKV-induced neurotoxicity.
C1 [Souza, Isis N. O.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, Brazil.; Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
EM isis.de.o@gmail.com; fernandaqbarros@gmail.com;
   paulafrostufrj@gmail.com; claufig@gmail.com; juliaclarke@pharma.ufrj.br
RI Clarke, Julia/AAF-9434-2019; de Oliveira Souza, Isis Nem/AAA-3423-2019;
   Figueiredo, Claudia P/F-8424-2012
OI de Oliveira Souza, Isis Nem/0000-0002-0335-2541; da Silva Frost,
   Paula/0000-0002-3814-999X; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; Clarke, Julia/0000-0002-6777-2051
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Institutos Nacionais de Pesquisa-Inovacao em Medicamentos e
   Identificacao de Novos Alvos Terapeuticos; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Financiadora de
   Estudos e ProjetosCiencia Tecnologia e Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to I.N.O.S.,
   C.P.F. and J.R.C.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (P.S.F., F.G.Q.B.-A., C.P.F. and J.R.C.), Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos (to C.P.F.), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (to I.N.O.S.) and Financiadora de Estudos e
   Projetos (to C.P.F. and J.R.C.).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Arumugasaamy N, 2018, ANN BIOMED ENG, V46, P1963, DOI 10.1007/s10439-018-2090-y
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Bayer, 1988, YOM PACK INS
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DECLERCQ E, 1984, ANTIVIR RES, V4, P119, DOI 10.1016/0166-3542(84)90012-3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FDA, 2011, COP PACK INS
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Food and Drug Administration, 2012, ZITHROMAXR AZ TABL A, P2011
   Food and Drug Administration, 2003, FDA LAB NAM MEM HCI
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Janssen Pharmaceutica, 2015, REM PACK INS
   Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lim S.-Y., 2016, OPEN FORUM INFECT DI, DOI [10.1093/ofid/ofw195.05, DOI 10.1093/OFID/OFW195.05]
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lin CK, 2016, ONCOTARGET, V7, P8993, DOI 10.18632/oncotarget.7113
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   OFORIADJEI D, 2008, INT J RISK SAF MED, V20, P113, DOI DOI 10.3233/JRS-2008-0440
   Ojha CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208543
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO/WHO, 2018, ZIK CAS CONG SYNDR A
   Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pfizer, 2015, IBRANCE PALB FACT SH
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   Pressler R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00036
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   de Araujo PSR, 2019, J INFECT PUBLIC HEAL, V12, P97, DOI 10.1016/j.jiph.2018.04.010
   Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro MR, 2018, ARCH VIROL, V163, P2687, DOI 10.1007/s00705-018-3911-x
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sisk JM, 2015, ACS INFECT DIS, V1, P401, DOI 10.1021/acsinfecdis.5b00089
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Souza AI, 2018, PUBLIC HEALTH REP, V133, P461, DOI 10.1177/0033354918777256
   Stagni F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00265
   Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003
   The Lancet, 2018, Lancet, V392, P532, DOI 10.1016/S0140-6736(18)31801-4
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vliet SM, 2018, TOXICOL SCI, V166, P306, DOI 10.1093/toxsci/kfy214
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   WHO, 2017, IEEE T POWER SYSTEMS, V1~14, DOI DOI 10.13155/46607
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wiwanitkit S, 2017, ASIAN PAC J TROP MED, V10, P682, DOI 10.1016/j.apjtm.2017.06.012
   World Health Organization, ZIK FACT SHEET
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang XW, 2015, J MICROENCAPSUL, V32, P496, DOI 10.3109/02652048.2015.1057251
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 134
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2019
VL 12
IS 2
AR UNSP 60
DI 10.3390/ph12020060
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IL0ZM
UT WOS:000477028700015
PM 30999590
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chigbu, DI
   Jain, P
   Crumley, BL
   Patel, D
   Khan, ZK
AF Chigbu, DeGaulle I.
   Jain, Pooja
   Crumley, Brenndan L.
   Patel, Dip
   Khan, Zafar K.
TI Human T cell leukemia virus type 1 and Zika virus: tale of two
   reemerging viruses with neuropathological sequelae of public health
   concern
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE HTLV; Zika virus; HAM; TSP; GBS; Microcephaly
ID MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; I INTERFERON-PRODUCTION;
   TOLL-LIKE RECEPTOR-3; HTLV-I; IMMUNE-RESPONSE; TAX PROTEIN; ASYMPTOMATIC
   CARRIERS; SEXUAL TRANSMISSION; NEURAL PROGENITORS; MOLECULAR MIMICRY
AB Human T cell leukemia virus type 1 (HTLV-1) and Zika virus (ZIKV) have been considered neglected viruses of low public health concern until recently when incidences of HTLV-1 and ZIKV were observed to be linked to serious immune-related disease and neurological complications. This review will discuss the epidemiology, genomic evolution, virus-host interactions, virulence factors, neuropathological sequelae, and current perspectives of these reemerging viruses. There are no FDA-approved therapeutics or vaccines against these viruses, and as such, it is important for clinical trials to focus on developing vaccines that can induce cell-mediated immune response to confer long-term protective immunity. Furthermore, attention should be paid to reducing the transmission of these viruses through unprotected sex, infected blood during sharing of contaminated needles, donated blood and organs, and vertical transmission from mother to baby via breastfeeding. There is an urgent need to re-evaluate repurposing current antiviral therapies as well as developing novel antiviral agents with enhanced efficacy due to the high morbidity rate associated with these two reemerging chronic viral diseases.
C1 [Chigbu, DeGaulle I.; Jain, Pooja; Crumley, Brenndan L.; Patel, Dip; Khan, Zafar K.] Drexel Univ, Dept Microbiol & Immunol, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19102 USA.
   [Chigbu, DeGaulle I.; Jain, Pooja; Crumley, Brenndan L.; Patel, Dip; Khan, Zafar K.] Drexel Univ, Inst Mol Med & Infect Dis, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19102 USA.
   [Chigbu, DeGaulle I.] Salus Univ, PA Coll Optometry, 8360 Old York Rd, Elkins Pk, PA USA.
RP Khan, ZK (corresponding author), Drexel Univ, Dept Microbiol & Immunol, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19102 USA.; Khan, ZK (corresponding author), Drexel Univ, Inst Mol Med & Infect Dis, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19102 USA.
EM zkk22@drexel.edu
OI Crumley, Brenndan/0000-0001-7017-563X
FU NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01CA054559-20]; NINDS NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Neurological Disorders &
   Stroke (NINDS) [1R01NS097147-01A1]
CR Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x
   Alefantis T, 2007, BIOMED PHARMACOTHER, V61, P194, DOI 10.1016/j.biopha.2007.02.005
   Aliya Nishat, 2012, Leuk Res Treatment, V2012, P984754, DOI 10.1155/2012/984754
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Andrade RG, 2013, J CLIN VIROL, V56, P135, DOI 10.1016/j.jcv.2012.10.003
   Araujo AQC, 2006, LANCET NEUROL, V5, P1068, DOI 10.1016/S1474-4422(06)70628-7
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Azimi N, 1999, J IMMUNOL, V163, P4064
   Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452
   Bai XT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00400
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Bangham CRM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0272
   Barbeau B, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00226
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Catalan-Soares BC, 2009, MED MICROBIOL IMMUN, V198, P1, DOI 10.1007/s00430-008-0096-z
   CHEN YMA, 1991, P NATL ACAD SCI USA, V88, P1182, DOI 10.1073/pnas.88.4.1182
   Colisson R, 2010, BLOOD, V115, P2177, DOI 10.1182/blood-2009-06-224741
   Cook LBM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0236-7
   Cook LBM, 2014, J INFECT DIS, V209, P486, DOI 10.1093/infdis/jit558
   CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dias GAD, 2016, MICROB PATHOGENESIS, V92, P72, DOI 10.1016/j.micpath.2015.11.018
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delvecchio R, 2016, IRANIAN J BASIC MED, V8
   Desrames A, 2014, J VIROL, V88, P9782, DOI 10.1128/JVI.01591-14
   Di Paolo NC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00353
   Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
   Enose-Akahata Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02563
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fenizia C, 2014, J VIROL, V88, P393, DOI 10.1128/JVI.01788-13
   Ferreira OC, 1997, BLOOD REV, V11, P91, DOI 10.1016/S0268-960X(97)90015-1
   Gallo RC, 2017, BLOOD, V128, P2
   GESSAIN A, 1992, J VIROL, V66, P2288, DOI 10.1128/JVI.66.4.2288-2295.1992
   Ginwala R, 2017, J NEUROIMMUNE PHARM, V12, P504, DOI 10.1007/s11481-017-9740-y
   Grant C, 2008, BLOOD, V111, P5601, DOI 10.1182/blood-2007-11-123430
   Guerra M, 2018, CELL IMMUNOL, V334, P70, DOI 10.1016/j.cellimm.2018.09.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392
   Hasegawa A, 2003, J VIROL, V77, P2956, DOI 10.1128/JVI.77.5.2956-2963.2003
   Hishizawa M, 2004, BRIT J HAEMATOL, V125, P568, DOI 10.1111/j.1365-2141.2004.04956.x
   JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0
   Jain P, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0140-1
   Jain P, 2009, J VIROL, V83, P10908, DOI 10.1128/JVI.01054-09
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   Johnson JM, 2001, J VIROL, V75, P6086, DOI 10.1128/JVI.75.13.6086-6094.2001
   Journo C, 2011, VIRUSES-BASEL, V3, P1374, DOI 10.3390/v3081374
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kalume F, 2004, J NEUROSCI RES, V77, P82, DOI 10.1002/jnr.20137
   Kannagi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00323
   KINOSHITA K, 1987, JPN J CANCER RES, V78, P674
   KRAMER A, 1995, AM J EPIDEMIOL, V142, P1212
   Kress AK, 2011, VIRUSES-BASEL, V3, P1439, DOI 10.3390/v3081439
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lepoutre V, 2009, FRONT BIOSCI-LANDMRK, V14, P1152, DOI 10.2741/3300
   Levin MC, 2002, NAT MED, V8, P509, DOI 10.1038/nm0502-509
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241
   Ma GY, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0249-x
   Magri MC, 2012, AIDS RES HUM RETROV, V28, P110, DOI [10.1089/aid.2011.0117, 10.1089/AID.2011.0117]
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Mahgoub M, 2018, P NATL ACAD SCI USA, V115, pE1269, DOI 10.1073/pnas.1715724115
   Mahieux R, 2009, PATHOL BIOL, V57, P161, DOI 10.1016/j.patbio.2008.02.015
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011
   Manuel SL, 2013, J CLIN IMMUNOL, V33, P1223, DOI 10.1007/s10875-013-9918-x
   Manuel SL, 2009, J LEUKOCYTE BIOL, V86, P1205, DOI 10.1189/jlb.0309172
   Martins ML, 2018, J NEUROVIROL, V24, P432, DOI 10.1007/s13365-018-0632-6
   Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Montanheiro PA, 2009, SCAND J IMMUNOL, V70, P403, DOI 10.1111/j.1365-3083.2009.02291.x
   Murphy EL, 2004, J INFECT DIS, V190, P504, DOI 10.1086/422398
   Norris PJ, 2010, VIRULENCE, V1, P19, DOI 10.4161/viru.1.1.9868
   Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177
   Olindo S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006304
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Paiva A, 2017, J MED VIROL, V89, P1287, DOI 10.1002/jmv.24745
   Paiva A, 2014, REV SOC BRAS MED TRO, V47, P265, DOI 10.1590/0037-8682-0232-2013
   Paiva AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25939-y
   PARKER CE, 1992, VIROLOGY, V188, P628, DOI 10.1016/0042-6822(92)90517-S
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040
   Pise-Masison CA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004454
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Poland GA, 2018, LANCET INFECT DIS
   Quaresma JAS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010005
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rafatpanah Houshang, 2007, Iran J Immunol, V4, P94
   Rafatpanah H, 2013, IRAN J BASIC MED SCI, V16, P235
   Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   RATNER L, 1991, AIDS RES HUM RETROV, V7, P923, DOI 10.1089/aid.1991.7.923
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro MA, 2012, PEDIATR INFECT DIS J, V31, P1139, DOI 10.1097/INF.0b013e318263215e
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Sagar D, 2014, VACCINE, V32, P3274, DOI 10.1016/j.vaccine.2014.03.087
   Saito M, 2012, LEUK RES TREAT, V2012, P1, DOI [10.1155/2012/259045, DOI 10.1155/2012/259045]
   Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Schlub TE, 2014, J VIROL, V88, P3837, DOI 10.1128/JVI.03136-13
   Schutze M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00052
   Slater CMSA, 2012, ARQ NEURO-PSIQUIAT, V70, P686, DOI 10.1590/S0004-282X2012000900007
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Shuh M, 2005, MICROSC RES TECHNIQ, V68, P176, DOI 10.1002/jemt.20231
   SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Solomon I. H., 2016, J NEUROINFECT DIS, V7
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sugata K, 2012, BLOOD, V119, P434, DOI 10.1182/blood-2011-05-357459
   TAKAHASHI K, 1991, INT J CANCER, V49, P673, DOI 10.1002/ijc.2910490508
   Takeoka H, 2007, AM J TROP MED HYG, V77, P192, DOI 10.4269/ajtmh.2007.77.192
   Trevino A, 2014, AIDS RES HUM RETROV, V30, P856, DOI [10.1089/aid.2013.0128, 10.1089/AID.2013.0128]
   van Tienen C, 2012, ARCH GYNECOL OBSTET, V286, P255, DOI 10.1007/s00404-011-2211-4
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang J, 2018, BIOCH BIOPHYS RES CO
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yamano Y, 1997, J NEUROIMMUNOL, V76, P50, DOI 10.1016/S0165-5728(97)00041-6
   Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
   YU F, 1991, J NEUROIMMUNOL, V33, P121, DOI 10.1016/0165-5728(91)90056-D
   Yuen CK, 2016, J VIROL, V90, P3902, DOI 10.1128/JVI.00129-16
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao TJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020034
   Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199
NR 146
TC 0
Z9 0
U1 3
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2019
VL 25
IS 3
BP 289
EP 300
DI 10.1007/s13365-019-00720-7
PG 12
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA IJ1WB
UT WOS:000475688500001
PM 30693421
DA 2020-07-08
ER

PT J
AU Gingrich, JB
   Saltiel, TM
   Vincent, Z
   Sahraoui, R
AF Gingrich, Jack B.
   Saltiel, Troy M.
   Vincent, Zachary
   Sahraoui, Rebecca
TI A SURVEY FOR AEDES AEGYPTI IN DELAWARE AND THE VIRUS-POSITIVE POOL RATES
   OF AEDES ALBOPICTUS AND AEDES TRISERIATUS FOR WEST NILE AND ZIKA VIRUSES
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Aedes triseriatus; West Nile virus;
   Zika virus
ID AMERICAN MOSQUITOS DIPTERA; STEGOMYIA AEGYPTI; FEEDING PATTERNS;
   UNITED-STATES; CULICIDAE; VECTOR
AB The introduction of Zika virus to the USA in 2015 engendered heightened interest in its known vectors. Aedes aegypti is the primary vector, with Ae. albopictus considered a potential secondary vector, together with several other possible marginal vectors. In Delaware, Ae. aegypti has been collected rarely, but no breeding populations were detected during past intensive statewide surveillance efforts. However, there is an abundance of Ae. albopictus statewide. Both species are container breeders and are peri-domestic-increasing the risk for virus transmission to humans. From July through September 2017, Delaware Mosquito Control conducted surveillance in 16 container-breeding hot spots to search for Ae. aegypti, and also ascertain the virus-positive pool rates of Ae. albopictus and Ae. triseriatus for West Nile virus (WNV) and Zika virus (ZIKV). The survey concluded that there were no known breeding populations of Ae. aegypti in Delaware, and no WNV- or ZIKV-positive pools were detected among pools of mosquitoes of the aforementioned species.
C1 [Gingrich, Jack B.] Delaware Dept Nat Resources & Environm Control, Div Fish & Wildlife, Mosquito Control Sect, Dover, DE 19701 USA.
   [Saltiel, Troy M.] Univ Delaware, Dept Geog, Newark, DE 19716 USA.
   [Vincent, Zachary] Publ Hlth Command Atlantic, Fort George G Meade, MD 20755 USA.
   [Sahraoui, Rebecca] Frontier Dow Dupont Delaware, Newark, DE 19714 USA.
RP Gingrich, JB (corresponding author), Delaware Dept Nat Resources & Environm Control, Div Fish & Wildlife, Mosquito Control Sect, Dover, DE 19701 USA.
FU Delaware Department of Natural Resources and Environmental Control,
   Division of Fish and Wildlife, Mosquito Control Sections, at Glasgow;
   CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Delaware Department of Natural Resources and
   Environmental Control, Division of Fish and Wildlife, Mosquito Control
   Sections, at Milford, DE
FX Grateful acknowledgments are given to the Delaware Department of Natural
   Resources and Environmental Control, Division of Fish and Wildlife,
   Mosquito Control Sections, at Glasgow and Milford, DE, and the CDC for
   providing special funding and support for this project. Special thanks
   are also extended to the Delaware Division of Public Health Laboratory,
   Department of Health and Human Services for viral analyses.
CR Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   BURKOT TR, 1982, AM J TROP MED HYG, V31, P376, DOI 10.4269/ajtmh.1982.31.376
   CDC [Centers for Disease Control and Prevention], 2018, W NIL VIR CAS STAT 2
   CDC [Centers for Disease Control and Prevention], 2018, 2018 CAS COUNTS US
   CDC [Centers for Disease Control and Prevention], 2016, 2016 CAS COUNTS US
   ECDC [European Centre for Disease Prevention and Control], 2017, AED ALB FACTSH EXP
   ECDC [European Centre for Disease Prevention and Control], 2017, AED AEG FACTSH EXP
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Gingrich JB, 2005, J AM MOSQUITO CONTR, V21, P194, DOI 10.2987/8756-971X(2005)21[194:HPOSWN]2.0.CO;2
   Gingrich JB, 2017, P NEW JERS MOSQ CONT, P1045
   Harrison B., 2016, MOSQUITOES MIDATLANT
   Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1
   Holick J, 2002, J AM MOSQUITO CONTR, V18, P131
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MOORE CG, 1988, J AM MOSQUITO CONTR, V4, P356
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   NASCI RS, 1985, J MED ENTOMOL, V22, P619, DOI 10.1093/jmedent/22.6.619
   Perez-Ramirez E, 2014, VIRUSES-BASEL, V6, P752, DOI 10.3390/v6020752
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
NR 25
TC 0
Z9 0
U1 3
U2 3
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD JUN
PY 2019
VL 35
IS 2
BP 91
EP 96
DI 10.2987/18-6794.1
PG 6
WC Entomology
SC Entomology
GA IJ1VW
UT WOS:000475688000001
PM 31442131
OA Bronze
DA 2020-07-08
ER

PT J
AU Correa-Morales, F
   Dunbar, MW
   Dzul-Manzanilla, F
   Medina-Barreiro, A
   Morales-Rios, E
   Bibiano-marin, W
   Che-Mendoza, A
   Manrique-Saide, P
   Vazquez-Prokopec, GM
AF Correa-Morales, Fabian
   Dunbar, Mike W.
   Dzul-Manzanilla, Felipe
   Medina-Barreiro, Anuar
   Morales-Rios, Evaristo
   Bibiano-marin, Wilbert
   Che-Mendoza, Azael
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo M.
TI EVALUATION AND COMPARISON OF SPRAY EQUIPMENT FOR INDOOR RESIDUAL
   SPRAYING
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; hand compression pump; insecticide; spray equipment
AB The World Health Organization (WHO) has recently recommended indoor residual spraying (IRS) as part of a vector control strategy to combat Aedes-borne diseases, including dengue, chikungunya, and Zika viruses. Hand compression sprayers have been used in malaria prevention and control programs worldwide since the 1950s and are a standard for IRS application. However, there are technological advances that should be considered to improve IRS application (e.g., flow-control valves, rechargeable-battery equipment, reduced-drift nozzles, etc.), particularly if interventions are performed in urban areas to target Aedes aegypti. Using WHO guidelines, we contrasted technical characteristics of potential IRS equipment including hand compression sprayers (Hudson X-pert, Goizper IK Vector Control Super), rechargeable-battery sprayers (Solo 416, Birchmeier REC 15ABZ, Hudson NeverPump), and motorized sprayers (Honda WJR 2525, Kawashima AK35GX). Measurements included flow rate, droplet size, battery/fuel life, and technical/physical characteristics. Flow rate, the most important parameter, of the Hudson X-pert was stabilized at 550 ml/min by the use of a control flow valve (CFV). The IK Vector Control Super had integrated CFVs and produced a similar flow as the Hudson X-pert. Rechargeable-battery equipment provided consistent flow as well as negligible noise. Motorized sprayers also produced consistent flow, but their weight, high noise pollution when used indoors, and high engine temperature made them highly unpleasant for technicians. We identify alternatives to the more traditional hand compression Hudson X-pert sprayer with technical and operational considerations for performing IRS.
C1 [Correa-Morales, Fabian] Secretaria Salud Mexico, Ctr Nacl Programas Preventivos & Control Enfermed, Ciudad De Mexico 11800, Mexico.
   [Dunbar, Mike W.; Dzul-Manzanilla, Felipe; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Medina-Barreiro, Anuar; Morales-Rios, Evaristo; Bibiano-marin, Wilbert; Che-Mendoza, Azael; Manrique-Saide, Pablo] Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Merida 97100, Mexico.
RP Dunbar, MW (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
OI Correa Morales, Fabian/0000-0002-6193-1242
FU Emory Global Health Institute [00052002]; Marcus Foundation [00052002];
   Emory Global Health Institute Seed Grant [79816]; Centers for Disease
   and Prevention (CDC) [OADS BAA 2016-N-17844]; Mexico's CONACYTConsejo
   Nacional de Ciencia y Tecnologia (CONACyT) [000000000255141]
FX This project received support from Emory Global Health Institute and
   Marcus Foundation (project 00052002), Emory Global Health Institute Seed
   Grant (project 79816), Centers for Disease and Prevention (CDC; OADS BAA
   2016-N-17844), and Mexico's CONACYT (project 000000000255141). The
   findings and conclusions in this paper are those of the authors and do
   not necessarily represent the official position of the CDC. The funders
   had no role in the study design, data collection and analysis, decision
   to publish, or preparation of the manuscript. None of the authors have
   any conflicts of interest and are not associated with or employed by any
   of the companies that produce the sprayers evaluated in this manuscript.
CR Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Dunbar MW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007203
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Gunning CE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006378
   Hladish TJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006570
   Knapp J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0907-9
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Paz-Soldan VA, 2018, GLOB PUBLIC HEALTH, V13, P65, DOI 10.1080/17441692.2016.1178317
   Samuel M, 2017, PLOS NEGLECT TROP D, V11
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   *WHO, 2006, WHOHTMMAL20061112
   WHO, 2010, MON EV TOOL KIT IND
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   WHO [ World Health Organization], 2007, WHOCDSNTDWHOPESGCDPP
   WHO [ World Health Organization], 2018, EQ VECT CONTR SPEC G
   World Health Organization, 2015, IND RES SPRAYING OP
NR 18
TC 0
Z9 0
U1 0
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD JUN
PY 2019
VL 35
IS 2
BP 107
EP 112
DI 10.2987/18-6810.1
PG 6
WC Entomology
SC Entomology
GA IJ1VW
UT WOS:000475688000003
PM 31442127
OA Bronze
DA 2020-07-08
ER

PT J
AU Hung, NH
   Satyal, P
   Dai, DN
   Tai, TA
   Huong, LT
   Chuong, NTH
   Hieu, HV
   Tuan, PA
   Vuong, PV
   Setzer, WN
AF Nguyen Huy Hung
   Satyal, Prabodh
   Do Ngoc Dai
   Thieu Anh Tai
   Le Thi Huong
   Nguyen Thi Hong Chuong
   Ho Viet Hieu
   Pham Anh Tuan
   Pham Van Vuong
   Setzer, William N.
TI Chemical Compositions of Crassocephalum crepidioides Essential Oils and
   Larvicidal Activities Against Aedes aegypti, Aedes albopictus, and Culex
   quinquefasciatus
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE mosquito; vector control; dengue fever; myrcene
ID SITOPHILUS-ORYZAE; ZIKA VIRUS; PLANTS; DENGUE; TOXICITY; FUMIGANT; L.
AB The leaf, stem, and floral essential oils of Crassocephalum crepidioides growing wild in central Vietnam were obtained by hydrodistillation and analyzed by gas chromatography-mass spectrometry. The major component in all 3 oils was myrcene (59.3%, 26.1%, and 43.3%, respectively). The 24-hour mosquito larvicidal activities of the oil of the aerial parts (stems and leaves) were determined against wild-caught Aedes albopictus (IC50 = 14.3 mu g/mL), laboratory-reared Aedes aegypti (IC50 = 4.95 mu g/mL), and wild-caught Culex quinquefasciatus (IC50 = 18.4 mu g/mL). The high concentration of myrcene in the essential oil likely accounts for the mosquito larvicidal activity observed.
C1 [Nguyen Huy Hung; Nguyen Thi Hong Chuong] Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang, Vietnam.
   [Satyal, Prabodh; Setzer, William N.] Aromat Plant Res Ctr, 230 N 1200 E,Suite 100, Lehi, UT 84043 USA.
   [Do Ngoc Dai] Nghe An Econ Univ, Fac Agr Forestry & Fishery, Vinh City, Vietnam.
   [Thieu Anh Tai] Duy Tan Univ, Dept Pharm, Da Nang, Vietnam.
   [Le Thi Huong] Vinh Univ, Sch Nat Sci Educ, Vinh, Vietnam.
   [Ho Viet Hieu; Pham Anh Tuan] Duy Tan Univ, Dept Med, Parasitol & Entomol Unit, Da Nang, Vietnam.
   [Pham Van Vuong] 17 Mil Hosp, Pharm Dept, Da Nang, Vietnam.
   [Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RP Hung, NH (corresponding author), Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang, Vietnam.; Setzer, WN (corresponding author), Aromat Plant Res Ctr, 230 N 1200 E,Suite 100, Lehi, UT 84043 USA.
EM nguyenhuyhung@duytan.edu.vn; wsetzer@aromaticplant.org
RI Satyal, Prabodh/AAA-4627-2020
FU Duy Tan University
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   research was funded by Duy Tan University.
CR Abdelgaleil SAM, 2009, J CHEM ECOL, V35, P518, DOI 10.1007/s10886-009-9635-3
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Adjatin A, 2012, GENET RESOUR CROP EV, V59, P1867, DOI 10.1007/s10722-012-9901-z
   Albuquerque CMR, 1999, MEM I OSWALDO CRUZ, V94, P591, DOI 10.1590/S0074-02761999000500005
   Aniya Y, 2005, BIOL PHARM BULL, V28, P19, DOI 10.1248/bpb.28.19
   ASADA Y, 1985, PLANTA MED, V51, P539, DOI 10.1055/s-2007-969597
   Belcher RO, 1955, KEW B, V10, P455, DOI [10.2307/4109235, DOI 10.2307/4109235]
   bin Jantan I, 2005, PHARM BIOL, V43, P526, DOI 10.1080/13880200500220771
   Buckingham J., 2018, DICT NATURAL PRODUCT
   Chen GQ, 2009, WEED BIOL MANAG, V9, P123, DOI 10.1111/j.1445-6664.2009.00329.x
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   Coats R., 1991, ACS SYM SER, V449, P305
   Dairo F. A. S., 2007, Pakistan Journal of Nutrition, V6, P35
   Tan DT, 2012, FORESTS, V3, P997, DOI 10.3390/f3040997
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Quyen DL, 2018, AM J TROP MED HYG, V98, P402, DOI 10.4269/ajtmh.17-0630
   Finney D., 2009, PROBIT ANAL
   Joshi RK, 2014, J CHIL CHEM SOC, V59, P2363, DOI 10.4067/S0717-97072014000100025
   Joshi RK, 2011, INT J NAT PROD RES, V1, P19
   Kim SW, 2013, J ASIA-PAC ENTOMOL, V16, P443, DOI 10.1016/j.aspen.2013.07.002
   Lamorde M, 2010, J ETHNOPHARMACOL, V130, P43, DOI 10.1016/j.jep.2010.04.004
   Malan Djah F, 2011, Afr J Reprod Health, V15, P85
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Noumi E, 2001, FITOTERAPIA, V72, P246, DOI 10.1016/S0367-326X(00)00288-4
   Owokotomo IA, 2012, INT J CHEM, V4, P34
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Satyal P., 2015, THESIS
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Vanijajiva O, 2009, SYST BIODIVERS, V7, P269, DOI 10.1017/S147720000900303X
   Vourlioti-Arapi F, 2012, PARASITOL RES, V110, P1829, DOI 10.1007/s00436-011-2706-8
   Vu DT, 2017, GENET RESOUR CROP EV, V64, P1115, DOI 10.1007/s10722-017-0517-1
   Wang RL, 2014, ALLELOPATHY J, V33, P245
   Zollo PHA, 2000, J ESSENT OIL RES, V12, P533, DOI 10.1080/10412905.2000.9712152
NR 35
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD JUN
PY 2019
VL 14
IS 6
DI 10.1177/1934578X19850033
PG 5
WC Chemistry, Medicinal; Food Science & Technology
SC Pharmacology & Pharmacy; Food Science & Technology
GA IJ2WM
UT WOS:000475765700011
OA Other Gold
DA 2020-07-08
ER

PT J
AU Shropshire, JD
   Bordenstein, SR
AF Shropshire, J. Dylan
   Bordenstein, Seth R.
TI Two-By-One model of cytoplasmic incompatibility: Synthetic
   recapitulation by transgenic expression of cifA and cifB in Drosophila
SO PLOS GENETICS
LA English
DT Article
ID WOLBACHIA INFECTION; GENE-EXPRESSION; PROPHAGE WO; EVOLUTION; SPREAD;
   MELANOGASTER; SEGREGATION; CROSSES; SYSTEM; DRIVES
AB Wolbachia are maternally inherited bacteria that infect arthropod species worldwide and are deployed in vector control to curb arboviral spread using cytoplasmic incompatibility (CI). CI kills embryos when an infected male mates with an uninfected female, but the lethality is rescued if the female and her embryos are likewise infected. Two phage WO genes, cifA(wMel) and cifB(wMel) from the wMel Wolbachia deployed in vector control, transgenically recapitulate variably penetrant CI, and one of the same genes, cifA(wMel), rescues wild type CI. The proposed Two-by-One genetic model predicts that CI and rescue can be recapitulated by transgenic expression alone and that dual cifA(wMel) and cifB(wMel) expression can recapitulate strong CI. Here, we use hatch rate and gene expression analyses in transgenic Drosophila melanogaster to demonstrate that CI and rescue can be synthetically recapitulated in full, and strong, transgenic CI comparable to wild type CI is achievable. These data explicitly validate the Two-by-One model in wMel-infected D. melanogaster, establish a robust system for transgenic studies of CI in a model system, and represent the first case of completely engineering male and female animal reproduction to depend upon bacteriophage gene products.
   Author summary Releases of Wolbachia-infected mosquitos are underway worldwide because Wolbachia block replication of Zika and Dengue viruses and spread themselves maternally through arthropod populations via cytoplasmic incompatibility (CI). The CI drive system depends on a Wolbachia-induced sperm modification that results in embryonic lethality when an infected male mates with an uninfected female, but this lethality is rescued when the female and her embryos are likewise infected. We recently reported that the phage WO genes, cifA and cifB, cause the sperm modification and cifA rescues the embryonic lethality caused by the wMel Wolbachia strain deployed in vector control. These reports motivated proposal of the Two-by-One model of CI whereby two genes cause lethality and one gene rescues it. Here we provide unequivocal support for the model in the Wolbachia strain used in vector control via synthetic methods that recapitulate CI and rescue in the absence of a Wolbachia infections. Our results reveal the set of phage WO genes responsible for this powerful genetic drive system, act as a proof-of-concept that these genes alone can induce gene drive like crossing patterns, and establish methodologies and hypotheses for future studies of CI in Drosophila. We discuss the implications of the Two-by-One model towards functional mechanisms of CI, the emergence of incompatibility between Wolbachia strains, vector control applications, and CI gene nomenclature.
C1 [Shropshire, J. Dylan; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Shropshire, J. Dylan; Bordenstein, Seth R.] Vanderbilt Univ, Vanderbilt Microbiome Initiat, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Bordenstein, Seth R.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Shropshire, JD; Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Shropshire, JD; Bordenstein, SR (corresponding author), Vanderbilt Univ, Vanderbilt Microbiome Initiat, 221 Kirkland Hall, Nashville, TN 37235 USA.; Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Bordenstein, SR (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM shropxp@gmail.com; s.bordenstein@vanderbilt.edu
RI ; Bordenstein, Seth/F-1298-2010
OI Shropshire, Dylan/0000-0003-4221-2178; Bordenstein,
   Seth/0000-0001-7346-0954
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI132581,
   R21 HD086833]; National Science FoundationNational Science Foundation
   (NSF) [IOS 1456778]; Vanderbilt Microbiome Initiative
FX This work was supported by National Institutes of Health (NIH) awards
   R01 AI132581 and R21 HD086833 to SRB, National Science Foundation award
   IOS 1456778 to SRB, the National Science Foundation Graduate Research
   Fellowship to JDS, and the Vanderbilt Microbiome Initiative. Any
   opinion, findings, and conclusions or recommendations expressed in this
   material are those of the authors(s) and do not necessarily reflect the
   views of the National Institutes of Health or the National Science
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akbari OS, 2014, ACS SYNTH BIOL, V3, P915, DOI 10.1021/sb300079h
   Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Awrahman ZA, 2014, J EVOLUTION BIOL, V27, P1, DOI 10.1111/jeb.12270
   Beckmann JF, 2019, TRENDS GENET, V35, P175, DOI 10.1016/j.tig.2018.12.004
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P867, DOI 10.1016/j.ibmb.2013.07.002
   Ben-David E, 2017, SCIENCE, V356, P1051, DOI 10.1126/science.aan0621
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bonneau M, 2018, NATURE COMMUNICATION, P9, DOI [10.1038/s41467-017-01881-x, DOI 10.1038/S41467-017-01881-X]
   Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155
   Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543
   Bordenstein SR, 2003, GENETICS, V164, P223
   Bossan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019757
   Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017
   Bourtzis K, 1996, GENETICS, V144, P1063
   Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x
   Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011
   Callaini G, 1997, J CELL SCI, V110, P271
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Charlat S, 2001, GENETICS, V159, P1415
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Cooper BS, 2017, GENETICS, V205, P333, DOI 10.1534/genetics.116.196238
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272
   Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Grognet P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004387
   Gutzwiller F, 2015, G3-GENES GENOM GENET, V5, P2843, DOI 10.1534/g3.115.021931
   Hammond TM, 2012, P NATL ACAD SCI USA, V109, P12093, DOI 10.1073/pnas.1203267109
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hu W, 2017, ELIFE, V6, DOI 10.7554/eLife.26057
   Huang MG, 2018, J THEOR BIOL, V440, P1, DOI 10.1016/j.jtbi.2017.12.012
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x
   Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325
   Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914
   Kent BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024984
   Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343
   Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Leftwich PT, 2018, BIOCHEM SOC T, V46, P1203, DOI 10.1042/BST20180076
   LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Lindsey ARI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040141
   Lindsey ARI, 2018, GENOME BIOL EVOL, V10, P434, DOI 10.1093/gbe/evy012
   Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]
   Nikolouli K, 2018, J PEST SCI, V91, P489, DOI 10.1007/s10340-017-0944-y
   Nuckolls NL, 2017, ELIFE, V6, DOI 10.7554/eLife.26033
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234
   Poinsot D, 1998, GENETICS, V150, P227
   Rasgon JL, 2008, ADV EXP MED BIOL, V627, P114, DOI 10.1007/978-0-387-78225-6_10
   Reynolds KT, 2003, GENETICS, V164, P1027
   Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827
   SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Shropshire JD, 2019, TRENDS GENET, V35, P397, DOI 10.1016/j.tig.2019.03.004
   Shropshire JD, 2018, P NATL ACAD SCI USA, V115, P4987, DOI 10.1073/pnas.1800650115
   Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15
   Sutton ER, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-928
   Taylor MJ, 2018, MICROBIOL-SGM, V164, P1345, DOI 10.1099/mic.0.000724
   Tracey WD, 2000, GENETICS, V154, P273
   Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536
   Tram U, 2006, J CELL SCI, V119, P3655, DOI 10.1242/jcs.03095
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Turelli M, 2018, CURR BIOL, V28, P963, DOI 10.1016/j.cub.2018.02.015
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Van Doren M, 1998, CURR BIOL, V8, P243
   Wang GH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01867
   Wang GH, 2016, INFECT GENET EVOL, V41, P1, DOI 10.1016/j.meegid.2016.03.015
   Wang NX, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00136
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486
   Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702
   YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9
   Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 91
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUN
PY 2019
VL 15
IS 6
AR e1008221
DI 10.1371/journal.pgen.1008221
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA II8TK
UT WOS:000475464900036
PM 31242186
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Microcephaly and Zika virus during pregnancy and cephalic perimeter
   curve
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Letter
DE Zika Virus; Microcephaly; Pregnancy
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok 10440, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok 10440, Thailand.
EM sorayari@outlook.co.th
CR dos Santos GRB, 2018, REV ASSOC MED BRAS, V64, P635, DOI 10.1590/1806-9282.64.07.635
   Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JUN
PY 2019
VL 65
IS 6
BP 744
EP 744
DI 10.1590/1806-9282.65.6.744
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA IK5VJ
UT WOS:000476653100003
PM 31340296
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Trigueiro, SA
   Neves, BF
   de Aguiar, MSB
   de Araujo, JSS
AF Trigueiro, Silvana Aranha
   Neves, Barbara Freitas
   Barros de Aguiar, Michelle Salles
   Soares de Araujo, Juliana Sousa
TI Correlation between cephalic circumference at birth and ocular
   alterations in patients with microcephaly potentially associated with
   Zika Virus infection
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Review
DE Zika virus; Pregnancy; Microcephaly; Eye manifestations
ID INFANTS; BRAZIL; REGION
AB INTRODUCTION: The Zika virus (ZIKV) is an arbovirus isolated for the first time in 1947 and transmitted to humans by the Aedes aegypti mosquito. In Brasil, it was first detected in May 2015. Since then, ZIKV has been identified as the etiological agent of acute exanthematous disease in Brasil, and Neuropediatricians of the Recife warned about an epidemic of microcephaly, and the Brazilian Ministry of Health confirmed the association between ZIKV and Congenital malformations and neurological syndromes. The eye, as an extension of the developing brain, has been examined in patients with microcephaly and maternal history of ZIKV infection.
   METHODS: Twenty newborn patients with microcephaly, whose mothers had presumed Zika virus during pregnancy, were analyzed through medical records. The nonparametric chi-square statistic was used to verify the association between head circumference and ocular alteration at a significance level of 0.0001.
   RESULTS: The significance of P = 0.000 in the value of non-parametric chi-square statistics was lower than the value of alpha = 0.0001, demonstrating that, at a level of 0.0001, there is an association between head circumference and ocular alteration.
   CONCLUSION: Although the knowledge of the natural evolution of the disease is still scarce, the current evidence is strong enough to establish a causal relationship between ZIKV infection during pregnancy and the increased incidence of the microcephaly and serious eye alterations that lead to the severe lower vision of these children.
C1 [Trigueiro, Silvana Aranha; Soares de Araujo, Juliana Sousa] Candida Vargas Matern, Joao Pessoa, Paraiba, Brazil.
   [Neves, Barbara Freitas] Nova Esperanca Fac Med, Joao Pessoa, Paraiba, Brazil.
   [Barros de Aguiar, Michelle Salles] Univ Ctr Joao Pessoa Unipe, Joao Pessoa, Paraiba, Brazil.
   [Barros de Aguiar, Michelle Salles] Nikola Tesla Res Ctr, Joao Pessoa, Paraiba, Brazil.
RP Trigueiro, SA (corresponding author), Gen Bento Gama 107, BR-58040090 Joao Pessoa, Paraiba, Brazil.
EM drasilvanatrigueiro@gmail.com
OI neves, barbara/0000-0002-4613-9505
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bogas C, BRASIL ADOTA RECOMEN
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Paraguassu L, SITUACAO ZIKA VIRUS
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 21
TC 0
Z9 0
U1 0
U2 1
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JUN
PY 2019
VL 65
IS 6
BP 909
EP 913
DI 10.1590/1806-9282.65.6.909
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA IK5VJ
UT WOS:000476653100031
PM 31340324
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Khaiboullina, SF
   Lopes, P
   de Carvalho, TG
   Real, ALCV
   Souza, DG
   Costa, VV
   Teixeira, MM
   Bloise, E
   Verma, SC
   Ribeiro, FM
AF Khaiboullina, Svetlana F.
   Lopes, Priscila
   de Carvalho, Toniana G.
   Real, Ana Luiza C. V.
   Souza, Danielle G.
   Costa, Vivian V.
   Teixeira, Mauro M.
   Bloise, Enrrico
   Verma, Subhash C.
   Ribeiro, Fabiola M.
TI Host Immune Response to ZIKV in an Immunocompetent Embryonic Mouse Model
   of Intravaginal Infection
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; FVB; NJ mice; intravaginal infection; CCL2; CXCL1 and CXCL10
ID MALE SEXUAL TRANSMISSION; BIRTH-DEFECTS; VIRUS; EXPOSURE; DISEASE;
   STATES; SEMEN
AB Zika virus (ZIKV) only induces mild symptoms in adults; however, it can cause congenital Zika syndrome (CZS), including microcephaly. Most of the knowledge on ZIKV pathogenesis was gained using immunocompromised mouse models, which do not fully recapitulate human pathology. Moreover, the study of the host immune response to ZIKV becomes challenging in these animals. Thus, the main goal of this study was to develop an immunocompetent mouse model to study the ZIKV spread and teratogeny. FVB/NJ immune competent dams were infected intravaginally with ZIKV during the early stage of pregnancy. We found that the placentae of most fetuses were positive for ZIKV, while the virus was detected in the brain of only about 42% of the embryos. To investigate the host immune response, we measured the expression of several inflammatory factors. Embryos from ZIKV-infected dams had an increased level of inflammatory factors, as compared to Mock. Next, we compared the gene expression levels in embryos from ZIKV-infected dams that were either negative or positive for ZIKV in the brain. The mRNA levels of viral response genes and cytokines were increased in both ZIKV-positive and negative brains. Interestingly, the levels of chemokines associated with microcephaly in humans, including CCL2 and CXCL10, specifically increased in embryos harboring ZIKV in the embryo brains.
C1 [Khaiboullina, Svetlana F.; Verma, Subhash C.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA.
   [Lopes, Priscila; de Carvalho, Toniana G.; Real, Ana Luiza C. V.; Teixeira, Mauro M.; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza, Danielle G.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Costa, Vivian V.; Bloise, Enrrico] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Morphol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Verma, SC (corresponding author), Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA.; Ribeiro, FM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
EM sv.khaiboullina@gmail.com; pripsgraz@gmail.com; toniana_gc@hotmail.com;
   analuza321@gmail.com; souzadg@gmail.com; vivianvcosta@gmail.com;
   mmtex.ufmg@gmail.com; enrico_bloise@hotmail.com;
   scverma@medicine.nevada.edu; fmribeiro@icb.ufmg.br
RI Ribeiro, Fabiola/E-8831-2013; Bloise, Enrrico/O-6710-2018; Costa, Vivian
   VVC/I-2499-2018; Khaiboullina, Svetlana/M-4793-2016
OI Ribeiro, Fabiola/0000-0001-7042-9433; Bloise,
   Enrrico/0000-0003-0275-8686; Costa, Vivian VVC/0000-0002-0175-642X;
   Khaiboullina, Svetlana/0000-0002-5064-570X; DE CARVALHO,
   TONIANA/0000-0002-6475-9222; Verma, Subhash/0000-0002-0492-6578
FU Pro-Reitoria de Pesquisa (PRPq), Universidade Federal de Minas Gerais;
   FINEPCiencia Tecnologia e Inovacao (FINEP) [0271/16]; FAPEMIG-PPSUS
   [APQ-03744-17]
FX This work was supported by the Pro-Reitoria de Pesquisa (PRPq),
   Universidade Federal de Minas Gerais, and FINEP [grant number 0271/16]
   and FAPEMIG-PPSUS [grant number APQ-03744-17] grants to F.M.R.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumming HE, 2019, J LEUKOCYTE BIOL, V105, P353, DOI 10.1002/JLB.MR0318-122RR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 51
TC 1
Z9 1
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2019
VL 11
IS 6
DI 10.3390/v11060558
PG 12
WC Virology
SC Virology
GA II6MM
UT WOS:000475308000076
PM 31212905
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sabino, C
   Basic, M
   Bender, D
   Elgner, F
   Himmelsbach, K
   Hildt, E
AF Sabino, Catarina
   Basic, Michael
   Bender, Daniela
   Elgner, Fabian
   Himmelsbach, Kiyoshi
   Hildt, Eberhard
TI Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; viral life cycle; endosomal-lysosomal compartment;
   bafilomycin A1; U18666A; antiviral effect
ID CHOLESTEROL TRANSPORT INHIBITOR; VIRUS-INFECTION; DENGUE VIRUS; WEST
   NILE; REPLICATION; BIOLOGY; NIGERIA; FEVER; CELLS; AXL
AB Zika virus (ZIKV) is a highly transmissive virus that belongs to the Flaviviridae family, which comprises several other pathogens that threaten human health. This re-emerging virus gained attention during the outbreak in Brazil in 2016, where a considerable number of microcephaly cases in newborns was associated with ZIKV infection during pregnancy. Lacking a preventive vaccine or antiviral drugs, efforts have been made to better understand the viral life cycle. In light of this, the relevance of the endosomal-lysosomal compartment for the ZIKV life cycle was investigated. A549 and SH-SY5Y cells were infected with either the African strain (associated with mild symptoms) or the French Polynesia strain (associated with neurological complications). For both strains, the V-ATPase inhibitor, bafilomycin A1, efficiently inhibited ZIKV entry and prevented the spread of the infection by interfering with viral maturation. Additionally, affecting cholesterol metabolism and transport with the drug U18666A, which inactivates late endosomes and lysosomes, impairs the viral life cycle. The data presented show a clear antiviral effect of two compounds that target the same compartments in different ways. This highlights the relevance of the endosomal-lysosomal compartment for the viral life cycle that should be considered as a target for antivirals.
C1 [Sabino, Catarina; Basic, Michael; Bender, Daniela; Elgner, Fabian; Himmelsbach, Kiyoshi; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Hildt, Eberhard] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
RP Hildt, E (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.; Hildt, E (corresponding author), German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
EM catarina.sabino@pei.de; michael.basic@kgu.de; daniela.bender@pei.de;
   fabian.elgner@pei.de; kiyoshi.himmelsbach@pei.de; eberhard.hildt@pei.de
RI Hildt, Eberhard/A-1040-2015
OI Basic, Michael/0000-0001-6339-1262; Sabino,
   Catarina/0000-0002-0586-1235; Himmelsbach, Kiyoshi/0000-0002-1840-6012;
   Bender, Daniela/0000-0002-8991-126X
FU Federal Ministry of Health (BMG); LOEWE Center DRUID (Novel Drug Targets
   against Poverty-Related and Neglected Tropical Infectious Diseases);
   European Virus Archive goes Global (EVAg) project from the European
   Union's Horizon 2020 research and innovation program [653316]; ZIKV
   Uganda 976 strain
FX This research was funded by a grant from the Federal Ministry of Health
   (BMG) to E.H. and by a grant from the LOEWE Center DRUID (Novel Drug
   Targets against Poverty-Related and Neglected Tropical Infectious
   Diseases) to D.B. and E.H. This publication was supported by the
   European Virus Archive goes Global (EVAg) project that has received
   funding from the European Union's Horizon 2020 research and innovation
   program under grant agreement No 653316. Based on this funding, EVAg
   provided the ZIKV Uganda 976 strain.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Osuna-Ramos JF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00388
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Glitscher M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060301
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Takano T, 2017, ANTIVIR RES, V145, P96, DOI 10.1016/j.antiviral.2017.07.022
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
NR 46
TC 5
Z9 5
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2019
VL 11
IS 6
DI 10.3390/v11060524
PG 25
WC Virology
SC Virology
GA II6MM
UT WOS:000475308000042
PM 31174294
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sempere, RN
   Arias, A
AF Sempere, Raquel Navarro
   Arias, Armando
TI Establishment of a Cell Culture Model of Persistent Flaviviral
   Infection: Usutu Virus Shows Sustained Replication during Passages and
   Resistance to Extinction by Antiviral Nucleosides
SO VIRUSES-BASEL
LA English
DT Article
DE chronic viral infection; emerging arboviruses; defective viral genomes;
   antiviral therapies; lethal mutagenesis
ID HEPATITIS-C VIRUS; WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; ZIKA
   VIRUS; VIRAL GENOMES; NOROVIRUS; DENGUE; DISSEMINATION; TRANSMISSION;
   PATHOGENESIS
AB Chronic viral disease constitutes a major global health problem, with several hundred million people affected and an associated elevated number of deaths. An increasing number of disorders caused by human flaviviruses are related to their capacity to establish a persistent infection. Here we show that Usutu virus (USUV), an emerging zoonotic flavivirus linked to sporadic neurologic disease in humans, can establish a persistent infection in cell culture. Two independent lineages of Vero cells surviving USUV lytic infection were cultured over 82 days (41 cell transfers) without any apparent cytopathology crisis associated. We found elevated titers in the supernatant of these cells, with modest fluctuations during passages but no overall tendency towards increased or decreased infectivity. In addition to full-length genomes, viral RNA isolated from these cells at passage 40 revealed the presence of defective genomes, containing different deletions at the 5' end. These truncated transcripts were all predicted to encode shorter polyprotein products lacking membrane and envelope structural proteins, and most of non-structural protein 1. Treatment with different broad-range antiviral nucleosides revealed that USUV is sensitive to these compounds in the context of a persistent infection, in agreement with previous observations during lytic infections. The exposure of infected cells to prolonged treatment (10 days) with favipiravir and/or ribavirin resulted in the complete clearance of infectivity in the cellular supernatants (decrease of similar to 5 log(10) in virus titers and RNA levels), although modest changes in intracellular viral RNA levels were recorded (<2 log(10) decrease). Drug withdrawal after treatment day 10 resulted in a relapse in virus titers. These results encourage the use of persistently-infected cultures as a surrogate system in the identification of improved antivirals against flaviviral chronic disease.
C1 [Sempere, Raquel Navarro; Arias, Armando] Tech Univ Denmark, Life Sci & Bioengn Bldg, DK-2800 Lyngby, Denmark.
   [Sempere, Raquel Navarro] Abiopep Soc Ltd, Parque Cient Murcia, Murcia 30100, Spain.
RP Arias, A (corresponding author), Tech Univ Denmark, Life Sci & Bioengn Bldg, DK-2800 Lyngby, Denmark.
EM rnsempere@abiopep.com; aaesteban2@gmail.com
RI Arias, Armando/E-1393-2016
OI Arias, Armando/0000-0002-4138-4608
FU Independent Research Fund Denmark (Technology and Production Sciences,
   DFF-FTP) [6111-00104B]
FX This work is supported by funding procured from the Independent Research
   Fund Denmark (Technology and Production Sciences, DFF-FTP) to A.A.,
   application number 6111-00104B. R.N.S. was supported with an internship
   provided by Frederiksberg Kommune.
CR Aberle SW, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.43.1800545
   Adams AP, 2013, AM J TROP MED HYG, V88, P455, DOI 10.4269/ajtmh.12-0110
   Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Bakonyi T, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.41.17-00644
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Belova OA, 2017, TICKS TICK-BORNE DIS, V8, P895, DOI 10.1016/j.ttbdis.2017.07.008
   Juarez-Martinez AB, 2013, ARCH VIROL, V158, P583, DOI 10.1007/s00705-012-1525-2
   Bielefeldt-Ohmann H, 2017, MICROB PATHOGENESIS, V103, P71, DOI 10.1016/j.micpath.2016.12.018
   Bixler SL, 2018, ANTIVIR RES, V151, P97, DOI 10.1016/j.antiviral.2017.12.021
   Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   BRINTON MA, 1981, J VIROL, V39, P413, DOI 10.1128/JVI.39.2.413-421.1981
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131
   Castro Victoria, 2019, Methods Mol Biol, V1911, P157, DOI 10.1007/978-1-4939-8976-8_10
   Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Chvala S, 2005, AVIAN PATHOL, V34, P392, DOI 10.1080/03079450500268500
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   DAVIS JW, 1974, INFECT IMMUN, V10, P1362, DOI 10.1128/IAI.10.6.1362-1369.1974
   Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12
   Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01400-17, 10.1128/aac.01400-17]
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Guerrero NAS, 2018, ANTIVIR RES, V160, P137, DOI 10.1016/j.antiviral.2018.10.026
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach B.D., 2019, METHOD MOL BIOL, V510, P329
   Manzoni TB, 2018, FUTURE VIROL, V13, P493, DOI 10.2217/fvl-2018-0021
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlera L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090252
   Mlera L, 2016, MBIO, V7, DOI 10.1128/mBio.00314-16
   Mlera L, 2015, MBIO, V6, DOI 10.1128/mBio.00614-15
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Mohamed AA, 2015, WORLD J HEPATOL, V7, P2676, DOI 10.4254/wjh.v7.i26.2676
   Murali AR, 2015, WORLD J HEPATOL, V7, P2194, DOI 10.4254/wjh.v7.i19.2194
   Murray KO, 2017, AM J TROP MED HYG, V97, P1913, DOI 10.4269/ajtmh.17-0405
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Panigrahi R, 2015, J VIROL, V89, P626, DOI 10.1128/JVI.02492-14
   Paz-Bailey G., 2017, NEW ENGL J MED, V379
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459
   Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658
   Pesko KN, 2012, VIROLOGY, V427, P10, DOI 10.1016/j.virol.2012.01.028
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richards SL, 2012, J MED ENTOMOL, V49, P132, DOI 10.1603/ME10280
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Ruis C, 2018, NEW ENGL J MED, V379, P2173, DOI 10.1056/NEJMc1806941
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Tetro JA, 2017, MICROBES INFECT, V19, P380, DOI 10.1016/j.micinf.2017.05.004
   Thorne L, 2016, J INFECT DIS, V213, pS27, DOI 10.1093/infdis/jiv280
   Tsai P, 2018, J MICROBIOL IMMUNOL, V51, P446, DOI 10.1016/j.jmii.2016.11.004
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Williams BG, 2017, LANCET, V390, P357, DOI 10.1016/S0140-6736(17)31832-9
   Woodward J, 2017, CLIN EXP IMMUNOL, V188, P363, DOI 10.1111/cei.12884
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06
   Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 78
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2019
VL 11
IS 6
AR 560
DI 10.3390/v11060560
PG 21
WC Virology
SC Virology
GA II6MM
UT WOS:000475308000078
PM 31212939
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yen, PS
   Chen, CH
   Sreenu, V
   Kohl, A
   Failloux, AB
AF Yen, Pei-Shi
   Chen, Chun-Hong
   Sreenu, Vattipally
   Kohl, Alain
   Failloux, Anna-Bella
TI Assessing the Potential Interactions between Cellular miRNA and
   Arboviral Genomic RNA in the Yellow Fever Mosquito, Aedes aegypti
SO VIRUSES-BASEL
LA English
DT Article
DE Aedes aegypti; arboviruses; chikungunya; dengue; Zika; miRNA
ID DENGUE VIRUS-REPLICATION; ZIKA VIRUS; CHIKUNGUNYA VIRUS; BIOINFORMATICS
   DATABASE; ANTIVIRAL DEFENSE; INTERFERENCE RNAI; ANALYSIS RESOURCE;
   SEMLIKI-FOREST; WEST NILE; MICRORNA
AB Although the role of exogenous small interfering RNA (siRNA) and P-element induced wimpy testis (PIWI)-interacting RNA (piRNA) pathways in mosquito antiviral immunity is increasingly better understood, there is still little knowledge regarding the role of mosquito cellular microRNA (miRNA). Identifying direct interactions between the mosquito miRNAs and the RNA genome of arboviruses and choosing the relevant miRNA candidates to explore resulting antiviral mechanisms are critical. Here, we carried out genomic analyses to identify Aedes aegypti miRNAs that potentially interact with various lineages and genotypes of chikungunya, dengue, and Zika viruses. By using prediction tools with distinct algorithms, several miRNA binding sites were commonly found within different genotypes/and or lineages of each arbovirus. We further analyzed those miRNAs that could target more than one arbovirus, required a low energy threshold to form miRNA-viralRNA (vRNA) complexes, and predicted potential RNA structures using RNAhybrid software. We predicted miRNA candidates that might participate in regulating arboviral replication in Ae. aegypti. Even without any experimental validation, which should be done as a next step, this study can shed further light on the role of miRNA in mosquito innate immunity and targets for future studies.
C1 [Yen, Pei-Shi; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75015 Paris, France.
   [Chen, Chun-Hong] Natl Inst Infect Dis & Vaccinol, Natl Hlth Res Inst, Miaoli 35053, Taiwan.
   [Chen, Chun-Hong] Natl Mosquito Borne Dis Control Res Ctr, Miaoli 35053, Taiwan.
   [Sreenu, Vattipally; Kohl, Alain] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
RP Yen, PS; Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75015 Paris, France.
EM pei-shi.yen@pasteur.fr; chunhong@nhri.org.tw;
   Sreenu.Vattipally@glasgow.ac.uk; Alain.Kohl@glasgow.ac.uk;
   anna-bella.failloux@pasteur.fr
OI CHEN, CHUN-HONG/0000-0002-3028-5508; Yen, Pei-Shi/0000-0002-2113-7394;
   Vattipally, Bala Sreenu/0000-0001-6673-4697
FU European Union's Horizon 2020 Research and innovation program under
   "ZIKALLIANCE" [734548]; French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence "Integrative Biology of Emerging
   Infectious Diseases, IBEID"French National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; National Health Research InstitutesNational
   Health Research Institutes, JapanNational Health Research Institutes -
   Taiwan [NHRI-PP-108-0324-01-17-07]; UK Medical Research CouncilMedical
   Research Council UK (MRC) [MC_UU_12014]; Pasteur-Paris University (PPU)
   program
FX This study was partly supported by the European Union's Horizon 2020
   Research and innovation program under "ZIKALLIANCE" Grant Agreement no
   734548) (ABF, AK), the French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence "Integrative Biology of Emerging
   Infectious Diseases, IBEID" (grant no ANR-10-LABX-62-IBEID) (ABF), the
   National Health Research Institutes (NHRI-PP-108-0324-01-17-07) (CHC),
   and the UK Medical Research Council [MC_UU_12014] (AK and VS). PSY was
   supported by the Pasteur-Paris University (PPU) program.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Bai XT, 2015, J BIOL CHEM, V290, P5381, DOI 10.1074/jbc.M114.626325
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Brummer A, 2014, BIOESSAYS, V36, P617, DOI 10.1002/bies.201300104
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Dubey SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18043-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enright AJ, 2004, GENOME BIOL, V5
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Etebari K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005069
   Etebari K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15968
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996
   Hu W, 2015, INSECT MOL BIOL, V24, P240, DOI 10.1111/imb.12152
   Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639
   Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784
   Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581
   Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359
   Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maharaj PD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003386
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mukherjee S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-127
   Naqvi AR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00433
   Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007
   Pinzon N, 2017, GENOME RES, V27, P234, DOI 10.1101/gr.205146.116
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Powers AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005421
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Scheel TKH, 2016, CELL HOST MICROBE, V19, P409, DOI 10.1016/j.chom.2016.02.007
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292
   Su JX, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1966-2
   Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003
   Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van Mierlo JT, 2011, METHODS MOL BIOL, V721, P3, DOI 10.1007/978-1-61779-037-9_1
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wen BP, 2013, INTERVIROLOGY, V56, P195, DOI 10.1159/000348504
   Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112
   Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815
   Yang JS, 2014, NUCLEIC ACIDS RES, V42, P1987, DOI 10.1093/nar/gkt1038
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
   Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zhang XF, 2017, P NATL ACAD SCI USA, V114, pE1895, DOI 10.1073/pnas.1701474114
   Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12
   Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4
NR 117
TC 1
Z9 1
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2019
VL 11
IS 6
DI 10.3390/v11060540
PG 16
WC Virology
SC Virology
GA II6MM
UT WOS:000475308000058
PM 31185697
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Piontkivska, H
   Plonski, NM
   Miyamoto, MM
   Wayne, ML
AF Piontkivska, Helen
   Plonski, Noel-Marie
   Miyamoto, Michael M.
   Wayne, Marta L.
TI Explaining Pathogenicity of Congenital Zika and Guillain-Barre
   Syndromes: Does Dysregulation of RNA Editing Play a Role?
SO BIOESSAYS
LA English
DT Article
DE adenosine deaminases acting on RNA (ADAR) editing; congenital Zika
   syndrome (CZS); Guillain-Barre syndrome (GBS); innate immunity; RNA
   editing; Zika virus (ZIKV)
ID AICARDI-GOUTIERES-SYNDROME; HUMAN BRAIN-DEVELOPMENT; EMBRYONIC
   STEM-CELLS; VIRUS-INFECTION; MESSENGER-RNA; ADENOSINE-DEAMINASE;
   PARKINSONS-DISEASE; DOWN-REGULATION; BIRTH-DEFECTS; DENGUE VIRUS
AB Previous studies of Zika virus (ZIKV) pathogenesis have focused primarily on virus-driven pathology and neurotoxicity, as well as host-related changes in cell proliferation, autophagy, immunity, and uterine function. It is now hypothesized that ZIKV pathogenesis arises instead as an (unintended) consequence of host innate immunity, specifically, as the side effect of an otherwise well-functioning machine. The hypothesis presented here suggests a new way of thinking about the role of host immune mechanisms in disease pathogenesis, focusing on dysregulation of post-transcriptional RNA editing as a candidate driver of a broad range of observed neurodevelopmental defects and neurodegenerative clinical symptoms in both infants and adults linked with ZIKV infections. The authors collect and synthesize existing evidence of ZIKV-mediated changes in the expression of adenosine deaminases acting on RNA (ADARs), known links between abnormal RNA editing and pathogenesis, as well as ideas for future research directions, including potential treatment strategies.
C1 [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
   [Piontkivska, Helen; Plonski, Noel-Marie] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.
   [Miyamoto, Michael M.; Wayne, Marta L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Wayne, Marta L.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Piontkivska, H (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.; Piontkivska, H (corresponding author), Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.
EM opiontki@kent.edu
RI Piontkivska, Helen/AAK-3915-2020
OI Piontkivska, Helen/0000-0003-1844-864X; Plonski,
   Noel-Marie/0000-0003-0747-7664
FU Kent State University Research Council Seed Award; Brain Health
   Institute; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [GM083192]
FX The authors would like to thank Dr. W. F. Martin for encouragement and
   Dr. Andrew Moore and two anonymous reviewers for their constructive
   comments that helped in improving this manuscript. This work was
   partially supported by a Kent State University Research Council Seed
   Award and Brain Health Institute Pilot Award to H.P. M.L.W. was
   supported by the National Institutes of Health (Grant no. GM083192).
CR Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Barnard TR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120728
   Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501
   Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283
   Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951
   Bonini D, 2015, RNA BIOL, V12, P43, DOI 10.1080/15476286.2015.1008365
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Cox HC, 2012, NEUROGENETICS, V13, P261, DOI 10.1007/s10048-012-0325-x
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Cucca A, 2018, PARKINSONISM RELAT D, V46, pS83, DOI 10.1016/j.parkreldis.2017.07.019
   D'Angelo W, 2017, J IMMUNOL, V198, P2147, DOI 10.4049/jimmunol.1601068
   Danbolt NC, 2016, NEUROCHEM INT, V98, P29, DOI 10.1016/j.neuint.2016.05.009
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DesLucchini S., 2003, MOL BRAIN RES, V115, P196
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   Doncel-Perez E, 2016, J IMMUNOL, V196, P1102, DOI 10.4049/jimmunol.1502100
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fahn S, 2018, PARKINSONISM RELAT D, V46, pS1, DOI 10.1016/j.parkreldis.2017.07.020
   Fink KR, 2010, RADIOGRAPHICS, V30, P1779, DOI 10.1148/rg.307105043
   Fisher AJ, 2017, RNA BIOL, V14, P164, DOI 10.1080/15476286.2016.1267097
   Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962
   Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026
   Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018
   Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022
   Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208
   Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hensler JG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P300
   Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Holmgren M, 2015, CURR ISSUES MOL BIOL, V17, P23
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022
   Huntley MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2291-9
   Hurley MJ, 2013, BRAIN, V136, P2077, DOI 10.1093/brain/awt134
   Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337
   Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185
   Katrekar D, 2019, NAT METHODS, V16, P239, DOI 10.1038/s41592-019-0323-0
   Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Knorle R, 2018, NEUROTOX RES, V33, P515, DOI 10.1007/s12640-017-9804-z
   Kwak S, 2010, NEUROPATHOLOGY, V30, P182, DOI 10.1111/j.1440-1789.2009.01090.x
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Landry MD, 2017, PHYS THER, V97, P275, DOI 10.2522/ptj.20160476
   Lanzi G, 2005, NEUROLOGY, V64, P1621, DOI 10.1212/01.WNL.0000159864.05826.08
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539
   Licht K, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700129
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Livingston JH, 2016, NEUROPEDIATRICS, V47, P355, DOI 10.1055/s-0036-1592307
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Majumder Maimuna S, 2018, F1000Res, V7, P159, DOI 10.12688/f1000research.13858.1
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Marchesan S, 2017, SCIENCE, V356, P1010, DOI 10.1126/science.aan1227
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s095026881800359x, 10.1017/S095026881800359X]
   Merkle T, 2019, NAT BIOTECHNOL, V37, P133, DOI 10.1038/s41587-019-0013-6
   Mittaz L, 1997, HUM GENET, V100, P398, DOI 10.1007/s004390050523
   Nigita G, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00037
   Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4
   O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136
   Oakes E, 2017, J BIOL CHEM, V292, P4326, DOI 10.1074/jbc.M117.779868
   Obajemu AA, 2017, J IMMUNOL, V199, P3808, DOI 10.4049/jimmunol.1700807
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Pachernegg S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00069
   Pardy RD, 2019, CYTOKINE, V119, P7, DOI 10.1016/j.cyto.2019.02.009
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Picardi E, 2017, RNA, V23, P860, DOI 10.1261/rna.058271.116
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Piontkivska H, 2017, ECOL EVOL, V7, P4475, DOI 10.1002/ece3.3033
   Piontkivska H, 2016, GENOME BIOL EVOL, V8, P2952, DOI 10.1093/gbe/evw212
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Prata-Barbosa A, 2018, INT J INFECT DIS, V72, P25, DOI 10.1016/j.ijid.2018.04.4320
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414
   Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308
   Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180
   Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010
   Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008
   Sailer A, 1999, J NEUROSCI, V19, P8757, DOI 10.1523/JNEUROSCI.19-20-08757.1999
   Samuel CE, 2019, J BIOL CHEM, V294, P1710, DOI 10.1074/jbc.TM118.004166
   Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004
   Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252
   Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3
   Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410
   Tan BZ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-13
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099
   Tohda M, 2006, J PHARMACOL SCI, V100, P427, DOI 10.1254/jphs.CPJ06005X
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Trus I, 2018, VIRULENCE, V9, P1338, DOI 10.1080/21505594.2018.1504558
   Uchida S, 2018, BIOMATERIALS, V150, P162, DOI 10.1016/j.biomaterials.2017.09.033
   van der Laan S, 2017, DRUG DISCOV TODAY, V22, P1056, DOI 10.1016/j.drudis.2017.01.017
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   vansden Berg B., 2014, NAT REV NEUROL, V10, P469
   vansLeeuwen N., 2016, PLOS ONE, V11
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Walkley C. R., 2011, ADENOSINE DEAMINASES, P197
   Walkley CR, 2012, CURR TOP MICROBIOL, V353, P197, DOI 10.1007/82_2011_150
   Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765
   Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438
   Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wou K, 2015, EXPERT REV MOL DIAGN, V15, P989, DOI 10.1586/14737159.2015.1051529
   Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111
   Yamashita T, 2012, NEUROSCI RES, V73, P42, DOI 10.1016/j.neures.2012.02.002
   Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 135
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD JUN
PY 2019
VL 41
IS 6
AR 1800239
DI 10.1002/bies.201800239
PG 9
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA IH8VE
UT WOS:000474783900004
PM 31106880
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Kim, YH
   Kim, TY
   Park, JS
   Park, JS
   Lee, J
   Moon, J
   Chong, CK
   Neves, I
   Ferry, FR
   Ahn, HJ
   Bhatt, L
   Nam, HW
AF Kim, Yeong Hoon
   Kim, Tae-Yun
   Park, Ji-Seon
   Park, Jin Suk
   Lee, Jihoo
   Moon, Joungdae
   Chong, Chom-Kyu
   Neves Junior, Ivan
   Ferry, Fernando Raphael
   Ahn, Hye-Jin
   Bhatt, Lokraj
   Nam, Ho-Woo
TI Development and Clinical Evaluation of a Rapid Diagnostic Test for
   Yellow Fever Non-Structural Protein 1
SO KOREAN JOURNAL OF PARASITOLOGY
LA English
DT Article
DE Yellow fever; diagnostics; RDT; monoclonal antibody; NS1
ID DENGUE; NS1; ANTIGEN; VIRUS; ANTIBODIES; THREAT
AB A rapid diagnostic test (RDT) kit was developed to detect non-structural protein 1 (NS1) of yellow fever virus (YFV) using monoclonal antibody. NS1 protein was purified from the cultured YFV and used to immunize mice. Monoclonal antibody to NS1 was selected and conjugated with colloidal gold to produce the YFV NS1 RDT kit. The YFV RDTs were evaluated for sensitivity and specificity using positive and negative samples of monkeys from Brazil and negative human blood samples from Korea. Among monoclonal antibodies, clones 3A11 and 3B7 proved most sensitive, and used for YFV RDT kit. Diagnostic accuracy of YFV RDT was fairly high; Sensitivity was 0.0% and specificity was 100% against Dengue viruses type 2 and 3, Zika, Chikungunya and Mayaro viruses. This YFV RDT kit could be employed as a test of choice for point-of-care diagnosis and large scale surveys of YFV infection under clinical or field conditions in endemic areas and on the globe.
C1 [Kim, Yeong Hoon] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul 06591, South Korea.
   [Kim, Tae-Yun; Park, Ji-Seon; Park, Jin Suk; Lee, Jihoo; Moon, Joungdae; Chong, Chom-Kyu] Genbody Inc, Cheonan 31116, South Korea.
   [Neves Junior, Ivan; Ferry, Fernando Raphael] Univ Fed Rio de Janeiro, Gafree & Guinie Univ Hosp, Del Castilho, RJ, Brazil.
   [Ahn, Hye-Jin; Bhatt, Lokraj; Nam, Ho-Woo] Catholic Univ Korea, Coll Med, Dept Parasitol, Seoul 06591, South Korea.
RP Nam, HW (corresponding author), Catholic Univ Korea, Coll Med, Dept Parasitol, Seoul 06591, South Korea.
EM howoo@catholic.ac.kr
FU Technology development Program - Ministry of SMEs and Startups (MSS,
   Korea) of 2017 [S2517043]
FX This work was supported by the Technology development Program (S2517043)
   funded by the Ministry of SMEs and Startups (MSS, Korea) of 2017.
CR Alcala AC, 2016, VIROLOGY, V488, P278, DOI 10.1016/j.virol.2015.11.020
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   CHERNESKY MA, 1984, YALE J BIOL MED, V57, P757
   Chong CK, 2011, KOREAN J PARASITOL, V49, P207, DOI 10.3347/kjp.2011.49.3.207
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Kubota RL, 2003, REV SAUDE PUBL, V37, P263, DOI 10.1590/S0034-89102003000200017
   Lee J, 2015, DIAGN MICR INFEC DIS, V82, P128, DOI 10.1016/j.diagmicrobio.2015.03.009
   McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002
   Ministerio da Saude Secretaria de Vigilancia em Saude, INFORME N 30 2017
   Morlais I, 2003, INSECT MOL BIOL, V12, P631, DOI 10.1046/j.1365-2583.2003.00449.x
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Ravel S, 2002, ACTA TROP, V82, P39, DOI 10.1016/S0001-706X(02)00028-1
   RICHMAN DD, 1984, J INFECT DIS, V149, P298, DOI 10.1093/infdis/149.3.298
   Tomlinson Wallace, 2005, J La State Med Soc, V157, P216
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   World Health Organization, YELLOW FEVER
NR 22
TC 0
Z9 0
U1 1
U2 5
PU KOREAN SOC PARASITOLOGY, SEOUL NATL UNIV COLL MEDI
PI SEOUL
PA DEPT PARASITOLOGY, SEOUL, 00000, SOUTH KOREA
SN 0023-4001
EI 1738-0006
J9 KOREAN J PARASITOL
JI Korean J. Parasitol.
PD JUN
PY 2019
VL 57
IS 3
BP 283
EP 290
DI 10.3347/kjp.2019.57.3.283
PG 8
WC Parasitology
SC Parasitology
GA IH5ID
UT WOS:000474526800009
PM 31284351
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Crupi, MJF
   Bell, JC
   Singaravelu, R
AF Crupi, Mathieu J. F.
   Bell, John C.
   Singaravelu, Ragunath
TI Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche
   Using Oncolytic Viruses
SO STEM CELLS
LA English
DT Review
DE Oncolytic virus; Cancer stem cells; Immunotherapy; BiTE; CAR T cell
ID RECEPTOR T-CELLS; ADVANCED MELANOMA; CHECKPOINT BLOCKADE; INTERFERON
   PATHWAY; I-INTERFERON; TUMOR-CELLS; ZIKA VIRUS; ANTIBODY; PD-L1;
   FIBROBLASTS
AB Cancer stem cells (CSCs) have the capacity to self-renew and differentiate to give rise to heterogenous cancer cell lineages in solid tumors. These CSC populations are associated with metastasis, tumor relapse, and resistance to conventional anticancer therapies. Here, we focus on the use of oncolytic viruses (OVs) to target CSCs as well as the OV-driven interferon production in the tumor microenvironment (TME) that can repress CSC properties. We explore the ability of OVs to deliver combinations of immune-modulating therapeutic transgenes, such as immune checkpoint inhibitor antibodies. In particular, we highlight the advantages of virally encoded bi-specific T cell engagers (BiTEs) to not only target cell-surface markers on CSCs, but also tumor-associated antigens on contributing components of the surrounding TME and other cancer cells. We also highlight the crucial role of combination anticancer treatments, evidenced by synergy of OV-delivered BiTEs and chimeric-antigen receptor T cell therapy. Stem Cells 2019;37:716-723
C1 [Crupi, Mathieu J. F.; Bell, John C.; Singaravelu, Ragunath] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON K1H 8L6, Canada.
   [Crupi, Mathieu J. F.; Bell, John C.; Singaravelu, Ragunath] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada.
RP Singaravelu, R (corresponding author), Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON K1H 8L6, Canada.; Singaravelu, R (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada.
EM r.singaravelu@gmail.com
OI Singaravelu, Ragunath/0000-0002-2692-3650
FU Canadian Cancer Society Research Institute; Canadian Institutes of
   Health Research (CIHR)Canadian Institutes of Health Research (CIHR);
   Ontario Institute of Cancer Research; Terry Fox Foundation; CIHR
   Postdoctoral FellowshipCanadian Institutes of Health Research (CIHR)
FX J.C.B. was supported by the Canadian Cancer Society Research Institute,
   the Canadian Institutes of Health Research (CIHR), the Ontario Institute
   of Cancer Research, and the Terry Fox Foundation. R.S. was supported by
   a CIHR Postdoctoral Fellowship. All figures were composed by Christine
   Kenney (http://ckenneyillustration.com/).
CR Fajardo CA, 2017, CANCER RES, V77, P2052, DOI 10.1158/0008-5472.CAN-16-1708
   Arulanandam R, 2015, CANCER CELL, V28, P210, DOI 10.1016/j.ccell.2015.06.009
   Bach P, 2013, CANCER RES, V73, P865, DOI 10.1158/0008-5472.CAN-12-2221
   Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545
   Bartee MY, 2017, CANCER RES, V77, P2952, DOI 10.1158/0008-5472.CAN-16-1638
   Bourgeois-Daigneault MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao1641
   Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694
   Budczies J, 2017, GENE CHROMOSOME CANC, V56, P651, DOI 10.1002/gcc.22468
   Castiello L, 2018, CANCER IMMUNOL RES, V6, P658, DOI 10.1158/2326-6066.CIR-17-0675
   Cazet AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05220-6
   Cha JH, 2018, MOL CELL, V71, P606, DOI 10.1016/j.molcel.2018.07.030
   Chaurasiya S, 2018, CANCERS, V10, DOI 10.3390/cancers10040124
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   Dai PH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal1713
   de Sostoa J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0505-4
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   Dias JD, 2012, GENE THER, V19, P988, DOI 10.1038/gt.2011.176
   Doherty MR, 2017, P NATL ACAD SCI USA, V114, P13792, DOI 10.1073/pnas.1713728114
   Engeland CE, 2014, MOL THER, V22, P1949, DOI 10.1038/mt.2014.160
   Freedman JD, 2018, CANCER RES, V78, P6852, DOI 10.1158/0008-5472.CAN-18-1750
   Freedman JD, 2017, EMBO MOL MED, V9, P1067, DOI 10.15252/emmm.201707567
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Hamilton JR, 2018, CELL REP, V22, P1, DOI 10.1016/j.celrep.2017.12.025
   Hanauer JRH, 2016, Mol Ther-Oncolytics, V3, DOI 10.1038/mto.2016.3
   Hsu JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04313-6
   Hu YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125625
   Ilkow CS, 2015, NAT MED, V21, P530, DOI 10.1038/nm.3848
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kim JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18762-4
   Kim WT, 2017, BMB REP, V50, P285, DOI 10.5483/BMBRep.2017.50.6.039
   Kleinpeter P, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1220467
   Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594
   Lee Y, 2016, CLIN CANCER RES, V22, P3571, DOI 10.1158/1078-0432.CCR-15-2665
   Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760
   Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442
   Martin NT, 2018, MOL THER, V26, P1414, DOI 10.1016/j.ymthe.2018.04.001
   Nishio N, 2014, CANCER RES, V74, P5195, DOI 10.1158/0008-5472.CAN-14-0697
   Ottolino-Perry K, 2010, MOL THER, V18, P251, DOI 10.1038/mt.2009.283
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428
   Przepiorka D, 2015, CLIN CANCER RES, V21, P4035, DOI 10.1158/1078-0432.CCR-15-0612
   Quezada SA, 2013, BRIT J CANCER, V108, P1560, DOI 10.1038/bjc.2013.117
   Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027
   Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093
   Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2
   Sagiv-Barfi I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4488
   Samson A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7577
   Sato-Dahlman M, 2017, ONCOTARGET, V8, P76044, DOI 10.18632/oncotarget.18340
   Schmohl JU, 2017, CANCER RES TREAT, V49, P1140, DOI 10.4143/crt.2016.491
   Scott EM, 2018, MACROMOL BIOSCI, V18, DOI 10.1002/mabi.201700187
   Sethumadhavan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187314
   Shaw AR, 2017, MOL THER, V25, P6
   Shibata T, 2016, GENE THER, V23, P479, DOI 10.1038/gt.2016.17
   Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362
   Speck T, 2018, CLIN CANCER RES, V24, P2128, DOI 10.1158/1078-0432.CCR-17-2651
   Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558
   Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009
   Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233
   Tanoue K, 2017, CANCER RES, V77, P2040, DOI 10.1158/0008-5472.CAN-16-1577
   Terai K, 2018, STEM CELLS, V36, P1154, DOI 10.1002/stem.2835
   Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001
   Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110
   Valenti G, 2017, CANCER RES, V77, P2134, DOI 10.1158/0008-5472.CAN-15-3490
   Wang F, 2009, J VIROL, V83, P5928, DOI 10.1128/JVI.02587-08
   Watanabe K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99573
   Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8
   Wing A, 2018, CANCER IMMUNOL RES, V6, P605, DOI 10.1158/2326-6066.CIR-17-0314
   Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029
   Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033
   Yamada S, 2014, ANN SURG ONCOL, V21, P436, DOI 10.1245/s10434-014-3575-z
   Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897
   Yu F, 2017, CANC TRANSL MED, V3, P122, DOI [10.4103/ctm.ctm_13_17, DOI 10.4103/CTM.CTM_13_17]
   Yu F, 2014, MOL THER, V22, P102, DOI 10.1038/mt.2013.240
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845
NR 79
TC 6
Z9 6
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD JUN
PY 2019
VL 37
IS 6
BP 716
EP 723
DI 10.1002/stem.3004
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA IG8IB
UT WOS:000474038500003
PM 30875126
OA Bronze
DA 2020-07-08
ER

PT J
AU Frumence, E
   Viranaicken, W
   Bos, S
   Alvarez-Martinez, MT
   Roche, M
   Arnaud, JD
   Gadea, G
   Despres, P
AF Frumence, Etienne
   Viranaicken, Wildriss
   Bos, Sandra
   Alvarez-Martinez, Maria-Teresa
   Roche, Marjolaine
   Arnaud, Jacques-Damien
   Gadea, Gilles
   Despres, Philippe
TI A Chimeric Zika Virus between Viral Strains MR766 and BeH819015
   Highlights a Role for E-glycan Loop in Antibody-mediated Virus
   Neutralization
SO VACCINES
LA English
DT Article
DE arbovirus; Zika virus; viral clone; chimeric virus; vaccine; immunity;
   mouse model; humoral response; viral envelope protein; neutralizing
   antibody
ID STRUCTURAL BASIS; EPIDEMIC; INFECTION; IMMUNITY; BIOLOGY
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus which is of major public health concern. ZIKV infection is recognized as the cause of congenital Zika disease and other neurological defects, with no specific prophylactic or therapeutic treatments. As the humoral immune response is an essential component of protective immunity, there is an urgent need for effective vaccines that confer protection against ZIKV infection. In the present study, we evaluate the immunogenicity of chimeric viral clone ZIKBeHMR-2, in which the region encoding the structural proteins of the African strain MR766 backbone was replaced with its counterpart from the epidemic strain BeH819015. Three amino-acid substitutions I152T, T156I, and H158Y were introduced in the glycan loop of the E protein (E-GL) making ZIKBeHMR-2 a non-glycosylated virus. Adult BALB/c mice inoculated intraperitoneally with ZIKBeHMR-2 developed anti-ZIKV antibodies directed against viral proteins E and NS1 and a booster dose increased antibody titers. Immunization with ZIKBeHMR-2 resulted in a rapid production of neutralizing anti-ZIKV antibodies. Antibody-mediated ZIKV neutralization was effective against viral strain MR766, whereas epidemic ZIKV strains were poorly sensitive to neutralization by anti-ZIKBeHMR-2 immune sera. From our data, we propose that the three E-GL residues at positions E-152, E-156, and E-158 greatly influence the accessibility of neutralizing antibody epitopes on ZIKV.
C1 [Frumence, Etienne; Viranaicken, Wildriss; Bos, Sandra; Roche, Marjolaine; Gadea, Gilles; Despres, Philippe] Univ La Reunion, Unite Mixte Processus Infect Milieu Insulaire Tro, INSERM U1187, CNRS UMR 9192,IRD UMR 249, F-97491 La Reunion, France.
   [Alvarez-Martinez, Maria-Teresa; Arnaud, Jacques-Damien] Univ Montpellier, Plateforme CECEMA, F-34095 Montpellier, France.
RP Despres, P (corresponding author), Univ La Reunion, Unite Mixte Processus Infect Milieu Insulaire Tro, INSERM U1187, CNRS UMR 9192,IRD UMR 249, F-97491 La Reunion, France.
EM etienne.frumence@univ-reunion.fr; wildriss.viranaicken@univ-reunion.fr;
   sandrabos.lab@gmail.com; maria-teresa.alvarez-martinez@umontpellier.fr;
   marjolaine.roche@univ-reunion.fr; damien.arnaud@montpellier.fr;
   gilles.gadea@inserm.fr; philippe.despres@univ-reunion.fr
OI viranaicken, wildriss/0000-0002-0915-8635; Gilles,
   Gadea/0000-0001-6325-4866; BOS, Sandra/0000-0001-5036-0336
FU INSERM-transfert (ZIKALIVax program, CoPoC) [MAT-16225-A-02]; POE FEDER
   2014-20 of the Conseil General de La Reunion (ZIKAlert program)
   [SYNERGIE RE00001902]; FEDER Region (ZIKALIVax 2.0 program) [SYNERGIE
   RE0012406]; La Reunion University
FX This work was supported by grants from INSERM-transfert (ZIKALIVax
   program, CoPoC No MAT-16225-A-02) and POE FEDER 2014-20 of the Conseil
   General de La Reunion (ZIKAlert program, No SYNERGIE RE00001902). EF
   received funding from FEDER Region (ZIKALIVax 2.0 program, No SYNERGIE
   RE0012406) and La Reunion University.
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Wispelaere M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004081
   de Wispelaere M, 2015, J VIROL, V89, P5862, DOI 10.1128/JVI.00358-15
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gallichotte EN, 2017, J INFECT DIS, V216, P1196, DOI 10.1093/infdis/jix473
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Runge-Ranzinger S, 2019, TROP MED INT HEALTH, V24, P523, DOI 10.1111/tmi.13216
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith AJ, 2018, LAB ANIM-UK, V52, P135, DOI 10.1177/0023677217724823
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Viranaicken W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010038
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
NR 46
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD JUN
PY 2019
VL 7
IS 2
AR 55
DI 10.3390/vaccines7020055
PG 16
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA II1AM
UT WOS:000474937000022
PM 31238493
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Louis, L
   Wise, MC
   Choi, H
   Villarreal, DO
   Muthumani, K
   Weiner, DB
AF Louis, Lumena
   Wise, Megan C.
   Choi, Hyeree
   Villarreal, Daniel O.
   Muthumani, Kar
   Weiner, David B.
TI Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant
   Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in
   a Lethal Challenge Model
SO VACCINES
LA English
DT Article
DE IL-36; adjuvant; DNA; Zika
ID NF-KAPPA-B; ANTAGONIST IL-36RA; IL-12; IL-36-GAMMA; IMMUNOGENICITY;
   EXPRESSION; RESPONSES; PLASMID; CYTOKINES; LIGANDS
AB Identification of novel molecular adjuvants which can boost and enhance vaccine-mediated immunity and provide dose-sparing potential against complex infectious diseases and for immunotherapy in cancer is likely to play a critical role in the next generation of vaccines. Given the number of challenging targets for which no or only partial vaccine options exist, adjuvants that can address some of these concerns are in high demand. Here, we report that a designed truncated Interleukin-36 gamma (IL-36 gamma) encoded plasmid can act as a potent adjuvant for several DNA-encoded vaccine targets including human immunodeficiency virus (HIV), influenza, and Zika in immunization models. We further show that the truncated IL-36 gamma (opt-36 gamma t) plasmid provides improved dose sparing as it boosts immunity to a suboptimal dose of a Zika DNA vaccine, resulting in potent protection against a lethal Zika challenge.
C1 [Louis, Lumena; Choi, Hyeree; Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Wise, Megan C.] Inovio Pharmaceut, Plymouth Meeting, PA 19462 USA.
   [Villarreal, Daniel O.] Incyte Corp, Wilmington, DE 19803 USA.
RP Weiner, DB (corresponding author), Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM llouis@wistar.org; megan.wise@inovio.com; hychoi@wistar.org;
   dovill33@gmail.com; kmuthumani@wistar.org; dweiner@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065
FU NIH Pharmacology training grantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008076];
   NIH Training in HIV Pathogenesis grant [T32 AI007632]; NIAID grantUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI 109646]
FX This research was funded by an NIH Pharmacology training grant, grant
   number T32 GM008076, an NIH Training in HIV Pathogenesis grant, grant
   number T32 AI007632, and an NIAID grant, grant number U19 AI 109646.
CR Ainscough JS, 2017, P NATL ACAD SCI USA, V114, pE2748, DOI 10.1073/pnas.1620954114
   Andre S, 1998, J VIROL, V72, P1497
   Aoyagi T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006737
   Arakawa A, 2018, J INVEST DERMATOL, V138, P1338, DOI 10.1016/j.jid.2017.12.024
   Bharucha T, 2017, HUM VACC IMMUNOTHER, V13, P1789, DOI 10.1080/21645515.2017.1317410
   Boutet MA, 2016, CLIN EXP IMMUNOL, V184, P159, DOI 10.1111/cei.12761
   Boyer JD, 2005, J MED PRIMATOL, V34, P262, DOI 10.1111/j.1600-0684.2005.00124.x
   Boyle J, 2007, VACCINE, V25, P2541, DOI 10.1016/j.vaccine.2006.12.018
   Brito LA, 2013, SEMIN IMMUNOL, V25, P130, DOI 10.1016/j.smim.2013.05.007
   Catalan-Dibene J, 2018, J INTERF CYTOK RES, V38, P423, DOI 10.1089/jir.2018.0089
   Choi H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007042
   Chong SY, 2007, VACCINE, V25, P4967, DOI 10.1016/j.vaccine.2006.11.070
   Clancy DM, 2016, FEBS OPEN BIO, V6, P338, DOI 10.1002/2211-5463.12044
   Clavel G, 2013, JOINT BONE SPINE, V80, P449, DOI 10.1016/j.jbspin.2013.04.014
   Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440
   Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001
   Di Caprio R, 2017, ARCH DERMATOL RES, V309, P673, DOI 10.1007/s00403-017-1769-5
   Dietrich D, 2016, CYTOKINE, V84, P88, DOI 10.1016/j.cyto.2016.05.012
   Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001
   Ding LP, 2018, ONCOTARGET, V9, P2895, DOI 10.18632/oncotarget.22814
   Ellingford JM, 2016, J EUR ACAD DERMATOL, V30, P302, DOI 10.1111/jdv.13034
   Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481
   Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106
   Garcon N, 2017, HUM VACC IMMUNOTHER, V13, P19, DOI 10.1080/21645515.2016.1225635
   Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]
   Gardner JK, 2018, CYTOKINE, V111, P63, DOI 10.1016/j.cyto.2018.07.034
   Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003
   Harandi AM, 2018, SEMIN IMMUNOL, V39, P30, DOI 10.1016/j.smim.2018.08.001
   Hashiguchi Y, 2018, J IMMUNOL, V201, P167, DOI 10.4049/jimmunol.1701157
   Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072
   Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407
   Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056
   Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236
   Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231
   Kanazawa N, 2013, J DERMATOL, V40, P749, DOI 10.1111/1346-8138.12227
   Khosroshahi KH, 2012, PARASITOL RES, V111, P403, DOI 10.1007/s00436-012-2852-7
   Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624
   Kim JJ, 1997, J IMMUNOL, V158, P816
   Kovach MA, 2017, MUCOSAL IMMUNOL, V10, P1320, DOI 10.1038/mi.2016.130
   Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308
   Kumar S, 2006, DNA CELL BIOL, V25, P383, DOI 10.1089/dna.2006.25.383
   Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045
   Mahil SK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2514
   Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003
   Meier-Schiesser B, 2019, J INVEST DERMATOL, V139, P848, DOI 10.1016/j.jid.2018.10.023
   Milora KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05363-4
   Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011
   Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0
   Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/ERV.11.18, 10.1586/erv.11.18]
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Scott VL, 2015, HUM VACC IMMUNOTHER, V11, P1972, DOI 10.1080/21645515.2015.1022008
   Shah RR, 2017, METHODS MOL BIOL, V1494, P1, DOI 10.1007/978-1-4939-6445-1_1
   Sin JI, 1999, J IMMUNOL, V162, P2912
   Sly Jacqueline R, 2018, Nurs Womens Health, V22, P417, DOI 10.1016/j.nwh.2018.07.004
   Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169
   Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451
   Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009
   Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200
   Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922
   Traks T, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-018-0742-2
   Verma AH, 2018, J IMMUNOL, V201, P627, DOI 10.4049/jimmunol.1800515
   Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331
   Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026
   Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873
   Wang WM, 2017, INT J MED SCI, V14, P1002, DOI 10.7150/ijms.20809
   Wang XF, 2015, CANCER CELL, V28, P296, DOI 10.1016/j.ccell.2015.07.014
   Wen YM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.40
   Winkle SM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00955
   Wise MC, 2015, J VIROL, V89, P9154, DOI 10.1128/JVI.00652-15
   Yam KK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00207
   Yan J, 2011, VACCINE, V29, P7173, DOI 10.1016/j.vaccine.2011.05.076
   Yazdi AS, 2016, ADV EXP MED BIOL, V941, P21, DOI 10.1007/978-94-024-0921-5_2
NR 74
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD JUN
PY 2019
VL 7
IS 2
AR 42
DI 10.3390/vaccines7020042
PG 22
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA II1AM
UT WOS:000474937000009
PM 31121939
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bonica, MB
   Goenaga, S
   Martin, ML
   Feroci, M
   Luppo, V
   Muttis, E
   Fabbri, C
   Morales, MA
   Enria, D
   Micieli, MV
   Levis, S
AF Berenice Bonica, Melisa
   Goenaga, Silvina
   Laura Martin, Maria
   Feroci, Mariel
   Luppo, Victoria
   Muttis, Evangelina
   Fabbri, Cintia
   Alejandra Morales, Maria
   Enria, Delia
   Victoria Micieli, Maria
   Levis, Silvana
TI Vector competence of Aedes aegypti for different strains of Zika virus
   in Argentina
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; TRANSMISSION; INFECTION;
   ALBOPICTUS; MOSQUITOS; QUINQUEFASCIATUS; FLAVIVIRUS; BIOLOGY; DENGUE
AB The importance of Zika virus (ZIKV) has increased noticeably since the outbreak in the Americas in 2015, when the illness was associated with congenital disorders. Although there is evidence of sexual transmission of the virus, the mosquito Aedes aegypti is believed to be the main vector for transmission to humans. This species of mosquito has not only been found naturally infected with ZIKV, but also has been the subject of study in many vector competence assays that employ different strains of ZIKV around the world. In Argentina, the first case was reported in February 2016 and a total of 278 autochthonous cases have since been confirmed, however, ZIKV virus has not been isolated from any mosquito species yet in Argentina. In order to elucidate if Argentinian Ae. aegypti populations could be a possible vector of ZIKV, we conducted vector competence studies that involved a local strain of ZIKV from Chaco province, and a Venezuelan strain obtained from an imported case. For this purpose, Ae. aegypti adults from the temperate area of Argentina (Buenos Aires province) were fed with infected blood. Body, legs and saliva were harvested and tested by plaque titration on plates of Vero cells for ZIKV at 7, 11 and 14 days post infection (DPI) in order to calculate infection, transmission, and dissemination rates, respectively. Both strains were able to infect mosquitoes at all DPIs, whereas dissemination and transmission were observed at all DPIs for the Argentinian strain but only at 14 DPI for the Venezuelan strain. This study proves the ability of Ae. aegypti mosquitoes from Argentina to become infected with two different strains of ZIKV, both belonging to the Asian lineage, and that the virus can disseminate to the legs and salivary glands.
   Author summary Zika virus is a flavivirus transmitted by mosquitoes, isolated for the first time in the Ziika Forest in Uganda in 1947 from a rhesus macaque monkey. The disease is usually asymptomatic, but sometimes it causes a mild illness that comes with fever, rash, joint pain, and conjunctivitis. The World Health Organization focused the attention on this virus after the outbreak in the Americas, when the virus was linked to microcephaly and serious neurological diseases, including Guillain-Barre syndrome. Aedes aegypti was incriminated as the main vector of the virus as it was found both naturally and experimentally infected. This mosquito species was declared eradicated in Argentina by 1970 but re-emerged in 1989. Recent studies found a peculiarity in the genetics of Argentinian Ae. aegypti populations that consists in a combination between both subspecies: Ae. aegypti formosus and Ae. aegypti aegypti. Our study tries to elucidate if Ae. aegypti from Argentina are able to transmit the virus in order to add these mosquitoes to the list of possible vectors of ZIKV and, in future prospect, orient to fight the virus by controlling the vector.
C1 [Berenice Bonica, Melisa; Muttis, Evangelina; Victoria Micieli, Maria] Univ Nacl La Plata, CONICET, CEPAVE, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina.
   [Goenaga, Silvina; Laura Martin, Maria; Feroci, Mariel; Luppo, Victoria; Fabbri, Cintia; Alejandra Morales, Maria; Enria, Delia; Levis, Silvana] Inst Nacl Enfermedades Virales Humanas Dr Julio M, INEVH, ANLIS, Pergamino, Buenos Aires, Argentina.
RP Bonica, MB (corresponding author), Univ Nacl La Plata, CONICET, CEPAVE, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina.; Goenaga, S (corresponding author), Inst Nacl Enfermedades Virales Humanas Dr Julio M, INEVH, ANLIS, Pergamino, Buenos Aires, Argentina.
EM m.b.bonica@gmail.com; silvigoenaga@gmail.com
OI Bonica, Melisa/0000-0001-8629-5046; Micieli, Maria
   Victoria/0000-0003-0616-2214
FU National Agency for the Promotion of Science and Technology of Argentina
   (ANPCYT)ANPCyT [PICT 2015-0665]
FX MBB, EM and MVM received funds from the National Agency for the
   Promotion of Science and Technology of Argentina (ANPCYT) (PICT
   2015-0665). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chuchuy A, 2018, SCI REP, V8, P1
   Ciota AT, 2018, AM J TROP MED HYG, V99, P417, DOI 10.4269/ajtmh.18-0097
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P855
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Direccion de Epidemiologia, 2017, B INTEGRADO VIGILANC, VN 375 -SE 35
   Direccion de Epidemiologia, 2016, B INTEGRADO VIGILANC, VN 320 -SE 30
   Direccion de Epidemiologia, 2018, B INT VIG, VN 418 -SE 33
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fischer S, 2017, B ENTOMOL RES, V107, P225, DOI [10.1017/s0007485316000869, 10.1017/S0007485316000869]
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Good PI, 2006, RESAMPLING METHODS
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HOLLAND K, 1998, BUS WEEK        0112, P13
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Tellechea AL, 2018, BIRTH DEFECTS RES, V110, P1016, DOI 10.1002/bdr2.1347
   Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McMullen AR, 2013, J GEN VIROL, V94, P318, DOI 10.1099/vir.0.046888-0
   Medina F, 2012, CURR PROTOC MICROBIO, V27
   Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ott R.L., 2010, INTRO STAT METHODS D
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK SUSC CONF CAS RE
   R Core Team, 2018, R LANG ENV STAT COMP
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Richards SL, 2012, J MED ENTOMOL, V49, P132, DOI 10.1603/ME10280
   Rossi Gustavo C., 2015, Check List, V11, P1712
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wickham H, 2018, DPLYR GRAMMAR DATA M
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
NR 59
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007433
DI 10.1371/journal.pntd.0007433
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100033
PM 31188869
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fox, SJ
   Bellan, SE
   Perkins, TA
   Johansson, MA
   Meyers, LA
AF Fox, Spencer J.
   Bellan, Steven E.
   Perkins, T. Alex
   Johansson, Michael A.
   Meyers, Lauren Ancel
TI Downgrading disease transmission risk estimates using terminal
   importations
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; DENGUE; AEGYPTI; DIPTERA; CLIMATE; STATES; TEXAS; SIZE
AB As emerging and re-emerging infectious arboviruses like dengue, chikungunya, and Zika threaten new populations worldwide, officials scramble to assess local severity and transmissibility, with little to no epidemiological history to draw upon. Indirect estimates of risk from vector habitat suitability maps are prone to great uncertainty, while direct estimates from epidemiological data are only possible after cases accumulate and, given environmental constraints on arbovirus transmission, cannot be widely generalized beyond the focal region. Combining these complementary methods, we use disease importation and transmission data to improve the accuracy and precision of a priori ecological risk estimates. We demonstrate this approach by estimating the spatiotemporal risks of Zika virus transmission throughout Texas, a high-risk region in the southern United States. Our estimates are, on average, 80% lower than published ecological estimates-with only six of 254 Texas counties deemed capable of sustaining a Zika epidemic-and they are consistent with the number of autochthonous cases detected in 2017. Importantly our method provides a framework for model comparison, as our mechanistic understanding of arbovirus transmission continues to improve. Real-time updating of prior risk estimates as importations and outbreaks arise can thereby provide critical, early insight into local transmission risks as emerging arboviruses expand their global reach.
   Author summary When novel infectious diseases like chikungunya or Zika emerge and threaten global spread, public health officials worldwide must assess the risk for local introductions and outbreaks. These assessments are made in anticipation of local case data, and officials must draw upon historic evidence from similar diseases or locations. Thus, accurate local risk assessments have most often been limited to retrospective analyses and have been unavailable in real-time during an emerging epidemic. Here we present a method that can harness both historic and current data to produce early risk assessments and update projections in real-time. We demonstrate our approach by estimating local transmission risk for Zika throughout the state of Texas. Our findings suggest that the majority of Texas counties face little risk for sustaining a Zika epidemic, and successfully predict the number of locally transmitted cases across the state. Real-time updating of local transmission risk estimates during an emerging epidemic can thus provide actionable, early insight for public health response as emerging arboviruses expand their global reach.
C1 [Fox, Spencer J.; Meyers, Lauren Ancel] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
   [Bellan, Steven E.] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA USA.
   [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA.
RP Fox, SJ (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
EM spncrfx@gmail.com
OI Johansson, Michael/0000-0002-5090-7722
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000512]; Models of Infectious Disease Agent Study (MIDAS) program
   [U01GM087719]; National Institute of Health National Institute of
   Allergy and Infectious Diseases grant [K01AI125830]; MIDAS program
   [1U54GM088558]; National Science FoundationNational Science Foundation
   (NSF) [DEB 1641130]; Defense Advanced Research Projects AgencyUnited
   States Department of DefenseDefense Advanced Research Projects Agency
   (DARPA) [D16AP00114]
FX This publication was supported by Cooperative Agreement Number
   U01CK000512, funded by the Centers for Disease Control and Prevention.
   Its contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the Centers for Disease
   Control and Prevention or the Department of Health and Human Services.
   SJF and LAM would like to acknowledge funding from the Models of
   Infectious Disease Agent Study (MIDAS) program grant number U01GM087719;
   SEB received support from a National Institute of Health National
   Institute of Allergy and Infectious Diseases grant (K01AI125830); MAJ
   received partial support from the MIDAS program (Cooperative Agreement
   number 1U54GM088558); and TAP received support from the National Science
   Foundation (DEB 1641130) and the Defense Advanced Research Projects
   Agency (D16AP00114). The sponsors had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Asher J, 2017, PRELIMINARY RESULTS
   Blumberg S, 2013, EPIDEMICS-NETH, V5, P131, DOI 10.1016/j.epidem.2013.05.002
   Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Centers for Disease Control and Prevention, 2016, CDC ZIK INT RESP PLA
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005744
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   NOAA, 2017, PSD GRIDD CLIM DAT
   Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103
   Oidtman RJ, 2018, INTERANNUAL VARIATIO
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Perkins A., 2016, MODEL BASED PROJECTI
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Riehle MM, 2017, ELIFE, V6, DOI [10.7554/eLife.25813, 10.7554/elife.25813]
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Siraj AS, 2017, ASSESSING POPULATION, V2, DOI DOI 10.1136/BMJGH-2017-00030929082009
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Texas Department of State Health and Human Service, 2017, ZIK TEX
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   Turk T, 2017, ELIFE, V6, DOI [10.7554/eLife.28721, 10.7554/elife.28721]
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 48
TC 2
Z9 2
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007395
DI 10.1371/journal.pntd.0007395
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100020
PM 31199809
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jourdain, F
   Samy, AM
   Hamidi, A
   Bouattour, A
   Alten, B
   Faraj, C
   Roiz, D
   Petric, D
   Perez-Ramirez, E
   Velo, E
   Gunay, F
   Bosevska, G
   Salem, I
   Pajovic, I
   Maric, J
   Kanani, K
   Paronyan, L
   Dente, MG
   Picard, M
   Zgomba, M
   Sarih, M
   Haddad, N
   Gaidash, O
   Sukhiasvili, R
   Declich, S
   Shaibi, T
   Sulesco, T
   Harrat, Z
   Robert, V
AF Jourdain, Frederic
   Samy, Abdallah M.
   Hamidi, Afrim
   Bouattour, Ali
   Alten, Buelent
   Faraj, Chafika
   Roiz, David
   Petric, Dusan
   Perez-Ramirez, Elisa
   Velo, Enkeledja
   Guenay, Filiz
   Bosevska, Golubinka
   Salem, Ibrahim
   Pajovic, Igor
   Maric, Jelena
   Kanani, Khalil
   Paronyan, Lusine
   Dente, Maria-Grazia
   Picard, Marie
   Zgomba, Marija
   Sarih, M'hammed
   Haddad, Nabil
   Gaidash, Oleksandr
   Sukhiasvili, Roena
   Declich, Silvia
   Shaibi, Taher
   Sulesco, Tatiana
   Harrat, Zoubir
   Robert, Vincent
TI Towards harmonisation of entomological surveillance in the Mediterranean
   area
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID WEST NILE VIRUS; ALBOPICTUS DIPTERA-CULICIDAE; RIFT-VALLEY FEVER;
   AEDES-ALBOPICTUS; BG-SENTINEL; SUITABLE AREAS; LINEAGE 2; MOSQUITO;
   DENGUE; AEGYPTI
AB Background
   The Mediterranean Basin is historically a hotspot for trade, transport, and migration. As a result, countries surrounding the Mediterranean Sea share common public health threats. Among them are vector-borne diseases, and in particular, mosquito-borne viral diseases are prime candidates as (re)emerging diseases and are likely to spread across the area. Improving preparedness and response capacities to these threats at the regional level is therefore a major issue.
   The implementation of entomological surveillance is, in particular, of utmost importance. Guidance in designing entomological surveillance systems is critical, and these systems may pursue different specific objectives depending on the disease.
   The purpose of the proposed review is to draw up guidelines for designing effective and sustainable entomological surveillance systems in order to improve preparedness and response. However, we make it clear that there is no universal surveillance system, so the thinking behind harmonisation is to define evidence-based standards in order to promote best practises, identify the most appropriate surveillance activities, and optimise the use of resources.
   Such guidance is aimed at policymakers and diverse stakeholders and is intended to be used as a framework for the implementation of entomological surveillance programmes. It will also be useful to collaborate and share information with health professionals involved in other areas of disease surveillance. Medical entomologists and vector control professionals will be able to refer to this report to advocate for tailored entomological surveillance strategies.
   The main threats targeted in this review are the vectors of dengue virus, chikungunya virus, Zika virus, West Nile virus, and Rift Valley fever virus. The vectors of all these arboviruses are mosquitoes.
   Methods
   Current knowledge on vector surveillance in the Mediterranean area is reviewed. The analysis was carried out by a collaboration of the medical entomology experts in the region, all of whom belong to the MediLabSecure network, which is currently funded by the European Union and represents an international effort encompassing 19 countries in the Mediterranean and Black Sea region.
   Findings
   Robust surveillance systems are required to address the globalisation of emerging arboviruses. The prevention and management of mosquito-borne viral diseases must be addressed in the prism of a One Health strategy that includes entomological surveillance as an integral part of the policy. Entomological surveillance systems should be designed according to the entomological and epidemiological context and must have well-defined objectives in order to effect a tailored and graduated response. We therefore rely on different scenarios according to different entomological and epidemiological contexts and set out detailed objectives of surveillance. The development of multidisciplinary networks involving both academics and public authorities will provide resources to address these health challenges by promoting good practises in surveillance (identification of surveillance aims, design of surveillance systems, data collection, dissemination of surveillance results, evaluation of surveillance activities) and through the sharing of effective knowledge and information. These networks will also contribute to capacity building and stronger collaborations between sectors at both the local and regional levels. Finally, concrete guidance is offered on the vector of the main arbovirus based on the current situation in the area.
C1 [Jourdain, Frederic; Roiz, David; Picard, Marie; Robert, Vincent] Montpellier Univ, Res Unit MIVEGC IRD CNRS, French Natl Res Inst Sustainable Dev, Montpellier, France.
   [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Entomol Dept, Cairo, Egypt.
   [Hamidi, Afrim] Univ Prishtina, Fac Agr & Vet Sci, Prishtina, Kosovo.
   [Bouattour, Ali] Univ Tunis El Manar, Inst Pasteur Tunis, Serv Entomol Med, LR11IPT03, Tunis, Tunisia.
   [Alten, Buelent; Guenay, Filiz] Hacettepe Univ, Fac Sci, Biol Dept, Ecol Sect, Ankara, Turkey.
   [Faraj, Chafika] Inst Natl Hyg, Lab Entomol Medicale, Rabat, Morocco.
   [Petric, Dusan; Zgomba, Marija] Univ Novi Sad, Fac Agr, Dept Phytomed & Environm Protect, Lab Med Entomol, Novi Sad, Serbia.
   [Perez-Ramirez, Elisa] Ctr Invest Sanidad Anim, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Carretera Algete El Casar, Madrid, Spain.
   [Velo, Enkeledja] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
   [Bosevska, Golubinka] Inst Publ Hlth R Macedonia, Lab Virol & Mol Diagnost, Skopje, Macedonia.
   [Salem, Ibrahim] Minist Hlth, Cent Publ Hlth Lab, Ramallah, Palestine.
   [Pajovic, Igor] Univ Montenegro, Biotech Fac, Podgorica, Montenegro.
   [Maric, Jelena] PI Vet Inst Republ Srpska, Banja Luka, Bosnia & Herceg.
   [Kanani, Khalil] MOH, Parasit & Zoonot Dis Dept, Ramallah, Jordan.
   [Paronyan, Lusine] Natl Ctr Dis Control & Prevent, Minist Hlth, Epidemiol Vector Borne & Parasit Dis, Yerevan, Armenia.
   [Dente, Maria-Grazia] Natl Ctr Global Hlth, Ist Super Sanita, Rome, Italy.
   [Sarih, M'hammed] Inst Pasteur Maroc, Lab Malad Vectorielles, Casablanca, Morocco.
   [Haddad, Nabil] Fac Publ Hlth, Lab Immunol & Vector Borne Dis, Odessa, Ukraine.
   [Gaidash, Oleksandr] State Body Ukrainian II Mechnikov Res Antiplague, Minist Hlth Ukraine, Lab Especially Dangerous Infect Epizootol, Odessa, Ukraine.
   [Sukhiasvili, Roena] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia.
   [Shaibi, Taher] Univ Tripoli, Reference Lab Parasites & Vector Borne Dis, NCDC Libya, Fac Sci, Tripoli, Libya.
   [Shaibi, Taher] Univ Tripoli, Zool Dept, Fac Sci, Tripoli, Libya.
   [Sulesco, Tatiana] Minist Educ Culture & Res, Inst Zool, Kishinev, Moldova.
   [Harrat, Zoubir] Inst Pasteur, Lab Ecoepidemiol Parasitaire & Genet Populat, Algiers, Algeria.
   [Jourdain, Frederic] Sante Publ France, St Maurice, France.
RP Jourdain, F (corresponding author), Sante Publ France, St Maurice, France.
EM frederic.jourdain@ird.fr
RI Samy, Abdallah/B-4375-2010; Gunay, Filiz/AAC-7874-2020; Faraj,
   Chafika/AAF-3592-2020; Ahmed, Taher/AAM-6749-2020; Roiz,
   David/F-2082-2011; Pajovic, Igor/AAB-6897-2020
OI Samy, Abdallah/0000-0003-3978-1134; Gunay, Filiz/0000-0002-2583-6264;
   Ahmed, Taher/0000-0001-7198-5140; Roiz, David/0000-0002-5819-3648;
   Pajovic, Igor/0000-0001-8574-2094; Declich, Silvia/0000-0002-5916-3889
FU European CommissionEuropean Commission Joint Research Centre [DEVCO:
   IFS/21010/23/_194]
FX This study was partially funded by the European Commission (DEVCO:
   IFS/21010/23/_194) in the framework of MediLabSecure project. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abozeid S, 2018, LANCET INFECT DIS, V18, P142, DOI 10.1016/S1473-3099(18)30018-5
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alba A, 2014, ZOONOSES PUBLIC HLTH, V61, P181, DOI 10.1111/zph.12048
   Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26
   [Anonymous], 2014, J NETWORK SECURITY T, V07, P187
   [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173
   [Anonymous], 2019, NAT BIOTECHNOL, V37, P1
   [Anonymous], 2009, RESPIROLOGY S2, V14, pS44
   [Anonymous], 2016, CLIN DIABETOL SA, V5, pA20
   Aranda C, 2009, VECTOR-BORNE ZOONOT, V9, P171, DOI 10.1089/vbz.2008.0073
   Aranda C, 2018, EUROSURVEILLANCE, V23, P23, DOI 10.2807/1560-7917.ES.2018.23.47.1700837
   Arsevska E, 2016, TRANSBOUND EMERG DIS, V63, P658, DOI 10.1111/tbed.12331
   Arsevska E, 2016, B EPIDEMIOLOGIQUE SA, P25
   Authie E, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3180
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78
   Bargaoui R, 2015, TRANSBOUND EMERG DIS, V62, P55, DOI 10.1111/tbed.12077
   Barnett HC, 1962, P 11 INT C ENT, P341
   Bellini R, 2014, EUROSURVEILLANCE, V19, P16, DOI 10.2807/1560-7917.ES2014.19.44.20953
   Ben Hassine T, 2017, TRANSBOUND EMERG DIS, V64, P449, DOI 10.1111/tbed.12384
   Bengoa M, 2017, J AM MOSQUITO CONTR, V33, P246, DOI 10.2987/17-6636R.1
   Boo Chua Seow, 2001, Dengue Bulletin, V25, P69
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Calistri P, 2013, PREV VET MED, V110, P549, DOI 10.1016/j.prevetmed.2013.02.011
   Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915
   Calzolari M, 2013, VET ITAL, V49, P315
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235
   Abramides GC, 2011, T ROY SOC TROP MED H, V105, P281, DOI 10.1016/j.trstmh.2011.01.003
   Chevalier V, 2010, EUROSURVEILLANCE, V15, P18
   Chevalier V, 2014, INT J ENV RES PUB HE, V11, P67, DOI 10.3390/ijerph110100067
   Chevalier V, 2011, VECTOR-BORNE ZOONOT, V11, P1085, DOI 10.1089/vbz.2010.0234
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Conte A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146024
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   De Vos C, 2012, 11CVI0168
   Delisle E, 2015, EURO SURVEILL, V20
   Dente M, 2016, QUAD SOC ITAL MED TR, V1, P41
   Dente MG, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030489
   Di Sabatino D, 2014, BIOMED RES INT, DOI 10.1155/2014/907852
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   ECDC, 2012, GUID SURV INV MOSQ E
   ECDC, 2014, GUID SURV NAT MOSQ E
   EFSA, 2005, EFSA J, V267, P1, DOI DOI 10.2903/J.EFSA.2005.267
   El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   European Centre for Disease Prevention and Control (ECDC), 2009, TECHNICAL REPORT
   European Centre for Disease Prevention and Control (ECDC), 2009, EXP CONS W NIL VIR I
   Failloux Anna-Bella, 2017, Curr Trop Med Rep, V4, P27, DOI 10.1007/s40475-017-0101-y
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gossner CM, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.18.30526
   Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Johnson BJ, 2017, J MED ENTOMOL, V54, P340, DOI 10.1093/jme/tjw166
   Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301
   Jourdain F, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3127-7
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lacour G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145311
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Manrique-Saide P, 2011, OPERATIONAL GUIDE AS
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244
   Mroz C, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0993-8
   Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Napp S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006143
   Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997
   Palmer JRB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00914-9
   Papa A, 2014, T ROY SOC TROP MED H, V108, P555, DOI 10.1093/trstmh/tru100
   Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398
   Petric D, 2017, MOL CELL PROBE, V31, P28, DOI 10.1016/j.mcp.2016.10.011
   Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Ramirez AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2901-x
   Riccardo F, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.32.1800427
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Rostal MK, 2018, ONE HEALTH-AMSTERDAM, V5, P34, DOI 10.1016/j.onehlt.2018.01.001
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Sanchez-Vizcaino F, 2013, VET MICROBIOL, V165, P71, DOI 10.1016/j.vetmic.2013.03.016
   Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Shaibi T, J VECTOR BORNE DIS, V54, P183
   Sivan A, 2016, ACTA TROP, V156, P122, DOI 10.1016/j.actatropica.2016.01.015
   Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5
   Takken W, 2019, MANUAL PREVENTION ES
   Thomas SJ, 2015, AM J TROP MED HYG, V93, P24, DOI 10.4269/ajtmh.14-0242
   Tisseuil C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006236
   Tran A, 2013, TRANSBOUND EMERG DIS, V60, P14, DOI 10.1111/tbed.12156
   Trentini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27443-9
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   van den Hurk AF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/325659
   Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033
   Wagner S, 2018, MED VET ENTOMOL, V32, P175, DOI 10.1111/mve.12292
   Walther D, 2017, J MED ENTOMOL, V54, P1790, DOI 10.1093/jme/tjx166
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 2016, MON MAN INS RES AED
   WHO (World Health Organization), 2016, VECT SURV CONTR PORT
   World Health Organization, 2012, HDB INT VECT MAN
   Zehender G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179679
NR 129
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007314
DI 10.1371/journal.pntd.0007314
PG 28
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100007
PM 31194743
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kawai, Y
   Nakayama, E
   Takahashi, K
   Taniguchi, S
   Shibasaki, K
   Kato, F
   Maeki, T
   Suzuki, T
   Tajima, S
   Saijo, M
   Lim, CK
AF Kawai, Yasuhiro
   Nakayama, Eri
   Takahashi, Kenta
   Taniguchi, Satoshi
   Shibasaki, Ken-ichi
   Kato, Fumihiro
   Maeki, Takahiro
   Suzuki, Tadaki
   Tajima, Shigeru
   Saijo, Masayuki
   Lim, Chang-Kweng
TI Increased growth ability and pathogenicity of American- and
   Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast
   Asian-subtype ZIKV strain
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ENHANCEMENT; INFECTION
AB We investigated the growth properties and virulence in mice of three Zika virus (ZIKV) strains of Asian/American lineage, PRVABC59, ZIKV/Hu/Chiba/S36/2016 (ChibaS36), and ZIKV/Hu/NIID123/2016 (NIID123), belonging to the three distinct subtypes of this lineage. The American-subtype strain, PRVABC59, showed the highest growth potential in vitro, whereas the Southeast Asian-subtype strain, NIID123, showed the lowest proliferative capacity. Moreover, PRVABC59- and NIID123-infected mice showed the highest and lowest viremia levels and infectious virus levels in the testis, respectively, and the rate of damaged testis in PRVABC59-infected mice was higher than in mice infected with the other two strains. Lastly, ZIKV NS1 antigen was detected in the damaged testes of mice infected with PRVABC59 and the Pacific-subtype strain, ChibaS36, at 2 weeks post-inoculation and in the epididymides of PRVABC59-infected mice at 6 weeks post-inoculation. Our results indicate that PRVABC59 and ChibaS36 exhibit increased abilities to grow in vitro and in vivo and to induce testis damage in mice.
   Author summary Zika virus (ZIKV) is classified into two lineages, African and Asian/American. Phylogenetic analyses have revealed that Asian/American-lineage ZIKV strains can be divided into three distinct subtypes, the American, Pacific, and Southeast Asian subtypes, presenting several amino acid differences. In this study, we examined the in vitro and in vivo growth of three Asian/American lineage ZIKV strains belonging to the three subtypes. The American-subtype strain and the Southeast Asian-subtype strain exhibited the highest and lowest growth potential in vitro, respectively, and mice infected with these ZIKV strains also showed the highest and lowest viremia levels and infectious virus levels in the testis. Moreover, the rate and extent of testis damage were highest in mice infected with the American-subtype strain. Our results indicate that the American-subtype and Pacific-subtype strains exhibit increased ability to grow in vitro and in vivo and to induce testis damage in mice.
C1 [Kawai, Yasuhiro] Natl Inst Infect Dis, Div Biosafety Control & Res, Shinjuku Ku, Tokyo, Japan.
   [Nakayama, Eri; Taniguchi, Satoshi; Shibasaki, Ken-ichi; Kato, Fumihiro; Maeki, Takahiro; Tajima, Shigeru; Saijo, Masayuki; Lim, Chang-Kweng] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo, Japan.
   [Nakayama, Eri] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld, Australia.
   [Takahashi, Kenta; Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo, Japan.
RP Tajima, S (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo, Japan.
EM stajima@nih.go.jp
OI Shigeru, Tajima/0000-0002-1981-9062; Saijo, Masayuki/0000-0001-5458-7298
FU Research Program on Emerging and Re-emerging Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108035, JP18fk0108067];
   Daiichi Sankyo Foundation of Life Science
FX This research was supported by the Research Program on Emerging and
   Re-emerging Infectious Diseases of the Japan Agency for Medical Research
   and Development (AMED) under Grant Number JP18fk0108035 and
   JP18fk0108067. Eri Nakayama was supported in part by the Daiichi Sankyo
   Foundation of Life Science. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lindenbach B.D., 2013, FLAVIVIRIDAE
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Taira M, 2017, JPN J INFECT DIS, V70, P586, DOI 10.7883/yoken.JJID.2017.042
   Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 49
TC 2
Z9 2
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007387
DI 10.1371/journal.pntd.0007387
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100018
PM 31170143
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ryan, SJ
   Mundis, SJ
   Aguirre, A
   Lippi, CA
   Beltran, E
   Heras, F
   Sanchez, V
   Borbor-Cordova, MJ
   Sippy, R
   Stewart-Ibarra, AM
   Neira, M
AF Ryan, Sadie J.
   Mundis, Stephanie J.
   Aguirre, Alex
   Lippi, Catherine A.
   Beltran, Efrain
   Heras, Froilan
   Sanchez, Valeria
   Borbor-Cordova, Mercy J.
   Sippy, Rachel
   Stewart-Ibarra, Anna M.
   Neira, Marco
TI Seasonal and geographic variation in insecticide resistance in Aedes
   aegypti in southern Ecuador
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; MECHANISMS; IMPACT; ZIKA
AB Insecticide resistance (IR) can undermine efforts to control vectors of public health importance. Aedes aegypti is the main vector of resurging diseases in the Americas such as yellow fever and dengue, and recently emerging chikungunya and Zika fever, which have caused unprecedented epidemics in the region. Vector control remains the primary intervention to prevent outbreaks of Aedes-transmitted diseases. In many high-risk regions, like southern Ecuador, we have limited information on IR. In this study, Ae. aegypti IR was measured across four cities in southern Ecuador using phenotypic assays and genetic screening for alleles associated with pyrethroid IR. Bottle bioassays showed significant inter-seasonal variation in resistance to deltamethrin, a pyrethroid commonly used by the Ministry of Health, and alpha-cypermethrin, as well as between-city differences in deltamethrin resistance. There was also a significant difference in phenotypic response to the organophosphate, Malathion, between two cities during the second sampling season. Frequencies of the resistant V1016I genotype ranged from 0.13 to 0.68. Frequencies of the resistant F1534C genotype ranged from 0.63 to 1.0, with sampled populations in Machala and Huaquillas at fixation for the resistant genotype in all sampled seasons. In Machala and Portovelo, there were statistically significant inter-seasonal variation in genotype frequencies for V1016I. Resistance levels were highest in Machala, a city with hyperendemic dengue transmission and historically intense insecticide use. Despite evidence that resistance alleles conferred phenotypic resistance to pyrethroids, there was not a precise correspondence between these indicators. For the F1534C gene, 17.6% of homozygous mutant mosquitoes and 70.8% of heterozygotes were susceptible, while for the V1016I gene, 45.6% homozygous mutants and 55.6% of heterozygotes were susceptible. This study shows spatiotemporal variability in IR in Ae. aegypti populations in southern coastal Ecuador, and provides an initial examination of IR in this region, helping to guide vector control efforts for Ae. aegypti.
   Author summary Mosquito control is the primary method of managing the spread of many diseases transmitted by the yellow fever mosquito (Aedes aegypti). Throughout much of Latin America the transmission of diseases like dengue fever and Zika fever pose a serious risk to public health. The rise of insecticide resistance (IR) is a major threat to established vector control programs, which may fail if commonly used insecticides are rendered ineffective. Public health authorities in southern coastal Ecuador, a high-risk region for diseases vectored by Ae. aegypti, previously had limited information on the status of IR in local populations of mosquitoes. Here, we present the first assessment of IR in adult Ae. aegypti to insecticides (deltamethrin, Malathion, and alpha-cypermethrin) routinely used in public health vector control in four cities along Ecuador's southern coast. Observed patterns of IR differed between cities and seasons of mosquito sampling, suggesting that IR status may fluctuate in space and time. The highest overall resistance was detected in Machala, a city with hyperendemic dengue transmission and a long history of intense insecticide use. Monitoring for IR is an integral component of vector control services, where alternative management strategies are deployed when IR is detected.
C1 [Ryan, Sadie J.; Mundis, Stephanie J.; Lippi, Catherine A.; Sippy, Rachel] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat QDEC Lab, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.; Mundis, Stephanie J.; Lippi, Catherine A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Aguirre, Alex; Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer CISeAL, Quito, Ecuador.
   [Beltran, Efrain] Univ Tecn Machala, Machala, Ecuador.
   [Heras, Froilan; Sanchez, Valeria; Sippy, Rachel; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Heras, Froilan; Sanchez, Valeria; Sippy, Rachel; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral, Fac Ingn Maritima & Ciencias Mar, Guayaquil, Ecuador.
RP Ryan, SJ (corresponding author), Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat QDEC Lab, Gainesville, FL 32611 USA.; Ryan, SJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.; Neira, M (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer CISeAL, Quito, Ecuador.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
EM sjryan@ufl.edu; stewarta@upstate.edu; mvneira@puce.edu.ec
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321; Lippi,
   Catherine/0000-0002-7988-0324
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [2002017M93102]
FX SJR, MN, AMSI were funded by CDC 2002017M93102. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguirre A., 2016, THESIS
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Brogdon W, 2010, GUIDELINES EVALUATIN
   Chanda E, 2016, EMERG INFECT DIS, V22, P773, DOI 10.3201/eid2205.150984
   Chatchen S, 2017, ASIAN PAC J TROP MED, V10, P11, DOI 10.1016/j.apjtm.2016.12.002
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Graffelman J, 2015, J STAT SOFTW, V64, P1
   Gray L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30968-8
   Grossman MK, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-018-3275-9
   Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   IRAC, 2011, PREV MAN INS RES VEC
   Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lopez-Monroy B., 2018, PEST MANAG SCI
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   McAllister JC, 2012, J VECTOR ECOL, V37, P325, DOI 10.1111/j.1948-7134.2012.00234.x
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nicolopoulou-Stamati P, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00148
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pan American Health Organization, ZIK SUSP CONF CAS RE
   Pan American Health Organization / World Health Organization, NUMB REP CAS CHIK FE
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 43
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007448
DI 10.1371/journal.pntd.0007448
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100038
PM 31181073
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, DR
   Li, NL
   Wei, DH
   Liu, BM
   Guo, F
   Elbahesh, H
   Zhang, YZ
   Zhou, Z
   Chen, GY
   Li, K
AF Yang, Darong
   Li, Nan L.
   Wei, Dahai
   Liu, Baoming
   Guo, Fang
   Elbahesh, Husni
   Zhang, Yunzhi
   Zhou, Zhi
   Chen, Guo-Yun
   Li, Kui
TI The E3 ligase TRIM56 is a host restriction factor of Zika virus and
   depends on its RNA-binding activity but not miRNA regulation, for
   antiviral function
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEPATITIS-C VIRUS; DOUBLE-STRANDED-RNA; SEXUAL TRANSMISSION;
   INFLUENZA-A; PROTEIN; INFECTION; ACTIVATION; INDUCTION; REPRESSOR;
   REVEALS
AB Infection by Zika virus (ZIKV) is linked to microcephaly and other neurological disorders, posing a significant health threat. Innate immunity is the first line of defense against invading pathogens, but relatively little is understood regarding host intrinsic mechanisms that guard against ZIKV. Here, we show that host tripartite motif-containing protein 56 (TRIM56) poses a barrier to ZIKV infection in cells of neural, epithelial and fibroblast origins. Overexpression of TRIM56, but not an E3 ligase-dead mutant or one lacking a short C-terminal portion, inhibited ZIKV RNA replication. Conversely, depletion of TRIM56 increased viral RNA levels. Although the C-terminal region of TRIM56 bears sequence homology to NHL repeat of TRIM-NHL proteins that regulate miRNA activity, knockout of Dicer, which abolishes production of miRNAs, had no demonstrable effect on ZIKV restriction imposed by TRIM56. Rather, we found that TRIM56 is an RNA-binding protein that associates with ZIKV RNA in infected cells. Moreover, a recombinant TRIM56 fragment comprising the C-terminal 392 residues captured ZIKV RNA in cell-free reactions, indicative of direct interaction. Remarkably, deletion of a short C-terminal tail portion abrogated the TRIM56-ZIKV RNA interaction, concomitant with a loss in antiviral activity. Altogether, our study reveals TRIM56 is an RNA binding protein that acts as a ZIKV restriction factor and provides new insights into the antiviral mechanism by which this E3 ligase tackles flavivirus infections.
   Author summary The E3 ligase TRIM56 was previously shown to inhibit the replication of several viruses in the family Flaviviridae, including dengue virus serotype 2, yellow fever virus and bovine viral diarrhea virus, but had not demonstrable antiviral effect against hepatitis C virus, a hepatotropic virus in the same family. Nonetheless, the antiviral mechanism remains unclear and whether TRIM56 restricts other flaviviruses remains to be determined. In this study we demonstrated that TRIM56 inhibits ZIKVs of Asian and African lineages and a dengue virus serotype 1 replicon. We additionally uncovered that TRIM56 is an RNA-binding protein and that a portion of the C-terminal NHL-like domain mediates the association of TRIM56 with ZIKV RNAs in infected cells. Importantly, the RNA-binding activity of TRIM56 was found to be required for its antiviral function, although it alone is insufficient. In contrast, TRIM56 restricted ZIKV in Dicer-deficient cells, indicating an antiviral mechanism independent of miRNA regulation, a function known to be associated with NHL-containing proteins. In aggregate, our work identifies TRIM56 as a novel restriction factor of ZIKV and sheds new lights on the antiviral mechanism of TRIM56 against flaviviruses.
C1 [Yang, Darong; Li, Nan L.; Wei, Dahai; Liu, Baoming; Elbahesh, Husni; Zhang, Yunzhi; Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.
   [Yang, Darong; Chen, Guo-Yun] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Childrens Fdn,Res Inst,Le Bonheur Childrens Hosp, Memphis, TN 38163 USA.
   [Guo, Fang] Baruch S Blumberg Inst, Doylestown, PA USA.
   [Zhang, Yunzhi; Zhou, Zhi] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China.
   [Wei, Dahai] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai, Peoples R China.
   [Liu, Baoming] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Li, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.
EM kli1@uthsc.edu
OI Yang, Darong/0000-0002-5343-9047; Elbahesh, Husni/0000-0003-1243-0967;
   Liu, Baoming/0000-0003-2204-9828
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI069285, AI137812]
FX This work was supported in part by grants from the National Institutes
   of Health (AI069285 and AI137812). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Brewer GJ, 1996, NEUROREPORT, V7, P1509, DOI 10.1097/00001756-199606170-00014
   Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kumthip K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006713
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200
   Li K, 2002, HEPATOLOGY, V35, P1237, DOI 10.1053/jhep.2002.32968
   Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763
   Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu BM, 2016, J VIROL, V90, P4369, DOI 10.1128/JVI.03172-15
   Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14
   Loedige I, 2013, NUCLEIC ACIDS RES, V41, P518, DOI 10.1093/nar/gks1032
   Loedige I, 2009, CELL, V136, P818, DOI 10.1016/j.cell.2009.02.030
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976
   Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006
   Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018
   Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024
   Seo GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02936-3
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shen Y, 2012, J BIOL CHEM, V287, P36404, DOI 10.1074/jbc.M112.397075
   Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10
   Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486
   Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029
   Zhou Z, 2011, VIROLOGY, V409, P175, DOI 10.1016/j.virol.2010.10.008
   Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200
NR 66
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007537
DI 10.1371/journal.pntd.0007537
PG 27
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100074
PM 31251739
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chu, HW
   Lai, CS
   Ko, JY
   Harroun, SG
   Chuang, CI
   Wang, RYL
   Unnikrishnan, B
   Huang, CC
AF Chu, Han-Wei
   Lai, Chao-Sung
   Ko, Jo-Yun
   Harroun, Scott G.
   Chuang, Chiao-I
   Wang, Robert Y. L.
   Unnikrishnan, Binesh
   Huang, Chih-Ching
TI Nanoparticle-Based LDI-MS Immunoassay for the Multiple Diagnosis of
   Viral Infections
SO ACS SENSORS
LA English
DT Article
DE viruses; gold nanoparticles; laser desorption/ionization; cluster ions;
   signal amplification; simultaneous detection
ID AVIAN INFLUENZA-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; LASER-DESORPTION
   IONIZATION; INDUCED SIZE-REDUCTION; GOLD NANOPARTICLES; ENTEROVIRUS 71;
   COLORIMETRIC DETECTION; SIGNAL AMPLIFICATION; MASS-SPECTROMETRY; RAPID
   DETECTION
AB Many serious public health emergencies around the globe are caused by viral epidemics. Thus, developing a reliable method for viral screening is in high demand. Multiplex assays for simultaneous detection and fast screening of high-risk pathogens are especially needed. This study employs metal nanoparticles to generate specific mass spectral signals for different RNA viruses, which enables simultaneous detection of whole viruses by laser desorption/ionization mass spectrometry (LDI-MS). We developed a nanoparticle-based sandwich immunosorbent assay as a sensing platform for the detection of viruses and viral nonstructural protein by LDI-MS. Cellulose acetate membrane (CAM) serves as the substrate for the fabrication of the sandwich immunosorbent assay with the advantages of clean mass spectra and high enrichment of analytes. Antibody-modified metal nanoparticles (Ab-MNPs; M = Au or Ag) act as metallic biocodes for the LDI-MS detection. The signal amplification readout for the virus is through the pulsed laser-induced formation of metal cluster ions ([M-n](+); n = 1-3) from the Ab-MNPs which specifically bind on the CAM. Our sensing system is effective for the detection of intact viruses [Enterovirus 71 (EV71) and Japanese encephalitis virus (JEV)], nonstructural protein 1 (NS1) of Zika virus (ZIKV), EV71-spiked human serum samples, and the simultaneous detection of EV71 and ZIKV. Our probe efficiently detects EV71 in real clinical serum samples with >95% agreement with RT-qPCR results. This high-throughput LDI-MS viral detection system is simple, reliable, and high-throughput. We believe this platform has the potential to be employed for the routine screening of patients with viral infections.
C1 [Chu, Han-Wei; Ko, Jo-Yun; Chuang, Chiao-I; Unnikrishnan, Binesh; Huang, Chih-Ching] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung 20224, Taiwan.
   [Lai, Chao-Sung] Chang Gung Univ, Dept Elect Engn, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Chao-Sung] Chang Gung Mem Hosp, Dept Nephrol, New Taipei 33305, Taiwan.
   [Lai, Chao-Sung] Ming Chi Univ Technol, Dept Mat Engn, New Taipei 24301, Taiwan.
   [Harroun, Scott G.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada.
   [Wang, Robert Y. L.] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan 33302, Taiwan.
   [Wang, Robert Y. L.] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, New Taipei 33305, Taiwan.
   [Huang, Chih-Ching] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan.
   [Huang, Chih-Ching] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung 80708, Taiwan.
RP Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung 20224, Taiwan.; Wang, RYL (corresponding author), Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan 33302, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, New Taipei 33305, Taiwan.; Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan.; Huang, CC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung 80708, Taiwan.
EM yuwang@mail.cgu.edu.tw; huanging@ntou.edu.tw
RI Wang, Robert Y.L./AAI-8416-2020; UNNIKRISHNAN, BINESH/E-6077-2016;
   Huang, Chih-Ching/D-3103-2012
OI UNNIKRISHNAN, BINESH/0000-0003-2886-5682; Huang,
   Chih-Ching/0000-0002-0363-1129
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [106-2627-M-019-001-MY3, 107-2622-M-019-001-CC2,
   107-2918-I-019-004, 107-2113-M-019-004-MY3]; Center of Excellence for
   the Oceans, National Taiwan Ocean University from The Featured Areas
   Research Center Program
FX This study was supported by the Ministry of Science and Technology of
   Taiwan under Contract Nos. 106-2627-M-019-001-MY3,
   107-2622-M-019-001-CC2, 107-2918-I-019-004, and 107-2113-M-019-004-MY3
   and by the Center of Excellence for the Oceans, National Taiwan Ocean
   University from The Featured Areas Research Center Program within the
   framework of the Higher Education Sprout Project by the Ministry of
   Education (MOE) in Taiwan. The assistance of Ms. Ya-Yun Yang and Ms.
   Ching-Yen Lin from the Instrument Center of National Taiwan University
   (NTU) for TEM measurement is appreciated.
CR Abdelhamid HN, 2017, TRAC-TREND ANAL CHEM, V89, P68, DOI 10.1016/j.trac.2017.01.012
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   Chang CY, 2017, APL MATER, V5, DOI 10.1063/1.4976020
   Chen L, 2012, ANAL CHEM, V84, P3200, DOI 10.1021/ac203172x
   Clarke OJR, 2017, ANAL CHEM, V89, P1405, DOI 10.1021/acs.analchem.6b04710
   Draz MS, 2018, NANOSCALE, V10, P11841, DOI 10.1039/c8nr01646a
   Draz MS, 2018, THERANOSTICS, V8, P1985, DOI 10.7150/thno.23856
   Draz MS, 2012, ACS NANO, V6, P7634, DOI 10.1021/nn3034056
   Elci SG, 2017, ACS NANO, V11, P7424, DOI 10.1021/acsnano.7b03711
   Gonzalez-Rubio G, 2016, ACCOUNTS CHEM RES, V49, P678, DOI 10.1021/acs.accounts.6b00041
   HASHIMOTO N, 1963, VIROLOGY, V19, P261, DOI 10.1016/0042-6822(63)90063-1
   Hashimoto S, 2012, J PHOTOCH PHOTOBIO C, V13, P28, DOI 10.1016/j.jphotochemrev.2012.01.001
   Hematian Ali, 2016, Osong Public Health Res Perspect, V7, P77, DOI 10.1016/j.phrp.2015.11.011
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Hong S, 2018, PLANT PATHOLOGY J, V34, P85, DOI 10.5423/PPJ.RW.08.2017.0184
   Carod-Artal FJ, 2015, EXPERT REV ANTI-INFE, V13, P1185, DOI 10.1586/14787210.2015.1079128
   Jeon JW, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8010112
   Juang YM, 2016, TALANTA, V153, P347, DOI 10.1016/j.talanta.2016.03.001
   Kim J, 2018, BIOSENS BIOELECTRON, V112, P209, DOI 10.1016/j.bios.2018.04.047
   Klimpel GR, 1996, MED MICROBIOLOGY
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kulabhusan PK, 2017, APPL MICROBIOL BIOT, V101, P4459, DOI 10.1007/s00253-017-8232-6
   Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156110
   Lai SKM, 2016, J PHYS CHEM C, V120, P20368, DOI 10.1021/acs.jpcc.6b06261
   Lee J, 2015, BIOSENS BIOELECTRON, V64, P311, DOI 10.1016/j.bios.2014.09.021
   Li XP, 2012, TALANTA, V100, P1, DOI 10.1016/j.talanta.2012.08.041
   Li YJ, 2014, ACS APPL MATER INTER, V6, P15253, DOI 10.1021/am503615c
   Lin XC, 2016, ANAL CHEM, V88, P9881, DOI 10.1021/acs.analchem.6b02733
   Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010
   Liu YC, 2013, ANAL CHEM, V85, P1021, DOI 10.1021/ac302847n
   Lorey M, 2015, ANAL CHEM, V87, P5255, DOI 10.1021/acs.analchem.5b00304
   Lugo D, 2016, CURR OPIN PEDIATR, V28, P107, DOI 10.1097/MOP.0000000000000303
   Mandal HS, 2012, THERANOSTICS, V2, P251, DOI 10.7150/thno.3726
   Mokhtarzadeh A, 2017, TRAC-TREND ANAL CHEM, V97, P445, DOI 10.1016/j.trac.2017.10.005
   Mu B, 2010, J VIROL METHODS, V169, P282, DOI 10.1016/j.jviromet.2010.07.024
   Muto H, 2008, J PHYS CHEM C, V112, P5810, DOI 10.1021/jp711353m
   Neng J, 2013, BIOSENS BIOELECTRON, V41, P316, DOI 10.1016/j.bios.2012.08.048
   Nicolardi S, 2017, ACS NANO, V11, P8257, DOI 10.1021/acsnano.7b03402
   Oliveira ARS, 2018, ANN ENTOMOL SOC AM, V111, P295, DOI 10.1093/aesa/say025
   Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X
   Picca RA, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040075
   Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713
   Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Shevtsov M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070193
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Souf S., 2016, BIOSCI HORIZ, V9, phzw010, DOI [10.1093/biohorizons/hzw010., DOI 10.1093/BIOHORIZONS/HZW010]
   STEVENS PW, 1995, ANAL BIOCHEM, V225, P197, DOI 10.1006/abio.1995.1144
   Strasser M, 2014, J PHYS CHEM C, V118, P25748, DOI 10.1021/jp508316v
   Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001
   Tao ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04908
   Thomson DAC, 2012, BIOMACROMOLECULES, V13, P1981, DOI 10.1021/bm300717f
   Tung YT, 2016, BIOSENS BIOELECTRON, V77, P90, DOI 10.1016/j.bios.2015.09.007
   Unnikrishnan B, 2016, ANAL METHODS-UK, V8, P8123, DOI 10.1039/c6ay02378a
   WAHL M, 1994, NUCL INSTRUM METH B, V94, P36, DOI 10.1016/0168-583X(94)95655-3
   Wang JJ, 2015, ANAL CHEM, V87, P11105, DOI 10.1021/acs.analchem.5b03247
   Wei JH, 2014, ACS NANO, V8, P4600, DOI 10.1021/nn5002485
   Werner D, 2011, J PHYS CHEM C, V115, P8503, DOI 10.1021/jp112262u
   Werner D, 2011, J PHYS CHEM C, V115, P5063, DOI 10.1021/jp109255g
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xi ZJ, 2015, ACS APPL MATER INTER, V7, P11215, DOI 10.1021/acsami.5b01180
   Xiong LH, 2017, ACS APPL MATER INTER, V9, P14691, DOI 10.1021/acsami.7b02237
   Xu SH, 2017, ANAL CHEM, V89, P1617, DOI 10.1021/acs.analchem.6b03711
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zheng LT, 2017, BIOSENS BIOELECTRON, V91, P46, DOI 10.1016/j.bios.2016.12.037
   Zhong XQ, 2016, ANAL CHEM, V88, P6184, DOI 10.1021/acs.analchem.6b01142
   Zhou CH, 2014, ANAL CHEM, V86, P2752, DOI 10.1021/ac404177c
NR 70
TC 5
Z9 5
U1 11
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD JUN
PY 2019
VL 4
IS 6
BP 1543
EP 1551
DI 10.1021/acssensors.9b00054
PG 17
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA IG5FB
UT WOS:000473827800011
PM 31066548
DA 2020-07-08
ER

PT J
AU Prem, K
   Lau, MSY
   Tam, CC
   Ho, MZJ
   Ng, LC
   Cook, AR
AF Prem, Kiesha
   Lau, Max S. Y.
   Tam, Clarence C.
   Ho, Marc Z. J.
   Ng, Lee-Ching
   Cook, Alex R.
TI Inferring who-infected-whom-where in the 2016 Zika outbreak in
   Singapore-a spatio-temporal model
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE spatial models; temporal; Bayesian data augmentation; Zika; vector-borne
   outbreaks
ID DENGUE VIRUS-INFECTION; HUMAN MOVEMENT; CHIKUNGUNYA
AB Singapore experienced its first known Zika outbreak in 2016. Given the lack of herd immunity, the suitability of the climate for pathogen transmission, and the year-round presence of the vector-Aedes aegypti-Zika had the potential to become endemic, like dengue. Guillain-Barre syndrome and microcephaly are severe complications associated elsewhere with Zika and the risk of these complications makes understanding its spread imperative. We investigated the spatio-temporal spread of locally transmitted Zika in Singapore and assessed the relevance of non-residential transmission of Zika virus infections, by inferring the possible infection tree (i.e. who-infected-whom-where) and comparing inferences using geographically resolved data on cases' home, their work, or their home and work. We developed a spatio-temporal model using time of onset and both addresses of the Zika-confirmed cases between July and September 2016 to estimate the infection tree using Bayesian data augmentation. Workplaces were involved in a considerable fraction (64.2%) of infections, and homes and workplaces may be distant relative to the scale of transmission, allowing ambulant infected persons may act as the 'vector' infecting distant parts of the country. Contact tracing is a challenge for mosquito-borne diseases, but inferring the geographically structured transmission tree sheds light on the spatial transmission of Zika to immunologically naive regions of the country.
C1 [Prem, Kiesha; Tam, Clarence C.; Cook, Alex R.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Tahir Fdn Bldg,12 Sci Dr 2,10-01, Singapore 117549, Singapore.
   [Prem, Kiesha; Tam, Clarence C.; Cook, Alex R.] Natl Univ Hlth Syst, Tahir Fdn Bldg,12 Sci Dr 2,10-01, Singapore 117549, Singapore.
   [Lau, Max S. Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Tam, Clarence C.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Ho, Marc Z. J.] Minist Hlth, 16 Coll Rd, Singapore 169854, Singapore.
   [Ng, Lee-Ching] Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way, Singapore 138667, Singapore.
   [Lau, Max S. Y.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
RP Cook, AR (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Tahir Fdn Bldg,12 Sci Dr 2,10-01, Singapore 117549, Singapore.; Cook, AR (corresponding author), Natl Univ Hlth Syst, Tahir Fdn Bldg,12 Sci Dr 2,10-01, Singapore 117549, Singapore.
EM alex.richard.cook@gmail.com
RI ; Lau, Max S.Y./A-1611-2014
OI Prem, Kiesha/0000-0003-0528-798X; Tam, Clarence/0000-0003-1697-286X;
   Lau, Max S.Y./0000-0001-6590-0294
FU Singapore Ministry of Health's National Medical Research Council under
   the Centre Grant Programme, Singapore Population Health Improvement
   Centre [NMRC/CG/C026/2017_NUHS]
FX A.R.C. was supported by the Singapore Ministry of Health's National
   Medical Research Council under the Centre Grant Programme, Singapore
   Population Health Improvement Centre (NMRC/CG/C026/2017_NUHS).
CR Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Chen YR, 2015, EMERG INFECT DIS, V21, P1651, DOI 10.3201/eid2109.141030
   Cook AR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017355
   Cook AR, 2012, AM J TROP MED HYG, V87, P1116, DOI 10.4269/ajtmh.2012.11-0648
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Department of Statistics Singapore, 2010, 2010 STAT SING CENS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gelman A., 2014, BAYESIAN DATA ANAL
   Gibson GJ, 1998, IMA J MATH APPL MED, V15, P19
   GILKS W, 1998, MARKOV CHAIN MONTE C
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Lau MSY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004633
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Leo Y. S., 2003, Morbidity and Mortality Weekly Report, V52, P405
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Majumder MS, 2016, B WORLD HEALTH ORGAN, V10, P1, DOI DOI 10.2471/BLT.16.171009)
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   Ministry of Health, 2016, 2016 WEEKL INF DIS B
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ng LC, 2009, ISBT SCI SER, V4, P357, DOI DOI 10.1111/J.1751-2824.2009.01274.X
   Ng LC, 2016, EPIDEMIOL NEWS B, V42, P11
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   R Core Team, 2017, R LANG ENV STAT COMP
   Rajarethinam J, 2018, AM J TROP MED HYG, V99, P204, DOI 10.4269/ajtmh.17-0819
   Stephenson JR, 2005, T ROY SOC TROP MED H, V99, P643, DOI 10.1016/j.trstmh.2005.05.003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Worby CJ, 2016, ANN APPL STAT, V10, P395, DOI 10.1214/15-AOAS898
NR 42
TC 1
Z9 1
U1 2
U2 2
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUN
PY 2019
VL 16
IS 155
AR 20180604
DI 10.1098/rsif.2018.0604
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IG4EL
UT WOS:000473756800001
PM 31213175
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Ritchie, SA
   Staunton, KM
AF Ritchie, Scott A.
   Staunton, Kyran M.
TI Reflections from an old Queenslander: can rear and release strategies be
   the next great era of vector control?
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE Aedes aegypti; vector control; rear and release; Wolbachia; dengue;
   genetically modified mosquito
ID RUTILUS-RUTILUS DIPTERA; AEDES-AEGYPTI; DENGUE; WOLBACHIA; MOSQUITOS;
   ERADICATION; ELIMINATION; INSECTICIDE; POPULATION; BIOCONTROL
AB In this perspective, I discuss the great eras of vector control, centring on Aedes aegypti, the primary vector of dengue, Zika and several other viruses. Since the discovery and acceptance of the role of mosquitoes as vectors of disease agents, several significant strategies have been developed and deployed to control them and the diseases they transmit. Environmental management, insecticides and, to a lesser extent, biological control have emerged as great eras of vector control. In the past decade, the release of massive numbers of specifically modified mosquitoes that mate with wild populations has emerged as a significant new strategy to fight vector-borne diseases. These reared and released mosquitoes have been modified by the addition of a symbiont (e.g. Wolbachia bacteria), radiation or introduction of a genetic construct to either sterilize the wild mosquitoes they mate with, crashing the population, or to reduce the wild population's capacity to vector pathogens. Will these new rear and release strategies become the next great era of vector control? From my vantage point as a dengue control manager and researcher involved in two Wolbachia programmes, I will discuss the hurdles that rear and release programmes face to gain widespread acceptance and success.
C1 [Ritchie, Scott A.; Staunton, Kyran M.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.
   [Ritchie, Scott A.; Staunton, Kyran M.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
RP Staunton, KM (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.; Staunton, KM (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
EM kyran.staunton@jcu.edu.au
RI Staunton, Kyran/W-2263-2019
OI Staunton, Kyran/0000-0001-6812-3320
FU Monash University as part of the Eliminate Dengue Wolbachia programme;
   Verily Life Sciences
FX S.A.R. has received research funding from Monash University as part of
   the Eliminate Dengue Wolbachia programme and from Verily Life Sciences.
   K.M.S. has been funded by Verily Life Sciences. S.A.R. is employed by
   Monash University as part of the World Mosquito Program starting 1 May
   2019.
CR [Anonymous], 1975, NATURE, V256, P355
   Bartumeus F, 2018, TRENDS PARASITOL, V34, P727, DOI 10.1016/j.pt.2018.04.010
   Bell P., 1984, LECT N QUEENSLAND HI, V4, P36
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Chapman HC, 1985, AM MOSQ CONTROL ASS, V6, P218
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001
   FOCKS DA, 1983, J MED ENTOMOL, V20, P383, DOI 10.1093/jmedent/20.4.383
   FOCKS DA, 1982, J MED ENTOMOL, V19, P336, DOI 10.1093/jmedent/19.3.336
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Garziera L, 2017, ENTOMOL EXP APPL, V164, P327, DOI 10.1111/eea.12618
   Goldschmidt D, 2017, FLORIDA RELEASES EXP
   Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   James S, 2018, AM J TROP MED HYG, V98, P1, DOI 10.4269/ajtmh.18-0083
   Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6
   Kittayapong P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3214-9
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   KNIPLING E F, 1985, Miscellaneous Publications of the Entomological Society of America, V62, P4
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   LEPRINCE JA, 1916, MOSQUITO CONTROL PAN
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Montgomery BL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005505
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   REISEN WK, 1982, MOSQ NEWS, V42, P565
   Resnik DB, 2018, DEV WORLD BIOETH, V18, P135, DOI 10.1111/dewb.12147
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   SERVICE MW, 1983, MOSQ NEWS, V43, P113
   Sisson SR, 2018, SPRING SPRING RACHEL
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Stapleton DH, 2005, TECHNOL CULT, V46, P513, DOI 10.1353/tech.2005.0148
   Starr SF, 2018, RISE FALL NEW ORLEAN
   Strugarek M, 2019, APPL MATH MODEL, V68, P443, DOI 10.1016/j.apm.2018.11.026
   Subbaraman N, 2011, NAT BIOTECHNOL, V29, P9, DOI 10.1038/nbt0111-9a
   Tarter KD, 2019, J AM MOSQUITO CONTR, V35, P11, DOI 10.2987/18-6789.1
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Trewin BJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005848
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wigglesworth VB, 1976, INSECTS LIFE MAN, P13
   World Health Organization, 2014, GUID FRA TEST GEN MO
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2750-7
NR 52
TC 1
Z9 1
U1 1
U2 2
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD JUN
PY 2019
VL 286
IS 1905
AR 20190973
DI 10.1098/rspb.2019.0973
PG 8
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA IG4CT
UT WOS:000473752400009
PM 31238839
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Avila-Perez, G
   Park, JG
   Nogales, A
   Almazan, F
   Martinez-Sobrido, L
AF Avila-Perez, Gines
   Park, Jun-Gyu
   Nogales, Aitor
   Almazan, Fernando
   Martinez-Sobrido, Luis
TI Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome
   cDNA Clone
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 148; Arbovirus; flavivirus; Zika virus;
   reverse genetics; full-length cDNA infectious clones; bacterial
   artificial chromosome; cDNA transfection; virus rescue
ID DNA; CONSTRUCTION; RECOVERY
AB The association of Zika virus (ZIKV) infection with neurological complications during the recent worldwide outbreak and the lack of approved vaccines and/or antivirals have underscored the urgent need to develop ZIKV reverse genetic systems to facilitate the study of ZIKV biology and the development of therapeutic and/or prophylactic approaches. However, like with other flaviviruses, the generation of ZIKV full-length infectious cDNA clones has been hampered due to the toxicity of viral sequences during its amplification in bacteria. To overcome this problem, we have developed a nontraditional approach based on the use of bacterial artificial chromosomes (BACs). Using this approach, the full-length cDNA copy of the ZIKV strain Rio Grande do Norte Natal (ZIKV-RGN) is generated from four synthetic DNA fragments and assembled into the single-copy pBeloBAC11 plasmid under the control of the human cytomegalovirus (CMV) immediate-early promoter. The assembled BAC cDNA clone is stable during propagation in bacteria, and infectious recombinant (r)ZIKV is recovered in Vero cells after transfection of the BAC cDNA clone. The protocol described here provides a powerful technique for the generation of infectious clones of flaviviruses, including ZIKV, and other positive-strand RNA viruses, particularly those with large genomes that have stability problems during bacterial propagation.
C1 [Avila-Perez, Gines; Park, Jun-Gyu; Nogales, Aitor; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
   [Almazan, Fernando] Campus Univ Autonoma Madrid, CNB CSIC, Dept Mol & Cell Biol, Madrid, Spain.
RP Martinez-Sobrido, L (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
EM luis_martinez@urmc.rochester.edu
OI NOGALES, AITOR/0000-0002-2424-7900
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [BFU2016-79127-R]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R21AI120500]
FX The authors would like to thank Carla Gomez for her technical assistance
   in the BAC cDNA clone generation and Snezhana Dimitrova for helping with
   the video preparation. This work was supported in part by grants from
   the Spanish Ministry of Economy and Competitiveness (MINECO, grant
   number BFU2016-79127-R) to F.A.T. and the National Institutes of Health
   (NIH, grant number 1R21AI120500) to L.M.S. and F.A.T.
CR Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516
   Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06
   Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Avila- Perez G., 2018, VIRUSES, V10
   Balint A, 2012, J VIROL, V86, P6258, DOI 10.1128/JVI.00189-12
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cheng BYH, 2013, JOVE-J VIS EXP, DOI 10.3791/50662
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V317, P246, DOI 10.1001/jama.2016.20447
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Jamsai D, 2003, GENOMICS, V82, P68, DOI 10.1016/S0888-7543(03)00100-9
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   St-Jean JR, 2006, J VIROL, V80, P3670, DOI 10.1128/JVI.80.7.3670-3674.2006
   Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001
   Wang K, 1997, BIOTECHNIQUES, V23, P992, DOI 10.2144/97236bm04
   Weger- Lucarelli J., 2017, J VIROLOGY, V91
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
NR 44
TC 1
Z9 1
U1 1
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUN
PY 2019
IS 148
AR e59537
DI 10.3791/59537
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IF7WE
UT WOS:000473295900059
PM 31282877
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, M
   Wang, BB
   Li, LQ
   Wong, G
   Liu, YX
   Ma, JM
   Li, JD
   Lu, HZ
   Liang, MF
   Li, A
   Zhang, XQ
   Bi, YH
   Zeng, H
AF Li, Meng
   Wang, Beibei
   Li, Liqiang
   Wong, Gary
   Liu, Yingxia
   Ma, Jinmin
   Li, Jiandong
   Lu, Hongzhou
   Liang, Mifang
   Li, Ang
   Zhang, Xiuqing
   Bi, Yuhai
   Zeng, Hui
TI Rift Valley Fever Virus and Yellow Fever Virus in Urine: A Potential
   Source of Infection
SO VIROLOGICA SINICA
LA English
DT Letter
ID ZIKA VIRUS; DIAGNOSIS; EXCRETION; CHINA
C1 [Li, Meng] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China.
   [Wang, Beibei; Li, Ang; Zeng, Hui] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing Key Lab Emerging Infect Dis, Beijing 100015, Peoples R China.
   [Li, Meng; Li, Liqiang; Ma, Jinmin; Li, Jiandong; Zhang, Xiuqing] China Natl GeneBank, BGI Shenzhen, Shenzhen 518083, Peoples R China.
   [Li, Liqiang; Liu, Yingxia; Ma, Jinmin; Bi, Yuhai] Southern Univ Sci & Technol, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen Key Lab Pathogen & Immun,Hosp Affiliated, State Key Discipline Infect Dis,Shenzhen Peoples, Shenzhen 518112, Peoples R China.
   [Wong, Gary] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China.
   [Wong, Gary] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada.
   [Lu, Hongzhou] Fudan Univ, Shanghai Med Coll, Dept Internal Med, Shanghai 200032, Peoples R China.
   [Liang, Mifang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent IVDC, Key Lab Med Virol & Viral Dis, Minist Hlth,China CDC, Beijing 102206, Peoples R China.
   [Bi, Yuhai] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
RP Zeng, H (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing Key Lab Emerging Infect Dis, Beijing 100015, Peoples R China.; Bi, YH (corresponding author), Southern Univ Sci & Technol, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen Key Lab Pathogen & Immun,Hosp Affiliated, State Key Discipline Infect Dis,Shenzhen Peoples, Shenzhen 518112, Peoples R China.; Bi, YH (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
EM beeyh@im.ac.cn; zenghui@ccmu.edu.cn
FU National Science and Technology Major Project of China [2016ZX10004222,
   2016YFC1200800]; Strategic Priority Research Program of the Chinese
   Academy of SciencesChinese Academy of Sciences [XDB29010102]; Sanming
   Project of Medicine in Shenzhen [SZSM201412003]; Shenzhen Municipal
   Government of China [JCYJ20160427151920801]; Beijing Municipal Science &
   Technology CommissionBeijing Municipal Science & Technology Commission
   [Z161100000116049]; National Natural Science Foundation of China (NSFC)
   International Cooperation and Exchange Program [816110193]; NSFC
   Outstanding Young Scholars [31822055]; Youth Innovation Promotion
   Association of Chinese Academy of Sciences (CAS) [2017122]
FX This work is supported by grants from the National Science and
   Technology Major Project of China (2016ZX10004222 and 2016YFC1200800),
   Strategic Priority Research Program of the Chinese Academy of Sciences
   (XDB29010102), Sanming Project of Medicine in Shenzhen (SZSM201412003),
   Shenzhen Municipal Government of China (JCYJ20160427151920801) and
   Beijing Municipal Science & Technology Commission (Z161100000116049),
   and the National Natural Science Foundation of China (NSFC)
   International Cooperation and Exchange Program (816110193). Y.B. is
   supported by the NSFC Outstanding Young Scholars (31822055) and Youth
   Innovation Promotion Association of Chinese Academy of Sciences (CAS)
   (2017122).
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Chen C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006738
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Domingo C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0128-8
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haneche F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.18.30222
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Liu JY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.136
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Reusken CBEM, 2017, J CLIN MICROBIOL, V55, P3294, DOI 10.1128/JCM.01113-17
   Song R, 2018, EMERG INFECT DIS, V24, P1383, DOI 10.3201/eid2407.171868
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2018, POST DAT YELL FEV BR
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 18
TC 0
Z9 1
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD JUN
PY 2019
VL 34
IS 3
BP 342
EP 345
DI 10.1007/s12250-019-00096-2
PG 4
WC Virology
SC Virology
GA IF7CQ
UT WOS:000473239500015
PM 30888606
OA Green Published
DA 2020-07-08
ER

PT J
AU Zhuhadar, LP
   Thrasher, E
AF Zhuhadar, Lily Popova
   Thrasher, Evelyn
TI Data Analytics and Its Advantages for Addressing the Complexity of
   Healthcare: A Simulated Zika Case Study Example
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE healthcare analytics; data analytics; healthcare; information systems;
   hospital data analytics; healthcare crisis; discrete-event simulation;
   data analysis simulation; simulation
ID SYSTEMS
AB The need to control rising costs in healthcare has led to an increase in the use of data analytics to develop more efficient healthcare business models. This article discusses a simulation that uses data analytics to minimize the number of physicians and nurses needed in healthcare facilities during a crisis situation. Using a hypothetical emergency scenario, the hospital uses a healthcare analytical system to predict the necessary resources to govern the situation. Based on historical data regarding the flow of patients through the facility, a discrete-event simulation estimates resource scheduling and the resulting impact on both wait times and personnel demand. Furthermore, the value of multiple replications for discrete-event simulation models is discussed and defined, along with factors that enable greater control of multiple design points with this simulated experiment. The results of this study demonstrate the value of simulation modeling in effective resource planning. The addition of only a single doctor significantly reduced predicted wait times for patients during the crisis. Further, the findings support the use of data analytics and predictive modeling to mitigate rising healthcare costs in the United States through efficient planning and resource allocation.
C1 [Zhuhadar, Lily Popova; Thrasher, Evelyn] Western Kentucky Univ, Informat Syst Fac, Bowling Green, KY 42101 USA.
RP Zhuhadar, LP (corresponding author), Western Kentucky Univ, Informat Syst Fac, Bowling Green, KY 42101 USA.
EM lily.popova.zhuhadar@wku.edu; evelyn.thrasher@wku.edu
RI Popova Zhuhadar, Lily/E-6532-2015
OI Popova Zhuhadar, Lily/0000-0002-0421-428X
CR Alkhaldi F, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082531
   Allison P. D., 1982, SOCIOL METHODOL, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]
   Bonney W, 2013, PROCD SOC BEHV, V73, P257, DOI 10.1016/j.sbspro.2013.02.050
   Croll J., 2009, THESIS
   Fayyad U, 1996, AI MAG, V17, P37
   Fishman G.S., 1978, PRINCIPLES DISCRETE
   Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611
   Hernandez MA, 1998, DATA MIN KNOWL DISC, V2, P9, DOI 10.1023/A:1009761603038
   Islam MS, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020054
   Laerum H, 2001, BMJ-BRIT MED J, V323, P1344
   Lipsitz LA, 2012, JAMA-J AM MED ASSOC, V308, P243, DOI 10.1001/jama.2012.7551
   Mahmud R., 2018, P 19 INT C DISTR COM
   Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8
   Negash S, 2004, COMMUNICATIONS ASS I, V13, P177
   Perez E., 2016, IISE T HEALTHC SYST, V7, P43, DOI [10.1080/19488300.2016.1265616, DOI 10.1080/19488300.2016.1265616]
   Spruit M, 2018, TELEMAT INFORM, V35, P643, DOI 10.1016/j.tele.2018.04.002
   Spruit M, 2014, COMPUT HUM BEHAV, V30, P698, DOI 10.1016/j.chb.2013.07.038
   Standfield LB, 2018, AUST NZ J PUBL HEAL, V42, P291, DOI 10.1111/1753-6405.12700
   Yazdanparast R., 2018, J IND SYSTEMS ENG, V11, P287
NR 19
TC 1
Z9 1
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD JUN 1
PY 2019
VL 9
IS 11
AR UNSP 2208
DI 10.3390/app9112208
PG 16
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Engineering; Materials Science; Physics
GA IE8RO
UT WOS:000472641200036
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Camargos, VN
   Foureaux, G
   Medeiros, DC
   da Silveira, VT
   Queiroz, CM
   Matosinhos, ALB
   Figueiredo, AFA
   Sousa, CDF
   Moreira, TP
   Queiroz, VF
   Dias, ACF
   Santana, KTO
   Passos, I
   Real, ALCV
   Silva, LC
   Mourao, FAG
   Wnuk, NT
   Oliveira, MAP
   Macari, S
   Silva, T
   Garlet, GP
   Jackman, JA
   Soriani, FM
   Moraes, MFD
   Mendes, EMAM
   Ribeiro, FM
   Costa, GMJ
   Teixeira, AL
   Cho, NJ
   Oliveira, ACP
   Teixeira, MM
   Costa, VV
   Souza, DG
AF Camargos, Vidyleison N.
   Foureaux, Giselle
   Medeiros, Daniel C.
   da Silveira, Vivian T.
   Queiroz-Junior, Celso M.
   Matosinhos, Ana Luisa B.
   Figueiredo, Andre F. A.
   Sousa, Carla D. F.
   Moreira, Thaiane P.
   Queiroz, Victoria F.
   Dias, Ana Carolina F.
   Santana, Karina T. O.
   Passos, Ingredy
   Real, Ana Luiza C., V
   Silva, Ludmila C.
   Mourao, Flavio A. G.
   Wnuk, Natalia T.
   Oliveira, Milton A. P.
   Macari, Soraia
   Silva, Tarcilia
   Garlet, Gustavo P.
   Jackman, Joshua A.
   Soriani, Frederico M.
   Moraes, Marcio F. D.
   Mendes, Eduardo M. A. M.
   Ribeiro, Fabiola M.
   Costa, Guilherme M. J.
   Teixeira, Antonio L.
   Cho, Nam-Joon
   Oliveira, Antonio C. P.
   Teixeira, Mauro M.
   Costa, Vivian V.
   Souza, Danielle G.
TI In-depth characterization of congenital Zika syndrome in immunocompetent
   mice: Antibody-dependent enhancement and an antiviral peptide therapy
SO EBIOMEDICINE
LA English
DT Article
DE Congenital Zika virus infection (CZI); Congenital Zika Syndrome (CZS);
   Maternal immune activation (MIA); Antibody-dependent enhancement (ADE);
   Short and long-term outcomes
ID MATERNAL IMMUNE ACTIVATION; VIRUS-INFECTION; DENGUE-VIRUS; ABNORMALITIES
   RELEVANT; BRAIN-DEVELOPMENT; BIRTH-DEFECTS; SCHIZOPHRENIA; EXPOSURE;
   DISEASE; BRAZIL
AB Background: Zika virus (ZIKV) infection during pregnancy may cause major congenital defects, including microcephaly, ocular, articular and muscle abnormalities, which are collectively defined as Congenital Zika Syndrome. Here, we performed an in-depth characterization of the effects of congenital ZIKV infection (CZI) in immunocompetent mice.
   Methods: Pregnant dams were inoculated with ZIKV on embryonic day 5.5 in the presence or absence of a sub-neutralizing dose of a pan-flavivirus monoclonal antibody (4G2) to evaluate the potential role of antibody-dependent enhancement phenomenon (ADE) during short and long outcomes of CZI.
   Findings: ZIKV infection induced maternal immune activation (MIA), which was associated with occurrence of foetal abnormalities and death. Therapeutic administration of AH-D antiviral peptide during the early stages of pregnancy prevented ZIKV replication and death of offspring. In the post-natal period, CZI was associated with a decrease in whole brain volume, ophthalmologic abnormalities, changes in testicular morphology, and disruption in bone microarchitecture. Some alterations were enhanced in the presence of 4G2 antibody.
   Interpretation: Our results reveal that early maternal ZIKV infection causes several birth defects in immunocompetent mice, which can be potentiated by ADE phenomenon and are associated with MIA. Additionally, antiviral treatment with AH-D peptide may be beneficial during early maternal ZIKV infection. (C) 2019 Published by Elsevier B.V.
C1 [Camargos, Vidyleison N.; Sousa, Carla D. F.; Moreira, Thaiane P.; Queiroz, Victoria F.; Dias, Ana Carolina F.; Souza, Danielle G.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Host Microorganism Interact Lab, Belo Horizonte, MG, Brazil.
   [Foureaux, Giselle; Queiroz-Junior, Celso M.; Silva, Ludmila C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Transversal Biol Lab, Belo Horizonte, MG, Brazil.
   [Medeiros, Daniel C.; Mourao, Flavio A. G.; Moraes, Marcio F. D.; Mendes, Eduardo M. A. M.] Univ Fed Minas Gerais, Grad Program Elect Engn, Ctr Technol & Res Magnet Resonance, Belo Horizonte, MG, Brazil.
   [da Silveira, Vivian T.; Matosinhos, Ana Luisa B.; Oliveira, Antonio C. P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pharmacol, Neuropharmacol Lab, Belo Horizonte, MG, Brazil.
   [Figueiredo, Andre F. A.; Wnuk, Natalia T.; Costa, Guilherme M. J.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Cellular Biol Lab, Belo Horizonte, MG, Brazil.
   [Real, Ana Luiza C., V; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Inst Biol Sci, Neurobiochem Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Oliveira, Milton A. P.] Fed Univ Goicis, Trop Pathol & Publ Hlth Inst, Dept Microbiol Immunol Parasitol & Pathol, Goiania, Go, Brazil.
   [Macari, Soraia] Univ Fed Minas Gerais, Fac Dent, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil.
   [Silva, Tarcilia] Univ Fed Minas Gerais, Fac Dent, Dept Oral Pathol & Surg, Belo Horizonte, MG, Brazil.
   [Garlet, Gustavo P.] Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Bauru, SP, Brazil.
   [Jackman, Joshua A.; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.
   [Teixeira, Antonio L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Houston, Dept Psychiat & Behav Sci, Neuropsychiat Program, Houston, TX 77030 USA.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci, Immunopharmacol Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Santana, Karina T. O.; Passos, Ingredy; Soriani, Frederico M.; Teixeira, Mauro M.; Costa, Vivian V.] Univ Fed Minas Gerais, Inst Biol Sci, Ctr Drug Res & Dev Pharmaceut, Belo Horizonte, MG, Brazil.
   [Passos, Ingredy; Costa, Vivian V.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Res Grp Arboviral Dis, Belo Horizonte, MG, Brazil.
RP Costa, VV (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Souza, DG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM viviancosta@icb.ufmg.br; dani@icb.ufmg.br
RI Mendes, Eduardo/H-9717-2013; Costa, Vivian VVC/I-2499-2018; Camargos,
   Vidyleison/AAN-2202-2020; Teixeira, Antonio L/N-3315-2014; Ribeiro,
   Fabiola/E-8831-2013; Macari, Soraia/AAQ-3356-2020; Medeiros,
   Daniel/I-8215-2015; Mourao, Flavio/I-8219-2015; Costa,
   Guilherme/A-7369-2016; Moraes, Marcio/D-5285-2014
OI Mendes, Eduardo/0000-0002-3267-3862; Costa, Vivian
   VVC/0000-0002-0175-642X; Camargos, Vidyleison/0000-0002-7926-0950;
   Teixeira, Antonio L/0000-0002-9621-5422; Ribeiro,
   Fabiola/0000-0001-7042-9433; Medeiros, Daniel/0000-0003-0243-1309;
   Mourao, Flavio/0000-0002-4519-3585; Costa,
   Guilherme/0000-0002-2907-7760; Moraes, Marcio/0000-0002-2034-1836
FU National Institute of Science and Technology in Dengue and
   Host-microorganism Interaction (INCT dengue) - Brazilian National
   Science Council (CNPq, Brazil); Minas Gerais Foundation for Science
   (FAPEMIG, Brazil)Minas Gerais State Research Foundation (FAPEMIG);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [425359/2018]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brazil (CAPES)CAPES; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG) [APQ-02281-18]; National Research Foundation of
   SingaporeSingapore National Research Foundation [NRF-NRFF2011-01];
   Centre for Precision Biology at Nanyang Technological UniversityNanyang
   Technological University; Financiadora de Estudos e Pesquisa (Brazil)
   [FINEP 01.16.0050.00]; PP SUS [APQ-03744-17]
FX This work was supported by the National Institute of Science and
   Technology in Dengue and Host-microorganism Interaction (INCT dengue),
   which is a programme sponsored by the Brazilian National Science Council
   (CNPq, Brazil) and the Minas Gerais Foundation for Science (FAPEMIG,
   Brazil). This work also received support from Financiadora de Estudos e
   Pesquisa (FINEP 01.16.0050.00, Brazil), PP SUS: APQ-03744-17, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   425359/2018), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brazil (CAPES), FAPEMIG (APQ-02281-18), and by the National
   Research Foundation of Singapore through an NRF Fellowship grant
   (NRF-NRFF2011-01) and the Centre for Precision Biology at Nanyang
   Technological University. Funders had no role in study design, data
   collection, data analysis, interpretation of data, or writing of the
   report.
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   Alvino Ana Catarina Matos Ishigami, 2016, Rev. Bras. Saude Mater. Infant., V16, pS83, DOI 10.1590/1806-9304201600s100007
   AMANN RP, 1962, AM J ANAT, V110, P69, DOI 10.1002/aja.1001100107
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bitanihirwe BKY, 2010, SCHIZOPHR RES, V117, P273, DOI 10.1016/j.schres.2010.02.439
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Castanha PMS, 2017, J INFECT DIS, V216, P614, DOI 10.1093/infdis/jix346
   Costa GMJ, 2018, J THERM BIOL, V77, P14, DOI 10.1016/j.jtherbio.2018.07.010
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silveira VT, 2017, INT J DEV NEUROSCI, V58, P1, DOI 10.1016/j.ijdevneu.2017.01.009
   de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Doria JG, 2018, J NEUROCHEM, V147, P222, DOI 10.1111/jnc.14555
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Foureaux G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133149
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Funchal C, 2014, NEUROCIENCIAS MODELO
   Gilmore JH, 2004, NEUROPSYCHOPHARMACOL, V29, P1221, DOI 10.1038/sj.npp.1300446
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham AM, 2018, BIOL PSYCHIAT, V83, P109, DOI 10.1016/j.biopsych.2017.05.027
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   Jackman JA, 2019, ACS INFECT DIS, V5, P4, DOI 10.1021/acsinfecdis.8b00286
   JOHNSON L, 1981, BIOL REPROD, V24, P703, DOI 10.1095/biolreprod24.3.703
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kumar A, 2018, SCI REP, V8, P1
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Macari S, 2018, BONE, V110, P160, DOI 10.1016/j.bone.2018.01.032
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x
   Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rudolph MD, 2018, NAT NEUROSCI, P1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shi Y, 2018, SCI REP, V8, P1
   Shim JH, 2018, CALCIFIED TISSUE INT, V102, P533, DOI 10.1007/s00223-017-0373-1
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strange DP, 2018, SCI REP, V8, P1
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, P1
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yoon BK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041114
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
NR 70
TC 3
Z9 3
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN
PY 2019
VL 44
BP 516
EP 529
DI 10.1016/j.ebiom.2019.05.014
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA IF0LQ
UT WOS:000472768900053
PM 31130472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saw, WG
   Chan, KWK
   Vasudevan, SG
   Gruber, G
AF Saw, Wuan-Geok
   Chan, Kitti Wing-Ki
   Vasudevan, Subhash G.
   Gruber, Gerhard
TI Zika virus nonstructural protein 5 residue R681 is critical for dimer
   formation and enzymatic activity
SO FEBS LETTERS
LA English
DT Article
DE flavivirus; methyltransferase; nonstructural proteins; RNA-dependent RNA
   polymerase; Zika
ID DENGUE-VIRUS; CRYSTAL-STRUCTURE; NUCLEAR-LOCALIZATION; NS2B-NS3
   PROTEASE; RNA CAP; NS5; IDENTIFICATION; SCATTERING; SEROTYPES;
   METHYLTRANSFERASE
AB Zika virus (ZIKV) relies on its nonstructural protein 5 (NS5) for capping and synthesis of the viral RNA. Recent small-angle X-ray scattering (SAXS) data of recombinant ZIKV NS5 protein showed that it is dimeric in solution. Here, we present insights into the critical residues responsible for its dimer formation. SAXS studies of the engineered ZIKV NS5 mutants revealed that R681A mutation on NS5 (NS5(R681A)) disrupts the dimer formation and affects its RNA-dependent RNA polymerase activity as well as the subcellular localization of NS5(R681A) in mammalian cells. The critical residues involved in the dimer arrangement of ZIKV NS5 are discussed, and the data provide further insights into the diversity of flaviviral NS5 proteins in terms of their propensity for oligomerization.
C1 [Saw, Wuan-Geok; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Chan, Kitti Wing-Ki; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Chan, Kitti Wing-Ki; Vasudevan, Subhash G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
RP Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM ggrueber@ntu.edu.sg
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [NMRC/CBRG/0103/2016]; National Research Foundation
   [NRF2016NRF-CRP001-063]; Ministry of HealthMinistry of Health - Turkey
   [MOH-000086 (MOH-OFIRG18may-0006/2019)]; Ministry of Education MOE Tier
   3 grant [MOE2012-T3-1-008]
FX We acknowledge the facilities, and the scientific and technical
   assistance of the Advanced Bioimaging Core of Duke-NUS-Singapore Health
   Services. We thank Alvin Tan and Sean Kong for valuable discussion. The
   research was supported by National Medical Research Council grants
   NMRC/CBRG/0103/2016 to SGV; National Research Foundation grant
   NRF2016NRF-CRP001-063 as co-PI to SGV, and Ministry of Health grant
   MOH-000086 (MOH-OFIRG18may-0006/2019) to SGV and the Ministry of
   Education MOE Tier 3 grant (MOE2012-T3-1-008) to GG.
CR Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dreiss CA, 2006, J APPL CRYSTALLOGR, V39, P32, DOI 10.1107/S0021889805033091
   Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guinier A., 1939, Annales de Physique, V12, P161
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Manimekalai MSS, 2016, ACTA CRYSTALLOGR D, V72, P795, DOI 10.1107/S2059798316006665
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Saw WG, 2019, PROG BIOPHYS MOL BIO, V143, P67, DOI 10.1016/j.pbiomolbio.2018.08.008
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Svergun Dmitri I., 2013, SMALL ANGLE XRAY NEU
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597
   Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhao YQ, 2014, VIRUS RES, V179, P225, DOI 10.1016/j.virusres.2013.11.010
NR 62
TC 2
Z9 2
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUN
PY 2019
VL 593
IS 12
BP 1272
EP 1291
DI 10.1002/1873-3468.13437
PG 20
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA IE9CY
UT WOS:000472673700002
PM 31090058
OA Bronze
DA 2020-07-08
ER

PT J
AU Martinez-Correa, J
   Perez-Berenguer, J
   Correa-Rivas, M
   Garcia, I
   Davila-Castrodad, N
AF Martinez-Correa, Jose
   Perez-Berenguer, Juan
   Correa-Rivas, Maria
   Garcia, Ines
   Davila-Castrodad, Nicole
TI Congenital Zika Syndrome in Puerto Rico: Neuropathologic Findings and
   Review of Medical Literature
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 95th Annual Meeting of the American-Association-of-Neuropathologists-Inc
CY JUN 06-09, 2019
CL Atlanta, GA
SP Amer Assoc Neuropathologists Inc
C1 [Martinez-Correa, Jose] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.
   [Perez-Berenguer, Juan; Correa-Rivas, Maria] Univ Puerto Rico, Dept Pathol, Med Sci Campus, San Juan, PR 00936 USA.
   [Garcia, Ines; Davila-Castrodad, Nicole] Univ Puerto Rico, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2019
VL 78
IS 6
MA 111
BP 548
EP 548
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA IF0ZD
UT WOS:000472806000118
DA 2020-07-08
ER

PT J
AU Aretz, CD
   Morwitzer, MJ
   Sanford, AG
   Hogan, AM
   Portillo, MV
   Kharade, SV
   Kramer, M
   McCarthey, JB
   Trigueros, RR
   Piermarini, PM
   Denton, JS
   Hopkins, CR
AF Aretz, Christopher D.
   Morwitzer, M. Jane
   Sanford, Austin G.
   Hogan, Alicia M.
   Portillo, Madelene V.
   Kharade, Sujay V.
   Kramer, Meghan
   McCarthey, James B.
   Trigueros, Renata Rusconi
   Piermarini, Peter M.
   Denton, Jerod S.
   Hopkins, Corey R.
TI Discovery and Characterization of
   2-Nitro-5-(4-(phenylsulfonyl)piperazin-1-yl)-N-(pyridin-4-ylmethyl)anili
   nes as Novel Inhibitors of the Aedes aegypti Kir1 (AeKir1) Channel
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE Kir channels; Aedes aegypti; Zika; vector-borne diseases; larvae
ID RECTIFIER POTASSIUM CHANNELS; FUNCTIONAL-CHARACTERIZATION; CHIKUNGUNYA
   VIRUS; DENGUE
AB Mosquito-borne arboviral diseases such as Zika, dengue fever, and chikungunya are transmitted to humans by infected adult female Aedes aegypti mosquitoes and affect a large portion of the world's population. The Kir1 channel in Ae. aegypti (AeKir1) is an important ion channel in the functioning of mosquito Malpighian (renal) tubules and one that can be manipulated in order to disrupt excretory functions in mosquitoes. We have previously reported the discovery of various scaffolds that are active against the AeKir1 channel. Herein we report the synthesis and biological characterization of a new 2-nitro-5-(4-(phenylsulfonyl) piperazin-1-yl)-N-(pyridin-4-ylmethyl)anilines scaffold as inhibitors of AeKir1. This new scaffold is more potent in vitro compared to the previously reported scaffolds, and the molecules kill mosquito larvae.
C1 [Aretz, Christopher D.; Morwitzer, M. Jane; Sanford, Austin G.; Hopkins, Corey R.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
   [Hogan, Alicia M.; Portillo, Madelene V.] Univ Nebraska Med Ctr, High Sch Alliance, Omaha, NE 68198 USA.
   [Kharade, Sujay V.; Kramer, Meghan; McCarthey, James B.; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.
   [Trigueros, Renata Rusconi; Piermarini, Peter M.] Ohio State Univ, Dept Entomol, Wooster, OH 44691 USA.
RP Hopkins, CR (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
EM corey.hopkins@unmc.edu
OI Aretz, Christopher/0000-0002-7125-4388
FU National Institute of Allergy and Infectious Disease (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21 AI128418]
FX The authors would like to thank the National Institute of Allergy and
   Infectious Disease (NIAID) for an R21 award (R21 AI128418 to C.R.H.,
   J.S.D., P.M.P.).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Amelia-Yap ZH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2899-0
   Chen RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18489-2
   Kharade SV, 2018, MOL PHARMACOL, V94, P926, DOI 10.1124/mol.118.112359
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Piermarini PM, 2015, INSECT BIOCHEM MOLEC, V67, P59, DOI 10.1016/j.ibmb.2015.06.006
   Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Ren MM, 2018, INSECT BIOCHEM MOLEC, V99, P17, DOI 10.1016/j.ibmb.2018.05.007
   Rouhier MF, 2014, AM J PHYSIOL-REG I, V307, pR850, DOI 10.1152/ajpregu.00106.2014
   Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   Swale DR, 2017, PESTIC BIOCHEM PHYS, V141, P41, DOI 10.1016/j.pestbp.2016.11.005
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Trigueros Renata Rusconi, 2018, Insects, V9, P163, DOI 10.3390/insects9040163
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wendt MD, 2010, TETRAHEDRON LETT, V51, P641, DOI 10.1016/j.tetlet.2009.11.087
   WHO, 2014, GLOB TUB REP 2014, P54
   Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190
   Wu YP, 2015, AM J PHYSIOL-REG I, V309, pR747, DOI 10.1152/ajpregu.00148.2015
NR 25
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JUN
PY 2019
VL 5
IS 6
BP 917
EP 931
DI 10.1021/acsinfecdis.8b00368
PG 29
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA IE1BE
UT WOS:000472120100013
PM 30832472
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ng, IHW
   Chan, KWK
   Tan, MJA
   Gwee, CP
   Smith, KM
   Jeffress, SJ
   Saw, WG
   Swarbrick, CMD
   Watanabe, S
   Jans, DA
   Gruber, G
   Forwood, JK
   Vasudevan, SG
AF Ng, Ivan H. W.
   Chan, Kitti Wing-Ki
   Tan, Min Jie Alvin
   Gwee, Chin Piaw
   Smith, Kate M.
   Jeffress, Sarah J.
   Saw, Wuan-Geok
   Swarbrick, Crystall M. D.
   Watanabe, Satoru
   Jans, David A.
   Gruber, Gerhard
   Forwood, Jade K.
   Vasudevan, Subhash G.
TI Zika Virus NS5 Forms Supramolecular Nuclear Bodies That Sequester
   Importin-alpha and Modulate the Host Immune and Pro-Inflammatory
   Response in Neuronal Cells
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; Zika virus; dengue virus; NS5 protein; NS5 nuclear
   localization; importin-alpha-NLS structure
ID NONSTRUCTURAL PROTEIN 5; DENGUE-VIRUS; CRYSTAL-STRUCTURE; LOCALIZATION;
   SCATTERING; REPLICATION; INHIBITORS; INTERFERON; EPIDEMIC; FEATURES
AB The Zika virus (ZIKV) epidemic in the Americas was alarming because of its link with microcephaly in neonates and Guillain-Barre syndrome in adults. The unusual pathologies induced by ZIKV infection and the knowledge that the flaviviral nonstructural protein 5 (NS5), the most conserved protein in the flavivirus proteome, can modulate the host immune response during ZIKV infection prompted us to investigate the subcellular localization of NSS during ZIKV infection and explore its functional significance. A monopartite nuclear localization signal (NLS) sequence within ZIKV NS5 was predicted by the cNLS Mapper program, and we observed localization of ZIKV NS5 in the nucleus of infected cells by immunostaining with specific antibodies. Strikingly, ZIKV NS5 forms spherical shell-like nuclear bodies that exclude DNA. The putative monopartite NLS (KRPR393)-K-390 is necessary to direct FLAG-tagged NS5 to the nucleus as the NS5 (390)ARPA(393) mutant protein accumulates in the cytoplasm. Furthermore, coimmunostaining experiments reveal that NS5 localizes with and sequesters importin-alpha, but not importin-beta, in the observed nuclear bodies during virus infection. Structural and biochemical data demonstrate binding of ZIKV NS5 with importin-a and reveal important binding determinants required for their interaction and formation of complexes that give rise to the supramolecular nuclear bodies. Significantly, we demonstrate a neuronal-specific activation of the host immune response to ZIKV infection and a possible role of ZIKV NS5's nuclear localization toward this activation. This suggests that ZIKV pathogenesis may arise from a tissue-specific host response to ZIKV infection.
C1 [Ng, Ivan H. W.; Chan, Kitti Wing-Ki; Tan, Min Jie Alvin; Gwee, Chin Piaw; Swarbrick, Crystall M. D.; Watanabe, Satoru; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Tan, Min Jie Alvin] ASTAR, Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore.
   [Smith, Kate M.; Jeffress, Sarah J.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia.
   [Saw, Wuan-Geok; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Jans, David A.; Vasudevan, Subhash G.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
   [Chan, Kitti Wing-Ki; Vasudevan, Subhash G.] Natl Univ Singapore, Dept Microbiol & Immunol, 5 Sci Dr 2, Singapore 117545, Singapore.
RP Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.; Vasudevan, SG (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Vasudevan, SG (corresponding author), Natl Univ Singapore, Dept Microbiol & Immunol, 5 Sci Dr 2, Singapore 117545, Singapore.
EM subhash.vasudevan@duke-nus.edu.sg
OI Swarbrick, Crystall/0000-0002-9337-3361; Vasudevan,
   Subhash/0000-0002-5083-3831; Forwood, Jade/0000-0003-3267-9997
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [NMRC/CBRG/0103/2016, NMRC/OFYIRG/0006/2016]; Ministry of Education MOE
   Tier 3 grant [MOE2012-T3-1-008]; National Research Foundation
   [NRF2016NRF-CRP001-063]; Ministry of HealthMinistry of Health - Turkey
   [MOH 000086 (MOH-OFIRG18may-0006/2019)]
FX We thank Salvatore Albani, Camillus J. H. Chua, and Sharifah N. Hazirah
   for expert help with the NanoString Technology platform and Shawn Je,
   Eyleen Goh, and Bianca Victorio for providing neuronal cell lines. We
   acknowledge the facilities and the scientific and technical assistance
   of the Advanced Bioimaging Core of Duke-NUS-Singapore Health Services
   and the Australian Synchrotron. The research was supported by National
   Medical Research Council grants NMRC/CBRG/0103/2016 to S.G.V. and
   NMRC/OFYIRG/0006/2016 to M.J.A.T., National Research Foundation grant
   NRF2016NRF-CRP001-063 as co-PI to S.G.V., Ministry of Health grant MOH
   000086 (MOH-OFIRG18may-0006/2019) to S.G.V., and the Ministry of
   Education MOE Tier 3 grant (MOE2012-T3-1-008) to G.G.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233
   Dreiss CA, 2006, J APPL CRYSTALLOGR, V39, P32, DOI 10.1107/S0021889805033091
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fulcher AJ, 2008, FEBS LETT, V582, P1569, DOI 10.1016/j.febslet.2008.03.054
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guinier A., 1939, Annales de Physique, V12, P161
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32153
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   Miyatake H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115995
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004
   Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Xu Wenjie, 2016, Methods Mol Biol, V1361, P57, DOI 10.1007/978-1-4939-3079-1_3
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhao YQ, 2014, VIRUS RES, V179, P225, DOI 10.1016/j.virusres.2013.11.010
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 94
TC 9
Z9 9
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JUN
PY 2019
VL 5
IS 6
BP 932
EP 948
DI 10.1021/acsinfecdis.8b00373
PG 33
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA IE1BE
UT WOS:000472120100014
PM 30848123
DA 2020-07-08
ER

PT J
AU Castro, FL
   Geddes, VEV
   Monteiro, FLL
   Goncalves, RMDT
   Campanati, L
   Pezzuto, P
   Paquin-Proulx, D
   Schamber-Reis, BL
   Azevedo, GS
   Goncalves, AL
   Cunha, DP
   Moreira, MEL
   Vasconcelos, ZFM
   Chimeli, L
   Melo, A
   Tanuri, A
   Nixon, DF
   Ribeiro-Alves, M
   Aguiar, RS
AF Castro, Fernanda L.
   Geddes, Victor E. V.
   Monteiro, Fabio L. L.
   Goncalves, Raphael M. D. T.
   Campanati, Loraine
   Pezzuto, Paula
   Paquin-Proulx, Dominic
   Schamber-Reis, Bruno L.
   Azevedo, Girlene S.
   Goncalves, Alessandro L.
   Cunha, Daniela P.
   Moreira, Maria Elisabeth L.
   Vasconcelos, Zilton F. M.
   Chimeli, Leila
   Melo, Adriana
   Tanuri, Amilcar
   Nixon, Douglas F.
   Ribeiro-Alves, Marcelo
   Aguiar, Renato S.
TI MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus
   Infection
SO ASN NEURO
LA English
DT Article
DE miRNAs; microcephaly; neuroblastoma; postmortem brain autopsies; Zika
ID INVASION; BRAIN; CELLS; MIGRATION; PATHOLOGY; MIR-148A; REVEALS;
   MITOSIS; GROWTH; MODEL
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) member of the Flaviviridae family, which has been associated with the development of the congenital Zika syndrome (CZS). RNA viruses, such as flaviviruses, have been reported to exert a profound impact on host microRNAs (miRNAs). Cellular miRNAs modulated by ZIKV may help identify cellular pathways of relevance to pathogenesis. Here, we screened 754 human cellular miRNAs modulated by ZIKV infection (Brazilian PE strain) in a neuroblastoma cell line. Seven miRNAs (miR-99a*, miR-126*, miR-190b, miR-361-3p, miR-522-3p, miR-299-5p, and miR-1267) were downregulated during ZIKV infection, while miR-145 was upregulated. Furthermore, 11 miRNAs were exclusively expressed in ZIKV-infected (miR-148a, miR-342-5p, miR-598, and miR-708-3p) or mock cells (miR-208, miR-329, miR-432-5p, miR-488, miR-518b, miR-520g, and miR-767-5p). Furthermore, in silico analysis indicated that some central nervous system, cellular migration, and adhesion function-related biological processes were overrepresented in the list of target genes of the miRNAs regulated in ZIKV-infected cells, especially for miR-145 and miR-148a. The induction of miR-145 and miR-148a was confirmed in postmortem brain samples from stillborn with severe CZS. Finally, we determined the expression regulation of microcephaly related genes through RNA interference pathway caused by ZIKV directly on neuron cells.
C1 [Castro, Fernanda L.; Geddes, Victor E. V.; Monteiro, Fabio L. L.; Goncalves, Raphael M. D. T.; Pezzuto, Paula; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Paquin-Proulx, Dominic] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [Schamber-Reis, Bruno L.; Melo, Adriana] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
   [Azevedo, Girlene S.; Melo, Adriana] Inst Pesquisa Prof Amor Neto, Campina Grande, Brazil.
   [Goncalves, Alessandro L.] Hosp Vera Cruz, Serv Neurol, Belo Horizonte, MG, Brazil.
   [Cunha, Daniela P.; Moreira, Maria Elisabeth L.; Vasconcelos, Zilton F. M.] Inst Fernandes Figueira FIOCRUZ, Rio De Janeiro, Brazil.
   [Chimeli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nixon, Douglas F.] Weill Cornell Med, Div Infect Dis, New York, NY USA.
   [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
RP Aguiar, RS (corresponding author), Lab Virol Mol, Av Carlos Chagas Filho 373,Predio CCS,Bloco A2, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM santanarnt@gmail.com
RI Aguiar, Renato S/G-3542-2015; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Vasconcelos, Zilton/AAD-5784-2019; Melo, Adriana S
   O/H-5650-2016
OI Aguiar, Renato S/0000-0001-5180-3717; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Vasconcelos, Zilton/0000-0002-2193-2224;
   Paquin Proulx, Dominic/0000-0003-1407-3414; Lima Monteiro, Fabio
   Luis/0000-0002-9107-6865; Ribeiro-Alves, Marcelo/0000-0002-8663-3364
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440900/2016-6]; council for the Improvement of Higher Education
   (CAPES) [88881.130757/2016-01]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-18/2015]; CAPESCAPES
   [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by National Council for Scientific and Technological
   Development (CNPq) grant 440900/2016-6, council for the Improvement of
   Higher Education (CAPES) grant 88881.130757/2016-01 and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant E-18/2015.
   F.L.C. and V. E. V. G. are funded by CAPES (grant 001).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140
   [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Brasil P, 2016, OBSTET GYNECOL SURV, V71, P331, DOI 10.1097/01.ogx.0000483239.08585.8d
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034
   Chen ZT, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.572.6270
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Donzelli S, 2015, ONCOTARGET, V6, P35183, DOI 10.18632/oncotarget.5930
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ferreira RN, 2018, VIRAL IMMUNOL, V31, P583, DOI 10.1089/vim.2017.0186
   Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hu CW, 2013, J PROTEOME RES, V12, P3993, DOI 10.1021/pr400302w
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kakumani PK, 2016, GENE, V586, P7, DOI 10.1016/j.gene.2016.03.053
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652
   Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Muti P, 2014, CANCER EPIDEM BIOMAR, V23, P2471, DOI 10.1158/1055-9965.EPI-14-0398
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Romero DM, 2018, SEMIN CELL DEV BIOL, V76, P33, DOI 10.1016/j.semcdb.2017.09.031
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sachdeva M, 2010, AM J TRANSL RES, V2, P170
   Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511
   Shalev SA, 2014, PEDIATR DIABETES, V15, P252, DOI 10.1111/pedi.12086
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Zhang HJ, 2019, MOL NEUROBIOL, V56, P4072, DOI 10.1007/s12035-018-1358-4
   Zhang L, 2017, INT J CLIN EXP PATHO, V10, P8361
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
NR 62
TC 1
Z9 1
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1759-0914
J9 ASN NEURO
JI ASN Neuro
PD JUN
PY 2019
VL 11
AR 1759091419850983
DI 10.1177/1759091419850983
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA IE1TZ
UT WOS:000472170000001
PM 31213064
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salerno, J
   Peters, ES
   Pinney, SM
   Morain, S
   Hlaing, WM
AF Salerno, Jennifer
   Peters, Edward S.
   Pinney, Susan M.
   Morain, Stephanie
   Hlaing, WayWay M.
TI Untangling the ethical intersection of epidemiology, human subjects
   research, and public health
SO ANNALS OF EPIDEMIOLOGY
LA English
DT Article
DE Biomarkers; Epidemiology; Ethics; Interventions; Public Health;
   Population Registries; Zika virus
ID INCIDENTAL FINDINGS; RECRUITMENT; DESIGNS
AB Purpose: Members of the American College of Epidemiology (ACE) Ethics Committee identified current ethics and epidemiology topic areas to consider for further discussion, consultation, teaching opportunities, and conference presentation. This article reflects on the activities of the Committee at the ACE Annual Meeting in New Orleans, Louisiana, September 24-26, 2017.
   Methods: The overall aim for the Ethics Committee was to engage members of the College and other audiences and highlight the evolution of ethics and epidemiology since the inception of the original Ethics Guidelines published by the ACE Ethics and Standards of Practice Committee in 2000. The Ethics Committee organized a symposium session at the 2017 Annual Meeting of ACE on the ethics of human subjects research as it relates to specialized areas of epidemiology and the intersecting role of public health. This article presents a summary and further discussion of that symposium session.
   Results: Three topic areas were presented: an overview of ethics and epidemiology (E.S.P.), very high biomarker levels in environmental epidemiology research (S.M.P.), and the interface of epidemiology, human subjects research, and public health interventions (S.M.). This article begins by reviewing the foundations of epidemiology and public health and the well-known ethical principles of human subjects research. Then, it considers the ethical considerations in the use of population registry data in epidemiological research, environmental epidemiology, and epidemic surveillance and response. This article may form the basis of teaching of ethics principles related to epidemiology and public health and may serve as a companion piece to the original ACE Ethics Guidelines.
   Conclusions: Researchers are increasingly faced with ethical considerations in diverse, nontraditional, and specialized areas of epidemiology and public health. This article illustrates these challenges with real-world examples of clinical and population registry data, the study of environmental biomarkers, and Zika virus epidemic; it also reviews relevant ethical principles underpinning these examples and identifies where gaps in knowledge may exist. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Salerno, Jennifer] McMaster Univ, Sch Nursing, Aging Community & Hlth Res Unit, 1280 Main St West,Off 3N25D, Hamilton, ON L8S 4K1, Canada.
   [Peters, Edward S.] Louisiana State Univ, Sch Publ Hlth, Epidemiol Program, New Orleans, LA USA.
   [Pinney, Susan M.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.
   [Morain, Stephanie] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.
   [Hlaing, WayWay M.] Univ Miami, Dept Publ Hlth Sci, Div Epidemiol & Populat Sci, Miami, FL USA.
RP Salerno, J (corresponding author), McMaster Univ, Sch Nursing, Aging Community & Hlth Res Unit, 1280 Main St West,Off 3N25D, Hamilton, ON L8S 4K1, Canada.
EM salernoj@mcmaster.ca
RI ; Peters, Edward/H-1077-2015
OI Morain, Stephanie/0000-0001-7278-7517; Peters,
   Edward/0000-0003-4928-6532
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [R24 ES028527]
CR American College of Epidemiology, AM COLL EP ETH GUID
   [Anonymous], WHAT IS PUBL HLTH
   Beskow LM, 2006, AM J PUBLIC HEALTH, V96, P1920, DOI 10.2105/AJPH.2004.061556
   Brody JG, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-40
   Brown CH, 2017, ANNU REV PUBL HEALTH, V38, P1, DOI 10.1146/annurev-publhealth-031816-044215
   Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO
   Centers for Disease Control and Prevention, DIST PUBL HLTH RES P
   Centers for Disease Control and Prevention, 2018, NAT NOT COND
   Clinton-McHarg T, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-5
   Coughlin S, 2009, ETHICS EPIDEMIOLOGY
   Coughlin SS, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-16
   Cullum N, 2008, EVIDENCE BASED NURSI
   Farmanova E, 2016, INT J QUAL HEALTH C, V28, P830, DOI 10.1093/intqhc/mzw118
   Giannini CM, 2018, INT J HYG ENVIR HEAL, V221, P1040, DOI 10.1016/j.ijheh.2018.07.005
   Gliklich RE DN, 2014, REGISTRIES EVALUATIN
   Gurwitz JH, 2001, MED CARE, V39, P1339, DOI 10.1097/00005650-200112000-00009
   IOM (Institute of Medicine), 2015, INT RES PRACT HLTH S
   Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776
   LAST JM, 2001, DICT EPIDEMIOLOGY
   Meslin EM, 2001, MED CARE, V39, P1270, DOI 10.1097/00005650-200112000-00002
   Morello-Frosch R, 2015, ENVIRON RES, V136, P363, DOI 10.1016/j.envres.2014.10.001
   *NAT COMM PROT HUM, 1979, BELM REP ETH PRINC G
   Ontario Ministry of Health and Long-Term Care, HLTH SERV YOUR COMM
   U. S. Department of Health & Human Services, PROT HUM SUBJ 46
   Wolf SM, 2008, J LAW MED ETHICS, V36, P216, DOI 10.1111/j.1748-720X.2008.00265.x
   Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x
   Wolf SM, 2013, ANNU REV GENOM HUM G, V14, P557, DOI 10.1146/annurev-genom-091212-153506
   Wolfenden L, 2016, HEALTH PROMOT J AUST, V27, P204, DOI 10.1071/HE16056
   World Health Organization, WHO GUID PUBL HLTH S
   Young KT., 2005, ESSENTIALS DENT CARI, P1
NR 30
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1047-2797
EI 1873-2585
J9 ANN EPIDEMIOL
JI Ann. Epidemiol.
PD JUN
PY 2019
VL 34
BP 1
EP 5
DI 10.1016/j.annepidem.2019.03.009
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID0GS
UT WOS:000471362300001
PM 31005553
DA 2020-07-08
ER

PT J
AU Rocklov, J
   Tozan, Y
   Ramadona, A
   Sewe, MO
   Sudre, B
   Garrido, J
   de Saint Lary, CB
   Lohr, W
   Semenza, JC
AF Rocklov, Joacim
   Tozan, Yesim
   Ramadona, Aditya
   Sewe, Maquines O.
   Sudre, Bertrand
   Garrido, Jon
   de Saint Lary, Chiara Bellegarde
   Lohr, Wolfgang
   Semenza, Jan C.
TI Using Big Data to Monitor the Introduction and Spread of Chikungunya,
   Europe, 2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTIOUS-DISEASE SURVEILLANCE; ZIKA VIRUS; TRANSMISSION; DRIVERS
AB With regard to fully harvesting the potential of big data, public health lags behind other fields. To determine this potential, we applied big data (air passenger volume from international areas with active chikungunya transmission, Twitter data, and vectorial capacity estimates of Aedes albopictus mosquitoes) to the 2017 chikungunya outbreaks in Europe to assess the risks for virus transmission, virus importation, and short-range dispersion from the outbreak foci. We found that indicators based on voluminous and velocious data can help identify virus dispersion from outbreak foci and that vector abundance and vectorial capacity estimates can provide information on local climate suitability for mosquitoborne outbreaks. In contrast, more established indicators based on Wikipedia and Google Trends search strings were less timely. We found that a combination of novel and disparate datasets can be used in real time to prevent and control emerging and reemerging infectious diseases.
C1 [Rocklov, Joacim; Ramadona, Aditya; Sewe, Maquines O.; Lohr, Wolfgang] Umea Univ, Umea, Sweden.
   [Tozan, Yesim] NYU, New York, NY USA.
   [Sudre, Bertrand; Garrido, Jon; de Saint Lary, Chiara Bellegarde; Semenza, Jan C.] European Ctr Dis Prevent & Control, Stockholm, Sweden.
RP Rocklov, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden.
EM joacim.rocklov@umu.se
RI Lia Ramadona, Aditya/M-2677-2013
OI Lia Ramadona, Aditya/0000-0003-0968-988X; sewe,
   maquins/0000-0003-1267-649X; Rocklov, Joacim/0000-0003-4030-0449
FU Swedish Research Council for Sustainable Development (FORMAS)Swedish
   Research Council Formas [2017-01300]
FX J.R. received partial funding from the Swedish Research Council for
   Sustainable Development (FORMAS) (no. 2017-01300). The funder had no
   influence on the research conducted.
CR Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400
   Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923
   Broniatowski David Andre, 2015, JMIR Public Health Surveill, V1, pe5
   Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a
   Carletti F, 2017, MICROBIOL RESOUR ANN, V5, DOI 10.1128/genomeA.01306-17
   Centers for Disease Control and Prevention (CDC), TRAV HLTH
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113
   Gandomi A, 2015, INT J INFORM MANAGE, V35, P137, DOI 10.1016/j.ijinfomgt.2014.10.007
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Heitmueller A, 2014, HEALTH AFFAIR, V33, P1523, DOI 10.1377/hlthaff.2014.0771
   Istituto Superiore di Sanita, IT AUT CAS CHIK VIR
   Italy Ministry of Health, 2017, NAT PLAN SURV RESP A
   Jurdak R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131469
   Kim EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069305
   Laney D., 3D DATA MANAGEMENT C
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581
   Ramadona A, 2019, PLOS NEGL TROP DIS
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Semenza JC, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.13.20757
   Semenza JC, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx244
   Semenza JC, 2016, ANN NY ACAD SCI, V1382, P73, DOI 10.1111/nyas.13132
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Simonsen L, 2016, J INFECT DIS, V214, pS380, DOI 10.1093/infdis/jiw376
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11114, DOI 10.1073/pnas.1423542112
NR 31
TC 4
Z9 4
U1 5
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2019
VL 25
IS 6
BP 1041
EP 1049
DI 10.3201/eid2506.180138
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IC2FY
UT WOS:000470776900001
PM 31107221
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinez-Bello, DA
   Lopez-Quilez, A
   Prieto, AT
AF Adyro Martinez-Bello, Daniel
   Lopez-Quilez, Antonio
   Torres Prieto, Alexander
TI Joint Estimation of Relative Risk for Dengue and Zika Infections,
   Colombia, 2015-2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID PUBLIC-HEALTH; CHIKUNGUNYA
AB We jointly estimated relative risk for dengue and Zika virus disease (Zika) in Colombia, establishing the spatial association between them at the department and city levels for October 2015-December 2016. Cases of dengue and Zika were allocated to the 87 municipalities of 1 department and the 293 census sections of 1 city in Colombia. We fitted 8 hierarchical Bayesian Poisson joint models of relative risk for dengue and Zika, including area- and disease-specific random effects accounting for several spatial patterns of disease risk (clustered or uncorrelated heterogeneity) within and between both diseases. Most of the dengue and Zika high-risk municipalities varied in their risk distribution; those for Zika were in the northern part of the department and dengue in the southern to northeastern parts. At city level, spatially clustered patterns of dengue high-risk census sections indicated Zika high-risk areas. This information can be used to inform public health decision making.
C1 [Adyro Martinez-Bello, Daniel; Lopez-Quilez, Antonio] Univ Valencia, Valencia, Spain.
   [Torres Prieto, Alexander] Secretary Hlth Dept Santander, Bucaramanga, Colombia.
   [Lopez-Quilez, Antonio] Hlth & Environm Secretary, Bucaramanga, Colombia.
RP Martinez-Bello, DA (corresponding author), Univ Valencia, Dept Stat & Operat Res, Fac Math, C Dr Moliner 50, E-46100 Valencia, Spain.
EM danieladyro@gmail.com
RI Lopez-Quilez, Antonio/H-5945-2011
OI Lopez-Quilez, Antonio/0000-0002-7022-9260
FU Ministerio de Economia y CompetitividadSpanish Government
   [MTM2016-77501-P]; European Regional Development FundEuropean Union
   (EU); Colombian Administrative Department of Science and Technology
   [646-2014]
FX A.L.-Q. was supported by the Ministerio de Economia y Competitividad
   (research grant MTM2016-77501-P, jointly financed with the European
   Regional Development Fund). D.A.M.-B. was supported by the Colombian
   Administrative Department of Science and Technology (grant 646-2014) for
   doctoral studies abroad.
CR Administrative Department of National Statistics Colombia, 2005, DIR GEOST URB SECT L
   Martinez-Bello DA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071376
   Martinez-Bello DA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0104-x
   Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Banerjee S, 2014, CHAPMAN HALL CRC MON, P305
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Chien LC, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3085-x
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Costa S, 2018, DADOS-REV CIENC SOC, V61, P499, DOI 10.1590/001152582018166
   FERREIRA G, 2006, BRAZ J PROBAB STAT, V20, P29
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Jaramillo-Martinez GA, 2018, J INFECT PUBLIC HEAL, V11, P145, DOI 10.1016/j.jiph.2017.03.001
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680
   Ma H, BAYESIAN MULTIVARIAT
   Martinez-Bello D, 2018, STOCH ENV RES RISK A, V32, P1587, DOI 10.1007/s00477-017-1461-5
   National Health Institute, 2016, EV REP DENG
   National Health Institute of Colombia, NAT HLTH I COL WEEKL
   National Health Institute of Colombia, SUBREGISTER OF ZIKA
   Pacheco O, ZIKA VIRUS DIS COLOM, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]
   Rodrigues NCP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198357
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Rodriguez-Morales Alfonso J, 2017, Infez Med, V25, P241
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Romero-Vega Liliana, 2014, Rev. Saúde Pública, V48, P899, DOI [10.1590/S0034-8910.2014048005321, 10.1590/s0034-8910.2014048005321]
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Siraj AS, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.73
   Spiegelhalter D, OPENBUGS USER MANUAL
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
NR 39
TC 0
Z9 0
U1 0
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2019
VL 25
IS 6
BP 1118
EP 1126
DI 10.3201/eid2506.180392
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IC2FY
UT WOS:000470776900010
PM 31107226
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matheus, S
   Talla, C
   Labeau, B
   de Laval, F
   Briolant, S
   Berthelot, L
   Vray, M
   Rousset, D
AF Matheus, Severine
   Talla, Cheikh
   Labeau, Bhety
   de Laval, Franck
   Briolant, Sebastien
   Berthelot, Lena
   Vray, Muriel
   Rousset, Dominique
TI Performance of 2 Commercial Serologic Tests for Diagnosing Zika Virus
   Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; KINETICS; DISEASE; URINE; SERUM; RNA; KIT;
   IGM
AB Reliable serologic tests are needed for diagnosis and surveillance of Zika virus infection. We evaluated the Euroimmun and Dia.Pro serologic tests for detection of Zika virus IgM and IgG by using a panel of 199 samples from a region endemic for flaviviruses. Kinetics of Zika virus antibodies were monitored from 300 sequential specimens sampled over a period of 10 months after infection. We observed suboptimal performance; sensitivity for Zika virus IgM was low, especially in the Euroimmun assay (49%), whereas IgM could be detected for months with the Dia.pro assay. The specificity of the Zika virus IgG assays was also low, especially that of Dia.Pro (62%); findings were strongly influenced by the epidemiologic context. These results highlight the complexity of serologic diagnosis of Zika virus infection in regions endemic for flaviviruses. Accurate analysis of the performance of assays is required to adapt and interpret algorithms.
C1 [Matheus, Severine; Labeau, Bhety; Berthelot, Lena; Rousset, Dominique] Inst Pasteur, Cayenne, French Guiana.
   [Talla, Cheikh; Vray, Muriel] Inst Pasteur, Dakar, Senegal.
   [de Laval, Franck] French Armed Forces Hlth Serv French Guiana, Cayenne, France.
   [de Laval, Franck] French Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [Briolant, Sebastien] Inst Rech Biomed Armees, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, Marseille, France.
RP Rousset, D (corresponding author), Inst Pasteur, Lab Virol, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.
EM drousset@pasteur-cayenne.fr
OI Rousset, Dominique/0000-0002-1473-3147
FU Institut Pasteur de la Guyane; Sante Publique France (Saint-Maurice,
   France); French Agence Nationale de la RechercheFrench National Research
   Agency (ANR) [CEBA ANR-10-LABEX-25-01]
FX This study was supported by Institut Pasteur de la Guyane and Sante
   Publique France (Saint-Maurice, France) and received assistance from
   Investissement d'Avenir grants managed by the French Agence Nationale de
   la Recherche (CEBA ANR-10-LABEX-25-01).
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAYE O, 2014, PLOS NEGLECT TROP D, V8, P5624
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Olschlager S, 2017, AM J TROP MED HYG, V97, P1070, DOI 10.4269/ajtmh.17-0268
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998
   Yeo ASL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/420867
NR 27
TC 3
Z9 3
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2019
VL 25
IS 6
BP 1153
EP 1160
DI 10.3201/eid2506.180361
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IC2FY
UT WOS:000470776900014
PM 31107211
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Melo, VAD
   Silva, JRS
   La Corte, R
AF Dantas Melo, V. A.
   Santos Silva, J. R.
   La Corte, R.
TI Use of mosquito repellents to protect against Zika virus infection among
   pregnant women in Brazil
SO PUBLIC HEALTH
LA English
DT Article
DE Repellents; Zika virus; Pregnant women; Aedes aegypti; Vector control
ID KNOWLEDGE; OUTBREAK; SAFETY
AB Objectives: To evaluate the use of repellents among pregnant women as a protective measure against infection with the Zika virus.
   Study design: Pregnant women (n = 177) were interviewed between November 2016 and February 2017 at Basic Health Units in the city of Propria, state of Sergipe, Brazil. Two units were located in rural areas and eight in urban regions.
   Methods: Data were analysed using descriptive statistical methods, the Chi-squared test or Fisher's exact test and odds ratios. The independent variables were grouped by analysis of the main components, and adherence to the use of the repellent was analysed by the logistic regression method.
   Results: A total of 100 women reported using repellents at the time of the interview (56%). The use of repellents was greater among women with higher levels of education (83%) than those with only high school (68%) or elementary school (36%) education. Women assisted by the income transfer programme (Bolsa Familia) presented a 2.27 times greater chance of not using repellents compared with pregnant women who were not receiving benefits of the programme. Regarding the logistic regression model, we observed that low economic and social conditions of pregnant women, as well as their lack of advice, had a negative effect on the use of repellents.
   Conclusions: Repellents were generally used as a preventive measure in pregnant women with higher levels of schooling and fewer children. The relatively high cost of repellents was the main reason for non-use. (C) 2019 Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
C1 [Dantas Melo, V. A.; Santos Silva, J. R.; La Corte, R.] Univ Fed Sergipe, Grad Program Parasit Biol, Ave Marechal Rondon S-N, Sao Cristovao, SE, Brazil.
   [Santos Silva, J. R.] Univ Fed Sergipe, Dept Stat & Actuarial Sci, Ave Marechal Rondon S-N, Sao Cristovao, SE, Brazil.
   [La Corte, R.] Univ Fed Sergipe, Dept Morphol, Ave Marechal Rondon S-N, Sao Cristovao, SE, Brazil.
RP La Corte, R (corresponding author), Univ Fed Sergipe, Dept Morphol, Ave Marechal Rondon S-N, Sao Cristovao, SE, Brazil.
EM rlacorte@ufs.br
RI Silva, Jose Rodrigo S/A-2784-2016; Santos, Roseli LC/F-1735-2015
OI Santos Silva, Jose Rodrigo/0000-0002-1918-7122
CR Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019
   Alvarenga D., 2017, MEDO AEDES FAZ VENDA
   Andrade LH, 2016, 12 BRAZ S INF SYST
   Barr DB, 2010, SCI TOTAL ENVIRON, V408, P790, DOI 10.1016/j.scitotenv.2009.10.007
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Brasil, 2015, PROT AT SAUD RESP OC
   Brasil. Ministerio da Saude, 2015, DAT INF SAUD INF EP
   Brasil. Ministerio da saude. Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V47
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias Ministerio da Saude. Monitoramento dos casos de microcefalias no Brasil, 2016, MON CAS MICR BRAS, V32
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Freire MDGM, 2017, PERSP ONLINE BIOL SA, V7, P23
   Griffin I, 2018, J EPIDEMIOL COMMUN H, V72, P269, DOI 10.1136/jech-2017-210198
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   IBGE- Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ POP MUN BRAS
   Kuna Anna, 2017, Przegl Epidemiol, V71, P33
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   Liverani M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2059-6
   Michael GC, 2017, S AFR FAM PRACT, V59, P148, DOI 10.1080/20786190.2017.1313484
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   PAHO/ WHO, 2016, EP UPD ZIK EP UPD 29
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Paumgartten FJR, 2016, VIGIL SANIT DEBATE, V4, P97, DOI 10.3395/2317-269x.00736
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Swale DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103713
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 29
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD JUN
PY 2019
VL 171
BP 89
EP 96
DI 10.1016/j.puhe.2019.04.002
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IC3FQ
UT WOS:000470845200012
PM 31112836
DA 2020-07-08
ER

PT J
AU Tricarico, PM
   Caracciolo, I
   Gratton, R
   D'Agaro, P
   Crovella, S
AF Tricarico, Paola Maura
   Caracciolo, Ilaria
   Gratton, Rossella
   D'Agaro, Pierlanfranco
   Crovella, Sergio
TI 25-hydroxycholesterol reduces inflammation, viral load and cell death in
   ZIKV-infected U-87 MG glial cell line
SO INFLAMMOPHARMACOLOGY
LA English
DT Article
DE ZIKV; Inflammation; 25-hydroxycholesterol; U-87 MG glial cell line
ID VIRUS; OXYSTEROLS; ACTIVATION; EXPRESSION
AB Zika virus (ZIKV) infection is a global health issue due to its worldwide diffusion and to the related effects on neural progenitor cells with severe consequences on developing brain as well as on the central nervous system of adults. Previous studies showed that ZIKV infection induces an increment of IL1B expression in the central nervous system and also in the blood. IL-1 is a pro-inflammatory cytokine essential for cellular defence, tissue repair and neuroinflammation, a mechanism seen to be associated with several neuroinflammatory diseases. 25-hydroxycholesterol (25-HC) is a natural oxysterol, derived from hydroxylation of cholesterol, possessing important antiviral activity possibly correlated to its ability to alter host membrane structures. Furthermore, 25-HC is involved in the modulation of IL1B gene expression, being able to suppress IL-1 driven inflammation probably by blocking the activation of the SREB proteins. In our study, we analysed the antiviral action of 25-HC in ZIKV-infected U-87 MG cells, also evaluating its impact on inflammation and cell death. We demonstrated that 25-HC is able to reduce inflammation and cell death caused by ZIKV infection and also to diminish intracellular ZIKV load in U-87 MG glial cell line. Considering its antiviral activity and its ability to penetrate blood-brain barrier, 25-HC could be proposed, based on our results and literature findings, as a potential anti-ZIKV agent.
C1 [Tricarico, Paola Maura; Caracciolo, Ilaria; D'Agaro, Pierlanfranco; Crovella, Sergio] Univ Trieste, Piazzale Europa 1, I-34128 Trieste, Italy.
   [Gratton, Rossella; Crovella, Sergio] Inst Maternal & Child Hlth Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
RP Tricarico, PM (corresponding author), Univ Trieste, Piazzale Europa 1, I-34128 Trieste, Italy.
EM tricaricopa@gmail.com; crc.ilaria@gmail.com; rossella.gratton@gmail.com;
   pdagaro@units.it; sergio.crovella@burlo.trieste.it
RI tricarico, paola/AAB-8972-2019
OI tricarico, paola/0000-0002-1954-4126
FU MCTIC-CNPq/MEC-CAPES/MS-Decit/FNDCT [14/2016]; Institute for Maternal
   and Child Health-IRCCS "Burlo Garofolo", Trieste, Italy [11/12];
   European Virus Archive goes Global (EVAg) project from the European
   Union [653316]
FX The study has been supported by the Grant:
   MCTIC-CNPq/MEC-CAPES/MS-Decit/FNDCT No 14/2016-Prevencao e Combate ao
   virus Zika and by the Grant 11/12 of the Institute for Maternal and
   Child Health-IRCCS "Burlo Garofolo", Trieste, Italy. Robert Koch
   Institute (Berlin, Germany), supported by the European Virus Archive
   goes Global (EVAg) project that has received funding from the European
   Union's Horizon 2020 research and innovation programme under grant
   agreement No 653316, generously provided the quantified Zika MR766
   molecular standard. Prof. Del Sal G. (University of Trieste, Italy)
   generously provided U87-MG cells (human glioblastoma cell line).
CR Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001
   Chen JH, 2015, INT J CARDIOL, V184, P255, DOI 10.1016/j.ijcard.2015.02.047
   Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487
   Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009
   Goldman Steven A., 2005, V265, P66
   Guo S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005155
   He Z, 2018, J INFECT DIS
   Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lembo D, 2016, MOL ASPECTS MED, V49, P23, DOI 10.1016/j.mam.2016.04.003
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Zhao ML, 2001, J NEUROIMMUNOL, V115, P182, DOI 10.1016/S0165-5728(00)00463-X
NR 23
TC 5
Z9 5
U1 1
U2 3
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0925-4692
EI 1568-5608
J9 INFLAMMOPHARMACOLOGY
JI Inflammopharmacology
PD JUN
PY 2019
VL 27
IS 3
BP 621
EP 625
DI 10.1007/s10787-018-0517-6
PG 5
WC Immunology; Pharmacology & Pharmacy; Toxicology
SC Immunology; Pharmacology & Pharmacy; Toxicology
GA IC0YM
UT WOS:000470686000018
PM 30019309
DA 2020-07-08
ER

PT J
AU Estrada, JLT
   Moscoso, KEP
   Salas, IF
   Achee, NL
   Grieco, JP
AF Torres Estrada, Jose Luis
   Paiz Moscoso, Keila Elizabeth
   Fernandez Salas, Ildefonso
   Achee, Nicole L.
   Grieco, John Paul
TI Spatial repellency and other effects of transfluthrin and linalool on
   Aedes aegypti and Aedes albopictus
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Spatial repellents; mosquitoes; Aedes; high-throughput screening system
AB In the present study, the effects of two spatial repellents (SR) were determined for Aedes aegypti and Ae albopictus, the main vectors of dengue, Chikungunya, and Zika fever. The modular high-throughput screening system (HITSS) was used to evaluate the response of both species to transfluthrin and linalool SR at different concentrations. The highest spatial repellency results for Ae. aegypti were obtained by transfluthrin to 0.001% with 37.50 +/- 4.33%, and for linalool to 10% with 77.50 +/- 3.90%. For Ae. albopictus, the highest spatial repellency percentages for transfluthrin 0.01% were 45.00 +/- 3.78%, and linalool at 1% and 10% were 56.25 +/- 7.06% and 56.25 +/- 6.46%, respectively. Transfluthrin caused high levels of mortality with 71.25 +/- 6.66%, 79.75 +/- 8.65%, and 100% to Ae. aegypti and 70.00 +/- 5.98% and 98.75 +/- 0.82% to Aedes albopcitus. With the results of this study, we concluded that both the transfluthrin and linalool could be used as protection measures against the bite of Ae. aegypti and Ae. albopictus in the integral strategies for the control of vectors in Mexico.
C1 [Torres Estrada, Jose Luis; Paiz Moscoso, Keila Elizabeth; Fernandez Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 4 Ave Norte & 19 Calle Poniente Colonia Ctr, Tapachula, Chiapas, Mexico.
   [Achee, Nicole L.; Grieco, John Paul] Univ Notre Dame, ECK Inst Global Hlth, Notre Dame, IN 46556 USA.
RP Estrada, JLT (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 4 Ave Norte & 19 Calle Poniente Colonia Ctr, Tapachula, Chiapas, Mexico.
EM jltorres@insp.mx
FU CONACYT/Proyectos Cientificos para Atender Problemas Nacionales [2015
   Numero 1602]
FX The present study was support by CONACYT/Proyectos Cientificos para
   Atender Problemas Nacionales 2015 Numero 1602. Isaac Cortes Sanches,
   Julio Cesar Gopar Lopez, Alejandra Maldonado, Crescencio Diaz, and
   Sandra Robles are also thanked for their technical support in conducting
   this study.
CR Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164
   Govella NJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0937-8
   Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716
   Leyva M., 2009, REV BIOMED, V20, P5, DOI DOI 10.32776/revbiomed.v20i1.529
   Masalu JP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2132-6
   Muller GC, 2009, J VECTOR ECOL, V34, P2, DOI [10.3376/038.034.0102, 10.1111/j.1948-7134.2009.00002.x]
   Ogoma SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110433
   Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-54
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
NR 9
TC 0
Z9 0
U1 3
U2 4
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD JUN
PY 2019
VL 44
IS 1
BP 89
EP 93
DI 10.1111/jvec.12332
PG 5
WC Entomology
SC Entomology
GA IC0OO
UT WOS:000470659800010
PM 31124222
OA Bronze
DA 2020-07-08
ER

PT J
AU Lura, T
   Su, TY
   Brown, MQ
AF Lura, Taylor
   Su, Tianyun
   Brown, Michelle Q.
TI Preliminary evaluation of Thermo Fisher TaqMan((R)) Triplex q-PCR kit
   for simultaneous detection of chikungunya, dengue, and Zika viruses in
   mosquitoes
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
ID PATHOGENESIS; EPIDEMIOLOGY; INFECTION; OUTBREAK; FEVER
C1 [Lura, Taylor; Su, Tianyun; Brown, Michelle Q.] West Valley Mosquito & Vector Control Dist, 1295 E Locust St, Ontario, CA 91761 USA.
RP Su, TY (corresponding author), West Valley Mosquito & Vector Control Dist, 1295 E Locust St, Ontario, CA 91761 USA.
EM tsu@wvmvcd.org
OI Brown, Michelle/0000-0003-4165-4644
CR Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumoulin A, 2008, J CLIN MICROBIOL, V46, P3104, DOI 10.1128/JCM.01294-08
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Howe G.W., 1977, WORLD GEOGRAPHY HUMA, P302
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Su T, 2017, P PAP MOSQ VECTOR CO, V85, P109
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 23
TC 1
Z9 1
U1 0
U2 3
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD JUN
PY 2019
VL 44
IS 1
BP 205
EP 209
DI 10.1111/jvec.12347
PG 5
WC Entomology
SC Entomology
GA IC0OO
UT WOS:000470659800025
PM 31124226
OA Bronze
DA 2020-07-08
ER

PT J
AU Ruckert, C
   Prasad, AN
   Garcia-Luna, SM
   Robison, A
   Grubaugh, ND
   Weger-Lucarelli, J
   Ebel, GD
AF Ruckert, Claudia
   Prasad, Abhishek N.
   Garcia-Luna, Selene M.
   Robison, Alexis
   Grubaugh, Nathan D.
   Weger-Lucarelli, James
   Ebel, Gregory D.
TI Small RNA responses of Culex mosquitoes and cell lines during acute and
   persistent virus infection
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Mosquito; Culex; West nile virus; RNAi; Arbovirus; PIWI
ID WEST-NILE-VIRUS; AEDES-AEGYPTI; ANTIVIRAL IMMUNITY; ZIKA VIRUS;
   INTERFERENCE; EMERGENCE; TRANSMISSION; ARBOVIRUS; RESISTANCE; ALPHAVIRUS
AB RNA interference is a crucial antiviral mechanism in arthropods, including in mosquito vectors of arthropod-borne viruses (arboviruses). Although the exogenous small interfering RNA (siRNA) pathway constitutes an efficient antiviral response in mosquitoes, virus-derived P-element induced wimpy testis (PIWI)-interacting RNAs (piRNAs) have been implicated in the response to alpha-, bunya- and flaviviruses in Aedes spp. mosquitoes. Culex mosquitoes transmit several medically important viruses including West Nile virus (WNV), but are considerably less well studied than Aedes mosquitoes and little is known about antiviral RNA interference in Culex mosquitoes. Therefore, we sequenced small RNA (sRNA) libraries from different Culex cell lines and tissues infected with WNV. The clear majority of virus-derived sRNA reads were 21 nt siRNAs in all cell lines and tissues tested, with no evidence for a role of WNV-derived piRNAs. Additionally, we aligned sRNA reads from Culex quinquefasciatus Hsu cells to the insect-specific rhabdovirus, Merida virus, which persistently replicates in these cells. We found that a significant proportion of the sRNA response to Merida virus consisted of piRNAs. Since viral DNA forms have been implicated in siRNA and piRNA responses of Aedes spp. mosquitoes, we also tested for viral DNA forms in WNV infected Culex cells. We detected viral DNA in Culex tarsalis cells infected with WNV and, to a lesser amount, WNV and Merida virus-derived DNA in Culex quinquefasciatus Hsu cells. In conclusion, Hsu cells generated Merida virus-derived piRNAs, but our data suggests that the major sRNA response of Culex cells and mosquitoes to WNV infection is the exogenous siRNA response. It is also evident that sRNA responses differ significantly between specific virus-mosquito combinations. Future work using additional Culex-borne viruses may further elucidate how virus-derived piRNAs are generated in Culex cells and what role they may play in controlling replication of different viruses.
C1 [Ruckert, Claudia; Prasad, Abhishek N.; Garcia-Luna, Selene M.; Robison, Alexis; Grubaugh, Nathan D.; Weger-Lucarelli, James; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA.
   [Prasad, Abhishek N.] Univ Texas Med Branch, Dept Pathol, Galveston Natl Lab, Galveston, TX 77555 USA.
   [Garcia-Luna, Selene M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, Lab Epidemiol Publ Hlth, New Haven, CT USA.
   [Weger-Lucarelli, James] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
RP Ruckert, C; Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA.
EM claudia.rueckert@colostate.edu; gregory.ebel@colostate.edu
RI ; Prasad, Abhishek/K-6450-2019
OI Grubaugh, Nathan/0000-0003-2031-1933; Garcia-Luna, Selene
   M./0000-0001-8420-5078; Prasad, Abhishek/0000-0002-4147-2077; Ruckert,
   Claudia/0000-0003-3732-6752
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI067380]
FX The authors would like to thank Dr. Aaron Brault, Centers for Disease
   Control and prevention, for providing Hsu cells, CT cells, and the
   Calbertado virus sequence. The mosquito used in the graphical abstract
   was provided by Ana L. Ramirez through figshare (Ramirez, 2019). This
   study was funded by NIH grant AI067380.
CR Adelman ZN, 2002, J VIROL, V76, P12925, DOI 10.1128/JVI.76.24.12925-12933.2002
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845
   Chao J., 1976, INVERTEBRATE TISSUE, P263
   Ciota AT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-305
   Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   EBERLE MW, 1986, J AM MOSQUITO CONTR, V2, P38
   Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x
   Fragkoudis R, 2008, J GEN VIROL, V89, P2565, DOI 10.1099/vir.0.2008/002238-0
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   HSU SH, 1970, J MED ENTOMOL, V7, P703, DOI 10.1093/jmedent/7.6.703
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lozano-Fuentes S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000468
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307
   Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Ramirez A. L., 2019, CULEX QUINQUEFASCIAT
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ruckert Claudia, 2014, VirusDisease, V25, P249, DOI 10.1007/s13337-014-0217-9
   Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011
   Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5
   Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089
   Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tassetto M, 2017, CELL, V169, P314, DOI 10.1016/j.cell.2017.03.033
   Travanty EA, 2004, INSECT BIOCHEM MOLEC, V34, P607, DOI 10.1016/j.ibmb.2004.03.013
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang Y., 2018, VIRUSES, V10
   Watson M, 2013, BIOINFORMATICS, V29, P1902, DOI 10.1093/bioinformatics/btt297
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P175, DOI 10.1016/j.virol.2018.06.007
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 77
TC 7
Z9 8
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD JUN
PY 2019
VL 109
BP 13
EP 23
DI 10.1016/j.ibmb.2019.04.008
PG 11
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA IB3UD
UT WOS:000470192100002
PM 30959110
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Karnam, A
   Stephen-Victor, E
   Das, M
   Magy, L
   Vallat, JM
   Bolgert, F
   Simon-Loriere, E
   Kaveri, SV
   Sakuntabhai, A
   Bayry, J
AF Karnam, Anupama
   Stephen-Victor, Emmanuel
   Das, Mrinmoy
   Magy, Laurent
   Vallat, Jean-Michel
   Bolgert, Francis
   Simon-Loriere, Etienne
   Kaveri, Srini V.
   Sakuntabhai, Anavaj
   Bayry, Jagadeesh
TI Does intravenous immunoglobulin therapy in Guillain-Barre syndrome
   patients interfere with serological Zika detection?
SO AUTOIMMUNITY REVIEWS
LA English
DT Letter
ID VIRUS; AUTOIMMUNE; DISEASE
C1 [Karnam, Anupama; Stephen-Victor, Emmanuel; Das, Mrinmoy; Kaveri, Srini V.; Bayry, Jagadeesh] Sorbonne Univ, Ctr Rech Cordeliers, Equipe Immunopathol & Immunointervent Therapeut, INSERM, F-75006 Paris, France.
   [Magy, Laurent; Vallat, Jean-Michel] Hop Univ Limoges, Ctr Reference Neuropathies Peripher Rares, F-87042 Limoges, France.
   [Magy, Laurent; Vallat, Jean-Michel] Hop Univ Limoges, Serv Neurol, F-87042 Limoges, France.
   [Bolgert, Francis] Hop La Pitie Salpetriere, Neurol 1, Reanimat Neurol, F-75651 Paris, France.
   [Simon-Loriere, Etienne] Inst Pasteur, Genom Evolut Virus ARN, F-75015 Paris, France.
   [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.
   [Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, F-75015 Paris, France.
   [Sakuntabhai, Anavaj] Inst Pasteur, CNRS, UMR2000 Genom Evolut, F-75015 Paris, France.
RP Bayry, J (corresponding author), Ctr Rech Cordeliers, INSERM, Unite 1138, 15 Rue Ecole Med, F-75006 Paris, France.
EM jagadeesh.bayry@crc.jussieu.fr
OI Bayry, Jagadeesh/0000-0003-0498-9808
FU Institut National de la Sante et de la Recherche Medicale (INSEAM),
   Sorbonne Universite; Universite Paris Descartes; French Government's
   Investissement d'Avenir programFrench National Research Agency (ANR);
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases" [ANR-10-LABX-62-IBEID]; Indo-French Center for Promotion of
   Advanced Research (CEFIPRA) [5203-3, 4803-1]
FX The authors would like to acknowledge the Platform of Recombinant
   Proteins in Eukaryotic Cells (Citech-PFPR) and especially S. Petres,
   Institut Pasteur for the ZIKV EDIII recombinant protein. Supported by
   Institut National de la Sante et de la Recherche Medicale (INSEAM),
   Sorbonne Universite, Universite Paris Descartes, and French Government's
   Investissement d'Avenir program and Laboratoire d'Excellence
   "Integrative Biology of Emerging Infectious Diseases" (grant
   noANR-10-LABX-62-IBEID). AK and ESV are recipient of fellowships from
   Indo-French Center for Promotion of Advanced Research (CEFIPRA; Projects
   5203-3 and 4803-1 respectively).
CR Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002
   Belanger SS, 2012, CAN MED ASSOC J, V184, P1709, DOI 10.1503/cmaj.120019
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433
   Gilardin L, 2015, CAN MED ASSOC J, V187, P257, DOI 10.1503/cmaj.130375
   Ilboudo Christelle M, 2013, F1000Res, V2, P249, DOI 10.12688/f1000research.2-249.v1
   Krause I, 2002, TRANSFUSION MED, V12, P133, DOI 10.1046/j.1365-3148.2002.00360.x
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perez EE, 2017, J ALLERGY CLIN IMMUN, V139, pS1, DOI 10.1016/j.jaci.2016.09.023
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Sala TP, 2018, AUTOIMMUN REV, V17, P873, DOI 10.1016/j.autrev.2018.03.010
   Sanges S, 2017, AUTOIMMUN REV, V16, P377, DOI 10.1016/j.autrev.2017.02.008
   Shopsin B, 2016, CELL HOST MICROBE, V20, P555, DOI 10.1016/j.chom.2016.10.018
   Tenti S, 2018, AUTOIMMUN REV, V17, P791, DOI 10.1016/j.autrev.2018.02.010
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Watad A, 2017, LUPUS, V26, P1015, DOI 10.1177/0961203317696589
   Zuercher AW, 2016, AUTOIMMUN REV, V15, P781, DOI 10.1016/j.autrev.2016.03.018
NR 19
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD JUN
PY 2019
VL 18
IS 6
BP 632
EP 633
DI 10.1016/j.autrev.2019.01.004
PG 2
WC Immunology
SC Immunology
GA IA4GP
UT WOS:000469522300009
PM 30959213
DA 2020-07-08
ER

PT J
AU Mendoza, EJ
   Makowski, K
   Barairo, N
   Holloway, K
   Dimitrova, K
   Sloan, A
   Vendramelli, R
   Ranadheera, C
   Safronetz, D
   Drebot, MA
   Wood, H
AF Mendoza, Emelissa J.
   Makowski, Kai
   Barairo, Nicole
   Holloway, Kimberly
   Dimitrova, Kristina
   Sloan, Angela
   Vendramelli, Robert
   Ranadheera, Charlene
   Safronetz, David
   Drebot, Michael A.
   Wood, Heidi
TI Establishment of a comprehensive and high throughput serological
   algorithm for Zika virus diagnostic testing
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Diagnostic testing; Serology
ID HISTORY
AB The previous serological algorithm for Zika virus (ZIKV) comprised screening by anti-ZIKV IgM capture ELISA (MAC-ELISA) for samples collected within 3 months postexposure or onset (MPEO). Samples positive by MAC-ELISA and samples collected beyond 3 MPEO were tested by the confirmatory plaque reduction neutralization test (PRNT), which proved laborious and time-consuming during the 2015 outbreak. Thus, we evaluated several ZIKV ELISAs to establish an anti-IgM and anti-IgG combination for use as a screening tool for all samples prior to PRNT confirmation. The MAC-ELISA or InBios-M in combination with the Euroimmun-G demonstrated sensitivities of 99.1% and 97.2%, respectively, and nonflavivirus specificity of 96.0%. Their cross-reactivities were 71.4% and 50.0%, respectively, for sera positive for Dengue virus antibodies. Due to near-perfect interrater agreement with PRNT and excellent detection of samples collected beyond 3 MPEO, these combinations were recommended as a screening protocol in a new high-throughput algorithm with special considerations for ZIKV diagnostics. Crown Copyright (C) 2019 Published by Elsevier Inc. All rights reserved.
C1 [Mendoza, Emelissa J.; Makowski, Kai; Barairo, Nicole; Holloway, Kimberly; Dimitrova, Kristina; Sloan, Angela; Vendramelli, Robert; Ranadheera, Charlene; Safronetz, David; Drebot, Michael A.; Wood, Heidi] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
RP Wood, H (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
EM heidi.wood@canada.ca
FU Public Health Agency of Canada
FX This work was supported by the Public Health Agency of Canada.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubaut JP, 2017, J ASSIST REPROD GEN, V34, P1237, DOI 10.1007/s10815-017-0988-1
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Erbelding E, 2017, J INFECT DIS, V216, pS991, DOI 10.1093/infdis/jix492
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Tataryn J, 2018, Can Commun Dis Rep, V44, P18, DOI 10.14745/ccdr.v44i01a05
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 22
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD JUN
PY 2019
VL 94
IS 2
BP 140
EP 146
DI 10.1016/j.diagmicrobio.2019.01.004
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HZ9GR
UT WOS:000469164300007
PM 30744915
DA 2020-07-08
ER

PT J
AU Han, BA
   Majumdar, S
   Calmon, FP
   Glicksberg, BS
   Horesh, R
   Kumar, A
   Perer, A
   von Marschall, EB
   Wei, D
   Mojsilovic, A
   Varshney, KR
AF Han, Barbara A.
   Majumdar, Subhabrata
   Calmon, Flavio P.
   Glicksberg, Benjamin S.
   Horesh, Raya
   Kumar, Abhishek
   Perer, Adam
   von Marschall, Elisa B.
   Wei, Dennis
   Mojsilovic, Aleksandra
   Varshney, Kush R.
TI Confronting data sparsity to identify potential sources of Zika virus
   spillover infection among primates
SO EPIDEMICS
LA English
DT Article
DE Predictive analytics; Flavivirus; Arbovirus; Non-human primate; Machine
   learning; Bayesian multi-task learning; Imputation; Neotropical;
   Spillover; Spillback; Ecology; Surveillance
ID DISEASE; FEVER; HOST
AB The recent Zika virus (ZIKV) epidemic in the Americas ranks among the largest outbreaks in modern times. Like other mosquito-borne flaviviruses, ZIKV circulates in sylvatic cycles among primates that can serve as reservoirs of spillover infection to humans. Identifying sylvatic reservoirs is critical to mitigating spillover risk, but relevant surveillance and biological data remain limited for this and most other zoonoses. We confronted this data sparsity by combining a machine learning method, Bayesian multi-label learning, with a multiple imputation method on primate traits. The resulting models distinguished flavivirus-positive primates with 82% accuracy and suggest that species posing the greatest spillover risk are also among the best adapted to human habitations. Given pervasive data sparsity describing animal hosts, and the virtual guarantee of data sparsity in scenarios involving novel or emerging zoonoses, we show that computational methods can be useful in extracting actionable inference from available data to support improved epidemiological response and prevention.
C1 [Han, Barbara A.] Cary Inst Ecosyst Studies, Box AB, Millbrook, NY 12545 USA.
   [Majumdar, Subhabrata] Univ Florida, Informat Inst, 432 Newell Dr,CISE Bldg E251, Gainesville, FL 32611 USA.
   [Calmon, Flavio P.] Harvard Univ, 29 Oxford St, Cambridge, MA 02138 USA.
   [Glicksberg, Benjamin S.] Univ Calif San Francisco, Baker Computat Hlth Sci Inst, San Francisco, CA 94158 USA.
   [Majumdar, Subhabrata; Calmon, Flavio P.; Glicksberg, Benjamin S.; Horesh, Raya; Kumar, Abhishek; Perer, Adam; Wei, Dennis; Mojsilovic, Aleksandra; Varshney, Kush R.] IBM Res, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.
   [Perer, Adam] Carnegie Mellon Univ, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
   [von Marschall, Elisa B.] IBM Watson Media & Weather, 550 Assembly St, Columbia, SC 29201 USA.
   [Majumdar, Subhabrata] AT&T Labs Res, Florham Pk, NJ USA.
   [Kumar, Abhishek] Google Brain, Mountain View, CA USA.
RP Han, BA (corresponding author), Cary Inst Ecosyst Studies, Box AB, Millbrook, NY 12545 USA.
EM hanb@caryinstitute.org
RI Majumdar, Subhabrata/AAS-4590-2020
OI Majumdar, Subhabrata/0000-0003-3529-7820; Glicksberg,
   Benjamin/0000-0003-4515-8090
FU IBM Science for Social Good initiative; NSF EEID grant [DEB-1717282]
FX The authors would like to thank P. Feinberg and V. Ramesh for supporting
   data collation; C. Hough for generating the conceptual figure; Drs. K.
   Hanley, S. LaDeau, E. Han; C. Carlson and two anonymous reviewers for
   valuable manuscript comments; and M. Gillespie for editorial assistance.
   This work was conducted under the auspices of the IBM Science for Social
   Good initiative. Funding for B. Han was provided by NSF EEID grant
   (DEB-1717282).
CR Althouse BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03332-7
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Cardona-Ospina JA, 2018, INT J INFECT DIS, V76, P126, DOI 10.1016/j.ijid.2018.08.022
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Berger SA, 2005, INT J HEALTH GEOGR, V4, P10, DOI DOI 10.1186/1476-072X-4-10
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Butler G, 2009, POLITICAL ECONOMY NOW!: THE STRUGGLE FOR ALTERNATIVE ECONOMICS AT THE UNIVERSITY OF SYDNEY, P90
   Cable JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001130
   Crockett CM, 1998, INT J PRIMATOL, V19, P549, DOI 10.1023/A:1020316607284
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Goldstein T, 2018, NAT MICROBIOL, V3, P1084, DOI 10.1038/s41564-018-0227-2
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815
   Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007
   Han BA, 2016, EMBO REP, V17, P785, DOI 10.15252/embr.201642534
   Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x
   McKinney T, 2011, AM J PRIMATOL, V73, P439, DOI 10.1002/ajp.20919
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mitchell C., 2016, ZIKA CUMULATIVE CASE
   Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232
   Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x
   Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Raghunathan T, 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186
   Rai P., 2015, ADV NEURAL INFORM PR, V28, P3222
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   WHOh, 2018, ZIK VIR INF IND
   Yang XL, 2017, EMERG INFECT DIS, V23, P482, DOI 10.3201/eid2303.161119
   Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131
NR 37
TC 3
Z9 3
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2019
VL 27
BP 59
EP 65
DI 10.1016/j.epidem.2019.01.005
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA IA2UH
UT WOS:000469416700007
PM 30902616
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Ramirez-Vallejoa, E
   Alvarado-Arnez, LE
   Paniz-Mondolfi, A
   Zambrano, LI
   Ko, AI
AF Rodriguez-Morales, Alfonso J.
   Ramirez-Vallejoa, Eduardo
   Elena Alvarado-Arnez, Lucia
   Paniz-Mondolfi, Alberto
   Zambrano, Lysien I.
   Ko, Albert I.
TI Fatal Zika virus disease in adults: A critical reappraisal of an
   under-recognized clinical entity
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; COINFECTION
C1 [Rodriguez-Morales, Alfonso J.; Ramirez-Vallejoa, Eduardo] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.; Ramirez-Vallejoa, Eduardo; Paniz-Mondolfi, Alberto; Zambrano, Lysien I.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Ramirez-Vallejoa, Eduardo] Univ Franz Tamayo UNI FRANZ, Natl Res Coordinat, Cochabamba, Bolivia.
   [Paniz-Mondolfi, Alberto] Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Lara 3023, Venezuela.
   [Paniz-Mondolfi, Alberto] Venezuelan Sci Incubator & Zoonosis & Emerging Pa, Infect Dis Res Branch, Cabudare 3023, Lara, Venezuela.
   [Paniz-Mondolfi, Alberto] Inst Estudios Avanzados IDEA, Lab Senalizac Celular & Bioquim Parasitos, Caracas, Venezuela.
   [Paniz-Mondolfi, Alberto] Acad Nacl Med, Caracas, Venezuela.
   [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Sch Med, Dept Morphol Sci, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo, Escola Paulista Med UNIFESP EPM, Dept Physiol, Cardiovasc Div, Sao Paulo, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Arnez, Lucia Elena Alvarado/D-4690-2016; Zambrano, Lysien/R-5628-2019;
   AJ, Rodriguez-Morales/R-9765-2016; Ko, Albert Icksang/P-2343-2015
OI Arnez, Lucia Elena Alvarado/0000-0002-3537-6361; Zambrano,
   Lysien/0000-0001-9002-5807; AJ, Rodriguez-Morales/0000-0001-9773-2192;
   Ko, Albert Icksang/0000-0001-9023-2339; Paniz-Mondolfi, Alberto
   E./0000-0003-1259-1736
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mercado M, 2018, J CLIN VIROL, V103, P16, DOI 10.1016/j.jcv.2018.03.009
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s095026881800359x, 10.1017/S095026881800359X]
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Neaterour P, 2017, AM J TROP MED HYG, V97, P1085, DOI 10.4269/ajtmh.17-0250
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Rajahram GS, 2019, INT J INFECT DIS, V83, P163, DOI 10.1016/j.ijid.2019.01.047
   Ramacciotti E, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029618821184
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rodriguez-Morales AJ, 2018, INT J INFECT DIS, V73, P195, DOI 10.1016/j.ijid.2018.04.3856
   Rodriguez-Morales AJ, 2018, INT J INFECT DIS, V73, P71, DOI 10.1016/j.ijid.2018.04.3587
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Villamil-Gomez WE, 2018, MAYO CLIN PROC, V93, P393, DOI 10.1016/j.mayocp.2017.12.006
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villannil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P510, DOI 10.1016/j.tmaid.2016.06.004
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 33
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2019
VL 83
BP 160
EP 162
DI 10.1016/j.ijid.2019.03.002
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA IA1LJ
UT WOS:000469322300028
PM 30858118
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rajahram, GS
   Hale, G
   Bhatnagar, J
   Hiu, J
   Thayan, R
   William, T
   Wong, KT
   Tambyah, PA
   Yeo, TW
AF Rajahram, Giri Shan
   Hale, Gillian
   Bhatnagar, Julu
   Hiu, Jessie
   Thayan, Ravindran
   William, Timothy
   Wong, Kum Thong
   Tambyah, Paul Anantharajah
   Yeo, Tsin Wen
TI Postmortem evidence of disseminated Zika virus infection in an adult
   patient
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
C1 [Rajahram, Giri Shan] Queen Elizabeth Hosp, Dept Med, Infect Dis Unit, Kota Kinabalu, Sabah, Malaysia.
   [Rajahram, Giri Shan] Queen Elizabeth Hosp, Clin Res Ctr, Kota Kinabalu, Sabah, Malaysia.
   [Hale, Gillian; Bhatnagar, Julu] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA.
   [Hiu, Jessie] Queen Elizabeth Hosp, Dept Forens Med, Kota Kinabalu, Sabah, Malaysia.
   [Thayan, Ravindran] Inst Med Res, Infect Dis Res Ctr, Virol Unit, Kuala Lumpur, Malaysia.
   [William, Timothy] Jesselton Med Ctr, Kota Kinabalu, Sabah, Malaysia.
   [Wong, Kum Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Yeo, Tsin Wen] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Yeo, Tsin Wen] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
RP Rajahram, GS (corresponding author), Queen Elizabeth Hosp, Dept Med, Infect Dis Unit, Kota Kinabalu, Sabah, Malaysia.; Rajahram, GS (corresponding author), Queen Elizabeth Hosp, Clin Res Ctr, Kota Kinabalu, Sabah, Malaysia.
EM gsrajahram@gmail.com
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   ARETZ HT, 1987, HUM PATHOL, V18, P619
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 14
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2019
VL 83
BP 163
EP 166
DI 10.1016/j.ijid.2019.01.047
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA IA1LJ
UT WOS:000469322300029
PM 30763620
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Bonenfant, G
   Williams, N
   Netzband, R
   Schwarz, MC
   Evans, MJ
   Pager, CT
AF Bonenfant, Gaston
   Williams, Nina
   Netzband, Rachel
   Schwarz, Megan C.
   Evans, Matthew J.
   Pager, Cara T.
TI Zika Virus Subverts Stress Granules To Promote and Restrict Viral Gene
   Expression
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE G3BP1; HuR; stress granule; Zika virus
ID HEPATITIS-C VIRUS; RNA HELICASE DDX6; MINUS-STRAND RNA; WEST-NILE;
   BINDING PROTEIN-1; HUR PROTEIN; INITIATION FACTOR-2-ALPHA; SEXUAL
   TRANSMISSION; MESSENGER-RNAS; KINASE
AB Flaviviruses limit the cell stress response by preventing the formation of stress granules (SGs) and modulate viral gene expression by subverting different proteins involved in the stress granule pathway. In this study, we investigated the formation of stress granules during Zika virus (ZIKV) infection and the role stress granule proteins play during the viral life cycle. Using immunofluorescence and confocal microscopy, we determined that ZIKV disrupted the formation of arsenite-induced stress granules and changed the subcellular distribution, but not the abundance or integrity, of stress granule proteins. We also investigated the role of different stress granule proteins in ZIKV infection by using target-specific short interfering RNAs to deplete Ataxin2, G3BP1, HuR, TIA-1, TIAR, and YB1. Knockdown of TIA-1 and TIAR affected ZIKV protein and RNA levels but not viral titers. Conversely, depletion of Ataxin2 and YB1 decreased virion production despite having only a small effect on ZIKV protein expression. Notably, however, depletion of G3BP1 and HuR decreased and increased ZIKV gene expression and virion production, respectively. Using an MR766 Gaussia Luciferase reporter genome together with knock-down and overexpression assays, G3BP1 and HuR were found to modulate ZIKV replication. These data indicate that ZIKV disrupts the formation of stress granules by sequestering stress granule proteins required for replication, where G3BP1 functions to promote ZIKV infection while HuR exhibits an antiviral effect. The results of ZIKV relocalizing and subverting select stress granule proteins might have broader consequences on cellular RNA homeostasis and contribute to cellular gene dysregulation and ZIKV pathogenesis.
   IMPORTANCE Many viruses inhibit SGs. In this study, we observed that ZIKV restricts SG assembly, likely by relocalizing and subverting specific SG proteins to modulate ZIKV replication. This ZIKV-SG protein interaction is interesting, as many SG proteins are also known to function in neuronal granules, which are critical in neural development and function. Moreover, dysregulation of different SG proteins in neurons has been shown to play a role in the progression of neurodegenerative diseases. The likely consequences of ZIKV modulating SG assembly and subverting specific SG proteins are alterations to cellular mRNA transcription, splicing, stability, and translation. Such changes in cellular ribostasis could profoundly affect neural development and contribute to the devastating developmental and neurological anomalies observed following intrauterine ZIKV infection. Our study provides new insights into virus-host interactions and the identification of the SG proteins that may contribute to the unusual pathogenesis associated with this reemerging arbovirus.
C1 [Bonenfant, Gaston; Williams, Nina; Netzband, Rachel; Pager, Cara T.] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA.
   [Schwarz, Megan C.; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
RP Pager, CT (corresponding author), SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA.
EM ctpager@albany.edu
OI Bonenfant, Gaston/0000-0002-0081-7470
FU University at Albany-SUNY and New York State; University at Albany
   Presidential Initiatives Fund for Research and Scholarship (PIFRS);
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI133649, R21 AI140196, R21
   AI133617-01, R01 GM123050]; Burroughs Wellcome Fund Investigators in
   Pathogenesis of Infectious Disease Award
FX This work was supported by startup funds from the University at
   Albany-SUNY and New York State, the University at Albany Presidential
   Initiatives Fund for Research and Scholarship (PIFRS) to C.T.P., and NIH
   grants (R21 AI133617-01 and R01 GM123050) to C.T.P. M.J.E. received
   funding from the Burroughs Wellcome Fund Investigators in Pathogenesis
   of Infectious Disease Award and NIH grants (R21 AI133649 and R21
   AI140196).
CR Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z
   Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052
   Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092
   Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Beck ARP, 1996, NUCLEIC ACIDS RES, V24, P3829, DOI 10.1093/nar/24.19.3829
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bonenfant G, 2019, BIORXIV, DOI [10.1101/436865, DOI 10.1101/436865]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chatel-Chaix L, 2013, J VIROL, V87, P11704, DOI 10.1128/JVI.01474-13
   Chatel-Chaix L, 2011, J VIROL, V85, P11022, DOI 10.1128/JVI.00719-11
   CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729
   Chen TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005116
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Elbahesh H, 2011, VIROLOGY, V421, P51, DOI 10.1016/j.virol.2011.08.008
   Emara MM, 2008, J VIROL, V82, P10657, DOI 10.1128/JVI.00991-08
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fros JJ, 2012, J VIROL, V86, P10873, DOI 10.1128/JVI.01506-12
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Harding HP, 1999, NATURE, V397, P271
   Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7
   Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028
   Koyano S, 1999, NEUROSCI LETT, V273, P117, DOI 10.1016/S0304-3940(99)00656-4
   LEVIN DH, 1980, P NATL ACAD SCI-BIOL, V77, P832, DOI 10.1073/pnas.77.2.832
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117
   Lindenbach BD, 2013, FLAVIVIRIDAE FIELDS
   Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Maziuk B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00089
   McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996
   Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128
   Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003
   Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573
   Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045
   Velazquez-Perez LC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00472
   Wang MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105534
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006
   Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56
   Yi ZG, 2011, J VIROL, V85, P6996, DOI 10.1128/JVI.00013-11
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 88
TC 4
Z9 5
U1 1
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2019
VL 93
IS 12
AR e00520-19
DI 10.1128/JVI.00520-19
PG 22
WC Virology
SC Virology
GA IA1ZC
UT WOS:000469360000017
PM 30944179
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carbaugh, DL
   Baric, RS
   Lazear, HM
AF Carbaugh, Derek L.
   Baric, Ralph S.
   Lazear, Helen M.
TI Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; flavivirus; Ifnar1(-/-) mouse; glycosylation; DC-SIGN;
   CD209; DC-SIGNR; L-SIGN; CD209L
ID HUMAN DENDRITIC CELLS; DC-SIGN; DENGUE VIRUS; LINKED GLYCANS; IN-VITRO;
   INFECTION; DETERMINANTS; ANTIBODIES; TRANSMISSION; RECOGNITION
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus. Recent ZIKV outbreaks have produced serious human disease, including neurodevelopmental malformations (congenital Zika syndrome) and Guillain-Barre syndrome. These outcomes were not associated with ZIKV infection prior to 2013, raising the possibility that viral genetic changes could contribute to new clinical manifestations. All contemporary ZIKV isolates encode an N-linked glycosylation site in the envelope (E) protein (N154), but this glycosylation site is absent in many historical ZIKV isolates. Here, we investigated the role of E protein glycosylation in ZIKV pathogenesis using two contemporary Asian-lineage strains (H/PF/2013 and PRVABC59) and the historical African-lineage strain (MR766). We found that glycosylated viruses were highly pathogenic in Ifnar1(-/-) mice. In contrast, nonglycosylated viruses were attenuated, producing lower viral loads in the serum and brain when inoculated subcutaneously but remaining neurovirulent when inoculated intracranially. These results suggest that E glycosylation is advantageous in the periphery but not within the brain. Accordingly, we found that glycosylation facilitated infection of cells expressing the lectins dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) or DC-SIGN-related (DC-SIGNR), suggesting that inefficient infection of lectin-expressing leukocytes could contribute to the attenuation of nonglycosylated ZIKV in mice.
   IMPORTANCE It is unclear why the ability of Zika virus (ZIKV) to cause serious disease, including Guillain-Barre syndrome and birth defects, was not recognized until recent outbreaks. One contributing factor could be genetic differences between contemporary ZIKV strains and historical ZIKV strains. All isolates from recent outbreaks encode a viral envelope protein that is glycosylated, whereas many historical ZIKV strains lack this glycosylation. We generated nonglycosylated ZIKV mutants from contemporary and historical strains and evaluated their virulence in mice. We found that nonglycosylated viruses were attenuated and produced lower viral loads in serum and brains. Our studies suggest that envelope protein glycosylation contributes to ZIKV pathogenesis, possibly by facilitating attachment to and infection of lectin-expressing leukocytes.
C1 [Carbaugh, Derek L.; Baric, Ralph S.; Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM helen.lazear@med.unc.edu
OI Baric, Ralph/0000-0001-6827-8701; Carbaugh, Derek/0000-0002-5721-7097;
   Lazear, Helen/0000-0002-8649-4579
FU UNC Chapel Hill [P01AI106695, R21AI129431];  [T32AI007419]
FX This work was supported by grant number P01AI106695 to R.S.B. and grant
   number R21AI129431 and start-up funds from UNC Chapel Hill to H.M.L.
   D.L.C. was supported by grant number T32AI007419.
CR Agrelli A, 2019, INFECT GENET EVOL, V69, P22, DOI 10.1016/j.meegid.2019.01.018
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jaeger A, 2018, BIORXIV, DOI [10.1101/387118, DOI 10.1101/387118]
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liang JJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00239
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prow NA, 2011, J GEN VIROL, V92, P2286, DOI 10.1099/vir.0.034793-0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Schootman M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3371-8
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yan DW, 2018, J VIROL, V92, DOI [10.1128/jvi.00427-18, 10.1128/JVI.00427-18]
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 80
TC 9
Z9 10
U1 3
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2019
VL 93
IS 12
AR e00113-19
DI 10.1128/JVI.00113-19
PG 16
WC Virology
SC Virology
GA IA1ZC
UT WOS:000469360000005
PM 30944176
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU DeCocker, K
AF DeCocker, Karen
TI Zika Virus and Pregnancy Concerns
SO NURSING CLINICS OF NORTH AMERICA
LA English
DT Article
DE Congenital Zika syndrome; Zika virus; Microcephaly; Prenatal infection;
   Birth defect
ID TRANSMISSION; INFECTION
AB Understanding Zika virus (ZIKV) transmission and the risk of birth defects associated with infection during the childbearing years is imperative. Current knowledge helps guide communication, prevention, and planning efforts between health care providers and female patients of childbearing age. Providers must follow updated data and implement ongoing rapid, sensitive, and specific screening and diagnostic testing for ZIKV. Surveillance of infants with known, in utero ZIKV exposure or infection must be maintained to gain a broader understanding of potential defects or injuries that are not immediately obvious at birth and in early infancy.
C1 [DeCocker, Karen] Rush Univ, Coll Nursing, Dept Women Children & Family Nursing, 600 South Paulina St 1080, Chicago, IL 60612 USA.
RP DeCocker, K (corresponding author), Rush Univ, Coll Nursing, Dept Women Children & Family Nursing, 600 South Paulina St 1080, Chicago, IL 60612 USA.
EM karen_decocker@rush.edu
CR Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Centers for Disease Control and Prevention, 2018, US ZIK PREGN INF REG
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, 2018, OUTC PREGN LAB EV PO
   Centers for Disease Control and Prevention, 2018, PARENTS
   Centers for Disease Control and Prevention, PREGN WOM 2018
   Centers for Disease Control and Prevention, 2017 CAS COUNTS US
   Centers for Disease Control and Prevention, 2016, WHAT KNOW YOUR BAB W
   Centers for Disease Control and Prevention, PREV MOSQ BIT 2018
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   King NJC, 2017, TRENDS MICROBIOL, V25, P701, DOI 10.1016/j.tim.2017.05.005
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   World Health Organization, ZIK VIR 2018
   World Health Organization, HIST ZIK VIR 2017
   World Health Organization, ZIK VIR COMPL QUEST
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 20
TC 1
Z9 1
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0029-6465
EI 1558-1357
J9 NURS CLIN N AM
JI Nurs. Clin. North Am.
PD JUN
PY 2019
VL 54
IS 2
BP 285
EP +
DI 10.1016/j.cnur.2019.02.005
PG 12
WC Nursing
SC Nursing
GA IA1HW
UT WOS:000469311000011
PM 31027667
DA 2020-07-08
ER

PT J
AU Ali, K
   Zain-ul-abdin, K
   Li, C
   Johns, L
   Ali, AA
   Carcioppolo, N
AF Ali, Khudejah
   Zain-ul-abdin, Khawaja
   Li, Cong
   Johns, Lisa
   Ali, Ayesha Aziz
   Carcioppolo, Nicholas
TI Viruses Going Viral: Impact of Fear-Arousing Sensationalist Social Media
   Messages on User Engagement
SO SCIENCE COMMUNICATION
LA English
DT Article
DE crisis communication; health communication; infectious disease; risk
   communication; social media
ID ZIKA VIRUS; RISK COMMUNICATION; INFECTIOUS-DISEASE; NEWS COVERAGE;
   HEALTH; APPEALS; EBOLA; AMPLIFICATION; CREDIBILITY; INFORMATION
AB Social media presents a promising yet competitive communication landscape for health practitioners and organizations during the rapid spread of an emerging infectious disease. The current study examined the association between the level of fear-arousing sensationalism and user engagement in 800 Facebook posts regarding the 2016 Zika virus outbreak. Results revealed that the majority of nonnews posts completely lacked sensationalist elements, and that user engagement increased significantly as the level of fear-arousing sensationalism increased from low levels. We discuss the potential value of message design that can engender an appropriate level of public concern and increase user engagement on social media.
C1 [Ali, Khudejah; Li, Cong; Carcioppolo, Nicholas] Univ Miami, Sch Commun, Coral Gables, FL 33124 USA.
   [Zain-ul-abdin, Khawaja] Lahore Univ Management Sci, Suleman Dawood Sch Business, Lahore, Pakistan.
   [Johns, Lisa] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
   [Ali, Ayesha Aziz] Florida Int Univ, Herbert Werthe Coll Med, Miami, FL 33199 USA.
RP Ali, K (corresponding author), 5100 Brunson Dr, Coral Gables, FL 33146 USA.
EM kia16@miami.edu
CR ARKIN EB, 1990, PUBLIC HEALTH REP, V105, P219
   Bandura A., 1997, SELF EFFICACY EXERCI
   Black David R, 2015, J Emerg Manag, V13, P217, DOI 10.5055/jem.2015.0235
   Bucher Hans-Juergen, 2002, 1 MONDAY, V7, DOI [10.5210/fm.v7i4.943, DOI 10.5210/FM.V7I4.943]
   Cabling M. L., 2017, HEALTH COMMUN, V33, P1158, DOI DOI 10.1080/10410236.2017.1339370]
   Cappella JN, 2015, MEDIA PSYCHOL, V18, P396, DOI 10.1080/15213269.2014.941112
   Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231
   Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007
   Chan MPS, 2018, J PUBLIC HEALTH-UK, V40, P776, DOI 10.1093/pubmed/fdy085
   Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004
   Cho H, 2006, HEALTH COMMUN, V20, P91, DOI 10.1207/s15327027hc2001_9
   Chung CJ, 2012, J COMPUT-MEDIAT COMM, V17, P171, DOI 10.1111/j.1083-6101.2011.01565.x
   Dalrymple KE, 2016, SCI COMMUN, V38, P442, DOI 10.1177/1075547016655546
   Dunlop S, 2008, MEDIA PSYCHOL, V11, P52, DOI 10.1080/15213260701853112
   Farhadloo M, 2018, JMIR PUBLIC HLTH SUR, V4, P57, DOI 10.2196/publichealth.8186
   Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167
   Feinberg Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129587
   Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Freberg K, 2012, PUBLIC RELAT REV, V38, P416, DOI 10.1016/j.pubrev.2012.01.008
   Fung TKF, 2011, J HEALTH COMMUN, V16, P889, DOI 10.1080/10810730.2011.561913
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   GORNEY C, 1992, JOURNALISM QUART, V69, P455, DOI 10.1177/107769909206900219
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Grabe ME, 2001, J BROADCAST ELECTRON, V45, P635, DOI 10.1207/s15506878jobem4504_6
   Guttman N, 2011, ROUTL COMMUN SER, P632
   Hartmann P, 2014, INT J ADVERT, V33, P741, DOI 10.2501/IJA-33-4-741-765
   Hastings G, 2004, PSYCHOL MARKET, V21, P961, DOI 10.1002/mar.20043
   Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664
   Hermida A, 2012, JOURNALISM STUD, V13, P815, DOI 10.1080/1461670X.2012.664430
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X
   Ihekweazu C, 2017, HEALTH COMMUN, V32, P741, DOI 10.1080/10410236.2016.1172287
   Janis IL, 1967, ADV EXPT SOCIAL PSYC, V3, P166, DOI DOI 10.1016/S0065-2601(08)60344-5
   Kasperson J., 2003, SOCIAL AMPLIFICATION, P13, DOI DOI 10.1017/CBO9780511550461
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Lang A, 2000, J COMMUN, V50, P46, DOI 10.1093/joc/50.1.46
   Leask J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-535
   Lehmann J., 2012, USER MODELING ADAPTA, V7379, P164, DOI [DOI 10.1007/978-3-642-31454-4_14, 10.1007/978-3-642-31454-4_14]
   Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433
   Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763
   Liu BF, 2016, COMMUN RES, V43, P626, DOI 10.1177/0093650214565917
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Luminet O, 2000, COGNITION EMOTION, V14, P661, DOI 10.1080/02699930050117666
   McGough S. F., 2017, PLOS NEGLECT TROP D, V11, P1
   Metzger MJ, 2013, J PRAGMATICS, V59, P210, DOI 10.1016/j.pragma.2013.07.012
   Metzger MJ, 2003, COMM YEARB, V27, P293, DOI 10.1207/s15567419cy2701_10
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Morse Stephen S., 2009, P193
   Muthusamy N, 2009, J COMMUN, V59, P317, DOI 10.1111/j.1460-2466.2009.01418.x
   Nii-Trebi NI, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/5245021
   Paek HJ, 2016, HEALTH COMMUN, V31, P1051, DOI 10.1080/10410236.2015.1037419
   Pan American Health Organization/World Health Organization, 2016, ZIK CUM CAS 29 DEC 2
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD 29 DEC 20
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pew Research Center, 2012, WHY FAC US GET MOR T
   Pfefferbaum B, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0464-x
   Rhodes N, 2017, COMMUN RES, V44, P952, DOI 10.1177/0093650214565916
   Rimal RN, 2001, J COMMUN, V51, P633, DOI 10.1111/j.1460-2466.2001.tb02900.x
   RIME B, 1995, EVERYDAY CONCEPTIONS, P475, DOI DOI 10.1007/978-94-015-8484-5_27
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P100, DOI 10.1016/j.tmaid.2014.11.004
   Rundmo Torbjorn, 2002, J RISK RES, V5, P119, DOI DOI 10.1080/136698702753499597
   Rus HM, 2016, ANN BEHAV MED, V50, P678, DOI 10.1007/s12160-016-9793-9
   Schultz F, 2011, PUBLIC RELAT REV, V37, P20, DOI 10.1016/j.pubrev.2010.12.001
   Slattery K. L, 1994, J MASS MEDIA ETHICS, V1, P5, DOI [10.1207/s15327728jmme0901_1, DOI 10.1207/S15327728JMME0901_1]
   Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Smith W. A., 2000, ETHICS SOCIAL MARKET, P632
   Southwell B. G., 2007, COMMUNICATION YB, V31, P420, DOI DOI 10.1080/23808985.2007.11679072
   Statista, MOST POP SOC NETW WO
   Strekalova YA, 2017, J HEALTH COMMUN, V22, P849, DOI 10.1080/10810730.2017.1367336
   Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310
   Thackeray R, 2008, HEALTH PROMOT PRACT, V9, P338, DOI 10.1177/1524839908325335
   van Doorn J, 2010, J SERV RES-US, V13, P253, DOI 10.1177/1094670510375599
   Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002
   Vasterman PLM, 2013, EUR J COMMUN, V28, P436, DOI 10.1177/0267323113486235
   Veil S, 2008, HEALTH PROMOT PRACT, V9, p26S, DOI 10.1177/1524839908322113
   Veil SR, 2011, J CONTING CRISIS MAN, V19, P110, DOI 10.1111/j.1468-5973.2011.00639.x
   Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328
NR 83
TC 1
Z9 1
U1 21
U2 29
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1075-5470
EI 1552-8545
J9 SCI COMMUN
JI Sci. Commun.
PD JUN
PY 2019
VL 41
IS 3
BP 314
EP 338
DI 10.1177/1075547019846124
PG 25
WC Communication
SC Communication
GA IA2KC
UT WOS:000469389200003
DA 2020-07-08
ER

PT J
AU Krammer, F
   Lim, JK
AF Krammer, Florian
   Lim, Jean K.
TI Dengue and Zika: The Complexities of Being Related
SO TRENDS IN IMMUNOLOGY
LA English
DT Editorial Material
ID ANTIBODY-DEPENDENT ENHANCEMENT; VIRUS
AB Following the recent Zika virus (ZIKV) outbreak in the Americas, a major question that has arisen is how dengue virus (DENV) immunity impacts Zika virus infection and disease. A recent study (Rodriguez-Barraquer, I. et al. Science 2019;363:607-610) shows that DENV immunity is, for the most part, protective against ZIKV, but exceptions may exist.
C1 [Krammer, Florian; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
RP Lim, JK (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM jean.lim@mssm.edu
RI Krammer, Florian/H-3237-2019
OI Krammer, Florian/0000-0003-4121-776X
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129477, R21AI144844, R21AI139593]
FX The authors are supported by NIAID grants R21AI129477 (F.K.),
   R21AI144844 (J.K.L.), and R21AI139593(J.K.L.). We are grateful to Drs
   Dusan Bogunovic and Christopher J. Obara for invaluable review of the
   manuscript.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD JUN
PY 2019
VL 40
IS 6
BP 467
EP 469
DI 10.1016/j.it.2019.04.008
PG 4
WC Immunology
SC Immunology
GA IA1WK
UT WOS:000469353000003
PM 31072687
DA 2020-07-08
ER

PT J
AU Brown, CK
   Shugart, JM
AF Brown, Christopher K.
   Shugart, Jill M.
TI Zika virus in workers: Considerations for ongoing exposure prevention
SO AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
LA English
DT Editorial Material
DE arbovirus; infectious diseases; occupational health; vector-borne
   diseases; Zika
ID PERSONAL PROTECTION MEASURES; BIRTH-DEFECTS; INFECTION; INFANTS
AB Since at least 2015, a major Zika virus epidemic has impacted the Americas and the Caribbean. There is an ongoing risk of Aedes mosquito-borne transmission in more than 90 countries and territories worldwide. In these areas, as well as in places that are not experiencing active outbreaks, workers in a variety of jobs may be exposed to the virus. In addition to outdoor workers in places with ongoing, vector-borne transmission who may be exposed when bitten by Zika-infected mosquitoes, biomedical researchers studying the virus and health care workers and staff in clinical laboratories may encounter blood and infectious body fluids from infected individuals, including travelers from Zika virus-affected areas. Because of potentially serious health outcomes, including reproductive effects, sometimes associated with Zika, the Occupational Safety and Health Administration and National Institute for Occupational Safety and Health previously issued guidance to help US employers protect workers from exposure to the virus on the job. This commentary summarizes the details of these recommendations and explains their rationale, which is important to understand when adapting and implementing workplace controls to prevent occupational Zika virus exposures and infections at individual worksites. The industrial hygiene hierarchy of controls, including elimination and substitution, engineering controls, administrative controls, and safe work practices, and personal protective equipment, serves as a framework for infection prevention practices for at-risk workers discussed here.
C1 [Brown, Christopher K.] US Dept Labor, Occupat Safety & Hlth Adm, Off Emergency Management & Preparedness, 200 Constitut Ave NW, Washington, DC 20210 USA.
   [Shugart, Jill M.] NIOSH, US Dept HHS, Ctr Dis Control & Prevent, Emergency Preparedness & Response Off, Atlanta, GA USA.
RP Brown, CK (corresponding author), US Dept Labor, Occupat Safety & Hlth Adm, Off Emergency Management & Preparedness, 200 Constitut Ave NW, Washington, DC 20210 USA.
EM brown.christopher.k@dol.gov
RI Brown, Christopher/AAO-1740-2020
OI Brown, Christopher/0000-0001-7836-5964
CR Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Bohle P, 2000, OCCUPATIONAL HLTH SA
   BUESCHER MD, 1983, MOSQ NEWS, V43, P364
   Centers for Disease Control and Prevention, TRAV HLTH ZIK TRAV I
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Occupational Safety and Health Administration National Institute for Occupational Safety and Health, INT GUID PROT WORK O
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schoepke A, 1998, J TRAVEL MED, V5, P188, DOI 10.1111/j.1708-8305.1998.tb00505.x
   Shugart JM, 2019, APPL BIOSAF, V24, P8
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   World Health Organization, ZIK VIR INF IND
NR 20
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0271-3586
EI 1097-0274
J9 AM J IND MED
JI Am. J. Ind. Med.
PD JUN
PY 2019
VL 62
IS 6
BP 455
EP 459
DI 10.1002/ajim.22978
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HZ4DJ
UT WOS:000468797000001
PM 31025402
DA 2020-07-08
ER

PT J
AU Clyde, D
AF Clyde, Dorothy
TI Scanning for determinants of Zika virus host tropism
SO NATURE REVIEWS GENETICS
LA English
DT Editorial Material
CR Setoh YX, 2019, NAT MICROBIOL, V4, P876, DOI 10.1038/s41564-019-0399-4
NR 1
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD JUN
PY 2019
VL 20
IS 6
BP 320
EP 321
DI 10.1038/s41576-019-0120-8
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA HZ0ZI
UT WOS:000468574800007
PM 30918368
DA 2020-07-08
ER

PT J
AU Chiu, CY
   Miller, SA
AF Chiu, Charles Y.
   Miller, Steven A.
TI Clinical metagenomics
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID POLYMERASE-CHAIN-REACTION; REAL-TIME; ZIKA VIRUS; RNA-SEQ; POTENTIAL
   APPLICATIONS; LABORATORY DIAGNOSIS; PATHOGEN DETECTION; GENERATION;
   CANCER; DNA
AB Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host genetic material (DNA and RNA) in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing how physicians diagnose and treat infectious disease, with applications spanning a wide range of areas, including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics) and oncology. Here, we focus on the challenges of implementing mNGS in the clinical laboratory and address potential solutions for maximizing its impact on patient care and public health.
C1 [Chiu, Charles Y.; Miller, Steven A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA.
EM charles.chiu@ucsf.edu
OI Chiu, Charles/0000-0003-2915-2094
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01 HL105704]; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R33
   AI120977]
CR Afshinnekoo E, 2016, BRIT MED BULL, V120, P27, DOI 10.1093/bmb/ldw044
   Ahn SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063510
   ALLEGRETTI M, 2018, J EXP CLIN CANC RES, V37
   Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657
   Aravanis AM, 2017, CELL, V168, P571, DOI 10.1016/j.cell.2017.01.030
   Avey S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal4656
   Avraham R, 2016, NAT PROTOC, V11, P1477, DOI 10.1038/nprot.2016.090
   Babayan A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0533-6
   Banerjee A, 2017, TRANSL RES, V186, P62, DOI 10.1016/j.trsl.2017.06.007
   Basein T., 2017, OPEN FORUM INFECT DI, V4, pS627
   Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6
   Boja E, 2018, NAT MED, V24, P1301, DOI 10.1038/s41591-018-0180-x
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Bouquet J, 2016, MBIO, V7, DOI 10.1128/mBio.00100-16
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Brinkmann A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006075
   Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Castro-Wallace SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18364-0
   Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295
   Charalampous T, 2018, BIORXIV, DOI [10.1101/387548., 10.1101/387548, DOI 10.1101/387548]
   Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001
   Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   DeBiasi RL, 2004, CLIN MICROBIOL REV, V17, P903, DOI 10.1128/CMR.17.4.903-925.2004
   Deurenberg RH, 2017, J BIOTECHNOL, V243, P16, DOI 10.1016/j.jbiotec.2016.12.022
   DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126
   Emerson JB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0285-3
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096
   Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
   Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1
   Food and Drug Administration, 2016, INF DIS NEXT GEN SEQ
   Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gargis AS, 2016, J CLIN MICROBIOL, V54, P2857, DOI 10.1128/JCM.00949-16
   Gliddon HD, 2018, IMMUNOLOGY, V153, P171, DOI 10.1111/imm.12841
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Goodacre N, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00069-18
   GREAY TL, 2018, PARASITE VECTOR, V11
   Greninger AL, 2018, EXPERT REV MOL DIAGN, V18, P605, DOI 10.1080/14737159.2018.1487292
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Hampton-Marcell JT, 2017, MICROB BIOTECHNOL, V10, P228, DOI 10.1111/1751-7915.12699
   Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15
   Hong DK, 2018, DIAGN MICR INFEC DIS, V92, P210, DOI 10.1016/j.diagmicrobio.2018.06.009
   Ivy MI, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00402-18, 10.1128/jcm.00402-18]
   Jackson S. A., 2018, NIST DHS FDA WORKSH
   JAIN M, 2016, GENOME BIOL, V17
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012
   Kerkhof LJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0336-9
   Khare R, 2014, J CLIN MICROBIOL, V52, P3667, DOI 10.1128/JCM.01637-14
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Kukurba Kimberly R, 2015, Cold Spring Harb Protoc, V2015, P951, DOI 10.1101/pdb.top084970
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Langelier C, 2018, P NATL ACAD SCI USA, V115, pE12353, DOI 10.1073/pnas.1809700115
   Langelier C, 2018, AM J RESP CRIT CARE, V197, P524, DOI 10.1164/rccm.201706-1097LE
   Leber AL, 2016, J CLIN MICROBIOL, V54, P2251, DOI 10.1128/JCM.00730-16
   Lee HJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3619
   Lefterova MI, 2015, J MOL DIAGN, V17, P623, DOI 10.1016/j.jmoldx.2015.07.004
   Levy SE, 2016, ANNU REV GENOM HUM G, V17, P95, DOI 10.1146/annurev-genom-083115-022413
   Li R., 2017, SCI REP, V7
   Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3
   Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231
   Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]
   Marques AR, 2015, INFECT DIS CLIN N AM, V29, P295, DOI 10.1016/j.idc.2015.02.005
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   May M., 2016, NIST SPECIAL PUBLICA, V1222, P1
   McClain MT, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw007
   McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18
   McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   MILANI C, 2016, SCI REP UK, V6
   Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09
   Miller S., 2019, LAB VALIDATION CLIN, DOI [10.1101/330381, DOI 10.1101/330381]
   Mitsuhashi S, 2017, SCI REP, V7
   Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Nakagawa H, 2018, CANCER SCI, V109, P513, DOI 10.1111/cas.13505
   Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349
   Nutman A, 2019, CLIN MICROBIOL INFEC, V25, P688, DOI 10.1016/j.cmi.2018.09.017
   O'Neil Dominic, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0419s103
   Oikonomopoulos S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31602
   ONICIUC EA, 2018, GENES BASEL, V9
   Pallen MJ, 2014, PARASITOLOGY, V141, P1856, DOI 10.1017/S0031182014000134
   Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007
   Pine PS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0281-x
   Presidential Council, 2015, NAT ACT PLAN COMB AN
   Quan J., 2018, FLASH NEXT GENERATIO, DOI [10.1101/426338, DOI 10.1101/426338]
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   Rampini SK, 2011, CLIN INFECT DIS, V53, P1245, DOI 10.1093/cid/cir692
   Rascovan N, 2016, ANNU REV MICROBIOL, V70, P125, DOI 10.1146/annurev-micro-102215-095431
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Roy S, 2018, J MOL DIAGN, V20, P4, DOI 10.1016/j.jmoldx.2017.11.003
   Ruggiero P, 2014, J CLIN MICROBIOL, V52, P288, DOI 10.1128/JCM.02787-13
   Saha A, 2010, CANCER BIOL THER, V10, P961, DOI 10.4161/cbt.10.10.13923
   Salipante SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065226
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Samarkos M, 2018, EUR J INTERN MED, V50, P28, DOI 10.1016/j.ejim.2018.02.006
   Schlaberg R, 2017, J INFECT DIS, V215, P1407, DOI 10.1093/infdis/jix148
   Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA
   Shogbesan O, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/1394379
   Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881
   Singhania A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04579-w
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596
   Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289
   Stakaityte G, 2014, CANCERS, V6, P1267, DOI 10.3390/cancers6031267
   Stefan CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25904
   Street TL, 2017, J CLIN MICROBIOL, V55, P2334, DOI 10.1128/JCM.00462-17
   Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002
   Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437
   Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165
   Tang KW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0265
   Tang YW, 2016, J CLIN MICROBIOL, V54, P1912, DOI 10.1128/JCM.00482-16
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Ufarte L, 2015, BIOTECHNOL ADV, V33, P1845, DOI 10.1016/j.biotechadv.2015.10.009
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789
   WAGNER K, 2018, SCI REP UK, V8
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Young VB, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j831
   Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715
   Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1
   Zhang YH, 2017, ONCOTARGET, V8, P87494, DOI 10.18632/oncotarget.20903
   Zhao FQ, 2015, GENOM PROTEOM BIOINF, V13, P271, DOI 10.1016/j.gpb.2015.10.002
   Zhou YJ, 2016, J CLIN MICROBIOL, V54, P368, DOI 10.1128/JCM.01965-15
   Zinter MS, 2019, CLIN INFECT DIS, V68, P1847, DOI 10.1093/cid/ciy802
NR 143
TC 37
Z9 40
U1 28
U2 60
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD JUN
PY 2019
VL 20
IS 6
BP 341
EP 355
DI 10.1038/s41576-019-0113-7
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA HZ0ZI
UT WOS:000468574800011
PM 30918369
OA Green Published
DA 2020-07-08
ER

PT J
AU Ojha, CR
   Rodriguez, M
   Karuppan, MKM
   Lapierre, J
   Kashanchi, F
   El-Hage, N
AF Ojha, C. R.
   Rodriguez, M.
   Karuppan, Muthu M. K.
   Lapierre, J.
   Kashanchi, F.
   El-Hage, N.
TI Toll-like receptor 3 regulates Zika virus infection and associated host
   inflammatory response in primary human astrocytes
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Ojha, C. R.; Rodriguez, M.; Karuppan, Muthu M. K.; Lapierre, J.; El-Hage, N.] Florida Int Univ, Dept Immunol & Nanomed, Miami, FL 33174 USA.
   [Kashanchi, F.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.
FU Florida Department of Health; NIH/NIDAUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA); FIU StartUp Funds
FX Supported by Florida Department of Health, NIH/NIDA and FIU StartUp
   Funds
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD JUN
PY 2019
VL 14
IS 2
MA W34
BP 347
EP 347
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA HY7XT
UT WOS:000468351800071
DA 2020-07-08
ER

PT J
AU Seth, P
   Bhagat, R
AF Seth, P.
   Bhagat, R.
TI Molecular mechanisms of ZIKV induced alteration in developing brain
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Seth, P.; Bhagat, R.] Natl Brain Res Ctr, Cellular & Mol Neurosci, Manesar 122052, Haryana, India.
FU NBRC core funds
FX Supported by This research was funded by NBRC core funds.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD JUN
PY 2019
VL 14
IS 2
MA T43
BP 363
EP 363
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA HY7XT
UT WOS:000468351800132
DA 2020-07-08
ER

PT J
AU Kottkamp, AC
   De Jesus, E
   Grande, R
   Brown, JA
   Jacobs, AR
   Lim, JK
   Stapleford, KA
AF Kottkamp, Angelica Cifuentes
   De Jesus, Elfie
   Grande, Rebecca
   Brown, Julia A.
   Jacobs, Adam R.
   Lim, Jean K.
   Stapleford, Kenneth A.
TI Atovaquone Inhibits Arbovirus Replication through the Depletion of
   Intracellular Nucleotides
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika; antiviral; arbovirus; atovaquone; pregnancy
ID ZIKA VIRUS-INFECTION; BROAD-SPECTRUM; IN-VITRO; PLASMODIUM-FALCIPARUM;
   RIBAVIRIN; COMBINATION; ANTIVIRALS; FIDELITY; EFFICACY; FITNESS
AB Arthropod-borne viruses represent a significant public health threat worldwide, yet there are few antiviral therapies or prophylaxes targeting these pathogens. In particular, the development of novel antivirals for high-risk populations such as pregnant women is essential to prevent devastating disease such as that which was experienced with the recent outbreak of Zika virus (ZIKV) in the Americas. One potential avenue to identify new and pregnancy-acceptable antiviral compounds is to repurpose well-known and widely used FDA-approved drugs. In this study, we addressed the antiviral role of atovaquone, an FDA Pregnancy Category C drug and pyrimidine biosynthesis inhibitor used for the prevention and treatment of parasitic infections. We found that atovaquone was able to inhibit ZIKV and chikungunya virus virion production in human cells and that this antiviral effect occurred early during infection at the initial steps of viral RNA replication. Moreover, we were able to complement viral replication and virion production with the addition of exogenous pyrimidine nucleosides, indicating that atovaquone functions through the inhibition of the pyrimidine biosynthesis pathway to inhibit viral replication. Finally, using an ex vivo human placental tissue model, we found that atovaquone could limit ZIKV infection in a dose-dependent manner, providing evidence that atovaquone may function as an antiviral in humans. Taken together, these studies suggest that atovaquone could be a broad-spectrum antiviral drug and a potential attractive candidate for the prophylaxis or treatment of arbovirus infection in vulnerable populations, such as pregnant women and children.
   IMPORTANCE The ability to protect vulnerable populations such as pregnant women and children from Zika virus and other arbovirus infections is essential to preventing the devastating complications induced by these viruses. One class of antiviral therapies may lie in known pregnancy-acceptable drugs that have the potential to mitigate arbovirus infections and disease, yet this has not been explored in detail. In this study, we show that the common antiparasitic drug atovaquone inhibits arbovirus replication through intracellular nucleotide depletion and can impair ZIKV infection in an ex vivo human placental explant model. Our study provides a novel function for atovaquone and highlights that the rediscovery of pregnancy-acceptable drugs with potential antiviral effects can be the key to better addressing the immediate need for treating viral infections and preventing potential birth complications and future disease.
C1 [Kottkamp, Angelica Cifuentes] NYU, Sch Med, Dept Med, New York, NY USA.
   [De Jesus, Elfie; Grande, Rebecca; Stapleford, Kenneth A.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [Brown, Julia A.; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Brown, Julia A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Jacobs, Adam R.] Icahn Sch Med Mt Sinai, Dept Obstet & Gynecol, Pediat & Med Educ, New York, NY 10029 USA.
RP Stapleford, KA (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM Kenneth.stapleford@nyumc.org
OI Kottkamp, Angelica/0000-0003-4103-1666; Stapleford,
   Kenneth/0000-0002-7796-2254
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Oliveira RDAB, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3243-1
   ARTYMOWICZ RJ, 1993, CLIN PHARMACY, V12, P563
   Ashton TM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12308
   Baggish AL, 2002, ANTIMICROB AGENTS CH, V46, P1163, DOI 10.1128/AAC.46.5.1163-1173.2002
   BASCO LK, 1995, AM J TROP MED HYG, V53, P388, DOI 10.4269/ajtmh.1995.53.388
   Basurko C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202005
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beltrami S, 2014, J NEUROVIROL, V20, P137, DOI 10.1007/s13365-013-0222-6
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   dos Santos BMC, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00038218, 10.1590/0102-311X00038218]
   Cushion MT, 2000, ANTIMICROB AGENTS CH, V44, P713, DOI 10.1128/AAC.44.3.713-719.2000
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   de la Camara R, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.031
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gallegos KM, 2016, J INFECT DIS, V214, P1192, DOI 10.1093/infdis/jiw358
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hinton TM, 2016, ADV HEALTHC MATER, V5, P534, DOI 10.1002/adhm.201500841
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Hua C, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0694-0
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kottkamp AC, 2018, BIORXIV, DOI [10.1101/507152, DOI 10.1101/507152]
   KOVACS JA, 1992, LANCET, V340, P637, DOI 10.1016/0140-6736(92)92172-C
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004
   Ling J, 2002, CLIN INFECT DIS, V35, P825, DOI 10.1086/342578
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luthra P, 2018, ANTIVIR RES, V158, P288, DOI 10.1016/j.antiviral.2018.08.012
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Munawwar Arshi, 2016, J Lab Physicians, V8, P5, DOI 10.4103/0974-2727.176228
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramos R, 2018, PEDIATR INFECT DIS J, V37, P94, DOI 10.1097/INF.0000000000001690
   Raveh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082318
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro MR, 2018, ARCH VIROL, V163, P2687, DOI 10.1007/s00705-018-3911-x
   Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shanks GD, 1998, CLIN INFECT DIS, V27, P494, DOI 10.1086/514710
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Siregar JE, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2014.09.011
   Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317
   Stapleford KA, 2015, J VIROL, V89, P11233, DOI 10.1128/JVI.01553-15
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan KR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2352-z
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waghmare A, 2013, CLIN INFECT DIS, V57, P1731, DOI 10.1093/cid/cit639
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yeo AET, 1997, BIOCHEM PHARMACOL, V53, P943, DOI 10.1016/S0006-2952(96)00835-0
   Yeo KL, 2015, ANTIMICROB AGENTS CH, V59, P2086, DOI 10.1128/AAC.04779-14
   2018, PROG RETIN EYE RES, V66, P85, DOI DOI 10.1016/J.PRETEYERES.2018.04.004
   2017, CELL RES, V27, P1046, DOI DOI 10.1038/CR.2017.88
NR 83
TC 3
Z9 3
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2019
VL 93
IS 11
AR e00389-19
DI 10.1128/JVI.00389-19
PG 15
WC Virology
SC Virology
GA HY2CZ
UT WOS:000467925600022
PM 30894466
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Uraki, R
   Hastings, AK
   Marin-Lopez, A
   Sumida, T
   Takahashi, T
   Grover, JR
   Iwasaki, A
   Hafler, DA
   Montgomery, RR
   Fikrig, E
AF Uraki, Ryuta
   Hastings, Andrew K.
   Marin-Lopez, Alejandro
   Sumida, Tomokazu
   Takahashi, Takehiro
   Grover, Jonathan R.
   Iwasaki, Akiko
   Hafler, David A.
   Montgomery, Ruth R.
   Fikrig, Erol
TI Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of
   mice
SO NATURE MICROBIOLOGY
LA English
DT Article
ID MOSQUITO; PROTEINS
AB A recent epidemic of Zika virus in the Americas, affecting well over a million people, caused substantial mortality and morbidity, including Guillain-Barre syndrome, microcephaly and other fetal developmental defects(1,2). Preventive and therapeutic measures that specifically target the virus are not readily available. The transmission of Zika virus is predominantly mosquito-borne, and Aedes aegypti mosquitoes serve as a key vector for Zika virus(3). Here, to identify salivary factors that modulate mosquito-borne Zika virus infection, we focused on antigenic proteins in mice that were repeatedly bitten by mosquitoes and developed antibodies against salivary proteins. Using a yeast surface display screen, we identified five antigenic A. aegypti salivary proteins in mice. Antiserum against one of these five proteins-A. aegypti bacteria-responsive protein 1 (AgBR1)-suppressed early inflammatory responses in the skin of mice bitten by Zika-virus-infected mosquitoes. AgBR1 antiserum also partially protected mice from lethal mosquito-borne-but not needle-injected-Zika virus infection. These data suggest that AgBR1 is a target for the prevention of mosquito-transmitted Zika virus infection.
C1 [Uraki, Ryuta; Hastings, Andrew K.; Marin-Lopez, Alejandro; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Sumida, Tomokazu; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.
   [Sumida, Tomokazu; Takahashi, Takehiro; Iwasaki, Akiko; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.
   [Grover, Jonathan R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Iwasaki, Akiko; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
EM erol.fikrig@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856; Sumida,
   Tomokazu/0000-0002-9806-2642; Montgomery, Ruth/0000-0002-8661-4454;
   Uraki, Ryuta/0000-0003-0890-1922
FU Connecticut Regenerative Medicine Research Fund; Li Ka Shing Foundation;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI089992, AI127865]; Japan Society for
   the Promotion of Science Overseas Research FellowshipsMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of Science
FX We thank S. Shresta at the La Jolla Institute for Allergy and Immunology
   for originally providing us with the AG129 mouse strain. We also thank
   S. Ren, Y.-M. Chuang, S. Householder, S. Stanley, H. Sproch and B. V.
   Wyk for supporting experiments and analysing data. The imaging mass
   cytometry was conducted at the Yale CyTOF facility and the RNA-seq
   service was conducted at the Yale Stem Cell Center Genomics Core
   facility, which was supported by the Connecticut Regenerative Medicine
   Research Fund and the Li Ka Shing Foundation. This work was supported by
   NIH grant nos AI089992 and AI127865, and the Japan Society for the
   Promotion of Science Overseas Research Fellowships. E.F. and A.I. are
   investigators with the Howard Hughes Medical Institute.
CR Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Balaban AE, 2018, J MICROSC-OXFORD, V269, P78, DOI 10.1111/jmi.12610
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200
   CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A
   Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Coutinho-Abreu IV, 2015, CURR OPIN INSECT SCI, V10, P98, DOI 10.1016/j.cois.2015.04.014
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Fong SW, 2018, J VIROL, V92, DOI [10.1128/JVI.01004-17, 10.1128/jvi.01004-17]
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Hayashi H, 2012, THROMB RES, V129, P169, DOI 10.1016/j.thromres.2011.09.015
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Kieny MP, 2004, AM J PUBLIC HEALTH, V94, P1931, DOI 10.2105/AJPH.94.11.1931
   Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260
   Olsen B., 2016, LAKARTIDNINGEN, V113
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016
   Rathore APS, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180087
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Soo S, 2017, INT J MOB COMPUT MUL, V8, P1, DOI 10.4018/IJMCMC.2017100101
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626
   Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505
NR 36
TC 5
Z9 5
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JUN
PY 2019
VL 4
IS 6
BP 948
EP 955
DI 10.1038/s41564-019-0385-x
PG 8
WC Microbiology
SC Microbiology
GA HZ1RK
UT WOS:000468625400010
PM 30858571
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Li, MH
   Johnson, JR
   Truong, B
   Kim, G
   Weinbren, N
   Dittmar, M
   Shah, PS
   Von Dollen, J
   Newton, BW
   Jang, GM
   Krogan, NJ
   Cherry, S
   Ramage, H
AF Li, Minghua
   Johnson, Jeffrey R.
   Truong, Billy
   Kim, Grace
   Weinbren, Nathan
   Dittmar, Mark
   Shah, Priya S.
   Von Dollen, John
   Newton, Billy W.
   Jang, Gwendolyn M.
   Krogan, Nevan J.
   Cherry, Sara
   Ramage, Holly
TI Identification of antiviral roles for the exon-junction complex and
   nonsense-mediated decay in flaviviral infection
SO NATURE MICROBIOLOGY
LA English
DT Article
ID MESSENGER-RNA DECAY; ENHANCE TRANSLATION; VIRUS; PROTEIN; EXPRESSION;
   SCREEN; PYM; MECHANISM; INTERACTS; REVEALS
AB West Nile virus (WNV) is an emerging mosquito-borne flavivirus, related to dengue virus and Zika virus. To gain insight into host pathways involved in WNV infection, we performed a systematic affinity-tag purification mass spectrometry (APMS) study to identify 259 WNV-interacting human proteins. RNA interference screening revealed 26 genes that both interact with WNV proteins and influence WNV infection. We found that WNV, dengue and Zika virus capsids interact with a conserved subset of proteins that impact infection. These include the exon-junction complex (EJC) recycling factor PYM1, which is antiviral against all three viruses. The EJC has roles in nonsense-mediated decay (NMD), and we found that both the EJC and NMD are antiviral and the EJC protein RBM8A directly binds WNV RNA. To counteract this, flavivirus infection inhibits NMD and the capsid-PYM1 interaction interferes with EJC protein function and localization. Depletion of PYM1 attenuates RBM8A binding to viral RNA, suggesting that WNV sequesters PYM1 to protect viral RNA from decay. Together, these data suggest a complex interplay between the virus and host in regulating NMD and the EJC.
C1 [Li, Minghua; Truong, Billy; Kim, Grace; Weinbren, Nathan; Dittmar, Mark; Cherry, Sara; Ramage, Holly] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Johnson, Jeffrey R.; Shah, Priya S.; Von Dollen, John; Newton, Billy W.; Jang, Gwendolyn M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.
   [Johnson, Jeffrey R.; Shah, Priya S.; Von Dollen, John; Newton, Billy W.; Jang, Gwendolyn M.; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.
   [Johnson, Jeffrey R.; Shah, Priya S.; Von Dollen, John; Newton, Billy W.; Jang, Gwendolyn M.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA.
   [Shah, Priya S.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
RP Cherry, S; Ramage, H (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.; Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Krogan, NJ (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.; Krogan, NJ (corresponding author), J David Gladstone Inst, San Francisco, CA 94158 USA.
EM nevan.krogan@ucsf.edu; cherrys@pennmedicine.upenn.edu;
   hramage@pennmedicine.upenn.edu
OI Shah, Priya/0000-0001-7518-2839; Li, Minghua/0000-0003-0409-5214;
   Johnson, Jeffrey/0000-0002-4221-298X
FU American Liver Foundation Liver Scholar Award; Creative and Novel Ideas
   in HIV Research Award; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19 AI118610, U19
   AI135990, P50 GM082250, R01AI074951, RO1AI122749]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease AwardBurroughs
   Wellcome Fund
FX We thank members of the Cherry, Krogan and Ramage laboratories for
   discussion, advice and reagents. We thank the University of Pennsylvania
   High-Throughput Screening Core for providing reagents and technical
   expertise. We thank J. To for virus preparations, D. Tatomer for RNA
   analyses and M. Shales for graphical support. This work was supported by
   The American Liver Foundation Liver Scholar Award and the Creative and
   Novel Ideas in HIV Research Award to H.R.; NIH grants nos. R01AI074951
   and RO1AI122749 and the Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Award to S.C.; and NIH grants nos.
   U19 AI118610, U19 AI135990 and P50 GM082250 to N.J.K.
CR Agrawal T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01813
   Baird TD, 2018, ELIFE, V7, DOI 10.7554/eLife.33178
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351
   Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091
   Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321
   Evans MV, 2018, TRENDS PARASITOL, V34, P544, DOI 10.1016/j.pt.2018.02.010
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001
   Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4
   Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120
   Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042
   Giurgiu M., 2018, NUCLEIC ACIDS RES, V47, P559
   Hafirassou ML, 2018, CELL REP, V22, P1364, DOI 10.1016/j.celrep.2018.01.038
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Mao HQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006282
   Mao HQ, 2015, J NEUROSCI, V35, P7003, DOI 10.1523/JNEUROSCI.0018-15.2015
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mocquet V, 2012, J VIROL, V86, P7530, DOI 10.1128/JVI.07021-11
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Serquina AKP, 2013, J VIROL, V87, P8853, DOI 10.1128/JVI.00925-13
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Singh KK, 2013, RNA BIOL, V10, P1291, DOI 10.4161/rna.25827
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042
   Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785
   Toma KG, 2015, RNA, V21, P887, DOI 10.1261/rna.048637.114
   Verschueren E, 2015, CURR PROTOC BIOINFOR, V49, P11
   Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Ziehr B, 2016, VIROLOGY, V489, P194, DOI 10.1016/j.virol.2015.12.009
NR 56
TC 9
Z9 9
U1 6
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JUN
PY 2019
VL 4
IS 6
BP 985
EP 995
DI 10.1038/s41564-019-0375-z
PG 11
WC Microbiology
SC Microbiology
GA HZ1RK
UT WOS:000468625400014
PM 30833725
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hornstein, BD
   Olsen, EP
   Rubinstein, RJ
   Jin, S
   Zangeneh, A
   Liu, L
   Shah, UA
AF Hornstein, Benjamin D.
   Olsen, Erika P.
   Rubinstein, Rebecca J.
   Jin, Sherry
   Zangeneh, Ana
   Liu, Leann
   Shah, Umair A.
TI Provider and Public Health Adaptation to Changing Centers for Disease
   Control and Prevention Guidance for Zika Virus, 2015-2017
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID INTERIM GUIDANCE; UNITED-STATES; INFECTION
AB In 2015, Harris County (Texas) Public Health responded to the Zika virus (ZIKV) threat by investigating every report of potential ZIKV infection, including those with negative laboratory results, through December 2017. Before investigations, 40.6% of patients who were indicated for testing received it in accordance with Centers for Disease Control and Prevention guidelines. By investigating reportswith negative ZIKV results, we increased the number of patients receiving correct and complete laboratory testing to 54.5%, and improved dissemination of evolving guidelines to partners across the health care spectrum.
C1 [Hornstein, Benjamin D.; Olsen, Erika P.; Rubinstein, Rebecca J.; Jin, Sherry; Zangeneh, Ana; Liu, Leann] Harris Cty Publ Hlth, Off Sci Surveillance & Technol, 2223 West Loop S, Houston, TX 77030 USA.
   [Shah, Umair A.] Harris Cty Publ Hlth, Houston, TX USA.
RP Hornstein, BD (corresponding author), Harris Cty Publ Hlth, Off Sci Surveillance & Technol, 2223 West Loop S, Houston, TX 77030 USA.
EM benjamin.hornstein@phs.hctx.net
OI Shah, Umair/0000-0001-9042-4189
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [NU90TP921869-01-02, U50CK000378]
FX The public health surveillance activities in this report were funded in
   part by grants NU90TP921869-01-02 and U50CK000378 by the Centers for
   Disease Control and Prevention awarded to the Texas Department of State
   Health Services.
CR Centers for Disease Control and Prevention, ZIK VIR DIS ZIK VIR
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Hotez PJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005581
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUN
PY 2019
VL 109
IS 6
BP 895
EP 898
DI 10.2105/AJPH.2019.305036
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HX2OY
UT WOS:000467232500044
PM 30998408
OA Green Published
DA 2020-07-08
ER

PT J
AU Papa, A
AF Papa, Anna
TI Emerging arboviruses of medical importance in the Mediterranean region
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article; Proceedings Paper
CT 21st Annual Meeting of the European-Society-for-Clinical-Virology (ESCV)
CY SEP 23-26, 2018
CL Athens, GREECE
SP European Soc Clin Virol
DE Arbovirus; Mediterranean countries; Emerging; Humans
ID CONGO HEMORRHAGIC-FEVER; WEST-NILE-VIRUS; TOSCANA VIRUS; USUTU-VIRUS;
   GENOMIC CHARACTERIZATION; MOLECULAR-DETECTION; ZIKA VIRUS; 1ST REPORT;
   LINEAGE 2; EUROPE 1
AB The epidemiology of viral infections transmitted by arthropods is changing due to a variety of parameters related to the virus, the host and the environment. The Mediterranean region is highly affected by changes in the intensity and extension of global-scale climate patterns, and, due to its location, it provides a vulnerable environment for emergence of arboviral diseases. The main arboviruses that pose currently a public health threat in the Mediterranean region are West Nile virus and Crimean-Congo hemorrhagic fever virus and, in less extend, tick-borne encephalitis virus. Usutu virus that affects mainly birds, can infect also humans, while Dengue and Chikungunya viruses showed that they are capable to cause sporadic autochthonous cases, and even outbreaks in the Mediterranean region. Sandly-transmitted viruses continue to have a public health impact, and novel ones have been identified. The presence of competent vectors (mainly mosquitoes), combined by arbovirus introduction through viremic travelers returning from endemic regions, prompt for increased surveillance to mitigate the risk for local transmission. In order to tackle efficiently and effectively the emerging arboviral diseases, an integrated "One Health initiative" is required to be maintained, involving public health, animal health and environmental authorities. Awareness of medical and veterinary staff and laboratory capacity are crucial for the early detection of pathogens, while reporting the unusual and enhance surveillance are important.
C1 [Papa, Anna] Aristotle Univ Thessaloniki, Med Sch, Dept Microbiol, Thessaloniki 54124, Greece.
RP Papa, A (corresponding author), Aristotle Univ Thessaloniki, Med Sch, Dept Microbiol, Thessaloniki 54124, Greece.
EM annap@med.auth.gr
FU EU Horizon 2020 research and innovation programme COMPARE [643476]
FX The study is part of the EU Horizon 2020 research and innovation
   programme COMPARE (grant agreement No 643476).
CR Abozeid S, 2018, LANCET INFECT DIS, V18, P142, DOI 10.1016/S1473-3099(18)30018-5
   Anagnostou V, 2011, EMERG INFECT DIS, V17, P940, DOI 10.3201/eid1705.101958
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ayhan N, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00336
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Bakonyi T., 2017, EURO SURVEILL, V22
   Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669
   Beaute J, 2018, EURO SURVEILL, V23
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   Bordi L, 2018, EMERG INFECT DIS, V24, P178, DOI 10.3201/eid2401.171605
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Cadar D, 2017, EURO SURVEILL, V22
   Cajimat MNB, 2017, VECTOR-BORNE ZOONOT, V17, P714, DOI 10.1089/vbz.2017.2190
   Soler JC, 2009, GAC SANIT, V23, P295, DOI 10.1016/j.gaceta.2008.09.008
   Carhan A, 2010, J CLIN VIROL, V48, P264, DOI 10.1016/j.jcv.2010.05.011
   Carletti F, 2010, EMERG INFECT DIS, V16, P1979, DOI 10.3201/eid1612.101092
   Charrel RN, 2009, VECTOR-BORNE ZOONOT, V9, P519, DOI 10.1089/vbz.2008.0131
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869
   Cotar AI, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3145-5
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   Dorigatti I., 2017, EURO SURVEILL, V22
   Elevli M, 2010, INT J INFECT DIS, V14, pE213, DOI 10.1016/j.ijid.2009.07.017
   Ergunay K, 2011, CLIN MICROBIOL INFEC, V17, P575, DOI 10.1111/j.1469-0691.2010.03346.x
   European Center for Disease Prevention and Control, 2018, WEEKL UPD 2018 W NIL
   European Centre for Disease Prevention and Control, 2018, RAP RISK ASS LOC TRA
   Failloux Anna-Bella, 2017, Curr Trop Med Rep, V4, P27, DOI 10.1007/s40475-017-0101-y
   Fawzy M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020139
   Feki I, 2005, NEUROEPIDEMIOLOGY, V24, P1, DOI 10.1159/000081042
   Fezaa O, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0598-9
   Fyodorova M. V., 2007, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P41
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Grossi PA, 2018, NEW MICROBIOL, V41, P80
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P635, DOI 10.4269/ajtmh.1980.29.635
   Haussig J. M., 2018, EURO SURVEILL, V23
   Hellenic Center for Disease Control and Prevention, 2018, WEEKL UPD 2018 W NIL
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Huhtamo E, 2013, J GEN VIROL, V94, P1242, DOI 10.1099/vir.0.051359-0
   Karti SS, 2004, EMERG INFECT DIS, V10, P1379, DOI 10.3201/eid1008.030928
   Kautman M, 2016, EMERG INFECT DIS, V22, P354, DOI 10.3201/eid2202.151528
   Kenawy MA, 2018, ACTA TROP, V181, P40, DOI 10.1016/j.actatropica.2018.01.015
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lionello P, 2006, DEV EARTH ENV SCI, V4, P1, DOI 10.1016/s1571-9197(06)80003-0
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Louis C, 2012, EMERG INFECT DIS, V18, P78, DOI 10.3201/eid1801.110191
   Lustig Y., 2019, EURO SURVEILL, V24
   Lustig Y, 2016, J INFECT DIS, V213, P1107, DOI 10.1093/infdis/jiv556
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Markovinovic L, 2016, INFECTION, V44, P661, DOI 10.1007/s15010-016-0917-8
   Midilli K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-90
   Monastiri A, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0028-y
   Moriconi M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005660
   Negredo A, 2017, NEW ENGL J MED, V377, P154, DOI [10.1056/nejmoa1615162, 10.1056/NEJMoa1615162]
   NICOLETTI L, 1991, AM J TROP MED HYG, V45, P429, DOI 10.4269/ajtmh.1991.45.429
   Ozkaya E, 2010, VIRUS RES, V149, P64, DOI 10.1016/j.virusres.2009.12.014
   Panayotova E, 2016, TICKS TICK-BORNE DIS, V7, P1024, DOI 10.1016/j.ttbdis.2016.05.010
   Papa A, 2006, CLIN MICROBIOL INFEC, V12, P192, DOI 10.1111/j.1469-0691.2005.01330.x
   Papa A, 2011, CLIN MICROBIOL INFEC, V17, P585, DOI 10.1111/j.1469-0691.2010.03371.x
   Papa A, 2011, CLIN MICROBIOL INFEC, V17, P1176, DOI 10.1111/j.1469-0691.2010.03438.x
   Papa A., 2018, EURO SURVEILL, V23
   Papa A, 2017, PARASITOL RES, V116, P3057, DOI 10.1007/s00436-017-5616-6
   Papa A, 2014, EMERG INFECT DIS, V20, P1417, DOI 10.3201/eid2008.140248
   Papa A, 2014, TICKS TICK-BORNE DIS, V5, P590, DOI 10.1016/j.ttbdis.2014.04.008
   Papa A, 2013, TICKS TICK-BORNE DIS, V4, P417, DOI 10.1016/j.ttbdis.2013.04.003
   Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759
   Papadopoulos O., 1978, Deltion Ellinikis Mikrobiologikis Etaireias, V23, P20
   PAPAEVANGELOU G, 1977, J TROP MED HYG, V80, P46
   PECORARI M, 2009, EURO SURVEILL, V14
   Punda-Polic V, 2012, J CLIN VIROL, V55, P4, DOI 10.1016/j.jcv.2012.06.006
   Ravagnan S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1031-y
   Receveur MC, 2010, EURO SURVEILL, V15
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Riabi S, 2014, PATHOG GLOB HEALTH, V108, P148, DOI 10.1179/2047773214Y.0000000137
   Salinas S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005913
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Schmidt-Chanasit J., 2010, EURO SURVEILL, V15, DOI 10.2807/ese.15.40.19677-en
   Sherifi K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003168
   Sidira P, 2012, CLIN MICROBIOL INFEC, V18, pE16, DOI 10.1111/j.1469-0691.2011.03718.x
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Sirbu A, 2011, EURO SURVEILL, V16, P19762
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Spengler JR, 2018, ANTIVIR RES, V150, P137, DOI 10.1016/j.antiviral.2017.11.019
   Succo T, 2016, EURO SURVEILL, V21
   Venturi G., 2017, EURO SURVEILL, V22
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Zhioua E, 2010, J GEN VIROL, V91, P1275, DOI 10.1099/vir.0.019240-0
   2017, EMERG INFECT DIS, V23, P2078, DOI DOI 10.3201/EID2312.171002
   2017, EMERGENCIAS, V29, P290
NR 94
TC 4
Z9 4
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUN
PY 2019
VL 115
BP 5
EP 10
DI 10.1016/j.jcv.2019.03.007
PG 6
WC Virology
SC Virology
GA HX6TZ
UT WOS:000467537500002
PM 30928817
DA 2020-07-08
ER

PT J
AU Zhang, HJ
   Chang, YF
   Zhang, LB
   Kim, SN
   Otaegi, G
   Zhang, Z
   Nie, YZ
   Mubarak, T
   Li, C
   Qin, CF
   Xu, ZH
   Sun, T
AF Zhang, Haijun
   Chang, Yafei
   Zhang, Longbin
   Kim, Seung-Nam
   Otaegi, Gaizka
   Zhang, Zhen
   Nie, Yanzhen
   Mubarak, Taufif
   Li, Cui
   Qin, Cheng-Feng
   Xu, Zhiheng
   Sun, Tao
TI Upregulation of MicroRNA miR-9 Is Associated with Microcephaly and Zika
   Virus Infection in Mice
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Cerebral cortex; Neural progenitor; Apoptosis; miR-9; GDNF; Zika virus
ID NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; CEREBRAL ORGANOIDS;
   SUBSTANTIA-NIGRA; BRAIN; PROGENITORS; NEUROGENESIS; NEURONS;
   DIFFERENTIATION; PROMOTES
AB Proper growth of the mammalian cerebral cortex, which is determined by expansion and survival of neural progenitors and mature neurons, is crucial for cognitive functions. Here, we show a role of the dosage of microRNA miR-9 in controlling brain size. Cortical-specific upregulation of miR-9 causes microcephalic defects in mice, due to apoptosis, reduced neural progenitor pool, and decreased neurogenesis. Glial cell-derived neurotrophic factor (GDNF) is a target of miR-9, and protects neural progenitors from miR-9-induced apoptosis. Furthermore, Zika virus (ZIKV) infection in embryonic mouse cortex causes reduced numbers in neural progenitors and newborn neurons, and results in upregulation of miR-9, downregulation of its target GDNF. Our studies indicate an association of altered levels of miR-9 and its target GDNF with microcephaly and ZIKV infection in mice.
C1 [Zhang, Haijun; Kim, Seung-Nam; Otaegi, Gaizka; Mubarak, Taufif; Sun, Tao] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.
   [Chang, Yafei; Zhang, Zhen; Nie, Yanzhen] Shanghai Jiao Tong Univ, Sch Life Sci & Technol, Shanghai 200240, Peoples R China.
   [Zhang, Longbin; Sun, Tao] Huaqiao Univ, Sch Med, Ctr Precis Med, Xiamen 362021, Peoples R China.
   [Zhang, Longbin; Sun, Tao] Huaqiao Univ, Sch Biomed Sci, Xiamen 362021, Peoples R China.
   [Kim, Seung-Nam] Dongguk Univ, Dept Korean Med, 32 Donggukro, Goyangsi 10326, Gyeonggido, South Korea.
   [Li, Cui; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
RP Sun, T (corresponding author), Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.; Sun, T (corresponding author), Huaqiao Univ, Sch Med, Ctr Precis Med, Xiamen 362021, Peoples R China.; Sun, T (corresponding author), Huaqiao Univ, Sch Biomed Sci, Xiamen 362021, Peoples R China.
EM taosun@hqu.edu.cn
OI Chang, Yafei/0000-0002-6544-2366; Xu, Zhiheng/0000-0002-4809-2851; Qin,
   Cheng-Feng/0000-0002-0632-2807
FU NIH/NIMHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01-MH083680]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81471152, 31771141,
   81701132]; Hirschl/Weill-Caulier Trust
FX We thank members of the Sun laboratory for their valuable discussions
   and advice. This work was supported by an award from the
   Hirschl/Weill-Caulier Trust (T. S.), an R01-MH083680 grant from the
   NIH/NIMH (T. S.) and the National Natural Science Foundation of China
   (81471152, 31771141 and 81701132).
CR Bian S, 2013, CURR OPIN NEUROBIOL, V23, P928, DOI 10.1016/j.conb.2013.08.002
   Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037
   Bian S, 2011, MOL NEUROBIOL, V44, P359, DOI 10.1007/s12035-011-8211-3
   Bonev B, 2011, DEV CELL, V20, P19, DOI 10.1016/j.devcel.2010.11.018
   Burke RE, 2006, J NEURAL TRANSM-SUPP, P41
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063
   Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220
   Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gorski JA, 2002, J NEUROSCI, V22, P6309
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hong J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00151
   Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109
   Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659
   Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557
   Luxenhofer G, 2014, DEV BIOL, V386, P358, DOI 10.1016/j.ydbio.2013.12.023
   Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Oo TF, 2003, J NEUROSCI, V23, P5141
   Otaegi G, 2011, J NEUROSCI, V31, P809, DOI 10.1523/JNEUROSCI.4330-10.2011
   Perrelet D, 2002, NAT CELL BIOL, V4, P175, DOI 10.1038/ncb751
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rakic P, 2005, NAT NEUROSCI, V8, P981, DOI 10.1038/nn0805-981
   Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010
   Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008
   Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Volvert ML, 2012, CELL DEATH DIFFER, V19, P1573, DOI 10.1038/cdd.2012.96
   Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00001
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 61
TC 2
Z9 3
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUN
PY 2019
VL 56
IS 6
BP 4072
EP 4085
DI 10.1007/s12035-018-1358-4
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA HX6DJ
UT WOS:000467494000019
PM 30264295
DA 2020-07-08
ER

PT J
AU Chen, H
   Liu, KK
   Li, Z
   Wang, P
AF Chen, Hui
   Liu, Kengku
   Li, Zhao
   Wang, Ping
TI Point of care testing for infectious diseases
SO CLINICA CHIMICA ACTA
LA English
DT Review
ID EBOLA-VIRUS DISEASE; SURFACE-PLASMON RESONANCE; RAPID DIAGNOSTIC-TESTS;
   ON-A-CHIP; OF-CARE; CERVICAL-CANCER; CIRCULATING MICRORNAS; SENSITIVE
   DETECTION; IMMUNE-RESPONSES; TYPE-1 INFECTION
AB Infectious diseases are caused by pathogenic microorganisms and can be transmitted between individuals and populations thus threatening the general public health and potentially the economy. Efficient diagnostic tools are needed to provide accurate and timely guidance for case identification, transmission disruption and appropriate treatment administration. Point of care (POC) tests provide actionable results near the patient and thereby serve as a personal "radar". In this review, we review clinical needs for POC testing for several major pathogens, including malaria parasites, human immunodeficiency virus (HIV), human papillomavirus (HPV), dengue, Ebola and Zika viruses and Mycobacterium tuberculosis (TB). We compare different molecular approaches, including pathogen nucleic acid and protein, circulating microRNA and antibodies, used in the POC tests. Finally, we review recent advances in novel POC technologies focusing on microfluidic and plasmonicbased approaches.
C1 [Chen, Hui; Liu, Kengku; Li, Zhao; Wang, Ping] Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St,Founders 7-103, Philadelphia, PA 19104 USA.
RP Wang, P (corresponding author), Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St,Founders 7-103, Philadelphia, PA 19104 USA.
EM Ping.Wang2@uphs.upenn.edu
OI Chen, Hui/0000-0002-9422-8959
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1DA035868]; Penn Center for
   Precision Medicine; Department of Pathology and Laboratory Medicine at
   University of Pennsylvania
FX We would like to acknowledge NIH RO1DA035868, Penn Center for Precision
   Medicine and Department of Pathology and Laboratory Medicine at
   University of Pennsylvania for funding support.
CR Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Alizadehrad D, 2012, J BIOMECH, V45, P2684, DOI 10.1016/j.jbiomech.2012.08.026
   Alyassin MA, 2009, LAB CHIP, V9, P3364, DOI 10.1039/b911882a
   [Anonymous], 2012, NAT REV IMMUNOL, V12, P607
   Antia M, 2007, PLOS PATHOG, V3, P939, DOI 10.1371/journal.ppat.0030099
   Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015
   Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108
   Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989
   Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209
   Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benzine JW, 2016, J INFECT DIS, V214, pS234, DOI 10.1093/infdis/jiw330
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brangel P, 2018, ACS NANO, V12, P63, DOI 10.1021/acsnano.7b07021
   Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X
   Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6
   BUSCH MP, 1997, AM J MED, V102, P125
   Campos NG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3786-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0
   Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060
   Chen H, 2018, ACS APPL MATER INTER, V10, P31845, DOI 10.1021/acsami.8b01377
   Chen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24297
   Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005
   Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972
   Chin BS, 2007, J CLIN MICROBIOL, V45, P1659, DOI 10.1128/JCM.00166-07
   Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Correia CN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00118
   CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007
   DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0
   de Candia P, 2016, J BIOL CHEM, V291, P7221, DOI 10.1074/jbc.R115.708842
   Denkinger CM, 2013, EUR RESPIR J, V42, P544, DOI 10.1183/09031936.00081113
   Denny LA, 2013, VACCINE, V31, pF73, DOI 10.1016/j.vaccine.2012.11.077
   Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022
   Dhillon RS, 2014, LANCET, V384, P1409, DOI 10.1016/S0140-6736(14)61696-2
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839
   Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417
   Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11
   George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07
   Golightly RS, 2009, ACS NANO, V3, P2859, DOI 10.1021/nn9013593
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halas NJ, 2011, CHEM REV, V111, P3913, DOI 10.1021/cr200061k
   Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290
   Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09
   Hill CE, 2014, LABMEDICINE, V45, pE109, DOI 10.1309/LMTMW3VVN20HIFS
   HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0
   Holland CA, 2005, CURR OPIN MICROBIOL, V8, P504, DOI 10.1016/j.mib.2005.08.001
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Hou HW, 2010, LAB CHIP, V10, P2605, DOI 10.1039/c003873c
   Hwang H, 2018, DIS MARKERS, DOI 10.1155/2018/8509127
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   Inci F, 2013, ACS NANO, V7, P4733, DOI 10.1021/nn3036232
   Iwen PC, 2014, LABMEDICINE, V45, pE146, DOI 10.1309/LMTULFM62W3RKMYI
   Jarvis RM, 2008, CHEM SOC REV, V37, P931, DOI 10.1039/b705973f
   Jelden KC, 2016, J CLIN MICROBIOL, V54, P1031, DOI 10.1128/JCM.02905-15
   Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410
   Jindai K, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.017
   Jorgensen P, 2006, AM J TROP MED HYG, V74, P750, DOI 10.4269/ajtmh.2006.74.750
   Jung WE, 2015, MICROELECTRON ENG, V132, P46, DOI 10.1016/j.mee.2014.09.024
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kadri F, 2016, J CELL PHYSIOL, V231, P829, DOI 10.1002/jcp.25131
   Kaushik A, 2016, BIOSENS BIOELECTRON, V75, P254, DOI 10.1016/j.bios.2015.08.040
   Kellerman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000285
   KIM S, 2015, MALAR J, V14
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   Knight MW, 2014, ACS NANO, V8, P834, DOI 10.1021/nn405495q
   Laksanasopin T., 2015, SCIENCE, V7, P1
   Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/fmb.11.84, 10.2217/FMB.11.84]
   Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Linder V, 2005, ANAL CHEM, V77, P64, DOI 10.1021/ac049071x
   Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x
   Maffert P, 2017, EUR J CLIN MICROBIOL, V36, P1717, DOI 10.1007/s10096-017-3013-9
   Magro L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00758-9
   Mahe C, 2005, CANCER CAUSE CONTROL, V16, P657, DOI 10.1007/s10552-005-0296-4
   Mani V, 2014, ADV DRUG DELIVER REV, V78, P105, DOI 10.1016/j.addr.2014.05.015
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Mohammed SI, 2016, ONCOTARGET, V7, P18787, DOI 10.18632/oncotarget.7709
   Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002
   NATH N, 1987, J CLIN MICROBIOL, V25, P364, DOI 10.1128/JCM.25.2.364-369.1987
   Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013
   O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708
   OGorman MRG, 1997, CLIN DIAGN LAB IMMUN, V4, P173, DOI 10.1128/CDLI.4.2.173-179.1997
   Parker MM, 2018, J CLIN VIROL, V104, P89, DOI 10.1016/j.jcv.2018.05.005
   Qiu XX, 2017, J CLIN VIROL, V92, P62, DOI 10.1016/j.jcv.2017.05.005
   Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445
   RAKUSAN TA, 1991, J ACQ IMMUN DEF SYND, V4, P116
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Sebba D, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0944
   Sepulveda B, 2009, NANO TODAY, V4, P244, DOI 10.1016/j.nantod.2009.04.001
   Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772
   Stone M, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.02045-17, 10.1128/jcm.02045-17]
   Tadepalli S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16206
   Tan DX, 2014, J PINEAL RES, V57, P381, DOI 10.1111/jpi.12186
   Tay A, 2016, BIOTECHNOL ADV, V34, P404, DOI 10.1016/j.biotechadv.2016.02.002
   Tian LM, 2014, BIOSENS BIOELECTRON, V59, P208, DOI 10.1016/j.bios.2014.03.043
   Tsai TT, 2017, ACS SENSORS, V2, P1345, DOI 10.1021/acssensors.7b00450
   Uludag Y, 2012, ANAL CHEM, V84, P5898, DOI 10.1021/ac300278p
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Veigas B, 2012, LAB CHIP, V12, P4802, DOI 10.1039/c2lc40739f
   Vo-Dinh T, 2010, J BIOPHOTONICS, V3, P89, DOI 10.1002/jbio.200910015
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F
   Wang H, 2012, ANGEW CHEM INT EDIT, V51, P4349, DOI 10.1002/anie.201200732
   Wang P, 2018, CLIN CHEM, V64, P1439, DOI 10.1373/clinchem.2018.287052
   Wang WK, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00203-18
   Watkins NN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006870
   Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405
   West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Willyard C, 2007, NAT MED, V13, P1131, DOI 10.1038/nm1007-1131
   Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u
   Zarei M, 2017, BIOSENS BIOELECTRON, V98, P494, DOI 10.1016/j.bios.2017.07.024
   Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010
   Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162
   2016, ANAL CHEM, V88, P7289
   2018, AIDS, V32, P2089
   2018, PULMONOLOGY, V24, P73
   2009, BIOSENS BIOELECTRON, V25, P745
   2017, J CLIN MICROBIOL, V55, P3339
   2016, CELL STEM CELL, V18, P587
   2019, ACS NANO, V13, P1244
   2014, CHEM REV, V114, P5728
   2004, SCIENCE, V304, P1936
NR 142
TC 11
Z9 12
U1 16
U2 48
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD JUN
PY 2019
VL 493
BP 138
EP 147
DI 10.1016/j.cca.2019.03.008
PG 10
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA HW6TQ
UT WOS:000466823900020
PM 30853460
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Boga, JA
   Alvarez-Arguelles, ME
   Rojo-Alba, S
   Rodriguez, M
   de Ona, M
   Melon, S
AF Boga, Jose A.
   Alvarez-Arguelles, Marta E.
   Rojo-Alba, Susana
   Rodriguez, Mercedes
   de Ona, Maria
   Melon, Santiago
TI Simultaneous detection of Dengue virus, Chikungunya virus, Zika virus,
   Yellow fever virus and West Nile virus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Arbovirus; Diagnosis; Multiplex PCR
AB Although certain mosquito-borne virus, such as Dengue virus (DENV), Chikungunya virus (CHIKV), Zika virus (ZIKV), Yellow fever virus (YFV) and West Nile virus (WNV), are an important public health concern in those countries where transmitter mosquitoes are endemic, several cases of travelers from those endemic countries have been recently reported in Europe. Thus, early diagnosis of these viruses is essential for patient management and adoption of preventive measures. An assay for the simultaneous detection of DENV, CHIKV, ZIKV, YFV and WNV based on a multiplex real-time (RT)-PCR and its usefulness for diagnosis in infection screenings and surveillance of arbovirus in non-endemic countries are described.
C1 [Boga, Jose A.] HUCA, Serv Microbiol, Oviedo, Spain.
   Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain.
RP Boga, JA (corresponding author), HUCA, Serv Microbiol, Oviedo, Spain.
EM joseantonio.boga@sespa.es
OI Boga, Jose Antonio/0000-0002-5500-9972
CR Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Ramos Geldres T T, 2015, An Pediatr (Barc), V82, pe165, DOI 10.1016/j.anpedi.2014.04.012
   Van Den Bossche D, 2015, EPIDEMIOL INFECT, V143, P2227, DOI 10.1017/S0950268814000685
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   2016, INFECTION, V44, P797, DOI DOI 10.1007/S15010-016-0906-Y
NR 9
TC 1
Z9 1
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUN
PY 2019
VL 268
BP 53
EP 55
DI 10.1016/j.jviromet.2019.03.014
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA HW6TD
UT WOS:000466822600009
PM 30930286
DA 2020-07-08
ER

PT J
AU Ibrahim, IM
   Abdelmalek, DH
   Elfiky, AA
AF Ibrahim, Ibrahim M.
   Abdelmalek, Doaa H.
   Elfiky, Abdo A.
TI GRP78: A cell's response to stress
SO LIFE SCIENCES
LA English
DT Review
DE GRP78; Heat shock proteins; HSP70; Stress; Unfolded protein response;
   Membrane receptors
ID GLUCOSE-REGULATED PROTEIN; BORNA-DISEASE VIRUS; RESPIRATORY SYNDROME
   CORONAVIRUS; JAPANESE ENCEPHALITIS-VIRUS; MOLECULAR CHAPERONE BIP;
   BREAST-CANCER CELL; ENDOPLASMIC-RETICULUM; HEAT-SHOCK; COXSACKIEVIRUS
   A9; ZIKA VIRUS
AB Background: Glucose-Regulated Protein 78 (GRP78) is a chaperone heat shock protein that has been intensely studied in the last two decades. GRP78 is the master of the unfolded protein response (UBR) in the Endoplasmic Reticulum (ER) in normal cells. GRP78 force the unfolded proteins to refold or degrade using cellular degradation mechanisms.
   Scope: Under stress, the overexpression of GRP78 on the cell membrane mediates the vast amount of disordered proteins. Unfortunately, this makes it a tool for pathogens (bacterial, fungal and viral) to enter the cell and to start different pathways leading to pathogenesis. Additionally, GRP78 is overexpressed on the membranes of various cancer cells and increase the aggressiveness of the disease.
   Major conclusions: The current review summarizes structure, function, and different mechanisms GRP78 mediate in response to normal or stress conditions.
   General significance: GRP78 targeting and possible inhibition mechanisms are also covered in the present review aiming to prevent the virulence of pathogens and cancer.
C1 [Ibrahim, Ibrahim M.; Abdelmalek, Doaa H.; Elfiky, Abdo A.] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt.
RP Elfiky, AA (corresponding author), Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019; Ibrahim, Ibrahim/AAL-7891-2020
OI Mohamed, Abdo/0000-0003-4600-6240; 
CR Al-Hashimi A. A., 2018, CELL SURFACE GRP78 N, P63
   Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362
   Alexandrescu DT, 2005, MED ONCOL, V22, P101, DOI 10.1385/MO:22:2:101
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Arikan SK, 2014, ASIAN PAC J CANCER P, V15, P6087, DOI 10.7314/APJCP.2014.15.15.6087
   Bajramovic JJ, 2003, J VIROL, V77, P12222, DOI 10.1128/JVI.77.22.12222-12231.2003
   Baldin C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006408
   Bhattacharyya S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-11
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680
   Chang YJ, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0035123
   Chang YJ, 2015, TUMOR BIOL, V36, P1859, DOI 10.1007/s13277-014-2788-x
   Chen C., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1155/2013/541695
   Chen HH, 2017, ANTIVIR RES, V142, P158, DOI 10.1016/j.antiviral.2017.02.015
   Chen T., 2017, P 2017 4 INT C BIOM, P35
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Chiou SS, 2005, J MED VIROL, V76, P583, DOI 10.1002/jmv.20406
   Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998
   Chu H, 2018, J BIOL CHEM, V293, P11709, DOI 10.1074/jbc.RA118.001897
   Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685
   Conteduca V, 2014, INT J ONCOL, V44, P1417, DOI 10.3892/ijo.2014.2334
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dorman SN, 2016, MOL ONCOL, V10, P85, DOI 10.1016/j.molonc.2015.07.006
   DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801
   Earnest JT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006546
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339
   Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586
   Feldmann H, 1996, ARCH VIROL, P77
   Fennelly D, 1995, Oncology (Williston Park), V9, P911
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105
   Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439
   Gebremariam T, 2014, J CLIN INVEST, V124, P237, DOI 10.1172/JCI71349
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Gopal U., 2018, ENDOPLASMIC RETICULU, P9, DOI DOI 10.1016/B978-0-12-812351-5.00009-X
   Grist N. R., 1988, GEN PATHOGENICITY EP, P221
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71
   Hannun YA, 1997, BLOOD, V89, P1845, DOI 10.1182/blood.V89.6.1845
   Hardy B, 2012, CELL ONCOL, V35, P345, DOI 10.1007/s13402-012-0094-4
   HENDERSHOT LM, 1994, GENOMICS, V20, P281, DOI 10.1006/geno.1994.1166
   Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09
   Ibrahim AS, 2011, ESSENTIALS CLIN MYCO, P265
   Ikuta K, 2002, FRONT BIOSCI-LANDMRK, V7, pD470, DOI 10.2741/ikuta
   Ivaska J., 2011, SMALL GTPASES, V2, P1436
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI 10.3322/caac.20115
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317
   KIM KS, 1986, BIOCHEM BIOPH RES CO, V140, P881, DOI 10.1016/0006-291X(86)90717-5
   KIM YK, 1987, MOL CELL BIOL, V7, P2974, DOI 10.1128/MCB.7.8.2974
   KIM YK, 1987, J CELL PHYSIOL, V133, P553, DOI 10.1002/jcp.1041330317
   Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j
   Kuroda K, 2011, UROL INT, V87, P450, DOI 10.1159/000330883
   Landon LA, 2003, J CELL BIOCHEM, V90, P509, DOI 10.1002/jcb.10634
   LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9
   Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81
   Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002
   Liao PC, 2008, J CELL BIOCHEM, V104, P1509, DOI 10.1002/jcb.21730
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1
   Liu MF, 2010, J CLIN INVEST, V120, P1914, DOI 10.1172/JCI42164
   Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217
   Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06
   Martin S, 2010, PIGM CELL MELANOMA R, V23, P675, DOI 10.1111/j.1755-148X.2010.00731.x
   Muller F., 2000, ULLMANNS ENCY IND CH
   MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995
   MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Niu ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16067
   Ojha CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02340
   Pan H, 2013, WORLD NEUROSURG, V80, P363, DOI 10.1016/j.wneu.2011.06.063
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124
   Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029
   PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8
   Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9
   Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433
   Petrikkos G, 2012, CLIN INFECT DIS, V54, pS23, DOI 10.1093/cid/cir866
   Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007
   Pizzo S. V., 2018, CELL SURFACE GRP78 N, P1
   Reid SP, 2014, ANTIVIR RES, V109, P171, DOI 10.1016/j.antiviral.2014.07.004
   RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145
   Richt JA, 1998, J VIROL, V72, P4528, DOI 10.1128/JVI.72.5.4528-4533.1998
   ROIVAINEN M, 1994, VIROLOGY, V203, P357, DOI 10.1006/viro.1994.1494
   Roivainen M, 1998, J MED VIROL, V56, P74, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;74::AID-JMV12&gt;3.0.CO;2-W
   Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432
   Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010
   Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413
   Shahzidi S, 2011, PHOTOCH PHOTOBIO SCI, V10, P1773, DOI 10.1039/c1pp05169e
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Spellberg B, 2009, CLIN INFECT DIS, V48, P1743, DOI 10.1086/599105
   Teng YC, 2013, J OBSTET GYNAECOL RE, V39, P317, DOI 10.1111/j.1447-0756.2012.01970.x
   Tian SB, 2015, ANTI-CANCER DRUG, V26, P964, DOI 10.1097/CAD.0000000000000273
   TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275
   Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002
   Triantafilou M, 1999, J GEN VIROL, V80, P2591, DOI 10.1099/0022-1317-80-10-2591
   Triantafilou M, 2000, HUM IMMUNOL, V61, P453, DOI 10.1016/S0198-8859(00)00103-8
   Tsai Y.-L., 2018, CELL SURFACE GRP78 N, P41, DOI DOI 10.1016/C2016-0-00712-X
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144
   Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564
   Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0
   Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI 10.1089/ARS.2009.2485
   WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393
   Witkowski ER, 2013, J SURG ONCOL, V107, P97, DOI 10.1002/jso.23267
   Wu CT, 2014, TUMOR BIOL, V35, P195, DOI 10.1007/s13277-013-1024-4
   Xie J, 2016, BIOCHEM BIOPH RES CO, V474, P612, DOI 10.1016/j.bbrc.2016.03.002
   Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016
   Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001
   Yuan XP, 2015, MOL CELL BIOCHEM, V398, P55, DOI 10.1007/s11010-014-2204-2
   Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9
   Zhang Li-Ying, 2015, Asian Pac J Cancer Prev, V16, P3517
   Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679
   2016, J VIROL, V90, P9114, DOI DOI 10.1128/JVI.01133-16
   2010, MOL CELL PROTEOMICS, V9, P2690, DOI DOI 10.1074/MCP.M110.003418
   2007, VIROLOGY, V366, P415, DOI DOI 10.1016/J.VIROL.2007.05.007
NR 126
TC 16
Z9 16
U1 6
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD JUN 1
PY 2019
VL 226
BP 156
EP 163
DI 10.1016/j.lfs.2019.04.022
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HU8TS
UT WOS:000465564200016
PM 30978349
OA Green Published
DA 2020-07-08
ER

PT J
AU Cai, YL
   Wang, K
   Wang, WM
AF Cai, Yongli
   Wang, Kai
   Wang, Weiming
TI Global transmission dynamics of a Zika virus model
SO APPLIED MATHEMATICS LETTERS
LA English
DT Article
DE Zika virus (ZIKV); Basic reproduction number; Global stability; Lyapunov
   function
ID RIO-DE-JANEIRO; EPIDEMIC MODEL
AB In this paper, we define the basic reproduction number R-0 and prove that if R-0 > 1, the endemic equilibrium of the ZIKV model is globally stable by using the technique of Lyapunov function. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cai, Yongli; Wang, Weiming] Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
   [Wang, Kai] Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi 830011, Peoples R China.
RP Wang, WM (corresponding author), Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
EM caiyongli06@163.com; wangkaimath@sina.com; weimingwang2003@163.com
OI Wang, Weiming/0000-0002-7562-8260
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11601179, 61672013, 11461073]; Huaian Key
   Laboratory for Infectious Diseases Control and Prevention, Huaian,
   Jiangsu Province, China [HAP201704]
FX This research was supported by the National Natural Science Foundation
   of China (Grant Nos. 11601179, 61672013 and 11461073) and Huaian Key
   Laboratory for Infectious Diseases Control and Prevention, Huaian,
   Jiangsu Province, China (HAP201704).
CR Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cai YL, 2018, NONLINEAR ANAL-REAL, V40, P444, DOI 10.1016/j.nonrwa.2017.10.001
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Castillo-Chavez  C., 2001, MATH MODELS POPULATI
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Kibona I. E., 2017, Health, V9, P1190, DOI 10.4236/health.2017.98086
   La Salle J.P., 1960, Institute of Radio Engineers Transactions on Circuit Theory, VCT-7, P520
   Magal P, 2018, NONLINEARITY, V31, P5589, DOI 10.1088/1361-6544/aae1e0
   Sastry S., 1999, NONLINEAR SYSTEMS AN
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   Yang  B., 2018, ADV DIFFERENTIAL EQU, V2018, P462
NR 20
TC 22
Z9 22
U1 7
U2 91
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0893-9659
J9 APPL MATH LETT
JI Appl. Math. Lett.
PD JUN
PY 2019
VL 92
BP 190
EP 195
DI 10.1016/j.aml.2019.01.015
PG 6
WC Mathematics, Applied
SC Mathematics
GA HO2CI
UT WOS:000460718600029
DA 2020-07-08
ER

PT J
AU Gressick, K
   Gelpi, A
   Chanroo, T
AF Gressick, Kimberly
   Gelpi, Adriane
   Chanroo, Toni
TI Zika and abortion in Brazilian newspapers: how a new outbreak revived an
   old debate on reproductive rights
SO SEXUAL AND REPRODUCTIVE HEALTH MATTERS
LA English
DT Editorial Material
DE Zika; Brazilian newspapers; microcephaly; abortion
AB Since the beginning of the Zika virus epidemic, the Brazilian Ministry of Health has reported over 2000 confirmed cases of microcephaly associated with Zika virus in Brazil, with the cases concentrated in the northeast states. The Zika epidemic reopened a debate in Brazil that has played out in the national newspapers about expanding the abortion law to provide autonomy and legal protection to women. The argument for expanding the abortion law to include microcephaly secondary to Zika virus infection called for autonomy for women and, more broadly, protection of reproductive rights. The argument against expanding the current abortion law was separated into two main moral veins: those citing eugenics and those citing religious beliefs. However, the debate on abortion in the case of microcephaly accomplished more than giving a voice to two different viewpoints; it exposed health disparities that exist in Brazil, which were magnified by Zika virus, and reopened the political arena for discussion of the abortion law.
C1 [Gressick, Kimberly; Chanroo, Toni] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Gelpi, Adriane] Univ Miami, Miller Sch Med, Inst Bioeth & Hlth Policy, Dept Publ Hlth Sci, Miami, FL 33136 USA.
RP Gressick, K (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
EM kxg380@med.miami.edu
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, FOLHA SAO PAULO, pA2
   [Anonymous], 2016, GLOBO
   Araujo Guedes A., 2016, FOLHA SAO PAULO, pB12
   Belderrain JL, 2016, FOLHA SAO PAULO, pA3
   Cancian N., 2016, FOLHA SAO PAULO, pB3
   Guerra IMC, 2016, PORT J SOC SCI, V15, P3, DOI 10.1386/pjss.15.1.3_7
   Central Intelligence Agency, WORLD FACTBOOK
   Collucci C, 2016, FOLHA SAO PAULO, pB12
   Collucci C, 2016, FOLHA SAO PAULO, pB9
   Diniz D, 2017, CIENC SAUDE COLETIVA, V22, P653, DOI 10.1590/1413-81232017222.23812016
   Freitas Mohallem M, 2016, GLOBO, P19
   Luis Roberto G, 2016, GLOBO, P17
   Mariz R, 2016, GLOBO, P6
   Martins-MeloI FR, 2014, REV SAUDE PUBL, V48, P508, DOI 10.1590/S0034-8910.2014048004878
   Ministerio de Saude, MON CAS MICR BRAS
   Pitanguy J, 2016, GLOBO, P21
   Reis R., 2003, WORLD PRESS ENCY SUR, P117
   Russo R, 2016, FOLHA SAO PAULO, pB4
   Supremo Tribunal Federal, 2018, REL ENC AUD PUBL DES
   Turollo RJ, 2016, FOLHA SAO PAULO, pB9
   Wallack L, 1996, HEALTH EDUC QUART, V23, P293, DOI 10.1177/109019819602300303
   WHO, HIST ZIK VIR
NR 23
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2641-0397
J9 SEX REPROD HLTH MATT
JI Sex. Reprod. Hlth. Matters
PD MAY 31
PY 2019
VL 27
IS 2
BP 20
EP 23
DI 10.1080/26410397.2019.1586818
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KM5DV
UT WOS:000514156800005
PM 31533583
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Aguiar, GPCG
   Leite, CMGD
   Dias, B
   Vasconcelos, SMM
   de Moraes, RA
   de Moraes, MEA
   Vallinoto, ACR
   Macedo, DS
   Cavalcanti, LPD
   Miyajima, F
AF Costa Gomes de Aguiar, Gabriella Pequeno
   Goncalves da Silva Leite, Claudio Manuel
   Dias, Beatriz
   Mendes Vasconcelos, Silvania Maria
   de Moraes, Renata Amaral
   Amaral de Moraes, Maria Elisabete
   Rosario Vallinoto, Antonio Carlos
   Macedo, Danielle Silveira
   de Goes Cavalcanti, Luciano Pamplona
   Miyajima, Fabio
TI Evidence for Host Epigenetic Signatures Arising From Arbovirus
   Infections: A Systematic Review
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE systematic review; host epigenetics; microRNAs; histone modifications;
   arbovirus
ID JAPANESE ENCEPHALITIS-VIRUS; DENGUE-VIRUS; MICRORNA EXPRESSION;
   ANTIVIRAL ACTIVITY; RNA INTERFERENCE; PROTECTIVE ROLE; ACUTE-PHASE;
   REPLICATION; CHIKUNGUNYA; MECHANISM
AB Background: Arbovirus infections have steadily become a major pandemic threat. This study aimed at investigating the existence of host epigenetic markers arising from the principal arboviruses infections impacting on human health. We set to systematically review all published evidence describing any epigenetic modifications associated with infections from arboviruses, including, but not limited to, microRNAs, DNA methylation, and histone modifications.
   Methods: A comprehensive search was conducted using the electronic databases PubMed, Science Direct and Cochrane Library from inception to January 4th, 2018. We included reports describing original in vivo or in vitro studies investigating epigenetic changes related to arbovirus infections in either clinical subjects or human cell lines. Studies investigating epigenetic modifications related to the virus or the arthropod vector were excluded. A narrative synthesis of the findings was conducted, contextualizing comparative evidence from in vitro and in vivo studies.
   Results: A total of 853 unique references were identified and screened by two independent researchers. Thirty-two studiesmet the inclusion criteria and were reviewed. The evidence was centered mainly on microRNA and DNA methylation signatures implicated with secondary Dengue fever. Evidence for recent epidemic threats, such as the infections by Zika or Chikungunya viruses is still scant.
   Conclusions: Major epigenetic alterations found on arboviruses infections were miR-146, miR-30e and the Dicer complex. However, existing studies frequently tested distinct hypotheses resulting in a heterogeneity of methodological approaches. Whilst epigenetic signatures associated with arbovirus infections have been reported, existing studies have largely focused on a small number of diseases, particularly dengue. Validation of epigenetic signatures have an untapped potential, but concerted investigations are certainly required to deliver robust candidates of clinical utility for diagnosis, staging and prognosis of specific arboviral diseases.
C1 [Costa Gomes de Aguiar, Gabriella Pequeno; Amaral de Moraes, Maria Elisabete] Univ Fed Ceara, Fac Med, Postgrad Programme Med & Surg Sci, Fortaleza, Ceara, Brazil.
   [Goncalves da Silva Leite, Claudio Manuel; Mendes Vasconcelos, Silvania Maria; Amaral de Moraes, Maria Elisabete; Macedo, Danielle Silveira; Miyajima, Fabio] Univ Fed Ceara, Fac Med, Postgrad Programme Pharmacol, Fortaleza, Ceara, Brazil.
   [Dias, Beatriz; de Moraes, Renata Amaral; de Goes Cavalcanti, Luciano Pamplona] Unichristus Univ Ctr, Fac Med, Fortaleza, Ceara, Brazil.
   [Mendes Vasconcelos, Silvania Maria; de Moraes, Renata Amaral; Amaral de Moraes, Maria Elisabete; Macedo, Danielle Silveira] Univ Fed Ceara, Fac Med, Ctr Drug Res & Dev NPDM, Fortaleza, Ceara, Brazil.
   [de Moraes, Renata Amaral] Sao Jose Hosp Infect Dis, Fortaleza, Ceara, Brazil.
   [Rosario Vallinoto, Antonio Carlos] Fed Univ Para, Inst Biol Sci, Lab Virol, Belem, Para, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Fac Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Miyajima, Fabio] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.
   [Miyajima, Fabio] Univ Fed Ceara, Fac Med, Postgrad Programme Med Sci, Fortaleza, Ceara, Brazil.
   [Miyajima, Fabio] Oswaldo Cruz Fdn Fiocruz, Branch Ceara, Eusebio, Brazil.
RP Miyajima, F (corresponding author), Univ Fed Ceara, Fac Med, Postgrad Programme Pharmacol, Fortaleza, Ceara, Brazil.; Miyajima, F (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.; Miyajima, F (corresponding author), Univ Fed Ceara, Fac Med, Postgrad Programme Med Sci, Fortaleza, Ceara, Brazil.; Miyajima, F (corresponding author), Oswaldo Cruz Fdn Fiocruz, Branch Ceara, Eusebio, Brazil.
EM fabio.miyajima@fiocruz.br
RI Vallinoto, Antonio Carlos/AAL-9501-2020; Macedo, Danielle/E-3424-2014
OI Vallinoto, Antonio Carlos/0000-0003-1135-6507; Macedo,
   Danielle/0000-0001-8980-9970
CR Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003
   Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008
   Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5
   Balakrishnan L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110346
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayer A, 2018, PLACENTA, V61, P33, DOI 10.1016/j.placenta.2017.11.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Gomes AVBT, 2016, J MED VIROL, V88, P1297, DOI 10.1002/jmv.24478
   Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14
   Bruscella P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00824
   Casseb Alexandre do Rosario, 2013, Veterinaria e Zootecnia, V20, P391
   Casseb SMM, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027891
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen RF, 2014, J INFECTION, V69, P366, DOI 10.1016/j.jinf.2014.05.013
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Corridoni D, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00032
   Cavalcanti LPD, 2018, REV SOC BRAS MED TRO, V51, P63, DOI 10.1590/0037-8682-0440-2017
   Demir ZC, 2017, J MED VIROL, V89, P417, DOI 10.1002/jmv.24667
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Diosa-Toro M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005981
   Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003673
   Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849
   Kakumani PK, 2016, GENE, V586, P7, DOI 10.1016/j.gene.2016.03.053
   Kakumani PK, 2015, BIOCHEM J, V471, P89, DOI 10.1042/BJ20150445
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kanokudom S, 2017, ANTIVIR RES, V142, P169, DOI 10.1016/j.antiviral.2017.03.020
   KOZAK RA, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100297
   Kumari B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20263
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu SY, 2016, CELL MOL IMMUNOL, V13, P700, DOI 10.1038/cmi.2015.52
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Meltzer E, 2012, INFECT DIS CLIN N AM, V26, P479, DOI 10.1016/j.idc.2012.02.003
   Milavetz BI, 2015, METHODS MOL BIOL, V1238, P569, DOI 10.1007/978-1-4939-1804-1_30
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Ouyang XX, 2016, INT J MED SCI, V13, P195, DOI 10.7150/ijms.13996
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Pierro A., 2015, New Microbes and New Infections, V7, P23, DOI 10.1016/j.nmni.2015.04.002
   Pu JY, 2017, ARCH VIROL, V162, P3645, DOI 10.1007/s00705-017-3516-9
   Qi YM, 2013, MOL MED REP, V7, P791, DOI 10.3892/mmr.2013.1288
   Rastogi M, 2018, J MED VIROL, V90, P648, DOI 10.1002/jmv.24995
   Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578
   Saxena T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079886
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Selvamani SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103624
   Sharma N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0249-0
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Tambyah PA, 2016, ANN CLIN BIOCHEM, V53, P466, DOI 10.1177/0004563215604001
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011
   Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 59
TC 0
Z9 0
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 31
PY 2019
VL 10
AR 1207
DI 10.3389/fimmu.2019.01207
PG 14
WC Immunology
SC Immunology
GA IB3NI
UT WOS:000470173800003
PM 31214179
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorgacevski, J
   Korva, M
   Potokar, M
   Lisjak, M
   Avsic-Zupanc, T
   Zorec, R
AF Jorgacevski, Jernej
   Korva, Misa
   Potokar, Maja
   Lisjak, Marjeta
   Avsic-Zupanc, Tatjana
   Zorec, Robert
TI ZIKV Strains Differentially Affect Survival of Human Fetal Astrocytes
   versus Neurons and Traffic of ZIKV-Laden Endocytotic Compartments
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RADIAL GLIAL-CELLS; VIRUS-INFECTION; VESICLE MOBILITY; SUBVENTRICULAR
   ZONE; BRAIN; DENGUE; ENTRY; EXPRESSION; DISEASE; LIPIDS
AB Malformations of the fetal CNS, known as microcephaly, have been linked to Zika virus (ZIKV) infection. Here, the responses of mammalian and mosquito cell lines, in addition to primary human fetal astrocytes and neurons were studied following infection by ZIKV strains Brazil 2016 (ZIKV-BR), French Polynesia 2013 (ZIKV-FP), and Uganda #976 1947 (ZIKV-UG). Viral production, cell viability, infectivity rate, and mobility of endocytotic ZIKV-laden vesicles were compared. All cell types (SK-N-SH, Vero E6, C6/36, human fetal astrocytes and human fetal neurons) released productive virus. Among primary cells, astrocytes were more susceptible to ZIKV infection than neurons, released more progeny virus and tolerated higher virus loads than neurons. In general, the infection rate of ZIKV-UG strain was the highest. All ZIKV strains elicited differences in trafficking of ZIKV-laden endocytotic vesicles in the majority of cell types, including astrocytes and neurons, except in mosquito cells, where ZIKV infection failed to induce cell death. These results represent a thorough screening of cell viability, infection and production of three ZIKV strains in five different cell types and demonstrate that ZIKV affects vesicle mobility in all but mosquito cells.
C1 [Jorgacevski, Jernej; Potokar, Maja; Lisjak, Marjeta; Zorec, Robert] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.
   [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia.
   [Jorgacevski, Jernej; Potokar, Maja; Zorec, Robert] Celica BIOMED, Tehnoloski Pk 24, Ljubljana 1000, Slovenia.
RP Zorec, R (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.; Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia.; Zorec, R (corresponding author), Celica BIOMED, Tehnoloski Pk 24, Ljubljana 1000, Slovenia.
EM tatjana.avsic@mf.uni-lj.si; robert.zorec@mf.uni-lj.si
RI JORGACEVSKI, JERNEJ/AAH-5425-2019
OI JORGACEVSKI, JERNEJ/0000-0003-3550-2011; AVSIC ZUPANC,
   TATJANA/0000-0001-6243-0688
FU Research Agency of Slovenia [P3 0310, P3 0083, J3 6790, J3 6789, J3
   9266, J3 7605]; European Virus Archive goes Global (EVAg) project -
   European Union Horizon 2020 Research and Innovation Program [653316]
FX This work was supported by the Research Agency of Slovenia (grant
   numbers P3 0310, P3 0083, J3 6790, J3 6789, J3 9266 and J3 7605) and by
   the European Virus Archive goes Global (EVAg) project, which has
   received funding from the European Union Horizon 2020 Research and
   Innovation Program under grant agreement no. 653316. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. We gratefully acknowledge David
   Gricar, Primoz Runovc, and Nusa Smlatic for their help.
CR Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Baud D., 2016, AM J REPROD IMMUNOL
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foo KY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/427814
   Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007
   Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mazzon M, 2014, CELL MICROBIOL, V16, P1493, DOI 10.1111/cmi.12340
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y., 2017, NAT NEUROSCI
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Parpura V., 2010, NEUROCHEM INT
   Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Potokar M, 2005, BIOCHEM BIOPH RES CO, V329, P678, DOI 10.1016/j.bbrc.2005.02.030
   Potokar M, 2017, MOL NEUROBIOL, V54, P2458, DOI 10.1007/s12035-016-9834-1
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Potokar M, 2013, INT J MOL SCI, V14, P11238, DOI 10.3390/ijms140611238
   Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485
   Potokar M, 2012, GLIA, V60, P594, DOI 10.1002/glia.22293
   Potokar M, 2011, HISTOL HISTOPATHOL, V26, P277, DOI 10.14670/HH-26.277
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Stenovec M, 2016, GLIA, V64, P317, DOI 10.1002/glia.22931
   Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037
   Tang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117787
   Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vardjan N, 2015, CELL TRANSPLANT, V24, P599, DOI 10.3727/096368915X687750
   Vardjan N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-144
   Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714
   Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044
   Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980
NR 72
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 30
PY 2019
VL 9
AR 8069
DI 10.1038/s41598-019-44559-8
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA2UT
UT WOS:000469418100015
PM 31147629
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brandao, MD
   Frota, LMDP
   Miranda, JL
   Brasil, RMC
   Mancini, MC
AF Brandao, Marina de Brito
   da Costa Pinheiro Frota, Leda Maria
   Miranda, Jose Lucivan
   Cavalcante Brasil, Rita Maria
   Mancini, Marisa Cotta
TI Family-Centered Early Intervention Program for Brazilian Infants with
   Congenital Zika Virus Syndrome: A Pilot Study
SO PHYSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS
LA English
DT Article
DE Family; goals; infants; intervention; occupational therapy; physical
   therapy; speech therapy; Zika virus
ID CEREBRAL-PALSY; MOTOR DEVELOPMENT; HOME-ENVIRONMENT; HIGH-RISK;
   CHILDREN; AFFORDANCES; PARENTS; HEALTH; REHABILITATION; VALIDATION
AB Aims: To evaluate the effects of a 16-week program based on Goals-Activity-Motor Enrichment (GAME) principles on infants with congenital Zika virus syndrome (CZS)'s mother report of functional goal achievement, motor and cognitive abilities, home enrichment, and parents' perceptions regarding the service provided. Methods: Quasi-experimental study with infants (n = 32) with CZS and their mothers. Twenty-two infants composed the GAME-based group and 10 were included in the control group. The primary outcome measure was the Canadian Occupational Performance Measure. Secondary outcome measures were the Bayley Scales of Infant and Toddler Development, the Affordances in the Home Environment for Motor Development-Infant Scale, and the Measure of Processes of Care. All measures were performed by blinded assessors. Results: Mothers of infants in the GAME-based group reported significant improvements in their infants' performance on functional priorities (p = 0.0001) and satisfaction with their infants' performance (p = 0.0001), the extent in which services promoted enabling and partnership (p = 0.021), provided general information (p = 0.039), specific information (p = 0.0001), and an enriched home environment (p = 0.0001). Infants in both groups did not improve in motor or cognitive abilities. Conclusions: A family-centered early intervention program based on GAME principles improved mothers' individualized outcomes and enriched infants with CZS's environment. Future studies should elucidate long-term benefits of interventions for this population.
C1 [Brandao, Marina de Brito; da Costa Pinheiro Frota, Leda Maria; Mancini, Marisa Cotta] Univ Fed Minas Gerais, Sch Phys Educ Phys Therapy & Occupat Therapy, Grad Program Rehabil Sci, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Costa Pinheiro Frota, Leda Maria; Miranda, Jose Lucivan; Cavalcante Brasil, Rita Maria] Nucleo Tratamento & Estimulacao Precoce NUTEP, Fortaleza, Ceara, Brazil.
   [Miranda, Jose Lucivan] Univ Fed Ceara, Dept Maternal & Child Hlth, Fortaleza, Ceara, Brazil.
RP Brandao, MD (corresponding author), Univ Fed Minas Gerais, Sch Phys Educ Phys Therapy & Occupat Therapy, Grad Program Rehabil Sci, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM marinabbrandao@gmail.com
RI Mancini, Marisa/B-3951-2013
OI Mancini, Marisa/0000-0002-7415-5043; BRANDAO, MARINA/0000-0001-5192-0868
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil
   (CAPES)CAPES [001]; United Nations Children's Fund (UNICEF) Grant
   [SC140196]
FX This study was funded by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior Brasil (CAPES) - Finance Code 001 and United Nations
   Children's Fund (UNICEF) Grant [SC140196].
CR Almasri NA, 2018, PHYS OCCUP THER PEDI, V38, P427, DOI 10.1080/01942638.2017.1337664
   Alsem MW, 2017, RES DEV DISABIL, V60, P125, DOI 10.1016/j.ridd.2016.11.015
   AssociacAo Nacional de Empresas de Pesquisa/Brazilian Market Research Association (ABEP), 2016, BRAZ CRIT 2015 SOC C
   Bayley N., 2005, BAYLEY SCALES INFANT
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Cacola P, 2011, PEDIATR INT, V53, P820, DOI 10.1111/j.1442-200X.2011.03386.x
   Cacola PM, 2015, BRAZ J PHYS THER, V19, P507, DOI 10.1590/bjpt-rbf.2014.0112
   Cacola PM, 2015, PHYS THER, V95, P901, DOI 10.2522/ptj.20140011
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   Cunha AB, 2018, INFANT BEHAV DEV, V51, P52, DOI 10.1016/j.infbeh.2018.03.002
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hadders-Algra M, 2017, DEV MED CHILD NEUROL, V59, P246, DOI 10.1111/dmcn.13331
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   King G, 2017, CHILD CARE HLTH DEV, V43, P334, DOI 10.1111/cch.12435
   King S, 2004, CHILD HEALTH CARE, V33, P35, DOI 10.1207/s15326888chc3301_3
   King S, 1995, MEASURE PROCESSES CA
   King SM, 1996, DEV MED CHILD NEUROL, V38, P757, DOI 10.1111/j.1469-8749.1996.tb15110.x
   Landry MD, 2017, PHYS THER, V97, P275, DOI 10.2522/ptj.20160476
   Law M., 1998, CANADIAN OCCUPATIONA
   Lord C, 2018, CHILD CARE HLTH DEV, V44, P659, DOI 10.1111/cch.12592
   MacKean GL, 2005, HEALTH EXPECT, V8, P74, DOI 10.1111/j.1369-7625.2005.00319.x
   Maia M. F. S. C, 2012, INTERVENCAO PRECOCE
   Morgan C, 2016, DEV MED CHILD NEUROL, V58, P900, DOI 10.1111/dmcn.13105
   Morgan C, 2016, RES DEV DISABIL, V55, P256, DOI 10.1016/j.ridd.2016.04.005
   Morgan C, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0347-2
   Morgan C, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0203-2
   Morgan C, 2013, PEDIATRICS, V132, pE735, DOI 10.1542/peds.2012-3985
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rosenbaum P., 1998, PHYS OCCUPATIONAL TH, V18, P1, DOI DOI 10.1080/J006V18N01_01
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Spittle A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub4
   Tomczak M., 2014, TRENDS SPORT SCI, V1, P19, DOI DOI 10.5670/oceanog.2014.61
   Verkerk GJQ, 2006, CLIN REHABIL, V20, P980, DOI 10.1177/0269215506070703
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
NR 36
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0194-2638
EI 1541-3144
J9 PHYS OCCUP THER PEDI
JI Phys. Occup. Ther. Pediatr.
PD NOV 2
PY 2019
VL 39
IS 6
BP 642
EP 654
DI 10.1080/01942638.2019.1600100
EA MAY 2019
PG 13
WC Pediatrics; Rehabilitation
SC Pediatrics; Rehabilitation
GA JB9ES
UT WOS:000471584900001
PM 31144558
DA 2020-07-08
ER

PT J
AU Pleydell, DRJ
   Bouyer, J
AF Pleydell, David R. J.
   Bouyer, Jeremy
TI Biopesticides improve efficiency of the sterile insect technique for
   controlling mosquito-driven dengue epidemics
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; AUTODISSEMINATION STATION; STOCHASTIC SIMULATION;
   VIRUS TRANSMISSION; CULEX-PIPIENS; ALBOPICTUS; CULICIDAE; PYRIPROXYFEN;
   FIELD; POPULATION
AB Various mosquito control methods use factory raised males to suppress vector densities. But the efficiency of these methods is currently insufficient to prevent epidemics of arbovirus diseases such as dengue, chikungunya or Zika. Suggestions that the sterile insect technique (SIT) could be "boosted" by applying biopesticides to sterile males remain unquantified. Here, we assess mathematically the gains to SIT for Aedes control of either: boosting with the pupicide pyriproxifen (BSIT); or, contaminating mosquitoes at auto-dissemination stations. Thresholds in sterile male release rate and competitiveness are identified, above which mosquitoes are eliminated asymptotically. Boosting reduces these thresholds and aids population destabilisation, even at sub-threshold release rates. No equivalent bifurcation exists in the auto-dissemination sub-model. Analysis suggests that BSIT can reduce by over 95% the total release required to circumvent dengue epidemics compared to SIT. We conclude, BSIT provides a powerful new tool for the integrated management of mosquito borne diseases.
C1 [Pleydell, David R. J.; Bouyer, Jeremy] Univ Montpellier, INRA, CIRAD, UMR ASTRE, F-34398 Montpellier, France.
   [Pleydell, David R. J.] Univ Montpellier, INRA, CIRAD, UMR ASTRE, F-97170 Petit Bourg, Guadeloupe, France.
   [Bouyer, Jeremy] IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.
RP Pleydell, DRJ; Bouyer, J (corresponding author), Univ Montpellier, INRA, CIRAD, UMR ASTRE, F-34398 Montpellier, France.; Pleydell, DRJ (corresponding author), Univ Montpellier, INRA, CIRAD, UMR ASTRE, F-97170 Petit Bourg, Guadeloupe, France.; Bouyer, J (corresponding author), IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.
EM david.pleydell@inra.fr; j.bouyer@iaea.org
RI Bouyer, Jeremy/AAK-7370-2020
OI Bouyer, Jeremy/0000-0002-1913-416X; Pleydell, David/0000-0002-6450-1475
FU Institute Carnot Sante Animale (IVEMA project); European Research
   Council (ERC) under the European UnionEuropean Research Council (ERC)
   [682387]; REVOLINC (Revolutionising Insect Control) ERC Consolidator
   Grant
FX The authors would like to thank Mark Vreysen, Kostas Bourtzis, Andrew
   Parker, Nicole Culbert, Thierry Baldet and Haoues Alout for comments on
   early versions of this paper and Lyse Primault, Geoffrey Gimonneau and
   Fabrice Chandre for providing egg viability data. We also thank Randy
   Gaugler and Devi Shankar Suman for discussions regarding their venereal
   transfer experiment. Financial support was provided by the Institute
   Carnot Sante Animale (IVEMA project) and the REVOLINC (Revolutionising
   Insect Control) ERC Consolidator Grant. This project has received
   funding from the European Research Council (ERC) under the European
   Union's Horizon 2020 research and innovation programme (grant agreement
   No 682387).
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Agences Regionales de Sante Ocean Indien, EP DENG REUN CIRC VI
   ALI A, 1995, J AM MOSQUITO CONTR, V11, P72
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Amaku M, 2016, EPIDEMIOL INFECT, V144, P3435, DOI 10.1017/S0950268816001448
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2016, LANCET GLOB HEALTH, V4, pE364, DOI 10.1016/S2214-109X(16)00082-6
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629
   Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235
   Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   CluttonBrock T, 1997, BEHAV ECOL, V8, P392, DOI 10.1093/beheco/8.4.392
   Darriet F, 2006, J MED ENTOMOL, V43, P1190, DOI 10.1603/0022-2585(2006)43[1190:LEOPAS]2.0.CO;2
   de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Enkerlin WR, 2017, ENTOMOL EXP APPL, V164, P188, DOI 10.1111/eea.12611
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Fonseca D. M, 2015, J MED ENTOMOL, V1, P8
   FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869
   Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x
   Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q
   Gilbert JA, 2018, NAT BIOTECHNOL, V36, P781, DOI 10.1038/nbt0918-781a
   GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3
   Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322
   Greenhalgh D, 2018, J BIOL SYST, V26, P553, DOI 10.1142/S0218339018500250
   Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Joanne S, 2017, TROP MED INT HEALTH, V22, P1154, DOI 10.1111/tmi.12918
   Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116
   Kartzinel MA, 2016, J AM MOSQUITO CONTR, V32, P194, DOI 10.2987/16-6555.1
   Khan SU, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1155/2014/986567
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Le Goff G, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3329-7
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153
   Macoris M., 2008, DENGUE B, V32, P186
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Peccoud J, 2018, EVOLUTION, V72, P2503, DOI 10.1111/evo.13595
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Pleydell DRJ, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006085
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Primault L, 2015, THESIS
   R Core Team, 2018, R LANG ENV STAT COMP
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Ritchie SA, 2013, J MED ENTOMOL, V50, P1169, DOI 10.1603/ME13043
   Sawabe K, 2010, J MED ENTOMOL, V47, P442, DOI 10.1603/ME09256
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
   Suman DS, 2018, PEST MANAG SCI, V74, P885, DOI 10.1002/ps.4780
   Suman DS, 2013, J MED ENTOMOL, V50, P1261, DOI 10.1603/ME13068
   Tantowijoyo W, 2016, J MED ENTOMOL, V53, P188, DOI 10.1093/jme/tjv180
   Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576
   Unlu I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2034-7
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857
   Wang T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003677
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Weterings R, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9534
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   World Health Organization, 1990, PUBL HLTH IMP PEST U
   WYSS JH, ANN N Y ACAD SCI, V916, P186
   Xiao JP, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0131-z
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zhu DD, 2018, MATH METHOD APPL SCI, V41, P5388, DOI 10.1002/mma.5085
NR 94
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD MAY 29
PY 2019
VL 2
AR 201
DI 10.1038/s42003-019-0451-1
PG 11
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA IC1ZQ
UT WOS:000470759300002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shiao, SH
   Weng, SC
   Luan, LQ
   Vicente, MDH
   Jiang, XJ
   Ng, DKP
   Kolli, BK
   Chang, KP
AF Shiao, Shin-Hong
   Weng, Shih-Che
   Luan, Liqiang
   Vicente, Maria da Graca H.
   Jiang, Xiong-Jie
   Ng, Dennis K. P.
   Kolli, Bala Krishna
   Chang, Kwang Poo
TI Novel phthalocyanines activated by dim light for mosquito larva-and
   cell-inactivation with inference for their potential as broadspectrum
   photodynamic insecticides
SO PLOS ONE
LA English
DT Article
ID TRANSGENIC LEISHMANIA; CATIONIC PORPHYRIN; ALPHA-TERTHIENYL;
   PHOTOSENSITIZERS; TOXICITY; UROPORPHYRIA; PHOTOLYSIS; EFFICACY; THERAPY;
   VISION
AB Mosquitoes are significant vectors, responsible for transmitting serious infectious diseases, including the recent epidemics of global significance caused by, for example, Zika, Dengue and Chikungunya viruses. The chemical insecticides in use for mosquito control are toxic and ineffective due to the development of resistance to them. The new approach to reduce mosquito population by releasing genetically modified males to cause female infertility is still under environmental safety evaluation. Photodynamic insecticides (PDI) have long been known as a safe and effective alternative by using dyes as the photosensitizers (PS) for activation with light to generate insecticidal singlet oxygen and reactive oxygen species. This approach warrants re-examination with advances in the chemical synthesis of novel PS, e.g. phthalocyanines (PC). Nine PC were compared with five porphyrin derivatives and two classic PS of halogenated fluoresceins, i. e. cyanosine and rose bengal experimentally for photodynamic treatment (PDT) of the larvae of laboratory-reared Aedes mosquitoes and their cell lines. Groups of 2 nd instar larvae were first exposed overnight to graded concentrations of each PS in the dark followed by their exposure to dim light for up to 7 hours. Larvae of both experimental and control groups were examined hourly for viability based on their motility. Monolayers of mosquito cells were similarly PS-sensitized and exposed briefly to light at the PS-specific excitation wavelengths. Cell viability was assessed by MTT reduction assays. Of the 16 PS examined for photodynamic inactivation of the mosquito larvae, effective are three novel PC, i.e. amino-Si-PC1 and -PC2, anilinium Zn-PC3.4, pyridyloxy SiPC14 and two porphyrin derivatives, i.e. TPPS2 and TMAP. Their EC50 values were determined, all falling in the nanomolar range lower than those of rose bengal and cyanosine. All PS effective in vivo were also found to dose-dependently inactivate mosquito cells photodynamically in vitro, providing cellular basis for their larvicidal activities. The present findings of novel PC with effective photodynamic larvicidal activities provide fresh impetus to the development of PDI with their established advantages in safety and efficacy. Toward that end, the insect cell lines are of value for rapid screening of new PC. The optimal excitability of PC with insect-invisible red light is inferred to have the potential to broaden the range of targetable insect pests.
C1 [Shiao, Shin-Hong; Weng, Shih-Che] Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan.
   [Luan, Liqiang; Vicente, Maria da Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
   [Jiang, Xiong-Jie; Ng, Dennis K. P.] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China.
   [Kolli, Bala Krishna; Chang, Kwang Poo] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA.
RP Shiao, SH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan.; Chang, KP (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA.
EM shshiao@ntu.edu.tw; kwangpoo.chang@rosalindfranklin.edu
OI SHIAO, SHIN-HONG/0000-0002-7749-7807; Weng,
   Shih-Che/0000-0003-3315-9125; Ng, Dennis/0000-0001-9087-960X
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI097830, AI7712375, AI68835]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 CA179902]
FX This work was supported by the NIH/NIAID Grant #AI097830, AI7712375,
   AI68835 to KPC/BKK; NIH Grant #R01 CA179902 to GHV. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Al-Qahtani A, 2016, ANTIMICROB AGENTS CH, V60, P2003, DOI 10.1128/AAC.01879-15
   Arikawa K, 2017, J PHYSIOL-LONDON, V595, P5457, DOI 10.1113/JP273917
   Bayona AMD, 2017, CHEM BIOL DRUG DES, V89, P192, DOI 10.1111/cbdd.12792
   Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2
   Chang CH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006307
   Chang KP, 2018, PROC SPIE, V10479, DOI 10.1117/12.2281437
   Chang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1674-3
   Dondji B, 2005, J MED ENTOMOL, V42, P652, DOI 10.1603/0022-2585(2005)042[0652:AOLAFA]2.0.CO;2
   DOSDALL LM, 1992, J AM MOSQUITO CONTR, V8, P166
   Dougherty TJ, 2002, PHOTOCHEM PHOTOBIOL, V76, P91, DOI 10.1562/0031-8655(2002)076<0091:TROTPB>2.0.CO;2
   DUKE SO, 1993, ACS SYM SER, V524, P1
   Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P4474, DOI 10.1128/AAC.49.11.4474-4484.2005
   Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07
   Dutta S, 2012, EUKARYOT CELL, V11, P430, DOI 10.1128/EC.05202-11
   Dutta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020786
   Fabris C, 2012, ACTA TROP, V123, P239, DOI 10.1016/j.actatropica.2012.05.011
   Fabris C, 2012, PHOTOCH PHOTOBIO SCI, V11, P294, DOI 10.1039/c1pp05154g
   Futahashi R, 2016, CURR OPIN INSECT SCI, V17, P32, DOI 10.1016/j.cois.2016.05.014
   Guo B, 2017, SLAS TECHNOL, V22, P557, DOI 10.1177/2472630317698633
   HASSPIELER BM, 1988, J AM MOSQUITO CONTR, V4, P479
   Heitz J.R., 1987, ACS SYM SER, P1
   Heitz JR, 1995, ACS SYM SER, V616, P1
   HEITZ JR, 1987, ACS SYM SER, V339, P1
   Hung CH, 2008, CHEM COMMUN, P978, DOI 10.1039/b714412a
   Iqbal Z, 2015, CURR DRUG METAB, V16, P816, DOI 10.2174/1389200217666151120165404
   Jiang XJ, 2011, J MED CHEM, V54, P320, DOI 10.1021/jm101253v
   JORI G, 1989, CIBA F SYMP, V146, P78
   JORI G, 1984, TOPICS PHOTOMEDICINE, P183
   Latham JR, 2017, BIOTECHNOL GENET ENG, V33, P62, DOI 10.1080/02648725.2017.1357295
   Li HR, 2008, J MED CHEM, V51, P502, DOI 10.1021/jm070781f
   Lucantoni L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001434
   Lucht JM, 2015, VIRUSES-BASEL, V7, P4254, DOI 10.3390/v7082819
   Mangan RL, 2001, J ECON ENTOMOL, V94, P150, DOI 10.1603/0022-0493-94.1.150
   NIVSARKAR M, 1991, ARCH INSECT BIOCHEM, V16, P249, DOI 10.1002/arch.940160404
   Pavlidi N, 2018, CURR OPIN INSECT SCI, V27, P97, DOI 10.1016/j.cois.2018.04.007
   REBEIZ CA, 1995, CRIT REV PLANT SCI, V14, P329, DOI 10.1080/07352689509382363
   Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200
   Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7
   Song RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42058
   SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x
   Thomas AP, 2012, J MED CHEM, V55, P5110, DOI 10.1021/jm300009q
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Weng SC, 2015, INSECT BIOCHEM MOLEC, V61, P17, DOI 10.1016/j.ibmb.2015.03.010
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156
NR 44
TC 2
Z9 2
U1 3
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2019
VL 14
IS 5
AR e0217355
DI 10.1371/journal.pone.0217355
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA1LO
UT WOS:000469323000053
PM 31141567
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cortese, M
   Kumar, A
   Matula, P
   Kaderali, L
   Scaturro, P
   Erfle, H
   Acosta, EG
   Buehler, S
   Ruggieri, A
   Chatel-Chaix, L
   Rohr, K
   Bartenschlager, R
AF Cortese, Mirko
   Kumar, Anil
   Matula, Petr
   Kaderali, Lars
   Scaturro, Pietro
   Erfle, Holger
   Acosta, Eliana Gisela
   Buehler, Sandra
   Ruggieri, Alessia
   Chatel-Chaix, Laurent
   Rohr, Karl
   Bartenschlager, Ralf
TI Reciprocal Effects of Fibroblast Growth Factor Receptor Signaling on
   Dengue Virus Replication and Virion Production
SO CELL REPORTS
LA English
DT Article
ID HOST FACTORS; ZIKA VIRUS; ACTIVATION; PATHWAY; KINASE; IDENTIFICATION;
   RESIDUES; MUTATION
AB Dengue virus (DENV) is a human arboviral pathogen accounting for 390 million infections every year. The available vaccine has limited efficacy, and DENV-specific drugs have not been generated. To better understand DENV-host cell interaction, we employed RNA interference-based screening of the human kinome and identified fibroblast growth factor receptor 4 (FGFR4) to control the DENV replication cycle. Pharmacological inhibition of FGFR exerts a reciprocal effect by reducing DENV RNA replication and promoting the production of infectious virus particles. Addressing the latter effect, we found that the FGFR signaling pathway modulates intracellular distribution of DENV particles in a PI3K-dependent manner. Upon FGFR inhibition, virions accumulate in the trans-Golgi network compartment, where they undergo enhanced maturation cleavage of the envelope protein precursor membrane (prM), rendering virus particles more infectious. This study reveals an unexpected reciprocal role of a cellular receptor tyrosine kinase regulating DENV RNA replication and the production of infectious virions.
C1 [Cortese, Mirko; Kumar, Anil; Scaturro, Pietro; Acosta, Eliana Gisela; Buehler, Sandra; Ruggieri, Alessia; Chatel-Chaix, Laurent; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
   [Matula, Petr; Rohr, Karl] Heidelberg Univ, Biomed Comp Vis Grp, BioQuant, IPMB, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.
   [Matula, Petr; Rohr, Karl] German Canc Res Ctr, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.
   [Kaderali, Lars] Heidelberg Univ, ViroQuant Res Grp Modeling, BioQuant, Heidelberg, Germany.
   [Erfle, Holger] Heidelberg Univ, Adv Biol Screening Facil, BioQuant, D-69120 Heidelberg, Germany.
   [Bartenschlager, Ralf] German Ctr Infect Res, Heidelberg Partner Site,Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
   [Chatel-Chaix, Laurent] Inst Armand Frappier, Inst Natl Rech Sci, 531 Blvd Prairies Laval, Quebec City, PQ H7V 1B7, Canada.
   [Matula, Petr] Masaryk Univ, Fac Informat, Bot 68a, Brno 60200, Czech Republic.
   [Kaderali, Lars] Univ Med Greifswald, Inst Bioinformat, Walther Rathenau Str 48, D-17475 Greifswald, Germany.
   [Scaturro, Pietro] Tech Univ Munich, Inst Virol, Sch Med, Schneckenburgerstr 8, D-81675 Munich, Germany.
   [Kumar, Anil] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.
RP Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.; Bartenschlager, R (corresponding author), German Ctr Infect Res, Heidelberg Partner Site,Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
EM ralf.bartenschlager@med.uni-heidelberg.de
RI Matula, Petr/L-2119-2013
OI Matula, Petr/0000-0003-4125-1597; Ruggieri, Alessia/0000-0001-9981-3308;
   Scaturro, Pietro/0000-0001-9098-3087; Kumar, Anil/0000-0002-6179-4516;
   Cortese, Mirko/0000-0003-1786-4211
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SFB1129, TP11, BA1505/8-1]; Humboldt FoundationAlexander von Humboldt
   Foundation; Ministry of Education, Youth and SportsMinistry of
   Education, Youth & Sports - Czech Republic
   [CZ.02.1.01/0.0/0.0/16_013/0001775]; CellNetworks-Cluster of Excellence
   [EXC81]
FX We are grateful to the Electron Microscopy Core Facility at Heidelberg
   University, headed by Stefan Hillmer; the Infectious Diseases Imaging
   Platform (IDIP) at the Center for Integrative Infectious Disease
   Research in Heidelberg, headed by Vibor Laketa; and Ulrike Engel and
   Christian Ackermann at the Nikon Imaging Center (Heidelberg University)
   for support and access to their equipment. We are also grateful to
   Ulrike Herian, Stephanie Kallis, Marie Bartenschlager, and Fredy
   Huschmand for technical support and Volker Lohmann and Christopher J.
   Neufeldt for helpful discussions. We thank the European Virus Archive
   goes Global (EVAg) and Xavier de Lamballerie (Emergence des Pathologies
   Virales, Aix-Marseille University) for providing ZIKV MR766 and
   H/PF/2013 original stocks. We are grateful to Andrew Davidson for
   providing the DV-NGC-encoding plasmid, to Didier Trono (EPFL, Lausanne,
   Switzerland) for providing the lentivirus packaging constructs, and to
   Megan Stanifer for help with the VSV-G assay. This work was supported by
   the Deutsche Forschungsgemeinschaft (SFB1129, TP11, and BA1505/8-1) to
   R.B. E.G.A. was supported by the Humboldt Foundation. P.M. is grateful
   to the Ministry of Education, Youth and Sports
   (CZ.02.1.01/0.0/0.0/16_013/0001775) for financial support. The Advanced
   Biological Screening Facility is supported by the CellNetworks-Cluster
   of Excellence (EXC81).
CR Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Albarnaz JD, 2014, ANTIVIR RES, V111, P82, DOI 10.1016/j.antiviral.2014.09.004
   Anitei M, 2014, J CELL SCI, V127, P5079, DOI 10.1242/jcs.159608
   Bar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003605
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329
   DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379
   Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483
   Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455
   Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Gullberg RC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007261
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124651
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Matula P, 2009, CYTOM PART A, V75A, P309, DOI 10.1002/cyto.a.20662
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002
   Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014
   Ruhe JE, 2007, CANCER RES, V67, P11368, DOI 10.1158/0008-5472.CAN-07-2703
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Tang SY, 2018, CANCER SCI, V109, P3024, DOI 10.1111/cas.13759
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   van Asten SD, 2018, J VIROL, V92, DOI 10.1128/JVI.00260-18
   Wang LZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01357-4
   Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Willemsen J, 2017, MOL CELL, V65, P403, DOI 10.1016/j.molcel.2016.12.021
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao LJ, 2015, CYTOKINE, V72, P17, DOI 10.1016/j.cyto.2014.11.031
NR 53
TC 3
Z9 3
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAY 28
PY 2019
VL 27
IS 9
BP 2579
EP +
DI 10.1016/j.celrep.2019.04.105
PG 20
WC Cell Biology
SC Cell Biology
GA HZ9ZN
UT WOS:000469216500007
PM 31141684
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Valiant, WG
   Mattapallil, MJ
   Higgs, S
   Huang, YJS
   Vanlandingham, DL
   Lewis, MG
   Mattapallil, JJ
AF Valiant, William G.
   Mattapallil, Mary J.
   Higgs, Stephen
   Huang, Yan-Jang S.
   Vanlandingham, Dana L.
   Lewis, Mark G.
   Mattapallil, Joseph J.
TI Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does
   not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte
   Subsets and Biphasic Release of Pro-inflammatory Cytokines
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SERUM CREATINE-PHOSPHOKINASE; CLINICAL PRESENTATION; INFECTION; DISEASE;
   CHIKUNGUNYA; RESPONSES; MUCOSAL; RHESUS; RNA; SPECIMENS
AB The consequences of simultaneous infection with Zika (ZIKV) and Dengue (DENV) viruses are poorly understood. Here we show that rhesus macaques experimentally coinfected simultaneously with ZIKV and DENV-2 demonstrated ZIKV or DENV replication without an enhancement of either infection. Coinfection was accompanied by an increase in the proportions of CD14(+)CD16(+) pro-inflammatory subsets of monocytes and release of pro-inflammatory cytokines in the plasma. Numerous cytokines such as I-TAC, Eotaxin, RANTES, MCP-1, IFN gamma and MIG demonstrated a biphasic peak that coincided with the differences in kinetics of ZIKV and DENV replication suggesting that viral replication likely differentially modulated the release of these cytokines. Red blood cell indices significantly declined during acute infection suggesting transient anemia, and was accompanied by elevated levels of muscle, liver and renal injury markers. These findings have implications for understanding the pathogenesis of coinfection in ZIKV and DENV endemic regions, and is the 1st report of an experimental coinfection using the rhesus macaque model for ZIKV and DENV infections.
C1 [Valiant, William G.; Mattapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.
   [Mattapallil, Mary J.] NEI, NIH, Bethesda, MD 20892 USA.
   [Higgs, Stephen; Huang, Yan-Jang S.; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Lewis, Mark G.] Bioqual, Rockville, MD USA.
RP Mattapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.
EM joseph.mattapallil@usuhs.edu
OI Mattapallil, Joseph/0000-0002-7412-9507
FU Uniformed Services University
FX We would like to thank Jeffy George for assistance with processing the
   samples. The described project was supported by funds from the Uniformed
   Services University to J.J.M. The opinions or assertions contained
   herein are the private ones of the authors and are not to be construed
   as official or reflecting the views of the Department of Defense, the
   Uniformed Services University of the Health Sciences or any other agency
   of the U.S. Government.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abhishek KS, 2017, INDIAN J PATHOL MICR, V60, P66, DOI 10.4103/0377-4929.200027
   Aye Mra, 2016, Trop Med Infect Dis, V1, DOI 10.3390/tropicalmed1010006
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRAY GM, 1968, NEUROLOGY, V18, P480, DOI 10.1212/WNL.18.5.480
   Brown D, 2014, CLIN VACCINE IMMUNOL, V21, P1469, DOI 10.1128/CVI.00518-14
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Comesana M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193480
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Davis JS, 2004, CLIN INFECT DIS, V38, pE109, DOI 10.1086/392510
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dufour DR, 2000, CLIN CHEM, V46, P2027
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Faccini-Martinez AA, 2016, J INFECT PUBLIC HEAL, V9, P687, DOI 10.1016/j.jiph.2016.01.001
   Fernando S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1656-2
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   HESS JW, 1964, ANN INTERN MED, V61, P1015, DOI 10.7326/0003-4819-61-6-1015
   Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145
   Hira HS, 2012, J NEUROSCI RURAL PRA, V3, P36, DOI 10.4103/0976-3147.91928
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hutchinson EB, 2019, J COMP NEUROL, V527, P1706, DOI 10.1002/cne.24640
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Kalita J, 2005, Electromyogr Clin Neurophysiol, V45, P357
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kulkarni D, 2014, THER ADV INFECT DIS, V2, P97, DOI 10.1177/2049936114559918
   Kuwata T, 2006, J VIROL, V80, P1463, DOI 10.1128/JVI.80.3.1463-1475.2006
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Malheiros S M, 1993, Arq Neuropsiquiatr, V51, P159
   Mallhi TH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192510
   Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x
   Moghadam-Kia S, 2016, CLEV CLIN J MED, V83, P37, DOI 10.3949/ccjm.83a.14120
   Moore AC, 2012, J VIROL, V86, P1069, DOI 10.1128/JVI.06372-11
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paliwal VK, 2011, J NEUROL SCI, V300, P14, DOI 10.1016/j.jns.2010.10.022
   PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Radakovic-Fijan S, 2002, J AM ACAD DERMATOL, V46, P430, DOI 10.1067/mjd.2002.111904
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rossi AD, 2019, J INTERN MED, V285, P215, DOI 10.1111/joim.12829
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Sani SSM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2601-8
   Sargeant T, 2013, CASE REP MED, DOI 10.1155/2013/101058
   Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x
   Tamibmaniam J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161696
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Uchida N, 2011, EXP HEMATOL, V39, P795, DOI 10.1016/j.exphem.2011.04.002
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   Valiant WG, 2018, JOVE-J VIS EXP, DOI 10.3791/57371
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wagman Y, 2016, INJURY, V47, P2764, DOI 10.1016/j.injury.2016.10.018
   Woollard SM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030070
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zheng C G, 2016, Zhonghua Er Ke Za Zhi, V54, P375, DOI 10.3760/cma.j.issn.0578-1310.2016.05.013
NR 86
TC 2
Z9 2
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 27
PY 2019
VL 9
AR 7877
DI 10.1038/s41598-019-44323-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HZ7DJ
UT WOS:000469011800025
PM 31133721
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Niu, XF
   Zhao, LZ
   Qu, LB
   Yao, ZP
   Zhan, F
   Yan, QH
   Zhang, SN
   Liang, RS
   Chen, PH
   Luo, J
   Xu, W
   Lv, HB
   Liu, XL
   Lei, H
   Yi, CH
   Li, PC
   Wang, Q
   Wang, Y
   Yu, L
   Zhang, XY
   Bryan, AR
   Davidson, EGR
   Doranz, JB
   Feng, LQ
   Pan, WQ
   Zhang, FC
   Chen, L
AF Niu, Xuefeng
   Zhao, Lingzhai
   Qu, Linbing
   Yao, Zhipeng
   Zhan, Fan
   Yan, Qihong
   Zhang, Shengnan
   Liang, Renshan
   Chen, Peihai
   Luo, Jia
   Xu, Wei
   Lv, Huibin
   Liu, Xinglong
   Lei, Hui
   Yi, Changhua
   Li, Pingchao
   Wang, Qian
   Wang, Yang
   Yu, Lei
   Zhang, Xiaoyan
   Bryan, L. Aubrey
   Davidson, Edgar
   Doranz, J. Benjamin
   Feng, Liqiang
   Pan, Weiqi
   Zhang, Fuchun
   Chen, Ling
TI Convalescent patient-derived monoclonal antibodies targeting different
   epitopes of E protein confer protection against Zika virus in a neonatal
   mouse model
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; monoclonal antibody; animal model; neutralizing epitopes;
   therapeutics
ID DENGUE VIRUS; NEUTRALIZING ANTIBODIES; CROSS-REACTIVITY; POTENT;
   INFECTION; ENHANCEMENT; EMERGENCE; BRAZIL
AB The Zika virus (ZIKV) outbreak and its link to microcephaly triggered a public health concern. To examine antibody response in a patient infected with ZIKV, we used single-cell PCR to clone 31 heavy and light chain-paired monoclonal antibodies (mAbs) that bind to ZIKV envelope (E) proteins isolated from memory B cells of a ZIKV-infected patient. Three mAbs (7B3, 1C11, and 6A6) that showed the most potent and broad neutralization activities against the African, Asian, and American strains were selected for further analysis. mAb 7B3 showed an IC50 value of 11.6 ng/mL against the circulating American strain GZ02. Epitope mapping revealed that mAbs 7B3 and 1C11 targeted residue K394 of the lateral ridge (LR) epitope of the EDIII domain, but 7B3 has a broader LR epitope footprint and recognizes residues T335, G337, E370, and N371 as well. mAb 6A6 recognized residues D67, K118, and K251 of the EDII domain. Interestingly, although the patient was seronegative for DENV infection, mAb 1C11, originating from the VH3-23 and VK1-5 germline pair, neutralized both ZIKV and DENV1. Administration of the mAbs 7B3, 1C11, and 6A6 protected neonatal SCID mice infected with a lethal dose of ZIKV. This study provides potential therapeutic antibody candidates and insights into the antibody response after ZIKV infection.
C1 [Niu, Xuefeng; Liang, Renshan; Lv, Huibin; Lei, Hui; Wang, Yang; Pan, Weiqi; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Zhao, Lingzhai; Xu, Wei; Yu, Lei; Zhang, Fuchun; Chen, Ling] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Qu, Linbing; Yao, Zhipeng; Zhan, Fan; Yan, Qihong; Zhang, Shengnan; Luo, Jia; Liu, Xinglong; Yi, Changhua; Li, Pingchao; Wang, Qian; Zhang, Xiaoyan; Feng, Liqiang; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Lab Computat Biomed, Guangzhou, Guangdong, Peoples R China.
   [Yao, Zhipeng; Zhan, Fan; Chen, Peihai] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Anhui, Peoples R China.
   [Yan, Qihong; Zhang, Xiaoyan] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Bryan, L. Aubrey; Davidson, Edgar; Doranz, J. Benjamin] Integral Mol, Philadelphia, PA USA.
RP Pan, WQ; Chen, L (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.; Zhang, FC; Chen, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.; Chen, L (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Lab Computat Biomed, Guangzhou, Guangdong, Peoples R China.
EM pan_weiqi@gibh.ac.cn; gz8hzfc@126.com; chen_ling@gibh.ac.cn
FU National Science and Technology Major Project [2017ZX10304401];
   Guangzhou Science and Technology Program key projects [201904020037,
   201707020046]; Guangzhou Health Care and Cooperative Innovation Major
   Project [20174020229]; Special Program of Guangdong Provincial Science
   and Technology Department [2016A020250001, 2016A020248001]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81661148056]
FX This work was supported by The National Science and Technology Major
   Project [grant number 2017ZX10304401]; Guangzhou Science and Technology
   Program key projects [grant number 201904020037, 201707020046];
   Guangzhou Health Care and Cooperative Innovation Major Project [grant
   number 20174020229]; the Special Program of Guangdong Provincial Science
   and Technology Department [2016A020250001, 2016A020248001]; National
   Natural Science Foundation of China [grant number 81661148056].
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Meng WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066276
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004
   Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Yu L, 2017, PROCEEDINGS OF THE 2017 12TH INTERNATIONAL CONFERENCE ON MALICIOUS AND UNWANTED SOFTWARE (MALWARE), P91, DOI 10.1109/MALWARE.2017.8323961
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep25856
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007
NR 51
TC 4
Z9 5
U1 1
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 25
PY 2019
VL 8
IS 1
BP 749
EP 759
DI 10.1080/22221751.2019.1614885
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HZ5KQ
UT WOS:000468891200001
PM 31130109
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pruss, D
   Fujinuma, Y
   Daughton, AR
   Paul, MJ
   Arnot, B
   Szafir, DA
   Boyd-Graber, J
AF Pruss, Dasha
   Fujinuma, Yoshinari
   Daughton, Ashlynn R.
   Paul, Michael J.
   Arnot, Brad
   Szafir, Danielle Albers
   Boyd-Graber, Jordan
TI Zika discourse in the Americas: A multilingual topic analysis of Twitter
SO PLOS ONE
LA English
DT Article
ID SOCIAL MEDIA
AB This work examines Twitter discussion surrounding the 2015 outbreak of Zika, a virus that is most often mild but has been associated with serious birth defects and neurological syndromes. We introduce and analyze a collection of 3.9 million tweets mentioning Zika geolocated to North and South America, where the virus is most prevalent. Using a multilingual topic model, we automatically identify and extract the key topics of discussion across the dataset in English, Spanish, and Portuguese. We examine the variation in Twitter activity across time and location, finding that rises in activity tend to follow to major events, and geographic rates of Zika-related discussion are moderately correlated with Zika incidence (rho =.398).
C1 [Pruss, Dasha] Univ Pittsburgh, Dept Hist & Philosophy Sci, Pittsburgh, PA USA.
   [Fujinuma, Yoshinari; Paul, Michael J.; Arnot, Brad; Szafir, Danielle Albers] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.
   [Daughton, Ashlynn R.; Paul, Michael J.; Szafir, Danielle Albers] Univ Colorado, Dept Informat Sci, Boulder, CO 80309 USA.
   [Daughton, Ashlynn R.] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA.
   [Boyd-Graber, Jordan] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.
RP Paul, MJ (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.; Paul, MJ (corresponding author), Univ Colorado, Dept Informat Sci, Boulder, CO 80309 USA.
EM mpaul@colorado.edu
FU National Science Foundation Graduate Research FellowshipNational Science
   Foundation (NSF); National Science FoundationNational Science Foundation
   (NSF) [IIS-1564275]
FX Pruss was supported in part by a National Science Foundation Graduate
   Research Fellowship. Fujinuma, Paul, and Boyd-Graber were supported in
   part by National Science Foundation grant IIS-1564275. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR af Wahlberg A.E., 2000, J RISK RES, V3, P31, DOI DOI 10.1080/136698700376699
   Allem Jon-Patrick, 2017, JMIR Public Health Surveill, V3, pe98, DOI 10.2196/publichealth.8641
   Baumer EPS, 2017, J ASSOC INF SCI TECH, V68, P1397, DOI 10.1002/asi.23786
   Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Boyd-Graber J, 2017, FOUND TRENDS INF RET, V11, P144
   Boyd-Graber Jordan, 2009, P UNC ART INT
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Brody S, 2010, AMIA ANN S P
   Broniatowski DA, 2016, VACCINE, V34, P3225, DOI 10.1016/j.vaccine.2016.04.044
   Burke D, 2016, CNN
   CDC, 2014, ZIK SYMPT
   CDC, 2014, ZIK
   Chang J., 2009, P 22 INT C NEUR INF
   Chen L, 2015, DATA MINING KNOWLEDG
   Cohen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087555
   Cook J., 2013, P INT C WORLD WID WE, P225
   Culotta A., 2010, P 1 WORKSH SOC MED A, P115, DOI DOI 10.1145/1964858.1964874
   Dredze M., 2013, AAAI WORKSH EXP BOUN
   Dredze M, 2017, SYNTH LECT INF CONCE, V9, P1, DOI DOI 10.2200/S00791ED1V01Y201707ICR060
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duggan M., 2015, SOCIAL MEDIA UPDATE
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Ghosh D, 2013, CARTOGR GEOGR INF SC, V40, P90, DOI 10.1080/15230406.2013.776210
   Giabbanelli PJ, 2016, LECT NOTES COMPUT SC, V9742, P188, DOI 10.1007/978-3-319-39910-2_18
   Gomide J., 2011, P ACM WEBSCI 11 JUN, P1, DOI [10.1145/2527031.2527049, DOI 10.1145/2527031.2527049]
   Graham P, 2017, STOPWORDS JSON
   Hao S, 2018, N AM CHAPTER ASS COM
   Hong L, 2010, P 1 WORKSH SOC MED A, P80, DOI [DOI 10.1145/1964858.1964870, 10.1145/1964858.1964870]
   Jagarlamudi J, 2010, ECIR
   Ji X, 2013, IEEE INT C HEALTHC I
   Johnson I, 2017, C HUM FACT COMP SYST
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Kindhauser MK, 2016, B WHO 2016
   King G, 2017, AM J POLIT SCI, V61, P971, DOI 10.1111/ajps.12291
   Koehn P, 2009, STAT MACHINE TRANSLA
   Lampos V, 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088
   Lau Jey Han, 2014, P EUR CHAPT ASS COMP
   Lau JH, 2017, COMPUTATION SEMANTIC
   Lazard A. J., 2015, AM J INFECT CONTROL
   Levow GA, 2005, INFORM PROCESS MANAG, V41, P523, DOI 10.1016/j.ipm.2004.06.012
   Lu Y, 2011, INFORM RETRIEVAL, V14, P178, DOI 10.1007/s10791-010-9141-9
   Lucas C, 2015, POLIT ANAL, V23, P254, DOI 10.1093/pan/mpu019
   Lui Marco, 2012, P ACL 2012 SYST DEM, P25
   MALLET, 2019, TOP MOD
   Mayhew S, 2017, P 2017 C EMP METH NA
   McCallum A. K., 2002, MALLET MACHINE LEARN
   McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Microsoft, 2019, TRANSL TEXT DOC
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Mimno David, 2011, P EMP METH NAT LANG
   Mimno David, 2009, P EMP METH NAT LANG
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Muralidhara S, 2018, JMIR PUBLIC HLTH SUR, V4, P148, DOI 10.2196/10150
   Newman David, 2010, C N AM CHAPT ASS COM
   Ni Xiaochuan, 2009, P WORLD WID WEB C
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Paul MJ, 2011, INT C WEBL SOC MED I
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P100, DOI 10.1016/j.tmaid.2014.11.004
   Rolston Leanne, 2016, COLLECTION BILINGUAL
   Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513
   Schofield A., 2016, T ASS COMPUTATIONAL, V4, P287, DOI DOI 10.1162/tacl_a_00099
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shipman SA, 2011, PEDIATRICS, V127, P19, DOI 10.1542/peds.2010-0150
   Smith M, 2016, AAAI SPRING S OBS ST
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Sun L., 2016, WASHINGTON POST
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117259
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015
   Wallace BC, 2014, J AM MED INFORM ASSN, V21, P1098, DOI 10.1136/amiajnl-2014-002711
   Wallach HM, 2009, P 22 INT C NEUR INF
   World Health Organization, 2017, HIST ZIK VIR
   Xing L, 2018, AAAI C ART INT AAAI
NR 77
TC 0
Z9 0
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 23
PY 2019
VL 14
IS 5
AR e0216922
DI 10.1371/journal.pone.0216922
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HZ3VE
UT WOS:000468775700040
PM 31120935
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Byers, JE
   Schmidt, JP
   Pappalardo, P
   Haas, SE
   Stephens, PR
AF Byers, James E.
   Schmidt, J. P.
   Pappalardo, Paula
   Haas, Sarah E.
   Stephens, Patrick R.
TI What factors explain the geographical range of mammalian parasites?
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE biogeography; distributions; emerging diseases; geographical range
   sizes; host-parasite interactions; macroecology
ID HOST-SPECIFICITY; ZIKA VIRUS; SIZE; DIVERSITY; PATTERNS; ECOLOGY;
   DISTRIBUTIONS; EPIDEMIOLOGY; CONSERVATION; MACROECOLOGY
AB Free-living species vary substantially in the extent of their spatial distributions. However, distributions of parasitic species have not been comprehensively compared in this context. We investigated which factors most influence the geographical extent of mammal parasites. Using the Global Mammal Parasite Database we analysed 17 818 individual geospatial records on 1806 parasite species (encompassing viruses, bacteria, protozoa, arthropods and helminths) that infect 396 carnivore, ungulate and primate host species. As a measure of the geographical extent of each parasite species we quantified the number and area of world ecoregions occupied by each. To evaluate the importance of variables influencing the summed area of ecoregions occupied by a parasite species, we used Bayesian network analysis of a subset (n = 866) of the parasites in our database that had at least two host species and complete information on parasite traits. We found that parasites that covered more geographical area had a greater number of host species, higher average phylogenetic relatedness between host species and more sampling effort. Host and parasite taxonomic groups had weak and indirect effects on parasite ecoregion area; parasite transmission mode had virtually no effect. Mechanistically, a greater number of host species probably increases both the collective abundance and habitat breadth of hosts, providing more opportunities for a parasite to have an expansive range. Furthermore, even though mammals are one of the best-studied animal classes, the ecoregion area occupied by their parasites is strongly sensitive to sampling effort, implying mammal parasites are undersampled. Overall, our results support that parasite geographical extent is largely controlled by host characteristics, many of which are subsumed within host taxonomic identity.
C1 [Byers, James E.; Schmidt, J. P.; Pappalardo, Paula; Stephens, Patrick R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Byers, James E.; Schmidt, J. P.; Stephens, Patrick R.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Haas, Sarah E.] Texas Parks & Wildlife Dept, Inland Fisheries Div, Austin, TX USA.
RP Byers, JE (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.; Byers, JE (corresponding author), Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
EM jebyers@uga.edu
OI Schmidt, John Paul/0000-0001-8549-0587; Byers, James/0000-0001-9240-0287
FU NSFNational Science Foundation (NSF) [1316223]
FX The study was funded by NSF, DEB no. 1316223, Macroecology of Infectious
   Disease Research Coordination Network (P. Stephens, PI).
CR Aiken HM, 2007, FISH FISH, V8, P167, DOI 10.1111/j.1467-2679.2007.00248.x
   ANDERSON S, 1992, AUST J ZOOL, V40, P627, DOI 10.1071/ZO9920627
   Bensch S, 2003, J PARASITOL, V89, P388, DOI 10.1645/0022-3395(2003)089[0388:TASVOH]2.0.CO;2
   Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634
   Blackburn TM, 1997, PHILOS T ROY SOC B, V352, P419, DOI 10.1098/rstb.1997.0030
   Blakeslee AMH, 2008, ECOLOGY, V89, P1068, DOI 10.1890/07-0832.1
   Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597
   BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145
   Byers JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep12436
   Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259
   Clark NJ, 2018, DIVERS DISTRIB, V24, P13, DOI 10.1111/ddi.12661
   Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013
   Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X
   Dallas T, 2017, PARASITOLOGY, V144, P200, DOI 10.1017/S0031182016001608
   Dennis RLH, 2000, BIODIVERS CONSERV, V9, P343, DOI 10.1023/A:1008924329854
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x
   Faith DP, 2006, EVOL BIOINFORM, V2, P121
   Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x
   Gaston K. J., 2003, STRUCTURE DYNAMICS G
   Gaston KJ, 1996, CONSERV BIOL, V10, P638, DOI 10.1046/j.1523-1739.1996.10020638.x
   Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6
   Gehman ALM, 2018, P NATL ACAD SCI USA, V115, P744, DOI 10.1073/pnas.1705067115
   GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205
   GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215
   Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141
   Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686
   Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5
   Huang S, 2015, EVOLUTION, V69, P621, DOI 10.1111/evo.12611
   Hunter L, 2011, CARNIVORES WORLD
   Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779
   Korb KB, 2010, COM SCI DAT
   Krasnov BR, 2013, ECOGRAPHY, V36, P1042, DOI 10.1111/j.1600-0587.2012.00140.x
   Krasnov BR, 2005, OIKOS, V108, P449, DOI 10.1111/j.0030-1299.2005.13551.x
   Malmqvist B, 2000, BIOL CONSERV, V93, P271, DOI 10.1016/S0006-3207(99)00139-1
   Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12
   O'Brien DJ, 2002, PREV VET MED, V54, P47, DOI 10.1016/S0167-5877(02)00010-7
   Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2
   Pappalardo P, 2015, ECOGRAPHY, V38, P722, DOI 10.1111/ecog.01135
   Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005
   Poulin R, 2014, INT J PARASITOL, V44, P581, DOI 10.1016/j.ijpara.2014.02.003
   Poulin R, 2011, ADV PARASIT, V74, P1, DOI 10.1016/B978-0-12-385897-9.00001-X
   Ridgeway G., 2013, GBM GEN BOOSTED REGR
   Robinson AF, 1997, NEMATROPICA, V27, P127
   Rohde K, 1999, ECOGRAPHY, V22, P593, DOI 10.1111/j.1600-0587.1999.tb00509.x
   Ruggiero A, 2007, GLOBAL ECOL BIOGEOGR, V16, P401, DOI 10.1111/j.1466-8238.2006.00303.x
   Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Stephens PR, 2016, ECOL LETT, V19, P1159, DOI 10.1111/ele.12644
   Thieltges DW, 2009, J BIOGEOGR, V36, P1493, DOI 10.1111/j.1365-2699.2008.02066.x
   Turner WC, 2010, J WILDLIFE DIS, V46, P1108, DOI 10.7589/0090-3558-46.4.1108
   WALTHER BA, 1995, PARASITOL TODAY, V11, P306, DOI 10.1016/0169-4758(95)80047-6
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells K, 2019, ECOGRAPHY, V42, P416, DOI 10.1111/ecog.03886
   Wells K, 2018, GLOBAL CHANGE BIOL, V24, P3254, DOI 10.1111/gcb.14064
   Wood S. N., 2006, GEN ADDITIVE MODELS
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 59
TC 3
Z9 3
U1 1
U2 6
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD MAY 22
PY 2019
VL 286
IS 1903
AR 20190673
DI 10.1098/rspb.2019.0673
PG 8
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA IB2QX
UT WOS:000470114900017
PM 31113328
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, ZY
   Sun, MH
   Deng, JP
   Yu, JH
   Yang, XS
   Zhao, W
   Chen, GB
   Wang, PC
AF Zhang, Zongyi
   Sun, Menghan
   Deng, Jieping
   Yu, Jianhai
   Yang, Xuesong
   Zhao, Wei
   Chen, Guobing
   Wang, Pengcheng
TI Zika Virus Induced More Severe Inflammatory Response Than Dengue Virus
   in Chicken Embryonic Livers
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; Dengue virus; chicken embryo; liver; inflammation
ID INFECTION; INVOLVEMENT; CELLS
AB Dengue (DENV) and Zika virus (ZIKV) are important flaviviruses in tropical and subtropical regions, causing severe Dengue Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) and microcephaly, respectively. The infection of both viruses during pregnancy were reported with adverse fetal outcomes. To investigate the effects of ZIKV and DENV infections on fetal development, we established an infection model in chicken embryos. Compared with DENV-2, the infection of ZIKV significantly retarded the development of chicken embryos. High viral loads of both DENV-2 and ZIKV was detected in brain, eye and heart 7 and 11 days post-infection, respectively. Interestingly, only ZIKV but not DENV-2 was detected in the liver. Even both of them induced apparent liver inflammation, ZIKV infection showed a more severe inflammatory response than DENV-2 infection based on the inflammation scores and the gene expression levels of IL-1 beta, TNF, IL-6, and TGF beta-2 in liver. Our results demonstrated that ZIKV induced more severe inflammatory response in chicken embryo liver compared to DENV-2, which might partially attribute to viral replication in liver cells. Clinicians should be aware of the potential liver injury associated with ZIKV infection in patients, especially in perinatal fetuses.
C1 [Zhang, Zongyi; Sun, Menghan; Deng, Jieping; Chen, Guobing; Wang, Pengcheng] Jinan Univ, Sch Basic Med Sci, Dept Microbiol & Immunol, Guangzhou, Guangdong, Peoples R China.
   [Yu, Jianhai; Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.
   [Yang, Xuesong] Jinan Univ, Sch Basic Med Sci, Minist Educ, Div Histol & Embryol,Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.
RP Chen, GB; Wang, PC (corresponding author), Jinan Univ, Sch Basic Med Sci, Dept Microbiol & Immunol, Guangzhou, Guangdong, Peoples R China.; Zhao, W (corresponding author), Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.
EM zhaowhexy@126.com; guobingchen@jnu.edu.cn; twangpc@jnu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31741037, U1801285, 31470271, 81730110]; National
   Key R&D Program of China [2018YFC2002003, 2018YFC1602206]; Natural
   Science Foundation of Guangdong ProvinceNational Natural Science
   Foundation of Guangdong Province [2014A030313370]; Medical Scientific
   Research Foundation of Guangdong Province [A2017386]; Guangdong Science
   and Technology Program Key Projects [20181201SF0028]
FX This work was supported by the grants from the National Natural Science
   Foundation of China (Nos. 31741037 and U1801285 to GC, 31470271 and
   81730110 to WZ), National Key R&D Program of China (Nos. 2018YFC2002003
   to GC and, 2018YFC1602206 to WZ). Natural Science Foundation of
   Guangdong Province (No. 2014A030313370 to PW), Medical Scientific
   Research Foundation of Guangdong Province (No. A2017386 to PW), and
   Guangdong Science and Technology Program Key Projects (No.
   20181201SF0028 to WZ).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   Dalugama Chamara, 2017, J Med Case Rep, V11, P341, DOI 10.1186/s13256-017-1510-1
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dissanayake HA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1971
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Huerre MR, 2001, VIRCHOWS ARCH, V438, P107
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Long Y, 2018, CELL CYCLE, V17, P1757, DOI 10.1080/15384101.2018.1496743
   Meriwether LS, 2010, J ANIM PHYSIOL AN N, V94, pe115, DOI 10.1111/j.1439-0396.2010.00990.x
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Sharma S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1512-4
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan SS, 2013, BRAZ J INFECT DIS, V17, P164, DOI 10.1016/j.bjid.2012.09.007
   Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI 10.4269/ajtmh.2010.10-0138
   [吴德 Wu De], 2016, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V36, P247
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Yan Y, 2019, INFECT GENET EVOL, V69, P176, DOI 10.1016/j.meegid.2019.01.023
   Yu JH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070165
   Yudhishdran Jevon, 2014, BMC Res Notes, V7, P568, DOI 10.1186/1756-0500-7-568
   [曾胜强 Zeng Shengqiang], 2014, [四川农业大学学报, Journal of Sichuan Agricultural University], V32, P436
NR 39
TC 2
Z9 2
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 22
PY 2019
VL 10
AR 1127
DI 10.3389/fmicb.2019.01127
PG 9
WC Microbiology
SC Microbiology
GA HZ3GT
UT WOS:000468737100001
PM 31191474
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lannuzel, A
   Ferge, JL
   Lobjois, Q
   Signate, A
   Roze, B
   Tressieres, B
   Madec, Y
   Poullain, P
   Herrmann, C
   Najioullah, F
   McGovern, E
   Savidan, AC
   Valentino, R
   Breurec, S
   Cesaire, R
   Hirsch, E
   Lledo, PM
   Thiery, G
   Cabie, A
   Lazarini, F
   Roze, E
AF Lannuzel, Annie
   Ferge, Jean-Louis
   Lobjois, Quentin
   Signate, Aissatou
   Roze, Benoit
   Tressieres, Benoit
   Madec, Yoann
   Poullain, Pascale
   Herrmann, Cecile
   Najioullah, Fatiha
   McGovern, Eavan
   Savidan, Anne-Charlotte
   Valentino, Ruddy
   Breurec, Sebastien
   Cesaire, Raymond
   Hirsch, Etienne
   Lledo, Pierre-Marie
   Thiery, Guillaume
   Cabie, Andre
   Lazarini, Francoise
   Roze, Emmanuel
TI Long-term outcome in neuroZika When biological diagnosis matters
SO NEUROLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS-INFECTION; OUTBREAK; DISEASE;
   SEROPREVALENCE; MYELITIS; COLOMBIA; HISTORY
AB Objective
   To characterize the full spectrum, relative frequency, and prognosis of the neurologic manifestations in Zika virus (ZIKV) postnatal infection.
   Methods
   We conducted an observational study in consecutive ZIKV-infected patients presenting with neurologic manifestations during the French West Indies 2016 outbreak.
   Results
   Eighty-seven patients, including 6 children, were enrolled. Ninety-five percent of all cases required hospitalization. Guillain-Barre syndrome was the most frequent manifestation (46.0%) followed by encephalitis or encephalomyelitis (20.7%), isolated single or multiple cranial nerve palsies (9.2%), other peripheral manifestations (6.9%), and stroke (1.1%). Fourteen patients (16.1%), including one child, developed a mixed disorder involving both the central and peripheral nervous system. Mechanical ventilation was required in 21 cases, all of whom had ZIKV RNA in at least one biological fluid. Two adult patients died due to neuroZika. Clinical follow-up (median 14 months; interquartile range, 13-17 months) was available for 76 patients. Residual disability (modified Rankin Scale score >= 2) was identified in 19 (25.0%) patients; in 6 cases (7.9%), disability was severe (modified Rankin Scale score >= 4). Among patients with ZIKV RNA detected in one biological fluid, the risk of residual disability or death was higher (odds ratio 9.19; confidence interval 1.12-75.22; p = 0.039).
   Conclusions
   NeuroZika spectrum represents a heterogeneous group of clinical neurologic manifestations. During an outbreak, clinicians should consider neuroZika in patients presenting with cranial nerve palsies and a mixed neurologic disorder. Long-term sequelae are frequent in NeuroZika. ZIKV reverse-transcription PCR status at admission can inform prognosis and should therefore be taken into consideration in the management of hospitalized patients.
C1 [Lannuzel, Annie; Lobjois, Quentin] Ctr Hosp Univ Guadeloupe, Serv Neurol, Pointe A Pitre, Guadeloupe, France.
   [Poullain, Pascale] Ctr Hosp Univ Guadeloupe, Serv Radiol, Pointe A Pitre, Guadeloupe, France.
   [Herrmann, Cecile; Breurec, Sebastien] Ctr Hosp Univ Guadeloupe, Lab Microbiol Clin & Environnm, Pointe A Pitre, Guadeloupe, France.
   [Thiery, Guillaume] Ctr Hosp Univ Guadeloupe, Serv Reanimat, Pointe A Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Pointe A Pitre, Guadeloupe, France.
   [Lannuzel, Annie; Lobjois, Quentin; Cesaire, Raymond; Thiery, Guillaume; Cabie, Andre] Univ Antilles, Fac Med, Pointe A Pitre, Guadeloupe, France.
   [Najioullah, Fatiha; Cesaire, Raymond; Cabie, Andre] Univ Antilles, Equipe Accueil 4537, Pointe A Pitre, Guadeloupe, France.
   [Lannuzel, Annie; Hirsch, Etienne; Roze, Emmanuel] Sorbonne Univ, Fac Med, Paris, France.
   [Ferge, Jean-Louis; Savidan, Anne-Charlotte; Valentino, Ruddy] INSERM, U 1127, CNRS, UMR 7225,ICM,Inst Cerveau & Moelle Epiniere,Serv, Paris, France.
   [Signate, Aissatou] Ctr Hosp Univ Martinique, Serv Neurol, Fort De France, Martinique, France.
   [Roze, Benoit; Cabie, Andre] Ctr Hosp Univ Martinique, Serv Malad Infect & Trop, Fort De France, Martinique, France.
   [Cesaire, Raymond] Ctr Hosp Univ Martinique, Lab Virol, Fort De France, Martinique, France.
   [Cabie, Andre] Ctr Hosp Univ Martinique, Fort De France, Martinique, France.
   [Tressieres, Benoit; Cabie, Andre] Inserm CIC 1424, Paris, France.
   [Madec, Yoann] Ctr Invest Clin Antilles Guyane, Emerging Dis Epidemiol Unit, Paris, France.
   [McGovern, Eavan; Roze, Emmanuel] Inst Pasteur, Dept Neurol, Paris, France.
   [Lledo, Pierre-Marie; Lazarini, Francoise] Hop La Pitie Salpetriere, AP HP, Paris, France.
   [Lledo, Pierre-Marie; Lazarini, Francoise] CNRS, Inst Pasteur, Percept & Memory Unit, UMR 3571, Paris, France.
RP Lannuzel, A (corresponding author), Ctr Hosp Univ Guadeloupe, Serv Neurol, Pointe A Pitre, Guadeloupe, France.
EM annie.lannuzel@chu-guadeloupe.fr
RI Hirsch, Etienne/AAC-7655-2019
OI Hirsch, Etienne/0000-0003-4823-276X; Cabie, Andre/0000-0003-0117-3061;
   Lazarini, Francoise/0000-0001-5572-6982; Lannuzel,
   Annie/0000-0003-4084-8674
FU French Ministry of Health; French network for Research and Action
   targeting emerging infectious diseases (REACTing) of the French National
   Institute of Health and Medical Research (INSERM); Pasteur Institute of
   Paris
FX Study funded by the French Ministry of Health (Exceptional Support for
   Research and Innovation and Clinical Research Hospital Program, PHRC
   2009 NCT01099852), the French network for Research and Action targeting
   emerging infectious diseases (REACTing) of the French National Institute
   of Health and Medical Research (INSERM), and Pasteur Institute of Paris
   (GPF 2015 Microbes & brain "INFECSMELL").
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Ali M, 2005, AM J NEURORADIOL, V26, P289
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2018, J NEUROL SCI, V391, P3, DOI 10.1016/j.jns.2018.05.009
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Graham RC, 2006, J NEUROL NEUROSUR PS, V77, P973, DOI 10.1136/jnnp.2005.081547
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Isobe N, 2012, J NEUROL SCI, V316, P30, DOI 10.1016/j.jns.2012.02.007
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Keane JR, 2005, ARCH NEUROL-CHICAGO, V62, P1714, DOI 10.1001/archneur.62.11.1714
   KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Martinez ARM, 2018, MUSCLE NERVE, V57, pE100, DOI 10.1002/mus.25958
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   PAHO/ WHO, 2016, ZIK RES CAS DEF
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peric S, 2017, J PERIPHER NERV SYST, V22, P127, DOI 10.1111/jns.12206
   Pohl D, 2016, NEUROLOGY, V87, pS38, DOI 10.1212/WNL.0000000000002825
   Roze B, 2016, EURO SURVEILL, P21
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
NR 48
TC 1
Z9 1
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 21
PY 2019
VL 92
IS 21
BP E2406
EP E2420
DI 10.1212/WNL.0000000000007536
PG 15
WC Clinical Neurology
SC Neurosciences & Neurology
GA IQ5BU
UT WOS:000480767200002
PM 31028126
DA 2020-07-08
ER

PT J
AU Morando, MA
   Barbosa, GM
   Cruz-Oliveira, C
   Da Poian, AT
   Almeida, FCL
AF Morando, Maria A.
   Barbosa, Glauce M.
   Cruz-Oliveira, Christine
   Da Poian, Andrea T.
   Almeida, Fabio C. L.
TI Dynamics of Zika Virus Capsid Protein in Solution: The Properties and
   Exposure of the Hydrophobic Cleft Are Controlled by the alpha-Helix 1
   Sequence
SO BIOCHEMISTRY
LA English
DT Article
ID N-TERMINAL REGION; NMR-SPECTROSCOPY; TEMPERATURE COEFFICIENTS;
   CHEMICAL-SHIFTS; TORSION ANGLES; ASSIGNMENT; RELAXATION; H-1; INFECTION;
   BACKBONE
AB Zika virus (ZIKV) became an important public health concern because infection was correlated to the development of microcephaly and other neurological disorders. Although the structure of the virion has been determined by cryo-electron microscopy, information about the nucleocapsid is lacking. We used nuclear magnetic resonance to determine the solution structure and dynamics of full length ZIKV capsid protein (ZIKVC). Although most of the protein is structured as described for the capsid proteins of Dengue and West Nile viruses and for truncated ZIKVC (residues 23-98), here we show important differences in the alpha-helix 1 and N-terminal intrinsically disordered region (IDR). We distinguished two dynamical regions in the ZIKVC IDR, a highly flexible N-terminal end and a transitional disordered region, indicating that it contains ordered segments rather than being completely flexible. The unique size and orientation of alpha-helix 1 partially occlude the protein hydrophobic cleft. Measurements of the dynamics of alpha-helix 1, surface exposure, and thermal susceptibility of each backbone amide H-1 in protein structure revealed the occlusion of the hydrophobic cleft by alpha 1/alpha 1' and supported alpha-helix 1 positional uncertainty. On the basis of the findings described here, we propose that the dynamics of ZIKVC structural elements responds to a structure-driven regulation of interaction of the protein with intracellular hydrophobic interfaces, which would have an impact on the switches that are necessary for nucleocapsid assembly. Subtle differences in the sequence of alpha-helix 1 have an impact on its size and orientation and on the degree of exposure of the hydrophobic cleft, suggesting that alpha-helix 1 is a hot spot for evolutionary adaptation of the capsid proteins of flaviviruses.
C1 [Morando, Maria A.; Barbosa, Glauce M.; Cruz-Oliveira, Christine; Da Poian, Andrea T.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Program Struct Biol, Inst Med Biochem Leopoldo De Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Morando, Maria A.; Cruz-Oliveira, Christine; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, Brazil.
   [Morando, Maria A.] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, BR-21040361 Rio De Janeiro, Brazil.
RP Da Poian, AT; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Program Struct Biol, Inst Med Biochem Leopoldo De Meis, BR-21941902 Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, Brazil.
EM dapoian@bioqmed.ufrj.br; falmeida@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [201167, 201316, 215141, 210361, 239229,
   204432]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [306669/2013-7, 309564/2017-4, 457773/2014-6];
   FINEPCiencia Tecnologia e Inovacao (FINEP) [0267/16]; Capes-CDTS-Fiocruz
   visiting research scholarship [001/2012]; FAPERJ Senior Postdoc (PDS)
   scholarship [201.849/2017]
FX The work presented here was funded by FAPERJ Grants 215141, 210361,
   239229, and 204432, awarded to F.C.L.A., FAPERJ Grants 201167 and
   201316, awarded to A.T.D.P., CNPq Grants 309564/2017-4 and
   457773/2014-6, awarded to F.C.L.A., CNPq Grant 306669/2013-7, awarded to
   A.T.D.P., and FINEP Grant 0267/16, awarded to A.T.D.P. and F.C.L.A.
   M.A.M. is funded by a Capes-CDTS-Fiocruz visiting research scholarship
   (001/2012). C.C.-O. is funded by a FAPERJ Senior Postdoc (PDS)
   scholarship (201.849/2017).
CR ANDERSEN NH, 1992, BIOCHEMISTRY-US, V31, P1280, DOI 10.1021/bi00120a003
   Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cierpicki T, 2002, J MAGN RESON, V157, P178, DOI 10.1006/jmre.2002.2597
   Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hong JB, 2013, J BIOMOL NMR, V55, P71, DOI 10.1007/s10858-012-9689-3
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   Khazanov N, 2011, J MOL BIOL, V408, P335, DOI 10.1016/j.jmb.2011.01.059
   Krepel D, 2017, PHYS CHEM CHEM PHYS, V19, P30562, DOI 10.1039/c7cp05251k
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tomlinson JH, 2012, J BIOMOL NMR, V52, P57, DOI 10.1007/s10858-011-9583-4
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
NR 46
TC 2
Z9 2
U1 2
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 21
PY 2019
VL 58
IS 20
BP 2488
EP 2498
DI 10.1021/acs.biochem.9b00194
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IA1FE
UT WOS:000469303900003
PM 31034208
DA 2020-07-08
ER

PT J
AU del Carpio-Orantes, L
AF del Carpio-Orantes, Luis
TI Reply to letter to the editor: Zika virus infection in pregnant women in
   Mexico
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Letter; Early Access
C1 [del Carpio-Orantes, Luis] Inst Mexicano Seguro Social, Delegac Veracruz Norte, Veracruz, Mexico.
RP del Carpio-Orantes, L (corresponding author), Inst Mexicano Seguro Social, Delegac Veracruz Norte, Veracruz, Mexico.
EM neurona23@hotmail.com
RI Del Carpio-Orantes, Luis/H-6745-2017
OI Del Carpio-Orantes, Luis/0000-0003-2436-5744
CR Carpio-Orantesa L. del, 2018, Revista Medica del Instituto Mexicano del Seguro Social, V56, P410
   Del Carpio-Orantes Luis, 2018, Rev Med Inst Mex Seguro Soc, V56, P186
   del Carpio-Orantes L, 2019, J MATERN-FETAL NEO M, V32, P3509, DOI 10.1080/14767058.2018.1465916
   Garza-Gonzlez E, 2017, BRAZ J INFECT DIS, V21, P554, DOI 10.1016/j.bjid.2017.04.008
   Contreras-Capetillo SN, 2018, CLIN PEDIATR, V57, P927, DOI 10.1177/0009922817738341
   Sookaromdee P, 2019, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2019.1603291
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
NR 7
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
DI 10.1080/14767058.2019.1617689
EA MAY 2019
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HZ8VV
UT WOS:000469135900001
PM 31072181
DA 2020-07-08
ER

PT J
AU Mello, AS
   Bertozzi, APAP
   Rodrigues, MMD
   Gazeta, RE
   Moron, AF
   Soriano-Arandes, A
   Sarmento, SGP
   Vedovello, D
   Silva, ACB
   Fajardo, TCG
   Witkin, SS
   Passos, SD
AF Mello, Alexandra Siqueira
   Pascalicchio Bertozzi, Ana Paula A.
   Rodrigues, Maria Manoela D.
   Gazeta, Rosa Estela
   Moron, Antonio F.
   Soriano-Arandes, Antoni
   Pereira Sarmento, Stephanno Gomes
   Vedovello, Danila
   Silva, Andrea Cristina B.
   Grillo Fajardo, Thamirys C.
   Witkin, Steven S.
   Passos, Saulo D.
CA Cohort Zika Jundiai Consortium
TI Development of Secondary Microcephaly After Delivery: Possible
   Consequence of Mother-Baby Transmission of Zika Virus in Breast Milk
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article
DE Arbovirus Infections; Infectious Disease Transmission, Vertical; Milk,
   Human
AB Objective: Unusual clinical course
   Background: The Zika virus is an arbovirus that has as main source of transmission the bite of infected insects of the genus Aedes and has been associated with cases of congenital malformation and microcephaly in neonates. However, other sources of transmission have been identified since the emergence of this virus in the world population, such as vertical transmission by semen and possibly other body fluids such as vaginal secretion and breast milk.
   Case Report: An infant, born to a mother whose previous delivery was a baby with severe microcephaly, was normal and was negative for Zika virus at birth but developed secondary microcephaly 1 month later, that persisted. The baby was exclusively breast-fed and Zika virus was present in the mother's milk.
   Conclusions: We report the detection of Zika virus exclusively in the breast milk of a woman after her second delivery of an infant, who later developed microcephaly. This case is consistent with possible vertical transmission.
C1 [Mello, Alexandra Siqueira; Vedovello, Danila; Silva, Andrea Cristina B.; Grillo Fajardo, Thamirys C.; Passos, Saulo D.] Jundiai Sch Med, Dept Pediat, Lab Pediat Infectol, Sao Paulo, SP, Brazil.
   [Pascalicchio Bertozzi, Ana Paula A.; Rodrigues, Maria Manoela D.; Gazeta, Rosa Estela; Passos, Saulo D.; Cohort Zika Jundiai Consortium] Jundial Sch Med, Dept Pediat, Sao Paulo, SP, Brazil.
   [Moron, Antonio F.; Pereira Sarmento, Stephanno Gomes] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Moron, Antonio F.; Pereira Sarmento, Stephanno Gomes] Fed Univ Sao Paulo UNIFESP, Paulista Ctr Fetal Medidne, Sao Paulo, SP, Brazil.
   [Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Mello, AS (corresponding author), Jundiai Sch Med, Dept Pediat, Lab Pediat Infectol, Sao Paulo, SP, Brazil.
EM sauloduarte@uol.com.br
RI Witkin, Steven/AAF-3812-2019; MORON, ANTONIO F./H-4987-2013; Arandes,
   Antonio Soriano/Q-3348-2016
OI MORON, ANTONIO F./0000-0002-7963-1758; Arandes, Antonio
   Soriano/0000-0001-9613-7228; Alexandrasmello@gmail.com,
   Alexandra/0000-0002-7996-873X; FAJARDO, THAMIRYS/0000-0003-1096-1078
FU Foundation for Research Support of the State of Sao Paulo -
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/08578-0, 2017/22007-8]; London School of Hygiene and Tropical
   Medicine [PC0002/16]; MoH Brazil/RENE Zika [861306/2017, 861307/2017]
FX This study was funded by the Foundation for Research Support of the
   State of Sao Paulo - FAPESP (SDP #grant 2016/08578-0 and DV #grant
   2017/22007-8); London School of Hygiene and Tropical Medicine (SDV
   #grant PC0002/16); and MoH Brazil/RENE Zika (SDP #grant 861306/2017 and
   861307/2017)
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Oehler E, 2013, EUROSURVEILLANCE, V19, P9
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 14
TC 0
Z9 0
U1 0
U2 1
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD MAY 21
PY 2019
VL 20
BP 723
EP 725
DI 10.12659/AJCR.915726
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HZ3BV
UT WOS:000468723400001
PM 31110169
OA Green Published
DA 2020-07-08
ER

PT J
AU McKenzie, BA
   Wilson, AE
   Zohdy, S
AF McKenzie, Benjamin A.
   Wilson, Alan E.
   Zohdy, Sarah
TI Aedes albopictus is a competent vector of Zika virus: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID SEXUAL TRANSMISSION; DIPTERA-CULICIDAE; FEEDING PATTERNS; AMERICAN
   STRAINS; GLOBAL RISK; AEGYPTI; MOSQUITOS; NORTH; IDENTIFICATION;
   CHIKUNGUNYA
AB Background
   Much work has been done in recent years to determine the vector competence of Aedes albopictus (Skuse) for Zika virus (ZIKV). If competent, Ae. albopictus could become an important vector in the spread of ZIKV to areas which until now have been considered safe from the virus. Despite much speculation about Ae. albopictus' competence for ZIKV, there have been, to date, no quantitative syntheses of Ae. albopictus' competence, nor have the potentially confounding differences between studies been addressed.
   Methodology/principle findings
   This study represents a quantitative meta-analysis of the literature surrounding this topic by examining infection rates (IR) and transmission rates (TR) among sample populations of Ae. albopictus at 7 and 14 days post infection (dpi) across 15 journal articles comprising 23 studies. Our analyses examined potentially confounding variables in the studies contained therein, including: geographic origin of viral strain or mosquito population tested, whether sympatry of the tested viral strain and mosquito population was important, and freshness of blood meal. Our results suggest 1) Ae albopictus is a competent vector for ZIKV and 2) that origin of Ae. albopictus population and origin of viral strain had significant effects on the competence of Ae. albopictus to transmit ZIKV.
   Conclusions/significance
   These results indicate a need to further explore the effects of methodology on vector competence studies and to examine in more detail the geographic variation in the competence of Ae. albopictus for ZIKV as well as the underlying causes of said variation. The ability of Ae. albopictus to carry and transmit ZIKV also points to a need to create new vector control strategies in case of a ZIKV outbreak in an area where Ae. albopictus is prominent. Finally, this study represents a potential template for future meta-analyses in the field of vector competence, where this type of study has been under-utilized despite the abundance of relevant studies.
C1 [McKenzie, Benjamin A.; Zohdy, Sarah] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.
   [Wilson, Alan E.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA.
   [Zohdy, Sarah] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA.
RP McKenzie, BA; Zohdy, S (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.; Zohdy, S (corresponding author), Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA.
EM bam0073@auburn.edu; zohdy@auburn.edu
OI McKenzie, Benjamin/0000-0001-5525-0646; Zohdy, Sarah/0000-0001-5316-0567
FU United States Department of AgricultureUnited States Department of
   Agriculture (USDA)
FX Funding was provided by the United States Department of Agriculture to
   AW and SZ. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   [Anonymous], 2014, CDC
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Egger M, 2008, SYSTEMATIC REV HLTH, P23, DOI DOI 10.1002/9780470693926.CH2
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kim KS, 2009, J MED ENTOMOL, V46, P1230, DOI 10.1603/033.046.0535
   Knecht H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030067
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lozano-Fuentes S, 2019, J MED ENTOMOL, V56, P233, DOI 10.1093/jme/tjy114
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163
   MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira ARS, 2018, AM J TROP MED HYG, V98, P883, DOI 10.4269/ajtmh.17-0622
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pick JL, 2018, REPRODUCIBLE FLEXIBL, DOI [10.1101/247775, DOI 10.1101/247775]
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Richards SL, 2017, RES REP TROP MED, V8, P53, DOI 10.2147/RRTM.S133411
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284
   Silva GS, 2018, J CRIT CARE, V46, P106, DOI 10.1016/j.jcrc.2018.03.030
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vazeille M, 2018, MED VET ENTOMOL, V32, P251, DOI 10.1111/mve.12284
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), VECT BORN DIS
   Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548
   2014, J VIROL, V88, P6294, DOI DOI 10.1128/JVI.00370-14
   2016, NEW ENGL J MED, V374, P951, DOI DOI 10.1056/NEJMOA1600651
   2003, ADV VIRUS RES, V59, P315, DOI DOI 10.1016/S0065-3527(03)
NR 88
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2019
VL 14
IS 5
AR e0216794
DI 10.1371/journal.pone.0216794
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HY9HS
UT WOS:000468451000024
PM 31112569
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zapletal, J
   Gupta, H
   Erraguntla, M
   Adelman, ZN
   Myles, KM
   Lawley, MA
AF Zapletal, Josef
   Gupta, Himanshu
   Erraguntla, Madhav
   Adelman, Zach N.
   Myles, Kevin M.
   Lawley, Mark A.
TI Predicting aquatic development and mortality rates of Aedes aegypti
SO PLOS ONE
LA English
DT Article
ID TEMPERATURE-FLUCTUATIONS; ANOPHELES-GAMBIAE; LARVAL DENSITY; DIPTERA;
   ALBOPICTUS; MOSQUITO; VIRUS; POPULATION; CULICIDAE; VECTOR
AB Mosquito-borne pathogens continue to be a significant burden within human populations, with Aedes aegypti continuing to spread dengue, chikungunya, and Zika virus throughout the world. Using data from a previously conducted study, a linear regression model was constructed to predict the aquatic development rates based on the average temperature, temperature fluctuation range, and larval density. Additional experiments were conducted with different parameters of average temperature and larval density to validate the model. Using a paired t-test, the model predictions were compared to experimental data and showed that the prediction models were not significantly different for average pupation rate, adult emergence rate, and juvenile mortality rate. The models developed will be useful for modeling and estimating the upper limit of the number of Aedes aegypti in the environment under different temperature, diurnal temperature variations, and larval densities.
C1 [Zapletal, Josef; Gupta, Himanshu; Erraguntla, Madhav; Lawley, Mark A.] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.
   [Adelman, Zach N.; Myles, Kevin M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
RP Zapletal, J (corresponding author), Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.
EM jozinzapletal@tamu.edu
CR BAKER F. C., 1935, CANADIAN ENL, V67, P149
   Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x
   Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   HOLZAPFEL CM, 1981, CAN J ZOOL, V59, P1014, DOI 10.1139/z81-141
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   LOVE GJ, 1955, ECOLOGY, V36, P340, DOI 10.2307/1933243
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   MORI A, 1979, Tropical Medicine, V21, P85
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Pincebourde S, 2016, INTEGR COMP BIOL, V56, P45, DOI 10.1093/icb/icw016
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Wada Y, 1965, QUAEST ENTOMOL, P1
   Woods HA, 2015, J THERM BIOL, V54, P86, DOI 10.1016/j.jtherbio.2014.10.002
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zapletal J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194025
   1996, ECOL ENTOMOL, V21, P117
NR 43
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2019
VL 14
IS 5
AR e0217199
DI 10.1371/journal.pone.0217199
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HY9HS
UT WOS:000468451000041
PM 31112566
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fay, AP
AF Fay, Andre P.
TI Impact of Zika virus infection in human glioblastoma cell lines.
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
CY MAY 31-JUN 04, 2019
CL Chicago, IL
SP Amer Soc Clin Oncol
C1 [Fay, Andre P.] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD MAY 20
PY 2019
VL 37
IS 15
SU S
MA e13563
DI 10.1200/JCO.2019.37.15_suppl.e13563
PG 1
WC Oncology
SC Oncology
GA IZ8HT
UT WOS:000487345800380
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Vasquez, C
   Petrie, W
   Beier, JC
AF Wilke, Andre B. B.
   Vasquez, Chalmers
   Petrie, William
   Beier, John C.
TI Tire shops in Miami-Dade County, Florida are important producers of
   vector mosquitoes
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; AEDES-ALBOPICTUS; DENGUE; TRANSMISSION; AEGYPTI;
   URBANIZATION; EPIDEMIOLOGY; DIVERSITY; DIPTERA; TRADE
AB Human mobility in urban environments is a central part of urbanization and has determined the layout of how cities are projected, built and renovated. One of the most problematic issues of urbanization is how to properly dispose of used tires, considering the worldwide annual production of approximately 1.4 billion units every year. Despite the efforts to properly dispose of used tires, they still represent a major problem for public health, notably serving as potential breeding sites for vector mosquitoes. Miami-Dade County, Florida has been suffering from arbovirus outbreaks for decades, including dengue, West Nile and yellow fever viruses. The objective of this study was to survey tire shops inserted in the urban matrix across Miami-Dade County for the presence of vector mosquitoes. This study used a cross-sectional design to survey the production of vector mosquitoes at 12 tires shops. Mosquitoes were found in all but one of the tires shops surveyed. We collected a total of 1,110 mosquitoes comprising 528 adults and 582 immatures. Aedes aegypti and Culex quinquefasciatus were abundantly found in both their immature and adult forms, constituting 99.99% of the mosquito samples collected. Aedes aegypti was the most abundant species recorded displaying the highest values in the Shannon and Simpson indices. The findings of this study demonstrate that vector mosquitoes, primarily Ae. aegypti, are being produced in tires shops in Miami indicating these habitats are highly favorable breeding environments for the production of vector mosquitoes and emphasizing the need to address how the abundance and presence of mosquitoes may vary seasonally in these environments.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-03]
FX JCB - This research was supported by CDC (https://www.cdc.gov/) grant
   1U01CK000510-03: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. CDC had no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript.
CR Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P489
   Aydin H, 2012, FUEL, V102, P605, DOI 10.1016/j.fuel.2012.06.067
   Azael Che-Mendoza, 2011, OPERATIONAL GUIDE AS, P1
   BEIER JC, 1983, J MED ENTOMOL, V20, P76, DOI 10.1093/jmedent/20.1.76
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Buehler R, 2011, J TRANSP GEOGR, V19, P644, DOI 10.1016/j.jtrangeo.2010.07.005
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Colwell R. K., 2009, PRINCETON GUIDE ECOL, P257, DOI DOI 10.1111/J.1442-9993.2012.02436.X
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Darsie Jr RF, 2000, B FLORIDA MOSQUITO C
   Dinh ETN, 2018, J AM MOSQUITO CONTR, V34, P47, DOI 10.2987/17-6689.1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gill J, 2000, EMERG INFECT DIS, V6, P30
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1
   Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0
   Ilkilic C, 2011, FUEL PROCESS TECHNOL, V92, P1129, DOI 10.1016/j.fuproc.2011.01.009
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Li Y., 2018, INT J ORG INNOV, V11, P1, DOI DOI 10.1186/S13068-018-1048-5
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Musso D, 2018, LANCET INFECT DIS, V3099, P1
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855
   POND WL, 1966, AM J TROP MED HYG, V15, P205, DOI 10.4269/ajtmh.1966.15.205
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Satterthwaite D, 2008, ENVIRON URBAN, V20, P539, DOI 10.1177/0956247808096127
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Sienkiewicz M, 2012, WASTE MANAGE, V32, P1742, DOI 10.1016/j.wasman.2012.05.010
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Straif SC, 1996, J MED ENTOMOL, V33, P608, DOI 10.1093/jmedent/33.4.608
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   UN Deparment of Social and Economic Affairs, 2014, WORLD URB PROSP
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688
   Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156
   Yang HS, 2004, BIORESOURCE TECHNOL, V95, P61, DOI 10.1016/j.biortech.2004.02.002
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Yilmaz A, 2009, WASTE MANAGE, V29, P1541, DOI 10.1016/j.wasman.2008.11.002
NR 62
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 20
PY 2019
VL 14
IS 5
AR e0217177
DI 10.1371/journal.pone.0217177
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HY7BF
UT WOS:000468285200034
PM 31107881
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hery, L
   Boullis, A
   Delannay, C
   Vega-Rua, A
AF Hery, Lyza
   Boullis, Antoine
   Delannay, Christelle
   Vega-Rua, Anubis
TI Transmission potential of African, Asian and American Zika virus strains
   by Aedes aegypti and Culex quinquefasciatus from Guadeloupe (French West
   Indies)
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Aedes aegypti; Culex quinquefasciatus; Zika virus; Guadeloupe; vector
   competence
ID ARBOVIRUS INFECTION; MOSQUITO; COMPETENCE; CULICIDAE; VECTORS; DIPTERA
AB Zika virus (ZIKV) is an arbovirus that has dramatically spread in South America and the Caribbean regions since 2015. The majority of vector incrimination studies available for ZIKV showed that Aedes aegypti mosquitoes are important vectors for this virus. However, several reports suggest that Culex quinquefasciatus mosquitoes may be implicated in ZIKV transmission in certain urban settings. In the present study, we evaluated the vector competence for ZIKV of Cx. quinquefasciatus and Ae. aegypti mosquitoes from Guadeloupe using African, American and Asian strains. The results demonstrated that Cx. quinquefasciatus is refractory to ZIKV infection whatever the strain tested at 7, 14 or 21 days post-infection (dpi), while ZIKV transmission was recorded in Ae. aegypti for all the three strains. The African ZIKV strain was better transmitted by Ae. aegypti (similar to 50% mean transmission efficiency) and with a shorter incubation period (7 dpi) when compared to the Asian and American strains (<14% transmission efficiency; incubation period of 14-21 dpi). Taken together, these results suggest that only Ae. aegypti mosquitoes are involved in urban ZIKV transmission in Guadeloupe and highlight a higher infectiousness of the African ZIKV strain in this mosquito species when compared to the Asian and American ones.
C1 [Hery, Lyza; Boullis, Antoine; Delannay, Christelle; Vega-Rua, Anubis] Inst Pasteur Guadeloupe, Lab Vector Control Res, Unit Transmiss Reservoir & Pathogens Divers, F-97139 Les Abymes, Guadeloupe, France.
RP Vega-Rua, A (corresponding author), Inst Pasteur Guadeloupe, Lab Vector Control Res, Unit Transmiss Reservoir & Pathogens Divers, F-97139 Les Abymes, Guadeloupe, France.
EM avega@pasteur.fr
FU Horizon 2020 Research and Innovation Framework Programme under
   "ZIKALLIANCE" [734548]; Programme Operationnel FEDER-Guadeloupe-Conseil
   Regional 2014-2020 [2015-FED-192]; La Region Guadeloupe; Institut
   Pasteur Department of International Affairs
FX This work has been notably supported by the Horizon 2020 Research and
   Innovation Framework Programme under "ZIKALLIANCE" (grant agreement no.
   734548) and the Programme Operationnel FEDER-Guadeloupe-Conseil Regional
   2014-2020 (grant 2015-FED-192). LH is funded by a PhD scholarship from
   La Region Guadeloupe. AB is funded by a Calmette & Yersin postdoctoral
   fellowship from the Institut Pasteur Department of International
   Affairs.
CR Agence Regionale de Sante (ARS) Guadeloupe, 2017, BIL GEST ZIK REP FAC
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Arias-Goeta C, 2014, INFECT GENET EVOL, V24, P116, DOI 10.1016/j.meegid.2014.03.015
   Aubry F, 2018, BIORXIV, P1, DOI [10.1101/ 342741, DOI 10.1101/342741, 10.1101/342741]
   Azar SR, 2019, EMERG MICROBES INFEC, V8, P242, DOI 10.1080/22221751.2018.1561157
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Goindin D, 2018, ACTA TROP, V185, P314, DOI 10.1016/j.actatropica.2018.06.011
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lefrancois T, 2006, ANN NY ACAD SCI, V1081, P206, DOI 10.1196/annals.1373.025
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   R Core Team, 2014, R LANG ENV STAT COMP
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Rosine J., 1999, THESIS
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 47
TC 6
Z9 6
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 20
PY 2019
VL 8
IS 1
BP 699
EP 706
DI 10.1080/22221751.2019.1615849
PG 8
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HZ4GR
UT WOS:000468805800001
PM 31109248
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Memish, ZA
   Steffen, R
   White, P
   Dar, O
   Azhar, EI
   Sharma, A
   Zumla, A
AF Memish, Ziad A.
   Steffen, Robert
   White, Paul
   Dar, Osman
   Azhar, Esam I.
   Sharma, Avinash
   Zumla, Alimuddin
TI Mass gatherings medicine: public health issues arising from mass
   gathering religious and sporting events
SO LANCET
LA English
DT Review
ID RIO-DE-JANEIRO; RESPIRATORY SYNDROME CORONAVIRUS; KUMBH MELA; ZIKA
   VIRUS; RESISTANT BACTERIA; OLYMPIC GAMES; HAJJ PILGRIMS; RISK;
   TRAVELERS; SURVEILLANCE
AB Mass gathering events are associated with major public health challenges. The 2014 Lancet Series on the new discipline of mass gatherings medicine was launched at the World Health Assembly of Ministers of Health in Geneva in May, 2014. The Series covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health-care providers from mass gathering events in 2012 and 2013. This follow-up Review focuses on the main public health issues arising from planned mass gathering events held between 2013 and 2018. We highlight public health and research data on transmission of infectious diseases and antibiotic-resistant bacteria, mass casualty incidents, and non-communicable diseases, including thermal disorders. In the events discussed in this Review, the combination of a large influx of people, many from countries with outbreak-prone infectious diseases, with a high degree of crowd interactions imposed substantial burdens on host countries' health systems. The detection and transmission of antibiotic-resistant bacteria in pilgrims attending the Kumbh Mela and the Hajj raise concern of possible globalisation from mass-gathering religious events. Priorities for further investments and opportunities for research into prevention, surveillance, and management of these public health issues are discussed.
C1 [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Prince Mohamed Bin Abdulaziz Hosp, Minist Hlth, Dept Med & Res, Div Infect Dis, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Steffen, Robert] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.
   [Steffen, Robert] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA.
   [White, Paul] Commonwealth Hlth Care Corp, Commonwealth Northern Mariana Isl, Epidemiol & Lab Capac Program, Publ Hlth & Hosp Emergency Preparedness Program, Saipan, CM USA.
   [Dar, Osman] Publ Hlth England, London, England.
   [Dar, Osman] Royal Inst Int Affairs, Chatham House Ctr Global Hlth Secur, London, England.
   [Azhar, Esam I.] King Fahd Med Res Ctr, Infect Agents Unit, Jeddah, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Med Lab Technol Dept, Fac Appl Med Sci, Jeddah, Saudi Arabia.
   [Sharma, Avinash] Natl Ctr Microbial Resource, Pune, Maharashtra, India.
   [Sharma, Avinash] Natl Ctr Cell Sci, Pune, Maharashtra, India.
   [Zumla, Alimuddin] UCL, Div Infect, London, England.
   [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
RP Zumla, A (corresponding author), UCL, Div Infect & Immun, London WC1E 6BT, England.
EM a.zumla@ucl.ac.uk
RI Sharma, Avinash/AAD-9549-2020
OI Sharma, Avinash/0000-0001-9372-0178; Azhar, Esam/0000-0002-1736-181X;
   Zumla, Professor Sir Alimuddin/0000-0002-5111-5735
FU National Institutes of Health ResearchUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA; European and
   Developing Countries Clinical Trials Partnership programme under Horizon
   2020, the European Union's Framework Programme for Research and
   Innovation [RIA2016E-1609]
FX AZ is in receipt of a National Institutes of Health Research senior
   investigator award. AZ and OD are members of the PANDORA-ID-NET
   consortium (EDCTP Reg/Grant RIA2016E-1609), funded by the European and
   Developing Countries Clinical Trials Partnership programme, which is
   supported under Horizon 2020, the European Union's Framework Programme
   for Research and Innovation.
CR Ahmed QA, 2019, TRAVEL MED INFECT DI, V28, P91, DOI 10.1016/j.tmaid.2018.06.001
   Aitsi-Selmi A, 2016, INT J INFECT DIS, V47, P101, DOI 10.1016/j.ijid.2016.04.006
   Al Rabeeah A, 2012, LANCET, V380, P3, DOI 10.1016/S0140-6736(12)61073-3
   Al-Tawfiq JA, 2015, CLIN MICROBIOL INFEC, V21, P109, DOI [10.1016/j.cmi.2015.02.008, 10.1016/j.cmi.2014.11.013, 10.1016/j.cmi.2014.07.005]
   Al-Tawfiq JA, 2018, TRAVEL MED INFECT DI, V23, P6, DOI 10.1016/j.tmaid.2018.04.007
   Alaska YA, 2017, TRAVEL MED INFECT DI, V15, P67, DOI 10.1016/j.tmaid.2016.09.002
   AlBarrak A, 2018, INT J INFECT DIS, V69, P68, DOI 10.1016/j.ijid.2018.02.008
   Almutairi MM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006539
   Alotaibi BM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw087
   Alqahtani AS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay068
   [Anonymous], 2016, PACNET PPHSNS EARL W
   [Anonymous], 2018, 2018 ANN REV DIS PRI
   [Anonymous], 2018, UMR PERF STAT FIG
   [Anonymous], 2015, MONDE
   [Anonymous], 2015, 23 WORLD SCOUT JAMB
   Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Azhar EI, 2017, ADV EXP MED BIOL, V972, P49, DOI 10.1007/5584_2016_133
   Badandah AM, 2018, WORLD J CLIN CASES, V6, P1128, DOI 10.12998/wjcc.v6.i16.1128
   Badandah A, 2018, VACCINE, V36, P4593, DOI 10.1016/j.vaccine.2018.06.027
   Balaban V, 2012, J TRAVEL MED, V19, P163, DOI 10.1111/j.1708-8305.2012.00602.x
   Balsari S, 2013, EMCOUNING MELA CHENN
   Balsari S, 2016, J PUBLIC HEALTH POL, V37, P411, DOI 10.1057/s41271-016-0034-z
   BANKS AL, 1961, LANCET, V1, P162
   Baranwal A, 2015, PLOS CURR, V7
   Barasheed O, 2014, J TRAVEL MED, V21, P384, DOI 10.1111/jtm.12146
   Biddinger PD, 2013, NEW ENGL J MED, V368, P1958, DOI 10.1056/NEJMp1305480
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Cariappa M P, 2015, Med J Armed Forces India, V71, P278, DOI 10.1016/j.mjafi.2014.08.001
   David S, 2016, INT J INFECT DIS, V47, P42, DOI 10.1016/j.ijid.2016.01.010
   Diagne CT, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay123
   Dong YH, 2017, CHIN J TRAUMATOL, V20, P240, DOI 10.1016/j.cjtee.2016.08.005
   Dwivedi S, 2015, PREHOSP DISASTER MED, V30, P621, DOI 10.1017/S1049023X15005245
   Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210
   Edouard S, 2018, VACCINE, V36, P7415, DOI 10.1016/j.vaccine.2018.09.017
   Elachola H, 2016, J HLTH SPEC, V4, P178
   Elachola H, 2018, TRAVEL MED INFECT DI, V25, P3, DOI 10.1016/j.tmaid.2018.08.003
   European Centre for Disease Prevention and Control, 2018, RAP RISK ASS MASS GA
   Gandra S, 2017, SCOPING REPORT ANTIM
   Gautret P, 2016, EUROSURVEILLANCE, V21, P14, DOI 10.2807/1560-7917.ES.2016.21.27.30278
   Gautret P, 2018, TRAVEL MED INFECT DI, V23, P99, DOI 10.1016/j.tmaid.2018.04.016
   Greenough PG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3254
   Griffith MM, 2018, WEST PAC SURVEILL RE, V9, DOI [10.5365/wpsar.2017.8.4.002, 10.5365/wpsar.2018.9.1.010]
   Guam Visitors Bureau, 2016, 12 FEST PAC ARTS GUA
   Hales CM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw064
   Harrison Lee H, 2011, Vaccine, V29, P3363, DOI 10.1016/j.vaccine.2011.02.058
   Hasan OA, 2014, INFECT ECOL EPIDEMIO, V4, P1
   Hashim S, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav019
   Hays J. N., 2005, EPIDEMICS PANDEMICS, P193
   Hellmann Fernando, 2018, Indian J Med Ethics, V3, P326, DOI 10.20529/IJME.2018.026
   Hoy D, 2016, WEST PAC SURVEILL RE, V7, DOI 10.5365/wpsar.2016.7.1.004
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Jacobsson S, 2018, APMIS, V126, P337, DOI 10.1111/apm.12819
   Jammer I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-187
   Jani K, 2018, MICROB ECOL, V76, P706, DOI 10.1007/s00248-018-1169-1
   Jani K, 2018, INT J SYST EVOL MICR, V68, P241, DOI 10.1099/ijsem.0.002491
   Jani K, 2018, CURR MICROBIOL, V75, P79, DOI 10.1007/s00284-017-1352-5
   Karampourian Arezou, 2018, F1000Res, V7, P1448, DOI 10.12688/f1000research.15290.1
   Karimi Faith, 2015, CNN
   Khan ID, 2018, J INFECT PUBLIC HEAL, V11, P165, DOI 10.1016/j.jiph.2017.06.004
   Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536
   Leangapichart T, 2017, TRAVEL MED INFECT DI, V18, P3, DOI 10.1016/j.tmaid.2017.06.008
   Lodeiro-Colatosti A, 2018, EMERG INFECT DIS, V24, P1340, DOI 10.3201/eid2407.171712
   Lu TS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay106
   Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395
   Lund A, 2011, CAN J EMERG MED, V13, P231, DOI 10.2310/8000.2011.110305
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   McConnell J, 2010, LANCET INFECT DIS, V10, P818, DOI 10.1016/S1473-3099(10)70260-7
   Memish ZA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay065
   Memish ZA, 2014, LANCET, V383, P2030, DOI 10.1016/S0140-6736(14)60225-7
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Nikolic N, 2017, BRIT J SPORT MED, V51, P1572, DOI 10.1136/bjsports-2017-098003
   Nkengasong J, 2017, LANCET GLOB HEALTH, V5, pE1064, DOI 10.1016/S2214-109X(17)30363-7
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Peterson ME, 2018, INT J INFECT DIS, V73, P109, DOI 10.1016/j.ijid.2018.05.022
   Public Health England, 2018, NIP VIR EP OUTBR GUI
   Raslan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00283
   Riddle MS, 2017, J TRAVEL MED, V24, pS63, DOI 10.1093/jtm/tax026
   Rodriguez-Valero N, 2017, EMERG INFECT DIS, V23, P1426, DOI 10.3201/eid2308.170415
   Shafi S, 2016, INT J INFECT DIS, V47, P79, DOI 10.1016/j.ijid.2016.06.013
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   Smith-Palmer A, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.45.30392
   Sokhna C, 2017, TRAVEL MED INFECT DI, V19, P56, DOI 10.1016/j.tmaid.2017.08.005
   Sridhar S, 2015, CLIN MICROBIOL INFEC, V21, P128, DOI 10.1016/j.cmi.2014.11.021
   Tashani M, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax006
   Tashani M, 2016, POSTGRAD MED, V128, P541, DOI 10.1080/00325481.2016.1191956
   The FXB Center for Health and Human Rights at Harvard University, 2013, PUBL HLTH KUMBH MEL
   The Lancet, 2014, LANCET
   Turris SA, 2014, DISASTER MED PUBLIC, V8, P143, DOI 10.1017/dmp.2014.24
   Vortmann M, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0461-1
   White P, 2018, WEST PAC SURVEILL RE, V9, DOI 10.5365/wpsar.2016.7.4.001
   White P, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/WPSAR.2016.7.4.002, 10.5365/wpsar.2016.7.4.002]
   WHO, 2017, ZIK VIR COMPL 2016 P
   WHO, 2014, FREQ ASK QUEST CHIK
   WHO, 2017, DIPHTH YEM
   WHO Regional Office for South-East Asia, 2017, ANN TUB REP 2017
   Wilder-Smith A, 2003, CLIN INFECT DIS, V37, P1270, DOI 10.1086/378748
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay139
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   World Health Organization, 2016, WHAT IS WHOS ROL MAS
   World Health Organization, 2016, 1 M INT HLTH REG 200
   World Health Organization, 2015, PUBL HLTH MASS GATH
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
   Yezli S, 2018, VACCINE, V36, P4603, DOI 10.1016/j.vaccine.2018.06.030
   Yezli S, 2017, AM J TROP MED HYG, V97, P1304, DOI 10.4269/ajtmh.17-0271
   Zumla A, 2018, LANCET INFECT DIS, V18, P488, DOI 10.1016/S1473-3099(18)30242-1
   Zumla A, 2017, LANCET INFECT DIS, V17, P895, DOI 10.1016/S1473-3099(17)30454-1
   Zumla A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0686-3
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
   Zumla A, 2016, INT J INFECT DIS, V47, P86, DOI 10.1016/j.ijid.2016.02.003
   2016, ANTIMICROB AGENTS CH, V60, P5942, DOI DOI 10.1128/AAC.00669-16
   2017, VACCINE, V35, P2473, DOI DOI 10.1016/J.VACCINE.2017.03.027
   2016, ANTIMICROB AGENTS CH, V60, P3222, DOI DOI 10.1128/AAC.02396-15
   2016, TRAVEL MED INFECT DI, V14, P212, DOI DOI 10.1016/J.TMAID.2016.05.014
   2006, SAUDI MED J, V27, P1373
NR 116
TC 17
Z9 17
U1 16
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 18
PY 2019
VL 393
IS 10185
BP 2073
EP 2084
DI 10.1016/S0140-6736(19)30501-X
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HY4QC
UT WOS:000468112000030
PM 31106753
OA Green Published
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathum
   Wiwanitkit, Viroj
TI Prevention for Zika Virus Infection
SO INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Letter
C1 [Sookaromdee, Pathum] TWS Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Tropcial Med, Haikou, Hainan, Peoples R China.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Ali M, 2017, EUR J CONTRACEP REPR, V22, P102, DOI 10.1080/13625187.2017.1288902
   Jimenez A, 2017, TRANSFUSION, V57, P2077, DOI 10.1111/trf.14252
   Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Joob B, 2017, ASIAN PAC J TROP MED, V10, P199, DOI 10.1016/j.apjtm.2017.01.011
   Levi ME, 2017, CURR OPIN INFECT DIS, V30, P340, DOI 10.1097/QCO.0000000000000384
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 7
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2008-7802
EI 2008-8213
J9 INT J PREVENTIVE MED
JI Int. J. Preventive Med.
PD MAY 17
PY 2019
VL 10
AR 63
DI 10.4103/ijpvm.IJPVM_354_17
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA IA8HF
UT WOS:000469798800004
PM 31198498
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Badshah, SL
   Ahmad, N
   Rehman, AU
   Khan, K
   Ullah, A
   Alsayari, A
   Bin Muhsinah, A
   Mabkhot, YN
AF Badshah, Syed Lal
   Ahmad, Nasir
   Rehman, Ashfaq Ur
   Khan, Khalid
   Ullah, Asad
   Alsayari, Abdulrhman
   Bin Muhsinah, Abdullatif
   Mabkhot, Yahia N.
TI Molecular docking and simulation of Zika virus NS3 helicase
SO BMC CHEMISTRY
LA English
DT Article
DE ZIKV; Microcephaly; Nonstructural protein-3 Helicase; Molecular dynamics
   simulation; Molecular docking
ID NONNUCLEOSIDE INHIBITORS; FREE-ENERGY; DYNAMICS; INFECTION; VACCINATION;
   PROTEIN; DENGUE; FEVER; MODEL; AMBER
AB The Zika virus (ZIKV) has gained attention for the last few years due to the congenital microcephaly and Guillain-Barre Syndrome that resulted in humans. The non-structural protein-3 (NS3) helicase of ZIKV play an important role in viral RNA replication. In this article, we performed hundred nanosecond molecular dynamics simulation and molecular docking of the NS3 helicase of ZIKV with 1,4-benzothiazine derivatives. The root mean square deviation (RMSD) analyses showed the stability of the NS3 helicase. The simulation showed that the flexible and rigid domains of the protein play a crucial role during the RNA replication process. All such domains with ligand binding pockets can be targeted for drug design.The molecular docking showed that the strong hydrogen bonding and arene-cation interactions are responsible for the binding between NS3 and 1,4-benzothiazine derivatives, which provides a new dimension for potent drug design for ZIKV.
C1 [Badshah, Syed Lal; Ahmad, Nasir; Khan, Khalid; Ullah, Asad] Islamia Coll Univ, Dept Chem, Peshawar, Khyber Pakhtunk, Pakistan.
   [Rehman, Ashfaq Ur] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
   [Alsayari, Abdulrhman; Bin Muhsinah, Abdullatif] King Khalid Univ, Coll Pharm, Dept Pharmacognosy, Abha 62529, Saudi Arabia.
   [Mabkhot, Yahia N.] King Khalid Univ, Coll Pharamacy, Dept Pharmaceut Chem, Abha 61441, Saudi Arabia.
RP Badshah, SL; Khan, K (corresponding author), Islamia Coll Univ, Dept Chem, Peshawar, Khyber Pakhtunk, Pakistan.; Mabkhot, YN (corresponding author), King Khalid Univ, Coll Pharamacy, Dept Pharmaceut Chem, Abha 61441, Saudi Arabia.
EM shahbiochemist@gmail.com; drkhalidchem@yahoo.com; ygaber@kku.edu.sa
RI Rehman, Ashfaq Ur/AAN-9806-2020; BADSHAH, SYED LAL/H-3197-2017
OI Ullah, ASAD/0000-0002-0142-8565; BADSHAH, SYED LAL/0000-0002-0229-1425
FU King Khalid University
FX King Khalid University grant awarded to Dr. Yahia Mabkhot.
CR [Anonymous], MOL OP ENV MOE VERS
   Ash S, 1997, J CHEM INF COMP SCI, V37, P71, DOI 10.1021/ci960109j
   Badshah SL, 2016, OPEN CHEM, V14, P188, DOI 10.1515/chem-2016-0021
   Badshah SL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010007
   Badshah SL, 2016, MOLECULES, V21, DOI 10.3390/molecules21081054
   Bajpai Smrati, 2016, J Assoc Physicians India, V64, P42
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   De Clercq E, 2014, BIOCHEM PHARMACOL, V89, P441, DOI 10.1016/j.bcp.2014.04.005
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Vicente J, 2009, BIOORG MED CHEM LETT, V19, P3642, DOI 10.1016/j.bmcl.2009.05.004
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fang JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34550
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hendricks RT, 2009, BIOORG MED CHEM LETT, V19, P3637, DOI 10.1016/j.bmcl.2009.04.119
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kumar YN, 2012, BIOINFORMATION, V8, P543, DOI 10.6026/97320630008543
   Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   Ramharack P, 2017, RSC ADV, V7, P22133, DOI 10.1039/c7ra01376k
   Rehman Sidra, 2011, Genet Vaccines Ther, V9, P11, DOI 10.1186/1479-0556-9-11
   Ruhle V, 2007, THESIS, P1
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Syed S, 2018, CURRENT TOPICS ZIKA
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   2008, EMBO J, V27, P3209, DOI DOI 10.1038/EMBOJ.2008.2322599875
   2010, P NATL ACAD SCI USA, V107, P521, DOI DOI 10.1073/PNAS.0913380107
   2015, ANTIVIR RES, V118, P148, DOI DOI 10.1016/J.ANTIVIRAL.2015.03.014
   2010, VIROL SIN, V25, P246, DOI DOI 10.1007/S12250-010-3140-2
   2016, J ORG CHEM, V81, P8647, DOI DOI 10.1021/ACS.JOC.6B01668
   2016, MOL BIOSYST, V12, P3280, DOI DOI 10.1039/C6MB00521G
NR 49
TC 2
Z9 2
U1 1
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2661-801X
J9 BMC CHEM
JI BMC Chem.
PD MAY 17
PY 2019
VL 13
AR 67
DI 10.1186/s13065-019-0582-y
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA HY7GQ
UT WOS:000468301800003
PM 31384814
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chepkorir, E
   Tchouassi, DP
   Konongoi, SL
   Lutomiah, J
   Tigoi, C
   Irura, Z
   Eyase, F
   Venter, M
   Sang, R
AF Chepkorir, E.
   Tchouassi, D. P.
   Konongoi, S. L.
   Lutomiah, J.
   Tigoi, C.
   Irura, Z.
   Eyase, F.
   Venter, M.
   Sang, R.
TI Serological evidence of Flavivirus circulation in human populations in
   Northern Kenya: an assessment of disease risk 2016-2017
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue virus; Yellow fever virus; West Nile virus; Zika virus;
   Seroprevalence; Plaque reduction neutralization test; Flaviviruses risk
   assessment; Northern Kenya
ID WEST NILE VIRUS; 1ST RECORDED OUTBREAK; YELLOW-FEVER; ZIKA VIRUS;
   RIFT-VALLEY; TANA RIVER; DENGUE; TRANSMISSION; INFECTIONS; ANTIBODIES
AB BackgroundYellow fever, Dengue, West Nile and Zika viruses are re-emerging mosquito-borne Flaviviruses of public health concern. However, the extent of human exposure to these viruses and associated disease burden in Kenya and Africa at large remains unknown. We assessed the seroprevalence of Yellow fever and other Flaviviruses in human populations in West Pokot and Turkana Counties of Kenya. These areas border Uganda, South Sudan and Ethiopia where recent outbreaks of Yellow fever and Dengue have been reported, with possibility of spillover to Kenya.MethodologyHuman serum samples collected through a cross-sectional survey in West Pokot and Turkana Counties were screened for neutralizing antibodies to Yellow fever, Dengue-2, West Nile and Zika virus using the Plaque Reduction Neutralization Test (PRNT). Seroprevalence was compared by county, site and important human demographic characteristics. Adjusted odds ratios (aOR) were estimated using Firth logistic regression model.ResultsOf 877 samples tested, 127 neutralized with at least one of the four flaviviruses (14.5, 95% CI 12.3-17.0%), with a higher proportion in Turkana (21.1%, n=87/413) than in West Pokot (8.6%, n=40/464). Zika virus seroprevalence was significantly higher in West Pokot (7.11%) than in Turkana County (0.24%; P-2<0.0001). A significantly higher Yellow fever virus seroprevalence was also observed in Turkana (10.7%) compared to West Pokot (1.29%; (2) P<0.0001). A high prevalence of West Nile virus was detected in Turkana County only (10.2%) while Dengue was only detected in one sample, from West Pokot. The odds of infection with West Nile virus was significantly higher in males than in females (aOR=2.55, 95% CI 1.22-5.34). Similarly, the risk of Zika virus infection in West Pokot was twice higher in males than females (aOR=2.01, 95% CI 0.91-4.41).ConclusionEvidence of neutralizing antibodies to West Nile and Zika viruses indicates that they have been circulating undetected in human populations in these areas. While the observed Yellow Fever prevalence in Turkana and West Pokot Counties may imply virus activity, we speculate that this could also be as a result of vaccination following the Yellow Fever outbreak in the Omo river valley, South Sudan and Uganda across the border.
C1 [Chepkorir, E.; Tchouassi, D. P.; Tigoi, C.; Sang, R.] Int Ctr Insect Physiol & Ecol, POB 30772-00100, Nairobi, Kenya.
   [Chepkorir, E.; Venter, M.] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, POB 323, ZA-0007 Arcadia, South Africa.
   [Konongoi, S. L.; Lutomiah, J.] Kenya Govt Med Res Ctr, Ctr Virus Res, POB 54628-00200, Nairobi, Kenya.
   [Irura, Z.] Minist Hlth, Div Dis Surveillance & Response, POB 20781-00202, Nairobi, Kenya.
   [Eyase, F.] Jomo Kenyatta Univ Agr & Technol, POB 606, Nairobi, Kenya.
RP Chepkorir, E (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772-00100, Nairobi, Kenya.; Chepkorir, E (corresponding author), Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, POB 323, ZA-0007 Arcadia, South Africa.
EM echepkorir@icipe.org
RI Venter, Marietjie/P-9604-2016
OI Venter, Marietjie/0000-0003-2696-824X
FU German Academic Exchange Service (DAAD) In-Region Postgraduate
   Scholarship; L'Oreal-UNESCO for Women in Science Scholarship; National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R01AI099736-01A1];
   UK Aid from the UK Government; Swedish International Development
   Cooperation Agency (Sida); Swiss Agency for Development and Cooperation
   (SDC); Kenyan Government
FX EC was supported by a German Academic Exchange Service (DAAD) In-Region
   Postgraduate Scholarship and a L'Oreal-UNESCO for Women in Science
   Scholarship. We gratefully acknowledge the financial support for this
   research by the following organizations and agencies: National
   Institutes of Health (NIH), Grant No. 1R01AI099736-01A1 to RS; UK Aid
   from the UK Government; Swedish International Development Cooperation
   Agency (Sida); the Swiss Agency for Development and Cooperation (SDC);
   and the Kenyan Government. The views expressed herein do not necessarily
   reflect the official opinion of the donors.
CR Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Grossi-Soyster EN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005998
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Kenya National Bureau of Statistics, 2009, CENS REP
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Konongoi L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0641-0
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   LaBeaud AD, 2011, EMERG INFECT DIS, V17, P233, DOI 10.3201/eid1702.091666
   Lilay A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2435-4
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nawa M, 2000, CLIN DIAGN LAB IMMUN, V7, P774, DOI 10.1128/CDLI.7.5.774-777.2000
   Nyamwaya D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2019-8
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Odhiambo C, 2015, VECTOR-BORNE ZOONOT, V15, P329, DOI 10.1089/vbz.2014.1760
   Onyango CO, 2004, EMERG INFECT DIS, V10, P1064, DOI 10.3201/eid1006.030738
   R Foundation for Statistical Computing, 2008, LANG ENV STAT COMP
   Reiter P, 1998, AM J TROP MED HYG, V59, P650, DOI 10.4269/ajtmh.1998.59.650
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644, DOI 10.4269/ajtmh.1998.59.644
   Sang R C, 2001, East Afr Med J, V78, P655
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P835
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Tigoi C, 2015, VECTOR-BORNE ZOONOT, V15, P124, DOI 10.1089/vbz.2014.1686
   Vu DM, 2017, AM J TROP MED HYG, V96, P141, DOI 10.4269/ajtmh.16-0562
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2011, YELL FEV UG
   World Health Organization, 2016, YELL FEV UG
NR 38
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 17
PY 2019
VL 16
AR 65
DI 10.1186/s12985-019-1176-y
PG 10
WC Virology
SC Virology
GA HY8GU
UT WOS:000468376200001
PM 31101058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Palagyi, A
   Marais, BJ
   Abimbola, S
   Topp, SM
   McBryde, ES
   Negin, J
AF Palagyi, Anna
   Marais, Ben J.
   Abimbola, Seye
   Topp, Stephanie M.
   McBryde, Emma S.
   Negin, Joel
TI Health system preparedness for emerging infectious diseases: A synthesis
   of the literature
SO GLOBAL PUBLIC HEALTH
LA English
DT Article
DE Emerging infectious diseases; health systems; low; and middle-income
   country; health system strengthening
ID EBOLA-VIRUS DISEASE; WEST-AFRICA; PANDEMIC PREPAREDNESS; ANIMAL HEALTH;
   CARE-SYSTEM; ZIKA VIRUS; LESSONS; OUTBREAK; EPIDEMIC; INFLUENZA
AB This review reflects on what the literature to date has taught us about how health systems of low- and middle-income countries (LMICs) respond to emerging infectious disease (EID) outbreaks. These findings are then applied to propose a conceptual framework characterising an EID prepared health system. A narrative synthesis approach was adopted to explore the key elements of LMIC health systems during an EID outbreak. Overarching themes ('core health system constructs') and sub-themes ('elements') relevant to EID preparedness were extracted from 49 peer-reviewed articles. The resulting conceptual framework recognised six core constructs: four focused on material resources and structures (i.e. system 'hardware'), including (i) Surveillance, (ii) Infrastructure and medical supplies, (iii) Workforce, and (iv) Communication mechanisms; and two focused on human and institutional relationships, values and norms (i.e. system 'software'), including (i) Governance, and (ii) Trust. The article reinforces the interconnectedness of the traditional health system building blocks to EID detection, prevention and response, and highlights the critical role of system 'software' (i.e. governance and trust) in enabling LMIC health systems to achieve and maintain EID preparedness. The review provides recommendations for refining a set of indicators for an 'optimised' health system EID preparedness tool to aid health system strengthening efforts.
C1 [Palagyi, Anna; Abimbola, Seye; Negin, Joel] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia.
   [Palagyi, Anna; Abimbola, Seye] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia.
   [Marais, Ben J.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Marais, Ben J.] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW, Australia.
   [Topp, Stephanie M.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.
   [Topp, Stephanie M.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia.
   [McBryde, Emma S.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia.
RP Palagyi, A (corresponding author), Univ Sydney, Sch Publ Hlth, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.
EM apalagyi@georgeinstitute.org.au
RI Topp, Stephanie M/H-3923-2019
OI Topp, Stephanie M/0000-0002-3448-7983; Negin, Joel/0000-0002-2016-311X;
   Abimbola, Seye/0000-0003-1294-3850; McBryde, Emma/0000-0002-9570-9172;
   Palagyi, Anna/0000-0002-8127-9351
FU Department of Foreign Affairs and Trade, Australian Government
   [APP1132153]; National Health and Medical Council (NHMRC) Practitioner
   FellowshipNational Health and Medical Research Council of Australia
   [APP1139182]; NHMRC Early Career FellowshipNational Health and Medical
   Research Council of Australia [APP1139631]
FX A.P. is supported by grant funding from the Department of Foreign
   Affairs and Trade, Australian Government [grant number APP1132153]:
   Tropical partnerships to strengthen health systems responses to
   infectious diseases threats (PI: E.S.M.). B.J.M. is funded by a National
   Health and Medical Council (NHMRC) Practitioner Fellowship [grant number
   APP1139182]. S.A. is funded by an NHMRC Early Career Fellowship [grant
   number APP1139631].
CR Abimbola S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000758
   Abimbola S, 2017, HEALTH POLICY PLANN, V32, P1337, DOI 10.1093/heapol/czx083
   Abimbola S, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000481
   Adokiya MN, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.29763
   Aitken M, 2016, PLAN THEORY PRACT, V17, P557, DOI 10.1080/14649357.2016.1218919
   Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652
   Balajee SA, 2016, HEALTH SECUR, V14, P424, DOI 10.1089/hs.2015.0062
   Barasa EW, 2017, HEALTH POLICY PLANN, V32, P91, DOI 10.1093/heapol/czx118
   Bhatnagar N, 2016, ANN TROP MED PUBLIC, V9, P145, DOI 10.4103/1755-6783.181658
   Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387
   Buseh AG, 2015, NURS OUTLOOK, V63, P30, DOI 10.1016/j.outlook.2014.12.013
   Caceres P, 2017, REV SCI TECH OIE, V36, P539, DOI 10.20506/rst.36.2.2672
   Cancedda C, 2016, J INFECT DIS, V214, pS153, DOI 10.1093/infdis/jiw345
   Carroll LN, 2014, J BIOMED INFORM, V51, P287, DOI 10.1016/j.jbi.2014.04.006
   Cash RA, 2000, B WORLD HEALTH ORGAN, V78, P1358
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   Chee G, 2013, INT J HEALTH PLAN M, V28, P85, DOI 10.1002/hpm.2122
   Davies SE, 2017, MED LAW REV, V25, P270, DOI 10.1093/medlaw/fwx011
   DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1
   Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413
   Edmunds KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072279
   Espinal M, 2016, AM J PUBLIC HEALTH, V106, P279, DOI 10.2105/AJPH.2015.302969
   Fidler D. P., 2015, EBOLA REPORT MISSES
   Fidler D. P., 2015, BROWN J WORLD AFFAIR, V21, P180
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Forrester JD, 2014, MMWR-MORBID MORTAL W, V63, P891
   Fryatt RJ, 2017, LANCET GLOB HEALTH, V5, pE841, DOI 10.1016/S2214-109X(17)30294-2
   Gostin LO, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002042
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P2376, DOI 10.1001/jama.2009.849
   Grobler L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub3
   Haldane V, 2017, LANCET, V389, P1513, DOI 10.1016/S0140-6736(17)30946-7
   Hall LM, 2016, J NURS SCHOLARSHIP, V48, P91, DOI 10.1111/jnu.12182
   Hanvoravongchai P, 2011, J INFECT DIS, V204, pS82, DOI 10.1093/infdis/jir091
   Horby PW, 2013, EMERG INFECT DIS, V19, P853, DOI 10.3201/eid1906.121783
   Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5
   JONES K, 2004, QUALITATIVE REPORT, V9, P94
   Kaufman JA, 2008, J INFECT DIS, V197, pS7, DOI 10.1086/524990
   Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278
   Kinsman J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-15
   Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656
   Krah E, 2018, J COMMUN HEALTH, V43, P157, DOI 10.1007/s10900-017-0398-4
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3
   Lapao Luis Velez, 2015, Pan Afr Med J, V22 Suppl 1, P15, DOI 10.11694/pamj.supp.2015.22.1.6653
   Li RC, 2016, WEST PAC SURVEILL RE, V7, DOI 10.5365/wpsar.2016.7.1.005
   Martineau FP, 2016, INT HEALTH, V8, P307, DOI 10.1093/inthealth/ihw029
   Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576
   Mbonye AK, 2014, AFR HEALTH SCI, V14, P495, DOI 10.4314/ahs.v14i3.1
   McPake B, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0052-7
   Mounier-Jack S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-278
   Mulinge Ivy, 2016, Pan Afr Med J, V23, P121, DOI 10.11604/pamj.2016.23.121.8955
   Nyarko Y, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0094-z
   Nyenswah TG, 2016, EMERG INFECT DIS, V22, P169, DOI 10.3201/eid2202.151456
   Omole O, 2016, PERSPECT PUBLIC HEAL, V136, P333, DOI 10.1177/1757913916663141
   Ozawa S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1867-7
   Parsons C, 2015, T ROY SOC TROP MED H, V109, P481, DOI 10.1093/trstmh/trv053
   Purohit V, 2018, INT J HEALTH POLICY, V7, P154, DOI 10.15171/ijhpm.2017.54
   Qiu WQ, 2018, DISASTER MED PUBLIC, V12, P587, DOI 10.1017/dmp.2017.114
   Rabinowitz P, 2013, ANNU REV PUBL HEALTH, V34, P189, DOI 10.1146/annurev-publhealth-031912-114426
   Regmi Krishna, 2015, Infection Ecology & Epidemiology, V5, P28877, DOI 10.3402/iee.v5.28877
   Scott V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3071-4
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Sheikh K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001073
   Shiao JSC, 2007, NURS ETHICS, V14, P5, DOI 10.1177/0969733007071350
   Shoman H, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-016-0224-2
   Siedner MJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001804
   Siekmans K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4012-y
   Stoto MA, 2013, J PUBLIC HEALTH MAN, V19, P428, DOI 10.1097/PHH.0b013e3182751d3e
   Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]
   Topp SM, 2016, HEALTH POLICY PLANN, V31, P192, DOI 10.1093/heapol/czv041
   Topp SM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0703-9
   van Olmen J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-774
   WHO, 2010, MON BUILD BLOCKS HLT
   WHO Western Pacific Region, 2008, GUID EST EV BAS SURV
   Wilson K, 2010, HEALTH POLICY PLANN, V25, P505, DOI 10.1093/heapol/czq026
   Wilson NW, 2009, RURAL REMOTE HEALTH, V9
   Wolfe CM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005597
   World Bank, 2017, PAN NEGL INV HLTH SE
   World Health Organization, 2005, WHO INT HLTH REG 200
   World Health Organization, 2007, EV BUS STRENGTH HLTH
   World Health Organization Regional Office for the Western Pacific, 2016, UN HLTH COV MOV BETT
   Zakkar Moutasem, 2017, Online J Public Health Inform, V9, pe190, DOI 10.5210/ojphi.v9i2.8000
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
NR 84
TC 0
Z9 0
U1 4
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
PD DEC 2
PY 2019
VL 14
IS 12
BP 1847
EP 1868
DI 10.1080/17441692.2019.1614645
EA MAY 2019
PG 22
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JC1AH
UT WOS:000470399300001
PM 31084412
OA Bronze
DA 2020-07-08
ER

PT J
AU Wang, LP
   Zhao, HY
AF Wang, Liping
   Zhao, Hongyong
TI Dynamics analysis of a Zika-dengue co-infection model with dengue
   vaccine and antibody-dependent enhancement
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE Zika; Dengue; Co-infection; Vaccine; Antibody-dependent enhancement;
   Stability
ID VIRUS OUTBREAK; TRANSMISSION DYNAMICS; DISEASE-MODELS; INFECTION;
   CHIKUNGUNYA; PERSISTENCE; SEROTYPES; AWARENESS; IMPACT
AB Mounting clinical and experimental evidence indicates that antibodies against dengue can enhance Zika infection through the antibody-dependent enhancement (ADE) mechanism. ADE is an alarming evolutionary development that makes it difficult to develop a vaccination campaign against dengue. To better understand the effect of dengue vaccine and ADE on a Zika and dengue outbreak, we formulate a Zika-dengue co-infection model that describes the joint dynamics of Zika and dengue. We derive the basic and invasion reproduction numbers, which are threshold values to identify the existence and stability of a disease-free state and two boundary equilibrium points, where only one strain (Zika or dengue) is present, and to identify the persistence of disease. Our analysis and numerical simulations suggest that although vaccination against dengue has a positive effect on the control of dengue, it has a negative effect on the control of Zika, and the increasing level of ADE induces a large number of accumulated Zika cases. Later, in this paper, criteria of vaccination against dengue strategies are established for disease eradication. Finally, the model is applied to simulate the accumulated cases of Zika and dengue in Brazil from February 19, 2016 to April 14, 2018. Based on the parameters estimated, we obtain that in Brazil the dengue epidemic is endemic whereas the Zika epidemic will eventually disappear. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Wang, Liping; Zhao, Hongyong] Nanjing Univ Aeronaut & Astronaut, Dept Math, Nanjing 210016, Jiangsu, Peoples R China.
RP Zhao, HY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Math, Nanjing 210016, Jiangsu, Peoples R China.
EM hyzhao1967@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11571170]; Jiangsu Innovation Program for Graduate
   Education [KYZZ16_0162]
FX The authors highly appreciate the anonymous reviewers for providing
   valuable suggestions which helped us to improve the paper. The work is
   partially supported by National Natural Science Foundation of China
   under Grant 11571170. Funding of Jiangsu Innovation Program for Graduate
   Education KYZZ16_0162.
CR Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bicout DJ, 2002, PHYSICA A, V305, P597, DOI 10.1016/S0378-4371(01)00604-5
   Billings L, 2008, MATH BIOSCI, V211, P265, DOI 10.1016/j.mbs.2007.08.004
   Brazil Ministry of Health, ZIK CAS BRAZ MIN HLT
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Cohen  J., 2016, SCIENCE, V7, P7
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Esteva L, 1999, J MATH BIOL, V38, P220, DOI 10.1007/s002850050147
   Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4
   Feng ZL, 2013, MATH BIOSCI, V245, P171, DOI 10.1016/j.mbs.2013.07.003
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Gao D., 2016, SCI REP, V6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Hu K, 2013, J THEOR BIOL, V319, P62, DOI 10.1016/j.jtbi.2012.11.021
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mishra A, 2014, APPL MATH COMPUT, V246, P159, DOI 10.1016/j.amc.2014.07.115
   MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909
   Nuraini N, 2009, MATH COMPUT MODEL, V49, P1148, DOI 10.1016/j.mcm.2008.06.016
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pereira FMM, 2018, PHYSICA A, V499, P75, DOI 10.1016/j.physa.2018.01.029
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Saba H, 2014, PHYSICA A, V413, P205, DOI 10.1016/j.physa.2014.06.045
   Shuai ZS, 2013, SIAM J APPL MATH, V73, P1513, DOI 10.1137/120876642
   Sriprom M, 2007, MATH COMPUT MODEL, V45, P1053, DOI 10.1016/j.mcm.2006.09.011
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   World Health Organization, CAS DEF ZIK VIR
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zheng TT, 2018, J THEOR BIOL, V443, P82, DOI 10.1016/j.jtbi.2018.01.017
   1990, J MATH BIOL, V28, P365
NR 55
TC 4
Z9 4
U1 1
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-4371
EI 1873-2119
J9 PHYSICA A
JI Physica A
PD MAY 15
PY 2019
VL 522
BP 248
EP 273
DI 10.1016/j.physa.2019.01.099
PG 26
WC Physics, Multidisciplinary
SC Physics
GA HV5YM
UT WOS:000466061000022
DA 2020-07-08
ER

PT J
AU Viens, L
   Fleck-Derderian, S
   Baez-Santiago, M
   Oduyebo, T
   Broussard, C
   Meaney-Delman, D
AF Viens, L.
   Fleck-Derderian, S.
   Baez-Santiago, M.
   Oduyebo, T.
   Broussard, C.
   Meaney-Delman, D.
TI Congenital Zika Syndrome: A Systematic Review of the Role of Prenatal
   Ultrasound and Amniocentesis
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Viens, L.] Chickasaw Nation Ind Inc, Norman, OK USA.
   [Fleck-Derderian, S.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Baez-Santiago, M.] Eagle Med Serv, San Antonio, TX USA.
   [Oduyebo, T.; Broussard, C.; Meaney-Delman, D.] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2019
VL 111
IS 9
SI SI
MA P17
BP 511
EP 511
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HY3UB
UT WOS:000468051600113
DA 2020-07-08
ER

PT J
AU Sowunmi, S
   Eckert, V
   Olney, R
AF Sowunmi, S.
   Eckert, V
   Olney, R.
TI Assessing the Utility of Public Health Laboratory-Reported Clinical Data
   for Use in Extended Zika Birth Defects Surveillance in California
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Sowunmi, S.; Eckert, V; Olney, R.] Calif Dept Publ Hlth, Richmond, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2019
VL 111
IS 9
SI SI
MA P20
BP 512
EP 512
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HY3UB
UT WOS:000468051600116
DA 2020-07-08
ER

PT J
AU Krause, KH
   Ailes, E
   Gilboa, SM
   Tong, V
   Cragan, J
   Delaney, A
   Jones, A
   Nahabedian, J
   Olson, SM
   Roth, N
   Smoots, A
   Yowe-Conley, T
   Meaney-Delman, D
   Honein, M
AF Krause, K. H.
   Ailes, E.
   Gilboa, S. M.
   Tong, V
   Cragan, J.
   Delaney, A.
   Jones, A.
   Nahabedian, J.
   Olson, S. M.
   Roth, N.
   Smoots, A.
   Yowe-Conley, T.
   Meaney-Delman, D.
   Honein, M.
TI An Evaluation of Zika Birth Defects Surveillance: A Model for Rapid
   Surveillance of Birth Defects during an Emergency Response-United
   States, 2018
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Krause, K. H.; Ailes, E.; Gilboa, S. M.; Tong, V; Cragan, J.; Delaney, A.; Jones, A.; Nahabedian, J.; Olson, S. M.; Roth, N.; Smoots, A.; Yowe-Conley, T.; Meaney-Delman, D.; Honein, M.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Krause, K. H.] Epidem Intelligence Serv, Atlanta, GA USA.
   [Olson, S. M.] G2S Corp, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2019
VL 111
IS 9
SI SI
MA P55
BP 530
EP 530
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HY3UB
UT WOS:000468051600151
DA 2020-07-08
ER

PT J
AU Viens, L
   Fleck-Derderian, S
   Baez-Santiago, M
   Oduyebo, T
   Broussard, C
   Meaney-Delman, D
AF Viens, L.
   Fleck-Derderian, S.
   Baez-Santiago, M.
   Oduyebo, T.
   Broussard, C.
   Meaney-Delman, D.
TI Congenital Zika Syndrome: A Systematic Review of the Role of Prenatal
   Ultrasound and Amniocentesis
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Viens, L.] Chickasaw Nation Ind Inc, Norman, OK USA.
   [Fleck-Derderian, S.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Baez-Santiago, M.] Eagle Med Serv, San Antonio, TX USA.
   [Oduyebo, T.; Broussard, C.; Meaney-Delman, D.] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2019
VL 111
IS 9
SI SI
BP 553
EP 553
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HY3UB
UT WOS:000468051600168
DA 2020-07-08
ER

PT J
AU Glushakova, LG
   Alto, BW
   Kim, MS
   Hutter, D
   Bradley, A
   Bradley, KM
   Burkett-Cadena, ND
   Benner, SA
AF Glushakova, Lyudmyla G.
   Alto, Barry W.
   Kim, Myong-Sang
   Hutter, Daniel
   Bradley, Andrea
   Bradley, Kevin M.
   Burkett-Cadena, Nathan D.
   Benner, Steven A.
TI Multiplexed kit based on Luminex technology and achievements in
   synthetic biology discriminates Zika, chikungunya, and dengue viruses in
   mosquitoes
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Chikungunya; Dengue viruses; Reverse-transcription PCR; Luminex
   DHA; Cationic paper
ID WEST-NILE-VIRUS; AEDES-AEGYPTI; VECTOR COMPETENCE; VIRAL-RNA; SPREAD;
   ASSAY; ARBOVIRUSES; TRANSMISSION; INNOVATIONS; EMERGENCE
AB BackgroundThe global expansion of dengue (DENV), chikungunya (CHIKV), and Zika viruses (ZIKV) is having a serious impact on public health. Because these arboviruses are transmitted by the same mosquito species and co-circulate in the same area, a sensitive diagnostic assay that detects them together, with discrimination, is needed.MethodsWe present here a diagnostics panel based on reverse transcription-PCR amplification of viral RNA and an xMap Luminex architecture involving direct hybridization of PCRamplicons and virus-specific probes. Two DNA innovations (artificially expanded genetic information systems, AEGIS, and self-avoiding molecular recognition systems, SAMRS) increase the hybridization sensitivity on Luminex microspheres and PCR specificity of the multiplex assay compared to the standard approach (standard nucleotides).ResultsThe diagnostics panel detects, if they are present, these viruses with a resolution of 20 genome equivalents (DENV1), or 10 (DENV3-4, CHIKV) and 80 (DENV2, ZIKV) genome equivalents per assay. It identifies ZIKV, CHIKV and DENV RNAs in a single infected mosquito, in mosquito pools comprised of 5 to 50 individuals, and mosquito saliva (ZIKV, CHIKV, and DENV2). Infected mosquitoes and saliva were also collected on a cationic surface (Q-paper), which binds mosquito and viral nucleic acids electrostatically. All samples from infected mosquitoes displayed only target-specific signals; signals from non-infected samples were at background levels.ConclusionsOur results provide an efficient and multiplex tool that may be used for surveillance of emerging mosquito-borne pathogens which aids targeted mosquito control in areas at high risk for transmission.
C1 [Glushakova, Lyudmyla G.; Kim, Myong-Sang; Hutter, Daniel; Bradley, Andrea; Bradley, Kevin M.; Benner, Steven A.] Firebird Biomol Sci LLC, 13709 Progress Blvd,Box 17, Alachua, FL 32615 USA.
   [Alto, Barry W.; Burkett-Cadena, Nathan D.] Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Benner, SA (corresponding author), Firebird Biomol Sci LLC, 13709 Progress Blvd,Box 17, Alachua, FL 32615 USA.
EM manuscripts@firebirdbio.com
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI128188]; Florida
   Department of Health [7ZK15]; Florida Department of Agriculture and
   Consumer Services [024376]
FX Research reported in this publication was supported by the National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health under Award Number R21AI128188, Florida Department of Health
   (7ZK15), and the Florida Department of Agriculture and Consumer Services
   (contract#024376). The design of the study, analysis and interpretation
   of data, and writing the manuscript is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH, FDH or FDACS.
CR Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Burkett-Cadena ND, 2016, J MED ENTOMOL, V53, P1449, DOI 10.1093/jme/tjw106
   Burkhalter KL, 2014, J AM MOSQUITO CONTR, V30, P21, DOI 10.2987/13-6386.1
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   GALUN R, 1963, SCIENCE, V142, P1674, DOI 10.1126/science.142.3600.1674
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Glushakova LG, 2018, J VIROL METHODS, V261, P71, DOI 10.1016/j.jviromet.2018.08.004
   Glushakova LG, 2017, J VIROL METHODS, V246, P104, DOI 10.1016/j.jviromet.2017.04.013
   Glushakova LG, 2015, ANAL BIOCHEM, V489, P62, DOI 10.1016/j.ab.2015.08.015
   Glushakova LG, 2015, J VIROL METHODS, V214, P60, DOI 10.1016/j.jviromet.2015.01.003
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Kaur P, 2016, METHODS MOL BIOL, V1426, P93, DOI 10.1007/978-1-4939-3618-2_9
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Maxian  O., 2017, EPIDEMICS
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Nasci RS, 2002, J AM MOSQUITO CONTR, V18, P294
   Nishiura Hiroshi, 2016, Uirusu, V66, P79, DOI 10.2222/jsv.66.79
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Theel E. S., 2018, J CLIN MICROBIOL, V56
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Yang F, 2013, WATER SCI TECHNOL, V67, P2560, DOI 10.2166/wst.2013.140
   Yang ZY, 2013, ANAL CHEM, V85, P4705, DOI 10.1021/ac400422r
NR 58
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 14
PY 2019
VL 19
AR 418
DI 10.1186/s12879-019-3998-z
PG 15
WC Infectious Diseases
SC Infectious Diseases
GA HY3UM
UT WOS:000468052700002
PM 31088375
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Braun, E
   Hotter, D
   Koepke, L
   Zech, F
   Gross, R
   Sparrer, KMJ
   Muller, JA
   Pfaller, CK
   Heusinger, E
   Wombacher, R
   Sutter, K
   Dittmer, U
   Winkler, M
   Simmons, G
   Jakobsen, MR
   Conzelmann, KK
   Pohlmann, S
   Munch, J
   Fackler, OT
   Kirchhoff, F
   Sauter, D
AF Braun, Elisabeth
   Hotter, Dominik
   Koepke, Lennart
   Zech, Fabian
   Gross, Ruediger
   Sparrer, Konstantin M. J.
   Mueller, Janis A.
   Pfaller, Christian K.
   Heusinger, Elena
   Wombacher, Rebecka
   Sutter, Kathrin
   Dittmer, Ulf
   Winkler, Michael
   Simmons, Graham
   Jakobsen, Martin R.
   Conzelmann, Karl-Klaus
   Poehlmann, Stefan
   Muench, Jan
   Fackler, Oliver T.
   Kirchhoff, Frank
   Sauter, Daniel
TI Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by
   Inhibiting Furin-Mediated Processing of Viral Envelope Proteins
SO CELL REPORTS
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; VESICULAR STOMATITIS-VIRUS; HIV-1
   INFECTION; CLEAVAGE SITE; IN-VITRO; T-CELLS; INTERFERON; GLYCOPROTEIN;
   PROPROTEIN; REPLICATION
AB Guanylate-binding protein (GBP) 5 is an interferon (IFN)-inducible cellular factor reducing HIV-1 infectivity by an incompletely understood mechanism. Here, we show that this activity is shared by GBP2, but not by other members of the human GBP family. GBP2/5 decrease the activity of the cellular proprotein convertase furin, which mediates conversion of the HIV-1 envelope protein (Env) precursor gp160 into mature gp120 and gp41. Because this process primes HIV-1 Env for membrane fusion, viral particles produced in the presence of GB 2/5 are poorly infectious due to increased incorporation of non-functional gp160. Furin activity is critical for the processing of envelope glycoproteins of many viral pathogens. Consistently, GBP2/5 also inhibit Zika, measles, and influenza A virus replication and decrease infectivity of viral particles carrying glycoproteins of Marburg and murine leukemia viruses. Collectively, our results show that GPB2/5 exert broad antiviral activity by suppressing the activity of the virus-dependency factor furin.
C1 [Braun, Elisabeth; Hotter, Dominik; Koepke, Lennart; Zech, Fabian; Gross, Ruediger; Sparrer, Konstantin M. J.; Mueller, Janis A.; Heusinger, Elena; Muench, Jan; Kirchhoff, Frank; Sauter, Daniel] Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.
   [Pfaller, Christian K.] Paul Ehrlich Inst, D-63225 Langen, Germany.
   [Wombacher, Rebecka; Fackler, Oliver T.] Univ Hosp Heidelberg, Ctr Integrat Infect Dis Res, Integrat Virol, D-69120 Heidelberg, Germany.
   [Sutter, Kathrin; Dittmer, Ulf] Univ Duisburg Essen, Univ Clin Essen, Inst Virol, D-45147 Essen, Germany.
   [Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Leibniz Inst Primate Res, Infect Biol Unit, D-37077 Gottingen, Germany.
   [Simmons, Graham] Univ Calif San Francisco, Blood Syst Res Inst, Dept Pathol & Lab Med, San Francisco, CA 94118 USA.
   [Jakobsen, Martin R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark.
   [Conzelmann, Karl-Klaus] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst Virol, Med Fac, D-81377 Munich, Germany.
   [Conzelmann, Karl-Klaus] Ludwig Maximilians Univ Munchen, Gene Ctr, D-81377 Munich, Germany.
   [Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, D-37073 Gottingen, Germany.
   [Fackler, Oliver T.] German Ctr Infect Res DZIF, Partner Site Heidelberg, D-69120 Heidelberg, Germany.
RP Sauter, D (corresponding author), Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.
EM daniel.sauter@uni-ulm.de
RI Pohlmann, Stefan/H-2395-2011; Sparrer, Konstantin/AAF-5371-2019; Sutter,
   Kathrin/AAE-9019-2020; Conzelmann, Karl-Klaus/L-7239-2013
OI Pohlmann, Stefan/0000-0001-6086-9136; Sutter,
   Kathrin/0000-0001-6397-6551; , Martin/0000-0001-8847-9201; Sparrer,
   Konstantin/0000-0002-8682-1779; Pfaller, Christian/0000-0003-3302-0780;
   Koepke, Lennart/0000-0001-9788-1972; Jan, Munch/0000-0001-7316-7141;
   Conzelmann, Karl-Klaus/0000-0002-8614-3656
FU Ulm University; DFGGerman Research Foundation (DFG) [SPP 1923, TRR83,
   Ki548/16, TRR 237]; Collaborative Research Centre of the DFGGerman
   Research Foundation (DFG) [CRC1279]; Baden-Wurttemberg Stiftung; Marie
   Sklodowska-Curie Individual Fellowship from the European Union's
   Framework Program for Research and Innovation Horizon 2020
   (2014-2020)European Union (EU) [794803]; International Graduate School
   in Molecular Medicine Ulm (IGradU)
FX We thank Martha Mayer, Regina Linsenmeyer, Kerstin Regensburger, Susanne
   Engelhart, and Daniela Krnavek for excellent technical assistance, as
   well as Franziska Kruger and Dorota Kmiec for support with microscopic
   analyses and protein-protein interaction assays, respectively. We also
   thank Beatrice H. Hahn and Vicente Planelles for providing proviral
   HIV-1 clones, Stephan Becker and Christine Goffinet for expression
   plasmids, and Thomas Hoffmann and Johannes Doscher as well as the
   Bundeswehr Hospital Ulm for providing tonsils. Furthermore, we thank
   Martin Schwemmle for providing influenza A virus stocks and Christian
   Buchholz for providing MLV gp70 antiserum. Finally, we thank James B.
   Munro for advice regarding the insertion of a FLAG-tag in Env. This work
   was funded by Ulm University starting grants "Baustein 3.2'' to D.H. and
   J.A.M.; the DFG priority program "Innate Sensing and Restriction of
   Retroviruses'' (SPP 1923) to K.S., U.D., O.T.F., F.K., and D.S.; the DFG
   TRR83 (project 15) to O.T.F.; and DFG Ki548/16 to F. K. F. Z. and F. K.
   are supported by the Collaborative Research Centre CRC1279 of the DFG.
   J. A. M. is indebted to the Baden-Wurttemberg Stiftung for financial
   support of this research project by the Elite programme for postdoctoral
   researchers. K. M. J. S. was supported by a Marie Sklodowska-Curie
   Individual Fellowship from the European Union's Framework Program for
   Research and Innovation Horizon 2020 (2014-2020) under the Grant
   Agreement No. 794803 ("VIAR''), and K.-K. C. by the DFG TRR 237. E. B.,
   L. K., F. Z., R. G., and E. H. were supported by the International
   Graduate School in Molecular Medicine Ulm (IGradU).
CR Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614
   Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134
   Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246
   Capurro M, 2015, J BIOL CHEM, V290, P7576, DOI 10.1074/jbc.M114.612705
   CHENG YSE, 1983, J BIOL CHEM, V258, P7746
   CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016
   Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166
   Corpet F, 1999, BIOINFORMATICS, V15, P1020, DOI 10.1093/bioinformatics/15.12.1020
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x
   Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7
   del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07
   Denault JB, 2002, FEBS LETT, V527, P309, DOI 10.1016/S0014-5793(02)03249-0
   DUBAY JW, 1995, J VIROL, V69, P4675, DOI 10.1128/JVI.69.8.4675-4682.1995
   DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379
   Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013
   Federici Thais, 2009, Genet Vaccines Ther, V7, P1, DOI 10.1186/1479-0556-7-1
   Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146
   Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531
   Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12
   Gao F, 2009, VIROLOGY, V394, P91, DOI 10.1016/j.virol.2009.07.041
   GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X
   Ghanem A, 2012, EUR J CELL BIOL, V91, P10, DOI 10.1016/j.ejcb.2011.01.008
   Girdlestone J, 1996, EUR J IMMUNOL, V26, P704, DOI 10.1002/eji.1830260329
   GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Harper MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005254
   Heinz F. X., 2018, ACTIVATION VIRUSES H, P109
   HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994
   Hotter Dominik, 2017, Small GTPases, V8, P31, DOI 10.1080/21541248.2016.1189990
   Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x
   Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195
   Kandil DH, 2009, ADV ANAT PATHOL, V16, P125, DOI 10.1097/PAP.0b013e3181992455
   Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007
   Klein-Szanto AJ, 2017, BIOCHEM PHARMACOL, V140, P8, DOI 10.1016/j.bcp.2017.04.027
   Krapp C, 2016, CELL HOST MICROBE, V19, P504, DOI 10.1016/j.chom.2016.02.019
   Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249
   Lavender KJ, 2016, J VIROL, V90, P6001, DOI 10.1128/JVI.00451-16
   Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598
   LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182
   Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9
   Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426
   Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886
   Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11
   Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328
   Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110
   Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689
   Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998
   Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051
   RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x
   Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346
   Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344
   Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260
   Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081
   Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7
   Schmier S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11434
   Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699
   SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7
   Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241
   Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730
   STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3
   Sun X, 2008, J BIOL CHEM, V283, P6418, DOI 10.1074/jbc.M708955200
   Thimon V, 2006, REPRODUCTION, V132, P899, DOI 10.1530/REP-06-0077
   Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102
   Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321
   Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110
   Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521
   Wenigenrath J, 2010, J GEN VIROL, V91, P1325, DOI 10.1099/vir.0.018226-0
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
   Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06
   Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06
   2016, ONCOTARGET, V7, P7841, DOI DOI 10.18632/ONCOTARGET.12512
   2014, P NATL ACAD SCI USA, V111, P6034, DOI DOI 10.1073/PNAS.1317972111
   2009, J EXP MED, V206, P1273, DOI DOI 10.1084/JEM.20090378
   1992, EMBO J, V11, P2407
   2005, VIROLOGY, V341, P313, DOI DOI 10.1016/J.VIROL.2005.07.023
NR 80
TC 10
Z9 10
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAY 14
PY 2019
VL 27
IS 7
BP 2092
EP +
DI 10.1016/j.celrep.2019.04.063
PG 23
WC Cell Biology
SC Cell Biology
GA HY0OL
UT WOS:000467811500014
PM 31091448
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU De Giorgi, V
   Zhou, HZ
   Alter, HJ
   Allison, RD
AF De Giorgi, Valeria
   Zhou, Huizhi
   Alter, Harvey J.
   Allison, Robert D.
TI A microarray-based pathogen chip for simultaneous molecular detection of
   transfusion-transmitted infectious agents
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Blood donor screening; Blood safety; Transfusion-transmitted infections;
   RNA virus; Microarray
ID BLOOD; DISEASES
AB BackgroundNew and emerging transfusion-transmitted infections remain a threat to the blood supply. Blood donors are currently screened for less than half of known agents, primarily by individual tests. A screening platform that could simultaneously detect all known transfusion-transmitted pathogens and allow rapid addition of new targets would significantly increase blood safety and could improve the response to new agents. We describe the early stage development and validation of a microarray-based platform (pathogen chip) for simultaneous molecular detection of transfusion-transmitted RNA viruses.MethodsSixteen RNA viruses that pose a significant risk for transfusion-transmission were selected for inclusion on the pathogen chip. Viruses were targeted for detection by 1769 oligonucleotide probes selected by Agilent eArray software. Differentially concentrated positive plasma samples were used to evaluate performance and limits of detection in the context of individual pathogens or combinations to simulate coinfection. RNA-viruses detection and concentration were validated by RT-qPCR.ResultsHepatitis A, B and C, Chikungunya, dengue 1-4, HIV 1-2, HTLV I-II, West Nile and Zika viruses were all correctly identified by the pathogen chip within the range of 10(5) to 10(2)copies/mL; hepatitis E virus from 10(5) to 10(4). In mixtures of 3-8 different viruses, all were correctly identified between 10(5) and 10(3) copies/mL.ConclusionsThis microarray-based multi-pathogen screening platform accurately and reproducibly detected individual and mixed RNA viruses in one test from single samples with limits of detection as low as 10(2) copies mL.
C1 [De Giorgi, Valeria; Zhou, Huizhi; Alter, Harvey J.; Allison, Robert D.] NIH, Infect Dis Sect, Dept Transfus Med, Hlth Clin Ctr, Bldg 10,Room 1C711,10 Ctr Dr, Bethesda, MD 20892 USA.
RP De Giorgi, V (corresponding author), NIH, Infect Dis Sect, Dept Transfus Med, Hlth Clin Ctr, Bldg 10,Room 1C711,10 Ctr Dr, Bethesda, MD 20892 USA.
EM degiorgiv@nih.gov
RI Allison, Robert D./H-7179-2019
OI Allison, Robert D./0000-0001-8458-5250
FU National Institutes of Health (NIH) Clinical Center, part of the NIH
   Intramural Research Program
FX Research reported in this publication was supported by the National
   Institutes of Health (NIH) Clinical Center, part of the NIH Intramural
   Research Program. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH.
CR Alter HJ, 2007, SEMIN HEMATOL, V44, P32, DOI 10.1053/j.seminhematol.2006.09.016
   Atreya Chintamani, 2011, Transfusion, V51, P1855, DOI 10.1111/j.1537-2995.2011.03084.x
   Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536
   Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896
   Dong M, 2016, J APPL MICROBIOL, V120, P1119, DOI 10.1111/jam.13082
   Duncan R, 2016, EXPERT REV MOL DIAGN, V16, P83, DOI 10.1586/14737159.2016.1112272
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694
   Leveton LB, 1996, TRANSFUSION, V36, P919, DOI 10.1046/j.1537-2995.1996.361097017180.x
   Mikhailovich V, 2008, BIOESSAYS, V30, P673, DOI 10.1002/bies.20781
   Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837
   Petrik J, 2001, VOX SANG, V80, P1, DOI 10.1046/j.1423-0410.2001.00010.x
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699
   Wolber PK, 2006, METHOD ENZYMOL, V410, P28, DOI 10.1016/S0076-6879(06)10002-6
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   World Health Organization, 2016, GLOB STAT REP BLOOD
NR 18
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD MAY 14
PY 2019
VL 17
AR 156
DI 10.1186/s12967-019-1905-4
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HY3XY
UT WOS:000468062200002
PM 31088488
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salazar, F
   Angeles, J
   Sy, AK
   Inobaya, MT
   Aguila, A
   Toner, T
   Bangs, MJ
   Thomsen, E
   Paul, RE
AF Salazar, Ferdinand
   Angeles, Jason
   Sy, Ava Kristy
   Inobaya, Marianette T.
   Aguila, Ariza
   Toner, Tom
   Bangs, Michael J.
   Thomsen, Edward
   Paul, Richard E.
TI Efficacy of the In2Care (R) auto-dissemination device for reducing
   dengue transmission: study protocol for a parallel, two-armed cluster
   randomised trial in the Philippines
SO TRIALS
LA English
DT Article
DE Auto-dissemination; Pyriproxyfen; Beauvaria; Dengue; Aedes aegypti
ID INSECT GROWTH-REGULATORS; AEDES-AEGYPTI; BEAUVERIA-BASSIANA; RESISTANCE;
   PYRIPROXYFEN; VIRUS; MOSQUITOS; INAPPARENT; HOMOPTERA; INFECTION
AB Background: Mosquito-borne viruses are imposing an ever increasing health burden worldwide. In addition to the recent Zika and chikungunya virus epidemics, dengue viruses have become the fastest growing problem with a 40-fold increase in the number of reported cases over the past five decades. Current mosquito control techniques involving larval source reduction, larviciding, and space spray of adulticides are costly, laborious, and of debatable efficacy. There remains an urgent need for the development of intervention methods that can be reasonably implemented in the context of modern day urbanisation. Auto-dissemination (AD) of insecticide by adult mosquitoes offers a potentially practical and useful tool in an integrated vector control programme. Recently, an immediately employable AD device, the In2Care (R) mosquito trap, has been commercialised and shows promise as an effective tool. However, there remains a lack of demonstration of epidemiological efficacy.
   Methods/design: This trial aims to assess the extent to which implementation of In2Care (R) mosquito traps can reduce vector Aedes (Stegomyia) spp. adult mosquito densities and dengue virus transmission as measured by sequential sero-conversion rates in children 6-16years of age in a dengue endemic location: Lipa City, Philippines. To achieve this, we will carry out a parallel, two-armed cluster randomised trial evaluating AD efficacy for reducing the incidence of dengue over a 2-year period with 4 consecutive months of vector control during peak dengue transmission each year.
   Discussion: For decades, it has been commonly accepted that an integrated approach to mosquito control is required. The World Health Organization (WHO) Global Strategic Framework for Integrated Vector Management recommends a range of interventions, in combination, to increase control impact to reduce transmission. This efficacy trial of the first commercial product using the AD approach will be informative in assessing the general utility of AD in reducing not only adult vector densities but, more importantly, reducing the incidence of dengue. The AD technique may complement source reduction and larviciding campaigns by more efficiently targeting the most productive containers and those beyond human reach. If successful, this mosquito control strategy could prove an invaluable tool in the fight against urban mosquito vectors and a reduction in the burden of associated disease.
C1 [Salazar, Ferdinand; Angeles, Jason; Aguila, Ariza] Filinvest City Alabang, Res Inst Trop Med, Dept Med Entomol, Muntinlupa, Philippines.
   [Sy, Ava Kristy] Filinvest City Alabang, Res Inst Trop Med, Dept Virol, Muntinlupa, Philippines.
   [Inobaya, Marianette T.] Filinvest City Alabang, Res Inst Trop Med, Dept Epidemiol & Biostat, Muntinlupa, Philippines.
   [Toner, Tom; Thomsen, Edward] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Bangs, Michael J.] PT Freeport Indonesia Int SOS, Kuala Kencana, Indonesia.
   [Bangs, Michael J.] Kasetsart Univ, Bangkok, Thailand.
   [Paul, Richard E.] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
   [Paul, Richard E.] CNRS, Genom Evolut Modelisat & Sante UMR 2000, Paris, France.
RP Thomsen, E (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.; Bangs, MJ (corresponding author), PT Freeport Indonesia Int SOS, Kuala Kencana, Indonesia.; Bangs, MJ (corresponding author), Kasetsart Univ, Bangkok, Thailand.; Paul, RE (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.; Paul, RE (corresponding author), CNRS, Genom Evolut Modelisat & Sante UMR 2000, Paris, France.
EM bangs_michael@yahoo.com; Edward.Thomsen@lstmed.ac.uk;
   richard.paul@pasteur.fr
RI Thomsen, Edward/AAH-3299-2020
OI Thomsen, Edward/0000-0003-1136-6430
FU Agence Francaise de Developpement; Institut Pasteur, Paris, France
FX This study was funded by the Agence Francaise de Developpement in the
   context of the Ecomore 2 programme (www.ecomore.org/).The funding body
   did not have any role in project design or in the writing of this
   manuscript. The trial sponsor is Institut Pasteur, Paris, France.
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   [Anonymous], 2012, GLOB STRAT DENG PREV
   [Anonymous], 2017, GLOBAL VECTOR CONTRO
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591
   Bravo L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003027
   Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Devine G., 2016, Outlooks on Pest Management, V27, P164, DOI 10.1564/v27_aug_04
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dubovskiy IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060248
   Edillo FE, 2015, AM J TROP MED HYG, V92, P360, DOI 10.4269/ajtmh.14-0139
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Eisen L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001016
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Hayes RJ, 2017, CLUSTER RANDOMISED T
   HOROWITZ AR, 1994, J ECON ENTOMOL, V87, P866, DOI 10.1093/jee/87.4.866
   Horowitz AR, 1999, PESTIC SCI, V55, P272, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;272::AID-PS908&gt;3.0.CO;2-
   Invest J., 2008, P 6 INT C URB PESTS, P239
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Kikankie CK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-71
   Knerer G, 2015, HEALTH CARE MANAG SC, V18, P205, DOI 10.1007/s10729-013-9263-x
   Kraaijeveld AR, 2008, HEREDITY, V100, P400, DOI 10.1038/sj.hdy.6801092
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li ZZ, 2010, BIOCONTROL SCI TECHN, V20, P117, DOI 10.1080/09583150903431665
   Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Maoz D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005651
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Nayar JK, 2002, J AM MOSQUITO CONTR, V18, P196
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045
   Overgaard HJ, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2490-1
   Paul R, 2014, LANCET, V384, P1747, DOI 10.1016/S0140-6736(14)62071-7
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Shah RM, 2015, PESTIC BIOCHEM PHYS, V119, P67, DOI 10.1016/j.pestbp.2015.02.003
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P521
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Thomsen EK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004342
   Trienens M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-206
   VSN International, 2015, GENST WIND
   WHO, 2006, PEST THEIR APPL CONT
   WHO, 2004, GLOB STRAT FRAM INT
   WHO, 2011, GUID DRINK WAT QUAL
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wolbers M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001937
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 61
TC 0
Z9 0
U1 4
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD MAY 14
PY 2019
VL 20
AR 269
DI 10.1186/s13063-019-3376-6
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HY4RZ
UT WOS:000468116900002
PM 31088515
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Daughton, AR
   Paul, MJ
AF Daughton, Ashlynn R.
   Paul, Michael J.
TI Identifying Protective Health Behaviors on Twitter: Observational Study
   of Travel Advisories and Zika Virus
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE social media; travel; behavior; communicable diseases; zika virus;
   public health; epidemiology; information science; travel-related illness
ID SOCIAL MEDIA; INFECTIOUS-DISEASES; SURVEILLANCE; TRANSMISSION;
   EMERGENCE; FACEBOOK; SPREAD
AB Background: An estimated 3.9 billion individuals live in a location endemic for common mosquito-borne diseases. The emergence of Zika virus in South America in 2015 marked the largest known Zika outbreak and caused hundreds of thousands of infections. Internet data have shown promise in identifying human behaviors relevant for tracking and understanding other diseases.
   Objective: Using Twitter posts regarding the 2015-16 Zika virus outbreak, we sought to identify and describe considerations and self-disclosures of a specific behavior change relevant to the spread of disease-travel cancellation. If this type of behavior is identifiable in Twitter, this approach may provide an additional source of data for disease modeling.
   Methods: We combined keyword filtering and machine learning classification to identify first-person reactions to Zika in 29,386 English-language tweets in the context of travel, including considerations and reports of travel cancellation. We further explored demographic, network, and linguistic characteristics of users who change their behavior compared with control groups.
   Results: We found differences in the demographics, social networks, and linguistic patterns of 1567 individuals identified as changing or considering changing travel behavior in response to Zika as compared with a control sample of Twitter users. We found significant differences between geographic areas in the United States, significantly more discussion by women than men, and some evidence of differences in levels of exposure to Zika-related information.
   Conclusions: Our findings have implications for informing the ways in which public health organizations communicate with the public on social media, and the findings contribute to our understanding of the ways in which the public perceives and acts on risks of emerging infectious diseases.
C1 [Daughton, Ashlynn R.] Los Alamos Natl Lab, Analyt Intelligence & Technol, Los Alamos, NM USA.
   [Daughton, Ashlynn R.; Paul, Michael J.] Univ Colorado, Informat Sci, Boulder, CO 80309 USA.
RP Daughton, AR (corresponding author), Univ Colorado, Informat Sci, Technol Learning Ctr, 1045 18th St,UCB 315, Boulder, CO 80309 USA.
EM adaughton@lanl.gov
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591
   Bakal G, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P485, DOI 10.1109/BHI.2017.7897311
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707
   Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200
   Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1516
   Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249
   Culotta A., 2010, P 1 WORKSH SOC MED A, P115, DOI DOI 10.1145/1964858.1964874
   Daughton A, 2017, AMIA WORKSH SOC MED
   Daughton A, 2019, AAAI INT WORKSH HLTH
   Daughton AR, 2018, ICWSM WORKSH SOC MED
   De Choudhury M, 2014, INT C WEBL SOC MED J
   Dredze M., 2013, AAAI WORKSH EXP BOUN, P20
   Dredze M, 2017, SYNTH LECT INF CONCE, V9, P1, DOI DOI 10.2200/S00791ED1V01Y201707ICR060
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   Efron B., 1993, INTRO BOOTSTRAP
   El Sherief M, 2018, INT AAAI C WEB SOC M
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Forman G, 2008, DATA MIN KNOWL DISC, V17, P164, DOI 10.1007/s10618-008-0097-y
   Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142
   Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892
   Ghenai A, 2017, IEEE INT C HEALTHC I, P518, DOI [10.1109/ICHI.2017.58, DOI 10.1109/ICHI.2017.58]
   Gilman SL, 2010, LANCET, V375, P1866, DOI 10.1016/S0140-6736(10)60862-8
   Gomide J, 2011, P 3 INT WEB SCI C WE
   Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146
   Gui XN, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P4520, DOI 10.1145/3025453.3025891
   Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361
   Huizer YL, 2015, TRAVEL MED INFECT DI, V13, P19, DOI 10.1016/j.tmaid.2014.11.008
   Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47
   Kanhabua N, 2013, P 22 INT C WORLD WID, DOI [10.1145/2487788.2488172, DOI 10.1145/2487788.2488172]
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Knowles R, 2016, P 1 WORKSH NLP COMP, P108
   Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3
   Lamb A., 2013, P NAACL HLT, V2013, P789
   Lampos V, 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088
   LaRocque RC, 2011, CURR OPIN INFECT DIS, V24, P403, DOI 10.1097/QCO.0b013e32834a1aef
   Lau JTF, 2005, EMERG INFECT DIS, V11, P417
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Manning CD, 2008, INTRO INFORM RETRIEV
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062
   Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Mislove A, 2011, INT C WEBL SOC MED J
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moran KR, 2016, J INFECT DIS, V214, pS404, DOI 10.1093/infdis/jiw375
   Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111
   O'Dowd A, 2007, BRIT MED J, V335, P418, DOI 10.1136/bmj.39318.516968.DB
   Olteanu A, 2018, INT AAAI C WEB SOC M
   PAHO Pan American Health Organization (PAHO), 2017, ZIK CUM CAS
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paul M. J., 2011, EMP NAT LANG PROC C, P1
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Pennebaker JW, 2007, LINGUISTIC INQUIRY W
   Rizoiu M, 2018, INT AAAI C WEB SOC M
   Saha K, 2018, INT AAAI C WEB SOC M
   Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shipman SA, 2011, PEDIATRICS, V127, P19, DOI 10.1542/peds.2010-0150
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Tay Y, 2018, INT AAAI C WEB SOC M
   Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201
NR 74
TC 1
Z9 1
U1 4
U2 9
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY 13
PY 2019
VL 21
IS 5
AR e13090
DI 10.2196/13090
PG 16
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA HY4LU
UT WOS:000468100500001
PM 31094347
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, W
   Tan, YW
   Keatyam, W
   Tu, HT
   Qiu, LF
   Tan, EK
   Chu, JJH
   Zeng, L
AF Zhang, Wei
   Tan, Yong Wah
   Keatyam, Wan
   Tu, Haitao
   Qiu, Lifeng
   Tan, Eng King
   Chu, Justin Jang Hann
   Zeng, Li
TI In utero infection of Zika virus leads to abnormal central nervous
   system development in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NEUROGENESIS; CELLS; BRAIN; MODEL
AB The World Health Organization has declared ZIKA virus (ZIKV) a global public health emergency, prompted by the association of ZIKV infections with severe brain abnormalities in the human fetus. ZIKV preferentially targets human neuronal precursor cells (NPCs) in both monolayer and cortical brain organoid culture systems and stunts their growth. Although ZIKV is well recognized to cause microcephaly, there is no systematic analysis to demonstrate the effect of ZIKV on central nervous system (CNS) development, including brain malformations and spinal cord dysfunction. Here, we conducted a longitudinal analysis to show that a novel mouse model (infected in utero and monitored after birth until adulthood) recapitulates the effects of ZIKV infection affecting neural stem cells fate and leads to a thinner cortex and a smaller brain. Furthermore, we demonstrate the effect of ZIKV on spinal cord function. Specifically, we found significant reductions in neuron numbers in the anterior horn of grey matter of the spinal cord and muscle dystrophy with a significant decrease in forepaw grip strength in the ZIKV group. Thus, the established mouse model of ZIKV infection leading to abnormal CNS development will help to further advance our understanding of the disease pathogenesis.
C1 [Zhang, Wei; Tu, Haitao; Qiu, Lifeng; Zeng, Li] Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore 308433, Singapore.
   [Tan, Yong Wah; Keatyam, Wan; Chu, Justin Jang Hann] Inst Mol & Cell Biol, Collaborat Translat Unit HFMD, Technol & Res STAR, Agcy Sci, Singapore 138673, Singapore.
   [Tan, Eng King] Natl Neurosci Inst, Res Dept, SGH Campus, Singapore 169856, Singapore.
   [Tan, Eng King] Natl Neurosci Inst, Dept Neurol, SGH Campus, Singapore 169856, Singapore.
   [Tan, Eng King; Zeng, Li] DUKE NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore 169857, Singapore.
   [Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Lab Mol RNA Virol & Antiviral Strategies, Singapore 117597, Singapore.
   [Zeng, Li] Lee Kong Chian Sch Med, Novena Campus,11 Mandalay Rd, Singapore 308232, Singapore.
RP Zeng, L (corresponding author), Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore 308433, Singapore.; Zeng, L (corresponding author), DUKE NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore 169857, Singapore.; Zeng, L (corresponding author), Lee Kong Chian Sch Med, Novena Campus,11 Mandalay Rd, Singapore 308232, Singapore.
EM Li_Zeng@nni.com.sg
FU A*STAR Biomedical Research Council, Singapore National Research
   Foundation under its Translational and Clinical Research Flagship
   ProgrammeSingapore National Research Foundation
FX This research was supported by the A*STAR Biomedical Research Council,
   Singapore National Research Foundation under its Translational and
   Clinical Research Flagship Programme and administered by the Singapore
   Ministry of Health's National Medical Research Council, National Medical
   Research Foundation's StaR Award, and Khoo Bridge Funding Award.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abrous DN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018952
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x
   Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dimitrov EL, 2014, J NEUROSCI, V34, P12304, DOI 10.1523/JNEUROSCI.0312-14.2014
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057
   Fernandes N., 2016, EXPT ZIKA VIRUS INFE
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Santos P., 2017, NEUROLOGY, V88
   Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taupin P, 2006, STEM CELL REV, V2, P213, DOI 10.1007/s12015-006-0049-0
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang H., 2018, MOL NEUROBIOLOGY
   Zhang W, 2018, METHODS MOL BIOL, V1680, P191, DOI 10.1007/978-1-4939-7339-2_13
   Zhang W, 2016, ELIFE, V5, DOI 10.7554/eLife.11324
   Zhang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4330
NR 45
TC 2
Z9 2
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 13
PY 2019
VL 9
AR 7298
DI 10.1038/s41598-019-43303-6
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX9EF
UT WOS:000467709100040
PM 31086212
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferdousi, T
   Cohnstaedt, LW
   McVey, DS
   Scoglio, CM
AF Ferdousi, Tanvir
   Cohnstaedt, Lee W.
   McVey, D. S.
   Scoglio, Caterina M.
TI Understanding the survival of Zika virus in a vector interconnected
   sexual contact network
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TRANSMISSION; DYNAMICS; SPREAD; MODEL; RISK
AB The recent outbreaks of the insect-vectored Zika virus have demonstrated its potential to be sexually transmitted, which complicates modeling and our understanding of disease dynamics. Autochthonous outbreaks in the US mainland may be a consequence of both modes of transmission, which affect the outbreak size, duration, and virus persistence. We propose a novel individual-based interconnected network model that incorporates both insect-vectored and sexual transmission of this pathogen. This model interconnects a homogeneous mosquito vector population with a heterogeneous human host contact network. The model incorporates the seasonal variation of mosquito abundance and characterizes host dynamics based on age group and gender in order to produce realistic projections. We use a sexual contact network which is generated on the basis of real world sexual behavior data. Our findings suggest that for a high relative transmissibility of asymptomatic hosts, Zika virus shows a high probability of sustaining in the human population for up to 3 months without the presence of mosquito vectors. Zika outbreaks are strongly affected by the large proportion of asymptomatic individuals and their relative transmissibility. The outbreak size is also affected by the time of the year when the pathogen is introduced. Although sexual transmission has a relatively low contribution in determining the epidemic size, it plays a role in sustaining the epidemic and creating potential endemic scenarios.
C1 [Ferdousi, Tanvir; Scoglio, Caterina M.] Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA.
   [Cohnstaedt, Lee W.; McVey, D. S.] USDA, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, Manhattan, KS 66502 USA.
RP Ferdousi, T (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA.
EM tanvirf@ksu.edu
OI Ferdousi, Tanvir/0000-0003-2847-3494
FU NSF/NIH/USDA/BBSRC Ecology and Evolution of Infectious Diseases (EEID)
   Program through USDA-NIFA [2015-67013-23818]; National Science
   FoundationNational Science Foundation (NSF) [CIF-1423411]; United States
   Department of AgricultureUnited States Department of Agriculture (USDA)
   [ABADRU-427647]
FX The work has been financially supported by the NSF/NIH/USDA/BBSRC
   Ecology and Evolution of Infectious Diseases (EEID) Program through
   USDA-NIFA Award 2015-67013-23818, the National Science Foundation award
   CIF-1423411, and the United States Department of Agriculture award
   ABADRU-427647. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agusto F., 2017, INFECT DIS MODELLING
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   [Anonymous], 2017, WORLD DEV INDICATORS
   [Anonymous], 2019, GEMFSIM VECTOR BORNE
   Boguna M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042108
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   Keeling M. J., 2011, MODELING INFECT DIS
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuhlman CJ, 2017, WINT SIMUL C PROC, P1085, DOI 10.1109/WSC.2017.8247857
   Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marini G, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.37.30612
   Masuda N, 2018, SIAM REV, V60, P95, DOI 10.1137/16M1055876
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mitchell P. K., 2018, AM J EPIDEMIOLOGY
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Monaghan A. J., 2016, PLOS CURRENTS, V8
   Moon SA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006875
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Newman M., 2018, NETWORKS
   Olawoyin O., 2018, INFECT DIS MODELLING
   Pugliese A, 2018, MATH BIOSCI ENG, V15, P125, DOI 10.3934/mbe.2018005
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Robinson K, 2012, THEOR POPUL BIOL, V81, P89, DOI 10.1016/j.tpb.2011.12.009
   Saad-Roy C., 2018, J MATH BIOL, P1
   Sahneh FD, 2017, J COMPUT SCI-NETH, V22, P36, DOI 10.1016/j.jocs.2017.08.014
   Sahneh FD, 2013, P AMER CONTR CONF, P2307
   Sasmal S. K., 2018, B MATH BIOL, P1
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith T. W., 1998, AM SEXUAL BEHAV TREN
   Terefe Y., 2018, THEOR BIOSCI, P1
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 41
TC 2
Z9 2
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 10
PY 2019
VL 9
AR 7253
DI 10.1038/s41598-019-43651-3
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX6WG
UT WOS:000467543700068
PM 31076660
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gonzalez-Gonzalez, E
   Mendoza-Ramos, JL
   Pedroza, SC
   Cuellar-Monterrubio, AA
   Marquez-Ipina, AR
   Lira-Serhan, D
   Trujillo-de Santiago, G
   Alvarez, MM
AF Gonzalez-Gonzalez, Everardo
   Lizeth Mendoza-Ramos, Jackelin
   Cristina Pedroza, Sara
   Alexandra Cuellar-Monterrubio, Aime
   Roberto Marquez-Ipina, Alan
   Lira-Serhan, Daniel
   Trujillo-de Santiago, Grissel
   Moises Alvarez, Mario
TI Validation of use of the miniPCR thermocycler for Ebola and Zika virus
   detection
SO PLOS ONE
LA English
DT Article
ID POINT-OF-CARE; DIAGNOSTICS; AMPLIFICATION; TECHNOLOGIES; DISEASE;
   RESOURCE; DNA
AB The development of point-of-care (POC) diagnostic systems has received well-deserved attention in recent years in the scientific literature, and many experimental systems show great promise in real settings. However, in the case of an epidemic emergency (or a natural disaster), the first line of response should be based on commercially available and validated resources. Here, we compare the performance and ease of use of the miniPCR, a recently commercially available compact and portable PCR device, and a conventional thermocycler for the diagnostics of viral nucleic acids. We used both thermocyclers to detect and amplify Ebola and Zika DNA sequences of different lengths (in the range of 91 to 300 nucleotides) at different concentrations (in the range of similar to 50 to 4.0 x 10(8) DNA copies). Our results suggest that the performance of both thermocyclers is quite similar. Moreover, the portability, ease of use, and reproducibility of the miniPCR makes it a reliable alternative for point-of-care nucleic acid detection and amplification.
C1 [Gonzalez-Gonzalez, Everardo; Lizeth Mendoza-Ramos, Jackelin; Cristina Pedroza, Sara; Alexandra Cuellar-Monterrubio, Aime; Roberto Marquez-Ipina, Alan; Trujillo-de Santiago, Grissel; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.
   [Gonzalez-Gonzalez, Everardo; Lizeth Mendoza-Ramos, Jackelin; Roberto Marquez-Ipina, Alan; Moises Alvarez, Mario] Tecnol Monterrey, Dept Bioingn, Monterrey, Nuevo Leon, Mexico.
   [Cristina Pedroza, Sara; Alexandra Cuellar-Monterrubio, Aime; Lira-Serhan, Daniel; Trujillo-de Santiago, Grissel] Tecnol Monterrey, Dept Ingn Mecatron & Elect, Monterrey, Nuevo Leon, Mexico.
RP Trujillo-de Santiago, G; Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.; Alvarez, MM (corresponding author), Tecnol Monterrey, Dept Bioingn, Monterrey, Nuevo Leon, Mexico.; Trujillo-de Santiago, G (corresponding author), Tecnol Monterrey, Dept Ingn Mecatron & Elect, Monterrey, Nuevo Leon, Mexico.
EM grissel@tec.mx; mario.alvarez@tec.mx
RI Gonzalez, Everardo Gonzalez/X-3440-2019
OI Gonzalez, Everardo Gonzalez/0000-0001-6588-5856; Marquez-Ipina, Alan
   Roberto/0000-0002-6278-5398; Alvarez, Mario Moises/0000-0002-9131-5344
FU Tecnologico de Monterrey [002EICIS01]; CONACyT (Consejo Nacional de
   Ciencia y Tecnologia, Mexico)Consejo Nacional de Ciencia y Tecnologia
   (CONACyT) [SNI 26048, SNI 256730, 635891, 856068, 814593];
   CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [635891,
   856068, 814593]
FX GTdS and MMA acknowledge the institutional funding received from
   Tecnologico de Monterrey (Grant 002EICIS01), and funding provided by
   CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico; Grants SNI
   26048 and 256730). GTdS, MMA, EGG, JLMR, and AACM are recipients of
   scholarship 635891, scholarship 814593, and scholarship 856068 provided
   by CONACyT. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; GTdS
   and MMA acknowledge the institutional funding received from Tecnologico
   de Monterrey (Grant 002EICIS01), and funding provided by CONACyT
   (Consejo Nacional de Ciencia y Tecnologia, Mexico) through grants (SNI
   26048, SNI 256730, and Scholarships 635891, 856068, and 814593). We
   gratefully acknowledge the experimental contribution of Brenda Gisele
   Flores-Garza, at Tecnologico de Monterrey.
CR Alvarez MM, 2017, ACS NANO, V11, P5195, DOI 10.1021/acsnano.7b01493
   Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176
   Boguraev AS, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0033-9
   Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X
   Broude NE, 2001, P NATL ACAD SCI USA, V98, P206, DOI 10.1073/pnas.98.1.206
   Chin CD, COMMERCIALIZATION MI, DOI [10.1039/c2lc21204h, DOI 10.1039/C2LC21204H]
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Debode F, 2017, BIOTECHNOL AGRON SOC
   Drancourt M, 2016, CLIN MICROBIOL REV, V29, P429, DOI 10.1128/CMR.00090-15
   Duchesne L, 2018, J VIRAL HEPATITIS, V25, P108, DOI 10.1111/jvh.12827
   Edwards MC, MANUAL SUPPLEMENT MU
   Elizondo-Montemayor L, 2011, INT J INFECT DIS, V15, pE781, DOI 10.1016/j.ijid.2011.07.002
   Gonzalez-Gonzalez E, 2017, CRIT REV BIOTECHNOL, V37, P53, DOI 10.3109/07388551.2015.1114465
   Guevara EE, 2018, CONSERV GENET RESOUR, V10, P119, DOI 10.1007/s12686-017-0758-5
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Hsieh KW, 2012, ANGEW CHEM INT EDIT, V51, P4896, DOI 10.1002/anie.201109115
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kaushik A, 2016, BIOSENS BIOELECTRON, V75, P254, DOI 10.1016/j.bios.2015.08.040
   Kersting S, 2014, MULTIPLEX ISOTHERMAL, DOI [10.1007/s00604-014-1198-5.pdf, DOI 10.1007/S00604-014-1198-5.PDF]
   Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17
   Kuhn JH, 2017, GUIDE CORRECT USE FI, P447
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marx V, 2015, NAT METHODS, V12, P393, DOI 10.1038/nmeth.3369
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Montague TG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205852
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pieters M, 2017, VET MICROBIOL, V203, P103, DOI 10.1016/j.vetmic.2017.02.014
   Pomerantz A, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy033
   Qiu XB, 2017, MICROSYST TECHNOL, V23, P2951, DOI 10.1007/s00542-016-2979-z
   Smither SJ, 2016, J INFECT DIS, V214, pS268, DOI 10.1093/infdis/jiw145
   Su WT, 2015, J CHROMATOGR A, V1377, P13, DOI 10.1016/j.chroma.2014.12.041
   van Vuren PJ, 2016, J CLIN MICROBIOL, V54, P359, DOI 10.1128/JCM.02724-15
   Wei TY, 2016, CELL CHEM BIOL, V23, P1056, DOI 10.1016/j.chembiol.2016.07.016
   Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zaky WI, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006962
   2016, ANAL SCI TECHNOL, V29, P79, DOI DOI 10.5806/AST.2016.29.2.79
   2016, SCIENCE, V353, P353, DOI DOI 10.1126/SCIENCE.AAG0219
NR 41
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2019
VL 14
IS 5
AR e0215642
DI 10.1371/journal.pone.0215642
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX6ZE
UT WOS:000467552100014
PM 31071117
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Machado-Silva, A
   Guindalini, C
   Fonseca, FL
   Pereira-Silva, MV
   Fonseca, BD
AF Machado-Silva, Alice
   Guindalini, Camila
   Fonseca, Fernanda Lopes
   Pereira-Silva, Marcus Vinicius
   Fonseca, Bruna de Paula
TI Scientific and technological contributions of Latin America and
   Caribbean countries to the Zika virus outbreak
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika; Latin America; S&T; Epidemic; Patents; Publications; Co-authorship
   networks
ID SCIENTOMETRIC ANALYSIS; BIBLIOMETRIC ANALYSIS; PUBLICATIONS; NETWORKS;
   SCIELO
AB BackgroundThe recent Zika virus (ZIKAV) epidemics disclosed a major public health threat and a scientific and technological (S&T) challenge. The lessons learned from the S&T response of Latin America and the Caribbean (LAC) countries are critical to inform further research and guide scientific investments. The present study aimed to assess how new S&T knowledge produced and disseminated regionally can contribute to address global health challenges.MethodsScientometric and social network analysis methods were used to assess the LAC scientific contribution and potential technological development on ZIKAV up to December 2017. ZIKAV-related publications were retrieved from the Web of Science, Scopus, and PubMed databases. Regionally published articles were obtained from SciELO (Scientific Electronic Library Online) and LILACS (Literature in the Health Sciences in Latin America and the Caribbean) databases. Patent registries were retrieved using Orbit Intelligence and Derwent Innovation. Records from each database were individually downloaded, integrated, standardized and analyzed.ResultsWe retrieved 5421 ZIKAV-related publications, revealing a sharp increase from 2015 onwards. LAC countries accounted for 20% of all publications and Brazil was among the top three most central countries in the global network for ZIKAV research. A total of 274 patent families backed up by experimental evidence were retrieved. Only 5% were filed by LAC assignees, all of them based in Brazil. The largest contribution of LAC research was on the clinical manifestations of the ZIKAV infection, along with vector control, which was also the main focusof patents.ConclusionsOur analysis offered a comprehensive overview of ZIKAV's research and development and showed that (i) LAC countries had a key role in generating and disseminating scientific knowledge on ZIKAV; (ii) LAC countries have expressively contributed to research on ZIKAV clinical manifestations; (iii) the Brazilian scientific community was potentially very effective in knowledge sharing and diffusion in the ZIKAV research network; (iv) Brazil was the single LAC country filing patents, mostly represented by independent inventors and low-tech patents. The paper advocates the need for a continued interdisciplinary approach to improve LAC countries ability to prevent, prepare for and control future outbreaks.
C1 [Machado-Silva, Alice; Guindalini, Camila; Fonseca, Fernanda Lopes; Fonseca, Bruna de Paula] Fiocruz MS, CDTS, Rio De Janeiro, Brazil.
   [Pereira-Silva, Marcus Vinicius] Fiocruz MS, Casa Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Machado-Silva, Alice] Fiocruz MS, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Guindalini, Camila; Fonseca, Fernanda Lopes; Pereira-Silva, Marcus Vinicius; Fonseca, Bruna de Paula] Fiocruz MS, Observ Ciencia Tecnol & Inovacao Saude, Rio De Janeiro, Brazil.
RP Fonseca, BD (corresponding author), Fiocruz MS, CDTS, Rio De Janeiro, Brazil.; Fonseca, BD (corresponding author), Fiocruz MS, Observ Ciencia Tecnol & Inovacao Saude, Rio De Janeiro, Brazil.
EM brufonseca@gmail.com
RI Pereira-Silva, Marcus Vinicius/AAD-8584-2020; Fonseca,
   Fernanda/V-3446-2019
OI Pereira-Silva, Marcus Vinicius/0000-0002-4135-4011; Fonseca, Bruna de
   Paula/0000-0002-8795-2578; Guindalini, Camila/0000-0002-6278-5881
FU Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas
   Negligenciadas (INCT-IDN)
FX Fundacao Oswaldo Cruz provided support in the form of salaries for
   authors AMS, CG, FLF and BPF. Software licenses were funded by the
   Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas
   Negligenciadas (INCT-IDN). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Attaran A, 2016, PODIUM WHY PUBLIC HL
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2014, ZIK VIR
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Delwiche Frances A., 2018, Science & Technology Libraries, V37, P113, DOI 10.1080/0194262X.2018.1431589
   Depoux A, 2018, PUBLIC HLTH REV, V39
   Diamond MS, 2017, NAT REV IMMUNOL
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Erbelding E, 2017, J INFECT DIS, V216, pS991, DOI 10.1093/infdis/jix492
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meneghini R, 2006, SCIENTOMETRICS, V69, P529, DOI 10.1007/s11192-006-0168-z
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Morel CM, 2005, HLTH INNOVATION DEV
   OECD, 2009, OECD PAT STAT MAN
   Singh Nirmal, 2016, VirusDisease, V27, P303, DOI 10.1007/s13337-016-0339-3
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Vasconcellos AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006469
   Velez-Cuartas G, 2016, PROF INFORM, V25, P35, DOI 10.3145/epi.2016.ene.05
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   WHO, 2017, ZIK RESP FUND
   WHO, WHO ZIK R D
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 2
Z9 2
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 9
PY 2019
VL 19
AR 530
DI 10.1186/s12889-019-6842-x
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HX7TR
UT WOS:000467609400002
PM 31072386
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hassert, M
   Brien, JD
   Pinto, AK
AF Hassert, Mariah
   Brien, James D.
   Pinto, Amelia K.
TI Mouse Models of Heterologous Flavivirus Immunity: A Role for
   Cross-Reactive T Cells
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE flavivirus; T cell cross-reactivity; heterologous immunity; original
   antigenic sin; Zika; dengue
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE
   HEMORRHAGIC-FEVER; ORIGINAL ANTIGENIC SIN; JAPANESE ENCEPHALITIS;
   ANTIVIRAL IMMUNITY; STRUCTURAL BASIS; TCR REPERTOIRE; INFECTION; MEMORY
AB Most of the world is at risk of being infected with a flavivirus such as dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, tick-borne encephalitis virus, and Zika virus, significantly impacting millions of lives. Importantly, many of these genetically similar viruses co-circulate within the same geographic regions, making it likely for individuals living in areas of high flavivirus endemicity to be infected with multiple flaviviruses during their lifetime. Following a flavivirus infection, a robust virus-specific T cell response is generated and the memory recall of this response has been demonstrated to provide long-lasting immunity, protecting against reinfection with the same pathogen. However, multiple studies have shown that this flavivirus specific T cell response can be cross-reactive and active during heterologous flavivirus infection, leading to the question: How does immunity to one flavivirus shape immunity to the next, and how does this impact disease? It has been proposed that in some cases unfavorable disease outcomes may be caused by lower avidity cross-reactive memory T cells generated during a primary flavivirus infection that preferentially expand during a secondary heterologous infection and function sub optimally against the new pathogen. While in other cases, these cross-reactive cells still have the potential to facilitate cross-protection. In this review, we focus on cross-reactive T cell responses to flaviviruses and the concepts and consequences of T cell cross-reactivity, with particular emphasis linking data generated using murine models to our new understanding of disease outcomes following heterologous flavivirus infection.
C1 [Hassert, Mariah; Brien, James D.; Pinto, Amelia K.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
RP Pinto, AK (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
EM amelia.pinto@health.slu.edu
FU Saint Louis University
FX This work was funded through institutional support provided by Saint
   Louis University.
CR Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015
   Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958
   Aslan N, 2017, MBIO, V8, DOI 10.1128/mBio.01841-17
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790
   Beaumier CM, 2010, VIRAL IMMUNOL, V23, P477, DOI 10.1089/vim.2010.0034
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205
   Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444
   Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806
   Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Charini WA, 2001, J IMMUNOL, V167, P4996, DOI 10.4049/jimmunol.167.9.4996
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727
   Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Doherty PC, 2000, PHILOS T R SOC B, V355, P1093, DOI 10.1098/rstb.2000.0647
   Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192
   DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561
   EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1
   FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848
   Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1965, AM J PUBLIC HEALTH N, V55, P1386, DOI 10.2105/AJPH.55.9.1386
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778
   Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259
   KHANDIA R, 2018, FRONT IMMUNOL, V9
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   KURANE I, 1991, J VIROL, V65, P1823, DOI 10.1128/JVI.65.4.1823-1828.1991
   KUTUBUDDIN M, 1991, MOL IMMUNOL, V28, P149, DOI 10.1016/0161-5890(91)90098-5
   Lazear HM, 2013, J VIROL, V87, P11401, DOI 10.1128/JVI.01403-13
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Manangeeswaran M, 2017, J IMMUNOL S, V198, P78
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7
   Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064
   Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pennock ND, 2013, ADV PHYSIOL EDUC, V37, P273, DOI 10.1152/advan.00066.2013
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321
   Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489
   Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705
   Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8
   Shehu Nathan Yakubu, 2018, Niger Postgrad Med J, V25, P67, DOI 10.4103/npmj.npmj_36_18
   SHI YC, 2018, SCI REP UK, V8
   Shirai K, 2015, ARCH VIROL, V160, P765, DOI 10.1007/s00705-014-2154-8
   Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9
   Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3
   Talarico LB, 2017, EBIOMEDICINE, V20, P202, DOI 10.1016/j.ebiom.2017.04.033
   Trobaugh DW, 2010, EUR J IMMUNOL, V40, P1315, DOI 10.1002/eji.200839108
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Uhrlaub JL, 2011, J IMMUNOL, V186, P3882, DOI 10.4049/jimmunol.1002799
   van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934
   Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vigano S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/153863
   Walzl G, 2000, J EXP MED, V192, P1317, DOI 10.1084/jem.192.9.1317
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
   2016, CELL REP, V17, P3091, DOI DOI 10.1016/J.CELREP.2016.11.070
   2018, NAT IMMUNOL, V19, P1189, DOI DOI 10.1038/S41590-018-0210-3
   2013, ARCH VIROL, V158, P1445, DOI DOI 10.1007/S00705-013-1645-3
   2009, J EXP MED, V206, P2735, DOI DOI 10.1084/JEM.20090222
   2016, EBIOMEDICINE, V13, P284, DOI DOI 10.1016/J.EBIOM.2016.10.006
NR 122
TC 2
Z9 2
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 9
PY 2019
VL 10
AR 1045
DI 10.3389/fimmu.2019.01045
PG 13
WC Immunology
SC Immunology
GA HX5KO
UT WOS:000467440300001
PM 31143185
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rong, Z
   Wang, Q
   Sun, NX
   Jia, XF
   Wang, KL
   Xiao, R
   Wang, SQ
AF Rong, Zhen
   Wang, Qiong
   Sun, Nanxi
   Jia, Xiaofei
   Wang, Keli
   Xiao, Rui
   Wang, Shengqi
TI Smartphone-based fluorescent lateral flow immunoassay platform for
   highly sensitive point-of-care detection of Zika virus nonstructural
   protein 1
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE Quantum dot microsphere; Lateral flow immunoassay; Smartphone;
   Point-of-care; Zika virus nonstructural protein 1
ID QUANTUM-DOT NANOBEADS; QUANTITATIVE DETECTION; HIGH-THROUGHPUT;
   IMMUNOCHROMATOGRAPHIC ASSAY; MULTIPLEXED DETECTION; EBOLA-VIRUS;
   DIAGNOSIS; AMPLIFICATION; STRIP; NANOPARTICLES
AB Simple, inexpensive, and rapid diagnostic tests in low-resource settings with limited laboratory equipment and technical expertise are instrumental in reducing morbidity and mortality from epidemic infectious diseases. We developed a smartphone-based fluorescent lateral flow immunoassay (LFIA) platform for the highly sensitive point-of-care detection of Zika virus nonstructural protein 1 (ZIKV NS1). An attachment was designed and 3D-printed to integrate the smartphone with external optical and electrical components, enabling the miniaturization of the instrument and reduction in cost and complexity. Quantum dot microspheres were utilized as probes in fluorescent LFIA because of their extremely bright fluorescence signal. This approach can achieve quantitative point-of-care detection of ZIKV NS1 within 20 min. Limits of detection (LODs) in buffer and serum were 0.045 and 0.15 ng mL(-1), respectively. Despite the high structural similarity, a high-level Dengue virus NS1 as interferent showed limited cross-reactivity. Furthermore, this assay was successfully applied to detecte ZIKV NS1 and virions spiked in complex biological samples, indicating its practical application capability. Given its low cost, compact size, and excellent analytical performance, the proposed smartphone-based fluorescent LFIA platform holds considerable potential in rapid and accurate point-of-care detection of ZIKV NS1 and provides new insight into the design and application of molecular diagnostic methods in low-resource settings. (C) 2018 Published by Elsevier B.V.
C1 [Rong, Zhen; Sun, Nanxi; Jia, Xiaofei; Wang, Keli; Xiao, Rui; Wang, Shengqi] Beijing Inst Radiat Med, Beijing 100850, Peoples R China.
   [Rong, Zhen; Xiao, Rui; Wang, Shengqi] Beijing Key Lab New Mol Diag Technol Infect Dis, Beijing 100850, Peoples R China.
   [Wang, Qiong] Beijing Meiling Biotechnol Corp, Beijing 102600, Peoples R China.
   [Jia, Xiaofei] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China.
   [Wang, Keli] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China.
RP Xiao, R; Wang, SQ (corresponding author), Beijing Inst Radiat Med, Beijing 100850, Peoples R China.
EM ruixiao203@sina.com; sqwang@bmi.ac.cn
FU National S&T Major Project for Infectious Diseases Control
   [2018ZX10712001-010];  [AWS13C007]
FX This work was supported by the National S&T Major Project for Infectious
   Diseases Control (2018ZX10712001-010), and the Major Projects (No.
   AWS13C007). We would like to acknowledge Dr. Chengfeng Qin for the
   supply of inactivated ZIKV virions.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Berg B, 2015, ACS NANO, V9, P7857, DOI 10.1021/acsnano.5b03203
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brangel P, 2018, ACS NANO, V12, P63, DOI 10.1021/acsnano.7b07021
   Camacho SA, 2018, ACS SENSORS, V3, P587, DOI 10.1021/acssensors.7b00639
   Chen WL, 2017, ANAL CHEM, V89, P11219, DOI 10.1021/acs.analchem.7b02478
   Chen YN, 2015, NANOSCALE, V7, P16381, DOI 10.1039/c5nr04987c
   Di Nardo F, 2016, TALANTA, V150, P463, DOI 10.1016/j.talanta.2015.12.072
   Duan DM, 2015, BIOSENS BIOELECTRON, V74, P134, DOI 10.1016/j.bios.2015.05.025
   Duan H, 2017, ANAL CHEM, V89, P7062, DOI 10.1021/acs.analchem.7b00869
   Guler E, 2017, ANAL CHEM, V89, P9629, DOI 10.1021/acs.analchem.7b03017
   Hu J, 2017, ANAL CHEM, V89, P13105, DOI 10.1021/acs.analchem.7b02222
   Hu J, 2016, ANAL CHEM, V88, P6577, DOI 10.1021/acs.analchem.6b01427
   Jiang T, 2016, ACS SENSORS, V1, P717, DOI 10.1021/acssensors.6b00019
   Kong JE, 2017, ACS NANO, V11, P2934, DOI 10.1021/acsnano.6b08274
   Kuhnemund M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13913
   Le TT, 2017, ANAL CHEM, V89, P6781, DOI 10.1021/acs.analchem.7b01149
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Li X, 2014, ACS APPL MATER INTER, V6, P6406, DOI 10.1021/am5012782
   Loynachan CN, 2018, ACS NANO, V12, P279, DOI 10.1021/acsnano.7b06229
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   McLeod E, 2015, ACS NANO, V9, P3265, DOI 10.1021/acsnano.5b00388
   Meng X, 2017, LAB CHIP, V17, P104, DOI 10.1039/c6lc01321j
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Paterson AS, 2017, LAB CHIP, V17, P1051, DOI 10.1039/c6lc01167e
   Petryayeva E, 2014, ANAL CHEM, V86, P3195, DOI 10.1021/ac500131r
   Qu HH, 2016, BIOSENS BIOELECTRON, V81, P358, DOI 10.1016/j.bios.2016.03.008
   Rong Z, 2018, ANALYST, V143, P2115, DOI 10.1039/c8an00160j
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2018, ANAL CHEM, V90, P4823, DOI 10.1021/acs.analchem.8b00283
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Song LW, 2015, ANAL CHEM, V87, P5173, DOI 10.1021/ac504832c
   Song SQ, 2014, ANAL CHEM, V86, P4995, DOI 10.1021/ac500540z
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang LJ, 2016, ANAL CHEM, V88, P8302, DOI 10.1021/acs.analchem.6b02211
   Wei QS, 2013, ACS NANO, V7, P9147, DOI 10.1021/nn4037706
   Wu F, 2016, BIOSENS BIOELECTRON, V77, P464, DOI 10.1016/j.bios.2015.10.002
   Xu GX, 2016, CHEM REV, V116, P12234, DOI 10.1021/acs.chemrev.6b00290
   Yelleswarapu VR, 2017, LAB CHIP, V17, P1083, DOI 10.1039/c6lc01489e
   You M., 2017, ACS NANO
   Zangheri M, 2015, BIOSENS BIOELECTRON, V64, P63, DOI 10.1016/j.bios.2014.08.048
   Zhang L, 2015, LANGMUIR, V31, P5537, DOI 10.1021/acs.langmuir.5b00592
   Zhao YY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2492
   Zhou CH, 2011, J MATER CHEM, V21, P7393, DOI 10.1039/c1jm10090d
   Zhou J, 2015, CHEM REV, V115, P11669, DOI 10.1021/acs.chemrev.5b00049
NR 50
TC 21
Z9 22
U1 39
U2 195
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD MAY 9
PY 2019
VL 1055
BP 140
EP 147
DI 10.1016/j.aca.2018.12.043
PG 8
WC Chemistry, Analytical
SC Chemistry
GA HL8MA
UT WOS:000458995400017
PM 30782365
DA 2020-07-08
ER

PT J
AU Assil, S
   Coleon, S
   Dong, CC
   Decembre, E
   Sherry, L
   Allatif, O
   Webster, B
   Dreux, M
AF Assil, Sonia
   Coleon, Severin
   Dong, Congcong
   Decembre, Elodie
   Sherry, Lee
   Allatif, Omran
   Webster, Brian
   Dreux, Marlene
TI Plasmacytoid Dendritic Cells and Infected Cells Form an Interferogenic
   Synapse Required for Antiviral Responses
SO CELL HOST & MICROBE
LA English
DT Article
ID VIRUS PATHOGENESIS; ARP2/3 COMPLEX; ACTIVATION; RECEPTORS; ADHESION;
   WASP
AB Type I interferon (IFN-I) is critical for antiviral defense, and plasmacytoid dendritic cells (pDCs) are a predominant source of IFN-I during virus infection. pDC-mediated antiviral responses are stimulated upon physical contact with infected cells, during which immunostimulatory viral RNA is transferred to pDCs, leading to IFN production via the nucleic acid sensor TLR7. Using dengue, hepatitis C, and Zika viruses, we demonstrate that the contact site of pDCs with infected cells is a specialized platform we term the interferogenic synapse, which enables viral RNA transfer and antiviral responses. This synapse is formed via aLb2 integrin-ICAM-1 adhesion complexes and the recruitment of the actin network and endocytic machinery. TLR7 signaling in pDCs promotes interferogenic synapse establishment and provides feed-forward regulation, sustaining pDC contacts with infected cells. This interferogenic synapse may allow pDCs to scan infected cells and locally secrete IFN-I, thereby confining a potentially deleterious response.
C1 [Assil, Sonia; Coleon, Severin; Dong, Congcong; Decembre, Elodie; Sherry, Lee; Allatif, Omran; Webster, Brian; Dreux, Marlene] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, CNRS,CIRI,INSERM,U1111,UMR5308, F-69007 Lyon, France.
RP Dreux, M (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, CNRS,CIRI,INSERM,U1111,UMR5308, F-69007 Lyon, France.
EM marlene.dreux@ens-lyon.fr
RI ; Dreux, Marlene/M-7295-2014
OI Sherry, Lee/0000-0002-4367-772X; Dreux, Marlene/0000-0002-6607-4796;
   Assil, Sonia/0000-0001-7765-2953; Decembre, Elodie/0000-0001-6891-6320
FU Agence Nationale de la Recherche (ANR-JCJC-EXAMIN)French National
   Research Agency (ANR); Agence Nationale pour la Recherche contre le SIDA
   et les Hepatites ViralesFrench National Research Agency (ANR) [ANRS-AO
   2017-01]; Fondation pour le recherche medicaleFondation pour la
   Recherche Medicale [DBI20141231313]; LabEx Ecofect grant
   [ANR-11-LABX-0048]; French ministry; Ligue Contre le CancerLigue
   nationale contre le cancer; EMBOEuropean Molecular Biology Organization
   (EMBO); ANRSANRSFrench National Research Agency (ANR)
FX We thank A.D. Davidson (University of Bristol, UK) for the molecular
   clone N.G.C., A. Kohl (MRC-University of Glasgow Centre for Virus
   Research, UK) and R. Freitas de Oliveira Franca (FIOCRUZ, Recife,
   Brazil) for clinical isolate ZIKV Brazil, the European Virus Archive for
   ZIKV H/PF, C.M. Rice (Rockeffeler University, New York, NY) for the
   anti-HCV NS5A, P. Despres (PIMIT, Universite de La Reunion-INSERM
   France) for providing the anti-DENV E, F.V. Chisari (Scripps Research
   Institute, La Jolla, CA) for the Huh7.5.1 cells, and V. Lotteau (CIRI,
   Lyon, France) for Influenza A virus. We are grateful to Y. Jaillais, H
   Paidassi, T. Walzer, and S. Munoz-Gonzalez for critical reading of the
   manuscript and to our colleagues for their encouragement and help. We
   thank the technical assistance of the staffs of PLATIM and
   AniRA-cytometry facilities - SFR Biosciences Lyon, Gerland (UMS3444/US8)
   for imaging and FACS analyses. We acknowledge the contribution of the
   EFS Confluence-Lyon. This work was supported by grants from the Agence
   Nationale de la Recherche (ANR-JCJC-EXAMIN), the Agence Nationale pour
   la Recherche contre le SIDA et les Hepatites Virales (ANRS-AO 2017-01),
   the Fondation pour le recherche medicale (DBI20141231313 DREUX Bioinfo
   2014), and LabEx Ecofect grant ANR-11-LABX-0048. S. A.'s PhD fellowship
   was sponsored by French ministry and Ligue Contre le Cancer. The
   post-doc fellowships for B.W. and D.C. were sponsored by EMBO and ANRS,
   respectively.
CR Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552
   Compeer EB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04088-w
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2
   de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043
   DeMali KA, 2014, BIOCHEMISTRY-US, V53, P7706, DOI 10.1021/bi501181p
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010
   Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106
   Dustin ML, 2016, ANNU REV CELL DEV BI, V32, P303, DOI 10.1146/annurev-cellbio-100814-125330
   Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527
   Garcia-Nicolas O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00771
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986
   Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023
   Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200
   Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284
   Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119
   Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010
   Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239
   Park YK, 2016, NAT REV NEUROSCI, V17, P745, DOI 10.1038/nrn.2016.138
   Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014
   Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1
   ROTHLEIN R, 1986, J IMMUNOL, V137, P1270
   Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492
   Saitoh SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01687-x
   Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200
   Sen M, 2018, J BIOL CHEM, V293, P6565, DOI 10.1074/jbc.RA117.000710
   Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6
   Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005
   Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004
   Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865
   Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020
   Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107
   Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564
   Webster B, 2018, ELIFE, V7, DOI 10.7554/eLife.34273
   Webster B, 2016, J VIROL, V90, P10050, DOI 10.1128/JVI.01692-16
   Wieland SF, 2014, J VIROL, V88, P752, DOI 10.1128/JVI.01714-13
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   2003, J MEMBRANE BIOL, V194, P77, DOI DOI 10.1007/S00232-003-2027-7
   CURR BIOL, V10, P311
   1998, CURR BIOL, V8, P1399
NR 51
TC 8
Z9 8
U1 3
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 8
PY 2019
VL 25
IS 5
BP 730
EP +
DI 10.1016/j.chom.2019.03.005
PG 22
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HX2LF
UT WOS:000467222600013
PM 31003939
OA Bronze
DA 2020-07-08
ER

PT J
AU Wang, R
   Gao, N
   Li, Y
   Fan, DY
   Zhen, ZD
   Feng, KH
   Chen, H
   An, J
AF Wang, Ran
   Gao, Na
   Li, Yun
   Fan, Dongying
   Zhen, Zida
   Feng, Kaihao
   Chen, Hui
   An, Jing
TI Cross-Protection Against Four Serotypes of Dengue Virus in Mice
   Conferred by a Zika DNA Vaccine
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; dengue virus (DENV); DNA vaccine; PrM/E proteins;
   cross-reactive immune responses; Zika-DNA-vaccination Confers
   Cross-protection to DENVs
ID IMMUNOGENICITY; ENHANCEMENT; INFECTION; CHILDREN
AB Both Zika virus (ZIKV) and four serotypes of dengue virus (DENV1-4) are antigenically related mosquito-borne flaviviruses that co-circulate in overlapping geographic distributions. The considerable amino acid sequence homology and structural similarities between ZIKV and DENV1-4 may be responsible for the complicated immunological cross-reactivity observed for these viruses. Thus, a successful Zika vaccine needs to not only confer protection from ZIKV infection but must also be safe during secondary exposures with other flavivirus, especially DENVs. In this study, we used a Zika DNA vaccine candidate (pV-ZME) expressing the ZIKV premembrane and envelop proteins to immunize BALB/c mice and evaluated the potential cross-reactive immune responses to DENV1-4. We observed that three doses of the pV-ZME vaccine elicited the production of cross-reactive antibodies, cytokines and CD8(+) T cell responses and generated cross-protection against DENV1-4. Our results demonstrate a novel approach for design and development of safe Zika and/or dengue vaccines.
C1 [Wang, Ran; Gao, Na; Li, Yun; Fan, Dongying; Zhen, Zida; Feng, Kaihao; Chen, Hui; An, Jing] Capital Med Univ, Dept Microbiol & Parasitol, Sch Basic Med Sci, Beijing, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
RP Chen, H; An, J (corresponding author), Capital Med Univ, Dept Microbiol & Parasitol, Sch Basic Med Sci, Beijing, Peoples R China.; An, J (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
EM chenhuicxh@ccmu.edu.cn; anjing@ccmu.edu.cn
RI Wang, Ran/O-9878-2019
OI Wang, Ran/0000-0002-0243-8538
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471957, 81772172, 81372935, 81671971, U1602223]
FX This study was supported by National Natural Science Foundation of China
   (81471957, 81772172, 81372935, 81671971, and U1602223).
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Agarwal R, 2017, ACTA MED INDONES, V49, P24
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chen HX, 2015, J MOL DIAGN, V17, P722, DOI 10.1016/j.jmoldx.2015.06.008
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   HAMPTON T, 2016, JAMA-J AM MED ASSOC, V316, P1755, DOI DOI 10.1001/JAMA.2016.15862
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Lam JH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94500
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 26
TC 2
Z9 3
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD MAY 8
PY 2019
VL 9
AR 147
DI 10.3389/fcimb.2019.00147
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HX4CY
UT WOS:000467343300002
PM 31139577
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ayres, CFJ
   Guedes, DRD
   Paiva, MHS
   Morais-Sobral, MC
   Krokovsky, L
   Machado, LC
   Melo-Santos, MAV
   Crespo, M
   Oliveira, CMF
   Ribeiro, RS
   Cardoso, OA
   Menezes, ALB
   Laperriere, RC
   Luna, CF
   Oliveira, ALS
   Leal, WS
   Wallau, GL
AF Junqueira Ayres, Constancia Flavia
   Duarte Guedes, Duschinka Ribeiro
   Santos Paiva, Marcelo Henrique
   Morais-Sobral, Mariana Carolina
   Krokovsky, Larissa
   Machado, Lais Ceschini
   Varjal Melo-Santos, Maria Alice
   Crespo, Monica
   Fontes Oliveira, Claudia Maria
   Ribeiro, Ricardo Silva
   Cardoso, Orlei Amaral
   Barbosa Menezes, Ana Lucia
   Laperriere-Jr, Roberto Costa
   Luna, Carlos Feitosa
   Sa Oliveira, Andre Luiz
   Leal, Walter Soares
   Wallau, Gabriel Luz
TI Zika virus detection, isolation and genome sequencing through Culicidae
   sampling during the epidemic in Vitoria, Espirito Santo, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Field-caught mosquitoes; Zika virus; RT-qPCR; Genome sequencing
ID AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; OROPOUCHE VIRUS; VECTOR;
   MOSQUITOS; TRANSMISSION; PERFORMANCE; DENGUE; STATES
AB BackgroundZika virus (ZIKV) has been isolated from many mosquito species in nature, but it is believed that the main vectors in urban environments are species of the genus Aedes. Here, we detected and isolated ZIKV in samples from Aedes aegypti, Aedes taeniorhynchus and Culex quinquefasciatus, collected during the Zika epidemic in Vitoria, southeast Brazil. Using quantitative real-time polymerase chain reaction, ZIKV detection was performed in mosquito samples collected from February to April 2016.ResultsOverall, six pools of mosquitoes were positive for ZIKV: four of Cx. quinquefasciatus, one of Ae. aegypti and one of Ae. taeniorhynchus. Their genomes were sequenced.ConclusionsThese results support and strengthen the hypothesis that other mosquito species can also be involved in ZIKV transmission.
C1 [Junqueira Ayres, Constancia Flavia; Duarte Guedes, Duschinka Ribeiro; Santos Paiva, Marcelo Henrique; Morais-Sobral, Mariana Carolina; Krokovsky, Larissa; Machado, Lais Ceschini; Varjal Melo-Santos, Maria Alice; Crespo, Monica; Fontes Oliveira, Claudia Maria; Wallau, Gabriel Luz] Fundacao Oswaldo Cruz, Dept Entomol, IAM, Recife, PE, Brazil.
   [Santos Paiva, Marcelo Henrique] Univ Fed Pernambuco, Caruaru, Brazil.
   [Ribeiro, Ricardo Silva; Cardoso, Orlei Amaral] Superintendencia Reg Saude Vitoria, Nucleo Vigilancia Saude, Cariacica, Brazil.
   [Barbosa Menezes, Ana Lucia] Secretaria Municipal Saude, Ctr Vigilancia Saude Ambiental, Vitoria, ES, Brazil.
   [Laperriere-Jr, Roberto Costa] Secretaria Estado Saude Sao Paulo, Nucleo Especial Vigilancia Ambiental, Gerencia Estrateg Vigilancia Saude, Vitoria, ES, Brazil.
   [Luna, Carlos Feitosa; Sa Oliveira, Andre Luiz] Fundacao Oswaldo Cruz, IAM, NEG, Recife, PE, Brazil.
   [Leal, Walter Soares] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Ayres, CFJ (corresponding author), Fundacao Oswaldo Cruz, Dept Entomol, IAM, Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020; Wallau, Gabriel Luz/B-5911-2008
OI Wallau, Gabriel Luz/0000-0002-1419-5713
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [FACEPE APQ-0078-2.02/16, APQ-0085-2.13/16]; Brazilian National Council
   for Research and Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [441100/2016-3]; National Institute of
   Allergy and Infectious Diseases at the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI128931]
FX This was supported by the Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE APQ-0078-2.02/16 and APQ-0085-2.13/16), the
   Brazilian National Council for Research and Development (CNPq; grant
   441100/2016-3) and the National Institute of Allergy and Infectious
   Diseases at the National Institutes of Health (R21AI128931).
CR Ahid SMM, 1999, REV SAUDE PUBL, V33, P560, DOI 10.1590/S0034-89101999000600007
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Azmi SA, 2015, J VECTOR DIS, V52, P252
   Barata EAMD, 2001, REV SAUDE PUBL, V35, P237, DOI 10.1590/S0034-89102001000300004
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Eastwood G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01519
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Hunter FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01248
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nunes VdN, 2013, AVALIACAO DA METODOL
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   REGIS L, 1995, MEM I OSWALDO CRUZ, V90, P115, DOI 10.1590/S0074-02761995000100022
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Stenn T, 2019, J MED ENTOMOL, V56, P10, DOI 10.1093/jme/tjy148
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 59
TC 4
Z9 4
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 8
PY 2019
VL 12
AR 220
DI 10.1186/s13071-019-3461-4
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HX7HH
UT WOS:000467575100005
PM 31068218
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Esquivel, RN
   Patel, A
   Kudchodkar, SB
   Park, DH
   Stettler, K
   Beltramello, M
   Allen, JW
   Mendoza, J
   Ramos, S
   Choi, H
   Borole, P
   Asija, K
   Bah, M
   Shaheen, S
   Chen, J
   Yan, J
   Durham, AC
   Smith, TRF
   Broderick, K
   Guibinga, G
   Muthumani, K
   Corti, D
   Humeau, L
   Weiner, DB
AF Esquivel, Rianne N.
   Patel, Ami
   Kudchodkar, Sagar B.
   Park, Daniel H.
   Stettler, Karin
   Beltramello, Martina
   Allen, Jeffrey W.
   Mendoza, Janess
   Ramos, Stephanie
   Choi, Hyeree
   Borole, Piyush
   Asija, Kanika
   Bah, Mamadou
   Shaheen, Shareef
   Chen, Jing
   Yan, Jian
   Durham, Amy C.
   Smith, Trevor R. F.
   Broderick, Kate
   Guibinga, Ghiabe
   Muthumani, Kar
   Corti, Davide
   Humeau, Laurent
   Weiner, David B.
TI In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human
   Primates against Zika Virus
SO MOLECULAR THERAPY
LA English
DT Article
ID DIVERSITY; INFECTION; DISEASE
AB Zika virus (ZIKV) infection is endemic to several world regions, and many others are at high risk for seasonal outbreaks. Synthetic DNA-encoded monoclonal antibody (DMAb) is an approach that enables in vivo delivery of highly potent mAbs to control infections. We engineered DMAb-ZK190, encoding the mAb ZK190 neutralizing antibody, which targets the ZIKV E protein DIII domain. In vivo-delivered DMAb-ZK190 achieved expression levels persisting >10 weeks in mice and >3 weeks in non-human primate (NHPs), which is protective against ZIKV infectious challenge. This study is the first demonstration of infectious disease control in NHPs following in vivo delivery of a nucleic acid-encoded antibody, supporting the importance of this new platform.
C1 [Esquivel, Rianne N.; Patel, Ami; Kudchodkar, Sagar B.; Park, Daniel H.; Choi, Hyeree; Borole, Piyush; Asija, Kanika; Bah, Mamadou; Shaheen, Shareef; Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Stettler, Karin; Beltramello, Martina; Corti, Davide] Humabs BioMed, Bellinzona, Switzerland.
   [Allen, Jeffrey W.; Mendoza, Janess; Ramos, Stephanie; Chen, Jing; Yan, Jian; Smith, Trevor R. F.; Broderick, Kate; Guibinga, Ghiabe; Humeau, Laurent] Inovio Pharmaceut, Plymouth Meeting, PA USA.
   [Durham, Amy C.] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA.
RP Weiner, DB (corresponding author), Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM dweiner@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065; Shaheen,
   Shareef/0000-0001-9429-2451; Ramos, Stephanie/0000-0002-5326-4937;
   Borole, Piyush/0000-0003-3327-5847; Bah, Mamadou/0000-0002-3238-1085
FU Bill & Melinda Gates FoundationGates Foundation [OPP1163327]; Emerging
   Infectious Disease NIH Training Grant [T32-AI055400]
FX We kindly thank the Wistar Histotechnology Core and The PennVet
   Comparative Pathology Core for their services. This work was supported
   in part by the Bill & Melinda Gates Foundation (OPP1163327). R.N.E. was
   supported by the Emerging Infectious Disease NIH Training Grant
   (T32-AI055400).
CR Amante DH, 2015, HUM GENE THER METHOD, V26, P134, DOI 10.1089/hgtb.2015.020
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Broderick KE, 2015, EXPERT REV VACCINES, V14, P195, DOI 10.1586/14760584.2015.990890
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2016, J INFECT DIS, V214, P369, DOI 10.1093/infdis/jiw111
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   van Meer PJK, 2013, MABS-AUSTIN, V5, P810, DOI 10.4161/mabs.25234
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wiley CA, 2017, NEUROPATHOLOGY, V37, P393, DOI 10.1111/neup.12385
NR 33
TC 8
Z9 7
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY 8
PY 2019
VL 27
IS 5
BP 974
EP 985
DI 10.1016/j.ymthe.2019.03.005
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA HX2UP
UT WOS:000467247800011
PM 30962164
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Li, Y
   Muffat, J
   Javed, AO
   Keys, HR
   Lungjangwa, T
   Bosch, I
   Khan, M
   Virgilio, MC
   Gehrke, L
   Sabatini, DM
   Jaenisch, R
AF Li, Yun
   Muffat, Julien
   Javed, Attya Omer
   Keys, Heather R.
   Lungjangwa, Tenzin
   Bosch, Irene
   Khan, Mehreen
   Virgilio, Maria C.
   Gehrke, Lee
   Sabatini, David M.
   Jaenisch, Rudolf
TI Genome-wide CRISPR screen for Zika virus resistance in human neural
   cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; neural progenitors; CRISPR screen; fetal CNS infection;
   human pluripotent stem cells
ID STEM-CELLS; INFECTION; IDENTIFICATION; DENGUE; DEFICIENCY; BRAIN; DRUG
AB Zika virus (ZIKV) is a neurotropic and neurovirulent arbovirus that has severe detrimental impact on the developing human fetal brain. To date, little is known about the factors required for ZIKV infection of human neural cells. We identified ZIKV host genes in human pluripotent stem cell (hPSC)-derived neural progenitors (NPs) using a genome-wide CRISPR-Cas9 knockout screen. Mutations of host factors involved in heparan sulfation, endocytosis, endoplasmic reticulum processing, Golgi function, and interferon activity conferred resistance to infection with the Uganda strain of ZIKV and a more recent North American isolate. Host genes essential for ZIKV replication identified in human NPs also provided a low level of protection against ZIKV in isogenic human astrocytes. Our findings provide insights into host-dependent mechanisms for ZIKV infection in the highly vulnerable human NP cells and identify molecular targets for potential therapeutic intervention.
C1 [Li, Yun; Muffat, Julien; Javed, Attya Omer; Keys, Heather R.; Lungjangwa, Tenzin; Khan, Mehreen; Virgilio, Maria C.; Sabatini, David M.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
   [Li, Yun] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada.
   [Li, Yun; Muffat, Julien] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.
   [Muffat, Julien] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 0A4, Canada.
   [Javed, Attya Omer] Univ Paris Saclay, Fac Pharm, Ecole Doctorale Innovat Therapeut 569, F-92290 Chatenay Malabry, France.
   [Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Bosch, Irene; Gehrke, Lee; Jaenisch, Rudolf] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.
   [Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Sabatini, David M.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA.
   [Bosch, Irene] E25Bio Inc, The Engine, Cambridge, MA 02139 USA.
   [Bosch, Irene] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
   [Virgilio, Maria C.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.
RP Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.
EM jaenisch@wi.mit.edu
RI ; Li, Yun/C-3367-2011
OI Virgilio, Maria/0000-0002-4940-188X; Li, Yun/0000-0002-5849-5910;
   /0000-0002-1446-7256; Bosch, Irene/0000-0003-1352-5888
FU Simons Postdoctoral Fellowship; International Rett Syndrome Foundation
   Postdoctoral Fellowship; National Alliance for Research on Schizophrenia
   and Depression (NARSAD) Young Investigator Grant; Canada First Research
   Excellence Fund; European Leukodystrophies Association; NARSAD Young
   Investigator GrantNARSAD; Canada Research Chairs programCanada Research
   Chairs; Jerome and Florence Brill Graduate Student Fellowship;
   Boehringer Ingelheim FondsBoehringer Ingelheim; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 MH104610, R01 N5088538, U19 AI131135, R33 AI100190]; Simons
   Foundation [SFARI 204106]; Emerald Foundation; BiogenBiogen
FX We thank Tim Wang for substantial input on the design, execution, and
   interpretation of primary and secondary CRISPR screens and RNA
   sequencing experiments; Dongdong Fu and Raaji Alagappan for technical
   support; all members of the R.J., L.G., and D.M.S. laboratories for
   helpful discussions; and Alexsia Richards for critical reading of this
   manuscript. Confocal microscopy was performed at the Whitehead Institute
   W. M. Keck Biological Imaging Facility. RNA sequencing and CRISPR screen
   sequencing was performed by the Whitehead Institute Genome Technology
   Core. Y.L. received funding from a Simons Postdoctoral Fellowship, an
   International Rett Syndrome Foundation Postdoctoral Fellowship, and a
   National Alliance for Research on Schizophrenia and Depression (NARSAD)
   Young Investigator Grant. This research was part of the University of
   Toronto's Medicine by Design initiative, which received funding from the
   Canada First Research Excellence Fund. J.M. received funding from the
   European Leukodystrophies Association, a NARSAD Young Investigator
   Grant, and the Canada Research Chairs program. A.O.J. was supported by a
   Jerome and Florence Brill Graduate Student Fellowship and Boehringer
   Ingelheim Fonds. Work for this project was supported by NIH Grants R01
   MH104610 and R01 N5088538 (to R.J.), U19 AI131135 (to R.J., L.G., and
   D.M.S.), and R33 AI100190 (to L.G.); the Simons Foundation (SFARI
   204106); the Emerald Foundation; and Biogen. D.M.S. is an investigator
   of the Howard Hughes Medical Institute and an American Cancer Society
   Research Professor.
CR Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shaheen R, 2019, GENET MED, V21, P545, DOI 10.1038/s41436-018-0140-3
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Speer SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11496
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801
NR 43
TC 6
Z9 6
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 7
PY 2019
VL 116
IS 19
BP 9527
EP 9532
DI 10.1073/pnas.1900867116
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX2MP
UT WOS:000467226400054
PM 31019072
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Thaker, SK
   Chapa, T
   Garcia, G
   Gong, D
   Schmid, EW
   Arumugaswami, V
   Sun, R
   Christofk, HR
AF Thaker, Shivani K.
   Chapa, Travis
   Garcia, Gustavo, Jr.
   Gong, Danyang
   Schmid, Ernst W.
   Arumugaswami, Vaithilingaraja
   Sun, Ren
   Christofk, Heather R.
TI Differential Metabolic Reprogramming by Zika Virus Promotes Cell Death
   in Human versus Mosquito Cells
SO CELL METABOLISM
LA English
DT Article
ID WEST-NILE; INFECTION; DENGUE; PATHOGENESIS; PROTEINS; NEURONS
AB Zika virus is a pathogen that poses serious consequences, including congenital microcephaly. Although many viruses reprogram host cell metabolism, whether Zika virus alters cellular metabolism and the functional consequences of Zika-induced metabolic changes remain unknown. Here, we show that Zika virus infection differentially reprograms glucose metabolism in human versus C6/36 mosquito cells by increasing glucose use in the tricarboxylic acid cycle in human cells versus increasing glucose use in the pentose phosphate pathway in mosquito cells. Infection of human cells selectively depletes nucleotide triphosphate levels, leading to elevated AMP/ATP ratios, AMP-activated protein kinase (AMPK) phosphorylation, and caspase-mediated cell death. AMPK is also phosphorylated in Zika virus-infected mouse brain. Inhibiting AMPK in human cells decreases Zika virus-mediated cell death, whereas activating AMPK in mosquito cells promotes Zika virus-mediated cell death. These findings suggest that the differential metabolic reprogramming during Zika virus infection of human versus mosquito cells determines whether cell death occurs.
C1 [Thaker, Shivani K.; Schmid, Ernst W.; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.
   [Thaker, Shivani K.; Chapa, Travis; Garcia, Gustavo, Jr.; Gong, Danyang; Arumugaswami, Vaithilingaraja; Sun, Ren; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Arumugaswami, Vaithilingaraja; Christofk, Heather R.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
   [Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90098 USA.
   [Sun, Ren; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.
   [Sun, Ren] Univ Calif Los Angeles, Samueli Sch Engn, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Sun, R; Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Christofk, HR (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Sun, R; Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Sun, R (corresponding author), Univ Calif Los Angeles, Samueli Sch Engn, Dept Bioengn, Los Angeles, CA 90095 USA.
EM rsun@mednet.ucla.edu; hchristofk@mednet.ucla.edu
OI Garcia Jr, Gustavo/0000-0002-1649-9251
FU UCLA Virology and Gene Therapy Training Grant [T32AI060567]; UCLA Tumor
   Immunology Training Grant (USHHS Ruth L. Kirschstein Institutional
   National Research Service Award) [T32 CA009056]; American Cancer
   SocietyAmerican Cancer Society [RSG-16-111-01-MPC]; NIH/NCIUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [RO1 CA215185-01]; UCLA Jonsson
   Comprehensive Cancer Center; Eli and Edythe Broad Center for
   Regenerative Medicine Ablon Scholars Program; California Institute for
   Regenerative Medicine (CIRM) award [DISC2-10188]
FX We thank Dr. Guoping Fan (UCLA) for providing the human fetal retinal
   pigment epithelial cells used in the experiments. We thank Dr. Laura
   Martinez for technical assistance. S.K.T. is a pre-doctoral fellow
   supported by the UCLA Virology and Gene Therapy Training Grant
   (T32AI060567) and UCLA Tumor Immunology Training Grant (USHHS Ruth L.
   Kirschstein Institutional National Research Service Award #T32
   CA009056). H.R.C. was supported by a Research Scholar Grant
   (RSG-16-111-01-MPC) from the American Cancer Society, NIH/NCI RO1
   CA215185-01, and the UCLA Jonsson Comprehensive Cancer Center and Eli
   and Edythe Broad Center for Regenerative Medicine Ablon Scholars
   Program. V.A. was supported by a California Institute for Regenerative
   Medicine (CIRM) award DISC2-10188.
CR Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0
   Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Jung GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30846
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Karpf AR, 1998, VIROLOGY, V240, P193, DOI 10.1006/viro.1997.8914
   Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341
   Liu ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091416
   McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661
   Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06
   Sanchez EL, 2017, J VIROL, V91, DOI 10.1128/JVI.02237-16
   Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109
   Thai M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9873
   Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124
   Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07
   Yang TC, 2009, VIRUS RES, V143, P77, DOI 10.1016/j.virusres.2009.03.007
   Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508
   2014, J VIROL, V88, P3246, DOI DOI 10.1128/JVI.02862-13
   2008, J GEN VIROL, V89, P1930, DOI DOI 10.1099/VIR.0.2008/000182-0
NR 52
TC 9
Z9 9
U1 3
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAY 7
PY 2019
VL 29
IS 5
BP 1206
EP +
DI 10.1016/j.cmet.2019.01.024
PG 15
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA HX0BI
UT WOS:000467054100019
PM 30827860
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lin, DL
   Inoue, T
   Chen, YJ
   Chang, A
   Tsai, B
   Tai, AW
AF Lin, David L.
   Inoue, Takamasa
   Chen, Yu-Jie
   Chang, Aaron
   Tsai, Billy
   Tai, Andrew W.
TI The ER Membrane Protein Complex Promotes Biogenesis of Dengue and Zika
   Virus Non-structural Multi-pass Transmembrane Proteins to Support
   Infection
SO CELL REPORTS
LA English
DT Article
ID REPLICATION; TOPOLOGY
AB Although flaviviruses co-opt the function of the host endoplasmic reticulum (ER) membrane protein complex (EMC) during infection, a mechanistic explanation for this observation remains unclear. Here, we show that the EMC promotes biogenesis of dengue virus (DENV) and Zika virus (ZIKV) non-structural multi-pass transmembrane proteins NS4A and NS4B, which are necessary for viral replication. The EMC binds to NS4B and colocalizes with the DENV replication organelle. Mapping analysis reveals that the two N-terminal marginally hydrophobic domains of NS4B confer EMC dependency. Furthermore, altering the hydrophobicity of these two marginally hydrophobic domains relieves NS4B's EMC dependency. We demonstrate that NS4B biogenesis, but not its stability, is reduced in EMC-depleted cells. Our data suggest that the EMC acts as a multi-pass transmembrane chaperone required for expression of at least two virally encoded proteins essential for flavivirus infection and point to a shared vulnerability during the viral life cycle that could be exploited for antiviral therapy.
C1 [Lin, David L.; Tai, Andrew W.] Univ Michigan, Dept Microbiol & Immunol, Med Sch, Ann Arbor, MI 48109 USA.
   [Inoue, Takamasa; Chen, Yu-Jie; Chang, Aaron; Tsai, Billy] Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.
   [Inoue, Takamasa] Japan Blood Prod Org, Infect Pathogen Res Sect, Cent Res Lab, Res & Dev Div, Kobe, Hyogo 6500047, Japan.
   [Tai, Andrew W.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Med Sch, Ann Arbor, MI 48109 USA.
   [Tai, Andrew W.] VA Ann Arbor Healthcare Syst, Med Serv, Ann Arbor, MI 48105 USA.
RP Tai, AW (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Med Sch, Ann Arbor, MI 48109 USA.; Tsai, B (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.
EM btsai@umich.edu; andrewwt@umich.edu
RI Tai, Andrew/M-8380-2017
OI Tai, Andrew/0000-0002-6877-450X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01DK097374, R01AI064296]; Molecular
   Mechanisms of Microbial Pathogenesis Training Program [T32AI007528];
   Training in Basic and Translational Digestive Sciences training grant
   [T32DK094775]; University of Michigan Center for Gastrointestinal
   Research (NIH) [P30DK034933]
FX We thank Claire Huang (Centers for Disease Control and Prevention [CDC])
   for providing the pD2/IC-30-P-NBX DENV cDNA clone, Dr. Chunya Puttikhunt
   (Mahidol University, Thailand) for providing the NS1 monoclonal
   antibody, and Dr. Alexander G. Pletnev (NIH) for providing the ZIKV-icd
   full-length infectious cDNA clone. This work was supported by NIH grants
   R01DK097374 (A.W.T.) and R01AI064296 (B.T.), the Molecular Mechanisms of
   Microbial Pathogenesis Training Program (T32AI007528 to D.L.L.), and the
   Training in Basic and Translational Digestive Sciences training grant
   (T32DK094775 to D.L.L.). Microscopy was performed at the University of
   Michigan Microscopy & Image Analysis Laboratory with support from the
   University of Michigan Center for Gastrointestinal Research (NIH grant
   P30DK034933). The funders had no role in study design, data collection
   and interpretation, or the decision to submit the work for publication.
CR Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Puttikhunt C, 2003, J VIROL METHODS, V109, P55, DOI 10.1016/S0166-0934(03)00045-4
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
NR 28
TC 11
Z9 11
U1 1
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAY 7
PY 2019
VL 27
IS 6
BP 1666
EP +
DI 10.1016/j.celrep.2019.04.051
PG 13
WC Cell Biology
SC Cell Biology
GA HX0DA
UT WOS:000467058500004
PM 31067454
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Lecouturier, V
   Bernard, MC
   Berry, C
   Carayol, S
   Richier, E
   Boudet, F
   Heinrichs, J
AF Lecouturier, Valerie
   Bernard, Marie-Clotilde
   Berry, Catherine
   Carayol, Sebastien
   Richier, Eric
   Boudet, Florence
   Heinrichs, Jon
TI Immunogenicity and protection conferred by an optimized purified
   inactivated Zika vaccine in mice
SO VACCINE
LA English
DT Article
DE Zika; Vaccine; Immunogenicity; Protection; Mouse
ID MONOCLONAL-ANTIBODIES; VIRUS; IMMUNIZATION; TRANSMISSION; CHALLENGE;
   IMMUNITY; MODEL
AB After decades of inconsequential infections, and sporadic outbreaks in the Asia-Pacific region between 2007 and 2013, Zika virus caused a widespread epidemic in South America in 2015 that was complicated by severe congenital infections. After the WHO declared a Public Health Emergency of International Concern in February 2016, vaccine development efforts based on different platforms were initiated. Several candidates have since been evaluated in clinical phase I studies. Of these, a Zika purified inactivated vaccine (ZPIV), adjuvanted with aluminum hydroxide, developed by the Walter Reed Army Institute of Research (WRAIR), yielded high seroconversion rates. Sanofi Pasteur further optimized the vaccine in terms of production scale, purification conditions and regulatory compliance, using its experience in flavivirus vaccine development. Here we report that the resulting optimized vaccine (ZPIV-SP) elicited robust seroneutralizing antibody responses and provided complete protection from homologous Zika virus strain challenge in immunocompetent BALB/c mice. ZPIV-SP also showed improved immunogenicity compared with the first-generation vaccine, and improved efficacy in the more permissive interferon receptor-deficient A129 mice. Finally, analysis of the IgG response directed towards nonstructural protein 1 (NS1) suggests that viral NS1 was efficiently removed during the optimized purification process of ZPIV-SP. Together, these results suggest that the optimized vaccine is well suited for further evaluation in larger animal models and late-stage clinical studies. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Lecouturier, Valerie; Bernard, Marie-Clotilde; Berry, Catherine; Boudet, Florence] Sanofi Pasteur, Res & Dev, Marcy Letoile, France.
   [Carayol, Sebastien] Sanofi Pasteur, Bioproc R&D, Marcy Letoile, France.
   [Richier, Eric] Sanofi Pasteur, Analyt R&D, Marcy Letoile, France.
   [Heinrichs, Jon] Sanofi Pasteur, Discovery Dr, Swiftwater, PA USA.
RP Lecouturier, V (corresponding author), 1541,Ave Marcel Merieux, F-69280 Marcy Letoile, France.
EM Valerie.lecouturier@sanofi.com
FU Sanofi Pasteur SA; Department of Health and Human Services; Office of
   the Assistant Secretary for Preparedness and Response; Biomedical
   Advanced Research and Development Authority, United States
   [HHS01002016000039C]
FX This study has been funded by Sanofi Pasteur SA and with Federal Funds
   from the Department of Health and Human Services; Office of the
   Assistant Secretary for Preparedness and Response; Biomedical Advanced
   Research and Development Authority, United States, under Contract No.
   HHS01002016000039C.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI [10.15585/mmwr.mm6534e1, DOI 10.15585/MMWR.MM6534E1]
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040
NR 33
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 6
PY 2019
VL 37
IS 20
BP 2679
EP 2686
DI 10.1016/j.vaccine.2019.04.013
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HZ2ZV
UT WOS:000468718200006
PM 30967310
OA Other Gold
DA 2020-07-08
ER

PT J
AU Farnesi, LC
   Belinato, TA
   Gesto, JSM
   Martins, AJ
   Bruno, RV
   Moreira, LA
AF Farnesi, Luana Cristina
   Belinato, Thiago Affonso
   Moledo Gesto, Joao Silveira
   Martins, Ademir Jesus
   Bruno, Rafaela Vieira
   Moreira, Luciano Andrade
TI Embryonic development and egg viability of wMel-infected Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Wolbachia; wMel strain; Desiccation resistance;
   Embryogenesis; Egg viability
ID ZIKA VIRUS; ANOPHELES-AQUASALIS; WOLBACHIA; DIPTERA; DENGUE;
   COMPETITION; RESISTANCE; POPULATIONS; CHIKUNGUNYA; STRAIN
AB BackgroundAedes aegypti is a major disease vector in urban habitats, involved in the transmission of dengue, chikungunya and Zika. Despite innumerous attempts to contain disease outbreaks, there are neither efficient vaccines nor definite vector control methods nowadays. In recent years, an innovative strategy to control arboviruses, which exploits the endosymbiotic bacterium Wolbachia pipientis, emerged with great expectations. The success of the method depends on many aspects, including Wolbachia's cytoplasmic incompatibility and pathogen interference phenotypes, as well as its effect on host fitness. In this work, we investigated the influence the Wolbachia strain wMel exerts on embryo development and egg viability and speculate on its field release use.MethodsWild-type (Br or Rockefeller) and Wolbachia-harboring specimens (wMelBr) were blood-fed and submitted to synchronous egg laying for embryo development assays. Samples were analyzed for morphological markers, developmental endpoint and egg resistance to desiccation (ERD). Quiescent egg viability over time was also assessed.ResultswMelBr samples completed embryogenesis 2-3hours later than wild-type. This delay was also observed through the onset of both morphological and physiological markers, respectively by the moments of germband extension and ERD acquisition. Following the end of embryonic development, wMelBr eggs were slightly less resistant to desiccation and showed reduced viability levels, which rapidly decayed after 40days into quiescence, from approximately 75% to virtually 0% in less than a month.ConclusionsOur data revealed that the wMel strain of Wolbachia slightly delays embryogenesis and also affects egg quality, both through reduced viability and desiccation resistance. These findings suggest that, although embryonic fitness is somehow compromised by wMel infection, an efficient host reproductive manipulation through cytoplasmic incompatibility seems sufficient to overcome these effects in nature and promote bacterial invasion, as shown by successful ongoing field implementation.
C1 [Farnesi, Luana Cristina; Moledo Gesto, Joao Silveira; Bruno, Rafaela Vieira] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Rio De Janeiro, RJ, Brazil.
   [Belinato, Thiago Affonso; Martins, Ademir Jesus] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetore, Rio De Janeiro, RJ, Brazil.
   [Belinato, Thiago Affonso; Moledo Gesto, Joao Silveira; Moreira, Luciano Andrade] Fiocruz MS, Inst Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
   [Moreira, Luciano Andrade] CNPq, INCT EM, Rio De Janeiro, Brazil.
RP Moreira, LA (corresponding author), Fiocruz MS, Inst Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
EM lfarnesi@hotmail.com; luciano.andrade@fiocruz.br
RI Bruno, Rafaela/AAQ-7611-2020; Martins, Ademir J./B-4117-2009; Gesto,
   Joao/L-2597-2018
OI Martins, Ademir/0000-0001-5739-1215; Gesto, Joao/0000-0002-4390-2034;
   Moreira, Luciano/0000-0002-9240-3506
FU Brazilian Ministry of Healthy; CNPqNational Council for Scientific and
   Technological Development (CNPq); INCT; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG); Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) Programme of the Grand Challenges in Global Health
   Initiatives of the Bill and Melinda Gates Foundation
FX This work was co-funded by the Brazilian Ministry of Healthy, CNPq,
   INCT, FAPEMIG and a grant to Monash University from the Foundation for
   the National Institutes of Health through the Vector-Based Transmission
   of Control: Discovery Research (VCTR) Programme of the Grand Challenges
   in Global Health Initiatives of the Bill and Melinda Gates Foundation.
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1559-5
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Clements A.N., 1992, BIOL MOSQUITOES, V1
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   de Almeida F, 2011, INFECT GENET EVOL, V11, P2138, DOI 10.1016/j.meegid.2011.08.022
   De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farnesi LC, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170362
   Farnesi LC, 2015, J INSECT PHYSIOL, V83, P43, DOI 10.1016/j.jinsphys.2015.10.006
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   KBewer J. W., 1961, Annals of the Entomological Society of America, V54, P912
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   McSweegan E, 2015, ANTIVIR RES, V120, P147, DOI 10.1016/j.antiviral.2015.06.003
   Gesto JSM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2695-x
   Monnerat AT, 2002, MEM I OSWALDO CRUZ, V97, P589, DOI 10.1590/S0074-02762002000400026
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Pereira TN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25236-8
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   ROSAY BETTINA, 1959, ANN ENT SOC AMER, V52, P481
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   VALLE D, 2015, DENGUE TEORIAS PRATI
   Vargas HCM, 2014, J INSECT PHYSIOL, V62, P54, DOI 10.1016/j.jinsphys.2014.02.001
   Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 61
TC 1
Z9 1
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 6
PY 2019
VL 12
AR 211
DI 10.1186/s13071-019-3474-z
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HX3DP
UT WOS:000467272100007
PM 31060581
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schneider, AD
   Wolfinger, MT
AF Schneider, Adriano de Bernardi
   Wolfinger, Michael T.
TI Musashi binding elements in Zika and related Flavivirus 3 ' UTRs: A
   comparative study in silico
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; RNA SECONDARY STRUCTURES; 3 UNTRANSLATED REGION;
   PROTEIN MUSASHI1; SUBGENOMIC RNA; SEXUAL TRANSMISSION;
   ENCEPHALITIS-VIRUS; MESSENGER-RNA; INFECTION; EXPRESSION
AB Zika virus (ZIKV) belongs to a class of neurotropic viruses that have the ability to cause congenital infection, which can result in microcephaly or fetal demise. Recently, the RNA-binding protein Musashi-1 (Msil), which mediates the maintenance and self-renewal of stem cells and acts as a translational regulator, has been associated with promoting ZIKV replication, neurotropism, and pathology. Msil predominantly binds to single-stranded motifs in the 3' untranslated region (UTR) of RNA that contain a UAG trinucleotide in their core. We systematically analyzed the properties of Musashi binding elements (MBEs) in the 3'UTR of flaviviruses with a thermodynamic model for RNA folding. Our results indicate that MBEs in ZIKV 3'UTRs occur predominantly in unpaired, single-stranded structural context, thus corroborating experimental observations by a biophysical model of RNA structure formation. Statistical analysis and comparison with related viruses show that ZIKV MBEs are maximally accessible among mosquito-borne flaviviruses. Our study addresses the broader question of whether other emerging arboviruses can cause similar neurotropic effects through the same mechanism in the developing fetus by establishing a link between the biophysical properties of viral RNA and teratogenicity. Moreover, our thermodynamic model can explain recent experimental findings and predict the Msil-related neurotropic potential of other viruses.
C1 [Schneider, Adriano de Bernardi] Univ Calif San Diego, Dept Med, 220 Dickinson St,Suite A, San Diego, CA 92103 USA.
   [Wolfinger, Michael T.] Univ Vienna, Dept Theoret Chem, Wahringerstr 17, A-1090 Vienna, Austria.
RP Wolfinger, MT (corresponding author), Univ Vienna, Dept Theoret Chem, Wahringerstr 17, A-1090 Vienna, Austria.
EM michael.wolfinger@univie.ac.at
RI Wolfinger, Michael Thomas/N-9538-2014; de Bernardi Schneider,
   Adriano/E-6252-2017
OI Wolfinger, Michael Thomas/0000-0003-0925-5205; de Bernardi Schneider,
   Adriano/0000-0001-7487-266X
FU Austrian science fund FWFAustrian Science Fund (FWF) [F43]
FX We thank Nikos Vasilakis for providing Spondweni virus sequences. We
   further thank Ivo Hofacker for fruitful discussions. This work was
   partly funded by the Austrian science fund FWF project F43 "RNA
   regulation of the transcriptome".
CR Akiyama B. M, 2016, SCIENCE
   Akiyama BM, 2016, CURR OPIN STRUC BIOL, V36, P40, DOI 10.1016/j.sbi.2015.12.006
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   ANDERSEN A A, 1970, Infection and Immunity, V2, P320
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   Antic S, 2015, MOL CELL BIOL, V35, P2309, DOI 10.1128/MCB.01346-14
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014
   Bernhart SH, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-3
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chavali P. L, 2017, SCIENCE
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FUJISAKI Y, 1983, NATL I ANIM HEALTH Q, V23, P21
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108
   Hofacker IL, 1998, NUCLEIC ACIDS RES, V26, P3825, DOI 10.1093/nar/26.16.3825
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001
   Iwaoka R, 2017, MOLECULES, V22, DOI 10.3390/molecules22071207
   Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192
   Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Kakooza-Mwesige A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00082
   Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915
   Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004
   Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Lorenz R, 2016, METHODS, V103, P86, DOI 10.1016/j.ymeth.2016.04.004
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   LVOV DK, 1976, ARCH VIROL, V50, P29, DOI 10.1007/BF01317998
   MacFadden A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02604-y
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Maran BAV, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.243.3668
   MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621
   McLEAN D M, 1959, Can Med Assoc J, V80, P708
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nagar N, 2016, PEDIATR INFECT DIS J, V8, P120
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Ochsenreiter R, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030298
   Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Rauscher S, 1997, RNA, V3, P779
   Richard A. S, 2017, P NATL ACAD SCI USA
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499
   Sakakibara S, 2001, J NEUROSCI, V21, P8091
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   Salinas S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005913
   Schnettler E, 2012, J VIROL
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sun EL, 2015, MOL BIOL CELL, V26, P1947, DOI 10.1091/mbc.E14-11-1497
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Uren PJ, 2015, MOL CELL BIOL, V35, P2965, DOI 10.1128/MCB.00410-15
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3
   Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065
   Witwer C, 2001, NUCLEIC ACIDS RES, V29, P5079, DOI 10.1093/nar/29.24.5079
   Wolfinger M. T, 2018, NCT CBNW NEWSLETTER, V58, DOI [10.5281/zenodo.1463018, DOI 10.5281/ZENODO.1463018]
   Wolfinger Michael T, 2015, F1000Res, V4, P50, DOI 10.12688/f1000research.6157.1
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
   Yang F, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-17, 10.1186/1743-422X-8-492]
   Yin XR, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658090, 10.1590/s1678-9946201658090]
   Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112
   2017, CLADISTICS, V33, P1, DOI DOI 10.1111/CLA.12178
NR 93
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 6
PY 2019
VL 9
AR 6911
DI 10.1038/s41598-019-43390-5
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HW7OK
UT WOS:000466878900011
PM 31061405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diderichsen, F
   Augusto, LGD
   Perez, B
AF Diderichsen, Finn
   da Silva Augusto, Lia Giraldo
   Perez, Bernadete
TI Understanding social inequalities in Zika infection and its
   consequences: A model of pathways and policy entry-points
SO GLOBAL PUBLIC HEALTH
LA English
DT Article
DE Zika virus; dengue fever; inequality; vulnerability; policy
ID HEALTH; DENGUE; BRAZIL; DETERMINANTS; RISK
AB The health consequences of arbovirus infections such as dengue fever (DENV), Chikungunya (CHIKV) and Zika (ZIKV) has in recent years become a public health challenge, due to failure of prevention followed by increased incidence and pronounced social inequality in occurrence and consequences. This motivates a more systematic analysis of the potential mechanisms and pathways that generate these inequalities. We present in the paper a model that delineates five possible mechanisms driving the inequality of ZIKV and congenital Zika syndrome (CZS). They include differential exposure to bad housing and sanitary conditions, differential exposure to vector density and virus, differential vulnerability to the health effects of exposure to virus, differential intrauterine susceptibility to the teratogenic effects of ZIKV infection and differential social consequences of caring for a disabled child. For each mechanism, we present empirical evidence or need for more research as well as a discussion about policy implications.
C1 [Diderichsen, Finn] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
   [Diderichsen, Finn; da Silva Augusto, Lia Giraldo] Fundacao Oswaldo Cruz, IAM FIOCRUZ PE, Av Prof Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
   [Perez, Bernadete] Fed Univ, Dept Med Social, Recife, PE, Brazil.
RP Diderichsen, F (corresponding author), Fundacao Oswaldo Cruz, IAM FIOCRUZ PE, Av Prof Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
EM fidi@sund.ku.dk
RI Diderichsen, Finn/P-4654-2019; da Silva Augusto, Lia
   Giraldo/AAF-5772-2019
OI Diderichsen, Finn/0000-0002-9998-4972; da Silva Augusto, Lia
   Giraldo/0000-0002-9322-6863
FU FACEBE [2016-04]
FX This work was supported by FACEBE 2016-04.
CR Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Birkmann J, 2013, NAT HAZARDS, V67, P193, DOI 10.1007/s11069-013-0558-5
   Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   da Silva MD, 2017, REV SOC BRAS MED TRO, V50, P104, DOI 10.1590/0037-8682-0272-2016
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Diderichsen F., 2001, CHALLENGING INEQUITI, DOI [10.1093/acprof:oso/9780195137408.001.0001, DOI 10.1093/ACPROF:OSO/9780195137408.001.0001]
   Diderichsen F, 2019, INT J EPIDEMIOL, V48, P268, DOI 10.1093/ije/dyy167
   Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Harzheim Erno, 2006, Cad. Saúde Pública, V22, P1649, DOI 10.1590/S0102-311X2006000800013
   IARC, 2015, IARC MONOGRAPHS
   Ives AM, 2017, J VIROL, V91, DOI 10.1128/JVI.00582-17
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI [DOI 10.1080/10714839.2016.1201268, DOI 10.1080/10714839.2016.120168]
   Levine ME, 2017, AM J EPIDEMIOL, V186, P503, DOI 10.1093/aje/kwx147
   Lilford RJ, 2017, LANCET, V389, P559, DOI [10.1016/S0140-6736(16)31848-7, 10.1016/s0140-6736(16)31848-7]
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Nakata Akinori, 2012, Methods Mol Biol, V934, P39, DOI 10.1007/978-1-62703-071-7_3
   Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Solar O, 2010, CONCEPTUAL FRAMEWORK
   Souza AI, 2018, PUBLIC HEALTH REP, V133, P461, DOI 10.1177/0033354918777256
   Stevanim L. F., 2016, REV RADIS, V163, P10
   Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012
   TenHave H., 2016, VULNERABILITY CHALLE
   VanderWeele TJ, 2015, EXPLANATION CAUSAL I
   Vicente CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175432
   World Health Organization, 2017, KEEP VECT OUT HOUS I
NR 40
TC 2
Z9 2
U1 1
U2 18
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
PD MAY 4
PY 2019
VL 14
IS 5
BP 675
EP 683
DI 10.1080/17441692.2018.1532528
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HO6TO
UT WOS:000461065000006
PM 30301438
DA 2020-07-08
ER

PT J
AU Hernandez-Triana, LM
   Barrero, E
   Delacour-Estrella, S
   Ruiz-Arrondo, I
   Lucientes, J
   de Marco, MDF
   Thorne, L
   Lumley, S
   Johnson, N
   Mansfield, KL
   Fooks, AR
AF Hernandez-Triana, Luis M.
   Barrero, Elsa
   Delacour-Estrella, Sarah
   Ruiz-Arrondo, Ignacio
   Lucientes, Javier
   de Marco, Maria del Mar Fernandez
   Thorne, Leigh
   Lumley, Sarah
   Johnson, Nicholas
   Mansfield, Karen L.
   Fooks, Anthony R.
TI Evidence for infection but not transmission of Zika virus by Aedes
   albopictus (Diptera: Culicidae) from Spain
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Zika virus; Vector competence; Spain
ID COMPETENCE; MOSQUITOS
AB BackgroundA number of mosquito-borne viruses such as dengue virus (DENV), Usutu virus (USUV), West Nile virus (WNV) are autochthonously transmitted in Europe and six invasive mosquito species have been detected in this temperate region. This has increased the risk for the emergence of further mosquito-borne diseases. However, there is a paucity of information on whether European populations of invasive mosquito species are competent to transmit arboviruses. In this study, the susceptibility of Aedes albopictus originating from Spain and a laboratory-adapted colony of Aedes aegypti, was assessed for infection with, and transmission of Zika virus (ZIKV). Vertical transmission in both species was also assessed.MethodsAedes albopictus colonised from eggs collected in Spain and an existing colony of Ae. aegypti were fed infectious blood meals containing ZIKV (Polynesian strain) at 1.6x10(7) PFU/ml. Blood-fed mosquitoes were separated and maintained at 20 degrees C or 25 degrees C. Legs, saliva and bodies were sampled from specimens at 7, 14 and 21days post-infection (dpi) in order to determine infection, dissemination and transmission rates. All samples were analysed by real-time RT-PCR using primers targeting the ZIKV NS1 gene.ResultsAt 14dpi and 21dpi, ZIKV RNA was detected in the bodies of both species at both temperatures. However, live virus only was detected in the saliva of Ae. aegypti at 25 degrees C with a transmission rate of 44%. No evidence for virus expectoration was obtained for Ae. albopictus under any condition. Notably, ZIKV RNA was not detectable in the saliva of Ae. aegypti at 20 degrees C after 21days. No vertical transmission of ZIKV was detected in this study.ConclusionsExperimental infection of Ae. albopictus colonized from Spain with ZIKV did not result in expectoration of virus in saliva in contrast to results for Ae. aegypti. No evidence of vertical transmission of virus was observed in this study. This suggests that this strain of Ae. albopictus is not competent for ZIKV transmission under the conditions tested.
C1 [Hernandez-Triana, Luis M.; Barrero, Elsa; de Marco, Maria del Mar Fernandez; Thorne, Leigh; Johnson, Nicholas; Mansfield, Karen L.; Fooks, Anthony R.] Anim & Plant Hlth Agcy, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
   [Delacour-Estrella, Sarah; Lucientes, Javier] Univ Zaragoza, Dept Anim Pathol, Fac Vet Med, Zaragoza, Spain.
   [Ruiz-Arrondo, Ignacio] Hosp Univ San Pedro, CIBIR, Ctr Rickettsiosis & Vector Borne Dis Grp, Logrono, Spain.
   [Lumley, Sarah] Publ Hlth England, Salisbury SP4 0JG, Wilts, England.
   [Johnson, Nicholas] Univ Surrey, Fac Hlth & Med, Guildford GU27XH, Surrey, England.
   [Fooks, Anthony R.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England.
RP Hernandez-Triana, LM (corresponding author), Anim & Plant Hlth Agcy, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
EM luis.hernandez-triana@apha.gov.uk
RI Arrondo, Ignacio Ruiz/R-8385-2018
OI Ruiz Arrondo, Ignacio/0000-0001-8198-8118
FU EUEuropean Union (EU) [653316]; Department for Environment Food and
   Rural Affairs (DEFRA)Department for Environment, Food & Rural Affairs
   (DEFRA) [SV3045, SE4113]; Scottish Government [SV3045, SE4113]; Welsh
   Government [SV3045, SE4113]
FX Funding was provided by the EU Framework Horizon 2020 Innovation Grant
   EVAg (No. 653316) and the Department for Environment Food and Rural
   Affairs (DEFRA), Scottish Government and Welsh Government through grants
   SV3045 and SE4113.
CR Alarcon-Elbal P.M., 2010, Revista Ibero-Latinoamericana de Parasitologia, V69, P140
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elliott R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006486
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hernandez-Triana LM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2959-5
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Jansen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0195-x
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lucientes-Curdi J, 2014, EUR J PUBLIC HEALTH, V24, P637, DOI 10.1093/eurpub/cku002
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Puggioli A, 2017, J MED ENTOMOL, V54, P142, DOI 10.1093/jme/tjw127
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 33
TC 3
Z9 3
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 3
PY 2019
VL 12
AR 204
DI 10.1186/s13071-019-3467-y
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HW8BX
UT WOS:000466914900007
PM 31053164
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Owczarek, K
   Chykunova, Y
   Jassoy, C
   Maksym, B
   Rajfur, Z
   Pyrc, K
AF Owczarek, Katarzyna
   Chykunova, Yuliya
   Jassoy, Christian
   Maksym, Beata
   Rajfur, Zenon
   Pyrc, Krzysztof
TI Zika virus: mapping and reprogramming the entry
SO CELL COMMUNICATION AND SIGNALING
LA English
DT Article
DE ZIKV; Trafficking; Ammonium chloride; Bafilomycin A1; Endocytosis;
   Recycling; Furin
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; MEMBRANE-FUSION;
   DENGUE-VIRUS; PH; INFECTION; BIOLOGY; ACTIVATION; INHIBITORS; ENDOSOME
AB BackgroundThe flaviviridae family comprises single-stranded RNA viruses that enter cells via clathrin-mediated pH-dependent endocytosis. Although the initial events of the virus entry have been already identified, data regarding intracellular virus trafficking and delivery to the replication site are limited. The purpose of this study was to map the transport route of Zika virus and to identify the fusion site within the endosomal compartment.MethodsTracking of viral particles in the cell was carried out with confocal microscopy. Immunostaining of two structural proteins of Zika virus enabled precise mapping of the route of the ribonucleocapsid and the envelope and, consequently, mapping the fusion site in the endosomal compartment. The results were verified using RNAi silencing and chemical inhibitors.ResultsAfter endocytic internalization, Zika virus is trafficked through the endosomal compartment to fuse in late endosomes. Inhibition of endosome acidification using bafilomycin A1 hampers the infection, as the fusion is inhibited; instead, the virus is transported to late compartments where it undergoes proteolytic degradation. The degradation products are ejected from the cell via slow recycling vesicles. Surprisingly, NH4Cl, which is also believed to block endosome acidification, shows a very different mode of action. In the presence of this basic compound, the endocytic hub is reprogrammed. Zika virus-containing vesicles never reach the late stage, but are rapidly trafficked to the plasma membrane via a fast recycling pathway after the clathrin-mediated endocytosis.Further, we also noted that, similarly as other members of the flaviviridae family, Zika virus undergoes furin- or furin-like-dependent activation during late steps of infection, while serine or cysteine proteases are not required for Zika virus maturation or entry.ConclusionsZika virus fusion occurs in late endosomes and is pH-dependent. These results broaden our understanding of Zika virus intracellular trafficking and may in future allow for development of novel treatment strategies. Further, we identified a novel mode of action for agents commonly used in studies of virus entry.
C1 [Owczarek, Katarzyna; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Gronostajowa 7a 2-25, PL-30387 Krakow, Poland.
   [Owczarek, Katarzyna; Chykunova, Yuliya] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Microbiol Dept, Gronostajowa 7, PL-30387 Krakow, Poland.
   [Jassoy, Christian] Univ Leipzig, Univ Clin, Inst Virol, Leipzig, Germany.
   [Jassoy, Christian] Univ Leipzig, Med Fac, Leipzig, Germany.
   [Maksym, Beata] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept Pharmacol, Zabrze, Poland.
   [Rajfur, Zenon] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Lojasiewicza 11, PL-30348 Krakow, Poland.
RP Pyrc, K (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Gronostajowa 7a 2-25, PL-30387 Krakow, Poland.
EM k.a.pyrc@uj.edu.pl
OI Pyrc, Krzysztof/0000-0002-3867-7688
FU National Science Center [UMO-2017/25/N/NZ6/01310,
   UMO-2012/07/E/NZ6/01712, UMO-2016/21/B/NZ6/01307,
   UMO-2017/27/B/NZ6/02488]; European UnionEuropean Union (EU)
   [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of
   the Republic of PolandMinistry of Science and Higher Education, Poland
FX This work was supported by grants from the National Science Center
   (UMO-2017/25/N/NZ6/01310 (KO), UMO-2012/07/E/NZ6/01712 and
   UMO-2016/21/B/NZ6/01307 and UMO-2017/27/B/NZ6/02488) (KP).; The Faculty
   of Biochemistry, Biophysics and Biotechnology of the Jagiellonian
   University is a beneficiary of the structural funds from the European
   Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for
   health").; Faculty of Biochemistry, Biophysics and Biotechnology of the
   Jagiellonian University is a partner of the Leading National Research
   Center supported by the Ministry of Science and Higher Education of the
   Republic of Poland. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016
   [Anonymous], 2015, ZIK VIR EP AM POT AS
   Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425
   Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767
   Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91
   Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307
   Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200
   Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Cocucci E, 2014, MOL BIOL CELL, V25, P3595, DOI 10.1091/mbc.E14-07-1240
   Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0
   Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172
   CRIDER BP, 1994, J BIOL CHEM, V269, P17379
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799
   Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   Fraile-Ramos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015318
   Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Gould EA, 2012, ANTIVIR RES, V95, P167, DOI 10.1016/j.antiviral.2012.05.005
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99
   Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12
   KIMURA T, 1986, J GEN VIROL, V67, P2423, DOI 10.1099/0022-1317-67-11-2423
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu CC, 2017, J VIROL, V91, DOI [10.1128/JVI.01113-17, 10.1128/jvi.01113-17]
   LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Matsuyama S, 2018, J VIROL, V92, DOI 10.1128/JVI.00683-18
   Maxfield F R, 1987, Adv Exp Med Biol, V225, P189
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000
   Owczarek K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25640-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Gerber PP, 2015, J CELL BIOL, V209, P435, DOI 10.1083/jcb.201409082
   PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Rawle RJ, 2018, ACS CENTRAL SCI, V4, P1503, DOI 10.1021/acscentsci.8b00494
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rinkenberger N, 2018, MBIO, V9, DOI 10.1128/mBio.02314-17
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2001, J VIROL, V75, P7392, DOI 10.1128/JVI.75.16.7392-7398.2001
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   Yang SB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-258
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YN, 2018, J VIROL, V92, DOI [10.1128/jvi.00797-18, 10.1128/JVI.00797-18]
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 76
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-811X
J9 CELL COMMUN SIGNAL
JI Cell Commun. Signal.
PD MAY 3
PY 2019
VL 17
AR 41
DI 10.1186/s12964-019-0349-z
PG 19
WC Cell Biology
SC Cell Biology
GA HW9RT
UT WOS:000467029000001
PM 31053158
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McHale, TC
   Romero-Vivas, CM
   Fronterre, C
   Arango-Padilla, P
   Waterlow, NR
   Nix, CD
   Falconar, AK
   Cano, J
AF McHale, Thomas C.
   Romero-Vivas, Claudia M.
   Fronterre, Claudio
   Arango-Padilla, Pedro
   Waterlow, Naomi R.
   Nix, Chad D.
   Falconar, Andrew K.
   Cano, Jorge
TI Spatiotemporal Heterogeneity in the Distribution of Chikungunya and Zika
   Virus Case Incidences during their 2014 to 2016 Epidemics in
   Barranquilla, Colombia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Chikungunya virus; Zika virus; spatial clustering; Bayesian Poisson
   models; conditional autoregressive models; socioeconomic risk factors;
   environmental risk factors
ID AEDES-AEGYPTI; DENGUE-FEVER; SPATIAL-DISTRIBUTION; TRANSMISSION; MODEL;
   DISPERSAL; INFECTION; OUTBREAKS; CLIMATE; DISEASE
AB Chikungunya virus (CHIKV) and Zika virus (ZIKV) have recently emerged as globally important infections. This study aimed to explore the spatiotemporal heterogeneity in the occurrence of CHIKV and ZIKV outbreaks throughout the major international seaport city of Barranquilla, Colombia in 2014 and 2016 and the potential for clustering. Incidence data were fitted using multiple Bayesian Poisson models based on multiple explanatory variables as potential risk factors identified from other studies and options for random effects. A best fit model was used to analyse their case incidence risks and identify any risk factors during their epidemics. Neighbourhoods in the northern region were hotspots for both CHIKV and ZIKV outbreaks. Additional hotspots occurred in the southwestern and some eastern/southeastern areas during their outbreaks containing part of, or immediately adjacent to, the major circular city road with its import/export cargo warehouses and harbour area. Multivariate conditional autoregressive models strongly identified higher socioeconomic strata and living in a neighbourhood near a major road as risk factors for ZIKV case incidences. These findings will help to appropriately focus vector control efforts but also challenge the belief that these infections are driven by social vulnerability and merit further study both in Barranquilla and throughout the world's tropical and subtropical regions.
C1 [McHale, Thomas C.; Fronterre, Claudio; Waterlow, Naomi R.; Nix, Chad D.; Cano, Jorge] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1E 7HT, England.
   [Romero-Vivas, Claudia M.; Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla 081007, Colombia.
   [Arango-Padilla, Pedro] Secretaria Salud Dist, Programa Prevenc & Control Enfermedades Trasmitid, Barranquilla 081007, Colombia.
RP Cano, J (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1E 7HT, England.
EM tc.mchale@gmail.com; clromero@uninorte.edu.co;
   claudio.fronterre@lshtm.ac.uk; arangopedrojose@gmail.com;
   naomi.walker1@lshtm.ac.uk; chadamson91@gmail.com;
   afalconar@uninorte.edu.co; jorge.cano@lshtm.ac.uk
RI ; Cano, Jorge/E-2962-2016
OI Nix, Chad/0000-0003-4260-055X; Waterlow, Naomi/0000-0002-9210-9657;
   Cano, Jorge/0000-0001-9864-5058; Fronterre, Claudio/0000-0001-6723-9727
FU Bill and Melinda Gates FoundationGates Foundation [OPP 1033751];
   European Union's 2020 Research and Innovation Programme [734584]
FX The research was funded by the Bill and Melinda Gates Foundation (OPP
   1033751) and the European Union's 2020 Research and Innovation Programme
   under Grant Agreement no. 734584 (ZikaPLAN).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   [Anonymous], 2017, ARCGIS DESKT REL 10
   Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x
   Anselin L., 2005, EXPLORING SPATIAL DA
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Botero D.S., 2016, I NACL SALUD, V1, P1
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002
   Costa JV, 2013, CAD SAUDE PUBLICA, V29, P1522, DOI [10.1590/S0102-311X2013001200005, 10.1590/0102-311X00110912]
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estallo EL, 2018, MED VET ENTOMOL, V32, P451, DOI 10.1111/mve.12323
   Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06
   Falconar Andrew K I, 2012, J Clin Med Res, V4, P33, DOI 10.4021/jocmr694w
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Flowerdew R, 2008, SOC SCI MED, V66, P1241, DOI 10.1016/j.socscimed.2007.11.042
   Fonzi E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003829
   Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hsueh YH, 2012, APPL GEOGR, V34, P587, DOI 10.1016/j.apgeog.2012.03.003
   Hua C, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0694-0
   Huang CC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091869
   Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512
   Khormi HM, 2011, SCI TOTAL ENVIRON, V409, P4713, DOI 10.1016/j.scitotenv.2011.08.028
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lee D, 2013, J R STAT SOC C-APPL, V62, P593, DOI 10.1111/rssc.12009
   Li XD, 2018, VIRUS RES, V254, P10, DOI 10.1016/j.virusres.2017.09.005
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13
   Nix C., 2015, INVESTIGATION TRANSM
   Orozco Antonio, 2014, Lect. Econ., P183
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qureshi EMA, 2017, J PAK MED ASSOC, V67, P1493
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rees EE, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2867-8
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reyes-Castro PA, 2017, ACTA TROP, V167, P174, DOI 10.1016/j.actatropica.2017.01.001
   Palacios JHR, 2016, COLOMB MEDICA, V47, P133
   Romero-Vivas CME, 2007, J MED ENTOMOL, V44, P930, DOI 10.1603/0022-2585(2007)44[930:TCFATA]2.0.CO;2
   Romero-Vivas CME, 2006, ANN TROP MED PARASIT, V100, pS87, DOI 10.1179/136485906X105543
   Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2
   Romero-Vivas CME, 2002, J AM MOSQUITO CONTR, V18, P40
   Roslan MA, 2013, J AM MOSQUITO CONTR, V29, P328, DOI 10.2987/13-6363.1
   Sainte-Marie M., 2014, P SPAT COGN INT C SP, P206
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   San Pedro A, 2009, CAD SAUDE PUBLICA, V25, P1937, DOI 10.1590/S0102-311X2009000900008
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stafford M, 2008, SOC SCI MED, V67, P891, DOI 10.1016/j.socscimed.2008.05.028
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Sterne JA, 2009, BMJ-BRIT MED J, V338, pb2393, DOI DOI 10.1136/BMJ.B2393
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Tarantine C., 2019, REV SALUD PUBLICA, V2, P1
   Tolosa Perez N., 2016, I NACL SALUD, V1, P1
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker N., 2014, INVESTIGATION CHIKUN
   Webber R., 2009, COMMUNICABLE DIS EPI
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Xu D., 2014, AM J REMOTE SENSING, V2, P10, DOI DOI 10.11648/j.ajrs.20140202.11
   Xu H.Q., 2005, J REMOTE SENSING, V2005, P589, DOI DOI 10.3321/J.ISSN:1007-4619.2005.05.012
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zellweger RELM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005471
   Zhang ZM, 2010, INT J REMOTE SENS, V31, P2837, DOI 10.1080/01431160903124682
NR 88
TC 2
Z9 2
U1 4
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY 2
PY 2019
VL 16
IS 10
AR 1759
DI 10.3390/ijerph16101759
PG 21
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IC4WF
UT WOS:000470967500093
PM 31109024
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haddad, JG
   Koishi, AC
   Gaudry, A
   dos Santos, CND
   Viranaicken, W
   Despres, P
   El Kalamouni, C
AF Haddad, Juliano G.
   Koishi, Andrea Cristine
   Gaudry, Arnaud
   Duarte dos Santos, Claudia Nunes
   Viranaicken, Wildriss
   Despres, Philippe
   El Kalamouni, Chaker
TI Doratoxylon apetalum, an Indigenous Medicinal Plant from Mascarene
   Islands, Is a Potent Inhibitor of Zika and Dengue Virus Infection in
   Human Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; dengue virus; antiviral activity; medicinal plant;
   nutraceuticals; polyphenol; Doratoxylon apetalum
ID ANTIVIRAL ACTIVITY; EPIGALLOCATECHIN GALLATE; ENTRY; POLYPHENOLS;
   EPIDEMIC
AB Zika virus (ZIKV) and Dengue virus (DENV) are mosquito-borne viruses of the Flavivirus genus that could cause congenital microcephaly and hemorrhage, respectively, in humans, and thus present a risk to global public health. A preventive vaccine against ZIKV remains unavailable, and no specific antiviral drugs against ZIKV and DENV are licensed. Medicinal plants may be a source of natural antiviral drugs which mostly target viral entry. In this study, we evaluate the antiviral activity of Doratoxylum apetalum, an indigenous medicinal plant from the Mascarene Islands, against ZIKV and DENV infection. Our data indicated that D. apetalum exhibited potent antiviral activity against a contemporary epidemic strain of ZIKV and clinical isolates of four DENV serotypes at non-cytotoxic concentrations in human cells. Time-of-drug-addition assays revealed that D. apetalum extract acts on ZIKV entry by preventing the internalisation of virus particles into the host cells. Our data suggest that D. apetalum-mediated ZIKV inhibition relates to virus particle inactivation. We suggest that D. apetalum could be a promising natural source for the development of potential antivirals against medically important flaviviruses.
C1 [Haddad, Juliano G.; Viranaicken, Wildriss; Despres, Philippe; El Kalamouni, Chaker] Univ Lla Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS,UMR 9192,UMR 249,INSERM,U1187,IRD, F-94791 St Clotilde, La Reunion, France.
   [Koishi, Andrea Cristine; Duarte dos Santos, Claudia Nunes] ICC FIOCRUZ PR, Inst Carlos Chagas, Mol Virol Lab, BR-81350010 Curitiba, Parana, Brazil.
   [Gaudry, Arnaud] Univ Geneva, Bioact Nat Prod Unit, Sch Pharmaceut Sci, EPGL, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.
RP El Kalamouni, C (corresponding author), Univ Lla Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS,UMR 9192,UMR 249,INSERM,U1187,IRD, F-94791 St Clotilde, La Reunion, France.
EM juliano.haddad@univ-reunion.fr; ackoishi@gmail.com;
   Arnaud.gaudry@unige.ch; clsantos@fiocruz.br;
   wildriss.viranaicken@univ-reunion.fr; philippe.despres@univ-reunion.fr;
   chaker.el-kalamouni@univ-reunion.fr
OI viranaicken, wildriss/0000-0002-0915-8635; Koishi,
   Andrea/0000-0002-3542-1353
FU POE FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert
   program) [SYNERGIE: RE00001902]; CAPES-COFECUBCAPES [Me889/17 ZIKANET];
   Research Federation BioST, Universite de La Reunion; Swiss-European
   Mobility program from University of Geneva (Switzerland); ZIKAlert
   program
FX Research was funded by POE FEDER 2014-20 of the Conseil Regional de La
   Reunion (ZIKAlert program, No. SYNERGIE: RE00001902), CAPES-COFECUB
   Me889/17 ZIKANET project and Research Federation BioST, Universite de La
   Reunion. J.G.H. received funding from the ZIKAlert program. A.G. has a
   Master degree scholarship from Swiss-European Mobility program from
   University of Geneva (Switzerland).
CR Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002
   Bos S, 2018, PATHOG GLOB HEALTH, V112, P294, DOI 10.1080/20477724.2018.1514136
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Clain E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081860
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   Dobi A, 2019, FREE RADICAL RES, V53, P150, DOI 10.1080/10715762.2018.1529866
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Huber RG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09391-8
   Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785
   Kuczera D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0548-9
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Ledoux A, 2018, INT J ANTIMICROB AG, V52, P622, DOI 10.1016/j.ijantimicag.2018.07.017
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Li FF, 2019, J BIOL CHEM, V294, P182, DOI 10.1074/jbc.RA118.005015
   Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Marimoutou M, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0055-6
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Norahmad NA, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2438-3
   Paemanee Atchara, 2018, BMC Res Notes, V11, P307, DOI 10.1186/s13104-018-3417-3
   Pascalis H, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01455
   Perera SD, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/2048530
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Qamar MTU, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38450-1
   Ralambondrainy M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196757
   Sharma N, 2019, ARCH VIROL, V164, P1095, DOI 10.1007/s00705-019-04179-z
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Sze A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100287
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011
   Zainal N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42998
   Zandi K, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-91
NR 47
TC 5
Z9 6
U1 5
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 2
PY 2019
VL 20
IS 10
AR 2382
DI 10.3390/ijms20102382
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IC5IP
UT WOS:000471001400013
PM 31091703
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kraemer, MUG
   Reiner, RC
   Brady, O
   Messina, JP
   Gilbert, M
   Pigott, DM
   Yi, D
   Johnson, K
   Earl, L
   Marczak, LB
   Shirude, S
   Weaver, N
   Bisanzio, D
   Perkins, TA
   Lai, SJ
   Lu, X
   Jones, P
   Coelho, GE
   Carvalho, RG
   Van Bortel, W
   Marsboom, C
   Hendrickx, G
   Schaffner, F
   Moore, CG
   Nax, HH
   Bengtsson, L
   Wetter, E
   Tatem, AJ
   Brownstein, JS
   Smith, DL
   Lambrechts, L
   Cauchemez, S
   Linard, C
   Faria, NR
   Pybus, OG
   Scott, TW
   Liu, Q
   Yu, H
   Wint, GRW
   Hay, SI
   Golding, N
AF Kraemer, Moritz U. G.
   Reiner, Robert C., Jr.
   Brady, Oliverj
   Messina, Jane P.
   Gilbert, Marius
   Pigott, David M.
   Yi, Dingdong
   Johnson, Kimberly
   Earl, Lucas
   Marczak, Laurie B.
   Shirude, Shreya
   Weaver, NicoleDavis
   Bisanzio, Donal
   Perkins, T. Alex
   Lai, Shengjie
   Lu, Xin
   Jones, Peter
   Coelho, Giovanini E.
   Carvalho, Roberta G.
   Van Bortel, Wim
   Marsboom, Cedric
   Hendrickx, Guy
   Schaffner, Francis
   Moore, Chester G.
   Nax, Heinrich H.
   Bengtsson, Linus
   Wetter, Erik
   Tatem, Andrew J.
   Brownstein, John S.
   Smith, David L.
   Lambrechts, Louis
   Cauchemez, Simon
   Linard, Catherine
   Faria, Nuno R.
   Pybus, Oliver G.
   Scott, Thomas W.
   Liu, Qiyong
   Yu, Hongjie
   Wint, G. R. William
   Hay, Simon, I
   Golding, Nick
TI Past and future spread of the arbovirus vectors Aedes aegypti and Aedes
   albopictus
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ZIKA VIRUS; UNITED-STATES; NICHE SHIFTS; CULICIDAE; MOSQUITO; DIPTERA;
   ESTABLISHMENT; TRANSMISSION; COMPETITION; INTENSITY
AB The global population at risk from mosquito-borne diseases-including dengue, yellow fever, chikungunya and Zika-is expanding in concert with changes in the distribution of two key vectors: Aedes aegypti and Aedes albopictus. The distribution of these species is largely driven by both human movement and the presence of suitable climate. Using statistical mapping techniques, we show that human movement patterns explain the spread of both species in Europe and the United States following their introduction. We find that the spread of Ae. aegypti is characterized by long distance importations, while Ae. albopictus has expanded more along the fringes of its distribution. We describe these processes and predict the future distributions of both species in response to accelerating urbanization, connectivity and climate change. Global surveillance and control efforts that aim to mitigate the spread of chikungunya, dengue, yellow fever and Zika viruses must consider the so far unabated spread of these mosquitos. Our maps and predictions offer an opportunity to strategically target surveillance and control programmes and thereby augment efforts to reduce arbovirus burden in human populations globally.
C1 [Kraemer, Moritz U. G.; Faria, Nuno R.; Pybus, Oliver G.; Wint, G. R. William] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Reiner, Robert C., Jr.; Pigott, David M.; Johnson, Kimberly; Earl, Lucas; Marczak, Laurie B.; Shirude, Shreya; Weaver, NicoleDavis; Smith, David L.; Hay, Simon, I] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Brady, Oliverj] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Brady, Oliverj] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Messina, Jane P.] Univ Oxford, Sch Geog & Environm, Oxford, England.
   [Messina, Jane P.] Univ Oxford, Oxford Sch Global & Area Studies, Oxford, England.
   [Gilbert, Marius; Linard, Catherine] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium.
   [Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium.
   [Yi, Dingdong] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Bisanzio, Donal] RTI Int, Washington, DC USA.
   [Bisanzio, Donal] Univ Nottingham, Sch Med, Epidemiol & Publ Hlth Div, Nottingham, England.
   [Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Lai, Shengjie; Yu, Hongjie] Fudan Univ, Sch Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.
   [Lai, Shengjie; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England.
   [Lai, Shengjie; Bengtsson, Linus; Wetter, Erik; Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Lu, Xin] Cent S Univ, Sch Business, Changsha, Hunan, Peoples R China.
   [Lu, Xin] Natl Univ Def Technol, Coll Syst Engn, Changsha, Hunan, Peoples R China.
   [Lu, Xin] Southwestern Univ Finance & Econ, Sch Business Adm, Chengdu, Sichuan, Peoples R China.
   [Jones, Peter] Waen Associates Ltd, Dolgellau, Gwynedd, Wales.
   [Coelho, Giovanini E.] PAHO, Washington, DC USA.
   [Carvalho, Roberta G.] Minist Hlth, Natl Dengue Control Program, Brasilia, DF, Brazil.
   [Van Bortel, Wim] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Van Bortel, Wim] Inst Trop Med, Antwerp, Belgium.
   [Marsboom, Cedric; Hendrickx, Guy] Avia GIS, Zoersel, Belgium.
   [Schaffner, Francis] Francis Schaffner Consultancy, Riehen, Switzerland.
   [Moore, Chester G.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Nax, Heinrich H.] Swiss Fed Inst Technol, Computat Social Sci, Zurich, Switzerland.
   [Bengtsson, Linus] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Wetter, Erik] Stockholm Sch Econ, Stockholm, Sweden.
   [Lambrechts, Louis] Inst Pasteur, Insect Virus Interact Unit, UMR2000, CNRS, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, UMR2000, CNRS, Paris, France.
   [Linard, Catherine] Univ Namur, Dept Geog, Namur, Belgium.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
   [Liu, Qiyong] Shandong Univ, Climate Change & Hlth Ctr, Sch Publ Hlth, Jinan, Shandong, Peoples R China.
   [Liu, Qiyong] WHO Collaborating Ctr Vector Surveillance & Manag, Beijing, Peoples R China.
   [Liu, Qiyong] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China.
   [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, Oxford, England.
   [Golding, Nick] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
RP Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Golding, N (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
EM moritz.kraemer@zoo.ox.ac.uk; sihay@uw.edu;
   nick.golding.research@gmail.com
RI Pybus, Oliver g/B-2640-2012; Hay, Simon I/F-8967-2015; lu,
   xin/C-1940-2009; Smith, David/L-8850-2013; Faria, Nuno
   Rodrigues/I-2975-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Hay, Simon I/0000-0002-0611-7272;
   lu, xin/0000-0002-3547-6493; Lai, Shengjie/0000-0001-9781-8148; Smith,
   David/0000-0003-4367-3849; Faria, Nuno Rodrigues/0000-0001-8839-2798;
   Moore, Chester/0000-0002-1837-7266; Davis Weaver,
   Nicole/0000-0002-7205-9621; Van Bortel, Wim/0000-0002-6644-518X
FU Society in Science; Branco Weiss Fellowship; National Institute of Child
   Health and Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; International Research Consortium on Dengue Risk
   Assessment Management and Surveillance (IDAMS; European Commission 7th
   Framework Programme) [21893]; Sir Henry Wellcome Fellowship - Wellcome
   TrustWellcome Trust [206471/Z/17/Z]; Bill and Melinda Gates
   FoundationGates Foundation [OP1183567]; Research for Health in
   Humanitarian Crises (R2HC) Programme [13468]; Department of
   International Development (DFiD); Wellcome TrustWellcome Trust [95066];
   Bill & Melinda Gates FoundationGates Foundation [OPP1106023, OPP1093011,
   OPP1132415, OPP1159934]; American people through the US Agency for
   International Development Emerging Pandemic Threats Program-2 PREDICT-2
   [AID-OAA-A-14-00102]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U10AI089674]; European
   Commission through the European Research Council [324247]; French
   Government's Investissement d'Avenir programFrench National Research
   Agency (ANR); Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases [ANR-10-LABX-62-IBEID]; French Agence Nationale de
   la RechercheFrench National Research Agency (ANR) [ANR-16-CE35-0004];
   City of Paris Emergence(s) programme in Biomedical Research; European
   Union's Horizon 2020 research and innovation programme under ZikaPLAN
   grant [734584]; AXA Research Fund; Investissement d'Avenir programFrench
   National Research Agency (ANR); Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID];
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences; INCEPTION project [PIA/ANR-16-CONV-0005];
   European Union's Horizon 2020 research and innovation programme under
   ZIKAlliance grant [734548]; University of Melbourne McKenzie fellowship;
   VBORNET, an ECDC; VectorNet, an ECDC; EFSA [ECDC/09/018,
   OC/EFSA/AHAW/2013/02]; National Institutes of Health Program Project
   grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P01 AI098670]; Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [71771213, 71522014, 71725001, 91846301, 71790615]
FX The authors thank S. Ray for providing comments during the revision
   process. M.U.G.K. acknowledges funding from the Society in Science, The
   Branco Weiss Fellowship, administered by the ETH Zurich. M.U.G.K. also
   acknowledges funding from the Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128). M.U.G.K., S.I.H.,
   J.P.M., N.G., O.J.B. and G.R.W.W. acknowledge funding from the
   International Research Consortium on Dengue Risk Assessment Management
   and Surveillance (IDAMS; European Commission 7th Framework Programme no.
   21893). O.B.J. was funded by a Sir Henry Wellcome Fellowship funded by
   the Wellcome Trust (grant number 206471/Z/17/Z) and a grant from the
   Bill and Melinda Gates Foundation (OP1183567). S.I.H. received a grant
   from the Research for Health in Humanitarian Crises (R2HC) Programme,
   managed by Enhancing Learning and Research for Humanitarian Assistance
   (ELRHA; no. 13468), which also supported M.U.G.K. and N.G. The R2HC
   programme aims to improve health outcomes by strengthening the evidence
   base for public health interventions in humanitarian crises. The 8 pound
   million R2HC programme is funded equally by the Wellcome Trust and
   Department of International Development (DFiD), with ELRHA overseeing
   the programme's execution and management. S. I. H. was also funded by a
   Senior Research Fellowship from the Wellcome Trust (no. 95066) and
   grants from the Bill & Melinda Gates Foundation (OPP1106023, OPP1093011,
   OPP1132415 and OPP1159934). This study was made possible by the support
   of the American people through the US Agency for International
   Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative
   Agreement number AID-OAA-A-14-00102), which also supported M.U.G.K.
   J.S.B. is supported by the National Library of Medicine of the National
   Institutes of Health (R01LM010812 and R01LM011965), which also supports
   M.U.G.K. D.L.S. is funded by the National Institutes of Health and
   National Institute of Allergy and Infectious Diseases (no. U10AI089674).
   H. H. N. was funded by the European Commission through the European
   Research Council Advanced Investigator Grant 'Momentum' 324247. L.L.
   received funding from the French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases (grant ANR-10-LABX-62-IBEID), the French Agence
   Nationale de la Recherche (grant ANR-16-CE35-0004), the City of Paris
   Emergence(s) programme in Biomedical Research, and the European Union's
   Horizon 2020 research and innovation programme under ZikaPLAN grant
   agreement No. 734584. S.C. received funding from the AXA Research Fund,
   the Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (Grant
   ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of
   the National Institute of General Medical Sciences, the INCEPTION
   project (PIA/ANR-16-CONV-0005), and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement No
   734548. N.G. is supported by a University of Melbourne McKenzie
   fellowship. W.V.B., G.H. and F.S. acknowledge funding from VBORNET and
   VectorNet, an ECDC and EFSA-funded project (no. ECDC/09/018 and
   OC/EFSA/AHAW/2013/02), and thank all contributing VBORNET and VectorNet
   experts for data sharing. T.W.S., R.C.R. and L.L. received funding from
   the National Institutes of Health Program Project grant (no. P01
   AI098670). X.L.; is supported by the Natural Science Foundation of China
   (71771213, 71522014, 71725001, 91846301 and 71790615). This work was
   also partially supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement no. 734548.
CR Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037
   Behrens JJW, 2013, INT J APPL GEOSPAT R, V4, P9, DOI 10.4018/jagr.2013040102
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   BERMAN M, 1989, J ROY STAT SOC B MET, V51, P81
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Canali M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040444
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Golding N., 2014, STREAMLINED FUNCTION
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hastie T.J., 1990, GEN ADDITIVE MODELS
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   Jongejans E, 2015, THEOR ECOL-NETH, V8, P207, DOI 10.1007/s12080-014-0245-5
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G, 2015, MOVEMENT FUNCTIONS A
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Leisnham PT, 2009, ECOLOGY, V90, P2405, DOI 10.1890/08-1569.1
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3
   Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2
   Osorio HC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040820
   Padilla DK, 1996, GLOBAL ECOL BIOGEOGR, V5, P353, DOI 10.2307/2997590
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prinzing A, 2002, ECOGRAPHY, V25, P721, DOI 10.1034/j.1600-0587.2002.250608.x
   R Core Team, 2016, R LANG ENV COMP
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Ruktanonchai NW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004846
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Samir KC, 2014, POPUL ENVIRON, V35, P243, DOI 10.1007/s11111-014-0205-4
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x
   Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324
   Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904
   Tisseuil C, 2016, ECOGRAPHY, V39, P409, DOI 10.1111/ecog.01393
   Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716
   United Nations Framework on Climate Change (UNFCCC), 2015, PAR AGR 21 C PART
   United Nations Population Division, 2014, WORLD URB PROSP 2014
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e
   Wesolowski A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004267
   Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431
NR 73
TC 64
Z9 64
U1 23
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAY
PY 2019
VL 4
IS 5
BP 854
EP 863
DI 10.1038/s41564-019-0376-y
PG 10
WC Microbiology
SC Microbiology
GA HU7QL
UT WOS:000465477000018
PM 30833735
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Lewnard, JA
   Reingold, AL
AF Lewnard, Joseph A.
   Reingold, Arthur L.
TI Emerging Challenges and Opportunities in Infectious Disease Epidemiology
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Editorial Material
DE infectious diseases; methods; modeling; surveillance
ID PNEUMOCOCCAL CONJUGATE VACCINE; DRUG-RESISTANT TUBERCULOSIS;
   PLACEBO-CONTROLLED TRIAL; PUBLIC-HEALTH; INFLUENZA VACCINE;
   ANTIBIOTIC-RESISTANCE; TRANSMISSION DYNAMICS; EBOLA VACCINE; ZIKA VIRUS;
   ANTIMICROBIAL RESISTANCE
AB Much of the intellectual tradition of modern epidemiology stems from efforts to understand and combat chronic diseases persisting through the 20th century epidemiologic transition of countries such as the United States and United Kingdom. After decades of relative obscurity, infectious disease epidemiology has undergone an intellectual rebirth in recent years amid increasing recognition of the threat posed by both new and familiar pathogens. Here, we review the emerging coalescence of infectious disease epidemiology around a core set of study designs and statistical methods bearing little resemblance to the chronic disease epidemiology toolkit. We offer our outlook on challenges and opportunities facing the field, including the integration of novelmolecular and digital information sources into disease surveillance, the assimilation of such data intomodels of pathogen spread, and the increasing contribution of models to public health practice. We next consider emerging paradigms in causal inference for infectious diseases, ranging from approaches to evaluating vaccines and antimicrobial therapies to the task of ascribing clinical syndromes to etiologic microorganisms, an age-old problem transformed by our increasing ability to characterize human-associated microbiota. These areas represent an increasingly important component of epidemiology training programs for future generations of researchers and practitioners.
C1 [Lewnard, Joseph A.; Reingold, Arthur L.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, 2121 Berkeley Way, Berkeley, CA 94720 USA.
RP Lewnard, JA (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, 2121 Berkeley Way, Berkeley, CA 94720 USA.
EM jlewnard@berkeley.edu
CR Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653
   Ahuka-Mundeke S, 2018, LANCET, V392, P213, DOI 10.1016/S0140-6736(18)31387-4
   Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832
   ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0
   Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0
   [Anonymous], 1948, BRIT MED J, V2, P791
   [Anonymous], 1910, J HYG-CAMBRIDGE, V10, P315
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8
   Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101
   Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488
   Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9
   Brooks LC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004382
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Buckee CO, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000538
   Budd W, 1918, AM J PUBLIC HEALTH, V8, P610, DOI 10.2105/AJPH.8.8.610
   Butler D, 2014, NATURE, V515, P18, DOI 10.1038/515018a
   Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P277
   Chaves SS, 2007, NEW ENGL J MED, V356, P1121, DOI 10.1056/NEJMoa064040
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Choe YJ, 2012, VACCINE, V30, P7439, DOI 10.1016/j.vaccine.2012.10.030
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597
   Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004
   Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880
   Cox D. R., 1992, BREAKTHROUGHS STAT, P527, DOI DOI 10.1007/978-1-4612-4380-9_37
   Crozier I, 2018, J INFECT DIS, V217, P513, DOI 10.1093/infdis/jix620
   Dagan R, 2016, LANCET INFECT DIS, V16, P480, DOI 10.1016/S1473-3099(15)00549-6
   de Celles MD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaj1748
   Dourado I, 2000, AM J EPIDEMIOL, V151, P524, DOI 10.1093/oxfordjournals.aje.a010239
   Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/elife.37324, 10.7554/eLife.31257]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667
   Eddy RG, 2001, NATURE, V412, P477, DOI 10.1038/35087748
   EVANS AS, 1978, AM J EPIDEMIOL, V108, P249, DOI 10.1093/oxfordjournals.aje.a112617
   Fales WT, 1928, AM J HYG, V8, P759, DOI 10.1093/oxfordjournals.aje.a121027
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328
   Farrow DC, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005248
   Feikin DR, 2000, J INFECT DIS, V181, P1501, DOI 10.1086/315382
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116
   Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020
   Fifer H, 2016, NEW ENGL J MED, V374, P2504, DOI 10.1056/NEJMc1512757
   Filia A, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.37.30614, 10.2807/1560-7917.es.2017.22.37.30614]
   Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705
   Greenwood M, 1931, J HYG-CAMBRIDGE, V31, P336, DOI 10.1017/S002217240001086X
   GREENWOOD M, 1988, REV INFECT DIS, V10, P492
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Halloran ME, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0985-3
   HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884
   Hambidge SJ, 2006, JAMA-J AM MED ASSOC, V296, P1990, DOI 10.1001/jama.296.16.1990
   Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w
   Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/NEJMoa1700153, 10.1056/nejmoa1700153]
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kahn R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002632
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Ki M, 2003, AM J EPIDEMIOL, V157, P158, DOI 10.1093/aje/kwf167
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Klemm EJ, 2018, MBIO, V9, DOI 10.1128/mBio.00105-18
   Klinkenberg D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005495
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778
   Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310
   Kunkel A, 2017, LANCET INFECT DIS, V17, pE429, DOI 10.1016/S1473-3099(17)30299-2
   Kunkel A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002142
   Kurum E, 2017, EPIDEMIOLOGY, V28, P889, DOI 10.1097/EDE.0000000000000719
   LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lessem E, 2015, INT J INFECT DIS, V32, P56, DOI 10.1016/j.ijid.2014.12.012
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leung R, 2015, JAMA PEDIATR, V169, P876, DOI 10.1001/jamapediatrics.2015.1530
   Levin BR, 2000, GENETICS, V154, P985
   Lewnard JA, 2018, AM J EPIDEMIOL, V187, P2686, DOI 10.1093/aje/kwy163
   Lewnard JA, 2018, LANCET, V392, P189, DOI 10.1016/S0140-6736(18)31443-0
   Lewnard JA, 2018, J INFECT DIS, V218, P1356, DOI 10.1093/infdis/jiy343
   Lewnard JA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5945
   Li LM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0541-9
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604
   Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001
   Lofgren ET, 2014, P NATL ACAD SCI USA, V111, P18095, DOI 10.1073/pnas.1421551111
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Majumder MS, 2017, LANCET INFECT DIS, V17, P361, DOI 10.1016/S1473-3099(17)30122-6
   Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483
   MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0
   Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662
   Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6
   Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   Muench H, 1934, J AM STAT ASSOC, V29, P25, DOI 10.2307/2278457
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804
   Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8
   Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894
   OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Panum PL, 1988, CHALLENGE EPIDEMIOLO, P37
   Perdue CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114857
   Petousis-Harris H, 2017, LANCET, V390, P1603, DOI 10.1016/S0140-6736(17)31449-6
   Power RA, 2017, NAT REV GENET, V18, P41, DOI 10.1038/nrg.2016.132
   Reed W, 1900, Public Health Pap Rep, V26, P37
   Reingold Arthur, 2003, Biosecur Bioterror, V1, P77, DOI 10.1089/153871303766275745
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Rivers C, 2014, NATURE, V515, P493, DOI 10.1038/515492a
   Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   Ross Ronald, 1911, PREVENTION MALARIA
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131
   Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49
   Sealey KL, 2015, J INFECT DIS, V212, P294, DOI 10.1093/infdis/jiu665
   SHIELDS WD, 1988, J PEDIATR-US, V113, P801, DOI 10.1016/S0022-3476(88)80004-0
   Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265
   Siu LL, 2015, CLIN CANCER RES, V21, P4536, DOI 10.1158/1078-0432.CCR-14-3215
   Snow J, 1855, MODE COMMUNICATION C
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stoesser N, 2014, ANTIMICROB AGENTS CH, V58, P7347, DOI 10.1128/AAC.03900-14
   Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064
   Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]
   Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174
   Tappero JW, 2017, EMERG INFECT DIS, V23
   Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8
   Tedijanto C, 2018, BIORXIV, DOI [10.1101/288704, DOI 10.1101/288704]
   Tsuzuki S, 2017, EUROSURVEILL, V22
   Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334
   US Agency for International Development, EM PAND THREATS PROG
   van Duijn PJ, 2018, LANCET INFECT DIS, V18, P401, DOI 10.1016/S1473-3099(18)30056-2
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2
   Widdowson MA, 2016, MMWR-MORBID MORTAL W, V65, P98, DOI 10.15585/mmwr.su6503a14
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wohl S, 2018, BIORXIV, DOI [10.1101/343897, DOI 10.1101/343897]
   Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149
   World Health Organization Regional Office for Africa, 9 WHO REG OFF AFR
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
NR 165
TC 0
Z9 0
U1 3
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD MAY
PY 2019
VL 188
IS 5
BP 873
EP 882
DI 10.1093/aje/kwy264
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JH8BM
UT WOS:000492993400011
PM 30877295
OA Green Published
DA 2020-07-08
ER

PT J
AU Kuller, LH
AF Kuller, Lewis H.
TI Epidemiologists of the Future: Data Collectors or Scientists?
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Editorial Material
DE causality; cervical cancer; epidemics; genomics; preventive medicine;
   teaching
ID UNITED-STATES; CANCER INCIDENCE; ZIKA VIRUS; HEALTH; ASSOCIATION;
   DISEASE; WOMEN; OPPORTUNITIES; MORTALITY; SOCIETY
AB Epidemiology is the study of epidemics. It is a biological science that includes expertise in many disciplines in social and behavioral sciences. Epidemiology is also a key component of preventive medicine and public health. Unfortunately, over recent years, academic epidemiology has lost its relationship with preventive medicine, as well as much of its focus on epidemics. The new "-omics" technologies to measure risk factors and phenotypes, and advances in genomics (e.g., host susceptibility) consistent with good epidemiology methods will likely enhance epidemiology research. There is a need based on these new technologies to modify training, especially for the first-level doctorate epidemiologist.
C1 [Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, 130 North Bellefield Ave,Room 354, Pittsburgh, PA 15261 USA.
RP Kuller, LH (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, 130 North Bellefield Ave,Room 354, Pittsburgh, PA 15261 USA.
EM kullerl@edc.pitt.edu
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1436
   Adami HO, 2016, EUR J EPIDEMIOL, V31, P1161, DOI 10.1007/s10654-016-0218-7
   Apovian CM, 2016, NEW ENGL J MED, V374, P177, DOI 10.1056/NEJMe1514957
   Bound J, 2015, HEALTH AFFAIR, V34, P2167, DOI 10.1377/hlthaff.2015.0481
   Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P585, DOI 10.1002/art.40383
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226
   Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Di Q, 2017, JAMA-J AM MED ASSOC, V318, P2446, DOI 10.1001/jama.2017.17923
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068
   Ebrahim S, 2001, INT J EPIDEMIOL, V30, P433, DOI 10.1093/ije/30.3.433
   EVANS AS, 1976, YALE J BIOL MED, V49, P175
   Fang D, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0954
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franceschini N, 2018, JAMA CARDIOL, V3, P712, DOI 10.1001/jamacardio.2018.1827
   Galea S, 2017, EUR J EPIDEMIOL, V32, P169, DOI 10.1007/s10654-017-0233-3
   Galea S, 2013, AM J EPIDEMIOL, V178, P1185, DOI 10.1093/aje/kwt172
   Gates B, 2018, NEW ENGL J MED, V378, P2057, DOI 10.1056/NEJMp1806283
   Gomes T, 2018, J ADDICT MED, V12, P418, DOI 10.1097/ADM.0000000000000412
   Greenland P, 2018, JAMA CARDIOL, V3, P789, DOI 10.1001/jamacardio.2018.1576
   Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6
   Hang D, 2018, EUR J EPIDEMIOL, V33, P485, DOI 10.1007/s10654-018-0382-z
   Hindy G, 2018, STROKE, V49, P820, DOI 10.1161/STROKEAHA.117.019653
   Institute of Medicine, 2011, NAT FRAM SURV CARD C
   Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210
   Jacobson MF, 2018, JAMA-J AM MED ASSOC, V320, P341, DOI 10.1001/jama.2018.7434
   Jemal A, 2018, NEW ENGL J MED, V378, P1999, DOI 10.1056/NEJMoa1715907
   Kitzman DW, 2014, J AM COLL CARDIOL, V63, P457, DOI 10.1016/j.jacc.2013.10.007
   Kuller L, 2007, AM J EPIDEMIOL, V166, P1109, DOI 10.1093/aje/kwm258
   Kuller LH, 2018, EUR J EPIDEMIOL, V33, P613, DOI 10.1007/s10654-018-0420-x
   Kuller LH, 2016, EUR J EPIDEMIOL, V31, P957, DOI 10.1007/s10654-016-0196-9
   Kuller LH, 2016, AM J EPIDEMIOL, V183, P372, DOI 10.1093/aje/kwv158
   Kuller LH, 2013, AM J EPIDEMIOL, V178, P1350, DOI 10.1093/aje/kwt239
   KULLER LH, 1987, YALE J BIOL MED, V60, P363
   Lee LK, 2018, JAMA-J AM MED ASSOC, V320, P543, DOI 10.1001/jama.2018.6566
   LILIENFELD A M, 1959, J Chronic Dis, V10, P41, DOI 10.1016/0021-9681(59)90016-5
   LILIENFELD AM, 1973, AM J EPIDEMIOL, V97, P135, DOI 10.1093/oxfordjournals.aje.a121494
   Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977
   Liu G, 2018, J AM COLL CARDIOL, V71, pS168, DOI 10.1016/j.jacc.2018.04.027
   Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003
   MARMOT MG, 1999, SOCIAL DETERMINANTS
   McClelland A, 2018, LANCET, V391, P2489
   Naimi TS, 2018, JAMA INTERN MED, V178, P894, DOI 10.1001/jamainternmed.2018.1406
   Neta G, 2018, AM J EPIDEMIOL, V187, P899, DOI 10.1093/aje/kwx323
   Ogilvie GS, 2018, JAMA-J AM MED ASSOC, V320, P43, DOI 10.1001/jama.2018.7464
   Ogino S, 2012, AM J EPIDEMIOL, V176, P659, DOI 10.1093/aje/kws226
   Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870
   PRIDAN H, 1971, ISRAEL J MED SCI, V7, P1465
   Richard MA, 2017, AM J HUM GENET, V101, P888, DOI 10.1016/j.ajhg.2017.09.028
   Roth GA, 2018, JAMA CARDIOL, V3, P375, DOI 10.1001/jamacardio.2018.0385
   Rothman KJ, 2017, EUR J EPIDEMIOL, V32, P863, DOI 10.1007/s10654-017-0314-3
   Said MA, 2018, JAMA CARDIOL, V3, P693, DOI 10.1001/jamacardio.2018.1717
   Saracci R, 2018, EUR J EPIDEMIOL, V33, P245, DOI 10.1007/s10654-018-0385-9
   Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326
   Stang A, 2017, EUR J EPIDEMIOL, V32, P21, DOI 10.1007/s10654-016-0211-1
   Stone DM, 2018, MMWR-MORBID MORTAL W, V67, P617, DOI 10.15585/mmwr.mm6722a1
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297
   Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668
   TERRIS M, 1992, AM J EPIDEMIOL, V136, P909, DOI 10.1093/oxfordjournals.aje.a116563
   Toy M, 2018, HEALTH AFFAIR, V37, P1033, DOI 10.1377/hlthaff.2018.0035
   Wurtz P, 2017, AM J EPIDEMIOL, V186, P1084, DOI 10.1093/aje/kwx016
   Yang J, 2018, LANCET, V391, P10135
NR 64
TC 1
Z9 1
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD MAY
PY 2019
VL 188
IS 5
BP 890
EP 895
DI 10.1093/aje/kwy221
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JH8BM
UT WOS:000492993400014
PM 30877293
DA 2020-07-08
ER

PT J
AU Sallam, MF
   Pereira, RM
   Batich, C
   Koehler, P
AF Sallam, Mohamed F.
   Pereira, Roberto M.
   Batich, Chris
   Koehler, Philip
TI Factors Affecting Short-Range Host-Seeking for the Yellow Fever Mosquito
   (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes; short-range cue; taxis box; vector-host interaction; Zika
ID CULEX-QUINQUEFASCIATUS DIPTERA; CARBON-DIOXIDE; AEDES-AEGYPTI; FLIGHT
   MANEUVERS; ODOR; RESPONSES; 1-OCTEN-3-OL; ATTRACTION; BEHAVIOR; ACETONE
AB Understanding short-range cues (e.g., host odorants, heat, moisture) of host-seeking female Aedes aegypti L. is very important for attempts to reduce mosquito bites, to complement current control strategies, and to develop potential spatial repellents. We investigated behavior under semi-field conditions utilizing a new portable uni-port taxis box with a caged chicken host. The combined influences of airflow regimes (0, 1.5, 3, 5, and 6 m/s), distance from host odor (10, 50, 100 cm), host-odor confinement (partial confinement/unconfined), and foraging periodicity (day/evening) were studied. Statistical regression analysis was used to delineate the significant factors that predict upwind flight behavior and short-range source location. Almost 15% of host-seeking Ae. aegypti were activated by an unconfined chicken odor in still air. This was double the number of attracted mosquitoes to confined host odor. The maximum behavioral response was reported with airflow of 5 m/s during daytime (76.7% +/- 2.85) at a distance of 10 (70.7% +/- 2.47) and 50 cm (56.7% +/- 8.88). However, airflow of 6 m/s activated host-seeking orientation during evening assays. The host-seeking response between indoor and outdoor experiments was not significantly different and demonstrated the reliability of the portable taxis box in evaluating mosquito short-range behavioral response toward hosts.
C1 [Sallam, Mohamed F.] New Orleans Mosquito Termite & Rodent Control Boa, New Orleans, LA 70122 USA.
   [Pereira, Roberto M.; Koehler, Philip] UF IFAS, Entomol & Nematol Dept, Urban Entomol Lab, Gainesville, FL 32608 USA.
   [Batich, Chris] UF, Mat Sci & Engn Dept, Gainesville, FL 32608 USA.
RP Sallam, MF (corresponding author), New Orleans Mosquito Termite & Rodent Control Boa, New Orleans, LA 70122 USA.
EM mwsallam2009@aol.com
RI ; Pereira, Rosa Maria Rodrigues/C-5192-2012
OI Sallam, Mohamed/0000-0003-2817-6190; Pereira, Rosa Maria
   Rodrigues/0000-0002-3723-5028
FU US Army through Deployed War Fighter Protection (DWFP) grant
   [W911QY-15-1-0003]
FX Authors would like to express their deep gratitude to the US Army for
   funding the current work through Deployed War Fighter Protection (DWFP)
   grant # W911QY-15-1-0003. We would like to thank our colleagues and
   co-workers at Urban Entomology Laboratory for support and encouragement,
   especially Mr. Eric T. Anderson. We extend our deep appreciation to Dr.
   D. Kline and Mr. Greg Kneu, USDA, Gainesville, for logistic support with
   the necessary laboratory mosquitoes. Any opinions, findings, and
   conclusions or recommendations expressed in this material are those of
   the author(s) and do not necessarily reflect the position or the policy
   of the Government and no official endorsement should be inferred.
CR Afify A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103765
   Allan SA, 2006, J MED ENTOMOL, V43, P225, DOI 10.1603/0022-2585(2006)043[0225:LEOAOF]2.0.CO;2
   Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2
   Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5
   Clements A.N, 1999, BIOL MOSQUITOES SENS, V2
   Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x
   Cooperband MF, 2008, J INSECT PHYSIOL, V54, P1184, DOI 10.1016/j.jinsphys.2008.05.003
   Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736
   Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x
   Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186
   Fikrig K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1946-y
   GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680
   Hao HL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7601
   Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x
   Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946
   Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486
   Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463
   Kuenen LPS, 2014, PHYSIOL ENTOMOL, V39, P271, DOI 10.1111/phen.12072
   Lacey ES, 2014, PHYSIOL ENTOMOL, V39, P60, DOI 10.1111/phen.12048
   Lacey ES, 2012, PHYSIOL ENTOMOL, V37, P153, DOI 10.1111/j.1365-3032.2011.00829.x
   Mboera LEG, 1998, J VECTOR ECOL, V23, P107
   Mboera LEG, 2000, B ENTOMOL RES, V90, P155, DOI 10.1017/S0007485300000262
   Ogoma SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110433
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   Pates HV, 2001, MED VET ENTOMOL, V15, P293, DOI 10.1046/j.0269-283x.2001.00310.x
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Pruck-Ngern M, 2015, VET PARASITOL, V207, P161, DOI 10.1016/j.vetpar.2014.10.032
   Puri SN, 2006, J MED ENTOMOL, V43, P207, DOI 10.1603/0022-2585(2006)043[0207:EABROC]2.0.CO;2
   SAS Institute Inc, 2015, JMP 12 DOC LIB
   Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7
   Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106
   Takken W, 1997, J INSECT BEHAV, V10, P395, DOI 10.1007/BF02765606
   Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002
   Uniyal A, 2016, J ARTHROPOD-BORNE DI, V10, P372
   Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x
NR 35
TC 1
Z9 1
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2019
VL 56
IS 3
BP 609
EP 616
DI 10.1093/jme/tjy230
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA IT5CI
UT WOS:000482879500004
PM 30689913
DA 2020-07-08
ER

PT J
AU Kantor, AM
   Lin, JY
   Wang, A
   Thompson, DC
   Franz, AWE
AF Kantor, Asher M.
   Lin, Jingyi
   Wang, Allen
   Thompson, Dana C.
   Franz, Alexander W. E.
TI Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae)
   and Transmission Potential of the Virus in Mixed Infections With
   Chikungunya Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Mayaro virus; chikungunya virus; mosquito; saliva; superinfection
   exclusion
ID HUMAN-DISEASE AGENT; ACUTE FEBRILE ILLNESS; WEST NILE; SUPERINFECTION
   EXCLUSION; CULEX-PIPIENS; ZIKA VIRUS; MOSQUITO; DENGUE; COINFECTION;
   ALBOPICTUS
AB Mayaro virus (MAYV; Togaviridae; Alphavirus) has drawn increasing attention as an arthropod-borne virus with potential to cause outbreaks among the human populations of the Western Hemisphere. In the tropical regions of Central and South America, the virus exists in sylvatic cycles between mosquitoes and primate reservoirs such as marmosets. Although forest-dwelling mosquitoes are regarded as important vectors for MAYV, it has been shown previously that the virus can infect and potentially be transmitted by the mosquitoes, Aedes aegypti and Aedes albopictus (Diptera: Culicidae). Here, we compare the infection and transmission efficiencies of two MAYV strains, IQT 4235 from Iquitos, Peru ('IQT') and the type strain of MAYV from Trinidad, TRVL 4675 ('TRVL') in two laboratory-adapted Ae. aegypti strains, Higgs White Eye and Orlando. The TRVL strain was less efficiently transmitted by both mosquito strains than MAYV IQT. Based on the full-length nucleotide sequences of the two viral genomes, we show that the TRVL prototype strain of MAYV is phylogenetically ancestral and more distantly related to the IQT strain. The TRVL strain efficiently infected wild-type Ae. albopictus from Missouri and readily disseminated in those. Considering scenarios in which natural MAYV transmission cycles may overlap with those of chikungunya virus (CHIKV; Togaviridae; Alphavirus), we assessed the effects of mixed infections of the two viruses in mosquitoes based on coinfection or superinfection. Although coinfection had no measurable effect on the transmission potential of either virus, we observed superinfection exclusion for CHIKV in MAYV-infected mosquitoes but not for MAYV in CHIKV-infected mosquitoes.
C1 [Kantor, Asher M.; Lin, Jingyi; Thompson, Dana C.; Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Wang, Allen] Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA.
RP Franz, AWE (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
EM franza@missouri.edu
FU National Institutes of Health - National Institute of Allergy and
   Infectious Diseases (NIH-NIAID)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI091972,
   R01AI134661]
FX The viruses used in this work were obtained through the UTMB-Galveston
   Arbovirus Reference Collection maintained at the World Reference Center
   for Emerging Viruses and Arboviruses (WRCEVA). All virus infection
   experiments have been carried out in the BSL3 virology suite of the
   Laboratory of Infectious Diseases Research (LIDR) at the University of
   Missouri. This work was funded by grants from the National Institutes of
   Health - National Institute of Allergy and Infectious Diseases
   (NIH-NIAID), R01AI091972 and R01AI134661. NIH did not have a role in
   study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Borucki MK, 1999, J GEN VIROL, V80, P3173, DOI 10.1099/0022-1317-80-12-3173
   Brustolin M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006895
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Dong S., 2016, SCI REP, V6
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gaidamovich S Y, 1973, Intervirology, V1, P193, DOI 10.1159/000148846
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Izurieta RO, 2011, J GLOB INFECT DIS, V3, P317, DOI 10.4103/0974-777X.91049
   Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Singh IR, 1997, VIROLOGY, V231, P59, DOI 10.1006/viro.1997.8492
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   SUNDIN DR, 1988, AM J TROP MED HYG, V38, P428, DOI 10.4269/ajtmh.1988.38.428
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   TRAVIS BV, 1946, J ECON ENTOMOL, V39, P627, DOI 10.1093/jee/39.5.627
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wendell MD, 2000, INSECT MOL BIOL, V9, P119, DOI 10.1046/j.1365-2583.2000.00166.x
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 49
TC 2
Z9 2
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2019
VL 56
IS 3
BP 832
EP 843
DI 10.1093/jme/tjy241
PG 12
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA IT5CI
UT WOS:000482879500031
PM 30668762
OA Green Published
DA 2020-07-08
ER

PT J
AU Yoshikawa, FSY
   Sato, MN
AF Yamada Yoshikawa, Fabio Seiti
   Sato, Maria Notomi
TI What are the implications of silent replication in fetal and newborn
   monocytes for Zika therapeutic development?
SO FUTURE VIROLOGY
LA English
DT Editorial Material
ID VIRUS; TARGET; DAMAGE
C1 [Yamada Yoshikawa, Fabio Seiti; Sato, Maria Notomi] Univ Sao Paulo, Lab Invest Dermatol & Imunodeficiencias LIM56, Inst Med Trop, Fac Med FMUSP, Sao Paulo, SP, Brazil.
   [Sato, Maria Notomi] Univ Sao Paulo, Dept Imunol, Inst Ciencias Biomed ICBUSP, Sao Paulo, SP, Brazil.
RP Sato, MN (corresponding author), Univ Sao Paulo, Lab Invest Dermatol & Imunodeficiencias LIM56, Inst Med Trop, Fac Med FMUSP, Sao Paulo, SP, Brazil.; Sato, MN (corresponding author), Univ Sao Paulo, Dept Imunol, Inst Ciencias Biomed ICBUSP, Sao Paulo, SP, Brazil.
EM marisato@usp.br
RI Yoshikawa, Fabio Seiti Yamada/F-3049-2014; Sato, Maria N/C-1196-2012
OI Yoshikawa, Fabio Seiti Yamada/0000-0002-6112-7107; Sato, Maria
   N/0000-0002-7911-1824
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/16840-6, 2016/09764-1]
FX This work was supported by Sao Paulo Research Foundation (FAPESP) grant
   numbers 2016/16840-6 and 2016/09764-1. The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   da Silva LRC, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020051
   Cardoso EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067036
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gorshkov K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03252
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hazleton JE, 2010, HIV AIDS-RES PALLIAT, V2, P39
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Yoshikawa FSY, 2019, J INFECT DIS
NR 19
TC 0
Z9 0
U1 0
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD MAY
PY 2019
VL 14
IS 5
BP 299
EP 301
DI 10.2217/fvl-2019-0029
PG 3
WC Virology
SC Virology
GA IO1RH
UT WOS:000479159100001
OA Bronze
DA 2020-07-08
ER

PT J
AU Pratheeba, T
   Vivekanandhan, P
   Faeza, AKN
   Natarajan, D
AF Pratheeba, T.
   Vivekanandhan, P.
   Faeza, A. K. Nur
   Natarajan, D.
TI Chemical constituents and larvicidal efficacy of Naringi crenulata
   (Rutaceae) plant extracts and bioassay guided fractions against Culex
   quinquefasciatus mosquito (Diptera: Culicidae)
SO BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY
LA English
DT Article
DE Culex quinquefasciatus; Larvicidal activity; Naringi crenulata; HPLC
   analysis; GC-MS analysis; Mosquitoes
ID ANOPHELES-STEPHENSI LISTON; AEDES-AEGYPTI; ESSENTIAL OIL; DENGUE;
   MALARIA; COMPOUND
AB Mosquitoes transmitted several vector borne diseases like malaria, dengue, lymphatic filariasis and now Zika virus. Synthetic chemicals cause much illness to humans, non-target organisms and natural ecosystem. In the present study, larvicidal efficacy of Naringi crenulata (Rutaceae) different leaf extracts and bioassay guided fractions against Culex quinquefasciatus, phytochemical screening and secondary metabolites were characterized by TLC, HPLC, GC-MS and FT-IR analysis. Our results show highest larval mortality was found in acetone extract. For 24h LC50 and LC90 values were, 1.020, 1.931 mg/l. And 48h LC50 and LC90 values were, 3.728, 4.771 mg/l respectively. Fraction 9th showed remarkable larvicidal activity on larvae of Cx. quinquefasciatus. For 24h LC50 and LC90 values were, 5.312, 9.130 mg/l), for 48h LC50 and LC90 values were, 5.000, 9.538 mg/l. Phytochemical screening of N. crenulata crude extract contains phenols, alkaloids, tannins, saponins in acetone extracts. GC-MS analysis results show, 9,12-Octadecadienoic Acid (Z, Z)- (26.846%) is a major chemical constituent may be involved in larvicidal activity. Thin layer chromatography analysis shows nine molecules were separated using chloroform: methanol in the ratio 9.7: 0.3 solvent system. A sharp single peak was obtained in the 9th fraction with retention time of 1.376min with a purity of 99%. FT-IR analysis results confirmed presence of alkynes, alcohols, phenols, carboxylic acids, stretching, wagging and bending of oxygenated bonding. The present study shows that chemical constituents obtained from N. crenulata extracts and 9th fraction have strong larvicidal properties these botanical derived molecules offered alternative to synthetic chemical insecticides.
C1 [Pratheeba, T.; Natarajan, D.] Periyar Univ, Sch Biosci, Dept Biotechnol, Nat Drug Res Lab, Salem 636011, Tamil Nadu, India.
   [Vivekanandhan, P.] Periyar Univ, Sch Biosci, Dept Biotechnol, Mol Entomol Lab, Salem 636011, Tamil Nadu, India.
   [Faeza, A. K. Nur] Univ Sains Malaysia, Sch Biol Sci, Med Entomol Lab, George Town 11800, Minden, Malaysia.
RP Natarajan, D (corresponding author), Periyar Univ, Sch Biosci, Dept Biotechnol, Nat Drug Res Lab, Salem 636011, Tamil Nadu, India.
EM natarajpu@gmail.com
RI Perumal, Vivekanandhan/H-2783-2017
OI Perumal, Vivekanandhan/0000-0002-3283-1306
CR ABOUELNAGA ZS, 2014, J ENTOMOL ZOOL STU G, V2, P340
   Bashir Ahmad, 2012, Journal of Medicinal Plants Research, V6, P4653
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bernhard L, 2003, ALTERN APPROACH PHYS, V89, P743, DOI DOI 10.1016/S0031-9406(05)60500-7
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M, 2013, PARASITOL RES, V113, P777
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Jaya Sree S, 2015, INT J PHARM PHARM RE, V3
   Kamaraj C, 2010, PARASITOL RES, V107, P1337, DOI 10.1007/s00436-010-2006-8
   Lakshmi V, 2015, INT J MULTIDISCIP RE, V2, P294
   Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7
   Mondal SK, 2003, INDIAN J CHEM B, V42, P437
   Pradeepa V, 2014, PARASITOL RES, V113, P3105, DOI 10.1007/s00436-014-4015-5
   PRATHEEBA T, 2015, INT J MOSQ RES A, V2, P1
   Rahuman AA, 2008, PARASITOL RES, V102, P981, DOI 10.1007/s00436-007-0864-5
   Raj GA, 2015, PARASITOL RES, V114, P3385, DOI 10.1007/s00436-015-4563-3
   Rajith N. P., 2010, Indian Journal of Natural Products and Resources, V1, P249
   Ramani R, 2010, INT J PHARM RES DEV, V2, P1
   Ramkumar G, 2015, PARASITOL RES, V114, P2553, DOI 10.1007/s00436-015-4459-2
   Ramkumar G, 2015, PARASITOL RES, V114, P167, DOI 10.1007/s00436-014-4173-5
   Samundeeswari A, 2012, INT J CURR SCI, V94, P2250
   Sanchez I, 2000, PHYTOTHER RES, V14, P89, DOI 10.1002/(SICI)1099-1573(200003)14:2&lt;89::AID-PTR569&gt;3.0.CO;2-C
   Sarada K., 2011, International Journal of ChemTech Research, V3, P1548
   Sargunam M. P, 2011, J BASIC APPL BIO, V5, P60
   Satheesh K. B, 2012, NUJHS, V2, P2249
   Senthilkumar M., 2006, TAMIL NADU NAT PROD, V5, P382
   Sharma G, 2014, PARASITOL RES, V113, P197, DOI 10.1007/s00436-013-3644-4
   Sudha T., 2013, Journal of Applied Pharmaceutical Science, V3, P126
   Thamaraiselvi P, 2012, ASIAN J PLANT SCI, V2, P115
   Torres RC, 2015, PARASITOL RES, V114, P3699, DOI 10.1007/s00436-015-4598-5
   Udayan PS, 2008, INDIAN J TRADIT KNOW, V7, P250
   Vivekanandhan P., 2018, J CLUST SCI, DOI [10.1007/s10876-018-1423-1.0, DOI 10.1007/S10876-018-1423-1.0]
   Vivekanandhan Perumal, 2019, Nat Prod Res, P1, DOI 10.1080/14786419.2018.1547290
   Vivekanandhan P, 2018, PATHOG GLOB HEALTH, V112, P37, DOI 10.1080/20477724.2018.1438228
   Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030440
   Vivekanandhan P, 2018, PHYSIOL MOL PLANT P, V101, P156, DOI 10.1016/j.pmpp.2017.05.005
   Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020388
   World Health Organization, 2005, GUID LAB FIELD TEST, V13, P10
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
NR 41
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1878-8181
J9 BIOCATAL AGRIC BIOTE
JI Biocatal. Agric. Biotechnol.
PD MAY
PY 2019
VL 19
AR UNSP 101137
DI 10.1016/j.bcab.2019.101137
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA IL9ZS
UT WOS:000477644800042
DA 2020-07-08
ER

PT J
AU Satoto, TBT
   Pascawati, NA
   Purwaningsih, W
   Josef, HK
   Purwono
   Rumbiwati
   Hermanto
   Mubarika, S
   Frutos, R
AF Satoto, Tri Baskoro T.
   Pascawati, Nur Alvira
   Purwaningsih, Wida
   Josef, Hari Kusnanto
   Purwono
   Rumbiwati
   Hermanto
   Mubarika, Sofia
   Frutos, Roger
TI Occurrence of Natural Vertical Transmission of "Zika like Virus" in
   Aedes aegypti Mosquito in Jambi City
SO KESMAS-NATIONAL PUBLIC HEALTH JOURNAL
LA English
DT Article
DE Transmission; vertical; Zika; Aedes aegypti
ID STATE; OUTBREAK
AB Zika virus can be transmitted through mosquitoes such as Aedes aegypti and Ae. albopictus. During the transition period of 2014-2015, an outbreak of dengue was reported in Jambi City, during which several sufferers were screened positive for Zika virus infection by the Eijkman Institute. It was interesting to note that all of those positive for Zika virus infection were indigenous residents and none of them had a history of international travel. This descriptive analytic study with a cross-sectional design study was conducted to present an overview of Aedes spp. population using ovitrap and egg colonization methods and to detect the presence of Zika virus. Samples were analyzed using reverse transcription polymerase chain reaction for detection of Zika "like" virus and the mapping results were described. The Ovitrap Index was 44.74%, and examination of egg colonization collected from 40 neighborhoods revealed the presence of Zika "like" virus in samples obtained from the fourth neighborhood in Talang Bakung village. This result indicates the occurrence of natural vertical transmission of Zika "like" virus in A. aegypti mosquito in Jambi City, which potentially resulted in an outbreak.
C1 [Satoto, Tri Baskoro T.] Univ Gadjah Mada, Fac Med, Ctr Trop Med, Yogyakarta, Indonesia.
   [Pascawati, Nur Alvira] Univ Respati, Fac Hlth Sci, Publ Hlth Study Program, Yogyakarta, Indonesia.
   [Purwaningsih, Wida] Port Hlth Quarantine Jambi Prov, Yogyakarta, Indonesia.
   [Josef, Hari Kusnanto] Univ Gadjah Mada, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia.
   [Purwono] Univ Gadjah Mada, Fac Med, Dept Parasitol, Yogyakarta, Indonesia.
   [Rumbiwati; Hermanto] Hlth Polytech Jambi Prov, Yogyakarta, Indonesia.
   [Mubarika, Sofia] Univ Gadjah Mada, Fac Med, Dept Histol, Yogyakarta, Indonesia.
   [Frutos, Roger] Univ Montpellier, Montpellier, France.
RP Pascawati, NA (corresponding author), Respati Yogyakarta Univ, Publ Hlth Studies Program, Fac Hlth Sci, A Bldg,Jalan Raya Tajem KM 1,5, Sleman, Indonesia.
EM irha011859@yahoo.com
RI Pascawati, Nur Alvira/AAO-8425-2020
OI Pascawati, Nur Alvira/0000-0003-2804-7620
FU Ministry Education and Research of Indonesia
   [4091/UN1-PIII/LT/Dit-Lit/2016]
FX Deepest gratitude is directed toward the Health Office of Jambi City,
   Talang Bakung Primary Health Center, supervisors, and all related
   individuals supporting the research. INSINAS Research Funds No
   4091/UN1-PIII/LT/Dit-Lit/2016 Ministry Education and Research of
   Indonesia.
CR Andriyani Y, 2009, DETEKSI DAN PENENTUA
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cahyati WH, 2016, UNNES J PUBLIC HLTH, V5, P330
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Javois L.C., 1999, IMMUNOCYTOCHEMICAL M
   Kendall LV, 2000, CONTEMP TOP LAB ANIM, V39, P42
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee H. L., 1992, Mosquito Borne Diseases Bulletin, V9, P9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Sasmono T, 2012, PROS INSINAS 2012, P1
   Satoto TBT, 2017, KESMAS, V11, P178, DOI 10.21109/kesmas.v11i4.1248
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Titi Fatmawati, 2014, UNNES J LIFE SCI, V3, P130
   WHO, 2016, WHO ZIK SIT REP
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 0
Z9 0
U1 0
U2 0
PU UNIV INDONESIA
PI DEPOK
PA DIRECTORATE RESEARCH & PUBLIC SERV, UI CAMPUS, KAMOUS UNIV INDONESIA,
   DEPOK, 16424, INDONESIA
SN 1907-7505
EI 2460-0601
J9 KESMAS
JI Kesmas
PD MAY
PY 2019
VL 13
IS 4
BP 189
EP 194
DI 10.21109/kesmas.v13i4.2709
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IN3KH
UT WOS:000478575300006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cuadrado, JLC
   Pinillos, EO
   Tito, R
   Mirones, CS
   Mendoza, NNG
AF Claros Cuadrado, Jose L.
   Pinillos, Elder O.
   Tito, Richard
   Seguil Mirones, Carlos
   Gamarra Mendoza, Norma N.
TI Insecticidal Properties of Capsaicinoids and Glucosinolates Extracted
   from Capsicum chinense and Tropaeolum tuberosum
SO INSECTS
LA English
DT Article
DE aphid pests; bioinsecticide; climate change; eco-friendly products;
   natural insecticides; natural products; pest control
ID APHIDS HEMIPTERA; CROP PESTS; ZIKA VIRUS; LOSSES; PLANT
AB Food security and biodiversity conservation are threatened by the emergence and spread of pest and pathogens, and thus there is a current need to develop pest management strategies that are sustainable and friendly to the environment and human health. Here, we performed laboratory and field bioassays to evaluate the insecticidal effects of several concentrations of capsaicinoids and glucosinolates (separately and mixed) on an aphid pest (Aphis cytisorum). The capsaicinoids were extracted from the fruits of Capsicum chinense and glucosinolates from the tubers of native Andean crop Tropaeolum tuberosum. We found that both capsaicinoids and glucosinolates have a biocidal effect on A. cytisorum, acting within a fairly short time. Under laboratory conditions, the toxicity of the compounds increased in relation to their concentrations, causing a high percentage of mortality (83-99%) when the aphids were exposed to dilutions of 10% capsaicinoids, 75-100% glucosinolates, or a mixture of 10% capsaicinoids and 90% glucosinolates. The mortality of aphids sprayed in the field with 5% capsaicinoids, 50% glucosinolates, or with a mixture of 5% capsaicinoids and 45% glucosinolates reached 87-97%. Results obtained from laboratory and field experiments were consistent. Our results suggest the potential use of bioinsecticides based on capsaicinoids and/or glucosinolates as an effective alternative to synthetic pesticides.
C1 [Claros Cuadrado, Jose L.; Gamarra Mendoza, Norma N.] Natl Univ Cent Peru, Fac Forest & Environmet Sci, Huancayo 12000, Peru.
   [Pinillos, Elder O.] Natl Inst Agr Innovat, Expt Stn Santa, Huancayo 12000, Peru.
   [Tito, Richard] Natl Univ San Antonio Abad Cusco, Sch Biol, Cuzco 08001, Peru.
   [Tito, Richard] Univ Miami, Dept Biol, Coral Gables, FL 33146 USA.
   [Tito, Richard] Natl Univ Cent Peru, High Mt Res Ctr, Huancayo 1200, Peru.
   [Seguil Mirones, Carlos; Gamarra Mendoza, Norma N.] Natl Univ Cent Peru, Fac Food Ind Engn, Huancayo 12000, Peru.
RP Mendoza, NNG (corresponding author), Natl Univ Cent Peru, Fac Forest & Environmet Sci, Huancayo 12000, Peru.; Tito, R (corresponding author), Natl Univ San Antonio Abad Cusco, Sch Biol, Cuzco 08001, Peru.; Tito, R (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33146 USA.; Tito, R (corresponding author), Natl Univ Cent Peru, High Mt Res Ctr, Huancayo 1200, Peru.; Mendoza, NNG (corresponding author), Natl Univ Cent Peru, Fac Food Ind Engn, Huancayo 12000, Peru.
EM jclaroscuadrado@gmail.com; ofeliapinillos@hotmail.com;
   rtitoleon@gmail.com; cseguil60@yahoo.com; aunonegame2016@outlook.com
OI GAMARRA MENDOZA, NORMA NELIDA/0000-0001-6559-6720; Tito,
   Richard/0000-0002-4184-5654
FU Fund for Innovation, Science, and Technology-FINCYT, Peru
   [219-FINCyT-IA-2013]
FX This work was supported by the Fund for Innovation, Science, and
   Technology-FINCYT, Peru, Grant Number No 219-FINCyT-IA-2013.
CR Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7
   Al Othman ZA, 2011, MOLECULES, V16, P8919, DOI 10.3390/molecules16108919
   Alexandratos N., 2012, 20121203 ESA, P12, DOI DOI 10.1016/S0264-8377(03)00047-4
   Asin L, 2001, ENVIRON ENTOMOL, V30, P1127, DOI 10.1603/0046-225X-30.6.1127
   Bebber DP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1398, DOI 10.1111/geb.12214
   Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/NCLIMATE1990, 10.1038/nclimate1990]
   BLACKMAN RL, 2000, APHIDS WORLDS CROPS
   Blanchard S, 2019, PHYSIOL ENTOMOL, V44, P77, DOI 10.1111/phen.12275
   Bourguet D., 2016, SUSTAIN AGR REV, P35, DOI DOI 10.1007/978-3-319-26777-7_2
   Bulacio E, 2012, B SOC ARGENT BOT, V47, P97
   DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x
   Edelson JV, 2002, PEST MANAG SCI, V58, P255, DOI 10.1002/ps.444
   Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2
   FERNANDEZ MVS, 1998, ZAPATERI REVTA ARAGO, V8, P113
   Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452
   Gamarra M.N., 2012, AVANCES INVESTIGACIO
   Guillen NG, 2018, PESQUI AGROPECU TROP, V48, P237, DOI 10.1590/1983-40632018v4852334
   Grau A., 2003, MASHUA TROPAEOLUM TU, P25
   Gudeva LK, 2013, HEM IND, V67, P671, DOI 10.2298/HEMIND120921110K
   Jeeatid N, 2017, HORTIC ENVIRON BIOTE, V58, P103, DOI 10.1007/s13580-017-0165-6
   Juangsamoot J., 2012, International Food Research Journal, V19, P1217
   Li FW, 2009, SEP PURIF TECHNOL, V64, P304, DOI 10.1016/j.seppur.2008.10.005
   Li WZ, 2014, TROP J PHARM RES, V13, P1303, DOI 10.4314/tjpr.v13i8.15
   Maliszewska J., 2012, Journal of Plant Protection Research, V52, P28, DOI 10.2478/v10045-012-0005-8
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MAZID S, 2011, INT J SC ADV TECHNOL, V1, P169, DOI DOI 10.1007/S10886-005-4244-2
   Mikkelsen MD, 2002, AMINO ACIDS, V22, P279, DOI 10.1007/s007260200014
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]
   Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708
   Olszewska J, 2010, ECOL CHEM ENG A, V17, P1355
   Ortego Jaime, 2004, Rev. Soc. Entomol. Argent., V63, P19
   Pandhair V, 2008, J PLANT BIOCHEM BIOT, V17, P23, DOI 10.1007/BF03263255
   Pane C., 2013, Agricultural Sciences, V4, P149
   Ramallo R, 2004, J SCI FOOD AGR, V84, P701, DOI 10.1002/jsfa.1691
   Ryalls J.M.W., 2016, GLOBAL CLIMATE CHANG, P148
   Sganzerla M, 2014, FOOD RES INT, V64, P718, DOI 10.1016/j.foodres.2014.08.003
   Suman Gupta, 2010, Journal of Biopesticides, V3, P186
   TAMBS-LYCHE H, 1971, Entomologica Scandinavica, V2, P125
   Tito R, 2018, GLOBAL CHANGE BIOL, V24, pE592, DOI 10.1111/gcb.13959
   Tito R, 2016, PLANT ECOL, V217, P817, DOI 10.1007/s11258-016-0596-7
   Tsao R, 1996, J AGR ENTOMOL, V13, P109
   Tsao Rong, 2002, BMC Ecology, V2, P1
   Mallqui KV, 2011, ECOL APL, V10, P93, DOI 10.21704/rea.v10i1-2.418
   WOOD BW, 1988, HORTSCIENCE, V23, P851
   Zewdie Y, 2000, EUPHYTICA, V111, P185, DOI 10.1023/A:1003837314929
   Zust T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.206, 10.1038/nplants.2015.206]
NR 48
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD MAY
PY 2019
VL 10
IS 5
AR 132
DI 10.3390/insects10050132
PG 9
WC Entomology
SC Entomology
GA IK8LO
UT WOS:000476846800014
PM 31064092
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pinheiro, GG
   Rocha, MN
   de Oliveira, MA
   Moreira, LA
   Andrade, JD
AF Pinheiro, Guilherme Garcia
   Rocha, Marcele Neves
   de Oliveira, Maria Angelica
   Moreira, Luciano Andrade
   Andrade Filho, Jose Dilermando
TI Detection of Yellow Fever Virus in Sylvatic Mosquitoes during Disease
   Outbreaks of 2017-2018 in Minas Gerais State, Brazil
SO INSECTS
LA English
DT Article
DE arboviruses; yellow fever; mosquitoes
ID MAYARO VIRUS; DENGUE; CHIKUNGUNYA; INFECTION; CULICIDAE; EPIDEMIC
AB Brazil has experienced several arbovirus outbreaks in recent years, among which yellow fever stands out. The state of Minas Gerais faced outbreaks of sylvatic yellow fever in 2017 and 2018, with 1002 confirmed cases and 340 deaths. This work presents the results of survey efforts to detect the yellow fever virus in mosquitoes from two conservation areas in the metropolitan region of Belo Horizonte, Brazil. A total of 867 mosquitoes of 20 species were collected between September 2017 and May 2018, the most abundant being Psorophora (Janthinosoma) ferox (von Humboldt, 1819) (31.3%), Limatus durhamii Theobald, 1901 (19.1%) and Haemagogus (Haemagogus) janthinomys Dyar, 1921 (18.2%). Total RNA was extracted from the mosquitoes for real-time PCR analysis for yellow fever, chikungunya, mayaro, Zika and dengue viruses. The yellow fever infection rate was 8.2% for Hg. janthinomys (13 mosquitoes), which is the main vector of sylvatic yellow fever in Brazil. In addition to surveying the mosquito fauna of these conservation units, this work demonstrates the importance of monitoring the circulation of viruses near large urban centers.
C1 [Pinheiro, Guilherme Garcia; de Oliveira, Maria Angelica] Inst Rene Rachou, Colecao Mosquitos Neotrop, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
   [Rocha, Marcele Neves; Moreira, Luciano Andrade] Inst Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
   [Pinheiro, Guilherme Garcia; Andrade Filho, Jose Dilermando] Inst Rene Rachou, Grp Estudos Leishmanioses, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
RP Pinheiro, GG (corresponding author), Inst Rene Rachou, Colecao Mosquitos Neotrop, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.; Pinheiro, GG; Andrade, JD (corresponding author), Inst Rene Rachou, Grp Estudos Leishmanioses, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM ggarciapinheiro@gmail.com; marcele.rocha@fiocruz.br;
   angelica.oliveira@fiocruz.br; luciano.andrade@fiocruz.br;
   jose.andrade@fiocruz.br
RI Filho, Jose Dilermando Andrade/B-7852-2013
OI Filho, Jose Dilermando Andrade/0000-0002-9754-8464; Rocha,
   Marcele/0000-0001-7130-6961; Pinheiro, Guilherme/0000-0001-7242-3385
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES [001]; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [302701/2016-8, 310446/2017-1]; Secretaria Municipal
   de Saude; Instituto Rene Rachou-FIOCRUZ Minas
FX This research was funded by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior-Brasil (CAPES)-Finance Code 001, FAPEMIG, CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (302701/2016-8 and
   310446/2017-1), Secretaria Municipal de Saude and Instituto Rene
   Rachou-FIOCRUZ Minas.
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   [Anonymous], 2016, ED MANAG, V28, pS1
   Bicca-Marques JC, 2010, TROP CONSERV SCI, V3, P78, DOI 10.1177/194008291000300107
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Dutra HLC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16045-6
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   Consoli R., 1994, PRINCIPAIS MOSQUITOS, P39
   de Souza RP, 2011, REV INST MED TROP SP, V53, P133, DOI 10.1590/S0036-46652011000300004
   Degallier N., 1993, ARTHROPOD BORNE VIRU, P21
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Forattini O. P., 1995, SAUDE PUBLICA, DOI [10.1590/S0102-311X1995000100027, DOI 10.1590/S0102-311X1995000100027]
   Franco O., 1969, HIST FEBRE AMARELA B, P8
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x
   HERVE J-P, 1985, Hileia Medica, V7, P31
   Instituto Estadual de Florstas, 2007, PLAN MAN PARQ EST SE, P11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Litvoc MN, 2018, REV ASSOC MED BRAS, V64, P106, DOI 10.1590/1806-9282.64.02.106
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Marcondes C.B., 2010, REV BIOMED, V21, P221
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondet B, 2002, VECTOR-BORNE ZOONOT, V2, P47, DOI 10.1089/153036602760260779
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Neves D. P., 1973, ARQ ESC VET UFMG, P25
   Pacidonio EC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2236-z
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P204, DOI 10.4269/ajtmh.1981.30.204
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017
   Rocha M. N., 2019, GATES OPEN RES, P1
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   World Health Organization, 2017, GLOB STRAT EL YELL F
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 39
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD MAY
PY 2019
VL 10
IS 5
AR 136
DI 10.3390/insects10050136
PG 12
WC Entomology
SC Entomology
GA IK8LO
UT WOS:000476846800018
PM 31083286
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Binns, C
   Low, WY
AF Binns, Colin
   Low, Wah Yun
TI Zika: Where Are You?
SO ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Binns, Colin] Curtain Univ, Sch Publ Hlth, Perth, WA, Australia.
   [Low, Wah Yun] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.
RP Binns, C (corresponding author), Curtain Univ, Fac Hlth Sci, Sch Publ Hlth, GPO Box U 1987, Perth, WA 6847, Australia.
EM c.binns@curtin.edu.au
RI Low, Wah-Yun/B-1775-2009
OI Low, Wah-Yun/0000-0003-4409-1509
CR Binns C, 2018, ASIA-PAC J PUBLIC HE, V30, P682, DOI 10.1177/1010539518809823
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Goodman AG, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00077
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2019, LANCET INFECT DIS, V19, P349, DOI 10.1016/S1473-3099(18)30793-X
   Hyder AA, 2007, ASIA-PAC J PUBLIC HE, V19, P16, DOI 10.1177/10105395070190020401
   Masel J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007060
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
NR 13
TC 1
Z9 1
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1010-5395
EI 1941-2479
J9 ASIA-PAC J PUBLIC HE
JI Asia-Pac. J. Public Health
PD MAY
PY 2019
VL 31
IS 4
BP 272
EP 274
DI 10.1177/1010539519849976
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IJ3CC
UT WOS:000475780300001
PM 31307217
OA Bronze
DA 2020-07-08
ER

PT J
AU Chaw, LL
   Tuah, NAA
   Idris, FI
   Yaw, JWY
   Naing, L
AF Chaw, Li Ling
   Tuah, Nik Anni Afiqah
   Idris, Fazean Irdayati
   Yaw, Justin Wong Yun
   Naing, Lin
TI Knowledge and Practice Survey on Zika Virus Infection Among General
   Adults in Brunei Darussalam
SO ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE knowledge; practices; Zika; general adults; Brunei
ID TRANSMISSION
AB A cross-sectional survey was conducted to assess the knowledge and practices on Zika virus infection among general adults in Brunei Darussalam. From February to June 2017, 439 adults were interviewed from outpatient health care settings. Most participants were Malays (87.0%) and females (61.5%), with a mean age of 40.7 years. Only 25.1% had a total knowledge score of 15 to 28 points (of a possible score of 0-28). Females and those living in households of <8 people were more likely to have higher total knowledge scores (15-28 points). Media was the preferred source to get updates. Also, 67.4% had a total prevention practice score of 19 to 36 points (of a possible score of 0-36). Those who attained secondary level education or below, had no pregnant women present in their household, and scored 15 to 28 points for knowledge were more likely to have higher prevention practice scores (19-36 points). Knowledge on Zika was significantly associated with prevention practices against mosquito bites and breeding.
C1 [Chaw, Li Ling; Tuah, Nik Anni Afiqah; Idris, Fazean Irdayati; Naing, Lin] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link BE1410, Gadong 1410, Brunei.
   [Tuah, Nik Anni Afiqah] Imperial Coll London, London, England.
   [Yaw, Justin Wong Yun] Minist Hlth, Bandar Seri Begawan, Brunei.
RP Chaw, LL (corresponding author), Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link BE1410, Gadong 1410, Brunei.
EM liling.chaw@ubd.edu.bn
RI Chaw, Liling/R-1591-2019
OI Chaw, Liling/0000-0003-3301-7565; Tuah, Nik/0000-0002-7149-4349
FU Ministry of Health, Brunei Darussalam
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   project received funds for printing costs from the Ministry of Health,
   Brunei Darussalam.
CR [Anonymous], 2017, R LANG ENV STAT COMP
   Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Bertakis KD, 2000, J FAM PRACTICE, V49, P147
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   BruDirect.com, 2016, BRUDIRECT
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandren JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003954
   Chaw LL, 2018, ASIAN PAC J TROP MED, V11, P638, DOI 10.4103/1995-7645.246340
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Department of Economic Planning and Development, POP 2016 POP HOUS CE
   Dony JJF, PLOS CURR OUTBREAKS, DOI [10.1371/currents.outbreaks.73b5c7d110f3bec90d75b2bb4dc9d23c, DOI 10.1371/CURRENTS.OUTBREAKS.73B5C7D110F3BEC90D75B2BB4DC9D23C]
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Harapan H, 2019, CLIN EPIDEMIOL GLOB, V7, P542, DOI 10.1016/j.cegh.2018.12.006
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Idris FH, 2013, J VECTOR ECOL, V38, P197, DOI 10.1111/j.1948-7134.2013.12029.x
   Katler Q, 2017, INFECT DIS OBSTET GY, V2017
   Lwin MO, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4657
   MACDONAL.WW, 1972, B WORLD HEALTH ORGAN, V46, P203
   Meragang National Housing Scheme Cleaning Campaign, 2016, BRUNEI NEWS GAZETTE
   Ministry of Health Brunei Darussalam, 2016, STAY INF STAY PROT Z
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Okogu J, 2011, INT J EC DEV RES INV, P2
   Orbeta Jr AC, POVERTY VULNERABILIT
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WHO, 2017, ZIK VIR COMPL 2016 P
   WHO, 2018, ZIK VIR
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   World Health Organization, 2018, ZIK VIR ZIKV CLASS T
   World Health Organization, 2016, EM PREP RESP KNOWL A
   Yung Chee F, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.44b19196298e01f3a6dcd4c09f235fa8
NR 35
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1010-5395
EI 1941-2479
J9 ASIA-PAC J PUBLIC HE
JI Asia-Pac. J. Public Health
PD MAY
PY 2019
VL 31
IS 4
BP 275
EP 287
DI 10.1177/1010539519850023
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IJ3CC
UT WOS:000475780300002
PM 31096777
DA 2020-07-08
ER

PT J
AU Singh, PK
   Kasetti, RB
   Zode, GS
   Goyal, A
   Juzych, MS
   Kumar, A
AF Singh, Pawan Kumar
   Kasetti, Ramesh B.
   Zode, Gulab S.
   Goyal, Anju
   Juzych, Mark S.
   Kumar, Ashok
TI Zika Virus Infects Trabecular Meshwork and Causes Trabeculitis and
   Glaucomatous Pathology in Mouse Eyes
SO MSPHERE
LA English
DT Article
DE RGC; Zika virus; axonal transport; eye; glaucoma; intraocular pressure;
   ocular infection; optic nerve; retina; trabeculitis
ID INTRAOCULAR-PRESSURE; CELL-DEATH; MANIFESTATIONS; INDUCTION; STRESS;
   AXONOPATHY; TGF-BETA-1; RECEPTOR; UVEITIS; DAMAGE
AB Zika virus (ZIKV) infection during pregnancy leads to devastating fetal outcomes, including neurological (microcephaly) and ocular pathologies such as retinal lesions, optic nerve abnormalities, chorioretinal atrophy, and congenital glaucoma. Only clinical case reports have linked ZIKV infection to causing glaucoma, a major blinding eye disease. In the present study, we have investigated the role of ZIKV in glaucoma pathophysiology using in vitro and in vivo experimental models. We showed that human primary trabecular meshwork (Pr. TM) cells, as well as a human GTM3 cell line, were permissive to ZIKV infection. ZIKV induced the transcription of various genes expressing pattern recognition receptors (TLR2, TLR3, and RIG-I), cytokines/chemokines (TNF-alpha, 1L-1 beta, CCL5, and CXCL10), interferons (IFN-alpha 2, IFN-beta 1, and IFN-gamma), and interferon-stimulated genes (ISG15 and OAS2) in Pr. TM cells. ZIKV infection in IFNAR1(-/-) and wild-type (WT) mouse eyes resulted in increased intraocular pressure (IOP) and the development of chorioretinal atrophy. Anterior chamber (AC) inoculation of ZIKV caused infectivity in iridocorneal angle and TM, leading to the death of TM cells in the mouse eyes. Moreover, anterior segment tissue of infected eyes exhibited increased expression of inflammatory mediators and interferons. Furthermore, ZIKV infection in IFNAR1(-/-) mice resulted in retinal ganglion cell (RGC) death and loss, coinciding with optic nerve infectivity and disruption of anterograde axonal transport. Because of similarity in glaucomatous pathologies in our study and other experimental glaucoma models, ZIKV infection can be used to study infectious triggers of glaucoma, currently an understudied area of investigation.
   IMPORTANCE Ocular complications due to ZIKV infection remains a major public health concern because of their ability to cause visual impairment or blindness. Most of the previous studies have shown ZIKV-induced ocular pathology in the posterior segment (i.e., retina) of the eye. However, some recent clinical reports from affected countries highlighted the importance of ZIKV in affecting the anterior segment of the eye and causing congenital glaucoma. Because glaucoma is the second leading cause of blindness worldwide, it is imperative to study ZIKV infection in causing glaucoma to identify potential targets for therapeutic intervention. In this study, we discovered that ZIKV permissively infects human TM cells and evokes inflammatory responses causing trabeculitis. Using a mouse model, we demonstrated that ZIKV infection resulted in higher IOP, increased RGC loss, and optic nerve abnormalities, the classical hallmarks of glaucoma. Collectively, our study provides new insights into ocular ZIKV infection resulting in glaucomatous pathology.
C1 [Singh, Pawan Kumar; Goyal, Anju; Juzych, Mark S.; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Opthalmol Visual & Anatom Sci, Kresge Eye Inst, Detroit, MI 48202 USA.
   [Kasetti, Ramesh B.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX USA.
   [Kasetti, Ramesh B.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA.
RP Singh, PK; Kumar, A (corresponding author), Wayne State Univ, Sch Med, Dept Opthalmol Visual & Anatom Sci, Kresge Eye Inst, Detroit, MI 48202 USA.
EM psing@med.wayne.edu; akumar@med.wayne.edu
OI Singh, Pawan Kumar/0000-0001-5517-1120
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI135583, R01EY026964, R01EY02738];
   Eversight Eye Bank grant; NIH center grantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P30EY004068]; Research to Prevent Blindness Inc.Research to Prevent
   Blindness (RPB)
FX This study was supported by NIH grants R21AI135583, R01EY026964, and
   R01EY02738 (to A.K.) and Eversight Eye Bank grant (to P.K.S.). Our
   research is also supported in part by an unrestricted grant to the
   Kresge Eye Institute/Department of Ophthalmology, Visual, and Anatomical
   Sciences from Research to Prevent Blindness Inc. The immunology resource
   core is supported by an NIH center grant, P30EY004068. The funders had
   no role in study design, data collection and interpretation, or the
   decision to submit the work for publication.
CR Alexander JP, 1998, CURR EYE RES, V17, P276, DOI 10.1076/ceyr.17.3.276.5219
   Anshu A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011908.pub2
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Choi JA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43349
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Crish SD, 2013, NEUROSCIENCE, V229, P55, DOI 10.1016/j.neuroscience.2012.10.069
   Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107
   Echevarria FD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00318
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Formichella C. R., 2014, J CLIN CELL IMMUNOL, V5, P188, DOI [10.4172/2155-9899.1000188, DOI 10.4172/2155-9899.1000188]
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5
   Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARDING SP, 1993, J MED VIROL, P97
   Hickman HD, 2016, TRENDS MOL MED, V22, P639, DOI 10.1016/j.molmed.2016.06.004
   Hoeksema L, 2017, AM J OPHTHALMOL, V181, P55, DOI 10.1016/j.ajo.2017.06.013
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jurgens I, 2018, ACTA OPHTHALMOL, V96, P423, DOI 10.1111/aos.13548
   Kasetti RB, 2018, J BIOL CHEM, V293, P9854, DOI 10.1074/jbc.RA118.002540
   Keorochana N, 2016, INT MED CASE REP J, V9, P213, DOI 10.2147/IMCRJ.S107089
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Liton PB, 2009, MOL VIS, V15, P326
   Liton PB, 2005, BIOCHEM BIOPH RES CO, V337, P1229, DOI 10.1016/j.bbrc.2005.09.182
   Liton PB, 2005, J CELL PHYSIOL, V205, P364, DOI 10.1002/jcp.20404
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Morris Robert W, 2004, Optometry, V75, P13, DOI 10.1016/S1529-1839(04)70007-X
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Puri LR, 2011, NEPAL J OPHTHALMOL, V3, P165, DOI http://dx.doi.org/10.3126/nepjoph.v3i2.5271
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826
   Sanchez-San Martin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32400-7
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shimizu D, 2018, JPN J OPHTHALMOL, V62, P667, DOI 10.1007/s10384-018-0618-1
   Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010
   Singh PK, 2019, OCUL SURF, V17, P551, DOI 10.1016/j.jtos.2019.03.006
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Thean JHJ, 2001, CLIN EXP OPHTHALMOL, V29, P406, DOI 10.1046/j.1442-9071.2001.d01-29.x
   Tiwari V, 2005, J VIROL, V79, P13173, DOI 10.1128/JVI.79.20.13173-13179.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781
   Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014
   Wensing B, 2011, OPHTHALMOLOGY, V118, P1905, DOI 10.1016/j.ophtha.2011.03.033
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu S, 2017, ANTIVIR RES, V145, P70, DOI 10.1016/j.antiviral.2017.07.012
   Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774
NR 71
TC 3
Z9 3
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAY-JUN
PY 2019
VL 4
IS 3
AR 00173-19
DI 10.1128/mSphere.00173-19
PG 14
WC Microbiology
SC Microbiology
GA IJ2SG
UT WOS:000475754600052
PM 31068433
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Peixoto, HM
   Romero, GAS
   de Araujo, WN
   de Oliveira, MRF
AF Peixoto, Henry Maia
   Sierra Romero, Gustavo Adolfo
   de Araujo, Wildo Navegantes
   Fernandes de Oliveira, Maria Regina
TI Guillain-Barre syndrome associated with Zika virus infection in Brazil:
   a cost-of-illness study
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE cost of illness; economic analysis; Guillain-Barre syndrome; Zika virus
AB Background: Guillain-Barre syndrome (GBS) is a serious, acute paralytic neuropathy of autoimmune aetiology, usually associated with a previous infection. The current study aims to estimate the costs of GBS associated with Zika virus (ZIKV) infection in Brazil.
   Methods: A cost-of-illness study was conducted from the perspective of the Brazilian public health system (Sistema Unico de Saude [SUS]) and Brazilian society for the year 2016. Direct and indirect costs were estimated by a mixed macrocosting and microcosting approach.
   Results: The total cost of ZIKV-associated GBS in Brazil was US$11 997 225.85, consisting of the costs of symptomatic ZIKV infection before onset of GBS (direct costs US$2011.51, indirect costs US$19 780.53) and the costs that followed development of GBS (direct costs US$4 722 980.89, indirect costs US$7 252 452.92). The cost of treatment with human immunoglobulin (US$3 263 210.50) and the cost of productivity losses associated with potential years of working life lost due to early mortality (US$4 398 551.72) were particularly noteworthy.
   Conclusions: These findings suggest that ZIKV-associated GBS is costly to Brazil, especially due to productivity losses and hospitalization. This highlights the importance of investing in the prevention of ZIKV infection and in the care of patients with GBS.
C1 [Peixoto, Henry Maia; Sierra Romero, Gustavo Adolfo; de Araujo, Wildo Navegantes; Fernandes de Oliveira, Maria Regina] Univ Brasilia UnB, Ctr Trop Med, Univ Campus Darcy Ribeiro, BR-70904970 Brasilia, DF, Brazil.
   [Peixoto, Henry Maia; Sierra Romero, Gustavo Adolfo; de Araujo, Wildo Navegantes; Fernandes de Oliveira, Maria Regina] Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil.
RP Peixoto, HM (corresponding author), Univ Brasilia UnB, Ctr Trop Med, Univ Campus Darcy Ribeiro, BR-70904970 Brasilia, DF, Brazil.; Peixoto, HM (corresponding author), Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil.
EM henrymaiap9@unb.br
RI Peixoto, Henry Maia/B-7997-2013
OI Peixoto, Henry Maia/0000-0001-5982-8855
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (Chamada MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit)National Council for
   Scientific and Technological Development (CNPq) [14/2016]; Fundacao de
   Apoio a Pesquisa do Distrito Federal (FAP-DF)National Council for
   Scientific and Technological Development (CNPq) [04/2016]; National
   Institute for Science and Technology for Health Technology Assessment
   (IATS/CNPq)
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) (Chamada
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No 14/2016-Prevencao e Combate ao
   virus Zika), Fundacao de Apoio a Pesquisa do Distrito Federal (FAP-DF)
   (Edital 04/2016-Demanda Induzida-Aedes Aegypti e as arboviroses Zika,
   Chikungunya e Dengue) and the National Institute for Science and
   Technology for Health Technology Assessment (IATS/CNPq).
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardona-Ospina JA, 2014, T R SOC TROP MED HYG, V2015, P793
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Instituto Brasileiro de Geografia e Estatistica, 2016, PESQ NAC AM DOM
   Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327
   Kandel N, 2016, B WORLD HEALTH ORGAN, V94, P705, DOI 10.2471/BLT.16.171504
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Ladner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130103
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Ministerio da Saude, 2016, SIST GER TAB PROC ME
   Ministerio da Saude, 2016, SIST INF HOSP SUS SI
   Ministerio da Saude, 2016, BANC PREC SAUD BPS
   Ministerio da Saude, 2017, GUIA VIG SAUD
   Ministerio da Saude, 2016, B EP MON CAS DENG FE
   Ministerio da Saude do Brasil, 2016, SIST INF AGR NOT SIN
   Ministerio do Planejamento Orcamento e Gestao, 2016, SIST NAC IND PREC CO
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Martelli CMT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004042
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328
   Wachira VK, 2019, TROP MED INT HEALTH, V24, P132, DOI 10.1111/tmi.13181
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 39
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2019
VL 113
IS 5
BP 252
EP 258
DI 10.1093/trstmh/trz010
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA IJ4TD
UT WOS:000475895700004
PM 30892628
DA 2020-07-08
ER

PT J
AU Delgado, S
   Latortue-Albino, P
   Mehta, P
AF Delgado, Stephanie
   Latortue-Albino, Paula
   Mehta, Pooja
TI The Voices on Zika Study: Reproductive Autonomy and Shared Decision
   Making in the Time of Zika
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Delgado, Stephanie] Boston Med Ctr, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 3S
BP 202S
EP 203S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000699
DA 2020-07-08
ER

PT J
AU Victorio, CB
   Ong, J
   Reolo, MJ
   bin Razeli, MH
   Watanabe, S
   Low, J
   Vasudevan, S
   Chacko, AM
AF Victorio, Carla Bianca
   Ong, Joanne
   Reolo, Marie Jennifer
   bin Razeli, Muhammad Haziq
   Watanabe, Satoru
   Low, Jenny
   Vasudevan, Subhash
   Chacko, Ann-Marie
TI Detection of Zika virus (ZIKV)-induced neuroinflammation in a murine
   infection model th translocator protein (TSPO) ligand 3 HPK11195
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Meeting Abstract
CT Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging
   (SNMMI)
CY JUN 22-25, 2019
CL Anaheim, CA
SP Soc Nucl Med & Mol Imaging
C1 [Victorio, Carla Bianca; Ong, Joanne; Reolo, Marie Jennifer; bin Razeli, Muhammad Haziq; Chacko, Ann-Marie] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore.
   [Watanabe, Satoru; Vasudevan, Subhash] Duke NUS Med Sch, Emerging Infect Dis, Singapore, Singapore.
   [Low, Jenny] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
EI 1535-5667
J9 J NUCL MED
JI J. Nucl. Med.
PD MAY 1
PY 2019
VL 60
SU 1
MA 221
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA IF5JJ
UT WOS:000473116800220
DA 2020-07-08
ER

PT J
AU Sulleiro, E
   Frick, MA
   Rodo, C
   Espasa, M
   Thorne, C
   Espiau, M
   Martin-Nalda, A
   Suy, A
   Giaquinto, C
   Melendo, S
   Rando, A
   Alarcon, A
   Martinon-Torres, F
   Pumarola, T
   Soler-Palacin, P
   Soriano-Arandes, A
AF Sulleiro, Elena
   Frick, Marie Antoinette
   Rodo, Carlota
   Espasa, Mateu
   Thorne, Claire
   Espiau, Maria
   Martin-Nalda, Andrea
   Suy, Anna
   Giaquinto, Carlo
   Melendo, Susana
   Rando, Ariadna
   Alarcon, Ana
   Martinon-Torres, Federico
   Pumarola, Tomas
   Soler-Palacin, Pere
   Soriano-Arandes, Antoni
TI The challenge of the laboratory diagnosis in a confirmed congenital Zika
   virus syndrome in utero A case report
SO MEDICINE
LA English
DT Article
DE arboviruses; microcephaly; serologic test; syndrome; ZIKA Virus
ID INFECTION
AB Introduction: Zika virus (ZIKV) has caused one of the most challenging global infectious epidemics in recent years because of its causal association with severe microcephaly and other congenital malformations. The diagnosis of viral infections usually relies on the detection of virus proteins or genetic material in clinical samples as well as on the infected host immune responses. Serial serologic testing is required for the diagnosis of congenital infection when diagnostic molecular biology is not possible.
   Patient concerns: A 2-year-old girl, born to a mother with confirmed ZIKV infection during pregnancy, with a confirmed ZIKV infection in utero, showed at birth a severe microcephaly and clinical characteristics of fetal brain disruption sequence compatible with a congenital ZIKV syndrome (CZS).
   Diagnosis: ZIKV-RNA and ZIKV-IgM serological response performed at birth and during the follow-up time tested always negative. Serial serologic ZIKV-IgG tests were performed to assess the laboratory ZIKV diagnosis, ZIKV-IgG seroreversion was observed at 21 months of age. ZIKVdiagnosisof thisbaby hadto bereliedonher clinical andradiological characteristics thatwere compatiblewith aCZS.
   Interventions: The patient was followed-up as per protocol at approximately 1, 4, 9, 12, 18-21, and 24 months of age. Neurological, radiological, audiological, and ophthalmological assessment were performed during this period of time. Prompt rehabilitation was initiated to prevent potential adverse long-term neurological outcomes.
   Outcomes: The growth of this girl showed a great restriction at 24 months of age with a weight of 8.5kg (-2.5 z-score) and a head circumference of 40.5cm (-4.8 z-score). She also had a great neurodevelopmental delay at the time of this report.
   Conclusion: We presume that as a consequence of prenatal ZIKV infection, the fetal brain and other organs are damaged before birth through direct injury. Following this, active infection ends during intrauterine life, and as a consequence the immune system of the infant is unable to build up a consistent immune response thereafter. Further understanding of the mechanisms taking part in the pathogenesis of ZIKV congenital infection is needed. This finding might change our paradigm regarding serological response in the ZIKV congenital infection.
C1 [Sulleiro, Elena; Frick, Marie Antoinette; Rodo, Carlota; Espasa, Mateu; Espiau, Maria; Martin-Nalda, Andrea; Suy, Anna; Melendo, Susana; Rando, Ariadna; Pumarola, Tomas; Soler-Palacin, Pere; Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Avinguda Drassanes 17-21, Barcelona 08001, Spain.
   [Sulleiro, Elena; Frick, Marie Antoinette; Rodo, Carlota; Thorne, Claire; Espiau, Maria; Martin-Nalda, Andrea; Suy, Anna; Giaquinto, Carlo; Alarcon, Ana; Martinon-Torres, Federico; Soriano-Arandes, Antoni] ZIKAct Consortium, European Unions Horizon 2020 Res & Innovat Progra, Padua, Italy.
   [Thorne, Claire] UCL, London, England.
   [Giaquinto, Carlo] Univ Padua, PENTA Fdn, Padua, Italy.
   [Alarcon, Ana] Hosp St Joan de Deu, Barcelona, Spain.
   [Martinon-Torres, Federico] Hosp Clin Univ, Santiago De Compostela, Spain.
RP Soriano-Arandes, A (corresponding author), Hosp Univ Vall dHebron, Avinguda Drassanes 17-21, Barcelona 08001, Spain.
EM tsorianoarandes@gmail.com
RI Arandes, Antonio Soriano/Q-3348-2016; Pumarola, Tomas/AAB-5532-2019;
   RODO, CARLOTA/K-9179-2017; Thorne, Claire/C-5943-2008; Giaquinto,
   Carlo/AAB-5016-2020; Martinon-Torres, Federico/E-4982-2016
OI Arandes, Antonio Soriano/0000-0001-9613-7228; Pumarola,
   Tomas/0000-0002-5171-7461; RODO, CARLOTA/0000-0001-8801-5677; Thorne,
   Claire/0000-0003-0389-1956; Martinon-Torres,
   Federico/0000-0002-9023-581X; Espasa, Mateu/0000-0003-4822-1024;
   Sulleiro, Elena/0000-0002-9783-6060; GIAQUINTO,
   CARLO/0000-0001-9365-0413
FU ZIKAction consortium, European Union's Horizon 2020 research and
   innovation programme [734857]
FX The publication of this manuscript has been funded by the ZIKAction
   consortium, European Union's Horizon 2020 research and innovation
   programme under grant agreement No 734857.
CR del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Goulder PJ, 2016, NAT REV IMMUNOL, V16, P259, DOI 10.1038/nri.2016.19
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Maldonado YA, 2017, PEDIATRICS, V139
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   PECKHAM CS, 1988, LANCET, V2, P1039
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Singh AE, 2013, PEDIATR INFECT DIS J, V32, P199, DOI 10.1097/INF.0b013e318273599c
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
NR 10
TC 0
Z9 0
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAY
PY 2019
VL 98
IS 20
AR e15532
DI 10.1097/MD.0000000000015532
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA IG3BT
UT WOS:000473676000026
PM 31096455
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Burdmann, EA
AF Burdmann, Emmanuel A.
TI Flaviviruses and Kidney Diseases
SO ADVANCES IN CHRONIC KIDNEY DISEASE
LA English
DT Article
DE Kidney; Dengue; Yellow fever; Zika; West Nile viruses
ID WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE
   TUBULAR-NECROSIS; DENGUE VIRUS; ZIKA VIRUS; HEMORRHAGIC-FEVER;
   INFECTIOUS-DISEASES; INJURY; PATIENT
AB The genus Flavivirus comprises approximately 73 viruses, which share several common aspects, such as dimension, structure, nucleic acid properties, and shape in electronic microscopy. Global incidence of flavivirus infection increased dramatically over the last decades, causing large outbreaks in several areas of the world. These viruses are expanding from endemic tropical and subtropical areas to previously nonendemic areas, affecting and causing diseases in millions of individuals worldwide and posing a formidable challenge to public health in several countries. The majority of clinically significant flavivirus-associated infections are mosquito borne (arboviruses-acronym for ARthropod-BOrne VIRUSES), such as dengue, yellow fever, Japanese encephalitis, Zika, and West Nile fever. Most diseases caused by flaviviruses are asymptomatic or manifest as self-limited, mild, undifferentiated febrile diseases. In a limited number of cases, these diseases may evolve to severe inflammatory, multisystem diseases, causing high morbidity and mortality. Some flaviviruses have been consistently identified in kidney tissue and urine and have been clinically associated with kidney diseases. In this review, we will provide an overview of the epidemiology, risk factors, kidney pathology, etiopathogenesis, and outcomes of acute and chronic kidney syndromes associated with dengue, yellow fever, Zika, and West Nile virus disease. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.
C1 [Burdmann, Emmanuel A.] Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455,Sala 3304 Cerqueira Cesar, BR-01246903 Sao Paulo, SP, Brazil.
RP Burdmann, EA (corresponding author), Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455,Sala 3304 Cerqueira Cesar, BR-01246903 Sao Paulo, SP, Brazil.
EM burdmann@usp.br
RI Burdmann, Emmanuel/B-7023-2009
OI Burdmann, Emmanuel/0000-0002-7644-8579
FU "Conselho Nacional de Desenvolvimento Cientifico - Tecnologico National
   Counsel of Technological and Scientific Development" (CNPq)National
   Council for Scientific and Technological Development (CNPq); "Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo Sao Paulo Research
   Foundation" (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX E.A.B is partially supported by grants from "Conselho Nacional de
   Desenvolvimento Cientifico - Tecnologico National Counsel of
   Technological and Scientific Development" (CNPq) and "Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo Sao Paulo Research Foundation"
   (FAPESP).
CR Alcendor DJ, 2018, J MOL MED, V96, P1145, DOI 10.1007/s00109-018-1692-z
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Arboviral Diseases-United States, 2017, MMWR MORB MORTAL WKL, V67, P1137
   Barreto D. F., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P121
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   Bhargava V, 2017, Indian J Nephrol, V27, P321, DOI 10.4103/0971-4065.202837
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOONPUCKNAVIG S, 1981, T ROY SOC TROP MED H, V75, P647, DOI 10.1016/0035-9203(81)90142-5
   BOONPUCKNAVIG V, 1976, ARCH PATHOL LAB MED, V100, P206
   Brener ZZ, 2007, NEPHROL DIAL TRANSPL, V22, P662, DOI [10.1093/ndt/gfl599, 10.1093/ndt/gf1599]
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burdmann EA, 2017, KIDNEY INT, V91, P1033, DOI 10.1016/j.kint.2016.09.051
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Chippaux JP, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0162-y
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Nieto-Rios JF, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12824
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Gurugama P, 2018, J CLIN VIROL, V101, P1, DOI 10.1016/j.jcv.2018.01.001
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hebbal P, 2016, TRAVEL MED INFECT DI, V14, P45, DOI 10.1016/j.tmaid.2016.01.003
   Hidalgo J, 2017, J CRIT CARE, V42, P366, DOI 10.1016/j.jcrc.2017.11.006
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Horvath R., 1999, Dengue Bulletin, V23, P24
   Huang CN, 2002, EMERG INFECT DIS, V8, P1367, DOI 10.3201/eid0812.020532
   Hutspardol S, 2011, SE ASIAN J TROP MED, V42, P579
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jha V, 2016, AM J KIDNEY DIS, V68, P148, DOI 10.1053/j.ajkd.2016.01.017
   JONES EMM, 1972, B WORLD HEALTH ORGAN, V46, P653
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090425
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Li GY, 2008, INT J CLIN EXP PATHO, V1, P169
   Lima EQ, 2007, NEPHROL DIAL TRANSPL, V22, P3322, DOI 10.1093/ndt/gfm431
   Litvoc MN, 2018, REV ASSOC MED BRAS, V64, P106, DOI 10.1590/1806-9282.64.02.106
   Lizarraga KJ, 2015, CLIN NEPHROL, V83, P104, DOI 10.5414/CN108217
   Mallhi TH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192510
   Mallhi TH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016805
   Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582
   Mallhi TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138465
   McGibbon E, 2018, VECTOR-BORNE ZOONOT, V18, P382, DOI 10.1089/vbz.2017.2223
   Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X
   Mohsin N, 2009, RENAL FAILURE, V31, P736, DOI 10.3109/08860220903003404
   Moi ML, 2018, METHODS MOL BIOL, V1604, P331, DOI 10.1007/978-1-4939-6981-4_25
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2010, AM J TROP MED HYG, V82, P919, DOI 10.4269/ajtmh.2010.10-0001
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109
   Murray KO, 2017, AM J TROP MED HYG, V97, P1913, DOI 10.4269/ajtmh.17-0405
   Nair JJ, 2016, J CLIN DIAGN RES, V10, pOC1, DOI 10.7860/JCDR/2016/19393.8243
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   OUDART JL, 1970, B WORLD HEALTH ORGAN, V42, P95
   Paddock CD, 2006, CLIN INFECT DIS, V42, P1527, DOI 10.1086/503841
   Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005
   Papa A, 2014, J MED VIROL, V86, P2142, DOI 10.1002/jmv.23949
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Peralta-Aros C, 2017, PEDIATR NEPHROL, V32, P897, DOI 10.1007/s00467-017-3588-5
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Petersen LR, 2005, J TRAVEL MED, V12, pS3
   Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0
   Oliveira JFP, 2015, CLIN KIDNEY J, V8, P681, DOI 10.1093/ckj/sfv106
   Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Rajadhyaksha A, 2012, LUPUS, V21, P999, DOI 10.1177/0961203312437807
   Ranjit S, 2018, INDIAN J CRIT CARE M, V22, P154, DOI 10.4103/ijccm.IJCCM_413_17
   Repizo LP, 2014, REV INST MED TROP SP, V56, P85, DOI 10.1590/S0036-46652014000100014
   Rivera J, 2014, BIOMEDICA, V34, P514, DOI [10.7705/biomedica.v34i4.2169, 10.1590/S0120-41572014000400003]
   Dias IKR, 2018, REV SOC BRAS MED TRO, V51, P261, DOI 10.1590/0037-8682-0130-2018
   Saxena V, 2017, CLIN LAB MED, V37, P243, DOI 10.1016/j.cll.2017.01.001
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Schirmer PL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006416
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P835
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Song ATW, 2019, HEPATOLOGY, V69, P1349, DOI 10.1002/hep.30273
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Song R, 2018, EMERG INFECT DIS, V24, P1383, DOI 10.3201/eid2407.171868
   Tabachnick WJ, 2016, ANNU REV VIROL, V3, P125, DOI 10.1146/annurev-virology-110615-035630
   Talib SH, 2013, INT MED CASE REP J, V6, P71, DOI 10.2147/IMCRJ.S50708
   Thomas ETA, 2019, NEPHROLOGY, V24, P564, DOI 10.1111/nep.13265
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Upadhaya BK, 2010, SAUDI J KIDNEY DIS T, V21, P521
   Vachvanichsanong Prayong, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P108
   Vasanwala FF, 2009, SINGAP MED J, V50, pE253
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Werneck GL, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180082
   Whittembury A, 2009, VACCINE, V27, P5974, DOI 10.1016/j.vaccine.2009.07.082
   Wiwanitkit V, 2016, SAUDI J KIDNEY DIS T, V27, P1280
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 102
TC 1
Z9 1
U1 3
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1548-5595
EI 1548-5609
J9 ADV CHRONIC KIDNEY D
JI Adv. Chronic Kidney Dis.
PD MAY
PY 2019
VL 26
IS 3
BP 198
EP 206
DI 10.1053/j.ackd.2019.01.002
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA IF5KN
UT WOS:000473119800007
PM 31202392
DA 2020-07-08
ER

PT J
AU Kim, YC
   Lopez-Camacho, C
   Garcia-Larragoiti, N
   Cano-Mendez, A
   Hernandez-Flores, KG
   Dominguez-Aleman, CA
   Mar, MA
   Vivanco-Cid, H
   Viveros-Sandoval, ME
   Reyes-Sandoval, A
AF Kim, Young Chan
   Lopez-Camacho, Cesar
   Garcia-Larragoiti, Nallely
   Cano-Mendez, Alan
   Guadalupe Hernandez-Flores, Karina
   Alonso Dominguez-Aleman, Carlos
   Antonieta Mar, Maria
   Vivanco-Cid, Hector
   Eva Viveros-Sandoval, Martha
   Reyes-Sandoval, Arturo
TI Development of an E2 ELISA Methodology to Assess Chikungunya
   Seroprevalence in Patients from an Endemic Region of Mexico
SO VIRUSES-BASEL
LA English
DT Article
DE Chikungunya virus; envelope protein 2; diagnosis; ELISA; febrile
   patients; CHIKV antibodies; Mexico
ID GLYCOPROTEIN ORGANIZATION; ENVELOPE PROTEINS; VIRUS; ASSAY;
   SERODIAGNOSIS; ALPHAVIRUSES; ANTIBODIES; EXPRESSION; INFECTION;
   DIAGNOSIS
AB Chikungunya fever is a debilitating disease caused by Chikungunya virus (CHIKV) that can result in long-lasting arthralgias. The early diagnosis of CHIKV relies on PCR during the acute infection phase to allow differential diagnosis with other co-circulating arboviruses such as dengue and Zika. Alternatively, serology can support diagnosis and provide epidemiological information on current and past outbreaks. Many commercial serological ELISA assays are based on the inactivated whole CHIKV, but their sensitivity and specificity show great variability. We produced recombinant CHIKV E2 that is suitable for ELISA assays, which was used for the serodiagnosis of CHIKV infections occurring in an arbovirus endemic Mexican region within Michoacan state. A cross-sectional study was conducted in 2016-2017; sera was obtained from 15 healthy donors and 68 patients presenting undifferentiated febrile illness. Serum samples were screened by RT-PCR and by our in-house ELISA assay. Our results indicate that IgM and IgG anti-CHIKV E2 antibodies were detected with our ELISA assay with higher sensitivity than a commercially available CHIKV ELISA kit. Our simple and sensitive ELISA assay for the serodiagnosis of CHIKV infections can be applied to population-based seroprevalence surveys and has potential for monitoring vaccine immunogenicity in CHIKV vaccine clinical trials.
C1 [Kim, Young Chan; Lopez-Camacho, Cesar; Reyes-Sandoval, Arturo] Univ Oxford, Ffi eld Dept Med, Jenner Inst, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7DQ, England.
   [Kim, Young Chan] Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.
   [Garcia-Larragoiti, Nallely; Cano-Mendez, Alan; Eva Viveros-Sandoval, Martha] UMSNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Div Estudios Posgrad, Lab Hemostasia & Biol Vasc, Morelia 58000, Michoacan, Mexico.
   [Garcia-Larragoiti, Nallely; Cano-Mendez, Alan; Eva Viveros-Sandoval, Martha] UMSNH, Oxford Univ, Fac Biol & Med Sci Dr Ignacio Chavez, Oxford Clin Res Lab UMOCRL, Morelia 58000, Michoacan, Mexico.
   [Guadalupe Hernandez-Flores, Karina; Alonso Dominguez-Aleman, Carlos; Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Medicobiol, Veracruz 91700, Veracruz, Mexico.
   [Alonso Dominguez-Aleman, Carlos] Univ Veracruzana, Inst Ciencias Salud, Programa Maestria Ciencias Salud, Xalapa 91190, Veracruz, Mexico.
   [Antonieta Mar, Maria] HGZMF, 12 Av Lazaro Cardenas,154 Col Ctr, Lazaro Cardenas 60950, Mexico.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Ffi eld Dept Med, Jenner Inst, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7DQ, England.
EM young.kim@some.ox.ac.uk; cesar.lopez-camacho@ndm.ox.ac.uk;
   garcia_larragoiti@hotmail.com; bqdalan@hotmail.com;
   karinahernandezflores@gmail.com; aleman_815@hotmail.com;
   maria.mar@imss.gob.mx; hvivanco@uv.mx; marthaevaviveros@yahoo.com.mx;
   arturo.reyes@ndm.ox.ac.uk
OI Kim, Young Chan/0000-0003-2847-9407
FU UK Department of Health and Social Care [972216, 971557]; CONACYTConsejo
   Nacional de Ciencia y Tecnologia (CONACyT); CONACYT Fonteras de la
   CienciaConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [2015-02-1192]; Ciencia Basica SEP-CONACyT [256235]; Fosiss-CONACyT
   [233697]
FX A.R.-S. is a Jenner Investigator and an Oxford Martin Fellow. This
   report is work commissioned by Innovate UK and the UK Department of
   Health and Social Care (projects No. 972216 and 971557). N.G.-L. and
   A.C.-M. are recipients of CONACYT fellowships. This work was supported
   by grants from CONACYT Fonteras de la Ciencia 2015-02-1192, Ciencia
   Basica SEP-CONACyT 256235, and Fosiss-CONACyT 233697 to H.V.-C. The
   views expressed in this publication are those of the author(s) and not
   necessarily those of Innovate UK or the Department of Health and Social
   Care.
CR Azami NAM, 2016, METHODS MOL BIOL, V1426, P273, DOI 10.1007/978-1-4939-3618-2_25
   Azami NAM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-67
   Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6
   CHENG RH, 1995, CELL, V80, P621
   Cho B, 2008, YONSEI MED J, V49, P828, DOI 10.3349/ymj.2008.49.5.828
   Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Fumagalli MJ, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1028-1
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Hierholzer J.C., 1996, VIROLOGY METHODS MAN
   HIGASHI N, 1967, VIROLOGY, V33, P55, DOI 10.1016/0042-6822(67)90093-1
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075
   Khan M, 2014, J MED VIROL, V86, P1169, DOI 10.1002/jmv.23752
   Kim YC, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1104-6
   Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55
   Kumar NP, 2011, MEM I OSWALDO CRUZ, V106, P912, DOI 10.1590/S0074-02762011000800003
   Kumar P, 2014, J VIROL METHODS, V206, P67, DOI 10.1016/j.jviromet.2014.05.014
   Lancaster C, 2016, J CHROMATOGR B, V1032, P218, DOI 10.1016/j.jchromb.2016.04.025
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lopez-Camacho C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040322
   MASON P. J., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P238
   Navarro J.-C., 2017, HUMAN VIROLOGY LATIN, P169
   Neffleship Joanne E., 2009, V498, P245, DOI 10.1007/978-1-59745-196-3_16
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Nunes M.R., 2010, J TROP MED PUBLIC HL, V13, P102
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pierro A., 2015, New Microbes and New Infections, V7, P23, DOI 10.1016/j.nmni.2015.04.002
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Telles JN, 2009, J MED MICROBIOL, V58, P1168, DOI 10.1099/jmm.0.010736-0
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Weaver SC, 2012, ANTIVIR RES, V94, P242, DOI 10.1016/j.antiviral.2012.04.002
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 39
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2019
VL 11
IS 5
AR 407
DI 10.3390/v11050407
PG 13
WC Virology
SC Virology
GA IE9EB
UT WOS:000472676600018
PM 31052472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Harris, ML
   Carter, ED
AF Harris, Miranda L.
   Carter, Eric D.
TI Muddying the waters: A political ecology of mosquito-borne disease in
   coastal Ecuador
SO HEALTH & PLACE
LA English
DT Article
DE Ecuador; Dengue; Chikungunya; Zika; Political ecology
ID GLOBAL HEALTH; DENGUE; PERCEPTIONS; GOVERNANCE; HISTORY; PLACE
AB The mosquito-borne arboviral diseases dengue, chikungunya, and Zika are major public health burdens in Latin America. To analyze the socio-environmental dynamics of these diseases, we apply a political ecology of health and disease framework that is attentive to local etiological frameworks, structural sociopolitical conditions, processes of identity construction, and the contested, politicized nature of public health work. We use multiple qualitative methods to analyze perceptions and interactions with the local environment in relation to mosquito-borne disease across three small communities in Manabi Province, Ecuador. We find that participants' perceptions and practices are complex and multilayered: subjects possess a mixed theory of causation, where these diseases are caused not only by mosquitoes, but also by people's interactions with a changing environment; most environmental management to control vector mosquitoes is carried out informally by women as part of domestic routines; and contrary to public health messaging that stresses the importance of individual agency, participants prefer some of the most invasive techniques for mosquito control (i.e. fumigation with insecticides). However, individual agency in disease control is constrained by poor water infrastructure and lack of public health coordination. Our approach advocates for recognition of local knowledges and sociopolitical constraints in the development of public health messages and interventions.
C1 [Harris, Miranda L.; Carter, Eric D.] Macalester Coll, St Paul, MN 55105 USA.
RP Carter, ED (corresponding author), Macalester Coll, Dept Geog, St Paul, MN 55105 USA.
EM mirandaharrismartinez@gmail.com; ecarter@macalester.edu
FU Macalester College
FX Macalester College provided small grants, but had no involvement in the
   completion of the study or this submission. No grant from any funding
   agency was received. The authors declare no conflict of interest.
CR [Anonymous], 2018, TELEGRAFO       0730
   Bandzuh JT, 2017, J LAT AM GEOGR, V16, P139, DOI 10.1353/lag.2017.0025
   Brisbois B, 2018, ANTIPODE, V50, P61, DOI 10.1111/anti.12340
   Charette M, 2017, SOC SCI MED, V174, P122, DOI 10.1016/j.socscimed.2016.12.010
   Connolly C, 2017, J POLIT ECOL, V24, P1
   Crews K. A, 2013, ECOLOGIES POLITICS H
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Egedus VL, 2014, REV BIOL TROP, V62, P859
   Green Edward, 1999, INDIGENOUS THEORIES
   Guthman J., 2011, WEIGHING OBESITY FOO
   Hanchette CL, 2008, HEALTH PLACE, V14, P209, DOI 10.1016/j.healthplace.2007.06.003
   Heggenhougen H. Kristian, 2003, BEHAV SOCIAL ASPECTS
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Jackson P, 2015, PROG HUM GEOG, V39, P47, DOI 10.1177/0309132513518832
   Jansen KA, 2013, MED ANTHROPOL, V32, P174, DOI 10.1080/01459740.2012.679981
   Kenneson A, 2017, BIORXIV, DOI [10.1101/136382, DOI 10.1101/136382]
   King B, 2017, STATES DIS POLITICAL
   King B, 2010, PROG HUM GEOG, V34, P38, DOI 10.1177/0309132509338642
   Launiala A., 2009, ANTHR MATTERS, V11, P1
   Leslie TE, 2017, GLOBAL HEALTH ACTION, V10, DOI [1, 10.1080/16549716.2017.1350394]
   Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI [DOI 10.1080/10714839.2016.1201268, DOI 10.1080/10714839.2016.120168]
   Mansfield B, 2008, ENVIRON PLANN A, V40, P1015, DOI 10.1068/a40366
   Mansfield B, 2008, SOC SCI MED, V66, P1084, DOI 10.1016/j.socscimed.2007.11.025
   Mayer JD, 1996, PROG HUM GEOG, V20, P441, DOI 10.1177/030913259602000401
   Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9
   Mera Toala J. F, 2017, DETERMINACION CALIDA
   MSP, 2017, EJ TRAB FUM AMB ULV
   MSP, 2018, SEMANA EPIDEMIOLOGIC, P7
   MSP [Ministerio de Salud Publica], 2015, PROGR FUM INTR EJ DI
   Mulligan K, 2012, HEALTH PLACE, V18, P613, DOI 10.1016/j.healthplace.2012.01.001
   Nading A.M., 2014, MOSQUITO TRAILS ECOL
   Nading AM, 2012, CULT ANTHROPOL, V27, P572, DOI 10.1111/j.1548-1360.2012.01162.x
   Neely AH, 2017, HEALTH PLACE, V45, P55, DOI 10.1016/j.healthplace.2017.03.001
   PAHO, 2007, HLTH AM, VII
   PAHO, 2015, REP CHIK VIR TRANSM
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Plua Sanchez L, 2015, PLAN ESTRATEGICO MUL
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Sorensen CJ, 2017, GEOHEALTH, V1, P298, DOI 10.1002/2017GH000104
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Suarez MR, 2005, SOC SCI MED, V61, P495, DOI 10.1016/j.socscimed.2004.11.069
   Valencia-Tobon A, 2016, MAGUARE, V30, P141
   vonHedemanna N, 2017, HEALTH PLACE, V43, P41, DOI 10.1016/j.healthplace.2016.11.004
   Whiteford LM, 1997, MED ANTHROPOL Q, V11, P202, DOI 10.1525/maq.1997.11.2.202
NR 45
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8292
EI 1873-2054
J9 HEALTH PLACE
JI Health Place
PD MAY
PY 2019
VL 57
BP 330
EP 338
DI 10.1016/j.healthplace.2019.05.010
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID7VC
UT WOS:000471889900036
PM 31152971
DA 2020-07-08
ER

PT J
AU Guarner, J
   Hale, GL
AF Guarner, Jeannette
   Hale, Gillian L.
TI Four human diseases with significant public health impact caused by
   mosquito-borne flaviviruses: West Nile, Zika, dengue and yellow fever
SO SEMINARS IN DIAGNOSTIC PATHOLOGY
LA English
DT Review
DE Flsvivirus; Yellow fever; Dengue; Zika; West Nile virus; Mosquito-borne
   flavivirus
ID VIRUS-INFECTION; CELLS; PATHOLOGY; STATES; LIVER
AB In this review we will discuss the epidemiology, clinical characteristics, diagnostic tests, pathologic features, treatment and disease prevention strategies for four mosquito-borne flaviviruses. West Nile and Zika viruses, once thought to be restricted geographically, emerged on the American continent in the first part of the 21st century. They have been constantly in the lay press and have caused a heightened awareness of emerging infections by the public, particularly given the manifestation of microcephaly in congenital Zika syndrome. Yellow fever and dengue viruses, with mosquito vectors similar to West Nile and Zika viruses, are endemic in many tropical areas of the world and produce frequent outbreaks. The global distribution of yellow fever and dengue viruses could also change and has great potential to do so. Factors that could contribute to reemergence of the diseases in areas of the world where they are currently only seen in travelers, include the presence of yellow fever and dengue virus vectors in temperate climates and growing urbanization. These two factors increase potential contact between vectors and naive human hosts, thus could result in reemergence of yellow fever or dengue virus infections.
C1 [Guarner, Jeannette] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Hale, Gillian L.] Univ Utah, Anat Pathol & Mol Oncol, Salt Lake City, UT USA.
RP Guarner, J (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
EM jguarne@emory.edu
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bhatnagar J, 2007, J CLIN VIROL, V38, P106, DOI 10.1016/j.jcv.2006.11.003
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers-for-Disease-and-Prevention-CDC, TYP ZIK VIR TESTS
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   International-Committee-on-Taxonomy-of-Viruses-(ITCV), GEN FLAV 10 REP
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   King JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03981-8
   Kobayashi Nobumichi, 2018, Open Virol J, V12, P131, DOI 10.2174/1874357901812010131
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Racsa L, 2014, DIAGN MICR INFEC DIS, V78, P132, DOI 10.1016/j.diagmicrobio.2013.11.006
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Sejvar James J, 2003, Ochsner J, V5, P6
   Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   World-Health-Organization, 2009, DENG GUID DIAGN TREA, V1
   World-Health-Organization, IMM VACC BIOL QQESTI
   Ye YH, 2016, AM J TROP MED HYG, V94, P812, DOI 10.4269/ajtmh.15-0801
NR 38
TC 5
Z9 5
U1 4
U2 10
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0740-2570
EI 1930-1111
J9 SEMIN DIAGN PATHOL
JI Semin. Diagn. Pathol.
PD MAY
PY 2019
VL 36
IS 3
BP 170
EP 176
DI 10.1053/j.semdp.2019.04.009
PG 7
WC Medical Laboratory Technology; Pathology
SC Medical Laboratory Technology; Pathology
GA IE1EE
UT WOS:000472127900006
PM 31006554
OA Bronze
DA 2020-07-08
ER

PT J
AU Runge-Ranzinger, S
   Morrison, AC
   Manrique-Saide, P
   Horstick, O
AF Runge-Ranzinger, S.
   Morrison, A. C.
   Manrique-Saide, P.
   Horstick, O.
TI Zika transmission patterns: a meta-review
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Review
DE Zika; transmission; meta-review
ID VIRUS-INFECTION; EPIDEMIOLOGY
AB ObjectiveTo assesses what is known and identify knowledge gaps for Zika virus (ZIKV) transmission patterns.
   MethodsMeta-review searching the databases BioSys; Cochrane Infectious Diseases Group Specialised Register and Cochrane Central Register of Controlled Trials; EMBASE; Google Scholar; LILACS; MEDLINE (PubMed); Web of Science; and WHOLIS with the term ZIKA'. Systematic reviews and reviews specifying the search methods and describing potential modes of transmission were eligible for analysis.
   ResultsOf 5,401 hits for Zika', 44 studies were assessed and 11 included after applying in- and exclusion criteria: six systematic reviews and five reviews with specified methods, covering all ways of possible transmission. Results can be grouped into transmission routes with good evidence and agreement between the studies (evidence on vector, mother-to-child and sexual transmission) and transmission routes with limited evidence. Transmission by breastfeeding, intrapartum, by animal bites or laboratory-based remains inconclusive, as these routes are suggested by single studies only. The risk of transfusion transmission is described and public health measures for safe transfusion should be taken as available.
   ConclusionOur results imply the need for public health measures to limit transmission via vectors, mother-to-child, sexual transmission and blood transfusion. Also needed are long-term prospective cohort studies covering periods of active Zika virus transmission and measuring epidemiological parameters to establish evidence on other routes of transmission; seroprevalence studies; transmission dynamics modelling and modelling health impacts by different modes of transmission.
C1 [Runge-Ranzinger, S.; Horstick, O.] Heidelberg Univ, Heidelberg Inst Global Hlth, Neuenheimer Feld 365, D-69120 Heidelberg, Germany.
   [Morrison, A. C.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Manrique-Saide, P.] Univ Autonoma Yucatan, Merida, Mexico.
RP Runge-Ranzinger, S (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Neuenheimer Feld 365, D-69120 Heidelberg, Germany.
EM Olaf.Horstick@uni-heidelberg.de
FU Special Programme for Research and Training in Tropical Diseases of the
   World Health Organization (WHO/TDR) [WCCPRD5295811 2017/700816]
FX This study received funding by the Special Programme for Research and
   Training in Tropical Diseases of the World Health Organization (WHO/TDR,
   contract number WCCPRD5295811 2017/700816).
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Levi ME, 2017, CURR OPIN INFECT DIS, V30, P340, DOI 10.1097/QCO.0000000000000384
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114
   Salge AKM, 2016, REV ELETRONICA ENFER, V18, P1
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WHO, 2017, WHO ZIK VIR SIT REP
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
NR 29
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD MAY
PY 2019
VL 24
IS 5
BP 523
EP 529
DI 10.1111/tmi.13216
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ID9GR
UT WOS:000471996100002
PM 30771269
OA Bronze
DA 2020-07-08
ER

PT J
AU Kulkarni, A
   Yu, WQ
   Jiang, JJ
   Sanchez, C
   Karna, AK
   Martinez, KJL
   Hanley, KA
   Buenemann, M
   Hansen, IA
   Xue, RD
   Ettestad, P
   Melman, S
   Duguma, D
   Debboun, M
   Xu, JN
AF Kulkarni, Aditi
   Yu, Wanqin
   Jiang, Jinjin
   Sanchez, Concepcion
   Karna, Ajit K.
   Martinez, Kalli J. L.
   Hanley, Kathryn A.
   Buenemann, Michaela
   Hansen, Immo A.
   Xue, Rui-de
   Ettestad, Paul
   Melman, Sandra
   Duguma, Dagne
   Debboun, Mustapha
   Xu, Jiannong
TI Wolbachia pipientis occurs in Aedes aegypti populations in New Mexico
   and Florida, USA
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Florida; New Mexico; Texas; wAlbB;
   Wolbachia
ID REPORTED DISTRIBUTION; STEGOMYIA ALBOPICTUS; DIPTERA-CULICIDAE; BLOCKS
   DENGUE; UNITED-STATES; MOSQUITOS; INFECTION; ESTABLISHMENT;
   TRANSMISSION; ENDOSYMBIONT
AB The mosquitoes Aedes aegypti (L.) and Ae. albopictus Skuse are the major vectors of dengue, Zika, yellow fever, and chikungunya viruses worldwide. Wolbachia, an endosymbiotic bacterium present in many insects, is being utilized in novel vector control strategies to manipulate mosquito life history and vector competence to curb virus transmission. Earlier studies have found that Wolbachia is commonly detected in Ae. albopictus but rarely detected in Ae. aegypti. In this study, we used a two-step PCR assay to detect Wolbachia in wild-collected samples of Ae. aegypti. The PCR products were sequenced to validate amplicons and identify Wolbachia strains. A loop-mediated isothermal amplification (LAMP) assay was developed and used for detecting Wolbachia in selected mosquito specimens as well. We found Wolbachia in 85/148 (57.4%) wild Ae. aegypti specimens from various cities in New Mexico, and in 2/46 (4.3%) from St. Augustine, Florida. Wolbachia was not detected in 94 samples of Ae. aegypti from Deer Park, Harris County, Texas. Wolbachia detected in Ae. aegypti from both New Mexico and Florida was the wAlbB strain of Wolbachia pipientis. A Wolbachia-positive colony of Ae. aegypti was established from pupae collected in Las Cruces, New Mexico, in 2018. The infected females of this strain transmitted Wolbachia to their progeny when crossed with males of Rockefeller strain of Ae. aegypti, which does not carry Wolbachia. In contrast, none of the progeny of Las Cruces males mated to Rockefeller females were infected with Wolbachia.
C1 [Kulkarni, Aditi; Yu, Wanqin; Jiang, Jinjin; Sanchez, Concepcion; Karna, Ajit K.; Martinez, Kalli J. L.; Hanley, Kathryn A.; Hansen, Immo A.; Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA.
   [Xue, Rui-de] Anastasia Mosquito Control Dist, St Augustine, FL USA.
   [Ettestad, Paul; Melman, Sandra] New Mexico Dept Hlth, Santa Fe, NM USA.
   [Duguma, Dagne; Debboun, Mustapha] Harris Cty Publ Hlth, Mosquito & Vector Control Div, Houston, TX USA.
RP Xu, JN (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM jxu@nmsu.edu
FU New Mexico Department of Health; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P20GM103451]
FX New Mexico Department of Health; National Institutes of Health,
   Grant/Award Number: P20GM103451
CR Ahantarig A, 2008, J VECTOR ECOL, V33, P173, DOI 10.3376/1081-1710(2008)33[173:RWDOFA]2.0.CO;2
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06
   Bhadra S., 2018, PLOS NEGLECT TROP D, V12
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   de Albuquerque AL, 2011, MEM I OSWALDO CRUZ, V106, P773, DOI 10.1590/S0074-02762011000600021
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Goncalves DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-228
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hegde S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02160
   HERTIG M., 1936, Parasitology, V28, P453, DOI 10.1017/S0031182000022666
   Hertig M, 1924, J MED RES, V44, P329
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Joanne S, 2015, ACTA TROP, V148, P38, DOI 10.1016/j.actatropica.2015.04.003
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Mavingui P, 2012, J BACTERIOL, V194, P1840, DOI 10.1128/JB.00036-12
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moghadam NN, 2018, FLY, V12, P1, DOI 10.1080/19336934.2017.1394558
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Thongsripong P, 2018, ECOL EVOL, V8, P1352, DOI 10.1002/ece3.3676
   Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
NR 42
TC 5
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD MAY
PY 2019
VL 9
IS 10
BP 6148
EP 6156
DI 10.1002/ece3.5198
PG 9
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA IC4GK
UT WOS:000470923500048
PM 31161026
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Binder, M
   Pilyugin, SS
AF Binder, Mike
   Pilyugin, Sergei S.
TI Stability analysis of a deterministic model of Zika/Dengue
   co-circulation
SO INTERNATIONAL JOURNAL OF BIOMATHEMATICS
LA English
DT Article
DE Zika; Dengue; secondary infection
ID VIRUS-INFECTION; DENGUE-DISEASE
AB We consider a deterministic model of Zika and Dengue viruses co-circulating in a human population. We study the system of differential equations modeling the dynamics of the diseases that can either be transmitted directly (host-to-host) or indirectly (host-vector-host). We use an SIR model for hosts and an SI model for vectors in the homogeneous populations. The stability of the model has been analyzed both qualitatively and quantitatively.
C1 [Binder, Mike; Pilyugin, Sergei S.] Univ Florida, Dept Math, Gainesville, FL 32611 USA.
RP Binder, M (corresponding author), Univ Florida, Dept Math, Gainesville, FL 32611 USA.
EM mikebinder@ufl.edu; pilyugin@ufl.edu
CR Ali T., 2015, FAR E J MATH SCI, V96, P419
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Martcheva M, 2015, INTRO MATH EPIDEMIOL
   McCluskey CC, 2018, J DYN GAMES, V5, P243, DOI 10.3934/jdg.2018016
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onuorah M., 2016, RES J MATH, V3
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pourbashash H, 2014, DISCRETE CONT DYN-B, V19, P3341, DOI 10.3934/dcdsb.2014.19.3341
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rodrigues HS, 2012, INT J COMPUT MATH, V89, P334, DOI 10.1080/00207160.2011.554540
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
NR 11
TC 1
Z9 1
U1 2
U2 7
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1793-5245
EI 1793-7159
J9 INT J BIOMATH
JI Int. J. Biomath.
PD MAY
PY 2019
VL 12
IS 4
AR 1950045
DI 10.1142/S1793524519500451
PG 39
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IC7TM
UT WOS:000471180000009
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Young, MP
   Bunz, M
   Xu, ZG
   Hattakam, S
   Vizcarra, E
   Regla-Nava, JA
   Tang, WW
   Yamabhai, M
   Wen, JS
   Shresta, S
AF Ngono, Annie Elong
   Young, Matthew P.
   Bunz, Maximilian
   Xu, Zhigang
   Hattakam, Sararat
   Vizcarra, Edward
   Regla-Nava, Jose Angel
   Tang, William W.
   Yamabhai, Montarop
   Wen, Jinsheng
   Shresta, Sujan
TI CD4(+) T cells promote humoral immunity and viral control during Zika
   virus infection (vol 15, e1007474, 2019)
SO PLOS PATHOGENS
LA English
DT Correction
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116813, R21 NS100477, R21 AI140063,
   R01 NS106387]; Chiba-UCSD Center for Mucosal Immunology, Allergy and
   Vaccine Development
FX This work was funded by NIAID/NIH grants R01 AI116813, R21 NS100477, R21
   AI140063, and R01 NS106387 to SS and the Chiba-UCSD Center for Mucosal
   Immunology, Allergy and Vaccine Development. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
NR 1
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2019
VL 15
IS 5
AR e1007821
DI 10.1371/journal.ppat.1007821
PG 1
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA IC7TP
UT WOS:000471180400045
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petridou, C
   Simpson, A
   Charlett, A
   Lyall, H
   Dhesi, Z
   Aarons, E
AF Petridou, Christina
   Simpson, Andrew
   Charlett, Andre
   Lyall, Hermione
   Dhesi, Zaneeta
   Aarons, Emma
TI Zika virus infection in travellers returning to the United Kingdom
   during the period of the outbreak in the Americas (2016-17): A
   retrospective analysis
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Epidemiology; United Kingdom; Serology
ID STATES
AB Background: In 2016, Zika virus (ZIKV) spread rapidly throughout the Americas and Caribbean in an explosive outbreak. In the UK, testing for ZIKV infection is performed at Public Health England's Rare and Imported Pathogens Laboratory. Here we present the UK's experience of imported ZIKV during the epidemic.
   Method: A retrospective review was performed on the laboratory computer system searching by orders for ZIKV PCR and/or ELISA serology tests between 1st January 2016 and 31st December 2017. Each individual request form and result was reviewed.
   Results: Of 6333 symptomatic patients tested for ZIKV, 374 (6%) had molecular or serological evidence consistent with recent infection; most of these had travelled to the Caribbean in 2016. On follow-up of PCR-confirmed cases, ZIKV IgM disappeared within 6 weeks and often didn't appear in patients with previous dengue infection. Rash was the commonest symptom in PCR-confirmed infection (93%). There were only single cases of presumed sexual transmission and of in-utero transmission.
   Conclusions: The rise and fall in numbers of imported ZIKV cases largely reflected the temporal course of the outbreak in the Caribbean. ZIKV serology is difficult to interpret but the absence of antibodies to ZIKV 14 days after symptom onset makes infection very unlikely.
C1 [Petridou, Christina; Simpson, Andrew; Dhesi, Zaneeta; Aarons, Emma] Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
   [Petridou, Christina] Queen Alexandra Hosp, Portsmouth NHS Fdn Trust, Portsmouth, Hants, England.
   [Charlett, Andre] Publ Hlth England, Stat & Modelling Econ Dept, London, England.
   [Lyall, Hermione] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Paediat Infect Dis Dept, London, England.
   [Dhesi, Zaneeta] Univ Coll Hosp NHS Fdn Trust, London, England.
RP Petridou, C (corresponding author), Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.; Petridou, C (corresponding author), Queen Alexandra Hosp, Portsmouth NHS Fdn Trust, Portsmouth, Hants, England.
EM christina.petridou@nhs.net; andrew.simpson@phe.gov.uk;
   andre.charlett@phe.gov.uk; hermione.lyall@nhs.net;
   zaneeta.dhesi@nhs.net; emma.aarons@phe.gov.uk
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Huits R, 2019, TRAVEL MED INFECT DI, V27, P107, DOI 10.1016/j.tmaid.2018.08.007
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Pyke AT, 2014, PLOS CURRENTS OUTBRE, V2014, DOI [10.1371/currents.outbreaks.4635a54dbffba2156fd76dc49f65e, DOI 10.1371/CURRENTS.OUTBREAKS.4635A54DBFFBA2156FD76DC49F65E]
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
NR 11
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2019
VL 29
BP 21
EP 27
DI 10.1016/j.tmaid.2019.03.001
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IC7RG
UT WOS:000471173600006
PM 30853504
DA 2020-07-08
ER

PT J
AU Sulleiro, E
   Rando, A
   Alejo, I
   Suy, A
   Gonce, A
   Rodo, C
   Torner, N
   Bardaji, A
   Fumado, V
   Soriano-Arandes, A
   Munoz, J
   Martinez, A
   Jane, M
   Marban-Castro, E
   Sanchez-Seco, MP
   Vazquez, A
   de Ory, F
   Pumarola, T
   Martinez, MJ
AF Sulleiro, Elena
   Rando, Ariadna
   Alejo, Izaskun
   Suy, Anna
   Gonce, Anna
   Rodo, Carlota
   Torner, Nuria
   Bardaji, Azucena
   Fumado, Victoria
   Soriano-Arandes, Antoni
   Munoz, Jose
   Martinez, Ana
   Jane, Mireia
   Marban-Castro, Elena
   Paz Sanchez-Seco, M.
   Vazquez, Ana
   de Ory, Fernando
   Pumarola, Tomas
   Martinez, Miguel J.
TI Screening for Zika virus infection in 1057 potentially exposed pregnant
   women, Catalonia (northeastern Spain)
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Pregnant women; Serological screening; Microcephaly;
   Congenital syndrome
C1 [Sulleiro, Elena; Rando, Ariadna; Pumarola, Tomas] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, PROSICS Barcelona, Dept Microbiol, Barcelona, Spain.
   [Alejo, Izaskun; Martinez, Miguel J.] Hosp Clin Barcelona, Dept Clin Microbiol, Escalera 11,5a Planta,Hosp Clin Villarroel 170, Barcelona 08036, Spain.
   [Suy, Anna; Rodo, Carlota] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Maternal Fetal Med Unit, Dept Obstet, Barcelona, Spain.
   [Gonce, Anna] Univ Barcelona, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Dept Maternal Fetal Med, Barcelona, Spain.
   [Gonce, Anna] Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain.
   [Torner, Nuria; Martinez, Ana; Jane, Mireia] Publ Hlth Agcy Catalonia, Generalitat Catalonia, Barcelona, Spain.
   [Torner, Nuria; Marban-Castro, Elena] Univ Barcelona, Dept Med, Madrid, Spain.
   [Torner, Nuria; Vazquez, Ana; de Ory, Fernando] CIBERESP, Madrid, Spain.
   [Bardaji, Azucena; Munoz, Jose; Martinez, Miguel J.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.
   [Fumado, Victoria] Hosp Univ St Joan Deu, Unitat Malalties Infeccioses & Importades, Serv Pediat Infect & Imported Dis, Pediat Unit, Barcelona, Spain.
   [Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Vall dHebron Res Inst, Dept Pediat, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Munoz, Jose] Hosp Clin Barcelona, Int Hlth Dept, Barcelona, Spain.
   [Paz Sanchez-Seco, M.; Vazquez, Ana; de Ory, Fernando] Natl Ctr Microbiol, Majadahonda, Spain.
RP Martinez, MJ (corresponding author), Hosp Clin Barcelona, Dept Clin Microbiol, Escalera 11,5a Planta,Hosp Clin Villarroel 170, Barcelona 08036, Spain.
EM myoldi@clinic.ub.es
RI Bardaji, Azucena/AAE-9145-2019; , Nuria/AAG-8951-2019; RODO,
   CARLOTA/K-9179-2017; Vazquez, Ana/H-4911-2013; Soriano-Arandes,
   Antoni/G-6851-2013; Gutierrez, Jose Munoz/AAH-6954-2020; Pumarola,
   Tomas/AAB-5532-2019; Arandes, Antonio Soriano/Q-3348-2016
OI Bardaji, Azucena/0000-0002-5135-0540; , Nuria/0000-0003-0143-5295; RODO,
   CARLOTA/0000-0001-8801-5677; Vazquez, Ana/0000-0002-9872-3316;
   Gutierrez, Jose Munoz/0000-0002-0945-1735; Pumarola,
   Tomas/0000-0002-5171-7461; Arandes, Antonio Soriano/0000-0001-9613-7228;
   Fernandez, Ivette/0000-0001-5179-0477; Sulleiro,
   Elena/0000-0002-9783-6060; Marban-Castro, Elena/0000-0002-9715-0595;
   Martinez, Miguel Julian/0000-0002-0682-1075; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704
FU Agencia de gestio Agencia de Gestio d'Ajuts Universitaris i de Recerca
   (AGAUR) - Departament d'Empresa i Coneixement. Generalitat de Catalunya
   [2017 SGR 794]; ISCIIIInstituto de Salud Carlos III [RD12/0018/0006,
   RD16CIII/0003/0003]; FEDER " Una manera de hacer Europa"
FX This study was partially supported by grant 2017 SGR 794 from the
   Agencia de gestio Agencia de Gestio d'Ajuts Universitaris i de Recerca
   (AGAUR) - Departament d'Empresa i Coneixement. Generalitat de Catalunya
   and by ISCIII, Projects RD12/0018/0006 and RD16CIII/0003/0003, "Red de
   Enfermedades Tropicales," Subprogram RETICS Plan Estatal de I + D + I
   2013-2016, and co-funded by FEDER " Una manera de hacer Europa."
CR Alvarado-Arnez LE, 2018, TRAVEL MED INFECT DI, V25, P1, DOI 10.1016/j.tmaid.2018.06.014
   [Anonymous], 2017, PROTOCOL ACTUACIO DA
   Coelho A, 2017, INT J MOL SCI, V18, P1
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
NR 6
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2019
VL 29
BP 69
EP 71
DI 10.1016/j.tmaid.2019.03.006
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IC7RG
UT WOS:000471173600016
PM 30885699
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ryu, S
   Chow, A
   Chun, BC
AF Ryu, Sukhyun
   Chow, Angela
   Chun, Byung Chul
TI Surveillance for Zika virus infection in travelers returning to the
   Republic of Korea
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
C1 [Ryu, Sukhyun] Gyeonggi Prov Govt, Div Infect Dis Control, Suwon, South Korea.
   [Ryu, Sukhyun] Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China.
   [Chow, Angela] Tan Tock Seng Hosp, Off Clin Epidemiol Analyt & Knowledge, Dept Clin Epidemiol, Singapore, Singapore.
   [Chun, Byung Chul] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
RP Chun, BC (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
EM chun@korea.ac.kr
OI Chun, Byung Chul/0000-0001-6576-8916
CR Choe YJ, 2017, TRAVEL MED INFECT DI, V19, P22, DOI 10.1016/j.tmaid.2017.09.003
   Jeon BH, 2018, PUB HLTH WEEK REP, V11, P212
   Kim H.-H., 2017, THESIS
   Korea Center for Disease Control and Prevention (KCDC), 2016, CAS DEF NAT NOT INF
   Korean Tourism Organization, NAT FOR TOUR MAJ DES
   Shin IS, PULSE
NR 6
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2019
VL 29
BP 72
EP 73
DI 10.1016/j.tmaid.2018.11.008
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IC7RG
UT WOS:000471173600017
PM 30445195
DA 2020-07-08
ER

PT J
AU Herrlinger, S
   Shao, Q
   Yang, M
   Chang, Q
   Liu, Y
   Pan, XH
   Yin, H
   Xie, LW
   Chen, JF
AF Herrlinger, Stephanie
   Shao, Qiang
   Yang, Mei
   Chang, Qing
   Liu, Yang
   Pan, Xiaohan
   Yin, Hang
   Xie, Li-Wei
   Chen, Jian-Fu
TI Lin28-mediated temporal promotion of protein synthesis is crucial for
   neural progenitor cell maintenance and brain development in mice
SO DEVELOPMENT
LA English
DT Article
DE Lin28; Protein synthesis; Ribosome biogenesis; Neural progenitor cell;
   Neural tube defect
ID RIBOSOMAL-RNA; MESSENGER-RNA; ZIKA VIRUS; STEM-CELLS; TRANSLATION;
   LIN28; GROWTH; PROLIFERATION; PLURIPOTENCY; NUCLEOLUS
AB Neural progenitor cells (NPCs) undergo rapid proliferation during neurulation. This rapid growth generates a high demand for mRNA translation in a timing-dependent manner, but its underlying mechanism remains poorly understood. Lin28 is an RNA-binding protein with two paralogs, Lin28a and Lin28b, in mammals. Mice with Lin28b deletion exhibit no developmental defects, whereas we have previously reported that Lin28a deletion leads to microcephaly. Here, we find that Lin28a/b double knockout (dKO) mice display neural tube defects (NTDs) coupled with reduced proliferation and precocious differentiation of NPCs. Using ribosomal protein 24 hypomorphic mice (Rp/24(Bstl+)) as a genetic tool to dampen global protein synthesis, we found that Lin28a(-/-);Rp124(Bstl+) compound mutants exhibited NTDs resembling those seen in Lin28alb dKO mice. Increased NPC numbers and brain sizes in Un28a-overexpressing mice were rescued by Rp124(Bstl+) heterozygosity. Mechanistically, polysome profiling revealed reduced translation of genes involved in the regulation of cell cycle, ribosome biogenesis and translation in dKO mutants. Ribosome biogenesis was reduced in dKO and increased in Lin28a-overexpressing NPCs. Therefore, Lin28-mediated promotion of protein synthesis is essential for NPC maintenance and early brain development.
C1 [Herrlinger, Stephanie; Shao, Qiang; Yang, Mei; Chang, Qing; Chen, Jian-Fu] Univ Southern Calif, Ctr Craniofacial & Mol Biol, Los Angeles, CA 90033 USA.
   [Herrlinger, Stephanie] Univ Georgia, Biomed & Hlth Sci Inst, Dept Genet, Athens, GA 30602 USA.
   [Liu, Yang; Yin, Hang] Univ Georgia, Dept Biochem & Mol Biol, Ctr Mol Med, Athens, GA 30602 USA.
   [Pan, Xiaohan; Xie, Li-Wei] Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.
RP Chen, JF (corresponding author), Univ Southern Calif, Ctr Craniofacial & Mol Biol, Los Angeles, CA 90033 USA.; Xie, LW (corresponding author), Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.
EM xielw@gdim.cn; jianfu@usc.edu
OI Shao, Qiang/0000-0001-5307-8264
FU Center for Craniofacial Molecular Biology, Herman Ostrow School of
   Dentistry at the University of Southern California; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS097231, R01NS096176]; National
   Institute of Health Blueprint Diversity Specialized Predoctoral to
   Postdoctoral Advancement in Neuroscience (D-SPAN) award
   [F99NS105187-01]; Achievement Rewards for College Scientists (ARCS)
   Global Impact Award; National Institutes of Health training grantUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [2T32GM007103-42]
FX J.-F.C.'s laboratory is supported by funds from the Associate Dean of
   Research Fund from the Center for Craniofacial Molecular Biology, Herman
   Ostrow School of Dentistry at the University of Southern California, and
   by grants R01NS097231 (to J.-F.C.) and R01NS096176 (to J.-F.C.) from the
   National Institutes of Health. This work was additionally supported by a
   National Institute of Health Blueprint Diversity Specialized Predoctoral
   to Postdoctoral Advancement in Neuroscience (D-SPAN) award
   F99NS105187-01 (to S.H.) and by a Achievement Rewards for College
   Scientists (ARCS) Global Impact Award (to S.H.), and was in part
   supported by a National Institutes of Health training grant
   2T32GM007103-42 (to S.H.). Deposited in PMC for release after 12 months.
CR Baker NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058266
   Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895
   Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449
   Burns JL, 2001, DEVELOPMENT, V128, P3819
   Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016
   Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023
   Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019
   Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9
   Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   FERRARI S, 1991, J BIOL CHEM, V266, P22770
   Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005
   Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004
   GARDEN GA, 1995, MOL CELL NEUROSCI, V6, P293, DOI 10.1006/mcne.1995.1023
   Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354
   Guzman-Ayala M, 2015, DEVELOPMENT, V142, P118, DOI 10.1242/dev.114843
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028
   Kraushar ML, 2014, P NATL ACAD SCI USA, V111, pE3815, DOI 10.1073/pnas.1408305111
   Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2
   Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752
   Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6
   Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07
   Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007
   Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346
   Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423
   Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005
   Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035
   Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001
   Vogt EJ, 2012, DEVELOPMENT, V139, P4514, DOI 10.1242/dev.083279
   Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002
   Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543
   Yang SL, 2015, DEV BIOL, V408, P140, DOI 10.1016/j.ydbio.2015.09.020
   Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384
NR 45
TC 2
Z9 1
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD MAY
PY 2019
VL 146
IS 10
AR UNSP dev173765
DI 10.1242/dev.173765
PG 11
WC Developmental Biology
SC Developmental Biology
GA IC4VA
UT WOS:000470963700009
PM 31064784
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Akiner, MM
   Ozturk, M
   Baser, AB
   Gunay, F
   Hacioglu, S
   Brinkmann, A
   Emanet, N
   Alten, B
   Ozkul, A
   Nitsche, A
   Linton, YM
   Ergunay, K
AF Akiner, Mustafa M.
   Ozturk, Murat
   Baser, Aykut Bugra
   Gunay, Filiz
   Hacioglu, Sabri
   Brinkmann, Annika
   Emanet, Nergis
   Alten, Bulent
   Ozkul, Aykut
   Nitsche, Andreas
   Linton, Yvonne-Marie
   Ergunay, Koray
TI Arboviral screening of invasive Aedes species in northeastern Turkey:
   West Nile virus circulation and detection of insect-only viruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID FIELD-COLLECTED MOSQUITOS; MERIDA VIRUS; 1ST EVIDENCE; FLAVIVIRUSES;
   SURVEILLANCE; TRANSMISSION; RHABDOVIRUS; ANATOLIA; DENGUE;
   IDENTIFICATION
AB Background The recent reports of Aedes aegypti and Ae. albopictus populations in Turkey, in parallel with the territorial expansion identified in several surrounding countries, have raised concerns about the establishment and re-establishment of these invasive Aedes mosquitoes in Turkey. This cross-sectional study was performed to detect Aedes aegypti and Ae. albopictus in regions of recent incursions, and screen for viral pathogens known to be transmitted elsewhere by these species.
   Methodology Mosquitoes were collected at several locations in Artvin, Rize and Trabzon provinces of the Black Sea region during 2016-2017, identified morphologically, pooled and analyzed via generic or specific nucleic acid amplification assays. Viruses in positive pools were identified by product sequencing, cell culture inoculation and next generation sequencing (NGS) in selected specimens.
   Principal findings The study group comprised 791 specimens. Aedes albopictus was the most abundant species in all locations (89.6%), followed by Ae. aegypti (7.8%) and Culex pipiens (2.5%). Mosquitoes were screened for viruses in 65 pools where fifteen (23.1%) were reactive. The infecting strains was identified as West Nile virus (WNV) in 5 pools (7.7%) with Ae. albopictus or Cx. pipiens mosquitoes. The obtained WNV sequences phylogenetically grouped with local and global lineage 1 clade 1a viruses. In 4 (6.2%) and 6 (9.2%) pools, respectively, cell fusing agent virus (CFAV) and Aedes flavivirus (AEFV) sequences were characterized. NGS provided a near-complete AEFV genome in a pool of Ae. albopictus. The strain is provisionally called AEFV-Turkey, and functional analysis of the genome revealed several conserved motifs and regions associated with virus replication. Merida-like virus Turkey (MERDLVT), a recently-described novel rhabdovirus, was also co-detected in a Cx. pipiens pool also positive for WNV.
   Conclusions/Significance Invasive Aedes mosquitoes are established in certain locations of northeastern Turkey. Herein we conclusively show the role of these species in WNV circulation in the region. Biosurveillance is imperative to monitor the spread of these species further into Asia Minor and to detect possible introduction of pathogens.
   Author summary Mosquitoes can transmit viruses to susceptible humans during blood-feeding. The presence and establishment of particular mosquito species within a region is the prerequisite for the introduction and emergence of the diseases transmitted by that species. Aedes mosquitoes transmit dengue and yellow fever, as well as recently-emergent chikungunya and Zika viruses to susceptible humans. Mosquitoes were collected in the Black Sea region of Anatolia, NE Turkey, where invasive Aedes mosquitoes have recently encroached, and specimens were screened for a variety of viruses. We observed particular Aedes species that are associated with disease transmission, suggesting that these species have been established in the region. We did not detect dengue, yellow fever, chikungunya or Zika viruses, but West Nile virus was found in several pools of these invasive species. Moreover, we detected a number of related viruses that exclusively infect mosquitoes, identified for the first time in Anatolia. Using advanced sequencing technologies, the near-complete genome of a new Aedes flavivirus (AEFV-Turkey) was achieved.
C1 [Akiner, Mustafa M.; Ozturk, Murat; Baser, Aykut Bugra] Recep Tayyip Erdogan Univ, Fac Arts & Sci, Dept Biol, Rize, Turkey.
   [Gunay, Filiz; Alten, Bulent] Hacettepe Univ, Fac Sci, Dept Biol, Div Ecol, Ankara, Turkey.
   [Hacioglu, Sabri; Ozkul, Aykut] Ankara Univ, Fac Vet Med, Dept Virol, Ankara, Turkey.
   [Brinkmann, Annika; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens 1 ZBS 1, Berlin, Germany.
   [Emanet, Nergis; Ergunay, Koray] Hacettepe Univ, Fac Med, Dept Med Microbiol, Virol Unit, Ankara, Turkey.
   [Linton, Yvonne-Marie] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, NHB 169, Washington, DC 20560 USA.
   [Linton, Yvonne-Marie] Museum Support Ctr, Smithsonian Inst, Walter Reed Biosystemat Unit, Suitland, MD USA.
RP Ergunay, K (corresponding author), Hacettepe Univ, Fac Med, Dept Med Microbiol, Virol Unit, Ankara, Turkey.
EM ekoray@hacettepe.edu.tr
RI Ergunay, Koray/I-8368-2013; Linton, Yvonne/AAG-2353-2019; Emanet,
   Nergis/Z-5074-2019; Gunay, Filiz/AAC-7874-2020; Ozkul, Aykut/A-1973-2016
OI Ergunay, Koray/0000-0001-5422-1982; Gunay, Filiz/0000-0002-2583-6264;
   Ozkul, Aykut/0000-0001-5008-9443; Hacioglu, Sabri/0000-0002-5493-0807
FU Armed Forces Health Surveillance Board, Global Emerging Infections
   Surveillance and Response System (AFHSB-GEIS), United States of America
   (FY18 award) under US Army [P0034_18_WR, W911QY-16C-0160]
FX This study was supported in part by the Armed Forces Health Surveillance
   Board, Global Emerging Infections Surveillance and Response System
   (AFHSB-GEIS), United States of America (FY18 award P0034_18_WR (PI:
   Yvonne-Marie Linton) under US Army subcontract W911QY-16C-0160). BA and
   FG were also included in AIM-COST. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The material to be published reflects the
   views of the authors and should not be construed to represent those of
   the US Department of the Army or the US Department of Defense.
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Caglayik DY, 2012, MIKROBIYOL BUL, V46, P122
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Charles J, 2016, J GEN VIROL, V97, P977, DOI 10.1099/jgv.0.000424
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P247
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Ergunay K, 2017, ARCH VIROL, V162, P1903, DOI 10.1007/s00705-017-3314-4
   Ergunay K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2087-7
   Ergunay K, 2016, INFECT GENET EVOL, V46, P138, DOI 10.1016/j.meegid.2016.11.008
   Ergunay K, 2015, EMERG INFECT DIS, V21, P352, DOI 10.3201/eid2102.141135
   Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028
   Ergunay K, 2013, VECTOR-BORNE ZOONOT, V13, P744, DOI 10.1089/vbz.2012.1288
   Ergunay K, 2010, MIKROBIYOL BUL, V44, P415
   Fernandes LN, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120666
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Gao Q, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3053-8
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grisenti M, 2015, J GEN VIROL, V96, P420, DOI 10.1099/vir.0.069625-0
   Gunay F, 2017, MOSKEYTOOL INTERACTI
   Hacioglu S, 2017, VECTOR-BORNE ZOONOT, V17, P698, DOI 10.1089/vbz.2017.2138
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Herbig A., 2016, BIORXIV, DOI [10.1101/050559., 10.1101/050559, DOI 10.1101/050559]
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957
   Kalaycioglu H, 2012, EUROSURVEILLANCE, V17, P12
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Monaco F, 2016, VET ITAL, V52, P77, DOI [10.12834/VetIt.838.4169.1, 10.12834/Vet|t.838.4169.1]
   Oncu C, 2018, INFECT GENET EVOL, V57, P36, DOI 10.1016/j.meegid.2017.11.003
   Oter K, 2013, VECTOR-BORNE ZOONOT, V13, P753, DOI 10.1089/vbz.2012.1093
   Ozkul A, 2013, INT J INFECT DIS, V17, pE546, DOI 10.1016/j.ijid.2013.02.005
   Roiz D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-223
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Sezen AI, 2018, MIKROBIYOL BUL, V52, P308, DOI 10.5578/mb.66991
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Uyar Y, 2013, MIKROBIYOL BUL, V47, P173
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Zehender G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179679
   Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 59
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007334
DI 10.1371/journal.pntd.0007334
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100030
PM 31059502
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caragata, EP
   Rocha, MN
   Pereira, TN
   Mansur, SB
   Dutra, HLC
   Moreira, LA
AF Caragata, Eric P.
   Rocha, Marcele N.
   Pereira, Thiago N.
   Mansur, Simone B.
   Dutra, Heverton L. C.
   Moreira, Luciano A.
TI Pathogen blocking in Wolbachia-infected Aedes aegypti is not affected by
   Zika and dengue virus co-infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; CO-CIRCULATION; TRANSMISSION; CHIKUNGUNYA;
   DISEASE; ESTABLISHMENT; STRAIN; IMPACT
AB Background Wolbachia's ability to restrict arbovirus transmission makes it a promising tool to combat mosquito-transmitted diseases. Wolbachia-infected Aedes aegypti are currently being released in locations such as Brazil, which regularly experience concurrent outbreaks of different arboviruses. A. aegypti can become co-infected with, and transmit multiple arboviruses with one bite, which can complicate patient diagnosis and treatment.
   Methodology/principle findings Using experimental oral infection of A. aegypti and then RT-qPCR, we examined ZIKV/DENV-1 and ZIKV/DENV-3 co-infection in Wolbachia-infected A. aegypti and observed that Wolbachia-infected mosquitoes experienced lower prevalence of infection and viral load than wildtype mosquitoes, even with an extra infecting virus. Critically, ZIKV/DENV co-infection had no significant impact on Wolbachia's ability to reduce viral transmission. Wolbachia infection also strongly altered expression levels of key immune genes Defensin C and Transferrin 1, in a virus-dependent manner.
   Conclusions/significance Our results suggest that pathogen interference in Wolbachia-infected A. aegypti is not adversely affected by ZIKV/DENV co-infection, which suggests that Wolbachia-infected A. aegypti will likely prove suitable for controlling mosquito-borne diseases in environments with complex patterns of arbovirus transmission.
   Author summary Wolbachia is an endosymbiotic bacterium that infects insects. It has been artificially transferred into Aedes aegypti, a mosquito species that can transmit medically important viruses including dengue, chikungunya, and Zika. Wolbachia in A. aegypti limits infection with these viruses, making the mosquitoes much less capable of transmitting them to people. In tropical areas, where these viral pathogens are commonly found, it is not unusual for outbreaks of different viruses to occur at the same time, which can complicate diagnosis and treatment for those afflicted. Mosquitoes with Wolbachia are currently being released into these areas to reduce transmission of these diseases. In our study, we assessed whether Wolbachia infection in A. aegypti mosquitoes could still effectively inhibit the dengue and Zika viruses if the mosquitoes were fed both viruses at the same time. We found that Wolbachia was still very effective at inhibiting the replication of both viruses in the mosquito, and likewise still greatly reduced the chance of transmission of either virus. Our results suggest that Wolbachia-infected mosquitoes should be able to limit infection with more than one virus, should they encounter them in the field.
C1 [Caragata, Eric P.; Rocha, Marcele N.; Pereira, Thiago N.; Mansur, Simone B.; Dutra, Heverton L. C.; Moreira, Luciano A.] Inst Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
   [Caragata, Eric P.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Dutra, Heverton L. C.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.
RP Moreira, LA (corresponding author), Inst Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
EM luciano.andrade@fiocruz.br
RI Dutra, Heverton Leandro Carneiro/V-7517-2019
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512; Moreira,
   Luciano/0000-0002-9240-3506; Rocha, Marcele/0000-0001-7130-6961
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES;
   Brazilian Ministry of Health (DECIT/SVS); Foundation for the National
   Institutes of Health through the Vector-Based Transmission of Control:
   Discovery Research (VCTR) program of the Grand Challenges in Global
   Health Initiatives of the Bill and Melinda Gates Foundation
FX This work was supported by FAPEMIG, CNPq, CAPES, the Brazilian Ministry
   of Health (DECIT/SVS), and a grant to Monash University from the
   Foundation for the National Institutes of Health through the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health Initiatives of the Bill and
   Melinda Gates Foundation. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   [Anonymous], 2018, FREE RADICAL BIO MED, V115, P361
   [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377
   [Anonymous], 2015, BMJ, V2015, ph1887
   [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141
   [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204
   Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539
   Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   DUCHEMIN JB, 2017, VIROL J, V14
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferdousi Farhana, 2015, Tropical Medicine and Health, V43, P253, DOI 10.2149/tmh.2015-16
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   GOSSNER CM, 2018, EUROSURVEILLANCE, V23, P2
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haqshenas G, 2019, CELL REP, V26, P529, DOI 10.1016/j.celrep.2018.12.068
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1988, GENETICS, V119, P435
   Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Lindsey ARI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040141
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mourya DT, 2018, INDIAN J MED RES, V147, P88, DOI 10.4103/ijmr.IJMR_1142_17
   OLIVEIRA H, 2018, VIRUSES-BASEL, V10, DOI DOI 10.1371/CURRENTS.OUTBREAKS.0BF6AEB4D30824DE63C4D5D745B217F5
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Pereira TN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25236-8
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Santos BS, 2018, J BIOSCIENCES MED, V6, P97, DOI [10.4236/jbm.2018.65011, DOI 10.4236/JBM.2018.65011]
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Shrinet J, 2018, J PROTEOME RES, V17, P3348, DOI 10.1021/acs.jproteome.8b00211
   Simoes ML, 2018, TRENDS PARASITOL, V34, P603, DOI 10.1016/j.pt.2018.04.011
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Vaddadi K, 2017, EPIDEMIOL INFECT, V145, P2563, DOI 10.1017/S0950268817001479
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WHO, ZIKA SITUATION REPOR
   WHO, 2018, DENG SEV DENG
   WHO, 2018, ZIK VIR FACT SHEETS
   World Helth Organization, GLOB STRAT DENG PREV
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zhou GL, 2009, INSECT BIOCHEM MOLEC, V39, P234, DOI 10.1016/j.ibmb.2008.12.004
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 86
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007443
DI 10.1371/journal.pntd.0007443
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100069
PM 31107912
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fonseca, V
   Libin, PJK
   Theys, K
   Faria, NR
   Nunes, MRT
   Restovic, MI
   Freire, M
   Giovanetti, M
   Cuypers, L
   Nowe, A
   Abecasis, A
   Deforche, K
   Santiago, GA
   de Siqueira, IC
   San, EJ
   Machado, KCB
   Azevedo, V
   Bispo-de Filippis, AM
   da Cunha, RV
   Pybus, OG
   Vandamme, AM
   Alcantara, LCJ
   de Oliveira, T
AF Fonseca, Vagner
   Libin, Pieter J. K.
   Theys, Kristof
   Faria, Nuno R.
   Nunes, Marcio R. T.
   Restovic, Maria I.
   Freire, Murilo
   Giovanetti, Marta
   Cuypers, Lize
   Nowe, Ann
   Abecasis, Ana
   Deforche, Koen
   Santiago, Gilberto A.
   de Siqueira, Isadora C.
   San, Emmanuel J.
   Machado, Kaliane C. B.
   Azevedo, Vasco
   Bispo-de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   Pybus, Oliver G.
   Vandamme, Anne-Mieke
   Alcantara, Luiz C. J.
   de Oliveira, Tulio
TI A computational method for the identification of Dengue, Zika and
   Chikungunya virus species and genotypes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; LARGE PHYLOGENIES; PERFORMANCE; ACCURATE;
   BURDEN; SYSTEM; HIV-1
AB In recent years, an increasing number of outbreaks of Dengue, Chikungunya and Zika viruses have been reported in Asia and the Americas. Monitoring virus genotype diversity is crucial to understand the emergence and spread of outbreaks, both aspects that are vital to develop effective prevention and treatment strategies. Hence, we developed an efficient method to classify virus sequences with respect to their species and sub-species (i.e. serotype and/or genotype). This tool provides an easy-to-use software implementation of this new method and was validated on a large dataset assessing the classification performance with respect to whole-genome sequences and partial-genome sequences. Available online: http://krisp.org.za/tools.php.
   Author summary Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) are considered major public health challenges. In addition to the epidemic caused by DENV, which has been described in many tropical countries, the introduction of CHIKV and ZIKV in these countries is a major public health concern. These arboviruses are primarily transmitted by mosquitoes of the species Ae. Aegypti and its related diseases result in increased financial costs associated with diagnosis and treatment. To support the design of efficient diagnosis, prevention and treatment strategies, a bioinformatics tool has been developed for the genotyping of these viruses based on appropriate evolutionary models in an automatic, accurate and rapid manner. A set of virus reference sequences was obtained from GenBank and used for the development of the tools. This process involved the alignment of the reference sequences followed by phylogenetic tree reconstructions. To assign the genotypes uploaded by the user, the tool analyses the sequences one by one, genotypes through identification, alignment and phylogenetic reconstruction. This computational method allows the high-throughput classification of these virus species and genotypes in seconds. As shown experimentally, genotypes are classified most confidently using the envelope gene or complete genome sequences.
C1 [Fonseca, Vagner; Giovanetti, Marta; Bispo-de Filippis, Ana Maria; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Fonseca, Vagner; San, Emmanuel J.; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Fonseca, Vagner; Azevedo, Vasco; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Libin, Pieter J. K.; Theys, Kristof; Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Restovic, Maria I.; Freire, Murilo; de Siqueira, Isadora C.; Machado, Kaliane C. B.] Fundacao Oswaldo Cruz, Lab Patol Expt, Salvador, BA, Brazil.
   [Abecasis, Ana; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Deforche, Koen] EMWEB Private Co, Herent, Belgium.
   [Santiago, Gilberto A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Coordenacao Vigilancia Saude & Lab Referencias, Rio De Janeiro, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com; tuliodna@gmail.com
RI Pybus, Oliver g/B-2640-2012; Fonseca, Vagner/R-5813-2019; de Siqueira,
   Isadora Cristina/R-9953-2016; Giovanetti, Marta/AAK-7408-2020; Azevedo,
   Vasco A/B-1556-2019; Abecasis, Ana/B-6295-2009; Faria, Nuno
   Rodrigues/I-2975-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Fonseca,
   Vagner/0000-0001-5521-6448; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Abecasis, Ana/0000-0002-3903-5265; Nowe,
   Ann/0000-0001-6346-4564; Faria, Nuno Rodrigues/0000-0001-8839-2798;
   Alcantara, Luiz/0000-0002-6769-9931
FU South African Medical Re-search Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; VIROGENESIS project -
   European Union's Horizon 2020 Research and Innovation Programme
   [634650]; National Institutes of Health Common FundUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U24HG006941]; FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen)FWO; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/201600, 88881.130825/2016-00, 88887.130823/2016-00]; EU's
   Horizon 2020 Programme through ZIKAlliance [PRES-005-FEX-17-4-2-33];
   Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [GHTM-UID/Multi/04413/2013]; Decit/SCTIE/MoH
FX Supported by a research Flagship grant from the South African Medical
   Re-search Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Programme (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. Pieter Libin was
   supported by a PhD grant of the FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen). This work was supported by Decit/SCTIE/MoH and CNPq
   (440685/2016-8 and 440856/2016-7); by CAPES (88887.130716/201600,
   88881.130825/2016-00 and 88887.130823/2016-00); and by EU's Horizon 2020
   Programme through ZIKAlliance (PRES-005-FEX-17-4-2-33). Ana Abecasis was
   supported by Fundacao para a Ciencia e Tecnologia (FCT) through funds to
   GHTM-UID/Multi/04413/2013. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1990, BASIC LOCAL ALIGNMEN
   [Anonymous], 2018, STROKE, V49, pe233
   Banoo S, 2006, NAT REV MICROBIOL, pS21, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ha Schmidt, 2002, BIOINFORMATICS, V18, P502, DOI [10.1093/bioinformatics/18.3.502, DOI 10.1093/BIOINFORMATICS/18.3.502]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Libin P., 2018, BIOINFORMATICS OXFOR
   Libin P, 2017, BIOINFORMATICS, V33, P3993, DOI 10.1093/bioinformatics/btx535
   Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALEMI M, 2003, PHYLOGENETIC HDB PRA
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 4
Z9 4
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007231
DI 10.1371/journal.pntd.0007231
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100009
PM 31067235
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Machado, LC
   de Morais-Sobral, MC
   Campos, TD
   Pereira, MR
   de Albuquerque, MDPM
   Gilbert, C
   Franca, RFO
   Wallau, GL
AF Machado, Lais Ceschini
   de Morais-Sobral, Mariana Carolina
   Campos, Tulio de Lima
   Pereira, Mylena Ribeiro
   Pessoa Militao de Albuquerque, Maria de Fatima
   Gilbert, Clement
   Oliveira Franca, Rafael Freitas
   Wallau, Gabriel Luz
TI Genome sequencing reveals coinfection by multiple chikungunya virus
   genotypes in a recent outbreak in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; ZIKA; DENGUE; MANIFESTATIONS; POPULATION;
   SPREAD; INDIA
AB Chikungunya virus (CHIKV) is an RNA virus from the Togaviridae family transmitted by mosquitoes in both sylvatic and urban cycles. In humans, CHIKV infection leads to a febrile illness, denominated Chikungunya fever (CHIKF), commonly associated with more intense and debilitating outcomes. CHIKV arrived in Brazil in 2014 through two independent introductions: the Asian/Caribbean genotype entered through the North region and the African ECSA genotype was imported through the Northeast region. Following their initial introduction, both genotypes established their urban cycle among large naive human populations causing several outbreaks in the Americas. Here, we sequenced CHIKV genomes from a recent outbreak in the Northeast region of Brazil, employing an in-house developed Next-Generation Sequencing (NGS) protocol capable of directly detecting multiple known CHIKV genotypes from clinical positive samples. Our results demonstrate that both Asian/Caribbean and ECSA genotypes expanded their ranges, reaching cocirculation in the Northeast region of Brazil. In addition, our NGS data supports the findings of simultaneous infection by these two genotypes, suggesting that coinfection might be more common than previously thought in highly endemic areas. Future efforts to understand CHIKV epidemiology should thus take into consideration the possibility of coinfection by different genotypes in the human population.
   Author summary Human infection by different arthropod borne viruses such as Chikungunya, Dengue and Zika causes a continuous and extensive health burden mainly in tropical regions of the world. Most of the CHIKV infections result in only mild symptoms, however more extreme manifestations can occur, occasionally leading to death. Different CHIKV genotypes have been circulating in almost all continent around the globe but so far human outbreaks were reported only for single CHIKV genotypes. In Brazil two CHIKV genotypes arrived in the North and Northeast region: the Asian/Caribbean and African ECSA respectively. Here, through viral genome sequencing, we showed that some samples were coinfected by both Asian/Caribbean and ECSA CHIKV genotypes, indicating that these two genotypes expanded their ranges and currently co-circulate in some areas of Brazil. In summary, such findings call for improved surveillance in order to detect co-circulation of different viral genotypes and further evaluate the impact of co-infection in disease epidemiology.
C1 [Machado, Lais Ceschini; de Morais-Sobral, Mariana Carolina; Wallau, Gabriel Luz] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Entomol, Recife, PE, Brazil.
   [Campos, Tulio de Lima] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Bioinformat Core Facil, Recife, PE, Brazil.
   [Pereira, Mylena Ribeiro] Fed Rural Univ Pernambuco UFRPE, Dept Vet Med, Recife, PE, Brazil.
   [Pessoa Militao de Albuquerque, Maria de Fatima] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Publ Hlth, Recife, PE, Brazil.
   [Gilbert, Clement] Univ Paris Sud, CNRS, UMR 9191, UMR 247,IRD,Lab Evolut Genomes Comportment Ecol, Ave Terrasse, Gif Sur Yvette, France.
   [Oliveira Franca, Rafael Freitas] Oswaldo Cruz Fdn Fiocruz, Dept Virol & Expt Therapy, Aggeu Magalhaes Inst, Recife, PE, Brazil.
RP Wallau, GL (corresponding author), Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Entomol, Recife, PE, Brazil.; Franca, RFO (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol & Expt Therapy, Aggeu Magalhaes Inst, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br; gabriel.wallau@cpqam.fiocruz.br
RI ; de Lima Campos, Tulio/N-5204-2018
OI Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; de Lima Campos,
   Tulio/0000-0003-0446-848X
FU Pernambuco Research Foundation (FACEPE) [APQ-0078-2.02/16,
   APQ-0044-2.11/16, APQ-00552.11/16]; CNPqNational Council for Scientific
   and Technological Development (CNPq) [439975/2016-6]; Agence Nationale
   de la RechercheFrench National Research Agency (ANR)
   [ANR-15-CE32-0011-01]
FX This work was supported by the Pernambuco Research Foundation (FACEPE)
   process no APQ-0078-2.02/16 under GLW coordination and APQ-0044-2.11/16;
   APQ-00552.11/16 and CNPq Grant Number 439975/2016-6 under RFOF
   coordination. CG is supported by a grant from Agence Nationale de la
   Recherche (ANR-15-CE32-0011-01 TransVir). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal A, 2017, J NEUROVIROL, V23, P504, DOI 10.1007/s13365-017-0516-1
   [Anonymous], 2017, J PROSTHET DENT, V11, pe1
   [Anonymous], 2017, J PROSTHET DENT, V11, pe1
   [Anonymous], 2016, EVIDENCE, V8, pe1000
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Charlys da Costa A, 2017, EMERG INFECT DIS, P23
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Deeba F, 2016, CURRENT TOPICS CHIKU
   Dhanoa A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1731-8
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Dublin, 2017, ENVIRON CONSERV, V19, P6, DOI [10.1017/S0376892900030733, DOI 10.1017/S0376892900030733]
   Edwards T, 2017, DIAGN MICR INFEC DIS, V89, P35, DOI 10.1016/j.diagmicrobio.2017.06.001
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719
   Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Iles JC, 2015, J CLIN MICROBIOL, V53, P3155, DOI 10.1128/JCM.00483-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Marinho PES, 2017, EMERG INFECT DIS, V23, P115, DOI 10.3201/eid2301.160817
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Xiao YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00354-5
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 53
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007332
DI 10.1371/journal.pntd.0007332
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100029
PM 31095561
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reiner, RC
   Stoddard, ST
   Vazquez-Prokopec, GM
   Astete, H
   Perkins, TA
   Sihuincha, M
   Stancil, JD
   Smith, DL
   Kochel, TJ
   Halsey, ES
   Kitron, U
   Morrison, AC
   Scott, TW
AF Reiner, Robert C.
   Stoddard, Steven T.
   Vazquez-Prokopec, Gonzalo M.
   Astete, Helvio
   Perkins, T. Alex
   Sihuincha, Moises
   Stancil, Jeffrey D.
   Smith, David L.
   Kochel, Tadeuz J.
   Halsey, Eric S.
   Kitron, Uriel
   Morrison, Amy C.
   Scott, Thomas W.
TI Estimating the impact of city-wide Aedes aegypti population control: An
   observational study in Iquitos, Peru
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VECTOR; CULICIDAE; DIPTERA; PRODUCTIVITY; MICROCLIMATE; DISPERSAL
AB During the last 50 years, the geographic range of the mosquito Aedes aegypti has increased dramatically, in parallel with a sharp increase in the disease burden from the viruses it transmits, including Zika, chikungunya, and dengue. There is a growing consensus that vector control is essential to prevent Aedes-borne diseases, even as effective vaccines become available. What remains unclear is how effective vector control is across broad operational scales because the data and the analytical tools necessary to isolate the effect of vector-oriented interventions have not been available. We developed a statistical framework to model Ae. aegypti abundance over space and time and applied it to explore the impact of citywide vector control conducted by the Ministry of Health (MoH) in Iquitos, Peru, over a 12-year period. Citywide interventions involved multiple rounds of intradomicile insecticide space spray over large portions of urban Iquitos (up to 40% of all residences) in response to dengue outbreaks. Our model captured significant levels of spatial, temporal, and spatio-temporal variation in Ae. aegypti abundance within and between years and across the city. We estimated the shape of the relationship between the coverage of neighborhood-level vector control and reductions in female Ae. aegypti abundance; i.e., the dose-response curve. The dose-response curve, with its associated uncertainties, can be used to gauge the necessary spraying effort required to achieve a desired effect and is a critical tool currently absent from vector control programs. We found that with complete neighborhood coverage MoH intra-domicile space spray would decrease Ae. aegypti abundance on average by 67% in the treated neighborhood. Our framework can be directly translated to other interventions in other locations with geolocated mosquito abundance data. Results from our analysis can be used to inform future vector-control applications in Ae. aegypti endemic areas globally.
   Author summary Despite the growing threat of arboviruses, there is a dearth of best practices' for the primary vector control tools used in the field. In the absence of cluster randomized control trials, evidence on the utility (or lack thereof) of vector control interventions must be gleaned from ongoing control programs. Motivated by 12 years of household-level Ae. aegypti abundance surveys and neighborhood-level space-spray campaign data from Iquitos, Peru, we developed a new framework to model mosquito abundance. In spite of significant spatial and temporal heterogeneity, we identified a statistically significant and practically important impact of the local Ministry of Health space-spray campaign, specifically, a reduction of mosquito abundance of 67% when coverage was optimal. Our framework can be directly applied to other locations with geolocated mosquito abundance data and our findings can be used to both optimize resources within Iquitos as well as inform future vector-control interventions in Ae. aegypti endemic areas globally.
C1 [Reiner, Robert C.; Smith, David L.] Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Sch Med, Seattle, WA 98195 USA.
   [Reiner, Robert C.; Smith, David L.] Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Sch Publ Hlth, Seattle, WA 98195 USA.
   [Reiner, Robert C.; Stoddard, Steven T.; Vazquez-Prokopec, Gonzalo M.; Perkins, T. Alex; Smith, David L.; Kitron, Uriel; Scott, Thomas W.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Stoddard, Steven T.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA.
   [Vazquez-Prokopec, Gonzalo M.; Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Astete, Helvio; Stancil, Jeffrey D.; Kochel, Tadeuz J.; Halsey, Eric S.; Morrison, Amy C.] US Naval Med Res, Unit 6, Lima, Peru.
   [Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Sihuincha, Moises] Hosp Apoyo, Iquitos, Peru.
   [Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.
RP Reiner, RC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Sch Med, Seattle, WA 98195 USA.; Reiner, RC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Sch Publ Hlth, Seattle, WA 98195 USA.; Reiner, RC (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
EM bcreiner@uw.edu
RI Smith, David/L-8850-2013
OI Smith, David/0000-0003-4367-3849
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01 AI098670]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   editorial Journal, 2014, NETW SECUR, V7, P1, DOI DOI 10.1186/1756-3305-7-1
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08
   Getis A, 2010, ADV SPAT SCI, P203, DOI 10.1007/978-3-642-01976-0_15
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gunning CE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006378
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   KOOPMANS LH, 1964, BIOMETRIKA, V51, P25, DOI 10.1093/biomet/51.1-2.25
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   LUMSDEN WHR, 1947, J EXP BIOL, V24, P361
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389
   Pya N, 2016, SCAM SHAPE CONSTRAIN
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Ritchie SA, 2002, DENGUE CONTROL N QUE
   Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x
NR 43
TC 2
Z9 2
U1 2
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007255
DI 10.1371/journal.pntd.0007255
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100013
PM 31145744
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sippy, R
   Herrera, D
   Gaus, D
   Gangnon, RE
   Patz, JA
   Osorio, JE
AF Sippy, Rachel
   Herrera, Diego
   Gaus, David
   Gangnon, Ronald E.
   Patz, Jonathan A.
   Osorio, Jorge E.
TI Seasonal patterns of dengue fever in rural Ecuador: 2009-2016
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES STEGOMYIA AEGYPTI; INFLUENZA-LIKE ILLNESS; RISK-FACTORS; DIPTERA;
   TEMPERATURE; CLIMATE; TUBERCULOSIS; SURVIVAL; SOUTHERN; LARVAL
AB Season is a major determinant of infectious disease rates, including arboviruses spread by mosquitoes, such as dengue, chikungunya, and Zika. Seasonal patterns of disease are driven by a combination of climatic or environmental factors, such as temperature or rainfall, and human behavioral time trends, such as school year schedules, holidays, and weekday-weekend patterns. These factors affect both disease rates and healthcare-seeking behavior. Seasonality of dengue fever has been studied in the context of climatic factors, but short- and long-term time trends are less well-understood. With 2009-2016 medical record data from patients diagnosed with dengue fever at two hospitals in rural Ecuador, we used Poisson generalized linear modeling to determine short- and long-term seasonal patterns of dengue fever, as well as the effect of day of the week and public holidays. In a subset analysis, we determined the impact of school schedules on school-aged children. With a separate model, we examined the effect of climate on diagnosis patterns. In the first model, the most important predictors of dengue fever were annual sinusoidal fluctuations in disease, long-term trends (as represented by a spline for the full study duration), day of the week, and hospital. Seasonal trends showed single peaks in case diagnoses, during mid-March. Compared to the average of all days, cases were more likely to be diagnosed on Tuesdays (risk ratio (RR): 1.26, 95% confidence interval (CI) 1.05-1.51) and Thursdays (RR: 1.25, 95% CI 1.02-1.53), and less likely to be diagnosed on Saturdays (RR: 0.81, 95% CI 0.65-1.01) and Sundays (RR: 0.74, 95% CI 0.58-0.95). Public holidays were not significant predictors of dengue fever diagnoses, except for an increase in diagnoses on the day after Christmas (RR: 2.77, 95% CI 1.46-5.24). School schedules did not impact dengue diagnoses in school-aged children. In the climate model, important climate variables included the monthly total precipitation, an interaction between total precipitation and monthly absolute minimum temperature, an interaction between total precipitation and monthly precipitation days, and a three-way interaction between minimum temperature, total precipitation, and precipitation days. This is the first report of long-term dengue fever seasonality in Ecuador, one of few reports from rural patients, and one of very few studies utilizing daily disease reports. These results can inform local disease prevention efforts, public health planning, as well as global and regional models of dengue fever trends.
   Author summary Dengue fever exhibits a seasonal pattern in many parts of the world, much of which has been attributed to climate and weather. However, additional factors may contribute to dengue seasonality. With 2009-2016 medical record data from rural Ecuador, we studied the short- and long-term seasonal patterns of dengue fever, as well as the effect of school schedules and public holidays. We also examined the effect of climate on dengue. We found that dengue diagnoses peak once per year in mid-March, but that diagnoses are also affected by day of the week. Dengue was also impacted by regional climate and complex interactions between local weather variables. This is the first report of long-term dengue fever seasonality in Ecuador, one of few reports from rural patients, and one of very few studies utilizing daily disease reports. This is the first report on the impacts of school schedules, holidays, and weekday-weekend patterns on dengue diagnoses. These results suggest a potential impact of human behaviors on dengue exposure risk. More broadly, these results can inform local disease prevention efforts and public health planning, as well as global and regional models of dengue fever trends.
C1 [Sippy, Rachel; Gangnon, Ronald E.; Patz, Jonathan A.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA.
   [Sippy, Rachel] Univ Wisconsin, Dept Family Med & Community Hlth, Madison, WI USA.
   [Herrera, Diego; Gaus, David] Salud & Desarrollo Andino, Pichincha, Ecuador.
   [Gangnon, Ronald E.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA.
   [Patz, Jonathan A.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI USA.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Sippy, Rachel] Univ Florida, Dept Med Geog, Gainesville, FL USA.
RP Osorio, JE (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM jorge.osorio@wisc.edu
OI Herrera Ramirez, Diego/0000-0001-5516-5767; Gangnon,
   Ronald/0000-0003-2587-6714; Sippy, Rachel/0000-0003-3617-2093
FU National Center for Complementary and Integrative Health; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 AT006956]
FX R.S. was supported by funding from the National Center for Complementary
   and Integrative Health (https://nccih.nih.gov/) at the National
   Institutes of Health (grant number T32 AT006956). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Fernandez-Nino JA, 2016, BIOMEDICA, V36, P44, DOI 10.7705/biomedica.v36i0.2869
   [Anonymous], 2007, ECUADOR INMEDIA 0616
   [Anonymous], B MET HIST
   [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40
   [Anonymous], 2009, EL UNIVERSO     1222
   [Anonymous], 2008, LA HORA         1230
   BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499
   Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445
   Cavailler P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1849-8
   Chakraborty A, 2015, PUBLIC HEALTH REP, V130, P269, DOI 10.1177/003335491513000314
   Chaparro PE, 2014, REV PANAM SALUD PUBL, V36, P197
   de Resende MC, 2013, MEM I OSWALDO CRUZ, V108, P1024, DOI 10.1590/0074-0276130128
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Fellows I., 2016, OPENSTREETMAP ACCESS
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02
   Harrell F., DASPLINE MACRO
   Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5
   Hijmans R.J., 2017, DISMO SPECIES DISTRI
   Hogan AB, 2016, EPIDEMICS-NETH, V16, P49, DOI 10.1016/j.epidem.2016.05.001
   Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   [Instituto Nacional de Meteorologia e Hidrologia Hidrologia INdMe], HIDR INDME
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Kahle D, 2016, GGMAP SPATIAL VISUAL
   Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2
   Lal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031883
   Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142382
   Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   Meacock R, 2017, J HEALTH SERV RES PO, V22, P12, DOI 10.1177/1355819616649630
   Ministerio de Turismo, 2012, CAL FER
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x
   Null J., 2018, EL NINO LA NINA YEAR
   Oliveira CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1456-8
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paynter S, 2015, J INFECTION, V70, P1, DOI 10.1016/j.jinf.2014.09.006
   Thai PQ, 2015, EPIDEMICS-NETH, V13, P65, DOI 10.1016/j.epidem.2015.06.002
   Pobesma E, 2016, SP CLASSES METHODS S
   Prado GP, 2017, J VECTOR ECOL, V42, P155, DOI 10.1111/jvec.12250
   [R Core Team Computing RFfS], 2013, COMP RFFS
   Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P785, DOI 10.1089/fpd.2009.0460
   Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383
   Tang JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002768
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Venables W. N., 2002, MODERN APPL STAT S
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Whitlock I, WEEKNO MACRO
   Wickham H., 2017, HAVEN IMPORT EXPORT
   Wilson E, 2015, J ENVIRON HEALTH, V77, P8
   Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121
   Yasuno M, B WHO, V43, P319
   You SM, 2016, ENVIRON POLLUT, V218, P1170, DOI 10.1016/j.envpol.2016.08.071
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 72
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007360
DI 10.1371/journal.pntd.0007360
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100037
PM 31059505
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waltmann, A
   Willcox, AC
   Balasubramanian, S
   Mayori, KB
   Guerrero, SM
   Sanchez, RSS
   Roach, J
   Condori Pino, C
   Gilman, RH
   Bern, C
   Juliano, JJ
   Levy, MZ
   Meshnick, SR
   Bowman, NM
AF Waltmann, Andreea
   Willcox, Alexandra C.
   Balasubramanian, Sujata
   Mayori, Katty Borrini
   Guerrero, Sandra Mendoza
   Sanchez, Renzo S. Salazar
   Roach, Jeffrey
   Condori Pino, Carlos
   Gilman, Robert H.
   Bern, Caryn
   Juliano, Jonathan J.
   Levy, Michael Z.
   Meshnick, Steven R.
   Bowman, Natalie M.
TI Hindgut microbiota in laboratory-reared and wild Triatoma infestans
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRYPANOSOMA-CRUZI; GUT MICROBIOTA; ZIKA VIRUS; WOLBACHIA; VECTOR;
   POPULATIONS; DISEASE; DENGUE; ESTABLISHMENT; COLONIZATION
AB Triatomine vectors transmit Trypanosoma cruzi, the etiological agent of Chagas disease in humans. Transmission to humans typically occurs when contaminated triatomine feces come in contact with the bite site or mucosal membranes. In the Southern Cone of South America, where the highest burden of disease exists, Triatoma infestans is the principal vector for T. cruzi. Recent studies of other vector-borne illnesses have shown that arthropod microbiota influences the ability of infectious agents to colonize the insect vector and transmit to the human host. This has garnered attention as a potential control strategy against T. cruzi, as vector control is the main tool of Chagas disease prevention. Here we characterized the microbiota in T. infestans feces of both wild-caught and laboratory-reared insects and examined the relationship between microbial composition and T. cruzi infection using highly sensitive high-throughput sequencing technology to sequence the V3-V4 region of the 16S ribosomal RNA gene on the MiSeq Illumina platform. We collected 59 wild (9 with T. cruzi infection) and 10 lab-reared T. infestans (4 with T. cruzi infection) from the endemic area of Arequipa, Peru. Wild T. infestans had greater hindgut bacterial diversity than laboratory-reared bugs. Microbiota of lab insects comprised a subset of those identified in their wild counterparts, with 96 of the total 124 genera also observed in laboratory-reared insects. Among wild insects, variation in bacterial composition was observed, but time and location of collection and development stage did not explain this variation. T. cruzi infection in lab insects did not affect - or -diversity; however, we did find that the -diversity of wild insects differed if they were infected with T. cruzi and identified 10 specific taxa that had significantly different relative abundances in infected vs. uninfected wild T. infestans (Bosea, Mesorhizobium, Dietzia, and Cupriavidus were underrepresented in infected bugs; Sporosarcina, an unclassified genus of Porphyromonadaceae, Nestenrenkonia, Alkalibacterium, Peptoniphilus, Marinilactibacillus were overrepresented in infected bugs). Our findings suggest that T. cruzi infection is associated with the microbiota of T. infestans and that inferring the microbiota of wild T. infestans may not be possible through sampling of T. infestans reared in the insectary.
   Author summary Chagas disease in humans is caused by the parasite Trypanosoma cruzi and it is endemic to the Americas. Poor populations are most at risk. The parasite infects an estimated six million people of 21 endemic countries in the Americas, with 30,000 new infections yearly. The main mode of transmission is vector-borne by triatomine bugs, which tend to live in close association with humans. The main Chagas disease vector in the Southern Cone of South America, where the highest burden of disease exists, is Triatoma infestans. As blood-sucking insects, triatomines become infected when they bite a T. cruzi-positive human and once infected they transmit the parasites in their feces. Controlling the vector populations is the main strategy of Chagas disease transmission reduction efforts. Microbiota-mediated methods to control this vector-borne disease are now being explored to determine whether microbes typically found in the vectors' gut have a detrimental effect on T. cruzi and how they may be used to modify the vector and curb the ability for T. cruzi to be transmitted to humans. To advance this new field, we first must gain better knowledge of the gut microbiota of triatomines. Our study is the first to use sensitive high-throughput methods to study the gut microbes of T. infestans, using both laboratory-reared and wild insects. We have found that the microbial composition of T. infestans in the laboratory does not reflect the complete collection of gut microbes of wild T. infestans and inferring the gut microbiota profile of wild insects through studying lab insects alone may not be possible. We also found evidence that in wild insects T. cruzi affects the composition of the gut microbiota and identified some bacterial taxa which may be important in modulating the T.infestans-T.cruzi relationship.
C1 [Waltmann, Andreea; Meshnick, Steven R.] Univ N Carolina, Inst Global Hlth & Infect Dis, Sch Med, Chapel Hill, NC 27599 USA.
   [Willcox, Alexandra C.; Balasubramanian, Sujata; Guerrero, Sandra Mendoza; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Mayori, Katty Borrini; Sanchez, Renzo S. Salazar; Condori Pino, Carlos] Univ Peruana Cayetano Heredia, Zoonot Dis Res Lab, Unidad Salud, Arequipa, Peru.
   [Roach, Jeffrey] Univ N Carolina, Sch Med, Microbiome Core Facil, Chapel Hill, NC USA.
   [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Bern, Caryn] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA.
   [Juliano, Jonathan J.; Bowman, Natalie M.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA.
   [Levy, Michael Z.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA.
RP Waltmann, A (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Sch Med, Chapel Hill, NC 27599 USA.
EM waltmann@email.unc.edu
OI Willcox, Alexandra/0000-0001-6037-6841
FU UNC Junior Faculty Development Award; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [K23
   AI11397];  [NIH-NIAID 5R01AI101229]
FX The following authors received specific funding for this project: ML,
   Grant number: NIH-NIAID 5R01AI101229; NMB (UNC Junior Faculty
   Development Award and NIH K23 AI11397). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abraham NM, 2017, P NATL ACAD SCI USA, V114, pE781, DOI 10.1073/pnas.1613422114
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andrews S, 2010, FASTQC QUALITY CONTR
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011
   Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007
   Barka EA, 2016, MICROBIOL MOL BIOL R, V80, pIII, DOI 10.1128/MMBR.00044-16
   Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Boone D.R., 2001, BERGEYS MANUAL SYSTE
   Brecher G., 1944, PARASITOLOGY, V35, P220, DOI 10.1017/S0031182000021648
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Carels N, 2017, BIOINFORM BIOL INSIG, V11, DOI 10.1177/1177932217733422
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x
   Curtis-Robles R, 2018, AM J TROP MED HYG, V98, P113, DOI 10.4269/ajtmh.17-0526
   da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Diaz S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1926-2
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x
   Durvasula RV, 2008, EXP PARASITOL, V119, P94, DOI 10.1016/j.exppara.2007.12.020
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Espino CI, 2009, APPL ENVIRON MICROB, V75, P547, DOI 10.1128/AEM.01665-08
   Franco-Paredes Carlos, 2007, BMC Int Health Hum Rights, V7, P7, DOI 10.1186/1472-698X-7-7
   Gumiel M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0836-z
   Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006
   Hernandez C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1907-5
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hol WHG, 2015, ECOLOGY, V96, P2042, DOI 10.1890/14-2359.1
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Koerner RJ, 2009, FEMS IMMUNOL MED MIC, V55, P296, DOI 10.1111/j.1574-695X.2008.00513.x
   Kollien AH, 1997, PARASITOL RES, V83, P781, DOI 10.1007/s004360050339
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Malele I, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1288-3
   Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542
   Montoya-Porras LM, 2018, ACTA TROP, V178, P327, DOI 10.1016/j.actatropica.2017.11.004
   Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001
   Oliveira JL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006709
   Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Roche, 2009, USING MULTIPLEX IDEN
   Rodriguez-Ruano SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01167
   Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483
   Salem H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2957
   SCHAUB GA, 1989, PARASITOL TODAY, V5, P185, DOI 10.1016/0169-4758(89)90142-7
   Seipke RF, 2012, ANTON LEEUW INT J G, V101, P443, DOI 10.1007/s10482-011-9621-y
   Stecher B, 2013, FEMS MICROBIOL REV, V37, P793, DOI 10.1111/1574-6976.12024
   Taracena ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003358
   Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6
   Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001
   van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175
   Vieira CS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0736-2
   Wang ZS, 2006, BIOTECHNIQUES, V41, P410, DOI 10.2144/000112255
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Zolnik CP, 2016, MOL ECOL, V25, P4963, DOI 10.1111/mec.13832
NR 73
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007383
DI 10.1371/journal.pntd.0007383
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100047
PM 31059501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu-Helmersson, J
   Rocklov, J
   Sewe, M
   Brannstrom, A
AF Liu-Helmersson, Jing
   Rockloev, Joacim
   Sewe, Macquin
   Braennstroem, Ake
TI Climate change may enable Aedes aegypti infestation in major European
   cities by 2100
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Aedes aegypti; Vector invasion; Europe; Climate change
ID DENGUE
AB Background Climate change allows Aedes aegypti to infest new areas. Consequently, it enables the arboviruses the mosquito transmits - e.g., dengue, chikungunya, Zika and yellow fever - to emerge in previously uninfected areas. An example is the Portuguese island of Madeira during 2012-13.
   Objective: We aim to understand how climate change will affect the future spread of this potent vector, as an aid in assessing the risk of disease outbreaks and effectively allocating resources for vector control.
   Methods: We used an empirically-informed, process-based mathematical model to study the feasibility of Aedes aegypti infestation into continental Europe. Based on established global climate-change scenario data, we assess the potential of Aedes aegypti to establish in Europe over the 21st century by estimating the vector population growth rate for five climate models (GCM5).
   Results: In a low carbon emission future (RCP2.6), we find minimal change to the current situation throughout the whole of the 21st century. In a high carbon future (RCP8.5), a large parts of southern Europe risks being invaded by Aedes aegypti.
   Conclusion: Our results show that successfully enforcing the Paris Agreement by limiting global warming to below 2 degrees C significantly lowers the risk for infestation of Aedes aegypti and consequently of potential large-scale arboviral disease outbreaks in Europe within the 21st century.
C1 [Liu-Helmersson, Jing] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
   [Rockloev, Joacim; Sewe, Macquin] Umea Univ, Dept Publ Hlth & Clin Med, Sustainable Hlth, Umea, Sweden.
   [Rockloev, Joacim] Heidelberg Univ, Inst Publ Hlth, Med Sch, Heidelberg, Germany.
   [Braennstroem, Ake] Umea Univ, Dept Math & Math Stat, Umea, Sweden.
   [Braennstroem, Ake] Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria.
RP Liu-Helmersson, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Forsorjningsvagen 7D, S-90187 Umea, Sweden.
EM Jing.Helmersson@umu.se
OI sewe, maquins/0000-0003-1267-649X; Rocklov, Joacim/0000-0003-4030-0449;
   Helmersson, Jing/0000-0001-9647-1015
FU European UnionEuropean Union (EU) [282589]; Swedish Research
   CouncilSwedish Research Council [2015-03917]; Swedish Research Funding
   Agency Formas [2017-01300]
FX This work was supported by the European Union Seventh Framework
   Programme, FP7/2007-2013 (282589), the Swedish Research Council
   (2015-03917) and the Swedish Research Funding Agency Formas
   (2017-01300).
CR [Anonymous], 2013, OUTBREAK DENGUE MADE
   Bhatt S, 2013, NATURE, V496, P504
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Caminade C, 2012, J R SOC INTERFACE
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Crimmins A, 2016, USGCRP IMPACTS CLIMA, P25
   Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Goosse H., 2013, INTRO CLIMATE DYNAMI
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Klausmeier CA, 2008, THEOR ECOL-NETH, V1, P153, DOI 10.1007/s12080-008-0016-2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Mosquito maps, 2016, AEDES AEGYPTI AEDES
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642, DOI 10.4269/ajtmh.1986.35.642
   Semenza J. C, 2017, FEMS MICROBIOL LETT
   Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6
   Yang HM, 2014, ECOLOGICAL MODELLING, P39
   Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186
NR 29
TC 7
Z9 7
U1 6
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
EI 1096-0953
J9 ENVIRON RES
JI Environ. Res.
PD MAY
PY 2019
VL 172
BP 693
EP 699
DI 10.1016/j.envres.2019.02.026
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HY8HH
UT WOS:000468377500079
PM 30884421
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Carta, KG
   Morr, I
   Britto, IJM
   Meza, Y
   Marques, JA
   Terzic, C
   Lopez-Jimenez, F
   Allison, T
   Mujica, IJM
AF Carta, K. Gonzalez
   Morr, I.
   Britto, I. J. Mendoza
   Meza, Y.
   Marques, J. A.
   Terzic, C.
   Lopez-Jimenez, F.
   Allison, T.
   Mujica, I. J. Mendoza
TI Acute heart failure in pregnancy, do not forget zika and the
   pericardium.
SO EUROPEAN JOURNAL OF HEART FAILURE
LA English
DT Meeting Abstract
C1 [Carta, K. Gonzalez; Terzic, C.] Mayo Clin, Rochester, MN USA.
   [Morr, I.; Meza, Y.; Marques, J. A.; Mujica, I. J. Mendoza] UCV, Trop Cardiol, Caracas, Venezuela.
   [Britto, I. J. Mendoza] Jackson Mem Hosp, Electrophysiol, Miami, FL 33136 USA.
   [Lopez-Jimenez, F.; Allison, T.] Mayo Clin, Cardiovasc Dis, Rochester, MN USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1388-9842
EI 1879-0844
J9 EUR J HEART FAIL
JI Eur. J. Heart Fail.
PD MAY
PY 2019
VL 21
SU 1
SI SI
MA 1323
BP 333
EP 333
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HZ6VN
UT WOS:000468990703231
DA 2020-07-08
ER

PT J
AU Kwan, MWC
   Bosak, A
   Kline, J
   Pita, MA
   Giel, N
   Pereira, RM
   Koehler, PG
   Kline, DL
   Batich, CD
   Willenberg, BJ
AF Kwan, Michael W. C.
   Bosak, Alexander
   Kline, Jedidiah
   Pita, Mario A.
   Giel, Nicholas
   Pereira, Roberto M.
   Koehler, Philip G.
   Kline, Daniel L.
   Batich, Christopher D.
   Willenberg, Bradley Jay
TI A Low-Cost, Passive Release Device for the Surveillance and Control of
   Mosquitoes
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Spatial repellent; controlled release; surveillance; military; malaria;
   field-deployable device; Zika
ID PUSH
AB Mosquitoes continue to be a major threat to global health, and the ability to reliably monitor, catch, and kill mosquitoes via passive traps is of great importance. Global, low-cost, and easy-to-use outdoor devices are needed to augment existing efforts in mosquito control that combat the spread of disease, such as Zika. Thus, we have developed a modular, portable, non-powered (passive), self-contained, and field-deployable device suitable for releasing volatiles with a wide range of applications such as attracting, repelling, and killing mosquitoes. This unique device relies on a novel nested wick and two-reservoir design that achieves a constant release of volatiles over several hundred hours. Devices loaded with one of either two compounds, geraniol or 1-methylpiperazine (MP), were tested in a controlled environment (32 degrees C and 70% relative humidity), and both compounds achieved a constant release from our devices at a rate of 2.4 mg/h and 47 mg/h, respectively. The liquid payload can be volatile attractants or repellants as well as mosquitocide-containing feeding solutions for capture and surveillance. This low-cost device can be utilized for both civilian and military mosquito control purposes, but it will be particularly important for protecting those in economically repressed environments, such as sub-Saharan Africa and Central and South America.
C1 [Kwan, Michael W. C.; Bosak, Alexander; Giel, Nicholas; Willenberg, Bradley Jay] Univ Cent Florida, Dept Internal Med, Coll Med, Orlando, FL 32827 USA.
   [Kline, Jedidiah; Batich, Christopher D.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
   [Pita, Mario A.; Kline, Daniel L.] USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
   [Pereira, Roberto M.; Koehler, Philip G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.
   [Batich, Christopher D.] Univ Florida, J Crayton Pruitt Family Biomed Engn, Gainesville, FL 32611 USA.
RP Willenberg, BJ (corresponding author), Univ Cent Florida, Dept Internal Med, Coll Med, Orlando, FL 32827 USA.
EM michael.kwan@ucf.edu; alexander.bosak@ucf.edu; Jedidiah.Kline@ucf.edu;
   mariapita99@gmail.com; ngiel06@gmail.com; rpereira@ufl.edu; pgk@ufl.edu;
   Dan.Kline@ARS.USDA.GOV; cbati@mse.ufl.edu; Bradley.willenberg@ucf.edu
RI Pereira, Roberto/B-5008-2010; Pereira, Rosa Maria Rodrigues/C-5192-2012
OI Pereira, Roberto/0000-0002-5618-7690; Pereira, Rosa Maria
   Rodrigues/0000-0002-3723-5028; Kwan, Michael/0000-0003-0782-8110; Bosak,
   Alexander/0000-0002-7531-8051
FU University of Florida (PI CBD) [12-00087085, FHTCC-1300090877]; Pest
   Natural, Inc. (Lady Lake, Fl) as part of the Florida High Tech Corridor
   Council's matching grants program [12-00087085, FHTCC-1300090877];
   Department of the Army, U.S. Army Contracting Command, Aberdeen Proving
   Ground, Natick Contracting Division, Ft Detrick MD; Armed Forces Pest
   Management Board (AFPMB) Deployed WarFighter Protection Research Program
   (DWFP-Grant) [W911QY-15-1-0003]
FX This research was funded in part by research agreements #12-00087085 and
   #FHTCC-1300090877 between the University of Florida (PI CBD) and Pest
   Natural, Inc. (Lady Lake, Fl) as part of the Florida High Tech Corridor
   Council's matching grants program and was also sponsored in part by the
   Department of the Army, U.S. Army Contracting Command, Aberdeen Proving
   Ground, Natick Contracting Division, Ft Detrick MD via a grant to CBD
   from the Armed Forces Pest Management Board (AFPMB) Deployed WarFighter
   Protection Research Program (DWFP-Grant No.: W911QY-15-1-0003).
CR Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407
   Darbro JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2004-0
   Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199
   IOM, 2008, VECT BORN DIS UND EN
   Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x
   Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330
   Kwan MWC, 2018, J CHROMATOGR A, V1573, P156, DOI 10.1016/j.chroma.2018.08.066
   Mackay D, 2014, ENVIRON SCI TECHNOL, V48, P10259, DOI 10.1021/es5029074
   Obermayr U, 2012, J MED ENTOMOL, V49, P1387, DOI 10.1603/ME12084
   Obermayr U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129878
   Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-54
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184
   Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009
   Revay EE, 2012, ACTA TROP, V124, P102, DOI 10.1016/j.actatropica.2012.06.008
   Reynolds TD, 2002, DRUG DEV IND PHARM, V28, P457, DOI 10.1081/DDC-120003007
   Rutledge LC, 1996, J AM MOSQUITO CONTR, V12, P39
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, WORLD MAL REP 2018
   Willenberg B. J., 2015, USA, Patent No. [9,258,988, 9258988]
   World Health Organization, WORLD MAL REP 2017
   World Health Organization, WORLD MAL REP 2015
   Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066
NR 23
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY 1
PY 2019
VL 16
IS 9
AR 1488
DI 10.3390/ijerph16091488
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IA4ER
UT WOS:000469517300013
PM 31035536
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jacobs, S
   Delang, L
   Verbeken, E
   Neyts, J
   Kaptein, SJF
AF Jacobs, Sofie
   Delang, Leen
   Verbeken, Eric
   Neyts, Johan
   Kaptein, Suzanne J. F.
TI A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the
   Reproductive Organs of Male Mice
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE antivirals; sexual transmission; Zika virus
ID SEXUAL TRANSMISSION; INFECTION; MODEL
AB In humans, Zika virus and viral RNA have been detected in semen up to 2.2 months and 6 months post infection (pi), respectively. Although the contribution of sexual transmission to the spread of ZIKV is too low to sustain an outbreak, it can increase the risk of infection and the epidemic size as well as prolong the duration of an outbreak. In this study, we explored the potential of antivirals to serve as an effective strategy to prevent sexual transmission. Male AG129 mice infected with a ZIKV isolate from Suriname were treated with the nucleoside analog, 7-deaza-2-C-methyladenosine (7DMA), that was previously shown to be efficacious in reducing ZIKV viremia and delaying ZIKV-induced disease in mice. Following treatment, viral RNA and infectious virus titers were consistently reduced in the male reproductive organs compared to vehicle-treated mice. This reduction of ZIKV loads in the testis was confirmed by the detection of lower levels of ZIKV antigens. Our data illustrate the value of this mouse model to validate the efficacy of new potential ZIKV drugs at the level of the male reproductive system.
C1 [Jacobs, Sofie; Delang, Leen; Neyts, Johan; Kaptein, Suzanne J. F.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
   [Verbeken, Eric] Lab Pathol, B-3000 Leuven, Belgium.
RP Neyts, J (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
EM sofie-jacobs@kuleuven.be; leen.delang@kuleuven.be;
   eric.verbeken@uzleuven.be; johan.neyts@kuleuven.be;
   suzanne.kaptein@kuleuven.be
RI Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017; Kaptein, Suzanne
   JF/O-8855-2018; Kaptein, Suzanne JF/O-4714-2019
OI Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514;
   Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Jacobs, Sofie/0000-0001-8657-6841
FU European UnionEuropean Union (EU) [734584, 734548]
FX This research was partially funded by the European Union's Horizon 2020
   Research and Innovation Programme under Grant Agreement no. 734584
   (ZikaPLAN) and 734548 (ZIKAlliance). S.J. is a fellow of the "Fund for
   Scientific Research" Flanders (FWO).
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2018, ZIK VIR SEX TRANSM P
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   European Centre for Disease Prevention and Control, RAP RISK ASS MICR BR
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 32
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 1
PY 2019
VL 20
IS 9
AR 2122
DI 10.3390/ijms20092122
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IA7RK
UT WOS:000469753500069
PM 31032814
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, GH
   Pan, A
   Gruber, G
   Lu, LY
AF Zhu, Guanhua
   Pan, Ankita
   Gruber, Gerhard
   Lu, Lanyuan
TI Conformational states of Zika virus non-structural protein 3 determined
   by molecular dynamics simulations with small-angle X-Ray scattering data
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Review
DE Zika virus; Non-structural protein 3; Conformational states; Molecular
   dynamics simulations; Replica exchange with solute tempering;
   Small-angle X-ray scattering
ID REPLICA-EXCHANGE; DENGUE VIRUS; NS2B-NS3 PROTEASE; STRUCTURE ENSEMBLE;
   CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; NS3; HELICASE; INHIBITORS;
   MACROMOLECULES
AB Zika virus (ZIKV) has become a great public health emergency. Its non-structural protein 3 (NS3) is a key enzyme in viral replication and has been considered as a potential therapeutic target. A conformational characterization of ZIKV NS3 is critical for a comprehensive understanding of its molecular interactions and functions. However, the high conformational flexibility of solution NS3 obstacles the structural characterization of NS3 solely from the experimental observable that averages over its heterogeneous conformations. Here, we employed replica exchange with solute tempering (REST) method to simulate the di-domain protein ZIKV NS3. Three independent MD simulations identified a conserved conformational ensemble of NS3, consisting of a major conformational state and several minor states from compact to loose conformations. The major state agrees well with the scattering profile from small-angle X-ray scattering (SAXS) experiments. Moreover, the simulated ensemble is supported by a direct data-fitting result that requires both short- and long-range structural contacts to recover the experimental data. We discussed the interplay between simulation and experiment in ensemble construction of flexible biomolecules and shed light on the physically derived conformational ensembles. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Zhu, Guanhua; Pan, Ankita; Gruber, Gerhard; Lu, Lanyuan] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Lu, LY (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM LYLU@ntu.edu.sg
FU Ministry of Education, SingaporeMinistry of Education, Singapore
   [MOE2012-T3-1-008]
FX This research is supported by the Tier 3 grant (MOE2012-T3-1-008) from
   the Ministry of Education, Singapore.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bernardi RC, 2015, BBA-GEN SUBJECTS, V1850, P872, DOI 10.1016/j.bbagen.2014.10.019
   Chen Y, 2007, BIOPHYS J, V93, P2300, DOI [10.1529/biophysj.107.104174, 10.1529/biophysj.l07.104174]
   Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200
   Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693
   Clore GM, 2013, BIOPHYS J, V104, P1635, DOI 10.1016/j.bpj.2013.01.060
   Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Fersht AR, 2002, P NATL ACAD SCI USA, V99, P14122, DOI 10.1073/pnas.182542699
   Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105
   Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004
   Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0
   Kozakov D, 2014, ELIFE, V3, DOI 10.7554/eLife.01370
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351
   Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102
   Liu W, 2016, BIOPHYS J, V110, P1943, DOI 10.1016/j.bpj.2016.04.009
   Lo Conte L, 1999, J MOL BIOL, V285, P2177
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Nguyen PH, 2005, PROTEINS, V61, P795, DOI 10.1002/prot.20696
   Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d
   Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pande VS, 2003, BIOPOLYMERS, V68, P91, DOI 10.1002/bip.10219
   Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d
   Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174
   Periole X, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2404954
   Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Sawle L, 2016, J CHEM THEORY COMPUT, V12, P861, DOI 10.1021/acs.jctc.5b00999
   Sindhikara D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2816560
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Terakawa T, 2014, BIOPHYS J, V107, P721, DOI 10.1016/j.bpj.2014.06.026
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X
   Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018
   van Gunsteren WF, 2008, CURR OPIN STRUC BIOL, V18, P149, DOI 10.1016/j.sbi.2007.12.007
   van Gunsteren WF, 2006, ANGEW CHEM INT EDIT, V45, P4064, DOI 10.1002/anie.200502655
   Wang LL, 2011, J PHYS CHEM B, V115, P9431, DOI 10.1021/jp204407d
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhu GH, 2017, J PHYS CHEM B, V121, P2252, DOI 10.1021/acs.jpcb.7b00051
NR 68
TC 0
Z9 0
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD MAY
PY 2019
VL 143
BP 13
EP 19
DI 10.1016/j.pbiomolbio.2018.09.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IA9TP
UT WOS:000469900000003
PM 30291845
OA Bronze
DA 2020-07-08
ER

PT J
AU Lim, L
   Gupta, G
   Roy, A
   Kang, J
   Srivastava, S
   Shi, JH
   Song, JX
AF Lim, Liangzhong
   Gupta, Garvita
   Roy, Amrita
   Kang, Jian
   Srivastava, Shagun
   Shi, Jiahai
   Song, Jianxing
TI Structurally- and dynamically-driven allostery of the chymotrypsin-like
   proteases of SARS, Dengue and Zika viruses
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Review
DE SARS coronavirus; Flavivirus; 3C-like protease; NS2B-NS3 protease;
   Chymotrypsin fold; Enzymatic allostery; Correlated motions; Natural
   product
ID ACUTE-RESPIRATORY-SYNDROME; CORONAVIRUS 3C-LIKE PROTEASE; RETRACTED
   ARTICLE. SEE; NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; ACTIVE-SITE;
   CONFORMATIONAL FLEXIBILITY; SERINE-PROTEASE; DIMER INTERFACE; NS3
   PROTEASES
AB Coronavirus 3C-like and Flavivirus NS2B-NS3 proteases utilize the chymotrypsin fold to harbor their catalytic machineries but also contain additional domains/co-factors. Over the past decade, we aimed to decipher how the extra domains/co-factors mediate the catalytic machineries of SARS 3C-like, Dengue and Zika NS2B-NS3 proteases by characterizing their folding, structures, dynamics and inhibition with NMR, X-ray crystallography and MD simulations, and the results revealed: 1) the chymotrypsin fold of the SARS 3C-like protease can independently fold, while, by contrast, those of Dengue and Zika proteases lack the intrinsic capacity to fold without co-factors. 2) Mutations on the extra domain of SARS 3C-like protease can transform the active catalytic machinery into the inactive collapsed state by structurally-driven allostery. 3) Amazingly, even without detectable structural changes, mutations on the extra domain are sufficient to either inactivate or enhance the catalytic machinery of SARS 3C-like protease by dynamically-driven allostery. 4) Global networks of correlated motions have been identified: for SARS 3C-like protease, N214A inactivates the catalytic machinery by decoupling the network, while STI/A and STIF/A enhance by altering the patterns of the network. The global networks of Dengue and Zika proteases are coordinated by their NS2B-cofactors. 5) Natural products were identified to allosterically inhibit Zika and Dengue proteases through binding a pocket on the back of the active site. Therefore, by introducing extra domains/cofactors, nature develops diverse strategies to regulate the catalytic machinery embedded on the chymotrypsin fold through folding, structurally- and dynamically-driven allostery, all of which might be exploited to develop antiviral drugs. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Lim, Liangzhong; Gupta, Garvita; Roy, Amrita; Kang, Jian; Srivastava, Shagun; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.
   [Shi, Jiahai] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.
RP Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.; Shi, JH (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.
EM jiahai.shi@cityu.edu.hk; dbssjx@nus.edu.sg
RI Kang, Jian/AAN-8616-2020
OI Kang, Jian/0000-0001-9935-4172
FU Ministry of Education - \Singapore Tier 3 Grant [MOE2012-T3-1-008
   (R-154-002-580-112)]; Ministry of Education - \Singapore Tier 2 Grant
   [MOE 2015-T2-1-111]
FX The studies were supported by Ministry of Education - \Singapore Tier 3
   Grant MOE2012-T3-1-008 (R-154-002-580-112), and also partly by Tier 2
   Grant MOE 2015-T2-1-111 to Jianxing Song.
CR ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0
   Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302
   Barrila J, 2010, BIOCHEMISTRY-US, V49, P4308, DOI 10.1021/bi1002585
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200
   Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Gibbs AC, 2018, BIOCHEMISTRY-US, V57, P1591, DOI 10.1021/acs.biochem.7b01127
   Guarnera E, 2016, CURR OPIN STRUC BIOL, V37, P1, DOI 10.1016/j.sbi.2015.10.004
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800
   Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936
   Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034
   Huan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074040
   Ippolito G, 2017, ADV EXP MED BIOL, V972, P1, DOI 10.1007/5584_2017_33
   KARPLUS M, 1983, ANNU REV BIOCHEM, V52, P263, DOI 10.1146/annurev.bi.52.070183.001403
   Khosla C, 2001, NATURE, V409, P247, DOI 10.1038/35051723
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9
   Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20918
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187
   Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941
   Lisi GP, 2017, CURR OPIN STRUC BIOL, V47, P123, DOI 10.1016/j.sbi.2017.08.002
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Masters JR, 2006, CURR OPIN STRUC BIOL, V16, P776, DOI 10.1016/j.sbi.2006.10.010
   McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001
   Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573
   Murthy HMK, 2000, J MOL BIOL, V301, P759, DOI 10.1006/jmbi.2000.3924
   Nichol ST, 2000, P NATL ACAD SCI USA, V97, P12411, DOI 10.1073/pnas.210382297
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034
   Pan A, 2017, ACTA CRYSTALLOGR D, V73, P402, DOI 10.1107/S2059798317003849
   Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987
   Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634
   Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n
   Qin HN, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-2
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x
   Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200
   Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07
   Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song Jianxing, 2018, Biophys Rev, V10, P503, DOI 10.1007/s12551-017-0369-0
   Song JX, 2017, PROTEIN PEPTIDE LETT, V24, P294, DOI 10.2174/0929866524666170209154001
   Song Jianxing, 2013, F1000Res, V2, P94, DOI 10.12688/f1000research.2-94.v1
   Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022
   Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012
   Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463
   Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f
   Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100
   Yin JA, 2007, J MOL BIOL, V371, P1060, DOI 10.1016/j.jmb.2007.06.001
   Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07
NR 86
TC 1
Z9 1
U1 9
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD MAY
PY 2019
VL 143
BP 52
EP 66
DI 10.1016/j.pbiomolbio.2018.08.009
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IA9TP
UT WOS:000469900000006
PM 30217495
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Saw, WG
   Pan, A
   Manimekalai, MSS
   Gruber, A
   Gruber, G
AF Saw, Wuan Geok
   Pan, Ankita
   Manimekalai, Malathy Sony Subramanian
   Gruber, Ardina
   Gruber, Gerhard
TI Structure and flexibility of non-structural proteins 3 and-5 of Dengue-
   and Zika viruses in solution
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Review
DE Flavivirus; Dengue; Zika; Nonstructural proteins; Viral polymerase;
   Methyltransferase; Protease; Helicase; Small-angle X-ray scattering
ID CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE; NS3 PROTEIN; LINKER REGION;
   HELICASE; SEROTYPES; INSIGHTS; FEATURES; TARGET; METHYLTRANSFERASE
AB Dengue- (DENV) and Zika viruses (ZIKV) rely on their non-structural protein 5 (NS5) including a methyltransferase (MTase) and a RNA-dependent RNA polymerase (RdRp) for capping and synthesis of the viral RNA, and the non-structural protein 3 (NS3) with its protease and helicase domain for polyprotein possessing, unwinding dsRNA proceeding replication, and NTPase/RTPase activities. Accumulation of data for DENV- and ZIKV NS3 and NS5 in solution during recent years provides information about their overall shape, substrate-induced alterations, oligomeric forms and flexibility, with the latter being essential for domain-domain crosstalk. The importance and differences of the linker regions that connect the two domains of NS3 or NS5 are highlighted in particular with respect to the different DENV serotypes (DENV-1 to -4) as well as to the sequence diversities between the DENV and ZIKV proteins. Novel mutants of the French Polynesia ZIKV NS3 linker presented, identify critical residues in protein stability and enzymatic activity. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Saw, Wuan Geok; Pan, Ankita; Manimekalai, Malathy Sony Subramanian; Gruber, Ardina; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM ggrueber@ntu.edu.sg
FU Ministry of Education MOE Tier 3, Singapore [MOE2012-T3-1-008]
FX This work as well as the research scholarship of Ankita Pan was
   supported by the Ministry of Education MOE Tier 3 (MOE2012-T3-1-008),
   Singapore to G.G.
CR Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007
   Glatter O, 1982, SMALL ANGLE XRAY SCA
   Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027
   Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu H, 2006, BIOCHEM SOC T, V34, P35, DOI 10.1042/BST0340035
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Manimekalai MSS, 2016, ACTA CRYSTALLOGR D, V72, P795, DOI 10.1107/S2059798316006665
   Pan A, 2017, ACTA CRYSTALLOGR D, V73, P402, DOI 10.1107/S2059798317003849
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
NR 51
TC 2
Z9 2
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD MAY
PY 2019
VL 143
BP 67
EP 77
DI 10.1016/j.pbiomolbio.2018.08.008
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IA9TP
UT WOS:000469900000007
PM 30171868
OA Bronze
DA 2020-07-08
ER

PT J
AU Pomar, L
   Musso, D
   Malinger, G
   Vouga, M
   Panchaud, A
   Baud, D
AF Pomar, Leo
   Musso, Didier
   Malinger, Gustavo
   Vouga, Manon
   Panchaud, Alice
   Baud, David
TI Zika virus during pregnancy: From maternal exposure to congenital Zika
   virus syndrome
SO PRENATAL DIAGNOSIS
LA English
DT Review
ID UPDATE INTERIM GUIDANCE; US TERRITORIES; BIRTH-DEFECTS; UNITED-STATES;
   INFECTION; FETAL; BRAZIL; OUTCOMES; INFANTS; MANAGEMENT
AB Zika virus (ZIKV), a vector-borne virus similar to dengue virus, was responsible for a global epidemic between 2013 and 2017 and has emerged as a new agent responsible for severe fetopathies. We present a review to describe the risks and complications of maternal and subsequent fetal infection by ZIKV. The risk of ZIKV infection during pregnancy depends on the incidence of the disease, which is highly variable in different affected geographic areas (less than 1% to 75%). Among infected pregnant women, the risk of any adverse fetal/neonatal outcome was estimated at 5% to 42%, with 1% to 4% of fetal loss and 4% to 9% of suspected congenital Zika syndrome (CZS). The estimated rate of maternal-fetal transmission ranges between 7% and 26%, depending on the methodology of the study.
   Findings associated with CZS are microcephaly (33%-64%), ventriculomegaly (63%-92%), calcifications (71%-92%), malformations of cortical development (79%-82%), anomalies of the corpus callosum (71%-100%) and of the posterior fossa (21%-82%), arthrogryposis (10%-25%), eye abnormalities (25%), and extra-neurologic signs such as intra uterine growth restriction (14%), placentomegaly, transient hepatitis, mild anemia. Infants who present with CZS at birth suffer from motor abnormalities (77%-100%), epilepsy (9%-54%), hearing loss, and neurologic impairments.
   Prenatal ultrasound with advanced neurosonography and appropriate virological follow-up represent the state-of-the art approach to adequately monitor at-risk pregnancies, in order to diagnose early signs of CZS and to inform parents about the neonatal prognosis.
C1 [Pomar, Leo; Vouga, Manon; Baud, David] Lausanne Univ Hosp, Dept Woman Mother Child, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Musso, Didier] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Malinger, Gustavo] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Lausanne Univ Hosp, Serv Pharm, Lausanne, Switzerland.
RP Baud, D (corresponding author), CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Panchaud, Alice/S-6535-2019; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Panchaud, Alice/0000-0001-6086-2401; Musso, Didier/0000-0002-9226-0971;
   Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   Flamand C, 2016, EURO SURVEILL, V22
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frutos MGL, 2018, FETAL DIAGN THER, V44, P72, DOI 10.1159/000479866
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hamer DH, 2019, J TRAVEL MED
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambert VPL, 2017, ULTRASOUND OBSTET S1, V50, P1
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215
   Loconsole D, 2018, VECTOR-BORNE ZOONOT, V18, P331, DOI 10.1089/vbz.2017.2260
   Luna E, 2018, INT J INFECT DIS, V73, P17, DOI 10.1016/j.ijid.2018.04.3464
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P447, DOI 10.1046/j.1469-0705.2002.00840.x
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Marques VM, 2018, PEDIAT NEUROL
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Pomar L, 2018, ULTRASOUND OBST GYN, V2018, P51
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Saxena SK, 2019, TRAVEL MED INFECT DI, V27, P121, DOI 10.1016/j.tmaid.2018.10.022
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, BIRTH DEFECTS RES A, V106, P443
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1998-4
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Watts AG, 2018, J TRAVEL MED
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 103
TC 7
Z9 7
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD MAY
PY 2019
VL 39
IS 6
BP 420
EP 430
DI 10.1002/pd.5446
PG 11
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA HZ4KC
UT WOS:000468815400002
PM 30866073
OA Bronze
DA 2020-07-08
ER

PT J
AU Caceres, VM
   Goodell, J
   Shaffner, J
   Turner, A
   Jacobs-Wingo, J
   Koirala, S
   Molina, M
   Leidig, R
   Celaya, M
   Pilote, KM
   Garrett-Cherry, T
   Carney, J
   Johnson, K
   Daley, WR
AF Caceres, Victor M.
   Goodell, Jessica
   Shaffner, Julie
   Turner, Alezandria
   Jacobs-Wingo, Jasmine
   Koirala, Samir
   Molina, Monica
   Leidig, Robynn
   Celaya, Martin
   Pilote, Kara McGinnis
   Garrett-Cherry, Tiana
   Carney, Jhetari
   Johnson, Kym
   Daley, W. Randolph
TI Centers for Disease Control and Prevention's Temporary Epidemiology
   Field Assignee program: Supporting state and local preparedness in the
   wake of Ebola
SO SAGE OPEN MEDICINE
LA English
DT Article
DE Ebola; Zika; preparedness; response; capacity building; surveillance;
   epidemiology; state and local readiness
ID UNITED-STATES; VIRUS DISEASE
AB Objectives: The Centers for Disease Control and Prevention launched the Temporary Epidemiology Field Assignee (TEFA) Program to help state and local jurisdictions respond to the risk of Ebola virus importation during the 2014-2016 Ebola Outbreak in West Africa. We describe steps taken to launch the 2-year program, its outcomes and lessons learned. Methods: State and local health departments submitted proposals for a TEFA to strengthen local capacity in four key public health preparedness areas: 1) epidemiology and surveillance, 2) health systems preparedness, 3) health communications, and 4) incident management. TEFAs and jurisdictions were selected through a competitive process. Descriptions of TEFA activities in their quarterly reports were reviewed to select illustrative examples for each preparedness area. Results: Eleven TEFAs began in the fall of 2015, assigned to 7 states, 2 cities, 1 county and the District of Columbia. TEFAs strengthened epidemiologic capacity, investigating routine and major outbreaks in addition to implementing event-based and syndromic surveillance systems. They supported improvements in health communications, strengthened healthcare coalitions, and enhanced collaboration between local epidemiology and emergency preparedness units. Several TEFAs deployed to United States territories for the 2016 Zika Outbreak response. Conclusion: TEFAs made important contributions to their jurisdictions' preparedness. We believe the TEFA model can be a significant component of a national strategy for surging state and local capacity in future high-consequence events.
C1 [Caceres, Victor M.; Goodell, Jessica; Shaffner, Julie; Turner, Alezandria; Jacobs-Wingo, Jasmine; Koirala, Samir; Molina, Monica; Leidig, Robynn; Celaya, Martin; Pilote, Kara McGinnis; Garrett-Cherry, Tiana; Carney, Jhetari; Johnson, Kym; Daley, W. Randolph] Ctr Dis Control & Prevent, Ctr Preparedness & Response, Div State & Local Readiness, Mailstop H21-5,1600 Clifton Rd, Atlanta, GA 30329 USA.
RP Caceres, VM (corresponding author), Ctr Dis Control & Prevent, Ctr Preparedness & Response, Div State & Local Readiness, Mailstop H21-5,1600 Clifton Rd, Atlanta, GA 30329 USA.
EM vac5@cdc.gov
CR Association of State and Territorial Health Officials, 2014, PROF STAT PUBL HLTH, V3
   Centers for Disease Control and Prevention, FIELD CDCS FIELD ASS
   Centers for Disease Control and Prevention, EB OUTBR W AFR CAS C
   Centers for Disease Control and Prevention, 2014 EB RESP SUPPL F
   Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087
   Danielson Jennifer, 2003, J Public Health Manag Pract, V9, P157
   FRIEDEN TR, 2016, MMWR MORBID MORTA S1, V65, P1
   Georgia Department of Public Health, TRAV CLIN ASS
   Jacobs-Wingo Jasmine, 2016, J Emerg Manag, V14, P391, DOI 10.5055/jem.2016.0303
   Kratochvil CJ, 2017, HEALTH SECUR, V15, P253, DOI 10.1089/hs.2017.0005
   Meyer PA, 2015, J PUBLIC HEALTH MAN, V21, pE19, DOI 10.1097/PHH.0000000000000214
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Savoia E, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2017.304051
   Shaffner J, 2017, COUNC STAT TERR EP A
   Stehling-Ariza T, 2015, MMWR-MORBID MORTAL W, V64, P685
   Thacker SB, 2011, AM J EPIDEMIOL, V174, pS4, DOI 10.1093/aje/kwr307
   Turner AK, 2017, COUNC STAT TERR EP A
   Turner AK, 2018, DISASTER MED PUBLIC, V12, P765, DOI 10.1017/dmp.2017.149
   Turner AK, 2019, DISASTER MED PUBLIC, V13, P74, DOI 10.1017/dmp.2018.102
   US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, 2016, US DEP HLTH HUM SERV
   Van Beneden CA, 2016, MMWR-MORBID MORTAL W, V65, P75, DOI 10.15585/mmwr.su6503a11
   Yacisin K, 2015, MMWR-MORBID MORTAL W, V64, P321
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2050-3121
J9 SAGE OPEN MED
JI SAGE Open Med.
PD MAY
PY 2019
VL 7
AR UNSP 2050312119850726
DI 10.1177/2050312119850726
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HZ5QP
UT WOS:000468907800001
PM 31205697
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ribeiro, JFF
   Pereira, MIA
   Assis, LG
   Cabral, PE
   Santos, BS
   Pereira, GAL
   Chaves, CR
   Campos, GS
   Sardi, SI
   Pereira, G
   Fontes, A
AF Ribeiro, Jessika F. F.
   Pereira, Maria I. A.
   Assis, Lara G.
   Cabral Filho, Paulo E.
   Santos, Beate S.
   Pereira, Giovannia A. L.
   Chaves, Claudilene R.
   Campos, Gubio S.
   Sardi, Silvia I.
   Pereira, Goreti
   Fontes, Adriana
TI Quantum dots-based fluoroimmunoassay for anti-Zika virus IgG antibodies
   detection
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Semiconductor nanocrystals; Zika virus; Immunofluorescence assay; IgG
   antibodies
ID SENSITIVE DETECTION; DIAGNOSIS; IMMUNOASSAY
AB Zika virus (ZIKV) has been declared a public health emergency of international concern. ZIKV has been associated with some neurological disorders, and their long-term effects are not completely understood. The majority of the methods for ZIKV diagnosis are based on the detection of IgM antibodies, which are the first signs of immunological response. However, the detection of IgG antibodies can be an important approach for ZIKV past infection diagnosis, especially for pregnant women, helping the comprehension/treatment of this disease. There has been a growing interest in applying nanoparticles for efficient ZIKV or antibodies detection. Quantum dots (QD) are unique fluorescent semiconductor nanoparticles, highly versatile for biological applications. In the present study, we explored the special QD optical properties to develop an immunofluorescence assay for anti-ZIKV IgG antibodies detection. Anti-IgG antibodies were successfully conjugated with QDs and applied in a fluorescence sensing nanoplatform. After optimization using IgG antibodies, the conjugates were employed to detect anti-ZIKV IgG antibodies in polystyrene microplates sensitized with ZIKV envelope E protein. The nanoplatform was able to detect anti-ZIKV IgG antibodies in a concentration at least 100-fold lower than the amount expected for protein E immune response. Moreover, conjugates were able to detect the antibodies for at least 4 months. Thus, our results showed that this QDs-based fluoroimmunoplatform can be considered practical, simple and promising to detect Zika past infections and/or monitoring immune response in vaccine trials.
C1 [Ribeiro, Jessika F. F.; Pereira, Maria I. A.; Assis, Lara G.; Cabral Filho, Paulo E.; Fontes, Adriana] Univ Fed Pernambuco, Dept Biofis & Radiobiol, BR-50670901 Recife, PE, Brazil.
   [Santos, Beate S.] Univ Fed Pernambuco, Dept Ciencias Farmaceut, Recife, PE, Brazil.
   [Pereira, Giovannia A. L.; Pereira, Goreti] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.
   [Chaves, Claudilene R.; Campos, Gubio S.; Sardi, Silvia I.] Univ Fed Bahia, Dept Ciencias Biointeracao, Salvador, BA, Brazil.
RP Fontes, A (corresponding author), Univ Fed Pernambuco, CB, Dept Biofis & Radiobiol, Ave Prof Moraes Rego S-N, BR-50670901 Recife, PE, Brazil.; Pereira, G (corresponding author), Univ Fed Pernambuco, CCEN, Dept Quim Fundamental, Ave Jornalista Anibal Fernandes S-N, BR-50740560 Recife, PE, Brazil.
EM goreti.pereira@ufpe.br; adriana.fontes@ufpe.br
RI Pereira, Giovannia A.L./K-2421-2012; Fontes, Adriana/T-5789-2019;
   Pereira, Goreti/G-2090-2011; sardi, silvia ines/P-9349-2016; Cabral
   Filho, Paulo/D-4672-2015
OI Pereira, Giovannia A.L./0000-0003-2906-238X; Fontes,
   Adriana/0000-0003-4675-2163; Pereira, Goreti/0000-0003-2604-6704; sardi,
   silvia ines/0000-0002-2002-8436; Cabral Filho, Paulo/0000-0002-1628-7769
FU Coordenacao de Pessoal de Nivel Superior (CAPES)CAPES; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Ciencia e a Tecnologia do Estado de Pernambuco (FACEPE)
   [APQ-0152-2.09/16]
FX This work was supported by the Brazilian agencies: Coordenacao de
   Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and, Fundacao de Amparo a Ciencia e a
   Tecnologia do Estado de Pernambuco (FACEPE, for J.F.F. Ribeiro
   scholarship and grant APQ-0152-2.09/16). This work is also linked to the
   National Institute of Photonics (INCT-INFo) and LARNANO/UFPE.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Ali I., 2017, Journal of Vaccines and Vaccination, V8, P368
   Andrade CG, 2013, INT J NANOMED, V8, P4623, DOI 10.2147/IJN.S51065
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Butch AW, 2000, CLIN CHEM, V46, P1719
   Cabral PE, 2016, BBA-GEN SUBJECTS, V1860, P28, DOI [10.1016/j.bbagen2015.09.021, 10.1016/j.bbagen.2015.09.021]
   Camacho SA, 2018, ACS SENSORS, V3, P587, DOI 10.1021/acssensors.7b00639
   Carlo  F., 2018, EMERG INFECT DIS J, V24, P888
   Carvalho KHG, 2014, J NANOSCI NANOTECHNO, V14, P3320, DOI 10.1166/jnn.2014.8721
   Chen LP, 2010, LUMINESCENCE, V25, P419, DOI 10.1002/bio.1167
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Draz MS, 2018, NANOSCALE, V10, P11841, DOI 10.1039/c8nr01646a
   Draz MS, 2018, ACS NANO, V12, P5709, DOI 10.1021/acsnano.8b01515
   Hu ZG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163682
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Pereira M.G.C., 2016, NANOCOLLOIDS M POINT, P131, DOI [10.1016/B978-0-12-801578-0.00004-7, DOI 10.1016/B978-0-12-801578-0.00004-7]
   ROBBINS BA, 1988, J CLIN LAB ANAL, V2, P62, DOI 10.1002/jcla.1860020112
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Tang MH, 2018, SPECTROCHIM ACTA A, V201, P82, DOI 10.1016/j.saa.2018.04.060
   Yao JJ, 2017, J BIOPHOTONICS, V10, P657, DOI 10.1002/jbio.201600005
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhang HW, 2017, MOLECULES, V22, DOI 10.3390/molecules22081250
   Zhang ZW, 2014, FOOD CHEM, V146, P314, DOI 10.1016/j.foodchem.2013.09.048
   2017, BIOSENS BIOELECTRON, V94, P513, DOI DOI 10.1016/J.BIOS.2017.03.046
   2015, INT J NANOMED, V10, P4393, DOI DOI 10.2147/IJN.S84551
NR 33
TC 0
Z9 0
U1 5
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD MAY
PY 2019
VL 194
BP 135
EP 139
DI 10.1016/j.jphotobiol.2019.03.019
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HY6OK
UT WOS:000468249400016
PM 30954872
DA 2020-07-08
ER

PT J
AU Sharma, A
   Kumar, S
   Tripathi, P
AF Sharma, Aarti
   Kumar, Sarita
   Tripathi, Pushplata
TI A facile and rapid method for green synthesis of Achyranthes aspera stem
   extract-mediated silver nano-composites with cidal potential against
   Aedes aegypti L.
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Silver nano-composites; Achyranthes aspera; Aedes aegypti; SEM; TEM;
   EDX; XRD; FT-IR
ID ANOPHELES-STEPHENSI LISTON; DENGUE VECTOR; CULEX-QUINQUEFASCIATUS;
   BACILLUS-THURINGIENSIS; LARVICIDAL ACTIVITY; PIPERONYL-BUTOXIDE;
   ARGEMONE-MEXICANA; NANOPARTICLES; MOSQUITO; DIPTERA
AB Aedes aegypti L. is the primary vector associated with transmission of globally concerned diseases; Zika, yellow fever, dengue and Chikungunya. Present study investigates an efficient, alternative and comparative approach for mosquito control which is safe to environment and non-target organisms. The silver nano-composites (AgNCs) were synthesized from the aqueous stem extract of Achyranthes aspera (AASE) using different concentration of aqueous silver nitrate (AgNO3). The synthesis was tracked by UV-vis spectrophotometer and particle size analyser (DLS). The evaluation of their larvicidal potential against early fourth instars of Ae. aegypti showed significant potency, the toxicity increasing with the concentration of silver nitrate. The 24, 48 and 72 h bioassays resulted in respective LC50 values of 26.693, 1.113 and 0.610 mu g/mL (3 mM AASE-AgNO3) 9.119, 0.420 and 0.407 mu g/mL (4 mM AASE-AgNO3) and that of 4.283, 0.3 and 0.248 mu g/mL (5 mM AASE-AgNO3). Keeping in view the significantly high larvicidal efficiency at lower concentration of silver nitrate, the 4 mM nano-composites were selected over 5 mM composites for further biophysical characterization carried out by X-ray Diffraction (XRD), Fourier transform infrared spectrometer (FTIR), Scanning electron microscopy (SEM), Energy dispersive X-ray (EDX) spectroscopy and Transmission electron microscopy (TEM). SEM and TEM confirmed the synthesis of spherical poly-dispersed AgNCs with average size ranging from 1-30 nm. Characterization through XRD showed the crystalline face-centered-cubic (fcc) structure of AgNCs with the highest intense peak obtained at 2 theta value of 31.82 degrees. FT-IR data suggests complex nature of AgNCs showing clearly defined peaks in different ranges. The present investigations recommend AgNCs of A. aspera stems as a low-cost and eco-friendly alternative to chemical insecticides for mosquito control. (C) 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Sharma, Aarti; Tripathi, Pushplata] Indira Gandhi Natl Open Univ, Sch Sci, New Delhi 110068, India.
   [Kumar, Sarita] Univ Delhi, Acharya Narendra Dev Coll, Dept Zool, New Delhi 110019, India.
RP Kumar, S (corresponding author), Univ Delhi, Acharya Narendra Dev Coll, Dept Zool, New Delhi 110019, India.
EM aartisharma001@gmail.com; saritakumar@andc.du.ac.in;
   ptripathi14r@rediffmail.com
RI Kumar, Sarita/AAF-3124-2020
OI Kumar, Sarita/0000-0002-1066-3057
CR Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007
   Amaladhas T.P., 2013, ADV MAT LETT, V4, P779, DOI DOI 10.5185/AMLETT.2013.2427
   Banu AN, 2014, PARASITOL RES, V113, P311, DOI 10.1007/s00436-013-3656-0
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Borase HP, 2013, J NANOMEDINE BIOTHER, V3, P1, DOI [10.4172/2155-983X.1000111, DOI 10.4172/2155-983X.1000111]
   Chitra G, 2015, PARASITOL RES, V114, P1407, DOI 10.1007/s00436-015-4320-7
   Elumalai D., 2016, ENG AGR ENV FOOD EAE, V9, P1, DOI [DOI 10.1016/j.eaef.2015.08.002, DOI 10.1016/J.EAEF.2015.08.002]
   Fatimah I, 2016, J ADV RES, V7, P961, DOI 10.1016/j.jare.2016.10.002
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V162, P646, DOI 10.1016/j.jphotobiol.2016.07.036
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gude V., 2012, ADV SCI ENG MED, V4, P1, DOI DOI 10.1166/ASEM.2012.1242
   Khalil MMH, 2014, ARAB J CHEM, V7, P1131, DOI 10.1016/j.arabjc.2013.04.007
   Kumar S, 2004, ANN TROP MED PARASIT, V98, P861, DOI 10.1179/000349804X3180
   Kumar S, 2002, ARCH INSECT BIOCHEM, V50, P1, DOI 10.1002/arch.10021
   Kumar Sarita, 2012, Asian Pacific Journal of Tropical Disease, V2, P395, DOI 10.1016/S2222-1808(12)60086-3
   Kumar S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00104
   Kuppusamy P, 2016, SAUDI PHARM J, V24, P473, DOI 10.1016/j.jsps.2014.11.013
   Li XH, 2011, J ONCOL, V2011, DOI 10.1155/2011/963614
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Marimuthu S, 2013, PARASITOL RES, V112, P4105, DOI 10.1007/s00436-013-3601-2
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mehlhorn H., 2016, PARASITOLOGY RES MON, V8
   Mukunthan K. S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P270, DOI 10.1016/S2221-1691(11)60041-5
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Naik B. R., 2014, ADV ENTOMOLOGY, V2, P93, DOI DOI 10.4236/AE.2014.22016
   NVBDCP, 2017, DENG CAS DEATHS COUN
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Peddi S. P., 2015, INT J PHYS RES, V5, P41
   Poopathi S, 2015, ENVIRON SCI POLLUT R, V22, P2956, DOI 10.1007/s11356-014-3560-x
   Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001
   REDDY MC, 2015, NANOBIOTECHNOLOGY, V14, P222, DOI DOI 10.5897/AJB2013.13299
   Reusch W., 2013, INFRARED SPECTROSCOP
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Shah M, 2015, MATERIALS, V8, P7278, DOI 10.3390/ma8115377
   Sharma Aarti, 2016, J Parasitol Res, V2016, P2857089, DOI 10.1155/2016/2857089
   Sharma Arun Kumar, 2015, J Epilepsy Res, V5, P1, DOI 10.14581/jer.15001
   Silverstein R.M., 1981, SPECTROMETRIC IDENTI
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Suganya G, 2014, PARASITOL RES, V113, P1673, DOI 10.1007/s00436-014-3811-2
   Suman TY, 2013, IND CROP PROD, V47, P239, DOI 10.1016/j.indcrop.2013.03.010
   Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   Vijayaraghavan K, 2012, MATER LETT, V75, P33, DOI 10.1016/j.matlet.2012.01.083
   WARIKOO R, 2014, J ENTOMOL ZOOL STU A, V2, P11
   Warikoo R, 2013, PARASITOL RES, V112, P3477, DOI 10.1007/s00436-013-3528-7
   World Health Organization, 2016, IMM VACC BIOL
   World Health Organization Report, 2005, WHO REPORT
   Xu HX, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246802
NR 57
TC 3
Z9 3
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD MAY
PY 2019
VL 26
IS 4
BP 698
EP 708
DI 10.1016/j.sjbs.2017.11.001
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HV4UJ
UT WOS:000465980900009
PM 31048994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brittain, AW
   August, EM
   Romero, L
   Sheahan, M
   Krashin, J
   Ntansah, C
   Honein, MA
   Jamieson, DJ
   Ellis, EM
   Davis, MS
   Lathrop, E
AF Brittain, Anna W.
   August, Euna M.
   Romero, Lisa
   Sheahan, Margaret
   Krashin, Jamie
   Ntansah, Charity
   Honein, Margaret A.
   Jamieson, Denise J.
   Ellis, Esther M.
   Davis, Michelle S.
   Lathrop, Eva
TI Community Perspectives on Contraception in the Context of the Zika Virus
   in the US Virgin Islands: Implications for Communication and Messaging
SO WOMENS HEALTH ISSUES
LA English
DT Article
ID UNITED-STATES; YOUNG-ADULTS; PUERTO-RICO; LOW-INCOME; HEALTH; PREGNANCY;
   PROGRAM; ACCESS; WOMEN; NEEDS
AB Background: Between January and October 2016, 575 symptomatic confirmed cases of Zika virus infection were reported in the U.S. Virgin Islands (USVI). Zika virus infection during pregnancy can cause serious birth defects. Preventing unintended pregnancy among women who choose to delay or avoid pregnancy is a primary strategy to reduce these adverse outcomes.
   Methods: A rapid assessment, using one men's and five women's focus groups (N = 43), was conducted to inform communication efforts to increase awareness of contraception as a means for preventing unintended pregnancy in the context of a Zika outbreak in the USVI.
   Results: Findings showed that people of reproductive age were aware of the relationship between Zika virus infection during pregnancy and adverse birth outcomes. However, when discussing methods for prevention, participants did not include preventing unintended pregnancy as a strategy to reduce these adverse outcomes. When asked about family planning in the USVI, participants discussed that, for some, planning pregnancies is not common. Participants wanted communications about contraception to include available methods, side effects, costs, and safety. Optimal communication channels included social media and local spokespersons. Participants identified health care providers as a trusted information source.
   Conclusions: Findings from this assessment informed the design of a culturally appropriate communication strategy to raise awareness of the prevention of unintended pregnancy as a primary strategy to reduce Zika-related adverse birth outcomes in the USVI. Published by Elsevier Inc. on behalf of Jacobs Institute of Women's Health.
C1 [Brittain, Anna W.; Romero, Lisa; Krashin, Jamie; Honein, Margaret A.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [August, Euna M.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA.
   [Sheahan, Margaret] Dept Hlth, Family Planning Program, St Thomas, VI USA.
   [Ntansah, Charity] Karna LLC, Atlanta, GA USA.
   [Ellis, Esther M.; Davis, Michelle S.] Dept Hlth, St Croix Off, Christiansted, VI USA.
   [Lathrop, Eva] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Jamieson, Denise J.] Emory Univ, Grady Mem Hosp, Dept Gynecol & Obstet, Sch Med, 80 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.
   [Lathrop, Eva] Emory Univ Hosp Midtown, 550 Peachtree St NE, Atlanta, GA 30308 USA.
RP Brittain, AW (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway, Atlanta, GA 30341 USA.
EM abrittain@cdc.gov
RI ; August, Euna/G-9273-2011
OI Jamieson, Denise/0000-0003-2597-1201; August, Euna/0000-0002-0345-9728
FU National Foundation for the Centers for Disease Control and Prevention,
   Inc. (CDC Foundation); March of DimesMarch of Dimes
FX Supported by the National Foundation for the Centers for Disease Control
   and Prevention, Inc. (CDC Foundation) and a Cooperative Agreement with
   the Centers for Disease Control and Prevention and the March of Dimes.
CR Aiken ARA, 2016, PERSPECT SEX REPRO H, V48, P147, DOI 10.1363/48e10316
   Ali M, 2017, EUR J CONTRACEP REPR, V22, P102, DOI 10.1080/13625187.2017.1288902
   Babalola S, 2008, STUD FAMILY PLANN, V39, P211, DOI 10.1111/j.1728-4465.2008.168.x
   Bailey EJ, 2000, J NATL MED ASSOC, V92, P136
   BEEBE J, 1995, HUM ORGAN, V54, P42, DOI 10.17730/humo.54.1.k84tv883mr2756l3
   Bensyl Diana M., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254
   Borrero S, 2015, CONTRACEPTION, V91, P150, DOI 10.1016/j.contraception.2014.09.014
   Burke A, 2016, SEMIN REPROD MED, V34, P305, DOI 10.1055/s-0036-1592068
   Callwood Gloria B, 2012, ABNF J, V23, P4
   Centers for Disease Control and Prevention, 2017, PREV TRANSM
   Centers for Disease Control and Prevention (CDC), 2018, ZIK BAS
   Centers for Medicare & Medicaid Services, 2016, RE MED FAM PLANN SER
   Corbin J.S., 1998, BASICS QUALITATIVE R
   Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fowler CI, 2018, FAMILY PLANNING ANN
   Gressel GM, 2014, CONTRACEPTION, V90, P588, DOI 10.1016/j.contraception.2014.07.010
   Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610
   Hennick M., 2011, QUALITATIVE RES METH
   Hindin MJ, 2016, J ADOLESCENT HEALTH, V59, pS4, DOI 10.1016/j.jadohealth.2016.07.009
   Janz NK, 1996, HEALTH EDUC QUART, V23, P80, DOI 10.1177/109019819602300106
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   MURRAY SA, 1994, BRIT MED J, V308, P698, DOI 10.1136/bmj.308.6930.698
   Neinstein LS, 2013, J ADOLESCENT HEALTH, V53, P559, DOI 10.1016/j.jadohealth.2013.08.014
   Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239
   Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Park MJ, 2006, J ADOLESCENT HEALTH, V39, P305, DOI 10.1016/j.jadohealth.2006.04.017
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shaw R, 2017, INT J GYNECOL OBSTET, V139, P370, DOI 10.1002/ijgo.12258
   Slater MD, 2003, J NUTR EDUC BEHAV, V35, P255, DOI 10.1016/S1499-4046(06)60056-0
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   U. S. Census Bureau, 2012, 2010 CENS US VIRG IS
   U. S. Virgin Islands (USVI) Department of Health, 2016, ZIK WEEKL SURV REP
   U. S. Virgin Islands (USVI) Department of Health, 2017, DOH REP 1 MICR CAS U
   U. S. Virgin Islands (USVI) Department of Human Services, 2016, FAM ASS PROGR
   *UN, 1994, PROGR ACT INT C POP
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Witte K, 1997, J COMMUN HEALTH, V22, P137, DOI 10.1023/A:1025116923109
   WOODS DR, 1991, PUBLIC HEALTH REP, V106, P616
NR 42
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1049-3867
EI 1878-4321
J9 WOMEN HEALTH ISS
JI Womens Health Iss.
PD MAY-JUN
PY 2019
VL 29
IS 3
BP 245
EP 251
DI 10.1016/j.whi.2019.01.007
PG 7
WC Public, Environmental & Occupational Health; Women's Studies
SC Public, Environmental & Occupational Health; Women's Studies
GA HY7PE
UT WOS:000468327300007
PM 30878263
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Islam, S
   Haque, CE
   Hossain, S
   Rochon, K
AF Islam, Sabrina
   Haque, C. Emdad
   Hossain, Shakhawat
   Rochon, Kateryn
TI Role of container type, behavioural, and ecological factors in Aedes
   pupal production in Dhaka, Bangladesh: An application of zero-inflated
   negative binomial model
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Pupae; Containers; Productivity; Behavioural factors; Ecological
   factors
ID DENGUE VECTOR; CULICIDAE PRODUCTIVITY; INDIA IMPLICATIONS; AEGYPTI
   DIPTERA; TRANSMISSION; PREVALENCE; ABUNDANCE; HABITATS; KOLKATA; TIME
AB The container-inhabiting Aedes mosquitoes are the major vectors transmitting dengue and several other arboviral diseases such as chikungunya and zika across the tropical world. Surveillance for immature Aedes, particularly pupae, is an effective tool for measuring dengue outbreak risk. While in Bangladesh, the greatest burden of dengue fever and dengue hemorrhagic fever cases has periodically been occurring since the first major outbreak in 2000, very limited research has yet been pursued to understand the dynamics of Aedes pupal production in this country. In this backdrop, this study was carried out to i) identify containers at household premises contributing to dengue vector productivity; ii) measure the extent of pupae productivity of household containers; and, iii) determine the effects of household ecological factors upon productivity of pupae in the city of Dhaka, Bangladesh. During the monsoon months of 2013, a total of 1,033 containers (674 wet and 363 dry) in 727 household premises in 12 wards of the city of Dhaka were inspected to measure container productivity and collect household ecological, and human behavioural data. The results reveal that the majority of immature mosquitoes (73.52% larvae and 84.91% pupae) developed in containers located outdoor that are used mostly for household chores. Plastic containers (57.55% of all immature mosquito-positive containers) used for household chores produce most of the immature mosquitos. The results of the zero-inflated negative binomial (ZINB) model reveal that pupae production significantly varies by container type (p-value = 0.0136) for the count regression group. However, when considering container size along with container type, container size is found significant for pupae production (p-value = 0.0041), showing that container size is confounded with the container type and the pupae production. Containers greater than 50 litres (L) are likely to produce 4.9 times more pupae than containers with < 1L. Two household ecological factors are found to be significant (shade: p-value = 0.005 in the count regression group and type of water: p-value = 0.001 in the excess zero group) for pupae production. We found that containers with partial shade produce 4.6 times more pupae than without any shade, whereas in the excess zero group the expected number of observed zero pupae count is 86.5% lower in containers filled with rain water than those with tap water, tube-well water, ring well water and water from other sources. The most commonly used plastic-made containers (i.e., refrigerator trays, drums, buckets) and flower tubs/trays are the most abundant immature mosquito-positive containers. These findings would help the concerned authorities to formulate programs for changing human behaviour targeting the most productive containers for Aedes habitat management and vector control in the city of Dhaka, Bangladesh.
C1 [Islam, Sabrina] North South Univ, Sch Hlth & Life Sci, Dhaka, Bangladesh.
   [Haque, C. Emdad] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada.
   [Hossain, Shakhawat] Univ Manitoba, Dept Math & Stat, Winnipeg, MB, Canada.
   [Rochon, Kateryn] Univ Manitoba, Dept Entomol, Winnipeg, MB, Canada.
RP Haque, CE (corresponding author), Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada.
EM cemdad.haque@umanitoba.ca
OI Rochon, Kateryn/0000-0002-1436-3692; Haque, Emdad/0000-0001-8008-2496
FU International Development Research Centre (IDRC), Ottawa, Canada
   [106040-001]; University of Manitoba, Winnipeg, Canada; North South
   University, Dhaka, Bangladesh; International Center for Diarrheal
   Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh; Social
   Science and Humanities Research Council, InSight Grant, Ottawa, Canada
   [435-2012-1748]; Natural Sciences and the Engineering Research Council
   of Canada, Ottawa, Canada [419428]; International Development Research
   Centre (IDRC), Ottawa, Canada, through an IDRC Doctoral Research Award
   (IDRA)
FX This work was supported by the International Development Research Centre
   (IDRC), Ottawa, Canada (Grant #106040-001); University of Manitoba,
   Winnipeg, Canada; North South University, Dhaka, Bangladesh; and
   International Center for Diarrheal Disease Research, Bangladesh
   (icddr,b), Dhaka, Bangladesh. Further financial assistance was received
   from the Social Science and Humanities Research Council, InSight Grant
   (Grant #435-2012-1748), Ottawa, Canada; Natural Sciences and the
   Engineering Research Council of Canada, Ottawa, Canada (Grant #419428)
   and from International Development Research Centre (IDRC), Ottawa,
   Canada, through an IDRC Doctoral Research Award (IDRA) to the first
   author. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allison P. D., 2012, LOGISTIC REGRESSION
   Anders KL, 2015, PLOS NTD, V9, P1, DOI DOI 10.1371/J0URNAL
   Arduino Mde B, 2014, J INSECTS, V2014, DOI [10.1155/2014/301083, DOI 10.1155/2014/301083]
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Banerjee S, 2015, INDIAN J MED RES, V142, P87, DOI 10.4103/0971-5916.176632
   Banerjee S, 2013, INDIAN J MED RES, V137, P549
   Banu S, 2012, TROP MED INT HEALTH, V17, P1086, DOI 10.1111/j.1365-3156.2012.03038.x
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   BBS, 2016, STAT YB 2016
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CDC (Centers for Disease Control and Prevention), 2016, EPIDEMIOLOGY
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   Elsinga J, 2018, AM J TROP MED HYG, V99, P195, DOI 10.4269/ajtmh.17-0528
   Ferdousi Farhana, 2015, Tropical Medicine and Health, V43, P253, DOI 10.2149/tmh.2015-16
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   FOCKS DA, 2006, TDRIRMDEN061 WHO
   Fulmali PV, 2008, INDIAN J MED RES, V127, P589
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Hossain MA, 2003, EMERG INFECT DIS, V9, P1411, DOI 10.3201/eid0911.030117
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Jeffery JAL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039067
   Jimenez-Alejo A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4294-8
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Long IS, 1997, REGRESSION MODELS CA, P328
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Morales-Perez A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4293-9
   Moreno-Madrinan MJ, 2014, ISPRS INT J GEO-INF, V3, P732, DOI 10.3390/ijgi3020732
   Ngowo H. S, 2017, WELLCOME OPEN RES, DOI [10.12688/wellcomeopenres.12928, DOI 10.12688/WELLCOMEOPENRES.12928]
   Ngugi HN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2271-9
   Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6
   Paul KK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199457
   Richardson KM, 2013, AUSTRAL ECOL, V38, P219, DOI 10.1111/j.1442-9993.2012.02394.x
   RUSSELL PK, 1966, AM J TROP MED HYG, V15, P573, DOI 10.4269/ajtmh.1966.15.573
   Ryan SJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2121-4
   Schafrick NH, 2013, AM J TROP MED HYG, V89, P758, DOI 10.4269/ajtmh.12-0485
   Sharmin S, 2015, T ROY SOC TROP MED H, V109, P619, DOI 10.1093/trstmh/trv067
   Sharmin S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003901
   Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209
   United Nations, 2016, WORLDS CIT 2016 DAT
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557
   WHO, 2011, OP GUID ASS PROD AED
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004500
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   Xu T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016471
   Yunus E. B, 2001, DEN B, V25
   Yunus E. B, 2000, BANGLADESH MED J KHU, V33, P46
   2015, BIOMEDICA, V35, P258, DOI DOI 10.7705/BIOMEDICA.V35I2.2567
NR 53
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2019
VL 193
BP 50
EP 59
DI 10.1016/j.actatropica.2019.02.019
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HU6CS
UT WOS:000465366900009
PM 30790554
OA Other Gold
DA 2020-07-08
ER

PT J
AU Pavela, R
   Maggi, F
   Iannarelli, R
   Benelli, G
AF Pavela, Roman
   Maggi, Filippo
   Iannarelli, Romilde
   Benelli, Giovanni
TI Plant extracts for developing mosquito larvicides: From laboratory to
   the field, with insights on the modes of action
SO ACTA TROPICA
LA English
DT Review
DE Biopesticides; Botanical insecticides; Chemical characterization;
   Culicidae; Dengue; Insecticide resistance; Filariasis; Malaria; Mosquito
   control; Microemulsions; Nanoparticles; Vector-borne disease; West Nile;
   Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; AEDES-AEGYPTI DIPTERA;
   CULEX-QUINQUEFASCIATUS SAY; ANOPHELES-STEPHENSI LISTON; DENGUE-FEVER
   MOSQUITO; EUPHORBIACEAE LEAF EXTRACT; RHIPICEPHALUS BOOPHILUS MICROPLUS;
   ANDROGRAPHIS-PANICULATA BURM.F.; BANCROFTIAN FILARIASIS VECTOR;
   SOLANUM-XANTHOCARPUM EXTRACT
AB In the last decades, major research efforts have been done to investigate the insecticidal activity of plant-based products against mosquitoes. This is a modem and timely challenge in parasitology, aimed to reduce the frequent overuse of synthetic pesticides boosting resistance development in mosquitoes and causing serious threats to human health and environment. This review covers the huge amount of literature available on plant extracts tested as mosquito larvicides, particularly aqueous and alcoholic ones, due to their easy formulation in water without using surfactants. We analysed results obtained on more than 400 plant species, outlining that 29 of them have outstanding larvicidal activity (i.e., LC50 values below 10 ppm) against major vectors belonging to the genera Anopheles, Aedes and Culex, among others. Furthermore, synergistic and antagonistic effects between plant extracts and conventional pesticides, as well as among selected plant extracts are discussed. The efficacy of pure compounds isolated from the most effective plant extracts and when available their mechanism of action, as well as the impact on non-target species, is also covered. These belong to the following class of secondary metabolites: alkaloids, alkamides, sesquiterpenes, triterpenes, sterols, flavonoids, coumarins, anthraquinones, xanthones, acetogenonins and aliphatics. Their mode of action on mosquito larvae ranges from neurotoxic effects to inhibition of detoxificant enzymes and larval development and/or midugut damages. In the final section, current drawbacks as well as key challenges for future research, including technologies to synergize efficacy and improve stability - thus field performances - of the selected plant extracts, are outlined. Unfortunately, despite the huge amount of laboratory evidences about their efficacy, only a limited number of studies was aimed to validate their efficacy in the field, nor the epidemiological impact potentially arising from these vector control operations has been assessed. This strongly limits the development of commercial mosquito larvicides of botanical origin, at variance with plant-borne products developed in the latest decades to kill or repel other key arthropod species of medical and veterinary importance (e.g., ticks and lice), as well as mosquito adults. Further research on these issues is urgently needed.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Maggi, Filippo; Iannarelli, Romilde] Univ Camerino, Sch Pharm, Via St Agostino, I-62032 Camerino, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Maggi, F (corresponding author), Univ Camerino, Sch Pharm, Via St Agostino, I-62032 Camerino, Italy.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM filippo.maggi@unicam.it; giovanni.benelli@unipi.it
RI Pavela, Roman/Q-8647-2016
OI Pavela, Roman/0000-0001-7866-4278
FU Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [R00418]
FX The authors are grateful to the Prof. John C. Beier for inviting this
   Review on Acta Tropica. Dr. Roman Pavela would like to thank the
   Ministry of Agriculture of the Czech Republic for its financial support
   concerning botanical pesticide and basic substances research (Project
   No. R00418). The Cx. quinquefasciatus photo used in the graphical
   abstract was kindly provided by Dr. Harry Weinburgh (PHIL-CDC).
CR Aarthi C, 2018, ENVIRON SCI POLLUT R, V25, P10317, DOI 10.1007/s11356-017-9203-2
   Aarthi N., 2010, J BIOPESTICIDES, V3, P199
   Abirami D, 2017, SE ASIAN J TROP MED, V48, P1188
   Abou-Elnaga ZS, 2011, CLEAN-SOIL AIR WATER, V39, P787, DOI 10.1002/clen.201000597
   AhbiRami R, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu042
   Ahn JY, 2013, J ASIA-PAC ENTOMOL, V16, P317, DOI 10.1016/j.aspen.2013.04.005
   Aivazi Ali-Ashraf, 2010, Toxicological and Environmental Chemistry, V92, P893, DOI 10.1080/02772240903092306
   Aivazi AA, 2009, PARASITOL RES, V104, P1289, DOI 10.1007/s00436-008-1325-5
   Al-Mekhlafi FA, 2013, PAK J ZOOL, V45, P241
   Al-Rehaily AJ, 2017, CHEM NAT COMPD+, V53, P670, DOI 10.1007/s10600-017-2087-z
   Ali SI, 2018, S AFR J BOT, V114, P117, DOI 10.1016/j.sajb.2017.10.018
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Alyahya SA, 2018, J PHOTOCH PHOTOBIO B, V181, P70, DOI 10.1016/j.jphotobiol.2018.02.019
   Amel A, 2015, ENRGY PROCED, V74, P1026, DOI 10.1016/j.egypro.2015.07.739
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Anbazhagan P, 2017, J CLUST SCI, V28, P91, DOI 10.1007/s10876-016-1047-2
   Andemo A, 2014, ACTA TROP, V136, P68, DOI 10.1016/j.actatropica.2014.04.016
   Arjunan N, 2012, PARASITOL RES, V110, P1435, DOI 10.1007/s00436-011-2646-3
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Azarudeen RMST, 2017, J ASIA-PAC ENTOMOL, V20, P359, DOI 10.1016/j.aspen.2017.02.007
   Azarudeen RMST, 2017, J CLUST SCI, V28, P369, DOI 10.1007/s10876-016-1103-y
   Azarudeen RMST, 2017, J CLUST SCI, V28, P179, DOI 10.1007/s10876-016-1067-y
   Azarudeen RMST, 2016, RSC ADV, V6, P96573, DOI 10.1039/c6ra23208f
   Azrag RS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1484-2
   Bagavan A, 2011, ASIAN PAC J TROP MED, V4, P29, DOI 10.1016/S1995-7645(11)60027-8
   Bagavan A, 2009, VET PARASITOL, V166, P286, DOI 10.1016/j.vetpar.2009.09.007
   Balasubramanian J, 2015, PARASITOL RES, V114, P4219, DOI 10.1007/s00436-015-4658-x
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bansal SK, 2015, J ENVIRON BIOL, V36, P633
   Bansal SK, 2014, J ENVIRON BIOL, V35, P327
   Bansal SK, 2012, J ENVIRON BIOL, V33, P617
   Bansal SK, 2011, J ENVIRON BIOL, V32, P71
   Bansal SK, 2009, J ENVIRON BIOL, V30, P883
   Bansal SK, 2009, J ENVIRON BIOL, V30, P221
   Banumathi B, 2017, J CLUST SCI, V28, P2857, DOI 10.1007/s10876-017-1263-4
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Barata C, 2006, AQUAT TOXICOL, V78, P1, DOI 10.1016/j.aquatox.2006.01.013
   Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004
   Baskar K, 2014, PHYTOPARASITICA, V42, P323, DOI 10.1007/s12600-013-0363-4
   Beck J. J, 2013, PEST MANAGEMENT NATU, P247
   Begum N, 2017, NATL ACAD SCI LETT, V40, P153, DOI 10.1007/s40009-017-0546-5
   Belmain SR, 2012, J AGR FOOD CHEM, V60, P10055, DOI 10.1021/jf3032217
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2019, J ETHNOPHARMACOL, V229, P272, DOI 10.1016/j.jep.2018.08.030
   Benelli G, 2018, TRENDS PARASITOL, V34, P351, DOI 10.1016/j.pt.2018.01.002
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10283, DOI 10.1007/s11356-017-8898-4
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10228, DOI 10.1007/s11356-017-8482-y
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P637, DOI 10.1007/s10876-017-1159-3
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bird BH, 2016, ANTIVIR RES, V132, P274, DOI 10.1016/j.antiviral.2016.07.005
   Bonin A, 2015, INFECT GENET EVOL, V35, P204, DOI 10.1016/j.meegid.2015.07.034
   Bonneau N, 2017, FOOD CHEM, V226, P32, DOI 10.1016/j.foodchem.2017.01.042
   Boonen J, 2012, J ETHNOPHARMACOL, V142, P563, DOI 10.1016/j.jep.2012.05.038
   Boreddy Y., 2000, Entomon, V25, P351
   Borges L. S., 2012, AM J PLANT PHYSL, V7, P135
   Bouic P J, 1999, Altern Med Rev, V4, P170
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Brunetti A, 2019, PHYTOMEDICINE, V52, P51, DOI 10.1016/j.phymed.2018.09.220
   Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2
   Chaithong U, 2006, J VECTOR ECOL, V31, P138, DOI 10.3376/1081-1710(2006)31[138:LEOPPO]2.0.CO;2
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088
   Changbunjong T, 2010, SE ASIAN J TROP MED, V41, P320
   Chansakaow S, 1996, CHEM PHARM BULL, V44, P1415, DOI 10.1248/cpb.44.1415
   Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0
   Chellappandian M, 2018, ENVIRON INT, V113, P214, DOI 10.1016/j.envint.2017.12.038
   Chen Y, 2012, J ETHNOPHARMACOL, V142, P462, DOI 10.1016/j.jep.2012.05.019
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P3617, DOI 10.1016/j.biortech.2007.07.038
   Chenniappan K, 2008, J ENTOMOL RES SOC, V10, P13
   Chenniappan K, 2011, J ENTOMOL RES SOC, V13, P71
   Choochote W, 2004, J VECTOR ECOL, V29, P340
   Chore JK, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu064
   Chowdhury N, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-10
   Chung HN, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey103
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Corbel V, 2002, PARASITE, V9, P255, DOI 10.1051/parasite/2002093255
   Costa MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160928
   Costa MS, 2017, PEST MANAG SCI, V73, P636, DOI 10.1002/ps.4350
   Cuthbert RN, 2018, J MED ENTOMOL, V55, P1656, DOI 10.1093/jme/tjy132
   Dantas-Torres F, 2016, TRENDS PARASITOL, V32, P43, DOI 10.1016/j.pt.2015.09.004
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793
   Porto KRD, 2017, AN ACAD BRAS CIENC, V89, P895, DOI 10.1590/0001-3765201720150017
   de Barros IB, 2011, BRAZ ARCH BIOL TECHN, V54, P535, DOI 10.1590/S1516-89132011000300015
   de Souza LG, 2016, CHEM-BIOL INTERACT, V254, P11, DOI 10.1016/j.cbi.2016.05.001
   Deepa J, 2015, INT J PURE APPL ZOOL, V3, P130
   DeLiberto ST, 2016, PEST MANAG SCI, V72, P1813, DOI 10.1002/ps.4330
   Devi P, 1997, BOT MAR, V40, P533, DOI 10.1515/botm.1997.40.1-6.533
   Donoghue MJ, 1998, TRENDS PLANT SCI, V3, P311, DOI 10.1016/S1360-1385(98)01278-3
   DREYER DL, 1976, TETRAHEDRON, V32, P2367, DOI 10.1016/0040-4020(76)87016-0
   Duraipandiyan Veeramuthu, 2015, Braz. arch. biol. technol., V58, P216, DOI 10.1590/S1516-8913201400128
   Rodriguez-Lopez CE, 2015, RSC ADV, V5, P106019, DOI 10.1039/c5ra22854a
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Efferth T, 2017, SEMIN CANCER BIOL, V46, P65, DOI 10.1016/j.semcancer.2017.02.009
   El -Sheikh TMY, 2016, J SAUDI CHEM SOC, V20, P13, DOI 10.1016/j.jscs.2012.05.009
   El-Wakeil NE, 2013, GESUNDE PFLANZ, V65, P125, DOI 10.1007/s10343-013-0308-3
   Elango G, 2009, PARASITOL RES, V104, P1381, DOI 10.1007/s00436-009-1339-7
   Elango G, 2011, PARASITOL RES, V109, P715, DOI 10.1007/s00436-011-2306-7
   Elemike EE, 2017, MOLECULES, V22, DOI 10.3390/molecules22050674
   Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1
   Enan EE, 2005, ARCH INSECT BIOCHEM, V59, P161, DOI 10.1002/arch.20076
   Eze EA, 2014, J VECTOR DIS, V51, P300
   Fang YT, 2017, J CHROMATOGR A, V1507, P63, DOI 10.1016/j.chroma.2017.05.048
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   Fotie Jean, 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P357, DOI 10.2174/187152106778520451
   FUKAMI H, 1971, NATURALLY OCCURRING, P71
   Gandhi PR, 2016, J ASIA-PAC ENTOMOL, V19, P1089, DOI 10.1016/j.aspen.2016.10.001
   Garcez WS, 2009, BIORESOURCE TECHNOL, V100, P6647, DOI 10.1016/j.biortech.2009.06.092
   GARDNER RO, 1977, BIOCHEM SYST ECOL, V5, P29, DOI 10.1016/0305-1978(77)90015-1
   Georges K, 2008, BIORESOURCE TECHNOL, V99, P2037, DOI 10.1016/j.biortech.2007.02.049
   Ghosh A, 2006, NAT PROD RES, V20, P371, DOI 10.1080/14786410600661575
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Leite JJG, 2009, REV SOC BRAS MED TRO, V42, P110, DOI 10.1590/S0037-86822009000200003
   Godara R, 2018, EXP APPL ACAROL, V75, P333, DOI 10.1007/s10493-018-0268-5
   Goodarzi S, 2017, ASIAN PAC J TROP MED, V10, P896, DOI 10.1016/j.apjtm.2017.08.007
   Govindarajan M, 2013, INDIAN J MED RES, V138, P128
   Govindarajan M, 2012, EUR REV MED PHARMACO, V16, P386
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P505, DOI 10.1016/S1995-7645(11)60135-1
   Govindarajan M, 2011, EUR REV MED PHARMACO, V15, P787
   Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P24, DOI 10.1016/S1995-7645(11)60026-6
   Govindarajan M, 2010, EUR REV MED PHARMACO, V14, P107
   Govindarajan M, 2017, J APPL BIOMED, V15, P87, DOI 10.1016/j.jab.2016.10.004
   Govindarajan M, 2017, ARTIF CELL NANOMED B, V45, P1317, DOI 10.1080/21691401.2016.1228664
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, NAT PROD RES, V30, P2491, DOI 10.1080/14786419.2016.1185721
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V162, P646, DOI 10.1016/j.jphotobiol.2016.07.036
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2014, PARASITOL RES, V113, P1435, DOI 10.1007/s00436-014-3784-1
   Govindarajan M, 2014, PARASITOL RES, V113, P777, DOI 10.1007/s00436-013-3709-4
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P176, DOI 10.1016/S1995-7645(11)60064-3
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Grzybowski A, 2013, PEST MANAG SCI, V69, P589, DOI 10.1002/ps.3409
   Grzybowski A, 2012, REV BRAS FARMACOGN, V22, P549, DOI 10.1590/S0102-695X2012005000026
   Jimenez-Cortes JG, 2018, ACTA TROP, V186, P69, DOI 10.1016/j.actatropica.2018.07.005
   Gusmao DS, 2002, MEM I OSWALDO CRUZ, V97, P371, DOI 10.1590/S0074-02762002000300017
   Han Y, 2013, PARASITOL RES, V112, P511, DOI 10.1007/s00436-012-3161-x
   Haq S, 2016, RES J PHARM BIOL CHE, V7, P463
   Harve Gauri, 2004, Indian Journal of Experimental Biology, V42, P1216
   He Q, 2014, J CHEM-NY, DOI 10.1155/2014/738796
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380
   HENNESSEY TM, 1992, COMP BIOCHEM PHYS C, V101, P1, DOI 10.1016/0742-8413(92)90191-9
   Hossain E, 2011, ASIAN PAC J TROP MED, V4, P436, DOI 10.1016/S1995-7645(11)60121-1
   HUFFORD L, 1992, ANN MO BOT GARD, V79, P218, DOI 10.2307/2399767
   Ibrahim MY, 2016, ARAB J CHEM, V9, P317, DOI 10.1016/j.arabjc.2014.02.011
   Ibrahim SRM, 2018, FITOTERAPIA, V125, P78, DOI 10.1016/j.fitote.2017.12.024
   Intirach J, 2016, ENVIRON SCI POLLUT R, V23, P23994, DOI 10.1007/s11356-016-7651-8
   Ishak AR, 2014, PROCD SOC BEHV, V153, P180, DOI 10.1016/j.sbspro.2014.10.052
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Isman MB, 2006, ADV PHYTOMED, V3, P29
   Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005
   Jankowska M, 2018, MOLECULES, V23, DOI 10.3390/molecules23010034
   Jayanthi P, 2012, PARASITOL RES, V111, P2129, DOI 10.1007/s00436-012-3061-0
   Jayaseelan C, 2011, PARASITOL RES, V109, P185, DOI 10.1007/s00436-010-2242-y
   Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x
   Kabir KE, 2013, ECOTOX ENVIRON SAFE, V90, P52, DOI 10.1016/j.ecoenv.2012.12.028
   Kadarohman A, 2013, J ESSENT OIL BEAR PL, V16, P749, DOI 10.1080/0972060X.2013.862075
   KADIR HA, 1989, PESTIC SCI, V25, P329, DOI 10.1002/ps.2780250402
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kalu IG, 2010, J MED PLANTS RES, V4, P496
   KALYANASUNDARAM M, 1982, INDIAN J MED RES, V76, P102
   KALYANASUNDARAM M, 1985, INDIAN J MED RES, V82, P19
   Kamalakannan S, 2011, J ASIA-PAC ENTOMOL, V14, P41, DOI 10.1016/j.aspen.2010.11.011
   Kamalakannan S, 2010, VECTOR-BORNE ZOONOT, V10, P817, DOI 10.1089/vbz.2009.0081
   Kamaraj C, 2008, PARASITOL RES, V103, P1361, DOI 10.1007/s00436-008-1142-x
   Kamaraj C, 2011, INDIAN J MED RES, V134, P101
   Kamaraj C, 2010, TROP BIOMED, V27, P211
   Kamaraj C, 2009, PARASITOL RES, V104, P1163, DOI 10.1007/s00436-008-1306-8
   Kamaraj C, 2011, ASIAN PAC J TROP MED, V4, P698, DOI 10.1016/S1995-7645(11)60177-6
   Kamaraj C, 2010, PARASITOL RES, V107, P1337, DOI 10.1007/s00436-010-2006-8
   Kanzok SM, 2006, TRENDS PARASITOL, V22, P49, DOI 10.1016/j.pt.2005.12.008
   Karmegam N, 1997, BIORESOURCE TECHNOL, V59, P137, DOI 10.1016/S0960-8524(96)00157-5
   Karunamoorthi K, 2010, EUR REV MED PHARMACO, V14, P57
   Kempraj V, 2011, PESTIC BIOCHEM PHYS, V100, P82, DOI 10.1016/j.pestbp.2011.02.009
   Khanna VG, 2011, PARASITOL RES, V109, P1373, DOI 10.1007/s00436-011-2384-6
   Kihampa C, 2009, J VECTOR DIS, V46, P145
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kiprop AK, 2005, B CHEM SOC ETHIOPIA, V19, P145
   Koodalingam A, 2009, PARASITOL RES, V105, P1425, DOI 10.1007/s00436-009-1574-y
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kovendan K, 2012, ASIAN PAC J TROP MED, V5, P299, DOI 10.1016/S1995-7645(12)60043-1
   Kovendan K, 2016, J ASIA-PAC ENTOMOL, V19, P1001, DOI 10.1016/j.aspen.2016.09.001
   Kovendan K, 2013, PARASITOL RES, V112, P1205, DOI 10.1007/s00436-012-3252-8
   Kovendan K, 2012, PARASITOL RES, V111, P1481, DOI 10.1007/s00436-012-2984-9
   Kovendan K, 2012, PARASITOL RES, V111, P1025, DOI 10.1007/s00436-012-2927-5
   Kovendan K, 2012, PARASITOL RES, V111, P531, DOI 10.1007/s00436-012-2865-2
   Kovendan K, 2012, PARASITOL RES, V110, P2105, DOI 10.1007/s00436-011-2736-2
   Kovendan K, 2012, PARASITOL RES, V110, P669, DOI 10.1007/s00436-011-2540-z
   Kovendan K, 2012, PARASITOL RES, V110, P571, DOI 10.1007/s00436-011-2525-y
   Kovendan K, 2011, PARASITOL RES, V109, P1251, DOI 10.1007/s00436-011-2368-6
   Krishnappa K, 2013, EUR REV MED PHARMACO, V17, P1273
   Krishnappa K, 2012, J VECTOR DIS, V49, P86
   Kumar D, 2018, PARASITOL RES, V117, P377, DOI 10.1007/s00436-017-5711-8
   Kumar KR, 2015, PARASITOL RES, V114, P411, DOI 10.1007/s00436-014-4198-9
   Kumar P. M, 2012, MOSQUITO LARVICIDAL
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kumar RB, 2010, PHARMACOGN RES, V2, P247, DOI 10.4103/0974-8490.69126
   Kumar S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00104
   Lallawmawma H, 2015, ENVIRON SCI POLLUT R, V22, P17753, DOI 10.1007/s11356-015-5001-x
   Lalrotluanga, 2012, PARASITOL RES, V111, P1007, DOI 10.1007/s00436-012-2925-7
   Lame Y, 2015, J ARTHROPOD-BORNE DI, V9, P226
   Larson RT, 2010, J MED ENTOMOL, V47, P249, DOI 10.1603/ME09160
   Lawler SP, 2017, ECOTOX ENVIRON SAFE, V139, P335, DOI 10.1016/j.ecoenv.2016.12.038
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Leitner WW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004107
   Li WS, 2015, ACTA TROP, V146, P36, DOI 10.1016/j.actatropica.2015.02.004
   Liang YP, 2015, MOLECULES, V20, P3238, DOI 10.3390/molecules20023238
   Lingampally V., 2014, J ENTOMOL ZOOL STU C, V2, P118
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9
   Lu HY, 2017, TROP J PHARM RES, V16, P179, DOI 10.4314/tjpr.v16i1.24
   Macedo ME, 1997, MEM I OSWALDO CRUZ, V92, P565, DOI 10.1590/S0074-02761997000400024
   Macel M, 2011, PHYTOCHEM REV, V10, P75, DOI 10.1007/s11101-010-9181-1
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Madhu S. K., 2010, Toxicological and Environmental Chemistry, V92, P115, DOI 10.1080/02772240902784242
   Magadula JJ, 2009, J MED PLANTS RES, V3, P674
   Maggi F., 2018, Mosquito-borne diseases: implications for public health, P69
   Mahyoub JA, 2016, EGYPT J BIOL PEST CO, V26, P833
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Maleck M., 2013, J NAT PHARM, V4, P32
   Mandal S, 2010, ASIAN PAC J TROP MED, V3, P605, DOI 10.1016/S1995-7645(10)60147-2
   Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7
   Mansour SA, 2014, IND CROP PROD, V54, P192, DOI 10.1016/j.indcrop.2014.01.011
   Marimuthu G, 2012, PARASITOL RES, V111, P65, DOI 10.1007/s00436-011-2802-9
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Markouk M, 2000, J ETHNOPHARMACOL, V73, P293, DOI 10.1016/S0378-8741(00)00257-9
   MARLES RJ, 1991, PESTIC BIOCHEM PHYS, V41, P89, DOI 10.1016/0048-3575(91)90063-R
   Matasyoh JC, 2008, AFR J BIOTECHNOL, V7, P912
   Mathew N, 2009, PARASITOL RES, V104, P1017, DOI 10.1007/s00436-008-1284-x
   Maurya P., 2012, ASIAN PACIFIC J TROP, V2, P110
   Maurya P, 2009, PARASITOL RES, V105, P1653, DOI 10.1007/s00436-009-1609-4
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MENDEL MJ, 1991, J ECON ENTOMOL, V84, P1158, DOI 10.1093/jee/84.4.1158
   Mischke CC, 2016, J WORLD AQUACULT SOC, V47, P212, DOI 10.1111/jwas.12243
   Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854
   Modise SA, 2016, TROP J PHARM RES, V15, P965, DOI 10.4314/tjpr.v15i5.10
   Mohan DR, 2007, AFR J BIOTECHNOL, V6, P631
   Mohan L, 2005, J ENVIRON BIOL, V26, P399
   Mohan Lalit, 2006, Entomological Research, V36, P220, DOI 10.1111/j.1748-5967.2006.00037.x
   Mohan L, 2010, SE ASIAN J TROP MED, V41, P311
   Mohan S, 2018, FOOD FUNCT, V9, P3860, DOI 10.1039/c8fo00439k
   Mohankumar TK, 2016, J ARTHROPOD-BORNE DI, V10, P305
   Molyneux RJ, 2011, FOOD ADDIT CONTAM A, V28, P293, DOI 10.1080/19440049.2010.547519
   Muema JM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1464-7
   Mukandiwa L, 2015, S AFR J BOT, V100, P169, DOI 10.1016/j.sajb.2015.05.016
   Murugan JM, 2016, NAT PROD RES, V30, P1193, DOI 10.1080/14786419.2015.1046069
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K, 2018, PHYSIOL MOL PLANT P, V101, P202, DOI 10.1016/j.pmpp.2017.02.004
   Murugan K, 2017, J CLUST SCI, V28, P437, DOI 10.1007/s10876-016-1115-7
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2013, PHYTOPARASITICA, V41, P307, DOI 10.1007/s12600-013-0291-3
   Murugan K, 2012, PARASITOL RES, V110, P2263, DOI 10.1007/s00436-011-2758-9
   Muthu C, 2012, PARASITOL RES, V111, P1059, DOI 10.1007/s00436-012-2932-8
   Muthu C, 2015, BRAZ ARCH BIOL TECHN, V58, P358, DOI 10.1590/S1516-8913201500481
   Muthukumaran U, 2015, PARASITOL RES, V114, P4385, DOI 10.1007/s00436-015-4677-7
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nath DR, 2006, DEFENCE SCI J, V56, P507, DOI 10.14429/dsj.56.1916
   Ni'mah T, 2015, BUL PENELIT KESEHAT, V43, P131
   Vasconcelos JNE, 2012, QUIM NOVA, V35, P1097, DOI 10.1590/S0100-40422012000600005
   Nyamoita MG, 2013, ACTA TROP, V127, P199, DOI 10.1016/j.actatropica.2013.05.003
   Oberlies NH, 1998, J NAT PROD, V61, P781, DOI 10.1021/np9800304
   Oliveira PES, 2008, REV BRAS FARMACOGN, V18, P713, DOI 10.1590/S0102-695X2008000500014
   Oliveira PV, 2010, PARASITOL RES, V107, P403, DOI 10.1007/s00436-010-1880-4
   OMAR M, 1983, J NAT PROD, V46, P153, DOI 10.1021/np50026a001
   Pandey V, 2013, ACTA HORTIC, V972, P87
   Pandey V, 2007, PARASITOL RES, V102, P171, DOI 10.1007/s00436-007-0763-9
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P847, DOI 10.1016/S1995-7645(13)60151-0
   Panneerselvam C, 2012, PARASITOL RES, V111, P2241, DOI 10.1007/s00436-012-3073-9
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Patel PK, 2012, J ETHNOPHARMACOL, V144, P160, DOI 10.1016/j.jep.2012.08.043
   Patil CD, 2014, J ARTHROPOD-BORNE DI, V8, P91
   Patil CD, 2011, PARASITOL RES, V108, P1253, DOI 10.1007/s00436-010-2174-6
   Patil SV, 2010, TROP BIOMED, V27, P360
   Pavela R, 2019, J PEST SCI
   Pavela R, 2008, PARASITOL RES, V102, P555, DOI 10.1007/s00436-007-0821-3
   Pavela R, 2019, IND CROP PROD, V129, P631, DOI 10.1016/j.indcrop.2018.11.073
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10493, DOI 10.1007/s11356-017-0267-9
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2016, EXP PARASITOL, V165, P51, DOI 10.1016/j.exppara.2016.03.016
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2015, IND CROP PROD, V67, P108, DOI 10.1016/j.indcrop.2015.01.011
   Pavela R, 2009, PARASITOL RES, V105, P887, DOI 10.1007/s00436-009-1511-0
   PERICH MJ, 1995, J AM MOSQUITO CONTR, V11, P307
   Pesticide Action Network, 2004, PEST REG COUNTR
   Pierre DYS, 2014, J VECTOR DIS, V51, P216
   Pluempanupat S, 2013, IND CROP PROD, V44, P653, DOI 10.1016/j.indcrop.2012.09.006
   Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012
   Prashanthi P, 2016, INDIAN J NAT PROD RE, V7, P141
   Prathibha KP, 2014, ENVIRON SCI POLLUT R, V21, P6736, DOI 10.1007/s11356-014-2591-7
   Price DN, 2006, J INSECT PHYSIOL, V52, P309, DOI 10.1016/j.jinsphys.2005.11.010
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Promsiri Suwannee, 2006, Insect Science, V13, P179, DOI 10.1111/j.1744-7917.2006.00080.x
   Puggioli A, 2016, ACTA TROP, V164, P473, DOI 10.1016/j.actatropica.2016.10.014
   Raghavendra BS, 2013, ENVIRON SCI POLLUT R, V20, P3830, DOI 10.1007/s11356-012-1308-z
   Raghavendra K, 2009, INDIAN J MED RES, V130, P74
   Rahuman AA, 2009, PARASITOL RES, V104, P1365, DOI 10.1007/s00436-009-1337-9
   Rahuman AA, 2008, PARASITOL RES, V103, P133, DOI 10.1007/s00436-008-0940-5
   Rahuman AA, 2008, PARASITOL RES, V102, P981, DOI 10.1007/s00436-007-0864-5
   Rahuman AA, 2009, PARASITOL RES, V104, P637, DOI 10.1007/s00436-008-1240-9
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Rajkumar S, 2009, PARASITOL RES, V104, P337, DOI 10.1007/s00436-008-1197-8
   Rajkumar S, 2004, J ETHNOPHARMACOL, V90, P87, DOI 10.1016/j.jep.2003.09.030
   Rajkumar Sankaran, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1588
   Ramkumar G, 2016, BIONANOSCIENCE, V6, P308, DOI 10.1007/s12668-016-0374-y
   Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Rawani A, 2014, INDIAN J MED RES, V140, P285
   Rawani A, 2014, INDIAN J MED RES, V140, P102
   Redwane A, 2002, J ETHNOPHARMACOL, V79, P261, DOI 10.1016/S0378-8741(01)00390-7
   Renugadevi G, 2013, ASIAN PAC J TROP MED, V6, P176, DOI 10.1016/S1995-7645(13)60019-X
   Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004
   Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3
   RodriguezSaona C, 1997, J CHEM ECOL, V23, P1819, DOI 10.1023/B:JOEC.0000006453.40940.a8
   Rongnoparut P, 2016, CURR ORG CHEM, V20, P2649, DOI 10.2174/1385272820666151026231234
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   RUPPRECHT JK, 1990, J NAT PROD, V53, P237, DOI 10.1021/np50068a001
   Sakthivadivel M, 2008, APPL ENTOMOL ZOOL, V43, P57, DOI 10.1303/aez.2008.57
   Sama W, 2014, AFR J TRADIT COMPLEM, V11, P84, DOI 10.4314/ajtcam.v11i4.14
   Samuel L, 2014, EXP PARASITOL, V141, P112, DOI 10.1016/j.exppara.2014.03.020
   Samuel M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1521-6
   Santhosh SB, 2015, PARASITOL RES, V114, P3087, DOI 10.1007/s00436-015-4511-2
   Santhosh SB, 2015, J PHOTOCH PHOTOBIO B, V153, P184, DOI 10.1016/j.jphotobiol.2015.09.018
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   SARAF DK, 2002, ASIAN J EXP SCI, V16, P9
   Sarmento UC, 2016, MEM I OSWALDO CRUZ, V111, P469, DOI 10.1590/0074-02760160134
   Schmahl G, 2010, PARASITOL RES, V107, P261, DOI 10.1007/s00436-010-1915-x
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scott Ian M., 2008, Phytochemistry Reviews, V7, P65, DOI 10.1007/s11101-006-9058-5
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   SENDELBACH LE, 1989, TOXICOLOGY, V57, P227, DOI 10.1016/0300-483X(89)90113-3
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Shaalan EAS, 2018, ENVIRON SCI POLLUT R, V25, P10207, DOI 10.1007/s11356-017-0408-1
   Shaalan EAS, 2005, J VECTOR ECOL, V30, P284
   Sharma G, 2014, PARASITOL RES, V113, P197, DOI 10.1007/s00436-013-3644-4
   Sharma G, 2012, J AM MOSQUITO CONTR, V28, P317, DOI 10.2987/12-6275R.1
   Sharma P, 2009, PARASITOL RES, V106, P171, DOI 10.1007/s00436-009-1644-1
   Sharma P, 2009, PARASITOL RES, V105, P1193, DOI 10.1007/s00436-009-1537-3
   Shivakumar MS, 2013, RES J BIOTECHNOL, V8, P67
   Singh DJ, 2017, SCIENTIFICA, V2017, DOI 10.1155/2017/5219194
   Singha Someshwar, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS159
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sperry JB, 2005, CURR OPIN DRUG DISC, V8, P723
   Sreedev P, 2014, J DHARMA, V39, P277
   Stevenson PC, 2012, PHYTOCHEMISTRY, V78, P135, DOI 10.1016/j.phytochem.2012.02.025
   Subarani S, 2013, ASIAN PAC J TROP MED, V6, P625, DOI 10.1016/S1995-7645(13)60107-8
   Subramaniam J, 2017, J CLUST SCI, V28, P413, DOI 10.1007/s10876-016-1113-9
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Suganya G, 2014, PARASITOL RES, V113, P1673, DOI 10.1007/s00436-014-3811-2
   Sukari MA, 2010, ASIAN J CHEM, V22, P7915
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Suresh U, 2018, PHYSIOL MOL PLANT P, V101, P225, DOI 10.1016/j.pmpp.2017.01.002
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Sut S, 2018, CURR MED CHEM, V25, P1241, DOI 10.2174/0929867324666170404150351
   Thandapani K, 2018, ENVIRON SCI POLLUT R, V25, P10328, DOI 10.1007/s11356-017-9177-0
   Thangam TS, 1997, INT J PHARMACOGN, V35, P69
   Thanigaivel A, 2017, ECOTOX ENVIRON SAFE, V137, P210, DOI 10.1016/j.ecoenv.2016.11.004
   Thongwat D, 2017, SE ASIAN J TROP MED, V48, P27
   Thongwat D, 2014, SE ASIAN J TROP MED, V45, P1292
   Torres R. C, 2015, LARVICIDAL ACTIVITY
   Torres RC, 2016, INDIAN J NAT PROD RE, V7, P252
   Torres RC, 2014, ASIAN PAC J TROP MED, V7, pS167, DOI 10.1016/S1995-7645(14)60225-X
   Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8
   Tripathy A, 2011, J MED ENTOMOL, V48, P291, DOI 10.1603/ME09122
   Unpaprom Y, 2015, CHIANG MAI J SCI, V42, P148
   Vats S, 2018, BIO-TECHNOL, V8, P13
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Vimala RTV, 2015, SPECTROCHIM ACTA A, V135, P110, DOI 10.1016/j.saa.2014.06.009
   Vinayachandra, 2011, PARASITOL RES, V109, P1671, DOI 10.1007/s00436-011-2440-2
   Vincent S, 2017, J CLUST SCI, V28, P37, DOI 10.1007/s10876-016-1038-3
   Wachira SW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-312
   Warikoo R, 2013, PARASITOL RES, V112, P3477, DOI 10.1007/s00436-013-3528-7
   Wen ZM, 2009, J CHEM ECOL, V35, P183, DOI 10.1007/s10886-009-9598-4
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Winderl B, 2016, J SEP SCI, V39, P4042, DOI 10.1002/jssc.201600734
   Wirth MC, 2015, J MED ENTOMOL, V52, P1028, DOI 10.1093/jme/tjv115
   Wu TS, 1997, PHYTOCHEMISTRY, V45, P1393, DOI 10.1016/S0031-9422(97)00176-3
   Xiang Y, 2014, J FOOD SCI, V79, pC1956, DOI 10.1111/1750-3841.12581
   Yadav R, 2015, J VECTOR DIS, V52, P88
   Yadav R, 2014, J ARTHROPOD-BORNE DI, V8, P174
   Yang YC, 2003, J AGR FOOD CHEM, V51, P7629, DOI 10.1021/jf034727t
   Yankanchi S. R., 2014, Journal of Biopesticides, V7, P22
   Yenesew A, 2003, PEST MANAG SCI, V59, P1159, DOI 10.1002/ps.740
   Yu JQ, 2018, FITOTERAPIA, V129, P54, DOI 10.1016/j.fitote.2018.06.006
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
   Zaridah MZ, 2006, J TROP FOR SCI, V18, P74
   Zhang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep39425
   Zuharah WF, 2014, TROP BIOMED, V31, P297
   Zuharah WF, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658044
   2013, IND CROP PROD, V45, P236, DOI DOI 10.1016/J.INDCROP.2012.12.025
   2006, FOOD CHEM, V94, P529, DOI DOI 10.1016/J.FOODCHEM.2004.11.042
   2015, SOUTHEAST ASIAN J TR, V46, P596
   2017, SAUDI J BIOL SCI, V24, P817, DOI DOI 10.1016/J.SJBS.2016.07.003
   2015, TROP MED INT HEALTH, V20, P685, DOI DOI 10.1111/TMI.12485
   2012, PARASITOL RES, V110, P195, DOI DOI 10.1007/S00436-011-2469-2
   2011, TROP BIOMED, V28, P343
NR 444
TC 40
Z9 41
U1 31
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2019
VL 193
BP 236
EP 271
DI 10.1016/j.actatropica.2019.01.019
PG 36
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HU6CS
UT WOS:000465366900034
PM 30711422
DA 2020-07-08
ER

PT J
AU Yao, Y
   Huo, T
   Lin, YL
   Nie, SY
   Wu, FR
   Hua, YD
   Wu, JY
   Kneubehl, AR
   Vogt, MB
   Rico-Hesse, R
   Song, YC
AF Yao, Yuan
   Huo, Tong
   Lin, Yi-Lun
   Nie, Shenyou
   Wu, Fangrui
   Hua, Yuanda
   Wu, Jingyu
   Kneubehl, Alexander R.
   Vogt, Megan B.
   Rico-Hesse, Rebecca
   Song, Yongcheng
TI Discovery, X-ray Crystallography and Antiviral Activity of Allosteric
   Inhibitors of Flavivirus NS2B-NS3 Protease
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID ZIKA VIRUS; MEDICINAL CHEMISTRY; POTENT INHIBITORS; CRYSTAL-STRUCTURE;
   DENGUE; ACTIVATION; BRAZIL
AB Flaviviruses, including dengue, West Nile and recently emerged Zika virus, are important human pathogens, but there are no drugs to prevent or treat these viral infections. The highly conserved Flavivirus NS2B-NS3 protease is essential for viral replication and therefore a drug target. Compound screening followed by medicinal chemistry yielded a series of drug-like, broadly active inhibitors of Flavivirus proteases with IC50 as low as 120 nM. The inhibitor exhibited significant antiviral activities in cells (EC68: 300-600 nM) and in a mouse model of Zika virus infection. X-ray studies reveal that the inhibitors bind to an allosteric, mostly hydrophobic pocket of dengue NS3 and hold the protease in an open, catalytically inactive conformation. The inhibitors and their binding structures would be useful for rational drug development targeting Zika, dengue and other Flaviviruses.
C1 [Yao, Yuan; Huo, Tong; Lin, Yi-Lun; Nie, Shenyou; Wu, Fangrui; Hua, Yuanda; Wu, Jingyu; Song, Yongcheng] Baylor Coll Med, Dept Pharmacol & Chem Biol, 1 Baylor Plaza, Houston, TX 77030 USA.
   [Kneubehl, Alexander R.; Vogt, Megan B.; Rico-Hesse, Rebecca] Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.
   [Vogt, Megan B.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA.
RP Song, YC (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM ysong@bcm.edu
RI Nie, Shenyou/AAL-2447-2020
FU USAMRAA of the U.S. Department of Defense [W81XWH-18-1-0368]; Cancer
   Prevention and Research Institute of Texas [RP150129, RP180177];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI099483, R01AI098715]
FX We thank the staff at the beamline 19-ID/-BM, Structural Biology Center
   at the Advanced Photon Source for assistance in X-ray data collection.
   This work was supported by a grant (W81XWH-18-1-0368) from USAMRAA of
   the U.S. Department of Defense and grants (RP150129 and RP180177) from
   Cancer Prevention and Research Institute of Texas to Y.S., NIH grants
   R01AI099483 and R01AI098715 to R.R.-H.
CR Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Su XC, 2009, FEBS J, V276, P4244, DOI 10.1111/j.1742-4658.2009.07132.x
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wu FR, 2016, J MED CHEM, V59, P253, DOI 10.1021/acs.jmedchem.5b01361
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   2003, AM J TROP MED HYG, V68, P539
NR 28
TC 11
Z9 12
U1 5
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 1
PY 2019
VL 141
IS 17
BP 6832
EP 6836
DI 10.1021/jacs.9b02505
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA HW9CJ
UT WOS:000466987900010
PM 31017399
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rutter, S
   Snyder, EL
AF Rutter, Sara
   Snyder, Edward L.
TI How do we horizontal ellipsis integrate pathogen reduced platelets into
   our hospital blood bank inventory?
SO TRANSFUSION
LA English
DT Article
ID PLASMA COMPONENTS; INACTIVATION; AMOTOSALEN; TRANSFUSION; SAFETY;
   IRRADIATION
AB For more than 50 years there has been an ongoing effort to combat transfusion-transmitted infections and provide patients with the safest possible blood. This initiative has driven much of the research within the transfusion community. Initial methods included screening donors for travel histories to banned areas and for high-risk behaviors, but pathogen-specific assays performed at the collection and manufacturing sites also have become key factors in assuring blood safety. Many of these have focused on donor and laboratory-based screening for transfusion-transmitted diseases, as evidenced by the hepatitis and human immunodeficiency virus screening in the 1970s, 1980s, and 1990s. More recently, this effort has expanded to develop donor screening assays to identify other blood-borne pathogens, such as Zika and West Nile viruses and Babesia. Bacterial contamination of units of platelets (PLTs), however, remains a significant concern. In recent years, the Food and Drug Administration has approved rapid tests to identify bacterially contaminated PLT units in the blood bank before transfusion. Other supplemental methods have been developed, however, that aim to inactivate blood-borne pathogen(s) present in the blood product, rather than to rely on our ability to identify and interdict contaminated and infected components. Pathogen reduction technology, as this is referred to, provides a proactive way to further reduce the risk posed by transfusion-transmitted infections.
C1 [Rutter, Sara; Snyder, Edward L.] Yale Univ, Sch Med, Div Transfus Med, Dept Lab Med, New Haven, CT 06511 USA.
RP Snyder, EL (corresponding author), Yale Univ, Sch Med, Yale New Haven Hosp, Blood Bank PS-329D,20 York St, New Haven, CT 06511 USA.
EM edward.snyder@yale.edu
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001863]
CR Agence Nationale de securite du medicament et des produits de sante, 2014, RAPP ACT HEM 2013
   Amato M, 2017, VOX SANG, V112, P47, DOI 10.1111/vox.12456
   Amsler L, 2017, HAEMOVIGILANCE ANN R
   Amsler L, 2016, HAEMOVIGILANCE ANN R
   Amsler L, 2014, HAEMOVIGILANCE ANN R
   Cazenave JP, 2010, TRANSFUSION, V50, P1210, DOI 10.1111/j.1537-2995.2009.02579.x
   Cerus Corporation, 2015, INTERCEPT BLOOD SYST
   Ciaravino V, 2001, HUM EXP TOXICOL, V20, P533, DOI 10.1191/096032701718120319
   Corash L, 2016, TRANSFUSION, V56, pS29, DOI 10.1111/trf.13530
   Corash L, 2011, BLOOD, V117, P1014, DOI 10.1182/blood-2010-06-293399
   Garban F, 2018, JAMA ONCOL, V4, P468, DOI 10.1001/jamaoncol.2017.5123
   GEHRIE E, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   GOKHALE A, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   GRAMINSKE S, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   Grass JA, 1998, BLOOD, V91, P2180, DOI 10.1182/blood.V91.6.2180.2180_2180_2188
   GUREVICH I, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   Jacquot C, 2018, TRANSFUSION, V58, P2095, DOI 10.1111/trf.14811
   Kacker S, 2019, TRANSFUSION, V59, P1291, DOI 10.1111/trf.15139
   Knutson F, 2015, VOX SANG, V109, P343, DOI 10.1111/vox.12287
   Lam S, 2007, TRANSFUSION, V47, p131A
   Lin L, 2005, TRANSFUSION, V45, P1610, DOI 10.1111/j.1537-2995.2005.00554.x
   Luban NLC, 2000, TRANSFUSION, V40, P348, DOI 10.1046/j.1537-2995.2000.40030348.x
   MARIA FS, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   McCullough J, 2015, TRANSFUSION, V55, P2312, DOI 10.1111/trf.13149
   Mundt JM, 2014, PHOTOCHEM PHOTOBIOL, V90, P957, DOI 10.1111/php.12311
   NGUYEN J, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   Nussbaumer W, 2017, VOX SANG, V112, P249, DOI 10.1111/vox.12489
   PELSZYNSKI MM, 1994, BLOOD, V83, P1683
   Pinna D, 2005, TRANSFUSION MED, V15, P269, DOI 10.1111/j.0958-7578.2005.00588.x
   PRICHARD A, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   Prioli KM, 2018, APPL HEALTH ECON HEA, V16, P889, DOI 10.1007/s40258-018-0409-3
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Rentas FJ, 2004, TRANSFUSION, V44, p104A
   Sampson-Johannes A, 2003, TRANSFUSION, V43, p83A
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Schulz W, 2019, J PEDIAT
   Seltsam A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00219
   Setlow RB, 1992, IRRADIATION BLOOD CO, P1
   Stokowski Laura A, 2011, Adv Neonatal Care, V11, pS10, DOI 10.1097/ANC.0b013e31822ee62c
   TRAN J, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
   U.S. Food and Drug Administration, 2018, BACT RISK CONTR STRA
   von Goetz M, 2018, TRANSFUSION, V58, p65A
   Vossoughi S, 2018, TRANSFUSION, V58, P60, DOI 10.1111/trf.14359
   WEINER E, 2019, TRANSFUSION S2, V11, P13, DOI DOI 10.1111/TRF.14903
NR 44
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAY
PY 2019
VL 59
IS 5
BP 1628
EP 1636
DI 10.1111/trf.15241
PG 9
WC Hematology
SC Hematology
GA HX7IP
UT WOS:000467578600004
PM 30883807
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, H
   Kayano, T
   Nishiura, H
AF Lee, Hyojung
   Kayano, Taishi
   Nishiura, Hiroshi
TI Predicting congenital rubella syndrome in Japan, 2018-2019
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Rubella virus; Statistical model; Forecasting; Outbreak; Epidemiology;
   Prediction; Japan
ID SAO-PAULO; VACCINATION; INFECTION; ZIKA; SEROPREVALENCE; ELIMINATION;
   EPIDEMIC; MEASLES; BRAZIL; RISK
AB Objectives: A rubella epidemic has been ongoing in Japan since August 2018. In the present study, we aimed to predict the likely size of a congenital rubella syndrome (CRS) epidemic during 2018-19.
   Methods: The expected number of CRS cases was estimated using an integral equation based on age-specific incidence of rubella among adult women, the time delay from gestational age of infection to diagnosis of CRS, and distribution of the mothers' age at delivery. We used epidemic data during 2012-14 to parameterize the model and applied this in the prediction for 2018-19.
   Results: In analyzing the 2012-14 epidemic data, the mean delay from the mother's infection to diagnosis was estimated at 24.2 weeks (95% confidence interval (CI): 20.7, 28.1). Applying the parameterized model, together with the more than 480 rubella cases in women in 2018 as well as delayed mother's age at delivery in 2017, we determined that the expected number of CRS cases would be 9.7 (95% CI: 6.5, 12.5) cases. As the epidemic is ongoing, the cumulative number of CRS cases could potentially reach 96.8 (95% CI: 65.3, 125.5) cases, if rubella cases in adult women rose to 10 times the number by week 49 in 2018.
   Conclusions: CRS is expected to occur an average of 24 weeks following the mother's infection with rubella virus. Accounting for an increase to 650 cases in women by week 5 in 2019, the expected number of CRS cases during 2018-19 has already exceeded 13 cases, as of week 5 in 2019. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Lee, Hyojung; Kayano, Taishi; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Lee, Hyojung; Kayano, Taishi; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
RP Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
EM nishiurah@med.hokudai.ac.jp
OI KAYANO, TAISHI/0000-0002-1884-9200
FU JSPSMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of Science; Japan Agency for
   Medical Research and Development (AMED)Japan Agency for Medical Research
   and Development (AMED) [JP18fk0108050, JP18fk0108066]; Japan Society for
   the Promotion of Science (JSPS) KAKENHIMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [16KT0130, 16K15356, 17H04701, 17H05808, 18H04895, 18H06385]; Inamori
   Foundation; Japan Science and Technology Agency (JST) CREST program
   [JPMJCR1413]
FX This work was supported as follows. HL received funding from the JSPS
   Program for Advancing Strategic International Networks to Accelerate the
   Circulation of Talented Researchers. HN received funding from the Japan
   Agency for Medical Research and Development (AMED) [grant number
   JP18fk0108050 and JP18fk0108066]; the Japan Society for the Promotion of
   Science (JSPS) KAKENHI [grant numbers, HN: 16KT0130, 16K15356, 17H04701,
   17H05808, and 18H04895], [grant number HL: 18H06385], the Inamori
   Foundation, and the Japan Science and Technology Agency (JST) CREST
   program [grant number JPMJCR1413]. The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079
   Berger BE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-340
   Best JM, 2005, J INFECT DIS, V192, P1890, DOI 10.1086/497607
   Chua YX, 2015, VACCINE, V33, P3150, DOI 10.1016/j.vaccine.2015.04.003
   Cutts FT, 2013, EXPERT REV VACCINES, V12, P917, DOI 10.1586/14760584.2013.814847
   Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176
   Duszak RS, 2009, OPTOMETRY, V80, P36, DOI 10.1016/j.optm.2008.03.006
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gao ZH, 2013, VACCINE, V31, P691, DOI 10.1016/j.vaccine.2012.11.043
   Giambi C, 2017, EUR J PEDIATR, V176, P955, DOI 10.1007/s00431-017-2935-7
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   Kinoshita R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009928
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MENSER MA, 1978, LANCET, V1, P57
   Miyakawa M, 2014, VACCINE, V32, P1192, DOI 10.1016/j.vaccine.2013.08.076
   Mori Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01513
   Mossong J, 2008, EPIDEMIOL INFECT, V136, P1059, DOI 10.1017/S0950268807009661
   National Institute of Infectious Diseases (NIID), 2014, INFECT AGENTS SURVEI
   National Institute of Infectious Diseases (NIID), 2018, EM INF RAP INCR RUB
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2015, INT J INFECT DIS, V38, P16, DOI 10.1016/j.ijid.2015.07.006
   OHKUSA Y, 2014, PLOS ONE, V6, DOI DOI 10.1371/CURRENTS.OUTBREAKS.8C74272F4348781C5D01C81E6150C2F7
   Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462
   Saito MM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040572
   Statistics Bureau Ministry of Internal Affairs and Communications, 2018, VIT STAT VIT STAT JA
   Tanaka Y, 2017, HUM VACC IMMUNOTHER, V13, P1859, DOI 10.1080/21645515.2017.1327929
   Tang JW, 2003, PRENATAL DIAG, V23, P509, DOI 10.1002/pd.631
   Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160
   Wesolowski A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1101
   Zanetta DMT, 2003, VACCINE, V21, P3795, DOI 10.1016/S0264-410X(03)00315-3
NR 32
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAY
PY 2019
VL 82
BP 1
EP 5
DI 10.1016/j.ijid.2019.02.021
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA HW1DZ
UT WOS:000466424400001
PM 30807870
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Carvalho-Sauer, R
   Costa, MDN
   Barreto, FR
   Teixeira, MG
AF Carvalho-Sauer, Rita
   Nascimento Costa, Maria da Conceicao
   Barreto, Florisneide R.
   Teixeira, Maria Gloria
TI Congenital Zika Syndrome: Prevalence of low birth weight and associated
   factors. Bahia, 2015-2017
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Low birth weight; Zika virus; Congenital anomaly; Microcephaly; Risk
   factors; Prevalence
ID VIRUS; BRAZIL
AB Objective: The clinical manifestations of Congenital Zika Syndrome (CZS) are not fully known, for example its effect on birth weight. This study estimated the prevalence of low birth weight (LBW) among children with CZS, and identified associated factors.
   Methods: Cross-sectional study involving 393 children with CZS living in Bahia, Brazil, in 2015-2017. Official Information Systems were the data sources. We calculated LBW prevalence and applied Logistic Regression to assess associated factors.
   Results: Prevalence of LBW among children with CZS was 37.2%. Excluding pre-term births the proportion was 29.9%. This prevalence was 81.0% and 28.0% among children born pre-term and term/post term, respectively. There was a higher proportion (53.2%) in female children, and in those delivered by cesarean section (51.4%). Most mothers were single/separated (62.1%) and had a low level of schooling (70.0%). In the model adjusted for type of delivery, preterm births presented a 10.8 times greater chance of presenting LBW than term/post-term ones. However, the Confidence Interval was very wide. Adjusting for gestation duration, children born by cesarean section had a 1.63 higher probability of presenting LBW than those born by vaginal delivery (OR = 1,63; CI95% 1.01, 2.63).
   Conclusions: The prevalence of LBW among children with CZS was very elevated, both preterm and term/post-term live births. This can contribute to increasing their risk for morbimortality. The association of LBW with prematurity and cesarean deliveries is known, but in children with CZS, it has not been clarified whether or not this is related to pathological conditions caused by fetal infection by the Zika virus. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Carvalho-Sauer, Rita] Secretaria Saude Estado Bahia, Setor Vigilancia Epidemiol Nucleo Reg Saude Leste, Ave Esperanca 406, BR-44570670 Santo Antonio De Jesus, BA, Brazil.
   [Nascimento Costa, Maria da Conceicao; Barreto, Florisneide R.; Teixeira, Maria Gloria] Univ Fed Bahia, Inst Saude Colet, Rua Basilio Gama S-N, BR-40110040 Salvador, BA, Brazil.
RP Teixeira, MG (corresponding author), Univ Fed Bahia, Inst Saude Colet, Rua Basilio Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM ritacarvalhosauer@gmail.com; mcncosta@ufba.br; florisneide@gmail.com;
   magloria@ufba.br
RI Rita, Carvalho-Sauer/W-5822-2019; Teixeira, Maria Gloria/G-4808-2012
OI Teixeira, Maria Gloria/0000-0003-3318-3408
CR [Anonymous], 2015, B EP SECR VIG SAUD
   Baid R, 2017, INT J RES MED SCI, V5, P1161
   Bismarck-Nasr EM, 2008, REV BRAS CRESCIMENTO, V18, P98
   Brasil M da S, CONSOLIDACAO SISTEMA
   Brasil. Ministerio da Saude, 2017, OR INT VIG AT SAUD A
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dammann O, 1996, DEV MED CHILD NEUROL, V38, P97
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   DIVEP/ SUVISA/ SESAB, 2017, 052017 DIVEPSUVISASE
   Faundes A, 1991, Cad Saude Publica, V7, P150, DOI 10.1590/S0102-311X1991000200003
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s
   Instituto Brasileiro de Geografia e Estatistica (IBGE) B, 2018, PROJ POP SEX ID IND
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Marrs JA, 2011, REV PAUL PEDIATR, V37, P9, DOI DOI 10.1590/S0103-05822011000300022
   MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mysorekar IU, 2016, NEW ENGL J MED, P1
   ORIOLI IM, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5018
   da Silva TRSR, 2012, EINSTEIN-SAO PAULO, V10, P380, DOI 10.1590/S1679-45082012000300023
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Victora C., 2013, PESQUISA ESTIMAR PRE
   WHO P, 2017, ZIK SUSP CONF CAS RE
   World Health Organization WHO, 1980, WORLD HLTH STAT Q RE, V33, P197
NR 29
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAY
PY 2019
VL 82
BP 44
EP 50
DI 10.1016/j.ijid.2019.02.040
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA HW1DZ
UT WOS:000466424400011
PM 30831221
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Philip, C
   Novick, CG
   Novick, LF
AF Philip, Celeste
   Novick, Carole G.
   Novick, Lloyd F.
TI Local Transmission of Zika Virus in Miami-Dade County: The Florida
   Department of Health Rises to the Challenge
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE reproductive health; risk communication strategies; surveillance; vector
   control; Zika virus transmission
AB As early as 2015, Florida and Centers for Disease Control and Prevention (CDC) public health officials recognized the potential danger of Zika for US residents and visitors. The Zika virus, a mosquito-borne flavivirus, is transmitted through the bite of the Aedes aegypti mosquito. A physician in Miami-Dade notified the Florida Department of Health (DOH) of the first non-travel-related Zika case in the United States. A 23-year old pregnant woman had presented on July 7, 2016, at 23 weeks of gestation, with a 3-day history of fever, widespread pruritic rash, and sore throat. Three more cases, involving men, were reported in Dade and Broward counties. These notifications set into motion additional activities from the DOH's Zika Playbook: increased mosquito surveillance; collaboration with the CDC on recommendations for mosquito abatement techniques; and increased awareness of the risks of Zika. In August, the department reported that active transmission of Zika virus was occurring in one small area in Miami-Dade County known as Wynwood. Mosquito trapping in the area with local transmission identified large numbers of the Zika vector, Aedes aegypti females and a large number of mosquito larval sites. Control efforts included larviciding, eliminating standing water, and backpack and truck spraying of insecticides. A communication strategy was developed that addressed risk mitigation, public concerns over application of noxious pesticides, loss of tourist revenue, and reproductive issues. It was reported on December 28, 2016, that there had been 256 locally acquired cases of infection of Zika, 1011 travel-related cases, and 208 pregnant women with laboratory evidence of Zika. At the end of 2018, 2 years after active Zika virus transmission was controlled in Florida, there have been 101 reported cases of Zika during 2018 but none have been linked to local transmission.
C1 East Carolina Sch Med, Dept Publ Hlth, Greenville, NC USA.
RP Novick, LF (corresponding author), 70 Forest St 17D, Stamford, CT 06901 USA.
EM novickl@ecu.edu
CR [Anonymous], 2018, NPR
   [Anonymous], MIAMI HERALD
   [Anonymous], 2017, ZIK 2017 DO WE GO NE
   Centers for Disease Control and Prevention, AB ZIK
   Centers for Disease Control and Prevention, REC MAN REP ZIK VIR
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Florida Department of Health, 2016, ZIK UPD
   Florida Department of Health, 2016, DAILY ZIKA UPDA 0720
   Florida Department of Health, 2016, DAILY ZIKA UPDA 0810
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Riley K, 2016, AMA WIRE        1129, P1
   Viglucci A., 2017, MIAMI HERALD
   World Health Organization, WHO RESP ZIK VIR ZIK
NR 14
TC 3
Z9 3
U1 1
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD MAY-JUN
PY 2019
VL 25
IS 3
BP 277
EP 287
DI 10.1097/PHH.0000000000000990
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HU9CW
UT WOS:000465591700016
PM 30933006
DA 2020-07-08
ER

PT J
AU Warnecke, JM
   Lattwein, E
   Saschenbrecker, S
   Stocker, W
   Schlumberger, W
   Steinhagen, K
AF Warnecke, Jens M.
   Lattwein, Erik
   Saschenbrecker, Sandra
   Stoecker, Winfried
   Schlumberger, Wolfgang
   Steinhagen, Katja
TI Added value of IgA antibodies against Zika virus non-structural protein
   1 in the diagnosis of acute Zika virus infections
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Flavivirus; Guillain-Barre syndrome; Microcephaly; NS1; Zika virus
ID RESPONSES; SERUM; KINETICS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus posing a public health threat due to its association with neurological complications in newborns and adults. In flavivirus-endemic areas, coming mosquito seasons will require the differentiation of primary versus secondary and acute versus past ZIKV/flavivirus infections. This is complicated by two major difficulties: [i] secondary infections often present with low or undetectable titres of specific IgM and with early-positive IgG, [ii] previous flavivirus infection(s) or vaccinations cause elevated cross-reactivities. Here, we analysed the anti-ZIKV IgA, IgG, and IgM responses at different stages of infection in an endemic setting, scrutinising the diagnostic relevance of specific IgA. Anti-ZIKV antibodies were measured by ELISA based on ZIKV non-structural protein 1 (NS1) in paired sera from 31 patients with suspected primary or (flavivirus-primed) secondary ZIKV infection. The control panel comprised samples from 136 DENV-infected patients. Among ZIKV samples collected 8-16 days after symptom onset, ELISA sensitivities for detecting anti-ZIKV NS1 IgA, IgG, and IgM were 93.5%, 100%, and 48.4%, respectively. The proportion of cases with negative IgM but positive IgA was higher in suspected secondary (61.9%) than in primary (30.0%) ZIKV infections. Combined IgA/IgM detection yielded a sensitivity of 100% at a specificity of 97.1%. In conclusion, at time points after PCR can detect the virus, the determination of anti-ZIKV NS1 IgA may improve the accuracy in diagnosing acute ZIKV infection in flavivirus-endemic regions in the context of both primary and secondary infection, especially when IgM is undetectable.
C1 [Warnecke, Jens M.; Lattwein, Erik; Saschenbrecker, Sandra; Stoecker, Winfried; Schlumberger, Wolfgang; Steinhagen, Katja] Euroimmun AG, Inst Expt Immunol, Seekamp 31, D-23560 Lubeck, Germany.
RP Warnecke, JM (corresponding author), Euroimmun AG, Inst Expt Immunol, Seekamp 31, D-23560 Lubeck, Germany.
EM j.warnecke@euroimmun.de
FU Euroimmun
FX This study was funded by Euroimmun.
CR Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Borena W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178175
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, MEM REV DIAGN TEST Z
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Groen J, 1999, MICROBES INFECT, V1, P1085, DOI 10.1016/S1286-4579(99)00208-7
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Saxena S. K., 2018, TRAVEL MED INFECT DI
   Shu PY, 2000, J MED VIROL, V62, P224, DOI 10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C
   Steinhagen K, 2016, INT J INFECT DIS, V53, P93, DOI 10.1016/j.ijid.2016.11.235
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   van Wyngaardt W, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-6
   Vazquez S, 2005, J CLIN VIROL, V33, P132, DOI 10.1016/j.jcv.2004.10.013
   WHO, 2017, ZIK SIT REP
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhao LB, 2018, J NAVIGATION, V71, P1210, DOI 10.1017/S0373463318000188
NR 36
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAY
PY 2019
VL 267
BP 8
EP 15
DI 10.1016/j.jviromet.2019.02.005
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA HU6CF
UT WOS:000465365600002
PM 30779938
OA Other Gold
DA 2020-07-08
ER

PT J
AU Moura-Neto, JA
   Silva, CAB
   Moura, AF
   Suassuna, JHR
AF Moura-Neto, Jose A.
   Braga Silva, Cassiano Augusto
   Moura, Ana Flavia
   Rocco Suassuna, Jose Hermogenes
TI Emergent Arboviruses and Renal Transplantation: A Global Challenge
SO KIDNEY INTERNATIONAL REPORTS
LA English
DT Review
DE arbovirus; immunosuppression; kidney transplantation; transplantation
ID WEST-NILE-VIRUS; YELLOW-FEVER VACCINATION; DENGUE HEMORRHAGIC-FEVER;
   ZIKA VIRUS; NEW-YORK; KIDNEY-TRANSPLANTATION; CHIKUNGUNYA INFECTION;
   VIRAL-INFECTION; UNITED-STATES; BLOOD-DONORS
AB In recent years, Zika, Chikungunya, Dengue, West Nile Fever, and Yellow Fever epidemics have generated some concerns. Besides difficulties related to vector control, there are challenges related to behavior of pathologies not yet fully understood. The transplanted population requires additional care due to immunosuppressive drugs. Furthermore, the potential risk of transmission during donation is another source of uncertainty and generates debate among nephrologists in transplant centers. Do the clinical outcomes and prognoses of these infections tend to be more aggressive in this population? Is there a risk of viral transmission via kidney donation? In this review article, we address these issues and discuss the relationship between arbovirus and renal transplantation.
C1 [Moura-Neto, Jose A.; Braga Silva, Cassiano Augusto; Moura, Ana Flavia] Grp CSB, Dept Nephrol, Salvador, BA, Brazil.
   [Rocco Suassuna, Jose Hermogenes] Univ Estado Rio De Janeiro, Clin & Acad Unit Nephrol, Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil.
RP Moura-Neto, JA (corresponding author), Grp CSB, Rua Maragogipe,38,Rio Vermelho, BR-41940250 Salvador, BA, Brazil.
EM mouraneto@grupocsb.com
RI Suassuna, Jose/N-5074-2014
OI Suassuna, Jose/0000-0002-4720-5391
CR Azevedo LS, 2012, TRANSPL INFECT DIS, V14, P237, DOI 10.1111/j.1399-3062.2011.00686.x
   Azevedo LS, 2007, TRANSPLANTATION, V84, P792, DOI 10.1097/01.tp.0000280547.91617.25
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chacko B, 2004, TRANSPLANTATION, V77, P634, DOI 10.1097/01.TP.0000114608.44000.D7
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Costa SD, 2015, AM J TROP MED HYG, V93, P394, DOI 10.4269/ajtmh.15-0038
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darrigo LG, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0612-2
   de Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, V353, pi3182
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Duchini A, 2003, CLIN MICROBIOL REV, V16, P357, DOI 10.1128/CMR.16.3.357-364.2003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   ECDC, 2017, RAP RISK ASS CLUST A
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Maia SHF, 2015, REV SOC BRAS MED TRO, V48, P783, DOI 10.1590/0037-8682-0205-2015
   Fernandes Paula Frassinetti Castelo Branco Camurca, 2017, World J Transplant, V7, P57, DOI 10.5500/wjt.v7.i1.57
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Girao ES, 2017, TRANSPL P, V49, P2076, DOI 10.1016/j.transproceed.2017.07.004
   Gowda R, 2004, EUR J HAEMATOL, V72, P299, DOI 10.1111/j.1600-0609.2004.00218.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grossi PA, 2009, AM J TRANSPLANT, V9, pS19, DOI 10.1111/j.1600-6143.2009.02889.x
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Handler MZ, 2017, INT J DERMATOL, V56, pe19, DOI 10.1111/ijd.13439
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   da Mota LMH, 2009, REV SOC BRAS MED TRO, V42, P23, DOI 10.1590/S0037-86822009000100006
   Ho YL, 2008, AIDS PATIENT CARE ST, V22, P65, DOI 10.1089/apc.2007.0059
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   L'Huillier AG, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14005
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lambert SL, 2016, PEDIATR TRANSPLANT, V20, P836, DOI 10.1111/petr.12768
   Levi ME, 2017, CURR OPIN INFECT DIS, V30, P340, DOI 10.1097/QCO.0000000000000384
   Lindsey NP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw045
   Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Liu LE, 2017, DISASTER MED PUBLIC, V11, P290, DOI 10.1017/dmp.2016.144
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Morris MI, 2018, TRANSPLANTATION, V102, pS42, DOI 10.1097/TP.0000000000002011
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moura-Neto JA, 2017, KIDNEY INT REP, V2, P1250, DOI 10.1016/j.ekir.2017.06.003
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nasim A, 2013, TRANSPL INFECT DIS, V15, P516, DOI 10.1111/tid.12114
   Nemes Z, 2004, EMERG INFECT DIS, V10, P1880, DOI 10.3201/eid1010.040464
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Pan American Health Organization/ World Health Organization, 2018, EP AL DENG
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Pierrotti L, 2016, 26 INT C TRANSPL SOC
   Pierrotti LC, 2017, INT J INFECT DIS, V64, P96, DOI 10.1016/j.ijid.2017.09.009
   Pistone T, 2010, CURR HIV RES, V8, P461, DOI 10.2174/157016210793499277
   Receveur M C, 2000, Clin Infect Dis, V31, pE7, DOI 10.1086/314031
   Renaud CJ, 2007, NEPHROLOGY, V12, P305, DOI 10.1111/j.1440-1797.2007.00785.x
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Rosso F, 2018, BRAZ J INFECT DIS, V22, P63, DOI 10.1016/j.bjid.2018.01.001
   Rust RS, 2012, SEMIN PEDIATR NEUROL, V19, P130, DOI 10.1016/j.spen.2012.03.002
   Scheinberg M, 2010, ARTHRIT CARE RES, V62, P896, DOI 10.1002/acr.20045
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Simkins J, 2018, AM J TRANSPLANT, V18, P731, DOI 10.1111/ajt.14582
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Soares CN, 2010, ARQ NEURO-PSIQUIAT, V68, P761, DOI 10.1590/S0004-282X2010000500016
   Sociedade Brasileira de Infectologia, 2017, FEBR AM INF PROF SAU
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Subbiah A, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12875
   Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Tattevin P, 2004, AIDS, V18, P825, DOI 10.1097/00002030-200403260-00020
   Thomas ETA, 2019, NEPHROLOGY, V24, P564, DOI 10.1111/nep.13265
   Trubiano JA, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw058
   Veit O, 2009, CLIN INFECT DIS, V48, P659, DOI 10.1086/597006
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weerakkody RM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0428-y
   Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409
   Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097
   Winston DJ, 2014, TRANSPLANTATION, V97, P881, DOI 10.1097/TP.0000000000000024
   Wiwanitkit V, 2012, TRANSPL INFECT DIS, V14, P330, DOI 10.1111/j.1399-3062.2012.00725.x
   World Health Assotiation, CHIK FACT SHEET
   Wyplosz B, 2013, AM J TRANSPLANT, V13, P2458, DOI 10.1111/ajt.12338
   Yax JA, 2009, J TRAVEL MED, V16, P365, DOI 10.1111/j.1708-8305.2009.00336.x
   2012, TRANSPL INFECT DIS, V14, P163, DOI DOI 10.1111/J.1399-3062.2011.00699.X
   2016, J INFECT DIS, V213, P694, DOI DOI 10.1093/INFDIS/JIV326
NR 109
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2468-0249
J9 KIDNEY INT REP
JI Kidney Int. Rep.
PD MAY
PY 2019
VL 4
IS 5
BP 647
EP 655
DI 10.1016/j.ekir.2019.02.013
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA HW6PT
UT WOS:000466813000005
PM 31080919
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leyser, M
   Marques, FJP
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda J. P.
   Nascimento, Osvaldo J. M.
TI A multilevel-based research framework on congenital Zika syndrome
SO PEDIATRIC RESEARCH
LA English
DT Editorial Material
C1 [Leyser, Marcio] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   [Marques, Fernanda J. P.; Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Antonio Pedro Univ Hosp, Dept Neurol, Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
EM marcio-leyser@uiowa.edu
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   2018, CHILDS NERV SYST, V34, P63
   2018, NAT MICROBIOL, V3, P1214
NR 7
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2019
VL 85
IS 6
BP 745
EP 746
DI 10.1038/s41390-019-0349-0
PG 2
WC Pediatrics
SC Pediatrics
GA HW0YI
UT WOS:000466408300005
PM 30791041
DA 2020-07-08
ER

PT J
AU Koh, XQ
   Chandran, NS
   Tambyah, PA
AF Koh, Xuan Qi
   Chandran, Nisha Suyien
   Tambyah, Paul Anantharajah
TI Mucocutaneous Features of Zika-a Review
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika; Exanthem; Conjunctivitis; Flavivirus; Arbovirus; Rash
ID GUILLAIN-BARRE-SYNDROME; MALE SEXUAL TRANSMISSION; VIRUS-INFECTION;
   VAGINAL SECRETIONS; PATIENT; SEMEN; PERSISTENCE; TRAVEL; EPIDEMIC;
   DISEASE
AB Purpose of ReviewWe review the range of dermatological signs seen in Zika infection and the possible relationship between the rash and viremia. We also hoped to explore the utility of mucocutaneous manifestations in narrowing the differential diagnosis from other similar flaviviruses.Recent FindingsClinical manifestations of Zika infection share many similarities with other mosquito-borne viruses such as dengue. These include non-specific symptoms such as a fever, rash, arthralgia, myalgia, and conjunctivitis. The morphology of the rash in Zika infection is not very specific and commonly described as maculopapular and centrifugal that usually extends to become diffuse.SummaryWe reviewed 123 publications, encompassing a total of 368 Zika cases. One hundred seven cases with rash had sufficient data for detailed analysis. 8.4% of cases with rash had hemorrhagic manifestations such as palatal petechiae and bleeding ulcers. Only 20 reported cases were tested for viremia during presence of rash, and 70.6% of these cases were positive. While mucocutaneous complications are common in Zika infection, more research is necessary to determine the impact of rash on diagnosis, prognosis, and transmissibility in Zika infection.
C1 [Koh, Xuan Qi] Natl Univ Hlth Syst, NUHS Residency Program, Med Affairs Educ Internal Med, 1E Kent Ridge Rd,NUHS Tower Block,Level 10, Singapore 119228, Singapore.
   [Chandran, Nisha Suyien] Natl Univ Hlth Syst, Div Dermatol, Singapore, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med Infect Dis, Singapore, Singapore.
RP Koh, XQ (corresponding author), Natl Univ Hlth Syst, NUHS Residency Program, Med Affairs Educ Internal Med, 1E Kent Ridge Rd,NUHS Tower Block,Level 10, Singapore 119228, Singapore.
EM xuan_qi_koh@nuhs.edu.sg; nisha_suyien_chandran@nuhs.edu.sg;
   paul_anantharajah_tambyah@nuhs.edu.sg
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burillo-Martinez S, 2016, ACTAS DERMO-SIFILOGR, V107, P687, DOI 10.1016/j.ad.2016.04.012
   Cardona-Cardona AF, 2016, J INFECT PUBLIC HEAL, V9, P372, DOI 10.1016/j.jiph.2016.03.001
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Correa-Oliveira GE, 2017, REV BRAS PSIQUIATR, V39, P381, DOI 10.1590/1516-4446-2017-2308
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira MI, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860015, 10.1590/S1678-9946201860015]
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dobson JS, 2019, CLIN EXP DERMATOL, V44, P4, DOI 10.1111/ced.13733
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   He A, 2017, AM J CLIN DERMATOL, V18, P231, DOI 10.1007/s40257-016-0243-z
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kulkarni SA, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.10.008
   Kutsuna S, 2014, EURO SURVEILL, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Regadas VC, 2018, REV ASSOC MED BRAS, V64, P11, DOI 10.1590/1806-9282.64.01.11
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan CH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010044
   Tan JJL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09479-5
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   Xu BY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2032-y
   Yan G, 2018, EMERG INFECT DIS, V24, P1565, DOI 10.3201/eid2408.171883
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 109
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD MAY
PY 2019
VL 21
IS 5
AR 18
DI 10.1007/s11908-019-0671-z
PG 18
WC Infectious Diseases
SC Infectious Diseases
GA HW9OE
UT WOS:000467019600001
PM 31041548
DA 2020-07-08
ER

PT J
AU Orlov, AA
   Khvatov, EV
   Koruchekov, AA
   Nikitina, AA
   Zolotareva, AD
   Eletskaya, AA
   Kozlovskaya, LI
   Palyulin, VA
   Horvath, D
   Osolodkin, DI
   Varnek, A
AF Orlov, Alexey A.
   Khvatov, Evgeny V.
   Koruchekov, Alexander A.
   Nikitina, Anastasia A.
   Zolotareva, Anastasia D.
   Eletskaya, Anastasia A.
   Kozlovskaya, Liubov I.
   Palyulin, Vladimir A.
   Horvath, Dragos
   Osolodkin, Dmitry I.
   Varnek, Alexandre
TI Getting to Know the Neighbours with GTM: The Case of Antiviral Compounds
SO MOLECULAR INFORMATICS
LA English
DT Article
DE antiviral activity; generative topographic mapping; flaviviruses;
   enteroviruses; biological activity prediction
ID REPRODUCTION; INHIBITORS; SPACE; IDENTIFICATION; REPLICATION; DISCOVERY;
   FRAGMENT; DATABASE; GOLGI; MAP
AB Recent outbreaks of dangerous viral infections, such as Ebola virus disease, Zika fever, etc., are forcing the search for new antiviral compounds. Preferably, such compounds should possess broad-spectrum antiviral activity, as the development of drugs for the treatment of dozens of viral infections lacking specific treatment would require significant resources. Antiviral activity data present in public resources are very sparse and further investigation of structure-activity relationships is necessary. One of the strategies could be the investigation of chemical space around known active compounds and assessment of activity against closely related viruses in order to fill in the antiviral activity matrix. Here we present an investigation of antiviral activity using universal maps built with generative topographic mapping (GTM) algorithm. The GTM-based maps were used to find commercially available compounds in close proximity to already known compounds with anti-flaviviral and anti-enteroviral activities. Selected compounds were then assessed in cell-based assays against tick-borne encephalitis virus (TBEV) and a panel of enteroviruses. This approach allowed us to identify 23 new compounds showing anti-TBEV activity with EC50 values in micromolar and submicromolar range.
C1 [Orlov, Alexey A.; Khvatov, Evgeny V.; Koruchekov, Alexander A.; Nikitina, Anastasia A.; Zolotareva, Anastasia D.; Eletskaya, Anastasia A.; Kozlovskaya, Liubov I.; Osolodkin, Dmitry I.] FSBSI Chumakov FSC R&D IBP RAS, Moscow 108819, Russia.
   [Orlov, Alexey A.; Khvatov, Evgeny V.; Nikitina, Anastasia A.; Eletskaya, Anastasia A.; Palyulin, Vladimir A.; Osolodkin, Dmitry I.] Lomonosov Moscow State Univ, Moscow 119991, Russia.
   [Zolotareva, Anastasia D.; Kozlovskaya, Liubov I.; Osolodkin, Dmitry I.] Sechenov First Moscow State Med Univ, Moscow 119991, Russia.
   [Horvath, Dragos; Varnek, Alexandre] Univ Strasbourg, Fac Chem, Lab Chemoinformat, F-67081 Strasbourg, France.
RP Osolodkin, DI (corresponding author), FSBSI Chumakov FSC R&D IBP RAS, Moscow 108819, Russia.; Osolodkin, DI (corresponding author), Lomonosov Moscow State Univ, Moscow 119991, Russia.; Osolodkin, DI (corresponding author), Sechenov First Moscow State Med Univ, Moscow 119991, Russia.; Varnek, A (corresponding author), Univ Strasbourg, Fac Chem, Lab Chemoinformat, F-67081 Strasbourg, France.
EM dmitry_o@qsar.chem.msu.ru; varnek@unistra.fr
RI Horvath, Dragos/W-9789-2018; Osolodkin, Dmitry/D-6732-2011; Kozlovskaya,
   Liubov I/E-2368-2014
OI Horvath, Dragos/0000-0003-0173-5714; Osolodkin,
   Dmitry/0000-0002-0462-2945; Kozlovskaya, Liubov I/0000-0002-3029-1035
FU Russian Science FoundationRussian Science Foundation (RSF)
   [16-15-10307]; French Embassy in Moscow
FX Alexey Orlov thanks the French Embassy in Moscow for the Ostrogradskii
   fellowship for the purpose of visiting The Strasbourg University. The
   authors thank Dr. Fanny Bonachera and Yulia Rogova for the technical
   assistance. This work was supported by Russian Science Foundation
   (project no. 16-15-10307).
CR [Anonymous], 2017, CHEMAXON STAND 17 1
   Aralov AV, 2017, EUR J MED CHEM, V138, P293, DOI 10.1016/j.ejmech.2017.06.014
   Ashton M, 2002, QUANT STRUCT-ACT REL, V21, P598, DOI 10.1002/qsar.200290002
   Banie H, 2007, J MED CHEM, V50, P5984, DOI 10.1021/jm0704907
   Bauer L, 2017, CURR OPIN VIROL, V24, P1, DOI 10.1016/j.coviro.2017.03.009
   Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953
   BLAIR W, 2016, F1000RES, V5, P202, DOI DOI 10.12688/F1000
   Burgi JJ, 2014, ACS CHEM NEUROSCI, V5, P346, DOI 10.1021/cn4002297
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Dai D., 2014, [No title captured], Patent No. [WO2014089378A1, 2014089378]
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Gaspar HA, 2015, MOL INFORM, V34, P348, DOI 10.1002/minf.201400153
   Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074
   Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Johnson Mark A., 1990, CONCEPTS APPL MOL SI
   Kawakami J, 2004, CHEM PHARM BULL, V52, P751, DOI 10.1248/cpb.52.751
   Kireeva N, 2012, MOL INFORM, V31, P301, DOI 10.1002/minf.201100163
   Klimenko K, 2016, J CHEM INF MODEL, V56, P1438, DOI 10.1021/acs.jcim.6b00192
   Kozlovskaya LI, 2018, CHEMISTRYSELECT, V3, P2321, DOI 10.1002/slct.201703052
   Lorenz R J, 1973, Monogr Ser World Health Organ, P321
   National Center for Biotechnology Information, PUBCHEM BIOASSAY DAT
   Nikitina AA, 2019, DATABASE-OXFORD, DOI 10.1093/database/bay139
   Orlov AA, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700353
   Orlov AA, 2017, BIOORG MED CHEM LETT, V27, P1267, DOI 10.1016/j.bmcl.2017.01.040
   Orlov AA, 2016, MEDCHEMCOMM, V7, P495, DOI 10.1039/c5md00538h
   Osolodkin DI, 2015, EXPERT OPIN DRUG DIS, V10, P959, DOI 10.1517/17460441.2015.1060216
   Osolodkin DI, 2013, ACS MED CHEM LETT, V4, P869, DOI 10.1021/ml400226s
   Proskurin GV, 2018, EUR J MED CHEM, V155, P77, DOI 10.1016/j.ejmech.2018.05.040
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w
   Ruzek D, 2019, ANTIVIR RES, V164, P23, DOI 10.1016/j.antiviral.2019.01.014
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schneider P, 2009, CURR MED CHEM, V16, P258, DOI 10.2174/092986709787002655
   Sedenkova KN, 2018, MENDELEEV COMMUN, V28, P592, DOI 10.1016/j.mencom.2018.11.009
   Sedenkova KN, 2015, ORG BIOMOL CHEM, V13, P3406, DOI 10.1039/c4ob02649g
   Sidorov P, 2015, J COMPUT AID MOL DES, V29, P1087, DOI 10.1007/s10822-015-9882-z
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   van der Linden L, 2015, VIRUSES-BASEL, V7, P4529, DOI 10.3390/v7082832
   Varnek A, 2008, CURR COMPUT-AID DRUG, V4, P191, DOI 10.2174/157340908785747465
   Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965
   Yao-Zhong D., 2018, ARCH MICROBIOL, V200, P841
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
NR 47
TC 2
Z9 2
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1868-1743
EI 1868-1751
J9 MOL INFORM
JI Mol. Inf.
PD MAY
PY 2019
VL 38
IS 5
AR UNSP 1800166
DI 10.1002/minf.201800166
PG 12
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications;
   Mathematical & Computational Biology
SC Pharmacology & Pharmacy; Computer Science; Mathematical & Computational
   Biology
GA HW2HX
UT WOS:000466504900005
PM 30779427
DA 2020-07-08
ER

PT J
AU Hishiki, T
   Kato, F
   Nio, Y
   Watanabe, S
   Tan, NWW
   Yamane, D
   Miyazaki, Y
   Lin, CC
   Suzuki, R
   Tajima, S
   Lim, CK
   Saijo, M
   Hijikata, M
   Vasudevan, SG
   Takasaki, T
AF Hishiki, Takayuki
   Kato, Fumihiro
   Nio, Yasunori
   Watanabe, Satoru
   Tan, Nicole Wei Wen
   Yamane, Daisuke
   Miyazaki, Yasuyuki
   Lin, Chun-Chieh
   Suzuki, Rieko
   Tajima, Shigeru
   Lim, Chang-Kweng
   Saijo, Masayuki
   Hijikata, Makoto
   Vasudevan, Subhash G.
   Takasaki, Tomohiko
TI Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Antiviral; Stearoyl-CoA desaturase-1; Unsaturated fatty acids; Dengue
   virus; Flavivirus; Replicon
ID VIRAL REPLICATION; DENGUE; INHIBITOR; DISCOVERY; INFECTION; MODEL
AB Dengue virus (DENV) is the most prevalent human arthropod-borne virus and causes severe problems worldwide, mainly in tropical and sub-tropical regions. However, there is no specific antiviral drug against DENV infection. We and others recently reported that stearoyl-CoA desaturase-1 (SCD1) inhibitor showed potent suppression of hepatitis C virus replication. In this study, we examined the impact of SCD1 on DENV replication. We found that SCD1 inhibitors (MK8245 and #1716) dramatically suppressed DENV replication in a dose dependent manner without cytotoxicity. This anti-DENV efficacy was observed against all four DENV serotypes and other flaviviruses, including Zika virus and Japanese encephalitis virus. A subgenomic replicon system of DENV was used to confirm that SCD1 inhibitor suppressed viral RNA replication. Interestingly, exogenous supplementation of unsaturated fatty acids resulted in recovery of the DENV titer even in the presence of SCD1 inhibitor, suggesting that fatty acid biosynthesis contributes to DENV genome replication. These findings indicate that SCD1 is a novel host factor required for DENV replication, and SCD1 inhibitor is a potential candidate for treating dengue fever.
C1 [Hishiki, Takayuki; Yamane, Daisuke; Miyazaki, Yasuyuki; Lin, Chun-Chieh] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo, Japan.
   [Hishiki, Takayuki; Suzuki, Rieko] Kanagawa Prefectural Inst Publ Hlth, Dept Microbiol, 1-3-1 Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
   [Kato, Fumihiro; Tajima, Shigeru; Lim, Chang-Kweng; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Nio, Yasunori] Takeda Pharmaceut Co, Regenerat Med Unit, T CiRA, Tokyo, Japan.
   [Watanabe, Satoru; Tan, Nicole Wei Wen; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Hijikata, Makoto] Kyoto Univ, Lab Tumor Viruses, Inst Frontier Life & Med Sci, Kyoto, Japan.
   [Takasaki, Tomohiko] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa, Japan.
RP Hishiki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo, Japan.; Hishiki, T (corresponding author), Kanagawa Prefectural Inst Publ Hlth, Dept Microbiol, 1-3-1 Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
EM hishiki.4e6r@pref.kanagawa.jp
RI Song, Eun Joo/Z-5130-2019
OI Vasudevan, Subhash/0000-0002-5083-3831; Saijo,
   Masayuki/0000-0001-5458-7298; Shigeru, Tajima/0000-0002-1981-9062
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP17K08870];
   Research Program on Emerging and Re-emerging Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108035]; National
   Medical Research CouncilMedical Research Council UK (MRC)
   [NMRC/CBRG/0103/2016]; National Research Foundation
   [NRF2016NRF-CRP001-063]
FX We thank the members of the Department of Microbiology and Cell Biology
   (Tokyo Metropolitan Institute of Medical Science) and the Department of
   Microbiology (Kanagawa Prefectural Institute of Public Health) for
   helpful discussions. This work was supported by JSPS KAKENHI under Grant
   Number JP17K08870, and by the Research Program on Emerging and
   Re-emerging Infectious Diseases of the Japan Agency for Medical Research
   and Development (AMED) under Grant Number JP18fk0108035. The research
   was also supported by National Medical Research Council grant
   NMRC/CBRG/0103/2016 and National Research Foundation grant
   NRF2016NRF-CRP001-063 to SGV lab.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen S, 2017, ADV MECH ENG, V9, DOI 10.1177/1687814017728853
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gullberg RC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007261
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hishiki T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01674
   Ito M, 2007, J TRAVEL MED, V14, P233, DOI 10.1111/j.1708-8305.2007.00130.x
   Kato F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21582-9
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Kato F, 2014, JPN J INFECT DIS, V67, P209, DOI 10.7883/yoken.67.209
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Lyn RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04549
   Moi ML, 2014, J GEN VIROL, V95, P591, DOI 10.1099/vir.0.060384-0
   Nerome R, 2007, J GEN VIROL, V88, P2762, DOI 10.1099/vir.0.82941-0
   Nguyen LN, 2014, J VIROL, V88, P12311, DOI 10.1128/JVI.01678-14
   Nio Y, 2016, ANTIVIR RES, V132, P262, DOI 10.1016/j.antiviral.2016.07.003
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Oballa RM, 2011, J MED CHEM, V54, P5082, DOI 10.1021/jm200319u
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Tajima S, 2006, VIRUS RES, V116, P38, DOI 10.1016/j.virusres.2005.08.015
   Watanabe S, 2018, ACS INFECT DIS, V4, P1048, DOI 10.1021/acsinfecdis.8b00054
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   WHO, 2018, DENG SEV DENG
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
NR 32
TC 3
Z9 3
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2019
VL 165
BP 42
EP 46
DI 10.1016/j.antiviral.2019.03.002
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HV8TL
UT WOS:000466256900005
PM 30853381
DA 2020-07-08
ER

PT J
AU Rolph, MS
   Mahalingam, S
AF Rolph, Michael S.
   Mahalingam, Suresh
TI Zika's passage to India
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Rolph, Michael S.; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Gold Coast Campus, Gold Coast, Qld 4222, Australia.
RP Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Gold Coast, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
CR Khaiboullina S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02126
   Perkins TA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.51
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Vijaykumar Santosh, 2018, Indian J Med Ethics, V3, P240, DOI :10.20529/IJME.2018.027
   Watts A. G, 2018, J TRAVEL MED, V26
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   2017, INFECT CHEMOTHER, V49, P91, DOI DOI 10.3947/IC.2017.49.2.91
   2019, INFECT GENET EVOL, V69, P199, DOI DOI 10.1016/J.MEEGID.2019.01.026
   2019, TRAVEL MED INFECT DI, V27, P121, DOI DOI 10.1016/J.TMAID.2018.10.022
NR 10
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2019
VL 19
IS 5
BP 469
EP 470
DI 10.1016/S1473-3099(19)30169-0
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA HV5PS
UT WOS:000466036400024
PM 31034391
OA Bronze
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dara
TI Making Zika weaker
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2019
VL 19
IS 5
BP 475
EP 475
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HV5PS
UT WOS:000466036400043
DA 2020-07-08
ER

PT J
AU Grillet, ME
   Hernandez-Villena, JV
   Llewellyn, MS
   Paniz-Mondolfi, AE
   Tami, A
   Vincenti-Gonzalez, MF
   Marquez, M
   Mogollon-Mendoza, AC
   Hernandez-Pereira, CE
   Plaza-Morr, JD
   Blohm, G
   Grijalva, MJ
   Costales, JA
   Ferguson, HM
   Schwabl, P
   Hernandez-Castro, LE
   Lamberton, PHL
   Streicker, DG
   Haydon, DT
   Miles, MA
   Acosta-Serrano, A
   Acquattela, H
   Basanez, MG
   Benaim, G
   Colmenares, LA
   Conn, JE
   Espinoza, R
   Freilij, H
   Graterol-Gil, MC
   Hotez, PJ
   Kato, H
   Lednicky, JA
   Martinez, CE
   Mas-Coma, S
   Morris, JG
   Navarro, JC
   Ramirez, JL
   Rodriguez, M
   Urbina, JA
   Villegas, L
   Segovia, MJ
   Carrasco, HJ
   Crainey, JL
   Luz, SLB
   Moreno, JD
   Gonzalez, OON
   Ramirez, JD
   Alarcon-de Noya, B
AF Grillet, Maria E.
   Hernandez-Villena, Juan V.
   Llewellyn, Martin S.
   Paniz-Mondolfi, Alberto E.
   Tami, Adriana
   Vincenti-Gonzalez, Maria F.
   Marquez, Marilianna
   Mogollon-Mendoza, Adriana C.
   Hernandez-Pereira, Carlos E.
   Plaza-Morr, Juan D.
   Blohm, Gabriella
   Grijalva, Mario J.
   Costales, Jaime A.
   Ferguson, Heather M.
   Schwabl, Philipp
   Hernandez-Castro, Luis E.
   Lamberton, Poppy H. L.
   Streicker, Daniel G.
   Haydon, Daniel T.
   Miles, Michael A.
   Acosta-Serrano, Alvaro
   Acquattela, Harry
   Basanez, Maria G.
   Benaim, Gustavo
   Colmenares, Luis A.
   Conn, Jan E.
   Espinoza, Raul
   Freilij, Hector
   Graterol-Gil, Mary C.
   Hotez, Peter J.
   Kato, Hirotomo
   Lednicky, John A.
   Martinez, Clara E.
   Mas-Coma, Santiago
   Morris, J. Glen, Jr.
   Navarro, Juan C.
   Ramirez, Jose L.
   Rodriguez, Marlenes
   Urbina, Julio A.
   Villegas, Leopoldo
   Segovia, Maikell J.
   Carrasco, Hernan J.
   Crainey, James L.
   Luz, Sergio L. B.
   Moreno, Juan D.
   Gonzalez, Oscar O. Noya
   Ramirez, Juan D.
   Alarcon-de Noya, Belkisyole
TI Venezuela's humanitarian crisis, resurgence of vector-borne diseases,
   and implications for spillover in the region
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID CHAGAS-DISEASE; BOLIVAR STATE; CHIKUNGUNYA; MALARIA; VIRUS;
   MUNICIPALITY; INFECTION; EPIDEMIC; SIFONTES; MAYARO
AB In the past 5-10 years, Venezuela has faced a severe economic crisis, precipitated by political instability and declining oil revenue. Public health provision has been affected particularly. In this Review, we assess the impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouring countries. Between 2000 and 2015, Venezuela witnessed a 359% increase in malaria cases, followed by a 71% increase in 2017 (411 586 cases) compared with 2016 (240 613). Neighbouring countries, such as Brazil, have reported an escalating trend of imported malaria cases from Venezuela, from 1538 in 2014 to 3129 in 2017. In Venezuela, active Chagas disease transmission has been reported, with seroprevalence in children (<10 years), estimated to be as high as 12.5% in one community tested (n=64). Dengue incidence increased by more than four times between 1990 and 2016. The estimated incidence of chikungunya during its epidemic peak is 6975 cases per 100 000 people and that of Zika virus is 2057 cases per 100 000 people. The re-emergence of many vector-borne diseases represents a public health crisis in Venezuela and has the possibility of severely undermining regional disease elimination efforts. National, regional, and global authorities must take action to address these worsening epidemics and prevent their expansion beyond Venezuelan borders.
C1 [Grillet, Maria E.; Hernandez-Villena, Juan V.] Univ Cent Venezuela, Inst Zool Ecol Trop, Caracas, Venezuela.
   [Benaim, Gustavo] Univ Cent Venezuela, Inst Biol Expt, Caracas, Venezuela.
   [Colmenares, Luis A.; Graterol-Gil, Mary C.; Martinez, Clara E.; Rodriguez, Marlenes; Segovia, Maikell J.; Carrasco, Hernan J.; Gonzalez, Oscar O. Noya; Alarcon-de Noya, Belkisyole] Univ Cent Venezuela, Inst Med Trop, Caracas, Venezuela.
   [Llewellyn, Martin S.; Ferguson, Heather M.; Schwabl, Philipp; Lamberton, Poppy H. L.; Streicker, Daniel G.; Haydon, Daniel T.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
   [Paniz-Mondolfi, Alberto E.; Marquez, Marilianna; Mogollon-Mendoza, Adriana C.; Hernandez-Pereira, Carlos E.; Plaza-Morr, Juan D.; Blohm, Gabriella] Clin IDB Cabudare, Inst Invest Biomed IDB, Dept Trop Med & Infect Dis, Infect Dis Res Incubator & Zoonosis & Emerging Pa, Cabudare, Venezuela.
   [Paniz-Mondolfi, Alberto E.; Benaim, Gustavo] Inst Estudios Avanzados, Caracas, Venezuela.
   [Tami, Adriana; Vincenti-Gonzalez, Maria F.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Marquez, Marilianna; Mogollon-Mendoza, Adriana C.; Hernandez-Pereira, Carlos E.] Univ Centrooccidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto, Lara State, Venezuela.
   [Plaza-Morr, Juan D.] Univ Nacl Expt Francisco Miranda, Coll Med, Hlth Sci Dept, Punto Fijo, Falcon State, Venezuela.
   [Blohm, Gabriella; Lednicky, John A.; Morris, J. Glen, Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Emerging Pathogens Inst, Gainesville, FL USA.
   [Costales, Jaime A.] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Ctr Res Hlth Latin Amer, Quito, Ecuador.
   [Grijalva, Mario J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Infect & Trop Dis Inst, Athens, OH 45701 USA.
   [Hernandez-Castro, Luis E.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.
   [Streicker, Daniel G.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Miles, Michael A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.
   [Acosta-Serrano, Alvaro; Basanez, Maria G.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   [Acosta-Serrano, Alvaro; Basanez, Maria G.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool, Merseyside, England.
   [Acquattela, Harry] Venezuelan Natl Acad Med, Caracas, Venezuela.
   [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, Albany, NY USA.
   [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
   [Espinoza, Raul] Hosp Miguel Perez Carreno, Inst Venezolano Seguros Sociales, Caracas, Venezuela.
   [Freilij, Hector] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina.
   [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Kato, Hirotomo] Jichi Med Univ, Dept Infect & Immun, Div Med Zool, Shimotsuke, Tochigi, Japan.
   [Mas-Coma, Santiago] Univ Valencia, Dept Parasitol, Valencia, Spain.
   [Navarro, Juan C.] Univ Int SEK, Ctr Biodiversidad, Enfermedades Emergentes Salud Ambiental, Quito, Ecuador.
   [Ramirez, Jose L.] Inst Estudios Avanzados, Biotechnol Ctr, Caracas, Venezuela.
   [Urbina, Julio A.] Venezuelan Inst Sci Res, Caracas, Venezuela.
   [Villegas, Leopoldo] Asociac Civil Impacto Social, Tumeremo, Bolivar State, Venezuela.
   [Crainey, James L.; Luz, Sergio L. B.] Fiocruz MS, ILMD, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Moreno, Juan D.; Gonzalez, Oscar O. Noya] Serv Autonomo Inst Altos Estudios Dr Arnoldo Gaba, MPPS, Ctr Invest Campo Dr Francesco Vitanza, Tumeremo, Venezuela.
   [Ramirez, Juan D.] Univ Rosario, Programa Biol, Grp Invest Microbiol UR, Bogota, Colombia.
RP Llewellyn, MS (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
EM martin.llewellyn@glasgow.ac.uk
RI Kato, Hirotomo/A-4820-2012; Benaim, Gustavo/H-5552-2019; Lamberton,
   Poppy/AAR-3591-2020; Crainey, lee/K-8322-2019; Lednicky, John
   A/C-5678-2012; Vincenti-Gonzalez, Maria/Y-1087-2019; Acosta Serrano,
   Alvaro/L-5503-2015; Grijalva, Mario/U-8356-2018
OI Kato, Hirotomo/0000-0001-5429-9536; Benaim, Gustavo/0000-0002-9359-5546;
   Conn, Jan/0000-0002-5301-7020; CARRASCO, HERNAN
   JOSE/0000-0001-7500-0927; Acosta Serrano, Alvaro/0000-0002-2576-7959;
   Luz, Sergio Luiz Bessa/0000-0001-5887-7372; Segovia,
   Maikell/0000-0002-6015-8120; Ferguson, Heather/0000-0002-9625-5176;
   Grijalva, Mario/0000-0003-1964-1425; Hernandez Castro, Luis
   Enrique/0000-0002-2342-1655; Crainey, James Lee/0000-0001-6812-9327
FU Scottish Funding Council Global Challenges Research Fund, (Small Grants
   Fund) [SFC/AN/12/2017]
FX This work was supported in part by the Scottish Funding Council Global
   Challenges Research Fund, (Small Grants Fund SFC/AN/12/2017). The
   authors would like to dedicate this work to the memory of Xoan Noya
   Alarcon.
CR Abou Orm S, 2017, B MALARIOL SALUD AMB, V57, P15
   Ache Alberto, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P37, DOI 10.1590/S0036-46652001000100008
   Acquatella Harry, 2003, Gac Méd Caracas., V111, P136
   Alarcon de Noya BA, 2011, BIOMEDICA S3, V31, P64
   Anez N, 2004, MEM I OSWALDO CRUZ, V99, P781, DOI 10.1590/S0074-02762004000800001
   [Anonymous], 2018, DEJ PAIS OMS SIN MAP
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Avilán Rovira J. M, 2008, Gac Méd Caracas., V116, P1
   Barrera R, 1995, Bull Pan Am Health Organ, V29, P193
   Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Blohm GM, 2018, CLIN INFECT DIS, V67, P619, DOI 10.1093/cid/ciy224
   Bonfante-Cabarcas R, 2011, CAD SAUDE PUBLICA, V27, P1917, DOI 10.1590/S0102-311X2011001000005
   Botto C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1313-z
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Burki T, 2015, LANCET INFECT DIS, V15, P641, DOI 10.1016/S1473-3099(15)00011-0
   Cardozo E., 2018, MAL CHAGAS DEJA 8 MU
   Carrasco HJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0602-7
   Convit J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-289
   Cucunuba ZM, 2017, BMJ GLOB HEALTH, V2, DOI [10.1136/bmjgh-2017-000345, DOI 10.1136/BMJGH-2017-000345]
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Du RY, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006136
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foster PG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170758
   Franco L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.03.016
   Griffing SM, 2014, EMERG INFECT DIS, V20, P1697, DOI 10.3201/eid2010.130917
   Grillet María Eugenia, 2016, Bol Mal Salud Amb, V56, P97
   Grillet ME, 2018, SCIENCE, V359, P528, DOI 10.1126/science.aar5440
   Grillet ME, 2014, ACTA TROP, V129, P52, DOI 10.1016/j.actatropica.2013.10.007
   Guevara JR, 2016, ESTADISTICAS LEISHMA
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005423
   Incani RN, 2010, PARASITOLOGY, P161
   Instituto Nacional de Salud, 2017, EST SIVIGILA 2017
   Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x
   Lugo Dennis A, 2015, Rev. Fac. Cienc. Vet., V56, P042
   Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x
   Moreno JE, 2015, B MALARIOL SALUD AMB, V55, P117
   Moreno JE, 2014, B MALARIOL SALUD AMB, V54, P236
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Navarro JC, 2005, EMERG INFECT DIS, V11, P1907
   Nebehay S, 2018, REUTERS
   Noya Belkisyolé Alarcón de, 2015, Mem. Inst. Oswaldo Cruz, V110, P377, DOI 10.1590/0074-02760140285
   Noya O, 2015, EPIDEMIOLOGIA CLIN T
   Oletta JF, 2016, GAC MED CARACAS, V124, P50
   Oletta L JF, 2016, GAC MED CARACAS, V124, P122
   Pan American Health Organization, 2018, REP CAS DENG FEV AM
   Pan American Health Organization, 2014, EPIDEMIOLOGICAL 1229, V52
   Pan American Health Organization/World Health Organization, 2018, EP UPD MEASL
   Paniz-Mondolfi AE, 2019, EMERG INFECT DIS, V25, P625, DOI 10.3201/eid2504.181305
   Patino LH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005876
   Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4
   Pimentel R, 2014, REV PANAM SALUD PUBL, V36, P336
   Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6
   Rodriguez-Bonfante C, 2007, CAD SAUDE PUBLICA, V23, P1133, DOI 10.1590/S0102-311X2007000500015
   Rodriguez-Morales AJ, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12688
   Ruiz-Guevara R, 2016, VENEZUELA ENFERMEDAD
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862
   Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438
   Torres JR, 2015, IDCases, V2, P6, DOI 10.1016/j.idcr.2014.12.002
   Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077
   United Nations Refugee Agency, 2018, VEN FLEE LAT AM UNHC
   United States Agency for International Development, 2018, RES DEV PROGR REP
   Vincenti-Gonzalez MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24003-z
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Wade L, 2014, SCIENCE, V346, P287, DOI 10.1126/science.346.6207.287
   WHO, 2018, WORLD MAL REP 2018
   Wide Albina, 2016, Bol Mal Salud Amb, V56, P160
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024
   2009, AM J TROP MED HYG, V81, P1035, DOI DOI 10.4269/AJTMH.2009.08-0594
   2005, INT J PARASITOL, V35, P1379, DOI DOI 10.1016/J.IJPARA.2005.05.003
   2013, EMERG INFECT DIS, V19, P1098, DOI DOI 10.3201/EID1907.121576
   2016, AM J TROP MED HYG, V95, P328, DOI DOI 10.4269/AJTMH.15-0679
   2014, AM J TROP MED HYG, V91, P1039, DOI DOI 10.4269/AJTMH.14-0127
NR 75
TC 21
Z9 21
U1 8
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2019
VL 19
IS 5
BP E149
EP E161
DI 10.1016/S1473-3099(18)30757-6
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA HV5PS
UT WOS:000466036400003
PM 30799251
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Peeling, RW
   Murtagh, M
   Olliaro, PL
AF Peeling, Rosanna W.
   Murtagh, Maurine
   Olliaro, Piero L.
TI Epidemic preparedness: why is there a need to accelerate the development
   of diagnostics?
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE; ASSAYS; TESTS; ZIKA
AB Global epidemics of infectious diseases are increasing in frequency and severity. Diagnostics are needed for rapid identification of the cause of the epidemic to facilitate effective control and prevention. Lessons learned from the recent Ebola virus and Zika virus epidemics are that delay in developing the right diagnostic for the right population at the right time has been a costly barrier to disease control and prevention. We believe that it is possible to accelerate and optimise diagnostic development through a five-pronged strategy: by doing a global landscape analysis of diagnostic availability worldwide; through strategic partnerships for accelerating test development, in particular with vaccine companies to identify novel diagnostic targets; by creating and sharing repositories of data, reagents, and well characterised specimens for advancing the development process; by involving key public and private stakeholders, including appropriate regulatory bodies and policy makers, to ensure rapid access for researchers to diagnostics; and last, by fostering an enabling environment for research and access to diagnostics in the countries that need them. The need is great, but not insurmountable and innovative and faster development pathways are urgently required to address current shortfalls.
C1 [Peeling, Rosanna W.] London Sch Hyg & Trop Med, Int Diagnost Ctr, London, England.
   [Murtagh, Maurine] Murtagh Grp, San Francisco, CA USA.
   [Olliaro, Piero L.] WHO, UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Olliaro, Piero L.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Res Bldg, Oxford OX3 7FZ, England.
RP Olliaro, PL (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Res Bldg, Oxford OX3 7FZ, England.
EM piero.olliaro@ndm.ox.ac.uk
FU UNICEF-UNDP-World Bank-WHO Special Programme for Research and Training
   in Tropical Diseases
FX The preparation of the diagnostic landscapes was supported by the
   UNICEF-UNDP-World Bank-WHO Special Programme for Research and Training
   in Tropical Diseases.
CR Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   FIND, 2018, DIAGN EP PREP OUTBR
   Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066905
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   London School of Hygiene & Tropical Medicine and International Diagnostics Centre, 2018, CHIK VIR DIAGN LANDS
   London School of Hygiene & Tropical Medicine and International Diagnostics Centre, 2018, ZIK VIR INF DIAGN LA
   London School of Hygiene & Tropical Medicine and International Diagnostics Centre, DENG VIR INF DIAGN L
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   U.S. Food and Drug Administration, 2017, FDA APPR 1 TEST SCRE
   U. S. Food and Drug Administration, 2017, EM US AUTH MED PROD
   US CDC, 2017, UPD GUID US LAB TEST
   US CDC, 2016, MEM REV DIAGN TEST Z
   WHO, 2018, GLOB OBS HLTH R D WH
   World Health Organization, 2014, TARG PROD PROF ZAIR
   2016, AM J TROP MED HYG, V95, P182, DOI DOI 10.4269/AJTMH.16-0013
NR 25
TC 3
Z9 3
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2019
VL 19
IS 5
BP E172
EP E178
DI 10.1016/S1473-3099(18)30594-2
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA HV5PS
UT WOS:000466036400005
PM 30551872
DA 2020-07-08
ER

PT J
AU Bonyah, E
   Khan, MA
   Okosun, KO
   Gomez-Aguilar, JF
AF Bonyah, E.
   Khan, M. A.
   Okosun, K. O.
   Gomez-Aguilar, J. F.
TI On the co-infection of dengue fever and Zika virus
SO OPTIMAL CONTROL APPLICATIONS & METHODS
LA English
DT Article
DE co-infection; dengue fever; numerical solution; optimal control problem;
   stability analysis; Zika virus
ID MATHEMATICAL-ANALYSIS; MALARIA; MODEL; HIV; TUBERCULOSIS; TRANSMISSION;
   CHEMOTHERAPY; DISEASES
AB In this paper, we present a co-infection mathematical model for dengue-Zika disease in order to carry out their synergistic relationship in the presence of prevention and treatment. Submodel analysis is investigated to establish the reproduction numbers for each disease and to determine the disease-free local stability equilibrium status. The endemic disease equilibrium is investigated using bifurcation analysis and shows backward bifurcation. We use Pontryagin's maximum principle to explore and determine the best optimal strategies to control both diseases. Numerical optimal control analysis indicates that effective prevention and treatment of each disease will help in the effective control and eradication of the diseases. Finally, the control of co-infection of dengue-Zika requires that communities should combine both prevention and treatment associated with each disease at the same time.
C1 [Bonyah, E.] Univ Educ, Dept Math Educ, Kumasi Campus, Kumasi, Ghana.
   [Khan, M. A.] City Univ Sci & Informat Technol, Dept Math, Peshawar, Pakistan.
   [Okosun, K. O.] Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa.
   [Gomez-Aguilar, J. F.] CONACyT Tecnol Nacl Mexico CENIDET, Interior Internado Palmira S-N, Cuernavaca, Morelos, Mexico.
RP Bonyah, E (corresponding author), Univ Educ, Dept Math Educ, Kumasi Campus, Kumasi, Ghana.
EM ebbonya@gmail.com
RI Aguilar, Jose Francisco Gomez/I-7027-2019; Khan, Muhammad
   Altaf/K-2201-2013; OKOSUN, KAZEEM/A-4335-2012
OI Aguilar, Jose Francisco Gomez/0000-0001-9403-3767; Khan, Muhammad
   Altaf/0000-0002-4483-7879; OKOSUN, KAZEEM/0000-0001-7798-5459
FU National Research Foundation, South African [115029, 115524]
FX National Research Foundation, South African, Grant/Award Number: 115029
   and 115524
CR Abdel-Gawad HI, 2008, KYUNGPOOK MATH J, V48, P395
   Adams BM, 2004, MATH BIOSCI ENG, V1, P223
   Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Atangana A, 2018, EUR PHYS J PLUS, V133, DOI 10.1140/epjp/i2018-11932-1
   Atangana A, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18020040
   Atangana A, 2016, COMPLEXITY, V21, P442, DOI 10.1002/cplx.21704
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Braselton J, 2015, J COMPUT SCI SYST BI, V8, P255
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Derouich M, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-4
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Gao D, 2008, SCI REP, V6
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Goswami A., 2017, COMMUNICATIONS NUMER, V2017, P80
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hengki T, 2012, INT J MATH MATH SCI, V2012
   Isea Raul, 2016, AM J MODERN PHYS APP, V3, P11
   Kealey A, 2010, J HEALTH CARE POOR U, V21, P53, DOI 10.1353/hpu.0.0270
   Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Lungu E, 2013, COMPUT MATH METHOD M, DOI 10.1155/2013/753424
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mtisi E, 2009, DISCRETE CONT DYN-B, V12, P827, DOI 10.3934/dcdsb.2009.12.827
   Mukandavire Z, 2009, MATH BIOSCI ENG, V6, P333, DOI 10.3934/mbe.2009.6.333
   Mutua JM, 2015, MATH BIOSCI, V264, P128, DOI 10.1016/j.mbs.2015.03.014
   Nuraini N, 2007, B MALAYS MATH SCI SO, V30, P143
   Okosun KO, 2014, MATH BIOSCI, V258, P19, DOI 10.1016/j.mbs.2014.09.008
   Okosun KO, 2016, MATH BIOSCI ENG, V10, P1
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Pongsumpun P., 2008, WORLD ACAD SCI ENG T, V44, P328
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Rocha F, 2016, INT J COMPUT MATH, V93, P1405, DOI 10.1080/00207160.2015.1050961
   Roeger LIW, 2009, MATH BIOSCI ENG, V6, P815, DOI 10.3934/mbe.2009.6.815
   Ruzhansky M. V., 2017, ADV REAL COMPLEX ANA
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 41
TC 6
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2087
EI 1099-1514
J9 OPTIM CONTR APPL MET
JI Optim. Control Appl. Methods
PD MAY
PY 2019
VL 40
IS 3
BP 394
EP 421
DI 10.1002/oca.2483
PG 28
WC Automation & Control Systems; Operations Research & Management Science;
   Mathematics, Applied
SC Automation & Control Systems; Operations Research & Management Science;
   Mathematics
GA HW2YG
UT WOS:000466555800002
OA Bronze
DA 2020-07-08
ER

PT J
AU Ciota, AT
AF Ciota, Alexander T.
TI The role of co-infection and swarm dynamics in arbovirus transmission
SO VIRUS RESEARCH
LA English
DT Review
DE Arbovirus; Mosquito; Co-infection; Co-transmission; Mutant swarm
ID NILE-VIRUS-INFECTION; INSECT-SPECIFIC FLAVIVIRUS; DENGUE VIRUS; ZIKA
   VIRUS; CHIKUNGUNYA VIRUS; SUPERINFECTION EXCLUSION; AEDES-ALBOPICTUS;
   MUTATION-RATES; MOSQUITO CELLS; RNA VIRUSES
AB Arthropod-borne viruses (arboviruses) are transmitted by hematophagous insects, primarily mosquitoes. The geographic range and prevalence of mosquito-borne viruses and their vectors has dramatically increased over the last 50 years. As a result, the most medically important arboviurses now co-exist in many regions, resulting in an increased frequency of co-infections in hosts and vectors. In addition to concurrent infections with human pathogens, mosquito-only viruses and/or enzootic viruses not associated with human disease are ubiquitous in mosquito populations. Moreover, mosquito-borne viruses are largely RNA viruses that exist within individual hosts as a diverse and dynamic swarm of closely related genotypes. Interactions among co-infecting viruses and genotypes can have profound effects on virulence, fitness and evolution. Here, we review our understanding of how these complex interactions influence transmission of mosquito-borne viruses, focusing on the often-neglected virus interactions in the mosquito vector, and identify gaps in our knowledge that should guide future studies.
C1 [Ciota, Alexander T.] New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, Slingerlands, NY 12159 USA.
   [Ciota, Alexander T.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA.
RP Ciota, AT (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, Slingerlands, NY 12159 USA.
EM alexander.ciota@health.ny.gov
RI Ciota, Alexander/E-1634-2017
OI Ciota, Alexander/0000-0001-6589-4728
CR Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030
   Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Bara JJ, 2014, ACTA TROP, V130, P71, DOI 10.1016/j.actatropica.2013.10.016
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Brackney DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024466
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185
   Ciota AT, 2007, J GEN VIROL, V88, P2398, DOI 10.1099/vir.0.83061-0
   Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0
   Ciota AT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-71
   Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58
   Ciota AT, 2012, INFECT GENET EVOL, V12, P557, DOI 10.1016/j.meegid.2012.01.022
   Ciota Alexander T., 2011, BMC Ecology, V11, P23, DOI 10.1186/1472-6785-11-23
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ebel GD, 2011, J VIROL, V85, P12605, DOI 10.1128/JVI.05637-11
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Garcia-Perez B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055654
   Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HAMMON WM, 1973, AM J TROP MED HYG, V22, P82, DOI 10.4269/ajtmh.1973.22.82
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Huang YJS, 2019, CURR OPIN VIROL, V34, P104, DOI 10.1016/j.coviro.2019.01.001
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   JOHNSTON RE, 1974, J VIROL, V14, P1076, DOI 10.1128/JVI.14.5.1076-1082.1974
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kantor A. M., 2019, J MED ENTOMOL, DOI [10.1093/jme/fly241, DOI 10.1093/JME/FLY241]
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76
   Moncayo AC, 2000, J MED ENTOMOL, V37, P701, DOI 10.1603/0022-2585-37.5.701
   Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Novella IS, 2004, J MOL BIOL, V342, P1423, DOI 10.1016/j.jmb.2004.08.004
   Novella IS, 2003, CURR OPIN MICROBIOL, V6, P399, DOI 10.1016/S1369-5274(03)00084-5
   OHIGGINS T, 2014, EURO SURVEILL, V19
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pepin KM, 2008, VECTOR-BORNE ZOONOT, V8, P821, DOI 10.1089/vbz.2008.0016
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Ruiz-Jarabo CM, 2000, J VIROL, V74, P3543, DOI 10.1128/JVI.74.8.3543-3547.2000
   Sachs JL, 2005, P NATL ACAD SCI USA, V102, P390, DOI 10.1073/pnas.0405738102
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Scott TW, 1998, AM J TROP MED HYG, V59, P341, DOI 10.4269/ajtmh.1998.59.341
   Shirogane Y, 2016, CURR TOP MICROBIOL, V392, P219, DOI 10.1007/82_2015_461
   Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   STOLLAR V, 1973, J VIROL, V11, P592, DOI 10.1128/JVI.11.4.592-595.1973
   Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2
   Van Slyke GA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005009
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WEAVER SC, 1992, AM J TROP MED HYG, V47, P691, DOI 10.4269/ajtmh.1992.47.691
   Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 94
TC 1
Z9 1
U1 3
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAY
PY 2019
VL 265
BP 88
EP 93
DI 10.1016/j.virusres.2019.03.010
PG 6
WC Virology
SC Virology
GA HV8TU
UT WOS:000466257800013
PM 30879977
DA 2020-07-08
ER

PT J
AU Williamson, ED
AF Williamson, E. D.
TI Vaccines for emerging pathogens: from research to the clinic
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Editorial Material
DE antibodies; antigen presentation; processing; vaccination
AB In this two-part series of reviews, we have invited experts in their fields to contribute articles on the status of vaccine research and development for emerging pathogens. This topic has been brought into sharp focus in recent years following significant outbreaks of viral diseases such as those causing severe acute respiratory syndrome and Middle East respiratory syndrome, as well as devastating outbreaks of diseases caused by the Ebola, Marburg, Zika and Lassa fever viruses, to name only a few examples. Additionally, bacterial infections leading to bubonic and pneumonic plague, most notably in Madagascar in 2018, as well as malaria in many tropical countries, melioidosis in south east Asia and tularaemia in northern Europe and North America, have incurred significant morbidity and mortality. In this review series, the life cycle of these pathogens and the epidemiology of disease have been reviewed in the context of potential points of intervention for the prevention of human infection. Many of the emerging pathogens are zoonoses and, as such, there is scope for intervention at the animal/insect/environmental reservoir. Other pathogens covered in this review series are considered to be re-emerging, such as multi-drug resistant tuberculosis.
C1 [Williamson, E. D.] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England.
RP Williamson, ED (corresponding author), Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England.
EM dewilliamson@dstl.gov.uk
RI Williamson, Ethel Diane/AAQ-8878-2020
OI Williamson, Diane/0000-0002-0322-5972
CR Afrough B, 2019, CLIN EXP IMMUNOL, V196, P157, DOI 10.1111/cei.13295
   Miquel-Clopes A, 2019, CLIN EXP IMMUNOL, V196, P205, DOI 10.1111/cei.13285
   Morici L, 2019, CLIN EXP IMMUNOL, V196, P178, DOI 10.1111/cei.13286
   Sharpe HR, 2019, CLIN EXP IMMUNOL, V196, P167, DOI 10.1111/cei.13292
   Wallis J, 2019, CLIN EXP IMMUNOL, V196, P189, DOI 10.1111/cei.13287
NR 5
TC 0
Z9 0
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD MAY
PY 2019
VL 196
IS 2
BP 155
EP 156
DI 10.1111/cei.13303
PG 2
WC Immunology
SC Immunology
GA HU2KT
UT WOS:000465100500002
PM 30993689
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Rodo, C
   Suy, A
   Sulleiro, E
   Soriano-Arandes, A
   Maiz, N
   Garcia-Ruiz, I
   Arevalo, S
   Rando, A
   Anton, A
   Mendez, EV
   Garrido, M
   Frick, A
   Rodrigo, C
   Pumarola, T
   Carreras, E
AF Rodo, C.
   Suy, A.
   Sulleiro, E.
   Soriano-Arandes, A.
   Maiz, N.
   Garcia-Ruiz, I.
   Arevalo, S.
   Rando, A.
   Anton, A.
   Vazquez Mendez, E.
   Garrido, M.
   Frick, A.
   Rodrigo, C.
   Pumarola, T.
   Carreras, E.
TI Pregnancy outcomes after maternal Zika virus infection in a non-endemic
   region: prospective cohort study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Amniotic fluid; brain malformation; congenital; prenatal diagnosis;
   ultrasound; Zika virus
ID INTERIM GUIDANCE
AB Objectives: The aim was to describe pregnancy outcomes after Zika virus (ZIKV) infection in a nonendemic region.
   Methods: According to the Spanish protocol issued after the ZIKV outbreak in Brazil in 2015, all pregnant women who had travelled to high-burden countries were screened for ZIKV. Serological and molecular tests were used to identify ZIKV-infected pregnant women. They were classified as confirmed ZIKV infection when reverse transcription (RT) PCR tested positive, or probable ZIKV infection when ZIKV immunoglobulin M and/or immunoglobulin G and ZIKV plaque reduction neutralization tests were positive. Women found positive using molecular or serological tests were prospectively followed-up with ultrasound scans and neurosonograms on a monthly basis until delivery; magnetic resonance imaging and amniotic fluid testing were performed after signed informed consent. Samples of placenta, and fetal and neonatal tissues were obtained.
   Results: Seventy-two pregnant women tested positive for ZIKV infection: ten were confirmed by RT-PCR, and 62 were probable cases based on serological tests. The prevalence of adverse perinatal outcomes was 33.3% (three out of nine, 95% CI 12.1-64.6%): two cases of congenital ZIKV syndrome (CZS) and one miscarriage, all born to women infected in the first trimester of gestation. All ZIKV-confirmed women had persistent viraemias beyond 2 weeks (median 61.50 days; IQR 35.50-80.75). Amniotic fluid testing was only positive in the two fetuses with anomalies.
   Conclusion: The prevalence of perinatal adverse outcomes for women with ZIKV-confirmed infection was 33.3%. Amniocentesis for ZIKV RT-PCR is recommended when fetal abnormalities are found. Intensive prenatal and postnatal follow-up of ZIKV-infected pregnancies is advised in confirmed cases. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Rodo, C.; Suy, A.; Maiz, N.; Garcia-Ruiz, I.; Arevalo, S.; Carreras, E.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Barcelona, Spain.
   [Sulleiro, E.; Rando, A.; Anton, A.; Pumarola, T.] Univ Autonoma Barcelona, PROSICS Barcelona, Hosp Univ Vall Hebron, Dept Microbiol, Barcelona, Spain.
   [Soriano-Arandes, A.; Frick, A.] Univ Autonoma Barcelona, PROSICS Barcelona, Hosp Univ Vall dHebron, Trop Med & Int Hlth Unit, Barcelona, Spain.
   [Soriano-Arandes, A.; Frick, A.; Rodrigo, C.] Univ Autonoma Barcelona, Pediat Infect Dis & Immunodeficiences Unit, Hosp Univ Vall dHebron, Barcelona, Spain.
   [Vazquez Mendez, E.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Paediat Radiol, Barcelona, Spain.
   [Garrido, M.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Pathol, Barcelona, Spain.
RP Rodo, C (corresponding author), Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Ps Vall dHebron 119-129, Barcelona 08035, Spain.
EM crodo@vhebron.net
RI Pumarola, Tomas/AAB-5532-2019; RODO, CARLOTA/K-9179-2017; Maiz,
   Nerea/E-8272-2010; Anton, Andres/B-3308-2011; Soriano-Arandes,
   Antoni/G-6851-2013; Arandes, Antonio Soriano/Q-3348-2016
OI Pumarola, Tomas/0000-0002-5171-7461; RODO, CARLOTA/0000-0001-8801-5677;
   Maiz, Nerea/0000-0001-8261-6383; Anton, Andres/0000-0002-1476-0815;
   Arandes, Antonio Soriano/0000-0001-9613-7228; Sulleiro,
   Elena/0000-0002-9783-6060; Arevalo Martinez, Silvia/0000-0001-8169-1322
CR Bardaji-Alonso A, 2016, PROTOCOL ACTUACIO DA
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cohain JS, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1620-1
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022
   Rossi AC, 2014, ULTRASOUND OBST GYN, V44, P388, DOI 10.1002/uog.13429
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   2016, JAMA NEUROL, V73, P1407, DOI DOI 10.1001/JAMANEUROL.2016.3720
NR 15
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2019
VL 25
IS 5
AR 633.e5
DI 10.1016/j.cmi.2019.02.008
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HU8SE
UT WOS:000465559800025
PM 30771526
OA Bronze
DA 2020-07-08
ER

PT J
AU Setoh, YX
   Amarilla, AA
   Peng, NYG
   Griffiths, RE
   Carrera, J
   Freney, ME
   Nakayama, E
   Ogawa, S
   Watterson, D
   Modhiran, N
   Nanyonga, FE
   Torres, FJ
   Slonchak, A
   Periasamy, P
   Prow, NA
   Tang, B
   Harrison, J
   Hobson-Peters, J
   Cuddihy, T
   Cooper-White, J
   Hall, RA
   Young, PR
   Mackenzie, JM
   Wolvetang, E
   Bloom, JD
   Suhrbier, A
   Khromykh, AA
AF Setoh, Yin Xiang
   Amarilla, Alberto A.
   Peng, Nias Y. G.
   Griffiths, Rebecca E.
   Carrera, Julio
   Freney, Morgan E.
   Nakayama, Eri
   Ogawa, Shinya
   Watterson, Daniel
   Modhiran, Naphak
   Nanyonga, Faith Elizabeth
   Torres, Francisco J.
   Slonchak, Andrii
   Periasamy, Parthiban
   Prow, Natalie A.
   Tang, Bing
   Harrison, Jessica
   Hobson-Peters, Jody
   Cuddihy, Thom
   Cooper-White, Justin
   Hall, Roy A.
   Young, Paul R.
   Mackenzie, Jason M.
   Wolvetang, Ernst
   Bloom, Jesse D.
   Suhrbier, Andreas
   Khromykh, Alexander A.
TI Determinants of Zika virus host tropism uncovered by deep mutational
   scanning
SO NATURE MICROBIOLOGY
LA English
DT Article
ID CEREBRAL ORGANOIDS; WEST NILE; GLYCOSYLATION; VIRULENCE; REGION
AB Arboviruses cycle between, and replicate in, both invertebrate and vertebrate hosts, which for Zika virus (ZIKV) involves Aedes mosquitoes and primates(1). The viral determinants required for replication in such obligate hosts are under strong purifying selection during natural virus evolution, making it challenging to resolve which determinants are optimal for viral fitness in each host. Herein we describe a deep mutational scanning (DMS) strategy(2-5) whereby a viral cDNA library was constructed containing all codon substitutions in the C-terminal 204 amino acids of ZIKV envelope protein (E). The cDNA library was transfected into C6/36 (Aedes) and Vero (primate) cells, with subsequent deep sequencing and computational analyses of recovered viruses showing that substitutions K316Q and S461G, or Q350L and T397S, conferred substantial replicative advantages in mosquito and primate cells, respectively. A 316Q/461G virus was constructed and shown to be replication-defective in mammalian cells due to severely compromised virus particle formation and secretion. The 316Q/461G virus was also highly attenuated in human brain organoids, and illustrated utility as a vaccine in mice. This approach can thus imitate evolutionary selection in a matter of days and identify amino acids key to the regulation of virus replication in specific host environments.
C1 [Setoh, Yin Xiang; Amarilla, Alberto A.; Peng, Nias Y. G.; Freney, Morgan E.; Watterson, Daniel; Modhiran, Naphak; Nanyonga, Faith Elizabeth; Torres, Francisco J.; Slonchak, Andrii; Periasamy, Parthiban; Harrison, Jessica; Hobson-Peters, Jody; Hall, Roy A.; Young, Paul R.; Khromykh, Alexander A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Griffiths, Rebecca E.; Cooper-White, Justin; Wolvetang, Ernst] Univ Queensland, UQ StemCARE, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.
   [Carrera, Julio; Mackenzie, Jason M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Ogawa, Shinya] Univ Tokyo, Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.
   [Prow, Natalie A.; Tang, Bing; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld, Australia.
   [Cuddihy, Thom] Univ Queensland, Res Comp Ctr, St Lucia, Qld, Australia.
   [Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.
   [Bloom, Jesse D.] Howard Hughes Med Inst, Seattle, WA USA.
RP Setoh, YX; Khromykh, AA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
EM y.setoh@uq.edu.au; alexander.khromykh@uq.edu.au
RI Slonchak, Andrii/Y-4162-2019; Peng, Nias Y./J-9329-2017; Khromykh,
   Alexander/X-7200-2018; Torres, Francisco J/F-6028-2019; Wolvetang, Ernst
   jurgen/D-6644-2017
OI Slonchak, Andrii/0000-0003-3258-0508; Peng, Nias Y./0000-0002-7488-5441;
   Khromykh, Alexander/0000-0001-6206-6935; Torres, Francisco
   J/0000-0003-1961-9754; Wolvetang, Ernst jurgen/0000-0002-2146-6614;
   Nanyonga, Faith Elizabeth/0000-0003-2691-4401; Mackenzie,
   Jason/0000-0001-6613-8350; Cooper-White, Justin/0000-0002-1920-8229;
   Ogawa, Shinya/0000-0001-8097-8954
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia
   [APP1144950]; Daiichi Sankyo Foundation of Life Science, Japan
FX This work was supported by the National Health and Medical Research
   Council (NHMRC) of Australia (grant No. APP1144950). A.K. and A.S. are
   Research Fellows with the NHMRC. E.N. was supported in part by the
   Daiichi Sankyo Foundation of Life Science, Japan. We thank R. Sullivan
   from the Queensland Brain Institute Microscopy and Histology Facility
   for help with preparation and imaging of the brain organoid slides.
   Organoid confocal microscopy work was performed in part at the
   Queensland node of the Australian National Fabrication Facility, a
   company established under the National Collaborative Research
   Infrastructure Strategy to provide nano-and microfabrication facilities
   for Australia's researchers.
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Amarilla AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44642
   Ashenberg O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006288
   Bloom JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0590-4
   Bloom JD, 2014, MOL BIOL EVOL, V31, P1956, DOI 10.1093/molbev/msu173
   Dingens AS, 2017, CELL HOST MICROBE, V21, P777, DOI 10.1016/j.chom.2017.05.003
   Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271
   Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155
   Dumevska B, 2016, STEM CELL RES, V16, P472, DOI 10.1016/j.scr.2016.02.011
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Qi HF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004064
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Setoh YX, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110326
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Setoh YX, 2015, J GEN VIROL, V96, P1297, DOI 10.1099/vir.0.000069
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sutarjono B, 2019, J INFECT DIS, V219, P734, DOI 10.1093/infdis/jiy572
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wu Nicholas C, 2014, Sci Rep, V4, P4942, DOI 10.1038/srep04942
   Xie DY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0006-9
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 42
TC 5
Z9 5
U1 7
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAY
PY 2019
VL 4
IS 5
BP 876
EP 887
DI 10.1038/s41564-019-0399-4
PG 12
WC Microbiology
SC Microbiology
GA HU7QL
UT WOS:000465477000020
PM 30886357
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Ng, BG
   Vezina, GL
   Bulas, DI
   Wolfe, LA
   Freeze, HH
   Ferreira, CR
AF Mulkey, Sarah B.
   Ng, Bobby G.
   Vezina, Gilbert L.
   Bulas, Dorothy, I
   Wolfe, Lynne A.
   Freeze, Hudson H.
   Ferreira, Carlos R.
TI Arrest of Fetal Brain Development in ALG11-Congenital Disorder of
   Glycosylation
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE Congenital disorder of glycosylation; Fetal brain disruption sequence;
   Congenital microcephaly; Fetal magnetic resonance imaging
ID ZIKA VIRUS-INFECTION; CONGENITAL DISORDER; DIAGNOSIS; SERUM; IA
AB Background: Arrest of fetal brain development and the fetal brain disruption sequence describe a severe phenotype involving microcephaly, occipital bone prominence, and scalp rugae. Congenital disorders of glycosylation are a heterogeneous group of inherited disorders involved in glycoprotein and glycolipid biosynthesis, which can cause microcephaly and severe neurodevelopmental disability.
   Methods: We report an example of fetal microcephaly diagnosed at 36 weeks' gestation with a history of normal fetal biometry at 20 weeks' gestation. Postnatal genetic testing was performed.
   Results: Fetal magnetic resonance imaging at 36 weeks' gestational age showed severe cortical thinning with a simplified gyral pattern for gestational age, ventriculomegaly, and agenesis of the corpus callosum. The fetal skull had a posterior shelf at the level of the lamb doi d suture, characteristic of fetal brain disruption sequence. Postnatal brain magnetic resonance imaging found no brain growth during the interval from the fetal to postnatal study. The infant was found to have biallelic pathologic mutations in ALG11.
   Conclusions: Arrest of fetal brain development, with image findings consistent with fetal brain disruption sequence, is a previously unreported phenotype of congenital microcephaly in ALG11-congenital disorder of glycosylation. ALG11-congenital disorder of glycosylation should be considered in the differential diagnosis of this rare form of congenital microcephaly. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Mulkey, Sarah B.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave, Washington, DC 20010 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA USA.
   [Vezina, Gilbert L.; Bulas, Dorothy, I] Childrens Natl Hlth Syst, Div Radiol, Washington, DC 20010 USA.
   [Wolfe, Lynne A.; Ferreira, Carlos R.] NHGRI, NIH, Bethesda, MD 20892 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
OI Mulkey, Sarah/0000-0002-8084-526X
FU Rocket Fund; National Institutes of Health (NIH)United States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01DK99551]
FX The authors thank the patient and his family for their kind cooperation.
   H.H.F. is supported by the Rocket Fund and National Institutes of Health
   (NIH) grant R01DK99551. S.B.M wrote the first draft of the manuscript.
   There was no honorarium, grant, or other form of payment to S.B.M or any
   of the coauthors to produce the manuscript.
CR Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   Al Teneiji A, 2017, MOL GENET METAB, V120, P235, DOI 10.1016/j.ymgme.2016.12.014
   Aronica E, 2005, ACTA NEUROPATHOL, V109, P433, DOI 10.1007/s00401-004-0975-3
   Chan B, 2016, HUM MOL GENET, V25, P2182, DOI 10.1093/hmg/ddw085
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   Edwards M, 2006, PRENATAL DIAG, V26, P985, DOI 10.1002/pd.1543
   Ferreira CR, 2018, J INHERIT METAB DIS, V41, P541, DOI 10.1007/s10545-018-0156-5
   Fiumara A, 2016, JIMD REP, V27, P93, DOI 10.1007/8904_2015_497
   Fletcher JM, 2000, J INHERIT METAB DIS, V23, P396, DOI 10.1023/A:1005660004047
   Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6
   Hahn SH, 2006, J INHERIT METAB DIS, V29, P235, DOI 10.1007/s10545-006-0210-6
   Jaeken J, 2013, HAND CLINIC, V113, P1737, DOI 10.1016/B978-0-444-59565-2.00044-7
   Kline-Fath BM, 2015, FUNDAMENTAL ADV FETA
   Lacey JM, 2001, CLIN CHEM, V47, P513
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o
   Pereira AG, 2017, EPILEPTIC DISORD, V19, P15, DOI 10.1684/epd.2017.0901
   Regal L, 2015, MOLEC GENET METAB RE, V2, P16, DOI 10.1016/j.ymgmr.2014.11.006
   Rind N, 2010, HUM MOL GENET, V19, P1413, DOI 10.1093/hmg/ddq016
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Thiel C, 2012, HUM MUTAT, V33, P485, DOI 10.1002/humu.22019
   Xia BY, 2013, ANAL BIOCHEM, V442, P178, DOI 10.1016/j.ab.2013.07.037
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAY
PY 2019
VL 94
BP 64
EP 69
DI 10.1016/j.pediatrneurol.2018.12.009
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA HU3ET
UT WOS:000465155700009
PM 30770273
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Arumugam, V
   Venkatesan, M
   Saravanan, N
   Ramachandran, S
   Sengodan, K
   Sundaresan, U
   Palanisamy, SK
AF Arumugam, Velusamy
   Venkatesan, Manigandan
   Saravanan, Nishakavya
   Ramachandran, Saravanan
   Sengodan, Karthi
   Sundaresan, Umamaheswari
   Palanisamy, Satheesh Kumar
TI Tunicates as a biocontrol tool for larvicides acute toxicity of Zika
   virus vector Aedes aegypti
SO 3 BIOTECH
LA English
DT Article
DE Sea squirts; Metabolites; GC-MS; Anti-bacterial; Zika vector; Larvicidal
AB In this present study, we conducted untargeted metabolic profiling using gas chromatography-mass spectrometry (GC-MS) analysis of ascidian Didemnum bistratum to assess the chemical constituents by searching in NIST library with promising biological properties against anti-bacterial and Zika virus vector mosquitocidal properties. Metabolites, steroids and fatty acids are abundant in crude compounds of ascidian D. bistratum and showed potential zone growth inhibition against bacterial strains Kluyvera ascorbate (10 mm). The active crude compounds of D. bistratum exhibited prominent larvicidal activity against the Zika vector mosquitoes of Aedes aegypti (LC50 values of 0.44 mg/ml) and Cluex quinquefasciatus (LC50 values of 2.23 mg/ml). The findings of this study provide a first evidence of the biological properties exhibited by D. bistratum extracts, thus increasing the knowledge about the Zika virus vector mosquitocidal properties of ascidian. Overall, ascidian D. bistratum is promising and biocontrol or eco-friendly tool against A. aegypti and C. quinquefasciatus with prospective toxicity against non-target organisms.
C1 [Arumugam, Velusamy; Sundaresan, Umamaheswari] Bharathidasan Univ, Sch Environm Sci, Dept Environm Biotechnol, Tiruchirappalli 620024, Tamil Nadu, India.
   [Venkatesan, Manigandan; Saravanan, Nishakavya; Ramachandran, Saravanan] Chettinad Acad Res & Educ, Dept Med Biotechnol, Native Med & Marine Pharmacol Lab, Chennai 603013, Tamil Nadu, India.
   [Sengodan, Karthi] KS Rangasamy Coll Arts & Sci Autonomous, Dept Biochem, Namakkal 637215, Tamil Nadu, India.
   [Palanisamy, Satheesh Kumar] Natl Univ Ireland, Ryan Inst, Sch Nat Sci, Dept Zool, Galway, Ireland.
RP Palanisamy, SK (corresponding author), Natl Univ Ireland, Ryan Inst, Sch Nat Sci, Dept Zool, Galway, Ireland.
EM indianscientsathish@gmail.com
OI Sengodan, Karthi/0000-0002-7474-2934; Palanisamy, Satheesh
   Kumar/0000-0002-2152-1265
FU DST-Science and Research Engineering Board, India [SB/YS/LS-374/2013];
   UGC-SAP, New DelhiUniversity Grants Commission, India; UGC-FIST
FX This work is supported by the DST-Science and Research Engineering
   Board, India under grant SB/YS/LS-374/2013, UGC-FIST and UGC-SAP, New
   Delhi.
CR Arivoli S, 2011, INT J CURR RES, V3, P296
   Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Donia MS, 2008, J NAT PROD, V71, P941, DOI 10.1021/np700718p
   Elumalai D., 2017, Journal of the Saudi Society of Agricultural Sciences, V16, P306, DOI 10.1016/j.jssas.2015.10.003
   Finlayson R, 2011, J NAT PROD, V74, P888, DOI 10.1021/np1008619
   Hussain S. Mohamed, 2009, Current Research Journal of Biological Sciences, V1, P168
   Kumaran N. Sri, 2014, Biosciences Biotechnology Research Asia, V11, P331
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Mendiola J, 2006, T ROY SOC TROP MED H, V100, P909, DOI 10.1016/j.trstmh.2005.11.013
   Morris LA, 2001, TETRAHEDRON, V57, P3185, DOI 10.1016/S0040-4020(01)00177-6
   Palanisamy SK, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1273-4
   Palanisamy SK, 2016, J BIOL RES-BOLL SOC, V89, P27, DOI 10.4081/jbr.2016.5812
   Palanisamy SK, 2018, J NAT PROD RES, DOI [10.1080/14786419.2018.148870, DOI 10.1080/14786419.2018.148870]
   Santalova EA, 2004, BIOCHEM SYST ECOL, V32, P153, DOI 10.1016/S0305-1978(03)00143-1
   Selva Prabhu A, 2012, INT J I PHAR LIFE SC, V2
   Suarez-Jimenez GM, 2012, MAR DRUGS, V10, P963, DOI 10.3390/md10050963
   World Health Organization [WHO], 2017, ZIK VIR INF IND
   Zhen XH, 2015, EUR J PHARMACOL, V768, P131, DOI 10.1016/j.ejphar.2015.10.041
NR 20
TC 0
Z9 0
U1 1
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-572X
EI 2190-5738
J9 3 BIOTECH
JI 3 Biotech
PD MAY
PY 2019
VL 9
IS 5
AR 172
DI 10.1007/s13205-019-1699-3
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA HT6US
UT WOS:000464700200001
PM 30997309
OA Green Published
DA 2020-07-08
ER

PT J
AU Botto-Menezes, CHA
   Neto, AM
   Calvet, GA
   Kara, EO
   Lacerda, MVG
   Castilho, MD
   Stroher, U
   de Brito, CAA
   Modjarrad, K
   Broutet, N
   Brasil, P
   de Filippis, AMB
   Franca, RFO
   de Abreu, AL
   Benzaken, AS
   Bermudez, XPD
   Broutet, NJN
   Giozza, SP
   Habib, N
   Landoulsi, S
   Lima, MC
   Lima, N
   de Mello, MB
   de Menezes, AIC
   Meurant, R
   Pimenta, C
   Storme, C
   Thorson, A
   Trautman, L
AF Aguiar Botto-Menezes, Camila Helena
   Neto, Armando Menezes
   Calvet, Guilherme Amaral
   Kara, Edna Oliveira
   Guimaraes Lacerda, Marcus Vinicius
   Castilho, Marcia da Costa
   Stroher, Ute
   Antunes de Brito, Carlos Alexandre
   Modjarrad, Kayvon
   Broutet, Nathalie
   Brasil, Patricia
   Bispo de Filippis, Ana Maria
   Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   Benzaken, Adele Schwartz
   Diaz Bermudez, Ximena Pamela
   Nicole Broutet, Nathalie Jeanne
   Giozza, Silvana Pereira
   Habib, Ndema
   Landoulsi, Sihem
   Lima, Morganna Costa
   Lima, Noemia
   de Mello, Maeve Brito
   Costa de Menezes, Ana Izabel
   Meurant, Robyn
   Pimenta, Cristina
   Storme, Casey
   Thorson, Anna
   Trautman, Lydie
CA ZIKABRA Study Team
TI Zika Virus in Rectal Swab Samples
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We detected Zika virus RNA in rectal swab samples from 10 patients by using real-time reverse transcription PCR, and we isolated the virus from 1 patient. The longest interval from symptom onset to detection was 14 days. These findings are applicable to diagnosis and infection prevention recommendations.
C1 [Aguiar Botto-Menezes, Camila Helena] Amazonas State Univ, Manaus, Amazonas, Brazil.
   [Aguiar Botto-Menezes, Camila Helena; Guimaraes Lacerda, Marcus Vinicius; Castilho, Marcia da Costa] Trop Med Fdn Doctor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Neto, Armando Menezes; Antunes de Brito, Carlos Alexandre; Oliveira Franca, Rafael Freitas] Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Kara, Edna Oliveira; Stroher, Ute; Broutet, Nathalie] WHO, Geneva, Switzerland.
   [Guimaraes Lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Bispo de Filippis, Ana Maria] Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
RP Franca, RFO (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Dept Virol & Expt Therapy, Av Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI ; Calvet, Guilherme/G-6959-2013
OI Thorson, Anna/0000-0002-8703-6561; Calvet, Guilherme/0000-0002-3545-5238
FU Wellcome TrustWellcome Trust [206522/Z/17/Z]; World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction); Brazilian
   Ministry of Health [837059/2016, 25000162039201616]; US National
   Institutes of Health National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI139777]; Henry M. Jackson Foundation
   for the Advancement of Military Medicine [W81XWH-18-2-0040]; US
   Department of the Army [W81XWH-18-2-0040]; US Defense Health Agency
   [0130602D16]; World Health Emergency Programme Organization
FX The research leading to these results received funding from Wellcome
   Trust grant no. 206522/Z/17/Z, World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction), World Health
   Emergency Programme Organization, Brazilian Ministry of Health (Convenio
   no. 837059/2016, Processo 25000162039201616), US National Institutes of
   Health National Institute of Allergy and Infectious Diseases (award no.
   R21AI139777). This work was supported by a cooperative agreement
   (W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the
   Advancement of Military Medicine and the US Department of the Army. The
   work was funded by the US Defense Health Agency (0130602D16). The
   funders had no role in study design, data collection, analysis, decision
   to publish, or preparation of the manuscript.
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li CF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0170-6
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
NR 13
TC 2
Z9 2
U1 1
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2019
VL 25
IS 5
BP 951
EP 954
DI 10.3201/eid2505.180904
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HU0TG
UT WOS:000464983500014
PM 31002058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hai, R
   Wang, BX
   Thurmond, S
   Song, JK
AF Hai, Rong
   Wang, Boxiao
   Thurmond, Stephanie
   Song, Jikui
TI Suppression of human STAT2 by ZIKV NS5
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Hai, Rong; Wang, Boxiao; Thurmond, Stephanie; Song, Jikui] Univ Calif Riverside, Riverside, CA 92521 USA.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 127.20
PG 2
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982501016
DA 2020-07-08
ER

PT J
AU Kumar, A
   Singh, S
   Singh, P
   Giri, S
AF Kumar, Ashok
   Singh, Sneha
   Singh, Pawan
   Giri, Shailendra
TI Activation of AMPK restricts Zika virus replication in endothelial cells
   by potentiating antiviral response and inhibiting viral-induced
   glycolysis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Kumar, Ashok; Singh, Sneha; Singh, Pawan] Wayne State Univ, Sch Med, Detroit, MI 48202 USA.
   [Giri, Shailendra] Henry Ford Hlth Syst, Detroit, MI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 127.19
PG 3
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982501014
DA 2020-07-08
ER

PT J
AU Liang, YJ
   Escano, J
   Sun, JR
AF Liang, Yuejin
   Escano, Jerome
   Sun, Jiaren
TI IL-33 promotes antiviral immunity and protects against congenital Zika
   disease in mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Liang, Yuejin; Escano, Jerome; Sun, Jiaren] Univ Texas Med Branch Galveston, Galveston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 75.4
PG 1
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982500403
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Young, MP
   Bunz, M
   Xu, ZG
   Hattakam, S
   Vizcarra, E
   Regla-Nava, JA
   Tang, WW
   Yamabhai, M
   Wen, JS
   Shresta, S
AF Ngono, Annie Elong
   Young, Matthew P.
   Bunz, Maximilian
   Xu, Zhigang
   Hattakam, Sararat
   Vizcarra, Edward
   Regla-Nava, Jose Angel
   Tang, William W.
   Yamabhai, Montarop
   Wen, Jinsheng
   Shresta, Sujan
TI CD4(+) T cells Promote Humoral Immunity and Viral Control during Zika
   Virus Infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Ngono, Annie Elong; Young, Matthew P.; Bunz, Maximilian; Xu, Zhigang; Hattakam, Sararat; Vizcarra, Edward; Regla-Nava, Jose Angel; Tang, William W.; Yamabhai, Montarop; Wen, Jinsheng; Shresta, Sujan] La Jolla Inst Immunol, La Jolla, CA USA.
   [Hattakam, Sararat; Yamabhai, Montarop] Suranaree Univ Technol, Inst Agr Technol, Nakhon Ratchasima, Thailand.
   [Wen, Jinsheng; Shresta, Sujan] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou, Peoples R China.
   [Shresta, Sujan] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 140.15
PG 2
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982501248
DA 2020-07-08
ER

PT J
AU Pardy, RD
   Richer, MJ
AF Pardy, Ryan D.
   Richer, Martin J.
TI A Brazilian Zika virus isolate suppresses type I interferon to establish
   a sustained infection in immunocompetent mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Pardy, Ryan D.; Richer, Martin J.] McGill Univ, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 197.6
PG 1
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982502117
DA 2020-07-08
ER

PT J
AU Song, H
   Shang, ZF
   Qi, JX
   Gao, GF
AF Song, Hao
   Shang, Zifang
   Qi, Jianxun
   Gao, George F.
TI Structural and functional insights of the capsid protein from Zika virus
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Song, Hao; Shang, Zifang; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China.
   [Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 197.26
PG 1
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982502113
DA 2020-07-08
ER

PT J
AU Strange, DP
   Jiyarom, B
   Zarandi, NP
   Xie, XP
   Sadri-Ardekani, H
   Shi, PY
   Verma, S
AF Strange, Daniel P.
   Jiyarom, Boonyanudh
   Zarandi, Nima Pourhabibi
   Xie, Xuping
   Sadri-Ardekani, Hooman
   Shi, Pei -Yong
   Verma, Saguna
TI Axl promotes ZIKV entry and modulates antiviral state of human Sertoli
   cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Strange, Daniel P.; Jiyarom, Boonyanudh; Verma, Saguna] Univ Hawaii, Manoa, HI USA.
   [Zarandi, Nima Pourhabibi; Sadri-Ardekani, Hooman] Wake Forest Sch Med, Winston Salem, NC 27101 USA.
   [Xie, Xuping; Shi, Pei -Yong] Univ Texas Med Branch, Galveston, TX 77555 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 197.13
PG 2
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982502102
DA 2020-07-08
ER

PT J
AU Wang, YT
   Hattakam, S
   Young, MP
   Regla-Nava, JA
   Shresta, S
AF Wang, Ying-Ting
   Hattakam, Sararat
   Young, Matthew Perry
   Regla-Nava, Jose Angel
   Shresta, Sujan
TI Monocytes and macrophages limit systemic infection and modulate the CD4
   T cell response during Zika virus infection in mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Wang, Ying-Ting; Hattakam, Sararat; Young, Matthew Perry; Regla-Nava, Jose Angel; Shresta, Sujan] La Jolla Inst Immunol, La Jolla, CA USA.
   [Hattakam, Sararat] Suranaree Univ Technol, Inst Agr Technol, Nakhon Ratchasima, Thailand.
   [Shresta, Sujan] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 140.5
PG 1
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982501256
DA 2020-07-08
ER

PT J
AU Wood, SC
AF Wood, Steven C.
TI Zika virus detection using a flow cytometry platform
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 103rd Annual Meeting of the American-Association-of-Immunologists
CY MAY 09-13, 2019
CL San Diego, CA
SP Amer Assoc Immunologists
C1 [Wood, Steven C.] US FDA, CDRH, Rockville, MD 20857 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2019
VL 202
IS 1
SU S
MA 130.39
PG 3
WC Immunology
SC Immunology
GA LB9WQ
UT WOS:000524982501075
DA 2020-07-08
ER

PT J
AU Reynoso, GV
   Weisberg, AS
   Shannon, JP
   McManus, DT
   Shores, L
   Americo, JL
   Stan, RV
   Yewdell, JW
   Hickman, HD
AF Reynoso, Glennys V.
   Weisberg, Andrea S.
   Shannon, John P.
   McManus, Daniel T.
   Shores, Lucas
   Americo, Jeffrey L.
   Stan, Radu V.
   Yewdell, Jonathan W.
   Hickman, Heather D.
TI Lymph node conduits transport virions for rapid T cell activation
SO NATURE IMMUNOLOGY
LA English
DT Article
ID FIBROBLASTIC RETICULAR CELLS; SUBCAPSULAR SINUS MACROPHAGES;
   CD8-ALPHA(+) DENDRITIC CELLS; IMMUNE-RESPONSE; VIRUS; INFECTION;
   ANTIGEN; MIGRATION; INNATE; LYMPHOCYTES
AB Despite intense interest in antiviral T cell priming, the routes by which virions move in lymph nodes (LNs) are imperfectly understood. Current models fail to explain how virus-infected cells rapidly appear within the LN interior after viral infection. To better understand virion trafficking in the LN, we determined the locations of virions and infected cells after administration to mice of vaccinia virus or Zika virus. Notably, many rapidly infected cells in the LN interior were adjacent to LN conduits. Through the use of confocal and electron microscopy, we clearly visualized virions within conduits. Functionally, CD8(+) T cells rapidly and preferentially associated with vaccinia virus-infected cells in the LN paracortex, which led to T cell activation in the LN interior. These results reveal that it is possible for even large virions to flow through LN conduits and infect dendritic cells within the T cell zone to prime CD8(+) T cells.
C1 [Reynoso, Glennys V.; Shannon, John P.; McManus, Daniel T.; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Weisberg, Andrea S.; Americo, Jeffrey L.] NIAID, Genet Engn Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Shores, Lucas; Yewdell, Jonathan W.] NIAID, Cell Biol Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Stan, Radu V.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Lebanon, NH USA.
   [Stan, Radu V.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA.
RP Hickman, HD (corresponding author), NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Yewdell, JW (corresponding author), NIAID, Cell Biol Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM jwyewdell@nih.gov; hhickman@nih.gov
RI ; Stan, Radu/E-8876-2011
OI Hickman, Heather/0000-0003-4168-4894; Stan, Radu/0000-0003-2969-1725
FU Intramural Research Program of NIAID, NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R21CA172983, R21CA175592, R01GM120592, AHA
   16GRNT27260362]
FX This work was supported by the Intramural Research Program of NIAID, NIH
   (H.D.H.). R.V.S. was supported by NIH grants R21CA172983, R21CA175592,
   R01GM120592, and AHA 16GRNT27260362. We thank K. Dowd and T. Pierson
   (Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID) for
   assistance with ZIKV infection and J. Kabat (Biological Imaging Section,
   NIAID) for assistance with microscopy image analysis. G. Oliver
   (University of Chicago) provided Prox1-CreERT2<SUP>tg/+</SUP> mice on
   the C57BL/6 genetic background.
CR Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814
   Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035
   Baden LR, 2018, J INFECT DIS, V218, P633, DOI 10.1093/infdis/jiy212
   Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011
   Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567
   Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996
   Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003
   Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965
   Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805
   Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111
   Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070
   Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300
   Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335
   Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024
   Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011
   Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425
   Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557
   Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009
   Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004
   Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545
   Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118
   Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4
   Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287
   Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012
   Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021
   Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113
   La Rosa C, 2017, BLOOD, V129, P114, DOI 10.1182/blood-2016-07-729756
   Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513
   Moss B, 1996, Adv Exp Med Biol, V397, P7
   MOSS B, 2001, FIELDS VIROLOGY, V2, P2849
   Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104
   Ng CT, 2012, P NATL ACAD SCI USA, V109, P7823, DOI 10.1073/pnas.1205850109
   Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762
   Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361
   Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101
   Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016
   Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013
   Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407
   Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003
   Steele KE, 2009, IMMUNOTHERAPY-UK, V1, P187, DOI 10.2217/1750743X.1.2.187
   Steele KE, 2009, EXPERT REV ANTI-INFE, V7, P423, DOI 10.1586/ERI.09.13
   Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015
   Thierry GR, 2018, J EXP MED, V215, P2972, DOI 10.1084/jem.20180344
   Twenhafel NA, 2013, VET PATHOL, V50, P514, DOI 10.1177/0300985812469636
   Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327
   Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111
NR 52
TC 12
Z9 12
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD MAY
PY 2019
VL 20
IS 5
BP 602
EP +
DI 10.1038/s41590-019-0342-0
PG 12
WC Immunology
SC Immunology
GA HU2ET
UT WOS:000465084800017
PM 30886418
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Ishtiaq, F
   Setoh, YX
   Ko, AI
AF Grubaugh, Nathan D.
   Ishtiaq, Farah
   Setoh, Yin Xiang
   Ko, Albert I.
TI Misperceived Risks of Zika-related Microcephaly in India
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
AB After the discovery that Zika virus (ZIKV) could cause microcephaly and other birth defects, we have scrambled to understand how. Now, spreading along with the virus is misinformation that a ZIKV mutation is responsible for microcephaly. Putting too much onus on a single mutation could enhance a crisis in India.
C1 [Grubaugh, Nathan D.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Ishtiaq, Farah] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India.
   [Setoh, Yin Xiang] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
RP Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
EM nathan.grubaugh@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Grubaugh,
   Nathan/0000-0003-2031-1933
CR Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ishtiaq F, 2018, TRENDS PARASITOL, V34, P92, DOI 10.1016/j.pt.2017.10.008
   Jaeger A, 2018, BIORXIV, DOI [10.1101/387118, DOI 10.1101/387118]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Siraj Amir S, 2017, BMJ Glob Health, V2, pe000309, DOI 10.1136/bmjgh-2017-000309
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 15
TC 7
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD MAY
PY 2019
VL 27
IS 5
BP 381
EP 383
DI 10.1016/j.tim.2019.02.004
PG 4
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA HS4XL
UT WOS:000463873700001
PM 30826180
DA 2020-07-08
ER

PT J
AU Bitirim, Y
AF Bitirim, Yiltan
TI An Evaluation on Popularity of the Prioritized Diseases Using Google
   Trends
SO JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS
LA English
DT Article
DE Google Trends; Prioritized Diseases; World Health Organization;
   Popularity Evaluation; Public Health
ID BEHAVIOR
AB Google is the most popular search engine in the world. Another service of Google Inc. is Google Trends which is based on Google search data. The World Health Organization held an informal consultation in 2017 and announced the priority disease list. There was an urgent need for research and development for the priority diseases. "Lassa Fever: "Marburg," "Middle East Respiratory Syndrome Coronavirus," "Severe Acute Respiratory Syndrome," "Nipah," "Severe Fever with Thrombocytopenia Syndrome," and "Zika" diseases are from the priority disease list. In this study, a popularity evaluation of these diseases is done by using Google Trends with the worldwide and 52 weeks of 2017 settings. Zika disease is the most popular disease with big difference compared to the others for every week of 2017. With general overview, Zika's popularity is decreased during the year. Its average Google Search Interest value is 67.2%. Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome Coronavirus, and Severe Fever with Thrombocytopenia Syndrome comes next with 10.7%, 2.2%, and 0.1% averages, respectively. Lassa Fever, Marburg, and Nipah have common average, 0%. When only Severe Fever with Thrombocytopenia Syndrome, Lassa Fever, Marburg, and Nipah are considered, Lassa Fever is the most popular with 4.9% average and then, Severe Fever with Thrombocytopenia Syndrome, Nipah, and Marburg comes with 4.5%, 2.4%, and 2.2% averages, respectively. This study reveals the tendency of people which is based on their interest, curiosity, worry, anxiety, problem, and so forth regarding the seven diseases. So, the authorities would be motivated to make further studies and take precautions for this tendency.
C1 [Bitirim, Yiltan] Eastern Mediterranean Univ, Fac Engn, Dept Comp Engn, Via Mersin 10, TR-99628 Famagusta, North Cyprus, Turkey.
RP Bitirim, Y (corresponding author), Eastern Mediterranean Univ, Fac Engn, Dept Comp Engn, Via Mersin 10, TR-99628 Famagusta, North Cyprus, Turkey.
RI Bitirim, Yiltan/AAA-8010-2019
OI Bitirim, Yiltan/0000-0002-1780-2806
CR [Anonymous], 2015, INT CONS WORKSH PRIO
   [Anonymous], 2018, 2018 ANN REV DIS PRI
   [Anonymous], 2017, PERT WHOOP COUGH
   Brigo F, 2015, EPILEPSY BEHAV, V49, P146, DOI 10.1016/j.yebeh.2015.02.029
   Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x
   Coogan S, 2018, PALGR COMMUN, V4, DOI 10.1057/s41599-017-0055-7
   Dewan V, 2018, J ARTHROSCOPY JOINT, V5, P175
   Gergaud O, 2017, ENHANCING PARTICIPAT, P337, DOI DOI 10.1007/978-3-319-09096-2_23
   Johnson AK, 2014, SEX TRANSM DIS, V41, P61, DOI 10.1097/OLQ.0000000000000065
   Mavragani A, 2016, TECHNOL FORECAST SOC, V109, P1, DOI 10.1016/j.techfore.2016.04.028
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Padhi SS, 2017, TOUR MANAG PERSPECT, V24, P34, DOI 10.1016/j.tmp.2017.07.001
   Parker J, 2017, J AFFECT DISORDERS, V213, P9, DOI 10.1016/j.jad.2016.10.038
   Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684
   Rogers K, 2018, EBOLAVIRUS
   Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195
   Sekhavat YA, 2016, 2016 SECOND INTERNATIONAL CONFERENCE ON WEB RESEARCH (ICWR), P8, DOI 10.1109/ICWR.2016.7498439
   Shariatpanahi SP, 2017, TELEMAT INFORM, V34, P904, DOI 10.1016/j.tele.2017.03.007
   Shin SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32920
   StatCounter, 2017, STATCOUNTER GLOB STA
   World Health Organization (WHO), 2017, 2017 ANN REV DIS PRI
   Zhang YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11195-z
NR 22
TC 0
Z9 0
U1 1
U2 5
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2156-7018
EI 2156-7026
J9 J MED IMAG HEALTH IN
JI J. Med. Imaging Health Inform.
PD MAY
PY 2019
VL 9
IS 4
BP 682
EP 687
DI 10.1166/jmihi.2019.2613
PG 6
WC Mathematical & Computational Biology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Mathematical & Computational Biology; Radiology, Nuclear Medicine &
   Medical Imaging
GA HQ9ZI
UT WOS:000462786400005
DA 2020-07-08
ER

PT J
AU Zhao, LZ
   Hong, WX
   Wang, J
   Yu, L
   Hu, FY
   Qiu, S
   Yin, CB
   Tang, XP
   Zhang, LQ
   Jin, X
   Zhang, FC
AF Zhao, Ling-Zhai
   Hong, Wen-Xin
   Wang, Jian
   Yu, Lei
   Hu, Feng-Yu
   Qiu, Shuang
   Yin, Chi-Biao
   Tang, Xiao-Ping
   Zhang, Lin-Qi
   Jin, Xia
   Zhang, Fu-Chun
TI Kinetics of antigen-specific IgM/IgG/IgA antibody responses during Zika
   virus natural infection in two patients
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE IgA; IgG; IgM; Zika virus
ID IGM
AB Understanding of kinetics of antibody responses is crucial for developing rapid serological tests and studying the mechanisms of Zika virus (ZIKV) infection. Most of the serological diagnostic assays previously published are based on either IgM or IgG titer, little is known on the level of IgA antibody in saliva and urine. In this study, we investigated the kinetics of IgM/IgG/IgA antibody responses in serum, saliva, and urine obtained from two ZIKV infected individuals from as early as the second day of onset of symptoms to as long as 2 years postinfection. Other than detecting robust early IgM response, long lasting IgG response, we discovered strong early IgA response specific for ZIKV in saliva in both patients. This unique observation provides a novel strategy and scientific basis for the development of noninvasive rapid tests for ZIKV infection.
C1 [Zhao, Ling-Zhai; Hong, Wen-Xin; Wang, Jian; Yu, Lei; Hu, Feng-Yu; Qiu, Shuang; Yin, Chi-Biao; Tang, Xiao-Ping; Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Inst Infect Dis, Guangzhou 510060, Guangdong, Peoples R China.
   [Zhang, Lin-Qi] Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Shanghai 200031, Peoples R China.
   [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Ctr, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
RP Zhang, FC (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Inst Infect Dis, Guangzhou 510060, Guangdong, Peoples R China.; Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Shanghai 200031, Peoples R China.; Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Ctr, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
EM xjin@ips.ac.cn; gz8hzfc@126.com
FU Major Program of Guangzhou healthcare collaborative innovation
   foundation [201704020229]; National Key Research and Development Program
   Project Grant of China [2016YFC1201000]; Guangdong provincial science
   and technology program on emergency preparedness of Zika
   [2016A020248001]; Ministry of Science and Technology of ChinaMinistry of
   Science and Technology, China [2017ZX10305501-003]
FX Major Program of Guangzhou healthcare collaborative innovation
   foundation, Grant/Award Number: 201704020229; National Key Research and
   Development Program Project Grant of China, Grant/Award Number:
   2016YFC1201000; 2016 Guangdong provincial science and technology program
   on emergency preparedness of Zika, Grant/Award Number: 2016A020248001;
   Ministry of Science and Technology of China, Grant/Award Number:
   2017ZX10305501-003
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Steinhagen K, 2016, INT J INFECT DIS, V53, P93, DOI 10.1016/j.ijid.2016.11.235
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27298
NR 19
TC 1
Z9 1
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2019
VL 91
IS 5
BP 872
EP 876
DI 10.1002/jmv.25366
PG 5
WC Virology
SC Virology
GA HN8UK
UT WOS:000460471800020
PM 30485459
DA 2020-07-08
ER

PT J
AU Soto-Hernandez, JL
   Rosales, SPD
   Canas, ESV
   Cardenas, G
   Loza, KC
   Diaz-Quinonez, JA
   Lopez-Martinez, I
   Jimenez-Corona, ME
   Ruiz-Matus, C
   Morales, PK
AF Luis Soto-Hernandez, Jose
   de Ledo Rosales, Samuel Ponce
   Vargas Canas, Edwin Steven
   Cardenas, Graciela
   Carrillo Loza, Karina
   Alberto Diaz-Quinonez, Jose
   Lopez-Martinez, Irma
   Jimenez-Corona, Maria-Eugenia
   Ruiz-Matus, Cuitlahuac
   Kuri Morales, Pablo
TI Guillain-Barre Syndrome Associated With Zika Virus Infection: A
   Prospective Case Series From Mexico
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Zika virus; Guillain-Barre Syndrome; cranial neuropathies multiple;
   RT-PCR; flavivirus infection
ID DIAGNOSIS
AB Background: On May 2016, anticipating the rainy season from June to October in Mexico, we expected an increase in cases of Zika virus (ZIKV) infections. With the goal of identifying cases of GBS associated with ZIKV infection, a prospective joint study was conducted by a reference center for neurological patients and the Secretary of Health in Mexico City from July 2016 to November 2016.
   Methods: Serum, cerebrospinal fluid, urine, and saliva were tested by RT-PCR for ZIKV, dengue virus, and chikungunya virus in patients referred from states with reported transmissions of ZIKV infection, and with clinical symptoms of GBS according to the Brighton Collaboration criteria. Clinical, electrophysiological, and long-term disability data were collected.
   Results: In the year 2016 twenty-eight patients with GBS were diagnosed at our institute. In five hospitalized patients with GBS, RT-PCR was positive to ZIKV in any collected specimen. Dengue and chikungunya RT-PCR results were negative. All five patients had areflexic flaccid weakness, and cranial nerves affected in three. Electrophysiological patterns were demyelinating in two patients and axonal in three. Three patients were discharged improved in 10 days or less, and two patients required intensive care unit admission, and completely recovered during follow-up.
   Conclusion: Our results are similar to those reported from the state of Veracruz, Mexico, in which out of 33 samples of urine of patients with GBS two had a positive RT-PCR for ZIKV. Simultaneous processing of serum, CSF, urine, and saliva by RT-PCR may increase the success of diagnosis of GBS associated to ZIKV.
C1 [Luis Soto-Hernandez, Jose; Cardenas, Graciela] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Dept Infect Dis, Mexico City, DF, Mexico.
   [de Ledo Rosales, Samuel Ponce] Univ Nacl Autonoma Mexico, Programa Univ Invest Salud, Mexico City, DF, Mexico.
   [Vargas Canas, Edwin Steven] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Dept Neurol, Neuromuscular Clin, Mexico City, DF, Mexico.
   [Carrillo Loza, Karina] Natl Inst Neurol & Neurosurg Manuel Velasco Sua, Dept Neuroloyy, Mexico City, DF, Mexico.
   [Alberto Diaz-Quinonez, Jose; Lopez-Martinez, Irma] Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Mexico City, DF, Mexico.
   [Alberto Diaz-Quinonez, Jose; Kuri Morales, Pablo] Univ Nacl Autonoma Mexico, Div Estudios Postgrad, Fac Med, Mexico City, DF, Mexico.
   [Jimenez-Corona, Maria-Eugenia; Ruiz-Matus, Cuitlahuac] Direcc Gen Epidemiol, Mexico City, DF, Mexico.
RP Soto-Hernandez, JL (corresponding author), Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Dept Infect Dis, Mexico City, DF, Mexico.
EM joseluis_sotohernandez@yahoo.com
OI Diaz-Quinonez, Jose Alberto/0000-0002-3503-7079; Soto Hernandez, Jose
   Luis/0000-0002-4712-1809
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Del Carpio-Orantes L, 2018, Neurologia, DOI 10.1016/j.nrl.2018.05.002
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Kalita J, 2008, J NEUROL NEUROSUR PS, V79, P289, DOI 10.1136/jnnp.2007.118000
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Pan_American_Health_Organization, 2016, GUID ZIK VIR DIS COM
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rivera-Osorio P, 2011, J CLIN MICROBIOL, V49, P3370, DOI 10.1128/JCM.00950-11
NR 16
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD APR 30
PY 2019
VL 10
AR 435
DI 10.3389/fneur.2019.00435
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HW2LE
UT WOS:000466515100001
PM 31114537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rayichandran, S
   Hahn, M
   Belaunzaran-Zamudio, PF
   Ramos-Castaneda, J
   Najera-Cancino, G
   Caballero-Sosa, S
   Navarro-Fuentes, KR
   Ruiz-Palacios, G
   Golding, H
   Beigel, JH
   Khurana, S
AF Rayichandran, Supriya
   Hahn, Megan
   Belaunzaran-Zamudio, Pablo F.
   Ramos-Castaneda, Jose
   Najera-Cancino, Gabriel
   Caballero-Sosa, Sandra
   Navarro-Fuentes, Karla R.
   Ruiz-Palacios, Guillermo
   Golding, Hana
   Beigel, John H.
   Khurana, Surender
TI Differential human antibody repertoires following Zika infection and the
   implications for serodiagnostics and disease outcome
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; DIAGNOSTIC ASSAY; HIV-INFECTIONS; DENGUE VIRUS;
   DYNAMICS; AFFINITY; ADULTS; STATE; FACE
AB Zika virus (ZIKV) outbreak in Americas led to extensive efforts to develop vaccines and ZIKV-specific diagnostics. In the current study, we use whole genome phage display library spanning the entire ZIKV genome (ZIKV-GFPDL) for in-depth immune profiling of IgG and IgM antibody repertoires in serum and urine longitudinal samples from individuals acutely infected with ZIKV. We observe a very diverse IgM immune repertoire encompassing the entire ZIKV polyprotein on day 0 in both serum and urine. ZIKV-specific IgG antibodies increase 10-fold between day 0 and day 7 in serum, but not in urine; these are highly focused on prM/E, NS1 and NS2B. Differential antibody affinity maturation is observed against ZIKV structural E protein compared with nonstructural protein NS1. Serum antibody affinity to ZIKV-E protein inversely correlates with ZIKV disease symptoms. Our study provides insight into unlinked evolution of immune response to ZIKV infection and identified unique targets for ZIKV serodiagnostics.
C1 [Rayichandran, Supriya; Hahn, Megan; Golding, Hana; Khurana, Surender] US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA.
   [Belaunzaran-Zamudio, Pablo F.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City 14080, DF, Mexico.
   [Ramos-Castaneda, Jose] Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico.
   [Najera-Cancino, Gabriel] Hosp Reg Alta Especialidad Ciudad Salud, Tapachula 30830, Chiapas, Mexico.
   [Caballero-Sosa, Sandra] Inst Seguridad & Serv Sociales Trabajadores Estad, Tapachula 30740, Chiapas, Mexico.
   [Navarro-Fuentes, Karla R.] Inst Mexicano Seguro Social, Tapachula 30700, Chiapas, Mexico.
   [Ruiz-Palacios, Guillermo] Minist Hlth, Inst Nacl Salud & Hosp Alta Especialidad, Mexico City 14080, DF, Mexico.
   [Beigel, John H.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
   [Beigel, John H.] NIAID, NIH, Bethesda, MD 20852 USA.
RP Khurana, S (corresponding author), US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA.
EM Surender.Khurana@fda.hhs.govkkk
RI Ramos-Castaneda, jose/V-6678-2019; Belaunzaran-Zamudio, Pablo
   Francisco/T-4085-2019
OI Navarro Fuentes, Karla Reyna/0000-0002-6894-8872; Beigel,
   John/0000-0002-4879-4941; Belaunzaran, Pablo/0000-0003-4775-4734
FU CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE) [71260, 127088]; Division of
   Clinical Research, National Institute of Allergy and Infectious
   Diseases, National Institutes of Health; National Cancer Institute,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [HHSN261200800001E, HHSN261201500003I]; FDA Medical
   Countermeasures Initiative (MCMi) funds
FX We thank Keith Peden and Marian Major for their insightful review of the
   manuscript. We thank A. Pletnev for generous gift of ZIKV-ICD plasmid.
   The La Red Zik01 study sites and staff instrumental in conducting the
   study and collecting the samples include: Hospital Regional de Alta
   Especialidad Ciudad Salud (HRAE) Tapachula: Jose M. Perez, Gabriel
   Najera, Karina Trujillo, Alfredo Vera, Alexander Lopez; Instituto de
   Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE)
   Tapachula: Sandra Caballero, Zoila Priego, Francisco Camas; Instituto
   Mexicano del Seguro Social (IMSS) Tapachula: Hector Rincon Karla
   Navarro, Antonia Sumuano, Cielo Mayorga; Instituto Nacional de Nutricion
   Salvador Zubiran (INNSZ): Alfredo Ponce de Leon, Miriam Bobadilla,
   Ernesto Maravilla, Luz Elena Cervantes, Fernando Arteaga, Fernando
   Ledesma, Pilar Ramos, Gustavo Rosales, and Alberto Garcia. La Red is
   collaboration between the Mexico Ministry of Health and the U.S.
   National Institute of Allergy and Infectious Diseases. This study has
   been funded in part by CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE,
   Projects No. 71260 and No. 127088). This study has been funded in part
   by the Division of Clinical Research, National Institute of Allergy and
   Infectious Diseases, National Institutes of Health. This project has
   been funded in part with federal funds from the National Cancer
   Institute, National Institutes of Health, under Contract No.
   HHSN261200800001E and HHSN261201500003I. The antibody characterization
   work described in this manuscript was supported by FDA Medical
   Countermeasures Initiative (MCMi) funds to S.K. The latter funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The content of this
   publication does not necessarily reflect the views or policies of the
   Department of Health and Human Services, nor does mention of trade
   names, commercial products, or organizations imply endorsement by the
   U.S. Government.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145
   Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Khurana S, 2006, J VIROL, V80, P2092, DOI 10.1128/JVI.80.5.2092-2099.2006
   Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f
   Khurana S, 2016, NAT MED, V22, P1439, DOI 10.1038/nm.4201
   Khurana S, 2011, J VIROL, V85, P12455, DOI 10.1128/JVI.06023-11
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624
   Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11
   Victora GD, 2014, CURR OPIN IMMUNOL, V28, P90, DOI 10.1016/j.coi.2014.02.010
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 51
TC 7
Z9 7
U1 3
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 26
PY 2019
VL 10
AR 1943
DI 10.1038/s41467-019-09914-3
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HV2RO
UT WOS:000465837900003
PM 31028263
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Busch, MP
   Bloch, EM
   Kleinman, S
AF Busch, Michael P.
   Bloch, Evan M.
   Kleinman, Steven
TI Prevention of transfusion-transmitted infections
SO BLOOD
LA English
DT Review
ID CREUTZFELDT-JAKOB-DISEASE; WEST-NILE-VIRUS; HEPATITIS-C VIRUS;
   UNITED-STATES; BLOOD-TRANSFUSION; BABESIA-MICROTI; ZIKA VIRUS;
   BACTERIAL-CONTAMINATION; RELATIVE EFFICACY; PUERTO-RICO
AB Since the 1970s, introduction of serological assays targeting virus-specific antibodies and antigens has been effective in identifying blood donations infected with the classic transfusion-transmitted infectious agents (TTIs; hepatitis B virus [HBV], HIV, human T-cell lymphotropic virus types I and II, hepatitis C virus [HCV]). Subsequently, progressive implementation of nucleic acid-amplification technology (NAT) screening for HIV, HCV, and HBV has reduced the residual risk of infectious-window-period donations, such that per unit risks are <1 in 1000000 in the United States, other high-income countries, and in high-incidence regions performing NAT. NAT screening has emerged as the preferred option for detection of newer TTIs including West Nile virus, Zika virus (ZIKV), and Babesia microti. Although there is continual need to monitor current risks due to established TTI, ongoing challenges in blood safety relate primarily to surveillance for emerging agents coupled with development of rapid response mechanisms when such agents are identified. Recent progress in development and implementation of pathogen-reduction technologies (PRTs) provide the opportunity for pro-active rather than reactive response to blood-safety threats. Risk-based decision-making tools and cost-effectiveness models have proved useful to quantify infectious risks and place new interventions in context. However, as evidenced by the 2015 to 2017 ZIKV pandemic, a level of tolerable risk has yet to be defined in such a way that conflicting factors (eg, theoretical recipient risk, blood availability, cost, and commercial interests) can be reconciled. A unified approach to TTIs is needed, whereby novel tests and PRTs replace, rather than add to, existing interventions, thereby ameliorating cost and logistical burden to blood centers and hospitals.
C1 [Busch, Michael P.] Vitalant Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
   [Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Kleinman, Steven] Univ British Columbia, Dept Pathol, Victoria, BC, Canada.
RP Busch, MP (corresponding author), Vitalant Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@vitalant.org
CR AABB, EM INF DIS AG THEIR
   Alter HJ, 2008, BLOOD, V112, P2617, DOI 10.1182/blood-2008-07-077370
   Atreya Chintamani, 2011, Transfusion, V51, P1855, DOI 10.1111/j.1537-2995.2011.03084.x
   Bakkour S, 2018, TRANSFUSION, V58, P2903, DOI 10.1111/trf.14889
   Betsem E, 2017, EMERG INFECT DIS, V23, P212, DOI 10.3201/eid2302.161058
   Biswas R, 2003, TRANSFUSION, V43, P788, DOI 10.1046/j.1537-2995.2003.00424.x
   Bloch EM, 2014, VOX SANG, V107, P333, DOI 10.1111/vox.12182
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Bloch EM, 2018, TRANSFUSION, V58, P1647, DOI 10.1111/trf.14618
   Bloch EM, 2012, TRANSFUSION, V52, P1517, DOI 10.1111/j.1537-2995.2011.03467.x
   Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006
   Bougard D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1257
   Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005
   Bres V, 2016, P AABB ANN M 22 25 O
   Bruhn R, 2015, TRANSFUSION, V55, P1195, DOI 10.1111/trf.13024
   Bruhn R, 2013, TRANSFUSION, V53, P2399, DOI 10.1111/trf.12299
   Busch MP, 2014, ISBT SCI SER, V9, P276, DOI 10.1111/voxs.12082
   Busch MP, 2006, TRANSFUSION, V46, P1663, DOI 10.1111/j.1537-2995.2006.00987.x
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Busch MP, 2012, BLOOD, V119, P6326, DOI 10.1182/blood-2011-12-393637
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Compston LI, 2008, J VIROL METHODS, V151, P47, DOI 10.1016/j.jviromet.2008.03.023
   Concha-Marambio L, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6188
   Coste J, 2012, VOX SANG, V103, P260, DOI 10.1111/j.1423-0410.2012.01597.x
   Crowder LA, 2017, TRANSFUSION, V57, P1875, DOI 10.1111/trf.14145
   Custer B, 2019, BLOOD SAFETY GUIDE M, P53
   Custer B, 2016, TRANSFUSION, V56, P1499, DOI 10.1111/trf.13632
   Custer B, 2015, TRANSFUSION, V55, P2039, DOI 10.1111/trf.13080
   Custer B, 2009, TRANSFUS MED REV, V23, P1, DOI 10.1016/j.tmrv.2008.09.001
   Devine DV, 2016, HEMATOL ONCOL CLIN N, V30, P609, DOI 10.1016/j.hoc.2016.01.005
   Diack AB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006642
   Dodd RY, 2013, PRACTICAL TRANSFUSIO, P161
   Drew WL, 2003, TRANSFUSION, V43, P309, DOI 10.1046/j.1537-2995.2003.00337.x
   Edgren G, 2016, ANN INTERN MED, V165, P316, DOI 10.7326/M15-2421
   Erony SM, 2018, TRANSFUSION, V58, P1933, DOI 10.1111/trf.14789
   EUFRAT, 2018, USER MANUAL
   Fiebig E, 2009, BLOOD BANKING TRANSF, P447
   Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005
   Food and Drug Administration, 2016, DEF PROD MAN RED RIS
   Food and Drug Administration, 2013, REC DON QUEST DEF RE
   Food and Drug Administration, 2018, BACT RISK CONTR STRA
   Food and Drug Administration, 2017, US SER TESTS RED RIS
   Food and Drug Administration, 2018, REV REC RED RISK ZIK
   Food and Drug Administration, 2015, TOP 1 ISS SUMM STRAT
   Fuller AK, 2009, TRANSFUSION, V49, P2588, DOI 10.1111/j.1537-2995.2009.02348.x
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x
   Glynn SA, 2002, TRANSFUSION, V42, P966, DOI 10.1046/j.1537-2995.2002.00200.x
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362
   Hewitt PE, 2006, VOX SANG, V91, P348, DOI 10.1111/j.1423-0410.2006.00837.x
   Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Hudnall SD, 2003, TRANSFUSION, V43, P85, DOI 10.1046/j.1537-2995.2003.00272.x
   Janssen MP, 2017, VOX SANG, V112, P518, DOI 10.1111/vox.12543
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Jimenez-Marco T, 2016, TRANSFUSION, V56, pS45, DOI 10.1111/trf.13344
   Juhl D, 2010, TRANSFUSION MED, V20, P38, DOI 10.1111/j.1365-3148.2009.00951.x
   Klein HG, 2017, NEW ENGL J MED, V377, P1485, DOI 10.1056/NEJMsb1706496
   Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x
   Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304
   Laperche S, 2013, TRANSFUSION, V53, P816, DOI 10.1111/j.1537-2995.2012.03797.x
   Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954
   Leiby DA, 2019, VOX SANG, V114, P17, DOI 10.1111/vox.12727
   Levin AE, 2016, TRANSFUSION, V56, P1866, DOI 10.1111/trf.13618
   Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120
   Moritz ED, 2016, NEW ENGL J MED, V375, P2236, DOI 10.1056/NEJMoa1600897
   Moritz ED, 2014, TRANSFUSION, V54, P2226, DOI 10.1111/trf.12693
   Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603
   Opoku-Okrah C, 2009, AFR HEALTH SCI, V9, P13
   Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petrik J, 2016, VOX SANG, V110, P93, DOI 10.1111/vox.12285
   Ponte ML, 2006, PLOS MED, V3, P1751, DOI 10.1371/journal.pmed.0030342
   Prugger C, 2016, VOX SANG, V110, P196, DOI 10.1111/vox.12327
   Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951
   Roth WK, 2012, VOX SANG, V102, P82, DOI 10.1111/j.1423-0410.2011.01506.x
   Russell WA, 2019, ANN INTERN MED, V170, P164, DOI 10.7326/M18-2238
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601
   SIEGEL SE, 1971, BLOOD-J HEMATOL, V37, P388, DOI 10.1182/blood.V37.4.388.388
   Silverman RH, 2011, SCIENCE, V334, P176, DOI 10.1126/science.334.6053.176-a
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841
   Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x
   Smith D, 2010, VOX SANG, V98, P29, DOI 10.1111/j.1423-0410.2009.01228.x
   Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141
   Stramer SL, 2015, ISBT SCI SER, V10, P55, DOI 10.1111/voxs.12152
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085
   Stramer SL, 2013, TRANSFUSION, V53, P2375, DOI 10.1111/trf.12371
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Turner ML, 2009, BRIT J HAEMATOL, V144, P14, DOI 10.1111/j.1365-2141.2008.07376.x
   Urwin PJM, 2016, VOX SANG, V110, P310, DOI 10.1111/vox.12371
   Vamvakas EC, 2005, TRANSFUS MED REV, V19, P181, DOI 10.1016/j.tmrv.2005.02.002
   Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018
   Wald M., 2014, BLOOD IND SHRINKS TR
   Ward SJ, 2018, TRANSFUSION, V58, P1916, DOI 10.1111/trf.14912
   Weimer A, 2019, TRANSFUSION, V59, P412, DOI 10.1111/trf.14949
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Ziemann M, 2013, TRANSFUSION, V53, P2183, DOI 10.1111/trf.12199
   Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003
   2015, TRANSFUSION, V55, P2983, DOI DOI 10.1111/TRF.13259
   2012, TRANSFUSION, V52, P1634, DOI DOI 10.1111/J.1537-2995.2012.03747.X
   2012, P NATL ACAD SCI USA, V109, P346, DOI DOI 10.1073/PNAS.1119641109
   2019, TRANSFUSION, V59, P1016, DOI DOI 10.1111/TRF.15118
   2008, TRANSFUSION, V48, P1180, DOI DOI 10.1111/J.1537-2995.2008.01685.X
   1993, TRANSFUSION, V33, P14
   2013, TRANSFUSION, V53, P1603, DOI DOI 10.1111/J.1537-2995.2012.03928.X
   2012, TRANSFUSION, V52, P1901, DOI DOI 10.1111/J.1537-2995.2012.03569.X
   2012, TRANSFUS MED REV, V26, P281, DOI DOI 10.1016/J.TMRV.2012.04.004
   2017, TRANSFUSION, V57, P2289, DOI DOI 10.1111/TRF.14306
   2006, TRANSFUSION, V46, P1624, DOI DOI 10.1111/J.1537-2995.2006.00957.X
   2015, TRANSFUS MED REV, V29, P153, DOI DOI 10.1016/J.TMRV.2015.03.001
   2018, VOX SANG, V113, P737, DOI DOI 10.1111/VOX.12708
   2010, P NATL ACAD SCI USA, V107, P1587, DOI DOI 10.1073/PNAS.1006901107
   2016, TRANSFUSION, V56, P2781, DOI DOI 10.1111/TRF.13759
   2017, TRANSFUSION S2, V57, P1625, DOI DOI 10.1111/TRF.14164
   2017, TRANSFUSION, V57, P2321, DOI DOI 10.1111/TRF.14216
   2004, LANCET, V364, P527
   2016, TRANSFUSION, V56, P1907, DOI DOI 10.1111/TRF.13677
   1991, ARCH INTERN MED, V151, P2043
   2016, J INFECT DIS, V213, P694, DOI DOI 10.1093/INFDIS/JIV326
   2014, TRANSFUSION, V54, P942, DOI DOI 10.1111/TRF.12468
NR 129
TC 15
Z9 15
U1 5
U2 10
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 25
PY 2019
VL 133
IS 17
BP 1854
EP 1864
DI 10.1182/blood-2018-11-833996
PG 11
WC Hematology
SC Hematology
GA HU8SY
UT WOS:000465562100011
PM 30808637
OA Bronze
DA 2020-07-08
ER

PT J
AU Yang, YQ
   Cao, L
   Gao, HY
   Wu, Y
   Wang, YX
   Fang, F
   Lan, TL
   Lou, ZY
   Rao, Y
AF Yang, Yiqing
   Cao, Lin
   Gao, Hongying
   Wu, Yue
   Wang, Yaxin
   Fang, Fang
   Lan, Tianlong
   Lou, Zhiyong
   Rao, Yu
TI Discovery, Optimization, and Target Identification of Novel Potent
   Broad-Spectrum Antiviral Inhibitors
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID HEPATITIS-C; DRUG DISCOVERY; DENGUE VIRUS; BIOLOGICAL EVALUATION;
   MEDICINAL CHEMISTRY; REVERSE DOCKING; DERIVATIVES; DESIGN; ANALOG;
   OXIDOREDUCTASE
AB Viral infections are increasing and probably long-lasting global risks. In this study, a chemical library was exploited by phenotypic screening to discover new antiviral inhibitors. After optimizations from hit to lead, a novel potent small molecule (RYL-634) was identified, showing excellent broad-spectrum inhibition activity against various pathogenic viruses, including hepatitis C virus, dengue virus, Zika virus, chikungunya virus, enterovirus 71, human immunodeficiency virus, respiratory syncytial virus, and others. The mechanism of action and potential targets of RYL-634 were further explored by the combination of activity-based protein profiling and other techniques. Finally, human dihydroorotate dehydrogenase was validated as the major target of RYL-634. We did not observe any mutant resistance under our pressure selections with RYL-634, and it had a strong synergistic effect with some Food and Drug Administration-approved drugs. Hence, there is great potential for developing new broad-spectrum antivirals based on RYL-634.
C1 [Yang, Yiqing; Gao, Hongying; Wu, Yue; Fang, Fang; Lan, Tianlong; Rao, Yu] Tsinghua Univ, MOE Key Lab Prot Sci, Sch Pharmaceut Sci, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
   [Lou, Zhiyong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
   [Lou, Zhiyong] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China.
   [Yang, Yiqing; Gao, Hongying] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing 100084, Peoples R China.
   [Cao, Lin] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.
   [Wang, Yaxin] Hebei Normal Univ, Coll Life Sci, Shijiazhuang 050024, Hebei, Peoples R China.
RP Rao, Y (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Sch Pharmaceut Sci, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
EM louzy@mail.tsinghua.edu.cn; yrao@tsinghua.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81811530340, 81773567, 81622042, 81573277,
   31770309]; Tsinghua University-Peking University Joint Center for Life
   Sciences; China Postdoctoral Science FoundationChina Postdoctoral
   Science Foundation [2017M620806]
FX We would like to thank Dr. Honglin Li, Dr. Pengfei Tu, Dr. Chu Wang, and
   Dr. Ojdong You for their kind help in ABPP study and enzymatic activity
   assays. This work was supported by the National Natural Science
   Foundation of China (81811530340, 81773567, 81622042, 81573277, and
   31770309), Tsinghua University-Peking University Joint Center for Life
   Sciences and China Postdoctoral Science Foundation (2017M620806).
CR Aldrich CC, 2016, ACS INFECT DIS, V2, P310, DOI 10.1021/acsinfecdis.6b00072
   Bar-Or A, 2014, DRUGS, V74, P659, DOI 10.1007/s40265-014-0212-x
   Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008
   Bauer U, 2012, BIOORG MED CHEM LETT, V22, P1944, DOI 10.1016/j.bmcl.2012.01.046
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108
   Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020
   Castro Marcia C, 2017, Lancet Infect Dis, V17, pe70, DOI 10.1016/S1473-3099(16)30545-X
   Chase R, 2009, ANTIVIR RES, V84, P178, DOI 10.1016/j.antiviral.2009.09.003
   Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125
   Das P, 2013, ACS MED CHEM LETT, V4, P517, DOI 10.1021/ml300464h
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   Deng XY, 2014, J MED CHEM, V57, P5381, DOI 10.1021/jm500481t
   Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104
   Guo Y, 2016, ANTIMICROB AGENTS CH, V60, P913, DOI 10.1128/AAC.02274-15
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138
   Jumper CC, 2012, ANAL CHEM, V84, P4411, DOI 10.1021/ac300120z
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Kharkar PS, 2014, FUTURE MED CHEM, V6, P333, DOI 10.4155/fmc.13.207
   Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17
   Kokkonda S, 2016, J MED CHEM, V59, P5416, DOI 10.1021/acs.jmedchem.6b00275
   Lee A, 2016, EXPERT OPIN DRUG DIS, V11, P707, DOI 10.1080/17460441.2016.1190706
   Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114
   Li ZQ, 2013, ANGEW CHEM INT EDIT, V52, P8551, DOI 10.1002/anie.201300683
   Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163
   Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106
   Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006
   Low JG, 2018, ADV EXP MED BIOL, V1062, P319, DOI 10.1007/978-981-10-8727-1_22
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Lucas-Hourani M, 2015, J MED CHEM, V58, P5579, DOI 10.1021/acs.jmedchem.5b00606
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luo QY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171433
   Madak JT, 2018, J MED CHEM, V61, P5162, DOI 10.1021/acs.jmedchem.7b01862
   Marschall M, 2013, ANTIVIR RES, V100, P640, DOI 10.1016/j.antiviral.2013.10.003
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Martini S, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0570-1
   Masaoka T, 2016, BIOCHEMISTRY-US, V55, P809, DOI 10.1021/acs.biochem.5b01254
   Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111
   Moffat JG, 2014, NAT REV DRUG DISCOV, V13, P588, DOI 10.1038/nrd4366
   Munier-Lehmann H, 2015, J MED CHEM, V58, P860, DOI 10.1021/jm501446r
   Munier-Lehmann H, 2013, J MED CHEM, V56, P3148, DOI 10.1021/jm301848w
   Pidathala C, 2012, J MED CHEM, V55, P1831, DOI 10.1021/jm201179h
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shang LQ, 2014, ANTIVIR RES, V112, P47, DOI 10.1016/j.antiviral.2014.10.009
   SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Speers Anna E, 2009, Curr Protoc Chem Biol, V1, P29
   Sun JH, 2015, NATURE, V527, P245, DOI 10.1038/nature15711
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039
   Wang C, 2015, ACTA CHIM SINICA, V73, P657, DOI 10.6023/A15040223
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Wang YX, 2014, ANTIVIR RES, V103, P1, DOI 10.1016/j.antiviral.2013.12.008
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   Yang YQ, 2017, J MED CHEM, V60, P1994, DOI 10.1021/acs.jmedchem.6b01733
   Yeo KL, 2015, ANTIMICROB AGENTS CH, V59, P2086, DOI 10.1128/AAC.04779-14
   Zhang HN, 2015, P NATL ACAD SCI USA, V112, P15084, DOI 10.1073/pnas.1521316112
   Zhang L, 2012, J CELL BIOL, V196, P315, DOI 10.1083/jcb.201107058
   Zhu JS, 2015, J MED CHEM, V58, P1123, DOI 10.1021/jm501127s
   Zhuang ST, 2017, ACS CENTRAL SCI, V3, P501, DOI 10.1021/acscentsci.7b00134
   2010, J AM CHEM SOC, V132, P656, DOI DOI 10.1021/JA907716F
   2016, CELL, V167, P171, DOI DOI 10.1016/J.CELL.2016.08.057
NR 74
TC 7
Z9 10
U1 13
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD APR 25
PY 2019
VL 62
IS 8
BP 4056
EP 4073
DI 10.1021/acs.jmedchem.9b00091
PG 18
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HV5VT
UT WOS:000466053900015
PM 30938999
DA 2020-07-08
ER

PT J
AU Palanichamy, K
   Joshi, A
   Mehmetoglu-Gurbuz, T
   Bravo, MF
   Shlain, MA
   Schiro, F
   Naeem, Y
   Garg, H
   Braunschweig, AB
AF Palanichamy, Kalanidhi
   Joshi, Anjali
   Mehmetoglu-Gurbuz, Tugba
   Bravo, M. Fernando
   Shlain, Milan A.
   Schiro, Frank
   Naeem, Yasir
   Garg, Himanshu
   Braunschweig, Adam B.
TI Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID VIRUS-INFECTION; ENVELOPE PROTEIN; DC-SIGN; IDENTIFICATION;
   TRANSMISSION; CELLS
AB Zika virus (ZIKV), a mosquito-borne flavivirus, is a global health concern because of its association with severe neurological disorders. Currently, there are no antiviral therapies that have been specifically approved to treat ZIKV, and there is an urgent need to develop effective anti-ZIKV agents. Here, we report anti-ZIKV activity of 16 synthetic carbohydrate receptors (SCRs) that inhibit ZIKV infection in Vero and HeLa cells. Using a ZIKV reporter virus particle-based infection assay, our data demonstrates these SCRs are highly potent with IC(50)s as low as 0.16 mu M and negligible toxicity at several-fold higher concentrations. Time-of-addition studies showed that these SCRs inhibit the early stages of the virus infection, which is consistent with the proposed mode of action, where the SCRs likely inhibit binding between the virus and cell-surface glycans, thereby preventing viral entry into the cells and, as such, this study demonstrates a potential new strategy against ZIKV.
C1 [Palanichamy, Kalanidhi; Bravo, M. Fernando; Shlain, Milan A.; Schiro, Frank; Naeem, Yasir; Braunschweig, Adam B.] CUNY, Grad Ctr, Adv Sci Res Ctr, Nanosci Initiat, 85 St Nicholas Terrace, New York, NY 10031 USA.
   [Palanichamy, Kalanidhi; Bravo, M. Fernando; Shlain, Milan A.; Schiro, Frank; Naeem, Yasir; Braunschweig, Adam B.] Hunter Coll, Dept Chem & Biochem, 695 Pk Ave, New York, NY 10065 USA.
   [Joshi, Anjali; Mehmetoglu-Gurbuz, Tugba; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr El Paso, Dept Biomed Sci, Ctr Emphasis Infect Dis, 5001 El Paso Dr, El Paso, TX 79905 USA.
   [Bravo, M. Fernando; Braunschweig, Adam B.] CUNY, Grad Ctr, PhD Program Chem, 365 Fifth Ave, New York, NY 10016 USA.
   [Braunschweig, Adam B.] CUNY, Grad Ctr, PhD Program Biochem, 365 Fifth Ave, New York, NY 10016 USA.
RP Braunschweig, AB (corresponding author), CUNY, Grad Ctr, Adv Sci Res Ctr, Nanosci Initiat, 85 St Nicholas Terrace, New York, NY 10031 USA.; Braunschweig, AB (corresponding author), Hunter Coll, Dept Chem & Biochem, 695 Pk Ave, New York, NY 10065 USA.; Garg, H (corresponding author), Texas Tech Univ, Hlth Sci Ctr El Paso, Dept Biomed Sci, Ctr Emphasis Infect Dis, 5001 El Paso Dr, El Paso, TX 79905 USA.; Braunschweig, AB (corresponding author), CUNY, Grad Ctr, PhD Program Chem, 365 Fifth Ave, New York, NY 10016 USA.; Braunschweig, AB (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, 365 Fifth Ave, New York, NY 10016 USA.
EM himanshu.garg@ttuhsc.edu; adam.braunschweig@asrc.cuny.edu
RI Mehmetoglu-Gurbuz, Tugba/M-7452-2016
OI Mehmetoglu-Gurbuz, Tugba/0000-0003-1417-9446
FU Air Force Office of Scientific ResearchUnited States Department of
   DefenseAir Force Office of Scientific Research (AFOSR)
   [FA9550-17-1-0356]; Hunter College
FX A.B.B. is grateful to the Air Force Office of Scientific Research
   (FA9550-17-1-0356) for financial support. M.A.S. and Y.N. are grateful
   to Hunter College for an Undergraduate Research Fellowship. The NMR data
   (Bruker Avance 300 MHz) presented herein were collected in part at the
   NMR facility of the City College of the CUNY. Mass spectra were
   collected at the Hunter College Mass Spectrometry Facility of the CUNY.
   We thank Dr. Barney Yoo (Hunter College Mass Spectrometry Facility) for
   his help in acquiring the spectral data. We thank Dr. Ted Pierson
   (NIAID) for the subgenomic GFP expressing WNV replicon plasmid.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BRODER S, 1985, LANCET, V2, P627
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Francesconi O, 2015, CHEM-EUR J, V21, P10089, DOI 10.1002/chem.201501030
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gulland A, 2016, BMJ-BRIT MED J, V352, pi657
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lozano V, 2011, J MED CHEM, V54, P5335, DOI 10.1021/jm200560r
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shan M, 2011, CHEMBIOCHEM, V12, P2587, DOI 10.1002/cbic.201100529
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Wang XH, 2017, FRONT MED-PRC, V11, P449, DOI 10.1007/s11684-017-0589-5
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   2007, ANTIVIR CHEM CHEMOTH, V18, P49
   2013, CHEM SCI, V4, P357, DOI DOI 10.1039/C2SC20873C
   2005, J VIROL, V79, P8698, DOI DOI 10.1128/JVI.79.14.8690.8706.2005
   2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/UOG.15831
   2018, CHEM-EUR J, V24, P1397, DOI DOI 10.1002/CHEM.201803317
   2010, J BIOL CHEM, V285, P2484, DOI DOI 10.1074/JBC.M110.128546
   2017, EUR J INTERN MED, V44, P12, DOI DOI 10.1016/J.EJIM.2017.08.001
   2017, ANTIVIR RES, V139, P49, DOI DOI 10.1016/J.ANTIVIRAL.2016.12.016
   2016, ACS INFECT DIS, V2, P170, DOI DOI 10.1021/ACSINFECDIS.6B00030
   2017, BIOMED PHARMACOTHER, V91, P1152, DOI DOI 10.1016/J.BIOPHA.2017.05.045
   2007, VIROLOGY, V368, P145, DOI DOI 10.1016/J.VIROL.2007.06.029
   2017, ANTIVIR RES, V137, P141, DOI DOI 10.1016/J.ANTIVIRAL.2016.11.015
   2018, DRUG DISCOV TODAY, V23, P1833, DOI DOI 10.1016/J.DRUDIS.2018.06.014
   2009, J GEN VIROL, V90, P2097, DOI DOI 10.1099/VIR.0.012120-0
   2016, EMERG INFECT DIS, V22, P933, DOI DOI 10.3201/EID2205.160065
   2017, ANTIVIR RES, V143, P230, DOI DOI 10.1016/J.ANTIVIRAL.2017.04.016
   2017, CLIN MICROBIOL INFEC, V23, P296, DOI DOI 10.1016/J.CMI.2016.12.027
   2007, NATURE, V446, P1038, DOI DOI 10.1038/NATURE05818
   2017, CELL REP, V18, P804, DOI DOI 10.1016/J.CELREP.2016.12.068
   1999, J MED VIROL, V57, P238
   2015, EMERG INFECT DIS, V21, P359, DOI DOI 10.3201/EID2102.141363
   2007, NAT REV MICROBIOL, V5, P583, DOI DOI 10.1038/NRMICRO1707
   2007, J VIROL, V81, P362, DOI DOI 10.1128/JVI.01404-06
   2017, ANTIVIR RES, V143, P186, DOI DOI 10.1016/J.ANTIVIRAL.2017.04.017
   2016, CELL HOST MICROBE, V20, P259, DOI DOI 10.1016/J.CHOM.2016.07.004
   2002, J VIROL, V76, P3596
   2012, MED RES REV, V32, P349, DOI DOI 10.1002/MED.20216
   2003, J EXP MED, V197, P823, DOI DOI 10.1084/JEM.20021840
   2016, BIOCHEM PHARMACOL, V100, P73, DOI DOI 10.1016/J.BCP.2015.11.001
   2014, BIOCHEM BIOPH RES CO, V453, P539, DOI DOI 10.1016/J.BBRC.2014.09.113
   2008, VIROLOGY, V379, P143, DOI DOI 10.1016/J.VIROL.2008.06.017
   2015, ANTIVIR RES, V121, P39, DOI DOI 10.1016/J.ANTIVIRAL.2015.06.013
   1989, J ANTIBIOT, V42, P344
   2014, LANCET INFECT DIS, V14, P706, DOI DOI 10.1016/S1473-3099(14)70730-3
   2017, J MED CHEM, V60, P511, DOI DOI 10.1021/ACS.JMEDCHEM.6B01021
NR 87
TC 2
Z9 2
U1 4
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD APR 25
PY 2019
VL 62
IS 8
BP 4110
EP 4119
DI 10.1021/acs.jmedchem.9b00142
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HV5VT
UT WOS:000466053900018
PM 30925051
DA 2020-07-08
ER

PT J
AU Nelson, EJ
   Luetke, MC
   Kianersi, S
   Willis, E
   Rosenberg, M
AF Nelson, Erik J.
   Luetke, Maya C.
   Kianersi, Sina
   Willis, Erik
   Rosenberg, Molly
TI Knowledge and perceptions of Zika virus transmission in the community of
   Puerto Plata, Dominican Republic
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Knowledge attitude and practices; KAP; Zika prevention;
   Dominican Republic
ID SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; PREGNANT-WOMEN;
   UNITED-STATES; RISK; COLORADO; DISEASE
AB BackgroundZika virus is associated with increased cases of both microcephaly and Guillain-Barre syndrome. Community knowledge, perceptions and practices to prevent infection with the Zika virus are not well understood, particularly among high risk populations living in resource-poor and Zika-endemic areas. Our objective was to assess knowledge of symptoms, health effects and prevention practices associated with Zika virus in rural communities on the northern coast of the Dominican Republic.MethodsStudy participants were contacted while attending community events such as free medical clinics and invited to be interviewed regarding their knowledge, attitudes, and perceptions of Zika virus using the World Health Organization's Zika survey tool.ResultsOf the 75 Dominicans that participated, 33% did not know who could become infected with Zika. In addition, only 40% of respondents were able to identify mosquitoes or sexual transmission as the primary routes of infection though 51% of respondents thought that Zika was an important issue in their community.ConclusionsThis study found that general knowledge regarding the basic risks and transmission of Zika were not well understood among a sample of rural Dominicans. Our findings highlight disparities in knowledge and perception of risk from Zika in rural areas compared to previous studies conducted in the Dominican Republic. Education about the basic risks and transmission of Zika are critically needed in these remote populations to reduce Zika transmission.
C1 [Nelson, Erik J.; Luetke, Maya C.; Kianersi, Sina; Rosenberg, Molly] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Room C03, Bloomington, IN 47405 USA.
   [Willis, Erik] Indiana Univ, Dept Spanish & Portuguese, Bloomington, IN USA.
RP Nelson, EJ (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Room C03, Bloomington, IN 47405 USA.
EM eriknels@indiana.edu
RI Nelson, Erik/R-7239-2019; Luetke, Maya/AAK-5915-2020
OI Nelson, Erik/0000-0003-1658-8294; Luetke, Maya/0000-0001-6793-245X;
   Rosenberg, Molly/0000-0001-6679-6791; Kianersi, Sina/0000-0003-0950-2675
CR [Anonymous], 2017, ZIK VIR HEALTHC PROV
   Arguelles-Nava VG, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112548
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Beer L, 2014, AIDS, V28, P105, DOI 10.1097/QAD.0000000000000021
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2017, ZIK VIR 2017 CAS COU
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Counotte Michel Jacques, 2018, F1000Res, V7, P196, DOI 10.12688/f1000research.13704.1
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gindi RM, 2011, SEX TRANSM DIS, V38, P260, DOI 10.1097/OLQ.0b013e3181f7d7f4
   Grossi PA, 2018, NEW MICROBIOL, V41, P80
   Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Jenkins P. H., 2010, Morbidity and Mortality Weekly Report, V59, P1637
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Leyser M, 2019, PEDIAT RES
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Ozawa H, 2018, JPN J INFECT DIS, V71, P72, DOI 10.7883/yoken.JJID.2017.256
   Pan American Health Organization, 2016, EM ZIKV RES PROC CON
   Pan American Health Organization, 2017, ZIK CUM CAS
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pooransingh S, 2018, PUBLIC HEALTH, V165, P146, DOI 10.1016/j.puhe.2018.09.025
   Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P457, DOI 10.1097/00007435-199810000-00003
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Shacham E, 2016, AIDS BEHAV, V20, P2863, DOI 10.1007/s10461-016-1383-0
   Shaw R, 2017, INT J GYNECOL OBSTET, V139, P370, DOI 10.1002/ijgo.12258
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827
   The World Bank, 2018, PHYS PER 1000 PEOPL
   US Department of State, 2008, 2008 COUNTR REP HUM
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Widmar Nicole J Olynk, 2017, Prev Med Rep, V6, P162, DOI 10.1016/j.pmedr.2017.02.023
   Workowski K, 2017, PERSPECTIVES SEX TOU
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2017, MAPP SOC SCI RES ZIK
   World Health Organization, 2017, ZIK VIR OUTBR GLOB R
   World Health Organization (WHO), 2016, ZIK VIR COMPL 2016 P
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 53
TC 2
Z9 2
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 24
PY 2019
VL 19
AR 339
DI 10.1186/s12879-019-3952-0
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA HU6RJ
UT WOS:000465408000002
PM 31014275
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Anfasa, F
   Goeijenbier, M
   Widagdo, W
   Siegers, JY
   Mumtaz, N
   Okba, N
   van Riel, D
   Rockx, B
   Koopmans, MPG
   Meijers, JCM
   Martina, BEE
AF Anfasa, Fatih
   Goeijenbier, Marco
   Widagdo, Widagdo
   Siegers, Jurre Y.
   Mumtaz, Noreen
   Okba, Nisreen
   van Riel, Debby
   Rockx, Barry
   Koopmans, Marion P. G.
   Meijers, Joost C. M.
   Martina, Byron E. E.
TI Zika Virus Infection Induces Elevation of Tissue Factor Production and
   Apoptosis on Human Umbilical Vein Endothelial Cells
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; endothelial cells; HUVECs; tissue factor; secondary
   hemostasis; apoptosis
ID HUMAN CYTOMEGALOVIRUS-INFECTION; FACTOR EXPRESSION; COAGULATION;
   FIBRINOLYSIS; INFLAMMATION; CHILDREN; ROLES
AB Zika virus (ZIKV) infection is typically characterized by a mild disease presenting with fever, maculopapular rash, headache, fatigue, myalgia, and arthralgia. A recent animal study found that ZIKV-infected pregnant Ifnar(-/-) mice developed vascular damage in the placenta and reduced amount of fetal capillaries. Moreover, ZIKV infection causes segmental thrombosis in the umbilical cord of pregnant rhesus macaques. Furthermore, several case reports suggest that ZIKV infection cause coagulation disorders. These results suggest that ZIKV could cause an alteration in the host hemostatic response, however, the mechanism has not been investigated thus far. This paper aims to determine whether ZIKV infection on HUVECs induces apoptosis and elevation of tissue factor (TF) that leads to activation of secondary hemostasis. We infected HUVECs with two ZIKV strains and performed virus titration, immunostaining, and flow cytometry to confirm and quantify infection. We measured TF concentrations with flow cytometry and performed thrombin generation test (TGT) as a functional assay to assess secondary hemostasis. Furthermore, we determined the amount of cell death using flow cytometry. We also performed enzyme-linked immunosorbent assay (ELISA) to determine interleukin (IL)-6 and IL-8 production and conducted blocking experiments to associate these cytokines with TF expression. Both ZIKV strains infected and replicated to high titers in HUVECs. We found that infection induced elevation of TF expressions. We also showed that increased TF expression led to shortened TGT time. Moreover, the data revealed that infection induced apoptosis. In addition, there was a significant increase of IL-6 and IL-8 production in infected cells. Here we provide in vitro evidence that infection of HUVECs with ZIKV induces apoptosis and elevation of TF expression that leads to activation of secondary hemostasis.
C1 [Anfasa, Fatih; Goeijenbier, Marco; Widagdo, Widagdo; Siegers, Jurre Y.; Mumtaz, Noreen; Okba, Nisreen; van Riel, Debby; Rockx, Barry; Koopmans, Marion P. G.; Martina, Byron E. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Anfasa, Fatih] Univ Indonesia, Fac Med, Jakarta, Indonesia.
   [Goeijenbier, Marco] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
   [Meijers, Joost C. M.] Sanquin Res, Dept Plasma Prot, Amsterdam, Netherlands.
   [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands.
   [Martina, Byron E. E.] Artemis One Hlth Res Inst, Delft, Netherlands.
RP Anfasa, F; Martina, BEE (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.; Anfasa, F (corresponding author), Univ Indonesia, Fac Med, Jakarta, Indonesia.; Martina, BEE (corresponding author), Artemis One Hlth Res Inst, Delft, Netherlands.
EM fatih.anfasa@gmail.com; b.martina@erasmusmc.nl
RI Okba, Nisreen MA/K-9984-2017; Koopmans, Marion/Y-9170-2019
OI Okba, Nisreen MA/0000-0002-2394-1079; Koopmans,
   Marion/0000-0002-5204-2312
FU Directorate of Higher Education (DIKTI) of the Ministry of Research,
   Technology and Higher Education of the Republic of Indonesia; European
   Union program ZIKAlliance [734548]
FX FA was supported by a Ph.D. scholarship grant from the Directorate of
   Higher Education (DIKTI) of the Ministry of Research, Technology and
   Higher Education of the Republic of Indonesia. This study was supported
   by the European Union program ZIKAlliance (Contract No. 734548). The
   funder had no role in study design, data collection, and interpretation,
   or the decision to publish the work.
CR Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Antoniak S, 2014, BLOOD, V123, P2605, DOI 10.1182/blood-2013-09-526277
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bester J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32188
   Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429
   Bouvy C, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24400
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013
   Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X
   Goeijenbier M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00220
   Greeno EW, 1996, LAB INVEST, V75, P281
   Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   KARBER G, 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lepais L, 2014, PLACENTA, V35, P611, DOI 10.1016/j.placenta.2014.04.012
   Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X
   Levi M, 2015, SEMIN THROMB HEMOST, V41, P9, DOI 10.1055/s-0034-1398376
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Neumann FJ, 1997, ARTERIOSCL THROM VAS, V17, P3399, DOI 10.1161/01.ATV.17.12.3399
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peyrefitte CN, 2006, J MED VIROL, V78, P229, DOI 10.1002/jmv.20532
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rahbar A, 2005, J VIROL, V79, P2211, DOI 10.1128/JVI.79.4.2211-2220.2005
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Ruf W, 2004, TRENDS IMMUNOL, V25, P461, DOI 10.1016/j.it.2004.07.002
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sosothikul D, 2007, THROMB HAEMOSTASIS, V97, P627, DOI 10.1160/TH06-02-0094
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takeuchi S, 2015, CANCER RES, V75, P2629, DOI 10.1158/0008-5472.CAN-14-2921
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   WADA H, 1995, BLOOD COAGUL FIBRIN, V6, pS26, DOI 10.1097/00001721-199506001-00005
   Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Yang AZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01188
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 48
TC 4
Z9 4
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 24
PY 2019
VL 10
AR 817
DI 10.3389/fmicb.2019.00817
PG 11
WC Microbiology
SC Microbiology
GA HU6SQ
UT WOS:000465411500001
PM 31068911
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhou, XJ
   Yang, C
   Liu, N
   Li, M
   Tong, Y
   Zeng, XP
   Qiu, XH
AF Zhou, Xiaojie
   Yang, Chan
   Liu, Nian
   Li, Mei
   Tong, Ying
   Zeng, Xiaopeng
   Qiu, Xinghui
TI Knockdown resistance (kdr) mutations within seventeen field populations
   of Aedes albopictus from Beijing China: first report of a novel V1016G
   mutation and evolutionary origins of kdr haplotypes
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; Insecticide resistance; kdr; Voltage-gated sodium
   channel; Haplotype; Beijing
ID PYRETHROID RESISTANCE; INSECTICIDE RESISTANCE; VGSC GENE; AEGYPTI;
   VECTOR; IDENTIFICATION; MOSQUITOS; F1534C; CITY
AB BackgroundAedes albopictus (Skuse) is an important vector of chikungunya, dengue, yellow fever and Zika viruses. In the absence of anti-viral medication and with limited availability of a commercial vaccine for public health use, vector control remains an effective means for reducing Aedes-borne disease morbidity. Knowledge about genetic mutations associated with insecticide resistance (IR) is a prerequisite for developing rapid resistance diagnosis, and the distribution and frequency of IR conferring mutations is important information for making smart vector control decisions.MethodsPartial DNA sequences of domain II and domain III of Ae. albopictus voltage gated sodium channel (VGSC) gene were amplified from a total of 426 individuals, collected from 17 sites in the Beijing municipality. These DNA fragments were sequenced to discover the possible genetic mutations mediating knockdown resistance (kdr) to pyrethroids. The frequency and distribution of kdr mutations were assessed in the 17 Ae. albopictus populations. The origin of kdr mutations was investigated by haplotype clarification and phylogenetic analysis.ResultsSequence alignments revealed the existence of multiple mutations (V1016G, I1532T, F1534S and F1534L) in VGSC. The highest frequency of the mutant 1016G allele (0.647) was found in Haidian, while 1016G was not detected in Huai Rou, Yan Qing, Ping Gu and Shun Yi. The frequency of 1532T was highest (0.537) in the population from the Olympic Forest Park (OFP, Chao Yang District), but not detectable in Huai Rou and Mi Yun. Two mutations were observed at codon 1534 with different distribution patterns: 1534L was only found in Tong Zhou (TZ) with a frequency of 0.017, while 1534S was distributed in TZ, OFP, Fang Shan, Da Xing and Shi Jing Shan with frequencies ranging from 0.019 (OFP) to 0.276 (TZ). One 1016G, one 1532T, one 1534L and two 1534S haplotypes were identified.ConclusionsMultiple mutations (V1016G, I1532T, F1534L/S) in VGSC were found in Ae. albopictus in Beijing. This represents the first report of V1016G in Ae. albopictus. Sequence alignment and phylogenetic analysis revealed multiple origins of 1534S. The spatial heterogeneity in distribution and frequency of kdr mutations calls for a site-specific strategy for the monitoring of insecticide resistance. The relatively high frequencies of V1016G warn of a risk of pyrethroid resistance in mosquitoes in the urban zones.
C1 [Zhou, Xiaojie; Tong, Ying; Zeng, Xiaopeng] Beijing Ctr Dis Control & Prevent, Beijing Res Ctr Prevent Med, Beijing 100013, Peoples R China.
   [Zhou, Xiaojie; Yang, Chan; Liu, Nian; Li, Mei; Qiu, Xinghui] Chinese Acad Sci, State Key Lab Integrated Management Pest Insects, Inst Zool, Beijing 100101, Peoples R China.
   [Yang, Chan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Liu, Nian] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230039, Anhui, Peoples R China.
RP Zeng, XP (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Res Ctr Prevent Med, Beijing 100013, Peoples R China.; Qiu, XH (corresponding author), Chinese Acad Sci, State Key Lab Integrated Management Pest Insects, Inst Zool, Beijing 100101, Peoples R China.
EM zhouxj@163.com; xpzeng@126.com; qiuxh@ioz.ac.cn
OI Qiu, Xinghui/0000-0003-2420-4705
FU Science and Technology Development Project of Beijing Municipal Medical
   Research Institutes [PXM2017_026278_000006]; State Key Laboratory of
   Integrated Management of Pest Insects and Rodents [IPM1812]
FX This work was supported by Science and Technology Development Project of
   Beijing Municipal Medical Research Institutes (PXM2017_026278_000006)
   and the State Key Laboratory of Integrated Management of Pest Insects
   and Rodents (IPM1812). The funders had no role in the study design, data
   collection, analysis, decision to publish or preparation of the
   manuscript.
CR Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chen Han-ming, 2018, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V29, P120
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003
   Gao JP, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0471-y
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Li YJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2581-y
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muthusamy R, 2015, ACTA TROP, V148, P137, DOI 10.1016/j.actatropica.2015.04.026
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Rath A, 2018, PEST MANAG SCI, V74, P1431, DOI 10.1002/ps.4827
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Zhang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042830
   Zhang Sheng-Nian, 2002, Environ Health Prev Med, V7, P132, DOI 10.1265/ehpm.2002.132
   Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548
NR 44
TC 3
Z9 4
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 24
PY 2019
VL 12
AR 180
DI 10.1186/s13071-019-3423-x
PG 16
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HU8BP
UT WOS:000465507600003
PM 31014392
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ruiz-Arrondo, I
   McMahon, BJ
   Hernandez-Triana, LM
   Santibanez, P
   Portillo, A
   Oteo, JA
AF Ruiz-Arrondo, Ignacio
   McMahon, Barry J.
   Hernandez-Triana, Luis M.
   Santibanez, Paula
   Portillo, Aranzazu
   Antonio Oteo, Jose
TI Surveillance of Mosquitoes (Diptera, Culicidae) in a Northern Central
   Region of Spain: Implications for the Medical Community
SO FRONTIERS IN VETERINARY SCIENCE
LA English
DT Article
DE surveillance; mosquito; One Health; flavivirus; molecular
   identification; La Rioja; Northern Spain
ID WEST NILE VIRUS; FLAVIVIRUSES; IDENTIFICATION; RICKETTSIA; MALARIA;
   ENGLAND; SYSTEM; FEVER
AB Mosquitoes are important to public and animal health due to their capacity to transmit diseases. Since the Zika virus was declared a pandemic by the WHO in 2016, and it has been recorded in different regions of Mediterranean Area (included Spain), the Government of La Rioja (Northern Spain) through the Center of Rickettsiosis and Arthropod-Borne Diseases, implemented an entomological surveillance programme of mosquitoes in La Rioja and in a close area of Navarra. This surveillance extended to some of the pathogens that they can transmit. Here we describe the framework of the initial surveillance programme for the detection of mosquitoes and associated human pathogens. We outline the benefits and the limitation of the programme to date, and explore how greater benefits can be achieved, for example using a One Health approach. Entomological surveillance has been carried out with BG-Sentinel traps, human bait technique and other methods such as collecting adults in resting places or immature stages by dipping in several wetlands. Since Aedes albopictus, vector of arbovirus such as Dengue, Chikungunya, and Zika, has not been detected yet in the region, the entomological programme included the surveillance of this exotic species using ovitraps in the most important cities. Morphological identification was supported using the mitochondrial cytochrome C oxidase subunit I and the internal transcribed spacer 2 genes analysis. In 2016 and 2017, more than 6,000 mosquitoes were collected. The mosquito's community included 21 species associated with six genera: Anopheles (n = 4), Aedes (n = 5), Culex (n = 6), Cullseta (n = 4), Uranotaenia (n = 1) and Coquillettidia (n = 1). Eleven species represent new records for La Rioja and Navarra regions. Several species were collected biting humans and a great proportion of the sampled mosquito population are competent vectors of several pathogens, such as West Nile virus. Sequences closely related to mosquito-only flavivirus have been detected in 0.34% of analysed pools. At the same time, the epidemiological surveillance emphasis is placed in the early detection of mosquito-borne diseases in primary health and emergency services. The surveillance programme represents a relevant and necessary assessment of the risk of pathogen transmission in a region, and it allows for the establishment of the appropriate preventive measures.
C1 [Ruiz-Arrondo, Ignacio; Santibanez, Paula; Portillo, Aranzazu; Antonio Oteo, Jose] Hosp Univ San Pedro, CIBIR, Ctr Rickettsiosis & Arthropod Borne Dis, Logrono, Spain.
   [McMahon, Barry J.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin, Ireland.
   [Hernandez-Triana, Luis M.] Anim & Plant Hlth Agcy, Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Addlestone, Surrey, England.
RP Oteo, JA (corresponding author), Hosp Univ San Pedro, CIBIR, Ctr Rickettsiosis & Arthropod Borne Dis, Logrono, Spain.
EM jaoteo@riojasalud.es
RI Oteo, Jose A./AAB-3134-2020; Arrondo, Ignacio Ruiz/R-8385-2018
OI McMahon, Barry John/0000-0003-3143-8075; Oteo, Jose
   A./0000-0001-7080-6542; Ruiz Arrondo, Ignacio/0000-0001-8198-8118
FU European Regional Development Fund (ERDF)European Union (EU); EUEuropean
   Union (EU) [653316]; UK Department for Environment and Rural Affairs
   (DEFRA)Department for Environment, Food & Rural Affairs (DEFRA);
   Scottish Government; Welsh Government [SV3045, SE4113]
FX This work was partly supported by the European Regional Development Fund
   (ERDF). LH-T would like thank the EU Framework Horizon 2020 Innovation
   Grant, European Virus Archive (EVAg, grant no. 653316) and the UK
   Department for Environment and Rural Affairs (DEFRA), Scottish
   Government and Welsh Government (grants nos. SV3045, SE4113) for
   contributions to funding this study.
CR Alarcon-Elbal P.M., 2012, Boletin de la SEA, V50, P359
   Alarcon-Elbal P.M., 2010, Revista Ibero-Latinoamericana de Parasitologia, V69, P140
   Alba A, 2014, ZOONOSES PUBLIC HLTH, V61, P181, DOI 10.1111/zph.12048
   Aranda C, 2009, VECTOR-BORNE ZOONOT, V9, P171, DOI 10.1089/vbz.2008.0073
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bellini R, 2014, EUROSURVEILLANCE, V19, P16, DOI 10.2807/1560-7917.ES2014.19.44.20953
   Bueno Mari R., 2012, ZUBIA, V30, P141
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176
   Chapman GE, 2017, VET REC, V180, P19, DOI 10.1136/vr.103825
   Danis K, 2013, TRAVEL MED INFECT DI, V11, P8, DOI 10.1016/j.tmaid.2013.01.001
   DASKOVA NG, 1982, B WORLD HEALTH ORGAN, V60, P893
   de La Rioja Gobierno, 2016, PLAN RIOJANO ACCION
   de La Rioja Gobierno, 2014, INFORM RESULTADOS CA
   Delacour Estrella S, 2011, 28 JORN AS ESP ENT P, P95
   ECDC, 2017, CLUST AUT CHIK CAS F
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   European Centre for Disease Prevention and Control, 2014, GUID SURV NAT MOSQ E
   European Centre for Disease Prevention and Control, 2018, LOC TRANSM DENG FEV
   Fernandez-Balbuena S, 2018, EVALUACION RAPIDA RI
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Figuerola J., 2018, REV ENF EMER, V17, P81
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   Garcia Ruiz JM, 1994, GEOGRAFIA RIOJA GEOG, V1, P36
   Gunay F, 2015, ACTA TROP, V143, P112, DOI 10.1016/j.actatropica.2014.10.013
   Haussig JM, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.32.1800428
   Healy JM, 2015, VECTOR-BORNE ZOONOT, V15, P147, DOI 10.1089/vbz.2014.1689
   Hernandez-Triana LM, 2017, ZOOTAXA, V4250, P67, DOI 10.11646/zootaxa.4250.1.5
   Ibarra V, 2012, CLIN MICROBIOL INFEC, V18, pE283, DOI 10.1111/j.1469-0691.2012.03887.x
   Johnson I, 2018, ZOONOSES PUBLIC HLTH, V65, pE229, DOI 10.1111/zph.12433
   Kampen H, 2003, AM J TROP MED HYG, V69, P195, DOI 10.4269/ajtmh.2003.69.195
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kruger A, 2001, TROP MED INT HEALTH, V6, P983, DOI 10.1046/j.1365-3156.2001.00816.x
   Lundstrom J. O., 1994, Bulletin of the Society for Vector Ecology, V19, P23
   Martinez-de la Puente J, 2018, TRACING PATHOGEN TRA
   Martinez-de la Puente J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20825-z
   McMahon BJ, 2018, ZOONOSES PUBLIC HLTH, V65, P755, DOI 10.1111/zph.12489
   Medlock J, 2018, EFSA SUPPORTING PUBL
   Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x
   Melero-Alcibar R., 2005, Boletin de la SEA, V36, P347
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Oteo JA, 2004, CLIN MICROBIOL INFEC, V10, P327, DOI 10.1111/j.1198-743X.2004.00782.x
   Palmer JRB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00914-9
   Palomar AM, 2016, TICKS TICK-BORNE DIS, V7, P983, DOI 10.1016/j.ttbdis.2016.05.004
   Paternoster G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188156
   Paternoster G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00236
   Petrovic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195439
   Portillo A, 2018, MED CLIN-BARCELONA, V151, P450, DOI 10.1016/j.medcli.2018.06.021
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Ruiz-Arrondo I, 2017, ZUBIA, V35, P123
   Ruiz-Arrondo I, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3046-7
   Sanchez A, 2013, INFORM SITUACION EVA
   Sanchez-Seco MP, 2010, VECTOR-BORNE ZOONOT, V10, P203, DOI 10.1089/vbz.2008.0188
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Santa-Olalla P, 2010, EUROSURVEILLANCE, V15, P9
   Schaffner F., 2001, MOSQUITOES EUROPE
   SHUTE PG, 1974, ROY SOC HEALTH J, V94, P23, DOI 10.1177/146642407409400111
   Sokolova Marina I., 2002, European Mosquito Bulletin, V12, P1
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Torok E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1484-7
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Versteirt V, 2015, MOL ECOL RESOUR, V15, P449, DOI 10.1111/1755-0998.12318
NR 67
TC 3
Z9 3
U1 4
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-1769
J9 FRONT VET SCI
JI Front. Vet. Sci.
PD APR 23
PY 2019
VL 6
AR 86
DI 10.3389/fvets.2019.00086
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA HX6NZ
UT WOS:000467521600001
PM 31065550
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oya, NJ
   Esler, WP
   Huard, K
   El-Kattan, AF
   Karamanlidis, G
   Blazquez, AB
   Ramos-Ibeas, P
   Escribano-Romero, E
   Louloudes-Lazaro, A
   Casas, J
   Sobrino, F
   Hoehn, K
   James, DE
   Gutierrez-Adan, A
   Saiz, JC
   Martin-Acebes, MA
AF Jimenez de Oya, Nereida
   Esler, William P.
   Huard, Kim
   El-Kattan, Ayman F.
   Karamanlidis, Georgios
   Blazquez, Ana-Belen
   Ramos-Ibeas, Priscila
   Escribano-Romero, Estela
   Louloudes-Lazaro, Andres
   Casas, Josefina
   Sobrino, Francisco
   Hoehn, Kyle
   James, David E.
   Gutierrez-Adan, Alfonso
   Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
TI Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase
   reduces flavivirus infection in mouse models
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Flavivirus; West Nile virus; dengue virus; Zika virus; antivirals
ID WEST NILE VIRUS; DENGUE; REPLICATION; COA; URINE
AB Flaviviruses are (re)-emerging RNA viruses strictly dependent on lipid metabolism for infection. In the search for host targeting antivirals, we explored the effect of pharmacological modulation of fatty acid metabolism during flavivirus infection. Considering the central role of acetyl-Coenzyme A carboxylase (ACC) on fatty acid metabolism, we analyzed the effect of three small-molecule ACC inhibitors (PF-05175157, PF-05206574, and PF-06256254) on the infection of medically relevant flaviviruses, namely West Nile virus (WNV), dengue virus, and Zika virus. Treatment with these compounds inhibited the multiplication of the three viruses in cultured cells. PF-05175157 induced a reduction of the viral load in serum and kidney in WNV-infected mice, unveiling its therapeutic potential for the treatment of chronic kidney disease associated with persistent WNV infection. This study constitutes a proof of concept of the reliability of ACC inhibitors to become viable antiviral candidates. These results support the repositioning of metabolic inhibitors as broad-spectrum antivirals.
C1 [Jimenez de Oya, Nereida; Blazquez, Ana-Belen; Escribano-Romero, Estela; Louloudes-Lazaro, Andres; Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Carretera A Coruna Km 7-5, Madrid 28040, Spain.
   [Esler, William P.; Huard, Kim; El-Kattan, Ayman F.; Karamanlidis, Georgios] Worldwide Res & Dev Pfizer, Cambridge, MA USA.
   [Ramos-Ibeas, Priscila; Gutierrez-Adan, Alfonso] INIA, Dept Anim Reprod, Madrid, Spain.
   [Casas, Josefina] Inst Adv Chem Catalonia IQAC CSIC, Dept Biomed Chem, Barcelona, Spain.
   [Casas, Josefina] CIBEREHD, Barcelona, Spain.
   [Sobrino, Francisco] Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Virol & Microbiol, Madrid, Spain.
   [Hoehn, Kyle] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [James, David E.] Univ Sydney, Sydney Med Sch, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Karamanlidis, Georgios] Cardiometab Disorders Amgen Discovery Res, Thousand Oaks, CA 91320 USA.
RP Saiz, JC; Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Carretera A Coruna Km 7-5, Madrid 28040, Spain.
EM jcsaiz@inia.es; martin.mangel@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Ramos-Ibeas, Priscila/Q-5943-2018;
   Gutierrez-Adan, Alfonso/A-1485-2014; de Oya, Nereida
   Jimenez/T-6449-2019; Blazquez, Ana/G-9791-2015; Escribano-Romero,
   Estela/H-1495-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Ramos-Ibeas,
   Priscila/0000-0003-4578-0189; Gutierrez-Adan,
   Alfonso/0000-0001-9893-9179; de Oya, Nereida
   Jimenez/0000-0003-3129-813X; Sobrino, Francisco/0000-0003-4968-8291;
   Hoehn, Kyle/0000-0002-0214-3238; Blazquez, Ana/0000-0002-0847-0977;
   Escribano-Romero, Estela/0000-0002-5036-7607
FU Spanish Ministry of Economy and Competitiveness (MINECO) Fondo Europeo
   de Desarrollo Regional (FEDER) [AGL2014-56518-JIN]; INIAInstituto de
   Investigacion Agropecuaria (INIA) [RTA2015-009]; Comunidad Autonoma de
   MadridComunidad de Madrid [P2013/ABI-2906]; Pfizer Compound Transfer
   Program [WI215864, WI201531]
FX This work was supported by Spanish Ministry of Economy and
   Competitiveness (MINECO) Fondo Europeo de Desarrollo Regional (FEDER)
   under Grant AGL2014-56518-JIN to M.A.M-A; INIA under Grant RTA2015-009
   to J.-C.S.; and the Comunidad Autonoma de Madrid under Grant
   P2013/ABI-2906 (PLATESA) to J.-C.S and F.S. We thank the Pfizer Compound
   Transfer Program (Grants WI215864 and WI201531 to M.A.M.-A.) for
   providing the ACC inhibitors for cell culture and in vivo assays.
CR Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102
   Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bagley SW, 2011, Patent No. [US 2011111046, 2011111046]
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Di L, 2011, J PHARM SCI-US, V100, P4974, DOI 10.1002/jps.22674
   Dow LR, 2012, Patent No. [US 2012270893, 2012270893]
   Ergunay K, 2015, J MED VIROL, V87, P1625, DOI 10.1002/jmv.24226
   Fleta-Soriano E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00739-17, 10.1128/aac.00739-17]
   Greseth MD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004021
   Griffith DA, 2014, J MED CHEM, V57, P10512, DOI 10.1021/jm5016022
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hardie DG, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0774
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Jones JEC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169566
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kao YT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004750
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liebscher S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007029
   Lyn RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04549
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray KO, 2017, AM J TROP MED HYG, V97, P1913, DOI 10.4269/ajtmh.17-0405
   Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Opie LH, 2015, TRENDS CARDIOVAS MED, V25, P216, DOI 10.1016/j.tcm.2014.10.002
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pombo JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01276
   Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Spencer CM, 2011, J VIROL, V85, P5814, DOI 10.1128/JVI.02630-10
   Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829
   Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zhang JS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02286
NR 58
TC 5
Z9 5
U1 2
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 19
PY 2019
VL 8
IS 1
BP 624
EP 636
DI 10.1080/22221751.2019.1604084
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HU0NR
UT WOS:000464968100002
PM 30999821
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ohki, CMY
   Benazzato, C
   Russo, FB
   Beltrao-Braga, PCB
AF Yde Ohki, Cristine Marie
   Benazzato, Cecilia
   Russo, Fabiele Baldino
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Developing animal models of Zika virus infection for novel drug
   discovery
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Review
DE Animal model; azithromycin; chloroquine; congenital Zika syndrome; drug
   discovery; galidesivir; niclosamide; novobiocin; sofosbuvir; ZIKV
AB Introduction: Just before the Brazilian outbreak, Zika virus was related to a mild infection, causing fever and skin rash. Congenital Zika Syndrome was first described in Brazil, causing microcephaly and malformations in newborns. Three years after the outbreak, the mechanisms of Zika pathogenesis are still not completely elucidated. Moreover, as of today, there is still no approved vaccine that can be administered to the susceptible population. Considering the unmet clinical need, animal models represent an unprecedented opportunity to study Zika pathophysiology and test drugs for the treatment and prevention of vertical transmission. Areas covered: The authors explore the current knowledge about Zika through animal models and advancements in drug discovery by highlighting drugs with the greatest potential to treat ZIKV infection and block vertical transmission. Expert opinion: Some drugs used to treat other infections have been repurposed to treat Zika infection, reducing the cost and time for clinical application. One promising example is Sofosbuvir, which protected mice models against Zika pathogenesis by preventing vertical transmission. Importantly, there is a lack on exploration on the long-term effects of Zika Congenital Syndrome, as well as the possible ways to treat its sequelae.
C1 [Yde Ohki, Cristine Marie; Benazzato, Cecilia; Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   [Benazzato, Cecilia] Univ Sao Paulo, Sch Vet Med, Dept Surg, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Av Prof Lineu Prestes 1374,2nd Floor,Room 227, BR-05508900 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Benazzato,
   Cecilia/AAB-8869-2019; Benazzato, Cecilia/U-5873-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Benazzato,
   Cecilia/0000-0002-8656-0871
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [18/16748-8,
   16/02978-6]; Brazilian NGO 'the tooth fairy project'; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)CAPES [001];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was sponsored by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) (18/16748-8; 16/02978-6), the Brazilian NGO 'the
   tooth fairy project' and in part by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001; and the
   CNPq.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   ABBINK P, 2018, INTERNET, V353, P1129, DOI DOI 10.1126/SCIENCE.AAH6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   ALVARADO MG, 2018, INTERNET, V141, P26, DOI DOI 10.5858/ARPA.2016-0382-RA
   AOKI K, 2018, INTERNET, V11, P105, DOI DOI 10.1186/1743-422X-11-105
   Azar SR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110661
   AZAR SR, 2018, AM J TROP MED HYG, V6, P1362, DOI DOI 10.4269/AJTMH.16-0111
   BARROWS NJ, 2018, INTERNET, V20, P259, DOI DOI 10.1016/J.CHOM.2016.07.004
   BERECZKY S, 2018, INTERNET, V91, P1473, DOI DOI 10.1099/VIR.0.019034-0
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bidokhti MRM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006811
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Broek MF, 1995, IMMUNOL REV, V148, P5
   Browning DJ, 2014, HYDROXYCHLOROQUINE C, DOI [10.1007/978-1-4939-0597-3, DOI 10.1007/978-1-4939-0597-3]
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   BULLARDFEIBELMA.KM, 2018, INTERNET, V137, P134, DOI DOI 10.1016/J.ANTIVIRAL.2016.11.023
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   CAOLORMEAU V, 2018, INTERNET, V387, P1531, DOI DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   CARTEAUX G, 2018, INTERNET, V374, P1595, DOI DOI 10.1056/NEJMC1602964
   CHAN J, 2018, INTERNET, V14, P112, DOI DOI 10.1016/J.EBIOM.2016.11.017
   Chang C., 2018, ROBOTICA, V05, P1
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARBELLAY J, 2018, INTERNET, V25, P73, DOI DOI 10.1016/J.EBIOM.2017.09.021
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   DENG Y, 2018, INTERNET, V8, P1648, DOI DOI 10.1038/S41467-017-01923-4
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DOWALL SD, 2018, INTERNET, V93, P560, DOI DOI 10.1099/VIR.0.038455-0
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   DOWD KA, 2018, INTERNET, V354, P237, DOI DOI 10.1126/SCIENCE.AAI9137
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FOY BD, 2018, INTERNET, V17, P880, DOI DOI 10.3201/EID1705.101939
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   GOVERO J, 2018, INTERNET, V540, P438, DOI DOI 10.1038/NATURE20556
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   HADDOW AD, 2018, INTERNET, V23, P1274, DOI DOI 10.3201/EID2308.170036
   HAZIN AN, 2018, INTERNET, V374, P2193, DOI DOI 10.1056/NEJMC1603617
   HUANG S, 2018, INTERNET, V259, P1742
   IMPERATO PJ, 2018, INTERNET, V41, P674, DOI DOI 10.1007/S10900-016-0177-7
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   LAMONICA BE, 2018, INTERNET, V22, P747, DOI DOI 10.1016/J.CONB.2012.03.006
   LAROCCA RA, 2018, INTERNET, V536, P474, DOI DOI 10.1038/NATURE18952
   LAZEAR HM, 2018, INTERNET, V19, P720, DOI DOI 10.1016/J.CHOM.2016.03.010
   LI C, 2018, INTERNET, V19, P120
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lim S-Y, 2016, OPEN FORUM INFECT DI, V3
   Lim SY, 2017, OPEN FORUM INFECT DI, DOI [DOI 10.1093/ofid/ofx162.129, 10.1093/ofid/ofx162.129]
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   LIZARRAGA SB, 2018, INTERNET, V137, P1907, DOI DOI 10.1242/DEV.040410
   MA W, 2005, INTERNET, V167, P1511, DOI DOI 10.1016/J.CELL.2016.11.016
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   MAGNANI DM, 2018, INTERNET, V9, P1, DOI DOI 10.1038/S41467-018-04056-4
   MEIER KC, 2018, INTERNET, V5
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Miller LJ, 2018, AM J TROP MED HYG, V98, P864, DOI 10.4269/ajtmh.17-0686
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MULLER U, 2018, INTERNET, V264, P1918
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   MUSSO D, 2018, INTERNET, V21, P359, DOI DOI 10.3201/EID2102.141363
   MUSSO D, 2018, INTERNET, V29, P487, DOI DOI 10.1128/CMR.00072-15
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Oliveira-Melo AS, 2016, INTERNET, V47, P6
   OROZCO S, 2018, INTERNET, V93, P2152, DOI DOI 10.1099/VIR.0.045088-0
   OSUNA CE, 2010, INTERNET, V216, pS928, DOI DOI 10.1093/INFDIS/JIX540
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   PARTIDOS CD, 2018, INTERNET, V30, P4638, DOI DOI 10.1016/J.VACCINE.2012.04.099
   Pessoa A, 2016, INTERNET, V65, P1343
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   PRESTWOOD TR, 2018, INTERNET, V86, P12561, DOI DOI 10.1128/JVI.06743-11
   PULVERS JN, 2018, INTERNET, V107, P16595, DOI DOI 10.1073/PNAS.1010494107
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Schuler-Faccini L, 2016, INTERNET, V65, P59
   SEYMOUR RL, 2018, INTERNET, V88, P1170, DOI DOI 10.4269/AJTMH.12-0674
   SHAN C, 2018, INTERNET, V19, P891, DOI DOI 10.1016/J.CHOM.2016.05.004
   SHRESTA S, 2018, INTERNET, V78, P2701, DOI DOI 10.1128/JVI.78.6.2701-2710.2004
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Sun YQ, 2018, INORG CHEM FRONT, V5, P145, DOI 10.1039/c7qi00491e
   TANG WW, 2018, INTERNET, V17, P3091, DOI DOI 10.1016/J.CELREP.2016.11.070
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Viranaicken W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010038
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WANG S, 2018, INTERNET, V27, P158, DOI DOI 10.1038/CR.2016.144
   WARREN TK, 2018, INTERNET, V508, P402, DOI DOI 10.1038/NATURE13027
   WIKAN N, 2018, INTERNET, V16, pE119, DOI DOI 10.1016/S1473-3099(16)30010-X
   WU K, 2018, INTERNET, V26, P645, DOI DOI 10.1038/CR.2016.58
   WU Y, 2018, INTERNET, V12
   YAUCH LE, 2018, INTERNET, V182, P4865, DOI DOI 10.4049/JIMMUNOL.0801974
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   YOCKEY LJ, 2005, INTERNET, V166, P1247, DOI DOI 10.1016/J.CELL.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 106
TC 2
Z9 2
U1 1
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD JUN 3
PY 2019
VL 14
IS 6
BP 577
EP 589
DI 10.1080/17460441.2019.1597050
EA APR 2019
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HY1MA
UT WOS:000466002200001
PM 30991850
DA 2020-07-08
ER

PT J
AU Collins, MH
   Tu, HA
   Gimblet-Ochieng, C
   Liou, GJA
   Jadi, RS
   Metz, SW
   Thomas, A
   McElvany, BD
   Davidson, E
   Doranz, BJ
   Reyes, Y
   Bowman, NM
   Becker-Dreps, S
   Bucardo, F
   Lazear, HM
   Diehl, SA
   de Silva, AM
AF Collins, Matthew H.
   Tu, Huy A.
   Gimblet-Ochieng, Ciara
   Liou, Guei-Jiun Alice
   Jadi, Ramesh S.
   Metz, Stefan W.
   Thomas, Ashlie
   McElvany, Benjamin D.
   Davidson, Edgar
   Doranz, Benjamin J.
   Reyes, Yaoska
   Bowman, Natalie M.
   Becker-Dreps, Sylvia
   Bucardo, Filemon
   Lazear, Helen M.
   Diehl, Sean A.
   de Silva, Aravinda M.
TI Human antibody response to Zika targets type-specific quaternary
   structure epitopes
SO JCI INSIGHT
LA English
DT Article
ID HUMAN NEUTRALIZING ANTIBODIES; TICK-BORNE ENCEPHALITIS; B-CELL
   RESPONSES; DENGUE VIRUS; MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY;
   DEPENDENT ENHANCEMENT; DISEASE ENHANCEMENT; YELLOW-FEVER; PROTECTION
AB The recent Zika virus (ZIKV) epidemic in the Americas has revealed rare but serious manifestations of infection. ZIKV has emerged in regions endemic for dengue virus (DENV), a closely related mosquito-borne flavivirus. Cross-reactive antibodies confound studies of ZIKV epidemiology and pathogenesis. The immune responses to ZIKV may be different in people, depending on their DENV immune status. Here, we focus on the human B cell and antibody response to ZIKV as a primary flavivirus infection to define the properties of neutralizing and protective antibodies generated in the absence of preexisting immunity to DENV. The plasma antibody and memory B cell response is highly ZIKV type-specific, and ZIKV-neutralizing antibodies mainly target quaternary structure epitopes on the viral envelope. To map viral epitopes targeted by protective antibodies, we isolated 2 type-specific monoclonal antibodies (mAbs) from a ZIKV case. Both mAbs were strongly neutralizing in vitro and protective in vivo. The mAbs recognize distinct epitopes centered on domains I and II of the envelope protein. We also demonstrate that the epitopes of these mAbs define antigenic regions commonly targeted by plasma antibodies in individuals from endemic and nonendemic regions who have recovered from ZIKV infections.
C1 [Collins, Matthew H.] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Collins, Matthew H.] Emory Univ, Sch Med, Div Infect Dis, Hope Clin,Emory Vaccine Ctr,Dept Med, Decatur, GA 30033 USA.
   [Collins, Matthew H.; Bowman, Natalie M.] Univ N Carolina, Sch Med, Div Infect Dis, Dept Med, Chapel Hill, NC 27515 USA.
   [Tu, Huy A.; Diehl, Sean A.] Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT USA.
   [Tu, Huy A.; McElvany, Benjamin D.; Diehl, Sean A.] Univ Vermont, Larner Coll Med, Vaccine Testing Ctr, Dept Microbiol & Mol Genet, Burlington, VT USA.
   [Gimblet-Ochieng, Ciara; Liou, Guei-Jiun Alice; Jadi, Ramesh S.; Metz, Stefan W.; Thomas, Ashlie; Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA.
   [Reyes, Yaoska; Bucardo, Filemon] Natl Autonomous Univ Leon, Fac Med Sci, Dept Microbiol, Leon, Nicaragua.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Publ Hlth, Dept Family Med, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP de Silva, AM (corresponding author), CB 7292,9024 Burnett Womack,160 Dent Circle, Chapel Hill, NC 27599 USA.; Diehl, SA (corresponding author), Room C205,Given Med Bldg,89 Beaumt Ave, Burlington, VT 05405 USA.
EM sean.diehl@med.uvm.edu; aravinda_desilva@med.unc.edu
RI Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X; Metz, Stefan/0000-0002-9249-2844; Liou,
   Guei-Jiun/0000-0003-4451-9077
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI107731, 5T32AI007151-40,
   T32AI055402, P20GM125498, CDC BAA 2017-N-18041, R21AI129532,
   S10-ODO18175, P30 GM118228, P30GM118228, HHSN272201400058C]; UNC
   Lineberger Comprehensive Cancer Center
FX We thank the study volunteers and clinical staff at the UNC Travelers
   Clinic and Edwin Centeno for assistance with specimens from Leon,
   Nicaragua. This study was supported by NIH grants R01AI107731 (to AMDS),
   5T32AI007151-40 (to MHC), T32AI055402 (to HAT), P20GM125498 (to SAD),
   and CDC BAA 2017-N-18041 (to AMDS). Mouse experiments were supported by
   start-up funds from the UNC Lineberger Comprehensive Cancer Center (to
   HML). The Zika-TS cohort in 749 Leon, Nicaragua was supported with NIH
   grant R21AI129532 (to SBD and FB). At the University of Vermont, cell
   sorting was performed by the UVM-COM Flow Cytometry and Cell Sorting
   Facility (with thanks to Roxana del Rio-Guerra) and supported by NIH
   grant S10-ODO18175 (to Jonathan Boyson) and NIH grant P30 GM118228.
   Sequencing work was performed by the Vermont Integrated Genomics
   Resource and supported by NIH grant P30GM118228. NIH contract
   HHSN272201400058C (to BJD) supported epitope mapping.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Collins M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.82
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadjilaou A, 2015, J IMMUNOL, V195, P3490, DOI 10.4049/jimmunol.1500918
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lo Conte L, 1999, J MOL BIOL, V285, P2177
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Metz SW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0970-2
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ng T, 2003, Dev Biol (Basel), V114, P221
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zent O, 2005, J TRAVEL MED, V12, P85
NR 84
TC 6
Z9 6
U1 0
U2 3
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD APR 18
PY 2019
VL 4
IS 8
AR e124588
DI 10.1172/jci.insight.124588
PG 18
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HU5QS
UT WOS:000465334200006
PM 30996133
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Neuroimaging findings using transfontanellar ultrasound in newborns with
   microcephaly and Zika virus infection: a comment
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Letter
ID BRAIN
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Joob B, 2017, CLIN NEUROPHYSIOL, V128, P289, DOI 10.1016/j.clinph.2016.12.009
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 6
TC 0
Z9 0
U1 1
U2 40
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD APR 18
PY 2019
VL 32
IS 8
BP 1397
EP 1397
DI 10.1080/14767058.2017.1404984
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HH1OI
UT WOS:000455489100026
PM 29132236
DA 2020-07-08
ER

PT J
AU Scalvenzi, L
   Radice, M
   Toma, L
   Severini, F
   Boccolini, D
   Bella, A
   Guerrini, A
   Tacchini, M
   Sacchetti, G
   Chiurato, M
   Romi, R
   Di Luca, M
AF Scalvenzi, Laura
   Radice, Matteo
   Toma, Luciano
   Severini, Francesco
   Boccolini, Daniela
   Bella, Antonino
   Guerrini, Alessandra
   Tacchini, Massimo
   Sacchetti, Gianni
   Chiurato, Matteo
   Romi, Roberto
   Di Luca, Marco
TI Larvicidal activity of Ocimum campechianum, Ocotea quixos and Piper
   aduncum essential oils against Aedes aegypti
SO PARASITE
LA English
DT Article
DE Ocimum campechianum; Ocotea quixos; Piper aduncum; Essential oil;
   Larvicidal activity; Aedes aegypti
ID LAM. KOSTERM.; NATURAL-PRODUCTS; BASIL; WILD; L.; ANTIPLATELET;
   EXTRACTS; SPINOSAD; EUGENOL; FRUITS
AB Aedes aegypti, the main arbovirus vector of the Yellow fever, Dengue, Chikungunya and Zika viruses, is widely distributed in tropical and subtropical areas throughout the world. Preventive control efforts have been implemented worldwide aimed at reducing its impact on human health. The recent reduction of chemicals available for vector control due to their negative impact on the environment and human health and the increase in mosquito resistance to insecticides have driven the research community to identify and evaluate sustainable alternatives to synthetic insecticides. In this study, the potential larvicidal effect of essential oils extracted from Ocimum campechianum, Ocotea quixos and Piper aduncum were tested in vitro. GC and GC-MS analyses showed that the main compounds were eugenol (18%), 1,8-cineole (39%) and dillapiole (48%), respectively. Susceptibility to essential oils was measured according to the WHO protocol. After 24 h, the mean percentage mortality ranged from 2.7 to 100% for P. aduncum, from 2.2 to 100% for O. campechianum, and from 2.9 to 100% for O. quixos. The highest potential was displayed by P. aduncum, followed by O. campechianum and O. quixos, with LC50 values of 25.7, 69.3 and 75.5 ppm, respectively. The rapid and effective larvicidal activity of these three oils led us to consider these results to be promising, also considering the possibility of local cultivation of these plants in tropical and subtropical areas and the simple technology for their large-scale preparation and production. Further studies are needed to evaluate the individual components and their activity as larvicides.
C1 [Scalvenzi, Laura; Radice, Matteo] Univ Estatal Amazonica, Dept Earth Sci, Km 2 1-2,Via Puyo Tena, Puyo 160150, Ecuador.
   [Guerrini, Alessandra; Tacchini, Massimo; Sacchetti, Gianni; Chiurato, Matteo] Univ Ferrara, Dept Life Sci & Biotechnol SVeB, Ple Chiappini 3, I-44123 Ferrara, Italy.
   [Toma, Luciano; Severini, Francesco; Boccolini, Daniela; Bella, Antonino; Romi, Roberto; Di Luca, Marco] ISS, Natl Inst Hlth, Dept Infect Dis, Vle Regina Elena 299, I-00161 Rome, Italy.
RP Di Luca, M (corresponding author), ISS, Natl Inst Hlth, Dept Infect Dis, Vle Regina Elena 299, I-00161 Rome, Italy.
EM marco.diluca@iss.it
RI Sacchetti, Gianni/D-1160-2013; Bella, Antonino/AAB-9943-2019
OI Sacchetti, Gianni/0000-0002-6833-1477; TACCHINI,
   Massimo/0000-0001-7958-355X; Scalvenzi, Laura/0000-0001-6015-9871
FU Universidad Estatal Amazonica, Ecuador; University of Ferrara, Italy;
   Ministry of the Environment of Ecuador [MAE - DNB - CM - 2015 - 0027];
   Universidad Estatal Amazonica [MAE - DNB - CM - 2015 - 0027]
FX This research was supported by a grant from the Universidad Estatal
   Amazonica, Ecuador and a grant from the University of Ferrara, Italy.
   The present article was produced within the framework of the MAE - DNB -
   CM - 2015 - 0027 agreement in force between the Ministry of the
   Environment of Ecuador and the Universidad Estatal Amazonica. Finally,
   we are grateful to the anonymous reviewers for their valuable comments.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Narciso JOA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-172
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Costa AA, 2017, J MED ENTOMOL, V54, P670, DOI 10.1093/jme/tjw222
   Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Ballabeni V, 2007, PHARMACOL RES, V55, P23, DOI 10.1016/j.phrs.2006.09.009
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Bhalla Y, 2013, J SCI FOOD AGR, V93, P3643, DOI 10.1002/jsfa.6267
   Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x
   Bruni R, 2004, FOOD CHEM, V85, P415, DOI 10.1016/j.foodchem.2003.07.019
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280
   Deschamps C, 2008, INT J PLANT SCI, V169, P981, DOI 10.1086/590454
   Finney D.T., 1971, PROBIT ANAL
   Finney DJ, 1952, J I ACTUARIES, V78, P388
   Gomes E. O, 2016, VECTOR BIOL J, V1, P8, DOI [10.4172/2473-4810.1000114, DOI 10.4172/2473-4810.1000114]
   Guerrini A, 2014, J APPL BOT FOOD QUAL, V87, P108, DOI 10.5073/JABFQ.2014.087.017
   Guerrini A, 2009, ENVIRON TOXICOL PHAR, V27, P39, DOI 10.1016/j.etap.2008.08.002
   KLOWDEN MJ, 1983, APPL ENVIRON MICROB, V46, P312, DOI 10.1128/AEM.46.2.312-315.1983
   Lima AD, 2014, PARASITOL RES, V113, P107, DOI 10.1007/s00436-013-3632-8
   MITTERMEIER RA, 1997, MEGADIVERSITY EARTHS
   Mota MSCS, 2017, ALLELOPATHY J, V40, P197
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   Noriega P., 2008, U POLITECNICA SALESI, V7, P3
   ObengOfori D, 1997, INT J PEST MANAGE, V43, P89, DOI 10.1080/096708797229040
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Pavela R, 2019, ACTA TROP, V193, P236, DOI 10.1016/j.actatropica.2019.01.019
   Pavela R, 2018, IND CROP PROD, V113, P46, DOI 10.1016/j.indcrop.2018.01.021
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Pohlit Adrian Martin, 2004, Acta Amaz., V34, P97, DOI 10.1590/S0044-59672004000100012
   Radice M, 2016, C MOL2NET 2017 INT C, V3
   Radice M, 2019, PLANT BIOSYST, V153, P344, DOI 10.1080/11263504.2018.1478902
   RATHY MC, 2015, INT J MOSQ RES A, V2, P29
   Rolli E, 2014, IND CROP PROD, V60, P280, DOI 10.1016/j.indcrop.2014.06.021
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P93, DOI 10.2987/8756-971X(2006)22[93:LEOTBS]2.0.CO;2
   Sacchetti G, 2004, J AGR FOOD CHEM, V52, P3486, DOI 10.1021/jf035145e
   Sacchetti G, 2006, FLAVOUR FRAG J, V21, P674, DOI 10.1002/ffj.1648
   Salleh WMNHW, 2017, J APPL PHARM SCI, V7, P204
   Scalvenzi L, 2017, MOLECULES, V22, DOI 10.3390/molecules22071163
   Scalvenzi L, 2016, BIOAGRO, V28, P39
   Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3
   Silva WC, 2009, VET PARASITOL, V164, P267, DOI 10.1016/j.vetpar.2009.06.006
   Tognolini M, 2006, LIFE SCI, V78, P1419, DOI 10.1016/j.lfs.2005.07.020
   Tunc I, 1998, ENTOMOL EXP APPL, V86, P183, DOI 10.1046/j.1570-7458.1998.00279.x
   W. H. O, 2016, MED CTR FACT SHEETS
   Ward R. A., 2005, IDENTIFICATION GEOGR, P1
   WHO, 2006, PEST THEIR APPL CONT
   *WHO, 1981, INSTR DET SUSC RES M
NR 49
TC 0
Z9 0
U1 0
U2 5
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1252-607X
EI 1776-1042
J9 PARASITE
JI Parasite
PD APR 17
PY 2019
VL 26
AR 23
DI 10.1051/parasite/2019024
PG 8
WC Parasitology
SC Parasitology
GA HU5LC
UT WOS:000465318600001
PM 30994444
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vielle, NJ
   Garcia-Nicolas, O
   Esteves, BIO
   Brugger, M
   Summerfield, A
   Alves, MP
AF Vielle, Nathalie J.
   Garcia-Nicolas, Obdulio
   Esteves, Blandina I. Oliveira
   Bruegger, Melanie
   Summerfield, Artur
   Alves, Marco P.
TI The Human Upper Respiratory Tract Epithelium Is Susceptible to
   Flaviviruses
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE flavivirus; non-vector borne transmission; nasal epithelial cells;
   respiratory epithelium; upper respiratory tract; air-liquid interface
   cultures
ID WEST-NILE-VIRUS; ZIKA VIRUS; RHINOVIRUS INFECTION; BRONCHIAL EPITHELIUM;
   UNITED-STATES; PRIMARY NASAL; DENGUE VIRUS; TRANSMISSION; CELLS;
   IDENTIFICATION
AB Flaviviruses replicate in a wide variety of species and have a broad cellular tropism. They are isolated from various body fluids, and Zika virus (ZIKV), Japanese encephalitis virus (JEV), and West Nile virus (WNV) RNAs have been detected in nasopharyngeal swabs. Consequently, we evaluated the cellular tropism and host responses upon ZIKV, JEV, WNV, and Usutu virus (USUV) infection using a relevant model of the human upper respiratory tract epithelium based on primary human nasal epithelial cells (NECs) cultured at the air-liquid interface. NECs were susceptible to all the viruses tested, and confocal analysis showed evidence of infection of ciliated and non-ciliated cells. Each flavivirus productively infected NECs, leading to apical and basolateral live virus shedding with particularly high basal release for JEV and WNV. As demonstrated by a paracellular permeability assay, the integrity of the epithelium was not affected by flavivirus infection, suggesting an active release of live virus through the basolateral surface. Also, we detected a significant secretion of interferon type III and the pro-inflammatory cytokine IP-10/ CXCL10 upon infection with JEV. Taken together, our data suggest that the human upper respiratory tract epithelium is a target for flaviviruses and could potentially play a role in the spread of infection to other body compartments through basolateral virus release. Undoubtedly, further work is required to evaluate the risks and define the adapted measures to protect individuals exposed to flavivirus-contaminated body fluids.
C1 [Vielle, Nathalie J.; Garcia-Nicolas, Obdulio; Esteves, Blandina I. Oliveira; Bruegger, Melanie; Summerfield, Artur; Alves, Marco P.] Inst Virol & Immunol, Bern, Switzerland.
   [Vielle, Nathalie J.; Garcia-Nicolas, Obdulio; Esteves, Blandina I. Oliveira; Bruegger, Melanie; Summerfield, Artur; Alves, Marco P.] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [Vielle, Nathalie J.; Bruegger, Melanie] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
RP Alves, MP (corresponding author), Inst Virol & Immunol, Bern, Switzerland.; Alves, MP (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
EM marco.alves@vetsuisse.unibe.ch
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIK Alliance Grant [734548]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIK Alliance Grant Agreement no.
   734548.
CR Altman MC, 2018, J ALLERGY CLIN IMMUN, V142, P451, DOI 10.1016/j.jaci.2017.10.004
   Alves MP, 2016, RESPIROLOGY, V21, P304, DOI 10.1111/resp.12692
   Austin RJ, 2004, CAN VET J, V45, P117
   Bharucha T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26333-4
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen Lin H, 2016, Trop Dis Travel Med Vaccines, V2, P15, DOI 10.1186/s40794-016-0032-y
   Cheng NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005520
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumre SP, 2013, AM J TROP MED HYG, V88, P677, DOI 10.4269/ajtmh.12-0436
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcia-Nicolas O, 2018, J VIROL, V92, DOI 10.1128/JVI.01091-18
   Garcia-Nicolas O, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050124
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gravina HD, 2019, VIROLOGY, V527, P98, DOI 10.1016/j.virol.2018.11.008
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09
   Lee C, 2019, INFECT DIS-NOR, V51, P150, DOI 10.1080/23744235.2018.1521004
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li XS, 2015, J CLIN MICROBIOL, V53, P2734, DOI 10.1128/JCM.00770-15
   Llorente F, 2015, VET RES, V46, DOI 10.1186/s13567-015-0233-9
   Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010
   Lyons AC, 2018, VECTOR-BORNE ZOONOT, V18, P469, DOI 10.1089/vbz.2018.2283
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Ong HX, 2016, MOL PHARMACEUT, V13, P2242, DOI 10.1021/acs.molpharmaceut.5b00852
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Ricklin ME, 2016, VET RES, V47, DOI 10.1186/s13567-016-0319-z
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC
   Schogler A, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0706-7
   Schogler A, 2016, J CYST FIBROS, V15, P332, DOI 10.1016/j.jcf.2015.10.013
   Schogler A, 2016, EUR RESPIR J, V47, P520, DOI 10.1183/13993003.00665-2015
   Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Stokes AB, 2014, EXP LUNG RES, V40, P327, DOI 10.3109/01902148.2014.925987
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P1523, DOI 10.1128/JCM.00209-07
   Travanty E, 2015, J VIROL, V89, P11935, DOI 10.1128/JVI.01792-15
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109
   WEISS K. E., 1956, ONDERSTEPOORT JOUR VET RES, V27, P183
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
NR 54
TC 2
Z9 2
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 16
PY 2019
VL 10
AR 811
DI 10.3389/fmicb.2019.00811
PG 10
WC Microbiology
SC Microbiology
GA HU0GY
UT WOS:000464950600001
PM 31057517
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lazear, HM
   Schoggins, JW
   Diamond, MS
AF Lazear, Helen M.
   Schoggins, John W.
   Diamond, Michael S.
TI Shared and Distinct Functions of Type I and Type III Interferons
SO IMMUNITY
LA English
DT Review
ID CHRONIC HEPATITIS-C; REGULATORY FACTOR FAMILY; T-CELL RESPONSES;
   IFN-LAMBDA; ZIKA VIRUS; ADJUVANT THERAPY; PEGINTERFERON ALPHA-2A;
   STIMULATED GENES; PEGYLATED INTERFERON-ALPHA-2B; ANTIVIRAL PROTECTION
AB Type I interferons (IFNs) (IFN-alpha,IFN-beta) and type III IFNs (IFN-lambda) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune primin anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and hignlignt gaps in understanding of the biology of type I and type III IFNs in health and disease.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM helen.lazear@med.unc.edu; mdiamond@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI139512, DP2AI117922, R01AI073755,
   R01AI127828, R01HD091218]
FX Research in the authors' laboratories is supported in part by NIH grants
   R01AI139512 to H.M.L.; DP2AI117922 to J.W.S.; and R01AI073755,
   R01AI127828, and R01HD091218 to M.S.D.
CR Aboulnasr F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141655
   Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3
   Alspach E., 2018, COLD SPRING HARB PER, V11
   Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029
   Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474
   Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16
   Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025
   Bamford CGG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007307
   Bayas Antonios, 2003, Journal of Neurology, V250, P3
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995
   Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657
   Booy S, 2015, J INTERF CYTOK RES, V35, P327, DOI 10.1089/jir.2014.0157
   Borden EC, 2019, NAT REV DRUG DISCOV, V18, P219, DOI 10.1038/s41573-018-0011-2
   Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016
   Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821
   Budhwani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00322
   Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Cascinelli N, 2001, LANCET, V358, P866, DOI 10.1016/S0140-6736(01)06068-8
   Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682
   Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773
   Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203
   de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR
   de Weerd NA, 2017, J BIOL CHEM, V292, P7554, DOI 10.1074/jbc.M116.773788
   de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667
   Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103
   Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99
   Di Trolio R, 2015, CYTOKINE GROWTH F R, V26, P203, DOI 10.1016/j.cytogfr.2014.11.008
   DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312
   Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114
   Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227
   DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655
   Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8
   Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556
   Espinosa V, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5357
   Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817
   Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933
   Fox JM, 2015, J INTERF CYTOK RES, V35, P554, DOI 10.1089/jir.2014.0052
   Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4
   Good C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4255
   Goodin DS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001972
   Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825
   Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GREENBERG HB, 1976, NEW ENGL J MED, V295, P517, DOI 10.1056/NEJM197609022951001
   Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902
   Grine L, 2015, CYTOKINE GROWTH F R, V26, P25, DOI 10.1016/j.cytogfr.2014.10.009
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232
   Hansson J, 2011, LANCET ONCOL, V12, P144, DOI 10.1016/S1470-2045(10)70288-6
   Harris BD, 2018, J BIOL CHEM, V293, P16057, DOI 10.1074/jbc.RA118.003617
   Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277
   Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463
   Hendricks MR, 2016, P NATL ACAD SCI USA, V113, P1642, DOI 10.1073/pnas.1516979113
   Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320
   Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719
   Huang Y, 2017, HEPATOB PANCREAT DIS, V16, P470, DOI 10.1016/S1499-3872(17)60044-4
   Hwang M, 2018, J VIROL, V92, DOI 10.1128/JVI.01901-17
   Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465
   Ingle H., 2018, VIRUSES, V10, pE46
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049
   JACOBS L, 1981, SCIENCE, V214, P1026, DOI 10.1126/science.6171035
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jakimovski D, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a032003
   Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653
   Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587
   Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382
   Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569
   Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681
   Khan UT, 2015, EXPERT OPIN BIOL TH, V15, P1077, DOI 10.1517/14712598.2015.1053206
   Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7
   Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354
   Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x
   Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142
   Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Krause CD, 2015, CYTOKINE, V76, P480, DOI 10.1016/j.cyto.2015.07.019
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200
   Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653
   Lasfar A, 2016, IMMUNOTHERAPY-UK, V8, P877, DOI 10.2217/imt-2015-0021
   Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074
   Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978
   Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1
   Lee SJ, 2012, INT J MOL MED, V30, P945, DOI 10.3892/ijmm.2012.1064
   LeMessurier KS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003727
   Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x
   Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]
   Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   Mahony R, 2017, CELL MOL LIFE SCI, V74, P1755, DOI 10.1007/s00018-016-2435-3
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052
   Martin PK, 2018, NAT MICROBIOL, V3, P1131, DOI 10.1038/s41564-018-0229-0
   Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200
   McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010
   Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017
   Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705
   Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009
   Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520
   Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565
   Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022
   Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08
   Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762
   Newsome SD, 2016, J NEUROL, V263, P1778, DOI 10.1007/s00415-016-8182-4
   Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005
   Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100
   Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086
   Odendall C, 2017, J IMMUNOL, V199, P3270, DOI 10.4049/jimmunol.1700250
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011
   Okanoue T, 1996, J HEPATOL, V25, P283, DOI 10.1016/S0168-8278(96)80113-9
   Oke V, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1344-7
   Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434
   Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014
   Pervolaraki K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007420
   Pervolaraki K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00459
   Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009
   Phillips S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00621
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521
   Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reichard O, 1998, LANCET, V351, P83, DOI 10.1016/S0140-6736(97)06088-1
   REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x
   Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11
   Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550
   Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001
   Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789
   Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033
   Sancho-Shimizu V, 2011, CURR OPIN VIROL, V1, P487, DOI 10.1016/j.coviro.2011.10.016
   Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105
   Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins John W, 2018, F1000Res, V7, P309, DOI 10.12688/f1000research.12450.1
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Schreiber G, 2017, J BIOL CHEM, V292, P7285, DOI 10.1074/jbc.R116.774562
   Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Sorgeloos F, 2013, VIRUSES-BASEL, V5, P834, DOI 10.3390/v5030834
   Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112
   Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755
   Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102
   Svensson A, 2007, J REPROD IMMUNOL, V74, P114, DOI 10.1016/j.jri.2006.09.002
   Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255
   Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214
   Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156
   Tezuka Y, 2012, LUNG CANCER, V78, P185, DOI 10.1016/j.lungcan.2012.09.005
   Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048
   Thorlacius GE, 2018, CURR OPIN RHEUMATOL, V30, P471, DOI 10.1097/BOR.0000000000000524
   van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014
   Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008
   Voigt EA, 2015, J INTERF CYTOK RES, V35, P734, DOI 10.1089/jir.2015.0008
   Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212
   Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128
   Wells AI, 2018, TRENDS IMMUNOL, V39, P848, DOI 10.1016/j.it.2018.08.008
   Wilcox DR, 2016, MBIO, V7, DOI 10.1128/mBio.00437-16
   Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208
   Witte E, 2016, J MOL MED, V94, P391, DOI 10.1007/s00109-015-1367-y
   Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245
   Wongthida P, 2010, CANCER RES, V70, P4539, DOI 10.1158/0008-5472.CAN-09-4658
   Wu Q, 2013, AUTOIMMUNITY, V46, P40, DOI 10.3109/08916934.2012.730587
   Wu Q, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3363
   Yan N, 2017, J INTERF CYTOK RES, V37, P198, DOI 10.1089/jir.2016.0086
   Yao JC, 2017, J CLIN ONCOL, V35, P1695, DOI 10.1200/JCO.2016.70.4072
   Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanoni I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01661
   Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801
   Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389
   Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06
NR 223
TC 59
Z9 59
U1 12
U2 35
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD APR 16
PY 2019
VL 50
IS 4
BP 907
EP 923
DI 10.1016/j.immuni.2019.03.025
PG 17
WC Immunology
SC Immunology
GA HT6FY
UT WOS:000464660800010
PM 30995506
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Acosta, MP
   Geoghegan, EM
   Lepenies, B
   Ruzal, S
   Kielian, M
   Martinez, MG
AF Prado Acosta, Mariano
   Geoghegan, Eileen M.
   Lepenies, Bernd
   Ruzal, Sandra
   Kielian, Margaret
   Martinez, Maria Guadalupe
TI Surface (S) Layer Proteins of Lactobacillus acidophilus Block Virus
   Infection via DC-SIGN Interaction
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE S-layer; DC-SIGN; alphavirus; flavivirus; Lactobacillus
ID C-TYPE LECTINS; SEMLIKI-FOREST-VIRUS; DENDRITIC-CELL; PATHOGEN
   RECOGNITION; NONINTEGRIN; INHIBIT; BINDING; FUSION
AB Alphaviruses and flaviviruses are important human pathogens that include Chikungunya virus (CHIKV), Dengue virus (DENV), and Zika virus (ZIKV), which can cause diseases in humans ranging from arthralgia to hemorrhagic fevers and microcephaly. It was previously shown that treatment with surface layer (S-layer) protein, present on the bacterial cell-envelope of Lactobacillus acidophilus, is able to inhibit viral and bacterial infections by blocking the pathogen's interaction with DC-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), a trans-membrane protein that is a C-type calcium-dependent lectin. DC-SIGN is known to act as an attachment factor for several viruses including alphaviruses and flaviviruses. In the present study, we used alphaviruses as a model system to dissect the mechanism of S-layer inhibition. We first evaluated the protective effect of S-layer using 3T3 cells, either wild type or stably expressing DC-SIGN, and infecting with the alphaviruses Semliki Forest virus (SFV) and CHIKV and the flaviviruses ZIKV and DENV. DC-SIGN expression significantly enhanced infection by all four viruses. Treatment of the cells with S-layer prior to infection decreased infectivity of all viruses only in cells expressing DC-SIGN. In vitro ELISA experiments showed a direct interaction between S-layer and DC-SIGN; however, confocal microscopy and flow cytometry demonstrated that S-layer binding to the cells was independent of DC-SIGN expression. S-layer protein prevented SFV binding and internalization in DC-SIGN-expressing cells but had no effect on virus binding to DC-SIGN-negative cells. Inhibition of virus binding occurred in a time-dependent manner, with a significant reduction of infection requiring at least a 30-min pre-incubation of S-layer with DC-SIGN-expressing cells. These results suggest that S-layer has a different mechanism of action compared to mannan, a common DC-SIGN-binding compound that has an immediate effect in blocking viral infection. This difference could reflect slower kinetics of S-layer binding to the DC-SIGN present at the plasma membrane (PM). Alternatively, the S-layer/DC-SIGN interaction may trigger the activation of signaling pathways that are required for the inhibition of viral infection. Together our results add important information relevant to the potential use of L. acidophilus S-layer protein as an antiviral therapy.
C1 [Prado Acosta, Mariano; Ruzal, Sandra] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Lab Bacterias Gram Posit,Dept Quim Biol IQUIBICEN, Buenos Aires, DF, Argentina.
   [Prado Acosta, Mariano; Geoghegan, Eileen M.; Kielian, Margaret; Martinez, Maria Guadalupe] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.
   [Lepenies, Bernd] Univ Vet Med Hannover, Immunol Unit, Hannover, Germany.
   [Lepenies, Bernd] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonosis, Hannover, Germany.
RP Kielian, M; Martinez, MG (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.
EM margaret.kielian@einstein.yu.edu; maria-guadalupe.martinez@inserm.fr
OI Ruzal, Sandra/0000-0001-6388-7567; Geoghegan, Eileen/0000-0003-3068-3503
FU National Institute of General MedicineUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01-GM057454]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01-AI075647]; Cancer Center Core Support Grant [NIH/NCI P30-CA13330];
   Fulbright-CONICET fellowship
FX This work was supported in part by grants to MK from the National
   Institute of General Medicine (R01-GM057454) and the National Institute
   of Allergy and Infectious Diseases (R01-AI075647), and by Cancer Center
   Core Support Grant NIH/NCI P30-CA13330. MPA was supported during his
   time in the Kielian lab by a Fulbright-CONICET fellowship.
CR Acosta MP, 2016, INT J BIOL MACROMOL, V92, P998, DOI 10.1016/j.ijbiomac.2016.07.096
   Ahn A, 1999, J VIROL, V73, P10029, DOI 10.1128/JVI.73.12.10029-10039.1999
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0
   Chacon E, 1997, IN VITRO METHODS PHA, P209, DOI DOI 10.1016/B978-012163390-5.50010-7
   Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s
   Froelich S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021491
   Gao X, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00137
   Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI [10.2217/fmb.09.51, 10.2217/FMB.09.51]
   Glomb-Reinmund S, 1998, J VIROL, V72, P4281, DOI 10.1128/JVI.72.5.4281-4287.1998
   Martinez MG, 2012, BIOCHEM BIOPH RES CO, V422, P590, DOI 10.1016/j.bbrc.2012.05.031
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hymes JP, 2016, APPL ENVIRON MICROB, V82, P2676, DOI 10.1128/AEM.00024-16
   Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2
   Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003
   Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105
   Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x
   KUHN RJ, 2013, FIELDS VIROLOGY, V1, P629
   Lightfoot YL, 2015, EMBO J, V34, P881, DOI 10.15252/embj.201490296
   Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200
   Long KM, 2013, J VIROL, V87, P5697, DOI 10.1128/JVI.01611-12
   Mayer S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00213
   Mayer S, 2017, HISTOCHEM CELL BIOL, V147, P223, DOI 10.1007/s00418-016-1523-7
   Mobili P, 2009, ANTON LEEUW INT J G, V95, P363, DOI 10.1007/s10482-009-9322-y
   Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Phanthanawiboon S, 2014, J VIROL METHODS, V209, P55, DOI 10.1016/j.jviromet.2014.08.023
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Acosta MP, 2008, APPL ENVIRON MICROB, V74, P7824, DOI 10.1128/AEM.01712-08
   Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2
   Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092
   Taverniti V, 2013, APPL ENVIRON MICROB, V79, P1221, DOI 10.1128/AEM.03056-12
   Tytgat HLP, 2016, J MOL MICROB BIOTECH, V26, P345, DOI 10.1159/000447091
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002
   Yu L, 2017, APMIS, V125, P655, DOI 10.1111/apm.12695
   Zhang F, 2014, INT REV IMMUNOL, V33, P54, DOI 10.3109/08830185.2013.834897
NR 38
TC 4
Z9 3
U1 1
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 16
PY 2019
VL 10
AR 810
DI 10.3389/fmicb.2019.00810
PG 12
WC Microbiology
SC Microbiology
GA HT4ZY
UT WOS:000464573100001
PM 31040840
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hillman, B
   Petersen, DN
   Galang, RR
   Godfred-Cato, S
   Mayers, C
   Thomas, Y
   Prosper, A
   Hawley, J
   Halbert, M
   Noe, M
   Reynolds, M
   Schoelles, D
   Brown-Shuler, L
   Fehrenbach, N
   Ellis, EM
AF Hillman, Braeanna
   Petersen, Derval N.
   Galang, Romeo R.
   Godfred-Cato, Shana
   Mayers, Charmaine
   Thomas, Yvonne
   Prosper, Andra
   Hawley, Janney
   Halbert, Monica
   Noe, Mary
   Reynolds, Megan
   Schoelles, Dan
   Brown-Shuler, Lessely
   Fehrenbach, Nicole
   Ellis, Esther M.
TI 2018 US Virgin Islands Zika health brigade: Providing recommended
   pediatric health screenings for infants born to mothers with laboratory
   evidence of Zika virus exposure during pregnancy
SO BIRTH DEFECTS RESEARCH
LA English
DT Letter
ID INFECTION
C1 [Hillman, Braeanna; Petersen, Derval N.; Mayers, Charmaine; Thomas, Yvonne; Prosper, Andra; Hawley, Janney; Halbert, Monica; Ellis, Esther M.] US Virgin Isl Dept Hlth, Christiansted, VI USA.
   [Hillman, Braeanna; Petersen, Derval N.; Mayers, Charmaine; Thomas, Yvonne; Prosper, Andra; Hawley, Janney; Halbert, Monica; Ellis, Esther M.] US Virgin Isl Dept Hlth, Charlotte Amalie, VI USA.
   [Galang, Romeo R.; Godfred-Cato, Shana; Reynolds, Megan; Fehrenbach, Nicole] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disabil, Atlanta, GA USA.
   [Noe, Mary] P3S Corp, San Antonio, TX USA.
   [Schoelles, Dan] Deloitte Consulting LLP, New York, NY USA.
   [Brown-Shuler, Lessely] Chickasaw Nation Ind, Norman, OK USA.
RP Schoelles, D (corresponding author), Deloitte Consulting LLP, 191 Peachtree St, Atlanta, GA 30303 USA.
EM dschoelles@deloitte.com
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Karoly L. A., 2005, EARLY CHILDHOOD INTE, DOI [10.7249/MG341, DOI 10.7249/MG341]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 3
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD APR 15
PY 2019
VL 111
IS 7
BP 360
EP 362
DI 10.1002/bdr2.1486
PG 3
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA ID4YX
UT WOS:000471683300003
PM 30856278
OA Bronze
DA 2020-07-08
ER

PT J
AU Knope, K
   Doggett, SL
   Jansen, CC
   Johansen, CA
   Kurucz, N
   Feldman, R
   Lynch, SE
   Hobby, MP
   Sly, A
   Jardine, A
   Bennett, S
   Currie, BJ
   Bennett, S
   Currie, B
   Daniels, P
   Doggett, S
   El Saadi, D
   Feldman, R
   Firman, J
   Hobby, M
   Knope, K
   Koehler, A
   Kurucz, N
   Lee, R
   Lindsay, M
   Mackenzie, J
   Muller, M
   Ritchie, S
   Russell, R
   Sanders, L
   Sly, A
   Smith, D
   Whelan, P
   Williams, C
   Williams, D
   Wall, J
   Wright, P
AF Knope, Katrina
   Doggett, Stephen L.
   Jansen, Cassie C.
   Johansen, Cheryl A.
   Kurucz, Nina
   Feldman, Rebecca
   Lynch, Stacey E.
   Hobby, Michaela P.
   Sly, Angus
   Jardine, Andrew
   Bennett, Sonya
   Currie, Bart J.
   Bennett, Sonya
   Currie, Bart
   Daniels, Peter
   Doggett, Stephen
   El Saadi, Debra
   Feldman, Rebecca
   Firman, Jenny
   Hobby, Michaela
   Knope, Katrina
   Koehler, Ann
   Kurucz, Nina
   Lee, Rogan
   Lindsay, Mike
   Mackenzie, John
   Muller, Mike
   Ritchie, Scott
   Russell, Richard
   Sanders, Lance
   Sly, Angus
   Smith, David
   Whelan, Peter
   Williams, Craig
   Williams, David
   Wall, Jennifer
   Wright, Phil
CA Natl Arbovirus Malaria Advisory Co
TI Arboviral diseases and malaria in Australia, 2014-15: Annual report of
   the National Arbovirus and Malaria Advisory Committee
SO COMMUNICABLE DISEASES INTELLIGENCE
LA English
DT Article
DE arbovirus; Barmah Forest virus; chikungunya; dengue; Zika; disease
   surveillance; epidemiology; flavivirus; Japanese encephalitis; West Nile
   virus; Kunjin virus; malaria; mosquito-borne disease; mosquitoes; Murray
   Valley encephalitis virus; Ross River virus; yellow fever; West Nile
   virus; exotic mosquitoes
ID ZIKA VIRUS; NORTH QUEENSLAND; DENGUE; OUTBREAK; SURVEILLANCE;
   TRANSMISSION; CHIKUNGUNYA; SALVADOR
AB This report describes the epidemiology of mosquito-borne diseases of public health importance in Australia during the 2014-15 season (1 July 2014 to 30 June 2015) and includes data from human notifications, sentinel chicken, vector and virus surveillance programs. The National Notifiable Diseases Surveillance System received notifications for 12,849 cases of disease transmitted by mosquitoes during the 2014-15 season. The Australasian alphaviruses Barmah Forest virus and Ross River virus accounted for 83% (n=10,723) of notifications. However, over-diagnosis and possible false positive diagnostic test results for these two infections mean that the true burden of infection is likely overestimated, and as a consequence, revised case definitions were implemented from 1 January 2016. There were 151 notifications of imported chikungunya virus infection. There were 74 notifications of dengue virus infection acquired in Australia and 1,592 cases acquired overseas, with an additional 34 cases for which the place of acquisition was unknown. Imported cases of dengue were most frequently acquired in Indonesia (66%). There were 7 notifications of Zika virus infection. No cases of locally-acquired malaria were notified during the 2014-15 season, though there were 259 notifications of overseas-acquired malaria and one notification for which no information on the place of acquisition was supplied. Imported cases of malaria were most frequently acquired in southern and eastern Africa (23%) and Pacific Island countries (20%). In 2014-15, arbovirus and mosquito surveillance programs were conducted in most of the states and territories. Surveillance for exotic mosquitoes at international ports of entry continues to be a vital part of preventing the establishment of vectors of mosquito-borne diseases such as dengue to new areas of Australia. In 2014-15, there was a sharp increase in the number of exotic mosquitoes detected at the Australian border, with 36 separate exotic mosquito detections made, representing a 280% increase from the 2013-14 period where there were 13 exotic mosquito detections.
C1 [Knope, Katrina] Dept Hlth, Off Hlth Protect, Hlth Protect Policy Branch, Zoonoses Foodborne & Emerging Infect Dis Sect, Canberra, ACT, Australia.
   [Doggett, Stephen L.] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Med Entomol Pathol West, Westmead, NSW, Australia.
   [Jansen, Cassie C.; Bennett, Sonya] Queensland Govt, Dept Hlth, Communicable Dis Branch, Herston, Qld 4006, Australia.
   [Johansen, Cheryl A.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Pathol & Lab Med, Arbovirus Surveillance & Res Lab, Nedlands, WA, Australia.
   [Johansen, Cheryl A.] Western Australian Dept Hlth, QEII Med Ctr, PathWest Lab Med WA, Div Microbiol & Infect Dis, Nedlands, WA, Australia.
   [Kurucz, Nina] Royal Darwin Hosp, Northern Terr Dept Hlth, Hlth Protect Div, Ctr Dis Control,Med Entomol, Casuarina, NT, Australia.
   [Feldman, Rebecca] Dept Hlth, Communicable Dis Prevent & Control, Melbourne, Vic, Australia.
   [Lynch, Stacey E.] AgriBio Ctr AgriBiosci, Agr Victoria Res, 5 Ring Rd, Bundoora, Vic 3083, Australia.
   [Hobby, Michaela P.] South Australian Dept Hlth, Hlth Protect Publ Hlth, Adelaide, SA, Australia.
   [Sly, Angus] Dept Agr & Water Resources, Compliance Div, Eagle Farm, Qld, Australia.
   [Jardine, Andrew] Dept Hlth, Med Entomol Environm Hlth Directorate, Perth, WA, Australia.
   [Currie, Bart J.] Royal Darwin Hosp Northern Terr, Menzies Sch Hlth Res, Darwin, NT, Australia.
RP Knope, K (corresponding author), Australian Govt Dept Hlth, Off Hlth Protect, Hlth Emergency Management Branch, Zoonoses Foodborne & Emerging Infect Dis Sect, Canberra, ACT 2601, Australia.
EM Katrina.Knope@health.gov.au
CR [Anonymous], 2012, DIS WATCH, V16
   [Anonymous], 2013, AUSTR IMM HDB
   Appuhamy R, 2016, ACT POPULATION HLTH, V5
   Australian Bureau of Statistics, 2011, 1216 0 AUSTR STAND G
   Australian Bureau of Statistics, 2015, AUSTR DEM STAT DEC 2
   Broom A K, 2001, Commun Dis Intell Q Rep, V25, P157
   Broom Annette K, 2003, Commun Dis Intell Q Rep, V27, P367
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Case Definitions Working Group, 2015, COMMUN DIS INTELL, V39
   Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888
   Doggett S, 2004, NEW S WALES ARBOVIRU
   Doggett S. CJ, 2013, NSW ARBOVIRUS SURVEI
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759
   Forbes JA, 1978, EPIDEMIC VARIANCE 19
   Gray TJ, 2012, COMMUN DIS INTELL, V36, P107
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P198
   Hanna JN, 2004, MED J AUSTRALIA, V180, P24, DOI 10.5694/j.1326-5377.2004.tb05769.x
   Harrington S, 2009, CHRISTMAS ISLAND COC
   Heymann DL, 2008, CONTROL COMMUNICABLE
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Knope K, 2016, COMMUN DIS INTELL, V40
   Knope KE, 2016, COMMUN DIS INTELL, V40, pE17
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Ministerio da Saude, 2015, CONF ZIK VIR BRAS
   Montgomery BL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005505
   Mpho M, 2002, HEREDITY, V88, P307, DOI 10.1038/sj.hdy.6800045
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NICHOLLS N, 1986, AUST J EXP BIOL MED, V64, P587, DOI 10.1038/icb.1986.62
   Pacific Public Health Surveillance Network, 2015, EM MEMB PACNET
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parida MM, 2008, FUTURE VIROL, V3, P179, DOI 10.2217/17460794.3.2.179
   Pyke AT, 2016, SCI REPORTS, P6
   Queensland Health, 2011, QUEENSL DENG MAN PLA
   Queensland Health, QUEENSL DENG MAN PLA
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rich G., 1993, Communicable Diseases Intelligence, V17, P208
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Romanes F., 2015, JAPANESE ENCEPHALITI
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   Selvey LA, 2014, COMMUN DIS INTELL, V38, pE114
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Sloan-Gardner T, 2016, COMMUN DIS INTELL, V40, pE48
   Souares Y, 2000, Pac Health Dialog, V7, P11
   van den Hurk AF, 2012, BIOMED RES INT, V2012
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, WORLD MAL REP 2015
   2011, AM J TROP MED HYG, V85, P952, DOI DOI 10.4269/AJTMH.2011.11-0165
   1995, J VIROL METHODS, V51, P201
   2014, VECTOR-BORNE ZOONOT, V14, P66, DOI DOI 10.1089/VBZ.2013.1373
NR 57
TC 2
Z9 2
U1 1
U2 1
PU AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING
PI CANBERRA
PA OFFICE HEALTH PROTECTION SURVEILLANCE BRANCH, GPO BOX 9848, CANBERRA,
   ACT 2601, AUSTRALIA
SN 0725-3141
EI 1445-4866
J9 COMMUN DIS INTELL
JI Commun. Dis. Intell.
PD APR 15
PY 2019
VL 43
DI 10.33321/cdi.2019.43.14
PG 69
WC Infectious Diseases
SC Infectious Diseases
GA HW7YH
UT WOS:000466905400003
PM 30982295
OA Bronze
DA 2020-07-08
ER

PT J
AU Wang, L
   Filer, JE
   Lorenz, MM
   Henry, CS
   Dandy, DS
   Geiss, BJ
AF Wang, Lei
   Filer, Jessica E.
   Lorenz, Meghan M.
   Henry, Charles S.
   Dandy, David S.
   Geiss, Brian J.
TI An ultra-sensitive capacitive microwire sensor for pathogen-specific
   serum antibody responses
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Capacitive affinity biosensor; Microwires; Antibody detection; Isotype;
   Zika virus; Mouse serum
ID ZIKA VIRUS-INFECTION; DEVICES; BRAZIL; ASSAY
AB Detection of viral infection is commonly performed using serological techniques like the enzyme-linked immunosorbent assay (ELISA) to detect antibody responses. Such assays may also be used to determine the infection phase based on isotype prevalence. However, ELISAs demonstrate limited sensitivity and are difficult to perform at the point of care. Here, we present a novel technique for label-free, rapid detection of ultra-low concentrations of virus specific antibodies. We have developed a simple, robust capacitive biosensor using microwires coated with Zika or Chikungunya virus envelope antigen. With little discernable nonspecific binding, the sensor can detect as few as 10 antibody molecules in a small volume (10 molecules/30 mu L) within minutes. It can also be used to rapidly, specifically, and accurately determine the isotype of antigen-specific antibodies. Finally, we demonstrate that anti-Zika virus antibody can be sensitively and specifically detected in dilute mouse serum and can be isotyped using the sensor. Overall, our findings suggest that our microwire sensor platform has the potential to be used as a reliable, sensitive, and inexpensive diagnostic tool to detect immune responses at the point of care.
C1 [Wang, Lei; Henry, Charles S.; Dandy, David S.; Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Filer, Jessica E.] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
   [Filer, Jessica E.; Lorenz, Meghan M.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Henry, Charles S.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Dandy, David S.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
RP Dandy, DS; Geiss, BJ (corresponding author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
EM David.Dandy@colostate.edu; Brian.Geiss@colostate.edu
RI Henry, Charles S/AAG-8084-2019
OI Henry, Charles S/0000-0002-8671-7728
FU NSFNational Science Foundation (NSF) [1332404]; National Science
   FoundationNational Science Foundation (NSF) [DGE-1450032]; NIH
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R01AI11.4675, 1R01AI132668]
FX This work was funded by NSF 1332404 to D.S.D. and NIH NIAID
   1R01AI11.4675 and 1R01AI132668 to B.J.G. The work reported here was also
   partially supported by a National Science Foundation grant
   (DGE-1450032). Any opinions, findings, conclusions or recommendations
   expressed are those of the authors and do not necessarily reflect the
   views of the National Science Foundation. We would like to thank Mr.
   Benjamin Fuller, Dr. Dick Bowen, Dr. Michael Diamond for providing
   assistance and reagents.
CR Adkins JA, 2015, ANAL CHIM ACTA, V891, P247, DOI 10.1016/j.aca.2015.07.019
   Adornetto G, 2015, ANAL BIOANAL CHEM, V407, P7189, DOI 10.1007/s00216-015-8884-y
   AOKI K, 1993, ELECTROANAL, V5, P627, DOI 10.1002/elan.1140050802
   Berggren C, 2001, ELECTROANAL, V13, P173, DOI 10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO;2-B
   Cabral-Miranda G, 2018, BIOSENS BIOELECTRON, V113, P101, DOI 10.1016/j.bios.2018.04.058
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA US EM
   Centers for Disease Control and Prevention, 2017, LAB GUID DIAGN TEST
   Channon RB, 2018, ANAL CHEM, V90, P7777, DOI 10.1021/acs.analchem.8b02042
   Crowther J. R, 2008, THEELISA GUIDEBOOK S
   Erturk G., 2017, SENSORS, V17, P1, DOI DOI 10.3390/S17020390
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Liu Y, 2004, ANAL CHEM, V76, P1513, DOI 10.1021/ac0350357
   Loyprasert S, 2010, BIOSENS BIOELECTRON, V25, P1977, DOI 10.1016/j.bios.2010.01.020
   Marks R. S., 2013, ELECTROCHEMICAL BIOS
   Mattiasson B, 2016, TRAC-TREND ANAL CHEM, V79, P233, DOI 10.1016/j.trac.2015.10.016
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Prado IC, 2018, BIOSENS BIOELECTRON, V100, P115, DOI 10.1016/j.bios.2017.08.029
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Salaun P, 2006, ANAL CHEM, V78, P5052, DOI 10.1021/ac060231+
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Suni II, 2008, TRAC-TREND ANAL CHEM, V27, P604, DOI 10.1016/j.trac.2008.03.012
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Wang L, 2017, BIOSENS BIOELECTRON, V87, P646, DOI 10.1016/j.bios.2016.09.006
   Watkins HM, 2018, LANGMUIR, V34, P14993, DOI 10.1021/acs.langmuir.8b01004
   Wu J, 2006, IEEE T NANOTECHNOL, V5, P84, DOI 10.1109/TNANO.2006.869645
   Wu P, 2008, J BIOMAT SCI-POLYM E, V19, P725, DOI 10.1163/156856208784522092
   Yang K, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2908026
NR 39
TC 3
Z9 3
U1 4
U2 31
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD APR 15
PY 2019
VL 131
BP 46
EP 52
DI 10.1016/j.bios.2019.01.040
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA HR7AH
UT WOS:000463303800007
PM 30822687
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Faria, HAM
   Zucolotto, V
AF Mendonca Faria, Henrique Antonio
   Zucolotto, Valtencir
TI Label-free electrochemical DNA biosensor for zika virus identification
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE DNA biosensor; Thermal evaporation; Label-free; Diagnosis; Zika virus;
   Dengue virus
ID SINGLE NUCLEOTIDE POLYMORPHISMS; GOLD ELECTRODES; HYBRIDIZATION;
   SPECTROSCOPY; MONOLAYERS; MOLECULES
AB Seventy years after its discovery, the zika virus emerged in Brazil and spread rapidly throughout the Americas, bringing unusual complications such as microcephaly. The World Health Organization classifies zika as the most harmful viral disease today and considers the development of new diagnostic methods for zika and related diseases, such as dengue, urgent. Although there are tests to identify both infections, current diagnostic methods are slow, nonspecific, and costly. This study describes an impedimetric electrochemical DNA biosensor for label free detection of zika virus. Disposable electrodes were fabricated by thermal evaporation on polyethylene terephthalate substrates covered with a nanometric gold layer manufactured in three-contact configurations. The disposable, evaporated electrodes were morphologically characterized by atomic force microscopy and scanning electron microscopy. The electrode surface was characterized by electroanalytical techniques. Genetic sequences of primers and complementary capture probes were designed based on analysis of the zika and dengue virus genomes. The biosensor used a three-contact electrode to identify DNA sequences in a drop of sample, and for detection of zika virus sequences, it allowed for direct reading of the hybridization event without labeling on disposable electrodes and with a 1.5 h response time. In this system, impedance measurements indicated a limit of detection of 25.0 +/- 1.7 nM. The developed biosensors showed selectivity for zika in the synthetic DNA assays, and therefore, are promising for clinical analysis.
C1 [Mendonca Faria, Henrique Antonio; Zucolotto, Valtencir] Univ Sao Paulo, Phys Inst Sao Carlos, Nanomed & Nanotoxicol Grp, CP 369, BR-13560970 Sao Carlos, SP, Brazil.
RP Zucolotto, V (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Nanomed & Nanotoxicol Grp, CP 369, BR-13560970 Sao Carlos, SP, Brazil.
EM henrique.fisica@ifsc.usp.br; zuco@ifsc.usp.br
RI Zucolotto, Valtencir/B-9103-2012; Faria, Henrique Antonio
   Mendonca/M-5774-2013
OI Faria, Henrique Antonio Mendonca/0000-0001-6976-6897; Zucolotto,
   Valtencir/0000-0003-4307-3077
FU CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq) [440496/2016-0]; CAPES, BrazilCAPES
   [88881.130763/2016-01, 2013-57062390615]
FX The authors gratefully acknowledge LNNANO, Campinas-Brazil, from support
   AFM measurement and financial support from CNPq, Brazil (grant number
   440496/2016-0) and CAPES, Brazil (grant number 88881.130763/2016-01) and
   (grant number 2013-57062390615).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carpini G, 2004, BIOSENS BIOELECTRON, V20, P167, DOI 10.1016/j.bios.2004.02.021
   Chang BY, 2010, ANNU REV ANAL CHEM, V3, P207, DOI 10.1146/annurev.anchem.012809.102211
   Chen CP, 2009, ANAL CHEM, V81, P36, DOI 10.1021/ac800986q
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Elshafey R, 2015, BIOSENS BIOELECTRON, V68, P295, DOI 10.1016/j.bios.2015.01.002
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gebala M, 2012, PHYS CHEM CHEM PHYS, V14, P14933, DOI 10.1039/c2cp42382k
   Gebala M, 2010, CHEMPHYSCHEM, V11, P2887, DOI 10.1002/cphc.201000210
   GOLAN Y, 1992, SURF SCI, V264, P312, DOI 10.1016/0039-6028(92)90188-C
   Gooding JJ, 2012, CHEM REC, V12, P92, DOI 10.1002/tcr.201100013
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hoogvliet JC, 2000, ANAL CHEM, V72, P2016, DOI 10.1021/ac991215y
   Ingebrandt S, 2007, BIOSENS BIOELECTRON, V22, P2834, DOI 10.1016/j.bios.2006.11.019
   Janegitz BC, 2014, J NANOSCI NANOTECHNO, V14, P378, DOI 10.1166/jnn.2014.9234
   Keighley SD, 2008, BIOSENS BIOELECTRON, V23, P1291, DOI 10.1016/j.bios.2007.11.012
   Labuda J, 2010, PURE APPL CHEM, V82, P1161, DOI 10.1351/PAC-REP-09-08-16
   Li CZ, 2005, ANAL CHEM, V77, P478, DOI 10.1021/ac048672l
   Lisdat F, 2008, ANAL BIOANAL CHEM, V391, P1555, DOI 10.1007/s00216-008-1970-7
   McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Oliveira ON, 2014, ACS APPL MATER INTER, V6, P14745, DOI 10.1021/am5015056
   Ozsoz M, 2012, ELECTROCHEMICAL DNA BIOSENSORS, P1, DOI 10.1201/b11988
   Papadopoulou E, 2015, ANAL CHEM, V87, P1605, DOI 10.1021/ac503063c
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park JY, 2008, ANAL CHIM ACTA, V619, P37, DOI 10.1016/j.aca.2008.02.055
   Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rant U, 2006, BIOPHYS J, V90, P3666, DOI 10.1529/biophysj.105.078857
   Rant U, 2004, LANGMUIR, V20, P10086, DOI 10.1021/la0492963
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Watterson J, 2002, ANAL CHIM ACTA, V469, P115, DOI 10.1016/S0003-2670(02)00125-3
   Witte C, 2011, ELECTROANAL, V23, P339, DOI 10.1002/elan.201000410
   Yan YR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18810
   Yang KH, 2017, MRS COMMUN, V7, P121, DOI 10.1557/mrc.2017.20
   Zhang DD, 2010, BIOSENS BIOELECTRON, V25, P1088, DOI 10.1016/j.bios.2009.09.032
   Zheng HY, 2013, ANAL METHODS-UK, V5, P5005, DOI 10.1039/c3ay40972d
NR 41
TC 14
Z9 14
U1 8
U2 52
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD APR 15
PY 2019
VL 131
BP 149
EP 155
DI 10.1016/j.bios.2019.02.018
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA HR7AH
UT WOS:000463303800021
PM 30831416
DA 2020-07-08
ER

PT J
AU Lee, S
   Lee, W
   Kim, H
   Bae, PK
   Park, J
   Kim, J
AF Lee, Sanghyun
   Lee, Wonhyung
   Kim, Hojin
   Bae, Pan Kee
   Park, Jaechan
   Kim, Joonwon
TI Oscillatory flow-assisted efficient target enrichment with small volumes
   of sample by using a particle-based microarray device
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Microfluidics; Microarray; Oscillatory flow; Immunoassay
ID MICROFLUIDIC MIXER
AB In the study, we describe an oscillatory flow-assisted efficient target enrichment method by using a particle based microarray device. Periodic oscillating flow effectively increased the mixing and binding performance between the target molecules in the sample solution and surface functionalized microparticles. Particles were trapped, secured, and released with an elastic microvalve structure operated via differences in the flow conditions. Single particle (20-mu m diameter) trapping efficiency exceeded 95%. Secured particles can freely move inside each array element based on oscillating sample flow. Furthermore, the particles can be released from the array and collected at the outlet of the device, and this provides an opportunity for further off-chip analysis. As a proof-of-concept, we used the interaction between streptavidin-coated microparticles and fluorescence labeled biotin solution and demonstrated that target enrichment and detection based on oscillatory flow were significantly more efficient than that based on unidirectional or static flow. The applicability of the method was further examined by conducting an on-chip immunoassay to detect the presence of anti-Zika nonstructural protein 1 (NS1) monoclonal antibody. The limit of detection (LOD) was as low as 1 ng/mL with an assay time of only 10 min and less than 10 mu L of sample consumption.
C1 [Lee, Sanghyun; Lee, Wonhyung; Kim, Joonwon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, 77 Cheongam Ro, Pohang 37673, Gyeongbuk, South Korea.
   [Kim, Hojin] RadianQbio, BioMEMS Lab, 53 Gasan Digital 2 Ro, Seoul 08588, South Korea.
   [Bae, Pan Kee] BioNano Hlth Guard Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.
   [Park, Jaechan] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
RP Kim, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, 77 Cheongam Ro, Pohang 37673, Gyeongbuk, South Korea.
EM Joonwon@postech.ac.kr
OI Park, Jaechan/0000-0001-7572-3260
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science and ICT [NRF-2017R1A2B4003328];
   Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI15C0001]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Science and ICT (No. NRF-2017R1A2B4003328) and a grant of the Korea
   Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI), funded by the Ministry of Health &
   Welfare, Republic of Korea (Grant No. HI15C0001).
CR Abolhasani M, 2014, LAB CHIP, V14, P2309, DOI 10.1039/c4lc00131a
   Ahmed D, 2009, MICROFLUID NANOFLUID, V7, P727, DOI 10.1007/s10404-009-0444-3
   Ballard M, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-016-1750-1
   Bezagu M, 2015, LAB CHIP, V15, P2025, DOI 10.1039/c5lc00247h
   Cheng DT, 2018, BIOMICROFLUIDICS, V12, DOI 10.1063/1.5025677
   Conde J, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00048
   Derveaux S, 2008, ANAL BIOANAL CHEM, V391, P2453, DOI 10.1007/s00216-008-2062-4
   Hong CC, 2004, LAB CHIP, V4, P109, DOI 10.1039/b305892a
   Kim DS, 2005, LAB CHIP, V5, P739, DOI 10.1039/b418314b
   Kim H., 2017, ADV MAT, V29
   Kim S, 2017, LAB CHIP, V17, P702, DOI 10.1039/c6lc01495j
   Kwak TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166068
   Li Y, 2014, ANAL CHEM, V86, P4333, DOI 10.1021/ac500112d
   Lin D, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/2/025601
   Liu YJ, 2003, ANAL BIOCHEM, V317, P76, DOI 10.1016/S0003-2697(03)00051-4
   Ng WY, 2009, LAB CHIP, V9, P802, DOI 10.1039/b813639d
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Phelan FR, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2830550
   Ryu KS, 2004, LAB CHIP, V4, P608, DOI 10.1039/b403305a
   Sub Y. K., 2010, MICROMACHINES, V1, P82
   Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863
   Wang X, 2011, TALANTA, V84, P565, DOI 10.1016/j.talanta.2011.01.065
   Ward K, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/9/094001
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Zhou BP, 2015, LAB CHIP, V15, P2125, DOI 10.1039/c5lc00173k
NR 25
TC 2
Z9 2
U1 3
U2 18
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD APR 15
PY 2019
VL 131
BP 280
EP 286
DI 10.1016/j.bios.2019.01.067
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA HR7AH
UT WOS:000463303800038
PM 30849728
DA 2020-07-08
ER

PT J
AU Furuya, AKM
   Hunt, D
   St George, K
   Dupuis, AP
   Kramer, LD
   Shi, PY
   Wong, S
AF Furuya, Andrea K. M.
   Hunt, Danielle
   St George, Kirsten
   Dupuis, Alan P., III
   Kramer, Laura D.
   Shi, Pei-Yong
   Wong, Susan
TI Use of the immunoglobulin G avidity assay to differentiate between
   recent Zika and past dengue virus infections
SO CLINICAL SCIENCE
LA English
DT Article
ID CROSS-REACTIVITY; ANTIBODIES; IMMUNOASSAY; DIAGNOSIS; STATES
AB Zika (ZIKV) and dengue (DENV) virus infections elicit a robust but cross-reactive antibody response against the viral envelope protein, while antibody responses against non-structural proteins (NS) are more virus specific. Building on this premise, we have previously developed a flavivirus multiplex microsphere immunoassay (MIA) for the serologic diagnosis of ZIKV and DENV infections. This assay significantly improved diagnostic accuracy; however, MIA could not differentiate more recent from past infections, which still represents a major diagnostic challenge. Therefore, an immunoglobulin G (IgG) based avidity assay was developed and its diagnostic performance evaluated. Specimens from New York State residents were submitted to the Wadsworth Center New York State Department of Health (NYSDOH) for routine clinical testing by Zika IgM ELISA and plaque reduction neutralization test (PRNT). Using our previously developed flavivirus MIA as a platform, we developed an IgG avidity assay to discriminate recent ZIKV from past DENV infections. Zika IgM positive specimens had an average Zika IgG avidity index of 14.8% (95% CI: 11.0-18.4%), while Zika IgM negative but flavivirus MIA and PRNT positive samples had an average Zika IgG avidity index of 34.9% (95% CI: 31.1-38.7%), Specimens positive for dengue antibodies by flavivirus MIA and PRNT had an average dengue IgG avidity index of 68.7% (95% CI: 62.7-75.0%). The IgG avidity assay accurately distinguished recent ZIKV from past DENV infections in patients who traveled to dengue endemic regions. This assay could be very useful in patients with high risk of Zika complications such as pregnant women and monitoring immune responses in vaccine trials.
C1 [Furuya, Andrea K. M.; Hunt, Danielle; Dupuis, Alan P., III; Wong, Susan] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.
   [St George, Kirsten; Kramer, Laura D.; Wong, Susan] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
RP Furuya, AKM; Wong, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.; Wong, S (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
EM andrea.furuya@health.ny.gov; susan.wong@health.ny.gov
FU New York State Department of Health (NYSDOH); Centers for Disease
   Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [NU50CK000423]
FX This work was supported by the New York State Department of Health
   (NYSDOH). A portion of the work described in this publication was
   supported by Co-operative Agreement Number NU50CK000423 from the Centers
   for Disease Control and Prevention. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the Centers for Disease Control and Prevention.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faber Jorge, 2014, Dental Press J. Orthod., V19, P27, DOI 10.1590/2176-9451.19.4.027-029.ebo
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fox JL, 2006, CLIN VACCINE IMMUNOL, V13, P33, DOI 10.1128/CVI.13.1.33-36.2006
   Gassmann C, 1997, J MED VIROL, V51, P242, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;242::AID-JMV17&gt;3.0.CO;2-M
   Graciaa DS, 2018, ANN INTERN MED, V169, P337, DOI 10.7326/M18-1112
   Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013
   Hazell Stuart L, 2007, Expert Opin Med Diagn, V1, P511, DOI 10.1517/17530059.1.4.511
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization W. H. O. Regional Office for the Americas, 2015, INCR MICR NE BRAZ
   Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14
   Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsai WY, 2018, EMERG INFECT DIS, V24, P1355, DOI 10.3201/eid2407.171170
   Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 32
TC 2
Z9 2
U1 1
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD APR 15
PY 2019
VL 133
IS 7
BP 859
EP 867
DI 10.1042/CS20180874
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HR7KL
UT WOS:000463332600006
PM 30902827
DA 2020-07-08
ER

PT J
AU Garcia-Serradilla, M
   Risco, C
   Pacheco, B
AF Garcia-Serradilla, Moises
   Risco, Cristina
   Pacheco, Beatriz
TI Drug repurposing for new, efficient, broad spectrum antivirals
SO VIRUS RESEARCH
LA English
DT Article
DE Virus; Antivirals; Drug repurposing
ID HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY SYNDROME
   CORONAVIRUS; IN-VITRO INHIBITION; VALLEY FEVER VIRUS; SILVER
   NANOPARTICLES; MYCOPHENOLIC-ACID; CYCLOSPORINE-A; CYCLOPHILIN-A; ZIKA
   VIRUS
AB Emerging viruses are a major threat to human health. Recent outbreaks have emphasized the urgent need for new antiviral treatments. For several pathogenic viruses, considerable efforts have focused on vaccine development. However, during epidemics infected individuals need to be treated urgently. High-throughput screening of clinically tested compounds provides a rapid means to identify undiscovered, antiviral functions for well-characterized therapeutics. Repurposed drugs can bypass part of the early cost and time needed for validation and authorization. In this review we describe recent efforts to find broad spectrum antivirals through drug repurposing. We have chosen several candidates and propose strategies to understand their mechanism of action and to determine how resistance to antivirals develops in infected cells.
C1 [Garcia-Serradilla, Moises; Risco, Cristina; Pacheco, Beatriz] UAM, CNB CSIC, Natl Res Council, Cell Struct Lab,Natl Ctr Biotechnol, Darwin 3,Campus Cantoblanco, Madrid 28049, Spain.
   [Pacheco, Beatriz] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.
RP Risco, C; Pacheco, B (corresponding author), UAM, CNB CSIC, Natl Res Council, Cell Struct Lab,Natl Ctr Biotechnol, Darwin 3,Campus Cantoblanco, Madrid 28049, Spain.; Pacheco, B (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.
EM crisco@cnb.csic.es; bpache01@ucm.es
RI Pacheco, Beatriz/Y-5100-2019; Risco, Cristina/K-4308-2014
OI Pacheco, Beatriz/0000-0003-0057-1973; Risco,
   Cristina/0000-0001-7501-5934
FU Spanish Ministry of Economy, Industry and Competitiveness
   [BIO2015-68758-R]; MINECO-FEDER; Severo Ochoa Center of Excellence
   Program
FX This work was supported by a research grant from the Spanish Ministry of
   Economy, Industry and Competitiveness (BIO2015-68758-R, MINECO-FEDER to
   CR). BP was recipient of a post-doctoral contract from the Severo Ochoa
   Center of Excellence Program.
CR Abu Bakar F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020071
   Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293
   Ashbrook AW, 2016, MBIO, V7, DOI 10.1128/mBio.00693-16
   Atkins M, 2006, NAT REV DRUG DISCOV, V5, P279, DOI 10.1038/nrd2012
   Baram-Pinto D, 2009, BIOCONJUGATE CHEM, V20, P1497, DOI 10.1021/bc900215b
   Barillo David J, 2014, Burns, V40 Suppl 1, pS3, DOI 10.1016/j.burns.2014.09.009
   Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275
   Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bematchez J. A., 2018, ANTIMICROB AGENTS CH, V62
   Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019
   Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524
   Bishop NE, 1998, INTERVIROLOGY, V41, P261, DOI 10.1159/000024948
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Borrego B, 2016, NANOMED-NANOTECHNOL, V12, P1185, DOI 10.1016/j.nano.2016.01.021
   Bose S, 2003, J GEN VIROL, V84, P1687, DOI 10.1099/vir.0.19074-0
   Brown AS, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.29
   Burdusel A. C., 2018, NANOMATERIALS-BASEL, P8
   Burkard C, 2015, J VIROL, V89, P4434, DOI 10.1128/JVI.03274-14
   Bykov YS, 2016, FEBS LETT, V590, P1877, DOI 10.1002/1873-3468.12153
   Cai HY, 2014, ANTIMICROB AGENTS CH, V58, P986, DOI 10.1128/AAC.01972-13
   Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010
   Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15
   CHAPPELL JB, 1954, NATURE, V174, P930, DOI 10.1038/174930b0
   Chapuis AG, 2000, NAT MED, V6, P762, DOI 10.1038/77489
   Damaso CRA, 1998, J GEN VIROL, V79, P339, DOI 10.1099/0022-1317-79-2-339
   de Castro IF, 2017, J CELL SCI, V130, P260, DOI 10.1242/jcs.181586
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   de Wilde AH, 2018, VIROLOGY, V522, P46, DOI 10.1016/j.virol.2018.06.011
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0
   Deivecchio R., 2016, VIRUSES, V8
   Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012
   Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001
   Dowell S. D., 2016, VIRUSES, V8
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   de Castro IF, 2014, METHOD CELL BIOL, V124, P55, DOI 10.1016/B978-0-12-801075-4.00003-3
   Ferraris O, 2015, ANTIVIR RES, V118, P75, DOI 10.1016/j.antiviral.2015.03.005
   Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131
   Francis AC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050275
   FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0
   Gheorghiade M, 2006, CIRCULATION, V113, P2556, DOI 10.1161/CIRCULATIONAHA.105.560110
   Grosso F, 2017, J VIROL, V91, DOI 10.1128/JVI.01623-16
   Guo J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-62
   Hamamoto I, 2013, JPN J INFECT DIS, V66, P276, DOI 10.7883/yoken.66.276
   HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408
   Hartley C, 2006, ARCH VIROL, V151, P2495, DOI 10.1007/s00705-006-0824-x
   Hartono C, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015487
   Hellstrom K, 2015, METHODS, V90, P49, DOI 10.1016/j.ymeth.2015.04.019
   Henry SD, 2006, GASTROENTEROLOGY, V131, P1452, DOI 10.1053/j.gastro.2006.08.027
   Hoenen Thomas, 2017, Methods Mol Biol, V1628, P189, DOI 10.1007/978-1-4939-7116-9_14
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015
   Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978
   Ishida J, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1031-5
   Iyidogan P, 2014, VIRUSES-BASEL, V6, P4095, DOI 10.3390/v6104095
   Jha BK, 2013, MOL THER, V21, P1749, DOI 10.1038/mt.2013.112
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kapoor A, 2012, ANTIMICROB AGENTS CH, V56, P4891, DOI 10.1128/AAC.00898-12
   Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546
   Kaur R, 2005, AIDS RES HUM RETROV, V21, P116, DOI 10.1089/aid.2005.21.116
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Khan SU, 2018, INT J NANOMED, V13, P733, DOI 10.2147/IJN.S153167
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   KONE BC, 1988, J MEMBRANE BIOL, V102, P11, DOI 10.1007/BF01875349
   Kovackova S, 2015, J MED CHEM, V58, P3393, DOI 10.1021/jm501759m
   Lai YC, 2018, ANTIVIR RES, V155, P28, DOI 10.1016/j.antiviral.2018.05.002
   Laird GM, 2014, J ANTIMICROB CHEMOTH, V69, P988, DOI 10.1093/jac/dkt471
   Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI 10.1186/1477-3155-8-1
   Leela SL, 2016, BIOCHEM BIOPH RES CO, V478, P410, DOI 10.1016/j.bbrc.2016.07.029
   LEMAITRE M, 1990, RES VIROLOGY, V141, P5, DOI 10.1016/0923-2516(90)90052-K
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li GD, 2017, ANTIVIR RES, V142, P83, DOI 10.1016/j.antiviral.2017.02.014
   Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28978
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037277
   Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063
   Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x
   Liu Yunying, 2013, Cell Regen (Lond), V2, P1, DOI 10.1186/2045-9769-2-1
   Lowen RG, 2018, ADV EXP MED BIOL, V1062, P303, DOI 10.1007/978-981-10-8727-1_21
   Lu L, 2008, ANTIVIR THER, V13, P253
   Luo C, 2004, BIOCHEM BIOPH RES CO, V321, P557, DOI 10.1016/j.bbrc.2004.07.003
   Ma CL, 2016, ANTIVIR RES, V133, P62, DOI 10.1016/j.antiviral.2016.07.019
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Margolis D, 1999, J ACQ IMMUN DEF SYND, V21, P362
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Martinez MG, 2014, J VIROL, V88, P6922, DOI 10.1128/JVI.00592-14
   Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2
   Mendel DB, 2003, CLIN CANCER RES, V9, P327
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005
   Mercorelli B, 2018, TRENDS MICROBIOL, V26, P865, DOI 10.1016/j.tim.2018.04.004
   Michaelis M, 2007, J ANTIMICROB CHEMOTH, V60, P981, DOI 10.1093/jac/dkm307
   Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x
   Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Mudhasani R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003095
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080
   Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013
   Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07
   Neveu G, 2015, J VIROL, V89, P4387, DOI 10.1128/JVI.02705-14
   Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845
   Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a
   Okuyama-Dobashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17047
   Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39
   Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102
   Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562
   Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357
   Papp I, 2010, SMALL, V6, P2900, DOI 10.1002/smll.201001349
   Paton NI, 2011, LANCET INFECT DIS, V11, P677, DOI 10.1016/S1473-3099(11)70065-2
   Perales C, 2015, VIRUSES-BASEL, V7, P5746, DOI 10.3390/v7112902
   Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331
   Pollastri MP, 2011, FUTURE MED CHEM, V3, P1307, DOI [10.4155/FMC.11.92, 10.4155/fmc.11.92]
   Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682
   Pu SY, 2018, ANTIVIR RES, V155, P67, DOI 10.1016/j.antiviral.2018.05.001
   Rainsford KD, 2015, INFLAMMOPHARMACOLOGY, V23, P231, DOI 10.1007/s10787-015-0239-y
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Risco C, 2014, ANNU REV VIROL, V1, P453, DOI 10.1146/annurev-virology-031413-085351
   Rogues P., 2018, VIRUSES, V10
   Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002
   SCHILTKNECHT E, 1985, CELL IMMUNOL, V91, P227, DOI 10.1016/0008-8749(85)90046-2
   SCHMID FX, 1995, CURR BIOL, V5, P993, DOI 10.1016/S0960-9822(95)00197-7
   Schor S, 2018, DNA CELL BIOL, V37, P63, DOI 10.1089/dna.2017.4033
   SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904
   Sharma D, 2015, J VIROL, V89, P1489, DOI 10.1128/JVI.02027-14
   Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Farias KJS, 2014, MICROBIOL IMMUNOL, V58, P318, DOI 10.1111/1348-0421.12154
   SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J
   SMITH T W, 1988, New England Journal of Medicine, V318, P358
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   SPERBER K, 1993, AIDS RES HUM RETROV, V9, P91, DOI 10.1089/aid.1993.9.91
   Speshock Janice L., 2010, Journal of Nanobiotechnology, V8, P19, DOI 10.1186/1477-3155-8-19
   Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183
   Sun RWY, 2005, CHEM COMMUN, P5059, DOI 10.1039/b510984a
   Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277
   Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tan KH, 2014, METHODS MOL BIOL, V1138, P99, DOI 10.1007/978-1-4939-0348-1_7
   Tanner WD, 2015, EPIDEMIOL INFECT, V143, P3359, DOI 10.1017/S0950268815001570
   Tenorio R, 2018, MBIO, V9, DOI 10.1128/mBio.01253-18
   THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0
   Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004
   Thorley AJ, 2013, PHARMACOL THERAPEUT, V140, P176, DOI 10.1016/j.pharmthera.2013.06.008
   To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   WAINBERG MA, 1988, BLOOD, V72, P1904
   Walters MS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-135
   Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982
   White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107
   Witte R, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040202
   Wong RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003241
   Xiang DX, 2011, J VIROL METHODS, V178, P137, DOI 10.1016/j.jviromet.2011.09.003
   Xiang DX, 2013, INT J NANOMED, V8, P4103, DOI 10.2147/IJN.S53622
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022
   Zhu JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00517
   Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003
NR 171
TC 8
Z9 9
U1 21
U2 35
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD APR 15
PY 2019
VL 264
BP 22
EP 31
DI 10.1016/j.virusres.2019.02.011
PG 10
WC Virology
SC Virology
GA HQ0QO
UT WOS:000462100300004
PM 30794895
OA Green Published
DA 2020-07-08
ER

PT J
AU Huang, SM
   Gu, JJ
   Ye, J
   Fang, B
   Wan, SF
   Wang, CY
   Ashraf, U
   Li, Q
   Wang, XG
   Shao, L
   Song, YF
   Zheng, XS
   Cao, FF
   Cao, SB
AF Huang, Shaomei
   Gu, Jiangjiang
   Ye, Jing
   Fang, Bin
   Wan, Shengfeng
   Wang, Caoyu
   Ashraf, Usama
   Li, Qi
   Wang, Xugang
   Shao, Lin
   Song, Yunfeng
   Zheng, Xinsheng
   Cao, Feifei
   Cao, Shengbo
TI Benzoxazine monomer derived carbon dots as a broad-spectrum agent to
   block viral infectivity
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Carbon dots; Benzoxazine monomers; Flaviviruses; Antivirus;
   Broad-spectrum agents
ID FLUORESCENCE TURN-ON; ONE-POT SYNTHESIS; QUANTUM DOTS; VIRUS;
   INHIBITORS; GRAPHENE; NANODOTS; NANOPARTICLES; THERANOSTICS; NANOPROBE
AB Multiple viruses can cause infection and death of millions annually. Of these, flaviviruses are found to be highly prevalent in recent years with no distinctive antiviral therapies. Therefore, there is a desperate need for broad-spectrum antiviral drugs that can be active against a large number of existing and emerging viruses. Herein, we prepared a kind of benzoxazine monomer derived carbon dots (BZM-CDs) and demonstrated their infection-blocking ability against life-threatening flaviviruses (Japanese encephalitis, Zika, and dengue viruses) and non-enveloped viruses (porcine parvovirus and adenovirus-associated virus). It was found that BZM-CDs could directly bind to the surface of the virion, and eventually the first step of virus-cell interaction was impeded. The developed nanoparticles are active against both flaviviruses and non-enveloped viruses in vitro. Thus, the application of BZM-CDs may constitute an intriguing broad-spectrum approach to rein in viral infections. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Huang, Shaomei; Ye, Jing; Wan, Shengfeng; Ashraf, Usama; Li, Qi; Wang, Xugang; Song, Yunfeng; Cao, Shengbo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Huang, Shaomei; Ye, Jing; Wan, Shengfeng; Ashraf, Usama; Li, Qi; Wang, Xugang; Song, Yunfeng; Cao, Shengbo] Huazhong Agr Univ, Coll Vet Med, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
   [Huang, Shaomei; Ye, Jing; Wan, Shengfeng; Ashraf, Usama; Li, Qi; Wang, Xugang; Song, Yunfeng; Cao, Shengbo] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China.
   [Gu, Jiangjiang; Fang, Bin; Wang, Caoyu; Zheng, Xinsheng; Cao, Feifei] Huazhong Agr Univ, Coll Sci, Wuhan 430070, Hubei, Peoples R China.
   [Shao, Lin] Wuhan Brain VTA Technol Co Ltd, Wuhan 430070, Hubei, Peoples R China.
RP Cao, SB (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; Gu, JJ (corresponding author), Huazhong Agr Univ, Coll Sci, Wuhan 430070, Hubei, Peoples R China.
EM jiangjianggu@mail.hzau.edu.cn; sbcao@mail.hzau.edu.cn
RI Ashraf, Usama/AAN-2536-2020; Gu, Jiangjiang/S-4018-2016
OI Gu, Jiangjiang/0000-0002-5161-2571; Ashraf, Usama/0000-0001-8686-9054
FU National Key Research and Development Program of China [2016YFD0500407];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31825025, 31502065, 21773078]; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [2662016Q003, 2662015PY083, 2662015PY163,
   2662016QD028]; State Key Laboratory of Agricultural Microbiology
   [AMLKF201702]
FX This work was supported by the National Key Research and Development
   Program of China (2016YFD0500407), the National Natural Science
   Foundation of China (31825025, 31502065, 21773078), the Fundamental
   Research Funds for the Central Universities (2662016Q003, 2662015PY083,
   2662015PY163, 2662016QD028) and the open funds of the State Key
   Laboratory of Agricultural Microbiology (AMLKF201702). The authors thank
   Pei Zhang from The Core Facility and Technical Support, Wuhan Institute
   of Virology, for helping in production of TEM micrographs.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Asebe  G., 2016, J INFECT DIS THER, V4
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Baker SN, 2010, ANGEW CHEM INT EDIT, V49, P6726, DOI 10.1002/anie.200906623
   Barras A, 2016, ACS APPL MATER INTER, V8, P9004, DOI 10.1021/acsami.6b01681
   Bimbo LM, 2013, ACS NANO, V7, P6884, DOI 10.1021/nn402062f
   Bing W, 2016, SMALL, V12, P4713, DOI 10.1002/smll.201600294
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Cagno V, 2018, NAT MATER, V17, P195, DOI [10.1038/NMAT5053, 10.1038/nmat5053]
   Ding CQ, 2014, ACCOUNTS CHEM RES, V47, P20, DOI 10.1021/ar400023s
   Dong XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00675-x
   Du T, 2016, CARBON, V110, P278, DOI 10.1016/j.carbon.2016.09.032
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Fang B, 2019, J COLLOID INTERF SCI, V536, P516, DOI 10.1016/j.jcis.2018.10.088
   Fang B, 2018, RSC ADV, V8, P7377, DOI 10.1039/c7ra10814a
   Ge JC, 2015, ADV MATER, V27, P4169, DOI 10.1002/adma.201500323
   Georgakilas V, 2015, CHEM REV, V115, P4744, DOI 10.1021/cr500304f
   Gu JJ, 2018, RSC ADV, V8, P12556, DOI 10.1039/c8ra01085d
   Gu JJ, 2016, NANOSCALE, V8, P3973, DOI 10.1039/c5nr04466a
   Huang P, 2012, ADV MATER, V24, P5104, DOI 10.1002/adma.201200650
   Iloni  G., 2018, IJPCBS, V8, P118
   Jackman JA, 2016, SMALL, V12, P1133, DOI 10.1002/smll.201500854
   Khan WU, 2018, INORG CHEM, V57, P15229, DOI 10.1021/acs.inorgchem.8b02524
   Kwon SJ, 2017, NAT NANOTECHNOL, V12, P48, DOI [10.1038/nnano.2016.181, 10.1038/NNANO.2016.181]
   Lauster D, 2017, ANGEW CHEM INT EDIT, V56, P5931, DOI 10.1002/anie.201702005
   Li F, 2017, ANGEW CHEM INT EDIT, V56, P9910, DOI 10.1002/anie.201705989
   Li N, 2018, BIOMATER SCI-UK, V6, P779, DOI 10.1039/c7bm00818j
   Li W, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201804004
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e
   Liu HB, 2017, RSC ADV, V7, P28016, DOI 10.1039/c7ra03167j
   Liu YF, 2018, NANOSCALE, V10, P6660, DOI 10.1039/c8nr00381e
   Lu XC, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8060443
   Pan LL, 2015, ADV MATER, V27, P7782, DOI 10.1002/adma.201503821
   Pelaz B, 2017, ACS NANO, V11, P2313, DOI 10.1021/acsnano.6b06040
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Sheik DA, 2015, ACS NANO, V9, P1829, DOI 10.1021/nn5067254
   Shi JL, 2013, EUR POLYM J, V49, P4054, DOI 10.1016/j.eurpolymj.2013.09.011
   Singh G, 2014, J CONTROL RELEASE, V194, P178, DOI 10.1016/j.jconrel.2014.09.002
   Sun J, 2016, BIOORGAN MED CHEM, V24, P3472, DOI 10.1016/j.bmc.2016.05.055
   Ting D, 2018, ACS APPL NANO MATER, V1, P5451, DOI 10.1021/acsanm.8b00779
   Wang C, 2018, J COLLOID INTERF SCI, V521, P33, DOI 10.1016/j.jcis.2018.03.021
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Xu MH, 2014, NANOSCALE, V6, P10307, DOI 10.1039/c4nr02792b
   Xu XW, 2016, ACS APPL MATER INTER, V8, P32706, DOI 10.1021/acsami.6b12252
   Yang YY, 2018, J COLLOID INTERF SCI, V509, P515, DOI 10.1016/j.jcis.2017.09.007
   Ye SY, 2015, ACS APPL MATER INTER, V7, P21571, DOI 10.1021/acsami.5b06876
   Zhang JL, 2018, TALANTA, V183, P39, DOI 10.1016/j.talanta.2018.02.009
   Zheng M, 2015, ACS NANO, V9, P11455, DOI 10.1021/acsnano.5b05575
   Zheng M, 2014, ADV MATER, V26, P3554, DOI 10.1002/adma.201306192
   Zheng XG, 2017, MATER LETT, V195, P58, DOI 10.1016/j.matlet.2017.02.094
   Zhou D, 2019, NANOSCALE HORIZ, V4, P388, DOI 10.1039/c8nh00247a
   Zhou D, 2017, SMALL, V13, DOI 10.1002/smll.201602055
   Zhou D, 2017, CHEM MATER, V29, P1779, DOI 10.1021/acs.chemmater.6b05375
   Zhu SJ, 2015, ANGEW CHEM INT EDIT, V54, P14626, DOI 10.1002/anie.201504951
   Zhu SJ, 2013, ANGEW CHEM INT EDIT, V52, P3953, DOI 10.1002/anie.201300519
NR 57
TC 8
Z9 8
U1 22
U2 80
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 2019
VL 542
BP 198
EP 206
DI 10.1016/j.jcis.2019.02.010
PG 9
WC Chemistry, Physical
SC Chemistry
GA HP2WP
UT WOS:000461536400022
PM 30739009
DA 2020-07-08
ER

PT J
AU Li, L
   Zhang, J
   Liu, C
   Zhang, HT
   Wang, Y
   Wang, Z
AF Li, Li
   Zhang, Jie
   Liu, Chen
   Zhang, Hong-Tao
   Wang, Yi
   Wang, Zhen
TI Analysis of transmission dynamics for Zika virus on networks
SO APPLIED MATHEMATICS AND COMPUTATION
LA English
DT Article
DE ZIKV; Complex networks; Basic reproduction number; Disease control
ID EPIDEMIC; VECTOR; MODELS
AB Transmission of Zika virus (ZIKV) is a serious problem in public health, which can make the babies suffer from microcephaly if their mothers are infected by ZIKV during pregnancy. In this paper, we develop a model of ZIKV transmission in Colombia on complex networks which considers both sexual transmission among humans and the transmission by an infective vector in the process of propagation. We estimate the basic reproduction number R-0 and prove that the disease-free equilibrium is globally asymptotically stable when R-0 < 1. In addition, we study the effects of sexual transmission and the transmission route by an infective vector on the process of propagation. Invasion regions of ZIKV were shown in two-parameters space. The obtained results may provide new insights for the control of ZIKV. (C) 2018 Published by Elsevier Inc.
C1 [Li, Li; Zhang, Jie] Shanxi Univ, Sch Comp & Informat Technol, Taiyuan 030006, Shanxi, Peoples R China.
   [Li, Li; Zhang, Hong-Tao] Shanxi Univ, Shanxi Key Lab Math Tech & Big Data Anal Dis Cont, Taiyuan 030006, Shanxi, Peoples R China.
   [Li, Li] North Univ China, Sci & Technol Elect Test & Measurement Lab, Taiyuan 030051, Shanxi, Peoples R China.
   [Liu, Chen] Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Shaanxi, Peoples R China.
   [Zhang, Hong-Tao] Shanxi Univ, Complex Syst Res Ctr, Taiyuan 030006, Shanxi, Peoples R China.
   [Wang, Yi] China Univ Geosci, Sch Math & Phys, Wuhan 430074, Hubei, Peoples R China.
   [Wang, Zhen] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Shaanxi, Peoples R China.
   [Wang, Zhen] Northwestern Polytech Univ, Ctr OPT IMagery Anal & Learning OPTIMAL, Xian 710072, Shaanxi, Peoples R China.
RP Liu, C (corresponding author), Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Shaanxi, Peoples R China.
EM lili831113@sxu.edu.cn; liuc317@neneu.edu.cn
FU National 1000 Young Talent Plan [W099102]; Fundamental Research Funds
   for the Central UniversitiesFundamental Research Funds for the Central
   Universities [3102017jc03007]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [11501338, 11747142];
   Program for the Outstanding Innovative Teams (OIT) of Higher Learning
   Institutions of Shanxi; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2017M621110]
FX The project is funded by the National 1000 Young Talent Plan W099102,
   the Fundamental Research Funds for the Central Universities
   3102017jc03007, the National Natural Science Foundation of China under
   Grant nos. 11501338, 11747142, Program for the Outstanding Innovative
   Teams (OIT) of Higher Learning Institutions of Shanxi, and China
   Postdoctoral Science Foundation under Grant no. 2017M621110.
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   d'Onofrio A, 2008, NONLINEAR ANAL-REAL, V9, P1567, DOI 10.1016/j.nonrwa.2007.04.001
   Dantas E., 2017, CALIBRATION SEIR EPI
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fan S. J., 1989, NATURAL SCI J HAINAN, V2, P91
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gao D., SCI REP
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   LAJMANOVICH A, 1976, Mathematical Biosciences, V28, P221, DOI 10.1016/0025-5564(76)90125-5
   Li L, 2018, INT J BIOMATH, V11, DOI 10.1142/S1793524518500304
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Miller J. C., 2017, INFECT DIS MODEL, V2, P1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P1
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pacheco O., 2016, N ENGL J MED, V2016
   Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Sun G. Q., 1943, PHYS LIFE REV
   Sun GQ, 2018, APPL MATH MODEL, V61, P200, DOI 10.1016/j.apm.2018.04.010
   Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Varga RS, 2009, MATRIX ITERATIVE ANA
   Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033
   Yorke J.A., 1967, MATH SYST THEORY, V1, P353, DOI DOI 10.1007/BF01695169
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 33
TC 18
Z9 18
U1 6
U2 117
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0096-3003
EI 1873-5649
J9 APPL MATH COMPUT
JI Appl. Math. Comput.
PD APR 15
PY 2019
VL 347
BP 566
EP 577
DI 10.1016/j.amc.2018.11.042
PG 12
WC Mathematics, Applied
SC Mathematics
GA HF3DW
UT WOS:000454116700046
DA 2020-07-08
ER

PT J
AU Park, JG
   Avila-Perez, G
   Madere, F
   Hilimire, TA
   Nogales, A
   Almazan, F
   Martinez-Sobrido, L
AF Park, Jun-Gyu
   Avila-Perez, Gines
   Madere, Ferralita
   Hilimire, Thomas A.
   Nogales, Aitor
   Almazan, Fernando
   Martinez-Sobrido, Luis
TI Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Flavivirus; Zika virus; aurintricarboxylic acid; antivirals;
   prophylactic; therapeutic; drug treatment
ID IN-VIVO ACTIVITY; TOPOISOMERASE-II; NUCLEIC-ACID; NS3 HELICASE; VITRO;
   CELLS; APOPTOSIS; EMERGENCE; INFECTION; EFFICACY
AB Zika virus (ZIKV) is one of the recently emerging vector-borne viruses in humans and is responsible for severe congenital abnormalities such as microcephaly in the Western Hemisphere. Currently, only a few vaccine candidates and therapeutic drugs are being developed for the treatment of ZIKV infections, and as of yet none are commercially available. The polyanionic aromatic compound aurintricarboxylic acid (ATA) has been shown to have a broad-spectrum antimicrobial and antiviral activity. In this study, we evaluated ATA as a potential antiviral drug against ZIKV replication. The antiviral activity of ATA against ZIKV replication in vitro showed median inhibitory concentrations (IC50) of 13.87 +/- 1.09 mu M and 33.33 +/- 1.13 mu M in Vero and A549 cells, respectively; without showing any cytotoxic effect in both cell lines (median cytotoxic concentration (CC50) > 1,000 mu M). Moreover, ATA protected both cell types from ZIKV-induced cytopathic effect (CPE) and apoptosis in a time- and concentration-dependent manner. In addition, pre-treatment of Vero cells with ATA for up to 72 h also resulted in effective suppression of ZIKV replication with similar IC50 . Importantly, the inhibitory effect of ATA on ZIKV infection was effective against strains of the African and Asian/American lineages, indicating that this inhibitory effect was not strain dependent. Overall, these results demonstrate that ATA has potent inhibitory activity against ZIKV replication and may be considered as a potential anti-ZIKV therapy for future clinical evaluation.
C1 [Park, Jun-Gyu; Avila-Perez, Gines; Madere, Ferralita; Hilimire, Thomas A.; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
   [Nogales, Aitor] INIA CISA, Ctr Anim Hlth Res, Madrid, Spain.
   [Almazan, Fernando] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cell Biol, Campus Univ Autonoma Madrid, Madrid, Spain.
RP Martinez-Sobrido, L (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
EM luis_martinez@urmc.rochester.edu
OI NOGALES, AITOR/0000-0002-2424-7900
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1R21AI130500]
FX This work was supported in part by the National Institutes of Health
   (NIH) grant 1R21AI130500 to LM-S and FA.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   AVILAPEREZ G, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10110597
   BALZARINI J, 1986, BIOCHEM BIOPH RES CO, V136, P64, DOI 10.1016/0006-291X(86)90877-6
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BENCHOKROUN Y, 1995, BIOCHEM PHARMACOL, V49, P305, DOI 10.1016/0006-2952(94)00465-X
   BINASTEIN M, 1976, MOL PHARMACOL, V12, P191
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   CATCHPOOLE DR, 1994, ANTICANCER RES, V14, P853
   Chen CW, 2002, BRIT J PHARMACOL, V137, P1011, DOI 10.1038/sj.bjp.0704955
   Chen Ye, 2009, Antivir Chem Chemother, V20, P19, DOI 10.3851/IMP1286
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   He RT, 2004, BIOCHEM BIOPH RES CO, V320, P1199, DOI 10.1016/j.bbrc.2004.06.076
   Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502
   Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006
   Klein P, 2008, J ANTIMICROB CHEMOTH, V62, P1101, DOI 10.1093/jac/dkn303
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liang FB, 2003, J BIOL CHEM, V278, P41734, DOI 10.1074/jbc.M307152200
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Mitra D, 1996, IMMUNOLOGY, V87, P581, DOI 10.1046/j.1365-2567.1996.510589.x
   Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623
   Myskiw C, 2007, J VIROL, V81, P3027, DOI 10.1128/JVI.02531-06
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Nazerai L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010029
   Nogales A, 2015, VIROLOGY, V476, P206, DOI 10.1016/j.virol.2014.12.006
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rivera-Concepcion JR, 2018, P R HEALTH SCI J, V37, pS93
   ROBERTSLEWIS JM, 1993, J NEUROCHEM, V61, P378, DOI 10.1111/j.1471-4159.1993.tb03583.x
   Rui H, 1998, J BIOL CHEM, V273, P28, DOI 10.1074/jbc.273.1.28
   Shadrick WR, 2013, BIOCHEMISTRY-US, V52, P6151, DOI 10.1021/bi4006495
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smee Donald F., 2010, Antiviral Chemistry & Chemotherapy, V20, P201, DOI 10.3851/IMP1480
   STRONY J, 1990, CIRCULATION, V81, P1106, DOI 10.1161/01.CIR.81.3.1106
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
NR 52
TC 3
Z9 3
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 12
PY 2019
VL 10
AR 718
DI 10.3389/fmicb.2019.00718
PG 10
WC Microbiology
SC Microbiology
GA HT1FG
UT WOS:000464308900001
PM 31031722
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Queiroz, A
   Pinto, IFD
   Lima, M
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Barreto, FK
   Canuto, GAB
   do Amaral, HR
   de Filippis, AMB
   Mascarenhas, DL
   Falcao, MB
   Santos, NP
   Azevedo, VAD
   Yoshinaga, MY
   Miyamoto, S
   Alcantara, LC
AF Queiroz, Adriano
   Dantas Pinto, Isabella Fernanda
   Lima, Maricelia
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Barreto, Fernanda Khouri
   Baptista Canuto, Gisele Andre
   do Amaral, Helineide Ramos
   Bispo de Filippis, Ana Maria
   Mascarenhas, Denise Lima
   Falcao, Melissa Barreto
   Santos, Normeide Pedreira
   de Carvalho Azevedo, Vasco Ariston
   Yoshinaga, Marcos Yukio
   Miyamoto, Sayuri
   Alcantara, Luiz Carlos Junior
TI Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients
   Infected With ZIKA Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; serum lipidomics; plasmalogens; phosphatidylethanolamine;
   arbovirus
ID DENGUE VIRUS; REPLICATION; PHOSPHATIDYLSERINE; PEROXISOMES; MEMBRANES
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the Flaviviridae family. Since the large outbreaks in French Polynesia in 2013-2014 and in Brazil in 2015, ZIKV has been considered a new public health threat. Similar to other related flavivirus, ZIKV is associated with mild and self-limiting symptoms such as rash, pruritus, prostration, headache, arthralgia, myalgia, conjunctivitis, lower back pain and, when present, a short-term low grade fever. In addition, ZIKV has been implicated in neurological complications such as neonatal microcephaly and Guillain-Barre syndrome in adults. Herein, serum lipidomic analysis was used to identify possible alterations in lipid metabolism triggered by ZIKV infection. Patients who presented virus-like symptoms such as fever, arthralgia, headache, exanthema, myalgia and pruritus were selected as the control group. Our study reveals increased levels of several phosphatidylethanolamine (PE) lipid species in the serum of ZIKV patients, the majority of them plasmenyl-phosphatidylethanolamine (pPE) (or plasmalogens) linked to polyunsaturated fatty acids. Constituting up to 20% of total phospholipids in humans, plasmalogens linked to polyunsaturated fatty acids are particularly enriched in neural membranes of the brain. The biosynthesis of plasmalogens requires functional peroxisomes, which are important sites for viral replication, including ZIKV. Thus, increased levels of plasmalogens in serum of ZIKV infected subjects suggest a link between ZIKV life cycle and peroxisomes. Our data provide important insights into specific host cellular lipids that are likely associated with ZIKV replication and may serve as platform for antiviral strategy against ZIKV.
C1 [Queiroz, Adriano; Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Alcantara, Luiz Carlos Junior] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Dantas Pinto, Isabella Fernanda; Yoshinaga, Marcos Yukio; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.
   [Lima, Maricelia] Univ Estadual Feira de Santana, Dept Saude, Feira De Santana, Brazil.
   [Giovanetti, Marta; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos Junior] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Barreto, Fernanda Khouri] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, Brazil.
   [Baptista Canuto, Gisele Andre] Univ Fed Bahia, Dept Quim Analit, Inst Quim, Salvador, BA, Brazil.
   [do Amaral, Helineide Ramos] Univ Estadual Feira de Santana, Nucleo Pesquisa Vigilancia Saude, Feira De Santana, Brazil.
   [Mascarenhas, Denise Lima; Falcao, Melissa Barreto; Santos, Normeide Pedreira] Secretaria Municipal Saude Municipio Feira de San, Feira De Santana, Brazil.
   [de Carvalho Azevedo, Vasco Ariston] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
RP Alcantara, LC (corresponding author), Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.; Yoshinaga, MY (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.; Alcantara, LC (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
EM marcosyukio@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020; Canuto, Gisele A B/N-7338-2015;
   Queiroz, Adriano/AAQ-1164-2020; Azevedo, Vasco A/B-1556-2019; Miyamoto,
   Sayuri/A-2144-2008
OI Canuto, Gisele A B/0000-0002-6616-3705; Queiroz,
   Adriano/0000-0003-0080-6509; Miyamoto, Sayuri/0000-0002-5714-8984;
   Alcantara, Luiz/0000-0002-6769-9931; Xavier, Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440685/20168, CNPq 424094/2016-9]; CAPESCAPES [88887.130716/2016-00];
   Financiadora de Estudos e ProjetosCiencia Tecnologia e Inovacao (FINEP)
   [FINEP 04.16.0060.00]; EU's Horizon 2020 Program through ZIKAlliance
   [734548]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [13/07937-8]; International Development Research Centre (IDRC)
   over the Grant [108411-001]; European UnionEuropean Union (EU) [734857];
   CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate
   Education within the Ministry of Education of Brazil); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [FAPESP 2014/11556-2]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq 440685/20168, CNPq 424094/2016-9), CAPES
   (88887.130716/2016-00), Financiadora de Estudos e Projetos (FINEP
   04.16.0060.00) and EU's Horizon 2020 Program through ZIKAlliance (Grant
   734548). The activities ofMY, IP, and SMwere funded by FAPESP
   (CEPID-Redoxoma grant 13/07937-8). And the activities of AF was
   supported by the International Development Research Centre (IDRC) over
   the Grant 108411-001 and by the European Union's Horizon 2020 grant
   agreement ZikAction no. 734857. AQ, MG, FB, and MY were funded by a post
   doc fellowship from CAPES (Brazilian Federal Agency for Support and
   Evaluation of Graduate Education within the Ministry of Education of
   Brazil) and IP by a Ph.D fellowship from Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP 2014/11556-2).
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Berger J, 2016, BBA-MOL CELL RES, V1863, P934, DOI 10.1016/j.bbamcr.2015.12.005
   Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308
   GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Odendall Charlotte, 2013, Subcell Biochem, V69, P67, DOI 10.1007/978-94-007-6889-5_4
   Melo CFOR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30385-x
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rog T, 2016, BBA-BIOMEMBRANES, V1858, P97, DOI 10.1016/j.bbamem.2015.10.023
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   SATOH O, 1990, J LIPID RES, V31, P1293
   Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Wewer CR, 2018, SOFT MATTER, V14, P5615, DOI 10.1039/c8sm00223a
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
NR 45
TC 4
Z9 4
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 12
PY 2019
VL 10
AR 753
DI 10.3389/fmicb.2019.00753
PG 10
WC Microbiology
SC Microbiology
GA HT1IR
UT WOS:000464317800001
PM 31031729
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathum
   Wiwanitkit, Viroj
TI Zika virus infection in pregnant women in Mexico
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Letter; Early Access
C1 [Sookaromdee, Pathum] TWS Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Coll, Haikou, Hainan, Peoples R China.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Del Carpio-Orantes Luis, 2019, J Matern Fetal Neonatal Med, P1, DOI 10.1080/14767058.2019.1582627
   Contreras-Capetillo SN, 2018, CLIN PEDIATR, V57, P927, DOI 10.1177/0009922817738341
NR 2
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
DI 10.1080/14767058.2019.1603291
EA APR 2019
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HV3KC
UT WOS:000465886500001
PM 30939961
DA 2020-07-08
ER

PT J
AU Lee, WS
   Webster, JA
   Madzokere, ET
   Stephenson, EB
   Herrero, LJ
AF Lee, Wai-Suet
   Webster, Julie A.
   Madzokere, Eugene T.
   Stephenson, Eloise B.
   Herrero, Lara J.
TI Mosquito antiviral defense mechanisms: a delicate balance between innate
   immunity and persistent viral infection
SO PARASITES & VECTORS
LA English
DT Review
DE Mosquito; Antiviral defense; RNAi pathway; Persistent infection;
   Transmission-blocking strategies
ID MALARIA VECTOR MOSQUITO; NILE VIRUS-INFECTION; DOUBLE-STRANDED-RNA;
   AEDES-AEGYPTI; ANTIMICROBIAL PEPTIDES; ANOPHELES-GAMBIAE; DISTINCT
   ROLES; HOST-DEFENSE; SIGNALING PATHWAY; WOLBACHIA
AB Mosquito-borne diseases are associated with major global health burdens. Aedes spp. and Culex spp. are primarily responsible for the transmission of the most medically important mosquito-borne viruses, including dengue virus, West Nile virus and Zika virus. Despite the burden of these pathogens on human populations, the interactions between viruses and their mosquito hosts remain enigmatic. Viruses enter the midgut of a mosquito following the mosquito's ingestion of a viremic blood meal. During infection, virus recognition by the mosquito host triggers their antiviral defense mechanism. Of these host defenses, activation of the RNAi pathway is the main antiviral mechanism, leading to the degradation of viral RNA, thereby inhibiting viral replication and promoting viral clearance. However, whilst antiviral host defense mechanisms limit viral replication, the mosquito immune system is unable to effectively clear the virus. As such, these viruses can establish persistent infection with little or no fitness cost to the mosquito vector, ensuring life-long transmission to humans. Understanding of the mosquito innate immune response enables the discovery of novel antivectorial strategies to block human transmission. This review provides an updated and concise summary of recent studies on mosquito antiviral immune responses, which is a key determinant for successful virus transmission. In addition, we will also discuss the factors that may contribute to persistent infection in mosquito hosts. Finally, we will discuss current mosquito transmission-blocking strategies that utilize genetically modified mosquitoes and Wolbachia-infected mosquitoes for resistance to pathogens.
C1 [Lee, Wai-Suet; Webster, Julie A.; Madzokere, Eugene T.; Stephenson, Eloise B.; Herrero, Lara J.] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4215, Australia.
   [Stephenson, Eloise B.] Griffith Univ, Environm Futures Res Inst, Gold Coast Campus, Southport, Qld 4215, Australia.
RP Herrero, LJ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4215, Australia.
EM l.herrero@griffith.edu.au
RI Webster, Julie/N-6081-2015; Herrero, Lara/A-4628-2015
OI Webster, Julie/0000-0003-2879-700X; Herrero, Lara/0000-0002-5661-9828
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia; ARCFondation ARC pour la
   Recherche sur le CancerAustralian Research Council [1081954,
   DE140101493]
FX This work was supported by the Australian National Health and Medical
   Research Council grant and ARC Discovery Early Career Researcher Award
   to LJH (Grant ID: 1081954 and DE140101493).
CR Amuzu HE, 2018, ECOL EVOL, V8, P5441, DOI 10.1002/ece3.4066
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Asad S, 2018, INSECT BIOCHEM MOLEC, V92, P45, DOI 10.1016/j.ibmb.2017.11.008
   Asgari S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/v6093514
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906
   Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010
   Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dong YM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006898
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Duneau DF, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0466-3
   Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Grigoraki L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12103-1
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hanson MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0805-y
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hillyer JF, 2014, CURR OPIN INSECT SCI, V3, P14, DOI 10.1016/j.cois.2014.07.002
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Lim EXY, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020084
   Liu PW, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1815-8
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martins GF, 2011, MEM I OSWALDO CRUZ, V106, P742, DOI 10.1590/S0074-02762011000600015
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nainu F, 2015, J IMMUNOL, V195, P5696, DOI 10.4049/jimmunol.1500613
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Nakatogawa S, 2009, CURR BIOL, V19, P779, DOI 10.1016/j.cub.2009.03.050
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Parikh GR, 2009, J GEN VIROL, V90, P292, DOI 10.1099/vir.0.005116-0
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Puthiyakunnon S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-230
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Romo H, 2018, AM J TROP MED HYG, V98, P1863, DOI 10.4269/ajtmh.17-0935
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Serrato-Salas J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00801
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200
   Sigle LT, 2018, INSECT MOL BIOL, V27, P429, DOI 10.1111/imb.12383
   Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089
   Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015
   Tran T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl173
   Tsuzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5628
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x
   Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   World Health Organization, 2017, VECT BORN DIS
   World Health Organization. WHO, 2017, DENG CONTR STRAT
   World Mosquito Program, 2017, EL DENG
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6
   Zhang J, 2018, HEMATOLOGY, V23, P1, DOI [10.1080/10245332.2017.1333294, DOI 10.1080/10245332.2017.1333294]
   Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]
NR 119
TC 3
Z9 4
U1 2
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 11
PY 2019
VL 12
AR 165
DI 10.1186/s13071-019-3433-8
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HT9BU
UT WOS:000464860500005
PM 30975197
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Patel, CD
   Backes, LM
   Taylor, SA
   Jiang, Y
   Marchant, A
   Pesola, JM
   Coen, DM
   Knipe, DM
   Ackerman, ME
   Leib, DA
AF Patel, Chaya D.
   Backes, Lara M.
   Taylor, Sean A.
   Jiang, Yike
   Marchant, Arnaud
   Pesola, Jean M.
   Coen, Donald M.
   Knipe, David M.
   Ackerman, Margaret E.
   Leib, David A.
TI Maternal immunization confers protection against neonatal herpes simplex
   mortality and behavioral morbidity
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID ANXIETY-LIKE BEHAVIOR; VIRUS-INFECTION; IMMUNE ACTIVATION; NEWBORN MICE;
   ZIKA VIRUS; NUDE-MICE; ANTIBODY; TRANSMISSION; REPLICATION; ACYCLOVIR
AB Neonatal herpes simplex virus (nHSV) infections cause devastating morbidity and mortality in infants. Most nHSV cases are associated with primary maternal infection, consistent with the hypothesis that maternal immunity is protective. In humans, we found HSV-specific neutralizing antibodies in newborns of immune mothers, indicating that placentally transferred HSV-specific antibody is protective. Using a murine model, we showed that passive administration of HSV-specific antibody to dams prevented disseminated infection and mortality in pups. Maternal immunization with an HSV-2 replication-defective vaccine candidate, dl5-29, led to transfer of HSV-specific antibodies into neonatal circulation that protected against nHSV neurological disease and death. Furthermore, we observed considerable anxiety-like behavior in adult mice that had been infected with low doses of HSV as neonates, despite a notable lack of signs of infection. This phenotype suggests that nHSV infection can have an unsuspected and permanent impact on behavior. These behavioral sequelae of nHSV were prevented by maternal immunization with dl5-29, demonstrating an unexpected benefit of immunization. These findings also support the general concept that maternal immunization can prevent neurotropic neonatal infections and associated morbidity and mortality.
C1 [Patel, Chaya D.; Backes, Lara M.; Taylor, Sean A.; Jiang, Yike; Leib, David A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
   [Patel, Chaya D.] Guarini Sch Grad & Adv Studies Dartmouth, Hanover, NH 03755 USA.
   [Backes, Lara M.; Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
   [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Charleroi, Belgium.
   [Pesola, Jean M.; Coen, Donald M.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Knipe, David M.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
RP Leib, DA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
EM david.a.leib@dartmouth.edu
OI Leib, David/0000-0001-5539-8480; Patel, Chaya/0000-0002-9055-5696;
   Backes, Iara/0000-0003-4389-6356; Ackerman,
   Margaret/0000-0002-4253-3476; Knipe, David/0000-0003-1554-6236
FU Munck-Pfefferkorn Education and Research Fund [P01 AI098681, R01
   AI131975, R01 AI057552, R01 EY09083]; Fondation Roi Baudouin
   [T32AI007519]
FX This study was supported by the Munck-Pfefferkorn Education and Research
   Fund to D.A.L.; P01 AI098681 to D.A.L., D.M.C., and D.M.K.; R01 AI131975
   to M.E.A.; R01 AI057552 to D.M.K.; R01 EY09083 to D.A.L.; Fondation Roi
   Baudouin to A.M.; and T32AI007519 to C.D.P.
CR Andrade EB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05492-y
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016
   Awasthi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006141
   BARON S, 1976, NATURE, V261, P505, DOI 10.1038/261505a0
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bernard MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121518
   Bilbo SD, 2005, BEHAV NEUROSCI, V119, P293, DOI 10.1037/0735-7044.119.1.293
   Bravo FJ, 1996, J INFECT DIS, V173, P1, DOI 10.1093/infdis/173.1.1
   Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007
   BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Cabore RN, 2017, VIRULENCE, V8, P1245, DOI 10.1080/21505594.2017.1296998
   Chen VCH, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.16m11312
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000
   Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994
   Dabbah-Assadi F, 2019, BRAIN BEHAV IMMUN, V79, P207, DOI 10.1016/j.bbi.2019.02.002
   Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020
   de Miranda AS, 2011, NEUROSCI LETT, V491, P202, DOI 10.1016/j.neulet.2011.01.038
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Diaz FM, 2016, VIROLOGY, V488, P61, DOI 10.1016/j.virol.2015.10.033
   Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]
   EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357
   Evans AK, 2014, BRAIN BEHAV IMMUN, V37, P122, DOI 10.1016/j.bbi.2013.11.012
   Evans IAC, 2002, J INFECT DIS, V185, P1550, DOI 10.1086/340572
   FIELDS BM, 1996, FUNDAMENTAL VIROLOGY
   Fouda Genevieve G, 2018, Immunohorizons, V2, P14, DOI 10.4049/immunohorizons.1700057
   French SS, 2013, PHYSIOL BEHAV, V119, P175, DOI 10.1016/j.physbeh.2013.06.018
   Goetghebuer T, 2019, CLIN INFECT DIS, V68, P1193, DOI 10.1093/cid/ciy673
   Gottlieb SL, 2019, VACCINE, V37, P7408, DOI 10.1016/j.vaccine.2017.10.084
   Guha SK, 2014, BRAIN BEHAV IMMUN, V42, P123, DOI 10.1016/j.bbi.2014.06.009
   Harris John Brock, 2017, J Pediatr Pharmacol Ther, V22, P88, DOI 10.5863/1551-6776-22.2.88
   HAYASHI Y, 1983, J GEN VIROL, V64, P1007, DOI 10.1099/0022-1317-64-5-1007
   Henderson B, 2017, J PEDIATR INFECT DIS, V6, pE177, DOI 10.1093/jpids/pix017
   Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022
   Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442
   James SH, 2014, J PEDIATR INFECT DIS, V3, pS19, DOI 10.1093/jpids/piu050
   James SH, 2009, ANTIVIR RES, V83, P207, DOI 10.1016/j.antiviral.2009.04.010
   Jiang Y, 2017, FUTURE VIROL, V12, P709, DOI 10.2217/fvl-2017-0105
   Jiang Y, 2017, MBIO, V8, DOI [10.1128/mBio.00678-17, 10.1128/mbio.00678-17]
   Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076
   Kimberlin DW, 2017, LANCET GLOB HEALTH, V5, pE234, DOI 10.1016/S2214-109X(17)30047-5
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   KINO Y, 1985, MICROBIOL IMMUNOL, V29, P143, DOI 10.1111/j.1348-0421.1985.tb00812.x
   KINO Y, 1982, J GEN VIROL, V63, P475, DOI 10.1099/0022-1317-63-2-475
   Knipe DM, 2014, VACCINE, V32, P1561, DOI 10.1016/j.vaccine.2014.01.052
   KOHL S, 1991, REV INFECT DIS, V13, pS950
   KOHL S, 1984, J INFECT DIS, V149, P38, DOI 10.1093/infdis/149.1.38
   KOHL S, 1989, J INFECT DIS, V160, P770, DOI 10.1093/infdis/160.5.770
   Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009
   Krehbiel K, 2018, J FORENSIC SCI, V63, P935, DOI 10.1111/1556-4029.13590
   Leas BF, 2015, J PEDIAT INF DIS SOC, V4, P126, DOI 10.1093/jpids/piu075
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   MALM G, 1991, ACTA PAEDIATR SCAND, V80, P226, DOI 10.1111/j.1651-2227.1991.tb11838.x
   Manivanh R, 2017, J VIROL, V91, DOI 10.1128/JVI.01156-17
   Marchant A, 2017, LANCET INFECT DIS, V17, pE197, DOI 10.1016/S1473-3099(17)30229-3
   McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321
   Muller WJ, 2017, PEDIATR RES, V81, P162, DOI 10.1038/pr.2016.191
   Nelson CS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94002
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031
   Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349
   PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503
   Qi ZZ, 2012, CLIN VACCINE IMMUNOL, V19, P1746, DOI 10.1128/CVI.00455-12
   RADER KA, 1993, J GEN VIROL, V74, P1859, DOI 10.1099/0022-1317-74-9-1859
   Royer DJ, 2016, J VIROL, V90, P5514, DOI 10.1128/JVI.00517-16
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434
   Shah SS, 2011, PEDIATRICS, V128, P1153, DOI 10.1542/peds.2011-0177
   SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6
   Spencer SJ, 2005, BEHAV BRAIN RES, V164, P231, DOI 10.1016/j.bbr.2005.06.032
   Stanfield BA, 2017, VACCINE, V35, P536, DOI 10.1016/j.vaccine.2016.12.018
   SULLENDER WM, 1988, J INFECT DIS, V157, P164, DOI 10.1093/infdis/157.1.164
   van Lint AL, 2007, VIROLOGY, V368, P227, DOI 10.1016/j.virol.2007.08.030
   Vermillion MS, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-017-0042-4
   Walker FR, 2004, BEHAV BRAIN RES, V154, P63, DOI 10.1016/j.bbr.2004.01.019
   Walz N, 2016, BIOL PSYCHIAT, V80, P390, DOI 10.1016/j.biopsych.2015.12.016
   WHITLEY RJ, 1980, PEDIATRICS, V66, P489
   WHITLEY RJ, 1994, PEDIATR INFECT DIS J, V13, P432, DOI 10.1097/00006454-199405000-00035
   Xu YQ, 2017, J IMMUNOL RES, DOI 10.1155/2017/7373196
   YAMAMOTO M, 1985, ANTIVIR RES, V5, P83, DOI 10.1016/0166-3542(85)90034-8
   YEAGER AS, 1980, INFECT IMMUN, V29, P532
   Yorty JL, 2003, J VIROL, V77, P6613, DOI 10.1128/JVI.77.12.6613-6619.2003
   Yu CX, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0384-17.2018
   Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493
NR 89
TC 6
Z9 6
U1 2
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD APR 10
PY 2019
VL 11
IS 487
AR eaau6039
DI 10.1126/scitranslmed.aau6039
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA HS6ZR
UT WOS:000464020300004
PM 30971454
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Diaz, MD
   Montalvo, A
   Hernandez, JR
   Montes, JG
   Vazquez, M
   Bolo-Diaz, M
   Montalvo, J
AF Diaz, Mayela Diaz
   Montalvo, Alexandra
   Hernandez, Janice Rodriguez
   Montes, Jessica Gonzalez
   Vazquez, Marisel
   Bolo-Diaz, Mireya
   Montalvo, Jocelyn
TI Case Series: Congenital Zika Virus Infection associated with Epileptic
   Spasms
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Academy-of-Neurology (AAN)
CY MAY 04-10, 2019
CL Philadelphia, PA
SP Amer Acad Neurol
C1 [Diaz, Mayela Diaz; Montalvo, Alexandra; Hernandez, Janice Rodriguez; Montes, Jessica Gonzalez; Vazquez, Marisel; Bolo-Diaz, Mireya; Montalvo, Jocelyn] UPR Sch Med, Child Neurol, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 9
PY 2019
VL 92
IS 15
SU S
MA P4.9-018
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA IJ5TN
UT WOS:000475965904321
DA 2020-07-08
ER

PT J
AU Kohler, A
   Farez, M
   Heck, E
   Barroso, FA
   Bruno, V
AF Kohler, Alejandro
   Farez, Mauricio
   Heck, Evelyn
   Adrian Barroso, Fabio
   Bruno, Veronica
TI Association between neurological syndromes and Arbovirus in Buenos Aires
   - Relationship between Guillain Barre Syndrome, Encephalitis and
   Myelitis with Zika, Dengue and Chikungunya
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Academy-of-Neurology (AAN)
CY MAY 04-10, 2019
CL Philadelphia, PA
SP Amer Acad Neurol
C1 [Kohler, Alejandro] FLENI, Neurol, Buenos Aires, DF, Argentina.
   [Farez, Mauricio; Heck, Evelyn; Adrian Barroso, Fabio] FLENI, Buenos Aires, DF, Argentina.
   [Bruno, Veronica] Univ Calgary, Dept Neurosci, Calgary, AB, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 9
PY 2019
VL 92
IS 15
SU S
MA P4.6-024
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA IJ5TN
UT WOS:000475965904194
DA 2020-07-08
ER

PT J
AU Pardo-Villamizar, C
   Gonzalez-Manrique, G
   Jimenez-Arango, JA
   Lizarazo, J
   Vargas, J
   Lopez, R
   Zea, AF
   Angarita, J
   Moyano, M
   Barreras, P
   Munoz-Arcos, L
   Quintero, JA
   Dominguez, S
   Ramos, G
   Beltran, CL
   Garcia-Dominguez, MA
   Benavides, J
   Cornblath, D
   Parra, B
   Osorio, L
AF Pardo-Villamizar, Carlos
   Gonzalez-Manrique, Guillermo
   Andres Jimenez-Arango, Jorge
   Lizarazo, Jairo
   Vargas, Jose
   Lopez, Reydmar
   Zea, Andres F.
   Angarita, Jorge
   Moyano, Martha
   Barreras, Paula
   Munoz-Arcos, Laura
   Quintero, Jaime A.
   Dominguez, Susana
   Ramos, Gustavo
   Beltran, Cindy L.
   Garcia-Dominguez, Maria A.
   Benavides, Julie
   Cornblath, David
   Parra, Beatriz
   Osorio, Lyda
TI GBS after the Zika-outbreak in Colombia: The newcomer is gone problem
   continues!
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Academy-of-Neurology (AAN)
CY MAY 04-10, 2019
CL Philadelphia, PA
SP Amer Acad Neurol
C1 [Pardo-Villamizar, Carlos; Barreras, Paula; Munoz-Arcos, Laura; Garcia-Dominguez, Maria A.; Cornblath, David] Johns Hopkins Univ, Sch Med, Neurol, Baltimore, MD USA.
   [Gonzalez-Manrique, Guillermo; Beltran, Cindy L.] Univ Surcolombiana, Neiva, Colombia.
   [Andres Jimenez-Arango, Jorge; Lopez, Reydmar] Univ Antioquia, Medellin, Colombia.
   [Lizarazo, Jairo] Hosp Univ Erasmo Meoz, Cucuta, Colombia.
   [Vargas, Jose] Clin La Misericordia Int, Barranquilla, Colombia.
   [Zea, Andres F.; Moyano, Martha; Quintero, Jaime A.; Parra, Beatriz] Univ Valle, Cali, Colombia.
   [Osorio, Lyda] Univ Valle, Epidemiol, Cali, Colombia.
   [Angarita, Jorge] Clin Medilaser, Neiva, Colombia.
   [Dominguez, Susana] NEAS, Barranquilla, Colombia.
   [Ramos, Gustavo] Univ Valle, Clin DIME, Univ Libre Cali, Cali, Colombia.
   [Benavides, Julie] Univ Cooperat Colombia, Pasto, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 9
PY 2019
VL 92
IS 15
SU S
MA P2.6-039
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA IJ5TN
UT WOS:000475965901447
DA 2020-07-08
ER

PT J
AU Walteros, D
   Soares, J
   Styczynski, A
   Abrams, J
   Galindo, J
   Acosta-Reyes, J
   Bravo, E
   Arteta, Z
   Solano, A
   Prieto, F
   Gonzales, M
   Lechuga, E
   Salinas, J
   Belay, E
   Schonberger, L
   Damon, I
   Ospina, M
   Sejvar, J
AF Walteros, Diana
   Soares, Jesus
   Styczynski, Ashley
   Abrams, Joseph
   Galindo, Jose
   Acosta-Reyes, Jorge
   Bravo, Elsa
   Arteta, Zuleima
   Solano, Alma
   Prieto, Franklyn
   Gonzales, Maritza
   Lechuga, Edgar
   Salinas, Jorge
   Belay, Ermias
   Schonberger, Lawrence
   Damon, Inger
   Ospina, Martha
   Sejvar, James
TI Long-Term Outcomes of Guillain-Barre Syndrome Associated with Zika Virus
   Infection
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Academy-of-Neurology (AAN)
CY MAY 04-10, 2019
CL Philadelphia, PA
SP Amer Acad Neurol
C1 [Walteros, Diana; Prieto, Franklyn; Gonzales, Maritza; Ospina, Martha] Natl Inst Hlth, Bogota, Colombia.
   [Soares, Jesus; Abrams, Joseph; Belay, Ermias; Schonberger, Lawrence; Damon, Inger] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Styczynski, Ashley] Stanford Univ, Palo Alto, CA 94304 USA.
   [Galindo, Jose] Inst Global Hlth, TEPHINET, Bogota, Colombia.
   [Acosta-Reyes, Jorge; Lechuga, Edgar] Univ Norte, Barranquilla, Colombia.
   [Bravo, Elsa; Arteta, Zuleima; Solano, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia.
   [Salinas, Jorge] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.
   [Sejvar, James] US Ctr Dis Control & Prevent, Atlanta, GA USA.
RI Acosta-Reyes, Jorge/D-1906-2011
OI Acosta-Reyes, Jorge/0000-0003-4303-3243
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 9
PY 2019
VL 92
IS 15
SU S
MA P4.6-025
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA IJ5TN
UT WOS:000475965904195
DA 2020-07-08
ER

PT J
AU Chen, ZZ
   Zhong, D
   Li, GZ
AF Chen, Zhuangzhuang
   Zhong, Di
   Li, Guozhong
TI The role of microglia in viral encephalitis: a review
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Review
DE Microglia; Viral encephalitis; IFN-1; P2Y12; A beta; Autophagy
ID I INTERFERON RESPONSE; MYELOID CELLS; TNF-ALPHA; ANTIVIRAL AUTOPHAGY;
   BRAIN PARENCHYMA; AMYLOID-BETA; INFECTION; MACROPHAGES; RECOGNITION;
   EXPRESSION
AB Viral encephalitis is still very prominent around the world, and traditional antiviral therapies still have shortcomings. Some patients cannot get effective relief or suffer from serious sequelae. At present, people are studying the role of the innate immune system in viral encephalitis. Microglia, as resident cells of the central nervous system (CNS), can respond quickly to various CNS injuries including trauma, ischemia, and infection and maintain the homeostasis of CNS, but this response is not always good; sometimes, it will exacerbate damage. Studies have shown that microglia also act as a double-edged sword during viral encephalitis. On the one hand, microglia can sense ATP signals through the purinergic receptor P2Y12 and are recruited around infected neurons to exert phagocytic activity. Microglia can exert a direct antiviral effect by producing type 1 interferon (IFN-1) to induce IFN-stimulated gene (ISG) expression of themselves or indirect antiviral effects by IFN-1 acting on other cells to activate corresponding signaling pathways. In addition, microglia can also exert an antiviral effect by inducing autophagy or secreting cytokines. On the other hand, microglia mediate presynaptic membrane damage in the hippocampus through complement, resulting in long-term memory impairment and cognitive dysfunction in patients with encephalitis. Microglia mediate fetal congenital malformations caused by Zika virus (ZIKV) infection. The gene expression profile of microglia in HIV encephalitis changes, and they tend to be a pro-inflammatory type. Microglia inhibited neuronal autophagy and aggravated the damage of CNS in HIV encephalitis; E3 ubiquitin ligase Pellino (pelia) expressed by microglia promotes the replication of virus in neurons. The interaction between amyloid-beta peptide (A beta) produced by neurons and activated microglia during viral infection is uncertain. Although neurons can mediate antiviral effects by activating receptor-interacting protein kinases 3 (RIPK3) in a death-independent pathway, the RIPK3 pathway of microglia is unknown. Different brain regions have different susceptibility to viruses, and the gene expression of microglia in different brain regions is specific. The relationship between the two needs to be further confirmed. How to properly regulate the function of microglia and make it exert more anti-inflammatory effects is our next research direction.
C1 [Chen, Zhuangzhuang; Zhong, Di; Li, Guozhong] Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, 23 You Zheng St, Harbin 150001, Heilongjiang, Peoples R China.
RP Chen, ZZ (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, 23 You Zheng St, Harbin 150001, Heilongjiang, Peoples R China.
EM 1195273019@qq.com
OI Li, Guozhong/0000-0002-5482-393X; Zhuangzhuang, Chen/0000-0001-6704-2991
CR Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   Alirezaei M, 2008, AUTOPHAGY, V4, P963, DOI 10.4161/auto.6805
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Arribas JR, 1996, ANN INTERN MED, V125, P577, DOI 10.7326/0003-4819-125-7-199610010-00008
   Bitsch A, 2004, ACTA NEUROL SCAND, V110, P386, DOI 10.1111/j.1600-0404.2004.00347.x
   Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491
   Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585
   Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003
   Cheeran MCJ, 2001, J NEUROVIROL, V7, P135
   Chhatbar C, 2018, CELL REP, V25, P118, DOI 10.1016/j.celrep.2018.09.003
   Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006
   Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x
   Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114
   Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030
   Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004
   Farfara D, 2011, ANN NEUROL, V69, P170, DOI 10.1002/ana.22191
   Fekete R, 2018, ACTA NEUROPATHOL, V136, P461, DOI 10.1007/s00401-018-1885-0
   Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244
   George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169
   Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246
   Ginsberg SD, 2018, ANN NEUROL, V83, P406, DOI 10.1002/ana.25160
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222
   Gras G, 2003, BRAIN PATHOL, V13, P211
   Grassi MP, 1998, CLIN INFECT DIS, V27, P504, DOI 10.1086/514682
   Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001
   Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408
   Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023
   Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007
   Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002
   Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030
   Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996
   Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lokensgard JR, 2001, J NEUROVIROL, V7, P208
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo HL, 2018, J CLIN INVEST, V128, P4980, DOI [10.1172/jci99902, 10.1172/JCI99902]
   Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Morris O, 2016, CELL HOST MICROBE, V20, P283, DOI 10.1016/j.chom.2016.08.003
   Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647
   Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14
   Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393
   Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309
   Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923
   Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348
   Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918
   Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008
   Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003
   Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Sperlagh B, 2007, PURINERG SIGNAL, V3, P117, DOI 10.1007/s11302-006-9043-x
   Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611
   Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804
   Troscher AR, 2019, ACTA NEUROPATHOL, V137, P619, DOI 10.1007/s00401-019-01958-5
   Tyler KL, 2018, NEW ENGL J MED, V379, P557, DOI 10.1056/NEJMra1708714
   Tzeng NS, 2018, NEUROTHERAPEUTICS, V15, P417, DOI 10.1007/s13311-018-0611-x
   Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158
   Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086
   Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003
   Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948
   Wheeler DL, 2018, J CLIN INVEST, V128, P931, DOI 10.1172/JCI97229
   Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822
   Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111
   Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477
   Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003
NR 100
TC 6
Z9 6
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD APR 9
PY 2019
VL 16
AR 76
DI 10.1186/s12974-019-1443-2
PG 12
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA HT7PD
UT WOS:000464756000001
PM 30967139
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Siddique, R
   Liu, Y
   Nabi, G
   Sajjad, W
   Xue, MZ
   Khan, S
AF Siddique, Rabeea
   Liu, Yang
   Nabi, Ghulam
   Sajjad, Wasim
   Xue, Mengzhou
   Khan, Suliman
TI Zika Virus Potentiates the Development of Neurological Defects and
   Microcephaly: Challenges and Control Strategies
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE Zika virus; emerging infection; microcephaly; neurological disorders;
   public health
ID CHRONIC HEPATITIS-B; INFECTION; BRAIN; TRANSMISSION; PREGNANCY; BRAZIL;
   ASSOCIATION; EPIDEMIOLOGY; ENTECAVIR; ORGANOIDS
AB Since the beginning of the Zika Virus (ZIKV) epidemic, thousands of cases presenting ZIKV symptoms were recorded in Brazil, Colombia (South America), French Polynesia and other countries of Central and North America. In Brazil, during ZIKV outbreak thousands of microcephaly cases occurred that caused a state of urgency among scientists and researchers to confirm the suspected association between ZIKV infection and microcephaly. In this review article we comprehensively studied scientific literature to analyze ZIKV relationship with microcephaly, recent experimental studies, challenge and shortcomings in previously published reports to know about the current status of this association. The evidences supporting the association of ZIKV infection with congenital microcephaly and fetal brain tissue damage is rapidly increasing, and supplying recent information about pathology, clinical medicine, epidemiology, mechanism and experimental studies. However, serious attention is required toward ZIKV vaccine development, standardization of anthropometric techniques, centralization of data, and advance research to clearly understand the mechanism of ZIKV infection causing microcephaly.
C1 [Siddique, Rabeea; Liu, Yang; Xue, Mengzhou; Khan, Suliman] Zhengzhou Univ, Henan Med Key Lab Translat Cerebrovasc Dis, Zhengzhou, Henan, Peoples R China.
   [Siddique, Rabeea; Liu, Yang; Xue, Mengzhou; Khan, Suliman] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou, Henan, Peoples R China.
   [Nabi, Ghulam; Khan, Suliman] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.
   [Nabi, Ghulam; Sajjad, Wasim] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Sajjad, Wasim] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Petr Resources, Gansu Prov Key Lab Petr Resources Res, Lanzhou, Gansu, Peoples R China.
RP Xue, MZ; Khan, S (corresponding author), Zhengzhou Univ, Henan Med Key Lab Translat Cerebrovasc Dis, Zhengzhou, Henan, Peoples R China.; Xue, MZ; Khan, S (corresponding author), Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou, Henan, Peoples R China.; Khan, S (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.
EM xuemengzhou@zzu.edu.cn; suliman.khan18@mails.ucas.ac.cn
RI khan, suliman/S-3492-2017
OI Khan, Suliman/0000-0003-4954-0748
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471174, 81520108011, 81870942]; National Key
   Research and Development Program of China [2018YFC1312200]; Innovation
   Scientists and Technicians Troop Constructions Projects of Henan
   Province of China
FX This research was funded by the National Natural Science Foundation of
   China (grants no: 81471174, 81520108011, and 81870942), National Key
   Research and Development Program of China (grant no: 2018YFC1312200),
   and Innovation Scientists and Technicians Troop Constructions Projects
   of Henan Province of China for MX.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Baid R, 2017, J POSTGRAD MED, V63, P206, DOI 10.4103/jpgm.JPGM_80_17
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bovier PA, 2008, EXPERT REV VACCINES, V7, P1141, DOI 10.1586/14760584.7.8.1141
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herzog CP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/34/343001
   Herzog E, 2009, TOXICOL APPL PHARM, V236, P276, DOI 10.1016/j.taap.2009.02.007
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Islan GA, 2017, ACTA TROP, V170, P16, DOI 10.1016/j.actatropica.2017.02.019
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Khan S, 2016, INT J GENOMICS, DOI 10.1155/2016/2405954
   Kim KY, 2007, NANOMED-NANOTECHNOL, V3, P103, DOI 10.1016/j.nano.2006.12.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7
   Molina P, 2017, CHEM REV, V117, P9907, DOI 10.1021/acs.chemrev.6b00814
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savasta S, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0574-x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Seto WK, 2016, AM J GASTROENTEROL, V111, P1788, DOI 10.1038/ajg.2016.436
   Seto WK, 2015, GUT, V64, P667, DOI 10.1136/gutjnl-2014-307237
   Seto WK, 2014, J GASTROEN HEPATOL, V29, P1028, DOI 10.1111/jgh.12476
   Singh S, 2010, J NANOSCI NANOTECHNO, V10, P7906, DOI 10.1166/jnn.2010.3617
   Singh Y, 2017, J CONTROL RELEASE, V252, P28, DOI 10.1016/j.jconrel.2017.03.008
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weist K, 2016, Euro Surveill, V21, DOI 10.2807/1560-7917.ES.2016.21.46.30399
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 78
TC 1
Z9 1
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD APR 9
PY 2019
VL 10
AR 319
DI 10.3389/fneur.2019.00319
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HS5ZX
UT WOS:000463951100001
PM 31024421
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Halbkat, L
   Luan, K
   Cave, G
   McCord, M
   Roe, M
   DenHartog, E
   Travanty, NJ
   Apperson, CS
   West, AJ
AF Halbkat, Lilah
   Luan, Kun
   Cave, Grayson
   McCord, Marian
   Roe, Michael
   DenHartog, Emiel
   Travanty, Nicholas J.
   Apperson, Charles S.
   West, Andre J.
TI Fabric infused with a botanical repellent for protection against
   mosquitoes
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE Infused; repellent; fabric; protective; garment; insect
ID INSECT REPELLENTS; ESSENTIAL OILS
AB Mosquito resistant apparel has become increasingly sought-after due to the rise in vector-borne illnesses such as the Zika Virus, Malaria, and Dengue Fever. Botanical insect repellents have been introduced to the market for consumers that desire a natural solution involving no pesticides or added chemicals. Fabric swatches consisting of 80% nylon and 20% elastane were separately treated with an organic repellent using a patented nonwoven vessel. The fabrics were then tested for effectiveness in repelling the mosquito Aedes aegypti using an arm-in-cage assay, the most commonly used method for mosquito repellents. The repellents were also evaluated and rated by study participants according to their preference for the appeal of the scent. The treatment method is user-friendly, enabling consumers to treat their clothing with an organic insect repellent as opposed to applying a synthetic chemical to their clothing and skin. The infused fabrics showed to be effective at repelling mosquitoes for up to 8 h after repellent infusion.
C1 [Halbkat, Lilah; Luan, Kun; DenHartog, Emiel; West, Andre J.] NC State Univ, Wilson Coll Text, Dept Text & Apparel Technol & Management, Raleigh, NC USA.
   [Cave, Grayson; Roe, Michael; Travanty, Nicholas J.; Apperson, Charles S.] NC State Univ, Coll Agr & Life Sci, Raleigh, NC USA.
   [McCord, Marian] NC State Univ, Coll Nat Resources, Raleigh, NC USA.
RP Halbkat, L (corresponding author), North Carolina State Univ, Dept Text & Apparel Technol & Management, Box 8301, Raleigh, NC 27695 USA.
EM lahalbka@ncsu.edu
RI Luan, Kun/P-8531-2019
OI Luan, Kun/0000-0003-4560-6754; McCord, Marian/0000-0002-9769-6723;
   DenHartog, Emiel/0000-0002-6959-1510
FU NC State Chancellor's Innovation Fund
FX The authors thank all participants of the study for their cooperation.
   The authors would also like to thank the researchers of the NCSU
   Dearstyne Entomology Lab for providing the knowledge and facilities
   necessary to conduct mosquito testing. In addition, the authors would
   like to thank the NC State Chancellor's Innovation Fund for support and
   interest in this venture.
CR Abu-Qare AW, 2008, XENOBIOTICA, V38, P294, DOI [10.1080/00498250701813230, 10.1080/00498250701813230 ]
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Anitha T. R., 2011, BIO PHYS, V40, P5196
   Anuar AA, 2016, FASH TEXT, V3, DOI 10.1186/s40691-016-0064-y
   Bernard H. R., 2017, ANAL QUALITATIVE DAT
   CDC, 2018, ZIK VIR
   Chattopadhyay P, 2015, ACTA TROP, V147, P45, DOI 10.1016/j.actatropica.2015.03.027
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Ghayempour S, 2016, J MICROENCAPSUL, V33, P497, DOI 10.1080/02652048.2016.1216187
   Griffin BA, 2008, BIOMETRICS, V64, P337, DOI 10.1111/j.1541-0420.2007.00926.x
   Maji TK, 2009, J APPL POLYM SCI, V111, P779, DOI 10.1002/app.29001
   Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004
   SCHRECK CE, 1977, ANNU REV ENTOMOL, V22, P101, DOI 10.1146/annurev.en.22.010177.000533
   Strickman M. D., 2006, INSECT REPELLENTS PR
   West A., 2016, INT J DESIGNED OBJEC, V10, P17
   Yu SJ, 2014, TOXICOLOGY BIOCH INS
NR 16
TC 0
Z9 0
U1 4
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PD OCT 3
PY 2019
VL 110
IS 10
BP 1468
EP 1474
DI 10.1080/00405000.2019.1603576
EA APR 2019
PG 7
WC Materials Science, Textiles
SC Materials Science
GA IS7GV
UT WOS:000466670600001
DA 2020-07-08
ER

PT J
AU Zhang, XW
   Xie, XP
   Zou, J
   Xia, HJ
   Shan, C
   Chen, XW
   Shi, PY
AF Zhang, Xianwen
   Xie, Xuping
   Zou, Jing
   Xia, Hongjie
   Shan, Chao
   Chen, Xinwen
   Shi, Pei-Yong
TI Genetic and biochemical characterizations of Zika virus NS2A protein
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; flavivirus replication; virion assembly; flavivirus NS2A;
   membrane topology
ID GUILLAIN-BARRE-SYNDROME; SUBCELLULAR-LOCALIZATION; NONSTRUCTURAL
   PROTEINS; MEMBRANE TOPOLOGY; CDNA-CLONES; RNA; REPLICATION; CLEAVAGE;
   MUTATIONS; INFECTION
AB Zika virus (ZIKV) can cause devastating congenital Zika syndromes in pregnant women and Guillain-Barre syndrome in adults. Understanding the molecular mechanism of ZIKV replication is essential for antiviral and vaccine development. Here we report the structural and functional characterization of ZIKV NS2A protein. Biochemical structural probing suggests that ZIKV NS2A has a single segment that traverses the ER membrane and six segments that peripherally associate with the ER membrane. Functional analysis has defined distinct NS2A residues essential for viral RNA synthesis or virion assembly. Only the virion assembly-defective mutants, but not the RNA synthesis-defective mutants, could be rescued through trans complementation with a wide-type NS2A protein. These results suggest that the NS2A molecules in virion assembly complex could be recruited in trans, whereas the NS2A molecules in viral replication complex must be recruited in cis. Together with previous results, we propose a flavivirus assembly model where NS2A plays a central role in modulating viral structural and nonstructural proteins as well as genomic RNA during virion assembly.
C1 [Zhang, Xianwen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
   [Zhang, Xianwen; Chen, Xinwen] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Zhang, Xianwen; Xie, Xuping; Zou, Jing; Xia, Hongjie; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Chen, Xinwen] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Chen, XW (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Chen, XW (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Xie, XP; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Chen, XW (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM xuxie@utmb.edu; chenxw@wh.iov.cn; peshi@utmb.edu
RI Xia, Hongjie/M-9241-2019; Xie, Xuping/AAD-7406-2019
OI Xia, Hongjie/0000-0002-2520-7038; 
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000512]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AI127744, AI136126]; University of Texas Medical Branch [UL1TR-001439];
   John S. Dunn Foundation; Amon G. Carter Foundation; Summerfield Robert
   Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
FX This work was supported by Centers for Disease Control and Prevention
   [grant number U01CK000512]; National Institutes of Health [grant number
   AI127744, AI136126, u19AI142759]; University of Texas Medical Branch
   [grant number UL1TR-001439]; the John S. Dunn Foundation, the Amon G.
   Carter Foundation, the Summerfield Robert Foundation, and the Robert J.
   Kleberg, Jr. and Helen C. Kleberg Foundation.
CR Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12
   Vossmann S, 2015, J VIROL, V89, P4951, DOI 10.1128/JVI.03351-14
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Wu RH, 2017, J VIROL, V91, DOI [10.1128/JVI.01836-16, 10.1128/jvi.01836-16]
   Wu RH, 2015, J VIROL, V89, P4281, DOI 10.1128/JVI.03011-14
   Xia HJ, 2018, ACS INFECT DIS, V4, P656, DOI 10.1021/acsinfecdis.8b00004
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
NR 57
TC 6
Z9 6
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 8
PY 2019
VL 8
IS 1
BP 585
EP 602
DI 10.1080/22221751.2019.1598291
PG 18
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HS4FT
UT WOS:000463818100002
PM 30958095
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lin, XM
   Wu, MY
   Wang, WB
   Gao, YH
   Zhang, W
   Wu, D
   Wu, YN
   Zhou, XM
   Li, G
AF Lin, Xuemei
   Wu, Maoyong
   Wang, Wenbiao
   Gao, Yuhang
   Zhang, Wei
   Wu, De
   Wu, Yina
   Zhou, Xiaoming
   Li, Geng
TI Visual detection of Zika virus by isothermal nucleic acid amplification
   combined with a lateral-flow device
SO ANALYTICAL METHODS
LA English
DT Article
ID SENSITIVE DETECTION; INFECTION
AB The Zika virus (ZIKV) did not receive significant attention in the past until the ZIKV outbreak occurred a few years ago. It has been shown that ZIKV can trigger congenital microcephaly, Guillain-Barr ' e syndrome and other neurological syndromes. To fight against ZIKV, the efficient diagnosis of ZIKV is absolutely required; this has prompted us to establish a visual detection method for ZIKV with high accuracy and sensitivity. We applied reverse transcription loop-mediated isothermal amplification (RT-LAMP) with primers targeted to the specific conserved region of the non-structural protein 5 (NS5) gene fragment; moreover, using a lateral flow device (LFD), the detection of the ZIKA genome was completed within 1 hour in a 65 degrees C water bath. Compared with one-step real-time PCR (one-step RT-PCR), a RT-LAMP-turbidimeter, and quantitative reverse transcription PCR (RT-qPCR), our method is more convenient, sensitive, and specific, less time-consuming, and has equal detection performance. The newly developed method was evaluated for 12 clinical serum samples, and the results were consistent with the previous RT-qPCR detection results obtained by the Centers for Disease Control and Prevention of Guangdong; this supported that the developed method could be a potential solution for ZIKV diagnosis.
C1 [Lin, Xuemei; Wu, Maoyong; Zhang, Wei; Wu, Yina] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Wu, Maoyong] Qingyuan Hosp Tradit Chinese Med, Qingyuan 511500, Peoples R China.
   [Wang, Wenbiao] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
   [Wang, Wenbiao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
   [Gao, Yuhang] Guangzhou Univ Chinese Med, Sch Chinese Materia Med, Guangzhou 510006, Guangdong, Peoples R China.
   [Wu, De] Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhou, Xiaoming] South China Normal Univ, Coll Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
   [Li, Geng] Guangzhou Univ Chinese Med, Ctr Anim Expt, Guangzhou 510405, Guangdong, Peoples R China.
RP Wu, YN (corresponding author), Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.; Zhou, XM (corresponding author), South China Normal Univ, Coll Life Sci, Guangzhou 510631, Guangdong, Peoples R China.; Li, G (corresponding author), Guangzhou Univ Chinese Med, Ctr Anim Expt, Guangzhou 510405, Guangdong, Peoples R China.
EM zywyn@gzucm.edu.cn; zhouxm@scnu.edu.cn; lg@gzucm.edu.cn
OI Lin, Xuemei/0000-0001-8828-1617; Wu, Maoyong/0000-0003-4269-2108
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81803813]; Major Program of the Guangdong Natural
   Science Foundation of China [S201230006598]; Science & Technology
   Planning Project of Guangzhou [201804010029]; Science & Technology
   Planning Project of the Guangdong Province Office of Education
   [2014GKXM032]; Innovative Program of Guangzhou University of Chinese
   Medicine
FX This work was supported by the National Natural Science Foundation of
   China (No. 81803813), the Major Program of the Guangdong Natural Science
   Foundation of China (No. S201230006598), the Science & Technology
   Planning Project of Guangzhou (No. 201804010029), the Science &
   Technology Planning Project of the Guangdong Province Office of
   Education (No. 2014GKXM032), and the Innovative Program of Guangzhou
   University of Chinese Medicine (No. pdjh2016b0115).
CR Cao Z., 2016, FRONT MICROBIOL, V7
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Cui LB, 2012, J CLIN MICROBIOL, V50, P3881, DOI 10.1128/JCM.01931-12
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Ge YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069941
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hatano B, 2010, JPN J INFECT DIS, V63, P36
   Khunthong S, 2013, J VIROL METHODS, V188, P51, DOI 10.1016/j.jviromet.2012.11.041
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ma CP, 2018, CHEM COMMUN, V54, P3118, DOI 10.1039/c8cc00150b
   Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005
   Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415
   Nie K, 2013, CLIN MICROBIOL INFEC, V19, pE372, DOI 10.1111/1469-0691.12263
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 25
TC 1
Z9 1
U1 3
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PD APR 7
PY 2019
VL 11
IS 13
BP 1795
EP 1801
DI 10.1039/c8ay02715c
PG 7
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA HR1EC
UT WOS:000462870500008
DA 2020-07-08
ER

PT J
AU Wichit, S
   Hamel, R
   Zanzoni, A
   Diop, F
   Cribier, A
   Talignani, L
   Diack, A
   Ferraris, P
   Liegeois, F
   Urbach, S
   Ekchariyawat, P
   Merits, A
   Yssel, H
   Benkirane, M
   Misse, D
AF Wichit, Sineewanlaya
   Hamel, Rodolphe
   Zanzoni, Andreas
   Diop, Fode
   Cribier, Alexandra
   Talignani, Loic
   Diack, Abibatou
   Ferraris, Pauline
   Liegeois, Florian
   Urbach, Serge
   Ekchariyawat, Peeraya
   Merits, Andres
   Yssel, Hans
   Benkirane, Monsef
   Misse, Dorothee
TI SAMHD1 Enhances Chikungunya and Zika Virus Replication in Human Skin
   Fibroblasts
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE SAMHD1; arbovirus; Chikungunya; Zika; IFIT; SILAC
ID RESTRICTION FACTOR SAMHD1; INDUCIBLE PROTEIN; IDENTIFICATION; GENE;
   TRANSMISSION; INFECTION; CELLS; P56; MACROPHAGES; INHIBITION
AB Chikungunya virus (CHIKV) and Zika virus (ZIKV) are emerging arboviruses that pose a worldwide threat to human health. Currently, neither vaccine nor antiviral treatment to control their infections is available. As the skin is a major viral entry site for arboviruses in the human host, we determined the global proteomic profile of CHIKV and ZIKV infections in human skin fibroblasts using Stable Isotope Labelling by Amino acids in Cell culture (SILAC)-based mass-spectrometry analysis. We show that the expression of the interferon-stimulated proteins MX1, IFIT1, IFIT3 and ISG15, as well as expression of defense response proteins DDX58, STAT1, OAS3, EIF2AK2 and SAMHD1 was significantly up-regulated in these cells upon infection with either virus. Exogenous expression of IFITs proteins markedly inhibited CHIKV and ZIKV replication which, accordingly, was restored following the abrogation of IFIT1 or IFIT3. Overexpression of SAMHD1 in cutaneous cells, or pretreatment of cells with the virus-like particles containing SAMHD1 restriction factor Vpx, resulted in a strong increase or inhibition, respectively, of both CHIKV and ZIKV replication. Moreover, silencing of SAMHD1 by specific SAMHD1-siRNA resulted in a marked decrease of viral RNA levels. Together, these results suggest that IFITs are involved in the restriction of replication of CHIKV and ZIKV and provide, as yet unreported, evidence for a proviral role of SAMHD1 in arbovirus infection of human skin cells.
C1 [Wichit, Sineewanlaya] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Salaya 73170, Nakhon Pathom, Thailand.
   [Hamel, Rodolphe; Diop, Fode; Talignani, Loic; Diack, Abibatou; Ferraris, Pauline; Liegeois, Florian; Misse, Dorothee] UM1, CNRS, UMR IRD 224, Lab MIVEGEC, F-34394 Montpellier, France.
   [Zanzoni, Andreas] Aix Marseille Univ, Inserm, TAGC UMR S1090, F-13288 Marseille, France.
   [Cribier, Alexandra; Benkirane, Monsef] Univ Montpellier, Inst Genet Humaine, CNRS, UMR 9002, F-34090 Montpellier, France.
   [Urbach, Serge] Inst Genet Fonct, Funct Prote Platform, F-34090 Montpellier, France.
   [Ekchariyawat, Peeraya] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10400, Thailand.
   [Merits, Andres] Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.
   [Yssel, Hans] UPMC, Sorbonne Univ, Ctr Immunol & Malad Infect, Hop Pitie Salpetriere,APHP,Inserm,U1135, F-75013 Paris, France.
RP Wichit, S (corresponding author), Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Salaya 73170, Nakhon Pathom, Thailand.; Misse, D (corresponding author), UM1, CNRS, UMR IRD 224, Lab MIVEGEC, F-34394 Montpellier, France.
EM sineewanlaya.wic@mahidol.ac.th; rodolphe.hamel@ird.fr;
   andreas.zanzoni@inserm.fr; fodediop@hotmail.com;
   alexandra.cribier@igh.cnrs.fr; loic.talignani@ird.fr; diack89@yahoo.fr;
   pauline.ferraris@ird.fr; florian.liegeois@ird.fr;
   serge.urbach@fpp.cnrs.fr; peeraya.ekc@mahidol.ac.th;
   andres.merits@ut.ee; hans.yssel@inserm.fr; monsef.benkirane@igh.cnrs.fr;
   dorothee.misse@ird.fr
RI Zanzoni, Andreas/I-1664-2019; Ferraris, Pauline/F-9077-2017; Merits,
   Andres/H-3125-2015; Hamel, Rodolphe/AAG-1714-2020; Yssel,
   Hans/C-6406-2009; Misse, Dorothee/A-7590-2012; Liegeois,
   Florian/D-3798-2013
OI Zanzoni, Andreas/0000-0002-4818-6161; Ferraris,
   Pauline/0000-0002-8796-3074; Merits, Andres/0000-0001-8193-0071; Hamel,
   Rodolphe/0000-0001-8603-7039; Yssel, Hans/0000-0001-7454-1836; Misse,
   Dorothee/0000-0002-6485-3841; Wichit, Sineewanlaya/0000-0001-8265-0936;
   Liegeois, Florian/0000-0003-1048-0661
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-14-CE14-0029, 15CE15-00028]; European Union's Horizon 2020 research
   and innovation programme under ZIKAlliance grant [734548]; Mahidol
   University [A39/2561]; Thailand Research FundThailand Research Fund
   (TRF) [MRG6280009]; French National Research Agency under the
   "Investissements d'avenir" programmeFrench National Research Agency
   (ANR) [ANR-16-IDEX-0006]
FX This work was funded by the Agence Nationale de la Recherche (grant
   ANR-14-CE14-0029 and 15CE15-00028), the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement No.
   734548, Mahidol University (A39/2561) and Thailand Research Fund
   (MRG6280009). This work was also publicly funded through the French
   National Research Agency under the "Investissements d'avenir" programme
   with the reference ANR-16-IDEX-0006.
CR Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800
   Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6
   Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115
   Chen ZM, 2014, BIOCHEM BIOPH RES CO, V450, P1462, DOI 10.1016/j.bbrc.2014.07.023
   Choi J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0174-4
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623
   Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2
   Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481
   Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195
   Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200
   Issac THK, 2014, J PROTEOMICS, V108, P445, DOI 10.1016/j.jprot.2014.06.003
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13
   Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117
   Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pellot A S, 2012, Med Trop (Mars), V72 Spec No, P88
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628
   Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16
   Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378
   Reynaud JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004863
   Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626
   Saikia P, 2010, J VIROL, V84, P13036, DOI 10.1128/JVI.01194-10
   Schmeisser H, 2010, J VIROL, V84, P10671, DOI 10.1128/JVI.00818-10
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241
   Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029
   Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019
NR 53
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR 5
PY 2019
VL 20
IS 7
AR 1695
DI 10.3390/ijms20071695
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HU0QT
UT WOS:000464976400003
PM 30959732
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nutho, B
   Mulholland, AJ
   Rungrotmongkol, T
AF Nutho, Bodee
   Mulholland, Adrian J.
   Rungrotmongkol, Thanyada
TI Quantum Mechanics/Molecular Mechanics (QM/MM) Calculations Support a
   Concerted Reaction Mechanism for the Zika Virus NS2B/NS3 Serine Protease
   with Its Substrate
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID DENSITY-FUNCTIONAL THEORY; PLESSET PERTURBATION-THEORY; NS2B-NS3
   PROTEASE; MOLECULAR-DYNAMICS; NS3 PROTEASE; AB-INITIO; PEPTIDE
   INHIBITORS; CRYSTAL-STRUCTURE; REACTION BARRIERS; ENZYME CATALYSIS
AB Zika virus (ZIKV) is mainly transmitted to humans by Aedes species mosquitoes and is associated with serious pathological disorders including microcephaly in newborns and Guillain-Barre syndrome in adults. Currently, there is no vaccine or anti-ZIKV drug available for preventing or controlling ZIKV infection. An attractive drug target for ZIKV treatment is a two-compartment (NS2B/NS3) serine protease that processes viral polyprotein during infection. Here, conventional molecular dynamics simulations of the ZIKV protease in complex with peptide substrate (TGKRS) sequence at the C-terminus of NS2B show that the substrate is in the active conformation for the cleavage reaction by ZIKV protease. Hybrid quantum mechanics/molecular mechanics (QM/MM) umbrella sampling simulations (PM6/ff14SB) of acylation results reveal that proton transfer from S135 to H51 and nucleophilic attack on the substrate by S135 are concerted. The rate-limiting step involves the formation of a tetrahedral intermediate. In addition, the single-point energy QM/MM calculations, precisely at the level of coupled cluster theory (LCCSD(T)/(aug)-cc-pVTZ), were performed to correct the potential energy profiles for the first step of the acylation process. The average computed activation barrier at this level of theory is 16.3 kcal mol(-1). Therefore, the computational approaches presented here are helpful for further designing of NS2B/NS3 inhibitors based on transition-state analogues.
C1 [Nutho, Bodee] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Unit, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.
   [Mulholland, Adrian J.] Univ Bristol, Sch Chem, Ctr Computat Chem, Bristol BS8 1TS, Avon, England.
RP Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Unit, Bangkok 10330, Thailand.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Fac Sci, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.; Mulholland, AJ (corresponding author), Univ Bristol, Sch Chem, Ctr Computat Chem, Bristol BS8 1TS, Avon, England.
EM adrian.mulholland@bristol.ac.uk; thanyada.r@chula.ac.th
OI Rungrotmongkol, Thanyada/0000-0002-7402-3235; Mulholland,
   Adrian/0000-0003-1015-4567
FU Rachadaphiseksomphot Endowment Fund, Chulalongkorn University (CU);
   Royal Golden Jubilee Ph.D. ProgramThailand Research Fund (TRF)
   [PHD/0020/2558]; 90th Anniversary of CU (Rachadaphiseksomphot Endowment
   Fund); Research Chair Grant, the National Science and Technology
   Development Agency (NSTDA), Thailand; EPSRCEngineering & Physical
   Sciences Research Council (EPSRC) [EP/M022609/1]
FX This research was supported by the Rachadaphiseksomphot Endowment Fund,
   Chulalongkorn University (CU). B.N. is thankful for the Royal Golden
   Jubilee Ph.D. Program (PHD/0020/2558) for Ph.D. scholarship and the 90th
   Anniversary of CU (Rachadaphiseksomphot Endowment Fund) for research
   funding. We also thank the Research Chair Grant, the National Science
   and Technology Development Agency (NSTDA), Thailand. A.J.M. thanks EPSRC
   for support (grant number EP/M022609/1)
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Amaro RE, 2018, NAT REV CHEM, V2, DOI 10.1038/s41570-018-0148
   Antony J, 2007, J PHYS CHEM A, V111, P4862, DOI 10.1021/jp070589p
   Antony J, 2011, J PHYS CHEM A, V115, P11210, DOI 10.1021/jp203963f
   AQVIST J, 1990, J PHYS CHEM-US, V94, P8021
   Bandyopadhyay A, 2016, CURR OPIN CHEM BIOL, V34, P110, DOI 10.1016/j.cbpa.2016.08.011
   Beadle BM, 2002, STRUCTURE, V10, P413, DOI 10.1016/S0969-2126(02)00725-6
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   BENDER ML, 1964, J AM CHEM SOC, V86, P3714, DOI 10.1021/ja01072a021
   Bentzien J, 1998, J PHYS CHEM B, V102, P2293, DOI 10.1021/jp973480y
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   BLOW DM, 1976, ACCOUNTS CHEM RES, V9, P145, DOI 10.1021/ar50100a004
   BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0
   Callegari D, 2018, CHEM SCI, V9, P2740, DOI 10.1039/c7sc04761d
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Case D. A., 2016, AMBER 16
   Chappell KJ, 2008, J GEN VIROL, V89, P1010, DOI 10.1099/vir.0.83447-0
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   CHRISTENSEN U, 1979, BIOCHIM BIOPHYS ACTA, V569, P177, DOI 10.1016/0005-2744(79)90052-4
   Chudyk EI, 2014, CHEM COMMUN, V50, P14736, DOI 10.1039/c4cc06495j
   Claeyssens F, 2006, ANGEW CHEM INT EDIT, V45, P6856, DOI 10.1002/anie.200602711
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DAGGETT V, 1991, J AM CHEM SOC, V113, P8926, DOI 10.1021/ja00023a047
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dhoke GV, 2015, ACS CATAL, V5, P3207, DOI 10.1021/cs501524k
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DiLabio GA, 2013, PHYS CHEM CHEM PHYS, V15, P12821, DOI 10.1039/c3cp51559a
   Docquier JD, 2018, DRUG RESIST UPDATE, V36, P13, DOI 10.1016/j.drup.2017.11.002
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605
   Fritz RA, 2018, BIOCHEMISTRY-US, V57, P3560, DOI 10.1021/acs.biochem.8b00480
   Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172
   Gkionis K, 2009, J MOL MODEL, V15, P1051, DOI 10.1007/s00894-009-0459-4
   Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Grimme S, 2003, J CHEM PHYS, V118, P9095, DOI 10.1063/1.1569242
   Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759
   Guo HB, 2005, J AM CHEM SOC, V127, P15662, DOI 10.1021/ja0520565
   Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364
   HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Helgaker T, 2004, J PHYS ORG CHEM, V17, P913, DOI 10.1002/poc.841
   Ishida T, 2003, J AM CHEM SOC, V125, P12035, DOI 10.1021/ja021369m
   Jindal G, 2016, J PHYS CHEM B, V120, P9913, DOI 10.1021/acs.jpcb.6b07203
   Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l
   Korth M, 2011, J CHEM THEORY COMPUT, V7, P2929, DOI 10.1021/ct200434a
   Korth M, 2010, J CHEM THEORY COMPUT, V6, P3808, DOI 10.1021/ct100408b
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745
   LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002
   Lawan N, 2014, CHEM PHYS LETT, V608, P380, DOI 10.1016/j.cplett.2014.06.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lima MCP, 2016, PHYS CHEM CHEM PHYS, V18, P30288, DOI 10.1039/c6cp03209e
   Lonsdale R, 2012, J CHEM THEORY COMPUT, V8, P4637, DOI 10.1021/ct300329h
   Lonsdale R, 2010, J PHYS CHEM LETT, V1, P3232, DOI 10.1021/jz101279n
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Metz S, 2014, WIRES COMPUT MOL SCI, V4, P101, DOI 10.1002/wcms.1163
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   Nemukhin AV, 2004, THEOR CHEM ACC, V111, P36, DOI 10.1007/s00214-003-0556-x
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Pan QW, 2012, WORLD J GASTROENTERO, V18, P6183, DOI 10.3748/wjg.v18.i43.6183
   Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614
   PERONA JJ, 1995, PROTEIN SCI, V4, P337
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PHILIPP M, 1983, MOL CELL BIOCHEM, V51, P5, DOI 10.1007/BF00215583
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   PIPEK J, 1989, J CHEM PHYS, V90, P4916, DOI 10.1063/1.456588
   Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x
   PULAY P, 1983, CHEM PHYS LETT, V100, P151, DOI 10.1016/0009-2614(83)80703-9
   Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899
   RAGHAVACHARI K, 1989, CHEM PHYS LETT, V157, P479, DOI 10.1016/S0009-2614(89)87395-6
   Ranaghan KE, 2017, J PHYS CHEM B, V121, P9785, DOI 10.1021/acs.jpcb.7b06892
   Reuter N, 2000, J PHYS CHEM A, V104, P1720, DOI 10.1021/jp9924124
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Rodriguez A, 2007, J PHYS CHEM B, V111, P12909, DOI 10.1021/jp0743469
   Rodriguez A, 2010, PHYS CHEM CHEM PHYS, V12, P8001, DOI 10.1039/c002116d
   ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I
   Rungrotmongkol T, 2009, PROTEINS, V76, P62, DOI 10.1002/prot.22318
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742
   Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684
   Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019
   Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Skorenski M, 2016, FUTURE VIROL, V11, P745, DOI 10.2217/fvl-2016-0106
   Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4
   STEIN RL, 1985, J AM CHEM SOC, V107, P5767, DOI 10.1021/ja00306a026
   Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4
   Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473
   van der Kamp MW, 2013, BIOCHEMISTRY-US, V52, P2708, DOI 10.1021/bi400215w
   van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t
   Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807
   WARSHEL A, 1986, J AM CHEM SOC, V108, P6569, DOI 10.1021/ja00281a021
   WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82
   Werner HJ, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3641642
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008
   Yu WB, 2009, J COMPUT CHEM, V30, P589, DOI 10.1002/jcc.21091
   ZERNER B, 1964, J AM CHEM SOC, V86, P3669, DOI 10.1021/ja01072a015
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao Y, 2005, J CHEM THEORY COMPUT, V1, P415, DOI 10.1021/ct049851d
   Zhao Y, 2005, J PHYS CHEM A, V109, P2012, DOI 10.1021/jp045141s
   Zhou YZ, 2011, CHEM COMMUN, V47, P1577, DOI 10.1039/c0cc04112b
NR 133
TC 3
Z9 3
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD APR 4
PY 2019
VL 123
IS 13
BP 2889
EP 2903
DI 10.1021/acs.jpcb.9b02157
PG 15
WC Chemistry, Physical
SC Chemistry
GA HS4PB
UT WOS:000463844200016
PM 30845796
DA 2020-07-08
ER

PT J
AU Lei, J
   Vermillion, MS
   Jia, B
   Xie, H
   Xie, L
   Mclane, MW
   Sheffield, JS
   Pekosz, A
   Brown, A
   Klein, SL
   Burd, I
AF Lei, Jun
   Vermillion, Meghan S.
   Jia, Bei
   Xie, Han
   Xie, Li
   Mclane, Michael W.
   Sheffield, Jeanne S.
   Pekosz, Andrew
   Brown, Amanda
   Klein, Sabra L.
   Burd, Irina
TI IL-1 receptor antagonist therapy mitigates placental dysfunction and
   perinatal injury following Zika virus infection
SO JCI INSIGHT
LA English
DT Article
ID MOUSE MODEL; BRAIN-INJURY; INTRAUTERINE INFLAMMATION; TROPHOBLAST
   INVASION; SEXUAL TRANSMISSION; PRETERM BIRTH; MURINE MODEL; FETAL;
   CELLS; INTERLEUKIN-1-BETA
AB Zika virus (ZIKV) infection during pregnancy causes significant adverse sequelae in the developing fetus, and results in long-term structural and neurologic defects. Most preventive and therapeutic efforts have focused on the development of vaccines, antivirals, and antibodies. The placental immunologic response to ZIKV, however, has been largely overlooked as a target for therapeutic intervention. The placental inflammatory response, specifically IL-1 beta secretion and signaling, is induced by ZIKV infection and represents an environmental factor that is known to increase the risk of perinatal developmental abnormalities. We show in a mouse model that maternally administrated IL-1 receptor antagonist (IRA; Kineret, or anakinra), following ZIKV exposure, can preserve placental function (by improving trophoblast invasion and placental vasculature), increase fetal viability, and reduce neurobehavioral deficits in the offspring. We further demonstrate that while ZIKV RNA is highly detectable in placentas, it is not correlated with fetal viability. Beyond its effects in the placenta. we show that IL-1 blockade may also directly decrease fetal neuroinflammation by mitigating fetal microglial activation in a dose-dependent manner. Our studies distinguish the role of placental inflammation during ZIKV-infected pregnancies, and demonstrate that maternal IRA may attenuate fetal neuroinflammation and improve perinatal outcomes.
C1 [Lei, Jun; Jia, Bei; Xie, Han; Xie, Li; Mclane, Michael W.; Sheffield, Jeanne S.; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Baltimore, MD 21287 USA.
   [Vermillion, Meghan S.; Pekosz, Andrew; Klein, Sabra L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 North Wolfe St,Room W2118, Baltimore, MD 21205 USA.
   [Vermillion, Meghan S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21287 USA.
   [Brown, Amanda; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
   [Klein, Sabra L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.
RP Klein, SL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 North Wolfe St,Room W2118, Baltimore, MD 21205 USA.; Burd, I (corresponding author), Johns Hopkins Univ, Sch Med, Integrated Res Ctr Fetal Med, 600 North Wolfe St,Phipps 217, Baltimore, MD 21287 USA.; Burd, I (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, 600 North Wolfe St,Phipps 217, Baltimore, MD 21287 USA.
EM Sklein2@jhu.edu; Iburd@jhmi.edu
OI Klein, Sabra/0000-0002-0730-5224; Brown, Amanda/0000-0002-4576-9636
FU Integrated Research Center for Fetal Medicine; Sheikh Abdullah Bugshan
   Fund; Sherrilyn and Ken Fisher Center for Environmental Infectious
   Diseases; ABOG/AAOGF Bridge Fund; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01HD097608,
   T32 OD011089]
FX The authors thank the expert animal care staff at Johns Hopkins for
   assistance with maintenance of ZIKV-infected dams in our facilities.
   This work was supported by the Integrated Research Center for Fetal
   Medicine (IB), Sheikh Abdullah Bugshan Fund (IB), Sherrilyn and Ken
   Fisher Center for Environmental Infectious Diseases (SLK), ABOG/AAOGF
   Bridge Fund (IB), NIH R01HD097608 (IB and SK), and NIH T32 OD011089
   Training Veterinarians for Careers in Biomedical Research (MSV).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Akash MSH, 2013, PHARM RES-DORDR, V30, P2951, DOI 10.1007/s11095-013-1118-0
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Beloosesky R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.032
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Chow KH, 2016, JOVE-J VIS EXP, DOI 10.3791/53643
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897
   Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014
   Dayton ET, 1996, J NEUROIMMUNOL, V71, P11, DOI 10.1016/S0165-5728(96)00111-7
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003
   Geusens N, 2010, PLACENTA, V31, P320, DOI 10.1016/j.placenta.2010.01.011
   Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gozes I, 2007, NEUROPEPTIDE TECHNIQ
   Huang SJ, 2008, J PATHOL, V214, P328, DOI 10.1002/path.2257
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumral A, 2007, NEONATOLOGY, V92, P269, DOI 10.1159/000105493
   Lamhot VB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.042
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei J, 2018, REPROD SCI, V25, P1175, DOI 10.1177/1933719117734321
   Lei J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12798
   Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li LP, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134627
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Liu JSH, 1998, J IMMUNOL, V161, P1989
   Lockwood CJ, 2011, SEMIN THROMB HEMOST, V37, P158, DOI 10.1055/s-0030-1270344
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   McKenney SL, 2016, CARDIOL YOUNG, V26, P1282, DOI 10.1017/S1047951115002346
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Migale R, 2015, AM J PATHOL, V185, P2390, DOI 10.1016/j.ajpath.2015.05.015
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nadeau-Vallee M, 2017, J IMMUNOL, V198, P2047, DOI 10.4049/jimmunol.1601600
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Novak CM, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12842
   O'Tierney-Ginn P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.031
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Pan American Health Organization/ WHO, ZIK CAS CONG SYNDR A
   Parmentier JH, 1997, BIOCHEM PHARMACOL, V54, P889, DOI 10.1016/S0006-2952(97)00256-6
   PILLAY V, 1993, PFLUG ARCH EUR J PHY, V424, P549, DOI 10.1007/BF00374921
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenzweig JM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00108
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savard A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0330-8
   Schaecher SR, 2007, J VIROL, V81, P718, DOI 10.1128/JVI.01691-06
   Scott LM, 2017, CYTOKINE, V99, P194, DOI 10.1016/j.cyto.2017.07.005
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2017, MBIO, V8, DOI 10.1128/mBio.00916-17
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Stigger F, 2013, INT J DEV NEUROSCI, V31, P820, DOI 10.1016/j.ijdevneu.2013.10.003
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsimis ME, 2017, BIOL REPROD, V97, P230, DOI 10.1093/biolre/iox081
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 94
TC 6
Z9 6
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD APR 4
PY 2019
VL 4
IS 7
AR e122678
DI 10.1172/jci.insight.122678
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HR7ZS
UT WOS:000463374500001
PM 30944243
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhan, QY
   Zhang, ZF
AF Zhan, Qingyi
   Zhang, Zhifang
TI Numerical Study on Zika Epidemic Early Warning Algorithms Driven by
   Dynamical Network Biomarker
SO DISCRETE DYNAMICS IN NATURE AND SOCIETY
LA English
DT Article
AB This paper focuses on the numerical study and precise forecast of Zika epidemic. An early warning index algorithm of Zika epidemic is given, and the applications of this algorithm are investigated. We pay attention to the mathematical approaches to estimate the tendency of Zika epidemic in detail. A numerical experiment is provided to illustrate the effectiveness of the proposed method by the numerical calculation of early warning index of Brazil.
C1 [Zhan, Qingyi] Fujian Agr & Forestry Univ, Coll Comp & Informat Sci, Fuzhou 350002, Peoples R China.
   [Zhang, Zhifang] Fujian Ctr Dis Control & Prevent, Dept Sci & Educ, Fuzhou 350001, Fujian, Peoples R China.
RP Zhang, ZF (corresponding author), Fujian Ctr Dis Control & Prevent, Dept Sci & Educ, Fuzhou 350001, Fujian, Peoples R China.
EM zhangzf1981@163.com
RI Zhan, Qingyi/AAH-8800-2020; Zhan, Qingyi/AAD-1038-2019
FU Science Research Projection of the Education Department of Fujian
   Province [JAT180122]; Natural Science Foundation of Fujian
   ProvinceNatural Science Foundation of Fujian Province [2015J01019];
   Education Reform Foundation of Fujian Agriculture and Forestry
   University [111418136]
FX This work is supported by the Science Research Projection of the
   Education Department of Fujian Province, No. JAT180122, the Natural
   Science Foundation of Fujian Province, No. 2015J01019, and the Education
   Reform Foundation of Fujian Agriculture and Forestry University, No.
   111418136.
CR Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carlson C. J., 2018, SCI REPORTS, V8, P1
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342
   Dahlem MA, 2015, CEPHALALGIA, V35, P627, DOI 10.1177/0333102414550108
   Barbeiro FMD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005568
   Golub GH, 2013, J HOPKINS STUDIES MA
   Lesterhuis WJ, 2017, NAT REV DRUG DISCOV, V16, P264, DOI 10.1038/nrd.2016.233
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Wang P, 2015, COMPUT APPL MATH, V34, P773, DOI 10.1007/s40314-014-0140-0
   Wang TC, 2011, J COMPUT APPL MATH, V235, P4237, DOI 10.1016/j.cam.2011.03.019
   Xie XD, 2009, NONLINEAR ANAL-THEOR, V70, P4217, DOI 10.1016/j.na.2008.09.017
   Zhan Q., 2018, DISCRETE DYN NAT SOC, V2018
   Zhan Q., 2015, ADV DIFFER EQU-NY, V292, P1
   Zhan Q., 2017, J NONLINEAR SCI APPL, V10, P5552
   Zhan QY, 2016, J NONLINEAR SCI APPL, V9, P2006
   Zhan QY, 2009, ABSTR APPL ANAL, DOI 10.1155/2009/187021
NR 20
TC 1
Z9 1
U1 3
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1026-0226
EI 1607-887X
J9 DISCRETE DYN NAT SOC
JI Discrete Dyn. Nat. Soc.
PD APR 3
PY 2019
VL 2019
AR 2092151
DI 10.1155/2019/2092151
PG 5
WC Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences
SC Mathematics; Science & Technology - Other Topics
GA IS4HL
UT WOS:000482114200001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mekonnen, ZA
   Grubor-Bauk, B
   Masavuli, MG
   Shrestha, AC
   Ranasinghe, C
   Bull, RA
   Lloyd, AR
   Gowans, EJ
   Wijesundara, DK
AF Mekonnen, Zelalem A.
   Grubor-Bauk, Branka
   Masavuli, Makutiro G.
   Shrestha, Ashish C.
   Ranasinghe, Charani
   Bull, Rowena A.
   Lloyd, Andrew R.
   Gowans, Eric J.
   Wijesundara, Danushka K.
TI Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis
   C Virus: Approaches to Elicit Localized Immunity for Protection
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE DNA vaccine; hepatitis C; human immunodeficiency virus; HIV/AIDS; HCV;
   tissue-resident memory; T cell immunity
ID RESIDENT MEMORY; HEALTHY-ADULTS; DOUBLE-BLIND; PLASMID DNA; ZIKA VIRUS;
   TISSUE; RESPONSES; INFECTION; VACCINATION; LIVER
AB Human immunodeficiency virus (HIV)-1 and hepatitis C virus (HCV) are major contributors to the global disease burden with many experts recognizing the requirement of an effective vaccine to bring a durable end to these viral epidemics. The most promising vaccine candidates that have advanced into pre-clinical models and the clinic to eliminate or provide protection against these chronic viruses are viral vectors [e.g., recombinant cytomegalovirus, Adenovirus, and modified vaccinia Ankara (MVA)]. This raises the question, is there a need to develop DNA vaccines against HIV-1 and HCV? Since the initial study from Wolff and colleagues which showed that DNA represents a vector that can be used to express transgenes durably in vivo, DNA has been regularly evaluated as a vaccine vector albeit with limited success in large animal models and humans. However, several recent studies in Phase I-Ilb trials showed that vaccination of patients with recombinant DNA represents a feasible therapeutic intervention to even cure cervical cancer, highlighting the potential of using DNA for human vaccinations. In this review, we will discuss the limitations and the strategies of using DNA as a vector to develop prophylactic T cell-mediated vaccines against HIV-1 and HCV. In particular, we focus on potential strategies exploiting DNA vectors to elicit protective localized CD8(+) T cell immunity in the liver for HCV and in the cervicovaginal mucosa for HIV-1 as localized immunity will be an important, if not critical component, of an efficacious vaccine against these viral infections.
C1 [Mekonnen, Zelalem A.; Grubor-Bauk, Branka; Masavuli, Makutiro G.; Shrestha, Ashish C.; Gowans, Eric J.; Wijesundara, Danushka K.] Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Virol Lab, Discipline Surg, Adelaide, SA, Australia.
   [Ranasinghe, Charani] Australian Natl Univ, John Curtin Sch Med Res, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT, Australia.
   [Bull, Rowena A.; Lloyd, Andrew R.] Univ New South Wales, Kirby Inst, Viral Immunol Syst Program, Sydney, NSW, Australia.
RP Wijesundara, DK (corresponding author), Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Virol Lab, Discipline Surg, Adelaide, SA, Australia.
EM danushka.wijesundara@adelaide.edu.au
RI Mekonnen, Zelalem Addis/X-5655-2019; Shrestha, Ashish/F-4588-2014
OI Mekonnen, Zelalem Addis/0000-0002-3705-4526; Shrestha,
   Ashish/0000-0001-5049-8351; Grubor-Bauk, Branka/0000-0002-4642-105X
FU National Health and Medical Research Council (NHMRC)National Health and
   Medical Research Council of Australia [APP1026293, APP525431, APP543139,
   APP543143]; Australian Centre for HIV and Hepatitis Virology Research;
   Hospital Research Foundation (THRF); Channel 7 Children's Research
   Foundation
FX The following grants have supported the work conducted in our
   laboratories and cited in the manuscript: From the National Health and
   Medical Research Council (NHMRC): grants APP1026293 (EG), APP525431
   (CR), APP543139 (EG), and APP543143 (EG). From the Australian Centre for
   HIV and Hepatitis Virology Research, CR and EG have received an EOI
   grant. From The Hospital Research Foundation (THRF) and the Channel 7
   Children's Research Foundation, DW received a project grant.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315
   Bailey JR, 2019, GASTROENTEROLOGY, V156, P418, DOI 10.1053/j.gastro.2018.08.060
   Bailey JR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92872
   Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001
   Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/S0140-6736(18)31364-3, 10.1016/s0140-6736(18)31364-3]
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Baumert TF, 2014, J HEPATOL, V61, pS34, DOI 10.1016/j.jhep.2014.09.009
   Belyakov IM, 2012, CURR TOP MICROBIOL, V354, P157, DOI 10.1007/82_2010_119
   Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3
   Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583
   Borgia SM, 2018, J INFECT DIS, V218, P1722, DOI 10.1093/infdis/jiy401
   Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Cafaro A, 2001, VACCINE, V19, P2862, DOI 10.1016/S0264-410X(01)00002-0
   Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225
   Cihlar T, 2016, CURR OPIN VIROL, V18, P50, DOI 10.1016/j.coviro.2016.03.004
   Cuburu N, 2018, INT J CANCER, V142, P1467, DOI 10.1002/ijc.31166
   Cuburu N, 2015, J VIROL, V89, P83, DOI 10.1128/JVI.02380-14
   Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287
   Davies B, 2017, J IMMUNOL, V198, P2233, DOI 10.4049/jimmunol.1601367
   Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548
   Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202
   GARMORY HS, 2003, GENET VACCINES THER, V1, P2, DOI DOI 10.1186/1479-0556-1-2
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718
   Gill US, 2019, GUT, V68, P1493, DOI 10.1136/gutjnl-2018-317071
   Gill US, 2018, GUT, V67, P767, DOI 10.1136/gutjnl-2017-314873
   Gola A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9128
   Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5
   Grubor-Bauk B, 2016, GENE THER, V23, P26, DOI 10.1038/gt.2015.86
   Gummow J, 2015, J VIROL, V89, P7991, DOI 10.1128/JVI.00803-15
   Gurtler L, 2016, TRANSFUS MED HEMOTH, V43, P203, DOI 10.1159/000445852
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hartnell F, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03175
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Hayton EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101591
   Holz LE, 2018, CELL REP, V25, P68, DOI 10.1016/j.celrep.2018.08.094
   Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x
   Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110
   Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803
   Jin X, 2015, VACCINE, V33, P2347, DOI 10.1016/j.vaccine.2015.03.036
   Jorritsma SHT, 2016, VACCINE, V34, P5488, DOI 10.1016/j.vaccine.2016.09.062
   Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471
   Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611
   Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299
   Kim TJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6317
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Latimer B, 2014, HUM VACC IMMUNOTHER, V10, P2357, DOI 10.4161/hv.29590
   Liu F, 2004, MOL THER, V9, P452, DOI 10.1016/j.ymthe.2003.12.003
   MacGregor RB, 2002, AIDS, V16, P2137, DOI 10.1097/00002030-200211080-00005
   MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613
   Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109
   Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867
   Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858
   McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844
   Moyo N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181382
   Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3
   Muruganandah V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01574
   Nagata T, 1999, BIOCHEM BIOPH RES CO, V261, P445, DOI 10.1006/bbrc.1999.1050
   Nganou-Makamdop K, 2012, PARASITE IMMUNOL, V34, P562, DOI 10.1111/pim.12000.x
   Okuda K, 1997, VACCINE, V15, P1049, DOI 10.1016/S0264-410X(97)00045-5
   Olsen TM, 2018, J IMMUNOL, V201, P1984, DOI 10.4049/jimmunol.1800740
   Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013
   Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115
   Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5
   Parsons MS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1483
   Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5
   Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659
   Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157
   Rosato PC, 2017, CURR OPIN VIROL, V22, P44, DOI 10.1016/j.coviro.2016.11.011
   Sacks-Davis R, 2015, J INFECT DIS, V212, P1407, DOI 10.1093/infdis/jiv220
   Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104
   Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277
   Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568
   Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522
   Shin SY, 2016, CLIN EXP VACCINE RES, V5, P6, DOI 10.7774/cevr.2016.5.1.6
   Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07
   Stone J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156213
   Sun Y, 2015, GENE THER, V22, P528, DOI 10.1038/gt.2015.17
   Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185
   Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6
   Tay SS, 2014, P NATL ACAD SCI USA, V111, pE2540, DOI 10.1073/pnas.1406674111
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tomusange K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29131
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281
   UNAIDS, 2018, MIL GO CLOS GAPS BRE
   Vanniasinkam T, 2006, VIROLOGY, V344, P412, DOI 10.1016/j.virol.2005.08.040
   Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438
   Wang HY, 2015, BIOMED RES INT, DOI 10.1155/2015/850132
   Weiland O, 2013, MOL THER, V21, P1796, DOI 10.1038/mt.2013.119
   Wijesundara DK, 2018, J VIROL, V92, DOI 10.1128/JVI.02133-17
   World Health Organization, 2017, GLOB HEP REP 2017
   Yu WB, 2014, VACCINE, V32, P3409, DOI 10.1016/j.vaccine.2014.04.014
   Zhang XQ, 2016, ACTA PHARM SIN B, V6, P26, DOI 10.1016/j.apsb.2015.09.008
NR 98
TC 1
Z9 1
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD APR 3
PY 2019
VL 9
AR 91
DI 10.3389/fcimb.2019.00091
PG 8
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HS0YG
UT WOS:000463586600002
PM 31001491
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mercaldo, RA
   Bellan, SE
AF Mercaldo, Rachel A.
   Bellan, Steven E.
TI Evaluation of alternative endpoints for ZIKV vaccine efficacy trials
SO VACCINE
LA English
DT Article
DE Zika virus; Teratogen; Clinical trial; Vaccine efficacy; Simulation
   study
ID VIRUS-INFECTION
AB Zika virus (ZIKV) infection during pregnancy is associated with microcephaly and other birth defects, collectively termed Congenital Zika Syndrome (CZS). During the epidemic in 2015-16, ZIKV spread through the Americas and quickly joined the list of other known teratogenic pathogens, TORCH. Multiple ZIKV vaccines have been developed for protection of pregnant women and women of childbearing age. However, ZIKV infection incidence has since waned substantially, and adverse birth outcomes are rare outcomes of infection. Studying a vaccine's protective efficacy against CZS in a large phase III clinical trial may be infeasible in such times of low incidence. Should trials be initiated, researchers may resort to alternative clinical endpoints.
   In this study, we simulate a variety of vaccine clinical trial scenarios to evaluate the feasibility of the CZS endpoint in vaccine studies and compare CZS to other potential outcomes: ZIKV infection detected through weekly, biweekly, or monthly testing and laboratory-confirmed, symptomatic Zika Virus Disease. We compare the sample size required for 80% statistical power to detect vaccine efficacy and trial duration for each scenario. Our results show the feasibility of CZS clinical endpoints depends on the timing of simulated clinical trials in the course of a seasonal epidemic, due to CZS risk varying with trimester of infection. This result highlights additional considerations needed when designing vaccine efficacy trials of protection against teratogenic pathogens. Published by Elsevier Ltd.
C1 [Mercaldo, Rachel A.; Bellan, Steven E.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Stellenbosch, South African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa.
RP Mercaldo, RA (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
EM mercaldo@uga.edu
OI Mercaldo, Rachel/0000-0003-2021-6020
FU National Institute of Allergy and Infectious Diseases K01 award
   [K01AI125830]
FX This work was supported by a National Institute of Allergy and
   Infectious Diseases K01 award (K01AI125830) (SEB). The authors thank
   Andreas Handel, Christopher Whalen, and Michael Welton for their time
   and comments.
CR Andersen K, 2018, ZIKA CASE NUMBERS PA
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2018, TEST GUID
   CDC, 2017, GUID EV PUBL HLTH MA, P1
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   European Union, 2014, REP CRIT RAW MAT EU, P1
   Justus CG, 1978, J APPL METEOROL, DOI [10.1175/1520-0450(1978)017<0350:MFEWSF>2.0.CO:2, DOI 10.1175/1520-0450(1978)017<0350:MFEWSF>2.0.CO:2]
   Lessler J, 2016, BIORXIV, DOI [10.1101/041913, DOI 10.1101/041913]
   Mehrjardi Mohammad Zare, 2017, Virology (Auckl), V8, p1178122X17708993, DOI [10.1177/1178122x17708993, 10.1177/1178122X17708993]
   Pan American Health Organization, 2018, COUNTR TERR AUT TRAN, P41696
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pass RF, 2014, J PEDIATR INFECT DIS, V3, pS2, DOI 10.1093/jpids/piu069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Taylor A, 2003, BRIT MED J, V327, P434, DOI 10.1136/bmj.327.7412.434
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   [United Nation Department of Economic and Social Affairs PD], 2015, TRENDS CONTR US WORL, DOI [10.1016/j.contraception.2012.08.029, DOI 10.1016/J.CONTRACEPTION.2012.08.029]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2017, WHO WORKSH M GEN
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 25
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 3
PY 2019
VL 37
IS 15
BP 2099
EP 2105
DI 10.1016/j.vaccine.2019.02.066
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HR9EW
UT WOS:000463463000008
PM 30871928
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Zhan, Y
   Deng, Y
   Huang, BY
   Song, QQ
   Wang, W
   Yang, Y
   Dai, LP
   Wang, WL
   Yan, JH
   Gao, GF
   Tan, WJ
AF Zhan, Ying
   Deng, Yao
   Huang, Baoying
   Song, Qianqian
   Wang, Wen
   Yang, Yang
   Dai, Lianpan
   Wang, Wenling
   Yan, Jinghua
   Gao, Gorge F.
   Tan, Wenjie
TI Humoral and cellular immunity against both ZIKV and poxvirus is elicited
   by a two-dose regimen using DNA and non-replicating vaccinia virus-based
   vaccine candidates
SO VACCINE
LA English
DT Article
DE Zika virus; Poxvirus; Vaccine; DNA; Non-replicating vaccinia virus;
   Immunity; Mice; T-cell epitope; Prime-boost
ID DENGUE VIRUS; IMMUNOGENICITY; ANTIBODY; ENHANCEMENT; ROBUST
AB The Zika virus (ZIKV) and poxvirus infection are considered as public health emergencies, necessitating the development of effective vaccines. Here, we report novel recombinant DNA-based and non-replicating vaccinia virus (NTV)-based vaccine candidates that express the precursor membrane-envelope (prME) or envelope (E) glycoproteins of ZIKV. After immunization of BABL/c mice with the vaccines using a homologous protocol (DNA/DNA, NTV/NTV) or heterogeneous (DNAJNTV) protocol, a similar level of anti-E IgG and neutralizing antibodies (microneutralization test) were detected in the mice. However, a significantly higher level of E-specific T cell responses was elicited in mice when a heterogeneous prime-boost protocol was used (DNA/NTV) with either the DNA-based or NTV-based vaccines. Furthermore, neutralizing antibodies and a T cell immune response against the vaccinia virus (W) were detected in mice that were subjected to the prime-boost protocol (DNA/NTV), whereas those subjected to a homologous NTV/NTV protocol had higher levels of anti-VV IgG and neutralizing antibodies. Lastly, a novel H-2d-restricted CD8 T-cell epitope, VRSYCYEASISDMAS, was identified in the ZIKV E protein. These data demonstrate proof of concept of a bivalent vaccine candidate against ZIKV and orthopoxvirus, and support the use of DNA-prME prime and NTV-E boost protocols to protect against ZIKV and orthopoxvirus infections. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhan, Ying; Song, Qianqian; Tan, Wenjie] Wenzhou Med Univ, Minist Educ, Wenzhou, Zhejiang, Peoples R China.
   [Zhan, Ying; Song, Qianqian; Tan, Wenjie] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Inst Med Virol, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China.
   [Zhan, Ying; Deng, Yao; Huang, Baoying; Song, Qianqian; Wang, Wen; Wang, Wenling; Gao, Gorge F.; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.
   [Yang, Yang; Gao, Gorge F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Guangdong, Peoples R China.
   [Dai, Lianpan; Yan, Jinghua; Gao, Gorge F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
RP Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.; Tan, WJ (corresponding author), Wenzhou Med Univ, Minist Educ, Shenzhen 325035, Zhejiang, Peoples R China.; Tan, WJ (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Inst Med Virol, Shenzhen 325035, Zhejiang, Peoples R China.
EM tanwj28@163.com
OI HUANG, Baoying/0000-0001-9516-1146
FU National Key Research and Development Program of China [2016YFD0500301,
   2016YFC1200901, 2016YFC1200200]; National Major Project for Control and
   Prevention of Infectious Disease in China [2016ZX10004001-003]
FX This work was supported by the National Key Research and Development
   Program of China (2016YFD0500301, 2016YFC1200901 and 2016YFC1200200) and
   the National Major Project for Control and Prevention of Infectious
   Disease in China (2016ZX10004001-003). The funding agencies had no role
   in the study design, data collection, data analysis, decision to
   publish, or preparation of the manuscript. We thank LetPub
   (www.letpub.com) for providing linguistic assistance during the
   preparation of this manuscript.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chen H, 2011, CLIN VACCINE IMMUNOL, V18, P1789, DOI 10.1128/CVI.05113-11
   Chuai X, 2018, VACCINE, V36, P3740, DOI 10.1016/j.vaccine.2018.05.061
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng Y, 2017, VACCINE, V35, P3347, DOI 10.1016/j.vaccine.2017.04.059
   Diamond MS, 2018, ANN REV MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033392
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Melamed S, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010008
   Perkus ME, 2010, ANN NY ACAD SCI, V754, P222
   Poon VK, 2018, J INFECT DIS
   Prow NA, 2018, EXPERT REV VACCINES, V17, P925, DOI 10.1080/14760584.2018.1522255
   Quinan BR, 2016, VACCINE, V34, P6120, DOI 10.1016/j.vaccine.2016.10.058
   Quinan BR, 2014, VACCINE, V32, P2972, DOI 10.1016/j.vaccine.2014.03.093
   Richner JM, 2017, CELL
   Roth A, 2014, EUR COMMUN DIS B, V19
   Shan C, 2017, NAT MED
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123
   Wen B, 2013, MOL THER, V21, P1787, DOI 10.1038/mt.2013.122
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
NR 42
TC 3
Z9 3
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 3
PY 2019
VL 37
IS 15
BP 2122
EP 2130
DI 10.1016/j.vaccine.2019.02.063
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HR9EW
UT WOS:000463463000010
PM 30851967
DA 2020-07-08
ER

PT J
AU Bergamaschi, G
   Fassi, EMA
   Romanato, A
   D'Annessa, I
   Odinolfi, MT
   Brambilla, D
   Damin, F
   Chiari, M
   Gori, A
   Colombo, G
   Cretich, M
AF Bergamaschi, Greta
   Fassi, Enrico M. A.
   Romanato, Alessandro
   D'Annessa, Ilda
   Odinolfi, Maria Teresa
   Brambilla, Dario
   Damin, Francesco
   Chiari, Marcella
   Gori, Alessandro
   Colombo, Giorgio
   Cretich, Marina
TI Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an
   Epitope with Flavivirus Immunodiagnostic Potential in Peptide
   Microarrays
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Dengue virus; epitope; antibody; infectious diseases; microarrays;
   diagnostics
ID MOLECULAR-DYNAMICS; LIBRARIES; PARAMETERS; MODEL; WATER
AB The mosquito-borne viral disease caused by the Dengue virus is an expanding global threat. Diagnosis in low-resource-settings and epidemiological surveillance urgently requires new immunoprobes for serological tests. Structure-based epitope prediction is an efficient method to design diagnostic peptidic probes able to reveal specific antibodies elicited in response to infections in patients' sera. In this study, we focused on the Dengue viral envelope protein (E); computational analyses ranging from extensive Molecular Dynamics (MD) simulations and energy-decomposition-based prediction of potentially immunoreactive regions identified putative epitope sequences. Interestingly, one such epitope showed internal dynamic and energetic properties markedly different from those of other predicted sequences. The epitope was thus synthesized as a linear peptide, modified for chemoselective immobilization on microarrays and used in a serological assay to discriminate Dengue-infected individuals from healthy controls. The synthetic epitope probe showed a diagnostic performance comparable to that of the full antigen in terms of specificity and sensitivity. Given the high level of sequence identity among different flaviviruses, the epitope was immune-reactive towards Zika-infected sera as well. The results are discussed in the context of the quest for new possible structure-dynamics-based rules for the prediction of the immunoreactivity of selected antigenic regions with potential pan-flavivirus immunodiagnostic capacity.
C1 [Bergamaschi, Greta; Fassi, Enrico M. A.; Romanato, Alessandro; D'Annessa, Ilda; Odinolfi, Maria Teresa; Brambilla, Dario; Damin, Francesco; Chiari, Marcella; Gori, Alessandro; Colombo, Giorgio; Cretich, Marina] CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.
   [Colombo, Giorgio] Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy.
RP Colombo, G; Cretich, M (corresponding author), CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.; Colombo, G (corresponding author), Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy.
EM gretabergamaschi@gmail.com; fassi.enrico@yahoo.it;
   alessandro.romanato@icrm.cnr.it; dnnldi00@uniroma2.it;
   tea.odinolfi@gmail.com; dario.brambilla@icrm.cnr.it;
   francesco.damin@icrm.cnr.it; marcella.chiari@icrm.cnr.it;
   alessandro.gori@icrm.cnr.it; g.colombo@unipv.it;
   marina.cretich@icrm.cnr.it
RI BERGAMASCHI, Greta/AAK-1164-2020; Gori, Alessandro/A-1357-2019;
   Brambilla, Dario/V-8812-2019; Colombo, Giorgio/A-2730-2012
OI BERGAMASCHI, Greta/0000-0002-4501-4057; Gori,
   Alessandro/0000-0003-1640-7238; Brambilla, Dario/0000-0003-3490-4481;
   Colombo, Giorgio/0000-0002-1318-668X; Romanato,
   Alessandro/0000-0002-1651-5338; Cretich, Marina/0000-0001-8251-5275;
   Fassi, Enrico Mario Alessandro/0000-0001-6282-4273; Damin,
   Francesco/0000-0003-1780-7823
FU Regione Lombardia, project READY (Regional Network for developing
   diagnostic methods in rapid response to emerging epidemics and
   bio-emergencies) [229472]; European Union's Horizon 2020 research and
   innovation programme [766466]
FX We acknowledge funding by Regione Lombardia, project READY (Regional
   Network for developing diagnostic methods in rapid response to emerging
   epidemics and bio-emergencies) ID 229472 and by European Union's Horizon
   2020 research and innovation programme under grant agreement no 766466
   (INDEX). We thank Mauro Bombaci and Renata Grifantini from INGM and
   Edoardo Marchisio and Cristina Scozzesi from Dia.Pro. srl for helpful
   discussions.
CR Aqvist J, 2004, CHEM PHYS LETT, V384, P288, DOI 10.1016/j.cplett.2003.12.039
   Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Capelli R, 2017, ACS INFECT DIS, V3, P736, DOI 10.1021/acsinfecdis.7b00080
   Carmona SJ, 2015, MOL CELL PROTEOMICS, V14, P1871, DOI 10.1074/mcp.M114.045906
   Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Ferraro M, 2019, J MED CHEM, V62, P60, DOI 10.1021/acs.jmedchem.8b00825
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Genoni A, 2012, J PHYS CHEM B, V116, P3331, DOI 10.1021/jp210568a
   Gori A, 2016, BIOCONJUGATE CHEM, V27, P2669, DOI 10.1021/acs.bioconjchem.6b00426
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SM, 2017, HDB ZOONOSES, P89
   Hunsperger EA, 2016, J CLIN MICROBIOL, V54, P2090, DOI 10.1128/JCM.00521-16
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614
   Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022
   Legnani L, 2015, J ORG CHEM, V80, P7412, DOI 10.1021/acs.joc.5b00878
   LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Meng XY, 2018, ANAL METHODS-UK, V10, P4614, DOI 10.1039/c8ay01442f
   Meuleman TJ, 2018, BIOCONJUGATE CHEM, V29, P1091, DOI 10.1021/acs.bioconjchem.7b00755
   Meyer B, 2016, J CHEM THEORY COMPUT, V12, P1052, DOI 10.1021/acs.jctc.5b01007
   Meyer B, 2016, J CHEM THEORY COMPUT, V12, P1068, DOI 10.1021/acs.jctc.5b01008
   Mizumoto K, 2014, J VECTOR DIS, V51, P153
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Morelli L, 2018, BIOORGAN MED CHEM, V26, P5682, DOI 10.1016/j.bmc.2018.10.016
   Peri C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32873
   Peri C, 2013, ACS CHEM BIOL, V8, P397, DOI 10.1021/cb300487u
   Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Scarabelli G, 2010, BIOPHYS J, V98, P1966, DOI 10.1016/j.bpj.2010.01.014
   Sharma KK, 2019, STRUCTURE, V27, P618, DOI 10.1016/j.str.2018.12.006
   Sharma S, 2015, BIOSENSORS-BASEL, V5, P577, DOI 10.3390/bios5030577
   Shen GM, 2009, CLIN VACCINE IMMUNOL, V16, P49, DOI 10.1128/CVI.00334-08
   Smeenk LEJ, 2012, ORG LETT, V14, P1194, DOI 10.1021/ol203259a
   Sola L, 2018, ACS INFECT DIS, V4, P998, DOI 10.1021/acsinfecdis.8b00014
   Sola L, 2016, LANGMUIR, V32, P10284, DOI 10.1021/acs.langmuir.6b02816
   Timmerman P., 2009, OPEN VACCINE J, V2, P56, DOI DOI 10.2174/1875035400902010056
   van de Langemheen H, 2014, ORG BIOMOL CHEM, V12, P4471, DOI 10.1039/c4ob00190g
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Yu H., 2015, POWER, VPP, P1, DOI 10.1109/TC.2015.2389827
   Zhang W, 2016, ANAL METHODS-UK, V8, P7847, DOI 10.1039/c6ay02158a
NR 48
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR 2
PY 2019
VL 20
IS 8
AR 1921
DI 10.3390/ijms20081921
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HX8ID
UT WOS:000467648700119
PM 31003530
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Clain, E
   Haddad, JG
   Koishi, AC
   Sinigaglia, L
   Rachidi, W
   Despres, P
   dos Santos, CND
   Guiraud, P
   Jouvenet, N
   El Kalamouni, C
AF Clain, Elodie
   Haddad, Juliano G.
   Koishi, Andrea C.
   Sinigaglia, Laura
   Rachidi, Walid
   Despres, Philippe
   Duarte dos Santos, Claudia N.
   Guiraud, Pascale
   Jouvenet, Nolwenn
   El Kalamouni, Chaker
TI The Polyphenol-Rich Extract from Psiloxylon mauritianum, an Endemic
   Medicinal Plant from Reunion Island, Inhibits the Early Stages of Dengue
   and Zika Virus Infection
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; Dengue virus; antiviral activity; natural compounds;
   nutraceuticals; Psiloxylon mauritianum
ID VITRO ANTIVIRAL ACTIVITY; EPIGALLOCATECHIN GALLATE; ENTRY; CELLS;
   BAILLON
AB The recent emergence and re-emergence of viral infections transmitted by vectors, such as the Zika virus (ZIKV) and Dengue virus (DENV), is a cause for international concern. These highly pathogenic arboviruses represent a serious health burden in tropical and subtropical areas of the world. Despite the high morbidity and mortality associated with these viral infections, antiviral therapies are missing. Medicinal plants have been widely used to treat various infectious diseases since millenaries. Several compounds extracted from plants exhibit potent effects against viruses in vitro, calling for further investigations regarding their efficacy as antiviral drugs. Here, we demonstrate that an extract from Psiloxylon mauritianum, an endemic medicinal plant from Reunion Island, inhibits the infection of ZIKV in vitro without exhibiting cytotoxic effects. The extract was active against different ZIKV African and Asian strains, including an epidemic one. Time-of-drug-addition assays revealed that the P. mauritianum extract interfered with the attachment of the viral particles to the host cells. Importantly, the P. mauritianum extract was also able to prevent the infection of human cells by four dengue virus serotypes. Due to its potency and ability to target ZIKV and DENV particles, P. mauritianum may be of value for identifying and characterizing antiviral compounds to fight medically-important flaviviruses.
C1 [Clain, Elodie; Haddad, Juliano G.; Despres, Philippe; Guiraud, Pascale; El Kalamouni, Chaker] Univ La Reunion, CNRS,INSERM, UMR 9192,IRD,UMR 249,Plateforme Technol CYROI, U1187,Unite Mixte Proc Infect Milieu Insulaire Tr, F-97490 St Clotilde, La Reunion, France.
   [Koishi, Andrea C.; Duarte dos Santos, Claudia N.] FIOCRUZ PR, ICC, Lab Virol Mol, BR-81350010 Curitiba, Parana, Brazil.
   [Sinigaglia, Laura; Jouvenet, Nolwenn] Inst Pasteur, CNRS, UMR 3569, Viral Genom & Vaccinat Unit, F-75724 Paris, France.
   [Sinigaglia, Laura] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France.
   [Rachidi, Walid] UGA, CNRS, UMR 5819, CEA,SYMMES,CIBEST,INAC, F-38000 Grenoble, France.
RP El Kalamouni, C (corresponding author), Univ La Reunion, CNRS,INSERM, UMR 9192,IRD,UMR 249,Plateforme Technol CYROI, U1187,Unite Mixte Proc Infect Milieu Insulaire Tr, F-97490 St Clotilde, La Reunion, France.
EM marie-elodie.clain@univ-reunion.fr; juliano.haddad@univ-reunion.fr;
   ackoishi@gmail.co; laura.sinigagli@gmail.com;
   Walid.rachidi@univ-grenoble-alpes.fr; philippe.despres@univ-reunion.fr;
   clsantos@fiocruz.br; pascale.guiraud@univ-reunion.fr;
   nolwenn.jouvenet@pasteur.fr; chaker.el-kalamouni@univ-reunion.fr
RI Santos, Claudia Duarte dos/P-4868-2019; Rachidi, Walid/H-1016-2018
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; El Kalamouni,
   Chaker/0000-0003-4673-6614; Rachidi, Walid/0000-0002-0829-7799
FU POE FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert
   program) [SYNERGIE: RE00001902]; INSERM-Transfert [R16029FS];
   CAPES-COFECUB projectCAPES [Me889/17 ZIKANET]; Research Federation
   BioST, Universite de La Reunion; DIRED from the Conseil Regional de La
   Reunion, France; ZIKAlert program; Pasteur Paris University (PPU)
   International PhD program through an 'Institut Carnot Pasteur Maladies
   Infectieuses' grant
FX This work was supported by POE FEDER 2014-20 of the Conseil Regional de
   La Reunion (ZIKAlert program, No SYNERGIE: RE00001902), INSERM-Transfert
   (project: no R16029FS), CAPES-COFECUB Me889/17 ZIKANET project and
   Research Federation BioST, Universite de La Reunion. E.C. is supported
   by a grant DIRED from the Conseil Regional de La Reunion, France.
   J.-G.H. received funding from the ZIKAlert program. L.S. is supported by
   the Pasteur Paris University (PPU) International PhD program through an
   'Institut Carnot Pasteur Maladies Infectieuses' grant.
CR Araujo SD, 2015, J ETHNOPHARMACOL, V170, P16, DOI 10.1016/j.jep.2015.04.044
   Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002
   Boldbaatar D, 2014, J ETHNOPHARMACOL, V155, P599, DOI 10.1016/j.jep.2014.06.005
   dos Santos FJB, 2012, J ETHNOPHARMACOL, V144, P474, DOI 10.1016/j.jep.2012.08.047
   Bos S, 2018, PATHOG GLOB HEALTH, V112, P294, DOI 10.1080/20477724.2018.1514136
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fortin H, 2002, FITOTERAPIA, V73, P346, DOI 10.1016/S0367-326X(02)00080-1
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jonville MC, 2008, J ETHNOPHARMACOL, V120, P382, DOI 10.1016/j.jep.2008.09.005
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Ledoux A, 2018, INT J ANTIMICROB AG, V52, P622, DOI 10.1016/j.ijantimicag.2018.07.017
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Lin KY, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-018-0694-0
   Mahomoodally MF, 2014, J INTERCULT ETHNOPHA, V3, P192, DOI 10.5455/jice.20140804010620
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Mootoosamy A, 2014, J ETHNOPHARMACOL, V151, P413, DOI 10.1016/j.jep.2013.10.069
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Njoya EM, 2014, J ETHNOPHARMACOL, V155, P823, DOI 10.1016/j.jep.2014.06.038
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Poullain C, 2004, J ETHNOPHARMACOL, V95, P19, DOI 10.1016/j.jep.2004.05.023
   Powers CN, 2016, COMB CHEM HIGH T SCR, V19, P516, DOI 10.2174/1386207319666160506123715
   Rangasamy O, 2014, S AFR J BOT, V93, P198, DOI 10.1016/j.sajb.2014.03.017
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Silva EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39157-7
   Tricot T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209097
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9
   Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011
NR 49
TC 5
Z9 5
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR 2
PY 2019
VL 20
IS 8
AR 1860
DI 10.3390/ijms20081860
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HX8ID
UT WOS:000467648700058
PM 30991717
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gorchakov, R
   Gulas-Wroblewski, BE
   Ronca, SE
   Ruff, JC
   Nolan, MS
   Berry, R
   Alvarado, RE
   Gunter, SM
   Murray, KO
AF Gorchakov, Rodion
   Gulas-Wroblewski, Bonnie E.
   Ronca, Shannon E.
   Ruff, Jeanne C.
   Nolan, Melissa S.
   Berry, Rebecca
   Alvarado, R. Elias
   Gunter, Sarah M.
   Murray, Kristy O.
TI Optimizing PCR Detection of West Nile Virus from Body Fluid Specimens to
   Delineate Natural History in an Infected Human Cohort
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE West Nile virus; virus shedding; PCR; prolonged detection; saliva;
   urine; whole blood; semen; Houston West Nile cohort
ID ZIKA VIRUS; WHOLE-BLOOD; RNA; URINE; OUTCOMES; PERSISTENCE; DENGUE;
   SALIVA
AB West Nile virus (WNV), a mosquito-borne arbovirus, remains a major global health concern. In this study, we optimized PCR methods then assessed serially-collected whole blood (WB), urine (UR), saliva, and semen specimens from a large cohort of WNV-positive participants to evaluate the natural history of infection and persistent shedding of WNV RNA. Viral RNA extraction protocols for frozen WB and UR specimens were optimized and validated through spiking experiments to maximize recovery of viral RNA from archived specimens and to assess the degradation of WNV RNA in stored UR specimens. The resultant procedures were used in conjunction with PCR detection to identify WNV-positive specimens and to quantify their viral loads. A total of 59 of 352 WB, 10 of 38 UR, and 2 of 34 saliva specimens tested positive for WNV RNA. Although a single semen specimen was positive 22 days post onset, we could not definitively confirm the presence of WNV RNA in the remaining specimens. WNV RNA-positive UR specimens exhibited profound loss of viral RNA during storage, highlighting the need for optimal preservation pre-storage. This study provides optimized methods for WNV RNA detection among different fluid types and offers alternative options for diagnostic testing during the acute stages of WNV.
C1 [Gorchakov, Rodion; Gulas-Wroblewski, Bonnie E.; Ronca, Shannon E.; Ruff, Jeanne C.; Berry, Rebecca; Alvarado, R. Elias; Gunter, Sarah M.; Murray, Kristy O.] Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA.
   [Gorchakov, Rodion; Gulas-Wroblewski, Bonnie E.; Ronca, Shannon E.; Ruff, Jeanne C.; Berry, Rebecca; Alvarado, R. Elias; Gunter, Sarah M.; Murray, Kristy O.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Gulas-Wroblewski, Bonnie E.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.
   [Nolan, Melissa S.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
RP Murray, KO (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA.; Murray, KO (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.
EM rodion.gorchakov@gmail.com; Bonnie.Gulas-Wroblewski@bcm.edu;
   ronca@bcm.edu; jruff@bcm.edu; MSNOLAN@mailbox.sc.edu; rberry@bcm.edu;
   Rojelio.Alvarado@bcm.edu; sm22@bcm.edu; kmurray@bcm.edu
OI Alvarado, Rojelio/0000-0002-1450-4854
FU Chao Foundation
FX This research and the APC was funded by The Chao Foundation.
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Anna N, 2017, ORVOSI HETILAP, V158, P791, DOI 10.1556/650.2017.30760
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Athar P, 2018, MUSCLE NERVE, V57, P77, DOI 10.1002/mus.25660
   Barrett ADT, 2014, AM J TROP MED HYG, V90, P389, DOI 10.4269/ajtmh.14-0009
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939
   Deng MY, 2005, J VET DIAGN INVEST, V17, P574, DOI 10.1177/104063870501700609
   El Bali Latifa, 2014, J Biomol Tech, V25, P96, DOI 10.7171/jbt.14-2504-002
   El-Khoury V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19529
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Garcia MN, 2014, VIRAL IMMUNOL, V27, P327, DOI 10.1089/vim.2014.0035
   Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057
   Gorchakov R, 2019, AM J TROP MED HYG, V100, P427, DOI 10.4269/ajtmh.18-0755
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Habu A, 1977, Uirusu, V27, P21
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Lustig Y, 2016, EMERG INFECT DIS, V22, P1647, DOI 10.3201/eid2209.160132
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray KO, 2017, AM J TROP MED HYG, V97, P1913, DOI 10.4269/ajtmh.17-0405
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Murray KO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102953
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Nolan MS, 2012, J CLIN PSYCHOL, V68, P801, DOI 10.1002/jclp.21871
   POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Wu XY, 2008, J GEN VIROL, V89, P3073, DOI 10.1099/vir.0.2008/003210-0
NR 47
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR 2
PY 2019
VL 20
IS 8
AR 1934
DI 10.3390/ijms20081934
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HX8ID
UT WOS:000467648700132
PM 31010160
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, SY
   Zhang, CZ
   Huang, LNS
   Zhang, XQ
   Xu, Y
   Fang, X
   Zhou, J
   Wu, MX
   Schooley, RT
   Huang, ZW
   An, J
AF Zhu, Siyu
   Zhang, Chaozai
   Huang, Lina S.
   Zhang, Xing-Quan
   Xu, Yan
   Fang, Xiong
   Zhou, Jiao
   Wu, Meixian
   Schooley, Robert T.
   Huang, Ziwei
   An, Jing
TI Discovery and Computational Analyses of Novel Small Molecule Zika Virus
   Inhibitors
SO MOLECULES
LA English
DT Article
DE Zika virus; flaviviruses; structure-based virtual screening;
   non-structural protein 3; benzenediol; tetrahydroxy pentanoate
ID NS2B-NS3 PROTEASE; NS3 HELICASE; CRYSTAL-STRUCTURE; DRUG DISCOVERY;
   IDENTIFICATION; REPLICATION; INFECTION; EMERGENCE; MECHANISM; DYNAMICS
AB Zika virus (ZIKV), one of the flaviviruses, has attracted worldwide attention since its large epidemics around Brazil. Association of ZIKV infection with microcephaly and neurological problems such as Guillain-Barre syndrome has prompted intensive pathological investigations. However, there is still a long way to go on the discovery of effective anti-ZIKV therapeutics. In this study, an in silico screening of the National Cancer Institute (NCI) diversity set based on ZIKV NS3 helicase was performed using a molecular docking approach. Selected compounds with drug-like properties were subjected to cell-based antiviral assays resulting in the identification of two novel lead compounds (named Compounds 1 and 2). They inhibited ZIKV infection with IC50 values at the micro-molar level (8.5 M and 15.2 M, respectively). Binding mode analysis, absolute binding free energy calculation, and structure-activity relationship studies of these two compounds revealed their possible interactions with ZIKV NS3 helicase, suggesting a mechanistic basis for further optimization. These two novel small molecules may represent new leads for the development of inhibitory drugs against ZIKV.
C1 [Zhu, Siyu; Fang, Xiong; Huang, Ziwei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Zhu, Siyu; Zhang, Chaozai; Huang, Lina S.; Zhang, Xing-Quan; Wu, Meixian; Schooley, Robert T.; Huang, Ziwei; An, Jing] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA.
   [Zhang, Chaozai] Jilin Univ, Sch Pharmaceut Sci, Changchun 130021, Jilin, Peoples R China.
   [Huang, Lina S.] Cornell Univ, Coll Arts & Sci, Ithaca, NY 14853 USA.
   [Xu, Yan] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Shenzhen 518172, Peoples R China.
   [Zhou, Jiao] Nobel Inst Biomed, Zhuhai 519000, Peoples R China.
RP Zhu, SY; Huang, ZW (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Zhu, SY; Huang, ZW; An, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA.
EM siz091@ucsd.edu; chaozai224@126.com; lsh83@cornell.edu; xiz002@ucsd.edu;
   xyupstate@gmail.com; fx_09shuo@163.com; zhouj229@nobel-institute.org;
   m4wu@ucsd.edu; rschooley@ucsd.edu; zhuang@ucsd.edu; jan@ucsd.edu
RI Zhu, Siyu/AAD-2743-2019
OI Fang, Xiong/0000-0002-7625-2306
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX This research was funded by grants from the National Institute of Health
   (to J.A.).
CR Allen JE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0346-9
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   CASTELLANI G, 1978, FARM ED PRAT, V33, P187
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Huang Z., 2007, NEW FRONTIERS POSTGE, V521, P516
   ISHITANI R, 1972, JPN J PHARMACOL, V22, P313, DOI 10.1254/jjp.22.313
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Joshi SK, 2003, J PHARMACOL EXP THER, V307, P367, DOI 10.1124/jpet.103.052829
   Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leelananda SP, 2016, BEILSTEIN J ORG CHEM, V12, P2694, DOI 10.3762/bjoc.12.267
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li K., 2010, PROBE REPORTS NIH MO
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Singla D, 2013, CURR TOP MED CHEM, V13, P1172, DOI 10.2174/1568026611313100005
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Spitzer R, 2012, J COMPUT AID MOL DES, V26, P687, DOI 10.1007/s10822-011-9533-y
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 53
TC 1
Z9 2
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD APR 2
PY 2019
VL 24
IS 8
AR 1465
DI 10.3390/molecules24081465
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HX9YT
UT WOS:000467765700020
PM 31013906
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Klofstad, CA
   Uscinski, JE
   Connolly, JM
   West, JP
AF Klofstad, Casey A.
   Uscinski, Joseph E.
   Connolly, Jennifer M.
   West, Jonathan P.
TI What drives people to believe in Zika conspiracy theories?
SO PALGRAVE COMMUNICATIONS
LA English
DT Article
ID VIRUS; SCIENCE; COMMUNICATION; OUTBREAK
AB Conspiracy theories and other pseudo-scientific claims about the Zika virus have been prominent on social media. To what extent are the public concerned about the virus, and to what extent have the public adopted Zika conspiracy theories? Using data from the 2016 Cooperative Congressional Election Study, we show that a majority of Americans are not concerned about the Zika virus, but approximately one in five Americans believes in at least one Zika-related conspiracy theory. The most widely believed is that the virus is caused by genetically modified mosquitoes. We find that elevated levels of conspiracy thinking are correlated with both concern over Zika and belief in Zika-related conspiracy theories. For example, a person scoring the maximum on the conspiratorial thinking scale is estimated to believe in .61 Zika conspiracy theories while a person scoring the minimum is estimated to believe in only .06 Zika conspiracy theories. This study demonstrates the role of predispositions, specifically underlying conspiracy thinking, in the acceptance of conspiratorial and unscientific beliefs.
C1 [Klofstad, Casey A.; Uscinski, Joseph E.; Connolly, Jennifer M.; West, Jonathan P.] Univ Miami, Polit Sci Dept, 1300 Campo Sano Ave, Coral Gables, FL 33146 USA.
RP Uscinski, JE (corresponding author), Univ Miami, Polit Sci Dept, 1300 Campo Sano Ave, Coral Gables, FL 33146 USA.
EM uscinski@miami.edu
CR Ansolabehere S, 2017, COOPERATIVE C ELECTI
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   Banas JA, 2013, HUM COMMUN RES, V39, P184, DOI 10.1111/hcre.12000
   Berinsky AJ, 2017, BRIT J POLIT SCI, V47, P241, DOI 10.1017/S0007123415000186
   Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Broniatowski DA, 2016, VACCINE, V34, P3225, DOI 10.1016/j.vaccine.2016.04.044
   Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carey JM, 2016, RES POLITICS, V3, DOI 10.1177/2053168016668671
   Clayton KD, 2019, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2019.1628137
   Craft S, 2017, COMMUN PUBLIC, V2, P388, DOI 10.1177/2057047317725539
   Cullen JT, 2018, CONSPIRACY THEORIES
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Enders Adam M., 2018, BRIT J POLIT SCI, DOI [10.1017/S0007123417000837, DOI 10.1017/S0007123417000837]
   Grimm F, 2016, THE MIAMI HERALD
   Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706
   Guess A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4586
   Hofstadter Richard, 1964, PARANOID STYLE AM PO
   Imhoff R, 2014, EUR J PERSONALITY, V28, P25, DOI 10.1002/per.1930
   Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Kadri S, 2016, ARCH CLIN MICROBIOL, V7, P3
   Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547
   Kahne J, 2017, AM EDUC RES J, V54, P3, DOI 10.3102/0002831216679817
   Leombruni LV, 2015, GLOBAL ENVIRON CHANG, V35, P148, DOI 10.1016/j.gloenvcha.2015.08.006
   Lewandowsky S, 2018, CONSPIRACY THEORIES
   Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637
   Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686
   Marietta M, 2018, CONSPIRACY THEORIES
   MCCLOSKY H, 1985, BRIT J POLIT SCI, V15, P329, DOI 10.1017/S0007123400004221
   Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234
   Motta M, 2018, SOC SCI MED, V211, P274, DOI 10.1016/j.socscimed.2018.06.032
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Nyhan B, 2016, J EXPT POLITICAL SCI, V3, P109, DOI DOI 10.1017/XPS.2015.21
   Nyhan B, 2013, MED CARE, V51, P127, DOI 10.1097/MLR.0b013e318279486b
   Oliver J.E., 2018, ENCHANTED AM INTUITI
   Pasek J, 2018, CONSPIRACY THEORIES
   Pearson AR, 2015, SCI COMMUN, V37, P805, DOI 10.1177/1075547015611131
   Roozenbeek J, 2019, J RISK RES, V22, P570, DOI 10.1080/13669877.2018.1443491
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Swami V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00280
   Uscinski J. E., 2014, AM CONSPIRACY THEORI
   Uscinski JE, 2017, OXFORD RES ENCY CLIM, P1, DOI [10.1093/acrefore/9780190228620.013.328, DOI 10.1093/ACREFORE/9780190228620.013.328]
   Uscinski JE, 2016, POLIT RES QUART, V69, P57, DOI 10.1177/1065912915621621
   van der Linden S, 2017, SCIENCE, V358, P1141, DOI 10.1126/science.aar4533
   van der Linden S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600008
   van der Linden S, 2015, PERS INDIV DIFFER, V87, P171, DOI 10.1016/j.paid.2015.07.045
   van Prooijen JW, 2017, APPL COGNITIVE PSYCH, V31, P50, DOI 10.1002/acp.3301
   Venkatraman A, 2016, TRAVEL MED INFECT DI, V14, P421, DOI 10.1016/j.tmaid.2016.05.018
   Vuong QH, 2018, NAT HUM BEHAV, V2, P5, DOI 10.1038/s41562-017-0281-4
   Wood MJ, 2018, CYBERPSYCH BEH SOC N, V21, P485, DOI 10.1089/cyber.2017.0669
   Wood MJ, 2017, BRIT J PSYCHOL, V108, P507, DOI 10.1111/bjop.12231
   Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786
   Zaller J.R., 1992, NATURE ORIGINS MASS
NR 55
TC 1
Z9 1
U1 3
U2 5
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 2055-1045
J9 PALGR COMMUN
JI Palgr. Commun.
PD APR 2
PY 2019
VL 5
AR 36
DI 10.1057/s41599-019-0243-8
PG 8
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA HW6BI
UT WOS:000466772700002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Houe, V
   Bonizzoni, M
   Failloux, AB
AF Houe, Vincent
   Bonizzoni, Mariangela
   Failloux, Anna-Bella
TI Endogenous non-retroviral elements in genomes of Aedes mosquitoes and
   vector competence
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
DE Aedes albopictus; arboviral diseases; vector competence; NIRVS
ID QUANTITATIVE TRAIT LOCI; CHIKUNGUNYA-VIRUS; RNA VIRUSES; DENGUE VIRUS;
   INTERSPECIFIC VARIATION; TRANSPOSABLE ELEMENTS; INVASIVE MOSQUITO;
   ANTIVIRAL DEFENSE; REUNION ISLAND; PIRNA PATHWAY
AB Recent extensive (re)emergences of arthropod-borne viruses (arboviruses) such as chikungunya (CHIKV), zika (ZIKV) and dengue (DENV) viruses highlight the role of the epidemic vectors, Aedes aegypti and Aedes albopictus, in their spreading. Differences of vector competence to arboviruses highlight different virus/vector interactions. While both are highly competent to transmit CHIKV (Alphavirus,Togaviridae), only Ae. albopictus is considered as a secondary vector for DENV (Flavivirus, Flaviviridae). Among other factors such as environmental temperature, mosquito antiviral immunity and microbiota, the presence of non-retroviral integrated RNA virus sequences (NIRVS) in both mosquito genomes may modulate the vector competence. Here we review the current knowledge on these elements, highlighting the mechanisms by which they are produced and endogenized into Aedes genomes. Additionally, we describe their involvement in antiviral immunity as a stimulator of the RNA interference pathways and in some rare cases, as producer of viral-interfering proteins. Finally, we mention NIRVS as a tool for understanding virus/vector co-evolution. The recent discovery of endogenized elements shows that virus/vector interactions are more dynamic than previously thought, and genetic markers such as NIRVS could be one of the potential targets to reduce arbovirus transmission.
C1 [Houe, Vincent; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, F-75015 Paris, France.
   [Houe, Vincent] Sorbonne Univ, Coll Doctoral, Paris, France.
   [Bonizzoni, Mariangela] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, F-75015 Paris, France.
EM anna-bella.failloux@pasteur.fr
OI Bonizzoni, Mariangela/0000-0003-0568-8564; FAILLOUX,
   Anna-Bella/0000-0001-6890-0820
FU Institut Pasteur; French Government's Investissement d'Avenir programme,
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases" [ANR-10-LABX-62-IBEID]; European Union's Horizon 2020 research
   and innovation programme under ZIKAlliance [734548]; European Research
   CouncilEuropean Research Council (ERC) [682394 - NIRV_HOST_INT]
FX This study was supported by the Institut Pasteur, the French
   Government's Investissement d'Avenir programme, Laboratoire d'Excellence
   "Integrative Biology of Emerging Infectious Diseases"
   (http://www.agence-nationale-recherche.fr/ProjetIA-10-LABX-0062) [grant
   number ANR-10-LABX-62-IBEID to A-BF], the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance
   (https://cordis.europa.eu/project/rcn/207455/factsheet/en) [grant
   agreement no. 734548 to A-BF], and the European Research Council
   (https://cordis.europa.eu/project/rcn/203246/reporting/en) [grant
   agreement no. 682394 - NIRV_HOST_INT to VH and MB].
CR Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688
   Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x
   Diniz DFA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2235-0
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007
   Au TK, 2006, J BACTERIOL, V188, P1829, DOI 10.1128/JB.188.5.1829-1834.2006
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Bagny Beilhe L, 2013, MED VET ENTOMOL, V27, P387, DOI 10.1111/j.1365-2915.2012.01062.x
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798
   Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101
   Biryukova I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1436-1
   BLACK WC, 1988, HEREDITY, V60, P173, DOI 10.1038/hdy.1988.29
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bosio CF, 2000, GENETICS, V156, P687
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   BUKHARI AI, 1972, NATURE-NEW BIOL, V236, P240
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Cancrini G, 2003, MED VET ENTOMOL, V17, P448, DOI 10.1111/j.1365-2915.2003.00463.x
   Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Christie James, 1882, Ind Med Gaz, V17, P76
   Christophers SR, 1960, AEDES AEGYPTI L YELL, P750
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   CRAIG N, 2002, MOBILE DNA
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416
   DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0
   Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005
   Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   ELLIOTT SA, 1980, T ROY SOC TROP MED H, V74, P747, DOI 10.1016/0035-9203(80)90192-3
   Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375
   Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105
   Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gomez-Machorro C, 2004, INSECT MOL BIOL, V13, P637, DOI 10.1111/j.0962-1075.2004.00522.x
   Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109
   HARDY JL, 1988, ARBOVIRUSES EPIDEMIO, V1, P87
   Hermanns K, 2017, J GEN VIROL, V98, P43, DOI 10.1099/jgv.0.000694
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6
   Hotta Susumu, 1998, Medical Entomology and Zoology, V49, P267
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   JUMALI, 1979, AM J TROP MED HYG, V28, P717
   Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kidwell MG, 1992, CURR OPIN GENET DEV, V2, P868, DOI 10.1016/S0959-437X(05)80109-1
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kittisriworapod S, 1991, FEVER RASH OUTBREAK
   KLAER R, 1981, MOL GEN GENET, V181, P169, DOI 10.1007/BF00268423
   Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876
   Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001
   KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008
   Luo L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0352-9
   Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038
   MATTINGLY PF, 1953, ANN TROP MED PARASIT, V47, P294, DOI 10.1080/00034983.1953.11685571
   McCLINTOCK BARBARA, 1956, BROOKHAVEN SYMPOSIA IN BIOL, P58
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   MCLAIN DK, 1987, HEREDITY, V58, P373, DOI 10.1038/hdy.1987.65
   METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10
   Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319
   Mura M, 2004, P NATL ACAD SCI USA, V101, P11117, DOI 10.1073/pnas.0402877101
   Murphy EJ, 1972, HIST AFRICAN CIVILIZ
   Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Pietrobelli M., 2008, Parassitologia (Rome), V50, P113
   Pischedda E, 2018, BIORXIV, DOI [10.1101/385666, DOI 10.1101/385666]
   Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008
   RAO PN, 1987, HEREDITY, V59, P253, DOI 10.1038/hdy.1987.120
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603
   Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Sanjuan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002685
   Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SINGH KRP, 1967, ACTA VIROL, V11, P517
   Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Taylor GM, 2001, J VIROL, V75, P11244, DOI 10.1128/JVI.75.22.11244-11248.2001
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   URCELAY E, 1995, J VIROL, V69, P2038, DOI 10.1128/JVI.69.4.2038-2046.1995
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   van Cleef KWR, 2011, METHODS MOL BIOL, V721, P201, DOI 10.1007/978-1-61779-037-9_12
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Vazeille M, 2003, AM J TROP MED HYG, V68, P203, DOI 10.4269/ajtmh.2003.68.203
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377
   WHITEHEAD RH, 1971, T ROY SOC TROP MED H, V65, P661, DOI 10.1016/0035-9203(71)90051-4
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Woodring JL, 1996, BIOL DIS VECTORS, P632
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Young SM, 2001, P NATL ACAD SCI USA, V98, P13525, DOI 10.1073/pnas.241508998
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0
   Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1
   Zhu F, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-210
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 177
TC 5
Z9 5
U1 3
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 2
PY 2019
VL 8
IS 1
BP 542
EP 555
DI 10.1080/22221751.2019.1599302
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HR3AW
UT WOS:000463009900003
PM 30938223
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wee, S
   Alli-Shaik, A
   Kek, R
   Swa, HLF
   Tien, WP
   Lim, VW
   Leo, YS
   Ng, LC
   Hapuarachchi, HC
   Gunaratne, J
AF Wee, Sheena
   Alli-Shaik, Asfa
   Kek, Relus
   Swa, Hannah L. F.
   Tien, Wei-Ping
   Lim, Vanessa W.
   Leo, Yee-Sin
   Ng, Lee-Ching
   Hapuarachchi, Hapuarachchige C.
   Gunaratne, Jayantha
TI Multiplex targeted mass spectrometry assay for one-shot flavivirus
   diagnosis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE targeted proteomics; PRM; dengue; flavivirus; diagnostics
ID DENGUE VIRUSES; PROTEOMICS; PROTEIN; COINFECTION; REVEALS; PLASMA;
   CANCER; ZIKA
AB Targeted proteomic mass spectrometry is emerging as a salient clinical diagnostic tool to track protein biomarkers. However, its strong analytical properties have not been exploited in the diagnosis and typing of flaviviruses. Here, we report the development of a sensitive and specific single-shot robust assay for flavivirus typing and diagnosis using targeted mass spectrometry technology. Our flavivirus parallel reaction monitoring assay (fvPRM) has the ability to track secreted flaviviral nonstructural protein 1 (NS1) over a broad diagnostic and typing window with high sensitivity, specificity, extendibility, and multiplexing capability. These features, pivotal and pertinent to efficient response toward flavivirus out-breaks, including newly emerging flavivirus strains, circumvent the limitations of current diagnostic assays. fvPRM thus carries high potential in positioning itself as a forerunner in delivering early and accurate diagnosis for disease management.
C1 [Wee, Sheena; Alli-Shaik, Asfa; Swa, Hannah L. F.; Gunaratne, Jayantha] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Kek, Relus; Tien, Wei-Ping; Ng, Lee-Ching; Hapuarachchi, Hapuarachchige C.] Natl Environm Agcy, Environm Hlth Inst, Singapore 138667, Singapore.
   [Lim, Vanessa W.; Leo, Yee-Sin] Natl Ctr Infect Dis, Infect Dis Res & Training Off, Singapore 308442, Singapore.
   [Lim, Vanessa W.; Leo, Yee-Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore 308433, Singapore.
   [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Gunaratne, Jayantha] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117549, Singapore.
   [Kek, Relus] Minist Hlth, Biosafety Branch, Coll Med Bldg, Singapore 169854, Singapore.
RP Gunaratne, J (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Gunaratne, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117549, Singapore.
EM jayanthag@imcb.a-star.edu.sg
OI Wee, Sheena/0000-0003-2536-3433; Alli-Shaik, Asfa/0000-0001-7477-0495;
   Hapuarachchi, Hapuarachchige Chanditha/0000-0001-7079-8538
FU Agency for Science, Technology and Research, SingaporeAgency for Science
   Technology & Research (ASTAR); National Environment Agency, Singapore
FX We thank Siok Ghee Ler for optimizing and maintaining the LC-MS and
   Rachel H. X. Li for building the spectral library of DENV peptides; the
   Diagnostics Group at the Environmental Health Institute, Singapore, for
   the collection and serotyping of DENV-infected sera by PCR; and Prof.
   Mariano Garcia-Blanco (University of Texas Medical Branch and
   Duke-National University Singapore Medical School) for reading the
   manuscript and providing valuable feedback. The work is supported by
   Agency for Science, Technology and Research, Singapore and the National
   Environment Agency, Singapore.
CR Aebersold R, 2003, J AM SOC MASS SPECTR, V14, P685, DOI 10.1016/S1044-0305(03)00289-7
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706
   Cho WC, 2017, EXPERT REV PROTEOMIC, V14, P725, DOI 10.1080/14789450.2017.1365604
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802
   Gauthier MS, 2015, METHODS, V81, P66, DOI 10.1016/j.ymeth.2015.03.003
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Martinez-Garcia E, 2017, CLIN CANCER RES, V23, P6458, DOI 10.1158/1078-0432.CCR-17-0474
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n
   Pechlaner R, 2017, J AM COLL CARDIOL, V69, P789, DOI 10.1016/j.jacc.2016.11.065
   Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
NR 23
TC 2
Z9 2
U1 1
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 2
PY 2019
VL 116
IS 14
BP 6754
EP 6759
DI 10.1073/pnas.1817867116
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR3VU
UT WOS:000463069900046
PM 30886083
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Viedma, MDM
   Puri, V
   Oldfield, LM
   Shabman, RS
   Tan, GS
   Pickett, BE
AF Viedma, Maria del Pilar Martinez
   Puri, Vinita
   Oldfield, Lauren M.
   Shabman, Reed S.
   Tan, Gene S.
   Pickett, Brett E.
TI Optimization of qRT-PCR assay for zika virus detection in human serum
   and urine
SO VIRUS RESEARCH
LA English
DT Article
DE Zika Virus (ZIKV); qRT-PCR; Clinical samples; Reverse transcriptase;
   Limit of detection (LOD)
ID WEST-NILE-VIRUS; TRANSMISSION; INHIBITORS
AB Zika Virus (ZIKV) is a mosquito-borne flavivirus that the World Health Organization (WHO) declared a global concern due to the severity of infection. This study focuses on determining the level of detection of ZIKV RNA in human serum and urine. Known amounts of Zika virus were added to uninfected human serum and urine samples. Different reverse transcriptases were compared to select the optimal enzyme for this application. Zika RNA in these samples was then quantified with qRT-PCR to determine the lower limit of detection in these fluids and to construct a standard curve. Student's t-test of paired samples was used in order to identify statistical differences. The SuperScript III enzyme was able to produce more ZIKV cDNA when compared to PrimeScript. Zika virus RNA was found to be detectable at lower levels (2.5 PFU/mL) in urine than in serum (250 PFU/mL) when using SuperScript III. This study demonstrates how the selection of both the human clinical specimen, and the reverse transcriptase enzyme involved in the molecular detection of ZIKV by quantitative real-time polymerase chain reaction (qRT-PCR), play an important role in enabling improved detection of the virus.
C1 [Viedma, Maria del Pilar Martinez; Tan, Gene S.] J Craig Venter Inst, 4120Capricorn Lane, La Jolla, CA 92037 USA.
   [Puri, Vinita; Oldfield, Lauren M.; Shabman, Reed S.; Pickett, Brett E.] J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
   [Tan, Gene S.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
EM pviedma@jcvi.org; purivinita@yahoo.com; loldfiel@jcvi.org;
   rshabman@atcc.org; gtan@jcvi.org; bpickett@jcvi.org
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110819]
FX This project has been funded in whole or part with federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services under
   Award Number U19AI110819.
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Konet DS, 2000, J VIROL METHODS, V84, P95, DOI 10.1016/S0166-0934(99)00131-7
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121
   Pickett BE, 2013, VIROLOGY, V447, P45, DOI 10.1016/j.virol.2013.08.021
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tien WP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2373-4
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   World Health Organization, 2016, ZIK SIT REP
NR 31
TC 0
Z9 0
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD APR 2
PY 2019
VL 263
BP 173
EP 178
DI 10.1016/j.virusres.2019.01.013
PG 6
WC Virology
SC Virology
GA HO9EN
UT WOS:000461264300024
PM 30742853
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Garcia, G
   Martinez, LE
   Contreras, D
   Gong, DY
   Sun, R
   Arumugaswami, V
AF Garcia, Gustavo
   Martinez, Laura E.
   Contreras, Deisy
   Gong, Danyang
   Sun, Ren
   Arumugaswami, Vaithilingaraja
TI Transmission of Zika Virus Through the Rectal Route Leads to Mucosal and
   Systemic Infection with Reduced Neuropathology in Mice
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting (EB)
CY APR 06-09, 2019
CL Orlando, FL
SP Amer Assoc Anat, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Expt Therapeut
FU Cedars-Sinai Medical Center's Institutional Research Award; California
   Institute for Regenerative Medicine (CIRM) Quest - Discovery Stage
   Research Projects Grant [DISC2-10188]; UCLA Interdisciplinary
   Postdoctoral Training Grant (T32) in Virology and Gene Therapy
FX This research was funded by Cedars-Sinai Medical Center's Institutional
   Research Award to V.A., the California Institute for Regenerative
   Medicine (CIRM) Quest - Discovery Stage Research Projects Grant
   (DISC2-10188) to V.A. at UCLA, and the UCLA Interdisciplinary
   Postdoctoral Training Grant (T32) in Virology and Gene Therapy to L.E.M.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2019
VL 33
SU 1
MA 662.57
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA JM9WB
UT WOS:000496555200252
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Buzzanco, AS
   Ruchela, P
   Micewicz, E
   French, SW
AF Khachatoorian, Ronik
   Buzzanco, Anthony S.
   Ruchela, Piotr
   Micewicz, Ewa
   French, Samuel W.
TI Structure Activity Relationship Optimization of a 1,3-Disubstituted
   Urea-based Inhibitor of Zika Virus Infection
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting (EB)
CY APR 06-09, 2019
CL Orlando, FL
SP Amer Assoc Anat, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Expt Therapeut
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2019
VL 33
SU 1
MA 670.11
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA JM9WB
UT WOS:000496555200370
DA 2020-07-08
ER

PT J
AU Peruri, A
   Brown, IAM
   Wang, TT
   Isakson, BE
AF Peruri, Alekhya
   Brown, Isola A. M.
   Wang, Tony T.
   Isakson, Brant E.
TI Zika Virus Localizes to Vascular Endothelial and Smooth Muscle Cells
   following In Vivo Infection
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting (EB)
CY APR 06-09, 2019
CL Orlando, FL
SP Amer Assoc Anat, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Expt Therapeut
FU Ford Foundation [HL 088554 R01]
FX Ford Foundation Postdoctoral Grant (IAMB), HL 088554 R01 (BEI)
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2019
VL 33
SU 1
MA 527.8
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA JM0ZB
UT WOS:000495951202434
DA 2020-07-08
ER

PT J
AU Westemeier, E
   Pina, I
   Hamann, MT
   Hamann, MJ
AF Westemeier, Emily
   Pina, Ivett
   Hamann, Mark T.
   Hamann, Michael J.
TI Purification of Recombinant Zika Virus NS3 Helicase for the
   Identification of an Antiviral Drug
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting (EB)
CY APR 06-09, 2019
CL Orlando, FL
SP Amer Assoc Anat, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Expt Therapeut
FU Bemidji State University Biology Department; Bemidji State University
   College of Business, Mathematics, and Science; Regenerative Medicine
   Minnesota [RMM-2017-EP-04]; Neilson Foundation, Bemidji, MN
FX This work was supported by Bemidji State University Biology Department
   and the College of Business, Mathematics, and Science. Support was also
   provided through the Neilson Foundation, Bemidji, MN and Regenerative
   Medicine Minnesota (RMM-2017-EP-04).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2019
VL 33
SU 1
MA 782.21
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA JM9WB
UT WOS:000496555203037
DA 2020-07-08
ER

PT J
AU Slavov, SN
   Ferreira, FU
   Rodrigues, ES
   Gomes, R
   Covas, DT
   Kashima, S
AF Slavov, Svetoslav Nanev
   Ferreira, Fernando Ursoli
   Rodrigues, Evandra Strazza
   Gomes, Rogerio
   Covas, Dimas Tadeu
   Kashima, Simone
TI Simultaneous zika and dengue serotype-4 viral detection and isolation
   from a donor plasma unit
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Article
DE Coinfection; dengue virus; serotyping; zika virus
ID VIRUS; TRANSMISSION; OUTBREAK
AB During zika and dengue viruse (ZIKV and DENV) outbreaks. the majority of the infected individuals remain clinically asymptomatic. Such asymptomatic individuals may occasionally acquire both arboviruses, donate blood, and contaminate haemoderivatives. The aim of this study was to characterize a ZIKViDENV-4 coinfection in asymptomatic blood donor who donated blood during a large mixed ZIKV/DENV outbreak in the Sao Paulo State, Brazil. On the basis of post-donation information, one blood donor sample was found positive for ZIKV and DENV RNA. The DENV molecular serotyping was performed by molecular testing. The sample was also titrated on VERO E6 cells in order to define the presence of infectious arboviruses. The real-time PCR testing of the blood donor sample demonstrated very high viral load for both ZIKV and DENV. Further, molecular serotyping of DENV showed that the presence of DENV-4. The viral titration in cell culture indicated a titre of 2.75 x10(6) PFU/ml which was concordant with the presence of infectious viruses in the blood donation. This is an interesting report for the simultaneous presence of infectious ZIKV and DENV-4 in asymptomatic blood sample. Special attention must be paid during mixed arboviral outbreaks for the possibility of transfusion-transmission of multiple arboviral agents.
C1 [Slavov, Svetoslav Nanev; Ferreira, Fernando Ursoli; Rodrigues, Evandra Strazza; Gomes, Rogerio; Covas, Dimas Tadeu; Kashima, Simone] Univ Sao Paulo, Fac Med Ribeirao Preto, Reg Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Slavov, Svetoslav Nanev; Covas, Dimas Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil.
RP Slavov, SN (corresponding author), Univ Sao Paulo, Blood Ctr Ribeirao Preto, Lab Mol Biol, BR-14051140 Ribeirao Preto, SP, Brazil.
EM svetoslay.slavov@hemocentro.fmrp.usp.br
RI Gomes, Rogerio/B-7689-2013; Kashima, Simone/G-4876-2012
OI Gomes, Rogerio/0000-0002-0126-1742; Kashima, Simone/0000-0002-1487-0141
FU Fundacao de Amparo e Pesquisa do Estado de Sao Paulo-FAPESP, Brazil
   [2009/16623-1, CTC-2013/081352]; Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico, Brazil [INCTC-573.754/2008-0,
   INCTC-2008/57.877-3]; FINEP, BrazilCiencia Tecnologia e Inovacao (FINEP)
   [245/2016]
FX The authors are grateful to Sandra Navarro Bresciani for the graphical
   designs. This study was supported by Fundacao de Amparo e Pesquisa do
   Estado de Sao Paulo-FAPESP, Brazil (Grant No. 2009/16623-1,
   CTC-2013/081352), Conselho Nacional do Desenvolvimento Cientifico e
   Tecnologico, Brazil (INCTC-573.754/2008-0 and INCTC-2008/57.877-3), and
   FINEP, Brazil (245/2016).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eldin C, 2019, TRAVEL MED INFECT DI, V28, P100, DOI 10.1016/j.tmaid.2019.01.002
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Ingelbeen B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007029
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Mavrouli M, 2019, AM J TROP MED HYG, V100, P420, DOI 10.4269/ajtmh.18-0339
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Rahman M, 2019, EMERG INFECT DIS, V25, P370, DOI 10.3201/eid2502.180188
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Vairo F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208896
   Laredo-Tiscareno SV, 2018, AM J TROP MED HYG, V99, P1308, DOI 10.4269/ajtmh.18-0426
   Laredo-Tiscareno SV, 2018, AM J TROP MED HYG, V99, P191, DOI 10.4269/ajtmh.18-0117
NR 18
TC 0
Z9 0
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD APR-JUN
PY 2019
VL 56
IS 2
BP 166
EP 169
AR PMID 31397393
DI 10.4103/0972-9062.263724
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IS2SH
UT WOS:000482003800012
PM 31397393
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Alwabli, AS
   Alattas, SG
   Alhebshi, AM
   Zabermawi, NM
   Alkenani, N
   Al-ghmady, K
   Qadri, I
AF Alwabli, Afaf S.
   Alattas, Sana G.
   Alhebshi, Alawiah M.
   Zabermawi, Nidal M.
   Alkenani, Naser
   Al-ghmady, Khalid
   Qadri, Ishtiaq
TI Molecular docking analysis of netropsin and novobiocin with the viral
   protein targets HABD, MTD and RCD
SO BIOINFORMATION
LA English
DT Article
DE Dengue; therapeutics; helicase ATP binding domain; methyl transferase
   and RNA catalytic domain
ID ZIKA VIRUS; ALGORITHM; BINDING; SURFACE; NS1
AB Dengue, West Nile and Zika virus belongs to the family flaviviridae and genus flavivirus. It is of interest to design and develop inhibitors with improved activity against these diseases. We used the helicases target to screen for potential inhibitors against these viruses using molecular docking analysis. NS3 helicases of flavivirus family of viruses such as Dengue, West Nile and Zika are prime targets for drug development. The computer aided molecular docking analysis of netropsin and novobiocin with the viral protein targets HABD, MTD and RCD is reported for further consideration.
C1 [Alwabli, Afaf S.; Alattas, Sana G.; Alhebshi, Alawiah M.; Zabermawi, Nidal M.; Alkenani, Naser; Al-ghmady, Khalid; Qadri, Ishtiaq] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21589, Saudi Arabia.
RP Alwabli, AS (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21589, Saudi Arabia.
EM afafalwabli@yahoo.com
RI Alwabli, Afaf S./Q-9652-2017; Alhebshi, Alawiah M/AAD-4587-2019;
   Zabermawi, Nidal M.O./M-5743-2017; Alwabli, Afaf Salim/AAB-1155-2019
OI Alwabli, Afaf S./0000-0002-8795-8355; Zabermawi, Nidal
   M.O./0000-0003-1216-7003; Alwabli, Afaf Salim/0000-0002-8795-8355
FU King Abdulaziz City for Science and Technology (KACST, Riyadh, Saudi
   Arabia), General Directorate of the research grants program
   [1-18-01-009-0035]; Deanship of Scientific Research (DSR) grant, King
   Abdulaziz University, Jeddah, Saudi Arabia; DSR
FX Authors are grateful to King Abdulaziz City for Science and Technology
   (KACST, Riyadh, Saudi Arabia), General Directorate of the research
   grants program for funding this study with grant No. (1-18-01-009-0035).
   This work was also funded by the Deanship of Scientific Research (DSR)
   grant, King Abdulaziz University, Jeddah, Saudi Arabia, The authors,
   therefore, acknowledge the DSR technical and financial support.
CR Ahmad K, 2017, LETT DRUG DES DISCOV, V14, P488, DOI 10.2174/1570180814666161214114322
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]
   Becker N, 2012, EXOTIC MOSQUITOES CO, P31
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gill BS, 2015, MED CHEM RES, V24, P3483, DOI 10.1007/s00044-015-1405-x
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kuno G, 1997, DENGUE DENGUE HEMORR, P23
   Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Machado CM, 2009, REV INST MED TROP SP, V51, P309, DOI 10.1590/S0036-46652009000600002
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mehlhorn H, 2012, ARTHROPODS VECTORS E, V3, P38
   Melaun C, 2015, PARASITOL RES, V114, P1051, DOI 10.1007/s00436-014-4274-1
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Repasky MP, 2007, CURR PROTOC BIOINFOR, V18, P8, DOI DOI 10.1002/0471250953.BI0812S18
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Szymanski MR, 2011, J BIOL CHEM, V286, P33095, DOI 10.1074/jbc.M111.255034
   Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341
   Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069
   Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17
   Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
   Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011
   Zhang Y, 2002, PROTEINS, V48, P192, DOI 10.1002/prot.10141
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 36
TC 0
Z9 0
U1 1
U2 3
PU BIOMEDICAL INFORMATICS
PI TAMIL NADU
PA NO 42, 2ND MAIN RD, CHENNAI, TAMIL NADU, 600 020, INDIA
SN 0973-8894
EI 0973-2063
J9 BIOINFORMATION
JI Bioinformation
PD APR
PY 2019
VL 15
IS 4
BP 233
EP 239
DI 10.6062/97320630015233
PG 7
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IR4QN
UT WOS:000481419400001
PM 31285639
DA 2020-07-08
ER

PT J
AU Chaiphongpachara, T
   Laojun, S
AF Chaiphongpachara, Tanawat
   Laojun, Sedthapong
TI Genetic diversity of the dengue vector Aedes aegypti assessed using DNA
   sequencing libraries
SO BIOSCIENCE RESEARCH
LA English
DT Article
DE Mosquito; Aedes aegypti; Genetic diversity; cytochrome oxidase subunit I
AB Aedes (Stegomyia) aegypti (Linnaeus) is the main vector for several human viruses including yellow fever, dengue, chikungunya, and Zika viruses. We assessed the worldwide genetic diversity of the dengue vector, Ae. aegypti using cytochrome oxidase subunit I (COI) nucleotide sequences from DNA sequencing libraries. Fifty-three COI Ae. aegypti sequences from 10 countries Thailand, Pakistan, India, Singapore, Laos, Russia, France, Kenya, Ecuador, and Chile were selected. We identified 12 haplotypes and 18 polymorphic sites in the 53 COI sequences, with a total haplotype diversity of 0.625 +/- 0.074 and nucleotide diversity of 0.006 +/- 0.002. The Ae. aegypti population in Ecuador had the highest haplotype diversity (1.000 +/- 0.500) and the highest nucleotide diversity (0.017 +/- 0.013). A pairwise F-ST analysis indicated that there was significant genetic differentiation between 12 pairs of countries: France and Thailand; Kenya and India; Kenya and France; Ecuador and Thailand; Ecuador and Pakistan; Ecuador and India; Ecuador and Singapore; Ecuador and Laos; Ecuador and Russia; Ecuador and France; China and Kenya; and China and Ecuador (p < 0.05). The results of this study indicate that there are differences in Ae. aegypti populations in many countries around the world. Therefore, it appears that the environment directly affects the genetics of this dengue vector.
C1 [Chaiphongpachara, Tanawat] Suan Sunandha Rajabhat Univ, Coll Allied Hlth Sci, Dept Publ Hlth & Hlth Promot, Samut Songkhram 75000, Thailand.
   [Laojun, Sedthapong] Suan Sunandha Rajabhat Univ, Coll Allied Hlth Sci, Publ Hlth, Samut Songkhram, Thailand.
RP Chaiphongpachara, T (corresponding author), Suan Sunandha Rajabhat Univ, Coll Allied Hlth Sci, Dept Publ Hlth & Hlth Promot, Samut Songkhram 75000, Thailand.
EM tanawat.ch@ssru.ac.th
FU College of Allied Health Science, Suan Sunandha Rajabhat University,
   Thailand
FX The authors would like to acknowledge the College of Allied Health
   Science, Suan Sunandha Rajabhat University, Thailand, for support of our
   research.
CR Beebe NW, 2020, PARASITOLOGY, V147, P126, DOI [10.1017/S0031182018000859, 10.1017/S0031182018000343]
   Chaiphongpachara T, 2019, J ANIM BEHAV BIOMETE, V7, P25, DOI 10.31893/2318-1265jabb.v7n1p25-30
   Chaiphongpachara T, 2018, J ARTHROPOD-BORNE DI, V12, P351
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Gao B, 2017, COMB CHEM HIGH T SCR, V20, P147, DOI 10.2174/1386207320666170217153548
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hernandez-Triana LM, 2019, ZOOKEYS, P57, DOI 10.3897/zookeys.832.32257
   Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218
   Joyce AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2594-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kress W John, 2012, Methods Mol Biol, V858, P3, DOI 10.1007/978-1-61779-591-6_1
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Rattanarithikul Rampa, 2010, Southeast Asian J Trop Med Public Health, V41 Suppl 1, P1
   Rosero DA, 2012, AM J TROP MED HYG, V87, P910, DOI 10.4269/ajtmh.2012.12-0285
   Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248
   Ruangsittichai J, 2011, INFECT GENET EVOL, V11, P2089, DOI 10.1016/j.meegid.2011.10.002
   Service M, 2008, MED ENTOMOLOGY STUDE, P33
   Sumruayphol S, 2016, ACTA TROP, V159, P1, DOI 10.1016/j.actatropica.2016.03.010
   WHO, 2014, WHO FACTSH VECT BORN
   WHO, 2018, DENG SEV DENG
   Wilson J, 2019, DNA BARCODING BIOINF, V3, P985
NR 23
TC 0
Z9 0
U1 1
U2 1
PU INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK
PI FAISALABAD
PA INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK, FAISALABAD, 00000,
   PAKISTAN
SN 1811-9506
EI 2218-3973
J9 BIOSCI RES
JI Biosci. Res.
PD APR-JUN
PY 2019
VL 16
IS 2
BP 1952
EP 1960
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IM1RW
UT WOS:000477770300116
DA 2020-07-08
ER

PT J
AU Shanmugam, RK
   Ramasamy, V
   Shukla, R
   Arora, U
   Swaminathan, S
   Khanna, N
AF Shanmugam, Rajgokul K.
   Ramasamy, Viswanathan
   Shukla, Rahul
   Arora, Upasana
   Swaminathan, Sathyamangalam
   Khanna, Navin
TI Pichia pastoris-expressed Zika virus envelope domain III on a virus-like
   particle platform: design, production and immunological evaluation
SO PATHOGENS AND DISEASE
LA English
DT Article
DE Zika virus; dengue virus; envelope domain III; antibody-dependent
   enhancement; virus-like particles; Pichia pastoris
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; CROSS-REACTIVITY;
   INFECTION; VACCINES; FETAL; NEUTRALIZATION; REPLICATION; VACCINATION
AB Zika virus (ZIKV) is an arbovirus which shares antigenic similarity and the mosquito vector with dengue viruses (DENVs). ZIKV is a neurotropic virus capable of causing congenital neurodevelopmental birth defects. As ZIKV antibodies (Abs) can potentially enhance infection by DENVs, a preventive ZIKV vaccine must be designed to eliminate antibody dependent enhancement of infection. We developed a Zika Subunit Vaccine (ZSV) consisting of two proteins, ZS and S, in a genetically pre-determined ratio of 1:4, using the methylotrophic yeast Pichia pastoris. ZS is an in-frame fusion of ZIKV envelope domain III with the Hepatitis B virus (HBV) surface antigen, and S is the un-fused HBV surface antigen. Using specific monoclonal Abs we showed the presence of ZS and S in the co-purified material which were found to co-assemble into virus-like particles (VLPs), based on dynamic light scattering and electron microscopic analyses. These VLPs were immunogenic in BALB/c mice, eliciting Abs capable of neutralizing ZIKV reporter virus particles. Further, the VLP-induced Abs did not enhance a sub-lethal DENV-2 challenge in AG129 mice. This important safety feature, coupled to the well-documented advantage of P. pastoris expression system, warrants further exploration of ZSV VLP as a possible vaccine candidate.
C1 [Shanmugam, Rajgokul K.; Ramasamy, Viswanathan; Shukla, Rahul; Arora, Upasana; Swaminathan, Sathyamangalam; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Div Mol Med, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.
   [Khanna, Navin] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad Gurgaon Expressway, Faridabad 121001, India.
   [Arora, Upasana] Sun Pharmaceut Ind Ltd, Vaccine R&D, R&D 3, Gurugram, India.
RP Swaminathan, S; Khanna, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Div Mol Med, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Khanna, N (corresponding author), NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad Gurgaon Expressway, Faridabad 121001, India.
EM swami@icgeb.res.in; navinkhanna5@gmail.com
OI Swaminathan, Sathyamangalam/0000-0002-4388-2248; Shukla,
   Rahul/0000-0002-4320-9512
FU ICGEB, New Delhi; University Grants Commission, Government of
   IndiaUniversity Grants Commission, India
FX This work was supported by intramural funds from ICGEB, New Delhi. RKS
   is supported by the University Grants Commission, Government of India.
   The funders had no role in study design, data collection, data
   interpretation, writing the manuscript or the decision to publish.
CR Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Batra G, 2010, J BIOSCI BIOENG, V110, P408, DOI 10.1016/j.jbiosc.2010.05.001
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gurramkonda C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-13
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khetarpal N, 2017, AM J TROP MED HYG, V96, P126, DOI 10.4269/ajtmh.16-0503
   Khetarpal N, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-15
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Patil A, 2012, J CHROMATOGR B, V898, P7, DOI 10.1016/j.jchromb.2012.03.041
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   The Lancet Infectious Diseases Editorial Board, 2018, LANCET INFECT DIS, V17, P1003
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 2
Z9 2
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2049-632X
J9 PATHOG DIS
JI Pathog. Dis.
PD APR
PY 2019
VL 77
IS 3
AR ftz026
DI 10.1093/femspd/ftz026
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IM5JJ
UT WOS:000478029900005
PM 31093663
OA Bronze
DA 2020-07-08
ER

PT J
AU Michelson, Y
   Lustig, Y
   Avivi, S
   Schwartz, E
   Danielli, A
AF Michelson, Yehudit
   Lustig, Yaniv
   Avivi, Shira
   Schwartz, Eli
   Danielli, Amos
TI Highly Sensitive and Specific Zika Virus Serological Assays Using a
   Magnetic Modulation Biosensing System
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE dengue; magnetic modulation biosensing; NS1; Zika
ID LINKED IMMUNOSORBENT ASSAYS; ANTIBODIES; DIAGNOSIS; IGM
AB Background. Zika virus has created global alarm because it has been associated with catastrophic fetal abnormalities, including microcephaly, spontaneous abortion, and intrauterine growth restriction. Current serological assays that detect antiviral antibodies suffer from low sensitivity and high cross-reactivity among different flaviviruses.
   Methods. In this study, utilizing a novel magnetic modulation biosensing (MMB) system and the Zika nonstructural 1 protein, we show highly sensitive and specific Zika serological assays. We blindly tested 60 reverse-transcription polymerase chain reaction Zika-positive samples and healthy patients' serum samples, as well as 44 serum samples from enzyme-linked immunosorbent assay (ELISA) West Nile-and dengue-positive patients. The Zika-positive samples were collected from Israeli travelers returning from Zika-endemic areas.
   Results. The MMB Zika assays have 88%-97% sensitivity, much higher than the current state-of-the-art EUROIMMUN ELISA assays (38%-74%). In addition, the specificity is 100%, and the cross-reactivity with West Nile and dengue viruses is minimal (0%-4%). Furthermore, the MMB assays detected Zika IgM antibodies as early as 5 days and as late as 180 days postsymptoms onset, significantly extending the number of days that the antibodies are detectable.
   Conclusions. The sensitivity, specificity, and simplicity of the MMB assays may significantly improve Zika diagnosis and provide accurate results for public health agencies.
C1 [Michelson, Yehudit; Avivi, Shira; Danielli, Amos] Bar Ilan Univ, Fac Engn, Ramat Gan, Israel.
   [Lustig, Yaniv] Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.
   [Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med, Tel Hashomer, Israel.
RP Danielli, A (corresponding author), Bar Ilan Univ, Max & Anna Webb St, IL-5290002 Ramat Gan, Israel.
EM amos.danielli@biu.ac.il
FU Israel Science FoundationIsrael Science Foundation [2152/15, 1142/15]
FX This work was funded by Israel Science Foundation Grants 2152/15 and
   1142/15.
CR Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Borysiak MD, 2016, LAB CHIP, V16, P1293, DOI 10.1039/c6lc00015k
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Danielli A, 2008, OPT EXPRESS, V16, P19253, DOI 10.1364/OE.16.019253
   Danielli A, 2009, BIOSENS BIOELECTRON, V25, P858, DOI 10.1016/j.bios.2009.08.047
   Di Gennaro A, 2014, CLIN VACCINE IMMUNOL, V21, P1460, DOI 10.1128/CVI.00426-14
   Granger D, 2016, CLIN VIR S MAY 19 22
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Schmidt-Chanasit J, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.3.20681
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Terato K, 2014, J IMMUNOL METHODS, V407, P15, DOI 10.1016/j.jim.2014.03.013
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Verbarg J, 2017, SENSOR ACTUAT B-CHEM, V241, P614, DOI 10.1016/j.snb.2016.10.089
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 29
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 1
PY 2019
VL 219
IS 7
BP 1035
EP 1043
DI 10.1093/infdis/jiy606
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IF0YZ
UT WOS:000472805600004
PM 30335151
DA 2020-07-08
ER

PT J
AU Zou, J
   Shi, PY
AF Zou, Jing
   Shi, Pei-Yong
TI Strategies for Zika drug discovery
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID VIRUS NS2B-NS3 PROTEASE; SMALL-MOLECULE INHIBITORS; DENGUE VIRUS;
   CRYSTAL-STRUCTURE; ENCEPHALITIS-VIRUS; IN-VITRO; MEMBRANE ASSOCIATION;
   POLYMERASE INHIBITOR; STRUCTURAL INSIGHT; PEPTIDE INHIBITORS
AB Zika virus (ZIKV) can cause devastating congenital syndrome in fetuses from pregnant women and autoimmune disorder Guillain-Barre syndrome in adults. No clinically approved vaccine or drug is currently available for ZIKV. This unmet medical need has motivated a global effort to develop countermeasures. Several promising ZIKV vaccine candidates have already entered clinical trials. In contrast, antiviral development of ZIKV is lagging behind. Here, we review the overall strategies for ZIKV drug discovery, including (i) repurposing of clinically approved drugs, (ii) viral replication based phenotypic screening for inhibitors, and (iii) targeted drug discovery of viral proteins. Along with vaccines, the development of antiviral treatment will provide a complementary means to control ZIKV infections.
C1 [Zou, Jing; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
EM peshi@utmb.edu
FU McLaughlin Endowment at University of Texas Medical Branch; Kleberg
   Foundation Award; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127744, AI136126]
FX J.Z. was awarded with postdoctoral fellowships from the McLaughlin
   Endowment at University of Texas Medical Branch. P.-Y.S. lab was
   supported by a Kleberg Foundation Award and NIH grants AI127744 and
   AI136126.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Alcaraz-Estrada SL, 2010, J GEN VIROL, V91, P2713, DOI 10.1099/vir.0.024083-0
   Amraiz D, 2016, ENZYME MICROB TECH, V92, P26, DOI 10.1016/j.enzmictec.2016.06.010
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barral K, 2013, ANTIVIR RES, V99, P292, DOI 10.1016/j.antiviral.2013.06.001
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elfiky AA, 2018, J MED VIROL, V90, P13, DOI 10.1002/jmv.24934
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gao GF, 2017, J VIROL, V91
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gehrke R, 2005, J GEN VIROL, V86, P1045, DOI 10.1099/vir.0.80677-0
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Graves TL, 2008, ANAL BIOCHEM, V373, P296, DOI 10.1016/j.ab.2007.09.025
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Oehler E, 2014, EURO SURVEILL, V19
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313
   Queiroz Sabrina Ribeiro de Almeida, 2018, Rev. Soc. Bras. Med. Trop., V51, P66, DOI 10.1590/0037-8682-0220-2017
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saxena SK, 2019, TRAVEL MED INFECT DI, V27, P121, DOI 10.1016/j.tmaid.2018.10.022
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Usme-Ciro JA, 2016, INTERVIROLOGY, V59, P275, DOI 10.1159/000476066
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Wyles DL, 2013, J INFECT DIS, V207, pS33, DOI 10.1093/infdis/jis761
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang QY, 2017, ARCH VIROL, V162, P3417, DOI 10.1007/s00705-017-3508-9
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 125
TC 8
Z9 8
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2019
VL 35
BP 19
EP 26
DI 10.1016/j.coviro.2019.01.005
PG 8
WC Virology
SC Virology
GA IE1CT
UT WOS:000472124200004
PM 30852345
DA 2020-07-08
ER

PT J
AU Phan, LT
   Luong, QC
   Do, THH
   Chiu, CH
   Cao, TM
   Nguyen, TTT
   Diep, HT
   Huynh, TP
   Nguyen, DT
   Le, NH
   Otsu, S
   Tran, PD
   Nguyen, TV
   Kato, M
AF Lan Trong Phan
   Quang Chan Luong
   Thi Hong Hien Do
   Chiu, Cindy H.
   Thang Minh Cao
   Thao Thi Thanh Nguyen
   Hai Thanh Diep
   Thao Phuong Huynh
   Dung Tri Nguyen
   Nga Hong Le
   Otsu, Satoko
   Phu Dac Tran
   Thuong Vu Nguyen
   Kato, Masaya
TI Findings and lessons from establishing Zika virus surveillance in
   southern Viet Nam, 2016
SO WESTERN PACIFIC SURVEILLANCE AND RESPONSE
LA English
DT Article
ID INFECTION
AB Objective: To document the evolution and optimization of the Zika virus (ZIKV) disease surveillance system in southern Viet Nam in 2016 and to describe the characteristics of the identified ZIKV-positive cases.
   Methods: We established a sentinel surveillance system to monitor ZIKV transmission in eight sites in eight provinces and expanded the system to 71 sites in 20 provinces in southern Viet Nam in 2016. Blood and urine samples from patients who met the case definition at the sentinel sites were tested for ZIKV using real-time reverse transcription polymerase chain reaction at the Pasteur Institute in Ho Chi Minh City (PI-HCMC). We conducted descriptive analysis and mapped the ZIKV-positive cases.
   Results: In 2016, 2190 specimens from 20 provinces in southern Viet Nam were tested for ZIKV at PI-HCMC; 626 (28.6%), 484 (22.1%), 35 (1.6%) and 1045 (47.7%) tests were conducted in the first, second, third and fourth quarters of the year, respectively. Of these tested specimens, 214 (9.8%) were ZIKV positive with 212 (99.1%) identified in the fourth quarter. In the fourth quarter, the highest positivity rate was those in age groups 30-39 years (30.0%) and 40-59 years (31.6%). Of the 214 ZIKV-positive patients, 210 (98.1%) presented with rash, 194 (90.7%) with fever, 149 (69.6%) with muscle pain, 123 (57.5%) with joint pain and 66 (30.8%) with conjunctivitis.
   Discussion: The surveillance system for ZIKV disease underwent several phases of optimization in 2016, guided by the most up-to-date local data. Here we demonstrate an adaptable surveillance system that detected ZIKV-positive cases in southern Viet Nam.
C1 [Lan Trong Phan; Quang Chan Luong; Thang Minh Cao; Thao Thi Thanh Nguyen; Hai Thanh Diep; Thao Phuong Huynh; Thuong Vu Nguyen] Pasteur Inst, Ho Chi Minh City, Vietnam.
   [Thi Hong Hien Do; Chiu, Cindy H.; Otsu, Satoko] WHO, Viet Nam Country Off, Hanoi, Vietnam.
   [Chiu, Cindy H.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan.
   [Dung Tri Nguyen; Nga Hong Le] Prevent Med Ctr, Ho Chi Minh City, Vietnam.
   [Phu Dac Tran] Minist Hlth, Gen Dept Prevent Med, Hanoi, Vietnam.
   [Kato, Masaya] WHO, Reg Off Western Pacific, Manila, Philippines.
RP Luong, QC (corresponding author), Pasteur Inst, Ho Chi Minh City, Vietnam.
EM lcq33new@gmail.com
FU World Health OrganizationWorld Health Organization; United States
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   United States Agency for International DevelopmentUnited States Agency
   for International Development (USAID)
FX This surveillance activity was funded by the World Health Organization,
   the United States Centers for Disease Control and Prevention and the
   United States Agency for International Development.
CR [Anonymous], 2016, GUID SURV PREV CONTR
   [Anonymous], 2016, GUID DIAGN TREATM ZI
   [Anonymous], 2016, ZIK VIR INF VIET NAM
   [Anonymous], 2018, DENG FACT SHEET
   [Anonymous], 2005, AS PAC STRAT EM DIS
   [Anonymous], 2017, GUID INT CHIK DENG Z
   [Anonymous], 2017, GUID SURV MICR FOET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Lan PT, 2017, PLOS CURR, V9, P9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   WHO, 2017, WHO GUID ETH ISS PUB
NR 20
TC 0
Z9 0
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION, REGIONAL OFFICE WESTERN PACIFIC
PI MANILA
PA PO BOX 2932, MANILA, 1000, PHILIPPINES
SN 2094-7321
EI 2094-7313
J9 WEST PAC SURVEILL RE
JI West. Pa. Surveill. Response
PD APR-JUN
PY 2019
VL 10
IS 2
DI 10.5365/wpsar.2018.9.2.014
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HZ9VI
UT WOS:000469205100004
PM 31720051
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petrova, EV
   Avadhanula, V
   Michel, S
   Gincoo, KE
   Piedra, PA
   Anandasabapathy, S
AF Petrova, Elena, V
   Avadhanula, Vasanthi
   Michel, Sarah
   Gincoo, Karen E.
   Piedra, Pedro A.
   Anandasabapathy, Sharmila
TI Remote Laboratory Management: Respiratory Virus Diagnostics
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Medicine; Issue 146; Deployable; expandable; remote laboratory;
   resource-constrained area; safety requirements; diagnostic test;
   respiratory virus; influenza
ID TIME RT-PCR; VACCINE EFFECTIVENESS; EBOLA; OUTBREAK; EPIDEMIC; DISEASE
AB An uptick in recent pandemics (Ebola, Zika, MERS, influenza, etc.) underlines the need for a more 'nimble,' coordinated response that addresses a multitude of issues ranging from transportation, access, facilities, equipment, and communication to provider training. To address this need, we have developed an innovative, scalable, logistics-enhanced, mobile, laboratory facility for emergencies and epidemics in resource-constrained global settings. Utilizing a background in clinical operations as an academic medical center, we designed a rapidly-deployable, modular BSL-2 and BSL-3 facility with user-friendly software for tracking and management of drugs and supplies in remote regions during epidemics and outbreaks. Here, we present our intermodal, mobile, expandable shipping-container laboratory units. The design of the laboratory facilitates off-grid usage by minimizing power consumption and allowing alternate water sources. The unit's information communication technology (ICT) platform provides (i) user-friendly tablet-based documentation, (ii) enhanced tracking of patients and supplies, and (iii) integrated communication onsite with built-in telehealth capabilities. To ensure quality in remote environments, we have developed a checklist for a basic laboratory workflow and a protocol for respiratory viral diagnosis using reverse-transcription polymerase chain reaction (RT-PCR). As described, this innovative and comprehensive approach allows for the provision of laboratory capability in resource-limited global environments.
C1 [Petrova, Elena, V; Michel, Sarah; Anandasabapathy, Sharmila] Baylor Coll Med, Baylor Global Hlth, Houston, TX 77030 USA.
   [Petrova, Elena, V; Anandasabapathy, Sharmila] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Avadhanula, Vasanthi; Gincoo, Karen E.; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Anandasabapathy, S (corresponding author), Baylor Coll Med, Baylor Global Hlth, Houston, TX 77030 USA.; Anandasabapathy, S (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
EM sharmila.anandasabapathy@bcm.edu
RI , VA/AAO-6566-2020
FU Paul G. Allen Family Foundation "Enhanced Zero-Impact, Emergency Smart
   Pod"
FX The content of this article does not necessarily reflect the views or
   policies of the US Department of Health and Human Services or of the
   institutions affiliated with the authors. This research was supported by
   Paul G. Allen Family Foundation "Enhanced Zero-Impact, Emergency Smart
   Pod". We deeply appreciate all the fruitful discussions and
   collaboration with the colleagues from Baylor College of Medicine, GSS
   Health, NASA's Johnson Space Center. We are sincerely thankful to Thermo
   Fisher Scientifics and its representatives for a loan of the RT-PCR
   machine, centrifuge, and automated pipettes to carry out a respiratory
   virus diagnostic test in the remote laboratory facility. The authors are
   thankful to Marta Storl-Desmond and Sidney Stephen Sorrell for their
   assistance in the manuscript preparation and videography.
CR Aly M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183850
   [Anonymous], 2019, EXP BIC SHELT COMM M
   [Anonymous], 2015, GUIDE US DEP HLTH HU
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Center for Disease Control and Prevention (CDC), 2017, WEBS CLEAN DIS
   Cherpillod P, 2016, J CLIN VIROL, V77, P9, DOI 10.1016/j.jcv.2016.01.017
   Cnops L, 2016, J INFECT DIS, V214, pS192, DOI 10.1093/infdis/jiw150
   Connelly S, 2015, TMC PULSE GLOBA 0304
   Dedkov VG, 2016, J VIROL METHODS, V228, P26, DOI 10.1016/j.jviromet.2015.11.007
   Ducharme J., 2018, TIME
   Fauci A. S, NEW ENGLAND J MED, V374, P601
   Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181
   Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Hersh D, 2015, FEDERAL TIMES   0220
   JoVE Science Education Database, 2018, JOVE
   Keitel Wendy A, 2013, BMC Res Notes, V6, P177, DOI 10.1186/1756-0500-6-177
   Lorenz TC, 2012, JOVE-J VIS EXP, DOI 10.3791/3998
   Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897
   Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10
   Spencer S, 2016, J MED VIROL, V88, P719, DOI 10.1002/jmv.24373
   Waite A, 2018, EMERGENCY SMART PODS
   Wolfel R, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.44.30055
   World Health Organization (WHO), 2006, COLL PRES SHIPP SPEC
   World Health Organization (WHO), 2018, MEDIA CTR DIS O 0318
NR 26
TC 0
Z9 0
U1 4
U2 4
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2019
IS 146
AR e59188
DI 10.3791/59188
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HW2GG
UT WOS:000466500600049
PM 31009009
OA Bronze
DA 2020-07-08
ER

PT J
AU Pawley, DC
   Ricciardi, MJ
   Dikici, E
   Deo, SK
   Daunert, S
AF Pawley, Devon C.
   Ricciardi, Michael J.
   Dikici, Emre
   Deo, Sapna K.
   Daunert, Sylvia
TI Highly Sensitive and Selective Direct Detection of Zika Virus Particles
   in Human Bodily Fluids for Accurate Early Diagnosis of Infection
SO ACS OMEGA
LA English
DT Article
AB Zika virus (ZIKV) is an arbovirus that caused widespread panic beginning in 2015 in northeastern Brazil due to the threatening link between infection and fetal abnormalities such as microcephaly, spontaneous abortions, and stillbirths. Since the epidemic began, the virus has been further investigated, unveiling that the long-term dangers of ZIKV infection go beyond fetal neurological impairment. Characterization of the active infection has proven difficult as only 20% of infected individuals are symptomatic. Additionally, ZIKV is often misdiagnosed due to serological cross-reactivity with similar flaviviruses such as dengue, yellow fever, and West Nile. To date, there is no approved vaccine or therapy against ZIKV, highlighting the urgent need to accurately identify active infection to help minimize the spread of the virus. Herein, we describe a highly specific and sensitive enzyme-linked immunosorbent assay to detect early active ZIKV using neutralizing human monoclonal antibodies isolated from infected patients in Brazil that do not cross-react with dengue viruses 1-4 and bind directly to a ZIKV immunodominant epitope. The calculated limits of detection of active ZIKV fall within the physiological ranges of the virus in human bodily fluids. This selective immunoassay creates the platform required for future translation toward a point-of-care assay for ZIKV, a necessity to diagnose active ZIKV in the remote regions of which it thrives.
C1 [Pawley, Devon C.; Dikici, Emre; Deo, Sapna K.; Daunert, Sylvia] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
   [Ricciardi, Michael J.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Pawley, Devon C.; Dikici, Emre; Deo, Sapna K.; Daunert, Sylvia] Univ Miami, Dr JT Macdonald Fdn, Biomed Nanotechnol Inst, Miami, FL 33136 USA.
   [Daunert, Sylvia] Univ Miami, Clin & Translat Sci Inst, Miami, FL 33136 USA.
RP Daunert, S (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Dr JT Macdonald Fdn, Biomed Nanotechnol Inst, Miami, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Clin & Translat Sci Inst, Miami, FL 33136 USA.
EM sdaunert@med.miami.edu
OI Daunert, Sylvia/0000-0003-4760-5528
FU Florida Department of Health [7ZK01]; NIGMSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM047915,
   R01GM127706]; National Science FoundationNational Science Foundation
   (NSF) [CHE-1506740]
FX This work was financially supported by the Zika Research Grant
   Initiative (7ZK01) from the Florida Department of Health. Inactivated
   Brazilian Fortaleza strain of the Zika virus and the primary anti-ZIKV
   antibodies were kindly provided by Dr David Watkins. The authors would
   like to thank NIGMS (R01GM047915, R01GM127706) and the National Science
   Foundation (CHE-1506740) for funding support. S.D. thanks the Miller
   School of Medicine of the University of Miami for the Lucille P. Markey
   Chair in Biochemistry and Molecular Biology.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179
   de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Barzon L., 2016, EUROSURVEILLANCE, V21
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hsieh HV, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7020029
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Rodo C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.008
   Roze B., 2016, EUROSURVEILLANCE, V21
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   WALKER P, 2018, AM J OBSTET GYNECOL, P45
   Wong R. C., 2009, LATERAL FLOW IMMUNOA, Vxii, P223
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   2016, ANAL CHEM, V88, P7289, DOI DOI 10.1021/ACS.ANALCHEM.6B01632
   2016, BIOSENS BIOELECTRON, V86, P420, DOI DOI 10.1016/J.BIOS.2016.06.085
   2015, EMERG INFECT DIS, V21, P84, DOI DOI 10.3201/EID2101.140894
   2016, EMERG INFECT DIS, V22, P940, DOI DOI 10.3201/EID2205.160107
   2006, J VIROL, V80, P9557, DOI DOI 10.1128/JVI.00080-06
   2016, LANCET INFECT DIS, V16, P405
   2014, AM J TROP MED HYG, V91, P1035, DOI DOI 10.4269/AJTMH.14-0151
   2015, EMERG INFECT DIS, V21, P359, DOI DOI 10.3201/EID2102.141363
   2016, LANCET, V387, P1051, DOI DOI 10.1016/S0140-6736(16)00624-3
   2017, EMERG INFECT DIS, V23, P773, DOI DOI 10.3201/EID2305.161630
   2017, EMERG INFECT DIS, V23, P1577, DOI DOI 10.3201/EID2309.162043
   2016, J ASSIST REPROD GEN, V33, P435, DOI DOI 10.1007/S10815-016-0684-6
   2015, J CLIN VIROL, V68, P53, DOI DOI 10.1016/J.JCV.2015.04.021
   2016, INT UROL NEPHROL, V48, P1961, DOI DOI 10.1007/S11255-016-1406-9
   2018, ADV NEONATAL CARE, V18, P350, DOI DOI 10.1097/ANC.0000000000000557
   2008, J IMMUNOL METHODS, V329, P112, DOI DOI 10.1016/J.JIM.2007.09.017
NR 37
TC 3
Z9 3
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD APR
PY 2019
VL 4
IS 4
BP 6808
EP 6818
DI 10.1021/acsomega.9b00374
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA HW2XD
UT WOS:000466552500080
PM 31058250
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shanmugaraj, B
   Malla, A
   Ramalingam, S
AF Shanmugaraj, Balamurugan
   Malla, Ashwini
   Ramalingam, Sathishkumar
TI Epidemiology, clinical features and transmission of re-emerging
   arboviral infection chikungunya
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
ID VIRUS-INFECTION; VACCINE
AB A number of re-emerging and emerging infectious diseases including chikungunya, West Nile, yellow fever, Zika, dengue, Japanese encephalitis, and others have increased in recent years, which threaten the public health across the globe. Chikungunya is a neglected re-emerging arboviral infection caused by chikungunya virus. Arboviral infections such as chikungunya, Zika and dengue have similar epidemiology, transmission cycles and clinical symptoms, which makes it difficult to diagnose these three infections. Moreover, there is no commercial vaccine or licensed therapy available for chikungunya infection, thus causing severe burden worldwide. Vector control may reduce the disease risk; however, this remains a challenge due to many factors including, but not limited to, evolution of insecticide resistance in mosquitoes, gaps in vector control tools, urbanization, environmental and demographic changes. Effective integrated vector control strategies and surveillance measures along with affordable vaccine development or anti-viral therapy are essential to control the infection. In this review, we discuss the epidemiology of mosquito-borne infection chikungunya which has re-emerged as an international concern in recent decades.
C1 [Shanmugaraj, Balamurugan; Malla, Ashwini; Ramalingam, Sathishkumar] Bharathiar Univ, Dept Biotechnol, Plant Genet Engn Lab, Coimbatore, Tamil Nadu, India.
   [Shanmugaraj, Balamurugan; Malla, Ashwini] Bharat Biotech Int Ltd, Hyderabad, India.
RP Ramalingam, S (corresponding author), Bharathiar Univ, Dept Biotechnol, Plant Genet Engn Lab, Coimbatore, Tamil Nadu, India.
EM rsathish@buc.edu.in
OI , Sathishkumar/0000-0002-3145-7324
FU Department of Biotechnology, Bharathiar University, Coimbatore, Tamil
   Nadu, India through DST-FIST; Department of Biotechnology, Bharathiar
   University, Coimbatore, Tamil Nadu, India through UGC-SAP; Department of
   Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India
   through UKIERI
FX This work is supported by the Department of Biotechnology, Bharathiar
   University, Coimbatore, Tamil Nadu, India through DST-FIST, UGC-SAP and
   UKIERI.
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Bartholomeeusen K, 2018, J VIROL, V92, DOI [10.1128/JVI.00152-18, 10.1128/jvi.00152-18]
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brown R. S, 2018, VIRUSES, V10, pE89
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Druce JD, 2007, EMERG INFECT DIS, V13, P509, DOI 10.3201/eid1303.060761
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Lim EXY, 2018, VIRUSES, V10, pE84
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Mudur Ganapati, 2006, BMJ, V333, P773, DOI 10.1136/bmj.333.7572.773-c
   Murali KS, 2015, ASIAN PAC J TROP MED, V8, P352, DOI 10.1016/S1995-7645(14)60343-6
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shanmugaraj BM, 2017, VECTOR BORNE DIS TRE, P1
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Singh A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23969-0
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Wagner JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094401
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   2015, J CLIN VIROL, V64, P144, DOI DOI 10.1016/J.JCV.2014.08.032
   AM J TROP MED HYG, V62, P681
   2008, AM J TROP MED HYG, V78, P212
   2008, J BIOSCIENCE, V33, P443, DOI DOI 10.1007/S12038-008-0063-2
   2009, VIROLOGY, V393, P183, DOI DOI 10.1016/J.VIROL.2009.07.024
   2014, J VIROL, V88, P2858, DOI DOI 10.1128/JVI.03453-13
   2014, LANCET, V384, P2046, DOI DOI 10.1016/S0140-6736(14)61185-5
   2016, BRAZ J MICROBIOL SUP, V47, P38, DOI DOI 10.1016/J.BJM.2016.10.008
   2013, ANTIVIR RES, V99, P345, DOI DOI 10.1016/J.ANTIVIRAL.2013.06.009
   2018, ARTHRITIS CARE RES H, V70, P1501, DOI DOI 10.1002/ACR.23519
   2015, LANCET INFECT DIS, V15, P519, DOI DOI 10.1016/S1473-3099(15)70043-5
NR 53
TC 2
Z9 2
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD APR
PY 2019
VL 9
IS 4
BP 135
EP 139
DI 10.4103/2221-1691.256726
PG 5
WC Tropical Medicine
SC Tropical Medicine
GA HV6WI
UT WOS:000466123100001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Holloway, EM
   Capeling, MM
   Spence, JR
AF Holloway, Emily M.
   Capeling, Meghan M.
   Spence, Jason R.
TI Biologically inspired approaches to enhance human organoid complexity
SO DEVELOPMENT
LA English
DT Review
DE Human development; Organoids; Stem cells
ID PLURIPOTENT STEM-CELLS; ENTERIC NERVOUS-SYSTEM; HEPATOCYTE-LIKE CELLS;
   MICROGLIA-LIKE CELLS; LONG-TERM EXPANSION; IN-VIVO MODEL; ZIKA VIRUS;
   SELF-ORGANIZATION; KIDNEY ORGANOIDS; FUNCTIONAL HEPATOCYTES
AB Organoids are complex three-dimensional in vitro organ-like model systems. Human organoids, which are derived from human pluripotent stem cells or primary human donor tissue, have been used to address fundamental questions about human development, stem cell biology and organ regeneration. Focus has now shifted towards implementation of organoids for biological discovery and advancing existing systems to more faithfully recapitulate the native organ. This work has highlighted significant unknowns in human biology and has invigorated new exploration into the cellular makeup of human organs during development and in the adult - work that is crucial for providing appropriate benchmarks for organoid systems. In this Review, we discuss efforts to characterize human organ cellular complexity and attempts to make organoid models more realistic through co-culture, transplantation and bioengineering approaches.
C1 [Holloway, Emily M.; Spence, Jason R.] Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.
   [Capeling, Meghan M.; Spence, Jason R.] Univ Michigan, Dept Biomed Engn, Coll Engn, Ann Arbor, MI 48109 USA.
   [Spence, Jason R.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.
   [Spence, Jason R.] Univ Michigan, Ctr Organogenesis, Med Sch, Ann Arbor, MI 48109 USA.
RP Spence, JR (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.; Spence, JR (corresponding author), Univ Michigan, Dept Biomed Engn, Coll Engn, Ann Arbor, MI 48109 USA.; Spence, JR (corresponding author), Univ Michigan, Div Gastroenterol, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.; Spence, JR (corresponding author), Univ Michigan, Ctr Organogenesis, Med Sch, Ann Arbor, MI 48109 USA.
EM spencejr@umich.edu
OI Holloway, Courtney Jean/0000-0003-3661-1957
FU Intestinal Stem Cell Consortium [U01DK103141]; National Institute of
   Diabetes and Digestive and Kidney Diseases (NIDDK)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK); National Institute of Allergy and Infectious Diseases
   (NIAID)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI116482]; NIAID Novel, Alternative
   Model Systems for Enteric Diseases (NAMSED) consortium [U19AI116482];
   National Heart, Lung and Blood Institute (NHLBI)United States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL119215]; University
   of Michigan Training in Basic and Translational Digestive Sciences;
   NIDDKUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [NIDDK DK094775]; University of
   Michigan Cellular and Biotechnology Training Program; National Institute
   of General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [NIGMS GM008353]
FX This work was supported by the Intestinal Stem Cell Consortium
   (U01DK103141), a collaborative research project funded by the National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the
   National Institute of Allergy and Infectious Diseases (NIAID) to J.R.S.;
   by the NIAID Novel, Alternative Model Systems for Enteric Diseases
   (NAMSED) consortium (U19AI116482) to J.R.S.; by the National Heart, Lung
   and Blood Institute (NHLBI) (R01HL119215) to J. R. S.; by the University
   of Michigan Training in Basic and Translational Digestive Sciences,
   funded by the NIDDK (NIDDK DK094775) to E. M. H., and the University of
   Michigan Cellular and Biotechnology Training Program, funded by the
   National Institute of General Medical Sciences (NIGMS GM008353) to M. M.
   C. and E. M. H. Deposited in PMC for release after 12 months.
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102
   Arora N, 2017, DEVELOPMENT, V144, P1128, DOI 10.1242/dev.142919
   Asai A, 2017, DEVELOPMENT, V144, P1056, DOI 10.1242/dev.142794
   Aurora M, 2016, DEV BIOL, V420, P230, DOI 10.1016/j.ydbio.2016.06.006
   Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Bertaux-Skeirik N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004663
   Boccellato F., 2018, GUT, V68, P400
   Broguiere N, 2018, ADV MATER, V30, DOI 10.1002/adma.201801621
   Burns AJ, 2005, INT J DEV BIOL, V49, P143, DOI 10.1387/ijdb.041935ab
   Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582
   Camp J. G., 2015, P NATL ACAD SCI USA, V112
   Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796
   Camp JG, 2017, DEVELOPMENT, V144, P1584, DOI 10.1242/dev.150458
   Capeling MM, 2019, STEM CELL REP, V12, P381, DOI 10.1016/j.stemcr.2018.12.001
   Carpentier A, 2014, J CLIN INVEST, V124, P4953, DOI 10.1172/JCI75456
   Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510
   Combes AN, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0615-0
   Cortez AR, 2018, SURGERY, V164, P643, DOI 10.1016/j.surg.2018.04.048
   Cruz-Acuna R, 2017, NAT CELL BIOL, V19, P1326, DOI 10.1038/ncb3632
   Czerniecki SM, 2018, CELL STEM CELL, V22, P929, DOI 10.1016/j.stem.2018.04.022
   Czerwinski M, 2017, CELL STEM CELL, V20, P9, DOI 10.1016/j.stem.2016.12.010
   Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948
   Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201
   Demehri FR, 2015, SURGERY, V158, P802, DOI 10.1016/j.surg.2015.03.055
   Demehri FR, 2014, PEDIATR SURG INT, V30, P1223, DOI 10.1007/s00383-014-3612-9
   Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009
   Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291
   Dye BR, 2016, ELIFE, V5, DOI 10.7554/eLife.19732
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951
   Finkbeiner SR, 2015, BIOL OPEN, V4, P1462, DOI 10.1242/bio.013235
   Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010
   Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12
   Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398
   Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715
   Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerrard DT, 2016, ELIFE, V5, DOI 10.7554/eLife.15657
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Gjorevski N, 2016, NATURE, V539, P359, DOI 10.1038/nature20168
   Hannoun Z, 2016, J HEPATOL, V65, P182, DOI 10.1016/j.jhep.2016.02.025
   Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117
   Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379
   Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8
   Hill DR, 2017, JOVE-J VIS EXP, DOI 10.3791/56960
   Hill DR, 2017, ELIFE, V6, DOI 10.7554/eLife.29132
   Hlavaty KA, 2014, AM J TRANSPLANT, V14, P1523, DOI 10.1111/ajt.12742
   Hoang P, 2018, NAT PROTOC, V13, P723, DOI 10.1038/nprot.2018.006
   Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111
   Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013
   Huch M, 2017, DEVELOPMENT, V144, P938, DOI 10.1242/dev.150201
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067
   Koehler KR, 2017, NAT BIOTECHNOL, V35, P583, DOI 10.1038/nbt.3840
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Konishi S, 2016, STEM CELL REP, V6, P18, DOI 10.1016/j.stemcr.2015.11.010
   Kozuka K, 2017, STEM CELL REP, V9, P1976, DOI 10.1016/j.stemcr.2017.10.013
   Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105
   La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14
   Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007
   Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889
   McCauley KB, 2017, CELL STEM CELL, V20, P844, DOI 10.1016/j.stem.2017.03.001
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Mead BE, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0527-2
   Menon R, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164038
   Miller AJ, 2019, NAT PROTOC, V14, P518, DOI 10.1038/s41596-018-0104-8
   Miller AJ, 2018, STEM CELL REP, V10, P101, DOI 10.1016/j.stemcr.2017.11.012
   Muffat J., 2018, P NATL ACAD SCI USA, V388
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Munera JO, 2017, CELL STEM CELL, V21, P51, DOI 10.1016/j.stem.2017.05.020
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021
   Nikolic MZ, 2017, ELIFE, V6, DOI [10.7554/eLife.26575.001, 10.7554/eLife.26575]
   Noel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45270
   Okumura R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.20
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Rajan A, 2018, MBIO, V9, DOI 10.1128/mBio.02419-17
   Ralls MW, 2013, PEDIATR SURG INT, V29, P151, DOI 10.1007/s00383-012-3198-z
   Ranga A, 2016, P NATL ACAD SCI USA, V113, pE6831, DOI 10.1073/pnas.1603529113
   Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041
   Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106
   Ronaldson-Bouchard K, 2018, CELL STEM CELL, V22, P310, DOI 10.1016/j.stem.2018.02.011
   Rouch JD, 2016, J PEDIATR SURG, V51, P1988, DOI 10.1016/j.jpedsurg.2016.09.023
   Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a
   Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300
   Sachs N, 2017, DEVELOPMENT, V144, P1107, DOI 10.1242/dev.143933
   Sampaziotis F, 2017, NAT MED, V23, P954, DOI 10.1038/nm.4360
   Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277
   Saxena K, 2017, P NATL ACAD SCI USA, V114, pE570, DOI 10.1073/pnas.1615422114
   Schlieve CR, 2017, STEM CELL REP, V9, P883, DOI 10.1016/j.stemcr.2017.07.017
   Senger S, 2018, CELL MOL GASTROENTER, V5, P549, DOI 10.1016/j.jcmgh.2018.01.014
   Shahbazi M. N., 2017, NATURE, V156, P1032
   Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w
   Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041
   Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7
   Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107
   Spence JR, 2018, CELL MOL GASTROENTER, V5, P159, DOI 10.1016/j.jcmgh.2017.11.003
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Stark R, 2012, J PEDIATR SURG, V47, P136, DOI 10.1016/j.jpedsurg.2011.10.031
   Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x
   Sueyoshi R, 2014, TISSUE ENG PT A, V20, P830, DOI 10.1089/ten.TEA.2013.0383
   Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012
   Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335
   Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takasato M, 2016, NAT PROTOC, V11, P1681, DOI 10.1038/nprot.2016.098
   Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695
   Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029
   Takebe T, 2017, CELL REP, V21, P2661, DOI 10.1016/j.celrep.2017.11.005
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thorne CA, 2018, DEV CELL, V44, P624, DOI 10.1016/j.devcel.2018.01.024
   Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506
   Trisno SL, 2018, CELL STEM CELL, V23, P501, DOI 10.1016/j.stem.2018.08.008
   Tsai YH, 2017, DEVELOPMENT, V144, P1045, DOI 10.1242/dev.138453
   van den Berg CW, 2018, STEM CELL REP, V10, P751, DOI 10.1016/j.stemcr.2018.01.041
   Vatanen T., 2018, NAT MICROBIOL, V171, P1481
   Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109
   Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484
   Wang YL, 2018, CELL MOL GASTROENTER, V5, P113, DOI 10.1016/j.jcmgh.2017.10.007
   Wang YL, 2017, BIOMATERIALS, V128, P44, DOI 10.1016/j.biomaterials.2017.03.005
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737
   Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386
   Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233
   Yui S, 2018, CELL STEM CELL, V22, P35, DOI 10.1016/j.stem.2017.11.001
   Zhang BY, 2018, NAT REV MATER, V3, P257, DOI 10.1038/s41578-018-0034-7
   Zhang YC, 2018, CELL STEM CELL, V23, P516, DOI 10.1016/j.stem.2018.08.009
   Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980
   2015, J CLIN INVEST, V125, P782, DOI DOI 10.1172/JCI78361
   2015, CELL HOST MICROBE, V17, P690, DOI DOI 10.1016/J.CHOM.2015.04.004
NR 157
TC 10
Z9 10
U1 3
U2 7
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR
PY 2019
VL 146
IS 8
AR UNSP dev166173
DI 10.1242/dev.166173
PG 13
WC Developmental Biology
SC Developmental Biology
GA HX9XO
UT WOS:000467762400004
PM 30992275
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Qian, XY
   Song, HJ
   Ming, GL
AF Qian, Xuyu
   Song, Hongjun
   Ming, Guo-li
TI Brain organoids: advances, applications and challenges
SO DEVELOPMENT
LA English
DT Review
DE Brain organoids; Neuroscience; Stem cell
ID PLURIPOTENT STEM-CELLS; HUMAN CEREBRAL-CORTEX; ZIKA VIRUS-INFECTION;
   CORTICAL DEVELOPMENT; SELF-ORGANIZATION; RADIAL GLIA; IN-VITRO; NEURAL
   PROGENITORS; GABAERGIC NEURONS; NEOCORTEX
AB Brain organoids are self-assembled three-dimensional aggregates generated from pluripotent stem cells with cell types and cytoarchitectures that resemble the embryonic human brain. As such, they have emerged as novel model systems that can be used to investigate human brain development and disorders. Although brain organoids mimic many key features of early human brain development at molecular, cellular, structural and functional levels, some aspects of brain development, such as the formation of distinct cortical neuronal layers, gyrification, and the establishment of complex neuronal circuitry, are not fully recapitulated. Here, we summarize recent advances in the development of brain organoid methodologies and discuss their applications in disease modeling. In addition, we compare current organoid systems to the embryonic human brain, highlighting features that currently can and cannot be recapitulated, and discuss perspectives for advancing current brain organoid technologies to expand their applications.
C1 [Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.
   [Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
RP Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
EM gming@pennmedicine.upenn.edu
RI ; Qian, Xuyu/C-1240-2017
OI Ming, Guo-li/0000-0002-2517-6075; Qian, Xuyu/0000-0001-5944-3816
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R37NS047344,
   P01NS097206, U19MH106434, R01MH105128, R35NS097370, U19AI131130]; Simons
   Foundation [575050]; Dr Miriam and Sheldon G. Adelson Medical Research
   Foundation
FX The research in the authors' laboratories was supported by grants from
   the National Institutes of Health (R37NS047344, P01NS097206, U19MH106434
   to H.S. and R01MH105128, R35NS097370, U19AI131130 to G.M.), The Simons
   Foundation (575050 to H.S.) and The Dr Miriam and Sheldon G. Adelson
   Medical Research Foundation (to G. M.). Deposited in PMC for release
   after 12 months.
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474
   Arber C, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0268-4
   Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Bayly PV, 2014, J MECH BEHAV BIOMED, V29, P568, DOI 10.1016/j.jmbbm.2013.02.018
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408
   Borrell V, 2018, J NEUROSCI, V38, P776, DOI 10.1523/JNEUROSCI.1106-17.2017
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Caronia-Brown G, 2014, DEVELOPMENT, V141, P2855, DOI 10.1242/dev.106914
   Chambers D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-202
   Chen HI, 2019, DEV DYNAM, V248, P53, DOI 10.1002/dvdy.24662
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Choi H, 2017, MOL NEUROBIOL, V54, P7789, DOI 10.1007/s12035-016-0274-8
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011
   De Clercq S, 2018, CEREB CORTEX, V28, P493, DOI 10.1093/cercor/bhw384
   del Toro D, 2017, CELL, V169, P621, DOI 10.1016/j.cell.2017.04.012
   Ding SL, 2017, J COMP NEUROL, V525, P407, DOI 10.1002/cne.24130
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Elsen GE, 2013, P NATL ACAD SCI USA, V110, P4081, DOI 10.1073/pnas.1209076110
   Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gjorevski N, 2016, NATURE, V539, P359, DOI 10.1038/nature20168
   Gonzalez C, 2018, MOL PSYCHIATR, V23, P2363, DOI 10.1038/s41380-018-0229-8
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Ip BK, 2011, CEREB CORTEX, V21, P1395, DOI 10.1093/cercor/bhq219
   Jabaudon D, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.172049
   Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245
   Jeong H, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00031
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Jorfi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20436-8
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kronenberg ZN, 2018, SCIENCE, V360, P1085, DOI 10.1126/science.aar6343
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779
   Lewitus E, 2016, SCIENCE, V351, DOI 10.1126/science.aad2029
   Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Meinhardt A, 2014, STEM CELL REP, V3, P987, DOI 10.1016/j.stemcr.2014.09.020
   Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683
   Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594
   Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   Nzou G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25603-5
   O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Ozair MZ, 2018, CELL STEM CELL, V23, P60, DOI 10.1016/j.stem.2018.05.024
   Ozone C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10351
   Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P362, DOI 10.14573/altex.1609122
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Phan DTT, 2017, EXP BIOL MED, V242, P1669, DOI 10.1177/1535370217694100
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Radonjic NV, 2014, CELL REP, V9, P2139, DOI 10.1016/j.celrep.2014.11.026
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Rajamani U, 2018, CELL STEM CELL, V22, P698, DOI 10.1016/j.stem.2018.03.009
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007
   Rambani K, 2009, J NEUROSCI METH, V180, P243, DOI 10.1016/j.jneumeth.2009.03.016
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992
   Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036
   Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027
   Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491
   Studer L, 2015, CELL STEM CELL, V16, P591, DOI 10.1016/j.stem.2015.05.004
   Subramanian L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14167
   Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070
   Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Vera E, 2016, CELL REP, V17, P1184, DOI 10.1016/j.celrep.2016.09.062
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xiao B, 2016, J NEUROL NEUROSUR PS, V87, P697, DOI 10.1136/jnnp-2015-312036
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye F, 2017, NEURON, V96, P1041, DOI 10.1016/j.neuron.2017.10.010
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0
   Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011
   Zembrzycki A, 2015, P NATL ACAD SCI USA, V112, P6736, DOI 10.1073/pnas.1424440112
   Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006
   2017, NAT CELL BIOL, V19, P1326, DOI DOI 10.1038/NCB3632
NR 133
TC 31
Z9 29
U1 8
U2 20
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR
PY 2019
VL 146
IS 8
AR UNSP dev166074
DI 10.1242/dev.166074
PG 12
WC Developmental Biology
SC Developmental Biology
GA HX9XO
UT WOS:000467762400003
PM 30992274
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Yang, CP
   Gong, R
   de Val, N
AF Yang, Chunpeng
   Gong, Rui
   de Val, Natalia
TI Development of Neutralizing Antibodies against Zika Virus Based on Its
   Envelope Protein Structure
SO VIROLOGICA SINICA
LA English
DT Review
DE Zika virus (ZIKV); Envelope protein; Neutralizing antibody; X-ray
   crystallography; Cryo-electron microscopy (cryo-EM)
ID FLAVIVIRUS; POTENT
AB As we know more about Zika virus (ZIKV), as well as its linkage to birth defects (microcephaly) and autoimmune neurological syndromes, we realize the importance of developing an efficient vaccine against it. Zika virus disease has affected many countries and is becoming a major public health concern. To deal with the infection of ZIKV, plenty of experiments have been done on selection of neutralizing antibodies that can target the envelope (E) protein on the surface of the virion. However, the existence of antibody-dependent enhancement (ADE) effect might limit the use of them as therapeutic candidates. In this review, we classify the neutralizing antibodies against ZIKV based on the epitopes and summarize the resolved structural information on antibody/antigen complex from X-ray crystallography and cryo-electron microscopy (cryo-EM), which might be useful for further development of potent neutralizing antibodies and vaccines toward clinical use.
C1 [Yang, Chunpeng; Gong, Rui] Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Yang, Chunpeng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [de Val, Natalia] NCI, Ctr Mol Microscopy, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [de Val, Natalia] Leidos Biomedical Res Inc, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
RP Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.; de Val, N (corresponding author), NCI, Ctr Mol Microscopy, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
EM gongr@wh.iov.cn; devalaldan2@mail.nih.gov
RI de Val, Natalia/AAF-4822-2019
OI DE VAL ALDA, Natalia/0000-0002-1506-2023; gong, rui/0000-0001-9222-5642
FU Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging
   Infectious Diseases and Biosafety; Wuhan National Bio-Safety Level 4 Lab
   of the Chinese Academy of Sciences; External Cooperation Program of
   Chinese Academy of SciencesChinese Academy of Sciences
   [153211KYSB20160001]; National Key Research and Development Program of
   China [2016YFC1202902]; Key Program of Chinese Academy of
   SciencesChinese Academy of Sciences [ZDRW-ZS-2016-4]; FNLCR
   [HHSN261200800001E]
FX We are thankful to The Core Facility and Technical Support, Wuhan
   Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of
   Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and
   Biosafety; as well as Wuhan National Bio-Safety Level 4 Lab of the
   Chinese Academy of Sciences for the supports. This work was funded by
   the External Cooperation Program of Chinese Academy of Sciences (Grant
   No. 153211KYSB20160001), the National Key Research and Development
   Program of China (Grant No. 2016YFC1202902), and the Key Program of
   Chinese Academy of Sciences (Grant No. ZDRW-ZS-2016-4). The EM part of
   the work was funded by FNLCR Contract HHSN261200800001E.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DELLAPORTA AJ, 1978, J GEN VIROL, V38, P1, DOI 10.1099/0022-1317-38-1-1
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Harrison SC, 2008, J CELL BIOL, V183, P177, DOI 10.1083/jcb.200809175
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Li M, 2017, SCI CHINA LIFE SCI, V60, P1396, DOI 10.1007/s11427-017-9192-0
   Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 31
TC 4
Z9 4
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2019
VL 34
IS 2
SI SI
BP 168
EP 174
DI 10.1007/s12250-019-00093-5
PG 7
WC Virology
SC Virology
GA HY4SR
UT WOS:000468118700005
PM 31020573
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Machi, AR
   Mayne, RR
   Gava, MA
   Arthur, PB
   Arthur, V
AF Machi, Andre Ricardo
   Mayne, Raquel Rodrigues
   Gava, Marcio Adriani
   Arthur, Paula Bergamin
   Arthur, Valter
TI Gamma Radiation Sterilization Dose of Adult Males in Asian Tiger
   Mosquito Pupae
SO INSECTS
LA English
DT Article
DE Aedes albopictus; ionizing radiation; pupae; mosquitoes; sterile
ID AEDES-ALBOPICTUS; MATING COMPETITIVENESS; RADIOSTERILIZED MALES;
   AEGYPTI; POPULATION; VECTORS; INSECTS; RELEASE; LEVEL
AB The pathogen-carrying tiger mosquito, Aedes albopictus, has spread from the Western Pacific and Southeast Asia to Europe, Africa, the Middle East, North and South America, and the Caribbean. This species of mosquito transmits arboviral infections, such as yellow fever, chikungunya, dengue, zika, and several encephalitides. The objective of this research was to provide a radiation dose inducing sterilization in adult male Ae. albopictus in the pupal stage. A cobalt-60 source of gamma radiation at a dose rate of 381 Gy/h was used. The pupae were irradiated with doses of 0 (control), 20, 30, 40, 50, and 60 Gy. Each treatment had a total of five replications using 60 pupae. After irradiation, the different phases of Ae. albopictus development (egg, larva, pupa, and adult) in the F1 generation were observed daily. Parameters such as viability, fertility, longevity, and mortality were recorded. The results from these studies showed that a dose of 60 Gy was necessary to sterilize 100% of the male Ae. albopictus pupae.
C1 [Machi, Andre Ricardo; Arthur, Paula Bergamin; Arthur, Valter] Univ Sao Paulo, Inst Nucl Energy Res IPEN, Dept Irradiat Technol Ctr CTR, BR-05508000 Sao Paulo, SP, Brazil.
   [Mayne, Raquel Rodrigues; Arthur, Valter] Univ Sao Paulo, Dept Radiobiol & Environm, Ctr Nucl Energy Agr CENA, BR-13400970 Piracicaba, SP, Brazil.
   [Gava, Marcio Adriani] AEB Sitio Santa Isabel, 95 Km Rd, BR-13515000 Charqueada, SP, Brazil.
RP Machi, AR (corresponding author), Univ Sao Paulo, Inst Nucl Energy Res IPEN, Dept Irradiat Technol Ctr CTR, BR-05508000 Sao Paulo, SP, Brazil.
EM rica_machi@hotmail.com; raquel.mayne@hotmail.com;
   marciogava@asrlaboratorio.com.br; paula.bergamin@hotmail.com;
   arthur@cena.usp.br
RI Arthur, Valter/Y-1861-2019
OI Machi, Andre/0000-0002-4439-7121
FU University of SAo Paulo
FX We would like to thank the authors, interns, and University of SAo Paulo
   for their support.
CR ABDELMALEK AA, 1966, J ECON ENTOMOL, V59, P672, DOI 10.1093/jee/59.3.672
   Adhami B.J., 1987, B U SHTET TIRANES SE, V1, P13
   Arthur V., 2012, CONTROLE DO AEDES
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   De Barro PJ, 2011, J VERBRAUCH LEBENSM, V6, P33, DOI 10.1007/s00003-011-0671-x
   de Castro MG, 2004, MEM I OSWALDO CRUZ, V99, P809, DOI 10.1590/S0074-02762004000800005
   ECONOMOPOULOS A P, 1972, Environmental Entomology, V1, P490, DOI 10.1093/ee/1.4.490
   Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6
   Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075
   Chaves LF, 2015, B INSECTOL, V68, P61
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   HALLINAN E, 1973, NATURE, V244, P368, DOI 10.1038/244368a0
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2
   Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41
   KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421
   Knipling EF, 1979, BASIC PRINCIPLES INS
   Lee Shae-Jinn, 1994, Chinese Journal of Entomology, V14, P13
   Lemos S.G., 2017, THESIS
   LIMA Karla Dias, 2015, THESIS
   LORIMER N, 1976, J ECON ENTOMOL, V69, P405, DOI 10.1093/jee/69.3.405
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   PAL R, 1974, ANNU REV ENTOMOL, V19, P269, DOI 10.1146/annurev.en.19.010174.001413
   Pan American Health Organization (PAHO), 2014, TECHN NOT TRANSG MOS
   PATTERSON RS, 1977, J MED ENTOMOL, V14, P299, DOI 10.1093/jmedent/14.3.299
   PATTERSON RS, 1975, MOSQ NEWS, V35, P1
   PROVERBS MD, 1969, ANNU REV ENTOMOL, V14, P81, DOI 10.1146/annurev.en.14.010169.000501
   R Development Core Team, 2013, R LANG ENV STAT COMP
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Sun W, 2013, J INFECT DIS, V207, P700, DOI 10.1093/infdis/jis744
   Valderrama A, 2016, REV MED PANAMA, V36, P30
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WEIDHAAS D. E., 1963, Mosquito News, V23, P32
   WEIDHAAS DONALD E., 1962, MOSQUITO NEWS, V22, P283
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   Yamada H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-318
NR 52
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD APR
PY 2019
VL 10
IS 4
AR 101
DI 10.3390/insects10040101
PG 11
WC Entomology
SC Entomology
GA HX3RL
UT WOS:000467309800018
PM 30965594
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Barros, ACWG
   Santos, KG
   Massad, E
   Coelho, FC
AF de Barros, Ana Carolina W. G.
   Santos, Kaline G.
   Massad, Eduardo
   Coelho, Flavio Codeco
TI Sex-Specific Asymmetrical Attack Rates in Combined Sexual-Vectorial
   Transmission Epidemics
SO MICROORGANISMS
LA English
DT Article
DE epidemiology; R-0; vector-borne disease; sexually-transmitted disease
ID ZIKA VIRUS OUTBREAK; REPRODUCTION NUMBER; MATHEMATICAL-MODELS; HISTORY;
   MEN
AB In 2015-2016, South America went through the largest Zika epidemic in recorded history. One important aspect of this epidemic was the importance of sexual transmission in combination with the usual vectorial transmission, with asymmetrical transmissibilities between sexual partners depending on the type of sexual contact; this asymmetry manifested itself in data as an increased risk to women. We propose a mathematical model for the transmission of the Zika virus including sexual transmission via all forms of sexual contact, as well as vector transmission, assuming a constant availability of mosquitoes. From this model, we derive an expression for <mml:semantics>R0</mml:semantics>, which is used to study and analyze the relative contributions of the male to female sexual transmission route vis-a-vis vectorial transmission. We also perform Bayesian inference of the model's parameters using data from the 2016 Zika epidemic in Rio de Janeiro.
C1 [de Barros, Ana Carolina W. G.; Santos, Kaline G.; Massad, Eduardo; Coelho, Flavio Codeco] Fundacao Getulio Vargas, Escola Matemat Aplicada, BR-22250900 Rio De Janeiro, Brazil.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Escola Matemat Aplicada, BR-22250900 Rio De Janeiro, Brazil.
EM acwgdb@gmail.com; kaline96.st@gmail.com; eduardo.massad@fgv.br;
   fccoelho@fgv.br
RI Coelho, Flavio/L-1089-2018
OI Coelho, Flavio/0000-0003-3868-4391; Gomes Santos,
   Kaline/0000-0002-4697-9328
FU projectZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]
FX This work has been partially supported by the he projectZikaPLAN, funded
   by the European Union's Horizon 2020 research and innovation programme
   under Grant Agreement No. 734584, which funded the APC.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   ANDERSON R M, 1991
   Anderson RM, 2000, SEX TRANSM DIS, V27, P636, DOI 10.1097/00007435-200011000-00012
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bastos MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205001
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616
   dos Santos BMC, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00038218, 10.1590/0102-311X00038218]
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7
   Hess KL, 2017, AIDS BEHAV, V21, P2811, DOI 10.1007/s10461-017-1799-1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Isea Raul, 2016, AM J MODERN PHYS APP, V3, P11
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD APR
PY 2019
VL 7
IS 4
DI 10.3390/microorganisms7040112
PG 14
WC Microbiology
SC Microbiology
GA HX3JN
UT WOS:000467288300020
PM 31027271
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Churakov, M
   Villabona-Arenas, CJ
   Kraemer, MUG
   Salje, H
   Cauchemez, S
AF Churakov, Mikhail
   Villabona-Arenas, Christian J.
   Kraemer, Moritz U. G.
   Salje, Henrik
   Cauchemez, Simon
TI Spatio-temporal dynamics of dengue in Brazil: Seasonal travelling waves
   and determinants of regional synchrony
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SPATIAL HIERARCHIES; HEMORRHAGIC-FEVER; ZIKA VIRUS; TRANSMISSION;
   COUNTRIES; EPIDEMICS; SPREAD; BURDEN
AB Dengue continues to be the most important vector-borne viral disease globally and in Brazil, where more than 1.4 million cases and over 500 deaths were reported in 2016. Mosquito control programmes and other interventions have not stopped the alarming trend of increasingly large epidemics in the past few years. Here, we analyzed monthly dengue cases reported in Brazil between 2001 and 2016 to better characterise the key drivers of dengue epidemics. Spatio-temporal analysis revealed recurring travelling waves of disease occurrence. Using wavelet methods, we characterised the average seasonal pattern of dengue in Brazil, which starts in the western states of Acre and Rondonia, then travels eastward to the coast before reaching the northeast of the country. Only two states in the north of Brazil (Roraima and Amapa) did not follow the countrywide pattern and had inconsistent timing of dengue epidemics throughout the study period. We also explored epidemic synchrony and timing of annual dengue cycles in Brazilian regions. Using gravity style models combined with climate factors, we showed that both human mobility and vector ecology contribute to spatial patterns of dengue occurrence. This study offers a characterization of the spatial dynamics of dengue in Brazil and its drivers, which could inform intervention strategies against dengue and other arboviruses.
C1 [Churakov, Mikhail; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, CNRS, UMR2000, Math Modelling Infect Dis Unit, Paris, France.
   [Villabona-Arenas, Christian J.] Univ Montpellier, IRD, TransVIHMI UMI233, Montpellier, France.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Churakov, Mikhail] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.
   [Villabona-Arenas, Christian J.] LSHTM, CMMID, London, England.
RP Churakov, M (corresponding author), Inst Pasteur, CNRS, UMR2000, Math Modelling Infect Dis Unit, Paris, France.; Churakov, M (corresponding author), Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.
EM mikhail.churakov@gmail.com
OI Villabona Arenas, Christian Julian/0000-0001-9928-3968; Churakov,
   Mikhail/0000-0001-9707-6885
FU National Institute of General Medical Sciences MIDAS grant
   [1U01GM110721-01]; AXA Research Fund; Investissement d'Avenir
   programFrench National Research Agency (ANR); Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program
   [ANR-10-LABX-62-IBEID]; INCEPTION project [PIA/ANR-16-CONV-0005]; IRD;
   Labex EpiGenMed/University of Montpellier, via the National Research
   Agency, Programme for Future Investment [ANR-10-LABX-12-01]; Branco
   Weiss Fellowship Society in Science; National Institute of Child Health
   and Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; National Library of Medicine of the National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812, R01LM011965]; European Research CouncilEuropean Research
   Council (ERC) [804744]
FX MC and SC received financial support from the National Institute of
   General Medical Sciences MIDAS grant 1U01GM110721-01. SC also
   acknowledges support from the AXA Research Fund, the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID) and
   the INCEPTION project (PIA/ANR-16-CONV-0005). CJVA was supported by a
   fellowship from IRD and the Labex EpiGenMed/University of Montpellier,
   via the National Research Agency, Programme for Future Investment
   ANR-10-LABX-12-01. MUGK is supported by The Branco Weiss Fellowship
   Society in Science, administered by the ETH Zurich and acknowledges
   funding from a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128) and the National Library of
   Medicine of the National Institutes of Health (R01LM010812,
   R01LM011965). HS was supported by the European Research Council
   (804744). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012
   Antonio FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180715
   Araujo Valdelaine Etelvina Miranda de, 2017, Rev Bras Epidemiol, V20Suppl 01, P205, DOI 10.1590/1980-5497201700050017
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Coelho GE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004705
   Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Cuong HQ, 2013, EMERG INFECT DIS, V19, P945, DOI 10.3201/eid1906.121323
   Kissler SM, 2018, EPIDEMICS, DOI DOI 10.1016/J.EPIDEM.2018.10.00230327253
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lourenco J, 2018, EVOL APPL, V11, P516, DOI 10.1111/eva.12554
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Nsoesie EO, 2016, EUROPEAN COMMUNICABL, V21, P1, DOI DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
NR 36
TC 2
Z9 2
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2019
VL 13
IS 4
AR e0007012
DI 10.1371/journal.pntd.0007012
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HW5PS
UT WOS:000466742100004
PM 31009460
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Hugo, LE
   Stassen, L
   La, J
   Gosden, E
   Ekwudu, O
   Winterford, C
   Viennet, E
   Faddy, HM
   Devine, GJ
   Frentiu, FD
AF Hugo, Leon E.
   Stassen, Liesel
   La, Jessica
   Gosden, Edward
   Ekwudu, O'mezie
   Winterford, Clay
   Viennet, Elvina
   Faddy, Helen M.
   Devine, Gregor J.
   Frentiu, Francesca D.
TI Vector competence of Australian Aedes aegypti and Aedes albopictus for
   an epidemic strain of Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRANSMISSION; CHIKUNGUNYA; OUTBREAK; AMERICA; DENGUE; INFECTION;
   MOSQUITOS; ISLAND; BRAZIL; FEVER
AB Background Recent epidemics of Zika virus (ZIKV) in the Pacific and the Americas have highlighted its potential as an emerging pathogen of global importance. Both Aedes (Ae.) aegypti and Ae. albopictus are known to transmit ZIKV but variable vector competence has been observed between mosquito populations from different geographical regions and different virus strains. Since Australia remains at risk of ZIKV introduction, we evaluated the vector competence of local Ae. aegypti and Ae. albopictus for a Brazilian epidemic ZIKV strain. In addition, we evaluated the impact of daily temperature fluctuations around a mean of 28 degrees C on ZIKV transmission and extrinsic incubation period.
   Methodology/Principal findings Mosquitoes were orally challenged with a Brazilian ZIKV strain (8.8 log CCID50/ml) and maintained at either 28 degrees C constant or fluctuating temperature conditions. At 3, 7 and 14 days post-infection (dpi), ZIKV RNA copies were quantified in mosquito bodies, as well as wings and legs, using qRT-PCR, while virus antigen in saliva (a proxy for transmission) was detected using a cell culture ELISA. Despite high body and disseminated infection rates in both vectors, the transmission rates of ZIKV in saliva of Ae. aegypti (50-60%) were significantly higher than in Ae. albopictus (10%) at 14 dpi. Both species supported a high viral load in bodies, with no significant differences between constant and fluctuating temperature conditions. However, a significant difference in viral load in wings and legs between species was observed, with higher titres in Ae. aegypti maintained at constant temperature conditions. For ZIKV transmission to occur in Ae. aegypti, a disseminated virus load threshold of 7.59 log(10) copies had to be reached.
   Conclusions/Significance Australian Ae. aegypti are better able to transmit a Brazilian ZIKV strain than Ae. albopictus. The results are in agreement with the global consensus that Ae. aegypti is the major vector of ZIKV.
   Author summary Zika virus (ZIKV) is a mosquito-borne pathogen that generally causes a mild febrile illness but mostly remains asymptomatic in 50-80% of infections. Infection during pregnancy can cause congenital malformations, notably microcephaly. In adults, it can cause Guillain-Barre syndrome. The recent ZIKV epidemic in the Americas has been linked to the urban vector Aedes aegypti. The presence of the species in Australia makes the region vulnerable to emerging mosquito-borne viruses. A mosquito's competence to transmit a pathogen will depend on both the virus and vector strains. Here, we determine the vector competence of Australian Ae. aegypti and Ae. albopictus mosquitoes for a ZIKV epidemic strain, originating from the epicentre of the Brazilian outbreak, under constant and fluctuating temperatures that simulate field environments in Australia. Our results demonstrate that, although both species were susceptible to ZIKV infection, Ae. aegypti is more likely to transmit virus. Our results may aid in the formulation of public health strategies to mitigate the threat of ZIKV.
C1 [Hugo, Leon E.; Devine, Gregor J.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.
   [Stassen, Liesel; La, Jessica; Gosden, Edward; Ekwudu, O'mezie; Frentiu, Francesca D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.
   [Stassen, Liesel; La, Jessica; Gosden, Edward; Ekwudu, O'mezie; Frentiu, Francesca D.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Winterford, Clay] QIMR Berghofer Med Res Inst, QIMR Berghofer Histotechnol Facil, Brisbane, Qld, Australia.
   [Viennet, Elvina; Faddy, Helen M.] Australian Red Cross Blood Serv, Res & Dev, Brisbane, Qld, Australia.
RP Frentiu, FD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Frentiu, FD (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia.
EM francesca.frentiu@qut.edu.au
RI Devine, Gregor J/H-1141-2014; Viennet, Elvina/M-5818-2019; Viennet,
   Elvina/D-9032-2017; Hugo, Leon/O-3013-2018
OI Devine, Gregor J/0000-0001-6312-0390; Viennet,
   Elvina/0000-0002-1418-1426; Viennet, Elvina/0000-0002-1418-1426; Gosden,
   Edward/0000-0002-8882-3233; Frentiu, Francesca/0000-0001-8628-4216;
   Hugo, Leon/0000-0002-6767-9850
FU Australia National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [APP1125317];
   Australian Infectious Diseases seed grant "Zika virus vector biology,
   diagnostics and vaccines"; Australian governmentsAustralian Government
FX Funding was provided by the Australia National Health and Medical
   Research Council (NHMRC) grant number APP1125317 to FDF and GJD, an
   Australian Infectious Diseases seed grant "Zika virus vector biology,
   diagnostics and vaccines" (Pls Young, Hall and Devine), and a donation
   from John and Elizabeth Hunter. Australian governments fund the
   Australian Red Cross Blood Service to provide blood, blood products and
   services to the Australian community. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   [Anonymous], 2016, BEAT, V21, P6
   [Anonymous], 2012, PLOS NEGLECT TROP D, V6, pA1
   Armstrong PM, 2018, PREPRINT, DOI [10.1101/246306, DOI 10.1101/246306]
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hall-Mendelin S, 2018, VECTOR-BORNE ZOONOT, V18, P317, DOI 10.1089/vbz.2017.2232
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, 2016, PLOS NEGLECT TROP D, V11
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Viennet E, 2016, PLOS CURR
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 82
TC 9
Z9 9
U1 3
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2019
VL 13
IS 4
AR e0007281
DI 10.1371/journal.pntd.0007281
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HW5PS
UT WOS:000466742100031
PM 30946747
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jaeger, AS
   Murrieta, RA
   Goren, LR
   Crooks, CM
   Moriarty, RV
   Weiler, AM
   Rybarczyk, S
   Semler, MR
   Huffman, C
   Mejia, A
   Simmons, HA
   Fritsch, M
   Osorio, JE
   Eickhoff, JC
   O'Connor, SL
   Ebel, GD
   Friedrich, TC
   Aliota, MT
AF Jaeger, Anna S.
   Murrieta, Reyes A.
   Goren, Lea R.
   Crooks, Chelsea M.
   Moriarty, Ryan V.
   Weiler, Andrea M.
   Rybarczyk, Sierra
   Semler, Matthew R.
   Huffman, Christopher
   Mejia, Andres
   Simmons, Heather A.
   Fritsch, Michael
   Osorio, Jorge E.
   Eickhoff, Jens C.
   O'Connor, Shelby L.
   Ebel, Gregory D.
   Friedrich, Thomas C.
   Aliota, Matthew T.
TI Zika viruses of African and Asian lineages cause fetal harm in a mouse
   model of vertical transmission
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INFECTION; STRAIN; EMERGENCE; INFANTS; BIRTH
AB Congenital Zika virus (ZIKV) infection was first linked to birth defects during the American outbreak in 2015/2016. It has been proposed that mutations unique to the Asian/American-genotype explain, at least in part, the ability of Asian/American ZIKV to cause congenital Zika syndrome (CZS). Recent studies identified mutations in ZIKV infecting humans that arose coincident with the outbreak in French Polynesia and were stably maintained during subsequent spread to the Americas. Here we show that African ZIKV can infect and harm fetuses and that the S139N substitution that has been associated with the American outbreak is not essential for fetal harm. Our findings, in a vertical transmission mouse model, suggest that ZIKV will remain a threat to pregnant women for the foreseeable future, including in Africa, Southeast Asia, and the Americas. Additional research is needed to better understand the risks associated with ZIKV infection during pregnancy, both in areas where the virus is newly endemic and where it has been circulating for decades.
   Author summary Zika virus (ZIKV) was first discovered in Uganda in 1947, and is thought to have spread from Africa through equatorial Asia in the middle of the 20(th) century. Along the way the virus diversified, so that now two genetic lineages, African and Asian/American, are recognized. Congenital Zika syndrome (CZS), the set of fetal and neonatal complications associated with ZIKV infection in pregnancy, was noted during the recent outbreak in the Americas. But the origins of CZS remain a mystery. In particular, it is unclear whether ZIKV recently acquired the ability to cause CZS, perhaps as Asian-lineage viruses spread to the Americas, or whether African-lineage viruses can also cause CZS. To address this question, we used a mouse model of vertical ZIKV transmission to assess pathogenic potential to the fetus of African and Asian/American ZIKV. Our data show that ZIKV of both African and Asian/American lineages can cause fetal harm in the mouse pregnancy model, and that this capacity does not require asparagine at amino acid residue 139, which recently emerged in Asian-lineage viruses and has been suggested to increase ZIKV's pathogenic potential for fetuses. Our results, therefore imply that ZIKV infection during pregnancy poses a risk for fetal harm in all regions where the virus is endemic.
C1 [Jaeger, Anna S.; Goren, Lea R.; Aliota, Matthew T.] Univ Minnesota Twin Cities, Dept Vet & Biomed Sci, St Paul, MN 55105 USA.
   [Murrieta, Reyes A.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Crooks, Chelsea M.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Moriarty, Ryan V.; Weiler, Andrea M.; Rybarczyk, Sierra; Huffman, Christopher; Mejia, Andres; Simmons, Heather A.; O'Connor, Shelby L.; Friedrich, Thomas C.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Semler, Matthew R.; Fritsch, Michael; O'Connor, Shelby L.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Eickhoff, Jens C.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA.
RP Aliota, MT (corresponding author), Univ Minnesota Twin Cities, Dept Vet & Biomed Sci, St Paul, MN 55105 USA.
EM mtaliota@umn.edu
OI Aliota, Matthew/0000-0002-6902-9149; Crooks,
   Chelsea/0000-0003-3874-4577; Moriarty, Ryan/0000-0001-7100-1906
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI131454,
   R01AI132563, R56AI132563, R01AI067380, R21AI125996]; University of
   Minnesota Department of Veterinary and Biomedical Sciences; NSFNational
   Science Foundation (NSF) [DGE-1450032]; Kirschstein National Research
   Service Award Individual FellowshipUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [F31AI134108]
FX Funding for this project came from National Institutes of Health grants
   R21AI131454, R01AI132563, R56AI132563, and start-up funds from the
   University of Minnesota Department of Veterinary and Biomedical Sciences
   to MTA; and National Institutes of Health grants R01AI067380 and
   R21AI125996 to GDE. RAM is supported in part by NSF training grant
   DGE-1450032 and by a Kirschstein National Research Service Award
   Individual Fellowship F31AI134108. The publication's contents are solely
   the responsibility of the authors and do not necessarily represent the
   official views of the NCRR or NIH. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Flores LE, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-38
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mathe P, 2018, J CLIN VIROL, V105, P35, DOI 10.1016/j.jcv.2018.05.011
   Maze MJ, 2018, CLIN MICROBIOL INFEC, V24, P808, DOI 10.1016/j.cmi.2018.02.011
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Ruchusatsawat K, 2019, LANCET INFECT DIS
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Satya RV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1073
   Seruyange E, 2018, J MED VIROL, V90, P1290, DOI 10.1002/jmv.25198
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sherman KE, 2018, JAIDS-J ACQ IMM DEF, V78, pE35, DOI 10.1097/QAI.0000000000001718
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015
   SOW A, 2016, MALARIA J, V15
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Valentine GC, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.005
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 47
TC 8
Z9 8
U1 2
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2019
VL 13
IS 4
AR UNSP e0007343
DI 10.1371/journal.pntd.0007343
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HW5PS
UT WOS:000466742100053
PM 30995223
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kamaraj, US
   Tan, JH
   Mei, OX
   Pan, L
   Chawla, T
   Uehara, A
   Wang, LF
   Ooi, EE
   Gubler, DJ
   Tissera, H
   Ng, LC
   Wilder-Smith, A
   de Sessions, PF
   Barkham, T
   Anderson, DE
   Sessions, OM
AF Kamaraj, Uma Sangumathi
   Tan, Jun Hao
   Mei, Ong Xin
   Pan, Louise
   Chawla, Tanu
   Uehara, Anna
   Wang, Lin-Fa
   Ooi, Eng Eong
   Gubler, Duane J.
   Tissera, Hasitha
   Ng, Lee Ching
   Wilder-Smith, Annelies
   de Sessions, Paola Florez
   Barkham, Timothy
   Anderson, Danielle E.
   Sessions, October Michael
TI Application of a targeted-enrichment methodology for full-genome
   sequencing of Dengue 1-4, Chikungunya and Zika viruses directly from
   patient samples
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EVOLUTION; EPIDEMIC; DECADES; EVENTS; VECTOR
AB The frequency of epidemics caused by Dengue viruses 1-4, Zika virus and Chikungunya viruses have been on an upward trend in recent years driven primarily by uncontrolled urbanization, mobility of human populations and geographical spread of their shared vectors, Aedes aegypti and Aedes albopictus. Infections by these viruses present with similar clinical manifestations making them challenging to diagnose; this is especially difficult in regions of the world hyperendemic for these viruses. In this study, we present a targeted-enrichment methodology to simultaneously sequence the complete viral genomes for each of these viruses directly from clinical samples. Additionally, we have also developed a customized computational tool (BaitMaker) to design these enrichment baits. This methodology is robust in its ability to capture diverse sequences and is amenable to large-scale epidemiological studies. We have applied this methodology to two large cohorts: a febrile study based in Colombo, Sri Lanka taken during the 2009-2015 dengue epidemic (n = 170) and another taken during the 2016 outbreak of Zika virus in Singapore (n = 162). Results from these studies indicate that we were able to cover an average of 97.04% 0.67% of the full viral genome from samples in these cohorts. We also show detection of one DENV3/ZIKV co-infected patient where we recovered full genomes for both viruses.
C1 [Kamaraj, Uma Sangumathi; Tan, Jun Hao; Mei, Ong Xin; Pan, Louise; Chawla, Tanu; Uehara, Anna; Wang, Lin-Fa; Ooi, Eng Eong; Gubler, Duane J.; Anderson, Danielle E.; Sessions, October Michael] Duke NUS Med Sch, Singapore, Singapore.
   [Tan, Jun Hao; Sessions, October Michael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Tissera, Hasitha] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [Ng, Lee Ching] Environm Hlth Inst, Singapore, Singapore.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [de Sessions, Paola Florez] Genome Inst Singapore, Singapore, Singapore.
   [Barkham, Timothy] Tan Tock Seng Hosp, Singapore, Singapore.
   [Sessions, October Michael] Natl Univ Singapore, Dept Pharm, Singapore, Singapore.
RP Sessions, OM (corresponding author), Duke NUS Med Sch, Singapore, Singapore.; Sessions, OM (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Sessions, OM (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore, Singapore.
EM october.sessions@nus.edu.sg
RI Tissera, Hasitha/AAQ-2516-2020
OI Ooi, Eng Eong/0000-0002-0520-1544; Wang, Lin-Fa/0000-0003-2752-0535
FU Singapore National Medical Research CouncilNational Medical Research
   Council, Singapore [NMRC/BNIG/2014/2014, CIRG13may040]; European
   UnionEuropean Union (EU) [282589]
FX We would also like to thank the Singapore National Medical Research
   Council (http://www.nmrc.gov.sg) for supporting this study through
   grants to OMS (NMRC/BNIG/2014/2014) and EEO (CIRG13may040) and the
   European Union (https://cordis.europa.eu/result/rcn/189834 en.html) for
   the grant to HT and AWS ("DengueTools" - 282589). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Andrews S, FASTQC QUALITY CONTR
   [Anonymous], 2016, J TRAVEL MED, V23, pNP1
   [Anonymous], 2016, EURO SURVEILL, V21
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Fu SH, 2011, PLOS NEGLECT TROP D, V5, pe1231
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Houldcroft CJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01317
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Krueger F., TRIM GALORE
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Liyanapathirana V, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-60
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Martin E, 2016, VIRUS RES, V213, P23, DOI 10.1016/j.virusres.2015.11.009
   Mateo R, 2007, J VIROL, V81, P1879, DOI 10.1128/JVI.01899-06
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miyazato P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28324
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Seidel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104233
   Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Singapore Zika Study G, 2017, LANCET INFECT DIS
   Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Suguitan Jr AL, 2011, PLOS ONE, V6
   Tissera H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004477
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Van den Hoecke S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1284-z
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vinner L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13201
   Vitarana T, 1997, DENGUE B, V21, P2
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WHO, 2018, ZIK VIR ZIKV CLASS T
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilm A, VIPR PIPELINE
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 53
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2019
VL 13
IS 4
AR e0007184
DI 10.1371/journal.pntd.0007184
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HW5PS
UT WOS:000466742100012
PM 31022183
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, JM
   Cheng, Y
   Shi, ZK
   Li, XF
   Xing, LS
   Jiang, H
   Wen, D
   Deng, YQ
   Zheng, AH
   Qin, CF
   Zou, Z
AF Wang, Ju-Mei
   Cheng, Yang
   Shi, Zuo-Kun
   Li, Xiao-Feng
   Xing, Long-Sheng
   Jiang, Hong
   Wen, Dan
   Deng, Yong-Qiang
   Zheng, Ai-Hua
   Qin, Cheng-Feng
   Zou, Zhen
TI Aedes aegypti HPX8C modulates immune responses against viral infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OXIDATIVE STRESS; VIRUS; ACTIVATION; PATHWAY; GENES; RECOGNITION;
   DYNAMICS; RECEPTOR; HORMONE; OXIDASE
AB Mosquitoes act as vectors of numerous pathogens that cause human diseases. Dengue virus (DENV) transmitted by mosquito, Aedes aegypti, is responsible for dengue fever epidemics worldwide with a serious impact on human health. Currently, disease control mainly relies on vector targeted intervention strategies. Therefore, it is imperative to understand the molecular mechanisms underlying the innate immune response of mosquitoes against pathogens. In the present study, the expression profiles of immunity-related genes in the midgut responding to DENV infection by feeding were analyzed by transcriptome and quantitative real-time PCR. The level of Antimicrobial peptides (AMPs) increased seven days post-infection (d.p.i.), which could be induced by the Toll immune pathway. The expression of reactive oxygen species (ROS) genes, including antioxidant genes, such as HPX7, HPX8A, HPX8B, HPX8C were induced at one d.p.i. and peaked again at ten d.p.i. in the midgut. Interestingly, down-regulation of the antioxidant gene HPX8C by RNA interference led to reduction in the virus titer in the mosquito, probably due to the elevated levels of ROS. Application of a ROS inhibitor and scavenger molecules further established the role of oxygen free radicals in the modulation of the immune response to DENV infection. Overall, our comparative transcriptome analyses provide valuable information about the regulation of immunity related genes in the transmission vector in response to DENV infection. It further allows us to identify novel molecular mechanisms underlying the host-virus interaction, which might aid in the development of novel strategies to control mosquito-borne diseases.
   Author summary HPX8C is a heme-containing peroxidase, which can move reactive oxygen species (ROS) damage to the organism by reducing H2O2 to H2O. Previously, the peroxidase gene has been shown to modulate midgut immunity and regulate anti-malarial response in mosquitoes. In this study, the classical immune signaling pathways, Toll and IMD genes might be late responses against the viruses. HPX8C was demonstrated here to play a role in antiviral immunity against DENV infection in Ae. Aegypti mosquitoes. HPX8C expression was induced by DENV infection and continued to increase with an elevated virus titer. In HPX8C-depleted mosquitoes, the ROS level was found to be increased with a corresponding decrease in the DENV and ZIKV virus titer. Therefore, it was speculated that HPX8C mediated immune responses against the DENV in the mosquito in the late stage of viral infection, which could be controlled by Toll pathway.
C1 [Wang, Ju-Mei; Cheng, Yang; Shi, Zuo-Kun; Xing, Long-Sheng; Jiang, Hong; Wen, Dan; Zheng, Ai-Hua; Zou, Zhen] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.
   [Cheng, Yang; Shi, Zuo-Kun; Zheng, Ai-Hua; Zou, Zhen] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Li, Xiao-Feng; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Li, Xiao-Feng; Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
RP Zheng, AH; Zou, Z (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.; Zheng, AH; Zou, Z (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Qin, CF (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
EM zhengaihua@ioz.ac.cn; qincf@bmi.ac.cn; zouzhen@ioz.ac.cn
OI Cheng, Yang/0000-0003-2126-282X
FU National Key Plan for Scientific Research and Development of China
   [2016YFD0500300]; Strategic Priority Research Program of the CAS
   [XDB11030600, XDB11030800]; National Basic Research Program of
   ChinaNational Basic Research Program of China [2014CB138405]
FX This work was supported by the National Key Plan for Scientific Research
   and Development of China (No. 2016YFD0500300), Strategic Priority
   Research Program of the CAS (No. XDB11030600, XDB11030800), National
   Basic Research Program of China (No. 2014CB138405). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aggrawal K, 2007, BIOCHEM SOC T, V35, P1496, DOI 10.1042/BST0351496
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   [Anonymous], 2014, PLOS PATHOG, V10, pe47
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Enoki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130248
   Escaffre O, 2015, J GEN VIROL, V96, P2961, DOI 10.1099/jgv.0.000243
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Goncalves RLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041083
   Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200
   Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407
   Hosakote YM, 2012, AM J PHYSIOL-LUNG C, V303, pL991, DOI 10.1152/ajplung.00192.2012
   Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kadam D B, 2016, J Assoc Physicians India, V64, P59
   Kajla M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01351
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2015, MOLECULES, V20, P2272, DOI 10.3390/molecules20022272
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Park Y, 2015, J INSECT PHYSIOL, V79, P63, DOI 10.1016/j.jinsphys.2015.06.005
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Vale N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00275
   Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Wong ZS, 2016, J GEN VIROL, V97, P1446, DOI 10.1099/jgv.0.000456
   World Health Organization (WHO), 2016, DENG SEV DENG
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848
   Yao ZC, 2016, ISME J, V10, P1037, DOI 10.1038/ismej.2015.202
   Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC
   Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877
   Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 55
TC 3
Z9 3
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2019
VL 13
IS 4
AR e0007287
DI 10.1371/journal.pntd.0007287
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HW5PS
UT WOS:000466742100033
PM 30986216
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chao, CH
   Wu, WC
   Lai, YC
   Tsai, PJ
   Perng, GC
   Lin, YS
   Yeh, TM
AF Chao, Chiao-Hsuan
   Wu, Wei-Chueh
   Lai, Yen-Chung
   Tsai, Pei-Jane
   Perng, Guey-Chuen
   Lin, Yee-Shin
   Yeh, Trai-Ming
TI Dengue virus nonstructural protein 1 activates platelets via Toll-like
   receptor 4, leading to thrombocytopenia and hemorrhage
SO PLOS PATHOGENS
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; EXPRESSION; RESPONSES; SEVERITY; DISEASE;
   ANTIGEN; VOLUME; CELLS
AB Dengue virus (DENV) infection, the most common mosquito-transmitted viral infection, can cause a range of diseases from self-limiting dengue fever to life-threatening dengue hemorrhagic fever and shock syndrome. Thrombocytopenia is a major characteristic observed in both mild and severe dengue disease and is significantly correlated with the progression of dengue severity. Previous studies have shown that DENV nonstructural protein 1 (NS1), which can be secreted into patients' blood, can stimulate immune cells via Toll-like receptor 4 (TLR4) and can cause endothelial leakage. However, it is unclear whether DENV NS1 can directly induce platelet activation or cause thrombocytopenia during DENV infection. In this study, we first demonstrated that DENV but not Zika virus cell culture supernatant could induce P-selectin expression and phosphatidylserine (PS) exposure in human platelets, both of which were abolished when NS1 was depleted from the DENV supernatant. Similar results were found using recombinant NS1 from all four serotypes of DENV, and those effects were blocked in the presence of anti-NS1 F(ab')(2), anti-TLR4 antibody, a TLR4 antagonist (Rhodobacter sphaeroides lipopolysaccharide, LPS-Rs) and a TLR4 signaling inhibitor (TAK242), but not polymyxin B (an LPS inhibitor). Moreover, the activation of platelets by DENV NS1 promoted subthreshold concentrations of adenosine diphosphate (ADP)-induced platelet aggregation and enhanced platelet adhesion to endothelial cells and phagocytosis by macrophages. Finally, we demonstrated that DENV-induced thrombocytopenia and hemorrhage were attenuated in TLR4 knockout and wild-type mice when NS1 was depleted from DENV supernatant. Taken together, these results suggest that the binding of DENV NS1 to TLR4 on platelets can trigger its activation, which may contribute to thrombocytopenia and hemorrhage during dengue infection.
   Author summary Over the past 50 years, dengue has been a continuing global threat, with no effective vaccine or specific antiviral drug. Dengue infection causes a wide range of outcomes, from fever-like symptoms to severe dengue hemorrhagic fever. Thrombocytopenia, a reduction in platelet count, is a common feature observed in both mild and severe dengue and is correlated with disease severity. In this study, we used dengue viral supernatant or DENV recombinant NS1 protein to stimulate human-isolated platelets. We found that DENV NS1 could directly activate platelets through TLR4 and could further enhance platelet aggregation, adhesion to endothelial cells and phagocytosis by macrophages, which could lead to thrombocytopenia. We also proved that both NS1 and TLR4 are critical for DENV-induced thrombocytopenia and hemorrhage using a DENV-induced hemorrhagic mouse model. Our study reveals a new pathogenic role of NS1 during dengue infection and highlights that NS1 should be a topic of attention in the development of therapeutic drugs and vaccines against dengue infection.
C1 [Chao, Chiao-Hsuan; Lai, Yen-Chung] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.
   [Wu, Wei-Chueh; Tsai, Pei-Jane; Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.
   [Perng, Guey-Chuen; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan.
RP Yeh, TM (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.
EM today@mail.ncku.edu.tw
RI Yeh, Trai-Ming/C-7193-2011
OI Yeh, Trai-Ming/0000-0003-3172-7432
FU National Health Research InstituteNational Health Research Institutes -
   Taiwan [NHRI-108A1-MRCO-0319191]; Ministry of Science and Technology of
   TaiwanMinistry of Science and Technology, Taiwan [107-2321-B-006-001]
FX This study was supported by grants from National Health Research
   Institute (NHRI-108A1-MRCO-0319191) and Ministry of Science and
   Technology of Taiwan (107-2321-B-006-001). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916
   [Anonymous], 2017, PLOS NEGLECT TROP D, V11, pe1
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469
   Chen HR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0462-0
   Chen HR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007033
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   Trugilho MRD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006385
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hally KE, 2017, THROMB RES, V158, P8, DOI 10.1016/j.thromres.2017.07.031
   Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178
   Hottz ED, 2014, J IMMUNOL, V193, P1864, DOI 10.4049/jimmunol.1400091
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   Khan Assir Muhammad Zaman, 2017, Evid Based Med, V22, P225, DOI 10.1136/ebmed-2017-110745
   Lai YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07308-3
   Lien TS, 2015, THROMB HAEMOSTASIS, V113, P1060, DOI 10.1160/TH14-07-0637
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Ntaios G, 2008, ACTA HAEMATOL-BASEL, V119, P173, DOI 10.1159/000135658
   Ojha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41697
   OP026, 2016, PLOS NEGLECT TROP D, V10, pS21
   Pang JX, 2017, J CLIN MICROBIOL, V55, P3339, DOI 10.1128/JCM.00707-17
   Parakash GM, 2016, INT J ADV MED, V3, P611
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5
   Saci A, 1999, J BIOL CHEM, V274, P1898, DOI 10.1074/jbc.274.4.1898
   Sharma K, 2015, J CLIN DIAGN RES, V9, pEC01, DOI 10.7860/JCDR/2015/14285.6710
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Theilmeier G, 1999, BLOOD, V94, P2725, DOI 10.1182/blood.V94.8.2725.420k18_2725_2734
   Thomas SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1255
   van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400
   Wan SW, 2016, THROMB HAEMOSTASIS, V115, P646, DOI 10.1160/TH15-06-0498
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884
NR 51
TC 6
Z9 6
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2019
VL 15
IS 4
AR e1007625
DI 10.1371/journal.ppat.1007625
PG 26
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HW5PY
UT WOS:000466742700007
PM 31009511
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferrero, DS
   Ruiz-Arroyo, VM
   Soler, N
   Uson, I
   Guarne, A
   Verdaguer, N
AF Ferrero, Diego S.
   Ruiz-Arroyo, Victor M.
   Soler, Nicolas
   Uson, Isabel
   Guarne, Alba
   Verdaguer, Nude
TI Supramolecular arrangement of the full-length Zika virus NS5
SO PLOS PATHOGENS
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; DENGUE-VIRUS; CRYSTAL-STRUCTURE; REPLICATION;
   PROTEINS; MACROMOLECULES; FEATURES; SYSTEM; METHYLTRANSFERASE; SEROTYPES
AB Zika virus (ZIKV), a member of the Flaviviridae family, has emerged as a major public health threat, since ZIKV infection has been connected to microcephaly and other neurological disorders. Flavivirus genome replication is driven by NS5, an RNA-dependent RNA polymerase (RdRP) that also contains a N-terminal methyltransferase domain essential for viral mRNA capping. Given its crucial roles, ZIKV NS5 has become an attractive antiviral target. Here, we have used integrated structural biology approaches to characterize the supramolecular arrangement of the full-length ZIKV NS5, highlighting the assembly and interfaces between NS5 monomers within a dimeric structure, as well as the dimer-dimer interactions to form higher order fibril-like structures. The relative orientation of each monomer within the dimer provides a model to explain the coordination between MTase and RdRP domains across neighboring NS5 molecules and mutational studies underscore the crucial role of the MTase residues Y25, K28 and K29 in NS5 dimerization. The basic residue K28 also participates in GTP binding and competition experiments indicate that NS5 dimerization is disrupted at high GTP concentrations. This competition represents a first glimpse at a molecular level explaining how dimerization might regulate the capping process.
   Author summary The lack of vaccine or antiviral drugs to combat Zika virus (ZIKV) infection has encouraged scientists to characterize in depth potential drug targets. One attractive candidate is NS5, responsible for the catalysis of the 5'-RNA capping, methylation and RNA synthesis, during flavivirus genome replication. To fulfill these activities, the methyltransferase and RNA-dependent RNA polymerase domains of NS5 need to cooperate with each other. The structural and biophysical data presented in this work demonstrate that the ZIKV NS5 protein has the ability to form dimers, as well as higher order oligomers that may participate in the fine-tuning regulation of the multiple enzyme functions in the replication complex. In addition, we have found that NS5 dimerization is disrupted at high GTP concentrations, explaining how dimerization might regulate the capping process.
C1 [Ferrero, Diego S.; Ruiz-Arroyo, Victor M.; Soler, Nicolas; Uson, Isabel; Verdaguer, Nude] CSIC, Struct Biol Unit, Inst Biol Mol Barcelona, Barcelona, Spain.
   [Uson, Isabel] ICREA, Barcelona, Spain.
   [Guarne, Alba] McGill Univ, Dept Biochem, Montreal, PQ, Canada.
RP Verdaguer, N (corresponding author), CSIC, Struct Biol Unit, Inst Biol Mol Barcelona, Barcelona, Spain.
EM nvmcri@ibmb.csic.es
OI Ferrero, Diego Sebastian/0000-0001-6848-9939; Verdaguer,
   Nuria/0000-0001-8826-7129
FU Spanish Ministry of Economy and Competitiveness (MINECO, Spain-FEDER)
   [BIO2014-54588-P, BIO2017-83906-P, BIO2015-64216-P]; Maria de Maeztu
   Unit of Excellence (MINECO) [MDM-2014-0435]; Canadian Institutes of
   Health ResearchCanadian Institutes of Health Research (CIHR)
   [MOP-67189]; Natural Sciences and Engineering Research Council of
   CanadaNatural Sciences and Engineering Research Council of Canada
   [288295]
FX Work in Barcelona was funded by the Spanish Ministry of Economy and
   Competitiveness, grants BIO2014-54588-P and BIO2017-83906-P to NV,
   BIO2015-64216-P to IU (MINECO, Spain-FEDER) and Maria de Maeztu Unit of
   Excellence MDM-2014-0435 (MINECO) to IU and NV. Work in Canada was
   supported by grants from the Canadian Institutes of Health Research
   (MOP-67189) and the Natural Sciences and Engineering Research Council of
   Canada (288295) to AG. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09
   Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101
   Clemente-Casares P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018515
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferrero D, 2018, SUBCELL BIOCHEM, V88, P39, DOI 10.1007/978-981-10-8456-0_3
   Ferrero DS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005265
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153
   Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0
   HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Manimekalai MSS, 2016, ACTA CRYSTALLOGR D, V72, P795, DOI 10.1107/S2059798316006665
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Millan C, 2015, IUCRJ, V2, P95, DOI 10.1107/S2052252514024117
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Read RJ, 2016, ACTA CRYSTALLOGR D, V72, P375, DOI 10.1107/S2059798315013236
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Shi Y, 2017, TRENDS BIOCH SCI, V15
   Smallwood S, 2002, VIROLOGY, V304, P135, DOI 10.1006/viro.2002.1644
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tickle I. J., 2016, STARANISO
   Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Uson I, 2018, ACTA CRYSTALLOGR D, V74, P106, DOI 10.1107/S2059798317015121
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Zamoto-Niikura A, 2009, J VIROL, V83, P12779, DOI 10.1128/JVI.01310-09
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 70
TC 10
Z9 10
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2019
VL 15
IS 4
AR e1007656
DI 10.1371/journal.ppat.1007656
PG 26
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HW5PY
UT WOS:000466742700014
PM 30951555
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Langerak, T
   Mumtaz, N
   Tolk, VI
   van Gorp, ECM
   Martina, BE
   Rockx, B
   Koopmans, MPG
AF Langerak, Thomas
   Mumtaz, Noreen
   Tolk, Vera, I
   van Gorp, Eric C. M.
   Martina, Byron E.
   Rockx, Barry
   Koopmans, Marion P. G.
TI The possible role of cross-reactive dengue virus antibodies in Zika
   virus pathogenesis
SO PLOS PATHOGENS
LA English
DT Review
ID DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; DISEASE SEVERITY; PREGNANCY
   OUTCOMES; HUMAN PLACENTA; INFECTION; CELLS; SYNCYTIOTROPHOBLAST;
   IMMUNOGLOBULINS; CYTOMEGALOVIRUS
AB Zika virus (ZIKV) has been known for decades to circulate in Africa and Asia. However, major complications of a ZIKV infection have recently become apparent for reasons that are still not fully elucidated. One of the hypotheses for the seemingly increased pathogenicity of ZIKV is that cross-reactive dengue antibodies can enhance a ZIKV infection through the principle of antibody-dependent enhancement (ADE). Recently, ADE in ZIKV infection has been studied, but conclusive evidence for the clinical importance of this principle in a ZIKV infection is lacking. Conversely, the widespread circulation of ZIKV in dengue virus (DENV)-endemic regions raises new questions about the potential contribution of ZIKV antibodies to DENV ADE. In this review, we summarize the results of the evidence to date and elaborate on other possible detrimental effects of cross-reactive flavivirus antibodies, both for ZIKV infection and the risk of ZIKV-related congenital anomalies, DENV infection, and dengue hemorrhagic fever.
C1 [Langerak, Thomas; Mumtaz, Noreen; Tolk, Vera, I; van Gorp, Eric C. M.; Martina, Byron E.; Rockx, Barry; Koopmans, Marion P. G.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
RP Koopmans, MPG (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM m.koopmans@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312; Langerak,
   Thomas/0000-0003-4340-1560
FU European UnionEuropean Union (EU) [734548]; ZonMwNetherlands
   Organization for Health Research and Development [522003001]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation program under grant agreement ZikAlliance No
   734548 and from the ZikaRisk project of ZonMw under project number
   522003001. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Aguiar M, 2018, LANCET INFECT DIS, V18, P245, DOI 10.1016/S1473-3099(17)30752-1
   Aguiar M, 2017, EXPERT REV VACCINES, V16, P301, DOI 10.1080/14760584.2017.1276831
   [Anonymous], 2017, PLOS ONE, V12, pS94, DOI 10.1055/s-0043-115953
   [Anonymous], 2017, JCI INSIGHT, V2, pe115
   [Anonymous], 2016, PLOS CURR, V8, pe1000
   Ayala-Nunez NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep28768
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Castanha PMS, 2017, J INFECT DIS, V216, P614, DOI 10.1093/infdis/jix346
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dekkers G, 2017, MABS-AUSTIN, V9, P767, DOI 10.1080/19420862.2017.1323159
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Duehr J, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00011-18, 10.1128/mspheredirect.00011-18]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goncalves PF, 2018, J PERIODONTAL RES, V53, P164, DOI 10.1111/jre.12505
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   Leach JL, 1996, J IMMUNOL, V157, P3317
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2002, VIROLOGY, V304, P53, DOI 10.1006/viro.2002.1661
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pan American Health Organization, 2016, REP INCR CONG MICR O
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pierson TC, 2010, CELL HOST MICROBE, V7, P85, DOI 10.1016/j.chom.2010.02.004
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE495, DOI 10.1016/S2214-109X(18)30123-2
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Sauter P, 2009, MICROBES INFECT, V11, P443, DOI 10.1016/j.micinf.2009.01.005
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Zavattoni M, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.31.30308
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 92
TC 13
Z9 13
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2019
VL 15
IS 4
AR e1007640
DI 10.1371/journal.ppat.1007640
PG 15
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HW5PY
UT WOS:000466742700011
PM 30998804
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Beck, S
   Zhu, Z
   Oliveira, MF
   Smith, DM
   Rich, JN
   Bernatchez, JA
   Siqueira-Neto, JL
AF Beck, Sungjun
   Zhu, Zhe
   Oliveira, Michelli F.
   Smith, Davey M.
   Rich, Jeremy N.
   Bernatchez, Jean A.
   Siqueira-Neto, Jair L.
TI Mechanism of Action of Methotrexate Against Zika Virus
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; antivirals; nucleotide metabolism; methotrexate;
   dihydrofolate reductase
ID DIHYDROFOLATE-REDUCTASE; FOLINIC ACID; CELL-LINES; THYMIDINE;
   INHIBITION; INFECTION; TOXICITY; THERAPY; RESCUE; PURINE
AB Zika virus (ZIKV), which is associated with microcephaly in infants and Guillain-Barre syndrome, reemerged as a serious public health threat in Latin America in recent years. Previous high-throughput screening (HTS) campaigns have revealed several potential hit molecules against ZIKV, including methotrexate (MTX), which is clinically used as an anti-cancer chemotherapy and anti-rheumatoid agent. We studied the mechanism of action of MTX against ZIKV in relation to its inhibition of dihydrofolate reductase (DHFR) in vitro using Vero and human neural stem cells (hNSCs). As expected, an antiviral effect for MTX against ZIKV was observed, showing up to 10-fold decrease in virus titer during MTX treatment. We also observed that addition of leucovorin (a downstream metabolite of DHFR pathway) rescued the ZIKV replication impaired by MTX treatment in ZIKV-infected cells, explaining the antiviral effect of MTX through inhibition of DHFR. We also found that addition of adenosine to ZIKV-infected cells was able to rescue ZIKV replication inhibited by MTX, suggesting that restriction of de novo synthesis adenosine triphosphate (ATP) pools suppresses viral replication. These results confirm that the DHFR pathway can be targeted to inhibit replication of ZIKV, similar to other published results showing this effect in related flaviviruses.
C1 [Beck, Sungjun; Bernatchez, Jean A.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Zhu, Zhe; Rich, Jeremy N.] Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Zhu, Zhe; Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.
   [Oliveira, Michelli F.; Smith, Davey M.] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA.
   [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA.
   [Bernatchez, Jean A.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.
RP Bernatchez, JA; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Bernatchez, JA; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.
EM sjbeck@ucsd.edu; zhz504@ucsd.edu; mfariadeoliveira@ucsd.edu;
   d13smith@ucsd.edu; drjeremyrich@gmail.com; jbernatchez@ucsd.edu;
   jairlage@ucsd.edu
RI Zhu, Zhe/H-6009-2019; Siqueira-Neto, Jair L/D-6040-2012; de Oliveira,
   Michelli Faria/J-4189-2019
OI Zhu, Zhe/0000-0002-5385-948X; Siqueira-Neto, Jair L/0000-0001-9574-8174;
   de Oliveira, Michelli Faria/0000-0001-5045-7939; Smith,
   Davey/0000-0003-3603-1733; Bernatchez, Jean/0000-0002-8309-1627
FU Clinical and Translational (CTRI) [UL1TR001442]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI100665, AI036214]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)-BrazilNational Council for Scientific
   and Technological Development (CNPq)
FX This research was supported by Clinical and Translational (CTRI) pilot
   grant UL1TR001442 (to J.L.S.N.), by NIH grants AI100665 and AI036214 (to
   D.M.S.) and by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)-Brazil (to M.F.O).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   BERNARD S, 1991, BRIT J CANCER, V63, P303, DOI 10.1038/bjc.1991.70
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   BLACK RL, 1964, JAMA-J AM MED ASSOC, V189, P743
   BOKKERINK JPM, 1988, BIOCHEM PHARMACOL, V37, P2329, DOI 10.1016/0006-2952(88)90359-0
   CHU E, 1990, J BIOL CHEM, V265, P8470
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Elango T, 2014, CLIN EXP MED, V14, P431, DOI 10.1007/s10238-013-0252-7
   ENSMINGER WD, 1977, CANCER RES, V37, P1857
   Fischer MA, 2013, J VIROL, V87, P9411, DOI 10.1128/JVI.00101-13
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   HOWELL SB, 1978, CANCER RES, V38, P325
   HRYNIUK WM, 1975, CANCER RES, V35, P1427
   HRYNIUK WM, 1969, J CLIN INVEST, V48, P2140, DOI 10.1172/JCI106181
   IVANETICH KM, 1990, FASEB J, V4, P1591
   JACKSON RC, 1980, MOL PHARMACOL, V18, P281
   JOLIVET J, 1983, NEW ENGL J MED, V309, P1094, DOI 10.1056/NEJM198311033091805
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837
   ROSENBLATT DS, 1982, MOL PHARMACOL, V21, P718
   Sramek M, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0289-2
   TANAKA T, 1982, FERTIL STERIL, V37, P851
   WALTHAM MC, 1988, BIOCHEM PHARMACOL, V37, P535, DOI 10.1016/0006-2952(88)90225-0
   WILLKENS RF, 1980, J RHEUMATOL, V7, P501
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 28
TC 2
Z9 2
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2019
VL 11
IS 4
AR 338
DI 10.3390/v11040338
PG 12
WC Virology
SC Virology
GA HX3RS
UT WOS:000467310600035
PM 30974762
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bernatchez, JA
   Coste, M
   Beck, S
   Wells, GA
   Luna, LA
   Clark, AE
   Zhu, Z
   Hecht, D
   Rich, JN
   Sohl, CD
   Purse, BW
   Siqueira-Neto, JL
AF Bernatchez, Jean A.
   Coste, Michael
   Beck, Sungjun
   Wells, Grace A.
   Luna, Lucas A.
   Clark, Alex E.
   Zhu, Zhe
   Hecht, David
   Rich, Jeremy N.
   Sohl, Christal D.
   Purse, Byron W.
   Siqueira-Neto, Jair L.
TI Activity of Selected Nucleoside Analogue ProTides against Zika Virus in
   Human Neural Stem Cells
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; nucleoside analogues; antiviral agents; NS5; prodrugs;
   ProTides; neural stem cells; RNA-dependent RNA polymerase
ID DEPENDENT RNA-POLYMERASE; ARYLOXY PHOSPHORAMIDATE TRIESTERS;
   CRYSTAL-STRUCTURE; IN-VITRO; INHIBITORS; NS5; PURIFICATION;
   CONFORMATION; REPLICATION; TECHNOLOGY
AB Zika virus (ZIKV), an emerging flavivirus that causes neurodevelopmental impairment to fetuses and has been linked to Guillain-Barre syndrome continues to threaten global health due to the absence of targeted prophylaxis or treatment. Nucleoside analogues are good examples of efficient anti-viral inhibitors, and prodrug strategies using phosphate masking groups (ProTides) have been employed to improve the bioavailability of ribonucleoside analogues. Here, we synthesized and tested a small library of 13 ProTides against ZIKV in human neural stem cells. Strong activity was observed for 2-C-methyluridine and 2-C-ethynyluridine ProTides with an aryloxyl phosphoramidate masking group. Substitution of a 2-(methylthio) ethyl phosphoramidate for the aryloxyl phosphoramidate ProTide group of 2-C-methyluridine completely abolished antiviral activity of the compound. The aryloxyl phosphoramidate ProTide of 2-C-methyluridine outperformed the hepatitis C virus (HCV) drug sofosbuvir in suppression of viral titers and protection from cytopathic effect, while the former compound's triphosphate active metabolite was better incorporated by purified ZIKV NS5 polymerase over time. These findings suggest both a nucleobase and ProTide group bias for the anti-ZIKV activity of nucleoside analogue ProTides in a disease-relevant cell model.
C1 [Bernatchez, Jean A.; Beck, Sungjun; Clark, Alex E.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Bernatchez, Jean A.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.
   [Coste, Michael; Wells, Grace A.; Luna, Lucas A.; Hecht, David; Sohl, Christal D.; Purse, Byron W.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA.
   [Clark, Alex E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Zhu, Zhe; Rich, Jeremy N.] Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Zhu, Zhe; Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.
   [Hecht, David] Southwestern Coll, Dept Chem, Chula Vista, CA 91910 USA.
   [Purse, Byron W.] San Diego State Univ, Viral Informat Inst, San Diego, CA 92182 USA.
RP Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.; Sohl, CD; Purse, BW (corresponding author), San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA.; Purse, BW (corresponding author), San Diego State Univ, Viral Informat Inst, San Diego, CA 92182 USA.
EM jbernatchez@ucsd.edu; michael.coste1@gmail.com; sjbeck@ucsd.edu;
   graceawells@gmail.com; luluna@ad.ucsd.edu; alexclark@ucsd.edu;
   zhz504@ucsd.edu; dhecht@swccd.edu; drjeremyrich@gmail.com;
   csohl@sdsu.edu; bpurse@sdsu.edu; jairlage@ucsd.edu
RI Zhu, Zhe/H-6009-2019; Siqueira-Neto, Jair L/D-6040-2012
OI Zhu, Zhe/0000-0002-5385-948X; Siqueira-Neto, Jair L/0000-0001-9574-8174;
   Bernatchez, Jean/0000-0002-8309-1627; Purse, Byron/0000-0002-0052-6067;
   Sohl, Christal/0000-0002-8048-0205; Hecht, David/0000-0003-0949-2681
FU Clinical and Translational (CTRI) pilot grant [UL1TR001442]; CSUPERB New
   Investigator grant; San Diego State University; California Metabolic
   Research Foundation
FX This research was supported by Clinical and Translational (CTRI) pilot
   grant UL1TR001442 (to J.L.S.-N.), and a CSUPERB New Investigator grant
   (to C.D.S). B.W.P., M.C., G.A.W., L.A.L., and C.D.S. thank San Diego
   State University and the California Metabolic Research Foundation for
   financial support.
CR Anandan S.K., 2017, 2 ETHYNYL NUCLEOSIDE
   [Anonymous], SCHROD PYMOL PYMOL M
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Arnold JJ, 1999, BIOTECHNIQUES, V27, P450, DOI 10.2144/99273bm11
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Bonnac LF, 2013, J MED CHEM, V56, P9403, DOI 10.1021/jm400653j
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cahard D, 2004, MINI-REV MED CHEM, V4, P371
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Ehteshami M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00492-17
   Eldrup AB, 2004, J MED CHEM, V47, P2283, DOI 10.1021/jm030424e
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Ferrero D, 2018, SUBCELL BIOCHEM, V88, P39, DOI 10.1007/978-981-10-8456-0_3
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   ITOH T, 1989, CHEM PHARM BULL, V37, P3184
   Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005
   Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kamkaew M, 2015, PROTEIN EXPRES PURIF, V112, P43, DOI 10.1016/j.pep.2015.04.008
   LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Mayberry J, 2019, MED CLIN N AM, V103, P43, DOI 10.1016/j.mcna.2018.08.007
   Mazar J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200358
   MCGUIGAN C, 1992, ANTIVIR RES, V17, P311, DOI 10.1016/0166-3542(92)90026-2
   McGuigan C, 2005, J MED CHEM, V48, P3504, DOI 10.1021/jm0491400
   Mehellou Y, 2018, J MED CHEM, V61, P2211, DOI 10.1021/acs.jmedchem.7b00734
   Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289
   Menendez-Arias L, 2017, VIRUS RES, V234, P153, DOI 10.1016/j.virusres.2016.12.019
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Okon A, 2017, J MED CHEM, V60, P8131, DOI 10.1021/acs.jmedchem.7b00916
   Ovadia R, 2019, BIOORGAN MED CHEM, V27, P664, DOI 10.1016/j.bmc.2019.01.005
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Ross BS, 2011, J ORG CHEM, V76, P8311, DOI 10.1021/jo201492m
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Sluis-Cremer N, 2015, FUTURE MICROBIOL, V10, P1773, DOI 10.2217/fmb.15.106
   Sofia MJ, 2013, ADV PHARMACOL, V67, P39, DOI 10.1016/B978-0-12-405880-4.00002-0
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang G, 2018, BIOORG MED CHEM LETT, V28, P2324, DOI 10.1016/j.bmcl.2018.04.069
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Zarrouk K, 2017, VIRUS RES, V234, P177, DOI 10.1016/j.virusres.2017.01.019
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 51
TC 3
Z9 3
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2019
VL 11
IS 4
AR 365
DI 10.3390/v11040365
PG 17
WC Virology
SC Virology
GA HX3RS
UT WOS:000467310600062
PM 31010044
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yuan, SF
   Chan, JFW
   Ye, ZW
   Wen, L
   Tsang, TGW
   Cao, JL
   Huang, JJ
   Chan, CCY
   Chik, KKH
   Choi, GKY
   Cai, JP
   Yin, FF
   Chu, H
   Liang, MF
   Jin, DY
   Yuen, KY
AF Yuan, Shuofeng
   Chan, Jasper Fuk-Woo
   Ye, Zi-Wei
   Wen, Lei
   Tsang, Terance Gi-Wai
   Cao, Jianli
   Huang, Jingjing
   Chan, Chris Chun-Yiu
   Chik, Kenn Ka-Heng
   Choi, Garnet Kwan-Yue
   Cai, Jian-Piao
   Yin, Feifei
   Chu, Hin
   Liang, Mifang
   Jin, Dong-Yan
   Yuen, Kwok-Yung
TI Screening of an FDA-Approved Drug Library with a Two-Tier System
   Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia
   Syndrome Virus
SO VIRUSES-BASEL
LA English
DT Article
DE antiviral; broxyquinoline; bunyavirales; eltrombopag; entry;
   hexachlorophene; Huaiyangshan banyangvirus; regorafenib; SFTSV;
   triclosan
ID TO-PERSON TRANSMISSION; ZIKA VIRUS; IN-VITRO; BUNYAVIRUS; INFECTION;
   PROTEIN; INACTIVATION; DISCOVERY; DISEASE; BINDING
AB Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne bunyavirus that causes severe disease in humans with case-fatality rates of up to 30%. There are currently very limited treatment options for SFTSV infection. We conducted a drug repurposing program by establishing a two-tier test system to rapidly screen a Food and Drug Administration- (FDA)-approved drug library for drug compounds with anti-SFTSV activity in vitro. We identified five drug compounds that inhibited SFTSV replication at low micromolar concentrations, including hexachlorophene, triclosan, regorafenib, eltrombopag, and broxyquinoline. Among them, hexachlorophene was the most potent with an IC50 of 1.3 +/- 0.3 mu M and a selectivity index of 18.7. Mechanistic studies suggested that hexachlorophene was a virus entry inhibitor, which impaired SFTSV entry into host cells by interfering with cell membrane fusion. Molecular docking analysis predicted that the binding of hexachlorophene with the hydrophobic pocket between domain I and domain III of the SFTSV Gc glycoprotein was highly stable. The novel antiviral activity and mechanism of hexachlorophene in this study would facilitate the use of hexachlorophene as a lead compound to develop more entry inhibitors with higher anti-SFTSV potency and lower toxicity.
C1 [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Chu, Hin; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Ye, Zi-Wei; Wen, Lei; Tsang, Terance Gi-Wai; Cao, Jianli; Huang, Jingjing; Chan, Chris Chun-Yiu; Chik, Kenn Ka-Heng; Choi, Garnet Kwan-Yue; Cai, Jian-Piao; Chu, Hin; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Carol Yu Ctr Infect,Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yin, Feifei; Yuen, Kwok-Yung] Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou 571101, Hainan, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yin, Feifei; Yuen, Kwok-Yung] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Key Lab Translat Trop Med, Haikou 571101, Hainan, Peoples R China.
   [Liang, Mifang] Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing 102206, Peoples R China.
   [Liang, Mifang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Carol Yu Ctr Infect,Pokfulam, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou 571101, Hainan, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
EM yuansf@hku.hk; jfwchan@hku.hk; zwye@hku.hk; wenlei07@hku.hk;
   terancet@connect.hku.hk; caojl@hku.hk; huangjj@hku.hk; cyc415@hku.hk;
   kchik929@connect.hku.hk; garnetchoi@yahoo.com; caijuice@hku.hk;
   yinfeifeiff@163.com; hinchu@hku.hk; mifangl@vip.sina.com; dyjin@hku.hk;
   kyyuen@hku.hk
RI ; Chan, Jasper Fuk-Woo/D-8007-2013
OI Yuen, Kwok-yung/0000-0002-2083-1552; Chan, Jasper
   Fuk-Woo/0000-0001-6336-6657; CHU, HIN/0000-0003-2855-9837; Cao,
   Jianli/0000-0003-1464-7377; Yuan, Shuofeng/0000-0001-7996-1119
FU Chow Sin Lan Charity Fund Limited; Hong Kong Hainan Commercial
   Association South China Microbiology Research Fund; Chan Yin Chuen
   Memorial Charitable Foundation; High Level Hospital-Summit Program in
   Guangdong, The University of Hong Kong-Shenzhen Hospital; Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of ChinaMinistry of Education, China
FX This work was partly supported by the donations of Michael Seak-Kan
   Tong, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Mr.
   PatrickWan-Keung Lee, Ms. Marina Man-Wai Lee, Chan Yin Chuen Memorial
   Charitable Foundation, and the Hong Kong Hainan Commercial Association
   South China Microbiology Research Fund; and funding from the High Level
   Hospital-Summit Program in Guangdong, The University of Hong
   Kong-Shenzhen Hospital; and the Collaborative Innovation Center for
   Diagnosis and Treatment of Infectious Diseases, the Ministry of
   Education of China. The sponsors had no role in the design and conduct
   of the study, in the collection, analysis and interpretation of data, or
   in the preparation, review or approval of the manuscript.
CR Baba Masanori, 2017, Antiviral Chemistry & Chemotherapy, V25, P83, DOI 10.1177/2040206617740303
   Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732
   Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2018, ANTIVIR RES, V160, P38, DOI 10.1016/j.antiviral.2018.10.007
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123
   Gong Z, 2015, CLIN MICROBIOL INFEC, V21, P1115, DOI 10.1016/j.cmi.2015.07.024
   Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113
   HENDLEY JO, 1978, ANTIMICROB AGENTS CH, V14, P690, DOI 10.1128/AAC.14.5.690
   Hsu JTA, 2004, FEBS LETT, V574, P116, DOI 10.1016/j.febslet.2004.08.015
   Jiang XL, 2015, CLIN MICROBIOL INFEC, V21, P274, DOI 10.1016/j.cmi.2014.10.006
   KIMBROUGH RD, 1973, J CLIN PHARMACOL, V13, P439, DOI 10.1002/j.1552-4604.1973.tb00196.x
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530
   Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   Novikov FN, 2012, J COMPUT AID MOL DES, V26, P725, DOI 10.1007/s10822-012-9549-y
   Ogawa M, 2018, J INFECT CHEMOTHER, V24, P597, DOI 10.1016/j.jiac.2018.03.005
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   SATTAR SA, 1983, CAN J MICROBIOL, V29, P1464, DOI 10.1139/m83-225
   Seguin SP, 2012, ANTIVIR RES, V96, P70, DOI 10.1016/j.antiviral.2012.07.012
   Smee DF, 2018, ANTIVIR RES, V160, P48, DOI 10.1016/j.antiviral.2018.10.013
   Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031
   Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15
   Tani H, 2016, J VIROL, V90, P5292, DOI 10.1128/JVI.00110-16
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yuan SF, 2016, J ANTIMICROB CHEMOTH, V71, P2489, DOI 10.1093/jac/dkw194
   Yuan SF, 2016, ACS INFECT DIS, V2, P471, DOI 10.1021/acsinfecdis.6b00064
   Yuan SF, 2016, ANTIVIR RES, V125, P34, DOI 10.1016/j.antiviral.2015.11.005
   Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331
   Zhu YH, 2018, J VIROL, V92, DOI [10.1128/JVI.01558-17, 10.1128/jvi.01558-17]
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 40
TC 3
Z9 3
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2019
VL 11
IS 4
AR 385
DI 10.3390/v11040385
PG 13
WC Virology
SC Virology
GA HX3RS
UT WOS:000467310600082
PM 31027241
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mani, D
   Wadhwani, A
   Krishnamurthy, PT
AF Mani, Divyabharathi
   Wadhwani, Ashish
   Krishnamurthy, Praveen Thaggikuppe
TI Drug Repurposing in Antiviral Research: A Current Scenario
SO JOURNAL OF YOUNG PHARMACISTS
LA English
DT Review
DE Antiviral; Drug resistance; Re-emerging viral infections; Repurposing
ID DENGUE VIRUS-INFECTION; IN-VITRO; HUMAN CYTOMEGALOVIRUS; EBOLA-VIRUS;
   IDENTIFIES INHIBITORS; APPROVED DRUGS; CHLOROQUINE; RESISTANCE;
   DISCOVERY; DISEASE
AB Better understand the unexplored parts of the drugs you know than the drugs unidentified. Drug repurposing is a promising, fast and cost-effective method that can overcome traditional de novo drug discovery and development challenges of targeting various diseases and disorders. Drug repurposing, the process of identifying new uses for the existing or candidate drugs is an effective strategy for drug discovery in various diseases. Identifying new drugs and new target is significant in today's world with a new disease emerging every day. With increase in number of the emerging viral infections day by day, the targeted therapies for those are not discovered in parallel. The drug repurposing approach has given many promising drug candidates for various viral infectious diseases like Ebola, ZIKA, dengue, influenza, HIV, HSV, CMV infections and various other infectious diseases. The emergence of resistance to existing antiviral drugs and re-emerging viral infections are the biggest challenges in the antiviral drug discovery. The drug repurposing approach is an assuring strategy in finding new potential antiviral agents within a short span of time to overcome the challenges in antiviral therapy. In this review, we describe the most promising results of the drug repurposing approach in the treatment of various infectious diseases.
C1 [Mani, Divyabharathi; Wadhwani, Ashish] JSS Acad Higher Educ & Res, Coll Pharm, Dept Pharmaceut Biotechnol, Ooty 643001, Tamil Nadu, India.
   [Krishnamurthy, Praveen Thaggikuppe] JSS Acad Higher Educ & Res, Coll Pharm, Dept Pharmacol, Ooty 643001, Tamil Nadu, India.
RP Wadhwani, A (corresponding author), JSS Acad Higher Educ & Res, Coll Pharm, Dept Pharmaceut Biotechnol, Ooty 643001, Tamil Nadu, India.
EM adwadhwaniad@gmail.com
FU Tamil Nadu Pharmaceutical sciences Welfare Trust, Chennai
FX The Authors gratefully acknowledges the scholarship received from Tamil
   Nadu Pharmaceutical sciences Welfare Trust, Chennai for carrying out
   research in the area of drug repurposing.
CR Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Bao J, 2016, ANGEW CHEM INT EDIT, V55, P3438, DOI 10.1002/anie.201511361
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Benedict A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00676
   Bhakat S, 2015, RSC ADV, V5, P85938, DOI 10.1039/c5ra14469h
   Botta L, 2018, FRONT BIOSCI-LANDMRK, V23, P997, DOI 10.2741/4630
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Dowall SD, 2015, J GEN VIROL, V96, P3484, DOI 10.1099/jgv.0.000309
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Erice A, 1999, CLIN MICROBIOL REV, V12, P286, DOI 10.1128/CMR.12.2.286
   Gardner TJ, 2015, ANTIVIR RES, V113, P49, DOI 10.1016/j.antiviral.2014.10.011
   Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809
   Guha M., 2015, PHARM J, V294, P7867
   Haffizulla J, 2014, LANCET INFECT DIS, V14, P609, DOI 10.1016/S1473-3099(14)70717-0
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Kapoor A, 2012, ANTIMICROB AGENTS CH, V56, P4891, DOI 10.1128/AAC.00898-12
   Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1510, DOI 10.1016/j.drudis.2014.05.012
   Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Mercorelli B, 2018, TRENDS MICROBIOL, V26, P865, DOI 10.1016/j.tim.2018.04.004
   Mercorelli B, 2016, CELL CHEM BIOL, V23, P340, DOI 10.1016/j.chembiol.2015.12.012
   Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9
   Mukhopadhyay R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005717
   Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a
   Perwitasari O, 2015, ASSAY DRUG DEV TECHN, V13, P638, DOI 10.1089/adt.2015.0003.drrr
   Pillay D, 1998, BRIT MED J, V317, P660, DOI 10.1136/bmj.317.7159.660
   Ponroy N, 2015, J MED VIROL, V87, P141, DOI 10.1002/jmv.23998
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758
   Salata C, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv032
   Savarino A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0178-0
   Sweiti H, 2017, CURR THER RES CLIN E, V84, P10, DOI 10.1016/j.curtheres.2017.01.007
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhao FB, 2015, FUTURE MED CHEM, V7, P1367, DOI 10.4155/fmc.15.76
   2017, CHEST, V151, P1069
NR 38
TC 1
Z9 1
U1 0
U2 1
PU INPHARM ASSOC, PHCOG NET
PI BANGELORE
PA 17, II FLOOR, BUDDHA VIHAR RD, COX TOWN, BANGELORE, 560 005, INDIA
SN 0975-1483
EI 0975-1505
J9 J YOUNG PHARM
JI J. Young Pharm.
PD APR-JUN
PY 2019
VL 11
IS 2
BP 117
EP 121
DI 10.5530/jyp.2019.11.26
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HW6JU
UT WOS:000466796800001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Oliver, GF
   Carr, JM
   Smith, JR
AF Oliver, Genevieve F.
   Carr, Jillian M.
   Smith, Justine R.
TI Emerging infectious uveitis: Chikungunya, dengue, Zika and Ebola: A
   review
SO CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Review
DE infectious disease; uveitis; viral
ID VIRUS-INFECTION; OCULAR MANIFESTATIONS; DISEASE; SURVIVORS; OUTBREAK;
   COMPLICATIONS; PATHOGENESIS; FEVER; MACULOPATHY; PERSPECTIVE
AB Recently recognized forms of uveitis include intraocular inflammations that occur during or following one of several emerging infectious diseases: chikungunya fever, dengue, Zika virus disease and Ebola virus disease. Anterior, intermediate, posterior and pan-uveitis have been described in individuals infected with chikungunya virus. Persons who contract dengue or Zika viruses also may develop different types of uveitis in the course of the infection: maculopathy is a common manifestation of dengue eye disease, and Zika eye disease may cause hypertensive anterior uveitis or mimic a white dot syndrome. Up to one-third of Ebola survivors develop aggressive uveitis, which is frequently associated with vision loss and complicated by cataract. There are no specific anti-viral drugs for these forms of uveitis, and thus treatment is largely supportive. In this article, we summarize the systemic infectious diseases and virology, and describe the clinical presentations, outcomes and management of emerging viral forms of uveitis.
C1 [Oliver, Genevieve F.; Carr, Jillian M.; Smith, Justine R.] Flinders Univ S Australia, Coll Med & Publ Hlth, Eye & Vis Hlth, Adelaide, SA, Australia.
RP Smith, JR (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Coll Med & Publ Hlth, Eye & Vis Hlth, Room 4E 431,Flinders Dr, Bedford Pk, SA 5042, Australia.
EM justine.smith@flinders.edu.au
RI Smith, Justine/Y-9044-2019
OI Smith, Justine/0000-0002-4756-5493; Carr, Jillian/0000-0002-1080-1472
FU Australian Research CouncilAustralian Research Council [FT130101648];
   National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [PGS1150282]
FX Australian Research Council, Grant/Award Number: FT130101648; National
   Health and Medical Research Council, Grant/Award Number: PGS1150282
CR Agarwal A, 2018, INDIAN J OPHTHALMOL, V66, P142, DOI [10.4103/ijo.IJO_572_17, 10.4103/ijo.ijo_572_17]
   Akanda M, 2018, OCUL IMMUNOL INFLAMM, V26, P671, DOI 10.1080/09273948.2017.1351571
   Babu K, 2014, OCUL IMMUNOL INFLAMM, V22, P356, DOI 10.3109/09273948.2013.841482
   Bacsal KE, 2007, ARCH OPHTHALMOL-CHIC, V125, P501, DOI 10.1001/archopht.125.4.501
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   BWAKA MA, 1999, J INFECT DIS S1, V179, pS, DOI DOI 10.1086/514308;
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carr JM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3164375
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chanana B, 2007, EYE, V21, P1020, DOI 10.1038/sj.eye.6702863
   Chancellor JR, 2016, EMERG INFECT DIS, V22, P295, DOI 10.3201/eid2202.151416
   Chee E, 2009, AM J OPHTHALMOL, V148, P910, DOI 10.1016/j.ajo.2009.06.030
   Chia A, 2006, ARCH OPHTHALMOL-CHIC, V124, P1421, DOI 10.1001/archopht.124.10.1421
   Davila PJ, 2017, RETIN CASES BRIEF RE
   desOliveira WK, 2017, LANCET, V390, P861
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Goel Neha, 2016, J Ophthalmic Vis Res, V11, P231, DOI 10.4103/2008-322X.158899
   Goldhardt R, 2016, OCUL IMMUNOL INFLAMM, V24, P610, DOI 10.3109/09273948.2015.1125513
   Groen-Hakan F, 2017, OCUL IMMUNOL INFLAMM, V25, P715, DOI 10.1080/09273948.2017.1353105
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i243
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Hereth-Hebert E, 2017, AM J OPHTHALMOL, V175, P114, DOI 10.1016/j.ajo.2016.12.005
   Jampol LM, 2015, JAMA OPHTHALMOL, V133, P1105, DOI 10.1001/jamaophthalmol.2015.2400
   Kawali A, 2018, OCUL IMMUNOL INFLAMM
   KIBADI K, 1999, J INFECT DIS S1, V179, pS1
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lai TYY, 2007, BRIT J OPHTHALMOL, V91, P1084, DOI 10.1136/bjo.2006.104240
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Levy Yves, 2018, Lancet, V392, P787, DOI 10.1016/S0140-6736(18)31710-0
   Lin J, 2018, OCUL IMMUNOL INFLAMM, V26, P680, DOI 10.1080/09273948.2016.1263340
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2
   Merle H, 2017, JAMA OPHTHALMOL, V135, P284, DOI 10.1001/jamaophthalmol.2016.5689
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Ng CWK, 2018, OCUL IMMUNOL INFLAMM, V26, P666, DOI 10.1080/09273948.2016.1254804
   Panday A, 2017, IDCases, V9, P104, DOI 10.1016/j.idcr.2017.06.010
   Pang CE, 2016, OSLI RETINA, V47, P596, DOI 10.3928/23258160-20160601-15
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierre PDP, 2008, ARQ BRAS OFTALMOL, V71, P265, DOI 10.1590/S0004-27492008000200025
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Samai M, 2018, J INFECT DIS, V217, pS6, DOI 10.1093/infdis/jiy020
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shantha JG, 2018, EBIOMEDICINE, V30, P217, DOI 10.1016/j.ebiom.2018.03.020
   Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011
   Shantha JG, 2016, OPHTHALMOLOGY, V123, P2626, DOI 10.1016/j.ophtha.2016.07.013
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Siqueira RC, 2004, OCUL IMMUNOL INFLAMM, V12, P323, DOI 10.1080/092739490500345
   Smith JR, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.12
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Steptoe PJ, 2017, AM J OPHTHALMOL, V181, P180, DOI 10.1016/j.ajo.2017.05.029
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tabbara K, 2012, ANN SAUDI MED, V32, P530, DOI 10.5144/0256-4947.2012.30.4.1105
   Tan JJL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09479-5
   Teoh S. C. B., 2006, Dengue Bulletin, V30, P184
   Teoh SC, 2010, RETINA-J RET VIT DIS, V30, P390, DOI 10.1097/IAE.0b013e3181bd2fc6
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wong CW, 2017, RETIN CASES BRIEF RE
   World Health Organization, 2009, DENG GUID DIAGN TREA, P91
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 84
TC 5
Z9 6
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1442-6404
EI 1442-9071
J9 CLIN EXP OPHTHALMOL
JI Clin. Exp. Ophthalmol.
PD APR
PY 2019
VL 47
IS 3
SI SI
BP 372
EP 380
DI 10.1111/ceo.13450
PG 9
WC Ophthalmology
SC Ophthalmology
GA HW6NW
UT WOS:000466807900007
PM 30474222
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Patel, N
   Anees, M
   Kola, R
   Acuna, J
   de laVega, PR
   Castro, G
   Ruiz, JG
   Rojas, P
AF Patel, Naiya
   Anees, Moneba
   Kola, Reema
   Acuna, Juan
   de la Vega, Pura Rodriguez
   Castro, Grettel
   Ruiz, Juan G.
   Rojas, Patria
TI Association between Knowledge of Zika Transmission and Preventative
   Measures among Latinas of Childbearing Age in Farm-Working Communities
   in South Florida
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Latinas; Zika; knowledge; transmission; prevention
ID VIRUS; PERCEPTIONS; WOMEN
AB Zika infection, an otherwise usually mild disease, is of serious public health concern due to the potential teratogenic effects of the virus. The incidence of Zika infection is difficult to document since it is mostly asymptomatic and detection of those carrying Zika is usually not possible. Currently, there is no vaccine for Zika; therefore, use of personal preventative measures is the only method of avoiding transmission. The aim of this study was to evaluate the association between knowledge of Zika transmission and the use of preventive measures among Latinas of childbearing age who lived in or near farm-working communities in South Florida. A secondary data analysis was performed on a cross-sectional study, sampling 100 Latina women aged 18-50 years. Sixty-nine percent demonstrated a high degree of knowledge of Zika transmission, and 68% were categorized as taking good preventative measures. Women with high knowledge were 5.86 times more likely to take good preventative measures than those with no knowledge (p-value = 0.05). Knowledge was associated with more preventative measures. Therefore, it is essential to further investigate this relationship in order to develop effective public health interventions for this population.
C1 [Patel, Naiya; Anees, Moneba; Kola, Reema; Acuna, Juan; de la Vega, Pura Rodriguez; Castro, Grettel; Ruiz, Juan G.] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
   [Rojas, Patria] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.
RP Acuna, J (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA.; Rojas, P (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.
EM npate086@med.fiu.edu; manee002@med.fiu.edu; rkola004@med.fiu.edu;
   jacuna@fiu.edu; rodrigup@fiu.edu; gcastro@fiu.edu; jruizpel@fiu.edu;
   proja003@fiu.edu
OI , Juan/0000-0003-1376-765X; Acuna, Juan/0000-0002-0212-5558
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIMHD P20MD002288-10]; NIMHD [1 S21
   MD010683-01]
FX This research received no external funding. The parent study (NIMHD
   P20MD002288-10) received NIH funding. The endowment grant number is
   NIMHD 1 S21 MD010683-01.
CR [Anonymous], CAS COUNTS US
   [Anonymous], ZIK AND PREGN
   [Anonymous], 2005, 5 M EM COMM INT HLTH
   Bedford J., 2016, KNOWLEDGE ATTITUDES
   Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   MacDonald PDM, 2018, PEDIATRICS, V141, pS137, DOI 10.1542/peds.2017-2038B
   McDonald JA, 2018, J COMMUN HEALTH, V43, P705, DOI 10.1007/s10900-018-0474-4
   Moise IK, 2018, EMERG INFECT DIS, V24, P1379, DOI 10.3201/eid2407.171650
   Noor R, 2018, J INFECT PUBLIC HEAL, V11, P611, DOI 10.1016/j.jiph.2018.04.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Quintana-Domeque C, 2018, ECON HUM BIOL, V30, P14, DOI 10.1016/j.ehb.2018.04.003
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Winneg KM, 2018, RISK ANAL, V38, P2546, DOI 10.1111/risa.13010
NR 17
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR 1
PY 2019
VL 16
IS 7
AR 1257
DI 10.3390/ijerph16071257
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HU9EF
UT WOS:000465595800170
PM 30970540
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vanwalscappel, B
   Gadea, G
   Despres, P
AF Vanwalscappel, Benedicte
   Gadea, Gilles
   Despres, Philippe
TI A Viperin Mutant Bearing the K358R Substitution Lost its Anti-ZIKA Virus
   Activity
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE innate immunity; ISG; viperin; arbovirus; Zika virus; A549 cells;
   mutational analysis; protein expression
ID INTERFERON-INDUCIBLE PROTEIN; ENCEPHALITIS-VIRUS; REPLICATION; BIOLOGY;
   SUMOYLATION; EMERGENCE; INFECTION; EPIDEMIC; HISTORY
AB Interferon-induced viperin (VP) was identified as playing an important role in the innate immune response against Zika virus (ZIKV). The 361 amino acid long human VP protein comprises of a highly conserved C-terminal region, which has been associated with VP antiviral properties against ZIKV. In the present study, we sought to determine whether the very last C-terminal amino-acid residues of VP might play a role in VP-mediated ZIKV inhibition. To address this issue, a recombinant human viperin (rVP(wt)) was overexpressed by transfection in human epithelial A549 cells. We confirmed that transient overexpression of rVP(wt) prior to ZIKV infection dramatically reduced viral replication in A549 cells. Deletion of the last 17 C-terminal amino acids of VP resulted in a higher expression level of mutant protein compared to wild-type VP. Mutational analysis revealed that residue substitution at positions 356 to 360 with five alanine led to the same phenotype. The charged residues Asp356, Lys358, and Asp360 were then identified to play a role in the weak level of VPwt protein in A549 cells. Mutant VP bearing the D360A substitution partially rescued ZIKV growth in A549 cells. Remarkably, a single Lys-to-Arg substitution at position 358 was sufficient to abrogate VP antiviral activity against ZIKV. In conclusion, our study showed that Asp356, Lys358, and Asp360 may have an influence on biochemical properties of VP. Our major finding was that Lys358 was a key amino-acid in VP antiviral properties against ZIKV.
C1 [Vanwalscappel, Benedicte; Gadea, Gilles; Despres, Philippe] Univ La Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-97491 St Clotilde, Reunion, France.
RP Despres, P (corresponding author), Univ La Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-97491 St Clotilde, Reunion, France.
EM benedicte.vanwalscappel@univ-reunion.fr; gilles.gadea@inserm.fr;
   philippe.despres@univ-reunion.fr
FU POE FEDER 2014-20 of the Conseil General de La Reunion (ZIKAlert
   program) [SYNERGIE: RE00001902]; ZIKAlert program
FX This work was supported by a grant from POE FEDER 2014-20 of the Conseil
   General de La Reunion (ZIKAlert program, No. SYNERGIE: RE00001902). B.V.
   received funding from the ZIKAlert program.
CR Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08
   Doiron K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00151-6
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293
   Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542
   Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200
   Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindqvist R, 2018, DNA CELL BIOL, V37, P725, DOI 10.1089/dna.2018.4328
   Lowrey AJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0183-0
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187
   Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200
   Yang Xiang-Jiao, 2013, F1000Prime Rep, V5, P45, DOI 10.12703/P5-45
NR 34
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2019
VL 20
IS 7
AR 1574
DI 10.3390/ijms20071574
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HU4PM
UT WOS:000465258100005
PM 30934824
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, DR
   Ventura, CV
   Esporcatte, BLB
   Gracitelli, CPB
   Dias, ND
   Ventura, LO
   Belfort, R
   Rolim-de-Moura, C
AF de Oliveira, Daniela R.
   Ventura, Camila V.
   Esporcatte, Bruno L. B.
   Gracitelli, Carolina P. B.
   Dias, Natalia de Carvalho
   Ventura, Liana O.
   Belfort, Rubens, Jr.
   Rolim-de-Moura, Christiane
TI Glaucoma Workup in Congenital Zika Syndrome
SO JOURNAL OF GLAUCOMA
LA English
DT Article
DE congenital glaucoma; Zika virus; ocular manifestations; microcephaly;
   congenital Zika syndrome
ID INTRAOCULAR-PRESSURE; OPHTHALMIC MANIFESTATIONS; SPECTRAL-DOMAIN; VIRUS;
   INFANTS; DISC
AB Purpose: The main aim of this study was to perform a glaucoma workup in infants with congenital Zika syndrome (CZS). Patient and Methods: This cross-sectional study included 188 eyes of 107 children (1.1 +/- 0.3 y; range, 0.3 to 1.8 y) with CZS. The confirmation of the syndrome was possible in 77 of 107 (72.0%) of the enrolled infants based on positive immunoglobulin M antibody capture enzyme-linked immunosorbent assay for Zika virus in the cerebrospinal fluid. All infants underwent a complete ophthalmic examination and bilateral fundus imaging was captured using a wide-angle digital fundus camera (RetCam). Results: Five eyes (2.6%) presented 2 criteria for glaucoma diagnosis: 1 eye (0.5%) presented increased intraocular pressure and increased vertical cup-to-disc ratio (CDR); 3 eyes (1.6%) presented increased horizontal corneal diameter and increased vertical, and 1 eye (0.5%) presented myopia related to increased axial length and increased vertical CDR. When excluding the CDR criterion, there was no case of glaucoma in this sample. A significant correlation was observed between high vertical CDR and small cephalic perimeter at birth (P=0.002) and the presence of clinical macular lesions (P=0.031). Conclusion and Relevance: Although childhood glaucoma was not detected in this sample, increased vertical CDR is present in children with CZS, associated with microcephaly and clinical macular lesions at birth. This finding may lead to a misdiagnosis of glaucoma.
C1 [de Oliveira, Daniela R.; Esporcatte, Bruno L. B.; Gracitelli, Carolina P. B.; Belfort, Rubens, Jr.; Rolim-de-Moura, Christiane] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Botucatu 821 Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
   [Ventura, Camila V.; Dias, Natalia de Carvalho; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Hope Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP de Oliveira, DR (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Botucatu 821 Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
EM dani_raposo@hotmail.com
RI Ventura, Camila V/N-2654-2018; de Moura, Christiane R Rolim/P-2489-2015;
   Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; de Moura, Christiane R
   Rolim/0000-0002-0636-8100; Ventura, Liana Vieira O/0000-0001-6529-6883;
   de Oliveira, Daniela/0000-0002-9951-644X
CR Aboobakar IF, 2016, J NEURO-OPHTHALMOL, V36, P402, DOI 10.1097/WNO.0000000000000436
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Chan WH, 2015, ASIA-PAC J OPHTHALMO, V4, P357, DOI 10.1097/APO.0000000000000138
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Flemmons MS, 2011, J AAPOS, V15, P153, DOI 10.1016/j.jaapos.2010.11.022
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Ghate D, 2016, J NEUROL SCI, V368, P25, DOI 10.1016/j.jns.2016.06.029
   Herrerias BTF, 2011, MEASUREMENT CORNEAL
   Kim J, 2015, EYE, V29, P1167, DOI 10.1038/eye.2015.99
   Koch EC, 2017, KLIN MONBL AUGENHEIL
   Lee KM, 2014, GRAEF ARCH CLIN EXP, V252, P1853, DOI 10.1007/s00417-014-2680-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Olatunji VA, 2016, SAUDI J OPHTHALMOL, V30, P185, DOI 10.1016/j.sjopt.2016.07.001
   PENSIERO S, 1992, J PEDIATR OPHTHALMOL, V29, P79, DOI 10.3928/0191-3913-19920301-05
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   RICHARDS.KT, 1968, INVEST OPHTH VISUAL, V7, P137
   RICHARDSON KT, 1966, AM J OPHTHALMOL, V62, P507, DOI 10.1016/0002-9394(66)91331-6
   SAMPAOLESI R, 1982, ARCH OPHTHALMOL-CHIC, V100, P574
   Shaffer R N, 1969, Trans Am Acad Ophthalmol Otolaryngol, V73, P923
   Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01
   Sihota R, 2006, J PEDIATR OPHTHALMOL, V43, P36
   Tamcelik N, 2014, INDIAN J OPHTHALMOL, V62, P565, DOI 10.4103/0301-4738.126988
   Uva MG, 2011, J AAPOS, V15, P367, DOI 10.1016/j.jaapos.2011.04.004
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weinreb RN, 2013, CHILDHOOD GLAUCOMA, V9
   WHO, 2017, ZIK SIT REP ZIK VIR
   World Health Organization, 2017, EP AL NEUR SYNDR CON
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD APR
PY 2019
VL 28
IS 4
BP 313
EP 317
DI 10.1097/IJG.0000000000001150
PG 5
WC Ophthalmology
SC Ophthalmology
GA HU5PH
UT WOS:000465330300016
PM 30531188
DA 2020-07-08
ER

PT J
AU Araujo, KM
   Bressan, AL
   Abulafia, LA
AF Araujo, K. M.
   Bressan, A. L.
   Abulafia, L. A.
TI Chikungunya, dengue and zika infections exacerbate psoriasis in patients
   under biological therapy
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Meeting Abstract
DE Arbovirus Infections; Biological Therapy; Chikungunya virus; Dengue;
   Precipitating Factors; Psoriasis; Zika Virus
C1 [Araujo, K. M.; Bressan, A. L.; Abulafia, L. A.] Univ Estado Rio De Janeiro, Dermatol, Rio De Janeiro, Brazil.
CR [Anonymous], 2011, J DERMATOL, V38, P1033
   [Anonymous], 2014, J CLIN VIROL, V61, P442
   [Anonymous], 2018, CLIN EXP DERMATOL, V43, P171
NR 3
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD APR
PY 2019
VL 33
SU 3
SI SI
MA P177
BP 79
EP 79
PG 1
WC Dermatology
SC Dermatology
GA HU9GU
UT WOS:000465603500154
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Fang, SY
   Mahesh, M
   Byrareddy, SN
AF Rothan, Hussin A.
   Fang, Shengyun
   Mahesh, Mohan
   Byrareddy, Siddappa N.
TI Zika Virus and the Metabolism of Neuronal Cells
SO MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Zika virus; Cellular metabolism; Neuronal cells; Microcephaly; Brain
   development
ID NEURAL STEM-CELLS; MITOCHONDRIAL ELONGATION; ENERGY-METABOLISM; MTOR
   PATHWAY; GLYCOLYSIS; BRAIN; DIFFERENTIATION; ACTIVATION; REGULATOR;
   BIOLOGY
AB Zika virus (ZIKV) infection is associated with abnormal functions of neuronal cells causing neurological disorders such as microcephaly in the newborns and Guillain-Barre syndrome in the adults. Typically, healthy brain growth is associated with normal neural stem cell proliferation, differentiation, and maturation. This process requires a controlled cellular metabolism that is essential for normal migration, axonal elongation, and dendrite morphogenesis of newly generated neurons. Thus, the remarkable changes in the cellular metabolism during early stages of neuronal stem cell differentiation are crucial for brain development. Recent studies show that ZIKV directly infects neuronal stem cells in the fetus and impairs brain growth. In this review, we highlighted the fact that the activation of P53 and inhibition of the mTOR pathway by ZIKV infection to neuronal stem cells induces early shifting from glycolysis to oxidative phosphorylation (OXPHOS) may induce immature differentiation, apoptosis, and stem cell exhaustion. We hypothesize that ZIKV infection to mature myelin-producing cells and resulting metabolic shift may lead to the development of neurological diseases, such as Guillain-Barre syndrome. Thus, the effects of ZIKV on the cellular metabolism of neuronal cells may lead to the incidence of neurological disorders as observed recently during ZIKV infection.
C1 [Rothan, Hussin A.; Fang, Shengyun] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.
   [Rothan, Hussin A.; Fang, Shengyun] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.
   [Mahesh, Mohan] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
RP Rothan, HA (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Rothan, HA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
EM harothan@som.umaryland.edu; sfang@som.umaryland.edu; mmohan@tulane.edu;
   sid.byrareddy@unmc.edu
FU Nebraska Neuroscience Alliance Endowed Fund;  [1U01GM117175]; 
   [R01AI113883]
FX This work is supported in part 1U01GM117175 to SF and R01AI113883 and
   Nebraska Neuroscience Alliance Endowed Fund Awarded to SNB.
CR Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Barbier V, 2017, VIROLOGY, V500, P149, DOI 10.1016/j.virol.2016.10.022
   Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006
   Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   Diaz-Castro B, 2015, EMBO REP, V16, P1511, DOI 10.15252/embr.201540982
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gascon S, 2016, CELL STEM CELL, V18, P396, DOI 10.1016/j.stem.2015.12.003
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Romine J, 2015, NEUROBIOL AGING, V36, P1716, DOI 10.1016/j.neurobiolaging.2015.01.003
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777
   Steib K, 2014, J NEUROSCI, V34, P6624, DOI 10.1523/JNEUROSCI.4972-13.2014
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Walton NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035264
   Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 53
TC 10
Z9 10
U1 12
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD APR
PY 2019
VL 56
IS 4
BP 2551
EP 2557
DI 10.1007/s12035-018-1263-x
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA HU7XZ
UT WOS:000465498200022
PM 30043260
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Fang, SY
   Mohan, M
   Byrareddy, SN
AF Rothan, Hussin A.
   Fang, Shengyun
   Mohan, Mahesh
   Byrareddy, Siddappa N.
TI Zika Virus and the Metabolism of Neuronal Cells (vol 56, pg 2551, 2019)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Correction
C1 [Rothan, Hussin A.; Fang, Shengyun] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.
   [Rothan, Hussin A.; Fang, Shengyun] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.
   [Mohan, Mahesh] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
RP Rothan, HA (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Rothan, HA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
EM harothan@som.umaryland.edu; sfang@som.umaryland.edu; mmohan@tulane.edu;
   sid.byrareddy@unmc.edu
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U01 GM117175]
CR FOTHAN HA, 2019, MOL NEUROBIOL, V56, P2551, DOI DOI 10.1007/S12035-018-1263-X
NR 1
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD APR
PY 2019
VL 56
IS 4
BP 2558
EP 2558
DI 10.1007/s12035-018-1337-9
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA HU7XZ
UT WOS:000465498200023
PM 30209773
OA Bronze
DA 2020-07-08
ER

PT J
AU Vincetti, P
   Kaptein, SJF
   Costantino, G
   Neyts, J
   Radi, M
AF Vincetti, Paolo
   Kaptein, Suzanne J. F.
   Costantino, Gabriele
   Neyts, Johan
   Radi, Marco
TI Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum
   Antivirals Blocking Dengue/Zika Replication
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Scaffold-morphing; furo[3,4-d]pyrimidin-7(5H)-one; broad-spectrum
   antivirals; dengue; zika
ID DISCOVERY; CHEMISTRY; TARGET
AB We have recently discovered a family of 2,6-diaminopurine derivatives acting as DENV inhibitors by targeting an allosteric pocket on the thumb of the viral NS5 polymerase. Although the following target-based optimization allowed conversion of the hits into broad-spectrum DENY/ZIKV inhibitors, no improvement of the antiviral potency was reached. Herein, we applied a phenotypic scaffold-morphing approach to explore additional biologically relevant chemical space around the original hits by converting the flat purine derivatives into more complex chemotypes characterized by a higher degree of saturation. A new microwave-assisted one-pot three-step protocol was also developed to quickly generate chemotypes 6 and 7. Cell-based phenotypic screening allowed identification of promising antiflaviviral agents belonging to different chemotypes. Compound 9d emerged as the most promising broad-spectrum antiviral, being 6 times more potent than ribavirin (RBV) against DENV and 3 times more potent than 7-deaza-2'-C-methyladenosine (7DMA) against ZIKV with good selectivity indexes (>46 and >41, respectively).
C1 [Vincetti, Paolo; Costantino, Gabriele; Radi, Marco] Univ Parma, Dipartimento Sci Alimenti & Farmaco, Viale Sci 27-A, I-43124 Parma, Italy.
   [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
   [Vincetti, Paolo] Aptuit Verona Srl, Med Res Ctr, Via Fleming 4, I-37135 Verona, Italy.
RP Radi, M (corresponding author), Univ Parma, Dipartimento Sci Alimenti & Farmaco, Viale Sci 27-A, I-43124 Parma, Italy.
EM marco.radi@unipr.it
RI Kaptein, Suzanne JF/O-4714-2019; Neyts, Johan/U-8267-2017; Kaptein,
   Suzanne JF/O-8855-2018; Radi, Marco/P-1457-2017
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts,
   Johan/0000-0002-0033-7514; Kaptein, Suzanne JF/0000-0002-7935-0219;
   Radi, Marco/0000-0002-0874-6697
FU University of Parma
FX This work was supported by the University of Parma (to MR).
CR Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Botta L, 2018, FRONT BIOSCI-LANDMRK, V23, P997, DOI 10.2741/4630
   Britikova N E, 1966, KHIM GETEROTSIKL, V5, P783
   Cantin LD, 2012, BIOORG MED CHEM LETT, V22, P2565, DOI 10.1016/j.bmcl.2012.01.124
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Egieyeh SA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1087-y
   Huang H, 2010, BIOORGAN MED CHEM, V18, P4615, DOI 10.1016/j.bmc.2010.05.032
   Ishikawa M, 2011, J MED CHEM, V54, P1539, DOI 10.1021/jm101356p
   Kaptein SJF, 2018, CHEMMEDCHEM, V13, P1371, DOI 10.1002/cmdc.201800178
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Pretorius S, 2018, DRUG DISCOV TODAY, V23, P1319, DOI 10.1016/j.drudis.2018.01.040
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236
   Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 21
TC 3
Z9 3
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD APR
PY 2019
VL 10
IS 4
SI SI
BP 558
EP 563
DI 10.1021/acsmedchemlett.8b00583
PG 11
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HT7TQ
UT WOS:000464767700029
PM 30996796
OA Green Published
DA 2020-07-08
ER

PT J
AU Araujo, E
   Facio, CL
   Machado-Paula, LA
   de Oliveira, MA
   Martinhago, CD
   Araujo, LP
   Araujo, LFP
AF Araujo Filho, Edilberto
   Facio, Cassio Leao
   Machado-Paula, Ligiane Alves
   de Oliveira, Mariana Angelozzi
   Martinhago, Ciro Dresch
   Araujo, Leonardo Previato
   Araujo, Ligia Fernanda P.
TI Case report of Zika virus during controlled ovarian hyperstimulation:
   results from follicular fluid, cumulus cells and oocytes
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Article
DE Zika virus; in vitro fertilisation; follicular fluid; oocytes; RT-PCR
ID MALE SEXUAL TRANSMISSION
AB We describe a case of a 37-year-old female, indicated for in vitro fertilisation. She developed skin rash on her trunk and limbs, during the treatment. RT-PCR results were positive in her blood and negative in her husband's blood and semen. Oocyte aspiration was performed, retrieving 7 oocytes, follicular fluid, and cumulus cells. RT-PCR results for the follicular fluid and cumulus cells were negative for ZIKV, and positive for only 2 oocytes. This is the first report in the literature analysing ZIKV in the follicular fluid, cumulus cells, and oocytes, and will contribute to the understanding of ZIKV infection and transmission.
C1 [Araujo Filho, Edilberto; Facio, Cassio Leao; Machado-Paula, Ligiane Alves; Araujo, Leonardo Previato; Araujo, Ligia Fernanda P.] Ctr Human Reprod Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
   [de Oliveira, Mariana Angelozzi; Martinhago, Ciro Dresch] Chromosome Genom Med, Sao Paulo, SP, Brazil.
RP Araujo, E (corresponding author), Ctr Human Reprod Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
EM earaujo@terra.com.br
CR [Anonymous], 2016, CDC CONCL ZIK CAUS M
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude (BR), 2016, INF EP 25 SEM EP SE
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 19
TC 4
Z9 4
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD APR-JUN
PY 2019
VL 23
IS 2
BP 172
EP 174
DI 10.5935/1518-0557.20180081
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HU1CB
UT WOS:000465008400017
PM 30614664
OA Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus during controlled ovarian hyperstimulation
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Araujo E, 2019, J BRAS REPROD ASSIST, V23, P172, DOI 10.5935/1518-0557.20180081
   Broughton DE, 2017, FERTIL STERIL, V108, pE35
   Taitson PF, 2017, J BRAS REPROD ASSIST, V21, P293, DOI 10.5935/1518-0557.20170064
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
NR 4
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD APR-JUN
PY 2019
VL 23
IS 2
BP 178
EP 178
DI 10.5935/1518-0557.20190022
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HU1CB
UT WOS:000465008400015
PM 31038293
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Rao, L
   Wang, WB
   Meng, QF
   Tian, MF
   Cai, B
   Wang, YC
   Li, AX
   Zan, MH
   Xiao, F
   Bu, LL
   Li, G
   Li, A
   Liu, YL
   Guo, SS
   Zhao, XZ
   Wang, TH
   Liu, W
   Wu, JG
AF Rao, Lang
   Wang, Wenbiao
   Meng, Qian-Fang
   Tian, Mingfu
   Cai, Bo
   Wang, Yingchong
   Li, Aixin
   Zan, Minghui
   Xiao, Feng
   Bu, Lin-Lin
   Li, Geng
   Li, Andrew
   Liu, Yingle
   Guo, Shi-Shang
   Zhao, Xing-Zhong
   Wang, Tza-Huei
   Liu, Wei
   Wu, Jianguo
TI A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and
   Fetal Microcephaly Development
SO NANO LETTERS
LA English
DT Article
DE Cell membrane-coated nanomaterials; biomimetic nanoparticles; Zika
   virus; fetal microcephaly; host-cell-mimicking nanodecoys
ID CELL MEMBRANE; NANOPARTICLES; DELIVERY; PROTECTION
AB Zika virus (ZIKV) has emerged as a global health threat due to its unexpected causal link to devastating neurological disorders such as fetal microcephaly; however, to date, no approved vaccine or specific treatment is available for ZIKV infection. Here we develop a biomimetic nanodecoy (ND) that can trap ZIKV, divert ZIKV away from its intended targets, and inhibit ZIKV infection. The ND, which is composed of a gelatin nanoparticle core camouflaged by mosquito medium host cell membranes, effectively adsorbs ZIKV and inhibits ZIKV replication in ZIKV-susceptible cells. Using a mouse model, we demonstrate that NDs significantly attenuate the ZIKV-induced inflammatory responses and degenerative changes and thus improve the survival rate of ZIKV-challenged mice. Moreover, by trapping ZIKV, NDs successfully prevent ZIKV from passing through physiologic barriers into the fetal brain and thereby mitigate ZIKV-induced fetal microcephaly in pregnant mice. We anticipate that this study will provide new insights into the development of safe and effective protection against ZIKV and various other viruses that threaten public health.
C1 [Rao, Lang; Wang, Wenbiao; Tian, Mingfu; Wang, Yingchong; Li, Aixin; Xiao, Feng; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
   [Rao, Lang; Meng, Qian-Fang; Cai, Bo; Zan, Minghui; Bu, Lin-Lin; Guo, Shi-Shang; Zhao, Xing-Zhong; Liu, Wei] Wuhan Univ, Sch Phys & Technol, Minist Educ, Key Lab Artificial Micro & Nanostruct, Wuhan 430072, Hubei, Peoples R China.
   [Wang, Wenbiao; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou 510632, Guangdong, Peoples R China.
   [Li, Geng] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Li, Andrew; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.
RP Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Liu, W (corresponding author), Wuhan Univ, Sch Phys & Technol, Minist Educ, Key Lab Artificial Micro & Nanostruct, Wuhan 430072, Hubei, Peoples R China.; Wu, JG (corresponding author), Jinan Univ, Inst Med Microbiol, Guangzhou 510632, Guangdong, Peoples R China.
EM wliu@whu.edu.cn; jwu@whu.edu.cn
RI Guo, Shi-shang/C-2098-2009; Cai, Bo/Y-8085-2019; Bu,
   Lin-Lin/AAK-8357-2020; Li, Aixin/AAO-7926-2020; Rao, Lang/H-4666-2017
OI Guo, Shi-shang/0000-0001-7210-4704; Li, Aixin/0000-0002-3158-0170; Rao,
   Lang/0000-0001-5010-0729
FU National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103005]; National Key RD Program [2016YFC1000700]; National Key
   R&D Program for Major Research Instruments [81527801]; National Natural
   Science Foundation for Outstanding Youth Foundation [61722405];
   Postdoctoral Science Foundation of ChinaChina Postdoctoral Science
   Foundation [2018T110923]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31200134, 31230 005,
   31270206, 61474084, 81471942, 81730061]
FX This work was supported by National Mega Project on Major Infectious
   Disease Prevention (Grant No. 2017ZX10103005), National Key R&D Program
   (Grant No. 2016YFC1000700), National Key R&D Program for Major Research
   Instruments (Grant No. 81527801), National Natural Science Foundation
   for Outstanding Youth Foundation (Grant No. 61722405), Postdoctoral
   Science Foundation of China (Grant No. 2018T110923), and National
   Natural Science Foundation of China (Grant Nos. 31200134, 31230 005,
   31270206, 61474084, 81471942, and 81730061).
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fang RH, 2018, ADV MATER, V30, DOI 10.1002/adma.201706759
   Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guimaraes PPG, 2018, ACS NANO, V12, P912, DOI 10.1021/acsnano.7b05876
   Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li JC, 2018, ACS NANO, V12, P8520, DOI 10.1021/acsnano.8b04066
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molinaro R, 2016, NAT MATER, V15, P1037, DOI 10.1038/NMAT4644
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Rao L, 2017, ACS NANO, V11, P3496, DOI 10.1021/acsnano.7b00133
   Rao L, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604774
   Rao L, 2016, ADV MATER, V28, P3460, DOI 10.1002/adma.201506086
   Rao L, 2015, SMALL, V11, P6225, DOI 10.1002/smll.201502388
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yu GT, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801389
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhang PF, 2015, P NATL ACAD SCI USA, V112, pE6129, DOI 10.1073/pnas.1505799112
NR 40
TC 12
Z9 12
U1 25
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD APR
PY 2019
VL 19
IS 4
BP 2215
EP 2222
DI 10.1021/acs.nanolett.8b03913
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA HT7UE
UT WOS:000464769100004
PM 30543300
DA 2020-07-08
ER

PT J
AU Ohlund, P
   Lunden, H
   Blomstrom, AL
AF Ohlund, Pontus
   Lunden, Hanna
   Blomstrom, Anne-Lie
TI Insect-specific virus evolution and potential effects on vector
   competence
SO VIRUS GENES
LA English
DT Review
DE Insect-specific virus; Arbovirus; Vector competence; Evolution
ID WEST-NILE-VIRUS; FUSING AGENT VIRUS; CULEX FLAVIVIRUS; AEDES-ALBOPICTUS;
   HOST-RANGE; SUPERINFECTION EXCLUSION; EILAT VIRUS; ZIKA VIRUS;
   TRANSMISSION DYNAMICS; NHUMIRIM VIRUS
AB The advancement in high-throughput sequencing technology and bioinformatics tools has spurred a new age of viral discovery. Arthropods is the largest group of animals and has shown to be a major reservoir of different viruses, including a group known as insect-specific viruses (ISVs). The majority of known ISVs have been isolated from mosquitoes and shown to belong to viral families associated with animal arbovirus pathogens, such as Flaviviridae, Togaviridae and Phenuiviridae. These insect-specific viruses have a strict tropism and are unable to replicate in vertebrate cells, these properties are interesting for many reasons. One is that these viruses could potentially be utilised as biocontrol agents using a similar strategy as for Wolbachia. Mosquitoes infected with the viral agent could have inferior vectorial capacity of arboviruses resulting in a decrease of circulating arboviruses of public health importance. Moreover, insect-specific viruses are thought to be ancestral to arboviruses and could be used to study the evolution of the switch from single-host to dual-host. In this review, we discuss new discoveries and hypothesis in the field of arboviruses and insect-specific viruses.
C1 [Ohlund, Pontus; Lunden, Hanna; Blomstrom, Anne-Lie] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Virol Sect, Box 7028, S-75007 Uppsala, Sweden.
RP Blomstrom, AL (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Virol Sect, Box 7028, S-75007 Uppsala, Sweden.
EM anne-lie.blomstrom@slu.se
OI Blomstrom, Anne-Lie/0000-0003-4455-311X
FU Swedish University of Agricultural Sciences (SLU); Swedish Research
   Council VRSwedish Research Council [2016-01251]
FX This work has been supported by the Swedish University of Agricultural
   Sciences (SLU) vice chancellor career support as well as by the Swedish
   Research Council VR (2016-01251).
CR Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1
   Contreras MA, 2017, AM J TROP MED HYG, V96, P100, DOI 10.4269/ajtmh.16-0403
   Auguste AJ, 2015, J VIROL, V89, P676, DOI 10.1128/JVI.02264-14
   Auguste AJ, 2014, J GEN VIROL, V95, P481, DOI 10.1099/vir.0.058412-0
   Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14
   BEATY BJ, 1983, VIROLOGY, V127, P83, DOI 10.1016/0042-6822(83)90373-2
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Borucki MK, 1999, J GEN VIROL, V80, P3173, DOI 10.1099/0022-1317-80-12-3173
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Domingo E, 2008, ORIGIN EVOLUTION VIR, P351
   Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796
   Dudas G, 2015, ELIFE, V4, DOI 10.7554/eLife.06837
   Erasmus JH, 2018, J VIROL, V92, DOI 10.1128/JVI.01274-17
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goenaga S, 2014, J MED ENTOMOL, V51, P900, DOI 10.1603/ME13172
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Halbach R, 2017, CURR OPIN INSECT SCI, V22, P16, DOI 10.1016/j.cois.2017.05.004
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hermanns K, 2017, J GEN VIROL, V98, P43, DOI 10.1099/jgv.0.000694
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   HSU SH, 1970, J MED ENTOMOL, V7, P703, DOI 10.1093/jmedent/7.6.703
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268
   JUNGLEN S, 2017, HOST, V2, DOI DOI 10.1128/MSPHERE.00375-16
   Junglen S, 2016, CURR OPIN INSECT SCI, V16, P81, DOI 10.1016/j.cois.2016.05.017
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Kuwata R, 2012, IN VITRO CELL DEV-AN, V48, P369, DOI 10.1007/s11626-012-9520-1
   Kyaw AK, 2018, VIRUS RES, V247, P120, DOI 10.1016/j.virusres.2018.01.007
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Marklewitz M, 2013, J VIROL, V87, P12850, DOI 10.1128/JVI.01862-13
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Plyusnin A, 2014, VIRUS RES, V187, P22, DOI 10.1016/j.virusres.2014.01.008
   Qin XC, 2014, P NATL ACAD SCI USA, V111, P6744, DOI 10.1073/pnas.1324194111
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Romoser WS, 2004, J MED ENTOMOL, V41, P467, DOI 10.1603/0022-2585-41.3.467
   ROZEBOOM LE, 1969, J MED ENTOMOL, V6, P407, DOI 10.1093/jmedent/6.4.407
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4
   Terenius O, 2008, CELL HOST MICROBE, V4, P417, DOI 10.1016/j.chom.2008.09.002
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Tokarz R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-26
   Tree MO, 2016, VIROLOGY, V497, P81, DOI 10.1016/j.virol.2016.07.005
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Walton WE, 2007, J AM MOSQUITO CONTR, V23, P184, DOI 10.2987/8756-971X(2007)23[184:LFIG]2.0.CO;2
   Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P175, DOI 10.1016/j.virol.2018.06.007
   WHO, 2012, WHO REPORT, P43
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   ZEBOVITZ E, 1968, J VIROL, V2, P1283, DOI 10.1128/JVI.2.11.1283-1289.1968
NR 109
TC 16
Z9 16
U1 2
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD APR
PY 2019
VL 55
IS 2
BP 127
EP 137
DI 10.1007/s11262-018-01629-9
PG 11
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA HT9RM
UT WOS:000464910200002
PM 30632016
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Duggal, NK
   McDonald, EM
   Weger-Lucarelli, J
   Hawks, SA
   Ritter, JM
   Romo, H
   Ebel, GD
   Brault, AC
AF Duggal, Nisha K.
   McDonald, Erin M.
   Weger-Lucarelli, James
   Hawks, Seth A.
   Ritter, Jana M.
   Romo, Hannah
   Ebel, Gregory D.
   Brault, Aaron C.
TI Mutations present in a low-passage Zika virus isolate result in
   attenuated pathogenesis in mice
SO VIROLOGY
LA English
DT Article
DE Zika virus; Flavivirus; Mouse model; Viral pathogenesis
ID BINDING VARIANTS; HEPARAN-SULFATE; DENGUE-VIRUS; ENCEPHALITIS;
   TRANSMISSION; ADAPTATION; CELLS; MODEL
AB Zika virus (ZIKV) infection can result in neurological disorders including Congenital Zika Syndrome in infants exposed to the virus in utero. Pregnant women can be infected by mosquito bite as well as by sexual transmission from infected men. Herein, the variants of ZIKV within the male reproductive tract and ejaculates were assessed in inoculated mice. We identified two non-synonymous variants at positions E-V330L and NS1-W98G. These variants were also present in the passage three PRVABC59 isolate and infectious clone relative to the patient serum PRVABC59 sequence. In subsequent studies, ZIKV E-330L was less pathogenic in mice than ZIKV E-330V as evident by increased average survival times. In Vero cells, ZIKV E-330L/NS1-98G outcompeted ZIKV E-330V/NS1-98W within 3 passages. These results suggest that the E-330L/NS1-98G variants are attenuating in mice and were enriched during cell culture passaging. Cell culture propagation of ZIKV could significantly affect animal model development and vaccine efficacy studies.
C1 [Duggal, Nisha K.; Weger-Lucarelli, James; Hawks, Seth A.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
   [Duggal, Nisha K.; McDonald, Erin M.; Romo, Hannah; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Weger-Lucarelli, James; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
RP Duggal, NK (corresponding author), 1981 Kraft Dr, Blacksburg, VA 24061 USA.; Brault, AC (corresponding author), 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM nduggal@vt.edu; abrault@cdc.gov
OI Brault, Aaron/0000-0001-5801-3021
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI067380]
FX This work was supported in part by NIH grant AI067380 (G.D.E.). We thank
   DVBD staff members Jason Velez for cell culture support and Sean Masters
   for his excellent contributions to animal husbandry and animal care
   needs throughout this study. The findings and conclusions of this report
   are those of the authors and do not necessarily represent the official
   position of the Centers for Disease Control and Prevention or the U.S.
   Agency for International Development.
CR Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2008, J VIROL
   Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Wang EY, 2003, J VIROL, V77, P1204, DOI 10.1128/JVI.77.2.1204-1210.2003
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
NR 27
TC 9
Z9 9
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD APR
PY 2019
VL 530
BP 19
EP 26
DI 10.1016/j.virol.2019.02.004
PG 8
WC Virology
SC Virology
GA HT7UR
UT WOS:000464770400003
PM 30763872
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, EM
   Titus, SA
   Xu, M
   Tang, HL
   Zheng, W
AF Lee, Emily M.
   Titus, Steven A.
   Xu, Miao
   Tang, Hengli
   Zheng, Wei
TI High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral
   Drugs
SO ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
LA English
DT Article
DE Zika virus; viral titer assay; compound screening; antiviral; high
   throughput; focus-forming unit
ID VIRUS-INFECTION; INHIBITORS
AB Zika virus has recently emerged as a worldwide pathogen and public health burden due to its rapid spread and identification as a causative agent for multiple neurological defects, including congenital microcephaly. While there has been a flurry of recent research to address this emerging pathogen, there are currently no approved drug treatments for ZIKV infection. The gold standard for testing antiviral activity is to quantify infectious virion production. However, current infectious viral production assays, such as the plaque-forming or focus-forming unit assay, are tedious and labor intensive with a low-screening throughput. To facilitate drug development, we developed a Zika viral titration assay using an automated imaging system and an image analysis algorithm for viral colony quantification. This assay retained the principle of the classical virus titer assay, while improving workflow and offering higher screening throughput. In addition, this assay can be broadly adapted to quantification of other viruses.
C1 [Lee, Emily M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.
   [Lee, Emily M.; Titus, Steven A.; Xu, Miao; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20850 USA.
RP Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.; Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20850 USA.
EM tang@bio.fsu.edu; wzheng@mail.nih.gov
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI119530, U19 AI131130]
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   FIELDS BN, FIELDS VIROLOGY
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670, DOI 10.3181/00379727-132-34285
   Simeonov A., 2015, ASSAY GUIDANCE MANUA
   WHO, 2017, ZIK SIT REP
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 17
TC 2
Z9 2
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-658X
EI 1557-8127
J9 ASSAY DRUG DEV TECHN
JI ASSAY DRUG DEV. TECHNOL.
PD APR 1
PY 2019
VL 17
IS 3
BP 128
EP 139
DI 10.1089/adt.2018.881
PG 12
WC Biochemical Research Methods; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA HS4DG
UT WOS:000463811500004
PM 30958701
OA Green Published
DA 2020-07-08
ER

PT J
AU Schwab, SR
   Stone, CM
   Fonseca, DM
   Fefferman, NH
AF Schwab, Samantha R.
   Stone, Chris M.
   Fonseca, Dina M.
   Fefferman, Nina H.
TI (Meta)population dynamics determine effective spatial distributions of
   mosquito-borne disease control
SO ECOLOGICAL APPLICATIONS
LA English
DT Article
DE dengue fever; epidemiological modeling; metapopulation dynamics;
   mosquito control; population dynamics; spatial epidemiology;
   vector-borne disease control; Zika virus
ID AEDES-ALBOPICTUS DIPTERA; ASIAN TIGER MOSQUITO; WEST-NILE-VIRUS;
   INVASIVE MOSQUITOS; CULICIDAE; AEGYPTI; EPIDEMIOLOGY; OVIPOSITION;
   COMPETITION; LARVAL
AB Recent epidemics of mosquito-borne dengue and Zika viruses demonstrate the urgent need for effective measures to control these diseases. The best method currently available to prevent or reduce the size of outbreaks is to reduce the abundance of their mosquito vectors, but there is little consensus on which mechanisms of control are most effective, or when and where they should be implemented. Although the optimal methods are likely context dependent, broadly applicable strategies for mosquito control, such as how to distribute limited resources across a landscape in times of high epidemic risk, can mitigate (re)emerging outbreaks. We used mathematical simulations to examine how the spatial distribution of larval mosquito control affects the size of disease outbreaks, and how mosquito metapopulation dynamics and demography might impact the efficacy of different spatial distributions of control. We found that the birth rate and mechanism of density-dependent regulation of mosquito populations affected the average outbreak size across all control distributions. These factors also determined whether control distributions favoring the interior or the edges of the landscape most effectively reduced human infections. Thus, understanding local mosquito population regulation and dispersion can lead to more effective control strategies.
C1 [Schwab, Samantha R.] Rutgers State Univ, Sch Environm & Biol Sci, Grad Program Ecol & Evolut, Environm & Nat Resource Sci Bldg,Room 150, New Brunswick, NJ 08901 USA.
   [Stone, Chris M.] Univ Illinois, Ilinois Nat Hist Survey, 1816 South Oak St,MC 652, Champaign, IL 61820 USA.
   [Stone, Chris M.; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, 447 Hesler Biol Bldg, Knoxvillle, TN 37996 USA.
   [Fonseca, Dina M.] Rutgers State Univ, Sch Environm & Biol Sci, Ctr Vector Biol, 178-180 Jones Ave, New Brunswick, NJ 08901 USA.
RP Schwab, SR (corresponding author), Rutgers State Univ, Sch Environm & Biol Sci, Grad Program Ecol & Evolut, Environm & Nat Resource Sci Bldg,Room 150, New Brunswick, NJ 08901 USA.
EM samantharoseschwab@gmail.com
RI Fonseca, Dina/B-9951-2011
OI Fonseca, Dina/0000-0003-4726-7100; Schwab, Samantha/0000-0002-4338-4943
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1640951]
FX We would like to thank Krisztian Magori and an anonymous reviewer for
   their helpful comments and suggestions that have greatly strengthened
   the manuscript. This material is based upon work supported by the
   National Science Foundation under grant no. DEB-1640951.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   AGUDELOSILVA F, 1984, AM J TROP MED HYG, V33, P1267, DOI 10.4269/ajtmh.1984.33.1267
   ANDERSON R M, 1991
   Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8
   Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   COOKE D, 1976, BIOMETRICS, V32, P435, DOI 10.2307/2529512
   Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Fonseca DM, 2015, J MED ENTOMOL, V52, P705, DOI 10.1093/jme/tjv060
   Fox JW, 2017, NAT ECOL EVOL, V1, P1271, DOI 10.1038/s41559-017-0271-y
   Godfray HCJ, 2013, J ANIM ECOL, V82, P15, DOI 10.1111/1365-2656.12003
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Hendrichs J., 2007, P3
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2
   Kiflawi M, 2003, ECOL ENTOMOL, V28, P168, DOI 10.1046/j.1365-2311.2003.00505.x
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734
   Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301
   LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237
   Lutambi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097065
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Onyabe DY, 1997, CAN ENTOMOL, V129, P1173, DOI 10.4039/Ent1291173-6
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schwab S., 2018, MATLAB CODE FILES ME, DOI [10.17632/58b4fphwk9.2, DOI 10.17632/58B4FPHWK9.2]
   Schwab SR, 2018, EPIDEMICS-NETH, V23, P55, DOI 10.1016/j.epidem.2017.12.004
   Skovmand O, 2009, J MED ENTOMOL, V46, P67, DOI 10.1603/033.046.0109
   Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749
   Smith DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071247
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Stone CM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0336
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006
   Unlu I, 2016, PEST MANAG SCI, V72, P1427, DOI 10.1002/ps.4174
   Walsh RK, 2011, J VECTOR ECOL, V36, P300, DOI 10.1111/j.1948-7134.2011.00170.x
   Wasserberg G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092658
   White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153
   White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x
   Yakob Laith, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.45deb8e03a438c4d088afb4fafae8747
NR 56
TC 1
Z9 1
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1051-0761
EI 1939-5582
J9 ECOL APPL
JI Ecol. Appl.
PD APR
PY 2019
VL 29
IS 3
AR UNSP e01856
DI 10.1002/eap.1856
PG 12
WC Ecology; Environmental Sciences
SC Environmental Sciences & Ecology
GA HS6BG
UT WOS:000463954800005
PM 30681219
OA Bronze
DA 2020-07-08
ER

PT J
AU Jones, DNM
   Wang, J
   Murphy, EJ
AF Jones, David N. M.
   Wang, Jing
   Murphy, Emma J.
TI Complete NMR chemical shift assignments of odorant binding protein 22
   from the yellow fever mosquito, Aedes aegypti, bound to arachidonic acid
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Aedes aegypti; Odorant binding protein 22; Arachidonic acid; NMR
   resonance assignments
ID SIDE-CHAIN RESONANCES; PHEROMONE-BINDING; SEQUENTIAL ASSIGNMENT;
   ANTHERAEA-POLYPHEMUS; BACKBONE AMIDE; GYPSY-MOTH; SPECTROSCOPY;
   RECONSTRUCTION; SENSITIVITY; ACTIVATION
AB Aedes aegypti mosquitoes are the vector for transmission of Dengue, Zika and chikungunya viruses. These mosquitos feed exclusively on human hosts for a blood meal. Previous studies have established that Dengue virus infection of the mosquito results in increased expression of the odorant binding proteins 22 and 10 within the mosquito salivary gland and silencing of these genes dramatically reduces blood-feeding behaviors. Odorant binding proteins are implicated in modulating the chemosensory perception of external stimuli that regulate behaviors such as host location, feeding and reproduction. However, the role that AeOBP22 plays in the salivary gland is unclear. Here, as a first step to a more complete understanding of the function of AeOBP22, we present the complete backbone and side chain chemical shift assignments of the protein in the complex it forms with arachidonic acid. These assignments reveal that the protein consists of seven -helices, and that the arachidonic acid is bound tightly to the protein. Comparison with the chemical shift assignments of the apo-form of the protein reveals that binding of the fatty acid is accompanied by a large conformational change in the C-terminal helix, which appears disordered in the absence of lipid. This NMR data provides the basis for determining the structure of AeOBP22 and understanding the nature of the conformational changes that occur upon ligand binding. This information will provide a path to discover novel compounds that can interfere with AeOBP22 function and impact blood feeding by this mosquito.
C1 [Jones, David N. M.; Wang, Jing; Murphy, Emma J.] Univ Colorado, Dept Pharmacol, Sch Med, 12801 East 17th Ave, Aurora, CO 80045 USA.
   [Jones, David N. M.] Univ Colorado, Program Struct Biol & Biochem, Sch Med, 12801 East 17th Ave, Aurora, CO 80045 USA.
RP Jones, DNM (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, 12801 East 17th Ave, Aurora, CO 80045 USA.; Jones, DNM (corresponding author), Univ Colorado, Program Struct Biol & Biochem, Sch Med, 12801 East 17th Ave, Aurora, CO 80045 USA.
EM david.jones@ucdenver.edu
OI Murphy, Emma/0000-0003-4551-8068
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [RO1 AI121253]; University of Colorado
   Cancer Center Support Grant [NIH 5P30-CA046934]
FX This work was supported by NIH/NIAID Grant RO1 AI121253 to DNMJ. The
   operation of the NMR facilities at CU School of Medicine is supported in
   part by the University of Colorado Cancer Center Support Grant (NIH
   5P30-CA046934).
CR BARNA JCJ, 1987, J MAGN RESON, V73, P69, DOI 10.1016/0022-2364(87)90225-3
   Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8
   Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200
   Coudevylle N, 2011, BIOCHEMISTRY-US, V50, P9192, DOI 10.1021/bi201115q
   Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003
   GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S
   GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402
   Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479
   Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998
   Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w
   IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960
   Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298
   Larter NK, 2016, ELIFE, V5, DOI 10.7554/eLife.20242
   Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046
   Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064
   LOHR F, 1995, J BIOMOL NMR, V6, P189, DOI 10.1007/BF00211783
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032
   Murphy EJ, 2013, J BIOL CHEM, V288, P4475, DOI 10.1074/jbc.M112.436386
   Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x
   Pompeia C, 2003, CELL BIOCHEM FUNCT, V21, P97, DOI 10.1002/cbf.1012
   Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012
   Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5
   Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8
   SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x
   Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Smallegange RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063602
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x
   VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R
   Verhulst NO, 2013, INFECT GENET EVOL, V18, P87, DOI 10.1016/j.meegid.2013.05.009
   Vogeli B, 2013, MOL PHYS, V111, P437, DOI 10.1080/00268976.2012.728257
   VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950
   Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031
   YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099
   Yang G, 2011, PROTEIN EXPRES PURIF, V75, P165, DOI 10.1016/j.pep.2010.09.004
   ZIEGELBERGER G, 1995, EUR J BIOCHEM, V232, P706, DOI 10.1111/j.1432-1033.1995.tb20864.x
   Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q
NR 51
TC 0
Z9 0
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD APR
PY 2019
VL 13
IS 1
BP 187
EP 193
DI 10.1007/s12104-019-09875-0
PG 7
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA HS1VE
UT WOS:000463649500036
PM 30684234
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, AL
   Brandi, IV
   Sarmento, M
   Brites, C
   Lucena, R
AF Carvalho, A. L.
   Brandi, I. V.
   Sarmento, M.
   Brites, C.
   Lucena, R.
TI Difficulties with laboratory confirmation of congenital Zika virus
   infection in a tertiary hospital in Northeastern Brazil
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Carvalho, A. L.; Brandi, I. V.; Sarmento, M.] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, C.; Lucena, R.] Univ Fed Bahia, Salvador, BA, Brazil.
RP Carvalho, AL (corresponding author), SARAH Salvador Hosp, Ave Tancredo Neves,2782 Caminho Arvores, BR-41820900 Salvador, BA, Brazil.
EM alessandracarvalhoped@gmail.com
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rodo C, 2017, CLIN MICROBIOL INFEC, V24, P2017
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 6
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2019
VL 25
IS 4
BP 524
EP 525
DI 10.1016/j.cmi.2018.12.021
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HR9LL
UT WOS:000463481300031
PM 30583057
OA Bronze
DA 2020-07-08
ER

PT J
AU Souza, NCSE
   Felix, AC
   de Paula, AV
   Levi, JE
   Pannuti, CS
   Romano, CM
AF Santiago e Souza, Nathalia Caroline
   Felix, Alvina Clara
   de Paula, Anderson Vicente
   Levi, Jose Eduardo
   Pannuti, Claudio Sergio
   Romano, Camila Malta
TI Evaluation of serological cross-reactivity between yellow fever and
   other flaviviruses
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Serological tests; Yellow fever; Dengue; Zika; Cross-reactivity
AB Objectives: This study was performed to determine whether neutralizing antibodies against yellow fever virus (YFV) generated by YFV vaccine could interfere in the specificity of dengue virus (DENV) and Zika virus (ZIKV) IgG ELISA tests.
   Methods: Seventy-nine pairs of serum samples (pre- and post-vaccination), collected during the years 1997-1998 from children with no history of yellow fever disease who had been vaccinated against YFV, were tested. The seroconversion post-vaccination was evaluated through plaque reduction neutralization test (PRNT), and four different commercial ELISA kits were used for the detection of DENV and ZIKV IgG antibodies.
   Results: A cross-reactivity rate of 3.9% with DENV IgG antibodies was found only with the Dengue Virus IgG Dx Select kit (Focus Diagnostics).
   Conclusions: As several countries have local transmission of multiple arboviruses, the absence of cross-reactivity or minimum cross-reactivity of YFV neutralizing antibodies with DENV and ZIKV antigens is a relevant finding, since the interpretation of sero-epidemiological investigations would be seriously impacted in many regions where YFV vaccination is mandatory. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Santiago e Souza, Nathalia Caroline; Felix, Alvina Clara; de Paula, Anderson Vicente; Levi, Jose Eduardo; Pannuti, Claudio Sergio; Romano, Camila Malta] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [Santiago e Souza, Nathalia Caroline] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP LIM52, Sao Paulo, Brazil.
RP Romano, CM (corresponding author), Inst Med Trop SP, Ave Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM cmromano@usp.br
RI Romano, Camila M/C-8185-2013
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/16069-8,
   2012/15381-7]; Programa de fomento as atividades de liderancas
   cientificas dos LIMs do Hospital das Clinicas da FMUSP (PROFAP-LIM /
   HCFMUSP) [02/2019]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) grant numbers 2016/16069-8 and 2012/15381-7; and by
   the Programa de fomento as atividades de liderancas cientificas dos LIMs
   do Hospital das Clinicas da FMUSP (PROFAP-LIM / HCFMUSP) number 02/2019.
CR Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Saude MD, 2018, MON PER SAZ FEBR AM
   Saude MD, 2018, OR QUANT VAC FEBR AM
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
NR 4
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2019
VL 81
BP 4
EP 5
DI 10.1016/j.ijid.2019.01.023
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA HS5DB
UT WOS:000463889700002
PM 30660799
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mello, S
   Tan, ASL
   Sanders-Jackson, A
   Bigman, CA
AF Mello, Susan
   Tan, Andy S. L.
   Sanders-Jackson, Ashley
   Bigman, Cabral A.
TI Gender Stereotypes and Preconception Health: Men's and Women's
   Expectations of Responsibility and Intentions to Engage in Preventive
   Behaviors
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Preconception health; Prescriptive gender stereotypes; Gender roles;
   Norms; Health education and promotion; Smoking; Communication;
   Responsibility
ID UNITED-STATES; FATHERS ROLE; CARE; SMOKING; STRATEGIES; PREGNANCY;
   AWARENESS; ISSUES
AB Introduction As mounting evidence underscores the importance of both men and women taking steps before pregnancy to improve reproductive outcomes, public health priorities are shifting toward a more gender-inclusive program of promoting preconception health (PCH). This study examined whether prescriptive gender stereotypes, defined as men's and women's beliefs about PCH behavioral norms each gender should uphold, were positively associated with intentions to engage in behaviors to protect a future child's health. Methods Data came from a June 2017 online survey of 609 U.S. men and women ages 18-44. Two six-item scales of prescriptive same- and opposite-gender stereotypes were used to predict a six-item scale of intentions to engage in six recommended PCH behaviors (i.e., avoiding smoking, secondhand smoke, drinking, exposure to bisphenol A and pesticides, and preventing Zika infection). Multiple linear regression models also adjusted for demographic, socioeconomic, and health characteristics. Results Among both male and female respondents, PCH prescriptive gender stereotypes for men were rated significantly lower than those for women. Adjusting for covariates, stronger prescriptive same-gender stereotypes were associated with increased PCH intentions (men: B=0.496, p<0.001; women: B=0.486, p<0.001). Opposite-gender stereotypes were also positively associated with PCH intentions (men: B=0.205, p<0.001; women: B=0.235, p<0.001). Current every day smoking status (men and women), being uninsured (women only), and having children (women only) were also associated with lower PCH intentions. Conclusion Prescriptive gender stereotypes may play an important, yet slightly different, role in promoting PCH behavior among men and women.
C1 [Mello, Susan] Northeastern Univ, Dept Commun Studies, 350 Huntington Ave, Boston, MA 02115 USA.
   [Tan, Andy S. L.] Dana Farber Canc Inst, Div Populat Sci, Ctr Community Based Res, Boston, MA 02115 USA.
   [Tan, Andy S. L.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.
   [Sanders-Jackson, Ashley] Michigan State Univ, Dept Advertising & Publ Relat, E Lansing, MI 48824 USA.
   [Bigman, Cabral A.] Univ Illinois, Dept Commun, Urbana, IL USA.
RP Mello, S (corresponding author), Northeastern Univ, Dept Commun Studies, 350 Huntington Ave, Boston, MA 02115 USA.
EM s.mello@northeastern.edu; ANDY_TAN@dfci.harvard.edu; sande411@msu.edu;
   cbigman@illinois.edu
OI Bigman, Cabral/0000-0002-4510-7878
CR Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Bonte P, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-5
   Bottorff JL, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0114-2
   Centers for Disease Control and Prevention, 2013, NAT AD TOB SURV NATS
   Centers for Disease Control and Prevention, 2017, PREC HLTH HLTH CAR
   Centers for Disease Control and Prevention (CDC), 2017, BEH RISK FACT SURV S
   Delgado CEF, 2008, MATERN CHILD HLTH J, V12, P774, DOI 10.1007/s10995-007-0300-6
   Delissaint D, 2011, HEALTH EDUC BEHAV, V38, P603, DOI 10.1177/1090198110389709
   Di Renzo GC, 2015, INT J GYNECOL OBSTET, V131, P219, DOI 10.1016/j.ijgo.2015.09.002
   Dohnke B, 2011, ADDICT BEHAV, V36, P286, DOI 10.1016/j.addbeh.2010.11.001
   Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408
   Fenstermaker S, 2002, DOING GENDER DOING D
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fishbein M., 2015, PREDICTING CHANGING
   Frey KA, 2006, MATERN CHILD HLTH J, V10, pS73, DOI 10.1007/s10995-006-0110-2
   Frey KA, 2012, J MENS HEALTH, V9, P25, DOI 10.1016/j.jomh.2011.11.001
   Genesoni L, 2009, BIRTH-ISS PERINAT C, V36, P305, DOI 10.1111/j.1523-536X.2009.00358.x
   Guttman N, 2001, J HEALTH COMMUN, V6, P117, DOI 10.1080/108107301750254466
   Jones MP, 1996, J AM STAT ASSOC, V91, P222, DOI 10.2307/2291399
   Kotelchuck M, 2017, MATERN CHILD HLTH J, V21, P2025, DOI 10.1007/s10995-017-2370-4
   Leavitt Judith Walzer, 2009, MAKE ROOM DADDY JOUR
   Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041
   Levis DM, 2013, AM J HEALTH PROMOT, V27, pS36, DOI 10.4278/ajhp.120113-QUAL-19
   Lewis MA, 2013, AM J HEALTH PROMOT, V27, pS20, DOI 10.4278/ajhp.120127-QUAL-65
   Martin LT, 2007, MATERN CHILD HLTH J, V11, P595, DOI 10.1007/s10995-007-0209-0
   May PA, 2013, DRUG ALCOHOL DEPEN, V133, P502, DOI 10.1016/j.drugalcdep.2013.07.013
   McBride BA, 2005, FAM RELAT, V54, P360, DOI 10.1111/j.1741-3729.2005.00323.x
   McBride N, 2016, AM J PREV MED, V51, P240, DOI 10.1016/j.amepre.2016.02.009
   McQuillan J, 2008, GENDER SOC, V22, P477, DOI 10.1177/0891243208319359
   Mitchell EW, 2013, AM J HEALTH PROMOT, V27, pS1, DOI 10.4278/ajhp/27.3.c1
   Mitchell EW, 2012, MATERN CHILD HLTH J, V16, P31, DOI 10.1007/s10995-010-0663-y
   Mitra M, 2016, MATERN CHILD HLTH J, V20, P507, DOI 10.1007/s10995-015-1848-1
   Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066
   Robbins CL, 2016, AM J PREV MED, V51, P336, DOI 10.1016/j.amepre.2016.02.013
   Sanchez-Lopez MP, 2012, WOMEN HEALTH, V52, P182, DOI 10.1080/03630242.2011.652352
   Sharm R, 2016, EUR UROL, V70, P635, DOI 10.1016/j.eururo.2016.04.010
   Thompson EL, 2017, MATERN CHILD HLTH J, V21, P1147, DOI 10.1007/s10995-016-2213-8
   Toivonen KI, 2017, PREV MED, V96, P1, DOI 10.1016/j.ypmed.2016.11.022
NR 38
TC 1
Z9 1
U1 2
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD APR
PY 2019
VL 23
IS 4
BP 459
EP 469
DI 10.1007/s10995-018-2654-3
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HS2JA
UT WOS:000463685700005
PM 30552600
DA 2020-07-08
ER

PT J
AU Saez-Alvarez, Y
   Arias, A
   del Aguila, C
   Agudo, R
AF Saez-Alvarez, Yanira
   Arias, Armando
   del Aguila, Carmen
   Agudo, Ruben
TI Development of a fluorescence-based method for the rapid determination
   of Zika virus polymerase activity and the screening of antiviral drugs
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; HEPATITIS-C VIRUS; NUCLEOSIDE INHIBITORS;
   ERROR CATASTROPHE; CHAIN-REACTION; CELL-CULTURE; NS5 PROTEIN;
   IDENTIFICATION; RIBAVIRIN; BIOLOGY
AB Zika virus (ZIKV) is an emerging pathogen that has been associated with large numbers of cases of severe neurologic disease, including Guillain-Barre syndrome and microcephaly. Despite its recent establishment as a serious global public health concern there are no licensed therapeutics to control this virus. Accordingly, there is an urgent need to develop methods for the high-throughput screening of antiviral agents. We describe here a fluorescence-based method to monitor the real-time polymerization activity of Zika virus RNA-dependent RNA polymerase (RdRp). By using homopolymeric RNA template molecules, de novo RNA synthesis can be detected with a fluorescent dye, which permits the specific quantification and kinetics of double-strand RNA formation. ZIKV RdRp activity detected using this fluorescence-based assay positively correlated with traditional assays measuring the incorporation of radiolabeled nucleotides. We also validated this method as a suitable assay for the identification of ZIKV inhibitors targeting the viral polymerase using known broad-spectrum inhibitors. The assay was also successfully adapted to detect RNA polymerization activity by different RdRps, illustrated here using purified RdRps from hepatitis C virus and foot-and-mouth disease virus. The potential of fluorescence-based approaches for the enzymatic characterization of viral polymerases, as well as for high-throughput screening of antiviral drugs, are discussed.
C1 [Saez-Alvarez, Yanira; del Aguila, Carmen; Agudo, Ruben] Univ San Pablo CEU, CEU Univ, Fac Farm, Madrid 28668, Spain.
   [Arias, Armando] Tech Univ Denmark, Life Sci & Bioengn Bldg, DK-2800 Lyngby, Denmark.
RP Agudo, R (corresponding author), Univ San Pablo CEU, CEU Univ, Fac Farm, Madrid 28668, Spain.
EM ruben.agudotorres@ceu.es
RI Arias, Armando/E-1393-2016
OI Arias, Armando/0000-0002-4138-4608
FU Ministerio de Economia, Industria y Competitividad [RYC-2015-17280,
   BIO2017-85124-R]; FPI-predoctoral fellowship from Universidad CEU San
   Pablo; Independent Research Fund Denmark (Technology and Production
   Sciences, DFF-FTP) [6111-00104B]
FX We would like to thank to laboratory of Professor Esteban Domingo
   (Centro de Biologia Molecular Severo Ochoa, Madrid) for providing
   plasmids pET-28a3Dpol, pET-28aD338A, Jc1FLAG2(p7-nsGluc2a) and
   Jc1FLAG2(p7-nsGluc2a)/GNN, and Professor Luis Blanco (Centro de Biologia
   Molecular Severo Ochoa, Madrid) for allowing the use of his laboratory
   to perform the polymerization experiments in the presence of
   radiolabeled nucleotides. This work was supported by grants
   RYC-2015-17280 and BIO2017-85124-R from Ministerio de Economia,
   Industria y Competitividad. Y S-A. is the recipient of an
   FPI-predoctoral fellowship from Universidad CEU San Pablo. AA is the
   recipient of a Research project-1 grant from Independent Research Fund
   Denmark (Technology and Production Sciences, DFF-FTP), application
   number 6111-00104B.
CR Agudo R, 2017, NUCLEIC ACIDS RES, V45, P9046, DOI 10.1093/nar/gkx633
   Arias A, 2005, J MOL BIOL, V353, P1021, DOI 10.1016/j.jmb.2005.09.022
   Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08
   Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002
   Bai XH, 2000, TRANSPLANT INT, V13, P146, DOI 10.1007/s001470050306
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BEUTLER E, 1990, BIOTECHNIQUES, V9, P166
   Bonnac LF, 2013, J MED CHEM, V56, P9403, DOI 10.1021/jm400653j
   Calmels C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03038-8
   Campagnola G, 2011, ANTIVIR RES, V91, P241, DOI 10.1016/j.antiviral.2011.06.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Crotty S, 2000, NAT MED, V6, P1375
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   De Clercq E, 2005, CURR OPIN MICROBIOL, V8, P552, DOI 10.1016/j.mib.2005.08.010
   Driscoll MD, 2014, FEBS J, V281, P2042, DOI 10.1111/febs.12760
   Eltahla AA, 2013, J BIOMOL SCREEN, V18, P1027, DOI 10.1177/1087057113489883
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Fay MM, 2017, J MOL BIOL, V429, P2127, DOI 10.1016/j.jmb.2017.05.017
   Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gong Edwin Yunhao, 2013, Methods Mol Biol, V1030, P237, DOI 10.1007/978-1-62703-484-5_19
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553
   Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Izuta S, 1996, J BIOCHEM, V119, P1038
   Julander JG, 2010, ANTIVIR RES, V86, P261, DOI 10.1016/j.antiviral.2010.03.004
   Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200
   Madhvi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04449-3
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005
   Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROSE KM, 1977, NATURE, V267, P178, DOI 10.1038/267178a0
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sambrook J, 2012, MOL CLONING LAB MANU
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06
   STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498
   Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107
   Vo NV, 2003, BIOCHEMISTRY-US, V42, P10462, DOI 10.1021/bi0344681
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 72
TC 1
Z9 2
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 1
PY 2019
VL 9
AR 5397
DI 10.1038/s41598-019-41998-1
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR1CC
UT WOS:000462864700003
PM 30932009
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Malinger, G
AF Malinger, G.
TI The Zika virus epidemic 3 years on: a personal perspective
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Editorial Material
C1 [Malinger, G.] Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, Weitzman St 6, IL-64239 Tel Aviv, Israel.
   [Malinger, G.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
RP Malinger, G (corresponding author), Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, Weitzman St 6, IL-64239 Tel Aviv, Israel.; Malinger, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
EM gmalinger@gmail.com
OI Malinger, Gustavo/0000-0003-0864-206X
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, INT GUID
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320
   Dhimal M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0426-3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ISUOG Outreach Webinar, CONG ZIK VIR SYNDR I
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   World Health Organization, 2011, UNS AB GLOB REG EST
NR 14
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD APR
PY 2019
VL 53
IS 4
BP 436
EP 437
DI 10.1002/uog.20199
PG 2
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA HR4VH
UT WOS:000463145000002
PM 30561172
DA 2020-07-08
ER

PT J
AU Rasmussen, SA
   Chu, V
   Glaser, C
   Petersen, LR
   Moore, CA
   Honein, MA
AF Rasmussen, S. A.
   Chu, V.
   Glaser, C.
   Petersen, L. R.
   Moore, C. A.
   Honein, M. A.
TI ZIKA VIRUS AS A CAUSE OF BIRTH DEFECTS: WERE THE TERATOGENIC EFFECTS OF
   ZIKA VIRUS MISSED FOR DECADES?
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Meeting Abstract
CT 39th Annual David W Smith Workshop on Malformations and Morphogenesis
CY AUG 24-29, 2018
CL Banff, CANADA
C1 [Rasmussen, S. A.; Moore, C. A.; Honein, M. A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Chu, V.; Glaser, C.] Kaiser Permanente, Oakland, CA USA.
   [Petersen, L. R.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2019
VL 179
IS 4
BP 675
EP 675
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA HQ8LS
UT WOS:000462676800032
DA 2020-07-08
ER

EF